PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Castillo, Y; Tachibana, M; Nakatsu, Y; Watanabe, K; Shimizu, T; Watarai, M				Castillo, Yussaira; Tachibana, Masato; Nakatsu, Yukiko; Watanabe, Kenta; Shimizu, Takashi; Watarai, Masahisa			Combination of Zinc and All-Trans Retinoic Acid Promotes Protection against Listeria monocytogenes Infection	PLOS ONE			English	Article							VITAMIN-A; IMMUNE-RESPONSES; SUPPLEMENTATION; NUTRITION; CHILDREN; TRIAL	Zinc (Zn) is the second most abundant transition metal after iron. It plays a vital role in living organisms and affects multiple aspects of the immune system. All-trans retinoic acid (atRA) is an isomeric form of the vitamin A or retinol. It possesses the greatest biological activity of Vitamin A. Vitamin A and related retinoids influence many aspects of immunity. In this study, we demonstrated that treatment with a combination of Zn and atRA contributes to host resistance against infection by Listeria monocytogenes. Pretreatment with Zn and atRA enhanced resistance against L. monocytogenes infection in mice and treatment with both Zn and atRA showed a higher protective effect than treatment with either alone. Supplementation with Zn, atRA or their combination decreased the number of L. monocytogenes present in target organs. In vitro, supplementation increased the bacterial uptake by macrophage cells and reduced the replication of L. monocytogenes. Our results suggest that the combination of Zn and atRA has a great bacteriostatic impact on L. monocytogenes and its infection.	[Castillo, Yussaira; Tachibana, Masato; Nakatsu, Yukiko; Watanabe, Kenta; Shimizu, Takashi; Watarai, Masahisa] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi 7538515, Japan	Yamaguchi University	Watarai, M (corresponding author), Yamaguchi Univ, United Grad Sch Vet Sci, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	watarai@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [26850181]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding: This work was supported by Japan Society for the Promotion of Science Grant Number 26850181 (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaventura P, 2015, AUTOIMMUN REV, V14, P277, DOI 10.1016/j.autrev.2014.11.008; Bottari NB, 2014, MICROB PATHOGENESIS, V74, P15, DOI 10.1016/j.micpath.2014.06.004; CHANDRA RK, 1992, LANCET, V340, P1124, DOI 10.1016/0140-6736(92)93151-C; Christian P, 1998, AM J CLIN NUTR, V68, p435S, DOI 10.1093/ajcn/68.2.435S; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Cossart P, 2014, FEBS LETT, V588, P2437, DOI 10.1016/j.febslet.2014.05.051; Crane JK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-145; Dardenne M, 2002, EUR J CLIN NUTR, V56, pS20, DOI 10.1038/sj.ejcn.1601479; Fischer W. C., 2004, ANNU REV NUTR, V24, P255, DOI DOI 10.1146/ANNUREV.NUTR.23.011702.073054; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Harrison EH, 2012, BBA-MOL CELL BIOL L, V1821, P70, DOI 10.1016/j.bbalip.2011.06.002; Kartasurya MI, 2012, BRIT J NUTR, V108, P2251, DOI 10.1017/S0007114512000499; Lahiri A, 2014, GASTROENTEROLOGY, V147, P835, DOI 10.1053/j.gastro.2014.06.024; Lo HM, 2014, FOOD FUNCT, V5, P140, DOI 10.1039/c3fo60309a; Long KZ, 2006, AM J CLIN NUTR, V83, P693, DOI 10.1093/ajcn.83.3.693; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; Rahman MM, 2002, AM J CLIN NUTR, V75, P92, DOI 10.1093/ajcn/75.1.92; Rink L, 2001, BIOMETALS, V14, P367, DOI 10.1023/A:1012986225203; SEMBA RD, 1994, CLIN INFECT DIS, V19, P489, DOI 10.1093/clinids/19.3.489; Simonyte Sandrita, 2003, Medicina (Kaunas), V39, P767; Smith J C Jr, 1980, Ann N Y Acad Sci, V355, P62, DOI 10.1111/j.1749-6632.1980.tb21328.x; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Todd WR, 1934, AM J PHYSIOL, V107, P146, DOI 10.1152/ajplegacy.1933.107.1.146; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; WEST KP, 1989, ANNU REV NUTR, V9, P63, DOI 10.1146/annurev.nu.09.070189.000431; Yamada H, 2007, J NUTR, V137, P2696, DOI 10.1093/jn/137.12.2696; Yang Y, 2011, NUTRITION, V27, P227, DOI 10.1016/j.nut.2009.11.024	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137463	10.1371/journal.pone.0137463	http://dx.doi.org/10.1371/journal.pone.0137463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351852	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800089
J	Granados, ML; Hudson, LG; Samudio-Ruiz, SL				Granados, Michaela L.; Hudson, Laurie G.; Samudio-Ruiz, Sabrina L.			Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells	PLOS ONE			English	Article							CISPLATIN-INDUCED ACTIVATION; RANDOMIZED PHASE-III; DNA METHYLATION; MONOCLONAL-ANTIBODY; REDOX REGULATION; EGF-RECEPTOR; CHEMOTHERAPY; ERLOTINIB; CARBOPLATIN; DECITABINE	Acquisition of platinum resistance following first line platinum/taxane therapy is commonly observed in ovarian cancer patients and prevents clinical effectiveness. There are few options to prevent platinum resistance; however, demethylating agents have been shown to resensitize patients to platinum therapy thereby demonstrating that DNA methylation is a critical contributor to the development of platinum resistance. We previously reported the Epidermal Growth Factor Receptor (EGFR) is a novel regulator of DNA methyltransferase (DNMT) activity and DNA methylation. Others have shown that EGFR activation is linked to cisplatin treatment and platinum resistance. We hypothesized that cisplatin induced activation of the EGFR mediates changes in DNA methylation associated with the development of platinum resistance. To investigate this, we evaluated EGFR signaling and DNMT activity after acute cisplatin exposure. We also developed an in vitro model of platinum resistance to examine the effects of EGFR inhibition on acquisition of cisplatin resistance. Acute cisplatin treatment activates the EGFR and downstream signaling pathways, and induces an EGFR mediated increase in DNMT activity. Cisplatin resistant cells also showed increased DNMT activity and global methylation. EGFR inhibition during repeated cisplatin treatments generated cells that were more sensitive to cisplatin and did not develop increases in DNA methylation or DNMT activity compared to controls. These findings suggest that activation of EGFR during platinum treatment contributes to the development of platinum resistance. Furthermore, EGFR inhibition may be an effective strategy at attenuating the development of platinum resistance thereby enhancing the effectiveness of chemotherapeutic treatment in ovarian cancer.	[Granados, Michaela L.; Hudson, Laurie G.; Samudio-Ruiz, Sabrina L.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	University of New Mexico	Samudio-Ruiz, SL (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.	SRuiz@salud.unm.edu			National Cancer Institute of the National Institutes of Health [K01CA172591]; NATIONAL CANCER INSTITUTE [K01CA172591] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R25HG007630] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number K01CA172591. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadollahi R, 2010, GYNECOL ONCOL, V118, P81, DOI 10.1016/j.ygyno.2010.03.015; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; Blank SV, 2010, GYNECOL ONCOL, V119, P451, DOI 10.1016/j.ygyno.2010.08.008; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Erdlenbruch B, 2001, EUR J CLIN PHARMACOL, V57, P393, DOI 10.1007/s002280100319; Fang F, 2014, CLIN CANCER RES, V20, P6504, DOI 10.1158/1078-0432.CCR-14-1553; Fang F, 2014, ONCOTARGET, V5, P3579, DOI 10.18632/oncotarget.1961; Fang F, 2010, CANCER-AM CANCER SOC, V116, P4043, DOI 10.1002/cncr.25204; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gifford G, 2004, CLIN CANCER RES, V10, P4420, DOI 10.1158/1078-0432.CCR-03-0732; Glasspool RM, 2014, BRIT J CANCER, V110, P1923, DOI 10.1038/bjc.2014.116; Gui T, 2012, CANCER EPIDEMIOL, V36, P490, DOI 10.1016/j.canep.2012.06.005; Hahne JC, 2012, ONCOL REP, V28, P2023, DOI 10.3892/or.2012.2041; Hiraishi Y, 2008, PATHOL ONCOL RES, V14, P39, DOI 10.1007/s12253-008-9020-5; Hirte H, 2010, GYNECOL ONCOL, V118, P308, DOI 10.1016/j.ygyno.2010.05.005; Hirte HW, 2013, ONCOTARGETS THER, V6, DOI 10.2147/OTT.S30373; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Hudson LG, 2009, FUTURE ONCOL, V5, P323, DOI 10.2217/FON.09.10; Garces AHI, 2015, CANCER CHEMOTH PHARM, V75, P221, DOI 10.1007/s00280-014-2581-y; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Koti M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-549; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Lu R, 2007, J BIOL CHEM, V282, P12249, DOI 10.1074/jbc.M608525200; Ludwig T, 2004, KIDNEY INT, V66, P196, DOI 10.1111/j.1523-1755.2004.00720.x; Ma L, 2014, ONCOL LETT, V8, P921, DOI 10.3892/ol.2014.2224; Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909; Matei DE, 2010, GYNECOL ONCOL, V116, P195, DOI 10.1016/j.ygyno.2009.09.043; Meng F, 2013, BRIT J CANCER, V108, P579, DOI 10.1038/bjc.2013.10; Murphy M, 2011, DRUG RESIST UPDATE, V14, P177, DOI 10.1016/j.drup.2011.02.004; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Peng DJ, 2010, BIOCHEM BIOPH RES CO, V394, P600, DOI 10.1016/j.bbrc.2010.03.029; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; Samudio-Ruiz S, 2014, MED CHEM; Samudio-Ruiz SL, 2012, EPIGENETICS-US, V7, P216, DOI 10.4161/epi.7.3.19273; Sheng Q, 2011, BRIT J CANCER, V104, P1241, DOI 10.1038/bjc.2011.62; Shi Z, 2009, ONCOL REP, V21, P483, DOI 10.3892/or_00000248; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siwak DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/568938; Tang Y, 2012, STEM CELLS, V30, P2645, DOI 10.1002/stem.1225; Truong TH, 2012, BIOCHEMISTRY-US, V51, P9954, DOI 10.1021/bi301441e; Vergote IB, 2014, J CLIN ONCOL, V32, P320, DOI 10.1200/JCO.2013.50.5669; Wang YN, 2014, CANCER RES, V74, P4922, DOI 10.1158/0008-5472.CAN-14-1022; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Yoshida T, 2008, FEBS LETT, V582, P4125, DOI 10.1016/j.febslet.2008.11.010; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409; Zeineldin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/414676; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611	55	24	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136893	10.1371/journal.pone.0136893	http://dx.doi.org/10.1371/journal.pone.0136893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351843	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800053
J	Saba, ES; Gueyffier, L; Danjoy, ML; Vanhems, P; Pozzetto, B; Sobh, M; Pottel, H; Michallet, M; Zrein, MA				Saba, Esber S.; Gueyffier, Lucie; Danjoy, Marie-Laure; Vanhems, Philippe; Pozzetto, Bruno; Sobh, Mohamad; Pottel, Hans; Michallet, Mauricette; Zrein, Maan A.			Trypanosoma-Cruzi Cross-Reactive Antibodies Longitudinal Follow-Up: A Prospective Observational Study in Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; IMMUNE RECONSTITUTION; T-CELLS; TRANSMISSION; VACCINATION; MYELOMA; DONORS; RISK; CMV	Antibodies named TcCRA "Trypanosoma cruzi Cross Reactive Antibodies" were detected in 47% of blood donors from French population unexposed to the parasite. In order to evaluate the passive or active transmissibility of TcCRA and further characterize its role and etiology, we have conducted a study in a cohort of 47 patients who underwent allogeneic Hematopoietic Stem Cell Transplantations (allo-HSCT). Donors and recipients were tested for TcCRA prior to transplantation. Recipients were further tested during follow-up after transplantation. Demographical, clinical and biological data were collected. Our primary end-point was to assess the risk of TcCRA acquisition after transplantation. During this initial analysis, we observed no seroconversion in patients receiving cells from TcCRA negative donors (n = 23) but detected seroconversion in 4 out of 24 patients who received hematopoietic stem cells from positive donors. Here, we are discussing possible scenarios to explain TcCRA-immune status in recipient after transplantation.	[Saba, Esber S.; Gueyffier, Lucie; Danjoy, Marie-Laure; Zrein, Maan A.] INFYN Biomarkers, Lyon, France; [Vanhems, Philippe; Sobh, Mohamad; Michallet, Mauricette; Zrein, Maan A.] Hosp Civils Lyon, Lyon, France; [Saba, Esber S.; Pozzetto, Bruno] Fac Med Jacques Lisfranc, GIMAP EA3064, Labs Bacteriol Virol, St Etienne, France; [Pottel, Hans] Katholieke Univ Leuven, Interdisciplinary Res Ctr, Kortrijk, Belgium	CHU Lyon; KU Leuven	Zrein, MA (corresponding author), INFYN Biomarkers, Lyon, France.	mzrein@infynity-biomarkers.com	Pottel, Hans/AAD-9444-2019; ZREIN, Maan/C-7666-2018	Pottel, Hans/0000-0003-0074-8919; ZREIN, Maan/0000-0002-3301-4252; POZZETTO, Bruno/0000-0002-2603-8467; Saba, Esber/0000-0003-1525-6394	INFYNITY-Biomarkers	INFYNITY-Biomarkers	This study was funded by INFYNITY-Biomarkers. Esber S. Saba, Lucie Gueyffier, Marie-Laure Danjoy and Maan A. Zrein are employed by INFYNITY-Biomarkers. Infynity-Biomarkers provided support in the form of salaries for authors [Esber S. Saba, Lucie Gueyffier, Marie-Laure Danjoy, Maan A. Zrein], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abu-Khader A, 2013, EUR J HAEMATOL, V91, P534, DOI 10.1111/ejh.12187; Avigan D, 2001, BIOL BLOOD MARROW TR, V7, P171, DOI 10.1053/bbmt.2001.v7.pm11302551; Behzad-Behbahani A, 2005, TRANSPL P, V37, P3211, DOI 10.1016/j.transproceed.2005.07.007; Bemark M, 2012, CLIN EXP IMMUNOL, V167, P15, DOI 10.1111/j.1365-2249.2011.04469.x; Bosch M, 2012, CURR OPIN HEMATOL, V19, P324, DOI 10.1097/MOH.0b013e328353bc7d; Dykewicz CA, 2001, CLIN INFECT DIS, V33, P139, DOI 10.1086/321805; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Foglietta M, 2013, BONE MARROW TRANSPL, V48, P269, DOI 10.1038/bmt.2012.132; LUM LG, 1986, BLOOD, V67, P582; Neelapu S, 2005, BONE MARROW TRANSPL, V36, P315, DOI 10.1038/sj.bmt.1705057; Popgeorgiev N, 2013, J CLIN VIROL, V58, P722, DOI 10.1016/j.jcv.2013.10.001; Popgeorgiev N, 2013, J INFECT DIS, V208, P1042, DOI 10.1093/infdis/jit292; Saba ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074493; Scheinberg P, 2009, BLOOD, V114, P5071, DOI 10.1182/blood-2009-04-214684; Storek J, 2004, BONE MARROW TRANSPL, V33, P337, DOI 10.1038/sj.bmt.1704336; Thiele T, 2011, TRANSFUSION, V51, P2620, DOI 10.1111/j.1537-2995.2011.03203.x	16	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137240	10.1371/journal.pone.0137240	http://dx.doi.org/10.1371/journal.pone.0137240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351849	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800071
J	Edessa, D; Likisa, J				Edessa, Dumessa; Likisa, Jimma			A Description of Mortality Associated with IPT plus ART Compared to ART Alone among HIV-Infected Individuals in Addis Ababa, Ethiopia: A Cohort Study	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; ACTIVE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; TUBERCULOSIS; ADULTS; ADHERENCE; TRIAL; PROGRESSION; IMPACT; RISK	Background Tuberculosis (TB) is the most common human immunodeficiency virus (HIV) associated opportunistic infection. It is the leading cause of death in HIV-infected individuals in sub-Saharan Africa. Anti-retroviral therapy (ART) and isoniazid preventive therapy (IPT) are the two useful TB preventative strategies available to reduce TB among people living with HIV (PLHIV). Therefore, the aim of this study is to compare mortality associated with IPT taken together with ART, as well as ART alone, among PLHIV. Methods A retrospective cohort study was undertaken at Tikur Anbessa Specialized Hospital (TASH) and Zewditu Memorial Hospital (ZMH) on 185 patients receiving IPT (6 months) plus ART and 557 patients receiving ART alone. Mortality rates (MR) per 100 person-years (PYs) were used to compare mortality rates amongst the groups. Time-to-death and survival probabilities of the patients were determined using the Kaplan Meier Method. The Cox Proportional Hazard Model was employed to estimate the effect of IPT plus ART on survival of PLHIV. Results The mortality cases noted in patients treated by IPT plus ART versus ART alone were 18 (4.5 cases/100 PYs) and 116 (10 cases/100 PYs), respectively. In reference to the ART alone, the IPT plus ART reduced the likelihood of death significantly (aHR 0.48; 95% CI 0.38-0.69) and median time to death was about 26 months (IQR 19-34). Moreover, WHO stage IV (aHR 2.42: 95% CI 1.42-4.11), CD4 values >= 350cells/mm3 (aHR 0.52; 95% CI 0.28-0.94), adherence to ART (aHR 0.12; 95% CI 0.08-0.20), primary levels of education (aHR 2.20; 95% CI 1.07-4.52); and alcohol consumption (aHR 1.71; 95% CI 1.04-2.81) were factors strongly associated with mortality. Conclusion We found that PLHIV treated by the IPT plus ART had a lower likelihood of mortality and delayed time-to-death when compared to patients treated by ART alone.	[Edessa, Dumessa] Haramaya Univ, Dept Pharmacol & Clin Pharm, Coll Hlth & Med Sci, Harar, Ethiopia; [Likisa, Jimma] Ambo Univ, Dept Pharm, Coll Med & Hlth Sci, Clin Pharm Unit, Ambo, Ethiopia	Haramaya University; Ambo University	Edessa, D (corresponding author), Haramaya Univ, Dept Pharmacol & Clin Pharm, Coll Hlth & Med Sci, Harar, Ethiopia.	jaarraa444@yahoo.com	Edessa, Dumessa/K-3885-2019; Edessa, Dumessa/K-2892-2019	Edessa, Dumessa/0000-0001-6558-5829; 				Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Akolo C, 2010, COCHRANE COLLABORATI; Apers L, 2005, TROP MED INT HEALTH, V10, P1209, DOI 10.1111/j.1365-3156.2005.01516.x; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; CHAISSON RE, 1995, NEW ENGL J MED, V333, P751, DOI 10.1056/NEJM199509213331202; Chakaya Jeremiah, 2008, J Int AIDS Soc, V11, P6, DOI 10.1186/1758-2652-11-6; Chamie G, 2010, CLIN INFECT DIS, V50, pS245, DOI 10.1086/651498; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Charalambous S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000391010.02774.6f; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Churchyard GJ, 2007, J INFECT DIS, V196, pS52, DOI 10.1086/518662; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Federal Ministry of Health of Ethiopia, 2007, IMPL GUID TB HIV COL; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Gordin FM, 1997, NEW ENGL J MED, V337, P315, DOI 10.1056/NEJM199707313370505; Grant AD, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000391011.40892.ff; Gray DM, 2009, COCHRANE LIB, P1; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; Hanf M., 2012, Journal of AIDS and Clinical Research, V3, P172; Hawken MP, 1997, AIDS, V11, P875, DOI 10.1097/00002030-199707000-00006; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Kleeberger CA, 2004, AIDS, V18, P683, DOI 10.1097/00002030-200403050-00013; Lawn SD, 2010, CLIN DEV IMMUNOL, V2011, P1; Madhi SA, 2011, N ENGL J MED, V365; Meya DB, 2007, J INTERN MED, V261, P309, DOI 10.1111/j.1365-2796.2007.01795.x; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Nemes MIB, 2004, AIDS, V18, pS15, DOI 10.1097/00002030-200406003-00004; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Schneider M., 2012, J AIDS CLIN RES, VS1:005, DOI [10.4712/2155-6113.S1-005, DOI 10.4172/2155-6113.S1-005]; Sharma SK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007545.pub2; Smieja M, 2010, COCHRANE LIB, P1; Straetemans M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015241; UNAIDS, 2013, REP GLOB AIDS EP; de Souza CTV, 2009, MEM I OSWALDO CRUZ, V104, P462, DOI 10.1590/S0074-02762009000300011; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; WHO, 2010, ANT THER HIV INF AD; WHO, 2012, GLOB TB CONTR REP; Zar HJ, 2006, BMJ; Zumla A, 2000, POSTGRAD MED J, V76, P259, DOI 10.1136/pmj.76.895.259	42	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137492	10.1371/journal.pone.0137492	http://dx.doi.org/10.1371/journal.pone.0137492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348618	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600048
J	Gonzalez, F				Gonzalez, Felipe			Drug Trafficking Organizations and Local Economic Activity in Mexico	PLOS ONE			English	Article								Little is known about the relationship between illegal firms and local economic activity. In this paper I study changes in satellite night lights across Mexican municipalities after the arrival of large drug trafficking organizations in the period 2000-2010. After accounting for state trends and differences in political regimes, results indicate no significant change in night lights after the arrival of these illegal firms. Estimated coefficients are precise, robust, and similar across different drug trafficking organizations.	Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Gonzalez, F (corresponding author), Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA.	fgonzalez@econ.berkeley.edu						Coscia M, 2012, P 21 ACM INT C INF K; Dell M., 2015, AM EC REV IN PRESS; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Doll C. N. H., 2008, CIESIN THEMATIC GUID; Grillo I., 2012, NARCO INSIDE MEXICOS; Guerrero E., 2011, NEXOS JUN; Henderson JV, 2012, AM ECON REV, V102, P994, DOI 10.1257/aer.102.2.994; International Labour Organization, 2013, PAN LAB 2013 AM LAT; Michalopoulos S, 2013, ECONOMETRICA, V81, P113, DOI 10.3982/ECTA9613; National Geophysical Data Center, 2013, VERS 4 DMSP OLS NIGH; Pedroni P., 2011, IMF WORKING PAPER; Pinkovskiy M.L., 2013, EC DISCONTINUITIES B; Rios V., 2014, LATIN AM RES REV, V49; United Nations Office on Drugs and Crime, 2014, WORLD DRUG REP	14	3	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137319	10.1371/journal.pone.0137319	http://dx.doi.org/10.1371/journal.pone.0137319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ8YQ	26348041	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600035
J	Ichikawa, K; Fujiwara, T; Nakayama, T				Ichikawa, Kayoko; Fujiwara, Takeo; Nakayama, Takeo			Effectiveness of Home Visits in Pregnancy as a Public Health Measure to Improve Birth Outcomes	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PRETERM BIRTH; PRENATAL-CARE; 1ST-TIME MOTHERS; WEIGHT INFANTS; BORN PRETERM; RISK-FACTORS; PROGRAM; METAANALYSIS; VISITATION	Background Birth outcomes, such as preterm birth, low birth weight (LBW), and small for gestational age (SGA), are crucial indicators of child development and health. Purpose To evaluate whether home visits from public health nurses for high-risk pregnant women prevent adverse birth outcomes. Methods In this quasi-experimental cohort study in Kyoto city, Japan, high-risk pregnant women were defined as teenage girls (range 14-19 years old), women with a twin pregnancy, women who registered their pregnancy late, had a physical or mental illness, were of single marital status, non-Japanese women who were not fluent in Japanese, or elderly primiparas. We collected data from all high-risk pregnant women at pregnancy registration interviews held at a public health centers between 1 July 2011 and 30 June 2012, as well as birth outcomes when delivered from the Maternal and Child Health Handbook (N = 964), which is a record of prenatal check-ups, delivery, child development and vaccinations. Of these women, 622 women were selected based on the home-visit program propensity score-matched sample (pair of N = 311) and included in the analysis. Data were analyzed between January and June 2014. Results In the propensity score-matched sample, women who received the home-visit program had lower odds of preterm birth (odds ratio [OR], 0.62; 95% confidence interval [CI], 0.39 to 0.98) and showed a 0.55-week difference in gestational age (95% CI: 0.18 to 0.92) compared to the matched controlled sample. Although the program did not prevent LBW and SGA, children born to mothers who received the program showed an increase in birth weight by 107.8 g (95% CI: 27.0 to 188.5). Conclusion Home visits by public health nurses for high-risk pregnant women in Japan might be effective in preventing preterm birth, but not SGA.	[Ichikawa, Kayoko; Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Ichikawa, Kayoko; Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan	Kyoto University; National Center for Child Health & Development - Japan	Fujiwara, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan.	fujiwara-tk@ncchd.go.jp	NAKAYAMA, Takeo/HCH-0537-2022	Nakayama, Takeo/0000-0002-7918-6252	Ministry of Health and Labour Sciences Research [H23-Seisaku-Ippan-005]; Japan Health Foundation	Ministry of Health and Labour Sciences Research; Japan Health Foundation(Japan Health Foundation)	This study was partly supported by a grant from the Ministry of Health and Labour Sciences Research Grant (H23-Seisaku-Ippan-005) and the Japan Health Foundation 2014.	Adirim T, 2013, PEDIATRICS, V132, pS59, DOI 10.1542/peds.2013-1021C; Avellar SA, 2013, PEDIATRICS, V132, pS90, DOI 10.1542/peds.2013-1021G; Baron IS, 2012, NEUROPSYCHOL REV, V22, P438, DOI 10.1007/s11065-012-9210-5; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Brett KM, 1997, AM J PUBLIC HEALTH, V87, P199, DOI 10.2105/AJPH.87.2.199; Carabin H, 2005, PAEDIATR PERINAT EP, V19, P194, DOI 10.1111/j.1365-3016.2005.00651.x; Cooper BP, 2013, MATERN CHILD HLTH J, V17, P1158, DOI 10.1007/s10995-012-1101-0; DiFranza JR, 2004, PEDIATRICS, V113, P1007; Donovan EF, 2007, PEDIATRICS, V119, P1145, DOI 10.1542/peds.2006-2411; Filene JH, 2013, PEDIATRICS, V132, pS100, DOI 10.1542/peds.2013-1021H; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goyal NK, 2013, PEDIATRICS, V132, pS118, DOI 10.1542/peds.2013-1021J; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Health Labour and Welfare Statistics Association, 2012, J HLTH WELFARE STAT; Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021; Hertz-Picciotto I, 1998, EPIDEMIOLOGY, V9, P61; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hobel CJ, 2008, CLIN OBSTET GYNECOL, V51, P333, DOI 10.1097/GRF.0b013e31816f2709; Hoffman S, 1996, PAEDIATR PERINAT EP, V10, P380, DOI 10.1111/j.1365-3016.1996.tb00063.x; Hokama T, 2009, ACTA PAEDIATR, V98, P242, DOI 10.1111/j.1651-2227.2008.01017.x; Issel LM, 2011, JOGNN-J OBST GYN NEO, V40, P157, DOI 10.1111/j.1552-6909.2011.01219.x; Japanese Nursing Association, 2014, MIDW IN JAP; Jongbloed-Pereboom M, 2012, NEUROSCI BIOBEHAV R, V36, P1314, DOI 10.1016/j.neubiorev.2012.02.005; Kitzman H, 1997, JAMA-J AM MED ASSOC, V278, P644, DOI 10.1001/jama.278.8.644; Lee E, 2009, AM J PREV MED, V36, P154, DOI 10.1016/j.amepre.2008.09.029; McGowan JE, 2011, PEDIATRICS, V127, P1111, DOI 10.1542/peds.2010-2257; MCLAUGHLIN FJ, 1992, PEDIATRICS, V89, P128; McNaughton DB, 2004, PUBLIC HEALTH NURS, V21, P207, DOI 10.1111/j.0737-1209.2004.021303.x; Ministry of Health Lavour and Welfare, 2014, REP COMM HLTH CAR HL; Nakamura Y, 2010, JPN MED ASS J, V53, P259; OLDS DL, 1986, PEDIATRICS, V77, P16; Peacock S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-17; Roman L, 2014, JAMA PEDIATR, V168, P220, DOI 10.1001/jamapediatrics.2013.4347; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Smith LK, 2007, ARCH DIS CHILD-FETAL, V92, pF11, DOI 10.1136/adc.2005.090308; Strathearn L, 2001, PEDIATRICS, V108, P142, DOI 10.1542/peds.108.1.142; Takimoto H, 2005, J OBSTET GYNAECOL RE, V31, P314, DOI 10.1111/j.1447-0756.2005.00294.x; Thompson JMD, 2006, PAEDIATR PERINAT EP, V20, P182, DOI 10.1111/j.1365-3016.2006.00711.x; van Noort-van der Spek IL, 2012, PEDIATRICS, V129, P745, DOI 10.1542/peds.2011-1728; Windham AM, 2004, CHILD ABUSE NEGLECT, V28, P645, DOI 10.1016/j.chiabu.2004.01.003; Wu SS, 2004, CHILD ABUSE NEGLECT, V28, P1253, DOI 10.1016/j.chiabu.2004.07.005; Xiong X, 2006, BJOG-INT J OBSTET GY, V113, P135, DOI 10.1111/j.1471-0528.2005.00827.x; Yorifuji T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-162	44	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137307	10.1371/journal.pone.0137307	http://dx.doi.org/10.1371/journal.pone.0137307			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ8YQ	26348847	gold, Green Published, Green Submitted			2022-12-27	WOS:000360897600032
J	Kwon, GH; Kim, KA; Hwang, SS; Park, SY; Kim, HA; Choi, SY; Kim, JW				Kwon, Gene-hyuk; Kim, Kyung Ah; Hwang, Seong Su; Park, Soo Youn; Kim, Hyun A.; Choi, Sun Young; Kim, Ji Woong			Efficiency of Non-Contrast-Enhanced Liver Imaging Sequences Added to Initial Rectal MRI in Rectal Cancer Patients	PLOS ONE			English	Article							EXTRAMURAL VASCULAR INVASION; COLORECTAL-CANCER; CARCINOMA; ACCURACY; METASTASIS; T1	Purpose The purpose of this study was to estimate the value of addition of liver imaging to initial rectal magnetic resonance imaging (MRI) for detection of liver metastasis and evaluate imaging predictors of a high risk of liver metastasis on rectal MRI. Methods We enrolled 144 patients who from October 2010 to May 2013 underwent rectal MRI with T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) (b values = 50, 500, and 900 s/mm(2)) of the liver and abdominopelvic computed tomography (APCT) for the initial staging of rectal cancer. Two reviewers scored the possibility of liver metastasis on different sets of liver images (T2WI, DWI, and combined T2WI and DWI) and APCT and reached a conclusion by consensus for different analytic results. Imaging features from rectal MRI were also analyzed. The diagnostic performances of CT and an additional liver scan to detect liver metastasis were compared. Multivariate logistic regression to determine independent predictors of liver metastasis among rectal MRI features and tumor markers was performed. This retrospective study was approved by the Institutional Review Board, and the requirement for informed consent was waived. Results All sets of liver images were more effective than APCT for detecting liver metastasis, and DWI was the most effective. Perivascular stranding and anal sphincter invasion were statistically significant for liver metastasis (p = 0.0077 and p = 0.0471), while extramural vascular invasion based on MRI (mrEMVI) was marginally significant (p = 0.0534). Conclusion The addition of non-contrast-enhanced liver imaging, particularly DWI, to initial rectal MRI in rectal cancer patients could facilitate detection of liver metastasis without APCT. Perivascular stranding, anal sphincter invasion, and mrEMVI detected on rectal MRI were important imaging predictors of liver metastasis.	[Kwon, Gene-hyuk; Kim, Kyung Ah; Hwang, Seong Su; Park, Soo Youn; Kim, Hyun A.] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Radiol, Seoul, South Korea; [Choi, Sun Young] Ewha Womans Univ, Sch Med, Dept Radiol, Seoul, South Korea; [Choi, Sun Young] Ewha Womans Univ, Sch Med, Med Res Inst, Seoul, South Korea; [Kim, Ji Woong] Hanseo Univ, Dept Chiropract, Grad Sch Hlth Promot, Seosan, South Korea	Catholic University of Korea; Ewha Womans University; Ewha Womans University; Hanseo University	Kim, KA (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Radiol, Seoul, South Korea.	bellenina@daum.net			St. Vincent's hospital [SVHR-2013-01]	St. Vincent's hospital	The financial support of the St. Vincent's hospital, research institute of medical science (SVHR-2013-01) for data analysis.	Adeyemo D, 2009, COLORECTAL DIS, V11, P259, DOI 10.1111/j.1463-1318.2008.01588.x; Akasu T, 2009, ANN SURG ONCOL, V16, P2787, DOI 10.1245/s10434-009-0613-3; [Anonymous], 2006, BMJ-BRIT MED J, V333, P779, DOI [10.1136/bmj.38937.646400.55, DOI 10.1136/BMJ.38937.646400.55]; Beets-Tan RGH, 2001, LANCET, V357, P497, DOI 10.1016/S0140-6736(00)04040-X; Chand M, 2014, BRIT J CANCER, V110, P19, DOI 10.1038/bjc.2013.603; Fang WL, 2005, HEPATO-GASTROENTEROL, V52, P1688; Galea N, 2013, J MAGN RESON IMAGING, V37, P1260, DOI 10.1002/jmri.23947; Heijnen LA, 2013, EUR RADIOL, V23, P3354, DOI 10.1007/s00330-013-2952-5; Kim MJ, 2003, J COMPUT ASSIST TOMO, V27, P48, DOI 10.1097/00004728-200301000-00010; Kim NK, 2000, ANN SURG ONCOL, V7, P732, DOI 10.1007/s10434-000-0732-3; Liang TY, 2012, CANCER IMAGING, V12, P290, DOI 10.1102/1470-7330.2012.0034; Lim GH, 2009, DIS COLON RECTUM, V52, P1487, DOI 10.1007/DCR.0013e3181a74d5e; Lim JS, 2004, KOREAN J RADIOL, V5, P225, DOI 10.3348/kjr.2004.5.4.225; Nascimbeni R, 2002, DIS COLON RECTUM, V45, P200, DOI 10.1007/s10350-004-6147-7; Smith NJ, 2008, BRIT J SURG, V95, P229, DOI 10.1002/bjs.5917; Smith NJ, 2008, AM J ROENTGENOL, V191, P1517, DOI 10.2214/AJR.08.1298; Yu SKT, 2014, EUR J CANCER, V50, P920, DOI 10.1016/j.ejca.2013.12.007	17	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137320	10.1371/journal.pone.0137320	http://dx.doi.org/10.1371/journal.pone.0137320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348217	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600036
J	Teeuw, WJ; Laine, ML; Bizzarro, S; Loos, BG				Teeuw, Wijnand J.; Laine, Marja L.; Bizzarro, Sergio; Loos, Bruno G.			A Lead ANRIL Polymorphism Is Associated with Elevated CRP Levels in Periodontitis: A Pilot Case-Control Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; ALTERNATIVE PATHWAY; SYSTEMIC MARKERS; ATHEROSCLEROSIS; REPLICATION; ACTIVATION; VARIANTS; SMOKING; 9P21.3	Elevated high sensitive C-reactive protein (hsCRP) is a marker for systemic inflammation and a risk marker for atherosclerotic cardiovascular disease (ACVD), and has also been associated with periodontitis. Inter-individual variation for hsCRP in periodontitis has been shown. ANRIL is the strongest genetic susceptibility locus for both periodontitis and ACVD, and it is speculated that genetic variation in ANRIL may modulate inflammatory processes. Therefore, we explored the possible association between hsCRP plasma levels and a leading ANRIL single nucleotide polymorphism (SNP) in periodontitis patients and controls. 171 healthy subjects with North European descent (115 periodontitis and 56 controls) were included in this case-control study. hsCRP levels were determined and subjects were genotyped for the leading ANRIL SNP rs1333048. In a multivariate analysis, periodontitis, female gender, increasing BMI and homozygosity for the major allele (AA-genotype) of rs1333048 were significantly associated with elevated hsCRP plasma levels (p = 0.012, p = 0.004, p = 0.007 and p = 0.003, respectively). Periodontitis patients with rs1333048 AA-genotype showed higher levels of hsCRP than those carrying the minor C allele (median: 4.5 mg/L vs. 1.6 mg/L, p(adjusted) = 0.007). This study is the first to show that, in addition to gender and BMI, also a leading SNP in ANRIL is explanatory for inter-individual variation in hsCRP levels in periodontitis patients of North European descent.	[Teeuw, Wijnand J.] Univ Amsterdam, Dept Periodontol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; Vrije Univ Amsterdam, Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Teeuw, WJ (corresponding author), Univ Amsterdam, Dept Periodontol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands.	W.Teeuw@acta.nl	Laine, Marja Leena/ABF-2341-2021		University of Amsterdam	University of Amsterdam	The Department of Periodontology at ACTA, the Netherlands is supported in part by a grant of the University of Amsterdam for its participation in the focal point "Oral Infections and Inflammation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For the rest of the study, the authors did not receive specific funding. There was no additional external funding received for this study.	Bizzarro S, 2007, J CLIN PERIODONTOL, V34, P574, DOI 10.1111/j.1600-051X.2007.01095.x; Bochenek G, 2013, HUM MOL GENET, V22, P4516, DOI 10.1093/hmg/ddt299; Congrains A, 2012, ATHEROSCLEROSIS, V220, P449, DOI 10.1016/j.atherosclerosis.2011.11.017; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Divaris K, 2012, J DENT RES, V91, pS21, DOI 10.1177/0022034512447951; Du Clos Terry W, 2013, ISRN Inflamm, V2013, P379040, DOI 10.1155/2013/379040; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Ernst FD, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-119; Geluk CA, 2008, ATHEROSCLEROSIS, V196, P372, DOI 10.1016/j.atherosclerosis.2006.11.013; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helmersson J, 2005, ATHEROSCLEROSIS, V181, P201, DOI 10.1016/j.atherosclerosis.2004.11.026; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Hugoson A, 2008, J CLIN PERIODONTOL, V35, P405, DOI 10.1111/j.1600-051X.2008.01225.x; Incalcaterra E, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0329-5; Loos BG, 2005, J PERIODONTOL, V76, P2106, DOI 10.1902/jop.2005.76.11-S.2106; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Lopez R, 2015, VIRULENCE, V6, P249, DOI 10.1080/21505594.2015.1014266; Mihlan M, 2011, FASEB J, V25, P4198, DOI 10.1096/fj.11-186460; MOLD C, 1984, J IMMUNOL, V133, P882; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pradeep AR, 2012, DIS MARKERS, V33, P207, DOI [10.3233/DMA-2012-0926, 10.1155/2012/173123]; Ridker PM, 2010, AM J CARDIOL, V106, P204, DOI 10.1016/j.amjcard.2010.03.018; Schaefer AS, 2015, CIRC-CARDIOVASC GENE, V8, P159, DOI 10.1161/CIRCGENETICS.114.000554; Schaefer AS, 2013, J CLIN PERIODONTOL, V40, P563, DOI 10.1111/jcpe.12092; Schaefer AS, 2011, J MED GENET, V48, P38, DOI 10.1136/jmg.2010.078998; Schaefer AS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000378; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Schwenk RW, 2012, J BIOL CHEM, V287, P37530, DOI 10.1074/jbc.M112.363630; Suankratay C, 1998, CLIN EXP IMMUNOL, V113, P353; Teeuw WJ, 2014, J CLIN PERIODONTOL, V41, P70, DOI 10.1111/jcpe.12171; van Greevenbroek MMJ, 2012, INT J CARDIOL, V154, P158, DOI 10.1016/j.ijcard.2010.09.017; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Woloshin S, 2005, NEW ENGL J MED, V352, P1611, DOI 10.1056/NEJM200504143521525; Zieske AW, 2005, ARTERIOSCL THROM VAS, V25, P1237, DOI 10.1161/01.ATV.0000164625.93129.64	39	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137335	10.1371/journal.pone.0137335	http://dx.doi.org/10.1371/journal.pone.0137335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348353	Green Submitted, Green Published, gold			2022-12-27	WOS:000360897600037
J	Alvarado-Arnez, LE; Amaral, EP; Sales-Marques, C; Duraes, SMB; Cardoso, CC; Sarno, EN; Pacheco, AG; Lana, FCF; Moraes, MO				Alvarado-Arnez, Lucia Elena; Amaral, Evaldo P.; Sales-Marques, Carolinne; Duraes, Sandra M. B.; Cardoso, Cynthia C.; Sarno, Euzenir Nunes; Pacheco, Antonio G.; Lana, Francisco C. F.; Moraes, Milton Ozorio			Association of IL10 Polymorphisms and Leprosy: A Meta-Analysis	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENE POLYMORPHISMS; SUSCEPTIBILITY; INTERLEUKIN-10; IMMUNITY; ALPHA; TESTS; RISK	Leprosy is a chronic infectious disease that depends on the interplay of several factors. Single nucleotide polymorphisms (SNPs) in host immune related genes have been consistently suggested as participants in susceptibility towards disease. Interleukin-10 (IL-10) is a crucial immunomodulatory cytokine inmycobacterial pathogenesis and especially the -819C>T SNP (rs1800871) has been tested in several case-control studies indicating association with leprosy risk, although a recent consensus estimate is still missing. In this study, we evaluated the association of the -819C>T SNP and leprosy in two new Brazilian family-based populations. Then, we performed meta-analysis for this polymorphism summarizing published studies including these Brazilian family-based groups. Finally, we also retrieved published studies for other distal and proximal IL10 polymorphisms: -3575 T>A (rs1800890), -2849 G>A (rs6703630), -2763 C>A (rs6693899), -1082 G>A (rs1800896) and -592 C>A (rs1800872). Results from meta-analysis supported a significant susceptibility association for the -819T allele, with pooled Odds Ratio of 1.22 (CI = 1.11-1.34) and P-value = 3x10(-5) confirming previous data. This result remained unaltered after inclusion of the Brazilian family-based groups (OR = 1.2, CI = 1.10-1.31, P-value = 2x10(-5)). Also, meta-analysis confirmed association of -592 A allele and leprosy outcome (OR = 1.24, CI = 1.03-1.50, P-value = 0.02). In support of this, linkage disequilibrium analysis in 1000 genomes AFR, EUR, ASN and AMR populations pointed to r(2) = 1.0 between the -592C>A and -819C>T SNPs. We found no evidence of association for the other IL10 polymorphisms analyzed for leprosy outcome. Our results reinforce the role of the -819C>T as a tag SNP (rs1800871) and its association with leprosy susceptibility.	[Alvarado-Arnez, Lucia Elena; Sales-Marques, Carolinne; Cardoso, Cynthia C.; Sarno, Euzenir Nunes; Moraes, Milton Ozorio] Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, BR-21045900 Rio De Janeiro, Brazil; [Amaral, Evaldo P.; Lana, Francisco C. F.] Univ Fed Minas Gerais, Dept Enfermagem Maternoinfantil & Saude Publ, Belo Horizonte, MG, Brazil; [Duraes, Sandra M. B.] Univ Fed Fluminense, Dept Med Clin, Serv Dermatol, Rio De Janeiro, Brazil; [Pacheco, Antonio G.] Fiocruz MS, Programa Comp Cient, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal Fluminense; Fundacao Oswaldo Cruz	Alvarado-Arnez, LE (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, BR-21045900 Rio De Janeiro, Brazil.	luciaelena.alvarado@gmail.com	Moraes, Milton/AFF-1842-2022; Cardoso, Cynthia/K-5824-2012; Arnez, Lucia Elena Alvarado/D-4690-2016; Moraes, Milton Ozório/G-9753-2011; Lana, Francisco CF/I-1438-2012; Pacheco, Antonio Guilherme/E-6378-2013; Lana, Francisco/AAD-1443-2019	Cardoso, Cynthia/0000-0003-0565-7047; Arnez, Lucia Elena Alvarado/0000-0002-3537-6361; Moraes, Milton Ozório/0000-0003-2653-0037; Lana, Francisco CF/0000-0001-9043-3181; Pacheco, Antonio Guilherme/0000-0003-3095-1774; Lana, Francisco/0000-0001-9043-3181; Nunes Sarno, Euzenir/0000-0003-0129-2159; Sales-Marques, Carolinne/0000-0003-2902-0657	CAPES; MS/SCTIE/Decit [12/2009]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); MS/SCTIE/Decit	LEAA is a postdoctoral fellow funded by CAPES and MS/SCTIE/Decit 12/2009.	Aggarwal S, 2011, J INFECT DIS, V204, P1264, DOI 10.1093/infdis/jir516; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2011, R A LANGUAGE AND ENV; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cardona-Castro N, 2012, BIOMEDICA REV I NACL, V32; Cardoso CC, 2011, J INFECT DIS, V204, P1256, DOI 10.1093/infdis/jir521; Cardoso CC, 2011, FUTURE MICROBIOL, V6, P533, DOI [10.2217/FMB.11.39, 10.2217/fmb.11.39]; Chen XH, 2013, GENET MOL RES, V12, P2876, DOI 10.4238/2013.August.12.3; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Gao X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127496; Garcia P, 2013, CLIN VACCINE IMMUNOL, V20, P1599, DOI 10.1128/CVI.00334-13; Gibson AW, 2001, J IMMUNOL, V166, P3915, DOI 10.4049/jimmunol.166.6.3915; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Liang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088448; Lima MCBS, 2000, SCAND J IMMUNOL, V51, P419, DOI 10.1046/j.1365-3083.2000.00703.x; Malhotra D, 2005, HUM GENET, V118, P295, DOI 10.1007/s00439-005-0042-8; Marques CD, 2013, J INFECT DIS, V208, P120, DOI 10.1093/infdis/jit133; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; Moraes MO, 2004, GENES IMMUN, V5, P592, DOI 10.1038/sj.gene.6364122; Moura DF, 2012, EUR J IMMUNOL, V42, P2925, DOI 10.1002/eji.201142198; Pereira AC, 2009, GENES IMMUN, V10, P174, DOI 10.1038/gene.2008.97; Santos AR, 2002, J INFECT DIS, V186, P1687, DOI 10.1086/345366; Tarique M, 2015, CYTOKINE, V73, P61, DOI 10.1016/j.cyto.2015.01.014; Felix JSV, 2012, LEPROSY REV, V83, P34; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	29	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136282	10.1371/journal.pone.0136282	http://dx.doi.org/10.1371/journal.pone.0136282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340474	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200007
J	Jin, YH; Zhang, Q; Shan, LF; Li, SP				Jin, Yonghong; Zhang, Qi; Shan, Lifei; Li, Sai-Ping			Characteristics of Venture Capital Network and Its Correlation with Regional Economy: Evidence from China	PLOS ONE			English	Article							SCALE-FREE NETWORK; SYNDICATION	Financial networks have been extensively studied as examples of real world complex networks. In this paper, we establish and study the network of venture capital (VC) firms in China. We compute and analyze the statistical properties of the network, including parameters such as degrees, mean lengths of the shortest paths, clustering coefficient and robustness. We further study the topology of the network and find that it has small-world behavior. A multiple linear regression model is introduced to study the relation between network parameters and major regional economic indices in China. From the result of regression, we find that, economic aggregate (including the total GDP, investment, consumption and net export), upgrade of industrial structure, employment and remuneration of a region are all positively correlated with the degree and the clustering coefficient of the VC sub-network of the region, which suggests that the development of the VC industry has substantial effects on regional economy in China.	[Jin, Yonghong; Zhang, Qi; Shan, Lifei] E China Univ Sci & Technol, Sch Business, Shanghai 200237, Peoples R China; [Li, Sai-Ping] Acad Sinica, Inst Phys, Taipei 11529, Taiwan	East China University of Science & Technology; Academia Sinica - Taiwan	Jin, YH (corresponding author), E China Univ Sci & Technol, Sch Business, Shanghai 200237, Peoples R China.	jyhsh@126.com	Li, Sai-Ping/AAP-9189-2021	Li, Sai-Ping/0000-0002-3233-2339				Ahlstrom D, 2001, ACAD MANAGE EXEC, V15, P72, DOI 10.5465/AME.2001.5897661; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Ausloos M, 2006, ARXIVPHYSICS0607139V; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bizhani G, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036110; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BOLLOBAS B, 1988, COMBINATORICA, V8, P49, DOI 10.1007/BF02122551; Bruton G, 2004, J WORLD BUS, V39, P72, DOI 10.1016/j.jwb.2003.08.002; Chen M, 2001, INSIDE CHINESE BUSIN; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; ERDOS P, 1960, B INT STATIST INST, V38, P343; Feder J., 1989, PHYS TODAY, V42, P90, DOI [10.1063/1.2811154, DOI 10.1063/1.2811154]; Garlaschelli D, 2007, ARXIVPHYSICS0701030V; Gulati R, 1995, ADMIN SCI QUART, V40, P619, DOI 10.2307/2393756; Hochberg YV, 2007, J FINANC, V62, P251, DOI 10.1111/j.1540-6261.2007.01207.x; Hussain J, 2006, J SMALL BUS ENTERP D, V13, P584, DOI 10.1108/14626000610705769; Ingram P, 2000, AM J SOCIOL, V106, P387, DOI 10.1086/316965; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Kim HJ, 2002, J KOREAN PHYS SOC, V40, P1105; Kim HJ, 2002, J PHYS SOC JPN, V71, P2133, DOI 10.1143/JPSJ.71.2133; Kogut B, 2007, MANAGE SCI, V53, P1181, DOI 10.1287/mnsc.1060.0620; Kronberger G, 2013, ARXIV12122044V2CSNE; Liu C, 2010, PHYSICA A, V389, P2675, DOI 10.1016/j.physa.2010.02.043; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Mas D, 2008, CONTRIB MANAG SCI, P373, DOI 10.1007/978-3-7908-2058-4_20; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Moody J, 2003, AM SOCIOL REV, V68, P103, DOI 10.2307/3088904; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ni XH, 2009, PHYS LETT A, V373, P3822, DOI 10.1016/j.physleta.2009.08.041; Pastor-Satorras R., 2007, EVOLUTION STRUCTURE; Podolny JM, 1997, AM SOCIOL REV, V62, P673, DOI 10.2307/2657354; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Song DM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026108; Tumminello M, 2010, J ECON BEHAV ORGAN, V75, P40, DOI 10.1016/j.jebo.2010.01.004; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xie WJ, 2011, PHYSICA A, V390, P3592, DOI 10.1016/j.physa.2011.04.020; Zeng A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056123; Zeng J K, 2004, SOCIAL NETWORK ANAL; Zhang X, 2014, PHYSICA A, V415, P43, DOI 10.1016/j.physa.2014.07.068; Zhou WX, 2007, PHYSICA A, V375, P741, DOI 10.1016/j.physa.2006.10.025	43	5	5	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137172	10.1371/journal.pone.0137172	http://dx.doi.org/10.1371/journal.pone.0137172			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ6BA	26340555	gold, Green Submitted, Green Published			2022-12-27	WOS:000360688200028
J	Toth, I; Kiss, DS; Jocsak, G; Somogyi, V; Toronyi, E; Bartha, T; Frenyo, LV; Horvath, TL; Zsarnovszky, A				Toth, Istvan; Kiss, David S.; Jocsak, Gergely; Somogyi, Virag; Toronyi, Eva; Bartha, Tibor; Frenyo, Laszlo V.; Horvath, Tamas L.; Zsarnovszky, Attila			Estrogen- and Satiety State-Dependent Metabolic Lateralization in the Hypothalamus of Female Rats	PLOS ONE			English	Article							MITOCHONDRIAL METABOLISM; SUPRACHIASMATIC NUCLEI; UNILATERAL IMPLANT; ENDOCRINE CONTROL; NEUROPEPTIDE-Y; LH-RH; ASYMMETRY; BRAIN; ESTRADIOL; PROTEIN	Hypothalamus is the highest center and the main crossroad of numerous homeostatic regulatory pathways including reproduction and energy metabolism. Previous reports indicate that some of these functions may be driven by the synchronized but distinct functioning of the left and right hypothalamic sides. However, the nature of interplay between the hemispheres with regard to distinct hypothalamic functions is still unclear. Here we investigated the metabolic asymmetry between the left and right hypothalamic sides of ovariectomized female rats by measuring mitochondrial respiration rates, a parameter that reflects the intensity of cell and tissue metabolism. Ovariectomized (saline injected) and ovariectomized+estrogen injected animals were fed ad libitum or fasted to determine 1) the contribution of estrogen to metabolic asymmetry of hypothalamus; and 2) whether the hypothalamic asymmetry is modulated by the satiety state. Results show that estrogen-priming significantly increased both the proportion of animals with detected hypothalamic lateralization and the degree of metabolic difference between the hypothalamic sides causing a right-sided dominance during state 3 mitochondrial respiration (St3) in ad libitum fed animals. After 24 hours of fasting, lateralization in St3 values was clearly maintained; however, instead of the observed right-sided dominance that was detected in ad libitum fed animals here appeared in form of either right- or left-sidedness. In conclusion, our results revealed estrogen- and satiety state-dependent metabolic differences between the two hypothalamic hemispheres in female rats showing that the hypothalamic hemispheres drive the reproductive and satiety state related functions in an asymmetric manner.	[Toth, Istvan; Kiss, David S.; Jocsak, Gergely; Somogyi, Virag; Bartha, Tibor; Frenyo, Laszlo V.] Szent Istvan Univ, Fac Vet Sci, Dept Physiol & Biochem, Budapest, Hungary; [Toronyi, Eva] Semmelweis Univ, Dept Transplantat & Surg, H-1085 Budapest, Hungary; [Horvath, Tamas L.; Zsarnovszky, Attila] Yale Univ, Sch Med, Div Comparat Med, New Haven, CT USA; [Horvath, Tamas L.; Zsarnovszky, Attila] Szent Istvan Univ, Fac Agr & Environm Sci, Dept Anim Physiol & Anim Hlth, Godollo, Hungary	Hungarian University of Agriculture & Life Sciences; Semmelweis University; Yale University; Hungarian University of Agriculture & Life Sciences	Toth, I (corresponding author), Szent Istvan Univ, Fac Vet Sci, Dept Physiol & Biochem, Budapest, Hungary.	toth.istvan@aotk.szie.hu			Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal [OTKA 104982, OTKA 72186]; Faculty of Veterinary Science [NKB 15930, KK UK-12021, KK PhD-15263]; Hungarian Ministry of Human Resources [9877-3/2015/FEKUT]	Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal; Faculty of Veterinary Science; Hungarian Ministry of Human Resources	This work was supported by OTKA 104982 (Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal; http://www.otka.hu/) to AZ, and OTKA 72186 (Nemzeti Kutatasi, Fejlesztesi es Innovacios Hivatal; http://www.otka.hu/) to TB (design, data collection, analysis); NKB 15930, KK UK-12021 (Faculty of Veterinary Science; http://www.univet.hu/hu/kiemeltegysegek/tkk/palyazatok-kutato-kar-2013-16/kutatokar/) (data collection); KK PhD-15263 (Faculty of Veterinary Science; http://www.univet.hu/hu/kiemeltegysegek/tkk/palyazatok-kutato-kar-2013-16/kutato-kar/) (preparation of the manuscript); and 9877-3/2015/FEKUT (grant of the Hungarian Ministry of Human Resources) (preparation of manuscript).	Ainslie DA, 2001, INT J OBESITY, V25, P1680, DOI 10.1038/sj.ijo.0801806; Aizawa H, 2013, ANAT SCI INT, V88, P1, DOI 10.1007/s12565-012-0158-6; Arnold S, 2012, J STEROID BIOCHEM, V131, P2, DOI 10.1016/j.jsbmb.2012.01.012; Arteaga-Lopez PR, 2003, ENDOCRINE, V21, P251, DOI 10.1385/ENDO:21:3:251; BAKALKIN GY, 1984, BRAIN RES, V296, P361, DOI 10.1016/0006-8993(84)90074-X; BETANCUR C, 1991, BRAIN BEHAV IMMUN, V5, P162, DOI 10.1016/0889-1591(91)90014-2; BORSONCHAZOT F, 1986, BRAIN RES, V382, P433, DOI 10.1016/0006-8993(86)91358-2; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Clegg DJ, 2007, DIABETES, V56, P1051, DOI 10.2337/db06-0015; Cruz ME, 2014, ALCOHOL CLIN EXP RES, V38, P1611, DOI 10.1111/acer.12399; CRUZ ME, 1989, J ENDOCRINOL, V123, P437, DOI 10.1677/joe.0.1230437; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; de la Iglesia HO, 2003, J NEUROSCI, V23, P7412; DELRUE C, 1994, BRAIN BEHAV IMMUN, V8, P137, DOI 10.1006/brbi.1994.1013; FUKUDA M, 1984, NEUROSCI LETT, V51, P365, DOI 10.1016/0304-3940(84)90404-X; GERENDAI I, 1978, NEUROSCI LETT, V9, P333, DOI 10.1016/0304-3940(78)90204-5; Grossmann A, 2013, NEUROBIOLOGY CYTOKIN, V16th, P302; Grundmann SJ, 2005, AM J PHYSIOL-REG I, V288, pR702, DOI 10.1152/ajpregu.00460.2004; Gupte AA, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/916585; Harris JA, 1996, NEUROSCI BIOBEHAV R, V20, P637, DOI 10.1016/0149-7634(95)00077-1; Hou GL, 2013, NEUROCHEM RES, V38, P453, DOI 10.1007/s11064-012-0954-3; INASE Y, 1992, BRAIN RES, V580, P338, DOI 10.1016/0006-8993(92)90964-B; Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5; Kelly MJ, 2008, MOL CELL ENDOCRINOL, V290, P14, DOI 10.1016/j.mce.2008.04.014; KING TR, 1985, PHYSIOL BEHAV, V35, P955, DOI 10.1016/0031-9384(85)90265-3; Kiss DS, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-31; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lopez E, 1997, ARCH MED RES, V28, P343; MITTLEMAN G, 1985, BEHAV BRAIN RES, V15, P263, DOI 10.1016/0166-4328(85)90182-2; Naftolin F, 2007, REPROD SCI, V14, P101, DOI 10.1177/1933719107301059; NANCE DM, 1984, BRAIN RES BULL, V13, P651, DOI 10.1016/0361-9230(84)90197-7; NANCE DM, 1983, BRAIN RES BULL, V10, P353, DOI 10.1016/0361-9230(83)90103-X; Ribolsi M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01010; ROY EJ, 1987, PHYSIOL BEHAV, V40, P267, DOI 10.1016/0031-9384(87)90219-8; Santollo J, 2008, BEHAV BRAIN RES, V191, P173, DOI 10.1016/j.bbr.2008.03.019; Stratton RC, 2010, J BIOL CHEM, V285, P27201, DOI 10.1074/jbc.M110.103630; Toth I, 2014, REPROD SCI, V21, P1492, DOI 10.1177/1933719114530188; Vanetsian G L, 2004, Neurosci Behav Physiol, V34, P703, DOI 10.1023/B:NEAB.0000036011.57653.fc; Xavier CH, 2009, NEUROSCIENCE, V164, P1360, DOI 10.1016/j.neuroscience.2009.09.018; Xavier CH, 2013, AM J PHYSIOL-REG I, V304, pR664, DOI 10.1152/ajpregu.00401.2012; ZHANG LM, 1995, NEUROREPORT, V6, P537, DOI 10.1097/00001756-199502000-00032; Zheng JB, 1999, J STEROID BIOCHEM, V68, P65, DOI 10.1016/S0960-0760(98)00161-7; Zheng JB, 1999, EUR J PHARMACOL, V368, P95, DOI 10.1016/S0014-2999(99)00012-6	44	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137462	10.1371/journal.pone.0137462	http://dx.doi.org/10.1371/journal.pone.0137462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339901	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200062
J	Gomez, JMT; Diaz-Gete, L; Martin-Cantera, C; Escurriola, MF; Moreno, ML; Leandro, RB; Quintero, AMG; Ballve, JL; Jimenez, MLC; Puig, EP; More, RC; Rueda, BG; Casajuana, M; Mendez-Aguirre, M; Bonias, DG; Maestre, SF; Fondevila, JS				Trujillo Gomez, Jose Manuel; Diaz-Gete, Laura; Martin-Cantera, Carlos; Fabregas Escurriola, Mireia; Lozano Moreno, Maribel; Buron Leandro, Raquel; Gomez Quintero, Ana Maria; Luis Ballve, Jose; Clemente Jimenez, Maria Lourdes; Puigdomenech Puig, Elisa; Casas More, Ramon; Garcia Rueda, Beatriz; Casajuana, Marc; Mendez-Aguirre, Marga; Garcia Bonias, David; Fernandez Maestre, Soraya; Sanchez Fondevila, Jessica			Intervention for Smokers through New Communication Technologies: What Perceptions Do Patients and Healthcare Professionals Have? A Qualitative Study	PLOS ONE			English	Article							SMOKING-CESSATION; E-MAIL; INTERNET; INFORMATION; PART	Background The use of information and communication technologies (ICTs) in the health service is increasing. In spite of limitations, such as lack of time and experience, the deployment of ICTs in the healthcare system has advantages which include patient satisfaction with secure messaging, and time saving benefits and utility for patients and health professionals. ICTs may be helpful as either interventions on their own or as complementary tools to help patients stop smoking. Objectives To gather opinions from both medical professionals and smokers about an email-based application that had been designed by our research group to help smoking cessation, and identify the advantages and disadvantages associated with interventions based on the utilization of ICTs for this purpose. Methods A qualitative, descriptive-interpretative study with a phenomenological perspective was performed to identify and interpret the discourses of the participating smokers and primary healthcare professionals. Data were obtained through two techniques: semi-structured individual interviews and discussion groups, which were recorded and later systematically and literally transcribed together with the interviewer's notes. Data were analyzed with the ATLAS TI 6.0 programme. Results Seven individual interviews and four focal groups were conducted. The advantages of the application based on the email intervention designed by our research group were said to be the saving of time in consultations and ease of access for patients who found work timetables and following a programme for smoking cessation incompatible. The disadvantages were thought to be a lack of personal contact with the healthcare professional, and the possibility of cheating/self-deception, and a greater probability of relapse on the part of the smokers. Conclusions Both patients and healthcare professionals viewed the email-based application to help patients stop smoking as a complementary aid to face-to-face consultations. Nevertheless, ICTs could not substitute personal contact in the smoking cessation programme.	[Trujillo Gomez, Jose Manuel] Ctr Salud Cuevas Almanzora, Serv Andaluz Salud, Almeria, Spain; [Trujillo Gomez, Jose Manuel; Martin-Cantera, Carlos; Puigdomenech Puig, Elisa; Casajuana, Marc; Sanchez Fondevila, Jessica] Primary Healthcare Univ Res Inst IDIAP Jordi Gol, Barcelona, Spain; [Diaz-Gete, Laura; Fernandez Maestre, Soraya] Inst Catala Salut, Ctr Atencio Primaria La Sagrera, Barcelona, Spain; [Martin-Cantera, Carlos; Lozano Moreno, Maribel] Inst Catala Salut, Ctr Atencio Primaria Passeig de St Joan, Barcelona, Spain; [Fabregas Escurriola, Mireia] Inst Catala Salut, Ctr Atencio Primaria La Marina, Barcelona, Spain; [Buron Leandro, Raquel; Gomez Quintero, Ana Maria] Inst Catala Salut, Ctr Atencio Primaria Turo, Barcelona, Spain; [Luis Ballve, Jose] Inst Catala Salut, Ctr Atencio Primaria Florida Nord, Lhospitalet De Llobregat, Spain; [Clemente Jimenez, Maria Lourdes] Ctr Salud Santo Grial, Serv Aragones Salud, Huesca, Spain; [Casas More, Ramon] Inst Catala Salut, Ctr Atencio Primaria St Antoni, Barcelona, Spain; [Garcia Rueda, Beatriz] Inst Catala Salut, Ctr Atencio Primaria Goretti Badia, Barcelona, Spain; [Garcia Bonias, David] Inst Catala Salut, Ctr Atencio Primaria Vallcarca St Gervasi, Barcelona, Spain		Gomez, JMT (corresponding author), Ctr Salud Cuevas Almanzora, Serv Andaluz Salud, Almeria, Spain.	aplaceinheaven@hotmail.com	Martin Cantera, Carlos/D-2693-2011	Martin Cantera, Carlos/0000-0003-0656-8126; Casajuana Closas, Marc/0000-0001-5653-996X	4a Convocatoria de moduls de recerca de l'ambit d'Atencio primaria de Barcelona ciutat	4a Convocatoria de moduls de recerca de l'ambit d'Atencio primaria de Barcelona ciutat	This work was supported by research grants from 4a Convocatoria de moduls de recerca de l'ambit d'Atencio primaria de Barcelona ciutat 2011.	Asociacion para la Investigacion de Medios de Comunicacion, 2014, EST GEN MED; Atherton H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007978.pub2; Atherton H, 2010, J TELEMED TELECARE, V16, P172, DOI 10.1258/jtt.2010.004002; Civljak M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007078.pub4; Cobb NK, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.3.e17; Coleman T, 2000, BRIT J GEN PRACT, V50, P207; Diaz-Gete L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-364; Flynn D, 2009, INT J MED INFORM, V78, P588, DOI 10.1016/j.ijmedinf.2009.03.008; Frisby G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e8; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.987; Herbec A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1070; Hsiung RC., 2002, CASE STUDIES GUIDING, P150; Illiger K, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3799; INE, 2020, ENC EQ US TECN INF C; Instituto Nacional de Estadistica (INE), 2015, EST PROF SAN COL; Klatt C, 2008, AM J PREV MED, V35, pS471, DOI 10.1016/j.amepre.2008.09.001; Koehler N, 2013, J MTM, V2, P14, DOI DOI 10.7309/JMTM.2.1.3; Lenert L, 2004, J AM MED INFORM ASSN, V11, P235, DOI 10.1197/jamia.M1464; Meis TM, 2002, JCMC, V7, P1; Patt MR, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.2.e9; Patten CA, 2006, PATIENT EDUC COUNS, V64, P249, DOI 10.1016/j.pec.2006.03.001; Poel FT, 2009, HEALTH EDUC RES, V24, P930, DOI 10.1093/her/cyp036; Polosa R, 2009, RESP CARE, V54, P1033; Puigdomenech E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/1471-2458-15-2; Richmond R, 2009, TOB CONTROL, V18, P176, DOI 10.1136/tc.2008.026393; Stadista, 2014, STAT PORT HOM SHAR M; Stadista. The Statistics Portal, 2014, STAT PORT NUMB MONTH; Wallwiener M, 2009, J TELEMED TELECARE, V15, P243, DOI 10.1258/jtt.2009.090111; World Health Organization Global Observatory for eHealth, 2011, ATLAS EHEALTH COUNTR, V1, P195; World Medical Association, 2013, WMA DECL HELS ETH PR	30	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137415	10.1371/journal.pone.0137415	http://dx.doi.org/10.1371/journal.pone.0137415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340346	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200056
J	Chen, YJ; Xiang, J; Wang, ZQ; Xiao, YM; Zhang, DM; Chen, X; Li, HT; Liu, MN; Zhang, QJ				Chen, Yongjie; Xiang, Jing; Wang, Zhiqiang; Xiao, Yaming; Zhang, Dongmei; Chen, Xia; Li, Huiting; Liu, Meina; Zhang, Qiuju			Associations of Bone Mineral Density with Lean Mass, Fat Mass, and Dietary Patterns in Postmenopausal Chinese Women: A 2-Year Prospective Study	PLOS ONE			English	Article							BODY-MASS; MILK SUPPLEMENTATION; MAJOR DETERMINANT; PROXIMAL FEMUR; VITAMIN-D; CALCIUM; OSTEOPOROSIS; MENOPAUSE; TISSUE; FRACTURES	Objective To assess factors associated with bone mineral density (BMD) in postmenopausal women in a longitudinal study, and to examine the relative contribution of lean mass, fat mass, dietary patterns, and years since menopause to BMD. Methods Two hundred and eighty-two postmenopausal women were randomly selected from Hongqi Community Health Center, in Harbin City, China. All participants were followed up from 2009 to 2011. Dietary data were collected using a Food Frequency Questionnaire. BMD of the left hip, the lumbar spine, and the total body, and the body composition were measured by dual-energy X-ray absorptiometry at baseline and follow-up. Results Lean mass and fat mass were positively associated with BMD of the spine, hip, and the total body at both baseline and follow-up. The association between fat mass and BMD at the spine at baseline (P = 0.210) and at the spine (P = 0.116) and hip (P = 0.073) in the second year was not statistically significant when height was adjusted. Six dietary patterns were identified but only cereal grains-fruits pattern (P = 0.001 in the spine, P = 0.037 in hip) and milk-root vegetables pattern (P = 0.010 in hip) were associated with BMD of the spine and hip. The linear mixed model of follow-up data showed that lean mass, years since menopause, and age of menophania were the significant determinants of BMD of all sites. Moreover, lean mass was the best determinant of BMD (VIP = 1.936). Conclusion Lean mass, years since menopause, age of menophania and dietary patterns are the important determinants of BMD of the spine, hip, and the total body. Lean mass is the best determinant of BMD.	[Chen, Yongjie; Xiang, Jing; Xiao, Yaming; Liu, Meina; Zhang, Qiuju] Harbin Med Univ, Coll Publ Hlth, Dept Biostat, Harbin, Heilongjiang Pr, Peoples R China; [Wang, Zhiqiang] Univ Queensland, Sch Med, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Zhang, Dongmei] First Peoples Hosp Tengzhou, Zaozhuang City, Shandong, Peoples R China; [Chen, Xia] Changsha Med Univ, Dept Epidemiol & Evidence Based Med, Coll Publ Hlth, Changsha, Hunan, Peoples R China; [Li, Huiting] Harbin Inst Technol Hosp, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Royal Brisbane & Women's Hospital; University of Queensland; Changsha Medical University; Harbin Institute of Technology	Liu, MN (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Biostat, Harbin, Heilongjiang Pr, Peoples R China.	liumeina369@163.com; zqj81129@sina.com	zhang, qiu/GXG-5600-2022; Wang, Zhiqiang/A-5835-2010	Wang, Zhiqiang/0000-0002-5839-743X	National Major Scientific and Technological Special Project of China [2014ZX08011005]	National Major Scientific and Technological Special Project of China	This study was supported by the National Major Scientific and Technological Special Project of China (2014ZX08011005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.nmp.gov.cn/	Bates DW, 2002, JAMA-J AM MED ASSOC, V288, P1898, DOI 10.1001/jama.288.15.1898; Blain H, 2004, CALCIFIED TISSUE INT, V75, P32, DOI 10.1007/s00223-003-0192-4; Chee WSS, 2003, OSTEOPOROSIS INT, V14, P828, DOI 10.1007/s00198-003-1448-6; Chen Z, 1997, J BONE MINER RES, V12, P144, DOI 10.1359/jbmr.1997.12.1.144; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Da Shao H, 2015, J BONE MINER METAB, V33, P507, DOI 10.1007/s00774-014-0613-7; Douchi T, 2003, MATURITAS, V45, P185, DOI 10.1016/S0378-5122(03)00143-9; Dytfeld J, 2011, ARCH GERONTOL GERIAT, V53, pE237, DOI 10.1016/j.archger.2011.01.002; Fu X, 2011, OSTEOPOROSIS INT, V22, P113, DOI 10.1007/s00198-010-1210-9; GAMBACCIANI M, 1993, J CLIN ENDOCR METAB, V77, P1148, DOI 10.1210/jcem.77.5.8077305; Gnudi S, 2007, J BONE MINER METAB, V25, P326, DOI 10.1007/s00774-007-0758-8; Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190; Ho-Pham LT, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-59; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Kruger MC, 2012, EUR J CLIN NUTR, V66, P856, DOI 10.1038/ejcn.2012.54; Lau EMC, 2001, J BONE MINER RES, V16, P1704, DOI 10.1359/jbmr.2001.16.9.1704; LEY CJ, 1992, AM J CLIN NUTR, V55, P950, DOI 10.1093/ajcn/55.5.950; Li GW, 2014, J BONE MINER METAB, P1; Li ST, 2013, AM J CLIN NUTR, V98, P1353, DOI 10.3945/ajcn.113.062844; Liu-Ambrose T, 2006, CALCIFIED TISSUE INT, V79, P145, DOI 10.1007/s00223-006-0098-z; Namwongprom S, 2013, INT J WOMENS HEALTH, V5, P87, DOI 10.2147/IJWH.S41884; Nguyen ND, 2007, J BONE MINER RES, V22, P1147, DOI [10.1359/jbmr.070412, 10.1359/JBMR.070412]; Ofluoglu D, 2005, CLIN RHEUMATOL, V24, P606, DOI 10.1007/s10067-005-1110-0; Ozdemir F, 2005, TOHOKU J EXP MED, V205, P277, DOI 10.1620/tjem.205.277; Park YW, 2001, OBES RES, V9, P381, DOI 10.1038/oby.2001.49; Piaseu Noppawan, 2001, Journal of the Medical Association of Thailand, V84, P772; RANNAR S, 1994, J CHEMOMETR, V8, P111, DOI 10.1002/cem.1180080204; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Sotunde OF, 2015, J NUTR HEALTH AGING, V19, P628, DOI 10.1007/s12603-015-0492-1; Taaffe DR, 2001, J BONE MINER RES, V16, P1343, DOI 10.1359/jbmr.2001.16.7.1343; Tobias RD, 1995, P ANN SAS US GROUP I; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; Woolf AD, 2003, BMJ-BRIT MED J, V327, P89, DOI 10.1136/bmj.327.7406.89; Yaegashi Y, 2008, EUR J EPIDEMIOL, V23, P219, DOI 10.1007/s10654-008-9225-7; Yang S, 2015, OSTEOPOROSIS INT, V26, P1381, DOI 10.1007/s00198-014-3009-6; Zhu K, 2015, BONE, V74, P146, DOI 10.1016/j.bone.2015.01.015; Zillikens MC, 2010, CALCIFIED TISSUE INT, V86, P116, DOI 10.1007/s00223-009-9319-6	39	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137097	10.1371/journal.pone.0137097	http://dx.doi.org/10.1371/journal.pone.0137097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335921	gold, Green Published, Green Submitted			2022-12-27	WOS:000360615400039
J	Miehe-Steier, A; Roscher, C; Reichelt, M; Gershenzon, J; Unsicker, SB				Miehe-Steier, Annegret; Roscher, Christiane; Reichelt, Michael; Gershenzon, Jonathan; Unsicker, Sybille B.			Light and Nutrient Dependent Responses in Secondary Metabolites of Plantago lanceolata Offspring Are Due to Phenotypic Plasticity in Experimental Grasslands	PLOS ONE			English	Article							IRIDOID GLYCOSIDES; CHEMICAL DEFENSE; MORPHOLOGICAL VARIATION; INVERTEBRATE HERBIVORY; QUANTITATIVE VARIATION; SPECIES RICHNESS; RESOURCE USE; GENERALIST; SPECIALIST; GROWTH	A few studies in the past have shown that plant diversity in terms of species richness and functional composition can modify plant defense chemistry. However, it is not yet clear to what extent genetic differentiation of plant chemotypes or phenotypic plasticity in response to diversity-induced variation in growth conditions or a combination of both is responsible for this pattern. We collected seed families of ribwort plantain (Plantago lanceolata) from six-year old experimental grasslands of varying plant diversity (Jena Experiment). The offspring of these seed families was grown under standardized conditions with two levels of light and nutrients. The iridoid glycosides, catalpol and aucubin, and verbascoside, a caffeoyl phenylethanoid glycoside, were measured in roots and shoots. Although offspring of different seed families differed in the tissue concentrations of defensive metabolites, plant diversity in the mothers' environment did not explain the variation in the measured defensive metabolites of P. lanceolata offspring. However secondary metabolite levels in roots and shoots were strongly affected by light and nutrient availability. Highest concentrations of iridoid glycosides and verbascoside were found under high light conditions, and nutrient availability had positive effects on iridoid glycoside concentrations in plants grown under high light conditions. However, verbascoside concentrations decreased under high levels of nutrients irrespective of light. The data from our greenhouse study show that phenotypic plasticity in response to environmental variation rather than genetic differentiation in response to plant community diversity is responsible for variation in secondary metabolite concentrations of P. lanceolata in the six-year old communities of the grassland biodiversity experiment. Due to its large phenotypic plasticity P. lanceolata has the potential for a fast and efficient adjustment to varying environmental conditions in plant communities of different species richness and functional composition.	[Miehe-Steier, Annegret; Reichelt, Michael; Gershenzon, Jonathan; Unsicker, Sybille B.] Max Planck Inst Chem Ecol, Jena, Germany; [Miehe-Steier, Annegret; Roscher, Christiane] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Roscher, Christiane] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany	Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Unsicker, SB (corresponding author), Max Planck Inst Chem Ecol, Jena, Germany.	sunsicker@ice.mpg.de	Gershenzon, Jonathan/K-1331-2013; Unsicker, Sybille B./AAW-6968-2021	Gershenzon, Jonathan/0000-0002-1812-1551; Unsicker, Sybille B./0000-0002-9738-0075	MPI for Chemical Ecology; MPI for Biogeochemistry; IMPRS-gBGC; German Science Foundation [FOR 456/1451]	MPI for Chemical Ecology; MPI for Biogeochemistry; IMPRS-gBGC; German Science Foundation(German Research Foundation (DFG))	This experiment was funded by MPI for Chemical Ecology, MPI for Biogeochemistry and IMPRS-gBGC. The Jena Experiment is funded by the German Science Foundation (FOR 456/1451).	Alexander JM, 2012, J ECOL, V100, P771, DOI 10.1111/j.1365-2745.2011.01951.x; ARNONE JA, 1995, OECOLOGIA, V104, P72, DOI 10.1007/BF00365564; Barton KE, 2008, OIKOS, V117, P917, DOI 10.1111/j.0030-1299.2008.16324.x; Barton KE, 2006, OECOLOGIA, V150, P442, DOI 10.1007/s00442-006-0531-z; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baythavong BS, 2011, AM NAT, V178, P75, DOI 10.1086/660281; Bennett AE, 2007, ECOLOGY, V88, P210, DOI 10.1890/0012-9658(2007)88[210:MSDAPG]2.0.CO;2; Bessler H, 2012, PLANT SOIL, V358, P301, DOI 10.1007/s11104-012-1181-z; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; Bode RF, 2012, J ECOL, V100, P795, DOI 10.1111/j.1365-2745.2012.01958.x; BOWERS MD, 1988, J CHEM ECOL, V14, P319, DOI 10.1007/BF01022549; BOWERS MD, 1993, ECOLOGY, V74, P1778, DOI 10.2307/1939936; BOWERS MD, 1992, J CHEM ECOL, V18, P985, DOI 10.1007/BF00980057; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Darrow K, 1997, BIOCHEM SYST ECOL, V25, P1, DOI 10.1016/S0305-1978(96)00090-7; DUDT JF, 1994, ECOLOGY, V75, P86, DOI 10.2307/1939385; Eichmann R, 2008, J PLANT PHYSIOL, V165, P5, DOI 10.1016/j.jplph.2007.05.004; Ellenberg H., 1988, Vegetation ecology of Central Europe.; FAJER ED, 1992, AM NAT, V140, P707, DOI 10.1086/285436; Fritz C, 2006, PLANT J, V46, P533, DOI 10.1111/j.1365-313X.2006.02715.x; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Harvey JA, 2005, J CHEM ECOL, V31, P287, DOI 10.1007/s10886-005-1341-1; Hemming JDC, 1999, J CHEM ECOL, V25, P1687, DOI 10.1023/A:1020805420160; Holeski LM, 2013, J CHEM ECOL, V39, P525, DOI 10.1007/s10886-013-0270-7; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ingersoll CM, 2010, BOTANY, V88, P1007, DOI 10.1139/B10-072; Jamieson MA, 2012, CHEMOECOLOGY, V22, P1, DOI 10.1007/s00049-011-0087-1; Jarzomski CM, 2000, OIKOS, V88, P371, DOI 10.1034/j.1600-0706.2000.880216.x; Kawoosa T, 2010, FUNCT INTEGR GENOMIC, V10, P393, DOI 10.1007/s10142-009-0152-9; Kerchev PI, 2012, PLANT CELL ENVIRON, V35, P441, DOI 10.1111/j.1365-3040.2011.02399.x; Klotz S, 2003, SCHRREIHE VEGKD, V38, P1; Kluge G, 2000, BER DTSCH WETTERDIEN, V213, P1; Lampert EC, 2010, J CHEM ECOL, V36, P1101, DOI 10.1007/s10886-010-9849-4; Larbat R, 2012, PLANT BIOLOGY, V14, P760, DOI 10.1111/j.1438-8677.2012.00564.x; Li H, 2010, PHYTOCHEMISTRY, V71, P1690, DOI 10.1016/j.phytochem.2010.06.019; Lipowsky A, 2011, BASIC APPL ECOL, V12, P360, DOI 10.1016/j.baae.2011.03.005; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; Marak HB, 2003, EVOLUTION, V57, P2519, DOI 10.1111/j.0014-3820.2003.tb01496.x; Marak HB, 2002, J CHEM ECOL, V28, P2429, DOI 10.1023/A:1021475800765; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; McCloud ES, 1999, ENTOMOL EXP APPL, V93, P233, DOI 10.1023/A:1003806316904; MOLGAARD P, 1986, BIOCHEM SYST ECOL, V14, P113, DOI 10.1016/0305-1978(86)90095-5; MOLGAARD P, 1986, J ECOL, V74, P1127, DOI 10.2307/2260239; Moreira X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105438; Mraja A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028055; Nieminen M, 2003, J CHEM ECOL, V29, P823, DOI 10.1023/A:1022923514534; Niinemets U, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00262; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Pellissier L, 2014, ECOGRAPHY, V37, P950, DOI 10.1111/ecog.00833; PEREYRA PC, 1988, J CHEM ECOL, V14, P917, DOI 10.1007/BF01018783; PUTTICK GM, 1988, J CHEM ECOL, V14, P335, DOI 10.1007/BF01022550; R Core Team, 2021, R LANGUAGE ENV STAT; REICHARDT PB, 1988, ACS SYM SER, V380, P130; Reudler JH, 2011, J CHEM ECOL, V37, P765, DOI 10.1007/s10886-011-9983-7; Reudler Talsma JH, 2008, J CHEM ECOL, V34, P1202, DOI 10.1007/s10886-008-9519-y; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2011, PLANT BIOLOGY, V13, P134, DOI 10.1111/j.1438-8677.2010.00338.x; Roscher C, 2011, ANN BOT-LONDON, V107, P965, DOI 10.1093/aob/mcr044; SAGAR GR, 1964, J ECOL, V52, P189, DOI 10.2307/2257792; Scherber C, 2006, OECOLOGIA, V147, P489, DOI 10.1007/s00442-005-0281-3; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; SHARMA N, 1992, ANN BOT-LONDON, V69, P7, DOI 10.1093/oxfordjournals.aob.a088309; SHOYAMA Y, 1987, PHYTOCHEMISTRY, V26, P983, DOI 10.1016/S0031-9422(00)82331-6; Smilanich AM, 2009, ECOL LETT, V12, P612, DOI 10.1111/j.1461-0248.2009.01309.x; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Suomi J, 2003, ANAL BIOANAL CHEM, V376, P884, DOI 10.1007/s00216-003-2003-1; Unsicker SB, 2006, OECOLOGIA, V150, P233, DOI 10.1007/s00442-006-0511-3; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Van Tienderen Peter H., 1996, Plant Species Biology, V11, P87; vanHinsberg A, 1997, J EVOLUTION BIOL, V10, P687, DOI 10.1007/s000360050049; VANTIENDEREN PH, 1990, EVOL TREND PLANT, V4, P35; Waterman P.G., 1989, P107; YOUNG KA, 1995, FUNCT ECOL, V9, P725, DOI 10.2307/2390245; Zuppinger-Dingley D, 2014, NATURE, V515, P108, DOI 10.1038/nature13869; Zuur Alain F., 2009, P1	76	21	21	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136073	10.1371/journal.pone.0136073	http://dx.doi.org/10.1371/journal.pone.0136073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336100	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400009
J	Neiman, J; Giuseffi, K; Smith, K; French, J; Waismel-Manor, I; Hibbing, J				Neiman, Jayme; Giuseffi, Karl; Smith, Kevin; French, Jeffrey; Waismel-Manor, Israel; Hibbing, John			Voting at Home Is Associated with Lower Cortisol than Voting at the Polls	PLOS ONE			English	Article							NEGATIVE AFFECT; VALIDATION; BEHAVIOR; PANAS	Previous research finds that voting is a socially stressful activity associated with increases in cortisol levels. Here we extend this research by investigating whether different voting modalities have differential effects on the stress response to voting. Results from a field experiment conducted during the 2012 presidential elections strongly suggest that traditional "at the polls" voting is more stressful, as measured by increases in cortisol levels, than voting at home by mail-in ballot or engaging in comparable non-political social activities. These findings imply that increased low-stress voting options such as mail-in ballots may increase political participation among individuals who are sensitive to social stressors.	[Neiman, Jayme] Univ No Iowa, Dept Polit Sci, Cedar Falls, IA 50614 USA; [Giuseffi, Karl; Smith, Kevin; Hibbing, John] Univ Nebraska, Dept Polit Sci, Lincoln, NE USA; [French, Jeffrey] Univ Nebraska, Dept Psychol, Omaha, NE 68182 USA; [Waismel-Manor, Israel] Univ Haifa, Sch Polit Sci, IL-31999 Haifa, Israel	University of Northern Iowa; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Haifa	Neiman, J (corresponding author), Univ No Iowa, Dept Polit Sci, Cedar Falls, IA 50614 USA.	jayme.neiman@uni.edu	waismel-manor, israel/GQA-3701-2022	waismel-manor, israel/0000-0001-6202-8111	Human and Social Dynamics initiative at the National Science Foundation [BCS-08-26828]	Human and Social Dynamics initiative at the National Science Foundation	This research was made possible by a grant (BCS-08-26828) from the Human and Social Dynamics initiative at the National Science Foundation (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Apicella CL, 2011, MAN IS NATURE POLITI, P261; Blanton H, 2012, POLIT COMMUN, V29, P447, DOI 10.1080/10584609.2012.736239; Clements AD, 1998, PSYCHONEUROENDOCRINO, V23, P613; French JA, 2014, PHYSIOL BEHAV, V133, P61, DOI 10.1016/j.physbeh.2014.05.004; Het S, 2012, PSYCHOSOM MED, V74, P23, DOI 10.1097/PSY.0b013e31823a4a25; Kudielka B. M., 2007, SOC NEUROSCI-UK, P56, DOI DOI 10.1007/978-1-4614-6852-3; Marcus G.E., 2010, SENTIMENTAL CITIZEN; McDermott R., 2011, MAN IS NATURE POLITI; Mcdermott R, 2007, ANN AM ACAD POLIT SS, V614, P15, DOI 10.1177/0002716207305268; Smyth J, 1998, PSYCHONEUROENDOCRINO, V23, P353, DOI 10.1016/S0306-4530(98)00008-0; Stanton SJ, 2010, PSYCHONEUROENDOCRINO, V35, P768, DOI 10.1016/j.psyneuen.2009.10.018; Susman EJ, 2007, DEV PSYCHOL, V43, P811, DOI 10.1037/0012-1649.43.4.811; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; van Honk J, 2003, NEUROREPORT, V14, P1993, DOI 10.1097/00001756-200310270-00023; Wai ST, 2004, PSYCHIAT RES, V126, P197; Waismel-Manor I, 2011, EUR NEUROPSYCHOPHARM, V21, P789, DOI 10.1016/j.euroneuro.2011.03.003; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Young EA, 2004, BIOL PSYCHIAT, V56, P205, DOI 10.1016/j.biopsych.2004.05.011	18	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0135289	10.1371/journal.pone.0135289	http://dx.doi.org/10.1371/journal.pone.0135289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335591	Green Published, gold			2022-12-27	WOS:000360615400004
J	Fiacconi, CM; Owen, AM				Fiacconi, Chris M.; Owen, Adrian M.			Using Psychophysiological Measures to Examine the Temporal Profile of Verbal Humor Elicitation	PLOS ONE			English	Article							CENTRAL ELECTROPHYSIOLOGY; HEART-RATE; EMOTION; ATTENTION; TIME	Despite its pervasiveness in popular culture, there remains much to be learned about the psychological and physiological processes that underlie our experience of humor. In the present study, we examined the temporal profile of verbal humor elicitation using psychophysiological measures of heart rate (HR) and facial electromyography (EMG). Consistent with recent prior research on cardiovascular changes to perceived humor, we found that HR acceleration was greater for jokes relative to non-jokes, and was positively related to the level of perceived humor elicited by these jokes. In addition, activity recorded from the zygomaticus major muscle that controls smiling was found to be greater for jokes relative to nonjokes. To link these physiological changes to the psychological processes that govern humor comprehension, we took the initial inflection point of the zygomatic EMG response as a marker for the onset of humor comprehension, and used this marker to probe the pattern of cardiovascular activity at this time-point. We estimated the onset of the humor response to occur during the initial HR deceleration phase, and found that jokes relative to non-jokes elicited a decreased HR response at this time-point. This result questions the previously forwarded notion that the psychological "moment of insight" that signals the start of the humor response is always associated with heightened cardiovascular activity. This discrepancy is discussed in relation to possible differences in the cognitive processes required to comprehend different forms of humor. At a broader level, our results also demonstrate the advantages of combining different psychophysiological measures to examine psychological phenomena, and illustrate how one such measure can constrain the interpretation of others.	[Fiacconi, Chris M.; Owen, Adrian M.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada	Western University (University of Western Ontario)	Fiacconi, CM (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON, Canada.	cfiacco@uwo.ca			Canada Excellence Research Chair in Cognitive Imaging and Neuroscience grant	Canada Excellence Research Chair in Cognitive Imaging and Neuroscience grant	This research was funded by a Canada Excellence Research Chair in Cognitive Imaging and Neuroscience grant awarded to A.M.O. without the support of any commercial sponsors.	Attardo S, 1997, HUMOR, V10, P395, DOI 10.1515/humr.1997.10.4.395; Bekinschtein TA, 2011, J NEUROSCI, V31, P9665, DOI 10.1523/JNEUROSCI.5058-10.2011; BERNTSON GG, 1992, ATTENTION AND INFORMATION PROCESSING IN INFANTS AND ADULTS, P163; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; de Vries M, 2010, PSYCHOL SCI, V21, P321, DOI 10.1177/0956797609359878; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; GRAHAM FK, 1978, PSYCHOPHYSIOLOGY, V15, P492, DOI 10.1111/j.1469-8986.1978.tb01422.x; Guerra P, 2012, INT J PSYCHOPHYSIOL, V85, P79, DOI 10.1016/j.ijpsycho.2011.06.004; Guerra P, 2011, BIOL PSYCHOL, V88, P196, DOI 10.1016/j.biopsycho.2011.08.002; Harmon-Jones E, 2001, PERS SOC PSYCHOL B, V27, P889, DOI 10.1177/0146167201277011; Iwase M, 2002, NEUROIMAGE, V17, P758, DOI 10.1006/nimg.2002.1225; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Lackner HK, 2013, BIOL PSYCHOL, V93, P33, DOI 10.1016/j.biopsycho.2013.01.014; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LIBBY WL, 1973, PSYCHOPHYSIOLOGY, V10, P270, DOI 10.1111/j.1469-8986.1973.tb00526.x; Marinkovic K, 2011, COGN AFFECT BEHAV NE, V11, P113, DOI 10.3758/s13415-010-0017-7; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Suls JM., 1972, PSYCHOL HUMOR THEORE, V1, P81, DOI 10.1016/B978-0-12-288950-9.50010-9; Vaid J, 2003, J PRAGMATICS, V35, P1431, DOI 10.1016/S0378-2166(02)00184-4; Vico C, 2010, NEUROPSYCHOLOGIA, V48, P2894, DOI 10.1016/j.neuropsychologia.2010.05.031; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989	27	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135902	10.1371/journal.pone.0135902	http://dx.doi.org/10.1371/journal.pone.0135902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26332843	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800045
J	Gao, W; Kim, H; Ho, M				Gao, Wei; Kim, Heungnam; Ho, Mitchell			Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; LIVER-REGENERATION; POOR-PROGNOSIS; TUMOR-GROWTH; EXPRESSION; MET; CANCER; ANGIOGENESIS; METASTASIS; PI-88	Heparan sulfate proteoglycans (HSPGs) participate in many processes related to tumor development, including tumorigenesis and metastasis. HSPGs contain one or more heparan sulfate (HS) chains that are covalently linked to a core protein. Glypican-3 (GPC3) is a cell surface-associated HSPG that is highly expressed in hepatocellular carcinoma (HCC). GPC3 is involved in Wnt3a-dependent HCC cell proliferation. Our previous study reported that HS20, a human monoclonal antibody targeting the HS chains on GPC3, inhibited Wnt3a/beta-catenin activation. In the current study, we showed that the HS chains of GPC3 could mediate HCC cells' migration and motility. Knocking down GPC3 or targeting the HS chains by HS20 inhibited HCC cell migration and motility. However, HS20 had no effect on GPC3 knockdown cells or GPC3 negative cells. In addition, an antibody that recognizes the core protein of GPC3 did not change the rate of cell motility. HCC cell migration and motility did not respond to either canonical or non-canonical Wnt induction, but did increase under hepatocyte growth factor (HGF) treatment. HS20-treated HCC cells exhibited less ability for HGF-mediated migration and motility. Furthermore, HS20 inhibited in vitro HCC spheroid formation and liver tumor growth in mice. GPC3 interacted with HGF; however, a mutant GPC3 lacking the HS chain showed less interaction with HGF. Blocking the HS chains on GPC3 with HS20 reduced c-Met activation in HGF-treated HCC cells and 3D-cultured spheroids. Taken together, our study suggests that GPC3 is involved in HCC cell migration and motility through HS chain-mediated cooperation with the HGF/Met pathway, showing how HS targeting has potential therapeutic implications for liver cancer.	[Gao, Wei; Kim, Heungnam; Ho, Mitchell] NCI, Antibody Therapy Sect, Mol Biol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ho, M (corresponding author), NCI, Antibody Therapy Sect, Mol Biol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	homi@mail.nih.gov		Ho, Mitchell/0000-0002-9152-5405	NATIONAL CANCER INSTITUTE [ZIABC010891] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Akutsu N, 2010, WORLD J GASTROENTERO, V16, P3521, DOI 10.3748/wjg.v16.i28.3521; Amicone L, 1997, EMBO J, V16, P495, DOI 10.1093/emboj/16.3.495; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Cecchi F, 2012, CANCER CELL, V22, P250, DOI 10.1016/j.ccr.2012.06.029; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Feng MQ, 2013, P NATL ACAD SCI USA, V110, pE1083, DOI 10.1073/pnas.1217868110; Ferro V, 2007, SEMIN THROMB HEMOST, V33, P557, DOI 10.1055/s-2007-982088; Ferro V, 2012, J MED CHEM, V55, P3804, DOI 10.1021/jm201708h; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Gao W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7536; Gao W, 2014, HEPATOLOGY, V60, P576, DOI 10.1002/hep.26996; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gerotziafas GT, 2007, PATHOPHYSIOL HAEMO T, V36, P204, DOI 10.1159/000175158; Giordano S, 2014, J HEPATOL, V60, P442, DOI 10.1016/j.jhep.2013.09.009; Gutierrez J, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-5; Ho M, 2005, J BIOL CHEM, V280, P607, DOI 10.1074/jbc.M409783200; Hsu HC, 1997, CANCER RES, V57, P5179; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Karihaloo A, 2004, MOL CELL BIOL, V24, P8745, DOI 10.1128/MCB.24.19.8745-8752.2004; Kayed H, 2006, INT J ONCOL, V29, P1139; Kudchadkar R, 2008, EXPERT OPIN INV DRUG, V17, P1769, DOI 10.1517/13543784.17.11.1769 ; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Liu CJ, 2009, J HEPATOL, V50, P958, DOI 10.1016/j.jhep.2008.12.023; Llovet JM, 2014, CLIN CANCER RES, V20, P2072, DOI 10.1158/1078-0432.CCR-13-0547; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Orentas RJ, 2012, FRONT ONCOL, V2, DOI [10.3389/fonc.2012.00194, 10.3389/fonc.2012.00003]; Parish CR, 1999, CANCER RES, V59, P3433; Perini MV, 2015, WORLD J HEPATOL, V7, P93, DOI 10.4254/wjh.v7.i1.93; Phung Y, 2012, MABS-AUSTIN, V4, P592, DOI 10.4161/mabs.20933; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Shirakawa H, 2009, CANCER SCI, V100, P1403, DOI 10.1111/j.1349-7006.2009.01206.x; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Venero Galanternik M, 2015, CELL REP; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Williamson D, 2007, CANCER RES, V67, P57, DOI 10.1158/0008-5472.CAN-06-1650	46	42	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137664	10.1371/journal.pone.0137664	http://dx.doi.org/10.1371/journal.pone.0137664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332121	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800137
J	Humphries, GRW				Humphries, Grant Richard Woodrow			Estimating Regions of Oceanographic Importance for Seabirds Using A-Spatial Data	PLOS ONE			English	Article							PELAGIC SEABIRD; SHEARWATER; HARVEST; TRENDS; OCEAN; CHICK; AVAILABILITY; BEHAVIOR; RAKIURA; COLONY	Advances in GPS tracking technologies have allowed for rapid assessment of important oceanographic regions for seabirds. This allows us to understand seabird distributions, and the characteristics which determine the success of populations. In many cases, quality GPS tracking data may not be available; however, long term population monitoring data may exist. In this study, a method to infer important oceanographic regions for seabirds will be presented using breeding sooty shearwaters as a case study. This method combines a popular machine learning algorithm (generalized boosted regression modeling), geographic information systems, long-term ecological data and open access oceanographic datasets. Time series of chick size and harvest index data derived from a long term dataset of Maori 'muttonbirder' diaries were obtained and used as response variables in a gridded spatial model. It was found that areas of the sub-Antarctic water region best capture the variation in the chick size data. Oceanographic features including wind speed and charnock (a derived variable representing ocean surface roughness) came out as top predictor variables in these models. Previously collected GPS data demonstrates that these regions are used as "flyways" by sooty shearwaters during the breeding season. It is therefore likely that wind speeds in these flyways affect the ability of sooty shearwaters to provision for their chicks due to changes in flight dynamics. This approach was designed to utilize machine learning methodology but can also be implemented with other statistical algorithms. Furthermore, these methods can be applied to any long term time series of population data to identify important regions for a species of interest.	[Humphries, Grant Richard Woodrow] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Humphries, Grant Richard Woodrow] Univ Otago, Dept Zool, Ctr Sustainabil Agr Food Energy & Environm, Dunedin, New Zealand	University of California System; University of California Davis; University of Otago	Humphries, GRW (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	grwhumphries@humphriesresearch.com		Humphries, Grant/0000-0001-5783-9892	National Geographic [WGS249-12]	National Geographic(National Geographic Society)	This project was funded by National Geographic, grant# WGS249-12 on behalf of the Waitt Foundation and the Department of Zoology at the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2010, MAR BIOL, V157, P915, DOI 10.1007/s00227-009-1367-y; Becker BH, 2007, MAR ECOL PROG SER, V329, P267, DOI 10.3354/meps329267; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Brooke M., 2004, ALBATROSSES PETRELS; Catry T, 2009, MAR ECOL PROG SER, V391, P231, DOI 10.3354/meps07717; Clucas R, 2012, NEW ZEAL J ZOOL, V39, P155, DOI 10.1080/03014223.2011.621438; Clucas R, 2011, ECOL APPL, V21, P1308, DOI 10.1890/09-0813.1; Croxall JP, 1999, MAR ECOL PROG SER, V177, P115, DOI 10.3354/meps177115; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; ESRI, 2014, ARCGIS DESKT; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Furness RW, 1996, ECOLOGY, V77, P1181, DOI 10.2307/2265587; Grecian WJ, 2012, BIOL CONSERV, V156, P43, DOI 10.1016/j.biocon.2011.12.010; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Huettmann F, 2001, ECOL MODEL, V141, P261, DOI 10.1016/S0304-3800(01)00278-2; Huettmann Falk, 2011, Marine Biodiversity, V41, P141, DOI 10.1007/s12526-011-0083-2; Humphries G, 2014, USING LONG TERM HARV; Humphries GRW, 2014, ECOL APPL, V24, P2107, DOI 10.1890/13-2023.1; HUTCHISON LV, 1980, CONDOR, V82, P314, DOI 10.2307/1367400; Hyrenbach K, 2005, FISH OCEANOGR, V14, P1, DOI [10.1016/j.theriogenology.2008.06.024, DOI 10.1016/J.THERIOGENOLOGY.2008.06.024]; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; KLEIN SA, 1995, J CLIMATE, V8, P1140, DOI 10.1175/1520-0442(1995)008<1140:OTRALC>2.0.CO;2; Lyver PO, 1999, MAR ECOL PROG SER, V188, P237, DOI 10.3354/meps188237; Meskhidze N, 2010, ADV METEOROL, V2010, DOI 10.1155/2010/239808; Michener WK, 2011, ECOL INFORM, V6, P13, DOI 10.1016/j.ecoinf.2010.11.005; Moller H, 2009, NEW ZEAL J ZOOL, V36, P211, DOI 10.1080/03014220909510152; Navarro J, 2007, OECOLOGIA, V151, P150, DOI 10.1007/s00442-006-0559-0; Nevitt G, 1999, MAR ECOL PROG SER, V177, P235, DOI 10.3354/meps177235; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinet P, 2011, MAR ECOL PROG SER, V423, P291, DOI 10.3354/meps08971; R Core Team, 2021, R LANGUAGE ENV STAT; Raymond B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010960; Richdale L, 1944, JSTOR, V46, P93; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Sala JE, 2012, MAR ECOL PROG SER, V464, P273, DOI 10.3354/meps09887; Salford Predictive Modeler, 2019, INTR TREENET GRAD BO; Salihoglu B, 2001, POLAR BIOL, V24, P328, DOI 10.1007/s003000000215; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; Sorensen MC, 2009, J ANIM ECOL, V78, P460, DOI 10.1111/j.1365-2656.2008.01492.x; Stevens MJ, 2006, J PAC HIST, V41, P273, DOI 10.1080/00223340600984737; Team N, 2013, NCAR COMM LANG VERS; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; WARHAM J, 1982, Notornis, V29, P269; Weimerskirch H, 2006, OECOLOGIA, V146, P681, DOI 10.1007/s00442-005-0226-x; Weimerskirch H, 1998, J ANIM ECOL, V67, P99, DOI 10.1046/j.1365-2656.1998.00180.x; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x; Zador S, 2013, MAR ECOL PROG SER, V485, P245, DOI 10.3354/meps10336	53	3	4	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137241	10.1371/journal.pone.0137241	http://dx.doi.org/10.1371/journal.pone.0137241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331957	gold, Green Submitted, Green Published			2022-12-27	WOS:000360613800115
J	Matsui, K; Adelsberger, JW; Kemp, TJ; Baseler, MW; Ledgerwood, JE; Pinto, LA				Matsui, Ken; Adelsberger, Joseph W.; Kemp, Troy J.; Baseler, Michael W.; Ledgerwood, Julie E.; Pinto, Ligia A.			Circulating CXCR5(+)CD4(+) T Follicular-Like Helper Cell and Memory B Cell Responses to Human Papillomavirus Vaccines	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; TFH CELLS; MONONUCLEAR-CELLS; IMMUNITY; EXPRESS; SUBSET; VIRUS; BLOOD	Through the interaction of T follicular helper (Tfh) cells and B cells, efficacious vaccines can generate high-affinity, pathogen-neutralizing antibodies, and memory B cells. Using CXCR5, CXCR3, CCR6, CCR7, PD1, and ICOS as markers, Tfh-like cells can be identified in the circulation and be classified into three functionally distinct subsets that are PD1(+)ICOS(+), PD1(+)ICOS(-), or PD1(-)ICOS(-). We used these markers to identify different subsets of CXCR5(+)CD4(+) Tfh-like cells in response to highly immunogenic and efficacious vaccines for human papillomaviruses (HPV): Cervarix and Gardasil. In this small study, we used PBMC samples from 11 Gardasil recipients, and 8 Cervarix recipients from the Vaccine Research Center 902 Study to examine the induction of circulating Tfh-like cells and IgD-CD38(Hi)CD27(+) memory B cells by flow cytometry. PD1(+)ICOS(+) CXCR3(+)CCR6(-)CXCR5(+)CD4(+) (Tfh1-like) cells were induced and peaked on Day (D) 7 post-first vaccination, but not asmuch on D7 post-third vaccination. We also observed a trend toward increase in PD1(+)ICOS(+) CXCR3(-)CCR6(-)CXCR5(+)CD4(+) (Tfh2-like) cells for both vaccines, and PD1(+)ICOS(+) CXCR3(-)CCR6(+)CXCR5(+)CD4(+) (Tfh17-like) subset was induced by Cervarix post-first vaccination. There were alsominimal changes in the other cellular subsets. In addition, Cervarix recipients had more memory B cells post-first vaccination than did Gardasil recipients at D14 and D30. We found frequencies ofmemory B cells at D30 correlated with anti-HPV16 and 18 antibody titers from D30, and the induction levels of memory B cells at D30 and PD1(+)ICOS(+)Tfh1-like cells at D7 post-first vaccination correlated for Cervarix. Our study showed that induction of circulating CXCR5(+)CD4(+) Tfh-like subsets can be detected following immunization with HPV vaccines, and potentially be useful as a marker of immunogenicity of vaccines. However, further investigations should be extended to different cohorts with larger sample size to better understand the functions of these T cells, as well as their relationship with B cells and antibodies.	[Matsui, Ken; Kemp, Troy J.; Pinto, Ligia A.] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Human Papillomavirus HPV Immunol Lab, Frederick, MD 21702 USA; [Adelsberger, Joseph W.; Baseler, Michael W.] Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, AIDS Monitoring Lab, Clin Serv Program,Appl & Dev Directorate, Frederick, MD USA; [Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pinto, LA (corresponding author), Frederick Natl Lab Canc Res, Leidos Biomed Res Inc, Human Papillomavirus HPV Immunol Lab, Frederick, MD 21702 USA.	pintol@mail.nih.gov			National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005047] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E.	Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Boswell KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003853; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Buck Christopher B, 2007, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2601s37; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Herrin DM, 2014, HUM VACC IMMUNOTHER, V10, P3446, DOI 10.4161/hv.34408; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Matsui K, 2013, BRIT J HAEMATOL, V163, P81, DOI 10.1111/bjh.12475; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Pinto LA, 2005, CYTOM PART B-CLIN CY, V63B, P47, DOI 10.1002/cyto.b.20038; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Schmitt N, 2014, TRENDS IMMUNOL, V35, P436, DOI 10.1016/j.it.2014.06.002; Schmitt N, 2013, IMMUNITY, V39, P629, DOI 10.1016/j.immuni.2013.09.011; Stanley M, 2012, VACCINE, V30, pF83, DOI 10.1016/j.vaccine.2012.04.106; Stanley MA, 2014, EXPERT REV VACCINES, V13, P1027, DOI 10.1586/14760584.2014.935767; Suan D, 2015, IMMUNITY, V42, P704, DOI 10.1016/j.immuni.2015.03.002; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tsai LM, 2014, IMMUNOL CELL BIOL, V92, P57, DOI 10.1038/icb.2013.68; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	44	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137195	10.1371/journal.pone.0137195	http://dx.doi.org/10.1371/journal.pone.0137195			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333070	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800108
J	Meyer, WM; Eble, JA; Franklin, K; McManus, RB; Brantley, SL; Henkel, J; Marek, PE; Hall, WE; Olson, CA; McInroy, R; Loaiza, EMB; Brusca, RC; Moore, W				Meyer, Wallace M., III; Eble, Jeffrey A.; Franklin, Kimberly; McManus, Reilly B.; Brantley, Sandra L.; Henkel, Jeff; Marek, Paul E.; Hall, W. Eugene; Olson, Carl A.; McInroy, Ryan; Bernal Loaiza, Emmanuel M.; Brusca, Richard C.; Moore, Wendy			Ground-Dwelling Arthropod Communities of a Sky Island Mountain Range in Southeastern Arizona, USA: Obtaining a Baseline for Assessing the Effects of Climate Change	PLOS ONE			English	Article							SPECIES RICHNESS; RESPONSES; INSECTS; DECOMPOSITION; BIODIVERSITY; GRADIENTS; ECOLOGY; DRIVEN; TAXON; FAUNA	The few studies that have addressed past effects of climate change on species distributions have mostly focused on plants due to the rarity of historical faunal baselines. However, hyperdiverse groups like Arthropoda are vital to monitor in order to understand climate change impacts on biodiversity. This is the first investigation of ground-dwelling arthropod (GDA) assemblages along the full elevation gradient of a mountain range in the Madrean Sky Island Region, establishing a baseline for monitoring future changes in GDA biodiversity. To determine how GDA assemblages relate to elevation, season, abiotic variables, and corresponding biomes, GDA were collected for two weeks in both spring (May) and summer (September) 2011 in the Santa Catalina Mountains, Arizona, using pitfall traps at 66 sites in six distinct upland (non-riparian/non-wet canyon) biomes. Four arthropod taxa: (1) beetles (Coleoptera), (2) spiders (Araneae), (3) grasshoppers and crickets (Orthoptera), and (4) millipedes and centipedes (Myriapoda) were assessed together and separately to determine if there are similar patterns across taxonomic groups. We collected 335 species of GDA: 192/3793 (species/specimens) Coleoptera, 102/1329 Araneae, 25/523 Orthoptera, and 16/697 Myriapoda. GDA assemblages differed among all biomes and between seasons. Fifty-three percent (178 species) and 76% (254 species) of all GDA species were found in only one biome and during only one season, respectively. While composition of arthropod assemblages is tied to biome and season, individual groups do not show fully concordant patterns. Seventeen percent of the GDA species occurred only in the two highest- elevation biomes (Pine and Mixed Conifer Forests). Because these high elevation biomes are most threatened by climate change and they harbor a large percentage of unique arthropod species (11-25% depending on taxon), significant loss in arthropod diversity is likely in the Santa Catalina Mountains and other isolated mountain ranges in the Southwestern US.	[Meyer, Wallace M., III; Eble, Jeffrey A.; Franklin, Kimberly; McManus, Reilly B.; Marek, Paul E.; Hall, W. Eugene; Olson, Carl A.; McInroy, Ryan; Moore, Wendy] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Brantley, Sandra L.] Univ New Mexico, Museum Southwestern Biol, Albuquerque, NM 87131 USA; [Henkel, Jeff; Brusca, Richard C.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Bernal Loaiza, Emmanuel M.] Univ Sonora, Hermosillo 83000, Sonora, Mexico; [Brusca, Richard C.] Arizona Sonora Desert Museum, Tucson, AZ USA	University of Arizona; University of New Mexico; University of Arizona; Universidad de Sonora	Meyer, WM (corresponding author), Pomona Coll, Dept Biol, Claremont, CA 91711 USA.	Wallace_meyer@pomona.edu	Brusca, Richard/S-1673-2019	Marek, Paul/0000-0002-7048-2514; Eble, Jeff/0000-0001-6308-3104; Moore, Wendy/0000-0003-4441-6203	National Institute of Health [5K12GM000708]; National Geographic Society [8964-11]; National Science Foundation [DBI-1203398, EF-1206382]; Div Of Biological Infrastructure [1206382, 1203398] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by 5K12GM000708, National Institute of Health, W.M.M. -(http://www.nigms.nih.gov/training/careerdev/Pages/TWDInstRes.aspx) 8964-11, National Geographic Society, W.M.M. -(http://www.nationalgeographic.com/explorers/grants-programs/cre) DBI-1203398, National Science Foundation, W.M. EF-1206382, National Science Foundation, W.M. (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Behan-Pelletier V, 1999, BIOSCIENCE, V49, P149, DOI 10.2307/1313540; Boggs CL, 1997, GLOBAL ECOL BIOGEOGR, V6, P39, DOI 10.2307/2997525; Brown D.E, 1994, BIOTIC COMMUNITIES S; Brusca R. C., 2013, NATURAL HIST SANTA C; Brusca RC, 2002, INVERTEBRATES; Brusca RC, 2013, ECOL EVOL, V3, P3307, DOI 10.1002/ece3.720; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clarke K.R., 2006, PRIMER V6 USER MANUA; Coe SJ, 2010, RMRSGTR273 USDA FOR; Coope GR, 1995, INSECTS CHANGING ENV, P30; Crimmins TM, 2011, NEW PHYTOL, V191, P468, DOI 10.1111/j.1469-8137.2011.03705.x; Crimmins TM, 2009, GLOBAL CHANGE BIOL, V15, P1141, DOI 10.1111/j.1365-2486.2008.01831.x; Daily GC, 1996, P NATL ACAD SCI USA, V93, P11709, DOI 10.1073/pnas.93.21.11709; Derkarabetian S, 2011, MOL PHYLOGENET EVOL, V61, P844, DOI 10.1016/j.ympev.2011.08.004; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Dieker P, 2011, BIOL CONSERV, V144, P2810, DOI 10.1016/j.biocon.2011.07.018; Dominguez F, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050762; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; DOUGLAS MW, 1993, J CLIMATE, V6, P1665, DOI 10.1175/1520-0442(1993)006<1665:TMM>2.0.CO;2; Driscoll DA, 2010, AUSTRAL ECOL, V35, P13, DOI 10.1111/j.1442-9993.2009.02007.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Garfin G, 2013, NCA REGION INPUT REP, P1, DOI 10.5822/978-1-61091-484-0; Goehring DM, 2002, J INSECT CONSERV, V6, P83, DOI 10.1023/A:1020905307244; GRAHAM RW, 1990, TRENDS ECOL EVOL, V5, P289, DOI 10.1016/0169-5347(90)90083-P; Guevara J, 2009, INSECT CONSERV DIVER, V2, P142, DOI 10.1111/j.1752-4598.2008.00043.x; Gutzler DS, 2011, CLIM DYNAM, V37, P835, DOI 10.1007/s00382-010-0838-7; Haslett JR, 1997, GLOBAL ECOL BIOGEOGR, V6, P3, DOI 10.2307/2997522; Higgins JW, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00270.1; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Jablonski D, 1996, ECOLOGY, V77, P1367, DOI 10.2307/2265534; Kimball S, 2010, GLOBAL CHANGE BIOL, V16, P1555, DOI 10.1111/j.1365-2486.2009.02106.x; Koprowski JL, 2013, MERGING SCI MANAGEME, V67, P140; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Kupfer JA, 2005, USDA FOREST SERVICE, P485; Lenoir L, 2007, BIOL FERT SOILS, V43, P281, DOI 10.1007/s00374-006-0103-8; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Masta SE, 2000, EVOLUTION, V54, P1699; McCord RD, 1995, USDA ROCKY, V264, P317; MCCOY ED, 1990, OIKOS, V58, P313, DOI 10.2307/3545222; Meyer WM, 2011, SOIL BIOL BIOCHEM, V43, P206, DOI 10.1016/j.soilbio.2010.10.005; Mitchell SG, 2013, QUATERNARY RES, V79, P274, DOI 10.1016/j.yqres.2012.11.001; Moore W, 2013, MERGING SCI MANAGEME, P140; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Niering WA, 1985, PLANT COMMUNITY ECOL, P159; Overpeck J, 2010, SCIENCE, V328, P1642, DOI 10.1126/science.1186591; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PICKETT S T A, 1989, P110; Powers JS, 2009, J ECOL, V97, P801, DOI 10.1111/j.1365-2745.2009.01515.x; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rasmann S, 2014, FUNCT ECOL, V28, P46, DOI 10.1111/1365-2435.12135; Richman DB, 2012, ZOOL STUD, V51, P793; Ricketts TH, 2002, BIOL CONSERV, V103, P361, DOI 10.1016/S0006-3207(01)00147-1; Robles M. D., 2010, MANAGING CHANGING LA; Sauer J, 2011, BIODIVERS CONSERV, V20, P3133, DOI 10.1007/s10531-011-0140-y; Schimel DS, 1996, CLIMATE CHANGE 1995, P76; Strange EE, 2010, CLIMATE CHANGE IMPAC; Stromberg JC, 2013, ECOSYSTEMS, V16, P411, DOI 10.1007/s10021-012-9606-3; Toranza Carolina, 2010, BMC Ecology, V10, P18, DOI 10.1186/1472-6785-10-18; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Wall DH, 2010, GLOBAL CHANGE BIOL, V14, P2661; Watling JI, 2006, CONSERV BIOL, V20, P1016, DOI 10.1111/j.1523-1739.2006.00482.x; WHITTAKER RH, 1952, ECOL MONOGR, V22, P1, DOI 10.2307/1948527; Whittaker RH., 1964, J ARIZONA ACAD SCI, V3, P9, DOI DOI 10.2307/40021924; Yang XD, 2009, SOIL BIOL BIOCHEM, V41, P910, DOI 10.1016/j.soilbio.2008.12.028	71	15	15	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135210	10.1371/journal.pone.0135210	http://dx.doi.org/10.1371/journal.pone.0135210			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332685	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800023
J	Smith, CL; Pivovarova, N; Reese, TS				Smith, Carolyn L.; Pivovarova, Natalia; Reese, Thomas S.			Coordinated Feeding Behavior in Trichoplax, an Animal without Synapses	PLOS ONE			English	Article							RHABDOCALYPTUS-DAWSONI LAMBE; HEXACTINELLID SPONGES; FIBER CELLS; GENOME; PLACOZOA; DICKINSONIA; SYSTEM	Trichoplax is a small disk-shaped marine metazoan that adheres to substrates and locomotes by ciliary gliding. Despite having only six cell types and lacking synapses Trichoplax coordinates a complex sequence of behaviors culminating in external digestion of algae. We combine live cell imaging with electron microscopy to show how this is accomplished. When Trichoplax glides over a patch of algae, its cilia stop beating so it ceases moving. A subset of one of the cell types, lipophils, simultaneously secretes granules whose content rapidly lyses algae. This secretion is accurately targeted, as only lipophils located near algae release granules. The animal pauses while the algal content is ingested, and then resumes gliding. Global control of gliding is coordinated with precise local control of lipophil secretion suggesting the presence of mechanisms for cellular communication and integration.	[Smith, Carolyn L.; Pivovarova, Natalia; Reese, Thomas S.] NINDS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Smith, CL (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	smithca@ninds.nih.gov			National Institutes of Neurological Diseases and Stroke, National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002972] Funding Source: NIH RePORTER	National Institutes of Neurological Diseases and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Neurological Diseases and Stroke, National Institutes of Health.	Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Aono K, 2008, BIOL BULL-US, V215, P272, DOI 10.2307/25470711; Brasier MD, 2008, PALAEOGEOGR PALAEOCL, V270, P311, DOI 10.1016/j.palaeo.2008.07.018; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; FARBMAN AI, 1992, CELL BIOL OLFACTION; Gehling JG, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P43; Gorr SU, 2005, J DENT RES, V84, P500, DOI 10.1177/154405910508400604; Grell K.G., 1991, P13; GRELL KG, 1972, Z MORPHOL TIERE, V73, P297, DOI 10.1007/BF00391925; GRELL KG, 1974, Z NATURFORSCH C, VC 29, P790; Guidi L, 2011, J MORPHOL, V272, P371, DOI 10.1002/jmor.10922; Hoef-Emden K, CRYPTOMONADS; Ivantsov AY, 2013, STRATIGR GEO CORREL+, V21, P252, DOI 10.1134/S0869593813030039; Ivantsov AY, 2011, PALEONTOL J+, V45, P237, DOI 10.1134/S0031030111030063; Jackson AM, 2009, INVERTEBR BIOL, V128, P205, DOI 10.1111/j.1744-7410.2009.00177.x; Jekely G, 2015, EVODEVO, V6, DOI 10.1186/2041-9139-6-1; Kana R, 2009, FEBS LETT, V583, P670, DOI 10.1016/j.febslet.2009.01.016; Liebeskind BJ, 2015, P NATL ACAD SCI USA, V112, pE846, DOI 10.1073/pnas.1501195112; MACHEMER H, 1972, J EXP BIOL, V57, P239; MACKIE GO, 1983, PHILOS T ROY SOC B, V301, P365, DOI 10.1098/rstb.1983.0028; MACKIE GO, 1983, PHILOS T ROY SOC B, V301, P401, DOI 10.1098/rstb.1983.0029; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Pozzo-Miller LD, 1999, MICROSC RES TECHNIQ, V46, P370, DOI 10.1002/(SICI)1097-0029(19990915)46:6<370::AID-JEMT5>3.0.CO;2-3; Rompolas P, 2009, METHOD CELL BIOL, V93, P81, DOI 10.1016/S0091-679X(08)93004-1; RUTHMANN A, 1986, ZOOMORPHOLOGY, V106, P115, DOI 10.1007/BF00312113; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; SCHUCHERT P, 1993, ACTA ZOOL-STOCKHOLM, V74, P115, DOI 10.1111/j.1463-6395.1993.tb01227.x; SCHULSINGER F, 1991, Acta Psychiatrica Scandinavica Supplementum, P1; Signorovitch AY, 2006, BIOL BULL-US, V211, P149, DOI 10.2307/4134589; Smith CL, 2014, CURR BIOL, V24, P1565, DOI 10.1016/j.cub.2014.05.046; Sperling EA, 2010, EVOL DEV, V12, P201, DOI 10.1111/j.1525-142X.2010.00404.x; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; THIEMANN M, 1989, ZOOMORPHOLOGY, V109, P89, DOI 10.1007/BF00312314; Ueda T, 1999, BIOSYSTEMS, V54, P65, DOI 10.1016/S0303-2647(99)00066-0; WENDEROTH H, 1986, Z NATURFORSCH C, V41, P343	37	66	69	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136098	10.1371/journal.pone.0136098	http://dx.doi.org/10.1371/journal.pone.0136098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333190	gold, Green Submitted, Green Published			2022-12-27	WOS:000360613800049
J	An, N; Shi, XY; Zhang, YM; Lv, N; Feng, L; Di, XB; Han, NJ; Wang, GQ; Cheng, SJ; Zhang, KT				An, Ning; Shi, Xiaoyu; Zhang, Yueming; Lv, Ning; Feng, Lin; Di, Xuebing; Han, Naijun; Wang, Guiqi; Cheng, Shujun; Zhang, Kaitai			Discovery of a Novel Immune Gene Signature with Profound Prognostic Value in Colorectal Cancer: A Model of Cooperativity Disorientation Created in the Process from Development to Cancer	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; SUPPRESSOR GENE; STEM-CELLS; PATHWAY; EPIDEMIOLOGY; RESISTANCE; EXPRESSION; AXL; CLASSIFICATION; HETEROGENEITY	Immune response-related genes play a major role in colorectal carcinogenesis by mediating inflammation or immune-surveillance evasion. Although remarkable progress has been made to investigate the underlying mechanism, the understanding of the complicated carcinogenesis process was enormously hindered by large-scale tumor heterogeneity. Development and carcinogenesis share striking similarities in their cellular behavior and underlying molecular mechanisms. The association between embryonic development and carcinogenesis makes embryonic development a viable reference model for studying cancer thereby circumventing the potentially misleading complexity of tumor heterogeneity. Here we proposed that the immune genes, responsible for intra-immune cooperativity disorientation (defined in this study as disruption of developmental expression correlation patterns during carcinogenesis), probably contain untapped prognostic resource of colorectal cancer. In this study, we determined the mRNA expression profile of 137 human biopsy samples, including samples from different stages of human colonic development, colorectal precancerous progression and colorectal cancer samples, among which 60 were also used to generate miRNA expression profile. We originally established Spearman correlation transition model to quantify the cooperativity disorientation associated with the transition from normal to precancerous to cancer tissue, in conjunction with miRNA-mRNA regulatory network and machine learning algorithm to identify genes with prognostic value. Finally, a 12-gene signature was extracted, whose prognostic value was evaluated using Kaplan-Meier survival analysis in five independent datasets. Using the log-rank test, the 12-gene signature was closely related to overall survival in four datasets (GSE17536, n = 177, p = 0.0054; GSE17537, n = 55, p = 0.0039; GSE39582, n = 562, p = 0.13; GSE39084, n = 70, p = 0.11), and significantly associated with disease-free survival in four datasets (GSE17536, n = 177, p = 0.0018; GSE17537, n = 55, p = 0.016; GSE39582, n = 557, p = 4.4e-05; GSE14333, n = 226, p = 0.032). Cox regression analysis confirmed that the 12-gene signature was an independent factor in predicting colorectal cancer patient's overall survival (hazard ratio: 1.759; 95% confidence interval: 1.126-2.746; p = 0.013], as well as disease-free survival (hazard ratio: 2.116; 95% confidence interval: 1.324-3.380; p = 0.002).	[An, Ning; Shi, Xiaoyu; Feng, Lin; Di, Xuebing; Han, Naijun; Cheng, Shujun; Zhang, Kaitai] Chinese Acad Med Sci, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [An, Ning; Shi, Xiaoyu; Feng, Lin; Di, Xuebing; Han, Naijun; Cheng, Shujun; Zhang, Kaitai] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Yueming; Wang, Guiqi] Chinese Acad Med Sci, Canc Hosp, Dept Endoscopy, Beijing 100730, Peoples R China; [Lv, Ning] Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Cheng, SJ (corresponding author), Chinese Acad Med Sci, Canc Inst Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	chengshj@263.net.cn; zhangkt_bingyin@sina.cn	Lv, Ning/V-5706-2019		National High Technology Research and Development Program of China [SS2014AA020801]; Sci-Tech Development Program of Beijing [D121100004712002]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Sci-Tech Development Program of Beijing	This work was supported by the National High Technology Research and Development Program of China (SS2014AA020801, http://www.863.gov.cn/) and the Sci-Tech Development Program of Beijing (D121100004712002, http://www.bjkw.gov.cn/n8785584/index.html) received by KZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres A, 2005, CRIT REV ONCOL HEMAT, V56, P71, DOI 10.1016/j.critrevonc.2004.11.010; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bockmayr M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-78; Bower M, 2006, CURR OPIN INFECT DIS, V19, P14, DOI 10.1097/01.qco.0000200295.30285.13; Boysen J, 2014, LEUKEMIA, V28, P451, DOI 10.1038/leu.2013.298; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Bruttel VS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00360; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Carlson M, 2013, HS EG DB GEN WID ANN; Chen GY, 2011, GASTROENTEROLOGY, V141, P1986, DOI 10.1053/j.gastro.2011.10.002; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098293; Cheng XH, 2014, ONCOTARGETS THER, V7, P1689, DOI 10.2147/OTT.S66502; Dal Maso L, 2001, EUR J CANCER, V37, P1188, DOI 10.1016/S0959-8049(01)00120-4; Davila RE, 2005, GASTROINTEST ENDOSC, V61, P1, DOI 10.1016/S0016-5107(04)02391-0; Dunne PD, 2014, CLIN CANCER RES, V20, P164, DOI 10.1158/1078-0432.CCR-13-1354; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Fang LK, 2014, ONCOTARGET, V5, P2974, DOI 10.18632/oncotarget.1614; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.035, 10.1053/j.gastro.2009.12.037]; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Hu HK, 2013, APPL IMMUNOHISTO M M, V21, P242, DOI 10.1097/PAI.0b013e3182655ab7; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jeng KS, 2015, CRIT REV ONCOL HEMAT, V94, P337, DOI 10.1016/j.critrevonc.2015.01.009; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kang HC, 2013, J INVEST DERMATOL, V133, P1311, DOI 10.1038/jid.2012.419; Kanthan, 2012, PATHOLOG RES INT, V2012, DOI [10.1155/2012/597497, DOI 10.1155/2012/597497]; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kim MS, 2013, HUM PATHOL, V44, P2064, DOI 10.1016/j.humpath.2012.11.027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Liu HY, 2006, PLOS MED, V3, P1090, DOI 10.1371/journal.pmed.0030232; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Calle ML, 2011, HUM HERED, V72, P121, DOI 10.1159/000330778; Ma YL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2276; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mees ST, 2010, INT J CANCER, V126, P114, DOI 10.1002/ijc.24695; Montgomery RK, 1999, GASTROENTEROLOGY, V116, P702, DOI 10.1016/S0016-5085(99)70193-9; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Pham Trang T, 2013, Genes Cancer, V4, P419, DOI 10.1177/1947601913513950; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ridolfi L, 2009, IMMUNOBIOLOGY, V214, P61, DOI 10.1016/j.imbio.2008.03.003; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schlicker A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-66; Shang JL, 2014, J CELL BIOCHEM, V115, P772, DOI 10.1002/jcb.24721; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Skibinski A, 2015, ONCOGENE, V34, P5309, DOI 10.1038/onc.2014.475; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stolte M, 2003, VIRCHOWS ARCH, V442, P99, DOI 10.1007/s00428-002-0680-3; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Teschendorff AE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-604; Troiani T, 2014, CURR MED CHEM, V21, P1639, DOI 10.2174/09298673113209990224; Ulrich C, 2004, DERMATOL SURG, V30, P622, DOI 10.1111/j.1524-4725.2004.30147.x; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Xie KP, 2003, CANCER CELL, V4, P245, DOI 10.1016/S1535-6108(03)00246-0; Yamaguchi T, 2014, ONCOLOGY-BASEL, V87, P58, DOI 10.1159/000363303; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yong FL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-280	66	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137171	10.1371/journal.pone.0137171	http://dx.doi.org/10.1371/journal.pone.0137171			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325386	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700102
J	Botta, F; Moat, HS; Stanley, HE; Preis, T				Botta, Federico; Moat, Helen Susannah; Stanley, H. Eugene; Preis, Tobias			Quantifying Stock Return Distributions in Financial Markets	PLOS ONE			English	Article							COMPUTATIONAL SOCIAL-SCIENCE; POWER-LAW DISTRIBUTIONS; BEHAVIOR; FLUCTUATIONS; INDEX; ECONOMICS; DYNAMICS; MODEL; MOVES	Being able to quantify the probability of large price changes in stock markets is of crucial importance in understanding financial crises that affect the lives of people worldwide. Large changes in stock market prices can arise abruptly, within a matter of minutes, or develop across much longer time scales. Here, we analyze a dataset comprising the stocks forming the Dow Jones Industrial Average at a second by second resolution in the period from January 2008 to July 2010 in order to quantify the distribution of changes in market prices at a range of time scales. We find that the tails of the distributions of logarithmic price changes, or returns, exhibit power law decays for time scales ranging from 300 seconds to 3600 seconds. For larger time scales, we find that the distributions tails exhibit exponential decay. Our findings may inform the development of models of market behavior across varying time scales.	[Botta, Federico] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England; [Botta, Federico; Moat, Helen Susannah; Preis, Tobias] Univ Warwick, Warwick Business Sch, Data Sci Lab, Behav Sci, Coventry CV4 7AL, W Midlands, England; [Stanley, H. Eugene] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Stanley, H. Eugene] Boston Univ, Dept Phys, Boston, MA 02215 USA	University of Warwick; University of Warwick; Boston University; Boston University	Botta, F (corresponding author), Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England.	f.botta@warwick.ac.uk	Botta, Federico/I-3688-2019; Preis, Tobias/A-2874-2009	Botta, Federico/0000-0002-5681-4535; Preis, Tobias/0000-0001-9185-0892; Stanley, H./0000-0003-2800-4495; Moat, Helen Susannah/0000-0001-8974-9277	UK EPSRC [EP/E501311/1]; Research Councils UK [EP/K039830/1]; IARPA; NSF [1411158, 1452061]; EPSRC [EP/K039830/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K039830/1, 1231220] Funding Source: researchfish	UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Research Councils UK(UK Research & Innovation (UKRI)); IARPA; NSF(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	FB acknowledges the support of UK EPSRC EP/E501311/1. HSM and TP acknowledge the support of the Research Councils UK Grant EP/K039830/1. HES acknowledges the support of IARPA and NSF (grants 1411158 and 1452061).	Abergel F., 2011, ECONOPHYSICS ORDER D; Alanyali M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03578; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Barchiesi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128470; Bertram WK, 2004, PHYSICA A, V341, P533, DOI 10.1016/j.physa.2004.04.132; Botta F, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150162; Carbone A, 2004, PHYSICA A, V344, P267, DOI 10.1016/j.physa.2004.06.130; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Conte R, 2012, EUR PHYS J-SPEC TOP, V214, P325, DOI 10.1140/epjst/e2012-01697-8; Coronel-Brizio HF, 2005, PHYSICA A, V354, P437, DOI 10.1016/j.physa.2005.03.001; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; de Montjoye YA, 2015, SCIENCE, V347, P536, DOI 10.1126/science.1256297; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Farmer JD, 2002, J ECON BEHAV ORGAN, V49, P149, DOI 10.1016/S0167-2681(02)00065-3; Feng L, 2012, P NATL ACAD SCI USA, V109, P8388, DOI 10.1073/pnas.1205013109; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gabaix X, 2009, ANNU REV ECON, V1, P255, DOI 10.1146/annurev.economics.050708.142940; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; Gu GF, 2008, PHYSICA A, V387, P495, DOI 10.1016/j.physa.2007.10.012; Hommes CH, 2002, P NATL ACAD SCI USA, V99, P7221, DOI 10.1073/pnas.082080399; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Lux T, 2009, NAT PHYS, V5, P2, DOI 10.1038/nphys1163; Makowiec D, 2001, ACTA PHYS POL B, V32, P1487; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; MANTEGNA RN, 2000, INTRO ECONOPHYSICS C; Matia K, 2004, EUROPHYS LETT, V66, P909, DOI 10.1209/epl/i2003-10267-y; Moat HS, 2014, BEHAV BRAIN SCI, V37, P92, DOI 10.1017/S0140525X13001817; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Mu GH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066103; Munnix MC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00644; Paul W., 2013, STOCHASTIC PROCESSES; Petersen AM, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036114; Plerou V, 2003, NATURE, V421, P130, DOI 10.1038/421130a; Podobnik B, 2009, P NATL ACAD SCI USA, V106, P22079, DOI 10.1073/pnas.0911983106; Preis T, 2006, EUROPHYS LETT, V75, P510, DOI 10.1209/epl/i2006-10139-0; Preis T, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140095; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03141; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00752; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Sornette D, 2003, WHY STOCK MARKETS CRASH: CRITICAL EVENTS IN COMPLEX FINANCIAL SYSTEMS, P1; Sornette D, 2009, PHYSICA A, V388, P1571, DOI 10.1016/j.physa.2009.01.011; Voit J, 2005, THE STATISTICAL MECH; Yan C, 2005, PHYSICA A, V353, P425, DOI 10.1016/j.physa.2005.02.010; Zhang JW, 2007, PHYSICA A, V377, P166, DOI 10.1016/j.physa.2006.11.012	47	31	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135600	10.1371/journal.pone.0135600	http://dx.doi.org/10.1371/journal.pone.0135600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327593	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700021
J	McGowan, A; Silvestri, G; Moore, E; Silvestri, V; Patterson, CC; Maxwell, AP; McKay, GJ				McGowan, Amy; Silvestri, Giuliana; Moore, Evelyn; Silvestri, Vittorio; Patterson, Christopher C.; Maxwell, Alexander P.; McKay, Gareth J.			Evaluation of the Retinal Vasculature in Hypertension and Chronic Kidney Disease in an Elderly Population of Irish Nuns	PLOS ONE			English	Article							VESSEL DIAMETERS; BLOOD-PRESSURE; DIABETIC-RETINOPATHY; FRACTAL ANALYSIS; MICROVASCULAR ABNORMALITIES; ARTERIOLAR DIAMETER; RISK; CALIBER; PREVALENCE; EPIDEMIOLOGY	Background Chronic kidney disease (CKD) and hypertension are global public health problems associated with considerable morbidity, premature mortality and attendant healthcare costs. Previous studies have highlighted that non-invasive examination of the retinal microcirculation can detect microvascular pathology that is associated with systemic disorders of the circulatory system such as hypertension. We examined the associations between retinal vessel caliber (RVC) and fractal dimension (D-F), with both hypertension and CKD in elderly Irish nuns. Methods Data from 1233 participants in the cross-sectional observational Irish Nun Eye Study (INES) were assessed from digital photographs with a standardized protocol using computer-assisted software. Multivariate regression analyses were used to assess associations with hypertension and CKD, with adjustment for age, body mass index (BMI), refraction, fellow eye RVC, smoking, alcohol consumption, ischemic heart disease (IHD), cerebrovascular accident (CVA), diabetes and medication use. Results In total, 1122 (91%) participants (mean age: 76.3 [range: 56-100] years) had gradable retinal images of sufficient quality for blood vessel assessment. Hypertension was significantly associated with a narrower central retinal arteriolar equivalent (CRAE) in a fully adjusted analysis (P = 0.002; effect size = -2.16 mu m; 95% confidence intervals [CI]: -3.51, -0.81 mu m). No significant associations between other retinal vascular parameters and hypertension or between any retinal vascular parameters and CKD were found. Conclusions Individuals with hypertension have significantly narrower retinal arterioles which may afford an earlier opportunity for tailored prevention and treatment options to optimize the structure and function of the microvasculature, providing additional clinical utility. No significant associations between retinal vascular parameters and CKD were detected.	[McGowan, Amy; Patterson, Christopher C.; Maxwell, Alexander P.; McKay, Gareth J.] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Silvestri, Giuliana] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland; [Silvestri, Giuliana; Moore, Evelyn; Silvestri, Vittorio] Royal Victoria Hosp, Dept Ophthalmol, Belfast BT12 6BA, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	McKay, GJ (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland.	g.j.mckay@qub.ac.uk	McKay, Gareth/AAZ-2601-2020	McKay, Gareth/0000-0001-8197-6280; Maxwell, Alexander P./0000-0002-6110-7253; Silvestri, Giuliana/0000-0001-5662-5374	United Kingdom Medical Research Council [MR/K003364/1]; Diabetes UK Grant [11/0004400]; Northern Ireland Health & Personal Social Services Research and Development Office, Belfast, Grant Recognised Research Group Project [4.41]; MRC [MR/K003364/1] Funding Source: UKRI; Medical Research Council [MR/K003364/1] Funding Source: researchfish; Public Health Agency [STL/4936/13] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK Grant(Diabetes UK); Northern Ireland Health & Personal Social Services Research and Development Office, Belfast, Grant Recognised Research Group Project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Public Health Agency	This work was supported by the United Kingdom Medical Research Council Grant MR/K003364/1; Diabetes UK Grant 11/0004400; and the Northern Ireland Health & Personal Social Services Research and Development Office, Belfast, Grant Recognised Research Group Project 4.41. The funding organizations had no role in the design, conduct or reporting of this research.	Bakris GL, 2009, J HYPERTENS, V27, P666, DOI 10.1097/HJH.0b013e328327706a; Baumann M, 2009, KIDNEY BLOOD PRESS R, V32, P428, DOI 10.1159/000264650; Cheung CY, 2012, AM J OPHTHALMOL, V154, P663, DOI 10.1016/j.ajo.2012.04.016; Cheung CYL, 2014, ALZHEIMERS DEMENT, V10, P135, DOI 10.1016/j.jalz.2013.06.009; Cheung CYL, 2013, STROKE, V44, P2402, DOI 10.1161/STROKEAHA.113.001738; Cheung N, 2012, ARCH OPHTHALMOL-CHIC, V130, P783, DOI 10.1001/archophthalmol.2012.727; Chew SKH, 2012, CURR HYPERTENS REP, V14, P144, DOI 10.1007/s11906-012-0252-0; Ding J, 2014, J HYPERTENS, V32, P207, DOI 10.1097/HJH.0b013e32836586f4; Ding J, 2012, CLIN EXP OPTOM, V95, P290, DOI 10.1111/j.1444-0938.2012.00725.x; Edwards MS, 2005, AM J KIDNEY DIS, V46, P214, DOI 10.1053/j.ajkd.2005.05.005; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hoerger TJ, 2015, AM J KIDNEY DIS, V65, P403, DOI 10.1053/j.ajkd.2014.09.023; Horowitz B, 2015, ADV CHRONIC KIDNEY D, V22, P88, DOI 10.1053/j.ackd.2014.09.004; Ikram MK, 2006, HYPERTENSION, V47, P189, DOI 10.1161/01.HYP.0000199104.61945.33; Jeganathan VSE, 2009, HYPERTENS RES, V32, P975, DOI 10.1038/hr.2009.130; Kang DH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133806; Kawasaki R, 2009, J HYPERTENS, V27, P2386, DOI 10.1097/HJH.0b013e3283310f7e; Klein R, 2005, DIABETES, V54, P527, DOI 10.2337/diabetes.54.2.527; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Kurniawan ED, 2012, INVEST OPHTH VIS SCI, V53, P470, DOI 10.1167/iovs.11-8835; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Levy BI, 2001, CIRCULATION, V104, P735, DOI 10.1161/hc3101.091158; Li LJ, 2011, OPHTHALMOLOGY, V118, P1459, DOI 10.1016/j.ophtha.2010.12.007; Liew G, 2012, KIDNEY BLOOD PRESS R, V35, P589, DOI 10.1159/000339173; Liew G, 2007, INVEST OPHTH VIS SCI, V48, P52, DOI 10.1167/iovs.06-0672; Liew G, 2006, HYPERTENSION, V48, pE10, DOI 10.1161/01.HYP.0000231652.97173.4c; Liew G, 2011, EUR HEART J, V32, P422, DOI 10.1093/eurheartj/ehq431; Lim LS, 2013, INVEST OPHTH VIS SCI, V54, P2970, DOI 10.1167/iovs.13-11941; MacGillivray TJ, 2007, P ANN INT IEEE EMBS, P6456; MAKI DD, 1995, ARCH INTERN MED, V155, P1073, DOI 10.1001/archinte.155.10.1073; McGowan A, 2015, INVEST OPHTH VIS SCI, V56, P382, DOI 10.1167/iovs.14-15523; Mitchell P, 2007, HYPERTENSION, V49, P1156, DOI 10.1161/HYPERTENSIONAHA.106.085910; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; PERNEGER TV, 1993, JAMA-J AM MED ASSOC, V269, P488, DOI 10.1001/jama.269.4.488; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Sabanayagam C, 2011, AM J KIDNEY DIS, V57, P682, DOI 10.1053/j.ajkd.2010.11.025; Sabanayagam C, 2009, J HYPERTENS, V27, P2209, DOI 10.1097/HJH.0b013e328330141d; Sabanayagam C, 2009, AM J EPIDEMIOL, V169, P625, DOI 10.1093/aje/kwn367; Sasongko MB, 2012, AM J OPHTHALMOL, V153, P176, DOI 10.1016/j.ajo.2011.06.005; Schwartz MM, 1998, NEPHROL DIAL TRANSPL, V13, P2547, DOI 10.1093/ndt/13.10.2547; Sherry LM, 2002, CLIN EXP OPHTHALMOL, V30, P179, DOI 10.1046/j.1442-9071.2002.00520.x; Smith W, 2004, HYPERTENSION, V44, P442, DOI 10.1161/01.HYP.0000140772.40322.ec; Sng CCA, 2010, NEPHROL DIAL TRANSPL, V25, P2252, DOI 10.1093/ndt/gfq007; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003; Tanabe Y, 2010, MICROCIRCULATION, V17, P94, DOI 10.1111/j.1549-8719.2009.00006.x; Thomas GN, 2014, INVEST OPHTH VIS SCI, V55, P2237, DOI 10.1167/iovs.13-13315; United States Renal Data System, 2012, ANNUAL DATA REPORT A; von Hanno T, 2014, ACTA OPHTHALMOL, V92, P40, DOI 10.1111/aos.12102; Wang JJ, 2006, HEART, V92, P1583, DOI 10.1136/hrt.2006.090522; Wang JJ, 2008, AM J EPIDEMIOL, V168, P80, DOI 10.1093/aje/kwn100; WHELTON PK, 1989, HYPERTENSION S1, V13, P19, DOI DOI 10.1161/HYPERTENSIONAHA.113.02250; Wong TY, 2011, ARCH OPHTHALMOL-CHIC, V129, P95, DOI 10.1001/archophthalmol.2010.347; Wong TY, 2004, J AM SOC NEPHROL, V15, P2469, DOI 10.1097/01.ASN.0000136133.28194.E4; Wong TY, 2004, BMJ-BRIT MED J, V329, P79, DOI 10.1136/bmj.38124.682523.55; Wong TY, 2004, ANN INTERN MED, V140, P248, DOI 10.7326/0003-4819-140-4-200402170-00006; Wong TY, 2004, DIABETES, V53, P179, DOI 10.2337/diabetes.53.1.179; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Yau JWY, 2012, DIABETES RES CLIN PR, V95, P265, DOI 10.1016/j.diabres.2011.10.027; Yau JWY, 2011, AM J KIDNEY DIS, V58, P39, DOI 10.1053/j.ajkd.2011.02.382	60	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136434	10.1371/journal.pone.0136434	http://dx.doi.org/10.1371/journal.pone.0136434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327531	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700042
J	Rief, M; Feger, S; Martus, P; Laule, M; Dewey, M; Schonenberger, E				Rief, Matthias; Feger, Sarah; Martus, Peter; Laule, Michael; Dewey, Marc; Schoenenberger, Eva			Acceptance of Combined Coronary CT Angiography and Myocardial CT Perfusion versus Conventional Coronary Angiography in Patients with Coronary Stents-Intraindividual Comparison	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; CARDIAC MAGNETIC-RESONANCE; ARTERY-DISEASE; DIAGNOSTIC PERFORMANCE; MULTICENTER; REVASCULARIZATION; METAANALYSIS; ASSOCIATION; ACCURACY; INTERVENTION	Objectives To evaluate how well patients with coronary stents accept combined coronary computed tomography angiography (CTA) and myocardial CT perfusion (CTP) compared with conventional coronary angiography (CCA). Background While combined CTA and CTP may improve diagnostic accuracy compared with CTA alone, patient acceptance of CTA/CTP remains to be defined. Methods A total of 90 patients with coronary stents prospectively underwent CTA/CTP (both with contrast agent, CTP with adenosine) and CCA as part of the CARS-320 study. In this group, an intraindividual comparison of patient acceptance of CTA, CTP, and CCA was performed. Results CTP was experienced to be significantly more painful than CTA (p<0.001) and was associated with a higher frequency of dyspnea (p<0.001). Comparison of CTA/CTP with CCA revealed no significant differences in terms of pain (p = 0.141) and comfort (p = 0.377). Concern before CTA/CTP and CCA and overall satisfaction were likewise not significantly different (p = 0.097 and p = 0.123, respectively). Nevertheless, about two thirds (n = 60, 68%) preferred CTA/CTP to CCA (p<0.001). Moreover, patients felt less helpless during CTA/CTP than during CCA (p = 0.026). Lack of invasiveness and absence of pain were the most frequently mentioned advantages of CTA/CTP over CCA in our patient population. Conclusions CCA and combined CTA/CTP are equally well accepted by patients; however, more patients prefer CTA/CTP. CTP was associated with more intense pain than CTA and more frequently caused dyspnea than CTA alone.	[Rief, Matthias; Feger, Sarah; Dewey, Marc] Charite, Sch Med, Dept Radiol, Berlin, Germany; [Martus, Peter] Univ Tubingen, Inst Clin Epidemiol & Appl Biostat, Tubingen, Germany; [Laule, Michael] Charite, Sch Med, Dept Cardiol, Berlin, Germany; [Schoenenberger, Eva] Hannover Med Sch, Dept Med, Hannover, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School	Dewey, M (corresponding author), Charite, Sch Med, Dept Radiol, Berlin, Germany.	dewey@charite.de		Dewey, Marc/0000-0002-4402-2733; Laule, Michael/0000-0002-7579-295X	BRACCO; Heisenberg Program of the DFG [DE 1361/14-1]; European Commission [603266-2, HEALTH-2012.2.4.-2]; European Regional Development Fund [20072013 2/05, 20072013 2/48]; German Heart Foundation/German Foundation of Heart Research [F/23/08, F/27/10]; German Research Foundation (DFG) [01KG1013, 01KG1110]; German Federal Ministry of Education and Research (BMBF) [01KG1013, 01KG1110]; GE Healthcare; Bracco Medical System; Guerbet Medical System; Toshiba Medical System; Toshiba Medical Systems; Guerbet; Cardiac MR Academy Berlin; Bayer	BRACCO; Heisenberg Program of the DFG(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Regional Development Fund(European Commission); German Heart Foundation/German Foundation of Heart Research; German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); GE Healthcare(General ElectricGE Healthcare); Bracco Medical System; Guerbet Medical System; Toshiba Medical System; Toshiba Medical Systems; Guerbet; Cardiac MR Academy Berlin; Bayer(Bayer AG)	The CARS-320 study was supported by a grant from BRACCO. The authors of this manuscript declare relationships with the following companies: Prof. Dewey has received grant support from the Heisenberg Program of the DFG for a professorship (DE 1361/14-1), the FP7 Program of the European Commission for the randomized multicenter DISCHARGE trial (603266-2, HEALTH-2012.2.4.-2), the European Regional Development Fund (20072013 2/05, 20072013 2/48), the German Heart Foundation/German Foundation of Heart Research (F/23/08, F/27/10), the Joint Program from the German Research Foundation (DFG) and the German Federal Ministry of Education and Research (BMBF) for meta-analyses (01KG1013, 01KG1110, 01KG1110), GE Healthcare, and Bracco, Guerbet, and Toshiba Medical Systems. The CARS-320 study has received grants from Bracco. Prof. Dewey has received lecture fees from Toshiba Medical Systems, Guerbet, Cardiac MR Academy Berlin, and Bayer (Schering-Berlex). Prof. Dewey is a consultant to Guerbet and one of the principal investigators of multi-center studies (CORE-64 and 320) on coronary CT angiography sponsored by Toshiba Medical Systems. He is the editor of Coronary CT Angiography and Cardiac CT, both published by Springer. He also offers hands-on workshops on cardiovascular imaging (www.ct-kurs.de), and is an associate editor of Radiology and European Radiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberg F, 2011, RADIOLOGY, V260, P689, DOI 10.1148/radiol.11110638; Bamberg F, 2010, EUR RADIOL, V20, P1168, DOI 10.1007/s00330-010-1715-9; Bettencourt N, 2013, JACC-CARDIOVASC IMAG, V6, P1062, DOI 10.1016/j.jcmg.2013.04.013; Bettencourt N, 2013, J AM COLL CARDIOL, V61, P1099, DOI 10.1016/j.jacc.2012.12.020; Blankstein R, 2009, J AM COLL CARDIOL, V54, P1072, DOI 10.1016/j.jacc.2009.06.014; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Caputo RP, 2011, CATHETER CARDIO INTE, V78, P823, DOI 10.1002/ccd.23052; CERQUEIRA MD, 1994, J AM COLL CARDIOL, V23, P384, DOI 10.1016/0735-1097(94)90424-3; Choi JH, 2011, JACC-CARDIOVASC IMAG, V4, P1149, DOI 10.1016/j.jcmg.2011.09.006; D'Ascenzo F, 2013, EUR HEART J-CARD IMG, V14, P782, DOI 10.1093/ehjci/jes287; Darlington M, 2015, EUR J HEALTH ECON, V16, P647, DOI 10.1007/s10198-014-0616-2; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Dewey M, 2009, CIRCULATION, V120, P867, DOI 10.1161/CIRCULATIONAHA.109.859280; Dorbala S, 2013, J AM COLL CARDIOL, V61, P176, DOI 10.1016/j.jacc.2012.09.043; Feuchtner G, 2011, CIRC-CARDIOVASC IMAG, V4, P540, DOI 10.1161/CIRCIMAGING.110.961250; Hosokawa K, 2011, CIRC J, V75, P1905, DOI 10.1253/circj.CJ-10-1144; Jaarsma C, 2012, J AM COLL CARDIOL, V59, P1719, DOI 10.1016/j.jacc.2011.12.040; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Keirns CC, 2009, JAMA-J AM MED ASSOC, V302, P1805, DOI 10.1001/jama.2009.1550; Kim HR, 2014, INT J CARDIOVAS IMAG, V30, P1, DOI 10.1007/s10554-014-0411-2; Kim YH, 2012, J AM COLL CARDIOL, V60, P181, DOI 10.1016/j.jacc.2012.02.061; Ko BS, 2012, JACC-CARDIOVASC IMAG, V5, P1097, DOI 10.1016/j.jcmg.2012.09.004; Ko BS, 2012, EUR HEART J, V33, P67, DOI 10.1093/eurheartj/ehr268; Ko SM, 2012, AM J ROENTGENOL, V198, P512, DOI 10.2214/AJR.11.7029; Miller JM, 2009, EUR RADIOL, V19, P816, DOI 10.1007/s00330-008-1203-7; Mumma BE, 2011, ANN EMERG MED, V57, P551, DOI 10.1016/j.annemergmed.2010.09.026; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; Pelliccia F, 2013, INT J CARDIOVAS IMAG, V29, P443, DOI 10.1007/s10554-012-0095-4; Qaseem A, 2012, ANN INTERN MED, V157, P729, DOI 10.7326/0003-4819-157-10-201211200-00010; Rief M, 2013, J AM COLL CARDIOL, V62, P1476, DOI 10.1016/j.jacc.2013.03.088; Rief M, 2013, KOREAN J RADIOL, V14, P21, DOI 10.3348/kjr.2013.14.1.21; Sandgaard NCF, 2012, J THORAC IMAG, V27, P36, DOI 10.1097/RTI.0b013e3182108091; Schonenberger E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000246; Schuetz GM, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-13; Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008; Schuijf JD, 2006, J AM COLL CARDIOL, V48, P2508, DOI 10.1016/j.jacc.2006.05.080; Stergiopoulos K, 2012, ARCH INTERN MED, V172, P312, DOI 10.1001/archinternmed.2011.1484; Sun ZH, 2009, EUR J RADIOL, V69, P489, DOI 10.1016/j.ejrad.2007.11.030; Tashakkor AY, 2012, CAN J CARDIOL, V28, P413, DOI 10.1016/j.cjca.2012.02.010; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Vavere AL, 2011, J CARDIOVASC COMPUT, V5, P370, DOI 10.1016/j.jcct.2011.11.001	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136737	10.1371/journal.pone.0136737	http://dx.doi.org/10.1371/journal.pone.0136737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327127	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700060
J	Silva, F; Stevens, CJ; Weisskopf, A; Castillo, C; Qin, L; Bevan, A; Fuller, DQ				Silva, Fabio; Stevens, Chris J.; Weisskopf, Alison; Castillo, Cristina; Qin, Ling; Bevan, Andrew; Fuller, Dorian Q.			Modelling the Geographical Origin of Rice Cultivation in Asia Using the Rice Archaeological Database	PLOS ONE			English	Article							PLANT DOMESTICATION; RADIOCARBON-DATES; WILD-RICE; AGRICULTURE; SPREAD; EAST; DISPERSAL; REVEALS; CHINA; BASES	We have compiled an extensive database of archaeological evidence for rice across Asia, including 400 sites from mainland East Asia, Southeast Asia and South Asia. This dataset is used to compare several models for the geographical origins of rice cultivation and infer the most likely region(s) for its origins and subsequent outward diffusion. The approach is based on regression modelling wherein goodness of fit is obtained from power law quantile regressions of the archaeologically inferred age versus a least-cost distance from the putative origin(s). The Fast Marching method is used to estimate the least-cost distances based on simple geographical features. The origin region that best fits the archaeobotanical data is also compared to other hypothetical geographical origins derived from the literature, including from genetics, archaeology and historical linguistics. The model that best fits all available archaeological evidence is a dual origin model with two centres for the cultivation and dispersal of rice focused on the Middle Yangtze and the Lower Yangtze valleys.	[Silva, Fabio; Stevens, Chris J.; Weisskopf, Alison; Castillo, Cristina; Bevan, Andrew; Fuller, Dorian Q.] UCL, Inst Archaeol, London, England; [Qin, Ling] Peking Univ, Sch Archaeol & Museol, Beijing 100871, Peoples R China	University of London; University College London; Peking University	Silva, F (corresponding author), UCL, Inst Archaeol, London, England.	fabio.silva@ucl.ac.uk	Fuller, Dorian/AAF-7400-2019; Fuller, Dorian Q/C-1908-2008	Fuller, Dorian/0000-0002-4859-080X; Fuller, Dorian Q/0000-0002-4859-080X; Bevan, Andrew/0000-0001-7967-3117; Silva, Fabio/0000-0003-1368-6331; Stevens, Chris/0000-0002-2669-5715	Natural Environment Research Council (UK) [NE/G005540/1]; European Research Council [323842]; Natural Environment Research Council [NE/K003402/1, NE/G005540/1, NRCF010002] Funding Source: researchfish; NERC [NE/G005540/1, NRCF010002, NE/K003402/1] Funding Source: UKRI	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research is part of the Natural Environment Research Council (UK, www.nerc.ac.uk/) funded project "The impact of evolving rice systems from China to Southeast Asia" (NE/G005540/1). Some work on the database by CJS was carried out as part of the European Research Council (erc.europa.eu/) project "Comparative Pathways to Agriculture" (Advanced Grant no. 323842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2010, ARCHAEOL ANTHROP SCI, V2, P89, DOI 10.1007/s12520-010-0029-9; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], ORIGINS CULTIVATED R; [Anonymous], 2014, R LANG ENV STAT COMP; Bellwood Peter, 1997, PREHISTORY INDOMALAY; Bellwood Peter, 2005, 1 FARMERS; Bengtsson H., MATLAB READ WRITE MA; Auban JB, 2015, ECOL MODEL, V307, P22, DOI 10.1016/j.ecolmodel.2015.03.015; Blench R., 2005, PERSPECTIVES PHYLOGE, P31; Bonhomme R, 2000, EUR J AGRON, V13, P1, DOI 10.1016/S1161-0301(00)00058-7; Bray F., 1986, RICE EC TECHNOLOGY D, DOI 10.1525/9780520914933; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chang T. T., 1989, Foraging and farming: the evolution of plant exploitation., P408; Chi Z, 2010, ANTIQUITY, V84, P11, DOI 10.1017/S0003598X00099737; Connolly J, 2006, GEOGRAPHIC INFORM SY; Crawford GW, 2012, HOLOCENE, V22, P613, DOI 10.1177/0959683611424177; Crawford GW, 2011, CURR ANTHROPOL, V52, pS331, DOI 10.1086/658369; Crawford GW, 1998, ANTIQUITY, V72, P858, DOI 10.1017/S0003598X00087494; De Smith M.J., 2007, GEOSPATIAL ANAL COMP; Douglas D. H., 1994, CARTOGRAPHICA, V31, P37, DOI [10.3138/D327-0323-2JUT-016M, DOI 10.3138/D327-0323-2JUT-016M]; Edwards AWF, 1992, LIKELIHOOD; Fishman G. S., 1995, MONTE CARLO CONCEPTS; Fort J, 2012, AM ANTIQUITY, V77, P203, DOI 10.7183/0002-7316.77.2.203; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2014, P NATL ACAD SCI USA, V111, P6147, DOI 10.1073/pnas.1308937110; Fuller DQ, 2011, RICE, V4, P78, DOI 10.1007/s12284-011-9078-7; Fuller DQ, 2011, CURR ANTHROPOL, V52, pS347, DOI 10.1086/658900; Fuller DQ, 2011, HOLOCENE, V21, P743, DOI 10.1177/0959683611398052; Fuller DQ, 2010, ARCHAEOL ANTHROP SCI, V2, P115, DOI 10.1007/s12520-010-0035-y; Fuller DQ, 2009, WORLD ARCHAEOL, V41, P88, DOI 10.1080/00438240802668321; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Gross BL, 2014, P NATL ACAD SCI USA, V111, P6190, DOI 10.1073/pnas.1308942110; Guedes JAD, 2015, P NATL ACAD SCI USA, V112, P5625, DOI 10.1073/pnas.1423708112; Guedes JD, 2014, QUATERN INT, V349, P29, DOI 10.1016/j.quaint.2014.08.003; Gurou P, 1984, RIZ ET CIVILISATION; Harris DavidR., 2014, ENCY GLOBAL ARCHAEOL, P104, DOI DOI 10.1007/978-1-4419-0465-2_64; Hazarika M, 2006, ANC ASIA, V1, P25, DOI 10.5334/aa.06104; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Higham C., 2005, HUMAN WORLD PREHISTO, P234; HIGHAM C, 2003, EXAMINING FARMING LA, P223; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Jiang LP, 2006, ANTIQUITY, V80, P355, DOI 10.1017/S0003598X00093674; Koenker R, 1999, J AM STAT ASSOC, V94, P1296, DOI 10.2307/2669943; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; KOENKER R., 2013, QUANTREG QUANTILE RE; Krige D.G, 1951, J S AFR I MIN METALL, V52, P201, DOI DOI 10.2307/3006914; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Lu H, 2006, BOREAS INT J QUATERN, V31, P378, DOI [10.1111/j.1502-3885.2002.tb01081.x, DOI 10.1111/J.1502-3885.2002.TB01081.X]; Makibayashi K, 2014, J WORLD PREHIST, V27, P295, DOI 10.1007/s10963-014-9082-0; McQuarrie ADR, 1998, REGRESSION TIMES SER; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; Nash JC, 2001, J STAT SOFTW, V43, P1; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pei AP, 1998, ANTIQUITY, V72, P878, DOI 10.1017/S0003598X00087512; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Royall R. M., 2000, STAT EVIDENCE LIKELI; Russell T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087854; Saerens M, 2009, NEURAL COMPUT, V21, P2363, DOI 10.1162/neco.2009.11-07-643; Sagart L, 2011, RICE, V4, P121, DOI 10.1007/s12284-011-9077-8; Sagart L, 2008, ROUTLEDGE STUD EARLY, V5, P133; Scott James, 2009, J SOUTHWEST; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Shelach-Lavi G., 2015, ARCHAEOLOGY EARLY CH; Silva F, 2014, J ARCHAEOL SCI, V52, P609, DOI 10.1016/j.jas.2014.04.021; Silva F, 2014, RADIOCARBON, V56, P723, DOI 10.2458/56.16937; Silva F, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525911003293; Steele J, 2010, J ARCHAEOL SCI, V37, P2017, DOI 10.1016/j.jas.2010.03.007; Toyama S, 2002, ORIGINS POTTERY AGR, P263; VAN DRIEM G., 1998, ARCHAEOLOGY LANGUAGE, P67; van Driem G, 2012, CR PALEVOL, V11, P117, DOI 10.1016/j.crpv.2011.07.004; van Etten J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012060; Vaughan DA, 2008, RICE, V1, P16, DOI 10.1007/s12284-008-9000-0; Weisskopf A, 2015, ANTIQUITY, V89, P1051, DOI 10.15184/aqy.2015.94; Yasuda Y., 2002, ORIGINS POTTERY AGR, P119; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524	80	72	79	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137024	10.1371/journal.pone.0137024	http://dx.doi.org/10.1371/journal.pone.0137024			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CQ2NK	26327225	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700083
J	Xie, QQ; Li, ZJ; Yang, LM; Lv, J; Jobe, TO; Wang, QQ				Xie, Qingqing; Li, Zhenji; Yang, Limin; Lv, Jing; Jobe, Timothy O.; Wang, Qiuquan			A Newly Identified Passive Hyperaccumulator Eucalyptus grandis x E. urophylla under Manganese Stress	PLOS ONE			English	Article							PHOTOSYSTEM-II; METAL ACCUMULATION; TOXICITY; PROTEIN; DETOXIFICATION; NEUROTOXICITY; PHOSPHORUS; COEXPOSURE; TOLERANCE; EXPOSURE	Manganese (Mn) is an essential micronutrient needed for plant growth and development, but can be toxic to plants in excess amounts. However, some plant species have detoxification mechanisms that allow them to accumulate Mn to levels that are normally toxic, a phenomenon known as hyperaccumulation. These species are excellent candidates for developing a cost-effective remediation strategy for Mn-polluted soils. In this study, we identified a new passive Mn-hyperaccumulator Eucalyptus grandis x E. urophylla during a field survey in southern China in July 2010. This hybrid can accumulate as much as 13,549 mg/ kg DW Mn in its leaves. Our results from Scanning Electron Microscope (SEM) X-ray microanalysis indicate that Mn is distributed in the entire leaf and stem cross-section, especially in photosynthetic palisade, spongy mesophyll tissue, and stem xylem vessels. Results from size-exclusion chromatography coupled with ICP-MS (Inductively coupled plasma mass spectrometry) lead us to speculate that Mn associates with relatively high molecular weight proteins and low molecular weight organic acids, including tartaric acid, to avoid Mn toxicity. Our results provide experimental evidence that both proteins and organic acids play important roles in Mn detoxification in Eucalyptus grandis x E. urophylla. The key characteristics of Eucalyptus grandis x E. urophylla are an increased Mn translocation facilitated by transpiration through the xylem to the leaves and further distribution throughout the leaf tissues. Moreover, the Mn-speciation profile obtained for the first time in different cellular organelles of Eucalyptus grandis x E. urophylla suggested that different organelles have differential accumulating abilities and unique mechanisms for Mn-detoxification.	[Xie, Qingqing; Yang, Limin; Wang, Qiuquan] Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, MOE Key Lab Spectrochem Anal & Instrumentat, Xiamen 361005, Peoples R China; [Li, Zhenji; Lv, Jing] Xiamen Univ, Coll Environm & Ecol, Xiamen 361102, Peoples R China; [Jobe, Timothy O.] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Wang, Qiuquan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Peoples R China	Xiamen University; Xiamen University; Cornell University; Boyce Thompson Institute for Plant Research; Xiamen University	Wang, QQ (corresponding author), Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, MOE Key Lab Spectrochem Anal & Instrumentat, Xiamen 361005, Peoples R China.	qqwang@xmu.edu.cn	Jobe, Timothy O/A-7087-2012; Wang, QQ/G-3413-2010	Jobe, Timothy O/0000-0002-5729-4981; 	National Basic Research 973 program of China [2014CB932004]; National Natural Science Foundation of China [21275120, 21475108]	National Basic Research 973 program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by The National Basic Research 973 program of China (No. 2014CB932004) and The National Natural Science Foundation of China (No. 21275120 and No. 21475108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, CHEMOSPHERE, V91, P869, DOI 10.1016/j.chemosphere.2013.01.075; Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bhatia NP, 2005, J EXP BOT, V56, P1343, DOI 10.1093/jxb/eri135; Bidwell SD, 2002, FUNCT PLANT BIOL, V29, P899, DOI 10.1071/PP01192; BLAMEY FPC, 1986, PLANT SOIL, V91, P171, DOI 10.1007/BF02181785; Boksha IS, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1012, DOI 10.1023/A:1020574003027; Bouchard M, 2008, NEUROTOXICOLOGY, V29, P577, DOI 10.1016/j.neuro.2008.04.013; Broadhurst CL, 2004, ENVIRON SCI TECHNOL, V38, P5797, DOI 10.1021/es0493796; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Deng H, 2010, AGR SCI TECHNOLOGY, V11; Divol F, 2013, PLANT CELL, V25, P1040, DOI 10.1105/tpc.112.107672; Doncheva S, 2009, ENVIRON EXP BOT, V65, P189, DOI 10.1016/j.envexpbot.2008.11.006; Dou CM, 2009, PLANT BIOLOGY, V11, P664, DOI 10.1111/j.1438-8677.2008.00163.x; Erikson KM, 2007, PHARMACOL THERAPEUT, V113, P369, DOI 10.1016/j.pharmthera.2006.09.002; Fecht-Christoffers MM, 2003, PLANT PHYSIOL, V133, P1935, DOI 10.1104/pp.103.029215; Fernando DR, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00319; Fernando DR, 2013, AM J BOT, V100, P690, DOI 10.3732/ajb.1200545; Fernando DR, 2012, PLANTA, V236, P1459, DOI 10.1007/s00425-012-1699-6; Fernando DR, 2009, ANN BOT-LONDON, V103, P931, DOI 10.1093/aob/mcp013; FOULDS W, 1993, NEW PHYTOL, V125, P529, DOI 10.1111/j.1469-8137.1993.tb03901.x; FOY CD, 1978, ANNU REV PLANT PHYS, V29, P511, DOI 10.1146/annurev.pp.29.060178.002455; Francides G., 2007, MIXTURES EUCALYPTUS; Fu XP, 2011, J HAZARD MATER, V186, P103, DOI 10.1016/j.jhazmat.2010.10.122; Gao L, 2013, INT J PHYTOREMEDIAT, V15, P307, DOI 10.1080/15226514.2012.702800; Gonzalez A, 1999, AUST J PLANT PHYSIOL, V26, P811, DOI 10.1071/PP99030; Henn BC, 2012, ENVIRON HEALTH PERSP, V120, P126, DOI 10.1289/ehp.1003300; Horst M, 2011, MINERAL NUTR HIGHER; Huang DY, 1998, BIOCHEM MOL BIOL INT, V46, P107; Inagaki N, 1996, PLANT MOL BIOL, V30, P39, DOI 10.1007/BF00017801; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Karki P, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-4; Kim Y, 2009, NEUROTOXICOLOGY, V30, P564, DOI 10.1016/j.neuro.2009.03.012; Krzeslowska M, 2011, ACTA PHYSIOL PLANT, V33, P35, DOI 10.1007/s11738-010-0581-z; Kukavica BM, 2012, J EXP BOT, V63, P4631, DOI 10.1093/jxb/ers139; Lai Y, 2006, TALANTA, V70, P26, DOI 10.1016/j.talanta.2005.12.062; Lianshui Zhang YsC, 2004, HUADONG FOREST MANAG, V2004; LICHTENTHALER HK, 1963, NATURE, V198, P1070, DOI 10.1038/1981070a0; Liu JB, 2014, LIVEST SCI, V167, P269, DOI 10.1016/j.livsci.2014.06.009; Lucchini RG, 2014, NEUROTOXICOLOGY, V45, P309, DOI 10.1016/j.neuro.2014.05.006; Marschner H., 2002, MINERAL NUTR HIGHER; MEMON AR, 1984, J PLANT NUTR, V7, P961, DOI 10.1080/01904168409363257; Mizuno T, 2008, J PLANT NUTR, V31, P1811, DOI 10.1080/01904160802325396; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Portier C.J., 2012, TOXICOLOGICAL PROFIL; Reeves RD, 2000, PHYTOREMEDIATION OF TOXIC METALS, P193; Reeves Roger D., 2004, Turkish Journal of Botany, V28, P147; Ren LM, 2007, J SOIL WATER CONSERV, V3; Socha AL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00106; Sugaya S, 2000, PLANT CELL PHYSIOL, V41, P503, DOI 10.1093/pcp/41.4.503; U.S. Geological Survey, 2013, MIN COMM SUMM 2013, P198, DOI DOI 10.3133/MINERAL2013; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Un S, 2013, INORG CHEM, V52, P3803, DOI 10.1021/ic302415s; [王华 WANG Hua], 2007, [生态环境, Ecology and Environment], V16, P830; Wang X, 2008, THESIS FUJIAN AGR FO; Xu M, 2010, ANAL CHEM, V82, P1616, DOI 10.1021/ac902902y; Xu XG, 2006, PLANT SOIL, V285, P323, DOI 10.1007/s11104-006-9018-2; Xue SG, 2004, ENVIRON POLLUT, V131, P393, DOI 10.1016/j.envpol.2004.03.011; Yang SX, 2008, PLANT SOIL ENVIRON, V54, P441, DOI 10.17221/401-PSE; Yao YN, 2012, CHEMOSPHERE, V89, P150, DOI 10.1016/j.chemosphere.2012.05.030	62	9	10	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136606	10.1371/journal.pone.0136606	http://dx.doi.org/10.1371/journal.pone.0136606			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327118	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700049
J	Hao, WR; Marsh, C; Friedman, A				Hao, Wenrui; Marsh, Clay; Friedman, Avner			A Mathematical Model of Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TGF-BETA; OXIDATIVE STRESS; LUNG; POLYMORPHISMS; INFLAMMATION; MACROPHAGES; MUTATIONS; TARGETS; IL-10	Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology, and life expectancy of 3-5 years after diagnosis. The incidence rate in the United States is estimated as high as 15 per 100,000 persons per year. The disease is characterized by repeated injury to the alveolar epithelium, resulting in inflammation and deregulated repair, leading to scarring of the lung tissue, resulting in progressive dyspnea and hypoxemia. The disease has no cure, although new drugs are in clinical trials and two agents have been approved for use by the FDA. In the present paper we develop a mathematical model based on the interactions among cells and proteins that are involved in the progression of the disease. The model simulations are shown to be in agreement with available lung tissue data of human patients. The model can be used to explore the efficacy of potential drugs.	[Hao, Wenrui; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Marsh, Clay] W Virginia Univ, Hlth Sci Ctr South, Morgantown, WV 26506 USA; [Friedman, Avner] Ohio State Univ, Dept Math, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; West Virginia University; University System of Ohio; Ohio State University	Hao, WR (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	hao.50@mbi.osu.edu		HAO, WENRUI/0000-0002-6925-7424	Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	This research has been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642 (http://nsf.gov/awardsearch/showAward?AWD_ID=0931642).	ALLEVA DG, 1994, J IMMUNOL, V153, P1674; Armanios M, 2012, NEW ENGL J MED, V367, P384, DOI 10.1056/NEJMc1206730; Bargagli E, 2011, PULM MED, V2011, DOI 10.1155/2011/717130; Bergeron A, 2003, EUR RESPIR J, V22, P69, DOI 10.1183/09031936.03.00014703; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/769214; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; Camelo A, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00173; Cho JH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-8; Clarke DL, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-20; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; Daniels CE, 2010, AM J RESP CRIT CARE, V181, P604, DOI 10.1164/rccm.200906-0964OC; Daniil ZD, 2008, PULM PHARMACOL THER, V21, P26, DOI 10.1016/j.pupt.2006.10.005; Day J, 2009, P NATL ACAD SCI USA, V106, P11246, DOI 10.1073/pnas.0904846106; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Hao WR, 2014, P NATL ACAD SCI USA, V111, P16065, DOI 10.1073/pnas.1417789111; Hao WR, 2014, P NATL ACAD SCI USA, V111, P14193, DOI 10.1073/pnas.1413970111; Hao WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090497; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Homer RJ, 2011, ARCH PATHOL LAB MED, V135, P780, DOI 10.1043/2010-0296-RA.1; IYONAGA K, 1994, HUM PATHOL, V25, P455, DOI 10.1016/0046-8177(94)90117-1; Jakubzick C, 2003, J IMMUNOL, V171, P2684, DOI 10.4049/jimmunol.171.5.2684; Jikov V. V., 1994, HOMOGENIZATION DIFFE; Kliment CR, 2010, FREE RADICAL BIO MED, V49, P707, DOI 10.1016/j.freeradbiomed.2010.04.036; Kuwano K, 2004, HISTOL HISTOPATHOL, V19, P867, DOI 10.14670/HH-19.867; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Lomas NJ, 2012, INT J CLIN EXP PATHO, V5, P58; Malli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053658; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; McRitchie DI, 2000, CYTOKINE, V12, P644, DOI 10.1006/cyto.1999.0656; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Nkyimbeng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073279; Noble PW, 2008, EUR RESPIR REV, V17, P123, DOI 10.1183/09059180.00010904; Nogee LM, 2002, CHEST, V121, p20S, DOI 10.1378/chest.121.3_suppl.20S; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; OLIVER JC, 1993, LYMPHOKINE CYTOK RES, V12, P115; Orbe J, 2003, ATHEROSCLEROSIS, V167, P45, DOI 10.1016/S0021-9150(02)00392-1; Park SW, 2009, J KOREAN MED SCI, V24, P614, DOI 10.3346/jkms.2009.24.4.614; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; Raghu G, 2008, AM J RESP CRIT CARE, V178, P948, DOI 10.1164/rccm.200709-1446OC; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Sanders YY, 2012, AM J RESP CRIT CARE, V186, P525, DOI 10.1164/rccm.201201-0077OC; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Stahl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081382; Takeda Y, 2014, PATIENT PREFER ADHER, V8, P361, DOI 10.2147/PPA.S37233; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Ulrich D, 2010, J PLAST RECONSTR AES, V63, P1015, DOI 10.1016/j.bjps.2009.04.021; Vasakova M, 2006, TISSUE ANTIGENS, V67, P229, DOI 10.1111/j.1399-0039.2006.00560.x; Vasakova M, 2013, HUM IMMUNOL, V74, P1346, DOI 10.1016/j.humimm.2013.07.011; Whittington HA, 2003, GENES IMMUN, V4, P258, DOI 10.1038/sj.gene.6363959; Xiao L, 2012, FRONT BIOSCI-LANDMRK, V17, P2667, DOI 10.2741/4077; Xue C, 2009, P NATL ACAD SCI USA, V106, P16782, DOI 10.1073/pnas.0909115106; Yang IV, 2015, TRANSL RES, V165, P48, DOI 10.1016/j.trsl.2014.03.011; Zoz DF, 2011, AM J MED SCI, V341, P435, DOI 10.1097/MAJ.0b013e31821a9d8e	59	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0135097	10.1371/journal.pone.0135097	http://dx.doi.org/10.1371/journal.pone.0135097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348490	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600002
J	Jia, ZL; Zhang, X; Guan, NY; Bo, XC; Barnes, MR; Luo, ZG				Jia, Zhilong; Zhang, Xiang; Guan, Naiyang; Bo, Xiaochen; Barnes, Michael R.; Luo, Zhigang			Gene Ranking of RNA-Seq Data via Discriminant Non-Negative Matrix Factorization	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; ENRICHMENT ANALYSIS; PACKAGE; ALGORITHM	RNA-sequencing is rapidly becoming the method of choice for studying the full complexity of transcriptomes, however with increasing dimensionality, accurate gene ranking is becoming increasingly challenging. This paper proposes an accurate and sensitive gene ranking method that implements discriminant non-negative matrix factorization (DNMF) for RNA-seq data. To the best of our knowledge, this is the first work to explore the utility of DNMF for gene ranking. When incorporating Fisher's discriminant criteria and setting the reduced dimension as two, DNMF learns two factors to approximate the original gene expression data, abstracting the up-regulated or down-regulated metagene by using the sample label information. The first factor denotes all the genes' weights of two metagenes as the additive combination of all genes, while the second learned factor represents the expression values of two metagenes. In the gene ranking stage, all the genes are ranked as a descending sequence according to the differential values of the metagene weights. Leveraging the nature of NMF and Fisher's criterion, DNMF can robustly boost the gene ranking performance. The Area Under the Curve analysis of differential expression analysis on two benchmarking tests of four RNA-seq data sets with similar phenotypes showed that our proposed DNMF-based gene ranking method outperforms other widely used methods. Moreover, the Gene Set Enrichment Analysis also showed DNMF outweighs others. DNMF is also computationally efficient, substantially outperforming all other benchmarked methods. Consequently, we suggest DNMF is an effective method for the analysis of differential gene expression and gene ranking for RNA-seq data.	[Jia, Zhilong] Natl Univ Def Technol, Coll Sci, Dept Biol & Chem, Changsha, Hunan, Peoples R China; [Jia, Zhilong; Barnes, Michael R.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Zhang, Xiang; Guan, Naiyang; Luo, Zhigang] Natl Univ Def Technol, Sci & Technol Parallel & Distributed Proc Lab, Coll Comp, Changsha, Hunan, Peoples R China; [Bo, Xiaochen] Inst Radiat Med, Beijing, Peoples R China	National University of Defense Technology - China; University of London; Queen Mary University London; National University of Defense Technology - China	Barnes, MR (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	m.r.barnes@qmul.ac.uk; zgluo@nudt.edu.cn	Jia, Zhilong/ABA-9776-2020	Jia, Zhilong/0000-0003-2370-5073; Barnes, Michael/0000-0001-9097-7381; Bo, Xiao-chen/0000-0003-1911-7922	Major Research Plan of The National Natural Science Foundation of China [U1435222]; Plan for interdisciplinary joint PhD students at NUDT; Plan for Innovative Graduate Student at NUDT [B140202]; National Institutes for Health Research (NIHR); China Scholarship Council; Medical Research Council [G1001516] Funding Source: researchfish; MRC [G1001516] Funding Source: UKRI	Major Research Plan of The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan for interdisciplinary joint PhD students at NUDT; Plan for Innovative Graduate Student at NUDT; National Institutes for Health Research (NIHR); China Scholarship Council(China Scholarship Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is partly supported by Major Research Plan of The National Natural Science Foundation of China (under grant no. U1435222) to XB, Plan for interdisciplinary joint PhD students at NUDT to ZL and Plan for Innovative Graduate Student at NUDT (under grant no. B140202) to ZJ. MRB is funded by the National Institutes for Health Research (NIHR), and this work forms part of the portfolio of translational research of the NIHR Cardiovascular Biomedical Research Unit at Barts. And ZJ is funded by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cheung VCK, 2005, P ANN INT IEEE EMBS, P4990, DOI 10.1109/IEMBS.2005.1615595; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Horiuchi T, 2001, STROKE, V32, P218, DOI 10.1161/01.STR.32.1.218; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim B., 2013, NEURAL INFORM PROCES; Kong W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S5-S7; Kotsia I, 2007, IEEE T INF FOREN SEC, V2, P588, DOI 10.1109/TIFS.2007.902017; Lee CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048238; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee SY, 2012, COGN NEURODYNAMICS, V6, P525, DOI 10.1007/s11571-012-9213-1; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Mostafavi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068141; Ni SY, 2012, J COMPUT BIOL, V19, P766, DOI 10.1089/cmb.2012.0026; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tjioe E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S14; Wang HQ, 2015, BIOINFORMATICS, V31, P572, DOI 10.1093/bioinformatics/btu679; Wang Y., 2004, P AS C COMP VIS CIT; Wang YX, 2013, IEEE T KNOWL DATA EN, V25, P1336, DOI 10.1109/TKDE.2012.51; Zafeiriou S, 2006, IEEE T NEURAL NETWOR, V17, P683, DOI 10.1109/TNN.2006.873291	32	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137782	10.1371/journal.pone.0137782	http://dx.doi.org/10.1371/journal.pone.0137782			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348772	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600058
J	Prinja, S; Bahuguna, P; Gupta, R; Sharma, A; Rana, SK; Kumar, R				Prinja, Shankar; Bahuguna, Pankaj; Gupta, Rakesh; Sharma, Atul; Rana, Saroj Kumar; Kumar, Rajesh			Coverage and Financial Risk Protection for Institutional Delivery: How Universal Is Provision of Maternal Health Care in India?	PLOS ONE			English	Article							EXPENDITURE; IMPACT; HARYANA; STATE; MODEL	Background India aims to achieve universal access to institutional delivery. We undertook this study to estimate the universality of institutional delivery care for pregnant women in Haryana state in India. To assess the coverage of institutional delivery, we analyze service coverage (coverage of public sector institutional delivery), population coverage (coverage among different districts and wealth quintiles of the population) and financial risk protection (catastrophic health expenditure and impoverishment as a result of out-of-pocket expenditure for delivery). Methods We analyzed cross-sectional data collected from a randomly selected sample of 12,191 women who had delivered a child in the last one year from the date of data collection in Haryana state. Five indicators were calculated to evaluate coverage and financial risk protection for institutional delivery-proportion of public sector deliveries, out-of-pocket expenditure, percentage of women who incurred no expenses, prevalence of catastrophic expenditure for institutional delivery and incidence of impoverishment due to out-of-pocket expenditure for delivery. These indicators were calculated for the public and private sectors for 5 wealth quintiles and 21 districts of the state. Results The coverage of institutional delivery in Haryana state was 82%, of which 65% took place in public sector facilities. Approximately 63% of the women reported no expenditure on delivery in the public sector. The mean out-of-pocket expenditures for delivery in the public and private sectors in Haryana were INR 771 (USD 14.2) and INR 12,479 (USD 229), respectively, which were catastrophic for 1.6% and 22% of households, respectively. Conclusion Our findings suggest that there is considerably high coverage of institutional delivery care in Haryana state, with significant financial risk protection in the public sector. However, coverage and financial risk protection for institutional delivery vary substantially across districts and among different socio-economic groups and must be strengthened. The success of the public sector in providing high coverage and financial risk protection in maternal health provides encouragement for the role that the public sector can play in universalizing health care.	[Prinja, Shankar; Bahuguna, Pankaj; Sharma, Atul; Rana, Saroj Kumar; Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Gupta, Rakesh] Natl Rural Hlth Mission, Dept Hlth & Family Welf, Panchkula, Haryana, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Prinja, S (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	shankarprinja@gmail.com		Bahuguna, Pankaj/0000-0001-9952-6077	National Rural Health Mission, Department of Health and Family Welfare, Government of Haryana	National Rural Health Mission, Department of Health and Family Welfare, Government of Haryana	The study was funded by the National Rural Health Mission, Department of Health and Family Welfare, Government of Haryana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MONITORING PROGR UNI; [Anonymous], 2014, MIDWIFERY, V30; Bonu S, 2009, HEALTH POLICY PLANN, V24, P445, DOI 10.1093/heapol/czp032; Cordova A., 2008, METHODOLOGICAL NOTE; Dongre AA, 2010, EFFECT MONETARY INCE; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Govil D, 2013, 27 IUSSP IN IN PRESS; Heijink R, 2011, VALIDITY COMP POCKET; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Kalter HD, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-41; Khan ME, 2010, J FAMILY WELFARE, V56; Khan N, 2012, J HLTH POPULATION NU; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; McKenzie DJ, 2005, J POPUL ECON, V18, P229, DOI 10.1007/s00148-005-0224-7; Ministry of Health and Family Welfare (MoHFW) Government of India & UNICEF, 2019, NAT POP POL 2000; Mohanty S, 2012, HLTH POLICY PLANNING, P1; MOHFW, 2011, GUIDL JAN SHISH SUR; Moreno-Serra R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001087; National Sample Survey Organization, 2006, MORB HLTH CAR COND A; NHSRC, 2011, PROGR EV JAN SUR YOJ; Pahwa P, 2013, GLOBAL J MED PUBLIC, V2; Planning Commission Government of India, 2013, 12 5 YEAR PLAN 2012, VII; Planning Commission of India, 2011, HIGH LEV EXP GROUP R; Prinja S, 2011, INDIAN J COMMUNITY M, V36; Prinja S, 2014, INDIAN J MED RES, V139, P883; Prinja S, 2013, INDIAN J MED RES, V138, P1003; Prinja S, 2012, INDIAN J MED RES, V136, P421; Raban MZ, 2013, B WORLD HEALTH ORGAN, V91, P726, DOI 10.2471/BLT.12.113100; Ram U, 2013, LANCET GLOBAL HLTH X, V109X, P70073; Reddy Hanimi, 2012, WHO South East Asia J Public Health, V1, P279, DOI 10.4103/2224-3151.207024; Reserve Bank of India, 2013, TABL 147 EXCH RAT IN; Salve H, 11 SEA REG SCI M INT; Suryanarayana M.H., 2011, INEQUALITY ADJUSTED, P31; Tandon A, 2010, ASSESSING PUBLIC EXP; Tripathi N, 2014, INDIAN PEDIATR, V51; UNICEF, 2010, 2009 COV EV REP; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WHO, 2010, WORLD MALARIA REPORT 2010, P1	39	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137315	10.1371/journal.pone.0137315	http://dx.doi.org/10.1371/journal.pone.0137315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ8YQ	26348921	gold, Green Published, Green Submitted			2022-12-27	WOS:000360897600033
J	Scharf, I; Braf, H; Ifrach, N; Rosenstein, S; Subach, A				Scharf, Inon; Braf, Hila; Ifrach, Naama; Rosenstein, Shai; Subach, Aziz			The Effects of Temperature and Diet during Development, Adulthood, and Mating on Reproduction in the Red Flour Beetle	PLOS ONE			English	Article							BENEFICIAL ACCLIMATION HYPOTHESIS; TRIBOLIUM-CASTANEUM; FLIGHT PERFORMANCE; THERMAL TOLERANCE; SEXUAL SELECTION; BODY-SIZE; PLASTICITY; POPULATION; GROWTH; PATTERNS	The effects of different temperatures and diets experienced during distinct life stages are not necessarily similar. The silver-spoon hypothesis predicts that developing under favorable conditions will always lead to better performing adults under all adult conditions. The environment-matching hypothesis suggests that a match between developmental and adult conditions will lead to the best performing adults. Similar to the latter hypothesis, the beneficial-acclimation hypothesis suggests that either developing or acclimating as adults to the test temperature will improve later performance under such temperature. We disentangled here between the effect of growth, adult, and mating conditions (temperature and diet) on reproduction in the red flour beetle (Tribolium castaneum), in reference to the reproduction success rate, the number of viable offspring produced, and the mean offspring mass 13 days after mating. The most influential stage affecting reproduction differed between the diet and temperature experiments: adult temperature vs. parental growth diet. Generally, a yeast-rich diet or warmer temperature improved reproduction, supporting the silver-spoon hypothesis. However, interactions between life stages made the results more complex, also fitting the environment-matching hypothesis. Warm growth temperature positively affected reproduction success, but only when adults were kept under the same warm temperature. When the parental growth and adult diets matched, the mean offspring mass was greater than in a mismatch between the two. Additionally, a match between warm adult temperature and warm off-spring growth temperature led to the largest offspring mass. These findings support the environment-matching hypothesis. Our results provide evidence for all these hypotheses and demonstrate that parental effects and plasticity may be induced by temperature and diet.	[Scharf, Inon; Braf, Hila; Ifrach, Naama; Rosenstein, Shai; Subach, Aziz] Tel Aviv Univ, Dept Zool, Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University	Scharf, I (corresponding author), Tel Aviv Univ, Dept Zool, Fac Life Sci, IL-69978 Tel Aviv, Israel.	scharfi@post.tau.ac.il	Scharf, Inon/AAF-2343-2020	Scharf, Inon/0000-0002-8506-7161	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA grant [333442]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA grant	This study was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no [333442]. The funding agency supported scholarships for students and salaries for research assistants.	Alabi T, 2008, ECOL ENTOMOL, V33, P716, DOI 10.1111/j.1365-2311.2008.01020.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2009, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.EMO126; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bauerfeind SS, 2005, OIKOS, V111, P514, DOI 10.1111/j.0030-1299.2005.13888.x; Benton TG, 2008, J ANIM ECOL, V77, P1038, DOI 10.1111/j.1365-2656.2008.01434.x; Best AR, 2012, ANIM BEHAV, V83, P1483, DOI 10.1016/j.anbehav.2012.03.022; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Bowler K, 2005, J THERM BIOL, V30, P125, DOI 10.1016/j.jtherbio.2004.09.001; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Bubliy OA, 2012, FUNCT ECOL, V26, P245, DOI 10.1111/j.1365-2435.2011.01928.x; Buckman KA, 2013, J ECON ENTOMOL, V106, P499, DOI 10.1603/EC12276; Campbell JF, 2010, J ECON ENTOMOL, V103, P991, DOI 10.1603/EC09347; Colinet H, 2012, FUNCT ECOL, V26, P84, DOI 10.1111/j.1365-2435.2011.01898.x; Daglish GJ, 2006, J STORED PROD RES, V42, P328, DOI 10.1016/j.jspr.2005.04.003; Davis JM, 2008, Q REV BIOL, V83, P363, DOI 10.1086/592851; Dmitriew C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017399; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fedina TY, 2008, BIOL REV, V83, P151, DOI 10.1111/j.1469-185X.2008.00037.x; Ferrer A, 2014, ENTOMOL EXP APPL, V151, P11, DOI 10.1111/eea.12163; Fischer K, 2003, P ROY SOC B-BIOL SCI, V270, P2051, DOI 10.1098/rspb.2003.2470; Frazier MR, 2008, J EXP BIOL, V211, P2116, DOI 10.1242/jeb.019422; Geister TL, 2007, BEHAV ECOL, V18, P658, DOI 10.1093/beheco/arm024; Gibbs M, 2010, PHYSIOL ENTOMOL, V35, P29, DOI 10.1111/j.1365-3032.2009.00706.x; Grazer V, 2013, THESIS ETH ZURICH SW; Halliday WD, 2014, J ZOOL, V294, P198, DOI 10.1111/jzo.12168; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Huey RB, 1999, AM ZOOL, V39, P323; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Kleinteich A, 2015, OIKOS, V124, P130, DOI 10.1111/oik.01421; LLOYD M, 1968, ECOLOGY, V49, P245, DOI 10.2307/1934453; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Mayhew PJ, 2001, TRENDS ECOL EVOL, V16, P165, DOI 10.1016/S0169-5347(00)02099-1; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Modlmeier AP, 2012, NATURWISSENSCHAFTEN, V99, P811, DOI 10.1007/s00114-012-0963-8; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Overgaard J, 2008, CRYOBIOLOGY, V56, P159, DOI 10.1016/j.cryobiol.2008.01.001; Park T, 1934, Q REV BIOL, V9, P36, DOI 10.1086/394454; Parthasarathy R, 2011, INSECT BIOCHEM MOLEC, V41, P294, DOI 10.1016/j.ibmb.2011.01.006; Philip BN, 2010, J INSECT PHYSIOL, V56, P679, DOI 10.1016/j.jinsphys.2009.12.003; Sabat P, 2000, J COMP PHYSIOL B, V170, P411, DOI 10.1007/s003600000118; Sbilordo SH, 2014, BIOL J LINN SOC, V112, P67, DOI 10.1111/bij.12262; Scharf I, 2015, EVOL BIOL, V42, P54, DOI 10.1007/s11692-014-9298-z; Scharf I, 2010, CLIM RES, V43, P115, DOI 10.3354/cr00907; Scharf I, 2009, OECOLOGIA, V160, P453, DOI 10.1007/s00442-009-1316-y; SIBLY R, 1986, J THEOR BIOL, V123, P311, DOI 10.1016/S0022-5193(86)80246-6; Stillwell RC, 2005, ECOLOGY, V86, P924, DOI 10.1890/04-0547; Stoks R, 2006, ECOLOGY, V87, P1566, DOI 10.1890/0012-9658(2006)87[1566:PCOCGI]2.0.CO;2; Teets NM, 2013, PHYSIOL ENTOMOL, V38, P105, DOI 10.1111/phen.12019; Terblanche JS, 2006, J EXP BIOL, V209, P1064, DOI 10.1242/jeb.02129; Thiery D, 2005, OECOLOGIA, V143, P548, DOI 10.1007/s00442-005-0022-7; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; Van Allen BG, 2014, OIKOS, V123, P699, DOI 10.1111/oik.01240; Van Allen BG, 2013, AM NAT, V181, P596, DOI 10.1086/670127; Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203; Wilson RS, 2007, P R SOC B, V274, P1199, DOI 10.1098/rspb.2006.0401; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9; Wong JWY, 2014, J EVOLUTION BIOL, V27, P2420, DOI 10.1111/jeb.12484; Woods HA, 2002, EVOLUTION, V56, P1863	60	33	35	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136924	10.1371/journal.pone.0136924	http://dx.doi.org/10.1371/journal.pone.0136924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348929	Green Submitted, gold, Green Published			2022-12-27	WOS:000360897600015
J	Wojakowska, A; Marczak, L; Jelonek, K; Polanski, K; Widlak, P; Pietrowska, M				Wojakowska, Anna; Marczak, Lukasz; Jelonek, Karol; Polanski, Krzysztof; Widlak, Piotr; Pietrowska, Monika			An Optimized Method of Metabolite Extraction from Formalin-Fixed Paraffin-Embedded Tissue for GC/MS Analysis	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; PROTEIN-ANALYSIS; CHALLENGES; BIOMARKERS; PROTEOMICS; SPECIMENS; SECTIONS; FIXATION	Formalin-fixed paraffin-embedded (FFPE) tissue specimens constitute a highly valuable source of clinical material for retrospective molecular studies. However, metabolomic assessment of such archival material remains still in its infancy. Hence, there is an urgent need for efficient methods enabling extraction and profiling of metabolites present in FFPE tissue specimens. Here we demonstrate the methodology for isolation of primary metabolites from archival tissues; either fresh-frozen, formalin-fixed or formalin-fixed and paraffin-embedded specimens of mouse kidney were analysed and compared in this work. We used gas chromatography followed by mass spectrometry (GC/MS approach) to identify about 80 metabolites (including amino acids, saccharides, carboxylic acids, fatty acids) present in such archive material. Importantly, about 75% of identified compounds were detected in all three types of specimens. Moreover, we observed that fixation with formalin itself (and their duration) did not affect markedly the presence of particular metabolites in tissue-extracted material, yet fixation for 24h could be recommended as a practical standard. Paraffin embedding influenced efficiency of extraction, which resulted in reduced quantities of several compounds. Nevertheless, we proved applicability of FFPE specimens for non-targeted GS/MS-based profiling of tissue metabolome, which is of great importance for feasibility of metabolomics studies using retrospective clinical material.	[Wojakowska, Anna; Jelonek, Karol; Widlak, Piotr; Pietrowska, Monika] Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, PL-44100 Gliwice, Poland; [Wojakowska, Anna; Jelonek, Karol; Widlak, Piotr; Pietrowska, Monika] Inst Oncol, Gliwice Branch, PL-44100 Gliwice, Poland; [Marczak, Lukasz] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland; [Polanski, Krzysztof] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; University of Warwick	Pietrowska, M (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, Wybrzeze Armii Krajowej 15, PL-44100 Gliwice, Poland.	m_pietrowska@io.gliwice.pl	Widlak, Piotr/AAL-8075-2021; Wojakowska, Anna/C-2075-2013; Marczak, Lukasz/C-9069-2011	Widlak, Piotr/0000-0001-5099-4726; Wojakowska, Anna/0000-0002-4541-1239; Marczak, Lukasz/0000-0001-8602-0077; Pietrowska, Monika/0000-0001-9317-7822; Jelonek, Karol/0000-0002-7233-7695; Polanski, Krzysztof/0000-0002-2586-9576	National Science Centre [UMO-2013/08/S/NZ2/00868, UMO2012/07/B/NZ4/01450]; ONKO;  [POIG. 02. 03. 01-24-099 / 13];  [POIG. 02.03.xx-xx-xxx / 13]	National Science Centre(National Science Centre, Poland); ONKO; ; 	This work was supported by the National Science Centre (grant No UMO-2013/08/S/NZ2/00868 and UMO2012/07/B/NZ4/01450). All the calculations were carried out using GeCONil infrastructure funded by grant POIG. 02. 03. 01-24-099 / 13 and ONKO. SYS infrastructure funded by grant POIG. 02.03.xx-xx-xxx / 13. The authors are grateful to Katarzyna Zorawska-Kulig for preparing the FFPE tissue sections.	Atkins D, 2004, J HISTOCHEM CYTOCHEM, V52, P893, DOI 10.1369/jhc.3A6195.2004; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Ganti S, 2012, CANCER RES, V72, P3471, DOI 10.1158/0008-5472.CAN-11-3105; Hackett MJ, 2011, ANALYST, V136, P2941, DOI 10.1039/c0an00269k; Hughes C, 2014, ANAL METHODS-UK, V6, P1028, DOI 10.1039/c3ay41308j; Kelly AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025357; Khoury T, 2009, MODERN PATHOL, V22, P1457, DOI 10.1038/modpathol.2009.117; Klopfleisch R, 2011, HISTOL HISTOPATHOL, V26, P797, DOI 10.14670/HH-26.797; Maes E, 2013, AMINO ACIDS, V45, P205, DOI 10.1007/s00726-013-1494-0; Ng ESM, 2014, CANCER CHEMOTH PHARM, V73, P475, DOI 10.1007/s00280-013-2346-z; Nirmalan NJ, 2008, MOL BIOSYST, V4, P712, DOI 10.1039/b800098k; Reimel BA, 2009, CURR PROTEOMICS, V6, P63, DOI 10.2174/157016409787847420; Richter S, 2014, J CLIN ENDOCR METAB, V99, P3903, DOI 10.1210/jc.2014-2151; Sahm F, 2012, BRAIN PATHOL, V22, P26, DOI 10.1111/j.1750-3639.2011.00506.x; Shi S.-R., 2000, ANTIGEN RETRIEVAL TE, P17; Sprung RW, 2009, MOL CELL PROTEOMICS, V8, P1988, DOI 10.1074/mcp.M800518-MCP200; Steiner C, 2014, PROTEOMICS, V14, P441, DOI 10.1002/pmic.201300311; Tanca A, 2012, PROTEOM CLIN APPL, V6, P7, DOI 10.1002/prca.201100044; Xu H, 2008, J PROTEOME RES, V7, P1098, DOI 10.1021/pr7006768; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	21	32	32	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136902	10.1371/journal.pone.0136902	http://dx.doi.org/10.1371/journal.pone.0136902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348873	gold, Green Submitted, Green Published			2022-12-27	WOS:000360897600014
J	Yim, AKY; Wong, JWH; Ku, YS; Qin, H; Chan, TF; Lam, HM				Yim, Aldrin Kay-Yuen; Wong, Johanna Wing-Hang; Ku, Yee-Shan; Qin, Hao; Chan, Ting-Fung; Lam, Hon-Ming			Using RNA-Seq Data to Evaluate Reference Genes Suitable for Gene Expression Studies in Soybean	PLOS ONE			English	Article							KNOWLEDGE-BASE SOYKB; TIME RT-PCR; HOUSEKEEPING GENES; WEB RESOURCE; NORMALIZATION; VALIDATION; IDENTIFICATION; TOLERANCE; SELECTION; SEQUENCE	Differential gene expression profiles often provide important clues for gene functions. While reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) is an important tool, the validity of the results depends heavily on the choice of proper reference genes. In this study, we employed new and published RNA-sequencing (RNA-Seq) datasets (26 sequencing libraries in total) to evaluate reference genes reported in previous soybean studies. In silico PCR showed that 13 out of 37 previously reported primer sets have multiple targets, and 4 of them have amplicons with different sizes. Using a probabilistic approach, we identified new and improved candidate reference genes. We further performed 2 validation tests (with 26 RNA samples) on 8 commonly used reference genes and 7 newly identified candidates, using RT-qPCR. In general, the new candidate reference genes exhibited more stable expression levels under the tested experimental conditions. The three newly identified candidate reference genes Bic-C2, F-box protein2, and VPS-like gave the best overall performance, together with the commonly used ELF1b. It is expected that the proposed probabilistic model could serve as an important tool to identify stable reference genes when more soybean RNA-Seq data from different growth stages and treatments are used.	[Yim, Aldrin Kay-Yuen; Wong, Johanna Wing-Hang; Ku, Yee-Shan; Qin, Hao; Chan, Ting-Fung; Lam, Hon-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Yim, Aldrin Kay-Yuen; Wong, Johanna Wing-Hang; Ku, Yee-Shan; Qin, Hao; Chan, Ting-Fung; Lam, Hon-Ming] Chinese Univ Hong Kong, Ctr Soybean Res, Partner State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Yim, Aldrin Kay-Yuen; Qin, Hao; Chan, Ting-Fung] Chinese Univ Hong Kong, Hong Kong Bioinformat Ctr, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Lam, HM (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	honming@cuhk.edu.hk	Wong-Bajracharya, Johanna/GLN-7159-2022; Lam, Hon-Ming/A-9866-2008; Chan, TingFung/A-6161-2013; Ku, Yee-Shan/ABZ-5538-2022	Lam, Hon-Ming/0000-0002-6673-8740; Chan, TingFung/0000-0002-0489-3884; Ku, Yee-Shan/0000-0002-9587-5648; Wong, Johanna Wing-Hang/0000-0001-6119-8645	Hong Kong RGC Collaborative Research Fund [CUHK3/CRF/11G]; Lo Kwee-Seong Biomedical Research Fund; Lee Hysan Foundation	Hong Kong RGC Collaborative Research Fund; Lo Kwee-Seong Biomedical Research Fund; Lee Hysan Foundation	This work is supported by the Hong Kong RGC Collaborative Research Fund (CUHK3/CRF/11G), the Lo Kwee-Seong Biomedical Research Fund and the Lee Hysan Foundation to HML and TFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Joshi T, 2014, NUCLEIC ACIDS RES, V42, pD1245, DOI 10.1093/nar/gkt905; Joshi T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S15; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Ku YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078181; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu J, 2013, PLANT CELL REP, V32, P415, DOI 10.1007/s00299-012-1374-1; Ma SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075271; Martin LBB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00066; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Qi XP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5340; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zonia L, 2007, TRENDS PLANT SCI, V12, P90, DOI 10.1016/j.tplants.2007.01.006	34	47	48	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136343	10.1371/journal.pone.0136343	http://dx.doi.org/10.1371/journal.pone.0136343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348924	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600006
J	Cao, SN; Liu, P; Zhu, HY; Gong, HY; Yao, JF; Sun, YW; Geng, GF; Wang, T; Feng, SZ; Han, MZ; Zhou, JX; Xu, YF				Cao, Shannan; Liu, Peng; Zhu, Haiyan; Gong, Haiyan; Yao, Jianfeng; Sun, Yawei; Geng, Guangfeng; Wang, Tong; Feng, Sizhou; Han, Mingzhe; Zhou, Jiaxi; Xu, Yuanfu			Extracellular Acidification Acts as a Key Modulator of Neutrophil Apoptosis and Functions	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; NADPH OXIDASE; PERITONEAL-FLUID; RESPIRATORY BURST; INNATE IMMUNITY; PH-DECREASE; ACIDOSIS; SUPEROXIDE; MACROPHAGES; ACTIVATION	In human pathological conditions, the acidification of local environment is a frequent feature, such as tumor and inflammation. As the pH of microenvironment alters, the functions of immune cells are about to change. It makes the extracellular acidification a key modulator of innate immunity. Here we detected the impact of extracellular acidification on neutrophil apoptosis and functions, including cell death, respiratory burst, migration and phagocytosis. As a result, we found that under the acid environment, neutrophil apoptosis delayed, respiratory burst inhibited, polarization augmented, chemotaxis differed, endocytosis enhanced and bacteria killing suppressed. These findings suggested that extracellular acidification acts as a key regulator of neutrophil apoptosis and functions.	[Cao, Shannan; Liu, Peng; Zhu, Haiyan; Gong, Haiyan; Sun, Yawei; Geng, Guangfeng; Wang, Tong; Zhou, Jiaxi; Xu, Yuanfu] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Cao, Shannan; Liu, Peng; Zhu, Haiyan; Gong, Haiyan; Sun, Yawei; Geng, Guangfeng; Wang, Tong; Zhou, Jiaxi; Xu, Yuanfu] Peking Union Med Coll, Tianjin, Peoples R China; [Yao, Jianfeng; Feng, Sizhou; Han, Mingzhe] Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Hematopoiet Stem Cell Transplantat Ctr, Tianjin, Peoples R China; [Yao, Jianfeng; Feng, Sizhou; Han, Mingzhe] Chinese Acad Med Sci, Tianjin, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Xu, YF (corresponding author), Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China.	xuyf@ihcams.ac.cn	zhu, xueqiong/U-1320-2019; Xu, Yuanfu/Z-1135-2019					Abou Alaiwa MH, 2014, P NATL ACAD SCI USA, V111, P18703, DOI 10.1073/pnas.1422091112; AUSTIN C, 1993, J PHYSIOL-LONDON, V466, P1; Bylund J, 2010, FREE RADICAL BIO MED, V49, P1834, DOI 10.1016/j.freeradbiomed.2010.09.016; COLOTTA F, 1992, BLOOD, V80, P2012; Jancic CC, 2012, CYTOKINE, V57, P258, DOI 10.1016/j.cyto.2011.11.013; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; EDLOW DW, 1971, P SOC EXP BIOL MED, V137, P1328; ENGIN K, 1995, INT J HYPERTHER, V11, P211, DOI 10.3109/02656739509022457; GABIG TG, 1979, BLOOD, V53, P1133; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; ICHIHARA K, 1984, AM J PHYSIOL, V246, pH652, DOI 10.1152/ajpheart.1984.246.5.H652; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Lam TI, 2013, P NATL ACAD SCI USA, V110, pE4362, DOI 10.1073/pnas.1313029110; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Latson KM, 2005, EQUINE VET J, V37, P342, DOI 10.2746/0425164054529319; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Lopez DH, 1999, IMMUNOLOGY, V98, P450, DOI 10.1046/j.1365-2567.1999.00884.x; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; Martinez D, 2006, J IMMUNOL, V176, P1163, DOI 10.4049/jimmunol.176.2.1163; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Prasad A, 2011, NAT IMMUNOL, V12, P752, DOI 10.1038/ni.2052; Rajamaki K, 2013, J BIOL CHEM, V288, P13410, DOI 10.1074/jbc.M112.426254; Sakai J, 2012, IMMUNITY, V37, P1037, DOI 10.1016/j.immuni.2012.08.017; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Scheel-Toellner D, 2004, BLOOD, V104, P2557, DOI 10.1182/blood-2004-01-0191; SIMCHOWITZ L, 1985, J CLIN INVEST, V76, P1079, DOI 10.1172/JCI112061; SIMMEN HP, 1993, AM J SURG, V166, P24, DOI 10.1016/S0002-9610(05)80576-8; TAKANAKA K, 1988, J BIOCHEM-TOKYO, V103, P656, DOI 10.1093/oxfordjournals.jbchem.a122324; Trevani AS, 1999, J IMMUNOL, V162, P4849; Van Hoogmoed L, 1999, J AM VET MED ASSOC, V214, P1032; Vogt S, 2007, J SURG RES, V139, P176, DOI 10.1016/j.jss.2006.07.041; WARD TT, 1978, AM J MED, V64, P933, DOI 10.1016/0002-9343(78)90446-1; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Xu YF, 2010, P NATL ACAD SCI USA, V107, P2950, DOI 10.1073/pnas.0912717107; Yang Ke-Ni, 2014, Cancer Biology Medicine, V11, P34, DOI 10.7497/j.issn.2095-3941.2014.01.003; ZIGMOND SH, 1981, J IMMUNOL, V126, P478	42	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137221	10.1371/journal.pone.0137221	http://dx.doi.org/10.1371/journal.pone.0137221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340269	Green Published, gold			2022-12-27	WOS:000360688200035
J	Gori, S; Inno, A; Fiorio, E; Foglietta, J; Ferro, A; Gulisano, M; Pinotti, G; Gubiotti, M; Cavazzini, MG; Turazza, M; Duranti, S; De Simone, V; Iezzi, L; Bisagni, G; Spazzapan, S; Cavanna, L; Saggia, C; Bria, E; Cretella, E; Vici, P; Santini, D; Fabi, A; Garrone, O; Frassoldati, A; Amaducci, L; Saracchini, S; Evangelisti, L; Barni, S; Gamucci, T; Mentuccia, L; Laudadio, L; Zoboli, A; Marchetti, F; Bogina, G; Lunardi, G; Boni, L				Gori, Stefania; Inno, Alessandro; Fiorio, Elena; Foglietta, Jennifer; Ferro, Antonella; Gulisano, Marcella; Pinotti, Graziella; Gubiotti, Marta; Cavazzini, Maria Giovanna; Turazza, Monica; Duranti, Simona; De Simone, Valeria; Iezzi, Laura; Bisagni, Giancarlo; Spazzapan, Simon; Cavanna, Luigi; Saggia, Chiara; Bria, Emilio; Cretella, Elisabetta; Vici, Patrizia; Santini, Daniele; Fabi, Alessandra; Garrone, Ornella; Frassoldati, Antonio; Amaducci, Laura; Saracchini, Silvana; Evangelisti, Lucia; Barni, Sandro; Gamucci, Teresa; Mentuccia, Lucia; Laudadio, Lucio; Zoboli, Alessandra; Marchetti, Fabiana; Bogina, Giuseppe; Lunardi, Gianluigi; Boni, Luca			The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer	PLOS ONE			English	Article							RECURRENCE RISK; TRASTUZUMAB; CHEMOTHERAPY; SURVIVAL; CARCINOMAS; COHORT; WOMEN; T1A	Background The management of pT1a-b pN0 HER2-positive breast cancer is controversial and no data about the efficacy of trastuzumab in this setting are available from randomized clinical trials. The aims of this retrospective study were to assess how patients are managed in clinical practice in Italy, which clinical or biological characteristics influenced the choice of adjuvant systemic therapy and the outcome of patients. Methods Data of consecutive patients who underwent surgery from January 2007 to December 2012 for HER2-positive, pT1a-b pN0 M0 breast cancer were retrospectively collected from 28 Italian centres. Analysis of contingency tables and multivariate generalized logit models were used to investigate the association between the baseline clinical and biological features and the treatment strategy adopted. Results Among 303 enrolled patients, 204 received adjuvant systemic therapy with trastuzumab, 65 adjuvant systemic therapy without trastuzumab and 34 did not receive adjuvant systemic therapy. At the multivariate analysis age, tumor size, proliferation index and hormone receptor status were significantly associated with the treatment choice. Five-year disease-free survival (DFS) probability was 95%, 94.3% and 69.6% for patients treated with adjuvant systemic therapy and trastuzumab, with adjuvant systemic therapy without trastuzumab and for patients who did not receive adjuvant systemic therapy, respectively (p<0.001). Conclusions The majority of patients (66%) with pT1a-b pN0 HER2-positive breast cancer enrolled in this retrospective study received adjuvant systemic therapy with trastuzumab, whereas only 11% patients did not receive any adjuvant systemic therapy. The choice of treatment type seems to be mainly influenced by tumor size, proliferation index, hormone receptor status and age. The 5-year DFS probability was significantly higher for patients receiving adjuvant systemic therapy with trastuzumab compared with patients not receiving adjuvant systemic therapy or receiving adjuvant systemic therapy without trastuzumab.	[Gori, Stefania; Inno, Alessandro; Turazza, Monica; Duranti, Simona; Marchetti, Fabiana; Lunardi, Gianluigi] Osped Sacro Cuore Don Calabria, Dept Oncol, Negrar Verona, Italy; [Fiorio, Elena] Osped Civile, Unit Oncol, I-37126 Verona, Italy; [Foglietta, Jennifer] Azienda Osped Perugia, Med Oncol, Perugia, Italy; [Ferro, Antonella] Osped Santa Chiara, Med Oncol, Trento, Italy; [Gulisano, Marcella] Osped S Bortolo, Med Oncol, Vicenza, Italy; [Pinotti, Graziella] Osped Circolo Varese, Dept Oncol, Varese, Italy; [Pinotti, Graziella] Univ Insubria, Varese, Italy; [Gubiotti, Marta] Osped Civile Macerata, Med Oncol, Macerata, Italy; [Cavazzini, Maria Giovanna] AO Carlo Poma, Unit Hematol & Oncol, Mantua, Italy; [De Simone, Valeria] Osped San Donato, Med Oncol, Arezzo, Italy; [Iezzi, Laura] Osped SS Annunziata, Med Oncol, Chieti, Italy; [Bisagni, Giancarlo] Arcispedale S Maria Nuova, Breast Unit, Med Oncol, Reggio Emilia, Italy; [Spazzapan, Simon] CRO IRCCS, Med Oncol, Aviano, Italy; [Cavanna, Luigi] Osped Guglielmo Saliceto, Dept Oncol & Hematol, Piacenza, Italy; [Saggia, Chiara] Osped Maggiore La Carita, Med Oncol, Novara, Italy; [Bria, Emilio] Univ Verona, Azienda Osped Univ Integrata, Med Oncol, Dept ofMedicine, I-37100 Verona, Italy; [Cretella, Elisabetta] Azienda Sanit Alto Adige, Med Oncol, Bolzano, Italy; [Vici, Patrizia] Regina Elena Inst Canc Res, Div Med Oncol B, Rome, Italy; [Santini, Daniele] Campus Biomed Univ, Dept Med Oncol, Rome, Italy; [Fabi, Alessandra] Regina Elena Inst Canc Res, Div Med Oncol A, Rome, Italy; [Garrone, Ornella] Azienda Osped S Croce & Carle, Div Med Oncol, Cuneo, Italy; [Frassoldati, Antonio] Univ Hosp, Med Oncol, Ferrara, Italy; [Amaducci, Laura] Osped Infermi, Med Oncol, Faenza Ravenna, Italy; [Saracchini, Silvana] Osped Santa Maria degli Angeli, Med Oncol, Pordenone, Italy; [Evangelisti, Lucia] ASL CN1, Med Oncol, Saluzzo Cuneo, Italy; [Barni, Sandro] Azienda Osped Treviglio, Med Oncol, Treviglio Bergamo, Italy; [Gamucci, Teresa; Mentuccia, Lucia] ASL Frosinone, Med Oncol Unit, Frosinone, Italy; [Laudadio, Lucio] Osped Floraspe Renzetti, Dept Oncol, Lanciano Chieti, Italy; [Zoboli, Alessandra] Osped San Sebastiano, Med Oncol, Correggio, Italy; [Bogina, Giuseppe] Osped Sacro Cuore Don Calabria, Pathol, Negrar Verona, Italy; [Boni, Luca] Azienda Osped Univ Careggi, Florence, Italy	IRCCS Sacro Cuore Don Calabria; University of Perugia; Azienda Ospedaliera di Perugia; Santa Chiara Hospital; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; University of Insubria; Hospital Carlo Poma; IRCCS Policlinico San Donato; IRCCS Arcispedale S. Maria Nuova; IRCCS Aviano (CRO); Guglielmo da Saliceto Hospital; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University Campus Bio-Medico - Rome Italy; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Ferrara; Arcispedale Sant'Anna; Hospital of Rimini; Azienda Ospedaliera Santa Maria degli Angeli Pordenone; IRCCS Sacro Cuore Don Calabria; University of Florence; Azienda Ospedaliero Universitaria Careggi	Gori, S (corresponding author), Osped Sacro Cuore Don Calabria, Dept Oncol, Negrar Verona, Italy.	stefania.gori@sacrocuore.it	frassoldati, antonio/J-9761-2016; Saracchini, Silvana/ABD-9637-2020; Garrone, Ornella/AAC-5978-2022; Duranti, Simona/ABD-7914-2021; Fiorio, Elena/AAC-5849-2022; Ferro, Antonella/AAA-8241-2020; Garrone, Ornella/HHS-9402-2022; Fabi, Alessandra/AAC-1021-2019; Spazzapan, Simon/ABE-1728-2020; Inno, Alessandro/AAA-8268-2022; Duranti, Simona/ABD-2502-2020; GORI, Stefania/AAB-4802-2022; Boni, Luca/ABI-6243-2020; GORI, Stefania/N-8827-2016; Bria, Emilio/A-8574-2019; Bisagni, Giancarlo/AAC-2735-2020; Cavanna, Luigi/AAL-5251-2020; Iezzi, Laura/J-3016-2018	frassoldati, antonio/0000-0003-3487-3259; Saracchini, Silvana/0000-0002-7626-872X; Garrone, Ornella/0000-0001-7359-5410; Fiorio, Elena/0000-0002-1354-4600; Ferro, Antonella/0000-0003-4109-6769; Spazzapan, Simon/0000-0003-3922-4960; Inno, Alessandro/0000-0001-6331-6908; Duranti, Simona/0000-0002-1924-238X; GORI, Stefania/0000-0001-6320-405X; Boni, Luca/0000-0003-2217-4047; GORI, Stefania/0000-0001-6320-405X; Bria, Emilio/0000-0002-2333-704X; Bisagni, Giancarlo/0000-0003-1042-3771; Cavanna, Luigi/0000-0002-0303-3778; Iezzi, Laura/0000-0002-4484-8009; Vici, Patrizia/0000-0001-7528-9783; Fabi, Alessandra/0000-0002-0758-8033				Curigliano G, 2009, J CLIN ONCOL, V27, P5693, DOI 10.1200/JCO.2009.22.0962; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Edge SB, 2010, AJCC CANC STAGING MA; Fehrenbacher L, 2014, J CLIN ONCOL, V32, P2151, DOI 10.1200/JCO.2013.52.0858; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Gonzalez-Angulo AM, 2009, J CLIN ONCOL, V27, P5700, DOI 10.1200/JCO.2009.23.2025; Hanrahan EO, 2007, J CLIN ONCOL, V25, P4952, DOI 10.1200/JCO.2006.08.0499; Horio A, 2012, INT J CLIN ONCOL, V17, P131, DOI 10.1007/s10147-011-0269-4; Houvenaeghel G, 2014, ANN ONCOL, V25, P623, DOI 10.1093/annonc/mdt532; Joensuu H, 2003, CLIN CANCER RES, V9, P923; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; Kennedy T, 2007, ANN SURG ONCOL, V14, P2918, DOI 10.1245/s10434-007-9441-5; Kolben T, 2015, BREAST, V24, P24, DOI 10.1016/j.breast.2014.10.007; McArthur HL, 2011, CANCER-AM CANCER SOC, V117, P5461, DOI 10.1002/cncr.26171; Perez EA, 2014, J CLIN ONCOL, V32, P3744, DOI 10.1200/JCO.2014.55.5730; Perez EA, 2011, J CLIN ONCOL, V29, P4491, DOI 10.1200/JCO.2011.36.7045; Petrelli F, 2012, MED ONCOL, V29, P2586, DOI 10.1007/s12032-012-0201-4; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Procter M, 2010, J CLIN ONCOL, V28, P3422, DOI 10.1200/JCO.2009.26.0463; Rodrigues MJ, 2013, ANN ONCOL, V24, P916, DOI 10.1093/annonc/mds536; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Schmidt F, 1998, CANCER, V83, P2516, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2516::AID-CNCR16>3.0.CO;2-#; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Spielmann M, 2009, J CLIN ONCOL, V27, P6129, DOI 10.1200/JCO.2009.23.0946; Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281; Vaz-Luis I, 2014, J CLIN ONCOL, V32, P2142, DOI 10.1200/JCO.2013.53.1608; Vaz-Luis I, 2014, J CLIN ONCOL, V32, P927, DOI 10.1200/JCO.2013.51.1261; Zhou Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083646	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136731	10.1371/journal.pone.0136731	http://dx.doi.org/10.1371/journal.pone.0136731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340098	Green Published, gold			2022-12-27	WOS:000360688200014
J	Holt, EA; Young, C; Keetch, J; Larsen, S; Mollner, B				Holt, Emily A.; Young, Craig; Keetch, Jared; Larsen, Skylar; Mollner, Brayden			The Greatest Learning Return on Your Pedagogical Investment: Alignment, Assessment or In-Class Instruction?	PLOS ONE			English	Article							ORDER THINKING SKILLS; SCIENCE; BIOLOGY; PERFORMANCE; PHYSICS; STRATEGIES; QUESTIONS; EDUCATION; FEEDBACK; FACULTY	Critical thinking is often considered an essential learning outcome of institutions in higher education. Previous work has proposed three pedagogical strategies to address this goal: more active, student-centered in-class instruction, assessments which contain higher-order cognitive questions, and greater alignment within a classroom (i.e., high agreement of the cognitive level of learning objectives, assessments, and in-class instruction). Our goals were to determine which of these factors, individually or the interactions therein, contributed most to improvements in university students' critical thinking. We assessed students' higher-order cognitive skills in introductory non-majors biology courses the first and last week of instruction. For each of the fifteen sections observed, we also measured the cognitive level of assessments and learning objectives, evaluated the learner-centeredness of each classroom, and calculated an alignment score for each class. The best model to explain improvements in students' high-order cognitive skills contained the measure of learner-centeredness of the class and pre-quiz scores as a covariate. The cognitive level of assessments, learning objectives, nor alignment explained improvements in students' critical thinking. In accordance with much of the current literature, our findings support that more student-centered classes had greater improvements in student learning. However, more research is needed to clarify the role of assessment and alignment in student learning.	[Holt, Emily A.; Young, Craig; Keetch, Jared; Larsen, Skylar; Mollner, Brayden] Utah Valley Univ, Dept Biol, Orem, UT 84058 USA	Utah System of Higher Education; Utah Valley University	Holt, EA (corresponding author), Utah Valley Univ, Dept Biol, Orem, UT 84058 USA.	eholt@uvu.edu			Presidential Fellowship; Utah Valley University	Presidential Fellowship; Utah Valley University	Research reported in this publication was partially supported by the Presidential Fellowship, Grant for Engaged Learning, and a Scholarly Activities Committee grant at Utah Valley University, which provided EAH reassign time to conduct and write up the results. The authors otherwise received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein-Beardsley A, 2012, EDUC ASSESS EVAL ACC, V24, P5, DOI 10.1007/s11092-011-9135-1; Anderson L. W., 2001, TAXONOMY LEARNING TE; Anderson WA, 2011, SCIENCE, V331, P152, DOI 10.1126/science.1198280; Andrews TM, 2011, CBE-LIFE SCI EDUC, V10, P394, DOI 10.1187/cbe.11-07-0061; ANGELO TA, 1995, TEACH PSYCHOL, V22, P6, DOI 10.1207/s15328023top2201_1; Antes AL, 2014, J MICROBIOL BIOL EDU, V15, P108, DOI 10.1128/jmbe.v15i2.852; Armbruster P, 2009, CBE-LIFE SCI EDUC, V8, P203, DOI 10.1187/cbe.09-03-0025; Aviles CB, 2000, JOINT C INT FED SOC; Barak M, 2009, J SCI TEACH EDUC, V20, P459, DOI 10.1007/s10972-009-9141-z; Barnett JE, 2012, EDUC PSYCHOL-UK, V32, P201, DOI 10.1080/01443410.2011.638619; Baruch Y, 1999, HUM RELAT, V52, P421, DOI 10.1023/A:1016905407491; Ben- Chaim D., 2001, RES SCI EDUC, V31, P437, DOI DOI 10.1023/A:1013172329170; Biggs J, 1996, HIGH EDUC, V32, P347, DOI 10.1007/BF00138871; Black P., 1998, ASSESS EDUC, V5, P7, DOI [DOI 10.1080/0969595980050102, 10.1080/0969595980050102]; Bloom B, 1956, HDB LONGMANS GREEN C, VI; Blumberg P, 2009, INNOV HIGH EDUC, V34, P93, DOI 10.1007/s10755-009-9095-2; Brewer CA, 2011, VISION CHANGE UNDERG; Burrowes PA, 2003, AM BIOL TEACH, V65, P491, DOI 10.1662/0002-7685(2003)065[0491:ASATTG]2.0.CO;2; Cheang KI, 2009, AM J PHARM EDUC, V73, DOI 10.5688/aj730342; Chun M., 2010, CHANGE MAGAZINE HIGH, V42, P22, DOI DOI 10.1080/00091381003590795; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cohen S.A., 1987, EDUC RESEARCHER, V16, P16, DOI [10.3102/0013189X016008016, DOI 10.3102/0013189X016008016]; Cornelius-White J, 2007, REV EDUC RES, V77, P113, DOI 10.3102/003465430298563; Crowe A, 2008, CBE-LIFE SCI EDUC, V7, P368, DOI 10.1187/cbe.08-05-0024; Dauer JM, 2014, CBE-LIFE SCI EDUC, V13, P397, DOI 10.1187/cbe.14-02-0028; Deslauriers L, 2011, SCIENCE, V332, P862, DOI 10.1126/science.1201783; Dewey J., 1938, EXPERIENCE ED; Ebert-May D, 2003, BIOSCIENCE, V53, P1221, DOI 10.1641/0006-3568(2003)053[1221:DRSFAO]2.0.CO;2; Ebert-May D, 2011, BIOSCIENCE, V61, P550, DOI 10.1525/bio.2011.61.7.9; ENGLISH FW, 1980, EDUC LEADERSHIP, V37, P558; ENNIS RH, 1985, EDUC LEADERSHIP, V43, P44; Evans C, 1999, EDUCATION, V119, P616; Evans C, 2013, REV EDUC RES, V83, P70, DOI 10.3102/0034654312474350; Freeman Scott, 2007, CBE Life Sci Educ, V6, P132, DOI 10.1187/cbe.06-09-0194; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Freeman S, 2011, CBE-LIFE SCI EDUC, V10, P175, DOI 10.1187/cbe.10-08-0105; Fuller D, 1997, J ATHL TRAINING, V32, P242; Gitomer DH, 2011, MEAS-INTERDISCIP RES, V9, P146, DOI 10.1080/15366367.2011.603616; Gregg CS, 2013, CBE-LIFE SCI EDUC, V12, P383, DOI 10.1187/cbe.12-05-0061; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Hall KL, 2011, EXAMINING THE IMPACT; Halpern DF, 1998, AM PSYCHOL, V53, P449, DOI 10.1037/0003-066X.53.4.449; Harden RM, 2001, MED TEACH, V23, P123, DOI 10.1080/01421590120036547; Hurtado S, 2012, UNDERGRADUAGE TEACHI; Jensen JL, 2014, EDUC PSYCHOL REV, V26, P307, DOI 10.1007/s10648-013-9248-9; Kang SHK, 2007, EUR J COGN PSYCHOL, V19, P528, DOI 10.1080/09541440601056620; Knight Jennifer K, 2005, Cell Biol Educ, V4, P298, DOI 10.1187/05-06-0082; Lam BH, 2013, AUST J TEACH EDUC, V38, P97, DOI 10.14221/ajte.2013v38n12.8; Lemons PP, 2013, CBE-LIFE SCI EDUC, V12, P47, DOI 10.1187/cbe.12-03-0024; Lombardi D, 2012, RES SCI EDUC, V42, P201, DOI 10.1007/s11165-010-9196-z; Luckie DB, 2012, ADV PHYSIOL EDUC, V36, P325, DOI 10.1152/advan.00017.2012; LUNDEBERG MA, 1991, REV EDUC RES, V61, P94, DOI 10.2307/1170668; Marshall JC, 2011, SCHOOL SCI MATH, V111, P306, DOI 10.1111/j.1949-8594.2011.00091.x; Martone A, 2009, REV EDUC RES, V79, P1332, DOI 10.3102/0034654309341375; Meltzer DE, 2002, AM J PHYS, V70, P1259, DOI 10.1119/1.1514215; Miri B, 2007, RES SCI EDUC, V37, P353, DOI 10.1007/s11165-006-9029-2; Momsen J, 2013, CBE-LIFE SCI EDUC, V12, P239, DOI 10.1187/cbe.12-08-0130; Momsen JL, 2010, CBE-LIFE SCI EDUC, V9, P435, DOI 10.1187/cbe.10-01-0001; Mundfrom DJ, 2009, QUALITY RESEARCH IN LITERACY AND SCIENCE EDUCATION: INTERNATIONAL PERSPECTIVES AND GOLD STANDARDS, P427, DOI 10.1007/978-1-4020-8427-0_21; National Association of College Employers, 2014, JOB OUTL 2015; Nehm RH, 2007, BIOSCIENCE, V57, P263, DOI 10.1641/B570311; O'Neill A, 2010, CAN J SCHOLARSH TEA, V1, DOI 10.5206/cjsotl-rcacea.2010.1.8; Palmer EJ., 2007, BMC MED EDUC, V7, P49, DOI DOI 10.1186/1472-6920-7-49; Pfund C, 2009, SCIENCE, V324, P470, DOI 10.1126/science.1170015; Piburn M., 2000, IN003 ACEPT; Pithers RT, 2000, EDUC RES-UK, V42, P237, DOI 10.1080/001318800440579; Putka DJ, 2008, J APPL PSYCHOL, V93, P959, DOI 10.1037/0021-9010.93.5.959; Reeves TC, 2006, INT J LEARN TECHNOL, V2, P294, DOI 10.1504/IJLT.2006.011336; Rice DC, 1998, J RES SCI TEACH, V35, P1103, DOI 10.1002/(SICI)1098-2736(199812)35:10<1103::AID-TEA4>3.0.CO;2-P; SADLER DR, 1989, INSTR SCI, V18, P119, DOI 10.1007/BF00117714; Sawada D, 2003, REFORMED TEACHER EDU; Sawada D., 2002, SCH SCI MATH, V102, P245, DOI [10.1111/j.1949-8594.2002.tb17883.x, DOI 10.1111/J.1949-8594.2002.TB17883.X]; Shepard L.A., 2000, EDUC RESEARCHER, V29, P4, DOI [10.3102/0013189X029007004, DOI 10.3102/0013189X029007004]; Shi J, 2010, CBE-LIFE SCI EDUC, V9, P453, DOI 10.1187/cbe.10-04-0055; Sirum K, 2011, BIOSCENE, V37, P9; Smith MK, 2008, CBE-LIFE SCI EDUC, V7, P422, DOI 10.1187/cbe.08-08-0045; Squires D., 2012, CLEARING HOUSE J ED, V85, P129, DOI DOI 10.1080/00098655.2012.657723; Stanger-Hall KF, 2012, CBE-LIFE SCI EDUC, V11, P294, DOI 10.1187/cbe.11-11-0100; Sternberg RJ, 2008, PERSPECT PSYCHOL SCI, V3, P486, DOI 10.1111/j.1745-6924.2008.00095.x; Taras M, 2005, BRIT J EDUC STUD, V53, P466, DOI 10.1111/j.1467-8527.2005.00307.x; ten Dam G, 2004, LEARN INSTR, V14, P359, DOI 10.1016/j.learninstruc.2004.01.005; Thiede KW, 2011, BRIT J EDUC PSYCHOL, V81, P264, DOI 10.1348/135910710X510494; Walker JD, 2008, CBE-LIFE SCI EDUC, V7, P361, DOI 10.1187/cbe.08-02-0004; Walker SE, 2003, J ATHL TRAINING, V38, P263; Wang L, 2009, MULTIVARIATE BEHAV R, V43, P479; Wiggins G., 2005, UNDERSTANDING DESIGN; Wilson Christopher D, 2006, CBE Life Sci Educ, V5, P323, DOI 10.1187/cbe.06-02-0142; Zohar A, 2003, J LEARN SCI, V12, P145, DOI 10.1207/S15327809JLS1202_1; ZOLLER U, 1993, J CHEM EDUC, V70, P195, DOI 10.1021/ed070p195; Zoller U, 2010, INT J SCI ED, V24, P185; Zoller U., 1990, HIGH ED EUR, V15, P5, DOI [10.1080/0379772900150402, DOI 10.1080/0379772900150402]	91	12	12	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137446	10.1371/journal.pone.0137446	http://dx.doi.org/10.1371/journal.pone.0137446			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ6BA	26340659	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200059
J	Kim, H; Kim, JH; Kim, SY; Jo, D; Park, HJ; Kim, J; Jung, S; Kim, HS; Lee, K				Kim, Hyosil; Kim, Ju-Hwa; Kim, So Youn; Jo, Deokyeon; Park, Ho Jun; Kim, Jihyun; Jung, Sungwon; Kim, Hyun Seok; Lee, KiYoung			Meta-Analysis of Large-Scale Toxicogenomic Data Finds Neuronal Regeneration Related Protein and Cathepsin D to Be Novel Biomarkers of Drug-Induced Toxicity	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; INTERACTION NETWORKS; GENOMIC BIOMARKERS; UPDATE; RATS; MICROARRAY; LIVER; ACTIVATION; HOMEOSTASIS; SIGNATURE	Undesirable toxicity is one of the main reasons for withdrawing drugs from the market or eliminating them as candidates in clinical trials. Although numerous studies have attempted to identify biomarkers capable of predicting pharmacotoxicity, few have attempted to discover robust biomarkers that are coherent across various species and experimental settings. To identify such biomarkers, we conducted meta-analyses of massive gene expression profiles for 6,567 in vivo rat samples and 453 compounds. After applying rigorous feature reduction procedures, our analyses identified 18 genes to be related with toxicity upon comparisons of untreated versus treated and innocuous versus toxic specimens of kidney, liver and heart tissue. We then independently validated these genes in human cell lines. In doing so, we found several of these genes to be coherently regulated in both in vivo rat specimens and in human cell lines. Specifically, mRNA expression of neuronal regeneration-related protein was robustly down-regulated in both liver and kidney cells, while mRNA expression of cathepsin D was commonly up-regulated in liver cells after exposure to toxic concentrations of chemical compounds. Use of these novel toxicity biomarkers may enhance the efficiency of screening for safe lead compounds in early-phase drug development prior to animal testing.	[Kim, Hyosil; Kim, So Youn; Jo, Deokyeon; Park, Ho Jun; Kim, Jihyun; Lee, KiYoung] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon 441749, South Korea; [Kim, Hyosil; Kim, Ju-Hwa; Kim, Hyun Seok] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Jung, Sungwon] Gachon Univ, Sch Med, Dept Genome Med & Sci, Inchon, South Korea; [Kim, Hyun Seok] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea	Ajou University; Yonsei University; Yonsei University Health System; Gachon University; Yonsei University; Yonsei University Health System	Jung, S (corresponding author), Gachon Univ, Sch Med, Dept Genome Med & Sci, Inchon, South Korea.	sjung@gachon.ac.kr; hsfkim@yuhs.ac		Kim, Hyun Seok/0000-0003-4498-8690	Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1323]; Yonsei University College of Medicine [6-2014-0066]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A3019523, 2010-0022887]	Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Yonsei University College of Medicine(General Electric); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	Funding was received from the Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea grant number: HI14C1323; a faculty research grant from Yonsei University College of Medicine for 2014 grant number: 6-2014-0066; and the the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology grant number: 2012R1A1A3019523, 2010-0022887.	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Andersen ME, 2009, TOXICOL SCI, V107, P324, DOI 10.1093/toxsci/kfn255; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartel J, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301009; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Calderone A, 2013, NAT METHODS, V10, P690, DOI 10.1038/nmeth.2561; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chautard E, 2011, NUCLEIC ACIDS RES, V39, pD235, DOI 10.1093/nar/gkq830; Chen MJ, 2012, TOXICOL SCI, V130, P217, DOI 10.1093/toxsci/kfs223; Chen Q, 2008, MOL PSYCHIATR, V13, P930, DOI 10.1038/sj.mp.4002051; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dunnick J, 2006, TOXICOL PATHOL, V34, P348, DOI 10.1080/01926230600798583; Fielden MR, 2005, TOXICOL PATHOL, V33, P675, DOI 10.1080/01926230500321213; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Godderis L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039205; Hah YS, 2012, CANCER LETT, V323, P208, DOI 10.1016/j.canlet.2012.04.012; Hedges LV, 2014, STAT METHODS META AN; Huang L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-288; Igarashi Y, 2015, NUCLEIC ACIDS RES, V43, pD921, DOI 10.1093/nar/gku955; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Knudsen TB, 2009, REPROD TOXICOL, V28, P209, DOI 10.1016/j.reprotox.2009.03.016; Kondo C, 2009, TOXICOLOGY, V265, P15, DOI 10.1016/j.tox.2009.09.003; Lee K, 2013, GENOME RES, V23, P1283, DOI 10.1101/gr.155499.113; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Mann PC, 2012, TOXICOL PATHOL, V40, P7, DOI 10.1177/0192623312438738; Mathivanan S, 2008, NAT BIOTECHNOL, V26, P164, DOI 10.1038/nbt0208-164; Minami K, 2005, TOXICOL SCI, V87, P296, DOI 10.1093/toxsci/kfi235; Mori Y, 2010, TOXICOLOGY, V271, P36, DOI 10.1016/j.tox.2010.02.015; Natsoulis G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.9; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Onizuka T, 2012, FEBS J, V279, P2645, DOI 10.1111/j.1742-4658.2012.08643.x; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi JH, 2006, EXP CELL RES, V312, P3432, DOI 10.1016/j.yexcr.2006.07.016; Singhal R, 2012, J PHARMACOL EXP THER, V341, P377, DOI 10.1124/jpet.111.189837; Stanger BZ, 2015, ANNU REV PHYSIOL, V77, P179, DOI 10.1146/annurev-physiol-021113-170255; Sun Wei, 2012, Zhonghua Shao Shang Za Zhi, V28, P213; Tamaki C, 2013, J TOXICOL SCI, V38, P581, DOI 10.2131/jts.38.581; Tan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009995; Wang EJ, 2008, TOXICOLOGY, V246, P91, DOI 10.1016/j.tox.2007.12.031; Waters M, 2008, NUCLEIC ACIDS RES, V36, pD892, DOI 10.1093/nar/gkm755; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Yu TW, 2011, IEEE ACM T COMPUT BI, V8, P723, DOI 10.1109/TCBB.2010.73; Zhang JD, 2014, PHARMACOGENOMICS J, V14, P208, DOI 10.1038/tpj.2013.39	58	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136698	10.1371/journal.pone.0136698	http://dx.doi.org/10.1371/journal.pone.0136698			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335687	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400021
J	Silvestrini, L; Rossi, B; Gallmetzer, A; Mathieu, M; Scazzocchio, C; Berardi, E; Strauss, J				Silvestrini, Lucia; Rossi, Beatrice; Gallmetzer, Andreas; Mathieu, Martine; Scazzocchio, Claudio; Berardi, Enrico; Strauss, Joseph			Interaction of Yna1 and Yna2 Is Required for Nuclear Accumulation and Transcriptional Activation of the Nitrate Assimilation Pathway in the Yeast Hansenula polymorpha	PLOS ONE			English	Article							GATA FACTOR AREA; IN-VIVO BINDING; NITROGEN REGULATORY PROTEIN; ENCODING NITRITE REDUCTASE; ASPERGILLUS-NIDULANS; NEUROSPORA-CRASSA; CHROMATIN-STRUCTURE; TRANSPORTER YNT1; GENE-EXPRESSION; MESSENGER-RNA	A few yeasts, including Hansenula polymorpha are able to assimilate nitrate and use it as nitrogen source. The genes necessary for nitrate assimilation are organised in this organism as a cluster comprising those encoding nitrate reductase (YNR1), nitrite reductase (YNI1), a high affinity transporter (YNT1), as well as the two pathway specific Zn(II)(2)Cys(2) transcriptional activators (YNA1, YNA2). Yna1p and Yna2p mediate induction of the systemand here we show that their functions are interdependent. Yna1p activates YNA2 as well as its own (YNA1) transcription thus forming a nitrate-dependent autoactivation loop. Using a split-YFP approach we demonstrate here that Yna1p and Yna2p form a heterodimer independently of the inducer and despite both Yna1p and Yna2p can occupy the target promoter as mono-or homodimer individually, these proteins are transcriptionally incompetent. Subsequently, the transcription factors target genes containing a conserved DNA motif (termed nitrate-UAS) determined in this work by in vitro and in vivo protein-DNA interaction studies. These events lead to a rearrangement of the chromatin landscape on the target promoters and are associated with the onset of transcription of these target genes. In contrast to other fungi and plants, in which nuclear accumulation of the pathway-specific transcription factors only occur in the presence of nitrate, Yna1p and Yna2p are constitutively nuclear in H. polymorpha. Yna2p is needed for this nuclear accumulation and Yna1p is incapable of strictly positioning in the nucleus without Yna2p. In vivo DNA footprinting and ChIP analyses revealed that the permanently nuclear Yna1p/Yna2p heterodimer only binds to the nitrate-UAS when the inducer is present. The nitrate-dependent up-regulation of one partner protein in the heterodimeric complex is functionally similar to the nitrate-dependent activation of nuclear accumulation in other systems.	[Silvestrini, Lucia; Gallmetzer, Andreas; Strauss, Joseph] BOKU Univ Nat Resources & Life Sci Vienna, Fungal Genet & Genom Unit, Div Microbial Genet & Pathogen Interact, Univ & Res Ctr Tulln, A-3430 Tulln Donau, Austria; [Silvestrini, Lucia; Rossi, Beatrice; Berardi, Enrico] Univ Politecn Marche, DiSA, Lab Genet Microb, I-60131 Ancona, Italy; [Rossi, Beatrice; Mathieu, Martine; Scazzocchio, Claudio] Univ Paris 11, CNRS, CEA, I2BC, F-91405 Orsay, France; [Scazzocchio, Claudio] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, London, England; [Strauss, Joseph] Univ & Res Ctr Tulln, Hlth & Environm Dept, Austrian Inst Technol GmbH AIT, A-3430 Tulln Donau, Austria	Marche Polytechnic University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Imperial College London	Strauss, J (corresponding author), BOKU Univ Nat Resources & Life Sci Vienna, Fungal Genet & Genom Unit, Div Microbial Genet & Pathogen Interact, Univ & Res Ctr Tulln, Konrad Lorenz Str 24, A-3430 Tulln Donau, Austria.	joseph.strauss@boku.ac.at	Silvestrini, Lucia/GZG-9705-2022	Silvestrini, Lucia/0000-0002-0476-2358; Strauss, Joseph/0000-0003-0474-6267	Austrian Science Fund FWF [20630, F3703]; Universite-Sud; CNRS; Institute Universitaire de France	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Universite-Sud; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institute Universitaire de France	Work at Vienna was supported by project P 20630 and Special Research Area project F3703 of the Austrian Science Fund FWF to JS, and work at Orsay was supported by the Universite-Sud, the CNRS and the Institute Universitaire de France.	Avila J, 2002, YEAST, V19, P537, DOI 10.1002/yea.847; AVILA J, 1995, FEBS LETT, V366, P137, DOI 10.1016/0014-5793(95)00511-7; Avila J, 1998, BIOCHEM J, V335, P647, DOI 10.1042/bj3350647; AXELROD JD, 1993, GENE DEV, V7, P857, DOI 10.1101/gad.7.5.857; BERARDI E, 1990, CURR GENET, V18, P169, DOI 10.1007/BF00312606; Berger H, 2006, MOL MICROBIOL, V59, P433, DOI 10.1111/j.1365-2958.2005.04957.x; Berger H, 2008, MOL MICROBIOL, V69, P1385, DOI 10.1111/j.1365-2958.2008.06359.x; Bernreiter A, 2007, MOL CELL BIOL, V27, P791, DOI 10.1128/MCB.00761-06; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; BRITO N, 1993, J BACTERIOL, V175, P6755, DOI 10.1128/jb.175.21.6755-6759.1993; Brito N, 1996, BIOCHEM J, V317, P89, DOI 10.1042/bj3170089; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; BURGER G, 1991, MOL CELL BIOL, V11, P5746, DOI 10.1128/MCB.11.11.5746; COSTANZO G, 1995, J BIOL CHEM, V270, P11091, DOI 10.1074/jbc.270.19.11091; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Feng B, 1996, CURR GENET, V29, P537; Fitzgerald MX, 2006, STRUCTURE, V14, P725, DOI 10.1016/j.str.2005.11.025; Gallmetzer A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005297; GIETL C, 1994, P NATL ACAD SCI USA, V91, P3151, DOI 10.1073/pnas.91.8.3151; GLEESON MA, 1988, YEAST, V4, P293, DOI 10.1002/yea.320040407; Gomez D, 2002, MOL MICROBIOL, V44, P585, DOI 10.1046/j.1365-2958.2002.02939.x; Gonzalez R, 1997, NUCLEIC ACIDS RES, V25, P3955, DOI 10.1093/nar/25.19.3955; Kang HA, 2001, APPL MICROBIOL BIOT, V55, P734, DOI 10.1007/s002530100605; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; LU Q, 1994, J CELL BIOCHEM, V55, P83, DOI 10.1002/jcb.240550110; Machin F, 2004, YEAST, V21, P265, DOI 10.1002/yea.1075; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Marchive C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2650; Martin Y, 2011, J BIOL CHEM, V286, P27225, DOI 10.1074/jbc.M111.265116; Mathieu M, 2005, MOL MICROBIOL, V56, P535, DOI 10.1111/j.1365-2958.2005.04559.x; Mo XK, 2003, CURR GENET, V42, P260, DOI 10.1007/s00294-002-0362-3; Morozov IY, 2001, MOL MICROBIOL, V42, P269, DOI 10.1046/j.1365-2958.2001.02636.x; Morse RH, 2003, BIOCHEM CELL BIOL, V81, P101, DOI 10.1139/o03-039; Muro-Pastor MI, 1999, EMBO J, V18, P1584, DOI 10.1093/emboj/18.6.1584; Narendja F, 2002, MOL MICROBIOL, V44, P573, DOI 10.1046/j.1365-2958.2002.02911.x; Navarro FJ, 2003, FEMS YEAST RES, V4, P149, DOI 10.1016/S1567-1356(03)00163-6; Navarro FJ, 2008, J BIOL CHEM, V283, P31208, DOI 10.1074/jbc.M802170200; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Perez MD, 1997, BIOCHEM J, V321, P397, DOI 10.1042/bj3210397; Sambrook J, 2001, MOLECULAR CLONING VO; Scazzocchio C, 2014, FUNGAL BIOLOGY AND B, V1; Schinko T, 2013, FUNGAL GENET BIOL, V54, P34, DOI 10.1016/j.fgb.2013.02.003; Schinko T, 2010, MOL MICROBIOL, V78, P720, DOI 10.1111/j.1365-2958.2010.07363.x; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Siverio JM, 2002, FEMS MICROBIOL REV, V26, P277, DOI 10.1016/S0168-6445(02)00100-6; Strauss J, 1998, MOL CELL BIOL, V18, P1339, DOI 10.1128/MCB.18.3.1339; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; SUDBERY PE, 1988, BIOCHEM SOC T, V16, P1081; Tao Y, 1999, CURR GENET, V36, P153, DOI 10.1007/s002940050485; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Wolschek MF, 1998, NUCLEIC ACIDS RES, V26, P3862, DOI 10.1093/nar/26.16.3862; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; XIAO XD, 1995, BIOCHEMISTRY-US, V34, P8861, DOI 10.1021/bi00027a038; Xu M, 1998, MOL CELL BIOL, V18, P1201, DOI 10.1128/MCB.18.3.1201	56	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0135416	10.1371/journal.pone.0135416	http://dx.doi.org/10.1371/journal.pone.0135416			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335797	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400006
J	Cabet, E; Batonnet-Pichon, S; Delort, F; Gausseres, B; Vicart, P; Lilienbaum, A				Cabet, Eva; Batonnet-Pichon, Sabrina; Delort, Florence; Gausseres, Blandine; Vicart, Patrick; Lilienbaum, Alain			Antioxidant Treatment and Induction of Autophagy Cooperate to Reduce Desmin Aggregation in a Cellular Model of Desminopathy	PLOS ONE			English	Article							STRESS-INDUCED AUTOPHAGY; OXIDATIVE STRESS; SKELETAL-MUSCLE; MYOFIBRILLAR MYOPATHIES; MONITORING AUTOPHAGY; SIGNALING PATHWAYS; DISEASE; CELLS; MUTATIONS; RAC1	Desminopathies, a subgroup of myofibrillar myopathies (MFMs), the progressive muscular diseases characterized by the accumulation of granulofilamentous desmin-positive aggregates, result from mutations in the desmin gene (DES), encoding a muscle-specific intermediate filament. Desminopathies often lead to severe disability and premature death from cardiac and/or respiratory failure; no specific treatment is currently available. To identify drug-targetable pathophysiological pathways, we performed pharmacological studies in C2C12 myoblastic cells expressing mutant DES. We found that inhibition of the Rac1 pathway (a G protein signaling pathway involved in diverse cellular processes), antioxidant treatment, and stimulation of macroautophagy reduced protein aggregation by up to 75% in this model. Further, a combination of two or three of these treatments was more effective than any of them alone. These results pave the way towards the development of the first treatments for desminopathies and are potentially applicable to other muscle or brain diseases associated with abnormal protein aggregation.	[Cabet, Eva; Batonnet-Pichon, Sabrina; Delort, Florence; Vicart, Patrick; Lilienbaum, Alain] Univ Paris Diderot, Sorbonne Paris Cite, Physiopathol Striated Muscle Lab, Unit Funct & Adapt Biol,CNRS,UMR 8251, Paris, France; [Gausseres, Blandine] Univ Paris Diderot, Sorbonne Paris Cite, Biol & Pathol Endocrine Pancreas Lab, Unit Funct & Adapt Biol,CNRS,UMR 8251, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Lilienbaum, A (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Physiopathol Striated Muscle Lab, Unit Funct & Adapt Biol,CNRS,UMR 8251, Paris, France.	alain.lilienbaum@univ-paris-diderot.fr		Cabet, Eva/0000-0002-9113-3153	Universite Paris Diderot; Centre National de la Recherche Scientifique" (CNRS) [UMR8251]; Association Francaise contre les Myopathies (AFM) [15454]	Universite Paris Diderot; Centre National de la Recherche Scientifique" (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by Universite Paris Diderot http://www.univ-paris-diderot.fr PV, Centre National de la Recherche Scientifique" (CNRS) http://www.cnrs.fr UMR8251 PV, and Association Francaise contre les Myopathies (AFM) 15454 PV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068; Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102; Barberi L, 2013, BIOGERONTOLOGY, V14, P273, DOI 10.1007/s10522-013-9429-4; BEHRENDT H, 1977, CELL TISSUE RES, V180, P303; Ben-Gedalya T, 2012, TRAFFIC, V13, P635, DOI 10.1111/j.1600-0854.2012.01330.x; Biol AJ, 2007, J NEUROPATH EXP NEUR, V66, P711, DOI 10.1097/nen.0b013e3181256b4c; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Chen JL, 2009, AUTOPHAGY, V5, P244, DOI 10.4161/auto.5.2.7549; Claeys KG, 2013, HAND CLINIC, V113, P1337, DOI 10.1016/B978-0-444-59565-2.00005-8; Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6; Dunlop RA, 2009, IUBMB LIFE, V61, P522, DOI 10.1002/iub.189; FERRANS VJ, 1973, J MOL CELL CARDIOL, V5, P247, DOI 10.1016/0022-2828(73)90065-5; Giordano S, 2014, REDOX BIOL, V2, P82, DOI 10.1016/j.redox.2013.12.013; Goldfarb LG, 2009, J CLIN INVEST, V119, P1806, DOI 10.1172/JCI38027; Goudeau B, 2001, HUM MUTAT, V18, P388, DOI 10.1002/humu.1210; Goudeau B, 2006, HUM MUTAT, V27, P906, DOI 10.1002/humu.20351; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Huang CQ, 2010, AM J PHYSIOL-HEART C, V298, pH570, DOI 10.1152/ajpheart.00716.2009; Ishida H, 2007, J BIOL CHEM, V282, P11836, DOI 10.1074/jbc.M610106200; Janue A, 2007, BRAIN PATHOL, V17, P377, DOI 10.1111/j.1750-3639.2007.00087.x; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Jordan SN, 2012, CYTOSKELETON, V69, P919, DOI 10.1002/cm.21071; Joseph JA, 1998, ANN NY ACAD SCI, V854, P268, DOI 10.1111/j.1749-6632.1998.tb09908.x; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kley RA, 2013, AUTOPHAGY, V9, P422, DOI 10.4161/auto.22921; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Launay N, 2006, EXP CELL RES, V312, P3570, DOI 10.1016/j.yexcr.2006.07.025; LAZARIDES E, 1976, P NATL ACAD SCI USA, V73, P4344, DOI 10.1073/pnas.73.12.4344; Lilienbaum A, CARDIOMYOPATHIES ASS; Madaro L, 2013, FASEB J, V27, P1990, DOI 10.1096/fj.12-215475; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mitomi Y, 2012, J BIOL CHEM, V287, P34764, DOI 10.1074/jbc.M112.387035; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nicolescu P G, 1984, Morphol Embryol (Bucur), V30, P251; Olive M, 2013, CURR OPIN NEUROL, V26, P527, DOI 10.1097/WCO.0b013e328364d6b1; Parrini Maria Carla, 2012, Cell Logist, V2, P78; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Reimann J, 2003, NEUROPATH APPL NEURO, V29, P45, DOI 10.1046/j.1365-2990.2003.00428.x; Romero NB, 2013, HAND CLINIC, V113, P1299, DOI 10.1016/B978-0-444-59565-2.00002-2; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Schroder R, 2013, ACTA NEUROPATHOL, V125, P1, DOI 10.1007/s00401-012-1071-8; Segard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076361; Selcen D, 2011, NEUROMUSCULAR DISORD, V21, P161, DOI 10.1016/j.nmd.2010.12.007; Shah SB, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/704061; Shah SB, 2004, BIOPHYS J, V86, P2993, DOI 10.1016/S0006-3495(04)74349-0; Su HB, 2010, CARDIOVASC RES, V85, P253, DOI 10.1093/cvr/cvp287; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Trippier PC, 2013, J MED CHEM, V56, P3121, DOI 10.1021/jm3015926; van Spaendonck-Zwarts KY, 2011, CLIN GENET, V80, P354, DOI 10.1111/j.1399-0004.2010.01512.x; Wei YM, 2013, CELL PHYSIOL BIOCHEM, V31, P925, DOI 10.1159/000350111; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Winslow AR, 2011, AUTOPHAGY, V7, P429, DOI 10.4161/auto.7.4.14393; Winter DL, 2014, HISTOCHEM CELL BIOL, V141, P1, DOI 10.1007/s00418-013-1148-z; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157	62	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137009	10.1371/journal.pone.0137009	http://dx.doi.org/10.1371/journal.pone.0137009			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333167	Green Submitted, gold, Green Published			2022-12-27	WOS:000360613800089
J	Choi, SJ; Kim, MH; Jeon, J; Kim, OY; Choi, Y; Seo, J; Hong, SW; Lee, WH; Jeon, SG; Gho, YS; Jee, YK; Kim, YK				Choi, Seng Jin; Kim, Min-Hye; Jeon, Jinseong; Kim, Oh Youn; Choi, Youngwoo; Seo, Jihye; Hong, Sung-Wook; Lee, Won-Hee; Jeon, Seong Gyu; Gho, Yong Song; Jee, Young-Koo; Kim, Yoon-Keun			Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; CLUMPING FACTOR-A; SURFACE-PROTEINS; VACCINE; ANTIBODIES; EPIDEMIOLOGY; PREVENTION; RESPONSES; EFFICACY; ANTIGENS	Staphylococcus aureus is an important pathogenic bacterium that causes various infectious diseases. Extracellular vesicles (EVs) released from S. aureus contain bacterial proteins, nucleic acids, and lipids. These EVs can induce immune responses leading to similar symptoms as during staphylococcal infection condition and have the potential as vaccination agent. Here, we show that active immunization (vaccination) with S. aureus-derived EVs induce adaptive immunity of antibody and T cell responses. In addition, these EVs have the vaccine adjuvant ability to induce protective immunity such as the up-regulation of co-stimulatory molecules and the expression of T cell polarizing cytokines in antigen-presenting cells. Moreover, vaccination with S. aureus EVs conferred protection against lethality induced by airway challenge with lethal dose of S. aureus and also pneumonia induced by the administration of sub-lethal dose of S. aureus. These protective effects were also found in mice that were adoptively transferred with splenic T cells isolated from S. aureus EV-immunized mice, but not in serum transferred mice. Furthermore, this protective effect of S. aureus EVs was significantly reduced by the absence of interferon-gamma, but not by the absence of interleukin-17. Together, the study herein suggests that S. aureus EVs are a novel vaccine candidate against S. aureus infections, mainly via Th1 cellular response.	[Choi, Seng Jin; Jeon, Jinseong; Kim, Oh Youn; Choi, Youngwoo; Seo, Jihye; Lee, Won-Hee; Jeon, Seong Gyu; Gho, Yong Song] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Kim, Min-Hye; Kim, Yoon-Keun] Ewha Womans Univ, Sch Med, Dept Med, Seoul, South Korea; [Kim, Min-Hye; Kim, Yoon-Keun] Ewha Womans Med Ctr, Ewha Inst Convergence Med, Seoul, South Korea; [Hong, Sung-Wook] Acad Immunol & Microbiol AIM, Inst Basic Sci IBS, Pohang, South Korea; [Hong, Sung-Wook] Pohang Univ Sci & Technol POSTECH, Dept Integrat Biosci & Biotechnol, Pohang, South Korea; [Jee, Young-Koo] Dankook Univ, Coll Med, Dept Internal Med, Cheonan, South Korea	Pohang University of Science & Technology (POSTECH); Ewha Womans University; Ewha Womans University; Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH); Dankook University	Jeon, SG (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea.	gene49@hanmail.net; juinea@ewha.ac.kr		Jeon, Jinseong/0000-0003-1829-7319; Jee, Young-Koo/0000-0001-5800-8038; Lee, Won Hee/0000-0003-0162-4176	Korea Drug Development Fund (KDDF) - MSIP; MOTIE; MOHW [KDDF-201212-05]; Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2694]	Korea Drug Development Fund (KDDF) - MSIP(Korea Drug Development Fund (KDDF)); MOTIE(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); MOHW; Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by Korea Drug Development Fund (KDDF) funded by MSIP, MOTIE, and MOHW (Grant No. KDDF-201212-05) and a grant of the Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2694).	Arrecubieta C, 2008, J INFECT DIS, V198, P571, DOI 10.1086/590210; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Baudner BC, 2009, PHARM RES-DORDR, V26, P1477, DOI 10.1007/s11095-009-9859-5; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Cook J, 2009, HUM VACCINES, V5, P254, DOI 10.4161/hv.5.4.6765; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Dejonge M, 2007, J PEDIATR-US, V151, P260, DOI 10.1016/j.jpeds.2007.04.060; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; EDWARDS SW, 1987, J GEN MICROBIOL, V133, P3591; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Harro CD, 2012, VACCINE, V30, P1729, DOI 10.1016/j.vaccine.2011.12.045; Hong SW, 2011, ALLERGY, V66, P351, DOI 10.1111/j.1398-9995.2010.02483.x; Jones T, 2009, CURR OPIN MOL THER, V11, P337; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Kamath AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003683; Kim HK, 2011, FASEB J, V25, P3605, DOI 10.1096/fj.11-187963; Kim MR, 2012, ALLERGY, V67, P1271, DOI 10.1111/all.12001; Kim OY, 2013, J IMMUNOL, V190, P4092, DOI 10.4049/jimmunol.1200742; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lee IT, 2010, AM J PATHOL, V176, P1671, DOI 10.2353/ajpath.2010.090714; Levine MM, 2004, NAT IMMUNOL, V5, P460, DOI 10.1038/ni0504-460; Lin HY, 2010, INT IMMUNOPHARMACOL, V10, P883, DOI 10.1016/j.intimp.2010.04.026; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Otto M, 2010, EXPERT OPIN BIOL TH, V10, P1049, DOI 10.1517/14712598.2010.495115; Park KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011334; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Robbins JB, 2004, AM HEART J, V147, P593, DOI 10.1016/j.ahj.2004.01.012; Schaffer AC, 2008, INT J ANTIMICROB AG, V32, pS71, DOI 10.1016/j.ijantimicag.2008.06.009; Spellberg B, 2008, INFECT IMMUN, V76, P4574, DOI 10.1128/IAI.00700-08; Spellberg B, 2012, SEMIN IMMUNOPATHOL, V34, P335, DOI 10.1007/s00281-011-0293-5; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tuchscherr LPN, 2008, INFECT IMMUN, V76, P5738, DOI 10.1128/IAI.00874-08; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; Vernachio JH, 2006, ANTIMICROB AGENTS CH, V50, P511, DOI 10.1128/AAC.50.2.511-518.2006; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208	48	54	59	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136021	10.1371/journal.pone.0136021	http://dx.doi.org/10.1371/journal.pone.0136021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333035	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800047
J	Ebranati, E; Pariani, E; Piralla, A; Gozalo-Marguello, M; Veo, C; Bubba, L; Amendola, A; Ciccozzi, M; Galli, M; Zanetti, AR; Baldanti, F; Zehender, G				Ebranati, Erika; Pariani, Elena; Piralla, Antonio; Gozalo-Margueello, Monica; Veo, Carla; Bubba, Laura; Amendola, Antonella; Ciccozzi, Massimo; Galli, Massimo; Zanetti, Alessandro Remo; Baldanti, Fausto; Zehender, Gianguglielmo			Reconstruction of the Evolutionary Dynamics of A(H3N2) Influenza Viruses Circulating in Italy from 2004 to 2012	PLOS ONE			English	Article							A H3N2 VIRUSES; EPIDEMIOLOGIC DYNAMICS; GENETIC EVOLUTION; HEMAGGLUTININ; REVEALS; CHINA; MODEL; PIGS	Background Influenza A viruses are characterised by their rapid evolution, and the appearance of point mutations in the viral hemagglutinin (HA) domain causes seasonal epidemics. The A (H3N2) virus has higher mutation rate than the A(H1N1) virus. The aim of this study was to reconstruct the evolutionary dynamics of the A(H3N2) viruses circulating in Italy between 2004 and 2012 in the light of the forces driving viral evolution. Methods Phylodinamic analyses were made using a Bayesian method, and codon-specific positive selection acting on the HA coding sequence was evaluated. Results Global and local phylogenetic analyses showed that the Italian strains collected between 2004 and 2012 grouped into five significant Italian clades that included viral sequences circulating in different epidemic seasons. The time of the most recent common ancestor (tMRCA) of the tree root was between May and December 2003. The tMRCA estimates of the major clades suggest that the origin of a new viral strain precedes the effective circulation of the strain in the Italian population by 6-31 months, thus supporting a central role of global migration in seeding the epidemics in Italy. The study of selection pressure showed that four codons were under positive selection, three of which were located in antigenic sites. Analysis of population dynamics showed the alternation of periods of exponential growth followed by a decrease in the effective number of infections corresponding to epidemic and inter-epidemic seasons. Conclusions Our analyses suggest that a complex interaction between the immune status of the population, migrations, and a few selective sweeps drive the influenza A(H3N2) virus evolution. Our findings suggest the possibility of the year-round survival of local strains even in temperate zones, a hypothesis that warrants further investigation.	[Ebranati, Erika; Veo, Carla; Galli, Massimo; Zehender, Gianguglielmo] Univ Milan, Dipartimento Sci Biomed & Clin Luigi Sacco, Sez Malattie Infett, Milan, Italy; [Pariani, Elena; Bubba, Laura; Amendola, Antonella; Zanetti, Alessandro Remo] Univ Milan, Dipartimento Sci Biomed Salute, Milan, Italy; [Piralla, Antonio; Gozalo-Margueello, Monica; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, SS Virol Mol, SC Virol & Microbiol, Pavia, Italy; [Gozalo-Margueello, Monica] Marques de Valdecilla Univ Hosp, Santander, Spain; [Ciccozzi, Massimo] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; IRCCS Fondazione San Matteo; Hospital Universitario Marques de Valdecilla (HUMV); Istituto Superiore di Sanita (ISS)	Zehender, G (corresponding author), Univ Milan, Dipartimento Sci Biomed & Clin Luigi Sacco, Sez Malattie Infett, Milan, Italy.	gianguglielmo.zehender@unimi.it	Piralla, Antonio/K-4756-2018; Pariani, Elena/M-3491-2016; Amendola, Antonella/M-8980-2016; Baldanti, Fausto/J-4924-2018; Ciccozzi, Massimo/AAC-3271-2022; CICCOZZI, MASSIMO/C-6484-2016; GALLI, MASSIMO/L-7282-2017	Piralla, Antonio/0000-0002-6062-2579; Pariani, Elena/0000-0001-5681-3455; Amendola, Antonella/0000-0002-0499-8977; Baldanti, Fausto/0000-0002-3358-8969; Ciccozzi, Massimo/0000-0003-3866-9239; CICCOZZI, MASSIMO/0000-0003-3866-9239; GALLI, MASSIMO/0000-0001-8887-6215; Bubba, Laura/0000-0003-4561-7971	Fondazione Cariplo [2011-0517]; Marques de Valdecilla University Hospital [WLA 03/1]; national flagship project NANOMAX of the Italian Ministero dell' Universita e della Ricerca	Fondazione Cariplo(Fondazione Cariplo); Marques de Valdecilla University Hospital; national flagship project NANOMAX of the Italian Ministero dell' Universita e della Ricerca	This work was supported by Fondazione Cariplo (grant No. 2011-0517, post-doc fellowships of LB and CV), the Marques de Valdecilla University Hospital (grant No. WLA 03/1, pre-doctoral fellowship of MG), and partially supported by the national flagship project NANOMAX of the Italian Ministero dell' Universita e della Ricerca.	Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Cheng XW, 2013, J INFECT DIS, V207, P106, DOI 10.1093/infdis/jis526; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; ELLIS JS, 1995, ARCH VIROL, V140, P1889, DOI 10.1007/BF01322680; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kobayashi Y, 2012, J VIROL, V86, P3446, DOI 10.1128/JVI.06147-11; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Okazaki K, 2000, ARCH VIROL, V145, P885, DOI 10.1007/s007050050681; Pariani E, 2013, INFECT GENET EVOL, V13, P252, DOI 10.1016/j.meegid.2012.10.019; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Schmidt R, 2002, ST HEAL T, V90, P420; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Westgeest KB, 2012, J GEN VIROL, V93, P1996, DOI 10.1099/vir.0.043059-0; Yu H, 2007, BIOCHEM BIOPH RES CO, V356, P91, DOI 10.1016/j.bbrc.2007.02.096; Zehender G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047517	28	2	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137099	10.1371/journal.pone.0137099	http://dx.doi.org/10.1371/journal.pone.0137099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331945	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800095
J	Gaffney, D; Summerhayes, GR; Ford, A; Scott, JM; Denham, T; Field, J; Dickinson, WR				Gaffney, Dylan; Summerhayes, Glenn R.; Ford, Anne; Scott, James M.; Denham, Tim; Field, Judith; Dickinson, William R.			Earliest Pottery on New Guinea Mainland Reveals Austronesian Influences in Highland Environments 3000 Years Ago	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; REMOTE OCEANIA; AGRICULTURE; CALIBRATION; CERAMICS	Austronesian speaking peoples left Southeast Asia and entered the Western Pacific c.4000-3000 years ago, continuing on to colonise Remote Oceania for the first time, where they became the ancestral populations of Polynesians. Understanding the impact of these peoples on the mainland of New Guinea before they entered Remote Oceania has eluded archaeologists. New research from the archaeological site of Wanelek in the New Guinea Highlands has broken this silence. Petrographic and geochemical data from pottery and new radiocarbon dating demonstrates that Austronesian influences penetrated into the highland interior by 3000 years ago. One potsherd was manufactured along the northeast coast of New Guinea, whereas others were manufactured from inland materials. These findings represent the oldest securely dated pottery from an archaeological context on the island of New Guinea. Additionally, the pottery comes from the interior, suggesting the movements of people and technological practices, as well as objects at this time. The antiquity of the Wanelek pottery is coincident with the expansion of Lapita pottery in the Western Pacific. Such occupation also occurs at the same time that changes have been identified in subsistence strategies in the archaeological record at Kuk Swamp suggesting a possible link between the two.	[Gaffney, Dylan; Summerhayes, Glenn R.; Ford, Anne] Univ Otago, Dept Anthropol & Archaeol, Dunedin 9054, New Zealand; [Scott, James M.] Univ Otago, Dept Geol, Dunedin 9054, New Zealand; [Denham, Tim] Australian Natl Univ, Coll Arts & Social Sci, Sch Archaeol & Anthropol, Canberra, ACT 0200, Australia; [Field, Judith] Univ New S Wales, Sch Biol Earth & Environm Sci, Kensington, NSW 2052, Australia; [Dickinson, William R.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA	University of Otago; University of Otago; Australian National University; University of New South Wales Sydney; University of Arizona	Gaffney, D (corresponding author), Univ Otago, Dept Anthropol & Archaeol, Dunedin 9054, New Zealand.	dylan.gaffney@otago.ac.nz	Scott, James M/E-1908-2017; Field, Judith H/C-7677-2011	Scott, James M/0000-0001-5185-6261; Denham, Tim/0000-0002-8164-2990; Field, Judith/0000-0001-6807-1858; Gaffney, Dylan/0000-0003-4869-9730; summerhayes, glenn/0000-0002-0654-1305	University of Otago Asian Migrations research group grant; University of Otago Humanities Research Grant; Australian Research Council [DP0666524]	University of Otago Asian Migrations research group grant; University of Otago Humanities Research Grant; Australian Research Council(Australian Research Council)	The project was funded by the University of Otago Asian Migrations research group grant awarded to DG, a University of Otago Humanities Research Grant awarded to GRS and AF and an Australian Research Council Grant (DP0666524) awarded to TD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B., 2014, GLOBAL PREHISTORY HU, P302; Arnold Dean E., 1988, CERAMIC THEORY CULTU; Bayliss-Smith T.P., 1996, ORIGINS SPREAD AGR P, P499; Bellwood P., 2013, 1 MIGRANTS ANCIENT M; Bulmer S, 2005, PAPUAN PASTS CULTURA, P387; Bulmer S., 1977, STONE TOOLS CULTURAL, P40; Bulmer S., 1985, INDO PACIFIC PREHIST, V6, P123; Bulmer S., 2007, VASTLY INGENIOUS ARC, P277; Bulmer S., 1973, NOTES 1972 EXCAVATIO; Carson MT, 2013, J ISL COAST ARCHAEOL, V8, P17, DOI 10.1080/15564894.2012.726941; Coutts PJF., 1967, MANKIND, V6, P482; David B, 2011, WORLD ARCHAEOL, V43, P576, DOI 10.1080/00438243.2011.624720; Denham T, 2012, ARCHAEOL OCEAN, V47, P39, DOI 10.1002/j.1834-4453.2012.tb00113.x; Denham TP, 2003, SCIENCE, V301, P189, DOI 10.1126/science.1085255; Dickinson WR, 2006, GEOL SOC AM SPEC PAP, V406, P1, DOI 10.1130/2006.2406; Dickinson WR, 2011, FIELDIANA ANTHR, V42, P241; Egloff B.J., 1975, RECORDS PAPUA NEW GU, V5, P15; Froh J, 2004, HYPERFINE INTERACT, V154, P159, DOI 10.1023/B:HYPE.0000032074.98045.cc; Galipaud J.-C, 1992, POTERIE LAPITA PEUPL; Golson J., 2002, NZ ARCHAEOLOGICAL J, V25, P69; Green RC., 1991, B INDOPACIFIC PREHIS, V11, P295, DOI [10.7152/bippa.v11i0.11393, DOI 10.7152/BIPPA.V11I0.11393]; HUGHES I, 1977, TERRA AUSTRALIS, V3; Matthews Peter J., 2003, Archaeology in Oceania, V38, P186; May P., 1982, BAY BOOKS KENSINGTON, DOI [10.2307/3336113, DOI 10.2307/3336113]; McNiven IJ, 2011, AUST ARCHAEOL, P1; Pawley, 1991, MAN HALF ESSAYS PACI, P470; Petrequin A.-M., 2006, OBJETS POUVOIR NOUVE; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Sharma S., 1996, APPL MULTIVARIATE TE; Shepard AO, 1956, CERAMICS ARCHAEOLOGI; Sheppard PJ, 2015, J PAC ARCHAEOL, V6, P26; Skelly R, 2014, ANTIQUITY, V88, P470, DOI 10.1017/S0003598X00101127; SPRIGGS M, 1989, ANTIQUITY, V63, P587, DOI 10.1017/S0003598X00076560; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Stuiver M, 2005, CALIB MANUAL; Summerhayes G, 2001, ARCHAEOLOGY LAPITA D, V17, P25; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; SUMMERHAYES GR, 2007, GENES LANGUAGE CULTU, P10; SUMMERHAYES GR, 2000, TERRA AUSTRALIS, V15; Swadling P, 1997, WORLD ARCHAEOL, V29, P1; Terrell JE, 2011, FIELDIANA ANTHR, V42, P87; Watson, 1977, PREHISTORY E HIGHLAN; Watson V, 1955, SOUTHWEST J ANTHROP, V11, P121, DOI 10.1086/soutjanth.11.2.3628965; White J.P., 1972, TERRA AUSTRALIS, V2; Winslow, 1977, MELANESIAN ENV, P61; Witter DC, 1990, DOING MULTIVARIATE A; Yen DE, 1995, ANTIQUITY, V69, P831, DOI 10.1017/S0003598X00082375	47	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134497	10.1371/journal.pone.0134497	http://dx.doi.org/10.1371/journal.pone.0134497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CQ4ZT	26331310	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800010
J	Huang, YD; Follmann, D; Nason, M; Zhang, L; Huang, Y; Mehrotra, DV; Moodie, Z; Metch, B; Janes, H; Keefer, MC; Churchyard, G; Robb, ML; Fast, PE; Duerr, A; McElrath, MJ; Corey, L; Mascola, JR; Graham, BS; Sobieszczyk, ME; Kublin, JG; Robertson, M; Hammer, SM; Gray, GE; Buchbinder, SP; Gilbert, PB				Huang, Yunda; Follmann, Dean; Nason, Martha; Zhang, Lily; Huang, Ying; Mehrotra, Devan V.; Moodie, Zoe; Metch, Barbara; Janes, Holly; Keefer, Michael C.; Churchyard, Gavin; Robb, Merlin L.; Fast, Patricia E.; Duerr, Ann; McElrath, M. Juliana; Corey, Lawrence; Mascola, John R.; Graham, Barney S.; Sobieszczyk, Magdalena E.; Kublin, James G.; Robertson, Michael; Hammer, Scott M.; Gray, Glenda E.; Buchbinder, Susan P.; Gilbert, Peter B.			Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials	PLOS ONE			English	Article							T-CELL RESPONSES; GAG/POL/NEF VACCINE; IMMUNOGENICITY EVALUATION; PHASE-1 SAFETY; SOUTH-AFRICA; DOUBLE-BLIND; FOLLOW-UP; DNA; EFFICACY; STEP	Background Three phase 2b, double-blind, placebo-controlled, randomized efficacy trials have tested recombinant Adenovirus serotype-5 (rAd5)-vector preventive HIV-1 vaccines: MRKAd5 HIV-1 gag/pol/nef in Step and Phambili, and DNA/rAd5 HIV-1 env/gag/pol in HVTN505. Due to efficacy futility observed at the first interim analysis in Step and HVTN505, participants of all three studies were unblinded to their vaccination assignments during the study but continued follow-up. Rigorous meta-analysis can provide crucial information to advise the future utility of rAd5-vector vaccines. Methods We included participant-level data from all three efficacy trials, and three Phase 1-2 trials evaluating the HVTN505 vaccine regimen. We predefined two co-primary analysis cohorts for assessing the vaccine effect on HIV-1 acquisition. The modified-intention-to-treat (MITT) cohort included all randomly assigned participants HIV-1 uninfected at study entry, who received at least the first vaccine/placebo, and the Ad5 cohort included MITT participants who received at least one dose of rAd5-HIV vaccine or rAd5-placebo. Multivariable Cox regression models were used to estimate hazard ratios (HRs) of HIV-1 infection (vaccine vs. placebo) and evaluate HR variation across vaccine regimens, time since vaccination, and subgroups using interaction tests. Findings Results are similar for the MITT and Ad5 cohorts; we summarize MITT cohort results. Pooled across the efficacy trials, over all follow-up time 403 (n = 224 vaccine; n = 179 placebo) of 6266 MITT participants acquired HIV-1, with a non-significantly higher incidence in vaccine recipients (HR 1.21, 95% CI 0.99-1.48, P = 0.06). The HRs significantly differed by vaccine regimen (interaction P = 0.03; MRKAd5 HR 1.41, 95% CI 1.11-1.78, P = 0.005 vs. DNA/rAd5 HR 0.88, 95% CI 0.61-1.26, P = 0.48). Results were similar when including the Phase 1-2 trials. Exploratory analyses based on the efficacy trials supported that the MRKAd5 vaccine-increased risk was concentrated in Ad5-positive or uncircumcised men early in follow-up, and in Ad5-negative or circumcised men later. Overall, MRKAd5 vaccine-increased risk was evident across subgroups except in circumcised Ad5-negative men (HR 0.97, 95% CI 0.58-1.63, P = 0.91); there was little evidence that the DNA/rAd5 vaccine, that was tested in this subgroup, increased risk (HR 0.88, 95% CI 0.61-1.26, P = 0.48). When restricting the analysis of Step and Phambili to follow-up time before unblinding, 114 (n = 65 vaccine; n = 49 placebo) of 3770 MITT participants acquired HIV-1, with a non-significantly higher incidence in MRKAd5 vaccine recipients (HR 1.30, 95% CI 0.89-1.14, P = 0.18). Interpretation and Significance The data support increased risk of HIV-1 infection by MRKAd5 over all follow-up time, but do not support increased risk of HIV-1 infection by DNA/rAd5. This study provides a rationale for including monitoring plans enabling detection of increased susceptibility to infection in HIV-1 at-risk populations.	[Huang, Yunda; Zhang, Lily; Huang, Ying; Moodie, Zoe; Metch, Barbara; Janes, Holly; Duerr, Ann; McElrath, M. Juliana; Corey, Lawrence; Kublin, James G.; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Follmann, Dean] NIAID, Bethesda, MD 20892 USA; [Follmann, Dean] NIH, Biostat Res Branch, Bethesda, MD 20892 USA; [Nason, Martha] NIAID, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Mehrotra, Devan V.] Merck Res Labs, N Wales, PA USA; [Keefer, Michael C.] Univ Rochester, Sch Med & Dent, Div Infect Dis, Rochester, NY USA; [Churchyard, Gavin] Aurum Inst Hlth Res, Johannesburg, South Africa; [Robb, Merlin L.] US Mil HIV Res Program, HJF HIV Program, Bethesda, MD USA; [Fast, Patricia E.] Int AIDS Vaccine Initiat, Res & Dev, New York, NY USA; [Mascola, John R.] NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Graham, Barney S.] NIAID, Viral Pathogenesis Lab, Bethesda, MD 20892 USA; [Sobieszczyk, Magdalena E.; Hammer, Scott M.] Columbia Univ, Dept Med, Div Infect Dis, New York, NY USA; [Robertson, Michael] Merck, Infect Dis Clin Res, Philadelphia, PA USA; [Gray, Glenda E.] Univ Witwatersrand, Johannesburg, South Africa; [Buchbinder, Susan P.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA	Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Merck & Company; University of Rochester; Walter Reed Army Institute of Research (WRAIR); International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; Merck & Company; University of Witwatersrand; San Francisco Department of Public Health	Gilbert, PB (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	pgilbert@scharp.org	Mascola, John/AAI-7193-2021; Graham, Barney S./AAC-5898-2019; Corey, Lawrence/AAE-1796-2020	Graham, Barney S./0000-0001-8112-0853; Corey, Lawrence/0000-0002-2179-2436; Churchyard, Gavin/0000-0002-4269-3699; Huang, Yunda/0000-0003-1546-6172	Division of AIDS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), in the US National Institutes of Health (NIH); NIH-sponsored HIV Vaccine Trials Network (HVTN); Merck Research Laboratories (MRL); NIAID [HVTN505, HVTN204]; HVTN; US Department of Health and Human Services (USDHHS) [RV172]; US Military HIV Research Program; American people through the United States Agency for International Development (USAID) [IAVI001]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069511, UM1AI068614, UM1AI068618, UM1AI068635, UM1AI069470, UM1AI069481] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), in the US National Institutes of Health (NIH); NIH-sponsored HIV Vaccine Trials Network (HVTN); Merck Research Laboratories (MRL)(Merck & Company); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HVTN; US Department of Health and Human Services (USDHHS); US Military HIV Research Program; American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This meta-analysis was supported by the Division of AIDS and the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), in the US National Institutes of Health (NIH), and the NIH-sponsored HIV Vaccine Trials Network (HVTN). The Step and Phambili studies were supported by Merck Research Laboratories (MRL), NIAID and HVTN; the HVTN505 and HVTN204 studies were supported by NIAID and HVTN; the RV172 study was supported by the US Department of Health and Human Services (USDHHS), the US Military HIV Research Program and NIAID; and the IAVI001 study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the HVTN and MRL for Step and Phambili, of HVTN for HVTN505 and HVTN204, of USMHRP for RV172, and of IAVI for IAVI001, and do not necessarily reflect the views of NIAID, USDHHS, USAID or the United States Government. The funder provided support in the form of salaries for authors DVM and MR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Choi Y, 2013, CLIN EXP VACCINE RES, V2, P97, DOI 10.7774/cevr.2013.2.2.97; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; De Rosa SC, 2011, J IMMUNOL, V187, P3391, DOI 10.4049/jimmunol.1101421; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Fisher DJ, 2011, J CLIN EPIDEMIOL, V64, P949, DOI 10.1016/j.jclinepi.2010.11.016; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Graham BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059340; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gray GE, 2014, LANCET INFECT DIS, V14, P388, DOI 10.1016/S1473-3099(14)70020-9; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Harro C, 2009, CLIN VACCINE IMMUNOL, V16, P1285, DOI 10.1128/CVI.00144-09; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Koblin BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024517; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Nicholson O, 2010, AIDS RES HUM RETROVI; Peiperl L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013579; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; R Core Team, 2012, R LANG ENV STAT COMP; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Tavel JA, 2007, JAIDS-J ACQ IMM DEF, V44, P601, DOI 10.1097/QAI.0b013e3180417cb6; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Wu L, 2002, BIOMETRICS, V58, P997, DOI 10.1111/j.0006-341X.2002.00997.x	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136626	10.1371/journal.pone.0136626	http://dx.doi.org/10.1371/journal.pone.0136626			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332672	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800063
J	Rong, EG; Zhang, ZW; Qiao, SP; Yang, H; Yan, XH; Li, H; Wang, N				Rong, Enguang; Zhang, Zhiwei; Qiao, Shupei; Yang, Hua; Yan, Xiaohong; Li, Hui; Wang, Ning			Functional Characterization of a Single Nucleotide Polymorphism in the 3 ' Untranslated Region of Sheep DLX3 Gene	PLOS ONE			English	Article							HAIR FOLLICLE; DIFFERENTIATION; MICRORNAS; SITE; SKIN; IDENTIFICATION; MUTATION	The Distal-less 3 (homeobox protein DLX-3), a transcription factor, is critical for the development of hair follicle and hair formation and regeneration. We previously identified and found that four SNPs (c.*118T>C, c.*228T>C, c.*688A>G and c.*1,038_1,039 insC) in 30 untranslated region (UTR) of sheep DLX3 were in high linkage disequilibrium with each other and significantly associated with wool crimp (P<0.05), however, the underlying mechanisms by which these SNPs affect the wool crimp remains unknown. In the present study, we performed association analysis between these four identified SNPs and DLX3 gene expression in sheep skin using quantitative real-time RT-PCR. The results showed that these SNPs were significantly associated with sheep skin DLX3 mRNA expression levels. Then, we constructed DLX3 3'UTR luciferase reporters and validated the association. The reporter assays showed that the three major haplotypes, derived from the four SNPs, had significantly different effects on luciferase reporter activity and the four SNPs also had significantly different allelic effects on the luciferase reporter activity (p<0.05). Bioinformatics analysis showed that the SNP (c.*1,038_1,039 insC) was located within a potential miR-188 binding site of the 3'UTR of sheep DLX3 mRNA. This SNP may affect miR-188-mediated DLX3 gene expression and result in phenotypic variation. To test the hypothesis, we investigated the effects of miR-188 mimic and inhibitor on the activity of the DLX3 3'UTR luciferase reporter with different SNP alleles. The results showed that in both sheep fetal fibroblasts (SFFs) and human HaCaT cells, miR-188 mimic could significantly decrease the allele D (deletion) luciferase reporter activity (p<0.05), but miR-188 inhibitor could increased the reporter activitiy. However, neither miR-188 mimc nor inhibitor could influence the allele I (insertion) reporter activity. In addition, transfection of miR-188 mimic dramatically decreased the endogenous expression of DLX3 in SFFs (p<0.05). Taken together, we demonstrated that DLX3 is a target gene of miR-188 and the SNP (c.*1,038_1,039 insC) is a functional SNP, and affects miR-188-mediated gene regulation of sheep DLX3. Our finding may in part explain allelic difference in gene expression and wool crimp in our tested sheep population.	[Rong, Enguang; Zhang, Zhiwei; Qiao, Shupei; Yan, Xiaohong; Li, Hui; Wang, Ning] Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Key Lab Chicken Genet & Breeding, Harbin 150030, Peoples R China; [Rong, Enguang; Zhang, Zhiwei; Qiao, Shupei; Li, Hui; Wang, Ning] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin 150030, Peoples R China; [Yang, Hua] Xinjiang Acad Agr & Reclamat Sci, Inst Anim Husb & Vet Inst, Shihezi 832000, Peoples R China; [Rong, Enguang] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China; China Agricultural University	Wang, N (corresponding author), Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Key Lab Chicken Genet & Breeding, Harbin 150030, Peoples R China.	wangning@neau.edu.cn			Domain-Specific projects [2013ZX08009-002, 2014ZX08009-002]	Domain-Specific projects	The authors appreciate the financial support provided by the Domain-Specific projects for transgenic biological breeding (2013ZX08009-002, 2014ZX08009-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beanan MJ, 2000, DEV DYNAM, V218, P545, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1026>3.0.CO;2-B; Bostjancic E, 2008, ACTA DERMATOVEN ALP, V17, P95; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Denning C, 2001, Cloning Stem Cells, V3, P221, DOI 10.1089/15362300152725945; Drouilhet L, 2009, ANIM GENET, V40, P804, DOI 10.1111/j.1365-2052.2009.01919.x; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Kim BK, 2012, J BIOL CHEM, V287, P16681, DOI 10.1074/jbc.M111.320770; Kim VN, 2005, MOL CELLS, V19, P1; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Morasso MI, 1996, J CELL BIOL, V135, P1879, DOI 10.1083/jcb.135.6.1879; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Nieminen P, 2011, CELLS TISSUES ORGANS, V194, P49, DOI 10.1159/000322561; Pesole G, 1997, GENE, V205, P95, DOI 10.1016/S0378-1119(97)00407-1; Price JA, 1998, HUM MOL GENET, V7, P563, DOI 10.1093/hmg/7.3.563; Rong EG, 2012, CHINESE J ANIMAL VET, V43, P358; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Sand M, 2009, J DERMATOL SCI, V53, P169, DOI 10.1016/j.jdermsci.2008.10.004; Sun KL, 2013, NAT REV GENET, V14, P535, DOI 10.1038/nrg3471; Zhang WG, 2007, OMICS, V11, P385, DOI 10.1089/omi.2006.0031	32	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137135	10.1371/journal.pone.0137135	http://dx.doi.org/10.1371/journal.pone.0137135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332462	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800101
J	Delestre, L; Bakey, Z; Prado, C; Hoffmann, S; Bihoreau, MT; Lelongt, B; Gauguier, D				Delestre, Laure; Bakey, Zeineb; Prado, Cecilia; Hoffmann, Sigrid; Bihoreau, Marie-Therese; Lelongt, Brigitte; Gauguier, Dominique			ANKS3 Co-Localises with ANKS6 in Mouse Renal Cilia and Is Associated with Vasopressin Signaling and Apoptosis In Vivo in Mice	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; STERILE ALPHA-MOTIF; SYSTEMS BIOLOGY; ANKYRIN REPEAT; SAM DOMAIN; BICAUDAL-C; PROTEIN; PROGRESSION; BICC1; CAMP	Mutations in Ankyrin repeat and sterile alpha motif domain containing 6 (ANKS6) play a causative role in renal cyst formation in the PKD/Mhm(cy/+) rat model of polycystic kidney disease and in nephronophthisis in humans. A network of protein partners of ANKS6 is emerging and their functional characterization provides important clues to understand the role of ANKS6 in renal biology and in mechanisms involved in the formation of renal cysts. Following experimental confirmation of interaction between ANKS6and ANKS3 using a Yeast two hybrid system, we demonstrated that binding between the two proteins occurs through their sterile alpha motif (SAM) and that the amino acid 823 in rat ANSK6 is key for this interaction. We further showed their interaction by co-immunoprecipitation and showed in vivo in mice that ANKS3 is present in renal cilia. Downregulated expression of Anks3 in vivo in mice by Locked Nucleic Acid (LNA) modified antisense oligonucleotides was associated with increased transcription of vasopressin-induced genes, suggesting changes in renal water permeability, and altered transcription of genes encoding proteins involved in cilium structure, apoptosis and cell proliferation. These data provide experimental evidence of ANKS3-ANKS6 direct interaction through their SAM domain and co-localisation in mouse renal cilia, and shed light on molecular mechanisms indirectly mediated by ANKS6 in the mouse kidney, that may be affected by altered ANKS3-ANKS6 interaction. Our results contribute to improved knowledge of the structure and function of the network of proteins interacting with ANKS6, which may represent therapeutic targets in cystic diseases.	[Delestre, Laure; Prado, Cecilia; Gauguier, Dominique] Univ Paris 05, Univ Paris 06, Sorbonne Univ, INSERM,UMR S1138,Cordeliers Res Ctr,Sorbonne Pari, Paris, France; [Bakey, Zeineb; Lelongt, Brigitte] Univ Paris 06, Sorbonne Univ, UMR S1155, Paris, France; [Bakey, Zeineb; Lelongt, Brigitte] Hop Tenon, INSERM, UMR S1155, F-75970 Paris, France; [Hoffmann, Sigrid] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany; [Bihoreau, Marie-Therese] Natl Genotyping Ctr, Evry, France; [Gauguier, Dominique] Univ Paris 06, Pitie Salpetriere Hosp, Inst Cardiometab & Nutr, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gauguier, D (corresponding author), Univ Paris 05, Univ Paris 06, Sorbonne Univ, INSERM,UMR S1138,Cordeliers Res Ctr,Sorbonne Pari, Paris, France.	dominique.gauguier@crc.jussieu.fr	Gauguier, Dominique/G-2190-2016; lelongt, brigitte/N-3746-2017	Gauguier, Dominique/0000-0001-6156-9530; lelongt, brigitte/0000-0002-9308-8798	Agence Nationale de la Recherche (RenalCyst) [ANR-10-BLAN-1124-02]; European Community Seventh Framework Programme (FP7) [HEALTH-F4-2010-241504 (EURATRANS)]; NIH [5RO1DK100482]; Institute of Cardiometabolism and Nutrition (ICAN) [ANR-10-IAHU-05]; Wellcome Senior Fellowship in Basic Biomedical Science [057733]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100482] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (RenalCyst)(French National Research Agency (ANR)); European Community Seventh Framework Programme (FP7); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Cardiometabolism and Nutrition (ICAN); Wellcome Senior Fellowship in Basic Biomedical Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Agence Nationale de la Recherche (RenalCyst, ANR-10-BLAN-1124-02) to DG and BL, the European Community Seventh Framework Programme (FP7/2007-2013) under grant agreement No. HEALTH-F4-2010-241504 (EURATRANS) to DG, the NIH (5RO1DK100482) to SH, the Institute of Cardiometabolism and Nutrition (ICAN, ANR-10-IAHU-05) to DG and a Wellcome Senior Fellowship in Basic Biomedical Science (057733) to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiari G, 2013, AM J NEPHROL, V37, P175, DOI 10.1159/000346812; Bakey Z, 2015, KIDNEY INT, V88, P299, DOI 10.1038/ki.2015.122; Bouvrette DJ, 2008, NEPHRON EXP NEPHROL, V108, pE27, DOI 10.1159/000112913; Brown JH, 2005, J AM SOC NEPHROL, V16, P3517, DOI 10.1681/ASN.2005060601; Chen Wen-Cheng, 2008, BMC Res Notes, V1, P131, DOI 10.1186/1756-0500-1-131; Cui XQ, 2009, AM J NEPHROL, V30, P413, DOI 10.1159/000235993; Czarnecki PG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7023; Czarnecki PG, 2012, TRENDS CELL BIOL, V22, P201, DOI 10.1016/j.tcb.2012.02.001; Devuyst O, 2013, CURR OPIN NEPHROL HY, V22, P459, DOI 10.1097/MNH.0b013e3283621510; Dweep H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053780; Fluiter Kees, 2009, V487, P189, DOI 10.1007/978-1-60327-547-7_9; Fu YL, 2010, EUR J CELL BIOL, V89, P428, DOI 10.1016/j.ejcb.2010.01.002; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Guron G, 2000, J HYPERTENS, V18, P123, DOI 10.1097/00004872-200018020-00001; Harris PC, 2010, NAT REV NEPHROL, V6, P197, DOI 10.1038/nrneph.2010.18; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Johnston AM, 2004, GENES CELLS, V9, P967, DOI 10.1111/j.1365-2443.2004.00776.x; Kerroch M, 2012, FASEB J, V26, P4079, DOI 10.1096/fj.11-194902; Kim J, 2010, MOL CELL BIOL, V30, P1582, DOI 10.1128/MCB.01605-09; Knight MJ, 2011, PROTEIN SCI, V20, P1697, DOI 10.1002/pro.703; Leettola CN, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-17; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; MANGOOKARIM R, 1989, P NATL ACAD SCI USA, V86, P6007, DOI 10.1073/pnas.86.15.6007; MANGOOKARIM R, 1989, FASEB J, V3, P2629, DOI 10.1096/fasebj.3.14.2480260; Mrug M, 2008, KIDNEY INT, V73, P63, DOI 10.1038/sj.ki.5002627; Neudecker S, 2010, AM J PATHOL, V177, P3000, DOI 10.2353/ajpath.2010.100569; Pandey P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-56; Piazzon N, 2012, J MOL CELL BIOL, V4, P398, DOI 10.1093/jmcb/mjs027; Riera M, 2006, KIDNEY INT, V69, P1558, DOI 10.1038/sj.ki.5000309; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Semple JI, 2005, BIOTECHNIQUES, V38, P927, DOI 10.2144/05386RR03; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Stagner EE, 2009, BIOCHEM BIOPH RES CO, V383, P16, DOI 10.1016/j.bbrc.2009.03.113; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Taskiran EZ, 2014, J AM SOC NEPHROL, V25, P1653, DOI 10.1681/ASN.2013060646; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; Woo DDL, 1997, J CLIN INVEST, V100, P1934, DOI 10.1172/JCI119724; Yakulov TA, 2015, KIDNEY INT, V87, P1191, DOI 10.1038/ki.2015.17	41	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136781	10.1371/journal.pone.0136781	http://dx.doi.org/10.1371/journal.pone.0136781			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327442	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700063
J	Li, YF; Rao, XY; Mattox, WW; Amos, CI; Liu, B				Li, Yafang; Rao, Xiayu; Mattox, William W.; Amos, Christopher I.; Liu, Bin			RNA-Seq Analysis of Differential Splice Junction Usage and Intron Retentions by DEXSeq	PLOS ONE			English	Article							HUMAN TRANSCRIPTOME; EXPRESSION ANALYSIS; GENE; MECHANISMS; HOMOLOG; CELLS	Alternative splicing is an important biological process in the generation of multiple functional transcripts from the same genomic sequences. Differential analysis of splice junctions (SJs) and intron retentions (IRs) is helpful in the detection of alternative splicing events. In this study, we conducted differential analysis of SJs and IRs by use of DEXSeq, a Bioconductor package originally designed for differential exon usage analysis in RNA-seq data analysis. We set up an analysis pipeline including mapping of RNA-seq reads, the preparation of count tables of SJs and IRs as the input files, and the differential analysis in DEXSeq. We analyzed the public RNA-seq datasets generated from RNAi experiments on Drosophila melanogaster S2-DRSC cells to deplete RNA-binding proteins (GSE18508). The analysis confirmed previous findings on the alternative splicing of the trol and Ant2 (sesB) genes in the CG8144 (ps)-depletion experiment and identified some new alternative splicing events in other RNAi experiments. We also identified IRs that were confirmed in our SJ analysis. The proposed method used in our study can output the genomic coordinates of differentially used SJs and thus enable sequence motif search. Sequence motif search and gene function annotation analysis helped us infer the underlying mechanism in alternative splicing events. To further evaluate this method, we also applied the method to public RNA-seq data from human breast cancer (GSE45419) and the plant Arabidopsis (SRP008262). In conclusion, our study showed that DEXSeq can be adapted to differential analysis of SJs and IRs, which will facilitate the identification of alternative splicing events and provide insights into the molecular mechanisms of transcription processes and disease development.	[Li, Yafang; Amos, Christopher I.] Dartmouth Coll, Geisel Sch Med, Dept Biomed Data Sci, Hanover, NH 03755 USA; [Rao, Xiayu; Mattox, William W.; Liu, Bin] Univ Texas MD Anderson Canc Ctr, Ctr Genet & Genom, Dept Genet, Houston, TX 77030 USA	Dartmouth College; University of Texas System; UTMD Anderson Cancer Center	Liu, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr Genet & Genom, Dept Genet, Houston, TX 77030 USA.	bliu1@mdanderson.org		Mattox, William/0000-0001-8084-9677; Liu, Bin/0000-0002-9113-9694	NCI NIH HHS [P30 CA023108] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA023108] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Aschoff M, 2013, BIOINFORMATICS, V29, P1141, DOI 10.1093/bioinformatics/btt101; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Bryant Douglas W Jr, 2012, Methods Mol Biol, V883, P97, DOI 10.1007/978-1-61779-839-9_7; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P423, DOI 10.1038/nbt0406-423; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Garg K, 2007, GENOME RES, V17, P1015, DOI 10.1101/gr.6347907; Ge Y, 2014, BIOESSAYS, V36, P236, DOI 10.1002/bies.201300156; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Jarosch A, 2011, P NATL ACAD SCI USA, V108, P15282, DOI 10.1073/pnas.1109343108; Kalari KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079298; Kalifa Y, 2006, DEV CELL, V10, P291, DOI 10.1016/j.devcel.2006.01.001; Kalifa Y, 2009, DEV BIOL, V326, P68, DOI 10.1016/j.ydbio.2008.10.032; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Puig T, 2008, BREAST CANCER RES TR, V109, P471, DOI 10.1007/s10549-007-9678-5; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Santhekadur PK, 2012, AM J CANCER RES, V2, P269; Seshaiah P, 2001, DEV BIOL, V239, P309, DOI 10.1006/dbio.2001.0429; Sette Claudio, 2013, Int J Cell Biol, V2013, P421606, DOI 10.1155/2013/421606; Shen SH, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1291; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turano M, 2013, BIOCHEM CELL BIOL, V91, P506, DOI 10.1139/bcb-2013-0047; Vazquez-Martin A, 2008, CELL PROLIFERAT, V41, P59, DOI 10.1111/j.1365-2184.2007.00498.x; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang XX, 2012, PLANT CELL, V24, P3278, DOI 10.1105/tpc.112.100081; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	38	20	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136653	10.1371/journal.pone.0136653	http://dx.doi.org/10.1371/journal.pone.0136653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327458	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700052
J	Harhay, MO; Kizer, JR; Criqui, MH; Lima, JAC; Tracy, R; Bluemke, DA; Kawut, SM				Harhay, Michael O.; Kizer, Jorge R.; Criqui, Michael H.; Lima, Joao A. C.; Tracy, Russell; Bluemke, David A.; Kawut, Steven M.			Adipokines and the Right Ventricle: The MESA-RV Study	PLOS ONE			English	Article							HEART-FAILURE; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS MESA; WEIGHT-LOSS; OBESITY; LEPTIN; HYPERTROPHY; ADIPONECTIN; MASS; INFLAMMATION	Objective Obesity is associated with changes in both right (RV) and left (LV) ventricular morphology, but the biological basis of this finding is not well established. We examined whether adipokine levels were associated with RV morphology and function in a population-based multiethnic sample free of clinical cardiovascular disease. Methods We examined relationships of leptin, resistin, TNF-alpha, and adiponectin with RV morphology and function (from cardiac MRI) in participants (n = 1,267) free of clinical cardiovascular disease from the Multi-Ethnic Study of Atherosclerosis (MESA)-RV study. Multivariable regressions (linear, quantile [25th and 75th] and generalized additive models [GAM]) were used to examine the independent association of each adipokine with RV mass, RV end-diastolic volume (RVEDV), RV end-systolic volume (RVESV), RV stroke volume (RVSV) and RV ejection fraction (RVEF). Results Higher leptin levels were associated with significantly lower levels of RV mass, RVEDV, RVESV and stroke volume, but not RVEF, after adjustment for age, gender, race, height and weight. These associations were somewhat attenuated but still significant after adjustment for traditional risk factors and covariates, and were completely attenuated when correcting for the respective LV measures. There were no significant interactions of age, gender, or race/ethnicity on the relationship between the four adipokines and RV structure or function. Conclusions Leptin levels are associated with favorable RV morphology in a multi-ethnic population free of cardiovascular disease, however these associations may be explained by a yet to be understood bi-ventricular process as this association was no longer present after adjustment for LV values. These findings complement the associations previously shown between adipokines and LV structure and function in both healthy and diseased patients. The mechanisms linking adipokines to healthy cardiovascular function require further investigation.	[Harhay, Michael O.; Kawut, Steven M.] Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Harhay, Michael O.; Kawut, Steven M.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Harhay, Michael O.; Kawut, Steven M.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kizer, Jorge R.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Criqui, Michael H.] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Lima, Joao A. C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Tracy, Russell] Univ Vermont, Sch Med, Dept Lab Med, Burlington, VT 05405 USA; [Bluemke, David A.] Natl Inst Biomed Imaging & Bioengn, Radiol & Imaging Sci, NIH, Ctr Clin, Bethesda, MD USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; Johns Hopkins University; University of Vermont; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Kawut, SM (corresponding author), Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA.	kawut@upenn.edu	Bluemke, David/GYU-8169-2022	Bluemke, David/0000-0002-8323-8086; Harhay, Michael/0000-0002-0553-674X	National Institutes of Health [F31-HL127947, R01-HL086719, R01-HL077612, RO1-HL088451, N01-HC95159 - HC95165, N01-HC95169]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095159, N01HC095163, N01HC095169, N01HC095161, N01HC095160, N01HC095162, N01HC095164, N01HC095165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL103844, R01HL086719, R01HL088451, F31HL127947, R01HL077612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, P60DK020541] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CLINICAL CENTER	The following National Institutes of Health grants and contracts provided funding for this study: F31-HL127947 (to MOH), R01-HL086719, R01-HL077612, RO1-HL088451, N01-HC95159 - HC95165, N01-HC95169. The authors thank the MESA investigators, staff, and participants for their valuable contributions. A full list of participating MESA Investigators and institutions can be found at http://www.mesa-nhlbi.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2013, AM J CARDIOL, V112, P726, DOI 10.1016/j.amjcard.2013.04.053; ALPERT MA, 1995, AM HEART J, V130, P1068, DOI 10.1016/0002-8703(95)90210-4; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bidulescu A, 2011, CIRC-HEART FAIL, V4, P747, DOI 10.1161/CIRCHEARTFAILURE.110.959742; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Chahal H, 2012, CHEST, V141, P388, DOI 10.1378/chest.11-0172; Chahal H, 2010, AM J CARDIOL, V106, P110, DOI 10.1016/j.amjcard.2010.02.022; Danias PG, 2003, J CARDIOV MAGN RESON, V5, P431, DOI 10.1081/JCMR-120022259; Di Blasio A, 2011, MENOPAUSE, V18, P77, DOI 10.1097/gme.0b013e3181e57813; ERIKSSON H, 1989, EUR HEART J, V10, P647, DOI 10.1093/oxfordjournals.eurheartj.a059542; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; Gustafsson S, 2010, EUR J ENDOCRINOL, V162, P543, DOI 10.1530/EJE-09-1006; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Hopkins TA, 2007, CARDIOVASC RES, V74, P11, DOI 10.1016/j.cardiores.2006.10.009; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kozakova M, 2008, J CLIN ENDOCR METAB, V93, P2811, DOI 10.1210/jc.2007-2580; Lieb W, 2009, AM J CARDIOL, V104, P602, DOI 10.1016/j.amjcard.2009.04.026; Lieb W, 2009, DIABETES CARE, V32, P612, DOI 10.2337/dc08-1596; McGaffin KR, 2008, CARDIOVASC RES, V77, P54, DOI 10.1093/cvr/cvm023; McManus DD, 2012, OBESITY, V20, P1882, DOI 10.1038/oby.2011.32; Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pladevall M, 2003, J HYPERTENS, V21, P1467, DOI 10.1097/00004872-200308000-00009; Rajapurohitam V, 2003, CIRC RES, V93, P277, DOI 10.1161/01.RES.0000089255.37804.72; Rider OJ, 2011, HEART, V97, P203, DOI 10.1136/hrt.2009.185009; Rider OJ, 2010, OBESITY, V18, P2311, DOI 10.1038/oby.2010.64; Rider OJ, 2009, J AM COLL CARDIOL, V54, P718, DOI 10.1016/j.jacc.2009.02.086; Rothman KJ, 1990, NO ADJUSTMENTS ARE N; Smith SR, 2003, DIABETES, V52, P1611, DOI 10.2337/diabetes.52.7.1611; Turkbey EB, 2010, JACC-CARDIOVASC IMAG, V3, P266, DOI 10.1016/j.jcmg.2009.10.012; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004	35	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136818	10.1371/journal.pone.0136818	http://dx.doi.org/10.1371/journal.pone.0136818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348768	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600013
J	Li, Z; Ye, B; Bao, MW; Xu, BB; Chen, QY; Liu, SD; Han, YD; Peng, MZ; Lin, ZF; Li, JP; Zhu, WZ; Lin, Q; Xiong, LW				Li, Zhao; Ye, Bo; Bao, Minwei; Xu, Binbin; Chen, Qinyi; Liu, Sida; Han, Yudong; Peng, Mingzhen; Lin, Zhifeng; Li, Jingpei; Zhu, Wenzhuo; Lin, Qiang; Xiong, Liwen			Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes	PLOS ONE			English	Article							INTERNATIONAL MULTIDISCIPLINARY CLASSIFICATION; COMPUTER-AIDED DIAGNOSIS; LYMPH-NODE METASTASIS; ONCOLOGY GROUP 0201; PULMONARY NODULES; SUBLOBAR RESECTION; LIMITED RESECTION; PROGNOSTIC-SIGNIFICANCE; RANDOMIZED-TRIAL; Z0030 TRIAL	Objective This study was to define preoperative predictors from radiologic findings for the pathologic risk groups based on long-term surgical outcomes, in the aim to help guide individualized patient management. Methods We retrospectively reviewed 321 consecutive patients with clinical stage IA lung adenocarcinoma with ground glass component on computed tomography (CT) scanning. Pathologic diagnosis for resection specimens was based on the 2011 IASLC/ATS/ERS classification of lung adenocarcinoma. Patients were classified into different pathologic risk grading groups based on their lymph node status, local regional recurrence and overall survival. Radiologic characteristics of the pulmonary nodules were re-evaluated by reconstructed three-dimension CT (3D-CT). Univariate and multivariate analysis identifies independent radiologic predictors from tumor diameter, total volume (TV), average CT value (AVG), and solid-to-tumor (S/T) ratio. Receiver operating characteristic curves (ROC) studies were carried out to determine the cutoff value(s) for the predictor(s). Univariate cox regression model was used to determine the clinical significance of the above findings. Results A total of 321 patients with clinical stage IA lung adenocarcinoma with ground glass components were included in our study. Patients were classified into two pathologic low- and high-risk groups based on their distinguished surgical outcomes. A total of 134 patients fell into the low-risk group. Univariate and multivariate analyses identified AVG (HR: 32.210, 95% CI: 3.020-79.689, P<0.001) and S/T ratio (HR: 12.212, 95% CI: 5.441-27.408, P<0.001) as independent predictors for pathologic risk grading. ROC curves studies suggested the optimal cut-off values for AVG and S/T ratio were-198 (area under the curve [AUC] 0.921), 2.9 (AUC 0.996) and 54% (AUC 0.907), respectively. The tumor diameter and TV were excluded for the low AUCs (0.778 and 0.767). Both the cutoff values of AVG and S/T ratio were correlated with pathologic risk classification (p<0.001). Univariate Cox regression model identified clinical risk classification (RR: 3.011, 95% CI: 0.796-7.882, P = 0.095) as a good predictor for recurrence-free survival (RFS) in patients with clinical stage IA lung adenocarcinoma. Statistical significance of 5-year OS and RFS was noted among clinical low-, moderate- and high-risk groups (log-rank, p = 0.024 and 0.010). Conclusions The AVG and the S/T ratio by reconstructed 3D-CT are important preoperative radiologic predictors for pathologic risk grading. The two cutoff values of AVG and S/T ratio are recommended in decision-making for patients with clinical stage IA lung adenocarcinoma with ground glass components.	[Li, Zhao; Xu, Binbin; Liu, Sida; Han, Yudong; Peng, Mingzhen; Lin, Zhifeng; Zhu, Wenzhuo; Lin, Qiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Thorac Surg, Shanghai 200030, Peoples R China; [Ye, Bo; Xiong, Liwen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai 200030, Peoples R China; [Bao, Minwei] Shanghai Jiao Tong Univ, Sch Med, Dept Thorac Surg, Shanghai Pulm Hosp, Shanghai 200030, Peoples R China; [Chen, Qinyi] Fudan Univ, Dept Dermatol, Huashan Hosp, Shanghai 200433, Peoples R China; [Li, Jingpei] Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou, Guangdong, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Guangzhou Medical University	Lin, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Thorac Surg, Shanghai 200030, Peoples R China.	xklinqiang@hotmail.com; Xiong_li_wen@126.com						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aida S, 2004, HISTOPATHOLOGY, V45, P468, DOI 10.1111/j.1365-2559.2004.01946.x; Allen MS, 2006, ANN THORAC SURG, V81, P1013, DOI 10.1016/j.athoracsur.2005.06.066; Asamura H, 2013, J THORAC CARDIOV SUR, V146, P24, DOI 10.1016/j.jtcvs.2012.12.047; Awai K, 2006, RADIOLOGY, V239, P276, DOI 10.1148/radiol.2383050167; Awai K, 2004, RADIOLOGY, V230, P347, DOI 10.1148/radiol.2302030049; Bergman P, 2013, ACTA ONCOL, V52, P1189, DOI 10.3109/0284186X.2012.742960; Crabtree T, 2013, J THORAC CARDIOV SUR, V145, P692, DOI 10.1016/j.jtcvs.2012.10.038; Darling GE, 2011, J THORAC CARDIOV SUR, V141, P662, DOI 10.1016/j.jtcvs.2010.11.008; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Gorai A, 2015, EUR J CARDIO-THORAC, V47, P653, DOI 10.1093/ejcts/ezu244; Jennings SG, 2004, RADIOLOGY, V231, P866, DOI 10.1148/radiol.2313030715; Kakinuma R, 2012, ACAD RADIOL, V19, P389, DOI 10.1016/j.acra.2011.12.002; Kodama K, 2001, LUNG CANCER-J IASLC, V33, P17, DOI 10.1016/S0169-5002(01)00185-4; Lardinois D, 2006, EUR J CARDIO-THORAC, V30, P787, DOI 10.1016/j.ejcts.2006.08.008; Lee HY, 2011, J THORAC IMAG, V26, P106, DOI 10.1097/RTI.0b013e3181fbaa64; Linning E, 2009, ACAD RADIOL, V16, P934, DOI 10.1016/j.acra.2009.02.020; Maksimovic R, 2000, INT J MED INFORM, V58, P29, DOI 10.1016/S1386-5056(00)00073-3; Matsuguma H, 2004, EUR J CARDIO-THORAC, V25, P1102, DOI 10.1016/j.ejcts.2004.02.004; Nakamura K, 2010, JPN J CLIN ONCOL, V40, P271, DOI 10.1093/jjco/hyp156; Nakata M, 2005, J THORAC CARDIOV SUR, V129, P1226, DOI 10.1016/j.jtcvs.2004.10.032; Nomori H, 2003, J THORAC CARDIOV SUR, V126, P1584, DOI 10.1016/S0022-5223(03)00885-7; Nomori H, 2003, ANN THORAC SURG, V76, P867, DOI 10.1016/S0003-4975(03)00729-X; Oda S, 2010, AM J ROENTGENOL, V194, P398, DOI 10.2214/AJR.09.2583; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Rami-Porta R, 2009, EUR RESPIR J, V33, P426, DOI 10.1183/09031936.00099808; Riquet M, 2014, ANN THORAC SURG, V98, P224, DOI 10.1016/j.athoracsur.2014.03.023; Russell PA, 2011, J THORAC ONCOL, V6, P1496, DOI 10.1097/JTO.0b013e318221f701; Sica G, 2010, AM J SURG PATHOL, V34, P1155, DOI 10.1097/PAS.0b013e3181e4ee32; Suzuki K, 2002, ANN THORAC SURG, V74, P1635, DOI 10.1016/S0003-4975(02)03895-X; Suzuki K, 2000, ANN THORAC SURG, V69, P893, DOI 10.1016/S0003-4975(99)01331-4; Suzuki K, 2011, J THORAC ONCOL, V6, P751, DOI 10.1097/JTO.0b013e31821038ab; Travis William D, 2011, Proc Am Thorac Soc, V8, P381, DOI 10.1513/pats.201107-042ST; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Warth A, 2012, J CLIN ONCOL, V30, P1438, DOI 10.1200/JCO.2011.37.2185; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Ye B, 2014, ANN THORAC SURG, V98, P217, DOI 10.1016/j.athoracsur.2014.03.005; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Zhang Y, 2013, ANN SURG ONCOL, V20, P1949, DOI 10.1245/s10434-012-2829-x	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136616	10.1371/journal.pone.0136616	http://dx.doi.org/10.1371/journal.pone.0136616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339917	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200012
J	Michel, L; Huguet-Lachon, A; Gourdon, G				Michel, Lise; Huguet-Lachon, Aline; Gourdon, Genevieve			Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY REGION; TRIPLET REPEAT; BINDING PROTEIN; CTG REPEATS; CUG REPEATS; EXPANSION; IDENTIFICATION; MISREGULATION; TRANSCRIPTION; EXPRESSION	Myotonic dystrophy type 1 (DM1) is caused by an unstable expanded CTG repeat located within the DMPK gene 3'UTR. The nature, severity and age at onset of DM1 symptoms are very variable in patients. Different forms of the disease are described, among which the congenital form (CDM) is the most severe. Molecular mechanisms of DM1 are well characterized for the adult form and involve accumulation of mutant DMPK RNA forming foci in the nucleus. These RNA foci sequester proteins from the MBNL family and deregulate CELF proteins. These proteins are involved in many cellular mechanisms such as alternative splicing, transcriptional, translational and post-translational regulation miRNA regulation as well as mRNA polyadenylation and localization. All these mechanisms can be impaired in DM1 because of the deregulation of CELF and MBNL functions. The mechanisms involved in CDM are not clearly described. In order to get insight into the mechanisms underlying CDM, we investigated if expanded RNA nuclear foci, one of the molecular hallmarks of DM1, could be detected in human DM1 fetal tissues, as well as in embryonic and neonatal tissues from transgenic mice carrying the human DMPK gene with an expanded CTG repeat. We observed very abundant RNA foci formed by sense DMPK RNA and, to a lesser extent, antisense DMPK RNA foci. Sense DMPK RNA foci clearly co-localized with MBNL1 and MBNL2 proteins. In addition, we studied DMPK sense and antisense expression during development in the transgenic mice. We found that DMPK sense and antisense transcripts are expressed from embryonic and fetal stages in heart, muscle and brain and are regulated during development. These results suggest that mechanisms underlying DM1 and CDM involved common players including toxic expanded RNA forming numerous nuclear foci at early stages during development.	[Michel, Lise; Huguet-Lachon, Aline; Gourdon, Genevieve] INSERM, UMR 1163, Paris, France; [Michel, Lise; Huguet-Lachon, Aline; Gourdon, Genevieve] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Gourdon, G (corresponding author), INSERM, UMR 1163, Paris, France.	genevieve.gourdon@inserm.fr	Gourdon, Genevieve/F-2996-2013	Gourdon, Genevieve/0000-0002-3319-1347	National Research Agency under the "Investments for the Future" program [ANR-10-IAHU-01, ANR-10BLAN-1121-01]; French Ministry for Higher Education and Research; Fondation de la Recherche Medicale FRM [FDT20140930889]	National Research Agency under the "Investments for the Future" program(French National Research Agency (ANR)); French Ministry for Higher Education and Research; Fondation de la Recherche Medicale FRM(Fondation pour la Recherche Medicale)	This program has received a state subsidy managed by the National Research Agency under the "Investments for the Future" program bearing the reference ANR-10-IAHU-01 and under the program ANR-10BLAN-1121-01. L.M. was funded by a PhD fellowship from the French Ministry for Higher Education and Research and by the Fondation de la Recherche Medicale FRM FDT20140930889.	ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Brouwer JR, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/567435; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gladman JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072907; Gomes-Pereira M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030052; Gomes-Pereira M, 2011, TRENDS MOL MED, V17, P506, DOI 10.1016/j.molmed.2011.05.004; HAGEMAN ATM, 1993, J NEUROL SCI, V115, P95, DOI 10.1016/0022-510X(93)90072-7; Harper PS, 2001, MYOTONIC DYSTROPHY; Hernandez-Hernandez O, 2013, BRAIN, V136, P957, DOI 10.1093/brain/aws367; Holt I, 2009, AM J PATHOL, V174, P216, DOI 10.2353/ajpath.2009.080520; Huguet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003043; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, GENE EXPR PATTERNS, V3, P459, DOI 10.1016/S1567-133X(03)00064-4; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kruse Bernd, 2008, Hum Mutat, V29, pE100, DOI 10.1002/humu.20791; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Liu YF, 2008, COMP BIOCHEM PHYS B, V151, P118, DOI 10.1016/j.cbpb.2008.06.005; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; Mykowska A, 2011, NUCLEIC ACIDS RES, V39, P8938, DOI 10.1093/nar/gkr608; Onishi H, 2008, J NEUROSCI RES, V86, P1994, DOI 10.1002/jnr.21655; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Sicot G, 2011, HUM MOL GENET, V20, pR116, DOI 10.1093/hmg/ddr343; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Todd PK, 2014, DIS MODEL MECH, V7, P143, DOI 10.1242/dmm.012427; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	40	36	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137620	10.1371/journal.pone.0137620	http://dx.doi.org/10.1371/journal.pone.0137620			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339785	gold, Green Submitted, Green Published			2022-12-27	WOS:000360688200071
J	Chen, SQ; Han, JY; Liu, YQ				Chen, Suqin; Han, Junying; Liu, Yeqi			Dual Opposing Roles of Metallothionein Overexpression in C57BL/6J Mouse Pancreatic beta-Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; DIABETES-MELLITUS; INSULIN-RESISTANCE; GLUCOSE; CATALASE; GENE; PROTECTION; MICE; HYPERINSULINEMIA; POLYMORPHISMS	Background Growing evidence indicates that oxidative stress (OS), a persistent state of excess amounts of reactive oxygen species (ROS) along with reactive nitrogen species (RNS), plays an important role in insulin resistance, diabetic complications, and dysfunction of pancreatic beta-cells. Pancreatic beta-cells contain exceptionally low levels of antioxidant enzymes, rendering them susceptible to ROS-induced damage. Induction of antioxidants has been proposed to be a way for protecting beta-cells against oxidative stress. Compared to other antioxidants that act against particular beta-cell damages, metallothionein (MT) is the most effective in protecting beta-cells from several oxidative stressors including nitric oxide, peroxynitrite, hydrogen peroxide, superoxide and streptozotocin (STZ). We hypothesized that MT overexpression in pancreatic beta-cells would preserve beta-cell function in C57BL/6J mice, an animal model susceptible to high fat diet-induced obesity and type 2 diabetes. Research Design and Methods The pancreatic beta-cell specific MT overexpression was transferred to C57BL/6J background by backcrossing. We studied transgenic MT (MT-tg) mice and wild-type (WT) littermates at 8 weeks and 18 weeks of age. Several tests were performed to evaluate the function of islets, including STZ in vivo treatment, intraperitoneal glucose tolerance tests (IPGTT) and plasma insulin levels during IPGTT, pancreatic and islet insulin content measurement, insulin secretion, and islet morphology assessment. Gene expression in islets was performed by quantitative real-time PCR and PCR array analysis. Protein levels in pancreatic sections were evaluated by using immunohistochemistry. Results The transgenic MT protein was highly expressed in pancreatic islets. MT-tg overexpression significantly protected mice from acute STZ-induced ROS at 8 weeks of age; unexpectedly, however, MT-tg impaired glucose stimulated insulin secretion (GSIS) and promoted the development of diabetes. Pancreatic beta-cell function was significantly impaired, and islet morphology was also abnormal in MT-tg mice, and more severe damage was detected in males. The unique gene expression pattern and abnormal protein levels were observed in MT-tg islets. Conclusions MT overexpression protected beta-cells from acute STZ-induced ROS damages at young age, whereas it impaired GSIS and promoted the development of diabetes in adult C57BL/6J mice, and more severe damage was found in males.	[Chen, Suqin; Han, Junying; Liu, Yeqi] Childrens Hosp New Orleans, Res Inst Children, New Orleans, LA 70118 USA; [Chen, Suqin] Sun Yat Sen Univ, Zhongshan Med Coll, Dept Med Genet, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yeqi] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA	Children's Hospital of New Orleans; Sun Yat Sen University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Chen, SQ (corresponding author), Childrens Hosp New Orleans, Res Inst Children, New Orleans, LA 70118 USA.	chensq@mail.sysu.edu.cn			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [1R01DK077624]; Research Institute for Children, Children's Hospital at New Orleans [6931]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077624] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Research Institute for Children, Children's Hospital at New Orleans; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, 1R01DK077624) and the Research Institute for Children, Children's Hospital at New Orleans (6931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci S, 2007, CURR OPIN CLIN NUTR, V10, P403, DOI 10.1097/MCO.0b013e3281e386c9; Chang YC, 2010, AM J TRANSL RES, V2, P316; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Chen HN, 2001, DIABETES, V50, P2040, DOI 10.2337/diabetes.50.9.2040; Chiaverini N, 2010, FREE RADICAL RES, V44, P605, DOI 10.3109/10715761003692511; Collins S, 2012, BEST PRACT RES CL EN, V26, P753, DOI 10.1016/j.beem.2012.08.002; Di Paola R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019462; Fang N, 2014, METABOLISM, V63, P822, DOI 10.1016/j.metabol.2014.03.003; Fu YX, 1999, FREE RADICAL BIO MED, V27, P605, DOI 10.1016/S0891-5849(99)00104-5; Giacconi R, 2008, MOL GENET METAB, V94, P98, DOI 10.1016/j.ymgme.2007.12.006; Gorogawa S, 2002, DIABETES RES CLIN PR, V57, P1, DOI 10.1016/S0168-8227(02)00005-0; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Han J, 2005, DIABETOLOGIA, V48, P1810, DOI 10.1007/s00125-005-1854-8; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kaneto H, 2009, CURR MED CHEM, V16, P3144, DOI 10.2174/092986709788802980; Kikumoto Y, 2010, BBA-MOL BASIS DIS, V1802, P240, DOI 10.1016/j.bbadis.2009.10.009; Kubisch HM, 1997, DIABETES, V46, P1563, DOI 10.2337/diabetes.46.10.1563; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lei XG, 2011, ANTIOXID REDOX SIGN, V14, P489, DOI 10.1089/ars.2010.3416; Leloup C, 2006, DIABETES, V55, P2084, DOI 10.2337/db06-0086; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li XY, 2006, DIABETES, V55, P1592, DOI 10.2337/db05-1357; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; Liu Q, 2014, J DIABETES INVEST, V5, P623, DOI 10.1111/jdi.12250; Liu YQ, 1998, J CLIN INVEST, V101, P1870, DOI 10.1172/JCI1211; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lortz S, 2003, FREE RADICAL BIO MED, V34, P683, DOI 10.1016/S0891-5849(02)01371-0; Mandic SA, 2011, J BIOL CHEM, V286, P28026, DOI 10.1074/jbc.M111.235366; Maret W, 2008, EXP GERONTOL, V43, P363, DOI 10.1016/j.exger.2007.11.005; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Muscogiuri G, 2013, DIABETES, V62, P4201, DOI 10.2337/db13-0314; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Robertson RP, 2009, TRENDS ENDOCRIN MET, V20, P388, DOI 10.1016/j.tem.2009.05.004; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Spinas GA, 1998, DIABETOLOGIA, V41, P292, DOI 10.1007/s001250050906; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Thams P, 1999, EUR J ENDOCRINOL, V140, P87, DOI 10.1530/eje.0.1400087; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XD, 2008, DIABETOLOGIA, V51, P1515, DOI 10.1007/s00125-008-1055-3; Xu B, 1999, FREE RADICAL BIO MED, V27, P830, DOI 10.1016/S0891-5849(99)00130-6; Yamamoto M, 2008, ANTIOXID REDOX SIGN, V10, P43, DOI 10.1089/ars.2007.1586; Yang L, 2008, AM J PHYSIOL-ENDOC M, V294, pE987, DOI 10.1152/ajpendo.90234.2008	49	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137583	10.1371/journal.pone.0137583	http://dx.doi.org/10.1371/journal.pone.0137583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335571	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400068
J	Nunez, JCB; Seale, TP; Fraser, MA; Burton, TL; Fortson, TN; Hoover, D; Travis, J; Oleksiak, MF; Crawford, DL				Nunez, J. C. B.; Seale, T. P.; Fraser, M. A.; Burton, T. L.; Fortson, T. N.; Hoover, D.; Travis, J.; Oleksiak, M. F.; Crawford, D. L.			Population Genomics of the Euryhaline Teleost Poecilia latipinna	PLOS ONE			English	Article							CLIMATE-CHANGE; NUCLEOTIDE POLYMORPHISM; DROSOPHILA-MELANOGASTER; PHENOTYPIC PLASTICITY; GENETIC DIVERSITY; SPECIES RICHNESS; ECOSYSTEM; DNA; EVOLUTIONARY; SELECTION	Global climate change and increases in sea levels will affect coastal marine communities. The conservation of these ecologically important areas will be a challenge because of their wide geographic distribution, ecological diversity and species richness. To address this problem, we need to better understand how the genetic variation of the species in these communities is distributed within local populations, among populations and between distant regions. In this study we apply genotyping by sequencing (GBS) and examine 955 SNPs to determine Sailfin molly (Poecilia latipinna) genetic diversity among three geographically close mangrove salt marsh flats in the Florida Keys compared to populations in southern and northern Florida. The questions we are asking are whether there is sufficient genetic variation among isolated estuarine fish within populations and whether there are significant divergences among populations. Additionally, we want to know if GBS approaches agree with previous studies using more traditional molecular approaches. We are able to identify large genetic diversity within each saltmarsh community (pi approximate to 36%). Additionally, among the Florida Key populations and the mainland or between southern and northern Florida regions, there are significant differences in allele frequencies seen in population structure and evolutionary relationships among individuals. Surprisingly, even though the cumulative F-ST value using all 955 SNPs within the three Florida Key populations is small, there are 29 loci with significant F-ST values, and 11 of these were outliers suggestive of adaptive divergence. These data suggest that among the salt marsh flats surveyed here, there is significant genetic diversity within each population and small but significant differences among populations. Much of the genetic variation within and among populations found here with GBS is very similar to previous studies using allozymes and microsatellites. However, the meaningful difference between GBS and these previous measures of genetic diversity is the number of loci examined, which allows more precise delineations of population structure as well as facilitates identifying loci with excessive F-ST values that could indicate adaptive divergence.	[Nunez, J. C. B.; Seale, T. P.; Fraser, M. A.; Burton, T. L.; Fortson, T. N.; Oleksiak, M. F.; Crawford, D. L.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Hoover, D.; Travis, J.] Florida State Univ, Dept Biol, Tallahassee, FL 32306 USA	University of Miami; State University System of Florida; Florida State University	Crawford, DL (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	dcrawford@rsmas.miami.edu	Nunez, Joaquin C. B./L-5355-2015	Nunez, Joaquin C. B./0000-0002-3171-8918; Crawford, Douglas/0000-0002-6239-4012	University of Miami's Marine Science undergraduate program; National Science Foundation, Molecular and Cellular Biosciences [1158241]; Division Of Integrative Organismal Systems [1147042] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1158241] Funding Source: National Science Foundation	University of Miami's Marine Science undergraduate program; National Science Foundation, Molecular and Cellular Biosciences; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Most of this research was supported by the University of Miami's Marine Science undergraduate program. Additional support for the adaptor primers was from National Science Foundation, Molecular and Cellular Biosciences 1158241 to MFO (http://www.nsf.gov/div/index.jsp?div=MCB).	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Apodaca JJ, 2013, AM NAT, V181, P254, DOI 10.1086/668831; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bierne N, 2013, MOL ECOL, V22, P2061, DOI 10.1111/mec.12241; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Day JW, 2008, ESTUAR COAST, V31, P477, DOI 10.1007/s12237-008-9047-6; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Engelhardt KAM, 2001, NATURE, V411, P687, DOI 10.1038/35079573; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feller IC, 2010, ANNU REV MAR SCI, V2, P395, DOI 10.1146/annurev.marine.010908.163809; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Harte J, 2004, NATURE, V430, P33, DOI [10.1038/430003a, DOI 10.1038/430003A]; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hedrick PW, 2006, ANNU REV ECOL EVOL S, V37, P67, DOI 10.1146/annurev.ecolsys.37.091305.110132; Hermisson J, 2009, HEREDITY, V103, P283, DOI 10.1038/hdy.2009.101; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Hyma KE, 2013, MOL ECOL, V22, P2917, DOI 10.1111/mec.12155; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2014, INTRO ADEGENET 1 41; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kemp SJ, 2008, MAR ECOL PROG SER, V371, P233, DOI 10.3354/meps07641; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; KREITMAN ME, 1986, GENETICS, V114, P93; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lotterhos KE, 2014, MOL ECOL, V23, P2178, DOI 10.1111/mec.12725; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Phillips PC, 1996, EVOLUTION, V50, P1334, DOI [10.2307/2410673, 10.1111/j.1558-5646.1996.tb02373.x]; Pritchard JK, 2000, GENETICS, V155, P945; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Reed DH, 2002, CONSERV BIOL, V17; Reusch TBH, 2006, ESTUARIES COASTS, V29, P159, DOI 10.1007/BF02784707; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rey JR, 2012, WETL ECOL MANAG, V20, P197, DOI 10.1007/s11273-011-9235-1; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; SLATKIN M, 1991, GENETICS, V127, P627; SLATKIN M, 1995, GENETICS, V139, P457; Slatkin Montgomery, 1994, P3; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sternberg LDSL, 1994, ECOLOGICAL APLICATIO, V4, P144; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Travis Joseph, 1994, P205; TREXLER JC, 1988, EVOLUTION, V42, P1006, DOI 10.1111/j.1558-5646.1988.tb02519.x; TREXLER JC, 1990, EVOLUTION, V44, P157, DOI 10.1111/j.1558-5646.1990.tb04286.x; TREXLER JC, 1990, EVOLUTION, V44, P143, DOI 10.1111/j.1558-5646.1990.tb04285.x; Twilley R.R., 1985, COASTAL SHELF SCI, V20, P543, DOI DOI 10.1016/0272-7714(85)90106-4; Williams LM, 2011, MOL ECOL, V20, P5236, DOI 10.1111/j.1365-294X.2011.05360.x; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	61	11	13	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137077	10.1371/journal.pone.0137077	http://dx.doi.org/10.1371/journal.pone.0137077			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335684	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400037
J	Akl, EA; El-Jardali, F; Karroum, LB; El-Eid, J; Brax, H; Akik, C; Osman, M; Hassan, G; Itani, M; Farha, A; Pottie, K; Oliver, S				Akl, Elie A.; El-Jardali, Fadi; Karroum, Lama Bou; El-Eid, Jamale; Brax, Hneine; Akik, Chaza; Osman, Mona; Hassan, Ghayda; Itani, Mira; Farha, Aida; Pottie, Kevin; Oliver, Sandy			Effectiveness of Mechanisms and Models of Coordination between Organizations, Agencies and Bodies Providing or Financing Health Services in Humanitarian Crises: A Systematic Review	PLOS ONE			English	Review							MENTAL-HEALTH; PSYCHOSOCIAL SUPPORT; DISASTER RESPONSE; COMPLEX EMERGENCIES; REPRODUCTIVE HEALTH; MEDICAL RESPONSE; INFORMATION; EARTHQUAKE; RELIEF; COLLABORATION	Background Effective coordination between organizations, agencies and bodies providing or financing health services in humanitarian crises is required to ensure efficiency of services, avoid duplication, and improve equity. The objective of this review was to assess how, during and after humanitarian crises, different mechanisms and models of coordination between organizations, agencies and bodies providing or financing health services compare in terms of access to health services and health outcomes. Methods We registered a protocol for this review in PROSPERO International prospective register of systematic reviews under number PROSPERO2014:CRD42014009267. Eligible studies included randomized and nonrandomized designs, process evaluations and qualitative methods. We electronically searched Medline, PubMed, EMBASE, Cochrane Central Register of Controlled Trials, CINAHL, PsycINFO, and the WHO Global Health Library and websites of relevant organizations. We followed standard systematic review methodology for the selection, data abstraction, and risk of bias assessment. We assessed the quality of evidence using the GRADE approach. Results Of 14,309 identified citations from databases and organizations' websites, we identified four eligible studies. Two studies used mixed-methods, one used quantitative methods, and one used qualitative methods. The available evidence suggests that information coordination between bodies providing health services in humanitarian crises settings may be effective in improving health systems inputs. There is additional evidence suggesting that management/directive coordination such as the cluster model may improve health system inputs in addition to access to health services. None of the included studies assessed coordination through common representation and framework coordination. The evidence was judged to be of very low quality. Conclusion This systematic review provides evidence of possible effectiveness of information coordination and management/directive coordination between organizations, agencies and bodies providing or financing health services in humanitarian crises. Our findings can inform the research agenda and highlight the need for improving conduct and reporting of research in this field.	[Akl, Elie A.] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon; [Akl, Elie A.; El-Jardali, Fadi] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [El-Jardali, Fadi; Karroum, Lama Bou] Amer Univ Beirut, Dept Hlth Management & Policy, Beirut, Lebanon; [El-Jardali, Fadi] McMaster Univ, McMaster Hlth Forum, Hamilton, ON, Canada; [El-Jardali, Fadi] Amer Univ Beirut, Issam Fares Inst Publ Policy & Int Affairs, Res Advocacy & Publ Policy Making Program, Beirut, Lebanon; [El-Eid, Jamale] Amer Univ Beirut, Med Affairs, Beirut, Lebanon; [Brax, Hneine] Univ St Joseph, Fac Med, Beirut, Lebanon; [Akik, Chaza] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Osman, Mona] Amer Univ Beirut, Dept Family Med, Beirut, Lebanon; [Hassan, Ghayda] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Itani, Mira] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Farha, Aida] Amer Univ Beirut, Saab Med Lib, Beirut, Lebanon; [Pottie, Kevin] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Pottie, Kevin] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Oliver, Sandy] Univ London, Inst Educ, Social Sci Res Unit, Dept Childhood Families & Hlth, London WC1N 1AZ, England	American University of Beirut; McMaster University; American University of Beirut; McMaster University; American University of Beirut; American University of Beirut; Saint Joseph University Beirut; University of London; London School of Hygiene & Tropical Medicine; American University of Beirut; University of Quebec; University of Quebec Montreal; American University of Beirut; American University of Beirut; University of Ottawa; University of Ottawa; University of London; University College London; UCL Institute of Education	Akl, EA (corresponding author), Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon.	ea32@aub.edu.lb	Akik, Chaza/O-5013-2019; Akl, Elie/K-5269-2019; Akl, Elie A/R-2079-2016; Pottie, Kevin/ABC-4385-2020	Akik, Chaza/0000-0002-0654-8750; Akl, Elie A/0000-0002-3444-8618; Itani, Mira/0000-0003-1703-6811; Oliver, Sandy/0000-0001-9571-269X; Farha, Aida/0000-0002-1948-4506	Alliance for Health Policy and Systems Research EA FE; Lebanese National Council for Scientific Research EA	Alliance for Health Policy and Systems Research EA FE; Lebanese National Council for Scientific Research EA	The Alliance for Health Policy and Systems Research EA FE The Lebanese National Council for Scientific Research EA The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abebe AM, 2010, REFUG SURV Q, V29, P28, DOI 10.1093/rsq/hdq029; Ablah E, 2007, AM J INFECT CONTROL, V35, P382, DOI 10.1016/j.ajic.2006.08.007; Ablah E, 2010, J COMMUN HEALTH, V35, P285, DOI 10.1007/s10900-010-9236-7; Abou--Saleh M.T., 2012, ARAB J PSYCHIAT, V23, P178; AbouZahr C, 2005, B WORLD HEALTH ORGAN, V83, P578; Abrams JY, 2013, EPIDEMIOL INFECT, V141, P1276, DOI 10.1017/S0950268812001793; Ager A, 2011, CHILD ABUSE NEGLECT, V35, P1045, DOI 10.1016/j.chiabu.2011.08.004; Altintas KH, 2004, EUR J EMERG MED, V11, P95, DOI 10.1097/01.mej.0000124508.23774.8e; Austin J, 2008, REPROD HEALTH MATTER, V16, P10, DOI 10.1016/S0968-8080(08)31351-2; Ayoya MA, 2013, B WORLD HEALTH ORGAN, V91, P612, DOI 10.2471/BLT.12.113936; Babcock C, 2010, DISASTER MED PUBLIC, V4, P169, DOI 10.1001/dmphp.4.2.169; Baca MJ, 2012, INTERVENTION, V10, P177, DOI 10.1097/WTF.0b013e328355eb59; Baingana F, 2011, INTERVENTION, V9, P291; Barnes PA, 2012, J PUBLIC HEALTH MAN, V18, pE14, DOI 10.1097/PHH.0b013e31822ca424; Bartschi Esther, 2008, Ther Umsch, V65, P36, DOI 10.1024/0040-5930.65.1.36; Bashir Zarnaaz, 2003, J Public Health Manag Pract, V9, P344; Benini AA, 1997, DISASTERS, V21, P335, DOI 10.1111/1467-7717.00066; Bile K. M., 2011, Eastern Mediterranean Health Journal, V17, P981; Bile K M, 2010, East Mediterr Health J, V16 Suppl, pS122; Bile K M, 2010, East Mediterr Health J, V16 Suppl, pS82; Bissell R A, 1994, Prehosp Disaster Med, V9, P96; Borton J, 1996, DISASTERS, V20, P305, DOI 10.1111/j.1467-7717.1996.tb01046.x; Botoseneanu A, 2011, J PUBLIC HEALTH-UK, V33, P361, DOI 10.1093/pubmed/fdq092; Bremer Rannveig, 2003, Prehosp Disaster Med, V18, P372; Burkle F M Jr, 1995, Prehosp Disaster Med, V10, P48; Burkle FM, CRIT CARE MED, V33, pS7; Buse K, 1996, HLTH POLICY, V38; Celik S, 2010, DISASTERS, V34, P137, DOI 10.1111/j.1467-7717.2009.01118.x; Center for Systematic Review On Health Policy and Systems Research (SPARK), 2013, PRIOR SETT M; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P799; Centers for Disease Control and Prevention School Health, 2011, MMWR RECOMMENDATIONS; [陈竺 Chen Zhu], 2012, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V12, P383; Comfort LK, 2004, AM BEHAV SCI, V48, P295, DOI 10.1177/0002764204268987; Connolly MiA., 2007, TUBERCULOSIS CARE CO; Curtis CA, 2008, COMMUNICATION COORDI; Dar OA, 2011, PREHOSP DISASTER MED, V26, P212, DOI 10.1017/S1049023X11006261; Dhillon P, 2012, PLOS CURRENTS; Dolan B, 2011, J EMERG NURS, V37, P506, DOI 10.1016/j.jen.2011.06.009; Dominguez PM, 2012, METAS ENFERMERIA, V15, P72; Donev D, 2002, CROAT MED J, V43, P184; DOW AAC, 1991, CRIT CARE CLIN, V7, P257, DOI 10.1016/S0749-0704(18)30305-1; Drifmeyer J, 2004, MIL MED, V169, P161, DOI 10.7205/MILMED.169.3.161; Eloul L, 2013, INTERVENTION, V11, P340, DOI 10.1097/wtf.0000000000000011; Elsayed E. A., 2004, Morbidity and Mortality Weekly Report, V53, P897; Emgushov O, 2008, PUBLIC HEALTH REP, V123, P371, DOI 10.1177/003335490812300317; Evidence Aid Priority Setting Group (EAPSG), 2013, PRIOR THEM RES QUEST; Gudi A, 2010, EFFECTIVE KNOWLEDGE, P4354; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Haar RJ, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-13; Hector LJ, 2011, PLANNING MODEL DISAS; HENDERSON PL, 1983, INT J HEALTH SERV, V13, P289, DOI 10.2190/QGL7-V3U2-39D6-TELY; Hossain L, 2010, DISASTERS, V34, P755, DOI 10.1111/j.1467-7717.2010.01168.x; Hunter JC, 2012, PLOS CURRENTS; Jalali R, 2002, DISASTERS, V26, P120, DOI 10.1111/1467-7717.00196; James T, 2012, WORLD MED HEALTH POL, V4, DOI 10.1515/1948-4682.14; Kapucu N, 2011, INT J EMERG MANAG, V8, P1, DOI 10.1504/IJEM.2011.040395; Khankeh HR, 2011, PREHOSP DISASTER MED, V26, P151, DOI 10.1017/S1049023X11006200; Kirkpatrick DV, 2007, J HEALTH CARE POOR U, V18, P299, DOI 10.1353/hpu.2007.0037; Kirsch T, 2012, DISASTER MED PUBLIC, V6, P200, DOI 10.1001/dmp.2012.48; Kolaczinski J, 2005, TROP MED INT HEALTH, V10, P888, DOI 10.1111/j.1365-3156.2005.01466.x; Kruke BI, 2012, DISASTERS, V36, P212, DOI 10.1111/j.1467-7717.2011.01255.x; Landegger J, 2011, INT HEALTH, V3, P108, DOI 10.1016/j.inhe.2011.03.005; Lanjouw S, 1999, HEALTH POLICY PLANN, V14, P229, DOI 10.1093/heapol/14.3.229; Lee VJ, 2006, PREHOSP DISASTER MED, V21, pS8, DOI 10.1017/S1049023X00015818; Leidel L, 2013, MMWR-MORBID MORTAL W, V62, P709; Libal K, 2011, J IMMIGR REFUG STUD, V9, P162, DOI 10.1080/15562948.2011.567153; Liu J, 2013, INT J EMERG MANAG, V9, P187, DOI 10.1504/IJEM.2013.058541; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Maese J, 2009, PREHOSPITAL DISASTER, V24, P73, DOI 10.1017/S1049023X00006579; Magloire R., 2010, Morbidity and Mortality Weekly Report, V59, P939; Male Serge, 1996, World Health Statistics Quarterly, V49, P221; Marklund LA, 2010, PREHOSP DISASTER MED, V25, P399, DOI 10.1017/S1049023X00008451; Marshall CS, KAOHSIUNG J MED SCI, V24, pS39; Marshall LW, AM J DISASTER MED, V3, P181; Martchenke J, 1995, Prehosp Disaster Med, V10, P225; Matsumoto H, 2013, PREHOSP DISASTER MED, V28, P166, DOI 10.1017/S1049023X12001835; McCabe OL, 2013, PREHOSP DISASTER MED, V28, P8, DOI 10.1017/S1049023X12001483; McCann DGC, 2011, WORLD MED HLTH POLIC, V3; Medecins du Monde, 2014, SYR ACC SANT POP DEP; Medecins du Monde, 2013, SYR URG DEUX APR; Medecins du Monde, 2013, SYR TOD ONL BOMBS AC; Medecins du Monde, 2014, HAITI RED THERE MORT; Medecins du Monde, 2014, NEPAL RENF ACC UT SE; Meynard J B, 2005, Med Trop (Mars), V65, P113; Miller CW, 2011, HEALTH PHYS, V101, P559, DOI 10.1097/HP.0b013e31822552d7; Minear L CU, UN COORDINATION INT; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montoya D, CMAJ, V137, P68; Moore S, 2003, DISASTERS, V27, P305, DOI 10.1111/j.0361-3666.2003.00235.x; Motamedi MH, 2009, CARE FOUNDATION, V24, P453; Myers Laura, 2010, J Bus Contin Emer Plan, V4, P338; O'Connell R, 2012, INTERVENTION, V10, P171, DOI 10.1097/WTF.0b013e3283561e64; O'Heir J, 2004, INTERAGENCY GLOBAL E; Oh N, 2014, J COMP POLICY ANAL R; Ondos EJ, 2008, EXAMINATION INFORM T; Patel A, 2013, J GEN INTERN MED, V28, pS446; Peake JB, 2006, MIL MED, V171, P27, DOI 10.7205/MILMED.171.1S.27; RAHMAN MO, 1993, SOC SCI MED, V36, P903, DOI 10.1016/0277-9536(93)90082-F; Rechel B, 2010, SOC SCI MED, V70, P1928, DOI 10.1016/j.socscimed.2010.02.029; Reindorp N., 2001, HUMANITARIAN COORDIN; Rey F., 1999, COMPLEX NATURE ACTOR; Rietjens SJ, 2009, DISASTERS, V33, P412, DOI 10.1111/j.1467-7717.2008.01081.x; Robert WD, 2007, STRENGHTENING PROTEC; Shearer D, 2007, DISASTERS, V31, P336, DOI 10.1111/j.1467-7717.2007.01012.x; Shen Ji, 2012, J Evid Based Med, V5, P75, DOI 10.1111/j.1756-5391.2012.01176.x; Stephenson M, 2005, DISASTERS, V29, P337, DOI 10.1111/j.0361-3666.2005.00296.x; Stumpenhorst M, 2011, J PUBLIC HEALTH-HEID, V19, P587, DOI 10.1007/s10389-011-0417-3; Subbarao I, 2010, J CLIN ETHIC, V21, P328; Tan NT, 2013, J SOC WORK DISABIL R, V12, P145, DOI 10.1080/1536710X.2013.784606; Tapia AH, 2012, INFORM TECHNOL PEOPL, V25, P240, DOI 10.1108/09593841211254312; Telford J, 2007, DISASTERS, V31, P1, DOI 10.1111/j.1467-7717.2007.00337.x; The SPHERE Project, 2014, HUM CHART MIN STAND; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; Troy DA, 2008, DISASTERS, V32, P149, DOI 10.1111/j.1467-7717.2007.01032.x; United Nations, 2013, SYR REG RSP PLAN RE; United Nations, 2008, REP COMM EN UN REL; United Nations High Commissioner for Refugees, 2014, REF FIG; United Nations High Commissioner for Refugees, 2014, 2014 SYR REG RESP PL; United Nations High Commissioner for Refugees, 1995, REF HLTH; United Nations High Commissioner for Refugees, 2008, ANN REP URB FACT SHE; United Nations High Commissioner for Refugees, 2014, SYR REG REF RESP; United Nations High Commissioner for Refugees, 2007, COUNTR OP PLAN 2007; United Nations High Commissioner for Refugees, 2011, ANN REP 2010 PUBL HL; United Nations High Commissioner for Refugees, 2007, HLTH NUTR HIV AIDS N; United Nations High Commissioner for Refugees, 2013, SYR REG RESP PLAN EG; United Nations High Commissioner for Refugees, 2006, HIV AIDS INT DISPL; United Nations High Commissioner for Refugees, 1999, REP CONS UNHCR HUM H; United Nations High Commissioner for Refugees, 2008, FIGHT HUNG MALN UNHC; United Nations High Commissioner for Refugees, 2007, PUBL HLTH MISS; United Nations High Commissioner for Refugees, 2001, REPROD HLTH GUID; United Nations High Commissioner for Refugees, 2012, UPD COOR ISSU STRAT; United Nations High Commissioner for Refugees, 2008, ANN REP PUBL HLTH HI; United Nations High Commissioner for Refugees, 2014, INT DISPL PEOPL FIG; United Nations High Commissioner for Refugees, 2012, LEB UPD SIT N LEB; United Nations Office for the Coordination of Humanitarian Affairs UN OCHA, 2014, CLUST COORD; United Nations Relief and Works Agency for Palestine Refugees, 2011, FIELD IMPL 2010 2011; United Nations Relief and Works Agency for Palestine Refugees, 2011, ANN REP DEP HLTH 201; United Nations Relief and Works Agency for Palestine Refugees, 2013, FIELD IMPL PLAN 2014; United Nations Relief and Works Agency for Palestine Refugees, 2013, HLTH DEP ANN REP 201; United Nations Relief and Works Agency for Palestine Refugees in the Near East, 2009, EM APP NO LEB FIN RE; United Nations-Economic and Social Council, 2000, STRENGTH COORD EM HU; United Nations-Economic and Social Council, 2001, STRENGTH COORD EM HU; Vayrynen R, 2001, INT MIGR REV, V35, P143; White C, 2004, ASSESSMENT CHANGE TI; Wiedrich TW, 2013, J PUBLIC HEALTH MAN, V19, P259, DOI 10.1097/PHH.0b013e3182641b39; World Health Organization, 2009, PROT HLTH VULN PEOPL; World Health Organization-Regional Office of the Mediterranean, 2008, MAN WHO HUM RESP FIE; World Health Organization-Regional Office of the Mediterranean, 2010, COUNTR COOPE STRAT; World Health Organization-Regional Office of the Mediterranean, 2003, COUNTR COOP STRAT HW; Yanay U, 2011, DISASTERS, V35, P183, DOI 10.1111/j.1467-7717.2010.01199.x; Yang YNE, 2010, DISASTERS, V34, P112, DOI 10.1111/j.1467-7717.2009.01117.x; Zahner SJ, 2005, PUBLIC HEALTH REP, V120, P76, DOI 10.1177/003335490512000113; Zoraster Richard M, 2010, Am J Disaster Med, V5, P215; Zoraster RM, 2006, CARE FOUNDATION, V21, ps13	155	15	16	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137159	10.1371/journal.pone.0137159	http://dx.doi.org/10.1371/journal.pone.0137159			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26332670	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000360613800103
J	Bonner, K; Welch, E; Elder, K; Cohn, J				Bonner, Kimberly; Welch, Emily; Elder, Kate; Cohn, Jennifer			Impact of Pneumococcal Conjugate Vaccine Administration in Pediatric Older Age Groups in Low and Middle Income Countries: A Systematic Review	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; STREPTOCOCCUS-PNEUMONIAE; IMMUNOGENICITY; CHILDREN; SAFETY; MENINGITIS; QUALITY; GRADE	Introduction Pneumococcal conjugate vaccine (PCV) is included in the World Health Organization's routine immunization schedule and is recommended by WHO for vaccination in high-risk children up to 60 months. However, many countries do not recommend vaccination in older age groups, nor have donors committed to supporting extended age group vaccination. To better inform decision-making, this systematic review examines the direct impact of extended age group vaccination in children over 12 months in low and middle income countries. Methods An a priori protocol was used. Using pre-specified terms, a search was conducted using PubMed, LILACS, Cochrane Infectious Diseases Group Specialized Register, Cochrane Central Register of Controlled Trials, CAB Abstracts, clinicaltrials.gov and the International Symposium on Pneumococci and Pneumococcal Diseases abstracts. The primary outcome was disease incidence, with antibody titers and nasopharyngeal carriage included as secondary outcomes. Results Eighteen studies reported on disease incidence, immune response, and nasopharyngeal carriage. PCV administered after 12 months of age led to significant declines in invasive pneumococcal disease. Immune response to vaccine type serotypes was significantly higher for those vaccinated at older ages than the unimmunized at the established 0.2ug/ml and 0.35ug/ml thresholds. Vaccination administered after one year of age significantly reduced VT carriage with odds ratios ranging from 0.213 to 0.69 over four years. A GRADE analysis indicated that the studies were of high quality. Discussion PCV administration in children over 12 months leads to significant protection. The direct impact of PCV administration, coupled with the large cohort of children missed in first year vaccination, indicates that countries should initiate or expand PCV immunization for extended age group vaccinations. Donors should support implementation of PCV as part of delayed or interrupted immunization for older children. For countries to effectively implement extended age vaccinations, access to affordably-priced PCV is critical.	[Bonner, Kimberly; Cohn, Jennifer] Access Campaign, Medecins Sans Frontieres, Geneva, Switzerland; [Elder, Kate] Access Campaign, Medecins Sans Frontieres, New York, NY USA; [Welch, Emily] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Cohn, Jennifer] Univ Penn, Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA	Doctors Without Borders; Boston University; University of Pennsylvania	Cohn, J (corresponding author), Access Campaign, Medecins Sans Frontieres, Geneva, Switzerland.	Jecohn6@gmail.com		Bonner, Kimberly/0000-0002-6942-4050				Andrade AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098128; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; [Anonymous], 2014, WHO UNICEF COV EST 2; Bosch-Capblanch X, 2012, TROP MED INT HEALTH, V17, P697, DOI 10.1111/j.1365-3156.2012.02989.x; Pirez MC, 2011, PEDIATR INFECT DIS J, V30, P669, DOI 10.1097/INF.0b013e3182152bf1; CDC, VACC CHILDR PROGR CD; Costa Isabel de Camargo, 2008, Rev. Saúde Pública, V42, P844, DOI 10.1590/S0034-89102008005000048; de Waroux OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086136; Dicko A, 2012, ISPPD 8; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Domingues CM, 2014, ISPPD 9, V9; Dotres CP, 2014, VACCINE, V32, P5266, DOI 10.1016/j.vaccine.2014.06.094; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hammitt LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085459; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hornshoj L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001509; Iriso R, 2008, ANN TROP PAEDIATR, V28, P211, DOI 10.1179/146532808X335660; Klugman KP, 2014, LANCET GLOB HEALTH, V2, pE365, DOI 10.1016/S2214-109X(14)70241-4; Lagos RM, 2011, HUM VACCINES, V7, P511, DOI 10.4161/hv.7.5.14634; Laiwani S, 2014, CLIN VACCINE IMMUNOL, V21, P1292, DOI 10.1128/CVI.00068-14; Makenga G, 2014, ISPPD 9; Mohamud AN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-865; Musher DM, 2012, CLIN INFECT DIS, V55, P265, DOI 10.1093/cid/cis364; Odusanya OO, 2014, HUM VACC IMMUNOTHER, V10, P757, DOI 10.4161/hv.27276; Ota MOC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042997; PAHO, REV FUND PRIC 2014 V; Poolman JT, 2010, CLIN VACCINE IMMUNOL, V17, P134, DOI 10.1128/CVI.00289-09; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Roca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072198; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Thanee C, 2011, VACCINE, V29, P5886, DOI 10.1016/j.vaccine.2011.06.072; UNICEF, SUPPL LOG GAVI; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Watanabe H, 2007, INTERNAL MED, V46, P1395, DOI 10.2169/internalmedicine.46.0149; Wells G, NEWCASTLE OTTAWA QUA; World Health Organization, 2014, GLOB IMM DAT	39	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135270	10.1371/journal.pone.0135270	http://dx.doi.org/10.1371/journal.pone.0135270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332848	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800025
J	Maixenchs, M; Boene, H; Anselmo, R; Mindu, C; Alonso, P; Menendez, C; Macete, E; Pool, R; Letang, E; Naniche, D; Munguambe, K				Maixenchs, Maria; Boene, Helena; Anselmo, Rui; Mindu, Carolina; Alonso, Pedro; Menendez, Clara; Macete, Eusebio; Pool, Robert; Letang, Emilio; Naniche, Denise; Munguambe, Khatia			Post-ART Symptoms Were Not the Problem: A Qualitative Study on Adherence to ART in HIV-Infected Patients in a Mozambican Rural Hospital	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; BARRIERS; TANZANIA; METAANALYSIS; CHALLENGES; SERVICES; DISTRICT; DISEASE	Objective The objective of this qualitative study was to explore how clinical symptoms may affect adherence to antiretroviral therapy (ART) in HIV patients, and to explore factors, perceptions and attitudes related to adherence to therapy. Design A qualitative study was carried out in the context of the prospective cohort study "Evaluation of Immune Reconstitution Following Initiation of Highly Active Antiretroviral Treatment in Manhica, Mozambique". In-depth Interviews were conducted twice in a sub-sample of the study cohort (51 participants), at six-month intervals. Results Most participants (73%) knew that AIDS is a chronic disease and that ART does not cure it. Nine participants (18%) were non-adherent at some point and two (4%) abandoned ART. All participants but five reported having symptoms after starting ART, mainly attributed to pills needing time to act and body's reaction to the treatment. In spite of the perceived severity of the symptoms, only two people reported they discontinued the treatment due to symptoms. Almost all participants reported feeling comfortable with the HIV clinic organization and procedures, but afraid of staff being hostile if they did not follow the rules or if the health worker visited their home. Family was one of the most important source of support according participants. Almost all participants with children said that a decisive factor to follow the treatment was the desire to be able to look after them. Conclusions Experiencing symptoms after starting treatment was not a barrier to adherence to ART. Factors related to adherence included control measures set up by the health facility (exhaustive follow up, support, information) and family and community support. Indirect ART-related expenses did jeopardise adherence.	[Maixenchs, Maria; Boene, Helena; Anselmo, Rui; Mindu, Carolina; Macete, Eusebio; Munguambe, Khatia] CISM, Manhica, Mozambique; [Maixenchs, Maria; Alonso, Pedro; Menendez, Clara; Pool, Robert; Letang, Emilio; Naniche, Denise] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Munguambe, Khatia] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique; [Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Letang, Emilio] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	Centro de Investigacao em Saude de Manhica; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Eduardo Mondlane University; University of Amsterdam; University of Basel; Swiss Tropical & Public Health Institute	Maixenchs, M (corresponding author), CISM, Manhica, Mozambique.	maria.maixenchs@manhica.net	Menéndez, Clara/Q-3446-2016; Alonso, Pedro L/AAZ-3645-2020; Naniche, Denise S/S-1814-2018	Menéndez, Clara/0000-0002-2641-6907; Alonso, Pedro L/0000-0003-3292-3443; Naniche, Denise S/0000-0002-4495-6325; Maixenchs, Maria/0000-0002-5782-8197	Fundacio "la Caixa''; Agencia Catalana de Cooperacio al Desenvolupament (ACCD); Spanish Agency for International Cooperation and Development; Spanish Ministry of Education and Science (Ramon y Cajal)	Fundacio "la Caixa''(La Caixa FoundationEuropean Commission); Agencia Catalana de Cooperacio al Desenvolupament (ACCD); Spanish Agency for International Cooperation and Development(Spanish Government); Spanish Ministry of Education and Science (Ramon y Cajal)(Spanish Government)	Financial support was received from the Fundacio "la Caixa'' and the Agencia Catalana de Cooperacio al Desenvolupament (ACCD). The Centro de Investigacao em Saude de Manhica receives core funding from the Spanish Agency for International Cooperation and Development. DN was supported by a grant from the Spanish Ministry of Education and Science (Ramon y Cajal). Funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; [Anonymous], EP FACT SHEETS HIV A; [Anonymous], 2003, ADHERENCE LONG TERM; Audu B, 2014, AIDS CARE, V26, P270, DOI 10.1080/09540121.2013.819410; Baranoski AS, 2014, AIDS CARE, V26, P26, DOI 10.1080/09540121.2013.802282; Barfod TS, 2006, HIV MED, V7, P285, DOI 10.1111/j.1468-1293.2006.00387.x; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053; Grant E, 2008, AIDS CARE, V20, P1155, DOI 10.1080/09540120701854634; Hardon A., 2006, ACCESS ADHERENCE CHA; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Instituto Nacional de Estadistica, 2007, TERC REC GER POP HAB; Letang E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016946; Letang E, 2010, JAIDS-J ACQ IMM DEF, V53, P589, DOI 10.1097/QAI.0b013e3181bc476f; Lyimo RA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-716; Merten S, 2010, TROP MED INT HEALTH, V15, P16, DOI 10.1111/j.1365-3156.2010.02510.x; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Murray LK, 2009, AIDS CARE, V21, P78, DOI 10.1080/09540120802032643; Nachega JB, 2012, PATIENT PREFER ADHER, V6, P887, DOI 10.2147/PPA.S38897; National AIDS Council-Republic of Mozambique, 2012, GLOB AIDS RESP PROGR; Ncama BP, 2008, INT J NURS STUD, V45, P1757, DOI 10.1016/j.ijnurstu.2008.06.006; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Nyanzi-Wakholi B, 2012, AIDS CARE, V24, P137, DOI 10.1080/09540121.2011.596518; Olowookere SA, 2008, J INFECT DEV COUNTR, V2, P369; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Rasschaert F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-364; Republica de Mozambique, 2008, ROND VIG EP HIV 2007; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Tomori C, 2014, AIDS CARE, V26, P907, DOI 10.1080/09540121.2013.861574; *UNAIDS WHO, 2008, REP GLOB AIDS EP; UNAIDS-WHO, 2014, GAP REP; UNGASS, 2010, UN GEN ASS SPEC SESS; Vervoort SCJM, 2007, AIDS, V21, P271, DOI 10.1097/QAD.0b013e328011cb20; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Watt MH, 2009, SOC SCI MED, V68, P1793, DOI 10.1016/j.socscimed.2009.02.037; Zaidi J, 2012, AIDS, V29, P997	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137336	10.1371/journal.pone.0137336	http://dx.doi.org/10.1371/journal.pone.0137336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26332680	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800123
J	Snyder, SM; Howard, MO				Snyder, Susan M.; Howard, Matthew O.			Patterns of Inhalant Use among Incarcerated Youth	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LATENT CLASS ANALYSIS; SUBSTANCE USE; ADOLESCENTS; PREVALENCE; DISORDERS; ALCOHOL; ADULTS	Inhalant use is especially prevalent among antisocial youth and can have serious health consequences. However, the extant literature has not investigated how use of various inhalants may co-occur among incarcerated youth. This study begins to address this gap in the literature by using latent class analyses to form distinct typologies of inhalant use. Study participants were residents (N = 723) of 27 Missouri Division of Youth Services facilities. Interviews assessed psychiatric symptoms, antisocial traits, delinquency, trauma, suicidality, and substance use behaviors. The mean age of the mostly male, ethnically diverse sample was 15.5 (S. D. = 1.2) years old. The study revealed the following classes of inhalant use: (1) severe polyinhalant use; (2) moderate polyinhalant use; (3) gas and permanent marker use; and (4) low-use. Compared to the low-use class, members of the severe polyinhalant use class had experienced more than double the rate of head injuries, the highest rates of traumatic experiences, and the highest rates of mental illness diagnoses. The gas and markers class had the highest rate of reporting hearing voices, followed by the severe polyinhalant use class, and the moderate polyinhalant use class. Results of this study underscore the need to address the high rate of head injuries and mental health diagnoses that contribute to severe polyinhalant use.	[Snyder, Susan M.] Georgia State Univ, Sch Social Work, Atlanta, GA 30303 USA; [Howard, Matthew O.] Univ N Carolina, Sch Social Work, Chapel Hill, NC USA	University System of Georgia; Georgia State University; University of North Carolina; University of North Carolina Chapel Hill	Snyder, SM (corresponding author), Georgia State Univ, Sch Social Work, Atlanta, GA 30303 USA.	ssnyder7@gsu.edu	Snyder, Susan M/AAN-2386-2021	Snyder, Susan M/0000-0002-6909-336X				[Anonymous], [No title captured]; Barnes GM, 2002, J DRUG ISSUES, V32, P153, DOI 10.1177/002204260203200107; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; Elliott DS, 1989, MULTIPLE PROBLEM YOU; Freedenthal S, 2007, DRUG ALCOHOL DEPEN, V90, P81, DOI 10.1016/j.drugalcdep.2007.02.021; Garland EL, 2011, EXP CLIN PSYCHOPHARM, V19, P134, DOI 10.1037/a0022859; Grisso T., 2000, MASSACHUSETTS YOUTH; Hatcher L., 2003, STEP BY STEP BASIC S; Howard MO, 2008, DRUG ALCOHOL DEPEN, V93, P197, DOI 10.1016/j.drugalcdep.2007.08.023; Howard Matthew O, 2011, Addict Sci Clin Pract, V6, P18; Howard MO, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-8; Howard MO, 1999, ADDICT BEHAV, V24, P59, DOI 10.1016/S0306-4603(98)00039-2; Johnston L., 2015, MONITORING FUTURE NA; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; Lanza S. T., 2003, HDB PSYCHOL RES METH, V2, P663, DOI [DOI 10.1002/0471264385.WEI0226, 10.1002/0471264385.wei0226]; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; McCutcheon A.L., 2002, APPL LATENT CLASS AN, P56, DOI [10.1017/ CBO9780511499531.003, DOI 10.1017/CBO9780511499531.003]; Mitchell M. L., 2012, RES DESIGN EXPLAINED, V8th; National Institute on Drug Abuse, 2012, NAT I DRUG AB RES RE; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Newson R, 2003, STATA J, V3, P109, DOI 10.1177/1536867X0300300202; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; Sickmund M, 2002, JUVENILE OFFENDERS R; Snyder S. M., 2013, J SOC SOC WORK RES, V4, P214, DOI [10.5243/jsswr.2013.15, DOI 10.5243/JSSWR.2013.15]; Snyder SM, SUBSTANCE A IN PRESS; Snyder SM, SUBST USE M IN PRESS; Snyder SM, 2015, SUBST USE MISUSE, V50, P226, DOI 10.3109/10826084.2014.966845; Snyder SM, 2014, J PSYCHOACTIVE DRUGS, V46, P188, DOI 10.1080/02791072.2014.914610; Snyder SM, 2013, CHILD YOUTH SERV REV, V35, P753, DOI 10.1016/j.childyouth.2013.01.021; Tofighi D, 2008, ADVANCES IN LATENT VARIABLE MIXTURE MODELS, P317; Vitacco MJ, 2003, ASSESSMENT, V10, P143, DOI 10.1177/1073191103010002005; Whitt A, 2012, J PSYCHOACTIVE DRUGS, V44, P365, DOI 10.1080/02791072.2012.736803; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wu LT, 2007, DRUG ALCOHOL DEPEN, V88, P146, DOI 10.1016/j.drugalcdep.2006.10.012; Wu LT, 2006, DRUG ALCOHOL DEPEN, V85, P1, DOI 10.1016/j.drugalcdep.2006.01.017; Yang CC, 2006, COMPUT STAT DATA AN, V50, P1090, DOI 10.1016/j.csda.2004.11.004	41	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135303	10.1371/journal.pone.0135303	http://dx.doi.org/10.1371/journal.pone.0135303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26333159	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800028
J	Dong, YL; Li, C; Tao, Y; Zhang, BY				Dong, Yali; Li, Cong; Tao, Yi; Zhang, Boyu			Evolution of Conformity in Social Dilemmas	PLOS ONE			English	Article							TIT-FOR-TAT; ITERATED PRISONERS-DILEMMA; ZERO-DETERMINANT STRATEGIES; CONDITIONAL COOPERATION; EXTORTION; DYNAMICS; EMERGENCE; NETWORKS; PLAYERS; HUMANS	People often deviate from their individual Nash equilibrium strategy in game experiments based on the prisoner's dilemma (PD) game and the public goods game (PGG), whereas conditional cooperation, or conformity, is supported by the data from these experiments. In a complicated environment with no obvious "dominant" strategy, conformists who choose the average strategy of the other players in their group could be able to avoid risk by guaranteeing their income will be close to the group average. In this paper, we study the repeated PD game and the repeated m-person PGG, where individuals' strategies are restricted to the set of conforming strategies. We define a conforming strategy by two parameters, initial action in the game and the influence of the other players' choices in the previous round. We are particularly interested in the tit-for-tat (TFT) strategy, which is the well-known conforming strategy in theoretical and empirical studies. In both the PD game and the PGG, TFT can prevent the invasion of non-cooperative strategy if the expected number of rounds exceeds a critical value. The stability analysis of adaptive dynamics shows that conformity in general promotes the evolution of cooperation, and that a regime of cooperation can be established in an AllD population through TFT-like strategies. These results provide insight into the emergence of cooperation in social dilemma games.	[Dong, Yali] Beijing Normal Univ, Sch Stat, Beijing 100875, Peoples R China; [Li, Cong] Univ Montreal, Dept Math & Stat, Montreal, PQ H3C 3J7, Canada; [Tao, Yi] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol, Beijing, Peoples R China; [Zhang, Boyu] Beijing Normal Univ, Sch Math Sci, Minist Educ, Lab Math & Complex Syst, Beijing 100875, Peoples R China	Beijing Normal University; Universite de Montreal; Chinese Academy of Sciences; Institute of Zoology, CAS; Beijing Normal University	Zhang, BY (corresponding author), Beijing Normal Univ, Sch Math Sci, Minist Educ, Lab Math & Complex Syst, Beijing 100875, Peoples R China.	zhangby@bnu.edu.cn		Tao, Yi/0000-0002-0749-6614; Li, Cong/0000-0002-7201-4140	National Natural Science Foundation of China [31270439, 11471311, 11301032]; "Fundamental Research Funds for the Central Universities" of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Fundamental Research Funds for the Central Universities" of China(Fundamental Research Funds for the Central Universities)	This research received financial support from the National Natural Science Foundation of China [http://www.nsfc.gov.cn/], no. 31270439, no. 11471311 and no. 11301032) and "the Fundamental Research Funds for the Central Universities" of China [http://www.mof.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3193; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bentley A, 2011, SIMPLICITY-DES TECHN, P1; BERNHEIM BD, 1994, J POLIT ECON, V102, P841, DOI 10.1086/261957; BOYD R, 1987, NATURE, V327, P58, DOI 10.1038/327058a0; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Cao ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049441; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; Chaudhuri A, 2011, EXP ECON, V14, P47, DOI 10.1007/s10683-010-9257-1; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Duersch P, 2014, INT J GAME THEORY, V43, P25, DOI 10.1007/s00182-013-0370-1; Duersch P, 2012, GAME ECON BEHAV, V76, P88, DOI 10.1016/j.geb.2012.05.002; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; FUDENBERG D, 1992, J ECON THEORY, V57, P420, DOI 10.1016/0022-0531(92)90044-I; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Grujic J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04615; Grujic J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047718; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Hauert C, 1997, P ROY SOC B-BIOL SCI, V264, P513, DOI 10.1098/rspb.1997.0073; Hilbe C, 2015, J THEOR BIOL, V374, P115, DOI 10.1016/j.jtbi.2015.03.032; Hilbe C, 2014, P NATL ACAD SCI USA, V111, P16425, DOI 10.1073/pnas.1407887111; Hilbe C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4976; Hilbe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077886; Hilbe C, 2013, P NATL ACAD SCI USA, V110, P6913, DOI 10.1073/pnas.1214834110; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Imhof LA, 2005, P NATL ACAD SCI USA, V102, P10797, DOI 10.1073/pnas.0502589102; Keser C, 2000, SCAND J ECON, V102, P23, DOI 10.1111/1467-9442.00182; Kirchkamp O, 2007, GAME ECON BEHAV, V58, P269, DOI 10.1016/j.geb.2006.04.002; Kurokawa S, 2009, P ROY SOC B-BIOL SCI, V276, P1379, DOI 10.1098/rspb.2008.1546; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; Le S, 2007, J THEOR BIOL, V245, P258, DOI 10.1016/j.jtbi.2006.09.016; Ledyard O., 1995, HDB EXPT EC; Maynard Smith J., 1982, pi; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK M, 1990, ACTA APPL MATH, V20, P247, DOI 10.1007/BF00049570; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Pinheiro FL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003945; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; Rand DG, 2014, P NATL ACAD SCI USA, V111, P17093, DOI 10.1073/pnas.1400406111; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Sigmund K., 2010, CALCULUS SELFISHNESS; Stewart AJ, 2013, P NATL ACAD SCI USA, V110, P15348, DOI 10.1073/pnas.1306246110; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1299; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vilone D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00686; Wahl LM, 1999, J THEOR BIOL, V200, P323, DOI 10.1006/jtbi.1999.0997; Wahl LM, 1999, J THEOR BIOL, V200, P307, DOI 10.1006/jtbi.1999.0996; Wilson EO, 2000, SOCIAL BIOL THE NEW; Wu JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06421; Zhang B, PREPRINT	67	7	7	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137435	10.1371/journal.pone.0137435	http://dx.doi.org/10.1371/journal.pone.0137435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26327137	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700115
J	Gaynes, JA; Otsuna, H; Campbell, DS; Manfredi, JP; Levine, EM; Chien, CB				Gaynes, John A.; Otsuna, Hideo; Campbell, Douglas S.; Manfredi, John P.; Levine, Edward M.; Chien, Chi-Bin			The RNA Binding Protein Igf2bp1 Is Required for Zebrafish RGC Axon Outgrowth In Vivo	PLOS ONE			English	Article							ACTIN MESSENGER-RNA; BETA-ACTIN; CELL-MIGRATION; GROWTH CONES; SIGNALING MECHANISMS; ARBOR FORMATION; VG1 RBP; LOCALIZATION; TRANSLATION; EXPRESSION	Attractive growth cone turning requires Igf2bp1-dependent local translation of beta-actin mRNA in response to external cues in vitro. While in vivo studies have shown that Igf2bp1 is required for cell migration and axon terminal branching, a requirement for Igf2bp1 function during axon outgrowth has not been demonstrated. Using a timelapse assay in the zebrafish retinotectal system, we demonstrate that the beta-actin 3'UTR is sufficient to target local translation of the photoconvertible fluorescent protein Kaede in growth cones of pathfinding retinal ganglion cells (RGCs) in vivo. Igf2bp1 knockdown reduced RGC axonal outgrowth and tectal coverage and retinal cell survival. RGC-specific expression of a phosphomimetic Igf2bp1 reduced the density of axonal projections in the optic tract while sparing RGCs, demonstrating for the first time that Igf2bp1 is required during axon outgrowth in vivo. Therefore, regulation of local translation mediated by Igf2bp proteins may be required at all stages of axon development.	[Gaynes, John A.; Levine, Edward M.; Chien, Chi-Bin] Univ Utah, Med Ctr, Program Neurosci, Salt Lake City, UT 84112 USA; [Gaynes, John A.; Otsuna, Hideo; Campbell, Douglas S.; Levine, Edward M.; Chien, Chi-Bin] Univ Utah, Med Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Gaynes, John A.; Levine, Edward M.] Univ Utah, Med Ctr, Dept Ophthalmol Visual Sci, John A Moran Ctr, Salt Lake City, UT USA; [Campbell, Douglas S.] Max Planck Inst Brain Res, Frankfurt, Germany; [Manfredi, John P.] Sfida BioLog Inc, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Max Planck Society	Levine, EM (corresponding author), Univ Utah, Med Ctr, Program Neurosci, Salt Lake City, UT 84112 USA.	ed.levine@utah.edu	Levine, Edward/N-3878-2015	Levine, Edward/0000-0003-1725-2805; Campbell, Douglas/0000-0002-7371-9484	National Institutes of Health (NIH) [EY012873, EY013760]; NEI Vision Core grant [P30-EY014800]; Research to Prevent Blindness, Inc.; Sfida BioLogic, Inc.; NATIONAL EYE INSTITUTE [P30EY014800, R01EY012873, R01EY013760] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI Vision Core grant; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Sfida BioLogic, Inc.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by National Institutes of Health (NIH) (http://www.nih.gov) grants EY012873 to Chi-Bin Chien, EY013760 to Ed Levine, and NEI Vision Core grant P30-EY014800. This work was supported in part by an unrestricted grant to the Department of Ophthalmology & Visual Sciences by Research to Prevent Blindness, Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sfida BioLogic, Inc. provided support in the form of salary for the author JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Baraban M, 2013, J NEUROSCI, V33, P15726, DOI 10.1523/JNEUROSCI.1510-13.2013; Caceres A, 2012, CURR OPIN CELL BIOL, V24, P547, DOI 10.1016/j.ceb.2012.05.011; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; De Felice E, 2014, J ANAT, V224, P564, DOI 10.1111/joa.12168; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Donnelly CJ, 2013, J NEUROSCI, V33, P3311, DOI 10.1523/JNEUROSCI.1722-12.2013; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Git A, 2002, RNA, V8, P1319, DOI 10.1017/S135583820202705X; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hornberg H, 2013, J NEUROSCI, V33, P10384, DOI 10.1523/JNEUROSCI.5858-12.2013; Hornberg H, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00081; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kalous A, 2014, DEV NEUROBIOL, V74, P303, DOI 10.1002/dneu.22110; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Leung KM, 2008, NAT PROTOC, V3, P1318, DOI 10.1038/nprot.2008.113; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Leung LC, 2013, NAT NEUROSCI, V16, P166, DOI 10.1038/nn.3290; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Manns RPC, 2012, J NEUROSCI, V32, P8554, DOI 10.1523/JNEUROSCI.5964-11.2012; Oberman F, 2007, RNA, V13, P1558, DOI 10.1261/rna.559507; Patel VL, 2012, GENE DEV, V26, P43, DOI 10.1101/gad.177428.111; Piper M, 2006, NEURON, V49, P215, DOI 10.1016/j.neuron.2005.12.008; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Randlett O, 2011, NEURON, V70, P266, DOI 10.1016/j.neuron.2011.03.013; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Stohr N, 2012, CELL ADHES MIGR, V6, P312, DOI 10.4161/cam.20628; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Tada M, 2012, DEVELOPMENT, V139, P3897, DOI 10.1242/dev.073007; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vacaru AM, 2014, J CELL SCI, V127, P485, DOI 10.1242/jcs.140194; Wan Y, 2012, IEEE PAC VIS SYMP, P201, DOI 10.1109/PacificVis.2012.6183592; Welshhans K, 2011, J NEUROSCI, V31, P9800, DOI 10.1523/JNEUROSCI.0166-11.2011; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zhang QH, 1999, MECH DEVELOP, V88, P101, DOI 10.1016/S0925-4773(99)00162-8; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	53	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0134751	10.1371/journal.pone.0134751	http://dx.doi.org/10.1371/journal.pone.0134751			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325373	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700014
J	Hirano, M; Satake, W; Ihara, K; Tsuge, I; Kondo, S; Saida, K; Betsui, H; Okubo, K; Sakamoto, H; Ueno, S; Ikuno, Y; Ishihara, R; Iwahashi, H; Ohishi, M; Mano, T; Yamashita, T; Suzuki, Y; Nakamura, Y; Kusunoki, S; Toda, T				Hirano, Makito; Satake, Wataru; Ihara, Kenji; Tsuge, Ikuya; Kondo, Shuji; Saida, Ken; Betsui, Hiroyuki; Okubo, Kazuhiro; Sakamoto, Hikaru; Ueno, Shuichi; Ikuno, Yasushi; Ishihara, Ryu; Iwahashi, Hiromi; Ohishi, Mitsuru; Mano, Toshiyuki; Yamashita, Toshihide; Suzuki, Yutaka; Nakamura, Yusaku; Kusunoki, Susumu; Toda, Tatsushi			The First Nationwide Survey and Genetic Analyses of Bardet-Biedl Syndrome in Japan	PLOS ONE			English	Article							MUTATIONS; DIAGNOSIS; PATIENT; BBS1	Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities. The causative genes have been identified as BBS1-19. In Western countries, this disease is often reported, but remains undiagnosed in many patients until later in life, while only a few patients with no mutations identified have been reported in Japan. We thus conducted the first nationwide survey of BBS in Japan by sending questionnaires to 2,166 clinical departments with board-certified specialists and found 7 patients with clinically definite BBS. We performed exome analyses combined with analyses of mRNA and protein in these patients. We identified 2 novel mutations in the BBS5 gene (p.R89X and IVS7-27 T>G) in 2 sibling patients. The latter mutation that resided far from the authentic splicing site was associated with skipping of exon 8. We also found 3 previously reported mutations in the BBS2 (p.R413X and p.R480X) and BBS7 (p.C243Y) genes in 2 patients. To our knowledge, a nationwide survey of BBS has not been reported in any other country. In addition, this is the first study to identify genetic alterations in Japanese patients with BBS. Our results indicate that BBS in Japan is genetically heterogeneous and at least partly shares genetic features with BBS in other countries.	[Hirano, Makito; Sakamoto, Hikaru; Ueno, Shuichi; Nakamura, Yusaku] Kinki Univ, Sakai Hosp, Fac Med, Dept Neurol, Sakai, Osaka, Japan; [Hirano, Makito; Ueno, Shuichi; Kusunoki, Susumu] Kinki Univ, Fac Med, Dept Neurol, Osakasayama, Japan; [Satake, Wataru; Toda, Tatsushi] Kobe Univ, Div Neurol Mol Brain Sci, Grad Sch Med, Kobe, Hyogo 657, Japan; [Ihara, Kenji; Okubo, Kazuhiro] Kyushu Univ, Grad Sch Med, Dept Pediat, Fukuoka 812, Japan; [Tsuge, Ikuya] Fujita Hlth Univ, Dept Pediat, Toyoake, Aichi, Japan; [Kondo, Shuji] Univ Tokushima, Dept Pediat, Tokushima 770, Japan; [Saida, Ken] Natl Ctr Child Hlth & Dev, Dept Nephrol, Tokyo, Japan; [Betsui, Hiroyuki] Haga Red Cross Hosp, Dept Pediat, Mooka, Tochigi, Japan; [Ikuno, Yasushi] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan; [Ishihara, Ryu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Gastrointestinal Oncol, Osaka, Japan; [Iwahashi, Hiromi] Osaka Univ, Dept Metab Med, Grad Sch Med, Suita, Osaka, Japan; [Ohishi, Mitsuru] Osaka Univ, Dept Geriatr Med, Grad Sch Med, Suita, Osaka, Japan; [Mano, Toshiyuki] Osaka Med Ctr, Dept Pediat Neurol, Izumi, Japan; [Mano, Toshiyuki] Res Inst Maternal & Child Hlth, Izumi, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kobe University; Kyushu University; Fujita Health University; Tokushima University; National Center for Child Health & Development - Japan; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; University of Tokyo	Hirano, M (corresponding author), Kinki Univ, Sakai Hosp, Fac Med, Dept Neurol, Sakai, Osaka, Japan.	hirano_makito@yahoo.co.jp	/ABA-5207-2021; Ihara, Kenji/AAE-3890-2020	/0000-0002-4686-6147; Ihara, Kenji/0000-0002-8831-1991; Yamashita, Toshihide/0000-0003-4559-7018	Ministry of Education, Culture, Sports, Science and Technology of Japan [25461297]; Health and Labour Science Research Grants (Research in Intractable Diseases) [10103346]; Grants-in-Aid for Scientific Research [25461297, 24591515, 26461613] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Science Research Grants (Research in Intractable Diseases); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MH recieved Grants-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25461297) and Health and Labour Science Research Grants (Research in Intractable Diseases, 10103346).	Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Hirano M, 2011, CLIN MED INSIGHT-CAS, V4, P17, DOI 10.4137/CCRep.S6622; Iannello S, 2002, Obes Rev, V3, P123, DOI 10.1046/j.1467-789X.2002.00055.x; Janssen S, 2011, HUM GENET, V129, P79, DOI 10.1007/s00439-010-0902-8; NAKAMURA F, 1990, J GASTROEN HEPATOL, V5, P206, DOI 10.1111/j.1440-1746.1990.tb01826.x; Saida K, 2014, BRAIN DEV-JPN, V36, P721, DOI 10.1016/j.braindev.2013.10.013; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Tonomura Y, 2009, CLIN NEUROL NEUROSUR, V111, P102, DOI 10.1016/j.clineuro.2008.08.008; Wang J, 2002, MOL CELL, V10, P951, DOI 10.1016/S1097-2765(02)00635-4; Wang X, 2013, J MED GENET, V50, P674, DOI 10.1136/jmedgenet-2013-101558; Yamada K, 2000, PEDIATR NEUROSURG, V33, P323, DOI 10.1159/000055979; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041	14	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136317	10.1371/journal.pone.0136317	http://dx.doi.org/10.1371/journal.pone.0136317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325687	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700038
J	Levy-Shraga, Y; Cohen, R; Ben Ami, M; Yeshayahu, Y; Temam, V; Modan-Moses, D				Levy-Shraga, Yael; Cohen, Rinat; Ben Ami, Michal; Yeshayahu, Yonatan; Temam, Vered; Modan-Moses, Dalit			Sun Exposure and Protection Habits in Pediatric Patients with a History of Malignancy	PLOS ONE			English	Article							VITAMIN-D INSUFFICIENCY; SKIN-CANCER PREVENTION; CHILDHOOD-CANCER; ADULT SURVIVORS; ULTRAVIOLET-RADIATION; ADOLESCENT CANCER; HEALTH BEHAVIORS; D DEFICIENCY; SUNLIGHT; CHILDREN	Background Survivors of childhood cancer are at high risk for developing non-melanoma skin cancer and therefore are firmly advised to avoid or minimize sun exposure and adopt skin protection measures. We aimed to compare sun exposure and protection habits in a cohort of pediatric patients with a history of malignancy to those of healthy controls. Methods Case-control study of 143 pediatric patients with a history of malignancy (aged 11.2 +/- 4.6y, Male = 68, mean interval from diagnosis 4.4 +/- 3.8y) and 150 healthy controls (aged 10.4 +/- 4.8y, Male = 67). Sun exposure and protection habits were assessed using validated questionnaires. Results Patients and controls reported similar sun exposure time during weekdays (94 +/- 82minutes/day vs. 81 +/- 65minutes/day; p = 0.83), while during weekends patients spent significantly less time outside compared to controls (103 +/- 85minutes/day vs. 124 +/- 87minutes/day; p = 0.02). Time elapsed from diagnosis positively correlated with time spent outside both during weekdays (r = 0.194, p = 0.02) and weekends (r = 0.217, p = 0.01), and there was a step-up in sun exposure starting three years after diagnosis. There was no significant difference regarding composite sun protection score between patients and controls. Age was positively correlated with number of sunburns per year and sun exposure for the purpose of tanning, and was negatively correlated with the use of sun protection measures. Conclusions Although childhood cancer survivors are firmly instructed to adopt sun protection habits, the adherence to these instructions is incomplete, and more attention should be paid to improve these habits throughout their lives. Since sunlight avoidance may results in vitamin D deficiency, dietary supplementation will likely be needed.	[Levy-Shraga, Yael; Ben Ami, Michal; Yeshayahu, Yonatan; Modan-Moses, Dalit] Chaim Sheba Med Ctr, Pediat Endocrinol Unit, Edmond & Lily Safra Childrens Hosp, IL-52621 Ramat Gan, Israel; [Cohen, Rinat] Meuhedet Hlth Serv, Primary Care Div, Tel Aviv, Israel; [Levy-Shraga, Yael; Ben Ami, Michal; Yeshayahu, Yonatan; Modan-Moses, Dalit] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Temam, Vered] Edmond & Lily Safra Childrens Hosp, Dept Pediat Hematol Oncol, Ramat Gan, Israel; [Temam, Vered] Edmond & Lily Safra Childrens Hosp, BMT, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Levy-Shraga, Y (corresponding author), Chaim Sheba Med Ctr, Pediat Endocrinol Unit, Edmond & Lily Safra Childrens Hosp, IL-52621 Ramat Gan, Israel.	yael.levy.shraga@gmail.com	Yeshayahu, Yonatan/Y-8019-2019	Yeshayahu, Yonatan/0000-0002-3864-9898	late Alter Jacob Israel and Layla environment and epidemiologic research Foundation; Israel Cancer association	late Alter Jacob Israel and Layla environment and epidemiologic research Foundation; Israel Cancer association	The study was supported by the late Alter Jacob Israel and Layla environment and epidemiologic research Foundation and the Israel Cancer association.	Armstrong BK, 2004, CANC PREV CANC CAUSE, V3, P89; Balk SJ, 2011, PEDIATRICS, V127, pE791, DOI [10.1542/peds.2010-3502, 10.1542/peds.2010-3501]; Banerjee P, 2003, MOL CELL BIOCHEM, V253, P247, DOI 10.1023/A:1026072118217; Branstrom R, 2010, CANCER EPIDEM BIOMAR, V19, P2199, DOI 10.1158/1055-9965.EPI-10-0196; Buchanan N, 2009, CANCER-AM CANCER SOC, V115, P4374, DOI 10.1002/cncr.24581; Choudhary A, 2013, PEDIATR BLOOD CANCER, V60, P1237, DOI 10.1002/pbc.24403; Dusza SW, 2012, PEDIATRICS, V129, P309, DOI 10.1542/peds.2011-0104; Esbenshade AJ, 2014, PEDIATR BLOOD CANCER, V61, P723, DOI 10.1002/pbc.24844; Glanz K, 2008, ARCH DERMATOL, V144, P217, DOI 10.1001/archdermatol.2007.46; Glanz K, 2010, AM J PUBLIC HEALTH, V100, P735, DOI 10.2105/AJPH.2008.155705; Helou M, 2014, J PEDIAT HEMATOL ONC, V36, P212, DOI 10.1097/MPH.0b013e31829f3754; Hennessy A, 2013, P NUTR SOC, V72, P433, DOI 10.1017/S002966511300339X; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Kaluski DN, 2003, ISR MED ASSOC J, V5, P277; Kyle RG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005137; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Larcombe I, 2002, BRIT J CANCER, V87, P1204, DOI 10.1038/sj.bjc.6600632; Linet Martha S., 2014, Journal of the National Cancer Institute Monographs, P26, DOI 10.1093/jncimonographs/lgu006; Macdonald HM, 2013, CALCIFIED TISSUE INT, V92, P163, DOI 10.1007/s00223-012-9634-1; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Modan-Moses D, 2012, PEDIATR RES, V72, P620, DOI 10.1038/pr.2012.131; Mullin GE, 2007, NUTR CLIN PRACT, V22, P305, DOI 10.1177/0115426507022003305; Ordonez-Moran P, 2005, FRONT BIOSCI-LANDMRK, V10, P2723, DOI 10.2741/1731; Palesh O, 2014, SUPPORT CARE CANCER, V22, P2973, DOI 10.1007/s00520-014-2286-0; Perkins JL, 2005, J CLIN ONCOL, V23, P3733, DOI 10.1200/JCO.2005.06.237; Rebholz CE, 2012, BRIT J CANCER, V107, P234, DOI 10.1038/bjc.2012.250; Reichrath J, 2009, BRIT J DERMATOL, V161, P54, DOI 10.1111/j.1365-2133.2009.09450.x; Robien K, 2011, BONE MARROW TRANSPL, V46, P1472, DOI 10.1038/bmt.2010.326; Simmons J, 2013, PEDIATR BLOOD CANCER, V60, P2025, DOI 10.1002/pbc.24684; Tercyak KP, 2006, PEDIATR BLOOD CANCER, V47, P825, DOI 10.1002/pbc.20602; Tsur A, 2011, OSTEOPOROSIS INT, V22, P2895, DOI 10.1007/s00198-010-1492-y; van Ginkel PR, 2007, J NEURO-ONCOL, V85, P255, DOI 10.1007/s11060-007-9418-z; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Watt TC, 2012, J NATL CANCER I, V104, P1240, DOI 10.1093/jnci/djs298; Zeichner SB, 2014, CLIN BREAST CANCER	35	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137453	10.1371/journal.pone.0137453	http://dx.doi.org/10.1371/journal.pone.0137453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348212	gold, Green Submitted, Green Published			2022-12-27	WOS:000360897600045
J	Tanigawa, T; Shibata, R; Kondo, K; Katahira, N; Kambara, T; Inoue, Y; Nonoyama, H; Horibe, Y; Ueda, H; Murohara, T				Tanigawa, Tohru; Shibata, Rei; Kondo, Kazuhisa; Katahira, Nobuyuki; Kambara, Takahiro; Inoue, Yoko; Nonoyama, Hiroshi; Horibe, Yuichiro; Ueda, Hiromi; Murohara, Toyoaki			Soybean beta-Conglycinin Prevents Age-Related Hearing Impairment	PLOS ONE			English	Article							ADIPONECTIN; COCHLEA; TISSUE	Obesity-related complications are associated with the development of age-related hearing impairment. beta-Conglycinin (beta-CG), one of the main storage proteins in soy, offers multiple health benefits, including anti-obesity and anti-atherosclerotic effects. Here, to elucidate the potential therapeutic application of beta-CG, we investigated the effect of beta-CG on age-related hearing impairment. Male wild-type mice (age 6 months) were randomly divided into beta-CG-fed and control groups. Six months later, the body weight was significantly lower in beta-CG-fed mice than in the controls. Consumption of beta-CG rescued the hearing impairment observed in control mice. Cochlear blood flow also increased in beta-CG-fed mice, as did the expression of eNOS in the stria vascularis (SV), which protects vasculature. beta-CG consumption also ameliorated oxidative status as assessed by 4-HNE staining. In the SV, lipofuscin granules of marginal cells and vacuolar degeneration of microvascular pericytes were decreased in beta-CG-fed mice, as shown by transmission electron microscopy. beta-CG consumption prevented loss of spiral ganglion cells and reduced the frequencies of lipofuscin granules, nuclear invaginations, and myelin vacuolation. Our observations indicate that beta-CG ameliorates age-related hearing impairment by preserving cochlear blood flow and suppressing oxidative stress.	[Tanigawa, Tohru; Katahira, Nobuyuki; Nonoyama, Hiroshi; Horibe, Yuichiro; Ueda, Hiromi] Aichi Med Univ, Dept Otolaryngol, Nagakute, Aichi, Japan; [Shibata, Rei; Kondo, Kazuhisa; Kambara, Takahiro; Inoue, Yoko; Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Aichi Medical University; Nagoya University	Tanigawa, T (corresponding author), Aichi Med Univ, Dept Otolaryngol, Nagakute, Aichi, Japan.	tanigawa@aichi-med-u.ac.jp; rshibata@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014					Adams MR, 2004, J NUTR, V134, P511, DOI 10.1093/jn/134.3.511; Ahn JH, 2008, NEUROREPORT, V19, P1265, DOI 10.1097/WNR.0b013e328308b338; Aoyama T, 2001, BIOSCI BIOTECH BIOCH, V65, P1071, DOI 10.1271/bbb.65.1071; Cheng AG, 1999, BRAIN RES, V850, P234, DOI 10.1016/S0006-8993(99)01983-6; CULLEN JR, 1993, J LARYNGOL OTOL, V107, P179, DOI 10.1017/S0022215100122571; Dalton DS, 1998, DIABETES CARE, V21, P1540, DOI 10.2337/diacare.21.9.1540; Ferreira ES, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-11; Fujimoto C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/582849; Guo YK, 2005, HEARING RES, V208, P54, DOI 10.1016/j.heares.2005.05.010; Hwang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060730; Hwang JH, 2012, INT J AUDIOL, V51, P920, DOI 10.3109/14992027.2012.721933; JERGER J, 1995, J AM GERIATR SOC, V43, P928, DOI 10.1111/j.1532-5415.1995.tb05539.x; Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; Kim TS, 2014, CLIN ENDOCRINOL, V80, P368, DOI 10.1111/cen.12184; Kinoshita M, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/325702; Kohno M, 2006, J ATHEROSCLER THROMB, V13, P247, DOI 10.5551/jat.13.247; Lamm K, 1996, Audiol Neurootol, V1, P148; Liu W, 2000, J CELL SCI, V113, P635; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Naganuma H, 2014, AURIS NASUS LARYNX, V41, P249, DOI 10.1016/j.anl.2013.12.004; Nishi T, 2003, J NUTR, V133, P352, DOI 10.1093/jn/133.2.352; Seidman MD, 2002, AGEING RES REV, V1, P331, DOI 10.1016/S1568-1637(02)00004-1; Someya S, 2007, NEUROBIOL AGING, V28, P1613, DOI 10.1016/j.neurobiolaging.2006.06.024; Suzuki K, 2000, LARYNGOSCOPE, V110, P1736, DOI 10.1097/00005537-200010000-00033; Tachibana N, 2010, BIOSCI BIOTECH BIOCH, V74, P1250, DOI 10.1271/bbb.100088; Tanigawa T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.140; Vasilyeva ON, 2009, HEARING RES, V249, P44, DOI 10.1016/j.heares.2009.01.007; Velasquez Manuel T, 2007, Int J Med Sci, V4, P72; Zhu SS, 2008, ORL-J OTO-RHIN-LARYN, V70, P373, DOI 10.1159/000163033	31	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137493	10.1371/journal.pone.0137493	http://dx.doi.org/10.1371/journal.pone.0137493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348726	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600049
J	Weller, S; Florentine, S; Sillitoe, J; Grech, C; McLaren, D; Chauhan, BS				Weller, Sandra; Florentine, Singarayer; Sillitoe, James; Grech, Charles; McLaren, David; Chauhan, Bhagirath Singh			Detecting the Seeds of Nassella neesiana in Large Round Hay Bales, by Means of Non-Destructive Core Sampling	PLOS ONE			English	Article							DISPERSAL; PASTURES; DYNAMICS; ECOLOGY; STORAGE; LOSSES; GRASS	In the last three decades or so there has been a significant increase in fodder trading, both in terms of the quantity of fodder traded and in terms of its economic value to the industry. Often, this fodder type may be supplied free of charge to graziers in distress due to circumstances that follow natural disasters such as bushfires, drought, and flood. However, because of the obvious urgency arising from these situations, it is suspected that much relief fodder may unintentionally pose an elevated risk for dispersal of weeds since it may be supplied from pasture not normally used for trade in fodder, and therefore is of unknown quality. Previous destructive method to detect weed propagules in bales of fodder are cumbersome, time consuming and of limited ecological and statistical value. Therefore, objective of this paper was to development of a convenient method to assess round pasture hay bales for the presence of weed propagules, to prevent unintentional spread of noxious species in hay bales. To examine this objective known quantity of seeds were added in a series of distributions to bales of seed free pasture hay, and a positive correlation for the amount of seed added per bale with that recovered in core samples was observed. Whilst the number of seeds detected per bale varied according to the distribution of seeds within the bales and the number of cores analysed, the absolute detection of seeds suggests that this sampling method is worthy of further examination. In addition, a pragmatic estimation of bale remnants after stock feeding has been investigated to more closely estimate the potential size of the remaining seed bank. The authors propose that development of this approach is timely, in the light of future climatic uncertainty driving extreme weather events that increase the need for relief fodder, which can be a potential vector for the spread of noxious weed seeds.	[Weller, Sandra; Florentine, Singarayer] Federat Univ Australia, Ctr Environm Management, Fac Sci & Technol, Mt Helen, Vic, Australia; [Sillitoe, James] Federat Univ, Res Serv, Mt Helen, Vic, Australia; [Grech, Charles; McLaren, David] Dept Environm & Primary Ind, Bundoora, Vic, Australia; [Chauhan, Bhagirath Singh] Univ Queensland, QAAFI, Toowoomba, Qld, Australia	Federation University Australia; Federation University Australia; University of Queensland	Florentine, S (corresponding author), Federat Univ Australia, Ctr Environm Management, Fac Sci & Technol, Mt Helen, Vic, Australia.	s.florentine@federation.edu.au	Florentine, Singarayer/Q-7198-2019; Florentine, Singarayer/ABA-7740-2020; Chauhan, Bhagirath/G-8892-2014	Florentine, Singarayer/0000-0002-5734-3421; Chauhan, Bhagirath/0000-0003-1540-4668; Weller, Sandra/0000-0003-4204-8582	Department of Environment and Primary Industries; Federation University Australia	Department of Environment and Primary Industries; Federation University Australia	This study was supported by the Department of Environment and Primary Industries to SF; Federation University Australia, PhD Scholarship to SW.	AFIA, 2007, AN AFIA LAB MAN REF, P8; Aljoe H, SAMPLING HAY STANDIN; BELYEA RL, 1985, J DAIRY SCI, V68, P3371, DOI 10.3168/jds.S0022-0302(85)81250-9; BOURDOT GW, 1992, NEW ZEAL J AGR RES, V35, P101; Bureau of Meterology, CLIM DAT ONL; Buskirk DD, 2003, J ANIM SCI, V81, P109; Clines J, 2005, P P CAL INV PLANTS C, P4; COBLE CG, 1987, BIOMASS, V14, P209, DOI 10.1016/0144-4565(87)90048-5; Collins M, 2000, HAY SAMPLING PRINCIP; Conn JS, 2010, INVAS PLANT SCI MANA, V3, P276, DOI 10.1614/IPSM-D-09-00041.1; DPI, INF IMP FODD NSW; DWLBC, BUYING FODD AR YOU G; FOREMAN DB, 1993, FLORA VICTORIA; Gardener M. R., 1998, BIOL NASSELLA NEESIA; Gardener MR, 2003, AUST J AGR RES, V54, P621, DOI 10.1071/AR01076; Invasive Species Council, VICT BUSHF COULD PAV; Kienzle LC, 1944, TOOL SAMPLING BALED, p[409, 592]; Marble VL, 1989, 19 CAL ALF S 6 7 DEC, P92; Martin P, 2009, AUSTR FODDER IND OVE; McIntyre GA, 1978, MEASUREMENT GRASSLAN, P8; McIntyre S, 2005, AUST J BOT, V53, P757, DOI 10.1071/BT05088; MCIVOR JG, 1987, AUST J EXP AGR, V27, P283, DOI 10.1071/EA9870283; MEYER JH, 1959, J ANIM SCI, V18, P1223, DOI 10.2527/jas1959.1841233x; NORDSKOG AW, 1945, J ANIM SCI, V4, P113, DOI 10.2527/jas1945.42113x; North American Weed Management Association, 2006, MIN CERT STAND N AM; Orloff S, 1999, 29 CAL ALF S 8 9 DEC, P120; PEART MH, 1979, J ECOL, V67, P843, DOI 10.2307/2259218; Schoenig S, 2007, CERTIFIED WEED FREE; Sheaffer CC, 2000, AGRON J, V92, P64, DOI 10.1007/s100870050008; Sindel BM, 2009, FINAL REPORT PATHWAY; Sinden Jack, 2005, Plant Protection Quarterly, V20, P25; STAMP NE, 1984, J ECOL, V72, P611, DOI 10.2307/2260070; THOMAS AG, 1984, J AUST I AGR SCI, V50, P103; Trounce B, 2007, WEED STRATEGIES FOLL; Vila M, 2000, J ECOL, V88, P479, DOI 10.1046/j.1365-2745.2000.00460.x; Weller S, 2015, CROP PROT, V70, P21, DOI 10.1016/j.cropro.2014.12.014; Weston PH, 1993, FLORA NEW S WALES, V4, P133; Wollner HJ, 1941, IND ENG CHEM, V13, P0883, DOI 10.1021/i560100a007	38	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137343	10.1371/journal.pone.0137343	http://dx.doi.org/10.1371/journal.pone.0137343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348493	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600038
J	Durkin, J; Bissett, J; Pahlavani, M; Mooney, B; Buchwaldt, L				Durkin, Jonathan; Bissett, John; Pahlavani, Mohammadhadi; Mooney, Brent; Buchwaldt, Lone			IGS Minisatellites Useful for Race Differentiation in Colletotrichum lentis and a Likely Site of Small RNA Synthesis Affecting Pathogenicity	PLOS ONE			English	Article							INTERGENIC SPACER REGION; RIBOSOMAL-RNA; SCLEROTINIA-SCLEROTIORUM; RFLP ANALYSIS; TRUNCATUM; SEQUENCE; FUSARIUM; DNA; RDNA; IDENTIFICATION	Colletotrichum lentis is a fungal pathogen of lentil in Canada but rarely reported elsewhere. Two races, Ct0 and Ct1, have been identified using differential lines. Our objective was to develop a PCR-probe differentiating these races. Sequences of the translation elongation factor 1 alpha (tef1 alpha), RNA polymerase II subunit B2 (rpb2), ATP citrate lyase subunit A (acla), and internal transcribed spacer (ITS) regions were monomorphic, while the intergenic spacer (IGS) region showed length polymorphisms at two minisatellites of 23 and 39 nucleotides (nt). A PCR-probe (39F/R) amplifying the 39 nt minisatellite was developed which subsequently revealed 1-5 minisatellites with 1-12 repeats in C. lentis. The probe differentiated race Ct1 isolates having 7, 9 or 7+9 repeats from race Ct0 having primarily 2 or 4 repeats, occasionally 5, 6, or 8, but never 7 or 9 repeats. These isolates were collected between 1991 and 1999. In a 2012 survey isolates with 2 and 4 repeats increased from 34% to 67%, while isolated with 7 or 9 repeats decreased from 40 to 4%, likely because Ct1 resistant lentil varieties had been grown. The 39 nt repeat was identified in C. gloeosporioides, C. trifolii, Ascochyta lentis, Sclerotinia sclerotiorum and Botrytis cinerea. Thus, the 39F/R PCR probe is not species specific, but can differentiate isolates based on repeat number. The 23 nt minisatellite in C. lentis exists as three length variants with ten sequence variations differentiating race Ct0 having 14 or 19 repeats from race Ct1 having 17 repeats, except for one isolate. RNA-translation of 23 nt repeats forms hairpins and has the appropriate length to suggest that IGS could be a site of small RNA synthesis, a hypothesis that warrants further investigation. Small RNA from fungal plant pathogens able to silence genes either in the host or pathogen thereby aiding infection have been reported.	[Durkin, Jonathan; Mooney, Brent; Buchwaldt, Lone] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Bissett, John] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada; [Pahlavani, Mohammadhadi] Gorgan Univ Agr Sci, Dept Agron & Plant Breeding, Gorgan, Iran	Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Buchwaldt, L (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada.	Lone.Buchwaldt@agr.gc.ca						Aminnejad M, 2009, AM EURASIAN J AGR EN, V6, P697; ANDERSON K. L., 1999, CAN PLANT DIS SURV, V79, P126; Appel DJ, 1996, MOL PLANT MICROBE IN, V9, P125, DOI 10.1094/MPMI-9-0125; Armstrong-Cho CL, 2006, MYCOL RES, V110, P951, DOI 10.1016/j.mycres.2006.06.002; Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; BALDRIDGE GD, 1992, J MOL EVOL, V35, P514, DOI 10.1007/BF00160212; Buchwaldt L, 2004, PHYTOPATHOLOGY, V94, P236, DOI 10.1094/PHYTO.2004.94.3.236; Buchwaldt L, 1996, PHYTOPATHOLOGY, V86, P1193, DOI 10.1094/Phyto-86-1193; Buchwaldt L, 2013, CAN J PLANT PATHOL, V35, P222, DOI 10.1080/07060661.2013.768296; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Chongo G, 1999, CAN J PLANT PATHOL, V21, P16, DOI 10.1080/07060661.1999.10600116; Clarkson JP, 2013, PLANT PATHOL, V62, P309, DOI 10.1111/j.1365-3059.2012.02635.x; Damm U, 2014, STUD MYCOL, P49, DOI 10.1016/j.simyco.2014.09.003; Diermeier SD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003786; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Ford R, 2004, AUSTRALAS PLANT PATH, V33, P559, DOI 10.1071/AP04058; Forseille L, 2011, CAN J PLANT PATHOL, V33, P512, DOI 10.1080/07060661.2011.619580; Gale LR, 2003, PLANT DIS, V87, P1433, DOI 10.1094/PDIS.2003.87.12.1433; Gossen BD, 2009, CAN J PLANT PATHOL, V31, P65, DOI 10.1080/07060660909507573; Grafenhan T, 2011, STUD MYCOL, P79, DOI 10.3114/sim.2011.68.04; Hinojo MJ, 2004, SYST APPL MICROBIOL, V27, P681, DOI 10.1078/0723202042369938; Hong SG, 2005, MYCOL RES, V109, P87, DOI 10.1017/S0953756204001388; Hoyos-Carvajal L, 2009, FUNGAL GENET BIOL, V46, P615, DOI 10.1016/j.fgb.2009.04.006; Kaiser WJ, 1998, PLANT DIS, V82, P128, DOI 10.1094/PDIS.1998.82.1.128C; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim HJ, 2001, J MICROBIOL, V39, P265; Kim Hyun-Jung, 2004, Mycobiology, V32, P119; KIM WK, 1992, CURR GENET, V22, P101, DOI 10.1007/BF00351468; Konstantinova P, 2004, INT J FOOD MICROBIOL, V95, P321, DOI 10.1016/j.ijfoodmicro.2003.12.010; Latunde-Dada AO, 2007, PLANT PATHOL, V56, P437, DOI 10.1111/j.1365-3059.2007.01576.x; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Llorens A, 2006, ANTON LEEUW INT J G, V89, P465, DOI 10.1007/s10482-005-9045-7; Morrall RAA, 1997, CAN J PLANT PATHOL, V19, P197, DOI 10.1080/07060669709500554; MORRALL RAA, 1988, PLANT DIS, V72, P994, DOI 10.1094/PD-72-0994D; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; Nagarajan Gopal, 2004, The Plant Pathology Journal, V20, P264; Nalim FA, 2009, PHYTOPATHOLOGY, V99, P462, DOI 10.1094/PHYTO-99-4-0462; Nunes CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-288; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pecchia S, 2004, MYCOPATHOLOGIA, V157, P317, DOI 10.1023/B:MYCO.0000024185.66158.7e; Pecchia S, 1998, FEMS MICROBIOL LETT, V166, P21, DOI 10.1111/j.1574-6968.1998.tb13178.x; Pramateftaki PV, 2000, FUNGAL GENET BIOL, V29, P19, DOI 10.1006/fgbi.1999.1178; Qutob D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2354; Roose-Amsaleg C, 2002, MYCOL RES, V106, P918, DOI 10.1017/S0953756202006251; Shaikh R, 2013, GENET RESOUR CROP EV, V60, P193, DOI 10.1007/s10722-012-9825-7; Shiue CN, 2014, NUCLEIC ACIDS RES, V42, P5505, DOI 10.1093/nar/gku183; Silva DN, 2012, MOL ECOL, V21, P2655, DOI 10.1111/j.1365-294X.2012.05557.x; SOMMERVILLE J, 1984, NATURE, V310, P189, DOI 10.1038/310189a0; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOLMSOFF WJ, 1983, ANNU REV PHYTOPATHOL, V21, P317, DOI 10.1146/annurev.py.21.090183.001533; Vandenberg A, 2006, CAN J PLANT SCI, V86, P497, DOI 10.4141/P05-071; Vandenberg A, 2002, CAN J PLANT SCI, V82, P111, DOI 10.4141/P01-003; VENETTE JR, 1994, PLANT DIS, V78, P1216, DOI 10.1094/PD-78-1216D; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137398	10.1371/journal.pone.0137398	http://dx.doi.org/10.1371/journal.pone.0137398			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340001	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200053
J	Haghiac, M; Yang, XH; Presley, L; Smith, S; Dettelback, S; Minium, J; Belury, MA; Catalano, PM; Hauguel-de Mouzon, S				Haghiac, Maricela; Yang, Xiao-hua; Presley, Larraine; Smith, Shoi; Dettelback, Shirley; Minium, Judi; Belury, Martha A.; Catalano, Patrick M.; Hauguel-de Mouzon, Sylvie			Dietary Omega-3 Fatty Acid Supplementation Reduces Inflammation in Obese Pregnant Women: A Randomized Double-Blind Controlled Clinical Trial	PLOS ONE			English	Article							N-3 FATTY-ACIDS; ADIPOSE-TISSUE MATRIX; INSULIN-RESISTANCE; MACROPHAGE ACCUMULATION; EXPRESSION; HUMANS; PURIFICATION; ADIPOCYTES; ADIPOKINES; SECRETION	Objective Long-chain omega 3 fatty acids, eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) exert potent anti-inflammatory properties in humans. This study characterized the effects of omega-3 omega-3 fatty acids supplements (omega-3 FA) on the inflammatory status in the placenta and adipose tissue of overweight/obese pregnant women. Study Design A randomized, double-masked controlled trial was conducted in overweight/obese pregnant women that were randomly assigned to receive DHA plus EPA (2g/day) or the equivalent of a placebo twice a day from week 10-16 to term. Inflammatory pathways were characterized in: 1) adipose tissue and placenta of treated vs. untreated women; and 2) adipose and trophoblast cells cultured with long chain FAs. Results The sum of plasma DHA and EPA increased by 5.8 fold and omega-3 FA/omega-6 FA ratio was 1.5 in treated vs. untreated women (p< 0.005). Plasma CRP concentrations were reduced (p<0.001). The adipose tissue and placenta of treated women exhibited a significant decrease in TLR4 adipose and placental expression as well as IL6, IL8, and TNF alpha In vitro, EPA and DHA suppressed the activation of TLR4, IL6, IL8 induced by palmitate in culture of adipose and trophoblast cells. Conclusion Supplementation of overweight/obese pregnant women with dietary omega-3 FAs for >25 weeks reduced inflammation in maternal adipose and the placental tissue. TLR4 appears as a central target of the anti-inflammatory effects at the cellular level.	[Haghiac, Maricela; Yang, Xiao-hua; Presley, Larraine; Smith, Shoi; Dettelback, Shirley; Minium, Judi; Catalano, Patrick M.; Hauguel-de Mouzon, Sylvie] Metrohlth Med Ctr, Dept Reprod Biol, Ctr Reprod Hlth, Cleveland, OH 44105 USA; [Belury, Martha A.] Ohio State Univ, Dept Human Nutr, Coll Educ & Human Ecol, Columbus, OH 43210 USA	MetroHealth System; University System of Ohio; Ohio State University	Hauguel-de Mouzon, S (corresponding author), Metrohlth Med Ctr, Dept Reprod Biol, Ctr Reprod Hlth, Cleveland, OH 44105 USA.	shdemouzon@metrohealth.org	Catalano, Patrick/GVR-9069-2022		National Institutes of Health award [NIH RHD057236]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	National Institutes of Health award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Institutes of Health award NIH RHD057236 (PMC, SHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Akabas SR, 2006, AM J CLIN NUTR, V83, p1536S, DOI 10.1093/ajcn/83.6.1536S; Bastard JP, 1999, CIRCULATION, V99, P2221; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Belury MA, 1997, LIPIDS, V32, P199, DOI 10.1007/s11745-997-0025-0; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Bowen JM, 2002, PLACENTA, V23, P239, DOI 10.1053/plac.2001.0781; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Carlson SE, 2013, AM J CLIN NUTR, V97, P808, DOI 10.3945/ajcn.112.050021; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Challier JC, 2008, PLACENTA, V29, P274, DOI 10.1016/j.placenta.2007.12.010; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garaulet M, 2006, INT J OBESITY, V30, P899, DOI 10.1038/sj.ijo.0803219; Harper M, 2010, OBSTET GYNECOL, V115, P234, DOI 10.1097/AOG.0b013e3181cbd60e; Hendrich S, 2010, ADV NUTR, V1, P3, DOI 10.3945/an.110.1003; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Katan MB, 1997, J LIPID RES, V38, P2012; KINGSBURY K, 1961, BIOCHEM J, V78, P541, DOI 10.1042/bj0780541; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kromhout D, 2012, CURR OPIN LIPIDOL, V23, P554, DOI 10.1097/MOL.0b013e328359515f; Lombardo YB, 2006, J NUTR BIOCHEM, V17, P1, DOI 10.1016/j.jnutbio.2005.08.002; Luo NL, 2010, DIABETES, V59, P791, DOI 10.2337/db09-1338; McCowen KC, 2005, CURR OPIN GASTROEN, V21, P207, DOI 10.1097/01.mog.0000153361.90653.cb; Melody SM, 2015, PLACENTA, V36, P34, DOI 10.1016/j.placenta.2014.10.013; Perrini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057892; Resi V, 2012, AM J PHYSIOL-ENDOC M, V303, pE832, DOI 10.1152/ajpendo.00002.2012; Saccone G, 2015, AM J OBSTET GYNECOL, V213, P135, DOI 10.1016/j.ajog.2015.03.013; SANJURJO P, 1993, HORM METAB RES, V25, P590, DOI 10.1055/s-2007-1002183; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Sivan E, 1998, J CLIN ENDOCR METAB, V83, P2338, DOI 10.1210/jc.83.7.2338; Staiger H, 2004, DIABETES, V53, P3209, DOI 10.2337/diabetes.53.12.3209; STOFFEL W, 1959, ANAL CHEM, V31, P307, DOI 10.1021/ac60146a047; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Taltavull N, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-31; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; White PJ, 2006, DIABETOLOGIA, V49, P1999, DOI 10.1007/s00125-006-0346-9; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	46	83	83	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137309	10.1371/journal.pone.0137309	http://dx.doi.org/10.1371/journal.pone.0137309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340264	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200045
J	Malcolm, HR; Blount, P				Malcolm, Hannah R.; Blount, Paul			Mutations in a Conserved Domain of E-coli MscS to the Most Conserved Superfamily Residue Leads to Kinetic Changes	PLOS ONE			English	Article							MECHANOSENSITIVE CHANNEL MSCS; BCNG ION CHANNELS; SMALL-CONDUCTANCE; SINGLE RESIDUE; MECHANISM; TENSION; IDENTIFICATION; PURIFICATION; PREFERENCE; FAMILIES	In Escherichia coli (E. coli) the mechanosensitive channel of small conductance, MscS, gates in response to membrane tension created from acute external hypoosmotic shock, thus rescuing the bacterium from cell lysis. E. coli MscS is the most well studied member of the MscS superfamily of channels, whose members are found throughout the bacterial and plant kingdoms. Homology to the pore lining helix and upper vestibule domain of E. coli MscS is required for inclusion into the superfamily. Although highly conserved, in the second half of the pore lining helix (TM3B), E. coli MscS has five residues significantly different from other members of the superfamily. In superfamilies such as this, it remains unclear why variations within such a homologous region occur: is it tolerance of alternate residues, or does it define functional variance within the superfamily? Point mutations (S114I/T, L118F, A120S, L123F, F127E/K/T) and patch clamp electrophysiology were used to study the effect of changing these residues in E. coli MscS on sensitivity and gating. The data indicate that variation at these locations do not consistently lead to wildtype channel phenotypes, nor do they define large changes in mechanosensation, but often appear to effect changes in the E. coli MscS channel gating kinetics.	[Malcolm, Hannah R.; Blount, Paul] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 76390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Blount, P (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 76390 USA.	Paul.Blount@utsouthwestern.edu		Malcolm, Hannah/0000-0001-9792-8494	Welch Foundation [I-1420]; Cancer Prevention & Research Institute of Texas (CPRIT) [RP100146]; National Institutes of Health [GM061028]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061028] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Cancer Prevention & Research Institute of Texas (CPRIT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant I-1420 of the Welch Foundation (Welch1.org), Grant RP100146 from the Cancer Prevention & Research Institute of Texas (CPRIT; http://www.cprit.state.tx.us/), and Grant GM061028 from the National Institutes of Health (NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Akitake B, 2007, NAT STRUCT MOL BIOL, V14, P1141, DOI 10.1038/nsmb1341; Balleza D, 2009, EUR BIOPHYS J BIOPHY, V38, P1013, DOI 10.1007/s00249-009-0460-y; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Belyy V, 2010, NAT STRUCT MOL BIOL, V17, P451, DOI 10.1038/nsmb.1775; Blount P, 1999, Methods Enzymol, V294, P458; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; Blount P, 1997, BIOL BULL, V192, P126, DOI 10.2307/1542585; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; Edwards MD, 2008, BIOPHYS J, V94, P3003, DOI 10.1529/biophysj.107.123448; Edwards MD, 2012, CHANNELS, V6, P272, DOI 10.4161/chan.20998; Haswell ES, 2008, CURR BIOL, V18, P730, DOI 10.1016/j.cub.2008.04.039; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Iscla I, 2011, FASEB J, V25, P694, DOI 10.1096/fj.10-170878; Kamaraju K, 2011, J GEN PHYSIOL, V138, P49, DOI 10.1085/jgp.201110606; Kloda A, 2002, EUR BIOPHYS J BIOPHY, V31, P14, DOI 10.1007/s002490100160; Kloda A, 2001, CELL BIOCHEM BIOPHYS, V34, P349, DOI 10.1385/CBB:34:3:349; Kloda A, 2008, INT J BIOCHEM CELL B, V40, P164, DOI 10.1016/j.biocel.2007.02.003; Koprowski P, 2003, J BIOL CHEM, V278, P11237, DOI 10.1074/jbc.M212073200; Koprowski P, 2011, J BIOL CHEM, V286, P877, DOI 10.1074/jbc.M110.176131; Lai JY, 2013, PROTEIN SCI, V22, P502, DOI 10.1002/pro.2222; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Maksaev G, 2012, P NATL ACAD SCI USA, V109, P19015, DOI 10.1073/pnas.1213931109; Maksaev G, 2011, J GEN PHYSIOL, V138, P641, DOI 10.1085/jgp.201110723; Malcolm HR, 2015, BBA-BIOMEMBRANES, V1848, P159, DOI 10.1016/j.bbamem.2014.10.022; Malcolm HR, 2012, EUR BIOPHYS J BIOPHY, V41, P1003, DOI 10.1007/s00249-012-0855-z; Malcolm HR, 2012, CHEMBIOCHEM, V13, P2037, DOI 10.1002/cbic.201200410; Malcolm HR, 2012, BIOCHEM BIOPH RES CO, V417, P972, DOI 10.1016/j.bbrc.2011.12.049; Malcolm HR, 2011, BIOPHYS J, V101, P345, DOI 10.1016/j.bpj.2011.05.058; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; Nakayama Y, 2014, CELL CALCIUM, V56, P467, DOI 10.1016/j.ceca.2014.10.001; Nakayama Y, 2014, FEMS YEAST RES, V14, P992, DOI 10.1111/1567-1364.12181; Nakayama Y, 2013, BIOPHYS J, V105, P1366, DOI 10.1016/j.bpj.2013.06.054; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Petrov E, 2013, BIOPHYS J, V104, P1426, DOI 10.1016/j.bpj.2013.01.055; Pivetti CD, 2003, MICROBIOL MOL BIOL R, V67, P66, DOI 10.1128/MMBR.67.1.66-85.2003; Rowe I, 2014, J GEN PHYSIOL, V143, P543, DOI 10.1085/jgp.201311114; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; Vasquez V, 2008, SCIENCE, V321, P1210, DOI 10.1126/science.1159674; Vasquez V, 2008, J MOL BIOL, V378, P55, DOI 10.1016/j.jmb.2007.10.086; Vasquez V, 2007, BIOCHEMISTRY-US, V46, P6766, DOI 10.1021/bi700322k; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2	49	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136756	10.1371/journal.pone.0136756	http://dx.doi.org/10.1371/journal.pone.0136756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340270	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200015
J	Bhargava, A; Cotton, JA; Dixon, BR; Gedamu, L; Yates, RM; Buret, AG				Bhargava, Amol; Cotton, James A.; Dixon, Brent R.; Gedamu, Lashitew; Yates, Robin M.; Buret, Andre G.			Giardia duodenalis Surface Cysteine Proteases Induce Cleavage of the Intestinal Epithelial Cytoskeletal Protein Villin via Myosin Light Chain Kinase	PLOS ONE			English	Article							ENTAMOEBA-HISTOLYTICA; CATHEPSIN-B; BARRIER FUNCTION; IN-VITRO; ACTIN CYTOSKELETON; MOLECULAR CHARACTERIZATION; MICROTUBULE NETWORK; ESCHERICHIA-COLI; CELL MIGRATION; GROWTH-FACTOR	Giardia duodenalis infections are among the most common causes of waterborne diarrhoeal disease worldwide. At the height of infection, G. duodenalis trophozoites induce multiple pathophysiological processes within intestinal epithelial cells that contribute to the development of diarrhoeal disease. To date, our understanding of pathophysiological processes in giardiasis remains incompletely understood. The present study reveals a previously unappreciated role for G. duodenalis cathepsin cysteine proteases in intestinal epithelial pathophysiological processes that occur during giardiasis. Experiments first established that Giardia trophozoites indeed produce cathepsin B and L in strain-dependent fashion. Co-incubation of G. duodenalis with human enterocytes enhanced cathepsin production by Assemblage A (NF and S2 isolates) trophozoites, but not when epithelial cells were exposed to Assemblage B (GSM isolate) trophozoites. Direct contact between G. duodenalis parasites and human intestinal epithelial monolayers resulted in the degradation and redistribution of the intestinal epithelial cytoskeletal protein villin; these effects were abolished when parasite cathepsin cysteine proteases were inhibited. Interestingly, inhibition of parasite proteases did not prevent degradation of the intestinal tight junction-associated protein zonula occludens 1 (ZO-1), suggesting that G. duodenalis induces multiple pathophysiological processes within intestinal epithelial cells. Finally, this study demonstrates that G. duodenalis-mediated disruption of villin is, at least, in part dependent on activation of myosin light chain kinase (MLCK). Taken together, this study indicates a novel role for parasite cathepsin cysteine proteases in the pathophysiology of G. duodenalis infections.	[Bhargava, Amol; Cotton, James A.; Gedamu, Lashitew; Buret, Andre G.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Bhargava, Amol; Cotton, James A.; Buret, Andre G.] Univ Calgary, Inflammat Res Network, Calgary, AB, Canada; [Bhargava, Amol; Cotton, James A.; Gedamu, Lashitew; Buret, Andre G.] Univ Calgary, Host Parasite Interact, Calgary, AB, Canada; [Dixon, Brent R.] Hlth Canada, Bur Microbial Hazards, Food Directorate, Hlth Prod & Food Branch, Ottawa, ON K1A 0L2, Canada; [Yates, Robin M.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Yates, Robin M.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; Health Canada; University of Calgary; University of Calgary	Buret, AG (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	aburet@ucalgary.ca	Yates, Robin/K-5032-2015	Yates, Robin/0000-0003-3122-1845	Natural Sciences and Engineering Research Council of Canada (NSERC) CREATE program [413888-2012]; NSERC Discovery grant [183681-2011]; NSERC graduate student scholarship; NSERC gradate student scholarship; Alberta Innovates Health Solutions (AIHS); Crohn's and colitis foundation of Canada (CCFC); Alberta Innovates [201400554] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada (NSERC) CREATE program(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC graduate student scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC gradate student scholarship; Alberta Innovates Health Solutions (AIHS); Crohn's and colitis foundation of Canada (CCFC); Alberta Innovates	AGB's laboratory is funded in part by a training grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) CREATE program, grant #413888-2012 (URL: http://www.nserc-crsng.gc.ca/) and an NSERC Discovery grant, #183681-2011 (URL: http://www.nserc-crsng.gc.ca/). AB is a recipient of an NSERC graduate student scholarship. JAC is a recipient of an NSERC gradate student scholarship and a joint IBD studentship from Alberta Innovates Health Solutions (AIHS) and the Crohn's and colitis foundation of Canada (CCFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; AGGARWAL A, 1989, MOL BIOCHEM PARASIT, V32, P39, DOI 10.1016/0166-6851(89)90127-8; Ankarklev J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001780; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Athman R, 2002, AM J PHYSIOL-GASTR L, V283, pG496, DOI 10.1152/ajpgi.00207.2002; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; AVILA EE, 1993, EXP PARASITOL, V76, P232, DOI 10.1006/expr.1993.1028; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909; Battle SE, 2014, INFECT IMMUN, V82, P3713, DOI 10.1128/IAI.01523-13; Rodriguez-Fuentes GB, 2006, MEM I OSWALDO CRUZ, V101, P693, DOI 10.1590/S0074-02762006000600020; Bilenko N, 2004, EUR J EPIDEMIOL, V19, P877, DOI 10.1023/B:EJEP.0000040533.75646.9c; Bonnin A, 1999, EUR J CELL BIOL, V78, P794, DOI 10.1016/S0171-9335(99)80030-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURET A, 1992, GASTROENTEROLOGY, V103, P506, DOI 10.1016/0016-5085(92)90840-U; BURET A, 1990, J INFECT DIS, V162, P231, DOI 10.1093/infdis/162.1.231; Buret AG, 2002, PARASITOLOGY, V125, P11, DOI 10.1017/S0031182002001853; Busatti HGNO, 2009, BIOL-TARGETS THER, V3, P273; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Coklin T, 2007, VET PARASITOL, V150, P297, DOI 10.1016/j.vetpar.2007.09.014; Coradi ST, 2006, PARASITOL RES, V99, P131, DOI 10.1007/s00436-005-0124-5; Cotton JA, 2014, INFECT IMMUN, V82, P2772, DOI 10.1128/IAI.01771-14; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; de Carvalho TB, 2008, PARASITOL RES, V104, P185, DOI 10.1007/s00436-008-1185-z; de Carvalho TB, 2014, REV INST MED TROP SP, V56, P43, DOI 10.1590/S0036-46652014000100006; DEBEAUREGARD MAC, 1995, EMBO J, V14, P409, DOI 10.1002/j.1460-2075.1995.tb07017.x; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; DuBois KN, 2008, J BIOL CHEM, V283, P18024, DOI 10.1074/jbc.M802133200; DuBois KN, 2006, PARASITOL RES, V99, P313, DOI 10.1007/s00436-006-0149-4; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Elliott DA, 2000, INFECT IMMUN, V68, P2315, DOI 10.1128/IAI.68.4.2315-2322.2000; FAVENNEC L, 1990, PARASITOL RES, V76, P581, DOI 10.1007/BF00932566; FINLAY BB, 1990, J INFECT DIS, V162, P1096, DOI 10.1093/infdis/162.5.1096; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Garcia-Rivera G, 1999, MOL MICROBIOL, V33, P556, DOI 10.1046/j.1365-2958.1999.01500.x; Goosney DL, 1999, EMERG INFECT DIS, V5, P216, DOI 10.3201/eid0502.990205; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Halliez MCM, 2013, WORLD J GASTROENTERO, V19, P8974, DOI 10.3748/wjg.v19.i47.8974; Heimer J, 2015, ACTA TROP, V145, P17, DOI 10.1016/j.actatropica.2015.01.011; Humen MA, 2011, CELL MICROBIOL, V13, P1683, DOI 10.1111/j.1462-5822.2011.01647.x; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; Jacobs T, 1998, MOL MICROBIOL, V27, P269, DOI 10.1046/j.1365-2958.1998.00662.x; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Kissoon-Singh V, 2011, ADV EXP MED BIOL, V712, P62, DOI 10.1007/978-1-4419-8414-2_5; Koh WH, 2013, J PARASITOL, V99, P353, DOI 10.1645/GE-3021.1; Krumkamp R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003568; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Lauwaet T, 2003, J BIOL CHEM, V278, P22650, DOI 10.1074/jbc.M300142200; Lauwaet T, 2010, J ANTIMICROB CHEMOTH, V65, P531, DOI 10.1093/jac/dkp501; Lhocine N, 2015, CELL HOST MICROBE, V17, P164, DOI 10.1016/j.chom.2014.12.003; Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103; Louvard RAD, 2003, MOL BIOL CELL, V14, P4641, DOI 10.1091/mbc.E03-02-0091; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Moncada DM, 2006, GASTROENTEROLOGY, V130, P721, DOI 10.1053/j.gastro.2005.11.012; Muller J, 2006, ANTIMICROB AGENTS CH, V50, P162, DOI 10.1128/AAC.50.1.162-170.2006; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; OLSON ME, 1995, AM J VET RES, V56, P1470; Olson ME, 1997, CAN VET J, V38, P703; Palm D, 2005, MOL BIOCHEM PARASIT, V141, P199, DOI 10.1016/j.molbiopara.2005.03.005; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Ringqvist E, 2008, MOL BIOCHEM PARASIT, V159, P85, DOI 10.1016/j.molbiopara.2008.02.005; Ringqvist E, 2011, INT J PARASITOL, V41, P277, DOI 10.1016/j.ijpara.2010.09.011; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Scott KGE, 2004, INFECT IMMUN, V72, P3536, DOI 10.1128/IAI.72.6.3536-3542.2004; Scott KGE, 2002, GASTROENTEROLOGY, V123, P1179, DOI 10.1053/gast.2002.36002; Solaymani-Mohammadi S, 2013, MUCOSAL IMMUNOL, V6, P369, DOI 10.1038/mi.2012.80; Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200; Stadelmann B, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-256; Stadelmann B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045325; TCHOUPE JR, 1991, BIOCHIM BIOPHYS ACTA, V1076, P149, DOI 10.1016/0167-4838(91)90232-O; Teoh DA, 2000, J PARASITOL, V86, P800; Tomar A, 2006, J BIOL CHEM, V281, P31972, DOI 10.1074/jbc.M604323200; Troeger H, 2007, GUT, V56, P328, DOI 10.1136/gut.2006.100198; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Upcroft JA, 2001, ANTIMICROB AGENTS CH, V45, P1810, DOI 10.1128/AAC.45.6.1810-1814.2001; Veenemans J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001158; Walker' ME, 2008, MICROBES INFECT, V10, P1440, DOI 10.1016/j.micinf.2008.08.014; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Wang YH, 2008, J BIOL CHEM, V283, P9454, DOI 10.1074/jbc.M707962200; Wang YH, 2007, AM J PHYSIOL-CELL PH, V292, pC1775, DOI 10.1152/ajpcell.00420.2006; Ward W, 1997, CELL, V89, P437, DOI 10.1016/S0092-8674(00)80224-X; Wensaas KA, 2012, GUT, V61, P214, DOI 10.1136/gutjnl-2011-300220; WILLIAMS AG, 1995, INT J PARASITOL, V25, P771, DOI 10.1016/0020-7519(94)00201-X; Xu FF, 2012, MOL BIOL EVOL, V29, P2895, DOI 10.1093/molbev/mss107; Yang WM, 2012, VIRUS RES, V163, P269, DOI 10.1016/j.virusres.2011.10.011; Yoder JS, 2010, MMWR SURVEILL SUMM, V59, P15	92	44	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136102	10.1371/journal.pone.0136102	http://dx.doi.org/10.1371/journal.pone.0136102			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334299	gold, Green Published, Green Submitted			2022-12-27	WOS:000360615400010
J	Lai, CT; Yao, WC; Lin, SY; Liu, HY; Chang, HW; Hu, FR; Chen, WL				Lai, Chun-Ting; Yao, Wei-Chieng; Lin, Szu-Yuan; Liu, Hsin-Yu; Chang, Huai-Wen; Hu, Fung-Rong; Chen, Wei-Li			Changes of Ocular Surface and the Inflammatory Response in a Rabbit Model of Short-Term Exposure Keratopathy	PLOS ONE			English	Article							DRY EYE DISEASE; INTENSIVE-CARE-UNIT; HERPES-ZOSTER OPHTHALMICUS; DESICCATING STRESS; SJOGRENS-SYNDROME; CYTOKINE PROFILES; MOUSE MODEL; TEAR FILM; EXPRESSION; ANTIBODY	Purpose To evaluate the ocular surface change and the inflammatory response in a rabbit model of short-term exposure keratopathy. Methods Short term exposure keratopathy by continuous eyelid opening was induced in New Zealand white rabbits for up to 4 hours. Ultrasound pachymetry was used to detect central total corneal thickness. In vivo confocal microscopy and impression cytology were performed to evaluate the morphology of ocular surface epithelium and the infiltration of inflammatory cells. Immunohistochemistry for macrophage, neutrophil, CD4(+) T cells, and CD8(+) T cells were performed to classify the inflammatory cells. Scanning electron microscopy(SEM) was performed to detect ocular surface change. The concentrations of IL-8, IL-17, Line and TNF-alpha were analyzed by multiplex immunobead assay. TUNEL staining was performed to detect cellular apoptosis. Results Significant decrease ofcentral total cornealthickness were found within the first 5 minutes and remained stable thereafter, while there were no changes of corneal epithelial thickness. No significant change of corneal, limbal and conjunctival epithelial morphology was found by in vivo confocal microscopy except the time dependent increase of superficial cellular defects in the central cornea. Impression cytology also demonstrated time dependent increase of sloughing superficial cells of the central cornea. Aggregations ofinflammatory cells were found at 1 hour in the limbal epithelium, 2 hours in the perilimbal conjunctival epithelium, and 3 hours in the peripheral corneal epithelium. In eyes receiving exposure for 4 hours, the infiltration of the inflammatory cells can still be detected at 8 hours after closing eyes. Immunohistochemical study demonstrated the cells to be macrophages, neutrophils, CD4-T cells and CD-8 T cells. SEM demonstrated time-depending increase of intercellular border and sloughing of superficial epithelial cells in corneal surface. Time dependent increase of IL-8, IL-17 and TNF-alpha in tear was found. TUNEL staining revealed some apoptotic cells in the corneal epithelium and superficial stroma at 3 hours after exposure. Conclusions Short term exposure keratopathy can cause significant changes to the ocular surface and inflammatory response. Decrease of central total corneal thickness, aggregation of inflammatory cells, and cornea epithelial cell and superficial keratocyte apoptosis were found no less than 4 hours following the insult.	[Lai, Chun-Ting; Liu, Hsin-Yu; Chang, Huai-Wen; Hu, Fung-Rong; Chen, Wei-Li] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Yao, Wei-Chieng] Min Sheng Gen Hosp, Dept Anesthesia, Taoyuan, Taiwan; [Lin, Szu-Yuan] Cathay Gen Hosp, Deparment Ophthalmol, Taipei, Taiwan; [Hu, Fung-Rong; Chen, Wei-Li] Natl Taiwan Univ Hosp, Ctr Corneal Tissue Engn & Stem Cell Biol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Cathay General Hospital; National Taiwan University; National Taiwan University Hospital	Chen, WL (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	chenweili@ntu.edu.tw		CHEN, WEI-LI/0000-0002-1538-2414; HU, FUNG-RONG/0000-0002-2102-5317	National Taiwan University Hospital Plan Asia One; Department of Medical Research at the NTUH; National Taiwan University Hospital [100001]; Ministry of Science and Technology, Taiwan [NSC 103-2314-B-002-074-MY3]; Min-Sheng General Hospital [100001]	National Taiwan University Hospital Plan Asia One; Department of Medical Research at the NTUH; National Taiwan University Hospital(National Taiwan University); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Min-Sheng General Hospital	Supported, in part, by the National Taiwan University Hospital Plan Asia One and the Department of Medical Research at the NTUH, the Jointed Research Grant between National Taiwan University Hospital and Min-Sheng General Hospital 100001, and Grant NSC 103-2314-B-002-074-MY3 from the Ministry of Science and Technology, Taiwan.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ang RT, 2001, CURR OPIN OPHTHALMOL, V12, P318, DOI 10.1097/00055735-200108000-00013; Asman P, 2003, ACTA OPHTHALMOL SCAN, V81, P437, DOI 10.1034/j.1600-0420.2003.00147.x; Barabino S, 2005, INVEST OPHTH VIS SCI, V46, P2766, DOI 10.1167/iovs.04-1326; Barabino S, 2012, PROG RETIN EYE RES, V31, P271, DOI 10.1016/j.preteyeres.2012.02.003; Barrera MJ, 2013, J AUTOIMMUN, V42, P7, DOI 10.1016/j.jaut.2013.02.001; Boehm N, 2011, INVEST OPHTH VIS SCI, V52, P7725, DOI 10.1167/iovs.11-7266; Bonini S, 2003, EYE, V17, P989, DOI 10.1038/sj.eye.6700616; Bron AJ, 2014, OCUL SURF, V12, pS1, DOI 10.1016/j.jtos.2014.02.002; Buratto L, 1997, Curr Opin Ophthalmol, V8, P59, DOI 10.1097/00055735-199708000-00009; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chen WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094205; Chen YH, 2013, INVEST OPHTH VIS SCI, V54, P2457, DOI 10.1167/iovs.12-11121; COBO LM, 1988, CORNEA, V7, P50; COLLINS M, 1989, ACTA OPHTHALMOL, V67, P525; Corrales RM, 2007, CORNEA, V26, P579, DOI 10.1097/ICO.0b013e318033a729; Pereira MVC, 2010, SEMIN OPHTHALMOL, V25, P72, DOI 10.3109/08820538.2010.488578; DANJO Y, 1994, ACTA OPHTHALMOL, V72, P433; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; Dinakaran S, 2002, EUR J OPHTHALMOL, V12, P331, DOI 10.1177/112067210201200415; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; El Annan J, 2009, INVEST OPHTH VIS SCI, V50, P3802, DOI 10.1167/iovs.08-2417; Ellenberg D, 2010, PROG RETIN EYE RES, V29, P208, DOI 10.1016/j.preteyeres.2010.01.002; Elner Victor M, 2003, Arch Facial Plast Surg, V5, P427, DOI 10.1001/archfaci.5.5.427; Ezra DG, 2005, BRIT J OPHTHALMOL, V89, P1068, DOI 10.1136/bjo.2004.062406; Feltham MH, 2002, CLIN EXP OPHTHALMOL, V30, P99, DOI 10.1046/j.1442-6404.2002.00496.x; Foster KW, 2005, J AM ACAD DERMATOL, V53, P707, DOI 10.1016/j.jaad.2005.03.063; Freegard TJ, 1997, EYE, V11, P465, DOI 10.1038/eye.1997.127; Gire A, 2013, OPHTHAL PLAST RECONS, V29, pE38, DOI 10.1097/IOP.0b013e3182674069; Grixti A, 2012, OCUL SURF, V10, P26, DOI 10.1016/j.jtos.2011.10.001; Jammal H, 2012, J CRIT CARE, V27, P537, DOI 10.1016/j.jcrc.2012.02.005; JESTER JV, 1982, INVEST OPHTH VIS SCI, V22, P660; Ji YW, 2013, INVEST OPHTH VIS SCI, V54, P7557, DOI 10.1167/iovs.12-11515; Johnson ME, 2004, PROG RETIN EYE RES, V23, P449, DOI 10.1016/j.preteyeres.2004.04.003; Jones DT, 1998, ADV EXP MED BIOL, V438, P533; Joo CK, 1999, J CATARACT REFR SURG, V25, P1165, DOI 10.1016/S0886-3350(99)00117-0; Khanal S, 2009, OPTOMETRY VISION SCI, V86, P1235, DOI 10.1097/OPX.0b013e3181bc63cc; Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Leinowitz H, 1998, CORNEAL DISORDERS CL, P2; Lenart S B, 2000, Am J Crit Care, V9, P188; Liesegang TJ, 1997, CORNEA, V16, P125; Maurice DM, 1984, EYE B, V1, P1; McGinnigle S, 2012, SURV OPHTHALMOL, V57, P293, DOI 10.1016/j.survophthal.2011.11.003; McHugh J, 2008, EYE, V22, P1465, DOI 10.1038/sj.eye.6702930; Moore JE, 2009, BRIT J OPHTHALMOL, V93, P66, DOI 10.1136/bjo.2007.131722; Moss SE, 2004, ARCH OPHTHALMOL-CHIC, V122, P369, DOI 10.1001/archopht.122.3.369; PFLUGFELDER SC, 1990, OPHTHALMOLOGY, V97, P985; PFLUGFELDER SC, 1986, OPHTHALMOLOGY, V93, P1513; Pflugfelder SC, 2008, CORNEA, V27, pS9, DOI 10.1097/ICO.0b013e31817f4075; Pflugfelder SC, 2013, EXP EYE RES, V117, P118, DOI 10.1016/j.exer.2013.08.013; Pflugfelder SC, 2009, OCUL SURF, V7, P67, DOI 10.1016/S1542-0124(12)70297-5; Rao NA, 2004, OPHTHALMOLOGY, P1105; Saritas TB, 2013, THESCIENTIFICWORLDJO, V2013, DOI [10.1155/2013/182038, DOI 10.1155/2013/182038]; Shaikh S, 2002, AM FAM PHYSICIAN, V66, P1723; Shan H, 2010, INT J OPHTHALMOL-CHI, V3, P346, DOI 10.3980/j.issn.2222-3959.2010.04.16; Shen MX, 2009, INVEST OPHTH VIS SCI, V50, P2722, DOI 10.1167/iovs.08-2704; Stern Michael E, 2004, Ocul Surf, V2, P124; Stevenson W, 2012, ARCH OPHTHALMOL-CHIC, V130, P90, DOI 10.1001/archophthalmol.2011.364; Tomlinson A, 2013, OCUL SURF, V11, P267, DOI 10.1016/j.jtos.2013.05.002; TSUBOTA K, 1995, ARCH OPHTHALMOL-CHIC, V113, P155, DOI 10.1001/archopht.1995.01100020037025; van der Wekken RJ, 2013, NETH J MED, V71, P204; Wei YH, 2013, J FORMOS MED ASSOC, V13, P358; Yeh S, 2003, INVEST OPHTH VIS SCI, V44, P124, DOI 10.1167/iovs.02-0581; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Yoon KC, 2011, INVEST OPHTH VIS SCI, V52, P7267, DOI 10.1167/iovs.11-7231; Yoon KC, 2010, INVEST OPHTH VIS SCI, V51, P643, DOI 10.1167/iovs.09-3425; Yuan YM, 2010, AM J OPHTHALMOL, V149, P932, DOI 10.1016/j.ajo.2010.01.004; Zeng L, 1996, J PATHOL, V178, P207; Zheng XF, 2010, J CELL PHYSIOL, V222, P95, DOI 10.1002/jcp.21926	71	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137186	10.1371/journal.pone.0137186	http://dx.doi.org/10.1371/journal.pone.0137186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334533	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400043
J	Ainaoui, N; Hantelys, F; Renaud-Gabardos, E; Bunel, M; Lopez, F; Pujol, F; Planes, R; Bahraoui, E; Pichereaux, C; Burlet-Schiltz, O; Parini, A; Garmy-Susini, B; Prats, AC				Ainaoui, Nadera; Hantelys, Fransky; Renaud-Gabardos, Edith; Bunel, Morgane; Lopez, Frederic; Pujol, Francoise; Planes, Remi; Bahraoui, Elmostafa; Pichereaux, Carole; Burlet-Schiltz, Odile; Parini, Angelo; Garmy-Susini, Barbara; Prats, Anne-Catherine			Promoter-Dependent Translation Controlled by p54(nrb) and hnRNPM during Myoblast Differentiation	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; CAP-INDEPENDENT TRANSLATION; TRANS-ACTING FACTORS; SPLICING REGULATORY PROTEIN; TRACT-BINDING-PROTEIN; MESSENGER-RNA; MEDIATED TRANSLATION; POLYPYRIMIDINE TRACT; GENE-EXPRESSION; IN-VIVO	Fibroblast growth factor 1 (FGF1) is induced during myoblast differentiation at both transcriptional and translational levels. Here, we identify hnRNPM and p54(nrb)/NONO present in protein complexes bound to the FGF1 promoter and to the mRNA internal ribosome entry site (IRES). Knockdown or overexpression of these proteins indicate that they cooperate in activating IRES-dependent translation during myoblast differentiation, in a promoter-dependent manner. Importantly, mRNA transfection and promoter deletion experiments clearly demonstrate the impact of the FGF1 promoter on the activation of IRES-dependent translation via p54(nrb) and hnRNPM. Accordingly, knockdown of either p54 or hnRNPM also blocks endogenous FGF1 induction and myotube formation, demonstrating the physiological relevance of this mechanism and the role of these two proteins in myogenesis. Our study demonstrates the cooperative function of hnRNPM and p54(nrb) as regulators of IRES-dependent translation and indicates the involvement of a promoter-dependent mechanism.	[Ainaoui, Nadera; Hantelys, Fransky; Renaud-Gabardos, Edith; Bunel, Morgane; Pujol, Francoise; Prats, Anne-Catherine] TRADGENE, UPS EA4554, Toulouse, France; [Lopez, Frederic] UPS, INSERM, UMR CRCT U1037, Toulouse, France; [Planes, Remi; Bahraoui, Elmostafa] UPS, INSERM, UMR CRCT U1043, Toulouse, France; [Pichereaux, Carole; Burlet-Schiltz, Odile] UPS, CNRS, UMR IPBS U5282, Toulouse, France; [Parini, Angelo; Garmy-Susini, Barbara] UPS, CNRS, UMR I2MC U1048, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Prats, AC (corresponding author), TRADGENE, UPS EA4554, Toulouse, France.	Anne-Catherine.Prats@inserm.fr	Hantelys, Haingo Fransky Mitchell/AAZ-3856-2020; Prats, Anne-Catherine/E-5051-2016; Garmy-Susini, Barbara/B-9735-2014	Hantelys, Haingo Fransky Mitchell/0000-0003-3504-2916; Prats, Anne-Catherine/0000-0002-5282-3776; GARMY-SUSINI, Barbara/0000-0001-6100-2294; Pichereaux, Carole/0000-0002-7559-5358; BAHRAOUI, ELMOSTAFA/0000-0003-1852-389X; Schiltz, Odile/0000-0002-3606-2356; Renaud-Gabardos, Edith/0000-0003-4209-2559; Parini, Angelo/0000-0002-9848-8838	Association Francaise contre les Myopathies [16966]; Association pour la Recherche sur le Cancer [PJA-20131200230]; Ligue pour la Recherche Contre le Cancer; Fondation de l'Avenir [ET0-583]; Region Midi-Pyrenees [11052677]; Fonds Europeen du Developpement Regional (grant REFBIO-VEMT); Canceropole Grand Sud-Ouest; Institut National du Cancer (grant RIBOCAN) [2008-039]	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue pour la Recherche Contre le Cancer; Fondation de l'Avenir; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); Fonds Europeen du Developpement Regional (grant REFBIO-VEMT); Canceropole Grand Sud-Ouest; Institut National du Cancer (grant RIBOCAN)	This work has been funded by Association Francaise contre les Myopathies (grant 16966), Association pour la Recherche sur le Cancer (grant PJA-20131200230), Ligue pour la Recherche Contre le Cancer, Canceropole Grand Sud-Ouest, Institut National du Cancer (grant RIBOCAN no. 2008-039), Fondation de l'Avenir (grant ET0-583), Region Midi-Pyrenees (grant 11052677), Fonds Europeen du Developpement Regional (grant REFBIO-VEMT). There was no commercial funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SD, 2007, NUCLEIC ACIDS RES, V35, P4664, DOI 10.1093/nar/gkm483; Basu A, 1997, MOL CELL BIOL, V17, P677, DOI 10.1128/MCB.17.2.677; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Bonnal S, 2003, J BIOL CHEM, V278, P39330, DOI 10.1074/jbc.M305580200; Bouyssie D, 2007, MOL CELL PROTEOMICS, V6, P1621, DOI 10.1074/mcp.T600069-MCP200; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Chotani MA, 1997, CELL GROWTH DIFFER, V8, P999; CHOTANI MA, 1995, NUCLEIC ACIDS RES, V23, P434, DOI 10.1093/nar/23.3.434; Cobbold LC, 2008, MOL CELL BIOL, V28, P40, DOI 10.1128/MCB.01298-07; Conte C, 2009, NUCLEIC ACIDS RES, V37, P5267, DOI 10.1093/nar/gkp550; DATAR KV, 1993, NUCLEIC ACIDS RES, V21, P439, DOI 10.1093/nar/21.3.439; Dobbyn HC, 2008, ONCOGENE, V27, P1167, DOI 10.1038/sj.onc.1210723; DONG BH, 1993, NUCLEIC ACIDS RES, V21, P4085, DOI 10.1093/nar/21.17.4085; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Jain RA, 2008, DEVELOPMENT, V135, P973, DOI 10.1242/dev.015438; JANG SK, 1990, GENE DEV, V4, P1560, DOI 10.1101/gad.4.9.1560; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kim YK, 2000, J MOL BIOL, V304, P119, DOI 10.1006/jmbi.2000.4179; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lisse TS, 2014, BONE RES, V2; Lopez F, 2003, PROTEOMICS, V3, P402, DOI 10.1002/pmic.200390055; Madiai F, 1999, J BIOL CHEM, V274, P11937, DOI 10.1074/jbc.274.17.11937; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Marko M, 2010, EXP CELL RES, V316, P390, DOI 10.1016/j.yexcr.2009.10.021; Martineau Y, 2004, MOL CELL BIOL, V24, P7622, DOI 10.1128/MCB.24.17.7622-7635.2004; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Miura P, 2010, HUM MOL GENET, V19, P1211, DOI 10.1093/hmg/ddp591; Morfoisse F, 2014, CELL REP, V6, P155, DOI 10.1016/j.celrep.2013.12.011; MYERS RL, 1995, ONCOGENE, V11, P785; MYERS RL, 1993, ONCOGENE, V8, P341; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Payson RA, 1998, J STEROID BIOCHEM, V66, P93, DOI 10.1016/S0960-0760(98)00051-X; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Prats AC, 2013, MICROVASCULAR RES; Roy R, 2014, NUCLEIC ACIDS RES, V42, P12483, DOI 10.1093/nar/gku953; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Shiroki K, 2002, NUCLEIC ACIDS RES, V30, P2851, DOI 10.1093/nar/gkf408; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Xodo Luigi, 2008, Nucleic Acids Symp Ser (Oxf), P159, DOI 10.1093/nass/nrn081	53	14	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136466	10.1371/journal.pone.0136466	http://dx.doi.org/10.1371/journal.pone.0136466			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332123	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800057
J	Chiang, TH; Lee, YC; Liao, WC; Chung, JH; Chiu, HM; Tu, CH; Chen, SC; Wu, MS				Chiang, Tsung-Hsien; Lee, Yi-Chia; Liao, Wan-Chung; Chung, Jui-Hung; Chiu, Han-Mo; Tu, Chia-Hung; Chen, Su-Chiu; Wu, Ming-Shiang			Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms	PLOS ONE			English	Article							OCCULT BLOOD-TEST; ESTROGEN PLUS PROGESTIN; METABOLIC SYNDROME; ADVANCED ADENOMAS; CANCER; PERFORMANCE; PREVALENCE; SEX; HEMOGLOBIN; GUIDELINES	Background Following a negative test, the performance of fecal immunochemical testing in the subsequent screening round is rarely reported. It is crucial to allocate resources to participants who are more likely to test positive subsequently following an initial negative result. Objective To identify risk factors associated with a positive result in subsequent screening. Methods Dataset was composed of consecutive participants who voluntarily underwent fecal tests and colonoscopy in a routine medical examination at the National Taiwan University Hospital between January 2007 and December 2011. Risk factor assessment of positive fecal test in subsequent screening was performed by using the Cox proportional hazards models. Results Our cohort consisted of 3783 participants during a 5-year period. In three rounds of subsequent testing, 3783, 1537, and 624 participants underwent fecal tests, respectively; 5.7%, 5.1%, and 3.9% tested positive, respectively, and the positive predictive values were 40.2%, 20.3%, and 20.8%, respectively. Age >= 60 years (adjusted hazard ratio: 1.53, 95% CI: 1.21-1.93) and male gender (1.32, 95% CI: 1.02-1.69) were risk factors; however, an interaction between age and gender was noted. Men had higher risk than women when they were <60 years of age (p = 0.002), while this difference was no longer observed when >= 60 years of age (p = 0.74). The optimal interval of screening timing for participant with baseline negative fecal test was 2 years. Conclusions Following a negative test, older age and male gender are risk factors for a positive result in the subsequent rounds while the gender difference diminishes with age. Biennial screening is sufficient following a negative fecal test.	[Chiang, Tsung-Hsien; Lee, Yi-Chia; Chiu, Han-Mo; Tu, Chia-Hung; Wu, Ming-Shiang] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Chiang, Tsung-Hsien; Tu, Chia-Hung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chiang, Tsung-Hsien] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Liao, Wan-Chung; Chung, Jui-Hung; Chen, Su-Chiu] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Wu, Ming-Shiang] Natl Taiwan Univ, Coll Med, Dept Primary Care Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taipei University of Nursing & Health Science (NTUNHS); National Taiwan University	Chen, SC (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan.	suchiu@ntunhs.edu.tw; mingshiang@ntu.edu.tw	Chiu, Han-Mo/AAY-6809-2020	LEE, YI-CHIA/0000-0002-8160-1216; Chiang, Tsung-Hsien/0000-0003-1308-9756; Wu, Ming-Shiang/0000-0002-1940-6428; CHIU, HAN-MO/0000-0003-2786-8056	National Taiwan University Hospital	National Taiwan University Hospital(National Taiwan University)	This study was supported by research grants from the National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Brenner H, 2010, ANN INTERN MED, V152, P697, DOI 10.7326/0003-4819-152-11-201006010-00002; Chang LC, 2014, GASTROINTEST ENDOSC, V79, P961, DOI 10.1016/j.gie.2013.11.035; Chiang TH, 2014, GASTROENTEROLOGY, V147, P1317, DOI 10.1053/j.gastro.2014.08.043; Chiang TH, 2011, CAN MED ASSOC J, V183, P1474, DOI 10.1503/cmaj.101248; Chiu HM, 2009, CLIN GASTROENTEROL H, V7, P463, DOI 10.1016/j.cgh.2008.11.026; Chiu HM, 2015, CANCER; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Crotta S, 2012, CLIN GASTROENTEROL H, V10, P633, DOI 10.1016/j.cgh.2012.02.030; Denters MJ, 2012, GASTROENTEROLOGY, V142, P497, DOI 10.1053/j.gastro.2011.11.024; Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferlitsch M, 2011, JAMA-J AM MED ASSOC, V306, P1352, DOI 10.1001/jama.2011.1362; Foster PA, 2013, INT J COLORECTAL DIS, V28, P737, DOI 10.1007/s00384-012-1628-y; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Kirkegaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5504; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lee JK, 2014, ANN INTERN MED, V160, P171, DOI 10.7326/M13-1484; Lieberman DA, 2005, CLIN GASTROENTEROL H, V3, P798, DOI 10.1016/S1542-3565(05)00405-2; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Smith A, 2006, CANCER, V107, P2152, DOI 10.1002/cncr.22230; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; World Endoscopy Organization, 5 FITTER WORLD END O	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136890	10.1371/journal.pone.0136890	http://dx.doi.org/10.1371/journal.pone.0136890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332318	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800079
J	Kongkaew, S; Yotmanee, P; Rungrotmongkol, T; Kaiyawet, N; Meeprasert, A; Kaburaki, T; Noguchi, H; Takeuchi, F; Kungwan, N; Hannongbua, S				Kongkaew, Sirilak; Yotmanee, Pathumwadee; Rungrotmongkol, Thanyada; Kaiyawet, Nopporn; Meeprasert, Arthitaya; Kaburaki, Toshikatsu; Noguchi, Hiroshi; Takeuchi, Fujio; Kungwan, Nawee; Hannongbua, Supot			Molecular Dynamics Simulation Reveals the Selective Binding of Human Leukocyte Antigen Alleles Associated with BehCet's Disease	PLOS ONE			English	Article							HLA-B ALLELES; CLASS-I; JAPANESE PATIENTS; MICA ANTIBODIES; GENE-A; HLA-B-ASTERISK-5101; COMPLEX; POLYMORPHISM; REGION	Behcet's disease (BD), a multi-organ inflammatory disorder, is associated with the presence of the human leukocyte antigen (HLA) HLA-B*51 allele in many ethnic groups. The possible antigen involvement of the major histocompatibility complex class I chain related gene A transmembrane (MICA-TM) nonapeptide (AAAAAIFVI) has been reported in BD symptomatic patients. This peptide has also been detected in HLA-A*26:01 positive patients. To investigate the link of BD with these two specific HLA alleles, molecular dynamics (MD) simulations were applied on the MICA-TM nonapeptide binding to the two BD-associated HLA alleles in comparison with the two non-BD-associated HLA alleles (B*35:01 and A*11:01). The MD simulations were applied on the four HLA/MICA-TM peptide complexes in aqueous solution. As a result, stabilization for the incoming MICA-TM was found to be predominantly contributed from van der Waals interactions. The P2/P3 residue close to the N-terminal and the P9 residue at the C-terminal of the MICA-TM nonapeptide served as the anchor for the peptide accommodated at the binding groove of the BD associated HLAs. The MM/PBSA free energy calculation predicted a stronger binding of the HLA/peptide complexes for the BD-associated HLA alleles than for the non-BD-associated ones, with a ranked binding strength of B*51:01 > B*35:01 and A*26:01 > A*11:01. Thus, the HLAs associated with BD pathogenesis expose the binding efficiency with the MICA-TM nonapeptide tighter than the non-associated HLA alleles. In addition, the residues 70, 73, 99, 146, 147 and 159 of the two BD-associated HLAs provided the conserved interaction for the MICA-TM peptide binding.	[Kongkaew, Sirilak] Chulalongkorn Univ, Fac Sci, Program Biotechnol, Bangkok, Thailand; [Yotmanee, Pathumwadee] Ramkhamhang Univ, Dept Chem, Fac Sci, Bangkok, Thailand; [Rungrotmongkol, Thanyada; Meeprasert, Arthitaya] Chulalongkorn Univ, Dept Biochem, Fac Sci, Bangkok, Thailand; [Rungrotmongkol, Thanyada] Chulalongkorn Univ, PhD Program Bioinformat & Computat Biol, Fac Sci, Bangkok, Thailand; [Kaiyawet, Nopporn; Hannongbua, Supot] Chulalongkorn Univ, Computat Chem Unit Cell, Dept Chem, Fac Sci, Bangkok, Thailand; [Kaburaki, Toshikatsu] Univ Tokyo, Dept Ophthalmol, Tokyo 113, Japan; [Noguchi, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Takeuchi, Fujio] Univ Tokyo, Fac Med, Dept Internal Med, Tokyo 113, Japan; [Kungwan, Nawee] Chiang Mai Univ, Dept Chem, Fac Sci, Chiang Mai 50000, Thailand	Chulalongkorn University; Ramkhamhaeng University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; University of Tokyo; University of Shizuoka; University of Tokyo; Chiang Mai University	Hannongbua, S (corresponding author), Chulalongkorn Univ, Computat Chem Unit Cell, Dept Chem, Fac Sci, Bangkok, Thailand.	Supot.h@chula.ac.th	Kaburaki, Toshikatsu/AAH-7091-2020; Noguchi, Hiroshi/AAV-8527-2020	Kongkaew, Sirilak/0000-0002-8045-2773; kungwan, nawee/0000-0002-2960-6853	Asia Research Center fund, Chulalongkorn University; Anniversary Chulalongkorn University Fund; Faculty of Science Ramkhamhaeng University; Thailand Research Fund [IRG5780008]; Ministry of Education, Culture, Sport, Science and Technology of Japan [23406031]; JSPS Bilateral Joint Research Projects; Chulalongkorn University	Asia Research Center fund, Chulalongkorn University; Anniversary Chulalongkorn University Fund; Faculty of Science Ramkhamhaeng University; Thailand Research Fund(Thailand Research Fund (TRF)); Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Bilateral Joint Research Projects; Chulalongkorn University(Chulalongkorn University)	This work was supported by Asia Research Center fund, Chulalongkorn University. SK thanks the 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship. PY accepted the Research Grant 2014 from Faculty of Science Ramkhamhaeng University. TR thanks the Thailand Research Fund (IRG5780008). TK, HN and FT received the funding support of Grants-in-Aid for Science Research from the Ministry of Education, Culture, Sport, Science and Technology of Japan (no. 23406031) and were supported by JSPS Bilateral Joint Research Projects. NKa and AM thank the Ratchadaphiseksomphot Endowment Fund from Chulalongkorn University for Postdoctoral fellowship.	Alvarez-Marquez A, 2009, TRANSPLANTATION, V87, P94, DOI 10.1097/TP.0b013e31818bd790; Baharav E, 2012, ISR MED ASSOC J, V14, P424; BENACERR.B, 1972, SCIENCE, V175, P273, DOI 10.1126/science.175.4019.273; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blicher T, 2005, ACTA CRYSTALLOGR D, V61, P1031, DOI 10.1107/S0907444905013090; Case D.A., 2008, AMBER10; Chambers JC, 2001, J AM COLL CARDIOL, V37, P517, DOI 10.1016/S0735-1097(00)01137-2; Chung Y M, 1990, J Formos Med Assoc, V89, P413; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Chambrun MP, 2012, AUTOIMMUN REV, V11, P687, DOI 10.1016/j.autrev.2011.11.026; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Decha P, 2008, BIOPHYS J, V95, P128, DOI 10.1529/biophysj.107.127456; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ergun T, 2001, J AM ACAD DERMATOL, V45, P904, DOI 10.1067/mjd.2001.117728; Guillot B, 2002, J MOL LIQ, V101, P219, DOI 10.1016/S0167-7322(02)00094-6; Holland CJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00172; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Itoh Y, 2006, TISSUE ANTIGENS, V67, P390, DOI 10.1111/j.1399-0039.2006.00586.x; Kaburaki T, 2010, CLIN EXP RHEUMATOL, V28, pS39; Kaburaki T, 2010, GRAEF ARCH CLIN EXP, V248, P709, DOI 10.1007/s00417-009-1234-z; Kaneko Fumio, 1997, Yonsei Medical Journal, V38, P444; Kang EH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3292; Kaya TI, 2012, PATHOLOG RES INT, V2012; Kurata R, 2014, MOJ IMMUNOL, V1; Lehner T, 1999, ANN MED INTERNE, V150, P483; Link J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036779; Macdonald IK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001149; MADRIGAL JA, 1993, TISSUE ANTIGENS, V41, P72, DOI 10.1111/j.1399-0039.1993.tb01982.x; Maenaka K, 2000, J IMMUNOL, V165, P3260, DOI 10.4049/jimmunol.165.6.3260; Marshall SE, 2004, BEST PRACT RES CL RH, V18, P291, DOI 10.1016/j.berh.2004.02.008; Menssen R, 1999, J MOL BIOL, V285, P645, DOI 10.1006/jmbi.1998.2363; Mizuki N, 1999, ARTHRITIS RHEUM, V42, P1961, DOI 10.1002/1529-0131(199909)42:9<1961::AID-ANR23>3.0.CO;2-7; MIZUKI N, 1993, AM J OPHTHALMOL, V116, P406, DOI 10.1016/S0002-9394(14)71396-0; Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298; Mizuki N, 1997, TISSUE ANTIGENS, V50, P57, DOI 10.1111/j.1399-0039.1997.tb02835.x; Mizuki N, 2007, JPN J OPHTHALMOL, V51, P431, DOI 10.1007/s10384-007-0473-y; Nunthaboot N, 2010, J CHEM INF MODEL, V50, P1410, DOI 10.1021/ci100038g; OHNO S, 1982, ARCH OPHTHALMOL-CHIC, V100, P1455; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PARHAM P, 1988, P NATL ACAD SCI USA, V85, P4005, DOI 10.1073/pnas.85.11.4005; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Ren PY, 2002, J COMPUT CHEM, V23, P1497, DOI 10.1002/jcc.10127; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Rungrotmongkol T, 2010, J MOL GRAPH MODEL, V29, P347, DOI 10.1016/j.jmgm.2010.09.010; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saadoun D, 2010, ARTHRITIS RHEUM-US, V62, P2806, DOI 10.1002/art.27568; Suarez-Alvarez B, 2006, TRANSPL IMMUNOL, V17, P43, DOI 10.1016/j.trim.2006.09.014; Tanaka T, 1999, OCUL IMMUNOL INFLAMM, V7, P69, DOI 10.1076/ocii.7.2.69.4018; Terasaki PI, 2007, AM J TRANSPLANT, V7, P408, DOI 10.1111/j.1600-6143.2006.01644.x; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Wallace GR, 1999, IMMUNOGENETICS, V49, P613, DOI 10.1007/s002510050656; Wang Q, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001025; Yasuoka H, 2004, ARTHRITIS RHEUM-US, V50, P3658, DOI 10.1002/art.20597	53	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135575	10.1371/journal.pone.0135575	http://dx.doi.org/10.1371/journal.pone.0135575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331842	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800034
J	Luo, MY; Duan, CJ; Qiu, JP; Li, WR; Zhu, DY; Cai, WL				Luo, Mingyue; Duan, Chaijie; Qiu, Jianping; Li, Wenru; Zhu, Dongyun; Cai, Wenli			Diagnostic Value of Multidetector CT and Its Multiplanar Reformation, Volume Rendering and Virtual Bronchoscopy Postprocessing Techniques for Primary Trachea and Main Bronchus Tumors	PLOS ONE			English	Article							PICTORIAL ESSAY; ROW CT; AIRWAYS; ANGIOGRAPHY; MDCT	Purpose To evaluate the diagnostic value of multidetector CT (MDCT) and its multiplanar reformation (MPR), volume rendering (VR) and virtual bronchoscopy (VB) postprocessing techniques for primary trachea and main bronchus tumors. Methods Detection results of 31 primary trachea and main bronchus tumors with MDCT and its MPR, VR and VB postprocessing techniques, were analyzed retrospectively with regard to tumor locations, tumor morphologies, extramural invasions of tumors, longitudinal involvements of tumors, morphologies and extents of luminal stenoses, distances between main bronchus tumors and trachea carinae, and internal features of tumors. The detection results were compared with that of surgery and pathology. Results Detection results with MDCT and its MPR, VR and VB were consistent with that of surgery and pathology, included tumor locations (tracheae, n = 19; right main bronchi, n = 6; left main bronchi, n = 6), tumor morphologies (endoluminal nodes with narrow bases, n = 2; endoluminal nodes with wide bases, n = 13; both intraluminal and extraluminal masses, n = 16), extramural invasions of tumors (brokethrough only serous membrane, n = 1; 4.0 mm-56.0 mm, n = 14; no clear border with right atelectasis, n = 1), longitudinal involvements of tumors (3.0 mm, n = 1; 5.0 mm-68.0 mm, n = 29; whole right main bronchus wall and trachea carina, n = 1), morphologies of luminal stenoses (irregular, n = 26; circular, n = 3; eccentric, n = 1; conical, n = 1) and extents (mild, n = 5; moderate, n = 7; severe, n = 19),distances between main bronchus tumors and trachea carinae (16.0 mm, n = 1; invaded trachea carina, n = 1; >20.0 mm, n = 10), and internal features of tumors (fairly homogeneous densities with rather obvious enhancements, n = 26; homogeneous density with obvious enhancement, n = 1; homogeneous density without obvious enhancement, n = 1; not enough homogeneous density with obvious enhancement, n = 1; punctate calcification with obvious enhancement, n = 1; low density without obvious enhancement, n = 1). Conclusion MDCT and its MPR, VR and VB images have respective advantages and disadvantages. Their combination could complement to each other to accurately detect locations, natures (benignancy, malignancy or low malignancy), and quantities (extramural invasions, longitudinal involvements, extents of luminal stenoses, distances between main bronchus tumors and trachea carinae) of primary trachea and main bronchus tumors with crucial information for surgical treatment, are highly useful diagnostic methods for primary trachea and main bronchus tumors.	[Luo, Mingyue; Qiu, Jianping; Li, Wenru; Zhu, Dongyun] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Duan, Chaijie] Tsinghua Univ, Grad Sch Shenzhen, Biomed Engn Res Ctr, Shenzhen 518057, Guangdong, Peoples R China; [Cai, Wenli] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Cai, Wenli] Harvard Univ, Sch Med, Boston, MA USA	Sun Yat Sen University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Luo, MY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China.	myluo720@163.com			National Natural Science Foundation of China [81230035]; Guangdong Provincial Science and Technology Programs [2013B051000016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Programs	This study was supported by National Natural Science Foundation of China (81230035) [http://www.nsfc.gov.cn/]; and Guangdong Provincial Science and Technology Programs (2013B051000016) [http://pro.gdstc.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar T, 2015, JPN J RADIOL, V33, P51, DOI 10.1007/s11604-014-0380-3; Adali F, 2010, ANN THORAC MED, V5, P104, DOI 10.4103/1817-1737.62474; Asano F, 2010, CLIN CHEST MED, V31, P75, DOI 10.1016/j.ccm.2009.08.007; Beigelman-Aubry C, 2009, RADIOL CLIN N AM, V47, P185, DOI 10.1016/j.rcl.2009.01.001; Boiselle PM, 2002, AM J ROENTGENOL, V179, P301, DOI 10.2214/ajr.179.2.1790301; Chan MY, 2009, IEEE T VIS COMPUT GR, V15, P1283, DOI 10.1109/TVCG.2009.172; De Filippo M, 2008, RADIOL MED, V113, P945, DOI 10.1007/s11547-008-0325-y; De Wever W, 2004, EUR RESPIR J, V23, P776, DOI 10.1183/09031936.04.00099804; Du Zhen-zong, 2009, Zhonghua Zhongliu Zazhi, V31, P152, DOI 10.3760/cma.j.issn.0253-3766.2009.02.018; Espinosa LA, 2010, AM J ROENTGENOL, V194, P70, DOI 10.2214/AJR.09.2380; Ferretti GR, 2009, RADIOL CLIN N AM, V47, P227, DOI 10.1016/j.rcl.2008.11.010; Hoppe H, 2002, AM J ROENTGENOL, V178, P1195, DOI 10.2214/ajr.178.5.1781195; Javidan-Nejad C, 2010, RADIOL CLIN N AM, V48, P157, DOI 10.1016/j.rcl.2009.10.003; Kim YK, 2007, AM J ROENTGENOL, V189, P393, DOI 10.2214/AJR.07.2079; Kim YH, 2009, RADIOLOGY, V250, P767, DOI 10.1148/radiol.2502071872; Laroia AT, 2010, WORLD J RADIOL, V2, P237, DOI 10.4329/wjr.v2.i7.237; Lawler LP, 2001, RADIOGRAPHICS, V21, P1257, DOI 10.1148/radiographics.21.5.g01se021257; Lee KS, 2010, J THORAC IMAG, V25, P112, DOI 10.1097/RTI.0b013e3181d7e721; Lei ZQ, 2009, ADV THER, V26, P976, DOI 10.1007/s12325-009-0071-0; Marchesin S, 2010, IEEE T VIS COMPUT GR, V16, P560, DOI 10.1109/TVCG.2010.30; Marom EM, 2001, AM J ROENTGENOL, V176, P707, DOI 10.2214/ajr.176.3.1760707; Naidich DP, 1997, J THORAC IMAG, V12, P11, DOI 10.1097/00005382-199701000-00003; Ravenel JG, 2001, J THORAC IMAG, V16, P269, DOI 10.1097/00005382-200110000-00008; Sodhi KS, 2008, INDIAN J PEDIATR, V75, P511, DOI 10.1007/s12098-008-0080-z; Yang Yi-meng, 2012, Zhonghua Jie He He Hu Xi Za Zhi, V35, P176	25	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137329	10.1371/journal.pone.0137329	http://dx.doi.org/10.1371/journal.pone.0137329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332466	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800121
J	Mattarozzi, K; Todorov, A; Marzocchi, M; Vicari, A; Russo, PM				Mattarozzi, Katia; Todorov, Alexander; Marzocchi, Michele; Vicari, Alba; Russo, Paolo Maria			Effects of Gender and Personality on First Impression	PLOS ONE			English	Article							SEX-DIFFERENCES; EMOTIONAL EXPRESSIONS; FACIAL EXPRESSIONS; TRUSTWORTHINESS; RECOGNITION; FACES; AGGRESSION; PERCEPTION; MOOD; SUSCEPTIBILITY	The present study explores whether and to what extent individual differences (i.e., gender and personality traits of perceiver) predict inferences of trustworthiness from emotionally neutral unfamiliar faces and the related confidence in judgment. Four hundred and ten undergraduate students participated in the study. Personality was assessed using the Big Five model (i.e., Extraversion, Neuroticism, Conscientiousness, Agreeableness and Openness to experience) and measures of trait anxiety and aggression. The results suggest that trustworthiness judgments are affected by the gender of the perceiver, although this effect depends on the valence of the face. Women tend to judge trustworthy-looking faces as significantly more trustworthy than men do, and this is particularly pronounced for judgments of female faces. There were no gender differences for judgments of untrustworthy-looking or neutral faces. Gender also seems to affect the confidence in judgment. Specifically, women were generally less confident than men in judging trustworthiness of unfamiliar faces. Personality also affected judgment. Both low agreeable individuals and high trait aggressive individuals tend to perceive unfamiliar faces as less trustworthy. The present findings suggest that both gender and personality traits are relevant for understanding how people evaluate the trustworthiness of others. Whom we decide to trust is a function not only of their facial features but also of gender and individual differences in personality traits.	[Mattarozzi, Katia; Vicari, Alba; Russo, Paolo Maria] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Todorov, Alexander] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Marzocchi, Michele] Univ Bologna, Dept Psychol, Bologna, Italy	University of Bologna; Princeton University; University of Bologna	Russo, PM (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	p.russo@unibo.it	Russo, Paolo/AAO-5351-2021	RUSSO, PAOLO MARIA/0000-0002-0575-5360; MATTAROZZI, KATIA/0000-0003-1784-750X				Ballew CC, 2007, P NATL ACAD SCI USA, V104, P17948, DOI 10.1073/pnas.0705435104; Barbaranelli C, 1997, EUR J PSYCHOL ASSESS, V13, P75, DOI 10.1027/1015-5759.13.2.75; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; CAPRARA GV, 1993, PERS INDIV DIFFER, V15, P281, DOI 10.1016/0191-8869(93)90218-R; De Raad B., 2000, BIG 5 PERSONALITY FA; Dodge KA, 2006, DEV PSYCHOPATHOL, V18, P791, DOI 10.1017/S0954579406060391; Dzhelyova M, 2012, BRAIN RES, V1435, P81, DOI 10.1016/j.brainres.2011.11.043; Epstein S, 1996, J PERS SOC PSYCHOL, V71, P390, DOI 10.1037/0022-3514.71.2.390; EPSTEIN S, 1973, AM PSYCHOL, V28, P404, DOI 10.1037/h0034679; Fischer A.H., 2000, GENDER EMOTION SOCIA, P71, DOI [10.1017/CBO9780511628191.005, DOI 10.1017/CBO9780511628191, 10.1017/CBO9780511628191]; Fossati A, 2003, EUR J PSYCHOL ASSESS, V19, P54, DOI 10.1027//1015-5759.19.1.54; Hahn AC, 2013, Q J EXP PSYCHOL, V66, P200, DOI 10.1080/17470218.2012.705860; Hall CW, 2006, J PSYCHOL, V140, P255, DOI 10.3200/JRLP.140.3.255-267; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Herlitz A, 2013, VIS COGN, V21, P1306, DOI 10.1080/13506285.2013.823140; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Honekopp J, 2006, J EXP PSYCHOL HUMAN, V32, P199, DOI 10.1037/0096-1523.32.2.199; Knyazev GG, 2008, PERS INDIV DIFFER, V44, P1093, DOI 10.1016/j.paid.2007.11.001; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Krohne HW, 2008, J RES PERS, V42, P1572, DOI 10.1016/j.jrp.2008.07.015; Larkin KT, 2002, J BEHAV MED, V25, P285, DOI 10.1023/A:1015384812283; LARSEN RJ, 1991, J PERS SOC PSYCHOL, V61, P132, DOI 10.1037/0022-3514.61.1.132; LARSEN RJ, 1989, PERS INDIV DIFFER, V10, P1221, DOI 10.1016/0191-8869(89)90233-X; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Lundqvist D., 1998, KAROLINSKA DIRECTED; McBain R, 2009, ACTA PSYCHOL, V130, P168, DOI 10.1016/j.actpsy.2008.12.005; Montepare JM, 2003, J NONVERBAL BEHAV, V27, P237, DOI 10.1023/A:1027332800296; Olivola CY, 2010, J NONVERBAL BEHAV, V34, P83, DOI 10.1007/s10919-009-0082-1; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Pacini R, 1999, J PERS SOC PSYCHOL, V76, P972, DOI 10.1037/0022-3514.76.6.972; Porter S, 2010, PSYCHOL CRIME LAW, V16, P477, DOI 10.1080/10683160902926141; Rusting CL, 1998, PSYCHOL BULL, V124, P165, DOI 10.1037/0033-2909.124.2.165; Said CP, 2009, EMOTION, V9, P260, DOI 10.1037/a0014681; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Thayer JF, 2000, SCAND J PSYCHOL, V41, P243, DOI 10.1111/1467-9450.00193; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; Vuoskoski JK, 2011, CORTEX, V47, P1099, DOI 10.1016/j.cortex.2011.04.011; Willis ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076825; Wincenciak J, 2013, VISION RES, V87, P30, DOI 10.1016/j.visres.2013.05.007	48	36	36	1	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135529	10.1371/journal.pone.0135529	http://dx.doi.org/10.1371/journal.pone.0135529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331610	Green Published, gold			2022-12-27	WOS:000360613800032
J	Chu, AHY; Ng, SHX; Koh, D; Muller-Riemenschneider, F				Chu, Anne H. Y.; Ng, Sheryl H. X.; Koh, David; Mueller-Riemenschneider, Falk			Reliability and Validity of the Self- and Interviewer-Administered Versions of the Global Physical Activity Questionnaire (GPAQ)	PLOS ONE			English	Article							CONVERGENT VALIDITY; HEALTH; IPAQ; CALIBRATION; VALIDATION	Objective The Global Physical Activity Questionnaire (GPAQ) was originally designed to be interviewer-administered by the World Health Organization in assessing physical activity. The main aim of this study was to compare the psychometric properties of a self-administered GPAQ with the original interviewer-administered approach. Additionally, this study explored whether using different accelerometry-based physical activity bout definitions might affect the questionnaire's validity. Methods A total of 110 participants were recruited and randomly allocated to an interviewer-(n = 56) or a self-administered (n = 54) group for test-retest reliability, of which 108 participants who met the wear time criteria were included in the validity study. Reliability was assessed by administration of questionnaires twice with a one-week interval. Criterion validity was assessed by comparing against seven-day accelerometer measures. Two definitions for accelerometry-data scoring were employed: (1) total-min of activity, and (2) 10-min bout. Results Participants had similar baseline characteristics in both administration groups and no significant difference was found between the two formats in terms of validity (correlations between the GPAQ and accelerometer). For validity, the GPAQ demonstrated fair-to-moderate correlations for moderate-to-vigorous physical activity (MVPA) for self-administration (rs = 0.30) and interviewer-administration (rs = 0.46). Findings were similar when considering 10-min activity bouts in the accelerometer analysis for MVPA (rs = 0.29 vs. 0.42 for self vs. interviewer). Within each mode of administration, the strongest correlations were observed for vigorous-intensity activity. However, Bland-Altman plots illustrated bias toward overestimation for higher levels of MVPA, vigorous- and moderate-intensity activities, and underestimation for lower levels of these measures. Reliability for MVPA revealed moderate correlations (rs = 0.61 vs. 0.63 for self vs. interviewer). Conclusions Our findings showed comparability between both self- and interviewer-administration modes of the GPAQ. The GPAQ in general but especially the self-administered version may offer a relatively inexpensive method for measuring physical activity of various types and at different domains. However, there may be bias in the GPAQ measurements depending on the overall physical activity. It is advisable to incorporate accelerometers in future studies, particularly when measuring different intensities of physical activity.	[Chu, Anne H. Y.; Ng, Sheryl H. X.; Koh, David; Mueller-Riemenschneider, Falk] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Koh, David] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Jalan Tungku Link, Gadong, Brunei; [Mueller-Riemenschneider, Falk] Charite, Ctr Berlin, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany	National University of Singapore; University Brunei Darussalam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chu, AHY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	anne.chu@u.nus.edu	Brucki, Sonia MD/B-5736-2014	Brucki, Sonia MD/0000-0002-8303-6732; Ng, Sheryl/0000-0001-5046-2666; Muller-Riemenschneider, Falk/0000-0003-1402-7477; Koh, David/0000-0001-6803-7879	National University of Singapore [WBS: R-608-000-063-133, WBS: R-608-000-071-112]	National University of Singapore(National University of Singapore)	This research was supported by grants WBS: R-608-000-063-133 and WBS: R-608-000-071-112 from the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107039; Altschuler A, 2009, MED SCI SPORT EXER, V41, P336, DOI 10.1249/MSS.0b013e318186b1b1; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Barreira TV, 2015, MED SCI SPORT EXER, V47, P937, DOI 10.1249/MSS.0000000000000486; Bassuk SS, 2014, AM J LIFESTYLE MED, V8, P144, DOI 10.1177/1559827613510870; Blair J, 2014, DESIGNING SURVEYS GU; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Cleland CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1255; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dinger MK, 2004, J SPORT MED PHYS FIT, V44, P186; Dwyer GM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-86; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Fleiss J. L., 1981, WILEY SERIES PROBABI, V13, P212; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Hagstromer M, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.182; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Herrmann SD, 2013, MEAS PHYS EDUC EXERC, V17, P221, DOI 10.1080/1091367X.2013.805139; Hoos T, 2012, J PHYS ACT HEALTH, V9, P698, DOI 10.1123/jpah.9.5.698; Humphreys BR, 2014, HEALTH ECON, V23, P33, DOI 10.1002/hec.2900; Kurtze N, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-63; Lachat CK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-37; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Leslie E, 2003, PREV MED, V37, P177, DOI 10.1016/S0091-7435(03)00113-0; Macfarlane DJ, 2006, J APPL PHYSIOL, V101, P1328, DOI 10.1152/japplphysiol.00336.2006; Mader U, 2006, MED SCI SPORT EXER, V38, P1255, DOI 10.1249/01.mss.0000227310.18902.28; Matthews CE, 2005, MED SCI SPORT EXER, V37, P986, DOI 10.1249/01.mss.0000171615.76521.69; Oyeyemi AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087233; Robertson W, 2011, J OBES, V2011, DOI 10.1155/2011/398918; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Sitthipornvorakul Ekalak, 2014, BMC Res Notes, V7, P280, DOI 10.1186/1756-0500-7-280; Skotte J, 2014, J PHYS ACT HEALTH, V11, P76, DOI 10.1123/jpah.2011-0347; Thuy AB, 2010, J PHYS ACT HEALTH, V7, P410, DOI 10.1123/jpah.7.3.410; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Trapp R.G., 2004, BASIC CLIN BIOSTATIS, V4th; Trinh OTH, 2009, J PHYS ACT HEALTH, V6, pS46, DOI 10.1123/jpah.6.s1.s46; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke Catrine, 2014, Appl Physiol Nutr Metab, V39, P53, DOI 10.1139/apnm-2013-0173; van Hees VT, 2013, J APPL PHYSIOL, V114, P1042, DOI 10.1152/japplphysiol.00984.2012; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Wolin KY, 2008, J PHYS ACT HEALTH, V5, P746, DOI 10.1123/jpah.5.5.746; World Health Organization, 2018, GLOB PHYS ACT QUEST	47	85	88	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136944	10.1371/journal.pone.0136944	http://dx.doi.org/10.1371/journal.pone.0136944			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327457	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700074
J	Mansara, PP; Deshpande, RA; Vaidya, MM; Kaul-Ghanekar, R				Mansara, Prakash P.; Deshpande, Rashmi A.; Vaidya, Milind M.; Kaul-Ghanekar, Ruchika			Differential Ratios of Omega Fatty Acids (AA/EPA plus DHA) Modulate Growth, Lipid Peroxidation and Expression of Tumor Regulatory MARBPs in Breast Cancer Cell Lines MCF7 and MDA-MB-231	PLOS ONE			English	Article							FISH-OIL; EICOSAPENTAENOIC ACID; DOCOSAHEXAENOIC ACID; GENETIC-VARIATION; ARACHIDONIC-ACID; CORN-OIL; N-3; ACTIVATION; SMAR1; DIET	Omega 3 (n3) and Omega 6 (n6) polyunsaturated fatty acids (PUFAs) have been reported to exhibit opposing roles in cancer progression. Our objective was to determine whether different ratios of n6/n3 (AA/EPA+DHA) FAs could modulate the cell viability, lipid peroxidation, total cellular fatty acid composition and expression of tumor regulatory Matrix Attachment Region binding proteins (MARBPs) in breast cancer cell lines and in noncancerous, MCF10A cells. Low ratios of n6/n3 (1:2.5, 1:4, 1:5, 1:10) FA decreased the viability and growth of MDA-MB-231 and MCF7 significantly compared to the non-cancerous cells (MCF10A). Contrarily, higher n6/n3 FA (2.5:1, 4:1, 5:1, 10:1) decreased the survival of both the cancerous and non-cancerous cell types. Lower ratios of n6/n3 selectively induced LPO in the breast cancer cells whereas the higher ratios induced in both cancerous and non-cancerous cell types. Interestingly, compared to higher n6/n3 FA ratios, lower ratios increased the expression of tumor suppressor MARBP, SMAR1 and decreased the expression of tumor activator Cux/CDP in both breast cancer and non-cancerous, MCF10A cells. Low n6/n3 FAs significantly increased SMAR1 expression which resulted into activation of p21WAF1/CIP1 in MDA-MB-231 and MCF7, the increase being ratio dependent in MDA-MB-231. These results suggest that increased intake of n3 fatty acids in our diet could help both in the prevention as well as management of breast cancer.	[Mansara, Prakash P.; Deshpande, Rashmi A.; Kaul-Ghanekar, Ruchika] Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs IRSHA, Cell & Translat Res Lab, Pune 411043, Maharashtra, India; [Vaidya, Milind M.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc ACTREC, Kharghar 410210, Navi Mumbai, India	Bharati Vidyapeeth Deemed University; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Kaul-Ghanekar, R (corresponding author), Bharati Vidyapeeth Univ, Interact Res Sch Hlth Affairs IRSHA, Cell & Translat Res Lab, Med Coll Campus, Pune 411043, Maharashtra, India.	ruchika.kaulghanekar@gmail.com		MANSARA, PRAKASH/0000-0002-2851-448X	Department of Biotechnology, Government of India [BT/PR-11868/FNS/20/402/2009]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology, Government of India, Grant Number: BT/PR-11868/FNS/20/402/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUELELA SH, 1989, CANCER RES, V49, P1434; Aggarwal BB, 2006, EXPERT OPIN THER TAR, V10, P87, DOI 10.1517/14728222.10.1.87; Alessandri JM, 2008, LIPIDS, V43, P19, DOI 10.1007/s11745-007-3117-6; BEGIN ME, 1986, JNCI-J NATL CANCER I, V77, P1053; BEGIN ME, 1988, J NATL CANCER I, V80, P188, DOI 10.1093/jnci/80.3.188; BEGIN ME, 1986, PROG LIPID RES, V25, P573, DOI 10.1016/0163-7827(86)90116-5; Bernard-Gallon DJ, 2002, BRIT J NUTR, V87, P281, DOI 10.1079/BJN2002522; Brown MD, 2006, BRIT J CANCER, V94, P842, DOI 10.1038/sj.bjc.6603030; Calder PC, 2005, BIOCHEM SOC T, V33, P423, DOI 10.1042/BST0330423; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Chattopadhyay Samit, 2007, Subcell Biochem, V41, P213; Corsetto PA, 2012, CELL BIOCHEM BIOPHYS, V64, P45, DOI 10.1007/s12013-012-9365-y; DAS UN, 1987, FREE RADICAL BIO MED, V3, P9, DOI 10.1016/0891-5849(87)90033-5; Das UN, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-159; Datta K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042224; Deshpande R, 2013, J MOL BIOCH, V2, P26; Donaldson MS, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-19; Ewaschuk JB, 2012, LIPIDS, V47, P1019, DOI 10.1007/s11745-012-3717-7; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Finstad HS, 2000, J LIPID RES, V41, P554; Friesen RW, 2009, J NUTR, V139, P2344, DOI 10.3945/jn.109.112565; Galande S, 2002, CURR CANCER DRUG TAR, V2, P157, DOI 10.2174/1568009023333917; German JB, 2003, J NUTR, V133, p2078S, DOI 10.1093/jn/133.6.2078S; Giltay EJ, 2004, J ENDOCRINOL, V182, P399, DOI 10.1677/joe.0.1820399; Candela CG, 2011, NUTR HOSP, V26, P323, DOI [10.1590/S0212-16112011000200013, 10.3305/nh.2011.26.2.5117]; Goodstine SL, 2003, J NUTR, V133, P1409; Hardman WE, 2001, CLIN CANCER RES, V7, P2041; Harnack K, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-8; HilakiviClarke L, 1996, JNCI-J NATL CANCER I, V88, P1821, DOI 10.1093/jnci/88.24.1821; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kacik M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112081; Kansal S, 2012, NUTR CANCER, V64, P559, DOI 10.1080/01635581.2012.675619; Kansal S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832025; Kansal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084627; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Kaul-Ghanekar R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-350; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Kris-Etherton PM, 2009, PROSTAG LEUKOTR ESS, V81, P99, DOI 10.1016/j.plefa.2009.05.011; Lever E, 2010, J PATHOL, V220, P114, DOI 10.1002/path.2651; Liu JJ, 2014, NUTRIENTS, V6, P5184, DOI 10.3390/nu6115184; MADHAVI N, 1994, CANCER LETT, V84, P31, DOI 10.1016/0304-3835(94)90355-7; Mahadik SP, 1996, PROSTAG LEUKOTR ESS, V55, P65, DOI 10.1016/S0952-3278(96)90147-7; Maillard V, 2002, INT J CANCER, V98, P78, DOI 10.1002/ijc.10130; Malonia SK, 2011, BBA-REV CANCER, V1815, P1, DOI 10.1016/j.bbcan.2010.08.003; MANKU MS, 1983, LIPIDS, V18, P906, DOI 10.1007/BF02534572; Manna S, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-6; Mansara Prakash, 2015, J Med Case Rep, V9, P148, DOI 10.1186/s13256-015-0619-3; Merendino N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/310186; Michl P, 2005, CANCER CELL, V7, P521, DOI 10.1016/j.ccr.2005.05.018; Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; Pachikian BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023365; SAGAR PS, 1995, PROSTAG LEUKOTR ESS, V53, P287, DOI 10.1016/0952-3278(95)90129-9; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Sarotra P, 2010, LIPIDS, V45, P785, DOI 10.1007/s11745-010-3459-3; Shin S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/568671; Signori C, 2011, CANCER RES, V71, P6091, DOI 10.1158/0008-5472.CAN-11-0977; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Simopoulos AP, 2008, ASIA PAC J CLIN NUTR, V17, P131; Singh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000660; Sjakste N, 2004, EXP ONCOL, V26, P170; Skerrett P J, 2003, Prev Cardiol, V6, P38, DOI 10.1111/j.1520-037X.2003.00959.x; Stoll BA, 2002, BRIT J NUTR, V87, P193, DOI [10.1079/BJN2001512, 10.1079/BJNBJN2001512]; Sun H, 2008, CANCER RES, V68, P2912, DOI 10.1158/0008-5472.CAN-07-2305; Vadnais C, 2014, BIOL OPEN, V3, P937, DOI 10.1242/bio.20148193; Vessby B, 2003, CURR OPIN LIPIDOL, V14, P15, DOI 10.1097/00041433-200302000-00004; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Wani KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107315; Wu M, 2005, INT J CANCER, V117, P340, DOI 10.1002/ijc.21238; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Zhu Q, 2004, MOL CELL BIOL, V24, P4810, DOI 10.1128/MCB.24.11.4810-4823.2004	74	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136542	10.1371/journal.pone.0136542	http://dx.doi.org/10.1371/journal.pone.0136542			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325577	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700048
J	Verma, RK; Gralla, J; Klinger-Gratz, PP; Schankath, A; Jung, S; Mordasini, P; Zubler, C; Arnold, M; Buehlmann, M; Lang, MF; El-Koussy, M; Hsieh, K				Verma, Rajeev Kumar; Gralla, Jan; Klinger-Gratz, Pascal Pedro; Schankath, Adrian; Jung, Simon; Mordasini, Pasquale; Zubler, Christoph; Arnold, Marcel; Buehlmann, Monika; Lang, Matthias F.; El-Koussy, Marwan; Hsieh, Kety			Infarction Distribution Pattern in Acute Stroke May Predict the Extent of Leptomeningeal Collaterals	PLOS ONE			English	Article							CT ANGIOGRAPHY; ENDOVASCULAR THERAPY; FLOW; IMPACT; HYPERINTENSITY; THROMBOLYSIS; SCORE	Objective The aim of this study was to evaluate whether the distribution pattern of early ischemic changes in the initial MRI allows a practical method for estimating leptomeningeal collateralization in acute ischemic stroke (AIS). Methods Seventy-four patients with AIS underwent MRI followed by conventional angiogram and mechanical thrombectomy. Diffusion restriction in Diffusion weighted imaging (DWI) and correlated T2-hyperintensity of the infarct were retrospectively analyzed and subdivided in accordance with Alberta Stroke Program Early CT score (ASPECTS). Patients were angiographically graded in collateralization groups according to the method of Higashida, and dichotomized in 2 groups: 29 subjects with collateralization grade 3 or 4 (well-collateralized group) and 45 subjects with grade 1 or 2 (poorly-collateralized group). Individual ASPECTS areas were compared among the groups. Results Means for overall DWI-ASPECTS were 6.34 vs. 4.51 (well vs. poorly collateralized groups respectively), and for T2-ASPECTS 9.34 vs 8.96. A significant difference between groups was found for DWI-ASPECTS (p<0.001), but not for T2-ASPECTS (p = 0.088). Regarding the individual areas, only insula, M1-M4 and M6 showed significantly fewer infarctions in the well-collateralized group (p-values <0.001 to 0.015). 89% of patients in the well-collateralized group showed 0-2 infarctions in these six areas (44.8% with 0 infarctions), while 59.9% patients of the poor-collateralized group showed 3-6 infarctions. Conclusion Patients with poor leptomeningeal collateralization show more infarcts on the initial MRI, particularly in the ASPECTS areas M1 to M4, M6 and insula. Therefore DWI abnormalities in these areas may be a surrogate marker for poor leptomeningeal collaterals and may be useful for estimation of the collateral status in routine clinical evaluation.	[Verma, Rajeev Kumar; Gralla, Jan; Klinger-Gratz, Pascal Pedro; Schankath, Adrian; Mordasini, Pasquale; Zubler, Christoph; Lang, Matthias F.; El-Koussy, Marwan; Hsieh, Kety] Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Verma, Rajeev Kumar] Spital Netz Bern, Tiefenau Hosp, Inst Radiol, Bern, Switzerland; [Jung, Simon; Arnold, Marcel; Buehlmann, Monika] Univ Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Verma, RK (corresponding author), Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland.	verma@gmx.ch	Mordasini, Pasquale/H-8321-2015					Bang OY, 2008, J NEUROL NEUROSUR PS, V79, P625, DOI 10.1136/jnnp.2007.132100; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Cho AH, 2008, STROKE, V39, P3424, DOI 10.1161/STROKEAHA.108.516740; Christoforidis GA, 2005, AM J NEURORADIOL, V26, P1789; Frolich AMJ, 2014, EUR RADIOL, V24, P390, DOI 10.1007/s00330-013-3024-6; Galimanis A, 2012, STROKE, V43, P1052, DOI 10.1161/STROKEAHA.111.639112; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Jung S, 2013, BRAIN, V136, P3554, DOI 10.1093/brain/awt246; Kim SJ, 2014, ANN NEUROL, V76, P356, DOI 10.1002/ana.24211; Kufner A, 2013, EUR J NEUROL, V20, P281, DOI 10.1111/j.1468-1331.2012.03841.x; Liebeskind DS, 2014, STROKE, V45, P2036, DOI 10.1161/STROKEAHA.114.004781; Liebeskind DS, 2014, STROKE, V45, P759, DOI 10.1161/STROKEAHA.113.004072; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Lima FO, 2010, STROKE, V41, P2316, DOI 10.1161/STROKEAHA.110.592303; Malik N, 2014, J STROKE CEREBROVASC, V23, P2018, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.018; Marks MP, 2014, STROKE, V45, P1035, DOI 10.1161/STROKEAHA.113.004085; Menon BK, 2013, J CEREBR BLOOD F MET, V33, P365, DOI 10.1038/jcbfm.2012.171; Nicoli F, 2014, NEURORADIOLOGY, V56, P117, DOI 10.1007/s00234-013-1310-2; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Qureshi Adnan I, 2008, J Vasc Interv Neurol, V1, P70; Ramaiah SS, 2014, J STROKE CEREBROVASC, V23, P399, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.012; Shin NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107379; Souza LCS, 2012, AM J NEURORADIOL, V33, P1331, DOI 10.3174/ajnr.A2985; Verma RK, 2014, EUR J RADIOL, V83, P1448, DOI 10.1016/j.ejrad.2014.05.001; Yeo LLL, 2015, AM J NEURORADIOL, V36, P289, DOI 10.3174/ajnr.A4117	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137292	10.1371/journal.pone.0137292	http://dx.doi.org/10.1371/journal.pone.0137292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327519	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700108
J	Wong, TH; Nguyen, HV; Chiu, MT; Chow, KY; Ong, MEH; Lim, GH; Nadkarni, NV; Bautista, DCT; Cheng, JYX; Loo, LMA; Seow, DCC				Wong, Ting Hway; Nguyen, Hai V.; Chiu, Ming Terk; Chow, Khuan Yew; Ong, Marcus Eng Hock; Lim, Gek Hsiang; Nadkarni, Nivedita Vikas; Bautista, Dianne Carrol Tan; Cheng, Jolene Yu Xuan; Loo, Lynette Mee Ann; Seow, Dennis Chuen Chai			The Low Fall as a Surrogate Marker of Frailty Predicts Long-Term Mortality in Older Trauma Patients	PLOS ONE			English	Article							INJURY SEVERITY SCORE; GERIATRIC TRAUMA; HIP FRACTURE; INTERNATIONAL CONSENSUS; CONSULTATION SERVICE; GENDER-DIFFERENCES; ELDERLY TRAUMA; BLUNT TRAUMA; RISK-FACTORS; OUTCOMES	Background Frailty is associated with adverse outcomes including disability, mortality and risk of falls. Trauma registries capture a broad range of injuries. However, frail patients who fall comprise a large proportion of the injuries occurring in ageing populations and are likely to have different outcomes compared to non-frail injured patients. The effect of frail fallers on mortality is under-explored but potentially significant. Currently, many trauma registries define low falls as less than three metres, a height that is likely to include non-frailty falls. We hypothesized that the low fall from less than 0.5 metres, including same-level falls, is a surrogate marker of frailty and predicts long-term mortality in older trauma patients. Methods Using data from the Singapore National Trauma Registry, 2011-2013, matched till September 2014 to the death registry, we analysed adults aged over 45 admitted via the emergency department in public hospitals sustaining blunt injuries with an injury severity score (ISS) of 9 or more, excluding isolated hip fractures from same-level falls in the over 65. Patients injured by a low fall were compared to patients injured by high fall and other blunt mechanisms. Logistic regression was used to analyze 12-month mortality, controlling for mechanism of injury, ISS, revised trauma score (RTS), co-morbidities, gender, age and age-gender interaction. Different low fall height definitions, adjusting for injury regions, and analyzing the entire adult cohort were used in sensitivity analyses and did not change our findings. Results Of the 8111 adults in our cohort, patients who suffered low falls were more likely to die of causes unrelated to their injuries (p<0.001), compared to other blunt trauma and higher fall heights. They were at higher risk of 12-month mortality (OR 1.75, 95% CI 1.18-2.58, p = 0.005), independent of ISS, RTS, age, gender, age-gender interaction and co-morbidities. Falls that were higher than 0.5m did not show this pattern. Males were at higher risk of mortality after low falls. The effect of age on mortality started at age 55 for males, and age 70 for females, and the difference was attributable to the additional mortality in male low-fallers. Conclusions The low fall mechanism can optimize prediction of long-term mortality after moderate and severe injury, and may be a surrogate marker of frailty, complementing broader-based studies on aging.	[Wong, Ting Hway; Ong, Marcus Eng Hock; Seow, Dennis Chuen Chai] Singapore Gen Hosp, Singapore, Singapore; [Wong, Ting Hway; Nguyen, Hai V.; Ong, Marcus Eng Hock; Nadkarni, Nivedita Vikas; Bautista, Dianne Carrol Tan] Duke Natl Univ Singapore, Singapore, Singapore; [Chiu, Ming Terk; Cheng, Jolene Yu Xuan] Tan Tock Seng Hosp, Singapore, Singapore; [Chow, Khuan Yew; Lim, Gek Hsiang] Hlth Promot Board, Singapore, Singapore; [Loo, Lynette Mee Ann] Natl Univ Hosp Syst, Singapore, Singapore	Singapore General Hospital; National University of Singapore; Tan Tock Seng Hospital; National University of Singapore	Wong, TH (corresponding author), Singapore Gen Hosp, Singapore, Singapore.	wong.ting.hway@sgh.com.sg	Loo, Lynette Mee Ann/A-4519-2018		Ministry of Health, Singapore	Ministry of Health, Singapore	The authors received no specific individual funding for this work. The collection and management of data for the National Trauma Registry is funded by the Ministry of Health, Singapore.	Abraham CM, 2014, ARCH PHYS MED REHAB, V95, P2382, DOI 10.1016/j.apmr.2014.08.005; Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; Al West T, 2000, J TRAUMA, V49, P530, DOI 10.1097/00005373-200009000-00022; American College of Surgeons Committee on T, 2014, NAT TRAUM DAT STAND; Ayoung-Chee P, 2014, J TRAUMA ACUTE CARE, V76, P498, DOI 10.1097/TA.0000000000000102; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brooks SE, 2014, J AM COLL SURGEONS, V219, P1020, DOI 10.1016/j.jamcollsurg.2014.08.001; Butcher N, 2009, INJURY, V40, pS12, DOI 10.1016/j.injury.2009.10.032; Caterino JM, 2010, AM J EMERG MED, V28, P151, DOI 10.1016/j.ajem.2008.10.027; Centers for Disease C Prevention, 2011, PROP MATR E COD GROU; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chien WC, 2013, INT J INJ CONTROL SA, V20, P50, DOI 10.1080/17457300.2012.674042; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; Davie G, 2008, INJURY PREV, V14, P250, DOI 10.1136/ip.2007.017640; Fallon WF, 2006, J TRAUMA, V61, P1040, DOI 10.1097/01.ta.0000238652.48008.59; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gelbard R, 2014, AM J SURG, V208, P249, DOI 10.1016/j.amjsurg.2013.12.034; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Goodmanson NW, 2012, SURGERY, V152, P668, DOI 10.1016/j.surg.2012.08.017; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Haider AH, 2009, J SURG RES, V153, P138, DOI 10.1016/j.jss.2008.04.011; Ho AF, 2014, PREHOSPITAL EMERGENC; Holt G, 2008, J BONE JOINT SURG BR, V90B, P480, DOI 10.1302/0301-620X.90B4.20264; Hranjec T, 2012, AM SURGEON, V78, P1369; Hwabejire JO, 2014, JAMA SURG, V149, P1054, DOI 10.1001/jamasurg.2014.473; Ichwan B, 2014, ANN EMERG MED; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Joseph B, 2014, J AM COLL SURGEONS, V219, P10, DOI 10.1016/j.jamcollsurg.2014.03.020; Kelley-Quon L, 2010, AM SURGEON, V76, P1055; Koh GCH, 2013, OSTEOPOROSIS INT, V24, P1981, DOI 10.1007/s00198-012-2183-7; Krishnan M, 2014, AGE AGEING, V43, P122, DOI 10.1093/ageing/aft084; Labib N, 2011, J TRAUMA, V71, P1908, DOI 10.1097/TA.0b013e31820989ed; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; Lenartowicz M, 2012, ANN SURG, V256, P1098, DOI 10.1097/SLA.0b013e318270f27a; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Matsushima K, 2014, JAMA SURG, V149, P319, DOI 10.1001/jamasurg.2013.4834; McKevitt EC, 2003, CAN J SURG, V46, P211; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; Moisey LL, 2013, CRIT CARE, V17, DOI 10.1186/cc12901; Moore L, 2012, INJURY, V43, P1580, DOI 10.1016/j.injury.2011.02.010; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; National Registry of Diseases Office Singapore, 2014, NAT TRAUM REG ANN RE; Oyetunji TA, 2012, J SURG RES, V173, P206, DOI 10.1016/j.jss.2011.05.003; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Puts MTE, 2005, J AM GERIATR SOC, V53, P40, DOI 10.1111/j.1532-5415.2005.53008.x; Romero-Ortuno R, 2012, AGE AGEING, V41, P684, DOI 10.1093/ageing/afs051; Schoeneberg C, 2013, CRITICAL CARE LONDON, V17, P10; Sletvold O, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-18; Sterling RS, 2011, CLIN ORTHOP RELAT R, V469, P1913, DOI 10.1007/s11999-010-1736-3; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x; Syddall H, 2010, AGE AGEING, V39, P197, DOI 10.1093/ageing/afp204; Tebby J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-111; Thompson HJ, 2010, ANN SURG, V252, P370, DOI 10.1097/SLA.0b013e3181df03d6; Tillou A, 2014, JAMA SURG, V149, P83, DOI 10.1001/jamasurg.2013.4244; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; Wasserman EB, 2014, PREHOSPITAL EMERGENC; Watne LO, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-63; Wehren LE, 2003, J BONE MINER RES, V18, P2231, DOI 10.1359/jbmr.2003.18.12.2231	62	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137127	10.1371/journal.pone.0137127	http://dx.doi.org/10.1371/journal.pone.0137127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327646	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700098
J	Gessner, DK; Grone, B; Couturier, A; Rosenbaum, S; Hillen, S; Becker, S; Erhardt, G; Reiner, G; Ringseis, R; Eder, K				Gessner, Denise K.; Groene, Birthe; Couturier, Aline; Rosenbaum, Susann; Hillen, Sonja; Becker, Sabrina; Erhardt, Georg; Reiner, Gerald; Ringseis, Robert; Eder, Klaus			Dietary Fish Oil Inhibits Pro-Inflammatory and ER Stress Signalling Pathways in the Liver of Sows during Lactation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED RECEPTOR-ALPHA; POLYUNSATURATED FATTY-ACIDS; FACTOR E2-RELATED FACTOR-2; ACUTE-PHASE RESPONSE; C-REACTIVE PROTEIN; TRANSITION PERIOD; DAIRY-COWS; OXIDATIVE STRESS; KAPPA-B	Lactating sows have been shown to develop typical signs of an inflammatory condition in the liver during the transition from pregnancy to lactation. Hepatic inflammation is considered critical due to the induction of an acute phase response and the activation of stress signaling pathways like the endoplasmic reticulum (ER) stress-induced unfolded protein response (UPR), both of which impair animal's health and performance. Whether ER stress-induced UPR is also activated in the liver of lactating sows and whether dietary fish oil as a source of anti-inflammatory effects n-3 PUFA is able to attenuate hepatic inflammation and ER stress-induced UPR in the liver of sows is currently unknown. Based on this, two experiments with lactating sows were performed. The first experiment revealed that ER stress-induced UPR occurs also in the liver of sows during lactation. This was evident from the up-regulation of a set of genes regulated by the UPR and numerically increased phosphorylation of the ER stress-transducer PERK and PERK-mediated phosphorylation of eIF2 alpha and I kappa B. The second experiment showed that fish oil inhibits ER stress-induced UPR in the liver of lactating sows. This was demonstrated by decreased mRNA levels of a number of UPR-regulated genes and reduced phosphorylation of PERK and PERK-mediated phosphorylation of eIF2 alpha and I kappa B in the liver of the fish oil group. The mRNA levels of various nuclear factor-kappa B-regulated genes encoding inflammatory mediators and acute phase proteins in the liver of lactating sows were also reduced in the fish oil group. In line with this, the plasma levels of acute phase proteins were reduced in the fish oil group, although differences to the control group were not significant. In conclusion, ER stress-induced UPR is present in the liver of lactating sows and fish oil is able to inhibit inflammatory signaling pathways and ER stress-induced UPR in the liver.	[Gessner, Denise K.; Groene, Birthe; Couturier, Aline; Rosenbaum, Susann; Ringseis, Robert; Eder, Klaus] Univ Giessen, Inst Anim Nutr & Nutr Physiol, D-35392 Giessen, Germany; [Hillen, Sonja; Becker, Sabrina; Reiner, Gerald] Univ Giessen, Dept Vet Clin Sci, Swine Dis, D-35392 Giessen, Germany; [Erhardt, Georg] Univ Giessen, Inst Anim Breeding & Genet, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Eder, K (corresponding author), Univ Giessen, Inst Anim Nutr & Nutr Physiol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	klaus.eder@ernaehrung.uni-giessen.de	Ringseis, Robert/AAH-1509-2021		German Research Foundation (Deutsche Forschungsgemeinschaft) [ED 70/9-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Funding: This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, grant number: ED 70/9-1, www.dfg.de) which financed the PhD position of SR and costs for the animal experiment and the analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO RJ, 1984, J DAIRY SCI, V67, P1707, DOI 10.3168/jds.S0022-0302(84)81496-4; Bossaert P, 2012, VET J, V192, P222, DOI 10.1016/j.tvjl.2011.06.004; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; COLLIER RJ, 1984, J ANIM SCI, V59, P498, DOI 10.2527/jas1984.592498x; Cray C, 2009, COMPARATIVE MED, V59, P517; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; Dewey KG, 1997, ANNU REV NUTR, V17, P19, DOI 10.1146/annurev.nutr.17.1.19; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Eckersall PD, 1996, VET IMMUNOL IMMUNOP, V51, P377, DOI 10.1016/0165-2427(95)05527-4; Feillet-Coudray C, 2013, BRIT J NUTR, V110, P1789, DOI 10.1017/S0007114513001311; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gessner DK, 2016, J ANIM PHYSIOL AN N, V100, P337, DOI 10.1111/jpn.12324; Gessner DK, 2013, J DAIRY SCI, V96, P1038, DOI 10.3168/jds.2012-5967; Gessner DK, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0368-y; Gessner DK, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-18; GESSNER DK, 2014, BMC VET RES, V10; Gutgesell A, 2009, J MOL ENDOCRINOL, V43, P241, DOI 10.1677/JME-09-0064; Gutgesell A, 2009, METABOLISM, V58, P226, DOI 10.1016/j.metabol.2008.09.018; Heegaard PMH, 1998, COMP BIOCHEM PHYS B, V119, P365, DOI 10.1016/S0305-0491(97)00362-3; Hsu JM, 2004, J ANIM SCI, V82, P683; Hulten C, 2003, VET MICROBIOL, V95, P75, DOI 10.1016/S0378-1135(03)00136-6; Katoh N, 2002, J VET MED SCI, V64, P293, DOI 10.1292/jvms.64.293; Kovac G, 2008, ACTA VET-BEOGRAD, V58, P459, DOI 10.2298/AVB0806459K; Lee JS, 2012, TOXICOL LETT, V211, P29, DOI 10.1016/j.toxlet.2012.02.017; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miles EA, 2012, BRIT J NUTR, V107, pS171, DOI 10.1017/S0007114512001560; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Myhrstad MCW, 2011, INFLAMM RES, V60, P309, DOI 10.1007/s00011-010-0302-5; Papadopoulos GA, 2009, BRIT J NUTR, V101, P348, DOI 10.1017/S0007114508026160; Ringseis R, 2011, MOL NUTR FOOD RES, V55, pS193, DOI 10.1002/mnfr.201100040; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rooke JA, 2001, BRIT J NUTR, V86, P21, DOI 10.1079/BJN2001363; Rooke JA, 2001, BRIT J NUTR, V86, P461, DOI 10.1079/BJN2001422; Rosenbaum S, 2012, COMP BIOCHEM PHYS D, V7, P370, DOI 10.1016/j.cbd.2012.09.001; Rosenbaum S, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-59; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Salamano G, 2008, VET J, V177, P110, DOI 10.1016/j.tvjl.2007.03.015; Samali Afshin, 2010, Int J Cell Biol, V2010, P830307, DOI 10.1155/2010/830307; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Smith MS, 2002, FRONT NEUROENDOCRIN, V23, P225, DOI 10.1016/S0091-3022(02)00002-X; Smits RJ, 2011, J ANIM SCI, V89, P2731, DOI 10.2527/jas.2010-3593; TRAYHURN P, 1982, NATURE, V298, P59, DOI 10.1038/298059a0; TROTTIER NL, 1995, J ANIM SCI, V73, P1086; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WILLIAMSON DH, 1986, BIOCHEM SOC T, V14, P225, DOI 10.1042/bst0140225; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	50	13	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137684	10.1371/journal.pone.0137684	http://dx.doi.org/10.1371/journal.pone.0137684			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351857	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800107
J	Kane, P; Zollman, KJS				Kane, Patrick; Zollman, Kevin J. S.			An Evolutionary Comparison of the Handicap Principle and Hybrid Equilibrium Theories of Signaling	PLOS ONE			English	Article							SIMPLE-MODEL; COST; TALK; GAME; COMMUNICATION; PREDATION; RELATIVES	The handicap principle has come under significant challenge both from empirical studies and from theoretical work. As a result, a number of alternative explanations for honest signaling have been proposed. This paper compares the evolutionary plausibility of one such alternative, the "hybrid equilibrium," to the handicap principle. We utilize computer simulations to compare these two theories as they are instantiated in Maynard Smith's Sir Philip Sidney game. We conclude that, when both types of communication are possible, evolution is unlikely to lead to handicap signaling and is far more likely to result in the partially honest signaling predicted by hybrid equilibrium theory.	[Kane, Patrick] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Zollman, Kevin J. S.] Carnegie Mellon Univ, Dept Philosophy, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Zollman, KJS (corresponding author), Carnegie Mellon Univ, Dept Philosophy, Pittsburgh, PA 15213 USA.	kzollman@andrew.cmu.edu		Zollman, Kevin/0000-0001-9776-1890	National Science Foundation [EF 1038456]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant No. EF 1038456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GAMES, DOI DOI 10.1016/j.paid.2008.09.031; Bergstrom CT, 1998, P NATL ACAD SCI USA, V95, P5100, DOI 10.1073/pnas.95.9.5100; Bergstrom CT, 2002, PHILOS T R SOC B, V357, P1595, DOI 10.1098/rstb.2002.1068; Bergstrom CT, 1997, PHILOS T ROY SOC B, V352, P609, DOI 10.1098/rstb.1997.0041; BORGIA G, 1993, AM NAT, V141, P729, DOI 10.1086/285502; Caro TM, 1995, BEHAV ECOL, V6, P442, DOI 10.1093/beheco/6.4.442; CHAPPELL MA, 1995, ANIM BEHAV, V49, P255, DOI 10.1016/0003-3472(95)80177-4; Crawford V, 1998, J ECON THEORY, V78, P286, DOI 10.1006/jeth.1997.2359; Cressman R, 2003, ECON LEARN SOC EVOL, P1; Gaunt AS, 1996, AUK, V113, P718, DOI 10.2307/4089004; Grafe TU, 2007, ETHOLOGY, V113, P772, DOI 10.1111/j.1439-0310.2007.01378.x; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Grose J, 2011, BIOL PHILOS, V26, P677, DOI 10.1007/s10539-011-9275-1; Haskell DG, 1999, ANIM BEHAV, V57, P893, DOI 10.1006/anbe.1998.1053; Hofbauer J, 1998, EVOLUTIONARY GAMES P; HORN AG, 1995, ANIM BEHAV, V50, P1171, DOI 10.1016/0003-3472(95)80033-6; Hurd PL, 1997, J THEOR BIOL, V184, P83, DOI 10.1006/jtbi.1996.0246; HURD PL, 1995, J THEOR BIOL, V174, P217, DOI 10.1006/jtbi.1995.0093; Huttegger SM, 2016, DYN GAMES APPL, V6, P347, DOI 10.1007/s13235-015-0159-x; Huttegger SM, 2013, BRIT J PHILOS SCI, V64, P637, DOI 10.1093/bjps/axs035; Huttegger SM, 2010, P ROY SOC B-BIOL SCI, V277, P1915, DOI 10.1098/rspb.2009.2105; JOHNSTONE RA, 1992, J THEOR BIOL, V156, P215, DOI 10.1016/S0022-5193(05)80674-5; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Leech SM, 1997, BEHAV ECOL, V8, P644, DOI 10.1093/beheco/8.6.644; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; McCarty JP, 1996, AUK, V113, P178, DOI 10.2307/4088944; Palagi E, 2009, AM J PHYS ANTHROPOL, V139, P182, DOI 10.1002/ajpa.20971; Pomiankowski A, 1998, EVOLUTION, V52, P928, DOI [10.1111/j.1558-5646.1998.tb03720.x, DOI 10.1111/J.1558-5646.1998.TB03720.X]; Rodriguez-Girones MA, 1998, P NATL ACAD SCI USA, V95, P4453, DOI 10.1073/pnas.95.8.4453; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Silk JB, 2000, ANIM BEHAV, V59, P423, DOI 10.1006/anbe.1999.1312; Smith CL, 2008, J EXP BIOL, V211, P2052, DOI 10.1242/jeb.017194; SMITH JM, 1991, ANIM BEHAV, V42, P1034, DOI 10.1016/S0003-3472(05)80161-7; Szamado S, 2000, ANIM BEHAV, V59, P221, DOI 10.1006/anbe.1999.1293; Szamado S, 1999, J THEOR BIOL, V198, P593, DOI 10.1006/jtbi.1999.0935; Szamado S, 2011, ANIM BEHAV, V81, P3, DOI 10.1016/j.anbehav.2010.08.022; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zahavi A, 1997, HANDICAP PRINCIPLE M; Zollman Kevin J. S., 2013, Biology Theory, V8, P127, DOI 10.1007/s13752-013-0107-1; Zollman KJS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1878	41	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137271	10.1371/journal.pone.0137271	http://dx.doi.org/10.1371/journal.pone.0137271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348617	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600030
J	Shiga, T; Althen, H; Cornella, M; Zarnowiec, K; Yabe, H; Escera, C				Shiga, Tetsuya; Althen, Heike; Cornella, Miriam; Zarnowiec, Katarzyna; Yabe, Hirooki; Escera, Carles			Deviance-Related Responses along the Auditory Hierarchy: Combined FFR, MLR and MMN Evidence	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; STIMULUS-SPECIFIC ADAPTATION; FEATURE CONJUNCTIONS; BRAIN-STEM; ELECTROPHYSIOLOGICAL EVIDENCE; EVOKED-POTENTIALS; NOVELTY DETECTION; SENSORY MEMORY; REGULARITY; CORTEX	The mismatch negativity (MMN) provides a correlate of automatic auditory discrimination in human auditory cortex that is elicited in response to violation of any acoustic regularity. Recently, deviance-related responses were found at much earlier cortical processing stages as reflected by the middle latency response (MLR) of the auditory evoked potential, and even at the level of the auditory brainstem as reflected by the frequency following response (FFR). However, no study has reported deviance-related responses in the FFR, MLR and long latency response (LLR) concurrently in a single recording protocol. Amplitude-modulated (AM) sounds were presented to healthy human participants in a frequency oddball paradigm to investigate deviance-related responses along the auditory hierarchy in the ranges of FFR, MLR and LLR. AM frequency deviants modulated the FFR, the Na and Nb components of the MLR, and the LLR eliciting the MMN. These findings demonstrate that it is possible to elicit deviance-related responses at three different levels (FFR, MLR and LLR) in one single recording protocol, highlight the involvement of the whole auditory hierarchy in deviance detection and have implications for cognitive and clinical auditory neuroscience. Moreover, the present protocol provides a new research tool into clinical neuroscience so that the functional integrity of the auditory novelty system can now be tested as a whole in a range of clinical populations where the MMN was previously shown to be defective.	[Shiga, Tetsuya; Althen, Heike; Cornella, Miriam; Zarnowiec, Katarzyna; Escera, Carles] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Catalonia, Spain; [Shiga, Tetsuya; Althen, Heike; Cornella, Miriam; Zarnowiec, Katarzyna; Escera, Carles] Univ Barcelona, Cognit Neurosci Res Grp, Dept Psychiat & Clin Psychobiol, Barcelona, Catalonia, Spain; [Shiga, Tetsuya; Yabe, Hirooki] Fukushima Med Univ, Dept Neuropsychiat, Fukushima, Japan	University of Barcelona; University of Barcelona; Fukushima Medical University	Shiga, T (corresponding author), Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Catalonia, Spain.	tetsuya3@fmu.ac.jp	Escera, Carles/A-8658-2010; Althen, Heike/E-2435-2016	Escera, Carles/0000-0001-8203-2951; Cornella, Miriam/0000-0002-2745-4518	Spanish Ministry of Economy and Knowledge [PSI2012-37174]; Excellence Research Group of the Generalitat de Catalunya [2014SGR-177]; ICREA Academia Distinguished Professorship award	Spanish Ministry of Economy and Knowledge(Spanish Government); Excellence Research Group of the Generalitat de Catalunya(Generalitat de Catalunya); ICREA Academia Distinguished Professorship award(ICREA)	This work was supported by the PSI2012-37174 grant from the Spanish Ministry of Economy and Knowledge, the 2014SGR-177 Excellence Research Group of the Generalitat de Catalunya, and the ICREA Academia Distinguished Professorship awarded to Carles Escera.	Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Alho K, 2012, EUR J NEUROSCI, V36, P2972, DOI 10.1111/j.1460-9568.2012.08219.x; Althen Heike, 2013, Tropical Medicine & International Health, V18, P3448, DOI 10.1111/ejn.12346; Althen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028522; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Bidelman GM, 2015, NEUROPSYCHOLOGIA, V68, P38, DOI 10.1016/j.neuropsychologia.2014.12.020; Bidelman GM, 2015, J NEUROSCI METH, V241, P94, DOI 10.1016/j.jneumeth.2014.12.019; Bidelman GM, 2014, NEUROBIOL AGING, V35, P2526, DOI 10.1016/j.neurobiolaging.2014.05.006; Bidelman GM, 2014, EUR J NEUROSCI, V40, P2662, DOI 10.1111/ejn.12627; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cacciaglia R, 2015, NEUROPSYCHOLOGIA, V68, P51, DOI 10.1016/j.neuropsychologia.2015.01.001; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; Cornella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043604; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Deouell LY, 2007, J PSYCHOPHYSIOL, V21, P188, DOI 10.1027/0269-8803.21.34.188; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Escera C, 2014, BRAIN TOPOGR, V27, P527, DOI 10.1007/s10548-013-0328-4; Escera C, 2014, PSYCHOPHYSIOLOGY, V51, P111, DOI 10.1111/psyp.12156; Gil-Da-Costa R, 2013, P NATL ACAD SCI USA, V110, P15425, DOI 10.1073/pnas.1312264110; Gomes H, 1997, PSYCHOPHYSIOLOGY, V34, P712, DOI 10.1111/j.1469-8986.1997.tb02146.x; Grimm S, 2012, BIOL PSYCHOL, V89, P232, DOI 10.1016/j.biopsycho.2011.10.014; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jackson AF, 2014, PSYCHOPHYSIOLOGY, V51, P1061, DOI 10.1111/psyp.12283; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Kleiner M, 2007, PERCEPTION, V36, P14; Lepisto T, 2006, CLIN NEUROPHYSIOL, V117, P2161, DOI 10.1016/j.clinph.2006.06.709; Leung S, 2013, CLIN NEUROPHYSIOL, V124, P2397, DOI 10.1016/j.clinph.2013.06.001; Leung S, 2012, PSYCHOPHYSIOLOGY, V49, P933, DOI 10.1111/j.1469-8986.2012.01375.x; Maess B, 2007, NEUROIMAGE, V37, P561, DOI 10.1016/j.neuroimage.2007.05.040; Malmierca MS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00111; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Malone BJ, 2015, J NEUROSCI, V35, P5904, DOI 10.1523/JNEUROSCI.4833-14.2015; Mullen T., 2012, CLEANLINE EEGLAB PLU; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2012, CLIN NEUROPHYSIOL, V123, P424, DOI 10.1016/j.clinph.2011.09.020; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; Naatanen R, 2000, AUDIOL NEURO-OTOL, V5, P105, DOI 10.1159/000013874; Naatanen R, 2015, INT J PSYCHOPHYSIOL, V95, P338, DOI 10.1016/j.ijpsycho.2014.12.012; Naatanen R, 2011, BRAIN, V134, P3432, DOI 10.1093/brain/awr064; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Opitz B, 2005, EUR J NEUROSCI, V21, P531, DOI 10.1111/j.1460-9568.2005.03839.x; PAAVILAINEN P, 1991, ELECTROEN CLIN NEURO, V78, P466, DOI 10.1016/0013-4694(91)90064-B; Pakarinen S, 2007, CLIN NEUROPHYSIOL, V118, P177, DOI 10.1016/j.clinph.2006.09.001; Pakarinen S, 2009, BIOL PSYCHOL, V82, P219, DOI 10.1016/j.biopsycho.2009.07.008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; Recasens M, 2014, HUM BRAIN MAPP, V35, P5701, DOI 10.1002/hbm.22582; Recasens M, 2014, CEREB CORTEX, V24, P143, DOI 10.1093/cercor/bhs295; Sawada M, 2008, PSYCHIAT CLIN NEUROS, V62, P479, DOI 10.1111/j.1440-1819.2008.01835.x; Schonwiesner M, 2007, J NEUROPHYSIOL, V97, P2075, DOI 10.1152/jn.01083.2006; Schroger E, 2014, BRAIN TOPOGR, V27, P565, DOI 10.1007/s10548-013-0334-6; Schroger E, 1996, NEUROREPORT, V7, P3005, DOI 10.1097/00001756-199611250-00041; Slabu L, 2012, J NEUROSCI, V32, P1447, DOI 10.1523/JNEUROSCI.2557-11.2012; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; Sonnadara RR, 2006, BRAIN RES, V1076, P187, DOI 10.1016/j.brainres.2005.12.093; Sussman E, 1998, BRAIN RES, V793, P95, DOI 10.1016/S0006-8993(98)00164-4; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Takegata R, 1999, NEUROSCI LETT, V266, P109, DOI 10.1016/S0304-3940(99)00267-0; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Yvert B, 2005, NEUROIMAGE, V28, P140, DOI 10.1016/j.neuroimage.2005.05.056; Yvert B, 2001, CEREB CORTEX, V11, P411, DOI 10.1093/cercor/11.5.411	73	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136794	10.1371/journal.pone.0136794	http://dx.doi.org/10.1371/journal.pone.0136794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348628	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600012
J	Madhavan, L; Daley, BF; Davidson, BL; Boudreau, RL; Lipton, JW; Cole-Strauss, A; Steece-Collier, K; Collier, TJ				Madhavan, Lalitha; Daley, Brian F.; Davidson, Beverly L.; Boudreau, Ryan L.; Lipton, Jack W.; Cole-Strauss, Allyson; Steece-Collier, Kathy; Collier, Timothy J.			Sonic Hedgehog Controls the Phenotypic Fate and Therapeutic Efficacy of Grafted Neural Precursor Cells in a Model of Nigrostriatal Neurodegeneration	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; STEM-CELLS; PARKINSONS-DISEASE; RAT MODEL; SUBVENTRICULAR ZONE; NEUROTROPHIC FACTOR; ADULT RATS; NEUROPROTECTION; TRANSPLANTATION	The expression of soluble growth and survival promoting factors by neural precursor cells (NPCs) is suggested to be a prominent mechanism underlying the protective and regenerative effects of these cells after transplantation. Nevertheless, how and to what extent specific NPC-expressed factors contribute to therapeutic effects is not well understood. Using RNA silencing, the current study investigated the roles of two donor NPC molecules, namely glial cell-line derived neurotrophic factor (GDNF) and sonic hedgehog (SHH), in the protection of substantia nigra dopamine neurons in rats treated with 6-hydroxydopamine (6-OHDA). Analyses indicate that as opposed to the knock-down of GDNF, SHH inhibition caused a profound decline in nigrostriatal neuroprotection. Further, SHH silencing also curbed endogenous neurogenesis and the migration of host brdU(+)/dcx(+) neural precursors into the striatum, which was present in the animals receiving control or GDNF silenced NPCs. A change in graft phenotype, mainly reflected by a reduced proportion of undifferentiated nestin(+) cells, as well as a significantly greater host microglial activity, suggested an important role for these processes in the attenuation of neuroprotection and neurogenesis upon SHH silencing. Overall these studies reveal core mechanisms fundamental to grafted NPC-based therapeutic effects, and delineate the particular contributions of two graft-expressed molecules, SHH and GDNF, in mediating midbrain dopamine neuron protection, and host plasticity after NPC transplantation.	[Madhavan, Lalitha] Univ Arizona, Dept Neurol, Tucson, AZ 85724 USA; [Davidson, Beverly L.] Childrens Hosp Philadelphia, Ctr Cell & Mol Therapy, Philadelphia, PA 19104 USA; [Boudreau, Ryan L.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Daley, Brian F.; Lipton, Jack W.; Cole-Strauss, Allyson; Steece-Collier, Kathy; Collier, Timothy J.] Michigan State Univ, Translat Sci & Mol Med, Grand Rapids, MI 49503 USA	University of Arizona; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Iowa; Michigan State University	Madhavan, L (corresponding author), Univ Arizona, Dept Neurol, Tucson, AZ 85724 USA.	lmadhavan@email.arizona.edu	Lipton, Jack/L-3631-2019	Lipton, Jack/0000-0003-0991-8275; Boudreau, Ryan/0000-0002-9800-5349; Davidson, Beverly/0000-0002-3715-6290	NIH [NS58830, NS055295]; Gardner Family Foundation at the University of Cincinnati; University of Arizona intramural funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS058830, R01NS055295] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gardner Family Foundation at the University of Cincinnati; University of Arizona intramural funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by: NIH grants NS58830 the Udall Center of Excellence in Parkinson's Disease Research at Michigan State University and NS055295 (TJC), Gardner Family Foundation at the University of Cincinnati (TJC and LM), and The University of Arizona intramural funds (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Balordi F, 2007, J NEUROSCI, V27, P5936, DOI 10.1523/JNEUROSCI.1040-07.2007; Boudreau RL, 2012, METHOD ENZYMOL, V507, P275, DOI 10.1016/B978-0-12-386509-0.00014-4; Breunig JJ, 2011, NEURON, V70, P614, DOI 10.1016/j.neuron.2011.05.005; Catalin B, 2013, ROM J MORPHOL EMBRYO, V54, P467; Chechneva OV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.446; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Drago D, 2013, BIOCHIMIE, V95, P2271, DOI 10.1016/j.biochi.2013.06.020; Gonzalez-Reyes LE, 2012, NEURON, V75, P306, DOI 10.1016/j.neuron.2012.05.018; Han SSW, 2002, EXP NEUROL, V177, P360, DOI 10.1006/exnr.2002.7995; Harper SQ, 2005, METH MOL B, V309, P219; Hayes L, 2013, DEV BIOL, V374, P115, DOI 10.1016/j.ydbio.2012.11.016; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Kobayashi T, 2006, STROKE, V37, P2361, DOI 10.1161/01.STR.0000236025.44089.e1; Kordower JH, 2013, MOVEMENT DISORD, V28, P96, DOI 10.1002/mds.25344; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Laganiere J, 2010, J NEUROSCI, V30, P16469, DOI 10.1523/JNEUROSCI.2440-10.2010; Liu J, 2013, J CELL MOL MED, V17, P1434, DOI 10.1111/jcmm.12123; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Madhavan L, 2007, STEM CELLS; Madhavan L, 2012, EUR J NEUROSCI, V35, P883, DOI 10.1111/j.1460-9568.2012.08019.x; Madhavan L, 2010, NEUROPHARMACOLOGY, V58, P835, DOI 10.1016/j.neuropharm.2009.10.005; Madhavan L, 2009, J COMP NEUROL, V515, P102, DOI 10.1002/cne.22033; Miao NN, 1997, J NEUROSCI, V17, P5891; Mine Y, 2013, NEUROBIOL DIS, V52, P191, DOI 10.1016/j.nbd.2012.12.006; Mosher KI, 2012, NAT NEUROSCI, V15, P1485, DOI 10.1038/nn.3233; Mujtaba T, 2002, EXP NEUROL, V174, P48, DOI 10.1006/exnr.2001.7847; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; PARK D, 2010, STEM CELLS; Pluchino S, 2010, ARCH ITAL BIOL, V148, P173; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Spieles-Engemann AL, 2011, J PARKINSON DIS, V1, P123, DOI 10.3233/JPD-2011-11008; Tsuboi K, 2002, EXP NEUROL, V173, P95, DOI 10.1006/exnr.2001.7825; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009	40	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137136	10.1371/journal.pone.0137136	http://dx.doi.org/10.1371/journal.pone.0137136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340267	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200025
J	Zhang, J; Gu, FF; Zhao, SY; Xiao, SZ; Wang, YC; Guo, XK; Ni, YX; Han, LZ				Zhang, Ji; Gu, Fei-Fei; Zhao, Sheng-Yuan; Xiao, Shu-Zhen; Wang, Yan-Chun; Guo, Xiao-Kui; Ni, Yu-Xing; Han, Li-Zhong			Prevalence and Molecular Epidemiology of Staphylococcus aureus among Residents of Seven Nursing Homes in Shanghai	PLOS ONE			English	Article							NASAL CARRIAGE; GENE-CLUSTER; COLONIZATION; INFECTIONS; STRAINS; MRSA; RESISTANCE; DIVERSITY; IMPACT	Background Residents in nursing homes (NHs) always represent potential reservoirs for Staphylococcus aureus and methicillin-resistant S. aureus (MRSA). To our knowledge, there is no epidemiological information up till now that describes the prevalence and molecular characteristics of S. aureus in nursing home residents in Shanghai, China. Methods Four hundred and ninety-one unique residents from 7 NHs were enrolled in this study. Specimens were collected among these residents including 491 nasal swabs, 487 axillary swabs and 119 skin swabs. S. aureus isolated and identified from the swabs was characterized according to antimicrobial susceptibility profiling, toxin gene prevalence, and multilocus sequence typing (MLST), spa and SCCmec typing. Results Among the 491 residents screened, S. aureus was isolated in 109 residents from 90 nasal swabs (90/491, 18.3%), 29 axillary swabs (29/487, 6.0%), and 22 skin swabs (22/119, 18.5%). Sixty-eight MRSA isolates were detected in 52 residents from 41 nasal carriers, 15 axillary carriers and 12 skin carriers. The overall prevalence rate of S. aureus and MRSA colonization was 22.2% and 10.6% respectively. Ten residents presented S. aureus in all three sample types and 12 residents presented S. aureus in two of the three sample types collected. Molecular analysis revealed CC1 (29.1%) to be the dominant clone in this study, followed by CC398 (19.9%), CC188 (13.5%) and CC5 (12.8%). The most common spa type was t127 (22.0%), followed by t14383 (12.8%) and t002 (10.6%). Conclusions A high prevalence of S. aureus and MRSA colonization was revealed in nursing home residents in Shanghai. CC1 was the most common clonal complex and t127 was the most common spa type among NH residents. The data provides an important baseline for future surveillance of S. aureus in NHs in Shanghai and other highly urbanized regions in China. Implementation of infection control strategies must be given high priority in NHs to fight such high prevalence of both MRSA and methicillin-susceptible S. aureus (MSSA).	[Zhang, Ji] Shanghai Peoples Hosp Putuo Dist, Dept Clin Lab, Shanghai, Peoples R China; [Gu, Fei-Fei; Zhao, Sheng-Yuan; Xiao, Shu-Zhen; Ni, Yu-Xing; Han, Li-Zhong] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China; [Wang, Yan-Chun; Guo, Xiao-Kui] Shanghai Jiao Tong Univ, Sch Med, Dept Microbiol & Parasitol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Han, LZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai 200030, Peoples R China.	hanlizhong1107@163.com	wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; wang, yixuan/GXW-2866-2022		National Natural Science Foundation of China [81472010]; Research Special Fund for Public Welfare Industry of Health [201002021]; Scientific Research Project of Independent Innovation of Shanghai Putuo District Health System [[Pu]KW11204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Special Fund for Public Welfare Industry of Health; Scientific Research Project of Independent Innovation of Shanghai Putuo District Health System	This study was supported by National Natural Science Foundation of China (No. 81472010), Research Special Fund for Public Welfare Industry of Health (No. 201002021) and Scientific Research Project of Independent Innovation of Shanghai Putuo District Health System ([Pu]KW11204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin NS, 2010, J HOSP INFECT, V76, P36, DOI 10.1016/j.jhin.2010.03.006; Baldwin NS, 2009, J AM GERIATR SOC, V57, P620, DOI 10.1111/j.1532-5415.2009.02181.x; Bradley SF, 2002, CLIN INFECT DIS, V34, P211, DOI 10.1086/338150; Brugnaro P, 2009, INFECTION, V37, P216, DOI 10.1007/s15010-008-8165-1; Budimir A, 2014, AM J INFECT CONTROL, V42, P1197, DOI 10.1016/j.ajic.2014.07.032; Chamchod F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029757; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072811; Chen X, 2012, BURNS, V38, P738, DOI 10.1016/j.burns.2011.12.023; Collery MM, 2009, J MED MICROBIOL, V58, P13, DOI 10.1099/jmm.0.005215-0; Conceicao T, 2012, MICROB DRUG RESIST, V18, P116, DOI 10.1089/mdr.2011.0182; Cox RA, 1999, J HOSP INFECT, V43, P115, DOI 10.1053/jhin.1999.0633; Cuny C, 2015, VET MICROBIOL, V177, P219, DOI 10.1016/j.vetmic.2015.02.031; Denis O, 2009, J ANTIMICROB CHEMOTH, V64, P1299, DOI 10.1093/jac/dkp345; Elias J, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-111; Franklin R., 2013, M100S23 ABMM, V33; Gu FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123557; Gu FF, 2015, SURG INFECT, V16, P97, DOI 10.1089/sur.2014.027; Han LZ, 2010, EMERG INFECT DIS, V16, P731, DOI 10.3201/eid1604.081324; Hudson LO, 2013, J CLIN MICROBIOL, V51, P3788, DOI 10.1128/JCM.01708-13; Hughes C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006354.pub4; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Lee BY, 2013, MED CARE, V51, P205, DOI 10.1097/MLR.0b013e3182836dc2; Lee BY, 2013, INFECT CONT HOSP EP, V34, P151, DOI 10.1086/669091; Lesse AJ, 2006, AM J INFECT CONTROL, V34, P642, DOI 10.1016/j.ajic.2006.06.008; Li Fenfang, 2010, Hawaii Med J, V69, P126; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Loeb MB, 2003, AM J EPIDEMIOL, V157, P40, DOI 10.1093/aje/kwf173; Murphy CR, 2013, INFECT CONT HOSP EP, V34, P325, DOI 10.1086/669519; Murphy CR, 2012, J AM GERIATR SOC, V60, P1012, DOI 10.1111/j.1532-5415.2012.03978.x; O'Sullivan NP, 2000, J HOSP INFECT, V45, P322, DOI 10.1053/jhin.2000.0758; Pfingsten-Wurzburg S, 2011, J HOSP INFECT, V78, P108, DOI 10.1016/j.jhin.2011.02.011; Qiao YH, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0582-4; Robert J, 2011, ANTIMICROB AGENTS CH, V55, P1734, DOI 10.1128/AAC.01221-10; Stark L, 2014, EPIDEMIOL INFECT, V142, P1310, DOI 10.1017/S0950268813002033; Suetens C, 2006, J AM GERIATR SOC, V54, P1854, DOI 10.1111/j.1532-5415.2006.00972.x; Tian SF, 2013, SCAND J INFECT DIS, V45, P915, DOI 10.3109/00365548.2013.830330; Verkade E, 2012, INFECT CONT HOSP EP, V33, P624, DOI 10.1086/665726; Verrall A, 2013, J HOSP INFECT, V83, P250, DOI 10.1016/j.jhin.2012.11.021; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038577	39	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137593	10.1371/journal.pone.0137593	http://dx.doi.org/10.1371/journal.pone.0137593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340648	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200069
J	de Pedro-Cuesta, J; Rabano, A; Martinez-Martin, P; Ruiz-Tovar, M; Alcalde-Cabero, E; Almazan-Isla, J; Avellanal, F; Calero, M				de Pedro-Cuesta, Jesus; Rabano, Alberto; Martinez-Martin, Pablo; Ruiz-Tovar, Maria; Alcalde-Cabero, Enrique; Almazan-Isla, Javier; Avellanal, Fuencisla; Calero, Miguel			Comparative Incidence of Conformational, Neurodegenerative Disorders	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CREUTZFELDT-JAKOB-DISEASE; 3 ELDERLY POPULATIONS; PARKINSONS-DISEASE; ALZHEIMER-DISEASE; MACULAR DEGENERATION; HUNTINGTONS-DISEASE; ESSENTIAL TREMOR; CENTRAL SPAIN; LEWY BODIES	Background The purpose of this study was to identify incidence and survival patterns in conformational neurodegenerative disorders (CNDDs). Methods We identified 2563 reports on the incidence of eight conditions representing sporadic, acquired and genetic, protein-associated, i.e., conformational, NDD groups and age-related macular degeneration (AMD). We selected 245 papers for full-text examination and application of quality criteria. Additionally, data-collection was completed with detailed information from British, Swedish, and Spanish registries on Creutzfeldt-Jakob disease (CJD) forms, amyotrophic lateral sclerosis (ALS), and sporadic rapidly progressing neurodegenerative dementia (sRPNDd). For each condition, age-specific incidence curves, age-adjusted figures, and reported or calculated median survival were plotted and examined. Findings Based on 51 valid reported and seven new incidence data sets, nine out of eleven conditions shared specific features. Age-adjusted incidence per million person-years increased from <= 1.5 for sRPNDd, different CJD forms and Huntington's disease (HD), to 1589 and 2589 for AMD and Alzheimer's disease (AD) respectively. Age-specific profiles varied from (a) symmetrical, inverted V-shaped curves for low incidences to (b) those increasing with age for late-life sporadic CNDDs and for sRPNDd, with (c) a suggested, intermediate, non-symmetrical inverted V-shape for fronto-temporal dementia and Parkinson's disease. Frequently, peak age-specific incidences from 20-24 to >= 90 years increased with age at onset and survival. Distinct patterns were seen: for HD, with a low incidence, levelling off at middle age, and long median survival, 20 years; and for sRPNDd which displayed the lowest incidence, increasing with age, and a short median disease duration. Interpretation These results call for a unified population view of NDDs, with an age-at-onset-related pattern for acquired and sporadic CNDDs. The pattern linking age at onset to incidence magnitude and survival might be explained by differential pathophysiological mechanisms associated with specific misfolded protein deposits.	[de Pedro-Cuesta, Jesus; Martinez-Martin, Pablo; Ruiz-Tovar, Maria; Alcalde-Cabero, Enrique; Almazan-Isla, Javier; Avellanal, Fuencisla] Natl Inst Hlth Carlos III, CNE, Dept Appl Epidemiol, Madrid, Spain; [de Pedro-Cuesta, Jesus; Martinez-Martin, Pablo; Ruiz-Tovar, Maria; Alcalde-Cabero, Enrique; Almazan-Isla, Javier; Avellanal, Fuencisla] Natl Inst Hlth Carlos III, Consortium Biomed Res Neurodegenerat Dis CIBERNED, Madrid, Spain; [Rabano, Alberto; Calero, Miguel] Reina Sofia Fdn, Alzheimers Dis Ctr, Madrid, Spain; [Calero, Miguel] Natl Inst Hlth Carlos III, CIBERNED, Majadahonda, Spain	Instituto de Salud Carlos III; CIBERNED; Instituto de Salud Carlos III; CIBERNED; Instituto de Salud Carlos III	de Pedro-Cuesta, J (corresponding author), Natl Inst Hlth Carlos III, CNE, Dept Appl Epidemiol, Madrid, Spain.	jpedro@isciii.es	Ruiz-Tovar, Maria/F-4631-2016; Martinez-Martin, Pablo/N-9909-2019; Calero, Miguel/H-5691-2015	Ruiz-Tovar, Maria/0000-0002-5102-4905; Martinez-Martin, Pablo/0000-0003-0837-5280; Calero, Miguel/0000-0001-5366-3324; Almazan-Isla, Javier/0000-0001-8723-339X	Consortium for Biomedical Research in Neurodegenerative Diseases (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas/CIBERNED); ISCIII Field Epidemiology Program; EU Joint Program - Neurodegenerative Disease Research (JPND - DEMTEST) [FIS PI11/03021]	Consortium for Biomedical Research in Neurodegenerative Diseases (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas/CIBERNED); ISCIII Field Epidemiology Program; EU Joint Program - Neurodegenerative Disease Research (JPND - DEMTEST)	Funding was received from the Consortium for Biomedical Research in Neurodegenerative Diseases (Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas/CIBERNED) as part of the 2014-2015 annual Budgets of the CIBERNED 509-group. Mr Alcalde received support from the ISCIII Field Epidemiology Program during 2014 and 2015. The study was partially supported by grant from the EU Joint Program - Neurodegenerative Disease Research (JPND - DEMTEST (Spanish FIS PI11/03021)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors other than EAC received no specific funding for this work.	ANDERSON DW, 1983, AM J EPIDEMIOL, V118, P613, DOI 10.1093/oxfordjournals.aje.a113671; Baldereschi M, 2000, NEUROLOGY, V55, P1358, DOI 10.1212/WNL.55.9.1358; Benito-Leon J, 2005, NEUROLOGY, V64, P1721, DOI 10.1212/01.WNL.0000161852.70374.01; Benito-Leon J, 2004, NEUROLOGY, V62, P734, DOI 10.1212/01.WNL.0000113727.73153.68; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195; Chaudhuri K Ray, 2005, Curr Neurol Neurosci Rep, V5, P275, DOI 10.1007/s11910-005-0072-6; Chen YY, 2010, NEUROEPIDEMIOLOGY, V35, P250, DOI 10.1159/000319462; Claveria LE, 2002, MOVEMENT DISORD, V17, P242, DOI 10.1002/mds.10087; Consonni M, 2013, BEHAV NEUROL, V27, P143, DOI [10.1155/2013/126010, 10.3233/BEN-2012-110202]; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; de Lau LML, 2004, NEUROLOGY, V63, P1240, DOI 10.1212/01.WNL.0000140706.52798.BE; Edland SD, 2002, ARCH NEUROL-CHICAGO, V59, P1589, DOI 10.1001/archneur.59.10.1589; Frost B, 2009, PRION, V3, P74, DOI 10.4161/pri.3.2.8754; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; GRANIERI E, 1991, ARCH NEUROL-CHICAGO, V48, P854, DOI 10.1001/archneur.1991.00530200096026; Gunnarsson LG, 1996, NEUROEPIDEMIOLOGY, V15, P142, DOI 10.1159/000109901; Hardy J, 2012, NEW ENGL J MED, V366, P2126, DOI 10.1056/NEJMcibr1202401; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Irwin DA, 2013, ECON CLASS, P1; Josephs KA, 2009, ARCH NEUROL-CHICAGO, V66, P201, DOI 10.1001/archneurol.2008.534; Kaur B, 2013, ALZ DIS ASSOC DIS, V27, P226, DOI 10.1097/WAD.0b013e31826f040d; Koperek O, 2002, AM J PATHOL, V161, P1979, DOI 10.1016/S0002-9440(10)64474-4; Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y; Kravitz E, 2012, RAMBAM MAIMONIDES ME, V3, DOI 10.5041/RMMJ.10092; Louis ED, 2014, NEUROEPIDEMIOLOGY, V42, P81, DOI 10.1159/000356351; Luchsinger Jose A, 2004, Curr Atheroscler Rep, V6, P261, DOI 10.1007/s11883-004-0056-z; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Morens DM, 1996, NEUROLOGY, V46, P1044, DOI 10.1212/WNL.46.4.1044; Nelson PT, 2011, ACTA NEUROPATHOL, V121, P571, DOI 10.1007/s00401-011-0826-y; Nilsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094901; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Olazaran J, 2013, J ALZHEIMERS DIS, V33, P495, DOI 10.3233/JAD-2012-121207; Owen CG, 2012, BRIT J OPHTHALMOL, V96, P752, DOI 10.1136/bjophthalmol-2011-301109; Perez F, 2010, J NEUROL NEUROSUR PS, V81, P742, DOI 10.1136/jnnp.2009.189142; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Rinaldi C, 2012, CAN J NEUROL SCI, V39, P48, DOI 10.1017/S0317167100012671; Roher AE, 2011, J ALZHEIMERS DIS, V24, P315, DOI 10.3233/JAD-2011-101809; Romero JP, 2012, TREMOR OTHER HYPERKI, P2; Ruitenberg A, 2001, NEUROBIOL AGING, V22, P575, DOI 10.1016/S0197-4580(01)00231-7; SantaCruz KS, 2011, J NEUROPATH EXP NEUR, V70, P832, DOI 10.1097/NEN.0b013e31822e8ae9; Shaw LM, 2007, NAT REV DRUG DISCOV, V6, P295, DOI 10.1038/nrd2176; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Sonnen JA, 2011, ARCH NEUROL-CHICAGO, V68, P1049, DOI 10.1001/archneurol.2011.157; Steenland K, 2010, NEUROEPIDEMIOLOGY, V35, P28, DOI 10.1159/000306055; Warren JD, 2013, TRENDS NEUROSCI, V36, P561, DOI 10.1016/j.tins.2013.06.007; Will RG, 2000, ANN NEUROL, V47, P575; Xi ZR, 2012, ARCH NEUROL-CHICAGO, V69, P1583, DOI 10.1001/archneurol.2012.2016; Yarchoan M, 2012, BRAIN, V135, P3749, DOI 10.1093/brain/aws271	51	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137342	10.1371/journal.pone.0137342	http://dx.doi.org/10.1371/journal.pone.0137342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335347	gold, Green Published, Green Submitted			2022-12-27	WOS:000360615400050
J	Li, ST; Jiang, FZ; Tu, JF; Zheng, XF				Li, Shaotang; Jiang, Feizhao; Tu, Jingfu; Zheng, Xiaofeng			Long-Term Oncologic Outcomes of Laparoscopic versus Open Surgery for Middle and Lower Rectal Cancer	PLOS ONE			English	Article							TOTAL MESORECTAL EXCISION; MRC CLASICC TRIAL; COLORECTAL-CANCER; SPHINCTER PRESERVATION; RANDOMIZED-TRIAL; RESECTION; COLON; COLECTOMY; CARCINOMA	Background Laparoscopic surgery for middle and lower rectal cancer remain controversial because anatomical and complex surgical procedures specifically influence oncologic outcomes. This study analyzes the long-term outcomes of laparoscopic versus open surgery for middle and lower rectal cancer. Methods Patients (laparoscopic: n = 129, open: n = 152) who underwent curative resection for middle and lower rectal cancer from 2003 to 2008 participated in the study. The same surgical team performed all operations. The mean follow up time of all patients was 74.3 months. Results No statistical difference in local recurrence rate (7.8% vs. 7.2%; log-rank = 0.024; P = 0.876) and distant recurrence rate (20.9% vs. 16.4%; log-rank = 0.699; P = 0.403) between laparoscopic and open groups were observed within 5 years. The 5-year overall survival rates of the laparoscopic and open groups were 72.9% and 75.7%, respectively; no significant statistical difference was observed between them (log-rank = 0.163; P = 0.686). The 5-year survival rates between groups were not different between stages: Stage I (92.6% vs. 86.7%; logrank = 0.533; P = 0.465); stage II (75.8% vs. 80.5%; log-rank = 0.212; P = 0.645); and Stage III (63.8% vs. 69.1%, log-rank = 0272; P = 0.602). However, significant statistical difference amongst different stages were observed (log-rank = 1.802; P = 0.003). Conclusion Laparoscopic and open surgery for middle and lower rectal cancer offer equivalent longterm oncologic outcomes. Laparoscopic surgery is feasible in these patients.	[Li, Shaotang; Jiang, Feizhao; Tu, Jingfu; Zheng, Xiaofeng] Wenzhou Med Univ, Dept Gen Surg, Affiliated Hosp 1, Wenzhou, Zhejian, Peoples R China	Wenzhou Medical University	Zheng, XF (corresponding author), Wenzhou Med Univ, Dept Gen Surg, Affiliated Hosp 1, Wenzhou, Zhejian, Peoples R China.	xfzheng163@163.com						Anderson C, 2008, EJSO-EUR J SURG ONC, V34, P1135, DOI 10.1016/j.ejso.2007.11.015; Aziz O, 2006, ANN SURG ONCOL, V13, P413, DOI 10.1245/ASO.2006.05.045; Bianchi PP, 2007, DIS COLON RECTUM, V50, P2047, DOI 10.1007/s10350-007-9055-9; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Braga M, 2007, DIS COLON RECTUM, V50, P464, DOI 10.1007/s10350-006-0798-5; Bretagnol F, 2005, SURG ENDOSC, V19, P892, DOI 10.1007/s00464-004-2228-x; Breukink S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005200.pub2; Delaney CP, 2003, ANN SURG, V238, P67, DOI 10.1097/01.sla.0000074967.53451.22; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Hasegawa H, 2003, SURG ENDOSC, V17, P636, DOI 10.1007/s00464-002-8516-4; Jayne DG, 2010, BRIT J SURG, V97, P1638, DOI 10.1002/bjs.7160; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5; Khalili TM, 1998, DIS COLON RECTUM, V41, P832, DOI 10.1007/BF02235361; Kiran RP, 2014, ARCH SURG-CHICAGO, V139, P39; Kuntz C, 1998, SURG ENDOSC-ULTRAS, V12, P963, DOI 10.1007/s004649900757; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Laurent C, 2009, ANN SURG, V250, P54, DOI 10.1097/SLA.0b013e3181ad6511; Law WL, 2007, ANN SURG, V245, P1, DOI 10.1097/01.sla.0000218170.41992.23; Leroy J, 2004, SURG ENDOSC, V18, P281, DOI 10.1007/s00464-002-8877-8; Leung KL, 2004, LANCET, V363, P1187, DOI 10.1016/S0140-6736(04)15947-3; Lezoche E, 2002, SURG ENDOSC, V16, P596, DOI 10.1007/s00464-001-9053-2; Li ST, 2011, SURG ENDOSC, V25, P3175, DOI 10.1007/s00464-011-1683-4; Liang JT, 2007, ANN SURG ONCOL, V14, P109, DOI 10.1245/s10434-006-9135-4; Lujan J, 2009, BRIT J SURG, V96, P982, DOI 10.1002/bjs.6662; Milsom JW, 2009, DIS COLON RECTUM, V52, P1215, DOI 10.1007/DCR0b013e3181a73e81; Milsom JW, 1998, J AM COLL SURGEONS, V187, P46, DOI 10.1016/S1072-7515(98)00132-X; Morino M, 2003, ANN SURG, V237, P335, DOI 10.1097/00000658-200303000-00006; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Ng KH, 2009, ANN SURG, V249, P82, DOI 10.1097/SLA.0b013e31818e418a; Ng SSM, 2008, ANN SURG ONCOL, V15, P2418, DOI 10.1245/s10434-008-9895-0; Ng SSM, 2009, DIS COLON RECTUM, V52, P558; Pechlivanides G, 2007, DIGEST DIS, V25, P94, DOI 10.1159/000099176; Penninckx F, 2013, BRIT J SURG, V100, P1368, DOI 10.1002/bjs.9211; Pugliese R, 2008, AM J SURG, V195, P233, DOI 10.1016/j.amjsurg.2007.02.020; Siani LM, 2012, G CHIR, V33, P404; Staudacher C, 2007, SURG ONCOL, V16, pS113, DOI 10.1016/j.suronc.2007.10.035; Young-Fadok TM, 2007, SURG ENDOSC, V21, P1063, DOI 10.1007/s00464-006-9172-x; Zhou ZG, 2004, SURG ENDOSC, V18, P1211, DOI 10.1007/s00464-003-9170-1	40	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0135884	10.1371/journal.pone.0135884	http://dx.doi.org/10.1371/journal.pone.0135884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335944	gold, Green Submitted, Green Published			2022-12-27	WOS:000360615400007
J	Kushniarevich, A; Utevska, O; Chuhryaeva, M; Agdzhoyan, A; Dibirova, K; Uktveryte, I; Mols, M; Mulahasanovic, L; Pshenichnov, A; Frolova, S; Shanko, A; Metspalu, E; Reidla, M; Tambets, K; Tamm, E; Koshel, S; Zaporozhchenko, V; Atramentova, L; Kucinskas, V; Davydenko, O; Goncharova, O; Evseeva, I; Churnosov, M; Pocheshchova, E; Yunusbayev, B; Khusnutdinova, E; Marjanovic, D; Rudan, P; Rootsi, S; Yankovsky, N; Endicott, P; Kassian, A; Dybo, A; Tyler-Smith, C; Balanovska, E; Metspalu, M; Kivisild, T; Villems, R; Balanovsky, O				Kushniarevich, Alena; Utevska, Olga; Chuhryaeva, Marina; Agdzhoyan, Anastasia; Dibirova, Khadizhat; Uktveryte, Ingrida; Moels, Maert; Mulahasanovic, Lejla; Pshenichnov, Andrey; Frolova, Svetlana; Shanko, Andrey; Metspalu, Ene; Reidla, Maere; Tambets, Kristiina; Tamm, Erika; Koshel, Sergey; Zaporozhchenko, Valery; Atramentova, Lubov; Kucinskas, Vaidutis; Davydenko, Oleg; Goncharova, Olga; Evseeva, Irina; Churnosov, Michail; Pocheshchova, Elvira; Yunusbayev, Bayazit; Khusnutdinova, Elza; Marjanovic, Damir; Rudan, Pavao; Rootsi, Siiri; Yankovsky, Nick; Endicott, Phillip; Kassian, Alexei; Dybo, Anna; Tyler-Smith, Chris; Balanovska, Elena; Metspalu, Mait; Kivisild, Toomas; Villems, Richard; Balanovsky, Oleg		Genographic Consortium	Genetic Heritage of the Balto-Slavic Speaking Populations: A Synthesis of Autosomal, Mitochondrial and Y-Chromosomal Data	PLOS ONE			English	Article							GEOGRAPHIC STRUCTURE; DNA VARIABILITY; EASTERN; DIVERSITY; EXPANSION; EUROPEANS; IDENTITY; GERMANY; TREE	The Slavic branch of the Balto-Slavic sub-family of Indo-European languages underwent rapid divergence as a result of the spatial expansion of its speakers from Central-East Europe, in early medieval times. This expansion-mainly to East Europe and the northern Balkans-resulted in the incorporation of genetic components from numerous autochthonous populations into the Slavic gene pools. Here, we characterize genetic variation in all extant ethnic groups speaking Balto-Slavic languages by analyzing mitochondrial DNA (n = 6,876), Y-chromosomes (n = 6,079) and genome-wide SNP profiles (n = 296), within the context of other European populations. We also reassess the phylogeny of Slavic languages within the Balto-Slavic branch of Indo-European. We find that genetic distances among Balto-Slavic populations, based on autosomal and Y-chromosomal loci, show a high correlation (0.9) both with each other and with geography, but a slightly lower correlation (0.7) with mitochondrial DNA and linguistic affiliation. The data suggest that genetic diversity of the present-day Slavs was predominantly shaped in situ, and we detect two different substrata: 'central-east European' for West and East Slavs, and 'south-east European' for South Slavs. A pattern of distribution of segments identical by descent between groups of East-West and South Slavs suggests shared ancestry or a modest gene flow between those two groups, which might derive from the historic spread of Slavic people.	[Kushniarevich, Alena; Metspalu, Ene; Reidla, Maere; Tambets, Kristiina; Tamm, Erika; Yunusbayev, Bayazit; Rootsi, Siiri; Metspalu, Mait; Kivisild, Toomas; Villems, Richard] Estonian Bioctr, Evolutionary Biol Grp, Tartu, Estonia; [Kushniarevich, Alena; Davydenko, Oleg] Natl Acad Sci Belarus, Inst Cytol & Genet, Minsk, BELARUS; [Utevska, Olga; Atramentova, Lubov] Kharkov Natl Univ, Dept Genet & Cytol, Kharkov, Ukraine; [Utevska, Olga; Chuhryaeva, Marina; Agdzhoyan, Anastasia; Dibirova, Khadizhat; Zaporozhchenko, Valery; Yankovsky, Nick; Balanovsky, Oleg] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Chuhryaeva, Marina; Agdzhoyan, Anastasia; Dibirova, Khadizhat; Pshenichnov, Andrey; Frolova, Svetlana; Shanko, Andrey; Zaporozhchenko, Valery; Evseeva, Irina; Balanovska, Elena; Balanovsky, Oleg] Russian Acad Sci, Med Genet Res Ctr, Moscow, Russia; [Uktveryte, Ingrida; Kucinskas, Vaidutis] Vilnius State Univ, Fac Med, Dept Human & Med Genet, Vilnius, Lithuania; [Moels, Maert] Univ Tartu, Inst Stat Math, EE-50090 Tartu, Estonia; [Mulahasanovic, Lejla] Ctr Genom & Transcript CeGaT GmbH, Tubingen, Germany; [Mulahasanovic, Lejla] Univ Sarajevo, Fac Pharm, Sarajevo 71000, Bosnia & Herceg; [Metspalu, Ene; Reidla, Maere; Tamm, Erika; Kivisild, Toomas; Villems, Richard] Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [Koshel, Sergey] Moscow MV Lomonosov State Univ, Fac Geog, Moscow, Russia; [Churnosov, Michail] Belgorod State Univ, Belgorod, Russia; [Pocheshchova, Elvira] Kuban State Med Univ, Krasnodar, Russia; [Evseeva, Irina] Northern State Med Univ, Arkhangel, Russia; [Goncharova, Olga] Natl Acad Sci Belarus, Hist Inst, Minsk, BELARUS; [Yunusbayev, Bayazit; Khusnutdinova, Elza] RAS, Ufa Res Ctr, Inst Biochem & Genet, Ufa, Bashkortostan, Russia; [Khusnutdinova, Elza] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa 450074, Bashkortostan, Russia; [Marjanovic, Damir] Int Burch Univ, Sarajevo, Bosnia & Herceg; [Marjanovic, Damir; Rudan, Pavao] Inst Anthropol Res, Zagreb, Croatia; [Endicott, Phillip] Musee Homme Paris, Paris, France; [Kassian, Alexei; Dybo, Anna] Russian Acad Sci, Inst Linguist, Moscow, Russia; [Kassian, Alexei] Russian Presidential Acad Natl Econ & Publ Adm, Sch Adv Studies Humanities, Moscow, Russia; [Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Kivisild, Toomas] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Villems, Richard] Estonian Acad Sci, EE-200103 Tallinn, Estonia	Estonian Biocentre; National Academy of Sciences of Belarus (NASB); Institute of Genetics & Cytology of the National Academy of Sciences of Belarus; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Research Centre for Medical Genetics; Russian Academy of Sciences; Vilnius University; University of Tartu; CeGaT; University of Sarajevo; University of Tartu; Lomonosov Moscow State University; Belgorod State University; Kuban State Medical University; Northern State Medical University; National Academy of Sciences of Belarus (NASB); Institute of History of the National Academy of Sciences of Belarus; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; Institute for Anthropological Research Zagreb; Museum National d'Histoire Naturelle (MNHN); Institute of Linguistics, Russian Academy of Sciences; Russian Academy of Sciences; Russian Presidential Academy of National Economy & Public Administration; Wellcome Trust Sanger Institute; University of Cambridge; Estonian Academy of Sciences	Kushniarevich, A (corresponding author), Estonian Bioctr, Evolutionary Biol Grp, Tartu, Estonia.	lkushniarevich@gmail.com	Koshel, Sergey M/B-2662-2012; Tambets, Kristiina/M-2568-2019; Yunusbaev, Bayazit/T-5444-2019; KUČINSKAS, Vaidutis/A-4798-2013; Kassian, Alexei S./C-7281-2015; Yankovsky, Nick/AAU-9657-2021; Metspalu, Mait/G-8671-2015; Kivisild, Toomas/P-5889-2017; Tamm, Erika/G-2818-2017; Haak, Wolfgang/Z-4947-2019; Agdzhoyan, Anastasia/G-1540-2014; Churnosov, Mikhail/W-1313-2017; Dybo, Anna/F-8623-2016; Khusnutdinova, Elza Kamilevna/A-4810-2013; Santos, Fabrício Rodrigues/H-2370-2011; Bertranpetit, Jaume/F-8550-2012	Koshel, Sergey M/0000-0002-4540-2922; Tambets, Kristiina/0000-0002-8173-6380; Kassian, Alexei S./0000-0003-1129-2611; Metspalu, Mait/0000-0003-3099-9161; Kivisild, Toomas/0000-0002-6297-7808; Tamm, Erika/0000-0003-0694-3598; Haak, Wolfgang/0000-0003-2475-2007; Agdzhoyan, Anastasia/0000-0002-8776-2934; Churnosov, Mikhail/0000-0003-1254-6134; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Utevska, Olga/0000-0002-5787-0467; Yankovsky, Nikolay/0000-0002-2467-2683; Javed, Asif/0000-0002-6945-9624; Adler, Christina/0000-0002-4731-5291; Bertranpetit, Jaume/0000-0003-0100-0590; mele, marta/0000-0001-8874-6453; Cooper, Alan/0000-0002-7738-7851; Marjanovic, Damir/0000-0002-7472-4525; zalloua, pierre/0000-0002-8494-5081; Atramentova, Lubov/0000-0002-7143-9411; Yunusbayev, Bayazit/0000-0002-6035-8763; merchant, nirav/0000-0002-1988-8180; Shanko, Andrei/0000-0001-9801-9911; Dybo, Anna/0000-0002-6077-7183; Endicott, Phillip/0000-0003-2452-8507	Russian Science Foundation [14-14-00827]; Programme of the Presidium of Russian Academy of Sciences "Molecular and cell biology"; Russian Foundation For Basic Research [13-04-01711, 13-06-00670, 13-04-90420]; Ukrainian State Fund for Fundamental Researches [F53.4/071]; European Union European Regional Development Fund through the Centre of Excellence in Genomics; European Commission [205419 ECOGENE]; Estonian Basic Research Grant [SF 0270177s08]; Estonian Research Council [IUT24-1]; Wellcome Trust [098051]; LITGEN project - European Social Fund under the Global Grant Measure [VP1-3.1-SMM-07-K-01-013]; Center for Genomics and Transcriptomics (CeGaT GmbH)	Russian Science Foundation(Russian Science Foundation (RSF)); Programme of the Presidium of Russian Academy of Sciences "Molecular and cell biology"; Russian Foundation For Basic Research(Russian Foundation for Basic Research (RFBR)); Ukrainian State Fund for Fundamental Researches(State Fund for Fundamental Research (SFFR)); European Union European Regional Development Fund through the Centre of Excellence in Genomics; European Commission(European CommissionEuropean Commission Joint Research Centre); Estonian Basic Research Grant; Estonian Research Council(Estonian Research Council); Wellcome Trust(Wellcome TrustEuropean Commission); LITGEN project - European Social Fund under the Global Grant Measure; Center for Genomics and Transcriptomics (CeGaT GmbH)	This work was supported by Russian Science Foundation (grant 14-14-00827 to OB, M. Chuhryaeva, AA and VZ), Programme of the Presidium of Russian Academy of Sciences "Molecular and cell biology", Russian Foundation For Basic Research (grants 13-04-01711, 13-06-00670, 13-04-90420); Ukrainian State Fund for Fundamental Researches (grant F53.4/071); the European Union European Regional Development Fund through the Centre of Excellence in Genomics to the Estonian Biocentre; by the European Commission grant 205419 ECOGENE to the Estonian Biocentre; the Estonian Basic Research Grant SF 0270177s08 and by Institutional Research Funding to the Estonian Biocentre from the Estonian Research Council IUT24-1; the European Commission grant 205419 ECOGENE to the Estonian Biocentre; the Wellcome Trust 098051 to CTS; the Lithuanian part was supported by the LITGEN project (VP1-3.1-SMM-07-K-01-013), funded by the European Social Fund under the Global Grant Measure. Center for Genomics and Transcriptomics (CeGaT GmbH) provided support in the form of salaries for author LM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of LM are articulated in the 'author contributions' section.	Alekseeva T., 2011, VOSTOCHNYE SLAVIANE; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2010, J LANGUAGE RELATIONS, V3, P79; Balanovska EV, 2011, GENOFOND RUSSKOGO SE, P27; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Barford P. M., 2001, EARLY SLAVS CULTURE; Behar D, 2013, HUM BIOL OPEN ACCESS; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Birnbaum H., 1975, COMMON SLAVIC PROGR; Blazek V, 2007, AUGUST SCHLEICHER SE, P35; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; BUNAK VV, 1965, PROISKHOZHDENIE ETNI; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Curta Florin, 2001, HIST ARCHAEOLOGY LOW, DOI DOI 10.1017/CBO9780511496295; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fortson Benjamin W., 2004, INDOEUROPEAN LANGUAG; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Heather Peter, 2010, EMPIRES BARBARIANS F; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Jozef Rostafinski, 1908, PIERWOTNYCH SIEDZIBA; Juras A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110839; Karachanak S, 2012, INT J LEGAL MED, V126, P497, DOI 10.1007/s00414-011-0589-y; Karmin M, 2015, GENOME RES, V25, P459, DOI 10.1101/gr.186684.114; Kasperaviciute D, 2004, ANN HUM GENET, V68, P438, DOI 10.1046/j.1529-8817.2003.00119.x; Kasperaviciute Dalia, 2002, Journal of Applied Genetics, V43, P255; Kayser M, 2005, HUM GENET, V117, P428, DOI 10.1007/s00439-005-1333-9; Khrunin AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058552; Koshel S. M., 2012, SOVREMENNAYA GEOGRAF, P158; Kovacevic L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105090; Kushniarevich A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066499; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Luca F, 2007, AM J PHYS ANTHROPOL, V132, P132, DOI 10.1002/ajpa.20500; Mallory J. P., 2006, OXFORD INTRO PROTO I; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk BA, 2003, ANN HUM GENET, V67, P412, DOI 10.1046/j.1469-1809.2003.00042.x; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; Manco J., 2013, ANCESTRAL JOURNEYS P; Mielnik-Sikorska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054360; Morozova I, 2012, AM J PHYS ANTHROPOL, V147, P341, DOI 10.1002/ajpa.21649; Nakhleh L, 2005, T PHILOL SOC, V103, P171, DOI 10.1111/j.1467-968X.2005.00149.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Novotna P, 2007, BALTISTICA, V42, P323; Novotna P, BALTISTICA, V42, P185; Novotna P, BALTISTICA, V42, P323; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; Pogodin AL, 1901, ISTORII SLAVYANSKIKH; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rebala K, 2007, J HUM GENET, V52, P406, DOI 10.1007/s10038-007-0125-6; Rebala K, 2013, EUR J HUM GENET, V21, P415, DOI 10.1038/ejhg.2012.190; Rexova K, 2003, CLADISTICS, V19, P120, DOI 10.1016/S0748-3007(02)00147-0; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Schafarik PJ, 1843, SLAWISCHE ALTERTHUME; Schleicher August, 1862, COMPENDIUM VERGLEICH, VII; Sedov V. V., 1982, VOSTOCHNYE SLAVIANE; Sedov VV, 1979, PROISHOZHEDNIE RANNY; Sedov VV, 2002, SLAVIANE ISTORIKO AR; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Starostin SA, 2007, OPREDELENIE USTOJCHI, P827; Sussex R., 2006, THE SLAVIC LANGUAGES; Toporov VN, 1962, LINGVISTICHESKIJ ANA; Underhill PA, 2015, EUR J HUM GENET, V23, P124, DOI 10.1038/ejhg.2014.50; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Veeramah KR, 2011, EUR J HUM GENET, V19, P995, DOI 10.1038/ejhg.2011.65; Wichmann S, 2014, ASJP; Wozniak M, 2010, AM J PHYS ANTHROPOL, V142, P540, DOI 10.1002/ajpa.21253; Yunusbayev B, 2015, PLOSGENET, DOI [10.1101/005850, DOI 10.1101/005850]; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221	77	65	71	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135820	10.1371/journal.pone.0135820	http://dx.doi.org/10.1371/journal.pone.0135820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CQ4ZT	26332464	Green Published, gold			2022-12-27	WOS:000360613800041
J	Latosinska, A; Vougas, K; Makridakis, M; Klein, J; Mullen, W; Abbas, M; Stravodimos, K; Katafigiotis, I; Merseburger, AS; Zoidakis, J; Mischak, H; Vlahou, A; Jankowski, V				Latosinska, Agnieszka; Vougas, Konstantinos; Makridakis, Manousos; Klein, Julie; Mullen, William; Abbas, Mahmoud; Stravodimos, Konstantinos; Katafigiotis, Ioannis; Merseburger, Axel S.; Zoidakis, Jerome; Mischak, Harald; Vlahou, Antonia; Jankowski, Vera			Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis	PLOS ONE			English	Article							SPECTROMETRY-BASED PROTEOMICS; TANDEM MASS-SPECTROMETRY; SHOTGUN PROTEOMICS; GENE-EXPRESSION; SAMPLE PREPARATION; BLADDER-CANCER; IDENTIFICATION; QUANTIFICATION; DATABASE; MECHANISMS	High resolution proteomics approaches have been successfully utilized for the comprehensive characterization of the cell proteome. However, in the case of quantitative proteomics an open question still remains, which quantification strategy is best suited for identification of biologically relevant changes, especially in clinical specimens. In this study, a thorough comparison of a label-free approach (intensity-based) and 8-plex iTRAQ was conducted as applied to the analysis of tumor tissue samples from non-muscle invasive and muscle-invasive bladder cancer. For the latter, two acquisition strategies were tested including analysis of unfractionated and fractioned iTRAQ-labeled peptides. To reduce variability, aliquots of the same protein extract were used as starting material, whereas to obtain representative results per method further sample processing and MS analysis were conducted according to routinely applied protocols. Considering only multiple-peptide identifications, LC-MS/MS analysis resulted in the identification of 910, 1092 and 332 proteins by label-free, fractionated and unfractionated iTRAQ, respectively. The label-free strategy provided higher protein sequence coverage compared to both iTRAQ experiments. Even though pre-fraction of the iTRAQ labeled peptides allowed for a higher number of identifications, this was not accompanied by a respective increase in the number of differentially expressed changes detected. Validity of the proteomics output related to protein identification and differential expression was determined by comparison to existing data in the field (Protein Atlas and published data on the disease). All methods predicted changes which to a large extent agreed with published data, with label-free providing a higher number of significant changes than iTRAQ. Conclusively, both label-free and iTRAQ (when combined to peptide fractionation) provide high proteome coverage and apparently valid predictions in terms of differential expression, nevertheless label-free provides higher sequence coverage and ultimately detects a higher number of differentially expressed proteins. The risk for receiving false associations still exists, particularly when analyzing highly heterogeneous biological samples, raising the need for the analysis of higher sample numbers and/or application of adjustment for multiple testing.	[Latosinska, Agnieszka; Vougas, Konstantinos; Makridakis, Manousos; Zoidakis, Jerome; Vlahou, Antonia] Acad Athens, Biomed Res Fdn, Div Biotechnol, Athens, Greece; [Latosinska, Agnieszka] Charite, D-13353 Berlin, Germany; [Klein, Julie] Fac Med Toulouse, INSERM, U1048, Inst Cardiovasc & Metab Dis, F-31073 Toulouse, France; [Klein, Julie] Univ Toulouse 3, F-31062 Toulouse, France; [Mullen, William; Mischak, Harald] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Abbas, Mahmoud] Hannover Med Sch, Dept Pathol, Hannover, Germany; [Stravodimos, Konstantinos; Katafigiotis, Ioannis] Laikon Gen Hosp, Med Sch Athens, Dept Urol, Athens, Greece; [Merseburger, Axel S.] Med Univ Lubeck, Dept Urol, D-23538 Lubeck, Germany; [Mischak, Harald] Mosa Diagnost GmbH, Hannover, Germany; [Jankowski, Vera] Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res IMCAR, D-52062 Aachen, Germany	Academy of Athens; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Glasgow; Hannover Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; University of Lubeck; Modular Open Systems Approach (MOSA) Solutions; RWTH Aachen University	Jankowski, V (corresponding author), Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res IMCAR, D-52062 Aachen, Germany.	vjankowski@ukaachen.de	Zoidakis, Jerome/P-9599-2018; Klein, Julie/ABE-2622-2020; Zoidakis, Jerome/AAO-8236-2021; Mullen, William/GWC-8078-2022; Klein, Julie/M-7088-2017	Zoidakis, Jerome/0000-0002-4557-3430; Klein, Julie/0000-0002-3279-0559; Zoidakis, Jerome/0000-0002-4557-3430; Klein, Julie/0000-0002-3279-0559; Mischak, Harald/0000-0003-0323-0306; Latosinska, Agnieszka/0000-0001-8917-2412; Mullen, William/0000-0002-5685-1563; Makridakis, Manousos/0000-0002-0063-3559; Vougas, Konstantinos/0000-0002-8873-4740; STRAVODIMOS, KONSTANTINOS/0000-0003-4030-4546; Vlahou, Antonia/0000-0003-3284-5713	Molecular Medicine for Bladder Cancer [PITN-GA-2012-317450 BCMolMed]; Mosaiques Diagnostics GmbH	Molecular Medicine for Bladder Cancer; Mosaiques Diagnostics GmbH	The work is supported by grant PITN-GA-2012-317450 BCMolMed (Molecular Medicine for Bladder Cancer) from the FP7 - PEOPLE - 2012 ITN program. Mosaiques Diagnostics GmbH provided support in the form of salaries for author HM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Abdallah C, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-37; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bastian F, 2008, LECT N BIOINFORMAT, V5109, P124, DOI 10.1007/978-3-540-69828-9_12; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Drabovich AP, 2010, J PROTEOME RES, V9, P1236, DOI 10.1021/pr900729g; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eriksson H, 2008, PROTEOMICS, V8, P3008, DOI 10.1002/pmic.200800174; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Husi H, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-110; Jain R, 2015, J PROTEOMICS, V113, P127, DOI 10.1016/j.jprot.2014.09.020; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kawakami K, 2006, ONCOL REP, V16, P521; Kil YJ, 2011, ANAL CHEM, V83, P5259, DOI 10.1021/ac200609a; Li Z, 2012, J PROTEOME RES, V11, P1582, DOI 10.1021/pr200748h; Liu Y, 2014, EUR UROL, V66, P982, DOI 10.1016/j.eururo.2014.07.045; McDowell GS, 2013, J PROTEOME RES, V12, P3809, DOI 10.1021/pr400032m; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Patel VJ, 2009, J PROTEOME RES, V8, P3752, DOI 10.1021/pr900080y; Pejchinovski M, 2015, PROTEOMICS CLIN APPL; Pottiez G, 2012, J PROTEOME RES, V11, P3774, DOI 10.1021/pr300414z; Qattan AT, 2010, J PROTEOME RES, V9, P495, DOI 10.1021/pr9008332; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sandberg A, 2014, J PROTEOMICS, V96, P133, DOI 10.1016/j.jprot.2013.10.035; Schiess R, 2009, MOL ONCOL, V3, P33, DOI 10.1016/j.molonc.2008.12.001; Serang O, 2012, STAT INTERFACE, V5, P3; Sharma S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07140; Simpson DM, 2010, J PROTEOME RES, V9, P444, DOI 10.1021/pr900806x; Sjodin MOD, 2013, J CHROMATOGR B, V928, P83, DOI 10.1016/j.jchromb.2013.03.027; Sobin L, 2009, TNM CLASSIFICATION M; Thingholm TE, 2010, J PROTEOME RES, V9, P4045, DOI 10.1021/pr100230q; Trinh Hung V, 2013, Int J Proteomics, V2013, P581862, DOI 10.1155/2013/581862; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang HX, 2012, J PROTEOME RES, V11, P487, DOI 10.1021/pr2008225; Werner T, 2014, ANAL CHEM, V86, P3594, DOI 10.1021/ac500140s; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhang SY, 2013, MOL VIS, V19, P812	48	67	73	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137048	10.1371/journal.pone.0137048	http://dx.doi.org/10.1371/journal.pone.0137048			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331617	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800092
J	Li Causi, E; Parikh, SC; Chudley, L; Layfield, DM; Ottensmeier, CH; Stevenson, FK; Di Genova, G				Li Causi, Eleonora; Parikh, Suraj C.; Chudley, Lindsey; Layfield, David M.; Ottensmeier, Christian H.; Stevenson, Freda K.; Di Genova, Gianfranco			Vaccination Expands Antigen-Specific CD4(+) Memory T Cells and Mobilizes Bystander Central Memory T Cells	PLOS ONE			English	Article							BONE-MARROW; SMALLPOX; EFFECTOR; HETEROGENEITY; IMMUNIZATION; STIMULATION; GENERATION; RESPONSES; IMMUNITY	CD4(+) T helper memory (Th-mem) cells influence both natural and vaccine-boosted immunity, but mechanisms for their maintenance remain unclear. Pro-survival signals from the common gamma-chain cytokines, in particular IL-7, appear important. Previously we showed in healthy volunteers that a booster vaccination with tetanus toxoid (TT) expanded peripheral blood TT-specific Th-mem cells as expected, but was accompanied by parallel increase of Thmem cells specific for two unrelated and non cross-reactive common recall antigens. Here, in a new cohort of healthy human subjects, we compare blood vaccine-specific and bystander Th-mem cells in terms of differentiation stage, function, activation and proliferative status. Both responses peaked 1 week post-vaccination. Vaccine-specific cytokine-producing Th-mem cells were predominantly effector memory, whereas bystander cells were mainly of central memory phenotype. Importantly, TT-specific Th-mem cells were activated (CD38(High) HLA-DR+), cycling or recently divided (Ki-67(+)), and apparently vulnerable to death (IL-7R alpha(Low) and Bcl-2 (Low)). In contrast, bystander Th-mem cells were resting (CD38(Low) HLA-DR- Ki-67(-)) with high expression of IL-7R alpha and Bcl-2. These findings allow a clear distinction between vaccine-specific and bystander Th-mem cells, suggesting the latter do not derive from recent proliferation but from cells mobilized from as yet undefined reservoirs. Furthermore, they reveal the interdependent dynamics of specific and bystander T-cell responses which will inform assessments of responses to vaccines.	[Li Causi, Eleonora; Parikh, Suraj C.; Chudley, Lindsey; Layfield, David M.; Ottensmeier, Christian H.; Stevenson, Freda K.; Di Genova, Gianfranco] Univ Southampton, Fac Med, Canc Sci Unit, Southampton SO9 5NH, Hants, England	University of Southampton	Di Genova, G (corresponding author), AstraZeneca R&D Oncol IMed, 33G197 Mereside,Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	g.digenova@outlook.com	Ottensmeier, Christian H/E-8131-2012; Ottensmeier, Christian/ABE-9056-2020	Ottensmeier, Christian H/0000-0003-3619-1657; Ottensmeier, Christian/0000-0003-3619-1657; Parikh, Suraj/0000-0002-1878-6510; Layfield, David/0000-0002-9224-8243; Stevenson, Freda/0000-0002-0933-5021	Leukaemia & Lymphoma Research [08028]; Cancer Research UK [15951, 20613] Funding Source: researchfish	Leukaemia & Lymphoma Research; Cancer Research UK(Cancer Research UK)	This study was supported by Leukaemia & Lymphoma Research https://leukaemialymphomaresearch.org.uk/ grant number 08028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangs SC, 2009, J IMMUNOL, V182, P1962, DOI 10.4049/jimmunol.0802596; Cellerai C, 2007, EUR J IMMUNOL, V37, P1129, DOI 10.1002/eji.200636885; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Cohen GB, 2005, J IMMUNOL METHODS, V302, P103, DOI 10.1016/j.jim.2005.05.002; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Demkowicz WE, 1996, J VIROL, V70, P2627, DOI 10.1128/JVI.70.4.2627-2631.1996; Di Genova G, 2006, BLOOD, V107, P2806, DOI 10.1182/blood-2005-08-3255; Di Genova G, 2010, EUR J IMMUNOL, V40, P976, DOI 10.1002/eji.200940017; DONNENBERG AD, 1984, SCAND J IMMUNOL, V20, P279, DOI 10.1111/j.1365-3083.1984.tb01004.x; FERNANDEZ V, 1994, EUR J IMMUNOL, V24, P1808, DOI 10.1002/eji.1830240813; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gonzalez-Garcia I, 2006, J IMMUNOL, V176, P4042, DOI 10.4049/jimmunol.176.7.4042; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324; Herndler-Brandstetter D, 2011, J IMMUNOL, V186, P6965, DOI 10.4049/jimmunol.1100243; Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306; Mayer S, 2002, IMMUNOBIOLOGY, V205, P282, DOI 10.1078/0171-2985-00131; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mitchell T, 1999, J IMMUNOL, V162, P4527; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; Osborne LC, 2010, CYTOKINE, V50, P105, DOI 10.1016/j.cyto.2009.09.008; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Shinoda K, 2012, P NATL ACAD SCI USA, V109, P7409, DOI 10.1073/pnas.1118539109; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Taylor JJ, 2011, CURR OPIN IMMUNOL, V23, P319, DOI 10.1016/j.coi.2011.03.010; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Varga SM, 2001, J IMMUNOL, V166, P1554, DOI 10.4049/jimmunol.166.3.1554; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	35	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136717	10.1371/journal.pone.0136717	http://dx.doi.org/10.1371/journal.pone.0136717			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332995	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800067
J	Sato, M; Sasaki, N; Ato, M; Hirakawa, S; Sato, K; Sato, K				Sato, Miwa; Sasaki, Naoki; Ato, Manabu; Hirakawa, Satoshi; Sato, Kiichi; Sato, Kae			Microcirculation-on-a-Chip: A Microfluidic Platform for Assaying Blood- and Lymphatic-Vessel Permeability	PLOS ONE			English	Article							BRAIN-BARRIER MODEL; IN-VITRO MODEL; ENDOTHELIAL-CELLS; SHEAR-STRESS; MICROVASCULAR TUBES; DRUG-DELIVERY; HISTAMINE; SYSTEM; ADHESION; FLOW	We developed a microfluidic model of microcirculation containing both blood and lymphatic vessels for examining vascular permeability. The designed microfluidic device harbors upper and lower channels that are partly aligned and are separated by a porous membrane, and on this membrane, blood vascular endothelial cells (BECs) and lymphatic endothelial cells (LECs) were cocultured back-to-back. At cell-cell junctions of both BECs and LECs, claudin-5 and VE-cadherin were detected. The permeability coefficient measured here was lower than the value reported for isolated mammalian venules. Moreover, our results showed that the flow culture established in the device promoted the formation of endothelial cell-cell junctions, and that treatment with histamine, an inflammation-promoting substance, induced changes in the localization of tight and adherens junction-associated proteins and an increase in vascular permeability in the microdevice. These findings indicated that both BECs and LECs appeared to retain their functions in the microfluidic coculture platform. Using this microcirculation device, the vascular damage induced by habu snake venom was successfully assayed, and the assay time was reduced from 24 h to 30 min. This is the first report of a microcirculation model in which BECs and LECs were cocultured. Because the micromodel includes lymphatic vessels in addition to blood vessels, the model can be used to evaluate both vascular permeability and lymphatic return rate.	[Sato, Miwa; Sasaki, Naoki; Sato, Kae] Japan Womens Univ, Dept Chem & Biol Sci, Fac Sci, Bunkyo Ku, Tokyo 112, Japan; [Ato, Manabu] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan; [Hirakawa, Satoshi] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan; [Sato, Kiichi] Gunma Univ, Sch Sci & Technol, Div Mol Sci, Kiryu, Gunma, Japan	Japan Womens University; National Institute of Infectious Diseases (NIID); Hamamatsu University School of Medicine; Gunma University	Sato, K (corresponding author), Japan Womens Univ, Dept Chem & Biol Sci, Fac Sci, Bunkyo Ku, Tokyo 112, Japan.	satouk@fc.jwu.ac.jp	Sato, Kae/J-4592-2015; Ato, Manabu/K-6452-2019	Sato, Kae/0000-0002-1618-2086; SASAKI, Naoki/0000-0003-1267-1744; Ato, Manabu/0000-0002-3178-2645	Tokyo Ohka Foundation for the Promotion of Science and Technology; Banyu Foundation Research Grant; Science Research Promotion Fund; Suzuken Memorial Foundation; JSPSJSPS [24350035, 25600065]; Core Research for Evolutional Science and Technology (JST, CREST) Program	Tokyo Ohka Foundation for the Promotion of Science and Technology(Tokyo Ohka Foundation for the Promotion of Science and Technology); Banyu Foundation Research Grant; Science Research Promotion Fund; Suzuken Memorial Foundation; JSPSJSPS; Core Research for Evolutional Science and Technology (JST, CREST) Program	This work was supported in part by Tokyo Ohka Foundation for the Promotion of Science and Technology (to Kae S, http://www.tok-foundation.or.jp/), Banyu Foundation Research Grant (to Kae S, http://www.banyu-zaidan.or.jp/), The Science Research Promotion Fund (to Kae S, http://www.shigaku.go.jp/s_shikin_menu.htm), Suzuken Memorial Foundation (to Kae S, http://www.suzukenzaidan.or.jp/), a Grant-in-Aid for Scientific Research (JSPS, KAKENHI; Grant Numbers 24350035 to Kiichi S and 25600065 to Kae S, https://www.jsps.go.jp/english/e-grants/grants01.html), and the Core Research for Evolutional Science and Technology (JST, CREST) Program (to Kae S, http://www.jst.go.jp/kisoken/crest/en/).	Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009; Booth R, 2014, ANN BIOMED ENG, V42, P2379, DOI 10.1007/s10439-014-1086-5; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Breslin Jerome W., 2009, Lymphatic Research and Biology, V7, P229, DOI 10.1089/lrb.2009.0015; Chan KLS, 2014, J BIOMED MATER RES A, V102, P3186, DOI 10.1002/jbm.a.34990; Chen C, 2013, INFLAMMATION, V36, P309, DOI 10.1007/s10753-012-9548-0; Chen MB, 2013, INTEGR BIOL-UK, V5, P1262, DOI 10.1039/c3ib40149a; Chen MB, 2013, LAB CHIP, V13, P2591, DOI [10.1039/c3lc00051f, 10.1039/c31c00051f]; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; Chueh BH, 2007, ANAL CHEM, V79, P3504, DOI 10.1021/ac062118p; Daly SM, 2013, J BIOPHOTONICS, V6, P217, DOI 10.1002/jbio.201200071; Dixon JB, 2006, MICROCIRCULATION, V13, P597, DOI 10.1080/10739680600893909; Farmer PJ, 2001, AM J PHYSIOL-LUNG C, V280, pL732, DOI 10.1152/ajplung.2001.280.4.L732; Granger DN, 2010, INFLAMMATION MICROCI, DOI DOI 10.4199/C00013ED1V01Y201006ISP008; Griep LM, 2013, BIOMED MICRODEVICES, V15, P145, DOI 10.1007/s10544-012-9699-7; Guo M, 2008, AM J PHYSIOL-CELL PH, V294, pC977, DOI 10.1152/ajpcell.90607.2007; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Imura Y, 2009, ANAL SCI, V25, P1403, DOI 10.2116/analsci.25.1403; Kano MR, 2009, CANCER SCI, V100, P173, DOI 10.1111/j.1349-7006.2008.01003.x; Kawai Y, 2010, AM J PHYSIOL-CELL PH, V298, pC647, DOI 10.1152/ajpcell.00249.2009; Kim S, 2013, LAB CHIP, V13, P1489, DOI 10.1039/c3lc41320a; Kondo H, 1960, JAPAN J MED SCI BIOL, V13, P43; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12; Lee H, 2014, MICROVASC RES, V91, P90, DOI 10.1016/j.mvr.2013.12.001; Maeda H, 2013, ADV DRUG DELIVER REV, V65, P71, DOI 10.1016/j.addr.2012.10.002; Margaris KN, 2012, J R SOC INTERFACE, V9, P601, DOI 10.1098/rsif.2011.0751; Morine N, 2008, TOXICON, V51, P345, DOI 10.1016/j.toxicon.2007.10.009; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Ono N, 2005, AM J PHYSIOL-HEART C, V289, pH1676, DOI 10.1152/ajpheart.01084.2004; Prabhakarpandian B, 2013, LAB CHIP, V13, P1093, DOI 10.1039/c2lc41208j; Price GM, 2008, MICROVASC RES, V76, P46, DOI 10.1016/j.mvr.2008.02.003; Qi D, 2012, EUR PHYS J-SPEC TOP, V204, P85, DOI 10.1140/epjst/e2012-01554-x; Reed AL, 2013, PHARM RES-DORDR, V30, P3271, DOI 10.1007/s11095-013-1218-x; Rigor RR, 2013, MED RES REV, V33, P911, DOI 10.1002/med.21270; Saito Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/804675; SARIA A, 1983, N-S ARCH PHARMACOL, V324, P212, DOI 10.1007/BF00503897; Sasaki N., 2013, P 17 INT C MIN SYST, V2013, P1818; Sasaki N, 2012, ELECTROPHORESIS, V33, P1729, DOI 10.1002/elps.201100691; Shao JB, 2010, BIOMED MICRODEVICES, V12, P81, DOI 10.1007/s10544-009-9362-0; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Srigunapalan S, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3530598; Tanaka Y, 2007, ANAL SCI, V23, P261, DOI 10.2116/analsci.23.261; Theakston RDG, 2003, TOXICON, V41, P541, DOI 10.1016/S0041-0101(02)00393-8; Thompson VF, 2000, ANAL BIOCHEM, V279, P170, DOI 10.1006/abio.1999.4475; Tsuji T, 2002, LAB INVEST, V82, P555, DOI 10.1038/labinvest.3780450; van der Meer AD, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3366720; Wong KHK, 2013, J BIOMED MATER RES A, V101, P2181, DOI 10.1002/jbm.a.34524; Wu MH, 2001, J PHYSIOL-LONDON, V532, P785, DOI 10.1111/j.1469-7793.2001.0785e.x; Yeon JH, 2012, LAB CHIP, V12, P2815, DOI [10.1039/c2lc40131b, 10.1039/C2LC40131B]; Young EWK, 2010, ANAL CHEM, V82, P808, DOI 10.1021/ac901560w; Zhang Xiao-Yu, 2014, Cancer Biology Medicine, V11, P247, DOI 10.7497/j.issn.2095-3941.2014.04.003; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109	56	79	79	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137301	10.1371/journal.pone.0137301	http://dx.doi.org/10.1371/journal.pone.0137301			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332321	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800119
J	Tian, X; Li, ZY; Chen, EX; Liu, QH; Yan, GJ; Wang, JD; Niu, Z; Zhao, SJ; Li, X; Pang, Y; Su, ZB; van der Tol, C; Liu, QW; Wu, CY; Xiao, Q; Yang, L; Mu, XH; Bo, YC; Qu, YH; Zhou, HM; Gao, SH; Chai, LN; Huang, HG; Fan, WJ; Li, SH; Bai, JH; Jiang, LM; Zhou, J				Tian, Xin; Li, Zengyuan; Chen, Erxue; Liu, Qinhuo; Yan, Guangjian; Wang, Jindi; Niu, Zheng; Zhao, Shaojie; Li, Xin; Pang, Yong; Su, Zhongbo; van der Tol, Christiaan; Liu, Qingwang; Wu, Chaoyang; Xiao, Qing; Yang, Le; Mu, Xihan; Bo, Yanchen; Qu, Yonghua; Zhou, Hongmin; Gao, Shuai; Chai, Linna; Huang, Huaguo; Fan, Wenjie; Li, Shihua; Bai, Junhua; Jiang, Lingmei; Zhou, Ji			The Complicate Observations and Multi-Parameter Land Information Constructions on Allied Telemetry Experiment (COMPLICATE)	PLOS ONE			English	Article							RADIATIVE-TRANSFER THEORY; SOIL-MOISTURE; HYPERSPECTRAL LIDAR; LEAF-AREA; L-BAND; MODEL; VEGETATION; CANOPY; REFLECTANCE; TEMPERATURE	The Complicate Observations and Multi-Parameter Land Information Constructions on Allied Telemetry Experiment (COMPLICATE) comprises a network of remote sensing experiments designed to enhance the dynamic analysis and modeling of remotely sensed information for complex land surfaces. Two types of experimental campaigns were established under the framework of COMPLICATE. The first was designed for continuous and elaborate experiments. The experimental strategy helps enhance our understanding of the radiative and scattering mechanisms of soil and vegetation and modeling of remotely sensed information for complex land surfaces. To validate the methodologies and models for dynamic analyses of remote sensing for complex land surfaces, the second campaign consisted of simultaneous satellite-borne, airborne, and ground-based experiments. During field campaigns, several continuous and intensive observations were obtained. Measurements were undertaken to answer key scientific issues, as follows: 1) Determine the characteristics of spatial heterogeneity and the radiative and scattering mechanisms of remote sensing on complex land surfaces. 2) Determine the mechanisms of spatial and temporal scale extensions for remote sensing on complex land surfaces. 3) Determine synergist inversion mechanisms for soil and vegetation parameters using multi-mode remote sensing on complex land surfaces. Here, we introduce the background, the objectives, the experimental designs, the observations and measurements, and the overall advances of COMPLICATE. As a result of the implementation of COMLICATE and for the next several years, we expect to contribute to quantitative remote sensing science and Earth observation techniques.	[Tian, Xin; Li, Zengyuan; Chen, Erxue; Pang, Yong; Liu, Qingwang] Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing, Peoples R China; [Tian, Xin; Su, Zhongbo; van der Tol, Christiaan] Univ Twente, Fac Geoinformat Sci & Earth Observat, NL-7500 AE Enschede, Netherlands; [Liu, Qinhuo; Niu, Zheng; Wu, Chaoyang; Xiao, Qing; Yang, Le; Gao, Shuai; Bai, Junhua] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Yan, Guangjian; Wang, Jindi; Zhao, Shaojie; Mu, Xihan; Bo, Yanchen; Qu, Yonghua; Zhou, Hongmin; Chai, Linna; Jiang, Lingmei] Beijing Normal Univ, Res Ctr Remote Sensing & GIS, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China; [Yan, Guangjian; Wang, Jindi; Zhao, Shaojie; Mu, Xihan; Bo, Yanchen; Qu, Yonghua; Zhou, Hongmin; Chai, Linna; Jiang, Lingmei] Beijing Normal Univ, Sch Geog, Beijing 100875, Peoples R China; [Li, Xin] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Huang, Huaguo] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Fan, Wenjie] Peking Univ, Inst Remote Sensing & Geog Informat Syst, Beijing 100871, Peoples R China; [Li, Shihua; Zhou, Ji] Univ Elect Sci & Technol China, Sch Resources & Environm, Chengdu 610054, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Resources Information Technique, CAF; University of Twente; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Beijing Forestry University; Peking University; University of Electronic Science & Technology of China	Li, ZY (corresponding author), Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing, Peoples R China.	zy@caf.ac.cn; chenerx@caf.ac.cn	Mu, Xihan/L-4762-2016; Su, Z. (Bob)/D-4383-2009; Li, Xin/F-7473-2011; Yang, Le/GZG-6603-2022; LIU, Qinhuo/S-1647-2016; li, xin/HHS-9461-2022; van der Tol, Christiaan/A-2403-2010; niu, zheng/M-9923-2017; Bo, Yanchen/B-2073-2015	Mu, Xihan/0000-0003-4812-3045; Li, Xin/0000-0003-2999-9818; LIU, Qinhuo/0000-0002-3713-9511; van der Tol, Christiaan/0000-0002-2484-8191; Huang, Huaguo/0000-0001-9355-2338; Bo, Yanchen/0000-0002-5136-9364; Pang, Yong/0000-0002-9760-6580; Su, Zhongbo/0000-0003-2096-1733; Yan, Guangjian/0000-0001-5030-748X	National Basic Research Program of China (973 Program) [2013CB733400]; National High Technology Research and Development Program ("863 Program") [2011AA120400, 2011AA120405, 2012AA12A304, 2012AA12A306]; National Natural Science Foundation (HiWATER) [91125001, 91125002, 91125003, 91125004]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program ("863 Program")(National High Technology Research and Development Program of China); National Natural Science Foundation (HiWATER)	This work is mainly supported by two kinds of projects, the National Basic Research Program of China (973 Program) (Grant No. 2013CB733400) and the National High Technology Research and Development Program ("863 Program") (Grant No. 2011AA120400, 2011AA120405, 2012AA12A304, 2012AA12A306). Some work was jointly supported by the National Natural Science Foundation (HiWATER, Grants No. 91125001, 91125002, 91125003, and 91125004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires F, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007362; Albinet C, 2012, IEEE J-STARS, V5, P1060, DOI 10.1109/JSTARS.2012.2201917; ATTEMA EPW, 1978, RADIO SCI, V13, P357, DOI 10.1029/RS013i002p00357; Chen JM, 1997, IEEE T GEOSCI REMOTE, V35, P1316, DOI 10.1109/36.628798; Chen L, 2010, IEEE GEOSCI REMOTE S, V7, P127, DOI 10.1109/LGRS.2009.2028443; Chen Y, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007163; Chen YW, 2010, SENSORS-BASEL, V10, P7057, DOI 10.3390/s100707057; Colliander A, 2012, REMOTE SENS ENVIRON, V121, P309, DOI 10.1016/j.rse.2012.02.002; Cuenca J, 2004, APPL OPTICS, V43, P4598, DOI 10.1364/AO.43.004598; Daumard F, 2010, IEEE T GEOSCI REMOTE, V48, P3358, DOI 10.1109/TGRS.2010.2046420; de Rosnay P, 2006, REMOTE SENS ENVIRON, V102, P377, DOI 10.1016/j.rse.2006.02.021; Delanoe J, 2013, J ATMOS OCEAN TECH, V30, P57, DOI 10.1175/JTECH-D-11-00200.1; DUBOIS PC, 1992, IEEE T GEOSCI REMOTE, V30, P1145, DOI 10.1109/36.193790; Flores AN, 2009, IEEE T GEOSCI REMOTE, V47, P2557, DOI 10.1109/TGRS.2009.2014743; FREEMAN A, 1992, IEEE T GEOSCI REMOTE, V30, P1107, DOI 10.1109/36.193786; Garrigues S, 2006, REMOTE SENS ENVIRON, V105, P286, DOI 10.1016/j.rse.2006.07.013; GOEL NS, 1991, REMOTE SENS ENVIRON, V36, P73, DOI 10.1016/0034-4257(91)90032-2; Hakala T, 2012, OPT EXPRESS, V20, P7119, DOI 10.1364/OE.20.007119; Dinh HTM, 2013, IEEE T GEOSCI REMOTE, V51, P4460, DOI 10.1109/TGRS.2013.2246795; Huemmrich KF, 2001, REMOTE SENS ENVIRON, V75, P423, DOI 10.1016/S0034-4257(00)00184-X; Ines AVM, 2013, REMOTE SENS ENVIRON, V138, P149, DOI 10.1016/j.rse.2013.07.018; Jiang LM, 2012, INT J REMOTE SENS, V33, P872, DOI 10.1080/01431161.2011.577835; JORDAN RL, 1995, IEEE T GEOSCI REMOTE, V33, P829, DOI 10.1109/36.406669; Katzfuss M, 2011, J TIME SER ANAL, V32, P430, DOI 10.1111/j.1467-9892.2011.00732.x; Kotchenova SY, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003288; KUUSK A, 1995, REMOTE SENS ENVIRON, V51, P342, DOI 10.1016/0034-4257(94)00059-V; Kuze A, 2014, IEEE T GEOSCI REMOTE, V52, P3991, DOI 10.1109/TGRS.2013.2278696; Lagouarde JP, 2012, REMOTE SENS ENVIRON, V117, P19, DOI 10.1016/j.rse.2011.06.022; Li X, 2007, PROG NAT SCI-MATER, V17, P881; Li X, 2013, B AM METEOROL SOC, V94, P1145, DOI 10.1175/BAMS-D-12-00154.1; Li X, 2012, INT J APPL EARTH OBS, V17, P33, DOI 10.1016/j.jag.2011.12.002; Li X, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011590; LI XW, 1988, IEEE T GEOSCI REMOTE, V26, P161, DOI 10.1109/36.3017; LI XW, 1992, IEEE T GEOSCI REMOTE, V30, P276, DOI 10.1109/36.134078; Li XW, 1999, IEEE T GEOSCI REMOTE, V37, P2508, DOI 10.1109/36.789646; Liu DW, 2010, IEEE T GEOSCI REMOTE, V48, P349, DOI 10.1109/TGRS.2009.2024301; Liu Q, 2012, INT J APPL EARTH OBS, V17, P66, DOI 10.1016/j.jag.2011.10.003; Macelloni G, 2013, IEEE T GEOSCI REMOTE, V51, P4718, DOI 10.1109/TGRS.2013.2277921; Marceau DJ., 1999, CAN J REMOTE SENS, V25, P18, DOI DOI 10.1080/07038992.1999.10874734; Mladenova IE, 2014, REMOTE SENS ENVIRON, V144, P197, DOI 10.1016/j.rse.2014.01.013; Morrison K, 2005, CAN J REMOTE SENS, V31, P1, DOI 10.5589/m04-053; Morsdorf F, 2010, REMOTE SENS ENVIRON, V114, P1403, DOI 10.1016/j.rse.2010.01.023; Morsdorf F, 2009, REMOTE SENS ENVIRON, V113, P2152, DOI 10.1016/j.rse.2009.05.019; Ni WJ, 2014, IEEE GEOSCI REMOTE S, V11, P273, DOI 10.1109/LGRS.2013.2255580; North PRJ, 1996, IEEE T GEOSCI REMOTE, V34, P946, DOI 10.1109/36.508411; Park SE, 2012, IEEE T GEOSCI REMOTE, V50, P4711, DOI 10.1109/TGRS.2012.2194153; Praks J, 2012, IEEE T GEOSCI REMOTE, V50, P3831, DOI 10.1109/TGRS.2012.2185803; Prevot L, 2003, AGRONOMIE, V23, P297, DOI 10.1051/agro:2003003; Puttonen E, 2010, FOREST ECOL MANAG, V260, P1843, DOI 10.1016/j.foreco.2010.08.031; Roncat A, 2014, IEEE GEOSCI REMOTE S, V11, P549, DOI 10.1109/LGRS.2013.2274557; Shi JC, 2002, IEEE T GEOSCI REMOTE, V40, P2674, DOI 10.1109/TGRS.2002.807003; Shi JC, 2012, SCI CHINA EARTH SCI, V55, P1052, DOI 10.1007/s11430-012-4444-x; Sun G, 2002, REMOTE SENS ENVIRON, V79, P279, DOI 10.1016/S0034-4257(01)00279-6; SUN GQ, 1995, IEEE T GEOSCI REMOTE, V33, P372, DOI 10.1109/TGRS.1995.8746018; Thomas V, 2011, INT J REMOTE SENS, V32, P8271, DOI 10.1080/01431161.2010.533211; Ulaby F T, 1990, J REMOTE SENSING, V11, P1223; van der Tol C, 2009, BIOGEOSCIENCES, V6, P3109, DOI 10.5194/bg-6-3109-2009; Verhoef W, 2007, REMOTE SENS ENVIRON, V109, P166, DOI 10.1016/j.rse.2006.12.013; Verhoef W, 2007, IEEE T GEOSCI REMOTE, V45, P1808, DOI 10.1109/TGRS.2007.895844; Verrelst J, 2014, IEEE T GEOSCI REMOTE, V52, P257, DOI 10.1109/TGRS.2013.2238242; Woodhouse IH, 2011, IEEE GEOSCI REMOTE S, V8, P839, DOI 10.1109/LGRS.2011.2113312; Wu H, 2009, SENSORS-BASEL, V9, P1768, DOI 10.3390/s90301768; Young SS, 2001, INT J REMOTE SENS, V22, P1457, DOI 10.1080/01431160116787; Zhang JX, 2012, PHOTOGRAMM ENG REM S, V78, P1110	64	17	18	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137545	10.1371/journal.pone.0137545	http://dx.doi.org/10.1371/journal.pone.0137545			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332035	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800136
J	Horowitz, J; Patton, J				Horowitz, Justin; Patton, James			I Meant to Do That: Determining the Intentions of Action in the Face of Disturbances	PLOS ONE			English	Article							OPTIMAL FEEDBACK-CONTROL; ARM; POINT; ADAPTATION; STIFFNESS; DYNAMICS	Our actions often do not match our intentions when there are external disturbances such as turbulence. We derived a novel modeling approach for determining this motor intent from targeted reaching motions that are disturbed by an unexpected force. First, we demonstrated how to mathematically invert both feedforward (predictive) and feedback controls to obtain an intended trajectory. We next examined the model's sensitivity to a realistic range of parameter uncertainties, and found that the expected inaccuracy due to all possible parameter mis-estimations was less than typical movement-to-movement variations seen when humans reach to similar targets. The largest sensitivity arose mainly from uncertainty in joint stiffnesses. Humans cannot change their intent until they acquire sensory feedback, therefore we tested the hypothesis that a straight-line intent should be evident for at least the first 120 milliseconds following the onset of a disturbance. As expected, the intended trajectory showed no change from undisturbed reaching for more than 150 milliseconds after the disturbance onset. Beyond this point, however, we detected a change in intent in five out of eight subjects, surprisingly even when the hand is already near the target. Knowing such an intent signal is broadly applicable: enhanced human-machine interaction, the study of impaired intent in neural disorders, the real-time determination (and manipulation) of error in training, and complex systems that embody planning such as brain machine interfaces, team sports, crowds, or swarms. In addition, observing intent as it changes might act as a window into the mechanisms of planning, correction, and learning.	[Horowitz, Justin; Patton, James] Univ Illinois, Bioengn, Chicago, IL 60607 USA; [Patton, James] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shirley Ryan AbilityLab	Patton, J (corresponding author), Univ Illinois, Bioengn, Chicago, IL 60607 USA.	pattonj@uic.edu			National of Institutes of Health (nih.gov) [US NIH NINDS1 R01 NS053606]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053606] Funding Source: NIH RePORTER	National of Institutes of Health (nih.gov)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research was supported by National of Institutes of Health (nih.gov) grant US NIH NINDS1 R01 NS053606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdet E, 2006, BIOL CYBERN, V94, P20, DOI 10.1007/s00422-005-0025-9; Crevecoeur F, 2014, PLOS COMPUT BIOL, V10, DOI [10.1371/journal.pcbi.1003869, 10.1371/journal.pcbi.1003996]; Dempster W.T., 1955, SPACE REQUIREMENTS S; FELDMAN AG, 1995, BEHAV BRAIN SCI, V18, P723, DOI 10.1017/S0140525X0004070X; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Fryar C. D., 2012, VITAL HLTH STAT, V11, P1; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Gomi H, 1998, J NEUROSCI, V18, P8965; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Hodgson AJ, 2000, IEEE T SYST MAN CY C, V30, P105, DOI 10.1109/5326.827459; MATLAB, 2008, VERS 7 6 0 324 R2008; Patton JL, 2006, EXP BRAIN RES, V168, P368, DOI 10.1007/s00221-005-0097-8; Patton JL, 2004, IEEE T BIO-MED ENG, V51, P636, DOI 10.1109/TBME.2003.821035; Pruszynski JA, 2012, EXP BRAIN RES, V218, P341, DOI 10.1007/s00221-012-3041-8; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; STUNKARD AJ, 1981, AM J CLIN NUTR, V34, P1593, DOI 10.1093/ajcn/34.8.1593; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; van Eesbeek S, 2010, J BIOMECH, V43, P2539, DOI 10.1016/j.jbiomech.2010.05.017; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	24	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137289	10.1371/journal.pone.0137289	http://dx.doi.org/10.1371/journal.pone.0137289			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327405	Green Submitted, gold, Green Published			2022-12-27	WOS:000360437700107
J	Buisine, N; Ruan, XA; Bilesimo, P; Grimaldi, A; Alfama, G; Ariyaratne, P; Mulawadi, F; Chen, JQ; Sung, WK; Liu, ET; Demeneix, BA; Ruan, YJ; Sachs, LM				Buisine, Nicolas; Ruan, Xiaoan; Bilesimo, Patrice; Grimaldi, Alexis; Alfama, Gladys; Ariyaratne, Pramila; Mulawadi, Fabianus; Chen, Jieqi; Sung, Wing-Kin; Liu, Edison T.; Demeneix, Barbara A.; Ruan, Yijun; Sachs, Laurent M.			Xenopus tropicalis Genome Re-Scaffolding and Re-Annotation Reach the Resolution Required for In Vivo ChIA-PET Analysis	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; DRAFT GENOME; RNA-SEQ; SEQUENCE; IDENTIFICATION; METAMORPHOSIS; TRANSCRIPTOME; EVOLUTION; MODEL	Genome-wide functional analyses require high-resolution genome assembly and annotation. We applied ChIA-PET to analyze gene regulatory networks, including 3D chromosome interactions, underlying thyroid hormone (TH) signaling in the frog Xenopus tropicalis. As the available versions of Xenopus tropicalis assembly and annotation lacked the resolution required for ChIA-PET we improve the genome assembly version 4.1 and annotations using data derived from the paired end tag (PET) sequencing technologies and approaches (e.g., DNA-PET [gPET], RNA-PET etc.). The large insert (similar to 10Kb, similar to 17Kb) paired end DNA-PET with high throughput NGS sequencing not only significantly improved genome assembly quality, but also strongly reduced genome "fragmentation", reducing total scaffold numbers by similar to 60%. Next, RNA-PET technology, designed and developed for the detection of full-length transcripts and fusion mRNA in whole transcriptome studies (ENCODE consortia), was applied to capture the 5' and 3' ends of transcripts. These amendments in assembly and annotation were essential prerequisites for the ChIA-PET analysis of TH transcription regulation. Their application revealed complex regulatory configurations of target genes and the structures of the regulatory networks underlying physiological responses. Our work allowed us to improve the quality of Xenopus tropicalis genomic resources, reaching the standard required for ChIA-PET analysis of transcriptional networks. We consider that the workflow proposed offers useful conceptual and methodological guidance and can readily be applied to other non-conventional models that have low-resolution genome data.	[Buisine, Nicolas; Bilesimo, Patrice; Grimaldi, Alexis; Alfama, Gladys; Demeneix, Barbara A.; Sachs, Laurent M.] Museum Natl Hist Nat, UMR CNRS 7221, F-75231 Paris, France; [Ruan, Xiaoan; Liu, Edison T.; Ruan, Yijun] Jackson Lab Genom Med, Farmington, CT 06302 USA; [Ruan, Xiaoan; Liu, Edison T.; Ruan, Yijun] Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT USA; [Ruan, Xiaoan; Ariyaratne, Pramila; Mulawadi, Fabianus; Chen, Jieqi; Sung, Wing-Kin; Liu, Edison T.; Ruan, Yijun] Genome Inst Singapore, Singapore, Singapore; [Bilesimo, Patrice] Watchfrog SAS, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); Jackson Laboratory; University of Connecticut; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ruan, YJ (corresponding author), Jackson Lab Genom Med, Farmington, CT 06302 USA.	Yijun.Ruan@jax.org; sachs@mnhn.fr	Sachs, Laurent/AAE-1504-2020	Sung, Wing-Kin/0000-0001-7806-7086	CRESCENDO [LSHM-CT-2005-01865]; TRIGGER [ANR-08-JCJC-0100-01]; IDEAL [259679]; Convention CIFRE [631/2006]; MERLION project [5.01.10]; ARC fellowship [SJ118-10]; NATIONAL CANCER INSTITUTE [R01CA186714] Funding Source: NIH RePORTER	CRESCENDO(European Commission); TRIGGER; IDEAL; Convention CIFRE; MERLION project; ARC fellowship(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the following grant: CRESCENDO, LSHM-CT-2005-01865, http:// www.tmpneo.com/site_crescendo/links.asp?rub=4 & TRIGGER, ANR-08-JCJC-0100-01, http://www.agence-nationale-recherche.fr/projet-anr/? tx_lwmsuivibilan_pi2[CODE]=ANR-08-JCJC-0100; IDEAL, 259679, http://ec.europa.eu/ research/health/medical-research/human-development-and-ageing/projects/ideal en.html; Convention CIFRE 631/2006; MERLION project 5.01.10; ARC fellowship SJ118-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Watchfrog S.A.S. provided support in form of salaries for author (P.B.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The roles of this author are articulated in the 'author contributions' section.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Ariyaratne PN, 2011, BIOINFORMATICS, V27, P167, DOI 10.1093/bioinformatics/btq626; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Buchholz DR, 2015, DEV BIOL, V408, P188, DOI 10.1016/j.ydbio.2015.02.018; Buisine Nicolas, 2009, BMC Res Notes, V2, P257, DOI 10.1186/1756-0500-2-257; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Eckalbar WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-49; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Grimaldi AG, 2013, HIGH THROUGHPUT SEQU, P277; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Huang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054732; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nieuwkoop PD, 1967, NORMAL TABLE OF XENO; Reese MG, 2000, GENOME RES, V10, P483, DOI 10.1101/gr.10.4.483; Ruan XA, 2012, METHODS MOL BIOL, V809, P535, DOI 10.1007/978-1-61779-376-9_35; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Shi YB, 1998, AMPHIBIAN METAMORPHO; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tata JR, 2006, MOL CELL ENDOCRINOL, V246, P10, DOI 10.1016/j.mce.2005.11.024; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Wells DE, 2011, DEV BIOL, V354, P1, DOI 10.1016/j.ydbio.2011.03.022; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174; Yao F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046152; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhuo Y, 2012, J BACTERIOL, V194, P4749, DOI 10.1128/JB.00931-12	46	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137526	10.1371/journal.pone.0137526	http://dx.doi.org/10.1371/journal.pone.0137526			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348928	Green Submitted, Green Published, gold			2022-12-27	WOS:000360897600051
J	Chen, Y; Wong, LLN; Zhu, SF; Xi, X				Chen, Yuan; Wong, Lena L. N.; Zhu, Shufeng; Xi, Xin			A Structural Equation Modeling Approach to Examining Factors Influencing Outcomes with Cochlear Implant in Mandarin-Speaking Children	PLOS ONE			English	Article							SPEECH-PERCEPTION; LANGUAGE-DEVELOPMENT; DEAF-CHILDREN; SPOKEN LANGUAGE; AUDITORY DEVELOPMENT; RESIDUAL HEARING; AGE; VOCABULARY; PERFORMANCE; EXPERIENCE	Objective To examine the direct and indirect effects of demographical factors on speech perception and vocabulary outcomes of Mandarin-speaking children with cochlear implants (CIs). Methods 115 participants implanted before the age of 5 and who had used CI before 1 to 3 years were evaluated using a battery of speech perception and vocabulary tests. Structural equation modeling was used to test the hypotheses proposed. Results Early implantation significantly contributed to speech perception outcomes while having undergone a hearing aid trial (HAT) before implantation, maternal educational level (MEL), and having undergone universal newborn hearing screening (UNHS) before implantation had indirect effects on speech perception outcomes via their effects on age at implantation. In addition, both age at implantation and MEL had direct and indirect effects on vocabulary skills, while UNHS and HAT had indirect effects on vocabulary outcomes via their effects on age at implantation. Conclusion A number of factors had indirect and direct effects on speech perception and vocabulary outcomes in Mandarin-speaking children with CIs and these factors were not necessarily identical to those reported among their English-speaking counterparts.	[Chen, Yuan; Wong, Lena L. N.] Univ Hong Kong, Div Speech & Hearing Sci, Clin Hearing Sci CHearS Lab, Hong Kong, Hong Kong, Peoples R China; [Zhu, Shufeng] South Univ Sci & Technol China, Dept Elect & Elect Engn, Shenzhen, Peoples R China; [Xi, Xin] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	University of Hong Kong; Southern University of Science & Technology; Chinese People's Liberation Army General Hospital	Chen, Y (corresponding author), Univ Hong Kong, Div Speech & Hearing Sci, Clin Hearing Sci CHearS Lab, Hong Kong, Hong Kong, Peoples R China.	chenyuan@hku.hk		CHEN, Yuan/0000-0001-6706-0962; Wong, Lena L N/0000-0003-2245-8592	University Grant Council General Research Fund [HKU780109]	University Grant Council General Research Fund	This work was supported by the University Grant Council General Research Fund (#HKU780109).	Adunka OF, 2008, LARYNGOSCOPE, V118, P2044, DOI 10.1097/MLG.0b013e3181820900; BALANDA KP, 1988, AM STAT, V42, P111, DOI 10.2307/2684482; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Blamey PJ, 2001, J SPEECH LANG HEAR R, V44, P264, DOI 10.1044/1092-4388(2001/022); Bornstein MH, 1998, J CHILD LANG, V25, P367, DOI 10.1017/S0305000998003456; Chen F, 2013, J ACOUST SOC AM, V134, pEL178, DOI 10.1121/1.4812820; Chen XQ, 2010, ACTA OTO-LARYNGOL, V130, P263, DOI 10.3109/00016480903150528; Chen Y, 2014, INT J PEDIATR OTORHI, V78, P1923, DOI 10.1016/j.ijporl.2014.08.025; Connor CM, 2006, EAR HEARING, V27, P628, DOI 10.1097/01.aud.0000240640.59205.42; Connor CM, 2000, J SPEECH LANG HEAR R, V43, P1185, DOI 10.1044/jslhr.4305.1185; Davidson Lisa S, 2011, Ear Hear, V32, p19S, DOI 10.1097/AUD.0b013e3181ffdb8b; Deggouj N, 2007, B-ENT, V3, P9; DesJardin JL, 2009, INT J AUDIOL, V48, P248, DOI 10.1080/14992020802607423; Eisenberg LS, 2002, EAR HEARING, V23, P450, DOI 10.1097/00003446-200210000-00007; El-Hakim H, 2002, ANN OTO RHINOL LARYN, V111, P102, DOI 10.1177/00034894021110S521; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Gantz BJ, 2000, ANN OTO RHINOL LARYN, V109, P33, DOI 10.1177/0003489400109S1214; Geers A, 2003, EAR HEARING, V24, p24S, DOI 10.1097/01.AUD.0000051687.99218.0F; Geers A, 2002, ANN OTO RHINOL LARYN, V111, P127, DOI 10.1177/00034894021110S525; Geers AE, 2002, LANG SPEECH HEAR SER, V33, DOI 10.1044/0161-1461(2002/015); Geers AE, 2003, EAR HEARING, V24, p46S, DOI 10.1097/01.AUD.0000051689.57380.1B; Hoff E, 2005, J COMMUN DISORD, V38, P271, DOI 10.1016/j.jcomdis.2005.02.003; Holt RF, 2005, EAR HEARING, V26, P132, DOI 10.1097/00003446-200504000-00003; Houston DM, 2010, OTOL NEUROTOL, V31, P1248, DOI 10.1097/MAO.0b013e3181f1cc6a; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hua Z, 2000, J CHILD LANG, V27, P3, DOI 10.1017/S030500099900402X; Li B, 2014, INT J PEDIATR OTORHI, V78, P1000, DOI 10.1016/j.ijporl.2014.03.020; Liang Qi, 2013, Cochlear Implants Int, V14 Suppl 1, pS26, DOI 10.1179/1467010013Z.00000000080; Lovas GS, 2011, FIRST LANG, V31, P83, DOI 10.1177/0142723709359241; Lu XP, 2013, RES DEV DISABIL, V34, P3526, DOI 10.1016/j.ridd.2013.07.010; Manrique M, 2004, ACTA OTO-LARYNGOL, V124, P55, DOI 10.1080/03655230410017148; Mondain M, 2002, INT J PEDIATR OTORHI, V63, P91, DOI 10.1016/S0165-5876(01)00638-3; Nicholas JG, 2007, J SPEECH LANG HEAR R, V50, P1048, DOI 10.1044/1092-4388(2007/073); Pisoni DB, 2004, SPR HDB AUD, V20, P377; Pisoni DB, 2003, EAR HEARING, V24, p106S, DOI 10.1097/01.AUD.0000051692.05140.8E; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Schorr EA, 2006, VOLTA REV, V106, P365; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Sininger YS, 2010, EAR HEARING, V31, P166, DOI 10.1097/AUD.0b013e3181c8e7b6; Spivak L, 2009, AM J AUDIOL, V18, P24, DOI 10.1044/1059-0889(2008/08-0015); Suhr D, 2006, THE BASICS OF STRUCT; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Tardif T, 2008, USERS GUIDE AND MANU; Teoh SW, 2004, LARYNGOSCOPE, V114, P1536; Waltzman S. B., 2006, COCHLEAR IMPLANTS; Waltzman SB, 2000, AM J OTOL, V21, P329, DOI 10.1016/S0196-0709(00)80040-X; [王慧琴 WANG HuiQin], 2007, [中国心理卫生杂志, Chinese Mental Health Journal], V21, P700; Wiley S, 2004, INT CONGR SER, V1273, P273, DOI 10.1016/j.ics.2004.08.089; Wong LLN, 2014, J SPEECH LANG HEAR R, V57, P1548, DOI 10.1044/2014_JSLHR-H-13-0024; Zheng Y, 2009, INT J AUDIOL, V48, P718, DOI 10.1080/14992020902902658; Zheng Y, 2009, EAR HEARING, V30, P600, DOI 10.1097/AUD.0b013e3181b4aba8; Zheng Y, 2009, AUDIOL NEURO-OTOL, V14, P214, DOI 10.1159/000189264; Zwolan T, 2009, PERSPECT HEARING HEA, V19, P4, DOI DOI 10.1044/HHDC19.1.4	55	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136576	10.1371/journal.pone.0136576	http://dx.doi.org/10.1371/journal.pone.0136576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348360	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600010
J	Yeh, WC; Lai, CM				Yeh, Wei-Chang; Lai, Chyh-Ming			Accelerated Simplified Swarm Optimization with Exploitation Search Scheme for Data Clustering	PLOS ONE			English	Article							K-MEANS ALGORITHM; PARTICLE SWARM; FEATURE-SELECTION; EVOLUTIONARY; CONVERGENCE	Data clustering is commonly employed in many disciplines. The aim of clustering is to partition a set of data into clusters, in which objects within the same cluster are similar and dissimilar to other objects that belong to different clusters. Over the past decade, the evolutionary algorithm has been commonly used to solve clustering problems. This study presents a novel algorithm based on simplified swarm optimization, an emerging population- based stochastic optimization approach with the advantages of simplicity, efficiency, and flexibility. This approach combines variable vibrating search (VVS) and rapid centralized strategy (RCS) in dealing with clustering problem. VVS is an exploitation search scheme that can refine the quality of solutions by searching the extreme points nearby the global best position. RCS is developed to accelerate the convergence rate of the algorithm by using the arithmetic average. To empirically evaluate the performance of the proposed algorithm, experiments are examined using 12 benchmark datasets, and corresponding results are compared with recent works. Results of statistical analysis indicate that the proposed algorithm is competitive in terms of the quality of solutions.	[Yeh, Wei-Chang; Lai, Chyh-Ming] Natl Tsing Hua Univ, Dept Ind Engn & Engn Management, Hsinchu, Taiwan	National Tsing Hua University	Lai, CM (corresponding author), 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	chyh.ming.lai@gmail.com	YEH, WEI-CHANG/AAH-4172-2019	YEH, WEI-CHANG/0000-0001-7393-0768				Adib AB, 2005, J PHYS A-MATH GEN, V38, P8487, DOI 10.1088/0305-4470/38/40/001; Bae C, 2012, INT J INNOV COMPUT I, V8, P4391; Bandyopadhyay S, 2002, INFORM SCIENCES, V146, P221, DOI 10.1016/S0020-0255(02)00208-6; Banharnsakun A, 2013, NEUROCOMPUTING, V116, P355, DOI 10.1016/j.neucom.2012.02.047; Ben Ghalia M, 2008, MIDWEST SYMP CIRCUIT, P759, DOI 10.1109/MWSCAS.2008.4616910; Boutsidis C., 2010, ADV NEURAL INFORM PR, V23, P298; Chaves AA, 2010, COMPUT OPER RES, V37, P552, DOI 10.1016/j.cor.2008.09.011; Chuang LY, 2011, EXPERT SYST APPL, V38, P14555, DOI 10.1016/j.eswa.2011.05.027; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Dean J, 2008, COMMUN ACM, V51, P107, DOI 10.1145/1327452.1327492; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Dy JG, 2004, J MACH LEARN RES, V5, P845; Fahad A, 2014, IEEE T EMERG TOP COM, V2, P267, DOI 10.1109/TETC.2014.2330519; Hatamlou A, 2012, SWARM EVOL COMPUT, V6, P47, DOI 10.1016/j.swevo.2012.02.003; Hatamlou A, 2013, INFORM SCIENCES, V222, P175, DOI 10.1016/j.ins.2012.08.023; Hatamlou A, 2011, COMM COM INF SC, V241, P383; Johnson W., 1984, CONT MATH, V26, P189, DOI [10.1090/conm/026/737400, DOI 10.1090/CONM/026/737400]; Kang U, 2011, KNOWL INF SYST, V27, P303, DOI 10.1007/s10115-010-0305-0; Kao YT, 2008, EXPERT SYST APPL, V34, P1754, DOI 10.1016/j.eswa.2007.01.028; Karaboga D, 2011, APPL SOFT COMPUT, V11, P652, DOI 10.1016/j.asoc.2009.12.025; Krishna K, 1999, IEEE T SYST MAN CY B, V29, P433, DOI 10.1109/3477.764879; Kudo M, 2000, PATTERN RECOGN, V33, P25, DOI 10.1016/S0031-3203(99)00041-2; Liu YG, 2008, INFORM SCIENCES, V178, P2680, DOI 10.1016/j.ins.2008.01.022; Maulik U, 2000, PATTERN RECOGN, V33, P1455, DOI 10.1016/S0031-3203(99)00137-5; Mitra P, 2002, IEEE T PATTERN ANAL, V24, P301, DOI 10.1109/34.990133; Ng RT, 2002, IEEE T KNOWL DATA EN, V14, P1003, DOI 10.1109/TKDE.2002.1033770; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; SELIM SZ, 1991, PATTERN RECOGN, V24, P1003, DOI 10.1016/0031-3203(91)90097-O; SELIM SZ, 1984, IEEE T PATTERN ANAL, V6, P81, DOI 10.1109/TPAMI.1984.4767478; Shelokar PS, 2004, ANAL CHIM ACTA, V509, P187, DOI 10.1016/j.aca.2003.12.032; Tsai CY, 2011, EXPERT SYST APPL, V38, P6565, DOI 10.1016/j.eswa.2010.11.082; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Yeh WC, 2014, KNOWL-BASED SYST, V64, P1, DOI 10.1016/j.knosys.2014.03.011; Yeh WC, 2012, INFORM SCIENCES, V197, P65, DOI 10.1016/j.ins.2012.02.009; Yeh WC, 2012, IEEE T SYST MAN CY A, V42, P250, DOI 10.1109/TSMCA.2011.2157135; Yeh WC, 2009, EXPERT SYST APPL, V36, P8204, DOI 10.1016/j.eswa.2008.10.004; Zhang L, 2011, INFORM SCIENCES, V181, P4658, DOI 10.1016/j.ins.2010.11.005	37	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137246	10.1371/journal.pone.0137246	http://dx.doi.org/10.1371/journal.pone.0137246			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348483	Green Submitted, gold, Green Published			2022-12-27	WOS:000360897600029
J	Maus, F; Sakry, D; Biname, F; Karram, K; Rajalingam, K; Watts, C; Heywood, R; Kruger, R; Stegmuller, J; Werner, HB; Nave, KA; Kramer-Albers, EM; Trotter, J				Maus, Frank; Sakry, Dominik; Biname, Fabien; Karram, Khalad; Rajalingam, Krishnaraj; Watts, Colin; Heywood, Richard; Krueger, Rejko; Stegmueller, Judith; Werner, Hauke B.; Nave, Klaus-Armin; Kraemer-Albers, Eva-Maria; Trotter, Jacqueline			The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2	PLOS ONE			English	Article							SERINE-PROTEASE HTRA2/OMI; GLIAL PROGENITOR CELLS; FUNCTIONAL-ANALYSIS; MULTIPLE-SCLEROSIS; PDZ DOMAIN; DEATH; EXPRESSION; GLIOMA; GLIOBLASTOMA; INHIBITOR	The NG2 proteoglycan is characteristically expressed by oligodendrocyte progenitor cells (OPC) and also by aggressive brain tumours highly resistant to chemo-and radiation therapy. Oligodendrocyte-lineage cells are particularly sensitive to stress resulting in cell death in white matter after hypoxic or ischemic insults of premature infants and destruction of OPC in some types of Multiple Sclerosis lesions. Here we show that the NG2 proteoglycan binds OMI/HtrA2, a mitochondrial serine protease which is released from damaged mitochondria into the cytosol in response to stress. In the cytosol, OMI/HtrA2 initiates apoptosis by proteolytic degradation of anti-apoptotic factors. OPC in which NG2 has been downregulated by siRNA, or OPC from the NG2-knockout mouse show an increased sensitivity to oxidative stress evidenced by increased cell death. The proapoptotic protease activity of OMI/ HtrA2 in the cytosol can be reduced by the interaction with NG2. Human glioma expressing high levels of NG2 are less sensitive to oxidative stress than those with lower NG2 expression and reducing NG2 expression by siRNA increases cell death in response to oxidative stress. Binding of NG2 to OMI/HtrA2 may thus help protect cells against oxidative stress-induced cell death. This interaction is likely to contribute to the high chemo-and radioresistance of glioma.	[Maus, Frank; Sakry, Dominik; Biname, Fabien; Karram, Khalad; Kraemer-Albers, Eva-Maria; Trotter, Jacqueline] Johannes Gutenberg Univ Mainz, Dept Biol, Mol Cell Biol, D-55122 Mainz, Germany; [Rajalingam, Krishnaraj] Johannes Gutenberg Univ Mainz, Med Ctr Mainz, Inst Immunol, Res Ctr Immune Therapy, D-55122 Mainz, Germany; [Krueger, Rejko] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Clin & Expt Neurosci, Luxembourg, Luxembourg; [Krueger, Rejko] Ctr Hosp Luxembourg, Luxembourg, Luxembourg; [Krueger, Rejko] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany; [Krueger, Rejko] Univ Tubingen, German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Werner, Hauke B.; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Karram, Khalad] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany; [Watts, Colin; Heywood, Richard] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Stegmueller, Judith] Max Planck Inst Expt Med, Cellular & Mol Neurobiol, D-37075 Gottingen, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Luxembourg; Luxembourg Hospital Center; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; Johannes Gutenberg University of Mainz; University of Cambridge; Max Planck Society	Trotter, J (corresponding author), Johannes Gutenberg Univ Mainz, Dept Biol, Mol Cell Biol, D-55122 Mainz, Germany.	trotter@uni-mainz.de	BINAME, Fabien/ABD-8279-2021; Eva-Maria, Kraemer-Albers/AAP-8805-2020; Maus, Frank/AAE-9241-2022	Eva-Maria, Kraemer-Albers/0000-0001-7994-1185; Biname, Fabien/0000-0002-9758-1512; Werner, Hauke/0000-0002-7710-5738; Krueger, Rejko/0000-0003-4258-6241; Sakry, Dominik/0000-0002-7144-7243	Deutsche Forschungsgemeinschaft [TR 1008/1-1, TR 1008/2-1, CRC TRR 128/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (TR 1008/1-1, TR 1008/2-1, CRC TRR 128/1).	Al-Mayhani MTF, 2011, NEURO-ONCOLOGY, V13, P830, DOI 10.1093/neuonc/nor088; Back SA, 2001, J NEUROSCI, V21, P1302; Barrantes-Freer A, 2013, J NEUROPATH EXP NEUR, V72, P307, DOI 10.1097/NEN.0b013e31828afdbd; Barritt DS, 2000, J CELL BIOCHEM, V79, P213, DOI 10.1002/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO;2-G; Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; Chatterjee N, 2008, J BIOL CHEM, V283, P8310, DOI 10.1074/jbc.M706074200; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Cilenti L, 2003, J BIOL CHEM, V278, P11489, DOI 10.1074/jbc.M212819200; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Cui QL, 2013, AM J PATHOL, V183, P516, DOI 10.1016/j.ajpath.2013.04.016; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Decker P, 2000, J BIOL CHEM, V275, P9043, DOI 10.1074/jbc.275.12.9043; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Fragoso G, 2004, J NEUROCHEM, V90, P392, DOI 10.1111/j.1471-4159.2004.02488.x; Guilfoyle MR, 2011, BRIT J CANCER, V104, P1810, DOI 10.1038/bjc.2011.153; Gupta S, 2004, J BIOL CHEM, V279, P45844, DOI 10.1074/jbc.M404940200; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Itoh T, 2003, J NEUROCHEM, V85, P1500, DOI 10.1046/j.1471-4159.2003.01795.x; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Joo NE, 2014, DNA CELL BIOL, V33, P854, DOI 10.1089/dna.2014.2399; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Khan FS, 2008, CELL DEATH DIFFER, V15, P1073, DOI 10.1038/cdd.2008.19; Khorchid A, 2002, GLIA, V40, P283, DOI 10.1002/glia.10123; Kilbride SM, 2013, ONCOGENE, V32, P2703, DOI 10.1038/onc.2012.348; Klupsch K, 2006, CELL DEATH DIFFER, V13, P2157, DOI 10.1038/sj.cdd.4401955; Kuninaka S, 2005, ONCOGENE, V24, P5287, DOI 10.1038/sj.onc.1208682; LEGRAND C, 1992, J BIOTECHNOL, V25, P231, DOI 10.1016/0168-1656(92)90158-6; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Liddell JR, 2010, GLIA, V58, P1500, DOI 10.1002/glia.21024; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; Ness JK, 2001, DEV NEUROSCI-BASEL, V23, P203, DOI 10.1159/000046144; Niehaus A, 1999, J NEUROSCI, V19, P4948; NISHIYAMA A, 1995, MOL BIOL CELL, V6, P1819, DOI 10.1091/mbc.6.12.1819; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Sakry D, 2015, BRAIN RES; Sakry D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127222; Sakry D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001993; Savopoulos JW, 2000, PROTEIN EXPRES PURIF, V19, P227, DOI 10.1006/prep.2000.1240; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Stallcup WB, 2008, CELL ADHES MIGR, V2, P192, DOI 10.4161/cam.2.3.6279; Stegmuller J, 2002, J NEUROCYTOL, V31, P497, DOI 10.1023/A:1025743731306; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Stelzer S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-27; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007; Zhang YN, 2007, PROTEIN SCI, V16, P1738, DOI 10.1110/ps.072833207	55	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137311	10.1371/journal.pone.0137311	http://dx.doi.org/10.1371/journal.pone.0137311			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340347	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200046
J	Pugliese, F; Acerbi, A; Marocco, D				Pugliese, Francesco; Acerbi, Alberto; Marocco, Davide			Emergence of Leadership in a Group of Autonomous Robots	PLOS ONE			English	Article							DECISION-MAKING; EVOLUTION; COMMUNICATION; PERSONALITY; ORIGINS; MODEL; SIZE	In this paper we examine the factors contributing to the emergence of leadership in a group, and we explore the relationship between the role of the leader and the behavioural capabilities of other individuals. We use a simulation technique where a group of foraging robots must coordinate to choose between two identical food zones in order to forage collectively. Behavioural and quantitative analysis indicate that a form of leadership emerges, and that groups with a leader are more effective than groups without. Moreover, we show that the most skilled individuals in a group tend to be the ones that assume a leadership role, supporting biological findings. Further analysis reveals the emergence of different "styles" of leadership (active and passive).	[Pugliese, Francesco] Italian Natl Inst Stat, Dept Natl Accounts & Econ Stat, Rome, Italy; [Acerbi, Alberto] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [Acerbi, Alberto] Eindhoven Univ Technol, Sch Innovat Sci, Philosophy & Eth, NL-5600 MB Eindhoven, Netherlands; [Marocco, Davide] Univ Plymouth, Sch Comp & Math, Plymouth PL4 8AA, Devon, England	University of Bristol; Eindhoven University of Technology; University of Plymouth	Pugliese, F (corresponding author), Italian Natl Inst Stat, Dept Natl Accounts & Econ Stat, Rome, Italy.	francesco.pugliese@istat.it	marocco, davide/GNM-7611-2022	MAROCCO, DAVIDE/0000-0001-5185-1313; Acerbi, Alberto/0000-0001-5827-8003				Acerbi A., 2009, Proceedings 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta), P20, DOI 10.1109/IJCNN.2009.5178607; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; BARNARD CJ, 1980, ANIM BEHAV, V28, P295, DOI 10.1016/S0003-3472(80)80032-7; Bornstein G, 2002, GAME ECON BEHAV, V41, P1, DOI 10.1016/S0899-8256(02)00012-X; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Collignon B, 2009, P ROYAL SOC LONDON B; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; de Greeff J, 2014, INTEL ROBOT AUTON AG, P179; Dyer JRG, 2008, ANIM BEHAV, V75, P461, DOI 10.1016/j.anbehav.2007.05.010; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Gigliotta O, 2010, ARTIFICIAL LIFE AND EVOLUTIONARY COMPUTATION, P167, DOI 10.1142/9789814287456_0015; Giraldeau LA, 1999, TRENDS ECOL EVOL, V14, P102, DOI 10.1016/S0169-5347(98)01542-0; Guilford T, 1996, P ROY SOC B-BIOL SCI, V263, P153, DOI 10.1098/rspb.1996.0024; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HOLLAND JH, 1992, SCI AM, V267, P66, DOI 10.1038/scientificamerican0792-66; Jacoby G, 2008, EL COMP ENG 2008 CCE; Judge TA, 2000, J APPL PSYCHOL, V85, P751, DOI 10.1037/0021-9010.85.5.751; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; Konig B, 1997, NATURWISSENSCHAFTEN, V84, P95, DOI 10.1007/s001140050356; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; LINDAUER M, 1957, NATURE, V179, P63, DOI 10.1038/179063a0; Lusseau D, 2009, BEHAV ECOL SOCIOBIOL, V63, P1067, DOI 10.1007/s00265-009-0740-7; Ma KHS, 2008, INT J COMPUT SCI NET, V8, P302; Miglino O, 1995, Artif Life, V2, P417, DOI 10.1162/artl.1995.2.4.417; Mondada F., 1999, PROC 1 INT KHEPERA W, P7; Nolfi S, 2002, TRENDS COGN SCI, V6, P31, DOI 10.1016/S1364-6613(00)01812-X; Noonan MP, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001940; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Simpson SA, 2005, J ACOUST SOC AM, V118, P2775, DOI 10.1121/1.2062650; Tarpy DR, 2009, ETHOL ECOL EVOL, V21, P147, DOI 10.1080/08927014.2009.9522503; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; Van Vugt M, 2006, PERS SOC PSYCHOL REV, V10, P354, DOI 10.1207/s15327957pspr1004_5; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; Venayagamoorthy GK, 2004, IEEE IND APPLIC SOC, P1200; VINACKE WE, 1964, SOCIOMETRY, V27, P25, DOI 10.2307/2785800; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Wright J, 2003, J ANIM ECOL, V72, P1003, DOI 10.1046/j.1365-2656.2003.00771.x	44	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137234	10.1371/journal.pone.0137234	http://dx.doi.org/10.1371/journal.pone.0137234			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ6BA	26340449	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200037
J	Rahman, M; Jhohura, FT; Mistry, SK; Chowdhury, TR; Ishaque, T; Shah, R; Afsana, K				Rahman, Mahfuzar; Jhohura, Fatema Tuz; Mistry, Sabuj Kanti; Chowdhury, Tridib Roy; Ishaque, Tanveen; Shah, Rasheduzzaman; Afsana, Kaosar			Assessing Community Based Improved Maternal Neonatal Child Survival (IMNCS) Program in Rural Bangladesh	PLOS ONE			English	Article							SKILLED ATTENDANCE; NEWBORN HEALTH; DELIVERY CARE; MORTALITY; DISTRICT; BIRTH; GHANA	Objectives A community based approach before, during and after child birth has been proven effective address the burden of maternal, neonatal and child morbidity and mortality in the low and middle income countries. We aimed to examine the overall change in maternal and newborn health outcomes due the "Improved Maternal Newborn and Child Survival" (IMNCS) project, which was implemented by BRAC in rural communities of Bangladesh. Methods The intervention was implemented in four districts for duration of 5-years, while two districts served as comparison areas. The intervention was delivered by community health workers who were trained on essential maternal, neonatal and child health care services. A baseline survey was conducted in 2008 among 7, 200 women with pregnancy outcome in last year or having a currently alive child of 12-59 months. A follow-up survey was administered in 2012-13 among 4, 800 women of similar characteristics in the same villages. Findings We observed significant improvements in maternal and essential newborn care in intervention areas over time, especially in health care seeking behaviors. The proportion of births taking place at home declined in the intervention districts from 84.3% at baseline to 71.2% at end line (P<0.001). Proportion of deliveries with skilled attendant was higher in intervention districts (28%) compared to comparison districts (27.4%). The number of deliveries was almost doubled at public sector facility comparing with baseline (P<0.001). Significant improvement was also observed in healthy cord care practice, delayed bathing of the newborn and reduction of infant mortality in intervention districts compared to that of comparison districts. Conclusions This study demonstrates that community-based efforts offer encouraging evidence and value for combining maternal, neonatal and child health care package. This approach might be considered at larger scale in similar settings with limited resources.	[Rahman, Mahfuzar; Jhohura, Fatema Tuz; Mistry, Sabuj Kanti; Chowdhury, Tridib Roy; Ishaque, Tanveen] BRAC, Res & Evaluat Div, Dhaka, Bangladesh; [Shah, Rasheduzzaman] Save Children USA, Dept Global Hlth, Washington, DC USA; [Afsana, Kaosar] BRAC, Populat Program, Nutr, Hlth, Dhaka, Bangladesh	Bangladesh Rural Advancement Committee BRAC; Save the Children; Bangladesh Rural Advancement Committee BRAC	Rahman, M (corresponding author), BRAC, Res & Evaluat Div, Dhaka, Bangladesh.	mahfuzar.rahman@brac.net	Ishaque, Tanveen/AAQ-8121-2021; Shah, Rashed Z/D-4688-2015	Ishaque, Tanveen/0000-0002-3523-243X; Shah, Rashed Z/0000-0001-9488-5134; Afsana, Kaosar/0000-0002-5197-8151	AusAID; UKAID	AusAID(Australian Aid (AusAID)); UKAID(CGIAR)	This research activity was funded by the Strategic Partnership Agreement (SPA) with AusAID and UKAID. BRAC acknowledges with gratitude the commitment of the AusAID and UKAID to its research efforts.	Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Asamoah BO, 2014, GLOBAL J HLTH SCI, V6, pp117; Baqui AH, 2008, B WORLD HEALTH ORGAN, V86, P796, DOI 10.2471/BLT.07.042226; Bazzano AN, 2008, INT J GYNECOL OBSTET, V102, P91, DOI 10.1016/j.ijgo.2008.02.004; Benova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093032; Bhutta ZA, 2010, LANCET, V375, P1142, DOI 10.1016/S0140-6736(10)60324-8; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chowdhury RI, 2007, HEALTH SOC CARE COMM, V15, P254, DOI 10.1111/j.1365-2524.2006.00681.x; Crissman Halley P, 2013, Afr J Reprod Health, V17, P15; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; Fottrell E, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-3; General Economic Division (GED) BPC Bangladesh. GotPsRo, 2012, MILL DEV GOALS BANGL; Gupta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101893; Hounton S, 2008, TROP MED INT HEALTH, V13, P44, DOI 10.1111/j.1365-3156.2008.02086.x; Hussein J, 2004, REPROD HEALTH MATTER, V12, P160, DOI 10.1016/S0968-8080(04)24136-2; Kaye D, 2004, E AFR MED J, V80, P144; Koblinsky M, 2006, J HEALTH POPUL NUTR, V24, P377; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Mannan I, 2008, J PERINATOL, V28, P632, DOI 10.1038/jp.2008.64; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; Montgomery AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095696; Moyer CA, 2014, MATERN CHILD HLTH J, V18, P109, DOI 10.1007/s10995-013-1240-y; Mushi D, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-14; National Institute of Population Research and Training (NIPORT), 2013, MITR ASS INT I BANGL; National Institute of Population Research and Training (NIPORT), 2012, MEASURE EV ICDDR B B; Nkwo PO, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-341; Okereke E, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-57; Pervin J, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-111; Pettersson Karen Odberg, 2004, Health Care Women Int, V25, P255; Rahman A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-914; Requejo J, 2012, BUILDING FUTURE WOME; Stephenson R, 2012, PUBLIC HEALTH REP, V127, P96; Wick L, 2012, REPROD HEALTH MATTER, V20, P7, DOI 10.1016/S0968-8080(12)40648-6; World Population Review, 2014, BANGL POP 2014	34	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136898	10.1371/journal.pone.0136898	http://dx.doi.org/10.1371/journal.pone.0136898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340672	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200019
J	Zhou, M; Peng, X; Mao, C; Tian, JH; Zhang, SW; Xu, F; Tu, JJ; Liu, S; Hu, M; Yu, GY				Zhou, Miao; Peng, Xin; Mao, Chi; Tian, Jia-he; Zhang, Shu-wen; Xu, Fang; Tu, Jing-jing; Liu, Sheng; Hu, Min; Yu, Guang-yan			The Value of SPECT/CT in Monitoring Prefabricated Tissue-Engineered Bone and Orthotopic rhBMP-2 Implants for Mandibular Reconstruction	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-2; CLINICAL-APPLICATIONS; MATRIX; GROWTH; CELLS; RESORPTION	Bone tissue engineering shows good prospects for mandibular reconstruction. In recent studies, prefabricated tissue-engineered bone (PTEB) by recombinant human bone morphogenetic proteins (rhBMPs) applied in vivo has found to be an effective alternative for autologous bone grafts. However, the optimal time to transfer PTEB for mandibular reconstruction is still not elucidated. Thus, here in an animal experiment of rhesus monkey, the suitable transferring time for PTEB to reconstruct mandibular defects was evaluated by Tc-99m-MDP SPECT/CT, and its value in monitoring orthotopic rhBMP-2 implants for mandibular reconstruction was also evaluated. The result of SPECT/CT showed higher Tc-99m-MDP uptake, indicating osteoinductivity, in rhBMP-2 incorporated demineralized freeze-dried bone allograft (DFDBA) and coralline hydroxyapatite (CHA) implants than those without BMP stimulation. Tc-99m-MDP uptake of rhBMP-2 implant peaked at 8 weeks following implantation while CT showed the density of these implants increased after 13 weeks' prefabrication. Histology confirmed that mandibular defects were repaired successfully with PTEB or orthotopically rhBMP-2 incorporated CHA implants, in accordance with SPECT/CT findings. Collectively, data shows Tc-99m-MDP SPECT/CT is a sensitive and noninvasive tool to monitor osteoinductivity and bone regeneration of PTEB and orthotopic implants. The PTEB achieved peak osteoinductivity and bone density at 8 to 13 weeks following ectopic implantation, which would serve as a recommendable time frame for its transfer to mandibular reconstruction.	[Zhou, Miao; Peng, Xin; Mao, Chi; Yu, Guang-yan] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China; [Zhou, Miao] Guangzhou Med Univ, Guangzhou Inst Oral Dis, Key Lab Oral Med, Stomatol Hosp, Guangzhou, Guangdong, Peoples R China; [Tian, Jia-he; Zhang, Shu-wen] Chinese Peoples Liberat Army Gen Hosp, Dept Nucl Med, Beijing, Peoples R China; [Xu, Fang; Tu, Jing-jing] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Liu, Sheng] Sun Yat Sen Univ, Dept Nucl Med, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Min] Chinese Peoples Liberat Army Gen Hosp, Dept Oral & Maxillofacial Surg, Beijing, Peoples R China	Peking University; Guangzhou Medical University; Chinese People's Liberation Army General Hospital; Zhejiang University of Technology; Sun Yat Sen University; Chinese People's Liberation Army General Hospital	Hu, M (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Oral & Maxillofacial Surg, Beijing, Peoples R China.	humin48@vip.163.com; gyyu@263.net			Beijing Municipal Science and Technology Commission [D090600704040291]; National Nature Science Foundation of China [81000421]; International Team for Implantology [881_2012]; Guangdong Provincial Department of Science and Technology [2013B021800314]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Team for Implantology; Guangdong Provincial Department of Science and Technology	This project was financially supported by the Beijing Municipal Science and Technology Commission (No. D090600704040291, http://www.bjkw.gov.cn/, PI:GYY), the National Nature Science Foundation of China (No. 81000421, http://www.nsfc.gov.cn/, PI:MZ), International Team for Implantology (No. 881_2012, http://www.iti.org/, PI:MZ) and Guangdong Provincial Department of Science and Technology (No. 2013B021800314, www.gdstc.gov.cn, PI:MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPENBERG P, 1992, ACTA ORTHOP SCAND, V63, P619; BAUER FCH, 1984, CLIN ORTHOP RELAT R, P139; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Keidar Z, 2003, SEMIN NUCL MED, V33, P205, DOI 10.1053/snuc.2003.127310; Kempen DHR, 2009, J CONTROL RELEASE, V134, P169, DOI 10.1016/j.jconrel.2008.11.023; Kusafuka K, 1998, VIRCHOWS ARCH, V432, P247, DOI 10.1007/s004280050162; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; LEITHA T, 1995, EUR J NUCL MED, V22, P308, DOI 10.1007/BF00941846; Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001; NILSSON OS, 1990, CLIN ORTHOP RELAT R, P280; O'Connor MK, 2006, SEMIN NUCL MED, V36, P258, DOI 10.1053/j.semnuclmed.2006.05.005; Ronga M, 2013, INJURY, V44, pS34, DOI 10.1016/S0020-1383(13)70008-1; Wang L, 2011, CANCER BIOL THER, V11, P457, DOI 10.4161/cbt.11.5.14372; Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050; Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3; Zhao M, 1998, J ORAL PATHOL MED, V27, P293; Zhou J, 2010, BIOMATERIALS, V31, P1171, DOI 10.1016/j.biomaterials.2009.10.043; Zhou M, 2010, BIOMATERIALS, V31, P4935, DOI 10.1016/j.biomaterials.2010.02.072	18	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137167	10.1371/journal.pone.0137167	http://dx.doi.org/10.1371/journal.pone.0137167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340447	Green Submitted, gold, Green Published			2022-12-27	WOS:000360688200027
J	Chow, WZ; Lim, SH; Ong, LY; Yong, YK; Takebe, Y; Kamarulzaman, A; Tee, KK				Chow, Wei Zhen; Lim, Sin How; Ong, Lai Yee; Yong, Yean Kong; Takebe, Yutaka; Kamarulzaman, Adeeba; Tee, Kok Keng			Impact of HIV-1 Subtype on the Time to CD4+T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients	PLOS ONE			English	Article							DISEASE PROGRESSION; SEX-DIFFERENCES; VIRAL LOAD; INFECTION; VIRUS; PATHOGENESIS; DECLINE; COHORTS; PLASMA; AIDS	Human immunodeficiency virus type 1 (HIV-1) subtypes have been shown to differ in the rate of clinical progression. We studied the association between HIV-1 subtypes and the rate of CD4+ T-cell recovery in a longitudinal cohort of patients on combination antiretroviral therapy (cART). We studied 103 patients infected with CRF01_AE (69%) and subtype B (31%) who initiated cART between 2006 and 2013. Demographic data, CD4+ T-cell counts and HIV-1 viral load were abstracted from patient medical charts. Kaplan-Meier was used to estimate the time to CD4+ T-cell count increase to >= 350 between subtypes and effects of covariates were analysed using Cox proportional hazards. An 87% of the study population were male adults (mean age of 38.7 years old). Baseline CD4+ T-cell counts and viral loads, age at cART initiation, sex, ethnicity and co-infection did not differ significantly between subtypes. A shorter median time for CD4+ T-cell count increase to >= 350 cells/mu L was observed for CRF01_AE (546 days; 95% confidence interval [CI], 186-906 days; P = .502) compared to subtype B (987 days; 95% CI, 894-1079 days). In multivariate analysis, female sex was significantly associated with a 2.7 times higher chance of achieving CD4+ T-cell recovery (adjusted hazard ratio [HR], 2.75; 95% CI, 1.21-6.22; P = .025) and both baseline CD4+ T-cell count (P = .001) and viral load (P = .001) were important predictors for CD4+ T-cell recovery. Immunological recovery correlated significantly with female sex, baseline CD4+ T-cell counts and viral load but not subtype.	[Chow, Wei Zhen; Lim, Sin How; Ong, Lai Yee; Yong, Yean Kong; Takebe, Yutaka; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan	Universiti Malaya; National Institute of Infectious Diseases (NIID)	Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Yong, Yean Kong/Q-5318-2016; Yong, Yean/B-9202-2017; Lim, Sin How/AAC-8004-2020; Lim, Sin How/L-7168-2017; Tee, Kok Keng/A-8148-2008; KAMARULZAMAN, ADEEBA/B-5216-2010	Yong, Yean/0000-0002-8409-6251; Lim, Sin How/0000-0002-8727-4826; Tee, Kok Keng/0000-0002-7923-5448; 	IAS-NIDA fellowship; Ministry of Education, Malaysia: High Impact Research [E-000001-20001]; High Impact Research [H-500001-00-A000012-000001]	IAS-NIDA fellowship; Ministry of Education, Malaysia: High Impact Research; High Impact Research	This work was supported in part by IAS-NIDA fellowship to S.H.L., grants from the Ministry of Education, Malaysia: High Impact Research E-000001-20001 to A.K., and High Impact Research H-500001-00-A000012-000001 to K.K.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2014, J INFECT DIS, V209, pS86, DOI 10.1093/infdis/jiu175; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Bhargava M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18944; Chang JJ, 2013, J INFECT DIS, V208, P830, DOI 10.1093/infdis/jit262; Chow WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062560; Collazos J, 2007, AIDS, V21, P835, DOI 10.1097/QAD.0b013e3280b0774a; Cornelissen M, 2012, CLIN INFECT DIS, V54, P539, DOI 10.1093/cid/cir849; Dorak MT, 2003, J INFECT DIS, V188, P856, DOI 10.1086/378071; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Frater J, 2014, AIDS, V28, P699, DOI 10.1097/QAD.0000000000000130; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Lee LK, 2012, CLIN INFECT DIS, V54, P1818, DOI 10.1093/cid/cis312; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mlisana K, 2014, CLIN INFECT DIS, V59, P1322, DOI 10.1093/cid/ciu573; Ng OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015738; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Scherrer AU, 2011, CLIN INFECT DIS, V53, P1143, DOI 10.1093/cid/cir669; Seng Remonie, 2015, AIDS, V29, P595, DOI 10.1097/QAD.0000000000000571; Touloumi G, 2013, CLIN INFECT DIS, V56, P888, DOI 10.1093/cid/cis1000; Williams JP, 2014, ELIFE, V3, DOI 10.7554/eLife.03821	26	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137281	10.1371/journal.pone.0137281	http://dx.doi.org/10.1371/journal.pone.0137281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335136	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400048
J	Cebey-Lopez, M; Herberg, J; Pardo-Seco, J; Gomez-Carballa, A; Martinon-Torres, N; Salas, A; Martinon-Sanchez, JM; Gormley, S; Sumner, E; Fink, C; Martinon-Torres, F				Cebey-Lopez, Miriam; Herberg, Jethro; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Gormley, Stuart; Sumner, Edward; Fink, Colin; Martinon-Torres, Federico		GENDRES Network	Viral Co-Infections in Pediatric Patients Hospitalized with Lower Tract Acute Respiratory Infections	PLOS ONE			English	Article							HUMAN BOCAVIRUS INFECTION; HUMAN CORONAVIRUSES 229E; PARAINFLUENZA VIRUSES 1; HUMAN METAPNEUMOVIRUS; SYNCYTIAL VIRUS; CLINICAL-SAMPLES; PCR ASSAYS; CHILDREN; INFANTS; RNA	Background Molecular techniques can often reveal a broader range of pathogens in respiratory infections. We aim to investigate the prevalence and age pattern of viral co-infection in children hospitalized with lower tract acute respiratory infection (LT-ARI), using molecular techniques. Methods A nested polymerase chain reaction approach was used to detect Influenza (A, B), metapneumovirus, respiratory syncytial virus (RSV), parainfluenza (1-4), rhinovirus, adenovirus (A-F), bocavirus and coronaviruses (NL63, 229E, OC43) in respiratory samples of children with acute respiratory infection prospectively admitted to any of the GENDRES network hospitals between 2011-2013. The results were corroborated in an independent cohort collected in the UK. Results A total of 204 and 97 nasopharyngeal samples were collected in the GENDRES and UK cohorts, respectively. In both cohorts, RSV was the most frequent pathogen (52.9% and 36.1% of the cohorts, respectively). Co-infection with multiple viruses was found in 92 samples (45.1%) and 29 samples (29.9%), respectively; this was most frequent in the 12-24 months age group. The most frequently observed co-infection patterns were RSV-Rhinovirus (23 patients, 11.3%, GENDRES cohort) and RSV-bocavirus/bocavirus-influenza (5 patients, 5.2%, UK cohort). Conclusion The presence of more than one virus in pediatric patients admitted to hospital with LT-ARI is very frequent and seems to peak at 12-24 months of age. The clinical significance of these findings is unclear but should warrant further analysis.	[Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Martinon-Torres, Federico] Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain; [Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Martinon-Torres, Federico] Univ Santiago de Compostela USC, Galicia, Spain; [Herberg, Jethro; Gormley, Stuart] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Paediat Sect, London, England; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patol & Ciencias Forenses, Galicia, Spain; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Inst Ciencias Forenses, GMX, Galicia, Spain; [Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Maria Martinon-Sanchez, Jose; Martinon-Torres, Federico] Hosp Clin Univ Santiago, Dept Pediat, Translat Pediat & Infect Dis Sect, Santiago De Compostela, Galicia, Spain; [Sumner, Edward; Fink, Colin] Univ Warwick, Micropathol Ltd, Coventry CV4 7AL, W Midlands, England	Universidade de Santiago de Compostela; Imperial College London; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; University of Warwick	Cebey-Lopez, M (corresponding author), Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain.		Martinon-Torres, Federico/E-4982-2016; Cebey, Miriam/K-9347-2014; Pardo-Seco, Jacobo J/G-3752-2016; Calvo, Cristina/T-5028-2018; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; Moreno Galarraga, Laura/B-2460-2017; Gómez-Carballa, Alberto/I-4610-2014	Martinon-Torres, Federico/0000-0002-9023-581X; Cebey, Miriam/0000-0003-0599-7519; Pardo-Seco, Jacobo J/0000-0002-8059-8908; Calvo, Cristina/0000-0002-6503-3423; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Moreno Galarraga, Laura/0000-0003-0293-0749; Gómez-Carballa, Alberto/0000-0003-0927-1272; Herberg, Jethro/0000-0001-6941-6491	Spanish Government [PI10/00540]; Regional Galician funds [10 PXIB 918 184 PR]; Ministerio de Ciencia e Innovacion [SAF2011-26983]; Plan Galego IDT, Xunta de Galicia [EM 2012/045]; Instituto de Investigacion Sanitaria de Santiago de Compostela; Instituto Carlos III (Intensificacion de la actividad investigadora); European Union's seventh Framework program under ECGA [279185]; Imperial College Comprehensive Biomedical Research Centre; Wellcome Trust Centre for Respiratory Infection at Imperial College (DMPED) [P26077]	Spanish Government(Spanish GovernmentEuropean Commission); Regional Galician funds; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT, Xunta de Galicia; Instituto de Investigacion Sanitaria de Santiago de Compostela; Instituto Carlos III (Intensificacion de la actividad investigadora)(Instituto de Salud Carlos III); European Union's seventh Framework program under ECGA; Imperial College Comprehensive Biomedical Research Centre; Wellcome Trust Centre for Respiratory Infection at Imperial College (DMPED)	This work was supported by the Spanish Government (Research Program Health Research Fund (FIS; PI10/00540) National Plan I + D + I and FEDER funds), Regional Galician funds (Promotion of Research Project 10 PXIB 918 184 PR) (FMT), Ministerio de Ciencia e Innovacion (SAF2011-26983) and the Plan Galego IDT, Xunta de Galicia (EM 2012/045) (AS). MC research activities have been supported by grants from Instituto de Investigacion Sanitaria de Santiago de Compostela. FMT research activities have been supported by grants from Instituto Carlos III (Intensificacion de la actividad investigadora). Additional funding was received from the European Union's seventh Framework program under ECGA no. 279185 (EUCLIDS) during the production of this paper. JH was supported by the Imperial College Comprehensive Biomedical Research Centre and the Wellcome Trust Centre for Respiratory Infection at Imperial College (DMPED P26077 to JAH).	Aguilar JC, 2000, J CLIN MICROBIOL, V38, P1191, DOI 10.1128/JCM.38.3.1191-1195.2000; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; Avellon A, 2001, J VIROL METHODS, V92, P113, DOI 10.1016/S0166-0934(00)00269-X; Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bezerra PGM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018928; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Brand HK, 2012, PEDIATR PULM, V47, P393, DOI 10.1002/ppul.21552; Brieu N, 2008, PEDIATR INFECT DIS J, V27, P969, DOI 10.1097/INF.0b013e31817acfaa; Canducci F, 2008, J MED VIROL, V80, P716, DOI 10.1002/jmv.21108; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Chorazy ML, 2013, PEDIAT INFECT DIS J; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; Dingle KE, 2004, J CLIN MICROBIOL, V42, P1003, DOI 10.1128/JCM.42.3.1003-1011.2004; do Amaral de Leon C, 2013, PEDIAT PULMONOL; Echevarria JE, 1998, J CLIN MICROBIOL, V36, P1388; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Garcia-Garcia M L, 2007, An Pediatr (Barc), V67, P212, DOI 10.1157/13108941; Garcia-Garcia ML, 2006, PEDIATR PULM, V41, P863, DOI 10.1002/ppul.20456; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Huang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064254; Huijskens EG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-276; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Jevsnik M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-365; Kahn JS, 2007, CURR OPIN PHARMACOL, V7, P478, DOI 10.1016/j.coph.2007.07.004; Lazar I, 2004, EMERG INFECT DIS, V10, P1318, DOI 10.3201/eid1007.030983; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596; Mullins JA, 2004, EMERG INFECT DIS, V10, P700, DOI 10.3201/eid1004.030555; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; MYINT S, 1994, MOL CELL PROBE, V8, P357, DOI 10.1006/mcpr.1994.1052; Nokso-Koivisto J, 2002, J MED VIROL, V66, P417, DOI 10.1002/jmv.2161; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Steininger C, 2001, J CLIN MICROBIOL, V39, P129, DOI 10.1128/JCM.39.1.129-133.2001; Suryadevara M, 2011, CLIN PEDIATR, V50, P513, DOI 10.1177/0009922810394834; Tan BH, 2009, J MED VIROL, V81, P82, DOI 10.1002/jmv.21361; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wolf DG, 2006, PEDIATR INFECT DIS J, V25, P320, DOI 10.1097/01.inf.0000207395.80657.cf	47	48	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136526	10.1371/journal.pone.0136526	http://dx.doi.org/10.1371/journal.pone.0136526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332375	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800060
J	Gordy, JW; Leonard, BR; Blouin, D; Davis, JA; Stout, MJ				Gordy, John W.; Leonard, B. Rogers; Blouin, David; Davis, Jeffrey A.; Stout, Michael J.			Comparative Effectiveness of Potential Elicitors of Plant Resistance against Spodoptera frugiperda (J. E. Smith) (Lepidoptera: Noctuidae) in Four Crop Plants	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; INDIRECT DEFENSE; JASMONIC ACID; INSECT HERBIVORES; HELICOVERPA-ZEA; SALICYLIC-ACID; TOMATO PLANTS; TRADE-OFFS; PATHOGENS; COTTON	Feeding by insect herbivores activates plant signaling pathways, resulting in the enhanced production of secondary metabolites and other resistance-related traits by injured plants. These traits can reduce insect fitness, deter feeding, and attract beneficial insects. Organic and inorganic chemicals applied as a foliar spray, seed treatment, or soil drench can activate these plant responses. Azelaic acid (AA), benzothiadiazole (BTH), gibberellic acid (GA), harpin, and jasmonic acid (JA) are thought to directly mediate plant responses to pathogens and herbivores or to mimic compounds that do. The effects of these potential elicitors on the induction of plant defenses were determined by measuring the weight gains of fall armyworm, Spodoptera frugiperda (J. E. Smith) (FAW) (Lepidoptera: Noctuidae) larvae on four crop plants, cotton, corn, rice, and soybean, treated with the compounds under greenhouse conditions. Treatment with JA consistently reduced growth of FAW reared on treated cotton and soybean. In contrast, FAWfed BTH-and harpin-treated cotton and soybean tissue gained more weight than those fed control leaf tissue, consistent with negative crosstalk between the salicylic acid and JA signaling pathways. No induction or inconsistent induction of resistance was observed in corn and rice. Follow-up experiments showed that the co-application of adjuvants with JA failed to increase the effectiveness of induction by JA and that soybean looper [Chrysodeixis includens (Walker)], a relative specialist on legumes, was less affected by JA-induced responses in soybean than was the polyphagous FAW. Overall, the results of these experiments demonstrate that the effectiveness of elicitors as a management tactic will depend strongly on the identities of the crop, the pest, and the elicitor involved.	[Gordy, John W.] Texas A&M Agrilife Extens, Rosenberg, TX USA; [Leonard, B. Rogers] Louisiana State Univ, Ctr Agr, Baton Rouge, LA 70803 USA; [Blouin, David] Louisiana State Univ, Ctr Agr, Dept Expt Stat, Baton Rouge, LA 70803 USA; [Davis, Jeffrey A.; Stout, Michael J.] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Stout, MJ (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.	mstout@agcenter.lsu.edu		Gordy, john/0000-0003-0141-083X	Louisiana Rice Research Board	Louisiana Rice Research Board	This work was funded by the Louisiana Rice Research Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; BAKER CJ, 1993, PLANT PHYSIOL, V102, P1341, DOI 10.1104/pp.102.4.1341; Barilli E, 2010, EUR J PLANT PATHOL, V128, P483, DOI 10.1007/s10658-010-9678-x; Bi JL, 1997, J CHEM ECOL, V23, P1805, DOI 10.1023/B:JOEC.0000006452.81324.b8; Black CA, 2003, ENVIRON ENTOMOL, V32, P1196, DOI 10.1603/0046-225X(2003)032[1196:JAAVAL]2.0.CO;2; Boughton AJ, 2005, J CHEM ECOL, V31, P2211, DOI 10.1007/s10886-005-6228-7; Boughton AJ, 2006, ENTOMOL EXP APPL, V120, P175, DOI 10.1111/j.1570-7458.2006.00443.x; Brown SA, 2012, THESIS LOUISIANA STA; Bruinsma M, 2007, J CHEM ECOL, V33, P655, DOI 10.1007/s10886-006-9245-2; Campos ML, 2014, J CHEM ECOL, V40, P657, DOI 10.1007/s10886-014-0468-3; Cottrell TE, 2010, PEST MANAG SCI, V66, P1236, DOI 10.1002/ps.2000; Davies PJ, 1995, PLANT HORMONES PHYSL, P1, DOI DOI 10.1007/978-94-011-0473-9; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; Felton GW, 2000, CURR OPIN PLANT BIOL, V3, P309, DOI 10.1016/S1369-5266(00)00086-8; Garelnabi M, 2010, N AM J MED SCI, V2, P397, DOI 10.4297/najms.2010.2397; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Hamm JC, 2010, J CHEM ECOL, V36, P192, DOI 10.1007/s10886-010-9751-0; Hardke JT, 2011, THESIS LOUISIANA STA; Herzog D.C., 1980, Springer Series in Experimental Entomology, P141; Inbar M, 2001, ENTOMOL EXP APPL, V99, P65, DOI 10.1023/A:1018952329549; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kahl J, 2000, PLANTA, V210, P336, DOI 10.1007/PL00008142; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Kollner TG, 2009, PHYTOCHEMISTRY, V70, P1139, DOI 10.1016/j.phytochem.2009.06.011; Leitner M, 2005, NEW PHYTOL, V167, P597, DOI 10.1111/j.1469-8137.2005.01426.x; Luttrell R. G., 1999, Journal of Cotton Science, V3, P35; Lyon GD, 2014, INDUCED RESISTANCE FOR PLANT DEFENSE: A SUSTAINABLE APPROACH TO CROP PROTECTION, 2ND EDITION, P11; Meagher RL, 2012, ANN ENTOMOL SOC AM, V105, P462, DOI 10.1603/AN11158; Musser F. R., 2012, MIDSOUTH ENTOMOL, V5, P11; Naqvi SSM, 2001, HDB PLANT CROP PHYSL, P501; Nombela G, 2005, J ECON ENTOMOL, V98, P2266, DOI 10.1603/0022-0493-98.6.2266; Omer AD, 2001, INT J PEST MANAGE, V47, P49, DOI 10.1080/09670870150215595; Pieterse CMJ, 2014, INDUCED RESISTANCE FOR PLANT DEFENSE: A SUSTAINABLE APPROACH TO CROP PROTECTION, 2ND EDITION, P58; Reglinski T, 2014, INDUCED RESISTANCE FOR PLANT DEFENSE: A SUSTAINABLE APPROACH TO CROP PROTECTION, 2ND EDITION, P249; Rodriguez-Saona C, 2003, J CHEM ECOL, V29, P2539, DOI 10.1023/A:1026314102866; Rostas M, 2008, BIOL CONTROL, V46, P178, DOI 10.1016/j.biocontrol.2008.04.012; SCHONHERR J, 1994, PESTIC SCI, V42, P185, DOI 10.1002/ps.2780420308; Schoonhoven L. M., 2005, Insect-plant biology; SINGH M, 1993, PESTIC SCI, V38, P219, DOI 10.1002/ps.2780380217; Smith JL, 2009, PEST MANAG SCI, V65, P497, DOI 10.1002/ps.1714; STEVENS PJG, 1993, PESTIC SCI, V38, P103, DOI 10.1002/ps.2780380206; Stout MJ, 2009, ENVIRON ENTOMOL, V38, P1174, DOI 10.1603/022.038.0426; Stout MJ, 2014, INDUCED RESISTANCE FOR PLANT DEFENSE: A SUSTAINABLE APPROACH TO CROP PROTECTION, 2ND EDITION, P81; Stout MJ, 2002, ARCH INSECT BIOCHEM, V51, P222, DOI 10.1002/arch.10066; Tamaoki D, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24260; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thaler JS, 1999, J CHEM ECOL, V25, P1597, DOI 10.1023/A:1020840900595; Thaler JS, 2001, ECOL ENTOMOL, V26, P312, DOI 10.1046/j.1365-2311.2001.00324.x; Tian DL, 2014, PLANTA, V239, P577, DOI 10.1007/s00425-013-1997-7; Traw MB, 2003, PLANT PHYSIOL, V133, P1367, DOI 10.1104/pp.103.027086; Turnipseed S. G., 1987, SOYBEANS IMPROVEMENT, P779; Weston PA, 2008, J ECON ENTOMOL, V101, P1466, DOI 10.1603/0022-0493(2008)101[1466:PDEFTP]2.0.CO;2; Williams M. R., 2013, COTTON INSECT LOSSES; Xin ZJ, 2012, NEW PHYTOL, V194, P498, DOI 10.1111/j.1469-8137.2012.04057.x; YANG B, 2005, POSTHARVEST BIOL TEC, V38, P183; Yuan JS, 2008, PLANT J, V55, P491, DOI 10.1111/j.1365-313X.2008.03524.x	58	31	33	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136689	10.1371/journal.pone.0136689	http://dx.doi.org/10.1371/journal.pone.0136689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332833	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800065
J	Gore, RJ; Diallo, S; Padilla, J				Gore, Ross Joseph; Diallo, Saikou; Padilla, Jose			You Are What You Tweet: Connecting the Geographic Variation in America's Obesity Rate to Twitter Content	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; PUBLIC-HEALTH; RECOMMENDATIONS; REDUCTION; EXERCISE; PATTERNS	We conduct a detailed investigation of the relationship among the obesity rate of urban areas and expressions of happiness, diet and physical activity on social media. We do so by analyzing a massive, geo-tagged data set comprising over 200 million words generated over the course of 2012 and 2013 on the social network service Twitter. Among many results, we show that areas with lower obesity rates: (1) have happier tweets and frequently discuss (2) food, particularly fruits and vegetables, and (3) physical activities of any intensity. Additionally, we provide evidence that each of these results offer different and unique insight into the variation of the obesity rate in urban areas within the United States. Our work shows how the contents of social media may potentially be used to estimate real-time, population-scale measures of factors related to obesity.	[Gore, Ross Joseph; Diallo, Saikou; Padilla, Jose] Old Dominion Univ, Virginia Modeling Anal & Simulat Ctr, Norfolk, VA 23529 USA	Old Dominion University	Gore, RJ (corresponding author), Old Dominion Univ, Virginia Modeling Anal & Simulat Ctr, Norfolk, VA 23529 USA.	rgore@odu.edu						Akcora C.G., 2010, P 1 WORKSH SOC MED A, P62, DOI DOI 10.1145/1964858.1964867; Balabantaray RC., 2012, INT J APPL INFORM SY, V4, P48, DOI DOI 10.5120/IJAIS12-450651; Boillot A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052708, 10.1371/journal.pone.0064417]; Bollen J., 2011, ICWSM, P450; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Food U., 2014, NUTR DAT DIET STUD 1; Fuhrman J, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-51; Fulgoni VL, 2009, J NUTR, V139, P1549, DOI 10.3945/jn.108.101360; Goncalves B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112074; Guenther PM, 2008, J AM DIET ASSOC, V108, P1896, DOI 10.1016/j.jada.2008.08.016; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Holmberg K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106086; Huberman B., 2008, 1 MONDAY, V14, P1, DOI [10.5210/fm.v14i1.2317, DOI 10.5210/FM.V14I1.2317]; Jones DA, 1998, ARCH FAM MED, V7, P285; Mohammad S. M., 2014, COMPUTATIONAL INTELL; Mohammad Saif, 2013, P 7 INT WORKSH SEM E; National Center for Health Statistics, 1994, PLAN OP 3 NAT HLTH N; Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417; Ogden CL, 2012, PREVALENCE OBESITY U; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Sintsova V., 2013, 4 WORKSHOP COMPUTATI; Smith, 2010, P INT AAAI C WEB SOC; Smith A., 2012, PEW INTERNET AM LIFE, P4; Togo P, 2001, INT J OBESITY, V25, P1741, DOI 10.1038/sj.ijo.0801819; Trogdon JG, 2012, OBESITY, V20, P214, DOI 10.1038/oby.2011.169; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Turk AM, 2011, BEST PRACTICES GUIDE; USD of Health, 1996, PHYS ACT HLTH REP SU; Variyam JN., 1998, USDAS HLTH EATING IN; Weltman A, 2008, J CLIN ENDOCR METAB, V93, P4711, DOI 10.1210/jc.2008-0998; Weyer C, 1998, INT J OBESITY, V22, P1071, DOI 10.1038/sj.ijo.0800728; Wing RR, 1999, MED SCI SPORT EXER, V31, pS547, DOI 10.1097/00005768-199911001-00010	39	75	75	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0133505	10.1371/journal.pone.0133505	http://dx.doi.org/10.1371/journal.pone.0133505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332588	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800004
J	Yoon, J; Cordasco, KM; Chow, A; Rubenstein, LV				Yoon, Jean; Cordasco, Kristina M.; Chow, Adam; Rubenstein, Lisa V.			The Relationship between Same-Day Access and Continuity in Primary Care and Emergency Department Visits	PLOS ONE			English	Article							CENTERED MEDICAL HOME; MENTAL-HEALTH CONDITIONS; RANDOMIZED-TRIAL; HOSPITAL ADMISSIONS; COLLABORATIVE CARE; VETERANS; QUALITY; IMPACT; VALIDATION; DEPRESSION	We examined how emergency department (ED) visits for potentially preventable, mental health, and other diagnoses were related to same-day access and provider continuity in primary care using administrative data from 71,296 patients in 22 VHA clinics over a threeyear period. ED visits were categorized as non-emergent; primary care treatable; preventable; not preventable; or mental health-related. We conducted multi-level regression models adjusted for patient and clinic factors. More same-day access significantly predicted fewer non-emergent and primary care treatable ED visits while continuity was not significantly related to any type of ED visit. Neither measure was related to ED visits for mental health problems.	[Yoon, Jean; Chow, Adam] VA Palo Alto, Hlth Econ Resource Ctr, Menlo Pk, CA 94025 USA; [Yoon, Jean] VA Palo Alto, Ctr Innovat Implementat, Menlo Pk, CA USA; [Cordasco, Kristina M.; Rubenstein, Lisa V.] Greater Los Angeles VA, Ctr Study Healthcare Innovat Implementat & Policy, Sepulveda, CA USA; [Cordasco, Kristina M.; Rubenstein, Lisa V.] UCLA Sch Med, Los Angeles, CA USA; [Cordasco, Kristina M.; Rubenstein, Lisa V.] RAND Corp, Santa Monica, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation	Yoon, J (corresponding author), VA Palo Alto, Hlth Econ Resource Ctr, Menlo Pk, CA 94025 USA.	jean.yoon@va.gov						Ballard DW, 2010, MED CARE, V48, P58, DOI 10.1097/MLR.0b013e3181bd49ad; Billings J., 2000, EMERGENCY DEP USE NE; Chaiyachati KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096356; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DeVries A, 2012, AM J MANAG CARE, V18, P534; Doran KM, 2013, ANN EMERG MED, V62, P151, DOI 10.1016/j.annemergmed.2013.02.016; Druss BG, 2001, ARCH GEN PSYCHIAT, V58, P861, DOI 10.1001/archpsyc.58.9.861; Fifield J, 2013, J GEN INTERN MED, V28, P778, DOI 10.1007/s11606-013-2386-4; FROOT KA, 1989, J FINANC QUANT ANAL, V24, P333, DOI 10.2307/2330815; Gill JM, 2000, ARCH FAM MED, V9, P333, DOI 10.1001/archfami.9.4.333; Harbrecht MG, 2012, HEALTH AFFAIR, V31, P2010, DOI 10.1377/hlthaff.2012.0359; Hazlett SB, 2004, ACAD EMERG MED, V11, P193, DOI 10.1197/j.aem.2003.09.014; Horton NJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-9; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; Larkin GL, 2005, PSYCHIAT SERV, V56, P671, DOI 10.1176/appi.ps.56.6.671; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reid RJ, 2013, ANN FAM MED, V11, pS19, DOI 10.1370/afm.1476; Roby DH, 2010, MED CARE RES REV, V67, P412, DOI 10.1177/1077558710368682; Rosland AM, 2013, AM J MANAG CARE, V19, pE263; Rust G, 2008, ARCH INTERN MED, V168, P1705, DOI 10.1001/archinte.168.15.1705; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Sarver JH, 2002, ACAD EMERG MED, V9, P916, DOI 10.1197/aemj.9.9.916; Smith RP, 2008, J CLIN PSYCHIAT, V69, P286, DOI 10.4088/JCP.v69n0215; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; US Department of Health and Human services, 2009, AR RES FIL ARF; Werner RM, 2014, J GEN INTERN MED, V29, P689, DOI 10.1007/s11606-013-2678-8; Yano EM, 2007, AM J PUBLIC HEALTH, V97, P2151, DOI 10.2105/AJPH.2007.115709	27	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135274	10.1371/journal.pone.0135274	http://dx.doi.org/10.1371/journal.pone.0135274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26332981	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800026
J	Blum, SE; Heller, ED; Sela, S; Elad, D; Edery, N; Leitner, G				Blum, Shlomo E.; Heller, Elimelech D.; Sela, Shlomo; Elad, Daniel; Edery, Nir; Leitner, Gabriel			Genomic and Phenomic Study of Mammary Pathogenic Escherichia coli	PLOS ONE			English	Article							BOVINE-MASTITIS; VIRULENCE FACTORS; DAIRY-COWS; ANTIMICROBIAL RESISTANCE; EPITHELIAL-CELLS; STRAINS; YERSINIABACTIN; SUSCEPTIBILITY; IDENTIFICATION; VISUALIZATION	Escherichia coli is a major etiological agent of intra-mammary infections (IMI) in cows, leading to acute mastitis and causing great economic losses in dairy production worldwide. Particular strains cause persistent IMI, leading to recurrent mastitis. Virulence factors of mammary pathogenic E. coli (MPEC) involved pathogenesis of mastitis as well as those differentiating strains causing acute or persistent mastitis are largely unknown. This study aimed to identify virulence markers in MPEC through whole genome and phenome comparative analysis. MPEC strains causing acute (VL2874 and P4) or persistent (VL2732) mastitis were compared to an environmental strain (K71) and to the genomes of strains representing different E. coli pathotypes. Intra-mammary challenge in mice confirmed experimentally that the strains studied here have different pathogenic potential, and that the environmental strain K71 is non-pathogenic in the mammary gland. Analysis of whole genome sequences and predicted proteomes revealed high similarity among MPEC, whereas MPEC significantly differed from the non-mammary pathogenic strain K71, and from E. coli genomes from other pathotypes. Functional features identified in MPEC genomes and lacking in the non-mammary pathogenic strain were associated with synthesis of lipopolysaccharide and other membrane antigens, ferric-dicitrate iron acquisition and sugars metabolism. Features associated with cytotoxicity or intra-cellular survival were found specifically in the genomes of strains from severe and acute (VL2874) or persistent (VL2732) mastitis, respectively. MPEC genomes were relatively similar to strain K-12, which was subsequently shown here to be possibly pathogenic in the mammary gland. Phenome analysis showed that the persistent MPEC was the most versatile in terms of nutrients metabolized and acute MPEC the least. Among phenotypes unique to MPEC compared to the non-mammary pathogenic strain were uric acid and D-serine metabolism. This study reveals virulence factors and phenotypic characteristics of MPEC that may play a role in pathogenesis of E. coli mastitis.	[Blum, Shlomo E.; Heller, Elimelech D.] Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, IL-7610001 Rehovot, Israel; [Blum, Shlomo E.; Leitner, Gabriel] Kimron Vet Inst, Natl Mastitis Reference Ctr, Dept Bacteriol, IL-50250 Bet Dagan, Israel; [Sela, Shlomo] ARO, Microbial Food Safety Res Unit, Dept Food Qual & Safety, Inst Postharvest & Food Sci,Volcani Ctr, Bet Dagan, Israel; [Blum, Shlomo E.; Elad, Daniel] Kimron Vet Inst, Dept Bacteriol, IL-50250 Bet Dagan, Israel; [Edery, Nir] Kimron Vet Inst, Dept Pathol, IL-50250 Bet Dagan, Israel	Kimron Veterinary Institute; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Kimron Veterinary Institute; Kimron Veterinary Institute	Blum, SE (corresponding author), Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, IL-7610001 Rehovot, Israel.	shlomo.blum@mail.huji.ac.il		Sela (Saldinger), Shlomo/0000-0002-9141-9696	Israeli Dairy Board	Israeli Dairy Board	This work was supported by research grants from the Israeli Dairy Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RA, 2011, VET RES COMMUN, V35, P89, DOI 10.1007/s11259-010-9455-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON JC, 1977, VET PATHOL, V14, P618, DOI 10.1177/030098587701400608; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Blum S, 2008, VET MICROBIOL, V132, P135, DOI 10.1016/j.vetmic.2008.05.012; Blum S, 2012, J BACTERIOL, V194, P3732, DOI 10.1128/JB.00535-12; Blum SE, 2014, VET J, V201, P72, DOI 10.1016/j.tvjl.2014.04.008; Blum SE, 2013, VET MICROBIOL, V163, P305, DOI 10.1016/j.vetmic.2012.12.037; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; Browning DF, 2013, MOL MICROBIOL, V87, P939, DOI 10.1111/mmi.12144; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CHANDLER RL, 1977, J COMP PATHOL, V87, P471, DOI 10.1016/0021-9975(77)90036-6; Chaturvedi KS, 2014, ACS CHEM BIOL, V9, P551, DOI 10.1021/cb400658k; Chen CY, 2007, PLASMID, V57, P29, DOI 10.1016/j.plasmid.2006.05.005; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connolly JP, 2014, ISME J, P1; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dego OK, 2012, VET MICROBIOL, V155, P291, DOI 10.1016/j.vetmic.2011.08.016; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Dogan B, 2012, VET MICROBIOL, V159, P163, DOI 10.1016/j.vetmic.2012.03.033; Dopfer D, 2001, VET MICROBIOL, V80, P285, DOI 10.1016/S0378-1135(01)00307-8; Dopfer D, 2000, VET MICROBIOL, V74, P331, DOI 10.1016/S0378-1135(00)00191-7; Dopfer D, 1999, J DAIRY SCI, V82, P80, DOI 10.3168/jds.S0022-0302(99)75211-2; Fernandes JBC, 2011, J VET DIAGN INVEST, V23, P1146, DOI 10.1177/1040638711425581; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Halasa T, 2009, LIVEST SCI, V124, P295, DOI 10.1016/j.livsci.2009.02.019; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; HILL AW, 1979, VET REC, V105, P299, DOI 10.1136/vr.105.13.299; Hogan J, 2003, VET RES, V34, P507, DOI 10.1051/vetres:2003022; Hogeveen H, 2011, NEW ZEAL VET J, V59, P16, DOI 10.1080/00480169.2011.547165; Huja S, 2015, MBIO, V6, DOI 10.1128/mBio.01681-14; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Koli P, 2011, MBIO, V2; Le Marechal C, 2011, DAIRY SCI TECHNOL, V91, P247, DOI 10.1007/s13594-011-0009-6; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S6; Leimbach A, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00182-15; Leitner G, 2011, INT DAIRY J, V21, P279, DOI 10.1016/j.idairyj.2010.11.013; Lin J, 1999, CLIN DIAGN LAB IMMUN, V6, P966, DOI 10.1128/CDLI.6.6.966-969.1999; Liu YX, 2014, RES MICROBIOL, V165, P273, DOI 10.1016/j.resmic.2014.03.007; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Moritz RL, 2006, J CLIN MICROBIOL, V44, P4038, DOI 10.1128/JCM.01172-06; Notebaert S, 2006, VET QUART, V28, P2, DOI 10.1080/01652176.2006.9695201; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Development Core Team, 2014, R LANG ENV STAT COMP; Richards VP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119799; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; Schubert S, 2004, INT J MED MICROBIOL, V294, P83, DOI 10.1016/j.ijmm.2004.06.026; Seroussi E, 2013, IMMUNOGENETICS, V65, P861, DOI 10.1007/s00251-013-0738-1; Shpigel NY, 2008, CURR OPIN MICROBIOL, V11, P60, DOI 10.1016/j.mib.2008.01.004; Silanikove N, 2007, BIOCHEM BIOPH RES CO, V363, P561, DOI 10.1016/j.bbrc.2007.08.188; Srinivasan V, 2007, VET MICROBIOL, V124, P319, DOI 10.1016/j.vetmic.2007.04.040; Suojala L, 2011, VET MICROBIOL, V147, P383, DOI 10.1016/j.vetmic.2010.07.011; Vaas LAI, 2013, BIOINFORMATICS, V29, P1823, DOI 10.1093/bioinformatics/btt291; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Vesth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060120; Vigil PD, 2011, INFECT IMMUN, V79, P2335, DOI 10.1128/IAI.00110-11; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Wenz JR, 2006, J DAIRY SCI, V89, P3408, DOI 10.3168/jds.S0022-0302(06)72377-3; White LJ, 2010, VET RES, V41, DOI 10.1051/vetres/2009061; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	69	27	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136387	10.1371/journal.pone.0136387	http://dx.doi.org/10.1371/journal.pone.0136387			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327312	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700040
J	Manoharan, B; Neale, HC; Hancock, JT; Jackson, RW; Arnold, DL				Manoharan, Bharani; Neale, Helen C.; Hancock, John T.; Jackson, Robert W.; Arnold, Dawn L.			The Identification of Genes Important in Pseudomonas syringae pv. phaseolicola Plant Colonisation Using In Vitro Screening of Transposon Libraries	PLOS ONE			English	Article							AIR-LIQUID INTERFACE; EFFECTOR PROTEINS; SECRETION SYSTEM; VIRULENCE; MUTANTS; PATHOGENESIS; SEQUENCE; BIOFILM	The bacterial plant pathogen Pseudomonas syringae pv. phaseolicola (Pph) colonises the surface of common bean plants before moving into the interior of plant tissue, via wounds and stomata. In the intercellular spaces the pathogen proliferates in the apoplastic fluid and forms microcolonies (biofilms) around plant cells. If the pathogen can suppress the plant's natural resistance response, it will cause halo blight disease. The process of resistance suppression is fairly well understood, but the mechanisms used by the pathogen in colonisation are less clear. We hypothesised that we could apply in vitro genetic screens to look for changes in motility, colony formation, and adhesion, which are proxies for infection, microcolony formation and cell adhesion. We made transposon (Tn) mutant libraries of Pph strains 1448A and 1302A and found 106/1920 mutants exhibited alterations in colony morphology, motility and biofilm formation. Identification of the insertion point of the Tn identified within the genome highlighted, as expected, a number of altered motility mutants bearing mutations in genes encoding various parts of the flagellum. Genes involved in nutrient biosynthesis, membrane associated proteins, and a number of conserved hypothetical protein (CHP) genes were also identified. A mutation of one CHP gene caused a positive increase in in planta bacterial growth. This rapid and inexpensive screening method allows the discovery of genes important for in vitro traits that can be correlated to roles in the plant interaction.	[Manoharan, Bharani; Neale, Helen C.; Hancock, John T.; Arnold, Dawn L.] Univ W England, Fac Hlth & Appl Sci, Ctr Res Biosci, Bristol BS16 1QY, Avon, England; [Jackson, Robert W.] Univ Reading, Sch Biol Sci, Reading RG6 6UR, Berks, England	University of West England; University of Reading	Arnold, DL (corresponding author), Univ W England, Fac Hlth & Appl Sci, Ctr Res Biosci, Frenchay Campus, Bristol BS16 1QY, Avon, England.	dawn.arnold@uwe.ac.uk	Jackson, Robert W/C-2973-2009; Arnold, Dawn/AAF-3484-2021	Jackson, Robert W/0000-0002-2042-4105; 	University of the West of England, Bristol; Biotechnology and Biological Sciences Research Council [BB/J014796/1]; Biotechnology and Biological Sciences Research Council [BB/J015350/1] Funding Source: researchfish; BBSRC [BB/J014796/1, BB/J015350/1] Funding Source: UKRI	University of the West of England, Bristol; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the University of the West of England, Bristol (http://www.uwe.ac.uk/) (BM and DLA) and Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) (BB/J014796/1) (HCN, RWJ and DLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Arnold DL, 2011, MOL PLANT PATHOL, V12, P617, DOI [10.1111/j.1364-3703.2010.00697.x, 10.1111/J.1364-3703.2010.00697.X]; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Bhagwat AA, 2009, MICROBIOL-SGM, V155, P229, DOI 10.1099/mic.0.023747-0; Bittel P, 2007, CURR OPIN PLANT BIOL, V10, P335, DOI 10.1016/j.pbi.2007.04.021; Boch J, 2002, MOL MICROBIOL, V44, P73, DOI 10.1046/j.1365-2958.2002.02877.x; Brooks DM, 2004, MOL PLANT MICROBE IN, V17, P162, DOI 10.1094/MPMI.2004.17.2.162; Burns BP, 2000, ARCH BIOCHEM BIOPHYS, V380, P78, DOI 10.1006/abbi.2000.1920; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Cullinane M, 2005, MICROBIOL-SGM, V151, P3071, DOI 10.1099/mic.0.27958-0; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gallie J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002109; Giddens SR, 2007, P NATL ACAD SCI USA, V104, P18247, DOI 10.1073/pnas.0706739104; Godfrey SAC, 2010, MOL PLANT MICROBE IN, V23, P1294, DOI 10.1094/MPMI-05-10-0114; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; HARSHEY RM, 1994, MOL MICROBIOL, V13, P389, DOI 10.1111/j.1365-2958.1994.tb00433.x; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Kanda E, 2011, MOL GENET GENOMICS, V285, P163, DOI 10.1007/s00438-010-0594-8; Keen N.T., 1992, MOL PLANT PATHOLOGY; KING EO, 1954, J LAB CLIN MED, V44, P301; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Koza A, 2009, MICROBIOL-SGM, V155, P1397, DOI 10.1099/mic.0.025064-0; Laue RE, 2000, MICROBIOL-UK, V146, P2469, DOI 10.1099/00221287-146-10-2469; Le Breton Y, 2013, INFECT IMMUN, V81, P862, DOI 10.1128/IAI.00837-12; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; LINDOW SE, 1993, APPL ENVIRON MICROB, V59, P1593, DOI 10.1128/AEM.59.5.1593-1601.1993; Lovell HC, 2011, MOL PLANT PATHOL, V12, P167, DOI 10.1111/j.1364-3703.2010.00658.x; Manoil C, 2000, METHOD ENZYMOL, V326, P35; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Pitman AR, 2005, CURR BIOL, V15, P2230, DOI 10.1016/j.cub.2005.10.074; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sarris PF, 2010, MOL PLANT PATHOL, V11, P795, DOI 10.1111/j.1364-3703.2010.00644.x; Schreiber KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041461; Schreiber KJ, 2011, MOL MICROBIOL, V80, P364, DOI 10.1111/j.1365-2958.2011.07571.x; Shah DSH, 2000, J BACTERIOL, V182, P5218, DOI 10.1128/JB.182.18.5218-5224.2000; Shyntum DY, 2015, MOL PLANT MICROBE IN, V28, P420, DOI 10.1094/MPMI-07-14-0219-R; SOMLYAI G, 1986, PHYSIOL MOL PLANT P, V29, P369, DOI 10.1016/S0048-4059(86)80053-4; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Tans-Kersten J, 2001, J BACTERIOL, V183, P3597, DOI 10.1128/JB.183.12.3597-3605.2001; Taylor JD, 1996, PLANT PATHOL, V45, P469, DOI 10.1046/j.1365-3059.1996.d01-147.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	52	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137355	10.1371/journal.pone.0137355	http://dx.doi.org/10.1371/journal.pone.0137355			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325299	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000360437700112
J	McAuliffe, PF; Evans, KW; Akcakanat, A; Chen, K; Zheng, XF; Zhao, H; Eterovic, AK; Sangai, T; Holder, AM; Sharma, C; Chen, HQ; Do, KA; Tarco, E; Gagea, M; Naff, KA; Sahin, A; Multani, AS; Black, DM; Mittendorf, EA; Bedrosian, I; Mills, GB; Gonzalez-Angulo, AM; Meric-Bernstam, F				McAuliffe, Priscilla F.; Evans, Kurt W.; Akcakanat, Argun; Chen, Ken; Zheng, Xiaofeng; Zhao, Hao; Eterovic, Agda Karina; Sangai, Takafumi; Holder, Ashley M.; Sharma, Chandeshwar; Chen, Huiqin; Do, Kim-Anh; Tarco, Emily; Gagea, Mihai; Naff, Katherine A.; Sahin, Aysegul; Multani, Asha S.; Black, Dalliah M.; Mittendorf, Elizabeth A.; Bedrosian, Isabelle; Mills, Gordon B.; Gonzalez-Angulo, Ana Maria; Meric-Bernstam, Funda			Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes	PLOS ONE			English	Article							HUMAN TUMOR XENOGRAFTS; CELL LUNG-CANCER; NEOADJUVANT CHEMOTHERAPY; IMMUNODEFICIENT MICE; PANCREATIC-CANCER; LARGE PANEL; NUDE-MICE; MODELS; SURVIVAL; GROWTH	Background Breast cancer patients who are resistant to neoadjuvant chemotherapy (NeoCT) have a poor prognosis. There is a pressing need to develop in vivo models of chemo resistant tumors to test novel therapeutics. We hypothesized that patient-derived breast cancer xenografts (BCXs) from chemo-naive and chemotherapy-exposed tumors can provide high fidelity in vivo models for chemoresistant breast cancers. Methods Patient tumors and BCXs were characterized with short tandem repeat DNA fingerprinting, reverse phase protein arrays, molecular inversion probe arrays, and next generation sequencing. Results Forty-eight breast cancers (24 post-chemotherapy, 24 chemo-naive) were implanted and 13 BCXs were established (27%). BCX engraftment was higher in TNBC compared to hormone-receptor positive cancer (53.8% vs. 15.6%, p = 0.02), in tumors from patients who received NeoCT (41.7% vs. 8.3%, p = 0.02), and in patients who had progressive disease on NeoCT (85.7% vs. 29.4%, p = 0.02). Twelve patients developed metastases after surgery; in five, BCXs developed before distant relapse. Patients whose tumors developed BCXs had a lower recurrence-free survival (p = 0.015) and overall survival (p<0.001). Genomic losses and gains could be detected in the BCX, and three models demonstrated a transformation to induce mouse tumors. However, overall, somatic mutation profiles including potential drivers were maintained upon implantation and serial passaging. One BCX model was cultured in vitro and re-implanted, maintaining its genomic profile. Conclusions BCXs can be established from clinically aggressive breast cancers, especially in TNBC patients with poor response to NeoCT. Future studies will determine the potential of in vivo models for identification of genotype-phenotype correlations and individualization of treatment.	[McAuliffe, Priscilla F.; Sangai, Takafumi; Holder, Ashley M.; Sharma, Chandeshwar; Black, Dalliah M.; Mittendorf, Elizabeth A.; Bedrosian, Isabelle; Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Evans, Kurt W.; Akcakanat, Argun; Tarco, Emily; Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Chen, Ken; Zheng, Xiaofeng; Zhao, Hao] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Sci, Houston, TX 77030 USA; [Eterovic, Agda Karina; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Chen, Huiqin; Do, Kim-Anh] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Gagea, Mihai; Naff, Katherine A.] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA; [Sahin, Aysegul] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Multani, Asha S.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Gonzalez-Angulo, Ana Maria] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Meric-Bernstam, F (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	fmeric@mdanderson.org	Akcakanat, Argun/AFU-2090-2022; Chen, Ken/AAU-1432-2021	Chen, Ken/0000-0003-4013-5279; Akcakanat, Argun/0000-0002-4012-9840; Holder, Ashley/0000-0002-6506-5871	National Institutes of Health [T32 CA009599]; MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; MD Anderson Stand Up to Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation [SU2C-AACR-DT0209 01]; MD Anderson Women's Cancers Moonshot Program; Susan G. Komen Foundation for the Cure grant [SAC10006]; Nellie B. Connally Breast Cancer Research Endowment; Barr funds; MD Anderson Cancer Center support grant [P30 CA016672];  [UL1TR000371]; NATIONAL CANCER INSTITUTE [T32CA009599, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; MD Anderson Stand Up to Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation; MD Anderson Women's Cancers Moonshot Program; Susan G. Komen Foundation for the Cure grant; Nellie B. Connally Breast Cancer Research Endowment; Barr funds; MD Anderson Cancer Center support grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Institutes of Health T32 CA009599 (PFM, AMH, FMB), the MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (FMB, KWE, AKE, HZ, KC, GBM), MD Anderson Stand Up to Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation SU2C-AACR-DT0209 01 (GBM, AA, FMB), MD Anderson Women's Cancers Moonshot Program (KWE, FMB), Susan G. Komen Foundation for the Cure grant SAC10006 (FMB, KAD), UL1TR000371 (FMB, KC, KAD), the Nellie B. Connally Breast Cancer Research Endowment (KWE, AA, FMB), the Barr funds, and the MD Anderson Cancer Center support grant (P30 CA016672).	Akcakanat A, 2008, CANCER-AM CANCER SOC, V112, P2352, DOI 10.1002/cncr.23456; Bergamaschi A, 2009, MOL ONCOL, V3, P469, DOI 10.1016/j.molonc.2009.07.003; Caudle AS, 2010, J CLIN ONCOL, V28, P1821, DOI 10.1200/JCO.2009.25.3286; Chen K, 2015, CLIN CHEM, V61, P544, DOI 10.1373/clinchem.2014.231100; Cottu P, 2012, BREAST CANCER RES TR, V133, P595, DOI 10.1007/s10549-011-1815-5; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Gonzalez-Angulo AM, 2011, MOL CANCER THER, V10, P1093, DOI 10.1158/1535-7163.MCT-10-1089; Hao CC, 2015, CANCER LETT, V357, P179, DOI 10.1016/j.canlet.2014.11.024; Hassan B, 2013, SURG ONCOL CLIN N AM, V22, P641, DOI 10.1016/j.soc.2013.06.008; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hylander BL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-110; Ilie M, 2015, CANCER MED-US, V4, P201, DOI 10.1002/cam4.357; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Klinghammer K, 2015, INT J CANCER, V136, P2940, DOI 10.1002/ijc.29344; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liedtke C, 2009, ANN ONCOL, V20, P1953, DOI 10.1093/annonc/mdp263; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lin MT, 2010, BIOTECHNIQUES, V48, P211, DOI 10.2144/000113363; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Meric-Bernstam F, 2014, CLIN CANCER RES, V20, P3870, DOI 10.1158/1078-0432.CCR-13-1507; Meric-Bernstam F, 2014, MOL CANCER THER, V13, P1382, DOI 10.1158/1535-7163.MCT-13-0482; Monsma DJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-125; Moro M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/568567; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Pathak S, 1997, BRIT J CANCER, V76, P1134, DOI 10.1038/bjc.1997.524; Pathak S, 1998, CANCER, V83, P1891, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1891::AID-CNCR3>3.0.CO;2-U; Morelli MP, 2012, J CLIN ONCOL, V30, pE45, DOI 10.1200/JCO.2011.36.9678; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Ring BZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-74; Rothenberg-Thurley M, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.49.49; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Ryba T, 2011, NAT PROTOC, V6, P870, DOI 10.1038/nprot.2011.328; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Thompson PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023543; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Visonneau S, 1998, AM J PATHOL, V152, P1299; Wang Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r246; Weroha SJ, 2014, CLIN CANCER RES, V20, P1288, DOI 10.1158/1078-0432.CCR-13-2611; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081	51	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136851	10.1371/journal.pone.0136851	http://dx.doi.org/10.1371/journal.pone.0136851			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325287	gold, Green Submitted, Green Published			2022-12-27	WOS:000360437700068
J	Schult, N; Reineking, T; Kluss, T; Zetzsche, C				Schult, Niclas; Reineking, Thomas; Kluss, Thorsten; Zetzsche, Christoph			Information-Driven Active Audio-Visual Source Localization	PLOS ONE			English	Article							TRACKING; INTEGRATION; MODELS	We present a system for sensorimotor audio-visual source localization on a mobile robot. We utilize a particle filter for the combination of audio-visual information and for the temporal integration of consecutive measurements. Although the system only measures the current direction of the source, the position of the source can be estimated because the robot is able to move and can therefore obtain measurements from different directions. These actions by the robot successively reduce uncertainty about the source's position. An information gain mechanism is used for selecting the most informative actions in order to minimize the number of actions required to achieve accurate and precise position estimates in azimuth and distance. We show that this mechanism is an efficient solution to the action selection problem for source localization, and that it is able to produce precise position estimates despite simplified unisensory preprocessing. Because of the robot's mobility, this approach is suitable for use in complex and cluttered environments. We present qualitative and quantitative results of the system's performance and discuss possible areas of application.	[Schult, Niclas; Reineking, Thomas; Kluss, Thorsten; Zetzsche, Christoph] Univ Bremen, Cognit Neuroinformat, D-28359 Bremen, Germany	University of Bremen	Schult, N (corresponding author), Univ Bremen, Cognit Neuroinformat, D-28359 Bremen, Germany.	niclasschult@googlemail.com	Kluss, Thorsten/AAR-7406-2020		German Research Foundation [SFB-TR8]	German Research Foundation(German Research Foundation (DFG))	This study has been supported by German Research Foundation (SFB-TR8 "Spatial Cognition" A5-[ActionSpace]) (http://www.sfbtr8.uni-bremen.de/en/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; [Anonymous], 1987, M IOC SPEECH GROUP A; Bar-Shalom Y., 2004, ESTIMATION APPL TRAC; Breebaart J, 2010, J AUDIO ENG SOC, V58, P126; Brunelli R., 2009, TEMPLATE MATCHING TE; Brungart DS, 1999, J ACOUST SOC AM, V106, P1465, DOI 10.1121/1.427180; Calvert G., 2004, HDB MULTISENSORY PRO; Cha Z, 2008, IEEE T MULTIMEDIA, V10, P538, DOI 10.1109/TMM.2008.917406; Chen SY, 2011, INT J ROBOT RES, V30, P1343, DOI 10.1177/0278364911410755; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Doucet A., 2001, SEQUENTIAL MONTE CAR; Gehrig T, 2005, IEEE WORK APPL SIG, P118, DOI 10.1109/ASPAA.2005.1540183; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Hu GN, 2007, IEEE T AUDIO SPEECH, V15, P396, DOI 10.1109/TASL.2006.881700; Hyvarinen A, 2010, TOP COGN SCI, V2, P251, DOI 10.1111/j.1756-8765.2009.01057.x; Iwaya Y., 2003, Acoustical Science and Technology, V24, P322, DOI 10.1250/ast.24.322; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Klemen J, 2012, NEUROSCI BIOBEHAV R, V36, P111, DOI 10.1016/j.neubiorev.2011.04.015; Lang S., 2003, P INT C MULT INT VAN, P28, DOI DOI 10.1145/958432.958441; Li T, 2006, IEEE T SIGNAL PROCES, V54, P3991, DOI 10.1109/TSP.2006.880213; Liang ZW, 2008, APPL ACOUST, V69, P673, DOI 10.1016/j.apacoust.2007.04.001; Meyer GF, 2001, NEUROREPORT, V12, P2557, DOI 10.1097/00001756-200108080-00053; Nickel K, 2005, P 7 INT C MULT INT I, P61, DOI DOI 10.1145/1088463.1088477; Okuno HG, 2002, LECT NOTES ARTIF INT, V2358, P725; Portello A, 2011, IEEE INT C INT ROBOT, P137, DOI [10.1109/IROS.2011.6048515, 10.1109/IROS.2011.6094842]; Reineking T., 2014, BELIEF FUNCTIONS THE; Schnupp J., 2011, AUDITORY NEUROSCIENC; Seilheimer RL, 2014, CURR OPIN NEUROBIOL, V25, P38, DOI 10.1016/j.conb.2013.11.008; Shapiro L, 2011, NEW PROBL PHILOS, P1; Slaney M, 1993, APPLE COMPUT PERCEPT, V35; Thrun S, 2001, ARTIF INTELL, V128, P99, DOI 10.1016/S0004-3702(01)00069-8; Valin JM, 2007, ROBOT AUTON SYST, V55, P216, DOI 10.1016/j.robot.2006.08.004; Valin JM, 2003, IROS 2003: PROCEEDINGS OF THE 2003 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P1228; Vermaak J, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P741, DOI 10.1109/ICCV.2001.937600; Wang D, 2006, COMPUTATIONAL AUDITO, V147; Ward DB, 2003, IEEE T SPEECH AUDI P, V11, P826, DOI 10.1109/TSA.2003.818112; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; Wuerger SM, 2003, PERCEPT PSYCHOPHYS, V65, P1188, DOI 10.3758/BF03194844; Yost W A., 2000, FUNDAMENTALS HEARING; Zetzsche C, 2008, COGN PROCESS, V9, P283, DOI 10.1007/s10339-008-0214-2; Zotkin DN, 2002, EURASIP J APPL SIG P, V2002, P1154, DOI 10.1155/S1110865702206058	44	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137057	10.1371/journal.pone.0137057	http://dx.doi.org/10.1371/journal.pone.0137057			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327619	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700087
J	Brage, S; Westgate, K; Franks, PW; Stegle, O; Wright, A; Ekelund, U; Wareham, NJ				Brage, Soren; Westgate, Kate; Franks, Paul W.; Stegle, Oliver; Wright, Antony; Ekelund, Ulf; Wareham, Nicholas J.			Estimation of Free-Living Energy Expenditure by Heart Rate and Movement Sensing: A Doubly-Labelled Water Study	PLOS ONE			English	Article							ASSESS PHYSICAL-ACTIVITY; MEASUREMENT ERROR; CALORIMETRIC VALIDATION; RELATIVE IMPORTANCE; BODY-COMPOSITION; SEDENTARY TIME; MOTION SENSOR; VALIDITY; INTENSITY; ACCELEROMETRY	Background Accurate assessment of energy expenditure (EE) is important for the study of energy balance and metabolic disorders. Combined heart rate (HR) and acceleration (ACC) sensing may increase precision of physical activity EE (PAEE) which is the most variable component of total EE (TEE). Objective To evaluate estimates of EE using ACC and HR data with or without individual calibration against doubly-labelled water (DLW) estimates of EE. Design 23 women and 23 men (22-55 yrs, 48-104 kg, 8-46% body fat) underwent 45-min resting EE (REE) measurement and completed a 20-min treadmill test, an 8-min step test, and a 3-min walk test for individual calibration. ACC and HR were monitored and TEE measured over 14 days using DLW. Diet-induced thermogenesis (DIT) was calculated from food-frequency questionnaire. PAEE (TEE divided by REE divided by DIT) and TEE were compared to estimates from ACC and HR using bias, root mean square error (RMSE), and correlation statistics. Results Mean(SD) measured PAEE and TEE were 66(25) kJ.day(-1).kg(-1), and 12(2.6) MJ.day(-1), respectively. Estimated PAEE from ACC was 54(15) kJ.day(-1).kg(-1) (p<0.001), with RMSE 24 kJ.day(-1).kg(-1) and correlation r = 0.52. PAEE estimated from HR and ACC+HR with treadmill calibration were 67(42) and 69(25) kJ.day(-1).kg(-1) (bias non-significant), with RMSE 34 and 20 kJ.day(-1).kg(-1) and correlations r = 0.58 and r = 0.67, respectively. Similar results were obtained with step-calibrated and walk-calibrated models, whereas non-calibrated models were less precise (RMSE: 37 and 24 kJ.day(-1).kg(-1), r = 0.40 and r = 0.55). TEE models also had high validity, with biases <5%, and correlations r = 0.71 (ACC), r = 0.66-0.76 (HR), and r = 0.76-0.83 (ACC+HR). Conclusions Both accelerometry and heart rate may be used to estimate EE in adult European men and women, with improved precision if combined and if heart rate is individually calibrated.	[Brage, Soren; Westgate, Kate; Franks, Paul W.; Wright, Antony; Ekelund, Ulf; Wareham, Nicholas J.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Franks, Paul W.] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Stegle, Oliver] Univ Cambridge, Dept Phys, Cambridge, England; [Stegle, Oliver] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Wright, Antony] MRC Human Nutr Res, Cambridge, England	University of Cambridge; Lund University; University of Cambridge; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Brage, S (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.	soren.brage@mrc-epid.cam.ac.uk	Stegle, Oliver/AAU-9177-2020; Ekelund, Ulf/AAE-8471-2019; Franks, Paul/AAA-3300-2020; Brage, Soren/C-6415-2013	Stegle, Oliver/0000-0002-8818-7193; Ekelund, Ulf/0000-0003-2115-9267; Brage, Soren/0000-0002-1265-7355; Franks, Paul/0000-0002-0520-7604; Westgate, Kate/0000-0002-0283-3562	Medical Research Council [MC_UU_12015/3]; Wellcome Trust; Unilever UK; Medical Research Council [MC_U106179473, MC_U105960384, MC_UU_12015/1, MC_U106179471] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish; MRC [MC_UU_12015/3, MC_U105960384, MC_UU_12015/1, MC_U106179473] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Unilever UK(Unilever); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study received funding from Medical Research Council (MC_UU_12015/3), Wellcome Trust, Unilever UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Assah FK, 2008, DIABETOLOGIA, V51, P1399, DOI 10.1007/s00125-008-1033-9; Assah FK, 2011, INT J EPIDEMIOL, V40, P112, DOI 10.1093/ije/dyq098; Assah FK, 2011, DIABETES CARE, V34, P491, DOI 10.2337/dc10-0990; AVONS P, 1988, EUR J CLIN NUTR, V42, P185; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; BLACK AE, 1993, J AM DIET ASSOC, V93, P572, DOI 10.1016/0002-8223(93)91820-G; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bouten CVC, 1996, J APPL PHYSIOL, V81, P1019, DOI 10.1152/jappl.1996.81.2.1019; Brage S, 2006, EUR J APPL PHYSIOL, V96, P517, DOI 10.1007/s00421-005-0112-6; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2013, ICAMPAM AMH C P 2013; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Calabro MA, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0119-7; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; CEESAY SM, 1989, BRIT J NUTR, V61, P175, DOI 10.1079/BJN19890107; Chen KY, 1997, J APPL PHYSIOL, V83, P2112, DOI 10.1152/jappl.1997.83.6.2112; Christensen DL, 2012, AM J HUM BIOL, V24, P723, DOI 10.1002/ajhb.22303; COLE TJ, 1992, AM J PHYSIOL, V263, pE965, DOI 10.1152/ajpendo.1992.263.5.E965; Cooper AJM, 2014, DIABETOLOGIA, V57, P73, DOI 10.1007/s00125-013-3069-8; COWARD WA, 1988, EUR J CLIN NUTR, V42, P207; COWARD WA, 1988, P NUTR SOC, V47, P209, DOI 10.1079/PNS19880037; Crouter SE, 2008, EUR J CLIN NUTR, V62, P704, DOI 10.1038/sj.ejcn.1602766; Dahl-Petersen IK, 2013, DIABETES RES CLIN PR, V102, P242, DOI 10.1016/j.diabres.2013.10.004; Davidson L, 1997, BRIT J NUTR, V78, P695, DOI 10.1079/BJN19970188; Day NE, 2004, INT J EPIDEMIOL, V33, P1373, DOI 10.1093/ije/dyh138; den Hoed M, 2013, AM J CLIN NUTR, V98, P1317, DOI 10.3945/ajcn.113.069849; Franks PW, 2002, BRIT J NUTR, V88, P307, DOI 10.1079/BJN2002663; Fraser GE, 2004, ANN EPIDEMIOL, V14, P287, DOI 10.1016/j.annepidem.2003.08.008; GOLDBERG GR, 1988, EUR J CLIN NUTR, V42, P137; Golubic R, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-58; HASKELL WL, 1993, MED SCI SPORT EXER, V25, P109, DOI 10.1249/00005768-199301000-00015; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P1025; Hustvedt BE, 2004, BRIT J NUTR, V92, P1001, DOI 10.1079/BJN20041272; Jakes RW, 2004, INT J EPIDEMIOL, V33, P1382, DOI 10.1093/ije/dyh181; Jarisch A, 1927, SKAND ARCH PHYSIOL, V51, P235, DOI 10.1111/j.1748-1716.1927.tb00223.x; Jequier E, 2002, INT J OBESITY, V26, pS12, DOI 10.1038/sj.ijo.0802123; Johansson HP, 2006, BRIT J NUTR, V95, P631, DOI 10.1079/BJN20051527; Kashiwazaki H, 1999, J NUTR SCI VITAMINOL, V45, P79, DOI 10.3177/jnsv.45.79; Kipnis V, 1997, AM J EPIDEMIOL, V146, P842, DOI 10.1093/oxfordjournals.aje.a009202; KLAKEG CH, 1955, AM HEART J, V49, P614, DOI 10.1016/0002-8703(55)90080-6; KLEIN PD, 1984, HUM NUTR-CLIN NUTR, V38C, P95; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Leenders NYJM, 2001, MED SCI SPORT EXER, V33, P1233; LIVINGSTONE MBE, 1990, AM J CLIN NUTR, V52, P59, DOI 10.1093/ajcn/52.1.59; Luke A, 1997, MED SCI SPORT EXER, V29, P144, DOI 10.1097/00005768-199701000-00021; Masse LC, 2004, J APPL PHYSIOL, V96, P1357, DOI 10.1152/japplphysiol.00901.2003; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Plasqui G, 2005, OBES RES, V13, P1363, DOI 10.1038/oby.2005.165; Rafamantanantsoa HH, 2002, J NUTR SCI VITAMINOL, V48, P517, DOI 10.3177/jnsv.48.517; Rennie K, 2000, EUR J CLIN NUTR, V54, P409, DOI 10.1038/sj.ejcn.1600973; Rietjens GJWM, 2001, INT J SPORTS MED, V22, P291, DOI 10.1055/s-2001-14342; Ritz P, 1996, AM J PHYSIOL-ENDOC M, V270, pE164, DOI 10.1152/ajpendo.1996.270.1.E164; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; SCHOELLER DA, 1986, AM J PHYSIOL, V251, pR1137, DOI 10.1152/ajpregu.1986.251.6.R1137; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; SEALE JL, 1993, J APPL PHYSIOL, V74, P402, DOI 10.1063/1.354123; SPURR GB, 1988, AM J CLIN NUTR, V48, P552, DOI 10.1093/ajcn/48.3.552; Stegle O, 2008, IEEE T BIO-MED ENG, V55, P2143, DOI 10.1109/TBME.2008.923118; Strath SJ, 2005, MED SCI SPORT EXER, V37, pS563, DOI 10.1249/01.mss.0000185650.68232.3f; Strath SJ, 2002, MED SCI SPORT EXER, V34, P888, DOI 10.1097/00005768-200205000-00025; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tate DF, 2003, JAMA-J AM MED ASSOC, V289, P1833, DOI 10.1001/jama.289.14.1833; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; Villars C, 2012, J APPL PHYSIOL, V113, P1763, DOI 10.1152/japplphysiol.01413.2011; Wareham NJ, 2000, AM J EPIDEMIOL, V152, P132, DOI 10.1093/aje/152.2.132; Wareham NJ, 2000, INT J EPIDEMIOL, V29, P655, DOI 10.1093/ije/29.4.655; Wareham NJ, 1998, INT J OBESITY, V22, pS30; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp Klaas R, 2004, Nutr Metab (Lond), V1, P5; Wickstrom G, 2000, SCAND J WORK ENV HEA, V26, P363, DOI 10.5271/sjweh.555; Withers RT, 1998, J APPL PHYSIOL, V85, P238, DOI 10.1152/jappl.1998.85.1.238; Wong MY, 1999, STAT MED, V18, P2831, DOI 10.1002/(SICI)1097-0258(19991115)18:21<2831::AID-SIM282>3.3.CO;2-V	75	81	81	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137206	10.1371/journal.pone.0137206	http://dx.doi.org/10.1371/journal.pone.0137206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26349056	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000360897600025
J	Hung, DZ; Yang, HJ; Li, YF; Lin, CL; Chang, SY; Sung, FC; Tai, SCW				Hung, Dong-Zong; Yang, Hao-Jan; Li, Yu-Fen; Lin, Cheng-Li; Chang, Shih-Yu; Sung, Fung-Chang; Tai, Sally C. W.			The Long-Term Effects of Organophosphates Poisoning as a Risk Factor of CVDs: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION INCIDENCE; SUDDEN CARDIAC DEATH; VENTRICULAR-ARRHYTHMIAS; AGRICULTURAL HEALTH; SARIN VAPOR; TOXICITY; EXPOSURE; RATS; POLYMORPHISM; ASSOCIATION	Background Organophosphorus pesticides are widely used throughout the world. Because of their ease of availability, organophosphorus compounds are commonly used for self-poisoning in developing countries. The acute effects of exposure to organophosphorus pesticides are well known, but the chronic effects are unclear. Recent studies suggest that abnormalities of the central and peripheral nervous systems persisted for up to 5 years after acute poisoning due to a single large dose of organophosphates (OPs). However, the long-term effects on cardiovascular diseases are poorly understood. Methodology/Principal Findings An OPs-exposed cohort (N = 7,561) and an age-and gender-matched control cohort (N = 30,244), both identified from the National Health Insurance Research Database, were compared. We utilized the multivariable Cox proportional model to estimate the risks of developing arrhythmia, coronary artery disease (CAD) and congestive heart failure (CHF). The patients with acute poisoning from OPs had higher incidence rates of arrhythmia (5.89 vs. 3.61 per 1,000 person-years), CAD (9.10 vs. 6.88 per 1,000 person-years), and CHF (3.89 vs. 2.98 per 1,000 person-years) compared with that of the non-OPs poisoning cohort, with a crude subhazard ratio (SHR) of 1.40, 1.13, and 1.12, respectively. Additionally, a significantly higher risk of arrhythmia was observed in the OPs poisoning cohort (adjusted SHR = 1.25) compared with the non-OPs poisoning cohort, particularly in male patients (adjusted SHR = 1.33) and those under 49 years of age (adjusted SHR = 3.16). After accounting for the competing risks of death, there was a higher risk of arrhythmia and CAD during a three year follow-up period (adjusted SHR = 1.50 for arrhythmia; adjusted SHR = 1.10 for CAD). We also found an adjusted SHR of 1.36 associated with developing CHF after 6 years of follow-up for OPs poisoning cohort. Conclusions Acute OPs poisoning may continuously impact human health through mechanisms that are unclear. Any supportive measurements that could contribute to a reduction in the risk of heart disease may be beneficial in cases of OPs poisoning survivors.	[Hung, Dong-Zong; Tai, Sally C. W.] China Med Univ Hosp, Dept Emergency, Toxicol Ctr, Taichung, Taiwan; [Hung, Dong-Zong; Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Yang, Hao-Jan; Chang, Shih-Yu] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Yang, Hao-Jan; Chang, Shih-Yu] Chung Shan Med Univ Hosp, Dept Family & Community Med, Taichung, Taiwan; [Li, Yu-Fen] China Med Univ, Inst Biostat, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Chang, SY (corresponding author), Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan.	sychang@csmu.edu.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004, MOHW104-TDU-B-212-113002]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004) and (MOHW104-TDU-B-212-113002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghabiklooei A, 2013, PAK J PHARM SCI, V26, P1247; Allon N, 2005, TOXICOL SCI, V87, P385, DOI 10.1093/toxsci/kfi263; Allon N, 2011, TOXICOL APPL PHARM, V253, P31, DOI 10.1016/j.taap.2011.03.007; Barrios V, 2008, REV ESP CARDIOL, V61, P1159, DOI 10.1016/S1885-5857(09)60030-X; Ben Amara I, 2013, ENVIRON TOXICOL, V28, P630, DOI 10.1002/tox.20759; Bird S., 2014, UPTODATE, V14, P339; Blanc-Lapierre A, 2013, AM J EPIDEMIOL, V177, P1086, DOI 10.1093/aje/kws346; Bruyndonckx R B, 2002, Eur J Emerg Med, V9, P238, DOI 10.1097/00063110-200209000-00006; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Dayton SB, 2010, J OCCUP ENVIRON MED, V52, P693, DOI 10.1097/JOM.0b013e3181e66d25; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fukushima Hidetada, 2010, Chudoku Kenkyu, V23, P41; Furlong CE, 2007, J BIOCHEM MOL TOXIC, V21, P197, DOI 10.1002/jbt.20181; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Jayasinghe SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037987; Karki P., 2004, SMJ Singapore Medical Journal, V45, P385; London L, 1997, ENVIRON RES, V73, P132, DOI 10.1006/enrs.1997.3715; Lotti M, 2006, MUSCLE NERVE, V34, P499, DOI 10.1002/mus.20620; Lotti Marcello, 2005, Toxicol Rev, V24, P37, DOI 10.2165/00139709-200524010-00003; LUDOMIRSKY A, 1982, AM J CARDIOL, V49, P1654, DOI 10.1016/0002-9149(82)90242-9; Lyzhnikov E A, 1975, Kardiologiia, V15, P126; MCDONOUGH JH, 1995, NEUROTOXICOLOGY, V16, P123; Mills KT, 2009, AM J EPIDEMIOL, V170, P892, DOI 10.1093/aje/kwp214; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; Velmurugan G, 2013, TOXICOLOGY, V307, P103, DOI 10.1016/j.tox.2012.11.022; Voetsch B, 2002, STROKE, V33, P1459, DOI 10.1161/01.STR.0000016928.60995.BD; World Heart Federation, CARD DIS RISK FACT; Xiao ZJ, 2009, ACTA NEUROL BELG, V109, P205; Xiong XM, 2010, PROG BIOCHEM BIOPHYS, V37, P1232, DOI 10.3724/SP.J.1206.2010.00332; Yanagisawa N, 2006, J NEUROL SCI, V249, P76, DOI 10.1016/j.jns.2006.06.007; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	32	51	53	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137632	10.1371/journal.pone.0137632	http://dx.doi.org/10.1371/journal.pone.0137632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339906	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200072
J	Li, YQ; Beckman, KB; Caberto, C; Kazma, R; Lum-Jones, A; Haiman, CA; Le Marchand, L; Stram, DO; Saxena, R; Cheng, I				Li, Yuqing; Beckman, Kenneth B.; Caberto, Christian; Kazma, Remi; Lum-Jones, Annette; Haiman, Christopher A.; Le Marchand, Loic; Stram, Daniel O.; Saxena, Richa; Cheng, Iona			Association of Genes, Pathways, and Haplogroups of the Mitochondrial Genome with the Risk of Colorectal Cancer: The Multiethnic Cohort	PLOS ONE			English	Article							WIDE ASSOCIATION; DNA; MTDNA; VARIANT; RARE; INSTABILITY; TESTS; CELLS; SCAN; LOOP	The mitochondrial genome encodes for the synthesis of 13 proteins that are essential for the oxidative phosphorylation (OXPHOS) system. Inherited variation in mitochondrial genes may influence cancer development through changes in mitochondrial proteins, altering the OXPHOS process, and promoting the production of reactive oxidative species. To investigate the role of the OXPHOS pathway and mitochondrial genes in colorectal cancer (CRC) risk, we tested 185 mitochondrial SNPs (mtSNPs), located in 13 genes that comprise four complexes of the OXPHOS pathway and mtSNP groupings for rRNA and tRNA, in 2,453 colorectal cancer cases and 11,930 controls from the Multiethnic Cohort Study. Using the sequence kernel association test, we examined the collective set of 185 mtSNPs, as well as subsets of mtSNPs grouped by mitochondrial pathways, complexes, and genes, adjusting for age, sex, principal components of global ancestry, and self-reported maternal race/ethnicity. We also tested for haplogroup associations using unconditional logistic regression, adjusting for the same covariates. Stratified analyses were conducted by self-reported maternal race/ethnicity. In European Americans, a global test of all genetic variants of the mitochondrial genome identified an association with CRC risk (P = 0.04). In mtSNP-subset analysis, the NADH dehydrogenase 2 (MT-ND2) gene in Complex I was associated with CRC risk at a P-value of 0.001 (q = 0.015). In addition, haplogroup T was associated with CRC risk (OR = 1.66, 95% CI: 1.19-2.33, P = 0.003). No significant mitochondrial pathway and gene associations were observed in the remaining four racial/ethnic groups-African Americans, Asian Americans, Latinos, and Native Hawaiians. In summary, our findings suggest that variations in the mitochondrial genome and particularly in the MT-ND2 gene may play a role in CRC risk among European Americans, but not in other maternal racial/ethnic groups. Further replication is warranted and future studies should evaluate the contribution of mitochondrial proteins encoded by both the nuclear and mitochondrial genomes to CRC risk.	[Li, Yuqing; Cheng, Iona] Canc Prevent Inst Calif, Fremont, CA 94538 USA; [Li, Yuqing; Cheng, Iona] Stanford Canc Inst, Palo Alto, CA USA; [Beckman, Kenneth B.] Univ Minnesota, Genom Ctr, Minneapolis, MN USA; [Caberto, Christian; Lum-Jones, Annette; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Kazma, Remi] CEA, Ctr Natl Genotypage, Evry, France; [Kazma, Remi] Novartis Inst BioMed Res, Biomarker Dev, Basel, Switzerland; [Haiman, Christopher A.; Stram, Daniel O.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Saxena, Richa] Massachusetts Gen Hosp, Ctr Human Genet Res, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Saxena, Richa] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, England	Cancer Prevention Institute of California; Stanford Cancer Institute; University of Minnesota System; University of Minnesota Twin Cities; Cancer Research Center of Hawaii; University of Hawaii System; CEA; UDICE-French Research Universities; Universite Paris Saclay; Novartis; University of Southern California; Harvard University; Massachusetts General Hospital	Li, YQ (corresponding author), Canc Prevent Inst Calif, Fremont, CA 94538 USA.	sarahyuqing.li@cpic.org	Saxena, Richa/AAG-7279-2020		NCI [CA140636, CA173782, CA63464, CA54281, CA33619, CA164973, CA98758]; NATIONAL CANCER INSTITUTE [R37CA054281, R03CA173782, P30CA071789, R01CA063464, UM1CA164973, R01CA140636, R01CA054281, P01CA033619, U01CA098758, U01CA063464, U01CA164973] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded through NCI (CA140636, CA173782, CA63464, CA54281, CA33619, CA164973 and CA98758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, CANCER FACTS FIGURES; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cano, 2014, ISRN ONCOL, V2014, P530675, DOI DOI 10.1155/2014/530675; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Crimi Marco, 2002, Hum Mutat, V20, P409, DOI 10.1002/humu.9079; Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421; Feng S, 2012, MOL MED REP, V6, P125, DOI 10.3892/mmr.2012.870; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hervouet E, 2007, BIOCHIMIE, V89, P1080, DOI 10.1016/j.biochi.2007.03.010; Hu SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087795; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Kim SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047881; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Kujoth GC, 2008, EXP GERONTOL, V43, P20, DOI 10.1016/j.exger.2007.09.010; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lim SW, 2012, INT J CANCER, V131, P1332, DOI 10.1002/ijc.27375; Mitchell SL, 2014, HUM GENET, V133, P861, DOI 10.1007/s00439-014-1421-9; Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Simonnet H, 2002, CARCINOGENESIS, V23, P759, DOI 10.1093/carcin/23.5.759; Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang HS, 2010, HUM GENET, V128, P165, DOI 10.1007/s00439-010-0841-4; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O., 1930, METABOLISM TUMORS, P254; Webb E, 2008, BRIT J CANCER, V99, P2088, DOI 10.1038/sj.bjc.6604805; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	40	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136796	10.1371/journal.pone.0136796	http://dx.doi.org/10.1371/journal.pone.0136796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340450	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200017
J	Otto, IA; Kon, M; Schuurman, AH; van Minnen, LP				Otto, Iris A.; Kon, Moshe; Schuurman, Arnold H.; van Minnen, L. Paul			Replantation versus Prosthetic Fitting in Traumatic Arm Amputations: A Systematic Review	PLOS ONE			English	Review							UPPER EXTREMITY REPLANTATION; UPPER-LIMB; MAJOR REPLANTATION; FOREARM; REHABILITATION; REVASCULARIZATION; REIMPLANTATION; IMMEDIATE; INJURIES	Background Traumatic arm amputations can be treated with replantation or surgical formalization of the stump with or without subsequent prosthetic fitting. In the literature, many authors suggest the superiority of replantation. This systematic review compared available literature to analyze whether replantation is functionally and psychologically more profitable than formalization and prosthetic fitting in patients with traumatic arm amputation. Methods Functional outcome and satisfaction levels were recorded of patients with amputation levels below elbow, through elbow, and above elbow. Results Functional outcomes of 301 replantation patients and 172 prosthesis patients were obtained. In the replantation group, good or excellent functional scores were reported in 39% of above elbow, 55% of through elbow, and 50% of below elbow amputation cases. Nearly 100% of patients were satisfied with the replanted limb. In the prosthesis group, full use of the prosthesis was attained in 48% of above elbow and in 89% of below elbow amputation patients. Here, 29% of patients elected not to use the prosthesis for reasons including pain and functional superfluity. In both replantation patients and prosthesis wearers, a below elbow amputation yielded better functional results than higher amputation levels. Conclusions Replantation of a traumatically amputated arm leads to good function and higher satisfaction rates than a prosthesis, regardless of the objective functional outcome. Sensation and psychological well-being seem the two major advantages of replantation over a prosthesis. The current review of the available literature shows that in carefully selected cases replantation could be the preferred option of treatment.	[Otto, Iris A.; Kon, Moshe; Schuurman, Arnold H.; van Minnen, L. Paul] Univ Med Ctr Utrecht, Dept Plast Reconstruct & Hand Surg, Utrecht, Netherlands; [Schuurman, Arnold H.] Hand Clin, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center	Otto, IA (corresponding author), Univ Med Ctr Utrecht, Dept Plast Reconstruct & Hand Surg, Utrecht, Netherlands.	i.a.otto@umcutrecht.nl						Atkins SE, 2008, CURR ORTHOPAED, V22, P31, DOI 10.1016/j.cuor.2008.02.001; Atzei A, 2005, MICROSURG, V25, P293, DOI 10.1002/micr.20131; AXELROD TS, 1991, J HAND SURG-AM, V16A, P574, DOI 10.1016/0363-5023(91)90176-C; Battiston B, 2007, J PLAST RECONSTR AES, V60, P849, DOI 10.1016/j.bjps.2007.02.017; Beaton D E, 2001, J Hand Ther, V14, P128; Bhaskaranand K, 2003, ARCH ORTHOP TRAUM SU, V123, P363, DOI 10.1007/s00402-003-0546-4; BURKHALTER WE, 1976, J BONE JOINT SURG AM, V58, P46, DOI 10.2106/00004623-197658010-00008; CHEN SHT, 1991, PLAST RECONSTR SURG, V87, P346, DOI 10.1097/00006534-199102000-00019; CHOW JA, 1983, ANN PLAS SURG, V10, P15, DOI 10.1097/00000637-198301000-00004; Chung-Wei C, 1978, World J Surg, V2, P513; DADDATO M, 1989, J TRAUMA, V29, P876, DOI 10.1097/00005373-198906000-00029; Dagum Alexander B, 2007, Tech Hand Up Extrem Surg, V11, P231, DOI 10.1097/bth.0b013e318070c716; Datta D, 2004, CLIN REHABIL, V18, P172, DOI 10.1191/0269215504cr716oa; Davidson Judith, 2002, J Hand Ther, V15, P62, DOI 10.1016/S0894-1130(02)50011-9; GOLD AH, 1981, J TRAUMA, V21, P551, DOI 10.1097/00005373-198107000-00009; Graham B, 1998, J HAND SURG-AM, V23A, P783, DOI 10.1016/S0363-5023(98)80151-2; Graham L, 2006, DISABIL REHABIL, V28, P797, DOI 10.1080/09638280500386742; Gulgonen A, 2012, J HAND SURG-EUR VOL, V37E, P225, DOI 10.1177/1753193411427228; HARVEY JP, 1974, CLIN ORTHOP RELAT R, P167; Hierner R, 2005, EUR J PLAST SURG, V28, P119, DOI 10.1007/s00238-005-0733-3; Ignatiadis IA, 2008, MICROSURG, V28, P131, DOI 10.1002/micr.20464; Jablecki J, 2009, TRANSPL P, V41, P513, DOI 10.1016/j.transproceed.2009.01.006; JACKSON A, 1992, SKELETAL RADIOL, V21, P155; JACOBS RR, 1975, J TRAUMA, V15, P966, DOI 10.1097/00005373-197511000-00004; Koul AR, 2004, PLAST RECONSTR SURG, V113, P1734, DOI 10.1097/01.PRS.0000117369.43393.98; Laing TA, 2012, J PLAST RECONSTR AES, V65, P931, DOI 10.1016/j.bjps.2012.01.012; Leclere FM, 2012, ARCH ORTHOP TRAUM SU, V132, P1797, DOI 10.1007/s00402-012-1590-8; Lerman JA, 2005, J PEDIATR ORTHOPED, V25, P405, DOI 10.1097/01.bpo.0000149866.80894.70; MALT RA, 1964, JAMA-J AM MED ASSOC, V189, P716; MALT RA, 1972, ANN SURG, V176, P334; Matsuda M, 1978, World J Surg, V2, P603; MATSUDA M, 1981, J TRAUMA, V21, P403, DOI 10.1097/00005373-198105000-00014; May J W Jr, 1980, Curr Probl Surg, V17, P633; Messinger SD, 2009, DISABIL REHABIL, V31, P2130, DOI [10.3109/09638280902943223, 10.3109/09638280902943223a]; MORTON JH, 1969, J TRAUM, V9, P3, DOI 10.1097/00005373-196901000-00001; NASSERI M, 1973, ANN SURG, V177, P121, DOI 10.1097/00000658-197301000-00021; Nguyen TH, 2009, J TRAUMA, V66, P1167, DOI 10.1097/TA.0b013e318173f846; NYE JE, 1982, HAND, V14, P25, DOI 10.1016/S0072-968X(82)80034-X; OBRIEN BM, 1974, HAND, V6, P217, DOI 10.1016/0072-968X(74)90030-8; Peacock K, 1985, CLIN ORTHOP RELAT R, V214, P153; Pezzin LE, 2004, ARCH PHYS MED REHAB, V85, P723, DOI 10.1016/j.apmr.2003.06.002; PINZUR MS, 1994, J HAND SURG-AM, V19A, P836, DOI 10.1016/0363-5023(94)90197-X; Raichle KA, 2008, J REHABIL RES DEV, V45, P961, DOI 10.1682/JRRD.2007.09.0151; RICH RH, 1977, J PEDIATR SURG, V12, P1027, DOI 10.1016/0022-3468(77)90615-7; RUSSELL RC, 1984, J HAND SURG-AM, V9A, P623, DOI 10.1016/S0363-5023(84)80001-5; Sabapathy SR, 2007, J HAND SURG-EUR VOL, V32E, P488, DOI 10.1016/j.jhse.2007.06.013; Saradjan A, 2008, DISABIL REHABIL, V30, P871, DOI 10.1080/09638280701427386; Sorensen K, 2009, TRAUMA, V11, P209, DOI 10.1177/1460408609349889; STURUP J, 1988, PROSTHET ORTHOT INT, V12, P50; Sugun TS, 2009, ACTA ORTHOP TRAUMATO, V43, P206, DOI 10.3944/AOTT.2009.206; Tamai S, 1979, World J Surg, V3, P17; Tintle SM, 2010, J BONE JOINT SURG AM, V92A, P2934, DOI [10.2106/JBJSJ.00258, 10.2106/JBJS.J.00258]; TROUM S, 1995, AM SURGEON, V61, P836; Waikakul S, 1998, J BONE JOINT SURG BR, V80B, P1024, DOI 10.1302/0301-620X.80B6.8761; WRIGHT TW, 1995, J HAND SURG-AM, V20A, P619, DOI 10.1016/S0363-5023(05)80278-3; ZUKER RM, 1988, J TRAUMA, V28, P544, DOI 10.1097/00005373-198804000-00024	56	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137729	10.1371/journal.pone.0137729	http://dx.doi.org/10.1371/journal.pone.0137729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340003	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200073
J	Perry, LK; Perlman, M; Lupyan, G				Perry, Lynn K.; Perlman, Marcus; Lupyan, Gary			Iconicity in English and Spanish and Its Relation to Lexical Category and Age of Acquisition	PLOS ONE			English	Article							SOUND-SYMBOLISM; SIGN-LANGUAGE; WINDOW	Signed languages exhibit iconicity (resemblance between form and meaning) across their vocabulary, and many non-Indo-European spoken languages feature sizable classes of iconic words known as ideophones. In comparison, Indo-European languages like English and Spanish are believed to be arbitrary outside of a small number of onomatopoeic words. In three experiments with English and two with Spanish, we asked native speakers to rate the iconicity of similar to 600 words from the English and Spanish MacArthur-Bates Communicative Developmental Inventories. We found that iconicity in the words of both languages varied in a theoretically meaningful way with lexical category. In both languages, adjectives were rated as more iconic than nouns and function words, and corresponding to typological differences between English and Spanish in verb semantics, English verbs were rated as relatively iconic compared to Spanish verbs. We also found that both languages exhibited a negative relationship between iconicity ratings and age of acquisition. Words learned earlier tended to be more iconic, suggesting that iconicity in early vocabulary may aid word learning. Altogether these findings show that iconicity is a graded quality that pervades vocabularies of even the most "arbitrary" spoken languages. The findings provide compelling evidence that iconicity is an important property of all languages, signed and spoken, including Indo-European languages.	[Perry, Lynn K.] Univ Miami, Coral Gables, FL 33124 USA; [Perlman, Marcus; Lupyan, Gary] Univ Wisconsin, Madison, WI USA	University of Miami; University of Wisconsin System; University of Wisconsin Madison	Perry, LK (corresponding author), Univ Miami, Coral Gables, FL 33124 USA.	lkp36@miami.edu	Perlman, Marcus/K-6972-2018	Perlman, Marcus/0000-0002-1269-3882; Lupyan, Gary/0000-0001-8441-7433; Perry, Lynn/0000-0001-6976-3741	National Science Foundation, Integrated NSF Support Promoting Interdisciplinary Research and Education (INSPIRE) [1344279]; Division Of Behavioral and Cognitive Sci [1344279] Funding Source: National Science Foundation	National Science Foundation, Integrated NSF Support Promoting Interdisciplinary Research and Education (INSPIRE); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Funding was provided by the National Science Foundation, Integrated NSF Support Promoting Interdisciplinary Research and Education (INSPIRE) Award 1344279 awarded to GL.	Ahlner F., 2010, SIGN SYST STUD, V38, P298, DOI [10.12697/SSS.2010.38.1-4.11, DOI 10.12697/SSS.2010.38.1-4.11]; Armstrong D.F., 2007, GESTURAL ORIGIN LANG; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Beavers J, 2010, J LINGUIST, V46, P331, DOI 10.1017/S0022226709990272; Bentley M, 1933, AM J PSYCHOL, V45, P76, DOI 10.2307/1414187; Bergen BK, 2004, LANGUAGE, V80, P290, DOI 10.1353/lan.2004.0056; Berlin B, 1994, EVIDENCE PERVASIVE S, P76, DOI DOI 10.1017/CBO9780511751806.006; BROWN R W, 1955, J Abnorm Psychol, V50, P388, DOI 10.1037/h0046820; Cuskley C, OXFORD HDB SYNAESTHE, P869; Cuskley C., 2013, PUBLIC J SEMIOTICS, V5, P39, DOI DOI 10.37693/pjos.2013.5.9651; Davies Mark, 2017, FREQUENCY DICT SPANI; Diffloth G., 1972, 8 REG M CHIC LING SO, P440; Dingemanse M, TRENDS COGN IN PRESS; Dingemanse M, 2014, PRAGMAT SOC, V5, P384, DOI 10.1075/ps.5.3.04din; Dingemanse M, 2012, LANG LINGUIST COMPAS, V6, P654, DOI 10.1002/lnc3.361; Farmer TA, 2006, P NATL ACAD SCI USA, V103, P12203, DOI 10.1073/pnas.0602173103; FENSON L, 1994, MONOGR SOC RES CHILD, V59, pR5; FRISHBERG N, 1975, LANGUAGE, V51, P696, DOI 10.2307/412894; GEBELS G, 1969, J VERB LEARN VERB BE, V8, P310, DOI 10.1016/S0022-5371(69)80083-6; HOCKETT CF, 1978, AM SPEECH, V53, P243, DOI 10.2307/455140; HOCKETT CF, 1960, SCI AM, V203, P88, DOI 10.1038/scientificamerican0960-88; Imai M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0298; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; Jackson-Maldonado D, 2003, USERS GUIDE TECHNICA; Jorgensen RN, 2010, J CHILD LANG, V37, P419, DOI 10.1017/S0305000909009544; Kantartzis K, 2011, COGNITIVE SCI, V35, P575, DOI 10.1111/j.1551-6709.2010.01169.x; La Polla R., 1994, SOUND SYMBOLISM; Lupyan G, 2015, LANG COGN, V7, P167, DOI 10.1017/langcog.2014.21; Masuda K., 2007, INSISTENT IMAGES, V5, P57; Monaghan P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0299; Nielsen A, 2012, LANG COGN, V4, P115, DOI 10.1515/langcog-2012-0007; Nuckolls JanisB., 2003, P 11 ANN S LANG SOC; Nygaard LC, 2009, COGNITIVE SCI, V33, P127, DOI 10.1111/j.1551-6709.2008.01007.x; Padden C, 2013, GESTURE, V13, P287, DOI 10.1075/gest.13.3.03pad; Perlman M., 2014, COGN SCI; Perlman M, GESTURE IN PRESS; Perniss P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0300; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; Plato, 1999, CRATYLUS; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Reppen R., 2005, AM NATL CORPUS ANC 2; Saussure F. de., 1983, COURSE GEN LINGUISTI; Shintel H, 2006, J MEM LANG, V55, P167, DOI 10.1016/j.jml.2006.03.002; Signs Morris C., 2011, LANGUAGE BEHAV; Strickland B, 2015, P NATL ACAD SCI USA, V112, P5968, DOI 10.1073/pnas.1423080112; TANZ C, 1971, LANG SPEECH, V14, P266, DOI 10.1177/002383097101400307; Taub S.F., 2001, LANGUAGE BODY ICONIC; Thompson RL, 2012, PSYCHOL SCI, V23, P1443, DOI 10.1177/0956797612459763; Tomasello M, 2008, JEAN NICOD LECT, P1; Ultan R., 1978, SIZE SOUND SYMBOLISM; Urban M, 2011, FOLIA LINGUIST, V45, P199, DOI 10.1515/FLIN.2011.007; Vigliocco G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0292; Vinson DP, 2008, BEHAV RES METHODS, V40, P1079, DOI 10.3758/BRM.40.4.1079; Voeltz F.K. Erhard, 2001, IDEOPHONES; Wilcox S., 2009, ANN REV COGN LING, V7, P89, DOI [DOI 10.1075/ARCL.7.04WIL, 10.1075/arcl.7.04wil]; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Yoshida H, 2012, J COGN DEV, V13, P232, DOI 10.1080/15248372.2011.573515	57	95	95	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137147	10.1371/journal.pone.0137147	http://dx.doi.org/10.1371/journal.pone.0137147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CQ6BA	26340349	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200026
J	Jung, YY; Kim, HM; Koo, JS				Jung, Yoon Yang; Kim, Hye Min; Koo, Ja Seung			Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer	PLOS ONE			English	Article							ACID SYNTHASE INHIBITION; ESTROGEN-RECEPTOR; DUCTAL CARCINOMA; BRAIN METASTASES; HIGH-RISK; RECURRENT; THERAPY; ENERGY	Purpose The tumor biology of metastatic breast cancers differ according to the metastatic sites, and the features of cancer metabolism may also be different. The aim of this study is to investigate the expression of lipid metabolism-related proteins in metastatic breast cancer according to metastatic site and discuss the clinical significance thereof. Methods Immunohistochemical staining for lipid metabolism-related proteins [fatty acid synthase (FASN), hormone-sensitive lipase (HSL), carnitine palmitoyltransferase IA (CPT-1A), acyl-CoA oxidase 1 (ACOX1), fatty acid binding protein 4 (FABP4,) and perilipin 1 (PLIN1)] was performed using a tissue microarray of 149 cases of metastatic breast cancer (bone metastasis = 39, brain metastasis = 37, liver metastasis = 21, and lung metastasis = 52). Results The expression levels of ACOX1 (p = 0.009) and FASN (p = 0.007) varied significantly according to metastatic site, with the highest expression in brain metastasis and the lowest expression in liver metastasis. ACOX1 positivity (p = 0.005) and FASN positivity (p = 0.003) correlated with HER-2 positivity. The expression of FASN was significantly higher in HER-2 type breast cancer, and lower in luminal A and TNBC type breast cancer (p<0.001). Among lipid metabolism-related proteins, PLIN1 positivity was found to be an independent poor prognostic factor on multivariate analysis (Hazard ratio: 4.979, 95% CI: 1.054-22.59, p = 0.043). Conclusion Different expression levels of lipid metabolism-related proteins were observed according to metastatic site. The expression of ACOX1 and FASN was highest in brain metastasis. These results suggest that the metastatic site should be considered when using lipid metabolism inhibitors for targeted therapy.	[Jung, Yoon Yang; Kim, Hye Min; Koo, Ja Seung] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	Yonsei University; Yonsei University Health System	Koo, JS (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.	kjs1976@yuhs.ac	JUNG, YOON YANG/T-3655-2019	Kim, Hye Min/0000-0002-2899-9480; koo, ja seung/0000-0003-4546-4709	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1420080]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2015R1A1A1A05001209]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1420080). This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2015R1A1A1A05001209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abali H, 2002, AM J CLIN ONCOL-CANC, V25, P632, DOI 10.1097/00000421-200212000-00023; Agoff SN, 2003, AM J CLIN PATHOL, V120, P725, DOI 10.1309/42F00D0DJD0J5EDT; Albiges L, 2005, ANN ONCOL, V16, P1846, DOI 10.1093/annonc/mdi351; ALLRED DC, 1992, J CLIN ONCOL, V10, P599, DOI 10.1200/JCO.1992.10.4.599; Arnold SM, 1999, CLIN CANCER RES, V5, P4028; Colleoni M, 2000, J CLIN ONCOL, V18, P3925, DOI 10.1200/JCO.2000.18.23.3925; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Evans AJ, 2004, CLIN ONCOL-UK, V16, P345, DOI 10.1016/j.clon.2004.03.012; Gaedcke J, 2007, MODERN PATHOL, V20, P864, DOI 10.1038/modpathol.3800830; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gomez-Fernandez C, 2008, AM J CLIN PATHOL, V130, P879, DOI 10.1309/AJCPD1AO3YSYQYNW; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hasebe T, 2008, HUM PATHOL, V39, P681, DOI 10.1016/j.humpath.2007.09.012; Hicks DG, 2006, AM J SURG PATHOL, V30, P1097; Jin QR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2777; Jones C, 2001, BRIT J CANCER, V85, P422, DOI 10.1054/bjoc.2001.1869; Kim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119473; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kuukasjarvi T, 1996, J CLIN ONCOL, V14, P2584, DOI 10.1200/JCO.1996.14.9.2584; Lee JS, 2013, PHYTOTHER RES, V27, P713, DOI 10.1002/ptr.4778; Lorincz T, 2006, PATHOL ONCOL RES, V12, P149; Luo DX, 2012, RECENT PAT ANTI-CANC, V7, P168, DOI 10.2174/157489212799972918; Lupu R, 2006, CURR PHARM BIOTECHNO, V7, P483, DOI 10.2174/138920106779116928; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Pucer A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-111; Puig T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3077; RASMUSSEN BB, 1989, PATHOL RES PRACT, V185, P856, DOI 10.1016/S0344-0338(89)80286-9; Schonfeld P, 2013, J CEREBR BLOOD F MET, V33, P1493, DOI 10.1038/jcbfm.2013.128; Thupari JN, 2001, BIOCHEM BIOPH RES CO, V285, P217, DOI 10.1006/bbrc.2001.5146; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wei B, 2008, HUM PATHOL, V39, P1809, DOI 10.1016/j.humpath.2008.05.010; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Won KY, 2010, HUM PATHOL, V41, P107, DOI 10.1016/j.humpath.2009.07.006; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Yang Ming, 2013, Zhonghua Bing Li Xue Za Zhi, V42, P257, DOI 10.3760/cma.j.issn.0529-5807.2013.04.010; Zidan J, 2005, BRIT J CANCER, V93, P552, DOI 10.1038/sj.bjc.6602738	38	22	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137204	10.1371/journal.pone.0137204	http://dx.doi.org/10.1371/journal.pone.0137204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334757	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400045
J	Tang, EYH; Harrison, SL; Errington, L; Gordon, MF; Visser, PJ; Novak, G; Dufouil, C; Brayne, C; Robinson, L; Launer, LJ; Stephan, BCM				Tang, Eugene Y. H.; Harrison, Stephanie L.; Errington, Linda; Gordon, Mark F.; Visser, Pieter Jelle; Novak, Gerald; Dufouil, Carole; Brayne, Carol; Robinson, Louise; Launer, Lenore J.; Stephan, Blossom C. M.			Current Developments in Dementia Risk Prediction Modelling: An Updated Systematic Review	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEUROPSYCHOLOGICAL TESTS; POPULATION; SCORE; INDIVIDUALS	Background Accurate identification of individuals at high risk of dementia influences clinical care, inclusion criteria for clinical trials and development of preventative strategies. Numerous models have been developed for predicting dementia. To evaluate these models we undertook a systematic review in 2010 and updated this in 2014 due to the increase in research published in this area. Here we include a critique of the variables selected for inclusion and an assessment of model prognostic performance. Methods Our previous systematic review was updated with a search from January 2009 to March 2014 in electronic databases (MEDLINE, Embase, Scopus, Web of Science). Articles examining risk of dementia in non-demented individuals and including measures of sensitivity, specificity or the area under the curve (AUC) or c-statistic were included. Findings In total, 1,234 articles were identified from the search; 21 articles met inclusion criteria. New developments in dementia risk prediction include the testing of non-APOE genes, use of non-traditional dementia risk factors, incorporation of diet, physical function and ethnicity, and model development in specific subgroups of the population including individuals with diabetes and those with different educational levels. Four models have been externally validated. Three studies considered time or cost implications of computing the model. Interpretation There is no one model that is recommended for dementia risk prediction in population-based settings. Further, it is unlikely that one model will fit all. Consideration of the optimal features of new models should focus on methodology (setting/sample, model development and testing in a replication cohort) and the acceptability and cost of attaining the risk variables included in the prediction score. Further work is required to validate existing models or develop new ones in different populations as well as determine the ethical implications of dementia risk prediction, before applying the particular models in population or clinical settings.	[Tang, Eugene Y. H.; Harrison, Stephanie L.; Robinson, Louise; Stephan, Blossom C. M.] Newcastle Univ, Inst Ageing, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Errington, Linda] Newcastle Univ, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Gordon, Mark F.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Visser, Pieter Jelle] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Visser, Pieter Jelle] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Alzheimer Ctr, Amsterdam, Netherlands; [Novak, Gerald] Janssen Pharmaceut Res & Dev, Titusville, NJ 08560 USA; [Dufouil, Carole] Team Neuroepidemiol, INSERM, U897, Res Ctr, F-33000 Bordeaux, France; [Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; [Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA	Newcastle University - UK; Newcastle University - UK; Boehringer Ingelheim; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Johnson & Johnson; Janssen Pharmaceuticals; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Tang, EYH (corresponding author), Newcastle Univ, Inst Ageing, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	e.y.h.tang@newcastle.ac.uk	Brayne, Carol/AAA-4285-2020; Dufouil, Carole/J-4968-2012; Visser, Pieter Jelle/S-5242-2019; Visser, Pieter J/C-8541-2015; Errington, Linda/R-5281-2018; Dufouil, Carole/F-5751-2014	Brayne, Carol/0000-0001-5307-663X; Visser, Pieter Jelle/0000-0001-8008-9727; Visser, Pieter J/0000-0001-8008-9727; Errington, Linda/0000-0002-1375-0033; Dufouil, Carole/0000-0003-2442-4476; Harrison, Stephanie/0000-0002-8846-0946; Robinson, Louise/0000-0003-0209-2503; Tang, Eugene/0000-0003-1030-9311	NIHR Academic Clinical Fellowship; Innovative Medicines Initiative Joint Undertaking under EMIF grant [115372]; European Union; EFPIA companies; Intramural research Program of the NIH, National institute on Aging; National Institute for Health Research [NF-SI-0611-10084, NIHR-RP-011-043, ACF-2012-01-012] Funding Source: researchfish	NIHR Academic Clinical Fellowship; Innovative Medicines Initiative Joint Undertaking under EMIF grant; European Union(European Commission); EFPIA companies; Intramural research Program of the NIH, National institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Health Research(National Institute for Health Research (NIHR))	Tang EYH is supported by an NIHR Academic Clinical Fellowship. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under EMIF grant agreement no. 115372, resources of which are composed of financial contributions from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. This research (LJL) was also supported in part by the Intramural research Program of the NIH, National institute on Aging. The funders had no role in the writing of the manuscript or decision to submit it for publication.	Anstey KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086141; Anstey KJ, 2013, PREV SCI, V14, P411, DOI 10.1007/s11121-012-0313-2; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; Barnes DE, 2014, ALZHEIMERS DEMENT, V10, P656, DOI 10.1016/j.jalz.2013.11.006; Barnes DE, 2010, ALZHEIMERS DEMENT, V6, P138, DOI 10.1016/j.jalz.2010.01.005; Board NC, 2013, FAC TIM DIAGN SUPP P; Chary E, 2013, ALZHEIMERS DEMENT, V9, P562, DOI 10.1016/j.jalz.2012.05.2188; Derby CA, 2013, NEUROLOGY, V80, P1307, DOI 10.1212/WNL.0b013e31828ab2c9; Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0; Ehreke L, 2011, DEMENT GERIATR COGN, V31, P89, DOI 10.1159/000323317; Exalto LG, 2014, ALZHEIMERS DEMENT, V10, P562, DOI 10.1016/j.jalz.2013.05.1772; Exalto LG, 2013, LANCET DIABETES ENDO, V1, P183, DOI 10.1016/S2213-8587(13)70048-2; Grober E, 2010, ALZ DIS ASSOC DIS, V24, P284, DOI 10.1097/WAD.0b013e3181cfc78b; Higgins JPT, 2009, COCHRANE HDB SYSTEMA, Vxxi; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jessen F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016852; Jorm AF, 2005, J AM GERIATR SOC, V53, P452, DOI 10.1111/j.1532-5415.2005.53163.x; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Madureira S, 2010, DEMENT GERIATR COGN, V29, P325, DOI 10.1159/000278333; Martin-Ponce E, 2010, CLIN NUTR, V29, P501, DOI 10.1016/j.clnu.2009.12.009; Mitnitski A, 2006, EUR J NEUROL, V13, P514, DOI 10.1111/j.1468-1331.2006.01297.x; Mossaheb N, 2012, J CLIN PSYCHIAT, V73, P1009, DOI 10.4088/JCP.11m06962; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Ohara T, 2011, J AM GERIATR SOC, V59, P1074, DOI 10.1111/j.1532-5415.2011.03405.x; Okereke OI, 2012, ALZ DIS ASSOC DIS, V26, P225, DOI 10.1097/WAD.0b013e318231cd30; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P835, DOI 10.1001/archneurol.2010.136; Restaino M, 2013, AGE AGEING, V42, P649, DOI 10.1093/ageing/aft082; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sheikhtaheri A, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0110-5; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Song Xiaowei, 2011, Neurology, V77, P227, DOI 10.1212/WNL.0b013e318225c6bc; Stephan BCM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2863; Stephan BCM, 2010, NAT REV NEUROL, V6, P318, DOI 10.1038/nrneurol.2010.54; Tierney MC, 2010, J ALZHEIMERS DIS, V22, P1231, DOI 10.3233/JAD-2010-100516; Tierney MC, 2005, NEUROLOGY, V64, P1853, DOI 10.1212/01.WNL.0000163773.21794.0B; Verhaaren BFJ, 2013, BIOL PSYCHIAT, V73, P429, DOI 10.1016/j.biopsych.2012.04.009; Wells G.A., NEWCASTLE OTTAWA SCA; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolfsgruber S, 2014, AM J GERIAT PSYCHIAT, V22, P1017, DOI 10.1016/j.jagp.2012.08.021	40	97	98	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136181	10.1371/journal.pone.0136181	http://dx.doi.org/10.1371/journal.pone.0136181			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334524	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400011
J	Alkenbrack, S; Chaitkin, M; Zeng, W; Couture, T; Sharma, S				Alkenbrack, Sarah; Chaitkin, Michael; Zeng, Wu; Couture, Taryn; Sharma, Suneeta			Did Equity of Reproductive and Maternal Health Service Coverage Increase during the MDG Era? An Analysis of Trends and Determinants across 74 Low- and Middle-Income Countries	PLOS ONE			English	Article							CHILD HEALTH; SOCIAL DETERMINANTS; INEQUALITIES; CARE; INTERVENTIONS; MORTALITY; COUNTDOWN; NEWBORN	Introduction Despite widespread gains toward the 5th Millennium Development Goal (MDG), pro-rich inequalities in reproductive health (RH) and maternal health (MH) are pervasive throughout the world. As countries enter the post-MDG era and strive toward UHC, it will be important to monitor the extent to which countries are achieving equity of RH and MH service coverage. This study explores how equity of service coverage differs across countries, and explores what policy factors are associated with a country's progress, or lack thereof, toward more equitable RH and MH service coverage. Methods We used RH and MH service coverage data from Demographic and Health Surveys (DHS) for 74 countries to examine trends in equity between countries and over time from 1990 to 2014. We examined trends in both relative and absolute equity, and measured relative equity using a concentration index of coverage data grouped by wealth quintile. Through multivariate analysis we examined the relative importance of policy factors, such as political commitment to health, governance, and the level of prepayment, in determining countries' progress toward greater equity in RH and MH service coverage. Results Relative equity for the coverage of RH and MH services has continually increased across all countries over the past quarter century; however, inequities in coverage persist, in some countries more than others. Multivariate analysis shows that higher education and greater political commitment (measured as the share of government spending allocated to health) were significantly associated with higher equity of service coverage. Neither country income, i.e., GDP per capita, nor better governance were significantly associated with equity. Conclusion Equity in RH and MH service coverage has improved but varies considerably across countries and over time. Even among the subset of countries that are close to achieving the MDGs, progress made on equity varies considerably across countries. Enduring disparities in access and outcomes underpin mounting support for targeted reforms within the broader context of universal health coverage (UHC).	[Alkenbrack, Sarah; Chaitkin, Michael; Zeng, Wu; Couture, Taryn; Sharma, Suneeta] Futures Grp Inc, Hlth Policy Project, Ctr Policy & Advocacy, Washington, DC 20004 USA		Couture, T (corresponding author), Futures Grp Inc, Hlth Policy Project, Ctr Policy & Advocacy, Washington, DC 20004 USA.	TCouture@futuresgroup.com	Chaitkin, Michael/AAE-4206-2022	Chaitkin, Michael/0000-0002-9368-7651; Zeng, Wu/0000-0002-3473-3638	Health Policy Project (USAID) [AIDOAA-A-10-00067]; Futures Group	Health Policy Project (USAID)(United States Agency for International Development (USAID)); Futures Group	This research was conducted with funds from the Health Policy Project (USAID Agreement No. AIDOAA-A-10-00067). Sarah Alkenbrack, Wu Zeng, Taryn Couture and Suneeta Sharma were employed by Health Policy Project, Center for Policy and Advocacy, Futures Group during the course of the study. Futures Group provided support in the form of salaries for authors SA, WZ, TC and SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2008, ANAL HLTH EQUITY USI; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Blas E, 2008, LANCET, V372, P1684, DOI 10.1016/S0140-6736(08)61693-1; Buisman L. R, 2014, 6894 WORLD BANK; Couttolenc B, 2013, 74957 WORLD BANK; CREESE AL, 1991, HEALTH POLICY PLANN, V6, P309, DOI 10.1093/heapol/6.4.309; De Allegri M, 2009, TROP MED INT HLTH; Dingle A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-51; Diop F, 2007, BROOKINGS GLOBAL; Ekman B, 2004, HEALTH POLICY PLANN, V19, P249, DOI 10.1093/heapol/czh031; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; Gwatkin DR, 2011, LANCET, V377, P2160, DOI 10.1016/S0140-6736(10)62058-2; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Joint FAO/WHO Expert Committee on Food Additives, 2006, World Health Organ Tech Rep Ser, V930, P1; Khadr Z, 2012, PUBLIC HLTH ARAB OW; Lagarde M, 2008, B WORLD HEALTH ORGAN, V86, P839, DOI 10.2471/BLT.07.049197; Lewis M, 2006, MILLENNIUM DEV GOALS; Logie DE, 2008, LANCET, V372, P256, DOI 10.1016/S0140-6736(08)60962-9; Makaka A, 2012, LANCET S2, V380, pS7, DOI DOI 10.1016/S0140-6736(13)60293-7; Malqvist M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066453; Marmot M., 2010, THE MARMOT REVIEW; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; McKinnon B, 2014, LANCET GLOB HEALTH, V2, pE165, DOI 10.1016/S2214-109X(14)70008-7; Nanda P, REPROD HLTH MATTERS, V10, P127; Rajkumar A.S, 2002, PUBLIC SPEIDNGIN OUT; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Ruiz-Rodriguez M, HLTH POLICY, V90, P149; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Thomsen S, 2011, REPROD HEALTH MATTER, V19, P176, DOI 10.1016/S0968-8080(11)38586-2; UNFPA, 1995, REP INT C POP DEV; United Nations, 2014, MILL DEV OGALS; USAID, DAT DEM HLTH; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wagstaff A, 2004, MILLENNIUM DEV GOALS; WHO, 2007, STADN MAT NEON CAR; WHO, 2014, DAT GLOB HLTH EXP; World Bank, DAT WORLDW GOV IND; World Bank, DATA WORLD EV; World Health Organization (WHO), 2014, DATGLOB HLTH ONBS; Yuan BB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-634; Zeng W, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-74	47	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134905	10.1371/journal.pone.0134905	http://dx.doi.org/10.1371/journal.pone.0134905			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331846	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800014
J	Robitaille, J; Chen, JK; Jolicoeur, M				Robitaille, Julien; Chen, Jingkui; Jolicoeur, Mario			A Single Dynamic Metabolic Model Can Describe mAb Producing CHO Cell Batch and Fed-Batch Cultures on Different Culture Media	PLOS ONE			English	Article							FLUX BALANCE ANALYSIS; ANTIBODY-PRODUCTION; IN-SILICO; DESIGN; GROWTH; KINASE; STATE	CHO cell culture high productivity relies on optimized culture medium management under fed-batch or perfused chemostat strategies enabling high cell densities. In this work, a dynamic metabolic model for CHO cells was further developed, calibrated and challenged using datasets obtained under four different culture conditions, including two batch and two fed-batch cultures comparing two different culture media. The recombinant CHO-DXB11 cell line producing the EG2-hFc monoclonal antibody was studied. Quantification of extracellular substrates and metabolites concentration, viable cell density, monoclonal antibody concentration and intracellular concentration of metabolite intermediates of glycolysis, pentose-phosphate and TCA cycle, as well as of energetic nucleotides, were obtained for model calibration. Results suggest that a single model structure with a single set of kinetic parameter values is efficient at simulating viable cell behavior in all cases under study, estimating the time course of measured and non-measured intracellular and extracellular metabolites. Model simulations also allowed performing dynamic metabolic flux analysis, showing that the culture media and the fed-batch strategies tested had little impact on flux distribution. This work thus paves the way to an in silico platform allowing to assess the performance of different culture media and fed-batch strategies.	[Robitaille, Julien; Chen, Jingkui; Jolicoeur, Mario] Ecole Polytech, Dept Chem Engn, Res Lab Appl Metab Engn, Montreal, PQ H3C 3A7, Canada	Universite de Montreal; Polytechnique Montreal	Jolicoeur, M (corresponding author), Ecole Polytech, Dept Chem Engn, Res Lab Appl Metab Engn, CP 6079,Ctr Ville Stn, Montreal, PQ H3C 3A7, Canada.	mario.jolicoeur@polymtl.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Network Grant program [NETGP380070-08]; Canada Research Chair program [950-201896]; Monoclonal Antibody Network (MabNet)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Network Grant program; Canada Research Chair program(Canada Research Chairs); Monoclonal Antibody Network (MabNet)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Research Network Grant program, grant no. NETGP380070-08 [http://www.nserc-crsng.gc.ca/]; the Canada Research Chair program, grant no. 950-201896 [http://www.chairschaires.gc.ca/home-accueil-fra.aspx], and the Monoclonal Antibody Network (MabNet). The funders had no role in that research.	Agrawal Vishal, 2012, Methods Mol Biol, V911, P287, DOI 10.1007/978-1-61779-968-6_18; Ahn WS, 2011, METAB ENG, V13, P598, DOI 10.1016/j.ymben.2011.07.002; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Butler M, 2005, APPL MICROBIOL BIOT, V68, P283, DOI 10.1007/s00253-005-1980-8; CASTRO PML, 1992, APPL MICROBIOL BIOT, V38, P84; Cloutier M, 2008, BIOTECHNOL BIOENG, V99, P189, DOI 10.1002/bit.21543; Cloutier M, 2007, PHYTOCHEMISTRY, V68, P2393, DOI 10.1016/j.phytochem.2007.04.028; Dash RK, 2008, IEEE T BIO-MED ENG, V55, P1298, DOI 10.1109/TBME.2007.913422; Dean J, 2013, BIOTECHNOL BIOENG, V110, P1735, DOI 10.1002/bit.24826; Dorka P, 2007, THESIS U WATERLOO AN; Dorka P, 2009, BIOPROC BIOSYST ENG, V32, P183, DOI 10.1007/s00449-008-0236-2; Europa AF, 2000, BIOTECHNOL BIOENG, V67, P25, DOI 10.1002/(SICI)1097-0290(20000105)67:1<25::AID-BIT4>3.0.CO;2-K; Gao JY, 2007, BIOTECHNOL PROGR, V23, P168, DOI 10.1021/bp060089y; Ghorbaniaghdam A, 2014, PLOS ONE, P9; Ghorbaniaghdam A, 2014, J THEOR BIOL, V357, P112, DOI 10.1016/j.jtbi.2014.04.035; Ghorbaniaghdam A, 2013, BIOPROC BIOSYST ENG, V36, P469, DOI 10.1007/s00449-012-0804-3; Goudar C, 2010, METAB ENG, V12, P138, DOI 10.1016/j.ymben.2009.10.007; Hacker DL, 2009, BIOTECHNOL ADV, V27, P1023, DOI 10.1016/j.biotechadv.2009.05.008; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Herwig C, 2002, BIOPROC BIOSYST ENG, V24, P395, DOI 10.1007/s00449-001-0277-2; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; Lequeux G, 2010, BIOMED RES INT; LLORENTE P, 1970, EUR J BIOCHEM, V13, P45, DOI 10.1111/j.1432-1033.1970.tb00897.x; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mailier J, 2011, BIOTECHNOL BIOENG, V108, P1108, DOI 10.1002/bit.23030; Martinez VS, 2013, BIOTECHNOL BIOENG, V110, P660, DOI 10.1002/bit.24728; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Mulukutla BC, 2012, METAB ENG, V14, P138, DOI 10.1016/j.ymben.2011.12.006; Mulukutla BC, 2010, TRENDS BIOTECHNOL, V28, P476, DOI 10.1016/j.tibtech.2010.06.005; Naderi S, 2011, BIOTECHNOL PROGR, V27, P1197, DOI 10.1002/btpr.647; Nolan RP, 2011, METAB ENG, V13, P108, DOI 10.1016/j.ymben.2010.09.003; Nyberg GB, 1999, BIOTECHNOL BIOENG, V62, P324, DOI 10.1002/(SICI)1097-0290(19990205)62:3<324::AID-BIT9>3.3.CO;2-3; Parampalli A, 2007, CYTOTECHNOLOGY, V54, P57, DOI 10.1007/s10616-007-9074-3; Poliquin PO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069146; Provost A, 2006, BIOPROC BIOSYST ENG, V29, P349, DOI 10.1007/s00449-006-0083-y; Provost A, 2004, J PROCESS CONTR, V14, P717, DOI 10.1016/j.jprocont.2003.12.004; Quek LE, 2010, METAB ENG, V12, P161, DOI 10.1016/j.ymben.2009.09.002; Sandadi S, 2006, BIOTECHNOL PROGR, V22, P595, DOI 10.1021/bp050300q; Segel IH., 1993, ENZYME KINETICS BEHA; Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445; Sen S, 2013, CYTOTECHNOLOGY, V65, P233, DOI 10.1007/s10616-012-9480-z; Sengupta N, 2011, BIOTECHNOL BIOENG, V108, P82, DOI 10.1002/bit.22890; Sheikh K, 2005, BIOTECHNOL PROGR, V21, P112, DOI 10.1021/bp0498138; Sheikholeslami Z, 2013, J BIOTECHNOL, V164, P469, DOI 10.1016/j.jbiotec.2013.01.025; Sin G, 2009, BIOTECHNOL PROGR, V25, P1043, DOI 10.1002/btpr.166; Templeton N, 2013, BIOTECHNOL BIOENG, V110, P2013, DOI 10.1002/bit.24858; Valancin A, 2013, BIOTECHNOL BIOENG, V110, P924, DOI 10.1002/bit.24747; Wong DCF, 2005, BIOTECHNOL BIOENG, V89, P164, DOI 10.1002/bit.20317; XIE LZ, 1994, CYTOTECHNOLOGY, V15, P17, DOI 10.1007/BF00762376; Xing ZZ, 2008, BIOTECHNOL PROGR, V24, P675, DOI 10.1021/bp070466m; Xing ZZ, 2010, BIOTECHNOL PROGR, V26, P208, DOI 10.1002/btpr.284; Zhang HF, 2013, CYTOTECHNOLOGY, V65, P363, DOI 10.1007/s10616-012-9488-4	53	41	42	31	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136815	10.1371/journal.pone.0136815	http://dx.doi.org/10.1371/journal.pone.0136815			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331955	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000360613800075
J	Serrano, E; Martinez, AB; Arruga, D; Perez-Pe, R; Sanchez-Ferrer, A; Muino-Blanco, T; Cebrian-Perez, JA				Serrano, Edith; Martinez, Ana B.; Arruga, Diana; Perez-Pe, Rosaura; Sanchez-Ferrer, Alvaro; Muino-Blanco, Teresa; Cebrian-Perez, Jose A.			New Insights into the Phylogeny and Gene Context Analysis of Binder of Sperm Proteins (BSPs)	PLOS ONE			English	Article							SEMINAL PLASMA-PROTEINS; SINGLE-STEP METHOD; MAJOR PROTEINS; RNA ISOLATION; LOCALIZATION; PURIFICATION; EXPRESSION; MEMBRANE; DAMAGE	Seminal plasma (SP) proteins support the survival of spermatozoa acting not only at the plasma membrane but also by inhibition of capacitation, resulting in higher fertilizing ability. Among SP proteins, BSP (binder of sperm) proteins are the most studied, since they may be useful for the improvement of semen diluents, storage and subsequent fertilization results. However, an updated and detailed phylogenetic analysis of the BSP protein superfamily has not been carried out with all the sequences described in the main databases. The update view shows for the first time an equally distributed number of sequences between the three families: BSP, and their homologs 1 (BSPH1) and 2 (BSPH2). The BSP family is divided in four subfamilies, BSP1 subfamily being the predominant, followed by subfamilies BSP3, BSP5 and BSP2. BSPH proteins were found among placental mammals (Eutheria) belonging to the orders Proboscidea, Primates, Lagomorpha, Rodentia, Chiroptera, Perissodactyla and Cetartiodactyla. However, BSPH2 proteins were also found in the Scandentia order and Metatheria clade. This phylogenetic analysis, when combined with a gene context analysis, showed a completely new evolutionary scenario for the BSP superfamily of proteins with three defined different gene patterns, one for BSPs, one for BSPH1/BSPH2/ELSPBP1 and another one for BSPH1/BSPH2 without ELSPBP1. In addition, the study has permitted to define concise conserved blocks for each family (BSP, BSPH1 and BSPH2), which could be used for a more reliable assignment for the incoming sequences, for data curation of current databases, and for cloning new BSPs, as the one described in this paper, ram seminal vesicle 20 kDa protein (RSVP20, Ovis aries BSP5b).	[Serrano, Edith; Arruga, Diana; Perez-Pe, Rosaura; Muino-Blanco, Teresa; Cebrian-Perez, Jose A.] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Inst Univ Invest Ciencias Ambientables Aragon IUC, Fac Veterinaria, E-50013 Zaragoza, Spain; [Martinez, Ana B.; Sanchez-Ferrer, Alvaro] Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, E-30100 Murcia, Spain; [Martinez, Ana B.; Sanchez-Ferrer, Alvaro] Murcia Biomed Res Inst IMIB Arrixaca, Murcia 30120, Spain	University of Zaragoza; University of Murcia	Sanchez-Ferrer, A (corresponding author), Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Reg Campus Int Excellence Campus Mare Nostrum, E-30100 Murcia, Spain.	alvaro@um.es; pcebrian@unizar.es	PEREZ-PE, ROSAURA/L-1924-2014; Sánchez-Ferrer, Alvaro/M-1631-2014	PEREZ-PE, ROSAURA/0000-0002-2312-6402; Sánchez-Ferrer, Alvaro/0000-0001-7266-4402; Cebrian Perez, Jose Alvaro/0000-0001-9842-6197; Muino Blanco, Maria Teresa/0000-0003-1306-8517	MINECO-FEDER [AGL2011-25850, AGL 2013-43328-P, BIO2010-22225-C02-01, BIO2013-45336-R]; Direccion General de Aragon [A-26FSE]; FPI fellowship [BES-2012-053094]	MINECO-FEDER; Direccion General de Aragon(Gobierno de Aragon); FPI fellowship(Spanish Government)	This work was supported by grants MINECO-FEDER (AGL2011-25850 and AGL 2013-43328-P), Direccion General de Aragon (A-26FSE), and MINECO-FEDER (BIO2010-22225-C02-01 and BIO2013-45336-R). E.S. was financed by the FPI fellowship BES-2012-053094, and A.B.M. is holder of a predoctoral research contract associated with BIO2013-45336-R.	Austin C.R., 1985, P121; Barrios B, 2005, J ANDROL, V26, P539, DOI 10.2164/jandrol.04172; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DESNOYERS L, 1992, J BIOL CHEM, V267, P10149; Fan JJ, 2006, GENE, V375, P63, DOI 10.1016/j.gene.2006.02.025; Fernandez-Juan M, 2006, J ANDROL, V27, P588, DOI 10.2164/jandrol.05187; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Lefebvre J, 2009, MOL HUM REPROD, V15, P105, DOI 10.1093/molehr/gan077; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; MANJUNATH P, 1987, BIOSCIENCE REP, V7, P231, DOI 10.1007/BF01124794; MANJUNATH P, 1989, J BIOL CHEM, V264, P16853; Manjunath P, 2002, BIOL REPROD, V67, P1250, DOI 10.1095/biolreprod67.4.1250; Manjunath P, 1988, MOL BIOL BRAIN ENDOC, P259; Manjunath P, 2009, BIOL REPROD, V80, P394, DOI 10.1095/biolreprod.108.074088; Mendoza N, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105650; Nauc V, 2000, BIOL REPROD, V63, P1058, DOI 10.1095/biolreprod63.4.1058; Perez-Pe R, 2002, MOL REPROD DEV, V61, P226, DOI 10.1002/mrd.1152; Perez-Pe R, 2001, INT J ANDROL, V24, P352, DOI 10.1046/j.1365-2605.2001.00315.x; Perez-Pe R, 2001, THERIOGENOLOGY, V56, P425, DOI 10.1016/S0093-691X(01)00574-X; Plante G, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114272; Plante G, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096644; Serrano E, 2013, GENE, V519, P271, DOI 10.1016/j.gene.2013.02.016; Therien I, 2005, MOL REPROD DEV, V71, P97, DOI 10.1002/mrd.20287; Tian X, 2009, BIOL REPROD, V80, P616, DOI 10.1095/biolreprod.108.073684; Wah DA, 2002, STRUCTURE, V10, P505, DOI 10.1016/S0969-2126(02)00751-7; Yanagimachi R., 1994, Zygote, V2, P371	31	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137008	10.1371/journal.pone.0137008	http://dx.doi.org/10.1371/journal.pone.0137008			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333091	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800088
J	Abitbol, M; Hitte, C; Bosse, P; Blanchard-Gutton, N; Thomas, A; Martignat, L; Blot, S; Tiret, L				Abitbol, Marie; Hitte, Christophe; Bosse, Philippe; Blanchard-Gutton, Nicolas; Thomas, Anne; Martignat, Lionel; Blot, Stephane; Tiret, Laurent			A COLQ Missense Mutation in Sphynx and Devon Rex Cats with Congenital Myasthenic Syndrome	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; NEUROMUSCULAR-JUNCTION; ANIMAL-MODELS; TAIL SUBUNIT; COLLAGEN Q; ACETYLCHOLINESTERASE; GRAVIS; DEFICIENCY; DOGS; PATHOGENESIS	An autosomal recessive neuromuscular disorder characterized by skeletal muscle weakness, fatigability and variable electromyographic or muscular histopathological features has been described in the two related Sphynx and Devon Rex cat breeds (Felis catus). Collection of data from two affected Sphynx cats and their relatives pointed out a single disease candidate region on feline chromosome C2, identified following a genome-wide SNP-based homozygosity mapping strategy. In that region, we further identified COLQ (collagen-like tail subunit of asymmetric acetylcholinesterase) as a good candidate gene, since COLQ mutations were identified in affected humans and dogs with endplate acetylcholinesterase deficiency leading to a synaptic form of congenital myasthenic syndrome (CMS). A homozygous c.1190G>A missense variant located in exon 15 of COLQ, leading to a C397Y substitution, was identified in the two affected cats. C397 is a highly-conserved residue from the C-terminal domain of the protein; its mutation was previously shown to produce CMS in humans, and here we confirmed in an affected Sphynx cat that it induces a loss of acetylcholinesterase clustering at the neuromuscular junction. Segregation of the c. 1190G>A variant was 100% consistent with the autosomal recessive mode of inheritance of the disorder in our cat pedigree; in addition, an affected, unrelated Devon Rex cat recruited thereafter was also homozygous for the variant. Genotyping of a panel of 333 cats from 14 breeds failed to identify a single carrier in non-Sphynx and non-Devon Rex cats. Finally, the percentage of healthy carriers in a European subpanel of 81 genotyped Sphynx cats was estimated to be low (3.7%) and 14 control Devon Rex cats were genotyped as wild-type individuals. Altogether, these results strongly support that the neuromuscular disorder reported in Sphynx and Devon Rex breeds is a CMS caused by a unique c.1190G>A missense mutation, presumably transmitted through a founder effect, which strictly and slightly disseminated in these two breeds. The presently available DNA test will help owners avoid matings at risk.	[Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] INSERM, IMRB, U955, F-94000 Creteil, France; [Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] Univ Paris Est, Ecole Natl Vet Alfort, F-94700 Maisons Alfort, France; [Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] Fac Med, F-94000 Creteil, France; [Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] Etab Francais Sang, F-94017 Creteil, France; [Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] Hop Univ Henri Mondor, AP HP, DHU Pepsy, F-94000 Creteil, France; [Abitbol, Marie; Bosse, Philippe; Blanchard-Gutton, Nicolas; Blot, Stephane; Tiret, Laurent] Ctr Reference Malad Neuromusculaires GNMH, F-94000 Creteil, France; [Hitte, Christophe] Univ Rennes 1, CNRS, UMR6290, IGDR, Rennes, France; [Thomas, Anne] Antagene, Anim Genet Lab, La Tour De Salvagny, France; [Martignat, Lionel] ONIRIS, UP Securite Sanit Biotechnol Reprod, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Abitbol, M (corresponding author), INSERM, IMRB, U955, E10, F-94000 Creteil, France.	m.abitbol@vet-alfort.fr	Tiret, Laurent/K-3877-2017; Blot, Stephane/K-7573-2019; Blot, Stephane/F-7420-2011	Tiret, Laurent/0000-0001-8573-8335; Abitbol, Marie/0000-0002-5615-7897; Hitte, Christophe/0000-0003-1714-437X; Bosse, Philippe/0000-0001-5701-6415; Blot, Stephane/0000-0002-8982-0317	LOOF (Livre Officiel des Origines Felines); Antagene; Morris Animal Foundation [D14FE-563]	LOOF (Livre Officiel des Origines Felines); Antagene; Morris Animal Foundation	This work was specifically supported by the LOOF (Livre Officiel des Origines Felines, www.loof.asso.fr). Purchase of the Illumina Infinium Feline 63K iSelect DNA array was allowed thanks to the Morris Animal Foundation (Grant-In-Aid Agreement no D14FE-563). Support for the development of the Illumina Infinium Feline 63K iSelect DNA array was provided by the Morris Animal Foundation (www.morrisanimalfoundation.org) via a donation from Hill's Pet Food, Inc. Medical genetics tools were partly provided by the CNM Project (www.labradorcnm.com). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Antagene provided support in the form of salary for author [AT] and research materials (DNA collection), but had no additional role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alhaddad H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053537; [Anonymous], 2007, MUSCLE BIOPSY; Arredondo J, 2014, HUM GENET, V133, P599, DOI 10.1007/s00439-013-1391-3; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Carville L., 1995, THESIS; CASAL ML, 1994, J AM ANIM HOSP ASSOC, V30, P600; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; Corpet F., 1988, NUCLEIC ACIDS RES, V16, P22; Dickinson PJ, 2005, J VET INTERN MED, V19, P920, DOI 10.1892/0891-6640(2005)19[920:CMGISM]2.0.CO;2; Engel AG, 2007, NEUROTHERAPEUTICS, V4, P252, DOI 10.1016/j.nurt.2007.01.001; Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7; Gandolfi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067105; Gandolfi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053173; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Ito M, 2012, MOL THER, V20, P1384, DOI 10.1038/mt.2012.34; JOHNSON RP, 1975, J SMALL ANIM PRACT, V16, P641, DOI 10.1111/j.1748-5827.1975.tb05790.x; Kimbell LM, 2004, J BIOL CHEM, V279, P10997, DOI 10.1074/jbc.M305462200; Kraner S, 2002, NEUROGENETICS, V4, P87, DOI 10.1007/s10048-002-0134-8; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; le Chevoir M, 2012, JAVMA-J AM VET MED A, V241, P1194, DOI 10.2460/javma.241.9.1194; Lipinski MJ, 2008, GENOMICS, V91, P12, DOI 10.1016/j.ygeno.2007.10.009; Littink KW, 2009, INVEST OPHTH VIS SCI, V50, P2344, DOI 10.1167/iovs.08-2553; MALIK R, 1993, J SMALL ANIM PRACT, V34, P539, DOI 10.1111/j.1748-5827.1993.tb03544.x; Martin PT, 2008, NEUROMUSCULAR DISORD, V18, P942, DOI 10.1016/j.nmd.2008.08.002; Menotti-Raymond M, 2008, GENOMICS, V91, P1, DOI 10.1016/j.ygeno.2007.08.008; Mihaylova V, 2008, BRAIN, V131, P747, DOI 10.1093/brain/awm325; MILLER LM, 1983, J AM VET MED ASSOC, V182, P694; Neto OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110888; Nigro Vincenzo, 2014, Acta Myol, V33, P1; ODA K, 1984, MUSCLE NERVE, V7, P705, DOI 10.1002/mus.880070904; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Ohno K, 2013, CHEM-BIOL INTERACT, V203, P335, DOI 10.1016/j.cbi.2012.08.020; Pond G., 1972, COMPLETE CAT ENCY; Proschowsky HF, 2007, J HERED, V98, P539, DOI 10.1093/jhered/esm026; Rinz CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106425; ROBINSON R, 1992, VET REC, V130, P302, DOI 10.1136/vr.130.14.302-a; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang ZJ, 2009, ILAR J, V50, P187, DOI 10.1093/ilar.50.2.187; Wargon I, 2012, NEUROMUSCULAR DISORD, V22, P318, DOI 10.1016/j.nmd.2011.09.002; Willet CE, 2014, ANIM GENET, V45, P614, DOI 10.1111/age.12169	42	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137019	10.1371/journal.pone.0137019	http://dx.doi.org/10.1371/journal.pone.0137019			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327126	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700082
J	Demonbreun, AR; Swanson, KE; Rossi, AE; Deveaux, HK; Earley, JU; Allen, MV; Arya, P; Bhattacharyya, S; Band, H; Pytel, P; McNally, EM				Demonbreun, Alexis R.; Swanson, Kaitlin E.; Rossi, Ann E.; Deveaux, H. Kieran; Earley, Judy U.; Allen, Madison V.; Arya, Priyanka; Bhattacharyya, Sohinee; Band, Hamid; Pytel, Peter; McNally, Elizabeth M.			Eps 15 Homology Domain (EHD)-1 Remodels Transverse Tubules in Skeletal Muscle	PLOS ONE			English	Article							CENTRONUCLEAR MYOPATHY; SARCOPLASMIC-RETICULUM; MUSCULAR-DYSTROPHY; AMPHIPHYSIN-2 BIN1; CA2+ RELEASE; PROTEINS; MICE; CELLS; MUTATIONS; DYSFERLIN	We previously showed that Eps15 homology domain-containing 1 (EHD1) interacts with ferlin proteins to regulate endocytic recycling. Myoblasts from Ehd1-null mice were found to have defective recycling, myoblast fusion, and consequently smaller muscles. When expressed in C2C12 cells, an ATPase dead-EHD1 was found to interfere with BIN1/amphiphysin 2. We now extended those findings by examining Ehd1-heterozygous mice since these mice survive to maturity in normal Mendelian numbers and provide a ready source of mature muscle. We found that heterozygosity of EHD1 was sufficient to produce ectopic and excessive T-tubules, including large intracellular aggregates that contained BIN1. The disorganized T-tubule structures in Ehd1-heterozygous muscle were accompanied by marked elevation of the T-tubule-associated protein DHPR and reduction of the triad linker protein junctophilin 2, reflecting defective triads. Consistent with this, Ehd1-heterozygous muscle had reduced force production. Introduction of ATPase dead-EHD1 into mature muscle fibers was sufficient to induce ectopic T-tubule formation, seen as large BIN1 positive structures throughout the muscle. Ehd1-heterozygous mice were found to have strikingly elevated serum creatine kinase and smaller myofibers, but did not display findings of muscular dystrophy. These data indicate that EHD1 regulates the maintenance of T-tubules through its interaction with BIN1 and links T-tubules defects with elevated creatine kinase and myopathy.	[Demonbreun, Alexis R.; Earley, Judy U.; Allen, Madison V.; McNally, Elizabeth M.] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [Swanson, Kaitlin E.; Pytel, Peter] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Rossi, Ann E.; Deveaux, H. Kieran] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Arya, Priyanka] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Bhattacharyya, Sohinee; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Pathol & Microbiol, Omaha, NE USA	Northwestern University; University of Chicago; University of Chicago; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Demonbreun, AR (corresponding author), Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA.	alexis.demonbreun@northwestern.edu	Band, Hamid/AAF-4701-2020; Bhattacharyya, Sohinee/AAN-6414-2021; McNally, Elizabeth/W-4909-2019	Demonbreun, Alexis/0000-0001-6823-125X; McNally, Elizabeth/0000-0002-1221-719X	National Institutes of Health [CA105489, CA116552, NS047726, NS072027, AR052646]; NATIONAL CANCER INSTITUTE [R01CA116552, R01CA105489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047726, P01NS072027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants CA105489 and CA116552 (to HB), and NS047726, NS072027, and AR052646 (to EMM).	Andersson DC, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-9; Behringer M, 2014, MED HYPOTHESES, V83, P758, DOI 10.1016/j.mehy.2014.10.005; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Brancaccio P, 2010, CLIN CHEM LAB MED, V48, P757, DOI 10.1515/CCLM.2010.179; Cai BS, 2013, J BIOL CHEM, V288, P30172, DOI 10.1074/jbc.M113.488627; Capote J, 2010, AM J PHYSIOL-CELL PH, V298, pC1077, DOI 10.1152/ajpcell.00428.2009; CHOU SM, 1980, ARCH NEUROL-CHICAGO, V37, P257, DOI 10.1001/archneur.1980.00500540035002; Cowling BS, 2014, J CLIN INVEST, V124, P1350, DOI 10.1172/JCI71206; Daumke O, 2007, NATURE; Demonbreun AR, 2014, AM J PATHOL, V184, P248, DOI 10.1016/j.ajpath.2013.09.009; DiFranco M, 2009, J VIS EXP; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Dowling J, 2014, NEUROTHERAPEUTICS, V11, P773, DOI 10.1007/s13311-014-0300-3; FLUCHER BE, 1992, DEV BIOL, V154, P245, DOI 10.1016/0012-1606(92)90065-O; Franzini-Armstrong C, 1998, ANN NY ACAD SCI, V853, P20, DOI 10.1111/j.1749-6632.1998.tb08253.x; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Grose WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039233; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Han J, 2013, SCI CHINA LIFE SCI, V56, P647, DOI 10.1007/s11427-013-4490-4; Heydemann A, 2005, NEUROMUSCULAR DISORD, V15, P601, DOI 10.1016/j.nmd.2005.05.004; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Jakobsson J, 2011, J NEUROSCI, V31, P13972, DOI 10.1523/JNEUROSCI.1289-11.2011; Jayasinghe ID, 2013, J CELL SCI, V126, P4048, DOI 10.1242/jcs.131565; JORGENSEN AO, 1989, J CELL BIOL, V109, P135, DOI 10.1083/jcb.109.1.135; Kerr JP, 2013, P NATL ACAD SCI USA, V110, P20831, DOI 10.1073/pnas.1307960110; Klinge L, 2010, MUSCLE NERVE, V41, P166, DOI 10.1002/mus.21166; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; LIU ZQ, 1991, APPL OPTICS, V30, P1369, DOI 10.1364/AO.30.001369; Marg A, 2012, TRAFFIC, V13, P1286, DOI 10.1111/j.1600-0854.2012.01386.x; Mate SE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-19; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; PORTER KR, 1957, J BIOPHYS BIOCHEM CY, V3, P269, DOI 10.1083/jcb.3.2.269; Posey AD, 2014, DEV BIOL, V387, P179, DOI 10.1016/j.ydbio.2014.01.004; Posey AD, 2011, J BIOL CHEM, V286, P7379, DOI 10.1074/jbc.M110.157222; Rainey MA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-37; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tjondrokoesoemo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025740; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0	49	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136679	10.1371/journal.pone.0136679	http://dx.doi.org/10.1371/journal.pone.0136679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325203	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700056
J	Itoh, M; Nakayama, K; Noguchi, R; Kamohara, K; Furukawa, K; Uchihashi, K; Toda, S; Oyama, J; Node, K; Morita, S				Itoh, Manabu; Nakayama, Koichi; Noguchi, Ryo; Kamohara, Keiji; Furukawa, Kojirou; Uchihashi, Kazuyoshi; Toda, Shuji; Oyama, Jun-ichi; Node, Koichi; Morita, Shigeki			Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae	PLOS ONE			English	Article							VASCULAR GRAFT; ACCESS; SPHEROIDS; DESIGN	Background Small caliber vascular prostheses are not clinically available because synthetic vascular prostheses lack endothelial cells which modulate platelet activation, leukocyte adhesion, thrombosis, and the regulation of vasomotor tone by the production of vasoactive substances. We developed a novel method to create scaffold-free tubular tissue from multicellular spheroids (MCS) using a "Bio-3D printer"-based system. This system enables the creation of pre-designed three-dimensional structures using a computer controlled robotics system. With this system, we created a tubular structure and studied its biological features. Methods and Results Using a "Bio-3D printer," we made scaffold-free tubular tissues (inner diameter of 1.5 mm) from a total of 500 MCSs (2.5x 10(4) cells per one MCS) composed of human umbilical vein endothelial cells (40%), human aortic smooth muscle cells (10%), and normal human dermal fibroblasts (50%). The tubular tissues were cultured in a perfusion system and implanted into the abdominal aortas of F344 nude rats. We assessed the flow by ultrasonography and performed histological examinations on the second (n = 5) and fifth (n = 5) day after implantation. All grafts were patent and remodeling of the tubular tissues (enlargement of the lumen area and thinning of the wall) was observed. A layer of endothelial cells was confirmed five days after implantation. Conclusions The scaffold-free tubular tissues made of MCS using a Bio-3D printer underwent remodeling and endothelialization. Further studies are warranted to elucidate the underlying mechanism of endothelialization and its function, as well as the long-term results.	[Itoh, Manabu; Noguchi, Ryo; Kamohara, Keiji; Furukawa, Kojirou; Morita, Shigeki] Saga Univ, Fac Med, Dept Thorac & Cardiovasc Surg, Saga 840, Japan; [Nakayama, Koichi] Saga Univ, Fus Grad Sch Sci & Engn, Biomed Engn Course Adv Technol, Saga 840, Japan; [Oyama, Jun-ichi; Node, Koichi] Saga Univ, Fac Med, Dept Cardiovasc Med, Saga 840, Japan; [Uchihashi, Kazuyoshi; Toda, Shuji] Saga Univ, Fac Med, Dept Pathol & Microbiol, Saga 840, Japan	Saga University; Saga University; Saga University; Saga University	Morita, S (corresponding author), Saga Univ, Fac Med, Dept Thorac & Cardiovasc Surg, Saga 840, Japan.	moritash@cc.saga-u.ac.jp		Nakayama, Koichi/0000-0002-7324-8862	Science and Technology Grants for Scientific Research (JP) Grant [25293298, 50555084]	Science and Technology Grants for Scientific Research (JP) Grant	This work was supported by Science and Technology Grants for Scientific Research (JP) Grant Nos. 25293298 and 50555084.	Ao PY, 2000, EUR J VASC ENDOVASC, V20, P241, DOI 10.1053/ejvs.2000.1177; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Cleary MA, 2012, TRENDS MOL MED, V18, P394, DOI 10.1016/j.molmed.2012.04.013; Daenens K, 2009, J VASC SURG, V49, P1210, DOI 10.1016/j.jvs.2008.12.009; Faries PL, 2000, J VASC SURG, V32, P1080, DOI 10.1067/mva.2000.111279; Ferrari ER, 2006, CURR OPIN CARDIOL, V21, P584; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Hodges TC, 1997, J VASC SURG, V26, P1009, DOI 10.1016/S0741-5214(97)70014-4; Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kelm JM, 2006, TISSUE ENG, V12, P2151, DOI 10.1089/ten.2006.12.2151; Kelm JM, 2010, J BIOTECHNOL, V148, P46, DOI 10.1016/j.jbiotec.2010.03.002; Kelm JM, 2005, J BIOTECHNOL, V118, P213, DOI 10.1016/j.jbiotec.2005.03.016; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Kelm JM, 2004, TISSUE ENG, V10, P201, DOI 10.1089/107632704322791853; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; Layer PG, 2002, TRENDS NEUROSCI, V25, P131, DOI 10.1016/S0166-2236(00)02036-1; Mancuso L, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/4/045011; Marga F, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/022001; McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8; Nakayama K, 2013, BIOFABRICATION: MICRO- AND NANO-FABRICATION, PRINTING, PATTERNING, AND ASSEMBLIES, P1; Nakayama Y, 2004, CELL TRANSPLANT, V13, P439, DOI 10.3727/000000004783983828; Nemeno-Guanzon JG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/956345; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Rosas SE, 2003, J VASC SURG, V37, P1036, DOI 10.1067/mva.2003.257; Sanchez-Bustamante CD, 2008, TISSUE ENG PT A, V14, P1969, DOI 10.1089/ten.tea.2007.0302; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Steffens L, 2009, J CELL MOL MED, V13, P3380, DOI 10.1111/j.1582-4934.2008.00418.x; Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1053/ejvs.2002.1654; TOMIZAWA Y, 1995, ARTIF ORGANS, V19, P39, DOI 10.1111/j.1525-1594.1995.tb02242.x; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Watanabe T, 2011, J BIOMED MATER RES B, V98B, P120, DOI 10.1002/jbm.b.31841; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204; Yamanami M, 2013, J ARTIF ORGANS, V16, P59, DOI 10.1007/s10047-012-0676-y; Yamanami M, 2010, J BIOMED MATER RES B, V92B, P156, DOI 10.1002/jbm.b.31501; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017	39	139	152	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136681	10.1371/journal.pone.0136681	http://dx.doi.org/10.1371/journal.pone.0136681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325298	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700057
J	Mastrandrea, R; Fournet, J; Barrat, A				Mastrandrea, Rossana; Fournet, Julie; Barrat, Alain			Contact Patterns in a High School: A Comparison between Data Collected Using Wearable Sensors, Contact Diaries and Friendship Surveys	PLOS ONE			English	Article							SOCIAL NETWORKS; INFECTIOUS-DISEASE; SPREAD; TRANSMISSION; BEHAVIOR; BIASES	Given their importance in shaping social networks and determining how information or transmissible diseases propagate in a population, interactions between individuals are the subject of many data collection efforts. To this aim, different methods are commonly used, ranging from diaries and surveys to decentralised infrastructures based on wearable sensors. These methods have each advantages and limitations but are rarely compared in a given setting. Moreover, as surveys targeting friendship relations might suffer less from memory biases than contact diaries, it is interesting to explore how actual contact patterns occurring in day-to-day life compare with friendship relations and with online social links. Here we make progresses in these directions by leveraging data collected in a French high school and concerning (i) face-to-face contacts measured by two concurrent methods, namely wearable sensors and contact diaries, (ii) self-reported friendship surveys, and (iii) online social links. We compare the resulting data sets and find that most short contacts are not reported in diaries while long contacts have a large reporting probability, and that the durations of contacts tend to be overestimated in the diaries. Moreover, measured contacts corresponding to reported friendship can have durations of any length but all long contacts do correspond to a reported friendship. On the contrary, online links that are not also reported in the friendship survey correspond to short face-to-face contacts, highlighting the difference of nature between reported friendships and online links. Diaries and surveys suffer moreover from a low sampling rate, as many students did not fill them, showing that the sensor-based platform had a higher acceptability. We also show that, despite the biases of diaries and surveys, the overall structure of the contact network, as quantified by the mixing patterns between classes, is correctly captured by both networks of self-reported contacts and of friendships, and we investigate the correlations between the number of neighbors of individuals in the three networks. Overall, diaries and surveys tend to yield a correct picture of the global structural organization of the contact network, albeit with much less links, and give access to a sort of backbone of the contact network corresponding to the strongest links, i.e., the contacts of longest cumulative durations.	[Mastrandrea, Rossana; Fournet, Julie; Barrat, Alain] Univ Toulon & Var, Aix Marseille Univ, CNRS, CPT,UMR 7332, F-13288 Marseille, France; [Barrat, Alain] ISI Fdn, Data Sci Lab, Turin, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulon	Barrat, A (corresponding author), Univ Toulon & Var, Aix Marseille Univ, CNRS, CPT,UMR 7332, F-13288 Marseille, France.	alain.barrat@cpt.univ-mrs.fr	Blanchard, Alain/I-3916-2019	Blanchard, Alain/0000-0003-4223-5185	A*MIDEX project - "Investissements d'Avenir" French Government program [ANR- 11-IDEX-0001-02]; French ANR project HarMS-flu [ANR-12-MONU-0018]; EU FET project Multiplex [317532]	A*MIDEX project - "Investissements d'Avenir" French Government program(French National Research Agency (ANR)); French ANR project HarMS-flu(French National Research Agency (ANR)); EU FET project Multiplex	This work was supported by the A*MIDEX project (ANR- 11-IDEX-0001-02) funded by the "Investissements d'Avenir" French Government program, managed by the French National Research Agency (ANR) to AB and RM. AB is also partially supported by the French ANR project HarMS-flu (ANR-12-MONU-0018) and by the EU FET project Multiplex 317532.	[Anonymous], DELIBERATIVE DEMOCRA, DOI [10.7551/mitpress/11633.003.0005, DOI 10.7551/MITPRESS/2324.003.0014, DOI 10.7551/MITPRESS/8022.001.0001]; Barabasi A.-L., 2010, BURSTS HIDDEN PATTER; Barrat A, 2014, CLIN MICROBIOL INFEC, V20, P10, DOI 10.1111/1469-0691.12472; Barrat A, 2013, EUR PHYS J-SPEC TOP, V222, P1295, DOI 10.1140/epjst/e2013-01927-7; Barrat A, 2010, P 9 INT SEM WEB C IS; Battiston F, 2013, STRUCTURAL MEASURES; Bernard H, 2009, EMERG INFECT DIS, V15, P1438, DOI 10.3201/eid1509.081475; BERNARD HR, 1984, ANNU REV ANTHROPOL, V13, P495, DOI 10.1146/annurev.an.13.100184.002431; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Collopy F, 1996, MANAGE SCI, V42, P758, DOI 10.1287/mnsc.42.5.758; Conlan AJK, 2011, P ROY SOC B-BIOL SCI, V278, P1467, DOI 10.1098/rspb.2010.1807; Danon L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1037; Danon L, 2012, J R SOC INTERFACE, V9, P2826, DOI 10.1098/rsif.2012.0357; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fournet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107878; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Gauvin L., 2015, ARXIV150102758; Gemmetto V, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0695-9; Genois M., 2015, ARXIV150304066; Hashemian M, 2010, P 6 INT WORKSH WIR N, P557; Hornbeck T, 2012, J INFECT DIS, V206, P1549, DOI 10.1093/infdis/jis542; Hui P, 2005, P 2005 ACM SIGCOMM W, P244, DOI DOI 10.1145/1080139.1080142; Hyett GP, 1979, VALIDATION DIARY REC, P136; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Karagiannis T, 2007, MOBICOM'07: PROCEEDINGS OF THE THIRTEENTH ACM INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P183; Lanyon R. I., 1997, PERSONALITY ASSESSME; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Moreno JL., 1953, MORENO DESCRIBES SUR; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; O'Neill E, 2006, LECT NOTES COMPUT SC, V4206, P315; Obadia T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004170; Paulhus D.L., 2007, HDB RES METHODS PERS, P224, DOI DOI 10.1111/J.1744-6570.2008.01133_6.X; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Smieszek T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-136; Stehle J, 2013, SOC NETWORKS, V35, P604, DOI 10.1016/j.socnet.2013.08.003; Toth DJA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0279; Van Kerckhove K, 2013, AM J EPIDEMIOL, V178, P1655, DOI 10.1093/aje/kwt196	46	209	214	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136497	10.1371/journal.pone.0136497	http://dx.doi.org/10.1371/journal.pone.0136497			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325289	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000360437700046
J	Turiho, AK; Muhwezi, WW; Okello, ES; Tumwesigye, NM; Banura, C; Katahoire, AR				Turiho, Andrew Kampikaho; Muhwezi, Wilson Winston; Okello, Elialilia Sarikiaeli; Tumwesigye, Nazarius Mbona; Banura, Cecil; Katahoire, Anne Ruhweza			Human Papillomavirus (HPV) Vaccination and Adolescent Girls' Knowledge and Sexuality in Western Uganda: A Comparative Cross-Sectional Study	PLOS ONE			English	Article							PARENTAL COMMUNICATION; ACCEPTANCE; ACCEPTABILITY; PERCEPTIONS; INTERCOURSE; PREDICTORS; ATTITUDES; BEHAVIOR; RISK	The purpose of the study was to investigate the influence of human papillomavirus (HPV) vaccination on adolescent girls' knowledge of HPV and HPV vaccine, perception of sexual risk and intentions for sexual debut. This cross-sectional comparative study was conducted in Ibanda and Mbarara districts. Data was collected using a standardized self-administered questionnaire and analyzed using the Statistical Package for the Social Sciences computer software. Univariate, bivariate, and logistic regression analyses were conducted with significance level set at p < .05. Results showed that HPV vaccination was associated with being knowledgeable (Crude OR: 5.26, CI: 2.32-11.93; p = 0.000). Vaccination against HPV did not predict perception of sexual risk. Knowledge was low (only 87/385 or 22.6% of vaccinated girls were knowledgeable), but predicted perception of a high sexual risk (Adjusted OR: 3.12, CI: 1.37-3.63; p = 0.008). HPV vaccination, knowledge and perceived sexual risk did not predict sexual behaviour intentions. High parental communication was associated with adolescent attitudes that support postponement of sexual debut in both bivariate and multiple regression analyses. In conclusion, findings of this study suggest that HPV vaccination is not likely to encourage adolescent sexual activity. Influence of knowledge on sexual behaviour intentions was not definitively explained. Prospective cohort studies were proposed to address the emerging questions.	[Turiho, Andrew Kampikaho; Muhwezi, Wilson Winston; Okello, Elialilia Sarikiaeli] Makerere Univ, Sch Med, Dept Psychiat, Kampala, Uganda; [Tumwesigye, Nazarius Mbona] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Banura, Cecil; Katahoire, Anne Ruhweza] Makerere Univ, Child Hlth & Dev Ctr, Kampala, Uganda	Makerere University; Makerere University; Makerere University	Turiho, AK (corresponding author), Makerere Univ, Sch Med, Dept Psychiat, Kampala, Uganda.	akturiho@chs.mak.ac.ug	Okello, Elialilia/S-8238-2019	Tumwesigye, Nazarius Mbona/0000-0001-7085-8780	Uganda National Council for Science and Technology (UNCST) through the Millennium Science Initiative (MSI)/College of Health Sciences (CHS) Young women's Human Papillomavirus (HPV) Project that was based in the College of Health Sciences; Carnegie Corporation of New York-Makerere University Next Generation of African Academicians (NGAA) Project; Makerere University	Uganda National Council for Science and Technology (UNCST) through the Millennium Science Initiative (MSI)/College of Health Sciences (CHS) Young women's Human Papillomavirus (HPV) Project that was based in the College of Health Sciences; Carnegie Corporation of New York-Makerere University Next Generation of African Academicians (NGAA) Project; Makerere University	The study was principally funded by the Uganda National Council for Science and Technology (UNCST) through the Millennium Science Initiative (MSI)/College of Health Sciences (CHS) Young women's Human Papillomavirus (HPV) Project that was based in the College of Health Sciences, Makerere University. Additional financial support came from the Carnegie Corporation of New York-Makerere University Next Generation of African Academicians (NGAA) Project (Small PhD Grants 2012). Both sources of financial support were channeled through Makerere University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048017; Bednarczyk RA, 2012, PEDIATRICS, V130, P798, DOI 10.1542/peds.2012-1516; Bowyer HL, 2013, VACCINE, V31, P1051, DOI 10.1016/j.vaccine.2012.12.038; Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048; Brabin L, 2009, BRIT J CANCER, V101, P1502, DOI 10.1038/sj.bjc.6605362; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Caskey R, 2009, J ADOLESCENT HEALTH, V45, P453, DOI 10.1016/j.jadohealth.2009.04.021; Davis Kristin, 2004, J Low Genit Tract Dis, V8, P188, DOI 10.1097/00128360-200407000-00005; DiAngi YT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025481; Fasula AM, 2006, J ADOLESCENT HEALTH, V38, P193, DOI 10.1016/j.jadohealth.2004.12.009; Forster AS, 2012, VACCINE, V30, P4939, DOI 10.1016/j.vaccine.2012.05.053; Hulton LA, 2000, STUD FAMILY PLANN, V31, P35, DOI 10.1111/j.1728-4465.2000.00035.x; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kahn JA, 2012, J ADOLESCENT HEALTH, V50, P464, DOI 10.1016/j.jadohealth.2011.09.005; Karofsky PS, 2001, J ADOLESCENT HEALTH, V28, P41, DOI 10.1016/S1054-139X(00)00156-7; Kayiki Simon P, 2011, Afr J Reprod Health, V15, P57; Khan AJ, 2004, J ADOLESCENT HEALTH, V35; Lenselink CH, 2008, EUR J OBSTET GYN R B, V137, P103, DOI 10.1016/j.ejogrb.2007.02.012; Liddon NC, 2012, AM J PREV MED, V42, P44, DOI 10.1016/j.amepre.2011.09.024; Lo B, 2006, BMJ-BRIT MED J, V332, P1106, DOI 10.1136/bmj.332.7550.1106; Marlow LAV, 2007, VACCINE, V25, P1945, DOI 10.1016/j.vaccine.2007.01.059; Marlow LAV, 2009, J ADOLESCENT HEALTH, V44, P446, DOI 10.1016/j.jadohealth.2008.09.011; Mayhew A, 2014, PEDIATRICS, V133, P404, DOI 10.1542/peds.2013-2822; Mullins TLK, 2012, ARCH PEDIAT ADOL MED, V166, P82, DOI 10.1001/archpediatrics.2011.186; Ntozi James P M, 2003, Afr Health Sci, V3, P107; Ogilvie G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000270; Olshen E, 2005, J ADOLESCENT HEALTH, V37, P248, DOI 10.1016/j.jadohealth.2005.05.016; Pandey R. M., 1999, Indian Journal of Pediatrics, V66, P533, DOI 10.1007/BF02727163; Paul P, 2012, ASIAN PAC J CANCER P, V13, P2587, DOI 10.7314/APJCP.2012.13.6.2587; Polar Engineering and Consulting, 2007, STAT PACK SOC SCI; Program for Appropriate Technology for Health (PATH), 2009, VACC WOM HLTH PREP W; Program for Appropriate Technology for Health Uganda National Expanded Programme on Immunization Child health and Development Centre, 2010, HPV VACC DEM PROJ OP; Remes P, 2012, VACCINE, V30, P5363, DOI 10.1016/j.vaccine.2012.06.025; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Fregnani JHTG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062647; Vermandere H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109353; Wamala R., 2012, ONLINE J SOCIAL SCI, V1, P139; WHO World Health Organization, 2007, CERV CANC HUM PAP HP; Wilde G J, 1998, Inj Prev, V4, P89; Woodhall SC, 2007, J ADOLESCENT HEALTH, V40, P466, DOI 10.1016/j.jadohealth.2007.01.005; Zimet GD, 2005, J ADOLESCENT HEALTH, V37, P179, DOI 10.1016/j.jadohealth.2005.06.004; Zimet GD, 2006, VACCINE, V24, P201, DOI 10.1016/j.vaccine.2006.06.017	43	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137094	10.1371/journal.pone.0137094	http://dx.doi.org/10.1371/journal.pone.0137094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26327322	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700095
J	Baker, WL				Baker, William L.			Are High-Severity Fires Burning at Much Higher Rates Recently than Historically in Dry-Forest Landscapes of the Western USA?	PLOS ONE			English	Article							MIXED-CONIFER FORESTS; PONDEROSA PINE; SIERRA-NEVADA; UNITED-STATES; CLIMATE-CHANGE; NATIONAL-PARK; BURNED AREA; WILDFIRE; VEGETATION; TRENDS	Dry forests at low elevations in temperate-zone mountains are commonly hypothesized to be at risk of exceptional rates of severe fire from climatic change and land-use effects. Their setting is fire-prone, they have been altered by land-uses, and fire severity may be increasing. However, where fires were excluded, increased fire could also be hypothesized as restorative of historical fire. These competing hypotheses are not well tested, as reference data prior to widespread land-use expansion were insufficient. Moreover, fire-climate projections were lacking for these forests. Here, I used new reference data and records of high-severity fire from 1984-2012 across all dry forests (25.5 million ha) of the western USA to test these hypotheses. I also approximated projected effects of climatic change on high-severity fire in dry forests by applying existing projections. This analysis showed the rate of recent high-severity fire in dry forests is within the range of historical rates, or is too low, overall across dry forests and individually in 42 of 43 analysis regions. Significant upward trends were lacking overall from 1984-2012 for area burned and fraction burned at high severity. Upward trends in area burned at high severity were found in only 4 of 43 analysis regions. Projections for A.D. 2046-2065 showed high-severity fire would generally be still operating at, or have been restored to historical rates, although high projections suggest high-severity fire rotations that are too short could ensue in 6 of 43 regions. Programs to generally reduce fire severity in dry forests are not supported and have significant adverse ecological impacts, including reducing habitat for native species dependent on early-successional burned patches and decreasing landscape heterogeneity that confers resilience to climatic change. Some adverse ecological effects of high-severity fires are concerns. Managers and communities can improve our ability to live with high-severity fire in dry forests.	Univ Wyoming, Dept 3371, Dept Geog, Program Ecol, Laramie, WY 82071 USA	University of Wyoming	Baker, WL (corresponding author), Univ Wyoming, Dept 3371, Dept Geog, Program Ecol, 1000 E Univ Ave, Laramie, WY 82071 USA.	bakerwl@uwyo.edu	Baker, William/A-7008-2008; Green, Judith L/AAC-4052-2022	green, judith/0000-0002-3379-6733				Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Anderson-Teixeira KJ, 2013, GLOBAL CHANGE BIOL, V19, P2001, DOI 10.1111/gcb.12194; [Anonymous], 2014, MON TRENDS BURN SEV; Bailey R.G, 2009, ECOSYSTEM GEOGRAPHY; Baker WL, 2007, J BIOGEOGR, V34, P251, DOI 10.1111/j.1365-2699.2006.01592.x; Baker WL, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00046.1; Baker WL, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00320.1; BAKER WL, 1995, LANDSCAPE ECOL, V10, P143, DOI 10.1007/BF00133028; Baker WL, 2002, US FOR SERV RMRS-P, P319; Baker WL, 2014, ECOLOGY EVOLUTION, V2; Baker WL., 2009, FIRE ECOLOGY ROCKY M; Barbour M.G., 2000, N AM TERRESTRIAL VEG, V2nd; BARRETT SW, 1997, INTGTR370 USDA FOR S; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigio E.R, 2013, THESIS U ARIZONA TUC; Bradstock R, 2014, GLOBAL CHANGE BIOL, V20, P1412, DOI 10.1111/gcb.12449; Calkin DE, 2014, P NATL ACAD SCI USA, V111, P746, DOI 10.1073/pnas.1315088111; Collier MP, 1997, SCI AM, V276, P82, DOI 10.1038/scientificamerican0197-82; Collins BM, 2006, CAN J FOREST RES, V36, P699, DOI 10.1139/X05-264; Collins BM, 2015, ECOL APPL, V25, P1167, DOI 10.1890/14-1797.1; Collins BM, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00026.1; Colombaroli D, 2010, P NATL ACAD SCI USA, V107, P18909, DOI 10.1073/pnas.1007692107; Comer P., 2003, ECOLOGICAL SYSTEMS U; DellaSala DA., 2015, ECOLOGICAL IMPORTANC; DellaSala DA, 2014, NAT AREA J, V34, P310, DOI 10.3375/043.034.0317; Dennison PE, 2014, GEOPHYS RES LETT, V41, P2928, DOI 10.1002/2014GL059576; Dugan AJ, 2015, J VEG SCI, V26, P697, DOI 10.1111/jvs.12266; Eidenshink J., 2007, FIRE ECOL, V3, P3, DOI [DOI 10.4996/FIREECOLOGY.0301003, 10.4996/fireecology.0301003]; Fitch E.P, 2013, THESIS U NEW MEXICO; Foster DR, 1998, ECOSYSTEMS, V1, P497, DOI 10.1007/s100219900046; Frechettes JD, 2009, HOLOCENE, V19, P639, DOI 10.1177/0959683609104031; Fule PZ, 2014, GLOBAL ECOL BIOGEOGR, V23, P825, DOI 10.1111/geb.12136; Graves HS, 1917, INSTRUCTIONS MAKING; Hagmann RK, 2014, FOREST ECOL MANAG, V330, P158, DOI [10.1016/j.foreco.2014.0, 10.1016/j.foreco.2014.06.044]; Hagmann RK, 2013, FOREST ECOL MANAG, V304, P492, DOI 10.1016/j.foreco.2013.04.005; Hanson Chad T., 2014, Western Birds, V45, P204; Hanson CT, 2014, INT J WILDLAND FIRE, V23, P1, DOI 10.1071/WF13016; Hanson CT, 2009, CONSERV BIOL, V23, P1314, DOI 10.1111/j.1523-1739.2009.01265.x; Hanson CT, 2015, NATURAL ARE IN PRESS; Harris L, 2015, ECOSYSTEMS, V18, P1192, DOI 10.1007/s10021-015-9890-9; Hessburg PF, 2007, LANDSCAPE ECOL, V22, P5, DOI 10.1007/s10980-007-9098-2; Holden ZA, 2009, FOREST ECOL MANAG, V258, P2399, DOI 10.1016/j.foreco.2009.08.017; Hutto RL, 2008, ECOL APPL, V18, P1827, DOI 10.1890/08-0895.1; Jenkins SE, 2011, INT J WILDLAND FIRE, V20, P125, DOI 10.1071/WF09093; Jiang XY, 2013, J CLIMATE, V26, P3671, DOI 10.1175/JCLI-D-12-00430.1; Kauffman JB, 2004, CONSERV BIOL, V18, P878, DOI 10.1111/j.1523-1739.2004.545_1.x; Keane RE, 2009, FOREST ECOL MANAG, V258, P1025, DOI 10.1016/j.foreco.2009.05.035; Kennedy RG, 2006, WILDFIRE AM SAVE LIV; Kolden CA, 2012, FOREST ECOL MANAG, V286, P38, DOI 10.1016/j.foreco.2012.08.020; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Liu YQ, 2010, FOREST ECOL MANAG, V259, P685, DOI 10.1016/j.foreco.2009.09.002; Long CJ, 2011, QUATERNARY RES, V75, P151, DOI 10.1016/j.yqres.2010.08.010; Lutz JA, 2011, FIRE ECOL, V7, P51, DOI 10.4996/fireecology.0702051; Marlon JR, 2012, P NATL ACAD SCI USA, V109, pE535, DOI 10.1073/pnas.1112839109; Maxwell RS, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00294.1; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Miller JD, 2012, ECOL APPL, V22, P184, DOI 10.1890/10-2108.1; Miller JD, 2012, FIRE ECOL, V8, P41, DOI 10.4996/fireecology.0803041; Moritz MA, 2014, NATURE, V515, P58, DOI 10.1038/nature13946; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; O'Connor CD, 2014, FOREST ECOL MANAG, V329, P264, DOI 10.1016/j.foreco.2014.06.032; Odion DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087852; Pierce J, 2008, INT J WILDLAND FIRE, V17, P84, DOI 10.1071/WF07027; Pierce JL, 2004, NATURE, V432, P87, DOI 10.1038/nature03058; Rehfeldt GE, 2014, FOREST ECOL MANAG, V324, P126, DOI 10.1016/j.foreco.2014.02.035; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; Savage M, 2005, CAN J FOREST RES, V35, P967, DOI 10.1139/X05-028; Sherriff RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106971; Stavros EN, 2014, CLIMATIC CHANGE, V126, P455, DOI 10.1007/s10584-014-1229-6; Stephens SL, 2013, SCIENCE, V342, P41, DOI 10.1126/science.1240294; Stephens SL, 2007, FOREST ECOL MANAG, V251, P205, DOI 10.1016/j.foreco.2007.06.005; Stephens SL, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00379.1; Stephens SL, 2014, FRONT ECOL ENVIRON, V12, P115, DOI 10.1890/120332; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Swetnam TL, 2010, INT J WILDLAND FIRE, V19, P1, DOI 10.1071/WF08001; van Mantgem PJ, 2013, ECOL LETT, V16, P1151, DOI 10.1111/ele.12151; Van Wagtendonk J., 2007, FIRE ECOL, V4, P3; VANKAT JL, 1978, J BIOGEOGR, V5, P377, DOI 10.2307/3038030; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Williams MA, 2014, GLOBAL ECOL BIOGEOGR, V23, P831, DOI 10.1111/geb.12152; Williams MA, 2013, LANDSCAPE ECOL, V28, P297, DOI 10.1007/s10980-012-9835-z; Williams MA, 2012, GLOBAL ECOL BIOGEOGR, V21, P1042, DOI 10.1111/j.1466-8238.2011.00750.x; Williams MA, 2012, ECOSYSTEMS, V15, P832, DOI 10.1007/s10021-012-9549-8; Williams MA, 2010, J BIOGEOGR, V37, P707, DOI 10.1111/j.1365-2699.2009.02257.x; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7; Yue X, 2013, ATMOS ENVIRON, V77, P767, DOI 10.1016/j.atmosenv.2013.06.003; Zhu Z, 2006, RMRSGTR175 USDA FOR, P197	90	41	42	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136147	10.1371/journal.pone.0136147	http://dx.doi.org/10.1371/journal.pone.0136147			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351850	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800026
J	Cooper, R; Wang, CL; Singh, N				Cooper, Richard; Wang, Changlu; Singh, Narinderpal			Mark-Release-Recapture Reveals Extensive Movement of Bed Bugs (Cimex lectularius L.) within and between Apartments	PLOS ONE			English	Article							TRAUMATIC INSEMINATION; AGGREGATION BEHAVIOR; HEMIPTERA CIMICIDAE; SEXUAL CONFLICT; CARBON-DIOXIDE; CHEMICAL LURE; INFESTATION; RESPONSES; BIOLOGY; TRAP	Understanding movement and dispersal of the common bed bug (Cimex lectularius L.) under field conditions is important in the control of infestations and for managing the spread of bed bugs to new locations. We investigated bed bug movement within and between apartments using mark-release-recapture (m-r-r) technique combined with apartment-wide monitoring using pitfall-style interceptors. Bed bugs were collected, marked, and released in six apartments. The distribution of marked and unmarked bed bugs in these apartments and their 24 neighboring units were monitored over 32 days. Extensive movement of marked bed bugs within and between apartments occurred regardless of the number of bed bugs released or presence/absence of a host. Comparison of marked and unmarked bed bug distributions confirms that the extensive bed bug activity observed was not an artifact of the m-r-r technique used. Marked bed bugs were recovered in apartments neighboring five of six m-r-r apartments. Their dispersal rates at 14 or 15 d were 0.0-5.0%. The estimated number of bed bugs per apartment in the six m-r-r apartments was 2,433-14,291 at 4-7 d after release. Longevity of bed bugs in the absence of a host was recorded in a vacant apartment. Marked large nymphs (3rd -5th instar), adult females, and adult males continued to be recovered up to 57, 113, and 134 d after host absence, respectively. Among the naturally existing unmarked bed bugs, unfed small nymphs (1st -2nd instar) were recovered up to 134 d; large nymphs and adults were still found at 155 d when the study ended. Our findings provide important insight into the behavioral ecology of bed bugs in infested apartments and have significant implications in regards to eradication programs and managing the spread of bed bugs within multi-occupancy dwellings.	[Cooper, Richard; Wang, Changlu; Singh, Narinderpal] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Cooper, R (corresponding author), Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08903 USA.	rcooper@aesop.rutgers.edu	Wang, Changlu/P-1381-2014		Norm Ehmann Urban Pest Management Award; New Jersey Agricultural Experiment Station; USDA-National Institute for Food and Agriculture, Hatch Multistate [NJ08127]; Oregon and Washington State Pest Management Associations; USDA NIFA	Norm Ehmann Urban Pest Management Award; New Jersey Agricultural Experiment Station; USDA-National Institute for Food and Agriculture, Hatch Multistate; Oregon and Washington State Pest Management Associations; USDA NIFA(United States Department of Agriculture (USDA))	This project was partially funded by the Norm Ehmann Urban Pest Management Award and the New Jersey Agricultural Experiment Station and by the USDA-National Institute for Food and Agriculture, Hatch Multistate project number NJ08127. The Norm Ehmann Award was funded by the Oregon and Washington State Pest Management Associations and was managed by Washington State University. The Hatch Multistate Project is through the New Jersey Agricultural Experiment Station which is funded by USDA NIFA. None of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aak A, 2014, PHYSIOL ENTOMOL, V39, P199, DOI 10.1111/phen.12062; Anderson JF, 2009, MED VET ENTOMOL, V23, P99, DOI 10.1111/j.1365-2915.2008.00790.x; BELL WJ, 1990, ANNU REV ENTOMOL, V35, P447, DOI 10.1146/annurev.en.35.010190.002311; Booth W, 2012, J MED ENTOMOL, V49, P535, DOI 10.1603/ME11256; Cooper R, 2014, J ECON ENTOMOL, V107, P2171, DOI 10.1603/EC14195; Cooper RA, 2016, PEST MANAG SCI, V72, P45, DOI 10.1002/ps.3982; Doggett S. L., 2008, 6th International Conference on Urban Pests, Budapest, Hungary, 13-16 July 2008, P407; GRIFFITHS D, 1980, J ANIM ECOL, V49, P99, DOI 10.2307/4279; Haynes KF, 2008, PESTWORLD        MAR, P5; How YF, 2010, J MED ENTOMOL, V47, P305, DOI 10.1603/ME10004; Johnson CG, 1937, P ZOOL SOC LOND A-GE, V107, P107; Johnson CG, 1941, J HYG-CAMBRIDGE, V41, P345, DOI 10.1017/S0022172400012560; Kemper H, 1936, Z KLEINTIERK PELZTIE, V12, P1; KEMPER HEINRICH, 1930, ZEITSCHR WISS BIOL ABT A MORPH U OKOL TIERE, V19, P160, DOI 10.1007/BF00412294; Lehnert M., 2013, THESIS CLEMSON U; Marx R., 1955, Zeitschrift fuer Parasitenkunde, V17, P41; MELLANBY KENNETH, 1939, PARASITOLOGY, V31, P200, DOI 10.1017/S0031182000012762; National Pest Management Association, 2011, BEST MAN PRACT BED B; Naylor R., 2012, THESIS U SHEFFIELD; Olson JF, 2009, J INSECT PHYSIOL, V55, P580, DOI 10.1016/j.jinsphys.2009.03.001; Omori N., 1941, Journal of the Medical Association of Formosa, V60, P555; Pfiester Margie, 2009, American Entomologist, V55, P244; Pfiester M, 2009, J MED ENTOMOL, V46, P1015, DOI 10.1603/033.046.0506; Pinto L. J., 2007, BED BUG HDB COMPLETE; Polanco Andrea M., 2011, Insects, V2, P232, DOI 10.3390/insects2020232; Potter M. F., 2013, Pest Control Technology, V41, P72; Potter MF, 2013, PEST CONTROL TECHNOL, V41, P80; Potter MF, 2013, PEST CONTROL TECHNOL, V41, P78; Potter MF, 2013, PEST CONTROL TECHNOL, V41, P76; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Reis MD, 2011, INSECTS, V2, P185; RIVNAY EZEKIEL, 1932, PARASITOLOGY, V24, P121, DOI 10.1017/S0031182000020461; Romero A, 2010, J INSECT PHYSIOL, V56, P1516, DOI 10.1016/j.jinsphys.2010.04.025; Romero A, 2009, J MED ENTOMOL, V46, P51, DOI 10.1603/033.046.0107; Saenz VL, 2012, J MED ENTOMOL, V49, P865, DOI 10.1603/ME11202; Singh N, 2012, PSYCHE; Singh N, 2013, J ECON ENTOMOL, V106, P1802, DOI 10.1603/EC13075; STRADLIN.DJ, 1970, J ANIM ECOL, V39, P575, DOI 10.2307/2855; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Usinger R., 1966, MONOGRAPH CIMICIDAE, V7; Wang C., 2012, P POST DEM TRACK, P4; Wang CL, 2011, J ECON ENTOMOL, V104, P274, DOI 10.1603/EC10141; Wang CL, 2010, J ECON ENTOMOL, V103, P172, DOI 10.1603/EC09230; Wang CL, 2009, J MED ENTOMOL, V46, P566, DOI 10.1603/033.046.0322	44	39	40	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136462	10.1371/journal.pone.0136462	http://dx.doi.org/10.1371/journal.pone.0136462			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352145	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800036
J	Schaub, NJ; Le Beux, C; Miao, JJ; Linhardt, RJ; Alauzun, JG; Laurencin, D; Gilbert, RJ				Schaub, Nicholas J.; Le Beux, Clementine; Miao, Jianjun; Linhardt, Robert J.; Alauzun, Johan G.; Laurencin, Danielle; Gilbert, Ryan J.			The Effect of Surface Modification of Aligned Poly-L-Lactic Acid Electrospun Fibers on Fiber Degradation and Neurite Extension	PLOS ONE			English	Article							SPINAL-CORD REPAIR; SCHWANN-CELL MIGRATION; NERVE REGENERATION; PLASMA TREATMENT; ENGINEERED NANOFIBERS; PERIPHERAL-NERVE; AXONAL GROWTH; STEM-CELLS; SCAFFOLDS; OUTGROWTH	The surface of aligned, electrospun poly-L-lactic acid (PLLA) fibers was chemically modified to determine if surface chemistry and hydrophilicity could improve neurite extension from chick dorsal root ganglia. Specifically, diethylenetriamine (DTA, for amine functionalization), 2-(2-aminoethoxy) ethanol (AEO, for alcohol functionalization), or GRGDS (cell adhesion peptide) were covalently attached to the surface of electrospun fibers. Water contact angle measurements revealed that surface modification of electrospun fibers significantly improved fiber hydrophilicity compared to unmodified fibers (p < 0.05). Scanning electron microscopy (SEM) of fibers revealed that surface modification changed fiber topography modestly, with DTA modified fibers displaying the roughest surface structure. Degradation of chemically modified fibers revealed no change in fiber diameter in any group over a period of seven days. Unexpectedly, neurites from chick DRG were longest on fibers without surface modification (1651 +/- 488 mu m) and fibers containing GRGDS (1560 +/- 107 mu m). Fibers modified with oxygen plasma (1240 +/- 143 mu m) or DTA (1118 +/- 82 mu m) produced shorter neurites than the GRGDS or unmodified fibers, but were not statistically shorter than unmodified and GRGDS modified fibers. Fibers modified with AEO (844 +/- 151 mu m) were significantly shorter than unmodified and GRGDS modified fibers (p<0.05). Based on these results, we conclude that fiber hydrophilic enhancement alone on electrospun PLLA fibers does not enhance neurite outgrowth. Further work must be conducted to better understand why neurite extension was not improved on more hydrophilic fibers, but the results presented here do not recommend hydrophilic surface modification for the purpose of improving neurite extension unless a bioactive ligand is used.	[Schaub, Nicholas J.; Miao, Jianjun; Linhardt, Robert J.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Schaub, Nicholas J.; Linhardt, Robert J.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Le Beux, Clementine; Alauzun, Johan G.; Laurencin, Danielle] Univ Montpellier, Inst Charles Gerhardt Montpellier, CNRS, UMR 5253,ENSCM, F-34095 Montpellier 05, France; [Miao, Jianjun; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Montpellier; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Gilbert, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	gilber2@rpi.edu	Alauzun, Johan/B-2461-2010	Alauzun, Johan/0000-0002-6531-0750; Laurencin, Danielle/0000-0002-7445-0528	NSF CAREER Award [1105125]; University of Montpellier; Rensselaer Polytechnic Institute	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); University of Montpellier; Rensselaer Polytechnic Institute	This work was supported by NSF CAREER Award 1105125 to RJG and a Partnership University Fund between the University of Montpellier and the Rensselaer Polytechnic Institute.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084; Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295; Binder C, 2013, J BIOMED MATER RES B, V101, P1200, DOI 10.1002/jbm.b.32931; Bockelmann J, 2011, TISSUE ENG PT A, V17, P475, DOI 10.1089/ten.TEA.2010.0369; Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609; Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441; Chow WN, 2007, NEURON GLIA BIOL, V3, P119, DOI 10.1017/S1740925X07000580; Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004; Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020; Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285; Daud MFB, 2012, BIOMATERIALS, V33, P5901, DOI 10.1016/j.biomaterials.2012.05.008; Delgado-Rivera R, 2009, MATRIX BIOL, V28, P137, DOI 10.1016/j.matbio.2009.02.001; Downing TL, 2012, J CONTROL RELEASE, V161, P910, DOI 10.1016/j.jconrel.2012.05.034; Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3; Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w; Gilbert Ryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P125, DOI 10.1615/CritRevBiomedEng.v39.i2.30; GURRATH M, 1992, EUR J BIOCHEM, V210, P911, DOI 10.1111/j.1432-1033.1992.tb17495.x; He J, 2012, FRONT MATER SCI, V6, P1, DOI 10.1007/s11706-012-0157-5; He LM, 2010, ACTA BIOMATER, V6, P2960, DOI 10.1016/j.actbio.2010.02.039; Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006; Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013; Kijenska-Gawronska E, 2012, J BIOMED MATER RES B, V100B, P1093, DOI 10.1002/jbm.b.32676; Klinkhammer K, 2010, J MATER SCI-MATER M, V21, P2637, DOI 10.1007/s10856-010-4112-7; Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014; Leach MK, 2011, JOVE-J VIS EXP, DOI 10.3791/2389; Lee S, 2013, NAT PROTOC, V8, P771, DOI 10.1038/nprot.2013.039; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Lee YS, 2011, POLYMERS-BASEL, V3, P413, DOI 10.3390/polym3010413; Lee YS, 2013, J NEUROSCI, V33, P10591, DOI 10.1523/JNEUROSCI.1116-12.2013; Liu T, 2012, TISSUE ENG PT A, V18, P1057, DOI [10.1089/ten.tea.2011.0430, 10.1089/ten.TEA.2011.0430]; Liu T, 2012, J BIOMED MATER RES A, V100A, P236, DOI 10.1002/jbm.a.33271; Liu XA, 2010, J BIOMED MATER RES A, V94A, P1004, DOI 10.1002/jbm.a.32675; Liu Y, 2009, J BIOMED MATER RES A, V90A, P1092, DOI 10.1002/jbm.a.32165; Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648; Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015; Neal RA, 2012, J BIOMED MATER RES A, V100A, P406, DOI 10.1002/jbm.a.33204; Neal RA, 2009, TISSUE ENG PART C-ME, V15, P11, DOI 10.1089/ten.tec.2007.0366; Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652; Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011; Park SY, 2015, J TISSUE ENG REGEN M, V9, P66, DOI 10.1002/term.1615; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Prabhakaran MP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/45/455102; Qu J, 2013, J BIOMED MATER RES A, V101, P2667, DOI 10.1002/jbm.a.34551; Schaub NJ, 2013, BIONANOSCIENCE, V3, P329, DOI 10.1007/s12668-013-0100-y; Schaub NJ, 2013, ACS APPL MATER INTER, V5, P10173, DOI 10.1021/am402827g; Schaub NJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046026; Schense JC, 2000, NAT BIOTECHNOL, V18, P415, DOI 10.1038/74473; Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009; Teraoka F, 2006, DENT MATER J, V25, P560, DOI 10.4012/dmj.25.560; Valmikinathan CM, 2009, BIOMACROMOLECULES, V10, P1084, DOI 10.1021/bm8012499; von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9; Wang G, 2010, VITRO CELL DEV BIOL, V47, P234; Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020; Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001; Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308; Yu WW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-68; Zamani F, 2014, J BIOMED MATER RES A, V102, P506, DOI 10.1002/jbm.a.34703; Zuidema JM, 2014, BIOMATERIALS, V35, P1439, DOI 10.1016/j.biomaterials.2013.10.079	63	27	28	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136780	10.1371/journal.pone.0136780	http://dx.doi.org/10.1371/journal.pone.0136780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340351	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200016
J	Semren, N; Habel-Ungewitter, NC; Fernandez, IE; Konigshoff, M; Eickelberg, O; Stoger, T; Meiners, S				Semren, Nora; Habel-Ungewitter, Nunja C.; Fernandez, Isis E.; Koenigshoff, Melanie; Eickelberg, Oliver; Stoeger, Tobias; Meiners, Silke			Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis	PLOS ONE			English	Article							CONSTITUTIVE PROTEASOME; IN-VITRO; TGF-BETA; LUNG; CELLS; SITES; MODEL; MICE	Proteasome inhibition has been shown to prevent development of fibrosis in several organs including the lung. However, effects of proteasome inhibitors on lung fibrosis are controversial and cytotoxic side effects of the overall inhibition of proteasomal protein degradation cannot be excluded. Therefore, we hypothesized that local lung-specific application of a novel, selective proteasome inhibitor, oprozomib (OZ), provides antifibrotic effects without systemic toxicity in a mouse model of lung fibrosis. Oprozomib was first tested on the human alveolar epithelial cancer cell line A549 and in primary mouse alveolar epithelial type II cells regarding its cytotoxic effects on alveolar epithelial cells and compared to the FDA approved proteasome inhibitor bortezomib (BZ). OZ was less toxic than BZ and provided high selectivity for the chymotrypsin-like active site of the proteasome. In primary mouse lung fibroblasts, OZ showed significant anti-fibrotic effects, i.e. reduction of collagen I and a smooth muscle actin expression, in the absence of cytotoxicity. When applied locally into the lungs of healthy mice via instillation, OZ was well tolerated and effectively reduced proteasome activity in the lungs. In bleomycin challenged mice, however, locally applied OZ resulted in accelerated weight loss and increased mortality of treated mice. Further, OZ failed to reduce fibrosis in these mice. While upon systemic application OZ was well tolerated in healthy mice, it rather augmented instead of attenuated fibrotic remodelling of the lung in bleomycin challenged mice. To conclude, low toxicity and antifibrotic effects of OZ in pulmonary fibroblasts could not be confirmed for pulmonary fibrosis of bleomycin-treated mice. In light of these data, the use of proteasome inhibitors as therapeutic agents for the treatment of fibrotic lung diseases should thus be considered with caution.	[Semren, Nora; Habel-Ungewitter, Nunja C.; Fernandez, Isis E.; Koenigshoff, Melanie; Eickelberg, Oliver; Stoeger, Tobias; Meiners, Silke] Univ Munich, Univ Hosp, Helmholtz Zentrum Munchen, CPC, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Meiners, S (corresponding author), Univ Munich, Univ Hosp, Helmholtz Zentrum Munchen, CPC, Munich, Germany.	silke.meiners@helmholtz-muenchen.de	Meiners, S/M-9822-2014; Stöger, Tobias/M-9861-2014	Meiners, S/0000-0003-3678-7995; Stöger, Tobias/0000-0002-2790-0389	thre Bundesministerium fur Bildung und Forschung (BMBF) [16EX1022N]; graduate school of the Comprehensive Pneumology Center	thre Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); graduate school of the Comprehensive Pneumology Center	SM and TS received funding by a grant of thre Bundesministerium fur Bildung und Forschung (BMBF) m4 (16EX1022N). NS and NHU were supported by the graduate school of the Comprehensive Pneumology Center.	Ahluwalia N, 2014, AM J RESP CRIT CARE, V190, P867, DOI 10.1164/rccm.201403-0509PP; Aumiller V, 2013, AM J RESP CELL MOL, V49, P96, DOI 10.1165/rcmb.2012-0524OC; Beck P, 2012, BIOL CHEM, V393, P1101, DOI 10.1515/hsz-2012-0212; Bieler S, 2009, PROTEOMICS, V9, P3257, DOI 10.1002/pmic.200800927; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Britton M, 2009, CHEM BIOL, V16, P1278, DOI 10.1016/j.chembiol.2009.11.015; Chauhan D, 2010, BLOOD, V116, P4906, DOI 10.1182/blood-2010-04-276626; Chou TF, 2011, J BIOL CHEM, V286, P16546, DOI 10.1074/jbc.M110.215319; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Dick LR, 2010, DRUG DISCOV TODAY, V15, P243, DOI 10.1016/j.drudis.2010.01.008; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Fine-Schi S, 2008, AM J RESP CELL MOL, V39, P458, DOI 10.1165/rcmb.2007-0320OC; Fineschi S, 2006, FASEB J, V20, P562, DOI 10.1096/fj.05-4870fje; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Goldman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018269; Haghi M, 2014, PHARMACOL THERAPEUT, V144, P235, DOI 10.1016/j.pharmthera.2014.05.003; Herndon TM, 2013, CLIN CANCER RES, V19, P4559, DOI 10.1158/1078-0432.CCR-13-0755; Hillebrandt S, 2002, GASTROENTEROLOGY, V123, P2041, DOI 10.1053/gast.2002.37069; Horie M, 2013, TOXICOL MECH METHOD, V23, P315, DOI 10.3109/15376516.2012.755595; Huber EM, 2012, ANGEW CHEM INT EDIT, V51, P8708, DOI 10.1002/anie.201201616; John G, 2014, CLIN SCI, V126, P207, DOI 10.1042/CS20130117; Kabanov AV, 2000, AMPHIPHILIC BLOCK COPOLYMERS: SELF-ASSEMBLY AND APPLICATIONS, P347, DOI 10.1016/B978-044482441-7/50016-5; Kimbrel EA, 2009, MOL IMAGING, V8, P140, DOI 10.2310/7290.2009.00007; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Koca SS, 2012, INFLAMMATION, V35, P810, DOI 10.1007/s10753-011-9380-y; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Malmsten M, 2000, AMPHIPHILIC BLOCK COPOLYMERS: SELF-ASSEMBLY AND APPLICATIONS, P319, DOI 10.1016/B978-044482441-7/50015-3; Meiners S, 2004, HYPERTENSION, V44, P471, DOI 10.1161/01.HYP.0000142772.71367.65; Meiners S, 2008, MED RES REV, V28, P309, DOI 10.1002/med.20111; Meiners S, 2006, FREE RADICAL BIO MED, V40, P2232, DOI 10.1016/j.freeradbiomed.2006.03.003; Meiners S, 2014, ANTIOXID REDOX SIGN, V21, P2364, DOI 10.1089/ars.2013.5798; Mirabella AC, 2011, CHEM BIOL, V18, P608, DOI 10.1016/j.chembiol.2011.02.015; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Mutlu GM, 2012, THORAX, V67, P139, DOI 10.1136/thoraxjnl-2011-200717; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2011, NAT REV DRUG DISCOV, V10, P489, DOI 10.1038/nrd3495; Roccaro AM, 2010, BLOOD, V115, P4051, DOI 10.1182/blood-2009-09-243402; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Sakairi T, 2011, NEPHROLOGY, V16, P76, DOI 10.1111/j.1440-1797.2010.01367.x; Soond SM, 2011, BIOESSAYS, V33, P749, DOI 10.1002/bies.201100057; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Weiss Curtis H, 2010, Proc Am Thorac Soc, V7, P77, DOI 10.1513/pats.200906-055JS; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zang Y, 2012, CLIN CANCER RES, V18, P5639, DOI 10.1158/1078-0432.CCR-12-1213	49	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136188	10.1371/journal.pone.0136188	http://dx.doi.org/10.1371/journal.pone.0136188			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340365	gold, Green Submitted, Green Published			2022-12-27	WOS:000360688200006
J	Tabe, Y; Kojima, K; Yamamoto, S; Sekihara, K; Matsushita, H; Davis, RE; Wang, ZQ; Ma, WC; Ishizawa, J; Kazuno, S; Kauffman, M; Shacham, S; Fujimura, T; Ueno, T; Miida, T; Andreeff, M				Tabe, Yoko; Kojima, Kensuke; Yamamoto, Shinichi; Sekihara, Kazumasa; Matsushita, Hiromichi; Davis, Richard Eric; Wang, Zhiqiang; Ma, Wencai; Ishizawa, Jo; Kazuno, Saiko; Kauffman, Michael; Shacham, Sharon; Fujimura, Tsutomu; Ueno, Takashi; Miida, Takashi; Andreeff, Michael			Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185	PLOS ONE			English	Article							MANTLE CELL LYMPHOMA; RESPONSIVE TRANSCRIPTION FACTOR; GENE-EXPRESSION; CANCER CELLS; CYCLIN D1; PROLIFERATION; PROTEIN; CRM1; KINASE; SIGNAL	Mantle cell lymphoma (MCL) is an aggressive B-cell lymphoma characterized by the aberrant expression of several growth-regulating, oncogenic effectors. Exportin 1 (XPO1) mediates the nucleocytoplasmic transport of numerous molecules including oncogenic growth-regulating factors, RNAs, and ribosomal subunits. In MCL cells, the small molecule KPT-185 blocks XPO1 function and exerts anti-proliferative effects. In this study, we investigated the molecular mechanisms of this putative anti-tumor effect on MCL cells using cell growth/viability assays, immunoblotting, gene expression analysis, and absolute quantification proteomics. KPT-185 exhibited a p53-independent anti-lymphoma effect on MCL cells, by suppression of oncogenic mediators (e.g., XPO1, cyclin D1, c-Myc, PIM1, and Bcl-2 family members), repression of ribosomal biogenesis, and downregulation of translation/chaperone proteins (e.g., PIM2, EEF1A1, EEF2, and HSP70) that are part of the translational/transcriptional network regulated by heat shock factor 1. These results elucidate a novel mechanism in which ribosomal biogenesis appears to be a key component through which XPO1 contributes to tumor cell survival. Thus, we propose that the blockade of XPO1 could be a promising, novel strategy for the treatment of MCL and other malignancies overexpressing XPO1.	[Tabe, Yoko; Kojima, Kensuke; Ishizawa, Jo; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Tabe, Yoko; Yamamoto, Shinichi; Sekihara, Kazumasa; Miida, Takashi] Juntendo Univ, Biomed Res Ctr, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan; [Yamamoto, Shinichi; Sekihara, Kazumasa] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Leading Ctr Dev & Res Canc Med, Tokyo, Japan; [Matsushita, Hiromichi] Tokai Univ Med, Dept Lab Med, Shibuya, Kanagawa, Japan; [Davis, Richard Eric; Wang, Zhiqiang; Ma, Wencai] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Kazuno, Saiko; Fujimura, Tsutomu; Ueno, Takashi] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Lab Prote & Biomol Sci, Tokyo, Japan; [Kauffman, Michael; Shacham, Sharon] Karyopharm Therapeut Inc, Natick, MA USA	University of Texas System; UTMD Anderson Cancer Center; Juntendo University; Juntendo University; University of Texas System; UTMD Anderson Cancer Center; Juntendo University	Andreeff, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA.	mandreef@mdanderson.org	松下, 弘道/AEX-6164-2022; Miida, Takashi/A-5589-2012	松下, 弘道/0000-0002-1629-6630; Miida, Takashi/0000-0002-4294-8030; Fujimura, Tsutomu/0000-0003-1744-7725	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan [S1311011]; National Institutes of Health [CA055164, CA083639, CA136411, CA100632, CA016672]; Paul and Mary Haas Chair in Genetics; NATIONAL CANCER INSTITUTE [P01CA055164, P50CA100632, P50CA136411, P50CA083639, P30CA016672] Funding Source: NIH RePORTER	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul and Mary Haas Chair in Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Grant-in-Aid for Scientific Research (C), Japan and by Grant-in-Aid (S1311011) from the Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan (to Y.T.), the National Institutes of Health awards (CA055164, CA083639, CA136411, CA100632 and the MD Anderson's Cancer Center Support Grant CA016672), and by the Paul and Mary Haas Chair in Genetics to (M.A.). Karyopharm Therapeutics Inc. also provided support in the form of salaries for M. Kauffman and S. Shacham, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Azmi AS, 2013, HAEMATOLOGICA, V98, P1098, DOI 10.3324/haematol.2012.074781; Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Benzeno S, 2004, J BIOL CHEM, V279, P56061, DOI 10.1074/jbc.M411910200; Bernard M, 2001, LEUKEMIA, V15, P1785, DOI 10.1038/sj.leu.2402272; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; de Billy E, 2012, ONCOTARGET, V3, P741; Ding LH, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn234; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Donati G, 2011, J CELL SCI, V124, P3017, DOI 10.1242/jcs.086074; Ekins S, 2006, XENOBIOTICA, V36, P877, DOI 10.1080/00498250600861660; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Flinn I, 2014, ASCO M, V32, P8518; Fukasawa M, 2010, BIOCHEM BIOPH RES CO, V391, P1166, DOI 10.1016/j.bbrc.2009.11.115; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gaubatz S, 2001, MOL CELL BIOL, V21, P1384, DOI 10.1128/MCB.21.4.1384-1392.2001; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Gomez-Abad C, 2011, BLOOD, V118, P5517, DOI 10.1182/blood-2011-03-344374; Gravina GL, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0085-1; Grimm T, 2006, NUCLEIC ACIDS RES, V34, P3030, DOI 10.1093/nar/gkl378; HAMAMOTO T, 1983, J ANTIBIOT, V36, P646, DOI 10.7164/antibiotics.36.646; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Hinnebusch AG, 2012, MOL CELL, V46, P717, DOI 10.1016/j.molcel.2012.06.001; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Iadevaia V, 2010, ONCOGENE, V29, P5490, DOI 10.1038/onc.2010.279; Kojima K, 2013, BLOOD, V121, P4166, DOI 10.1182/blood-2012-08-447581; Lapalombella R, 2012, BLOOD, V120, P4621, DOI 10.1182/blood-2012-05-429506; Li J, 2009, CANCER SCI, V100, P2255, DOI 10.1111/j.1349-7006.2009.01325.x; Liu F, 2013, EUR J HAEMATOL, V90, P51, DOI 10.1111/ejh.12030; Longworth J, 2012, J PROTEOME RES, V11, P5959, DOI 10.1021/pr300692t; Ma WC, 2010, CANCER EPIDEM BIOMAR, V19, P2445, DOI 10.1158/1055-9965.EPI-10-0565; Martin P, 2008, ANN ONCOL, V19, P1327, DOI 10.1093/annonc/mdn045; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Nagy B, 2003, BRIT J HAEMATOL, V120, P434, DOI 10.1046/j.1365-2141.2003.04121.x; Naud JF, 2007, NAT CELL BIOL, V9, P873, DOI 10.1038/ncb0807-873; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Quintanilla-Martinez L, 2003, BLOOD, V101, P3181, DOI 10.1182/blood-2002-01-0263; Rahal R, 2014, NAT MED, V20, P87, DOI 10.1038/nm.3435; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Savona M, 2013, BLOOD, V122; Sengupta J, 2010, J CELL BIOL, V189, P1079, DOI 10.1083/jcb.201001124; Tabe Y, 2014, ACTA HAEMATOL-BASEL, V131, P59, DOI 10.1159/000353164; Tai YT, 2014, LEUKEMIA, V28, P155, DOI 10.1038/leu.2013.115; Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Topisirovic I, 2009, EMBO J, V28, P1087, DOI 10.1038/emboj.2009.53; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Wang Shumin, 2014, Biomed Res Int, V2014, P507353, DOI 10.1155/2014/507353; Xu DR, 2012, MOL BIOL CELL, V23, P3673, DOI 10.1091/mbc.E12-01-0045; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yoshimura M, 2014, CANCER SCI, V105, P795, DOI 10.1111/cas.12430; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Zhang KJ, 2013, EXP HEMATOL, V41, P67, DOI 10.1016/j.exphem.2012.09.002; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	60	21	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137210	10.1371/journal.pone.0137210	http://dx.doi.org/10.1371/journal.pone.0137210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340096	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200034
J	Dube, FS; van Mens, SP; Robberts, L; Wolter, N; Nicol, P; Mafofo, J; Africa, S; Zar, HJ; Nicol, MP				Dube, Felix S.; van Mens, Suzan P.; Robberts, Lourens; Wolter, Nicole; Nicol, Paul; Mafofo, Joseph; Africa, Samantha; Zar, Heather J.; Nicol, Mark P.			Comparison of a Real-Time Multiplex PCR and Sequetyping Assay for Pneumococcal Serotyping	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CAPSULAR SEROTYPES; CONJUGATE VACCINE; CHILDREN; DISEASE; EPIDEMIOLOGY; COLONIZATION; DISCOVERY; DIAGNOSIS; CARRIAGE	Background Pneumococcal serotype identification is essential to monitor pneumococcal vaccine effectiveness and serotype replacement. Serotyping by conventional serological methods are costly, labour-intensive, and require significant technical expertise. We compared two different molecular methods to serotype pneumococci isolated from the nasopharynx of South African infants participating in a birth cohort study, the Drakenstein Child Health Study, in an area with high 13-valent pneumococcal conjugate vaccine (PCV13) coverage. Methods A real-time multiplex PCR (rmPCR) assay detecting 21 different serotypes/-groups and a sequetyping assay, based on the sequence of the wzh gene within the pneumococcal capsular locus, were compared. Forty pneumococcal control isolates, with serotypes determined by the Quellung reaction, were tested. In addition, 135 pneumococcal isolates obtained from the nasopharynx of healthy children were tested by both serotyping assays and confirmed by Quellung testing. Discordant results were further investigated by whole genome sequencing of four isolates. Results Of the 40 control isolates tested, 25 had a serotype covered by the rmPCR assay. These were all correctly serotyped/-grouped. Sequetyping PCR failed in 7/40 (18%) isolates. For the remaining isolates, sequetyping assigned the correct serotype/-group to 29/33 (88%) control isolates. Of the 132/135 (98%) nasopharyngeal pneumococcal isolates that could be typed, 69/132 (52%) and 112/132 (85%) were assigned the correct serotype/-group by rmPCR and sequetyping respectively. The serotypes of 63/132 (48%) isolates were not included in the rmPCR panel. All except three isolates (serotype 25A and 38) were theoretically amplified and differentiated into the correct serotype/-group with some strains giving ambigous results (serotype 13/20, 17F/33C, and 11A/D/1818F). Of the pneumococcal serotypes detected in this study, 69/91 (76%) were not included in the current PCV13. The most frequently identified serotypes were 11A, 13, 15B/15C, 16F and 10A. Conclusion The rmPCR assay performed well for the 21 serotypes/-groups included in the assay. However, in our study setting, a large proportion of serotypes were not detected by rmPCR. The sequetyping assay performed well, but did misassign specific serotypes. It may be useful for regions where vaccine serotypes are less common, however confirmatory testing is advisable.	[Dube, Felix S.; van Mens, Suzan P.; Robberts, Lourens; Africa, Samantha; Nicol, Mark P.] Univ Cape Town, Fac Hlth Sci, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [van Mens, Suzan P.] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands; [Nicol, Mark P.] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Zar, Heather J.] Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa; [Zar, Heather J.] Univ Cape Town, MRC Unit Child & Adolesscent Hlth, ZA-7925 Cape Town, South Africa; [Wolter, Nicole] Natl Hlth Lab Serv, Natl Inst Communicable Dis, CRDM, Johannesburg, South Africa; [Wolter, Nicole] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Nicol, Paul] Murdoch Univ, State Agr Biotechnol Ctr, Murdoch, WA 6150, Australia; [Mafofo, Joseph] CPGR, Cape Town, South Africa	University of Cape Town; St. Antonius Hospital Utrecht; University of Cape Town; University of Cape Town; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Murdoch University	Dube, FS (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Med Microbiol, ZA-7925 Cape Town, South Africa.	fdube82@gmail.com	Nicol, Mark/W-4149-2019; Zar, Heather/GZL-5350-2022	Nicol, Mark/0000-0002-1366-4805; Zar, Heather/0000-0002-9046-759X; Mafofo, Joseph/0000-0003-1964-1708; Dube, Felix Sizwe/0000-0003-2775-7786; Robberts, Lourens/0000-0003-4397-4852	Bill and Melinda Gates Foundation Global Health Grant [OPP1017641]; H3Africa [1U01 HG006961-01]; National Research Foundation of South Africa; St Antonius Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI110466] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation Global Health Grant; H3Africa; National Research Foundation of South Africa(National Research Foundation - South Africa); St Antonius Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by grants from the Bill and Melinda Gates Foundation Global Health Grant (OPP1017641) and H3Africa (1U01 HG006961-01). Felix S. Dube is supported by the National Research Foundation of South Africa; S.P. van Mens received funding from the St Antonius Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.12.20750; Andrews S, 2011, FASTQC QUALITY CONTR; [Anonymous], 2006, KONEMANSS COLOR ATLA; Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81; AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Batt SL, 2005, J CLIN MICROBIOL, V43, P2656, DOI 10.1128/JCM.43.6.2656-2661.2005; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Blaschke AJ, 2011, CLIN INFECT DIS, V52, pS331, DOI 10.1093/cid/cir048; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Bronsdon MA, 2004, J CLIN MICROBIOL, V42, P1596, DOI 10.1128/JCM.42.4.1596-1600.2004; Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Coles CL, 2009, TROP MED INT HEALTH, V14, P1025, DOI 10.1111/j.1365-3156.2009.02331.x; Dhoubhadel BG, 2014, J MED MICROBIOL, V63, P528, DOI 10.1099/jmm.0.071464-0; Dube FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068097; Guevara M, 2014, VACCINE, V32, P2553, DOI 10.1016/j.vaccine.2014.03.054; Jauneikaite E, 2015, J MICROBIOL METH, V113, P41, DOI 10.1016/j.mimet.2015.03.006; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kaplan SL, 2013, PEDIATR INFECT DIS J, V32, P203, DOI 10.1097/INF.0b013e318275614b; le Roux DM, 2015, LANCET GLOB HEALTH, V3, pE95, DOI 10.1016/S2214-109X(14)70360-2; Leung MH, 2012, J CLIN MICROBIOL, V50, P2419, DOI 10.1128/JCM.06384-11; Leung MHY, 2011, INFECT GENET EVOL, V11, P1989, DOI 10.1016/j.meegid.2011.09.002; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Massire C, 2012, J CLIN MICROBIOL, V50, P2018, DOI 10.1128/JCM.06735-11; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Moore CE, 2010, AM J TROP MED HYG, V83, P451, DOI 10.4269/ajtmh.2010.10-0225; Nunes MC, 2014, VACCINE; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; O'Sullivan MVN, 2011, JOVE-J VIS EXP, DOI 10.3791/2781; Olarte L, 2014, PEDIATR INFECT DIS J; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Resti M, 2010, CLIN INFECT DIS, V51, P1042, DOI 10.1086/656579; Richter SS, 2013, J CLIN MICROBIOL, V51, P4193, DOI 10.1128/JCM.01876-13; Rivera-Olivero IA, 2009, J MED MICROBIOL, V58, P584, DOI 10.1099/jmm.0.006726-0; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Selva L, 2012, J CLIN MICROBIOL, V50, P3451, DOI 10.1128/JCM.01368-12; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Van Hoek AJ, 2014, VACCINE; Von Gottberg A, 2013, EPIDEMIOLOGY OF INVA; Wang H, 2014, LANCET; Wasas AD, 1998, J CLIN MICROBIOL, V36, P1139, DOI 10.1128/JCM.36.4.1139-1140.1998	52	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137349	10.1371/journal.pone.0137349	http://dx.doi.org/10.1371/journal.pone.0137349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335454	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400051
J	Aubin, T; Jouventin, P; Charrier, I				Aubin, Thierry; Jouventin, Pierre; Charrier, Isabelle			Mother Vocal Recognition in Antarctic Fur Seal Arctocephalus gazella Pups: A Two-Step Process	PLOS ONE			English	Article							ACOUSTIC COMMUNICATION; IDENTIFY; COLONY	In otariids, mother's recognition by pups is essential to their survival since females nurse exclusively their own young and can be very aggressive towards non-kin. Antarctic fur seal, Arctocephalus gazella, come ashore to breed and form dense colonies. During the 4-month lactation period, females alternate foraging trips at sea with suckling period ashore. On each return to the colony, females and pups first use vocalizations to find each other among several hundred conspecifics and olfaction is used as a final check. Such vocal identification has to be highly efficient. In this present study, we investigated the components of the individual vocal signature used by pups to identify their mothers by performing playback experiments on pups with synthetic signals. We thus tested the efficiency of this individual vocal signature by performing propagation tests and by testing pups at different playback distances. Pups use both amplitude and frequency modulations to identify their mother's voice, as well as the energy spectrum. Propagation tests showed that frequency modulations propagated reliably up to 64m, whereas amplitude modulations and spectral content greatly were highly degraded for distances over 8m. Playback on pups at different distances suggested that the individual identification is a two-step process: at long range, pups identified first the frequency modulation pattern of their mother's calls, and other components of the vocal signature at closer range. The individual vocal recognition system developed by Antarctic fur seals is well adapted to face the main constraint of finding kin in a crowd.	[Aubin, Thierry; Charrier, Isabelle] Univ Paris 11, NeuroPSI, UMR 9197, F-91405 Orsay, France; [Aubin, Thierry; Charrier, Isabelle] CNRS, F-91405 Orsay, France; [Jouventin, Pierre] CEFE, UMR 5175, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Aubin, T (corresponding author), Univ Paris 11, NeuroPSI, UMR 9197, F-91405 Orsay, France.	thierry.aubin@u-psud.fr		CHARRIER, Isabelle/0000-0003-4873-2342	French Polar Institute, (IPEV) [ETHOTAAF 354]	French Polar Institute, (IPEV)	This field research was part of the program ETHOTAAF 354, program funded by the French Polar Institute, (IPEV).	Arnould JPY, 2001, BEHAV ECOL SOCIOBIOL, V50, P461, DOI 10.1007/s002650100386; Aubin T, 1998, P ROY SOC B-BIOL SCI, V265, P1665, DOI 10.1098/rspb.1998.0486; Aubin T, 2002, ADV STUD BEHAV, V31, P243, DOI 10.1016/S0065-3454(02)80010-9; AUBIN T, 1994, BIOACOUSTICS, V6, P80; Aubin Thierry, 1995, Bioacoustics, V6, P153; BONESS DJ, 1991, DETERMINANTS MATING; BONNER WN, 1968, FUR SEAL S GEORGIA; Charrier I, 2001, ETHOLOGY, V107, P961, DOI 10.1046/j.1439-0310.2001.00748.x; Charrier I, 2002, J EXP BIOL, V205, P603; Charrier I, 2003, ANIM BEHAV, V65, P543, DOI 10.1006/anbe.2003.2073; Charrier I, 2010, ANIM COGN, V13, P471, DOI 10.1007/s10071-009-0298-9; Charrier I, 2009, ANIM BEHAV, V78, P1127, DOI 10.1016/j.anbehav.2009.07.032; Dehnhardt G, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P116; Dobson FS, 2003, BEHAV PROCESS, V61, P77, DOI 10.1016/S0376-6357(02)00164-X; DOIDGE DW, 1989, POLAR BIOL, V9, P155, DOI 10.1007/BF00297170; Halliday TR., 1983, ANIM BEHAV, P43; HARCOURT R, 1992, J ZOOL, V226, P259, DOI 10.1111/j.1469-7998.1992.tb03838.x; Harcourt R, 1992, CAN J ZOOL; Insley Stephen J., 2003, Aquatic Mammals, V29, P181, DOI 10.1578/016754203101024149; KONISHI M, 1973, AM SCI, V61, P414; Lea MA, 2002, POLAR BIOL, V25, P269, DOI 10.1007/s00300-001-0339-6; Naguib M, 1996, BEHAVIOUR, V133, P541, DOI 10.1163/156853996X00206; Nyamsi Ruben G. Mbu, 1994, Bioacoustics, V5, P187; Page Brad, 2002, Bioacoustics, V13, P121; Pitcher BJ, 2012, ANIM BEHAV, V83, P681, DOI 10.1016/j.anbehav.2011.12.012; Pitcher BJ, 2011, BIOL LETTERS, V7, P60, DOI 10.1098/rsbl.2010.0569; Pitcher BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012195; Pitcher BJ, 2009, NATURWISSENSCHAFTEN, V96, P901, DOI 10.1007/s00114-009-0546-5; Randall R.B., 1987, FREQUENCY ANAL; SEGGIE D, 1987, PROCESSING I ACOUSTI, V8, P82; Stirling I, 1975, PROC VERB REUN, P169; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wartzok Douglas, 1999, P117; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047	34	13	13	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134513	10.1371/journal.pone.0134513	http://dx.doi.org/10.1371/journal.pone.0134513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331475	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800011
J	Lai, CWK; Law, HKW				Lai, Christopher W. K.; Law, Helen K. W.			Mammographic Breast Density in Chinese Women: Spatial Distribution and Autocorrelation Patterns	PLOS ONE			English	Article							SEGMENTATION; CANCER; RISK; TISSUE; TOOL	Mammographic breast density (MBD) is a strong risk factor for breast cancer. The spatial distribution of MBD in the breast is variable and dependent on physiological, genetic, environmental and pathological factors. This pilot study aims to define the spatial distribution and autocorrelation patterns of MBD in Chinese women aged 40-60. By analyzing their digital mammographic images using a public domain Java image processing program for segmentation and quantification of MBD, we found their left and right breasts were symmetric to each other in regard to their breast size (Total Breast Area), the amount of BMD (overall PD) and Moran's I values. Their MBD was also spatially autocorrelated together in the anterior part of the breast in those with a smaller breast size, while those with a larger breast size tend to have their MBD clustered near the posterior part of the breast. Finally, we observed that the autocorrelation pattern of MBD was dispersed after a 3-year observation period.	[Lai, Christopher W. K.; Law, Helen K. W.] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, HKSAR, Peoples R China	Hong Kong Polytechnic University	Lai, CWK (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, HKSAR, Peoples R China.	chris.lai@polyu.edu.hk	Lai, Christopher Wai Keung/A-3852-2014	Lai, Christopher Wai Keung/0000-0002-8010-7232	HKCRRT Research Fund [HKCRRT 2013]	HKCRRT Research Fund	This work is supported partly by the HKCRRT Research Fund (HKCRRT 2013), www.hkcrrt.org. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Couwenberg AM, 2014, CANCER CAUSE CONTROL, V25, P1037, DOI 10.1007/s10552-014-0404-4; Ferrari RJ, 2004, MED BIOL ENG COMPUT, V42, P378, DOI 10.1007/BF02344714; Ferrari RJ, 2004, MED BIOL ENG COMPUT, V42, P201, DOI 10.1007/BF02344632; Ganesan K, 2013, COMPUT METH PROG BIO, V110, P48, DOI 10.1016/j.cmpb.2012.10.020; Haars G, 2005, CANCER EPIDEM BIOMAR, V14, P2634, DOI 10.1158/1055-9965.EPI-05-0824; Habel LA, 2007, MENOPAUSE, V14, P891, DOI 10.1097/gme.0b013e318032569c; Harris HR, 2011, AM J EPIDEMIOL; Heine JJ, 2008, CANCER EPIDEM BIOMAR, V17, P3090, DOI 10.1158/1055-9965.EPI-08-0170; Heine JJ, 2011, ACAD RADIOL, V18, P547, DOI 10.1016/j.acra.2010.12.007; Iatrakis G, 2011, J Med Life, V4, P310; Kallenberg MGJ, 2011, PHYS MED BIOL, V56, P2715, DOI 10.1088/0031-9155/56/9/005; Li JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3238; Lokate M, 2011, BREAST CANCER RES, V13, P1; Malkov S, 2010, LECT NOTES COMPUT SC, V6136, P402, DOI 10.1007/978-3-642-13666-5_54; Nickson C, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3474; Oliver A, 2010, J DIGIT IMAGING, V23, P527, DOI 10.1007/s10278-009-9217-5; Pereira SMP, 2011, CANCER EPIDEM BIOMAR, V20, P1718, DOI 10.1158/1055-9965.EPI-11-0423; Pereira SMP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2318; Stone J, 2003, CANCER EPIDEM BIOMAR, V12, P625; TURNBULL AE, 1993, CLIN RADIOL, V48, P38, DOI 10.1016/S0009-9260(05)80105-9; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Vachon CM, 2007, CANCER RES, V67, P8412, DOI 10.1158/0008-5472.CAN-07-1076	22	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136881	10.1371/journal.pone.0136881	http://dx.doi.org/10.1371/journal.pone.0136881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332221	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800078
J	Li, H; Kuman, K; Li, CR				Li, Hao; Kuman, Kathleen; Li, Chaorong			Quantifying the Reduction Intensity of Handaxes with 3D Technology: A Pilot Study on Handaxes in the Danjiangkou Reservoir Region, Central China	PLOS ONE			English	Article							LARGE CUTTING TOOLS; FLAKE SCAR DENSITY; STONE TECHNOLOGY; GEOMETRIC INDEX; USE-LIFE	This paper presents an approach to analyzing the reduction intensity of handaxes with the aid of 3D scanning technology. Two quantitative reduction indices, the Scar Density Index (SDI) and the Flaked Area Index (FAI), are applied to handaxes from the third terrace of the Danjiangkou Reservoir Region (DRR), central China, dated to the Middle Pleistocene. The results show that most of the DRR handaxes in this sample show moderate reduction, which also reflects a least-effort reduction strategy and a generally short use-life for these tools. Detailed examination of the DRR handaxes by sector reveals that the tips generally show the most reduction, while the bases show the least shaping, with cortex often preserved on the base to facilitate handling. While western Acheulean assemblages in this regard are variable, there are many examples of handaxes of varying age with trimming of the bases. We also found no significant differences in the levels of reduction between the two main raw materials, quartz phyllite and trachyte. However, the type of blank used (large flakes versus cobbles) and the type of shaping (bifacial, partly bifacial and unifacial) do play a significant role in the reduction intensity of the DRR handaxes. Finally, a small number of handaxes from the younger (the early Late Pleistocene) second terrace of the DRR was compared with those from the third terrace. The results indicate that there is no technological change in the reduction intensity through time in these two DRR terraces.	[Li, Hao; Li, Chaorong] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Li, Hao; Kuman, Kathleen] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Kuman, Kathleen] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Witwatersrand; University of Witwatersrand	Li, H (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	wits_ivpp@hotmail.com	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210; Kuman, Kathleen/0000-0003-1252-9895	Chinese Government Graduate Student Overseas Study Program [[2013] 3009]; Chinese Natural Science Foundation [40972016]; Cultural Relics Protection Research Project of Hubei Reservoir Area of South-North Water Diversion Foundation [NK02]; CAS Pioneer Hundred Talents Program; China-South Africa Bilateral Programme in Palaeosciences, through grants provided by the Ministry of Science and Technology of China [2007DFB20330]; National Research Foundation of South Africa [68625]; NRF [68625]	Chinese Government Graduate Student Overseas Study Program; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Cultural Relics Protection Research Project of Hubei Reservoir Area of South-North Water Diversion Foundation; CAS Pioneer Hundred Talents Program; China-South Africa Bilateral Programme in Palaeosciences, through grants provided by the Ministry of Science and Technology of China; National Research Foundation of South Africa(National Research Foundation - South Africa); NRF	This research has been funded by: the Chinese Government Graduate Student Overseas Study Program (grant number [2013] 3009); the Chinese Natural Science Foundation (grant number 40972016); the Cultural Relics Protection Research Project of Hubei Reservoir Area of South-North Water Diversion Foundation (grant number NK02); the CAS Pioneer Hundred Talents Program; the China-South Africa Bilateral Programme in Palaeosciences, through grants provided by the Ministry of Science and Technology of China to Prof. Liu Wu (Institute of Vertebrate Paleontology and Paleoanthropology, Chinese Academy of Sciences, grant number 2007DFB20330) and by the National Research Foundation of South Africa to Prof. R.J. Clarke (University of the Witwatersrand, grant number 68625). Current funding is provided by grants in the same programme to Prof. Gao Xing (IVPP) and to K. Kuman (NRF grant number 88480).	Archer W, 2010, J ARCHAEOL SCI, V37, P201, DOI 10.1016/j.jas.2009.09.033; Braun DR, 2009, ARCHAEOMETRY, V51, P26, DOI 10.1111/j.1475-4754.2008.00393.x; Braun DR, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P167, DOI 10.1007/978-1-4419-6861-6_7; Braun DR, 2008, J HUM EVOL, V55, P1053, DOI 10.1016/j.jhevol.2008.05.020; Braun DR, 2005, J HUM EVOL, V48, P525, DOI 10.1016/j.jhevol.2005.02.002; Braun DR, 2005, PALEOANTHROPOLOGY A, VA23; Chauhan PR, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P119, DOI 10.1007/978-1-4419-6861-6_6; [陈全家 Chen Quanjia], 2014, [人类学学报, Acta Anthropologica Sinica], V33, P27; Clarkson C, 2014, J ARCHAEOL SCI, V49, P361, DOI 10.1016/j.jas.2014.05.031; Clarkson C, 2013, J ARCHAEOL SCI, V40, P4348, DOI 10.1016/j.jas.2013.06.007; Clarkson C, 2011, J ARCHAEOL SCI, V38, P1062, DOI 10.1016/j.jas.2010.12.001; Costa AG, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P23, DOI 10.1007/978-1-4419-6861-6_2; de Lumley H., 2008, SITE HOMME YUNXIAN; Dibble Harold L., 1995, J ARCHAEOL METHOD TH, V2, P299, DOI [10.1007/BF02229003, DOI 10.1007/BF02229003]; DIBBLE HL, 1995, J ARCHAEOL SCI, V22, P429, DOI 10.1006/jasc.1995.0042; DIBBLE HL, 1987, AM ANTIQUITY, V52, P109, DOI 10.2307/281062; Eren MI, 2009, J ARCHAEOL SCI, V36, P1243, DOI 10.1016/j.jas.2009.01.011; Eren MI, 2008, LITHIC TECHNOLOGY: MEASURES OF PRODUCTION, USE, AND CURATION, P49, DOI 10.1017/CBO9780511499661.004; Eren MI, 2005, J ARCHAEOL SCI, V32, P1190, DOI 10.1016/j.jas.2005.03.003; Fang Q., 2012, ACTA ANTHR SINICA, V31, P343; Hiscock P, 2005, J ARCHAEOL SCI, V32, P1015, DOI 10.1016/j.jas.2005.02.002; Hiscock P, 2003, J ARCHAEOL SCI, V30, P239, DOI 10.1006/jasc.2002.0830; Hiscock P, 2010, WORLD ARCHAEOL, V42, P545, DOI 10.1080/00438243.2010.517669; Hiscock P, 2009, J ARCHAEOL SCI, V36, P1576, DOI 10.1016/j.jas.2009.03.019; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Iovita R, 2011, J HUM EVOL, V61, P61, DOI 10.1016/j.jhevol.2011.02.007; [李浩 Li Hao], 2013, [人类学学报, Acta Anthropologica Sinica], V32, P144; KUHN SL, 1990, J ARCHAEOL SCI, V17, P583, DOI 10.1016/0305-4403(90)90038-7; Kuman K, 2014, J HUM EVOL, V76, P129, DOI 10.1016/j.jhevol.2014.08.002; [李超荣 LI Chao-rong], 2009, [人类学学报, Acta Anthropologica Sinica], V28, P337; Li H, 2014, J ARCHAEOL SCI, V52, P391, DOI 10.1016/j.jas.2014.08.033; Li H, 2014, QUATERN INT, V347, P163, DOI 10.1016/j.quaint.2014.03.059; Li H, 2014, WORLD ARCHAEOL, V46, P705, DOI 10.1080/00438243.2014.953707; [李浩 Li Hao], 2012, [人类学学报, Acta Anthropologica Sinica], V31, P113; Li T., 2001, YUNXIAN MAN; Liu Y, HANDAXES 100 50 KA B; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Lycett SJ, J ARCHAEOLOGICAL MET; Lycett SJ, 2010, NEW PERSPECTIVES OLD, P79; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P2640, DOI 10.1016/j.jas.2008.05.002; McNabb J, 2004, CURR ANTHROPOL, V45, P653, DOI 10.1086/423973; McPherron S., 1995, LITHICS, V16, P47; McPherron S. P., 1999, PREHISTOIRE EUROPEEN, V14, P9; McPherron SP, 2000, J ARCHAEOL SCI, V27, P655, DOI 10.1006/jasc.1999.0467; Morales JI, J ARCHAEOLO IN PRESS; Morales JI, 2014, J ARCHAEOL SCI, V49, P302, DOI 10.1016/j.jas.2014.05.025; [牛东伟 Niu Dongwei], 2012, [人类学学报, Acta Anthropologica Sinica], V31, P11; Pei SW, 2015, J ARCHAEOL SCI, V53, P391, DOI 10.1016/j.jas.2014.10.022; [裴树文 PEI Shuwen], 2008, [人类学学报, Acta Anthropologica Sinica], V27, P95; Pelcin AW, 1997, J ARCHAEOL SCI, V24, P1107, DOI 10.1006/jasc.1996.0190; Pelcin AW, 1997, J ARCHAEOL SCI, V24, P749, DOI 10.1006/jasc.1996.0156; Sharon G., 2007, BRIT ARCHAEOLOGICAL, V1701; Shipton C, 2015, J ARCHAEOL SCI-REP, V2, P169, DOI 10.1016/j.jasrep.2015.01.013; Shipton C, 2013, J HUM EVOL, V65, P93, DOI 10.1016/j.jhevol.2013.03.007; Shipton C., 2013, BRIT ARCHAEOLOGICAL, V2468; Shipton C, 2011, AFR ARCHAEOL REV, V28, P141, DOI 10.1007/s10437-011-9089-1; Shott M.J., 1995, LITHIC TECHNOL, V20, P53; Shott MJ, 2007, J ARCHAEOL SCI, V34, P1016, DOI 10.1016/j.jas.2006.09.009; Shott MJ, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P275, DOI 10.1007/978-1-4419-6861-6_12; Shott MJ, 2005, J ARCHAEOL SCI, V32, P653, DOI 10.1016/j.jas.2004.11.012; Shott MJ, 2004, AM ANTIQUITY, V69, P339, DOI 10.2307/4128424; Wang W, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044883, 10.1371/journal.pone.0052488]; [周振宇 ZHOU Zhen-yu], 2009, [人类学学报, Acta Anthropologica Sinica], V28, P246	63	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135613	10.1371/journal.pone.0135613	http://dx.doi.org/10.1371/journal.pone.0135613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331954	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800035
J	Los Arcos, A; Vazquez, JS; Martin, J; Lerga, J; Sanchez, F; Villagra, F; Zulueta, JJ				Los Arcos, Asier; Sebastian Vazquez, Juan; Martin, Juan; Lerga, Javier; Sanchez, Felipe; Villagra, Federico; Zulueta, Javier J.			Effects of Small-Sided Games vs. Interval Training in Aerobic Fitness and Physical Enjoyment in Young Elite Soccer Players	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSE; RUNNING PERFORMANCE; LOCOMOTOR PROFILE; LOAD; VARIABILITY; RELIABILITY; VARIABLES; EXERCISES; FOOTBALL; SPORTS	The purpose of this study was to compare the effects of Small-Sided Games (SSG) vs. Interval Training (IT) in soccer training on aerobic fitness and physical enjoyment in youth elite soccer players during the last 8 weeks of the season. Seventeen U-16 male soccer players (age = 15.5 +/- 0.6 years, and 8.5 years of experience) of a Spanish First Division club academy were randomized to 2 different groups for 6 weeks: SSG group (n = 9) and IT group (n = 8). In addition to the usual technical and tactical sessions and competitive games, the SSG group performed 11 sessions with different SSGs, whereas the IT group performed the same number of sessions of IT. Players were tested before and after the 6-week training intervention with a continuous maximal multistage running field test and the counter movement jump test (CMJ). At the end of the study, players answered the physical activity enjoyment scale (PACES). During the study, heart rate (HR) and session perceived effort (sRPE) were assessed. SSGs were as effective as IT in maintaining the aerobic fitness in elite young soccer players during the last weeks of the season. Players in the SSG group declared a greater physical enjoyment than IT (P = 0.006; ES = 1.86 +/- 1.07). Coaches could use SSG training during the last weeks of the season as an option without fear of losing aerobic fitness while promoting high physical enjoyment.	[Los Arcos, Asier] Univ Basque Country, Univ Sch Teaching, UPV EHU, Vitoria, Spain; [Sebastian Vazquez, Juan] Univ Navarra, Sch Med, E-31080 Pamplona, Spain; [Martin, Juan; Lerga, Javier; Sanchez, Felipe] Club Atlet Osasuna, Pamplona, Spain; [Villagra, Federico; Zulueta, Javier J.] Univ Navarra, Univ Navarra Clin, Resp Med Serv, E-31080 Pamplona, Spain; [Villagra, Federico; Zulueta, Javier J.] Univ Navarra, Univ Navarra Clin, Sports Med Serv, E-31080 Pamplona, Spain	University of Basque Country; University of Navarra; University of Navarra; University of Navarra	Zulueta, JJ (corresponding author), Univ Navarra, Univ Navarra Clin, Resp Med Serv, E-31080 Pamplona, Spain.	jzulueta@unav.es	Zulueta, Javier J/GXZ-5810-2022; Zulueta, Javier J/H-5127-2011	Zulueta, Javier J/0000-0003-3182-3555; Los Arcos, Asier/0000-0003-1001-7706				Akubat I, 2012, J SPORT SCI, V30, P1473, DOI 10.1080/02640414.2012.712711; Billat LV, 1996, SPORTS MED, V22, P90, DOI 10.2165/00007256-199622020-00004; Borg G, 1998, BORGSS PERCEIVED EXE; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Brandes M, 2012, J STRENGTH COND RES, V26, P1353, DOI 10.1519/JSC.0b013e318231ab99; Bravo DF, 2008, INT J SPORTS MED, V29, P668, DOI 10.1055/s-2007-989371; Briere NM, 1995, INT J SPORT PSYCHOL, V26, P465; Buchheit M, 2013, INT J SPORTS MED, V34, P40, DOI 10.1055/s-0032-1316363; Buchheit M, 2010, INT J SPORTS MED, V31, P818, DOI 10.1055/s-0030-1262838; Buchheit M, 2010, INT J SPORTS MED, V31, P709, DOI 10.1055/s-0030-1261897; Buchheit M, 2014, J SPORT SCI, V32, P1271, DOI 10.1080/02640414.2014.884721; Buchheit M, 2013, J SPORT SCI, V31, P1402, DOI 10.1080/02640414.2013.792947; Caldwell BP, 2009, J STRENGTH COND RES, V23, P1370, DOI 10.1519/JSC.0b013e3181a4e82f; Castagna C, 2013, J STRENGTH COND RES, V27, P2959, DOI 10.1519/JSC.0b013e31828d61a8; Castagna C, 2011, J STRENGTH COND RES, V25, P66, DOI 10.1519/JSC.0b013e3181fef3d3; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dellal A, 2012, J STRENGTH COND RES, V26, P2712, DOI 10.1519/JSC.0b013e31824294c4; Ford PR, 2010, J SPORT SCI, V28, P483, DOI 10.1080/02640410903582750; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Gravina L, 2008, J STRENGTH COND RES, V22, P1308, DOI 10.1519/JSC.0b013e31816a5c8e; Helgerud J, 2001, MED SCI SPORT EXER, V33, P1925, DOI 10.1097/00005768-200111000-00019; Hill-Haas SV, 2009, INT J SPORTS MED, V30, P636, DOI 10.1055/s-0029-1220730; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Impellizzeri FM, 2006, INT J SPORTS MED, V27, P483, DOI 10.1055/s-2005-865839; Ingebrigtsen J, 2013, J STRENGTH COND RES, V27, P1861, DOI 10.1519/JSC.0b013e31827647bd; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Krustrup P, 2006, MED SCI SPORT EXER, V38, P1666, DOI 10.1249/01.mss.0000227538.20799.08; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Leger L, 1980, Can J Appl Sport Sci, V5, P77; Los Arcos A, 2015, J SPORT SCI MED, V14, P394; Los Arcos A, 2014, J STRENGTH COND RES, V28, P3280, DOI 10.1519/JSC.0000000000000540; Los Arcos A, 2014, INT J SPORT PHYSIOL, V9, P480, DOI [10.1123/IJSPP.2013-0063, 10.1123/ijspp.2013-0063]; Los Arcos A, 2014, J STRENGTH COND RES, V28, P752, DOI 10.1519/JSC.0b013e3182a47f0b; Manzi V, 2013, J STRENGTH COND RES, V27, P631, DOI 10.1519/JSC.0b013e31825dbd81; MCAULEY E, 1989, J SPORT EXERCISE PSY, V11, P84, DOI 10.1123/jsep.11.1.84; Mendez-Villanueva A, 2010, PEDIATR EXERC SCI, V22, P497, DOI 10.1123/pes.22.4.497; Moreno JA, 2008, ESTUD PSICOL-MADRID, V29, P173, DOI 10.1174/021093908784485093; Motl RW, 2001, AM J PREV MED, V21, P110, DOI 10.1016/S0749-3797(01)00326-9; Radziminski L, 2013, INT J SPORTS SCI COA, V8, P455, DOI 10.1260/1747-9541.8.3.455; Rampinini E, 2007, J SPORT SCI, V25, P659, DOI 10.1080/02640410600811858; Rebelo A, 2014, EUR J SPORT SCI, V14, pS148, DOI 10.1080/17461391.2012.664171; Reilly T, 2004, J SPORTS SCI, V22, P559; SCANLAN TK, 1986, J SPORT EXERCISE PSY, V8, P25, DOI 10.1123/jsp.8.1.25; Simons P.J, 1993, PEDIATR EXERC SCI, V5, P275, DOI 10.1123/pes.5.3.275; Alvarez MS, 2009, SPAN J PSYCHOL, V12, P138, DOI 10.1017/S1138741600001554; Stone NM, 2009, SPORTS MED, V39, P615, DOI 10.2165/00007256-200939080-00002; Tonnessen E, 2013, INT J SPORT PHYSIOL, V8, P323, DOI 10.1123/ijspp.8.3.323; Weston M, 2015, J SCI MED SPORT, V18, P704, DOI 10.1016/j.jsams.2014.09.001	50	69	74	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137224	10.1371/journal.pone.0137224	http://dx.doi.org/10.1371/journal.pone.0137224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331623	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800112
J	Pomeroy, LW; Bjornstad, ON; Kim, H; Jumbo, SD; Abdoulkadiri, S; Garabed, R				Pomeroy, Laura W.; Bjornstad, Ottar N.; Kim, Hyeyoung; Jumbo, Simon Dickmu; Abdoulkadiri, Souley; Garabed, Rebecca			Serotype-Specific Transmission and Waning Immunity of Endemic Foot-and-Mouth Disease Virus in Cameroon	PLOS ONE			English	Article							ECONOMIC-IMPACTS; INFECTION; DYNAMICS; SPREAD; LIVESTOCK; EPIDEMIC; CATTLE; FORCE; OUTBREAKS	Foot-and-mouth disease virus (FMDV) causes morbidity and mortality in a range of animals and threatens local economies by acting as a barrier to international trade. The outbreak in the United Kingdom in 2001 that cost billions to control highlighted the risk that the pathogen poses to agriculture. In response, several mathematical models have been developed to parameterize and predict both transmission dynamics and optimal disease control. However, a lack of understanding of the multi-strain etiology prevents characterization of multi-strain dynamics. Here, we use data from FMDV serology in an endemic setting to probe strain-specific transmission and immunodynamics. Five serotypes of FMDV affect cattle in the Far North Region of Cameroon. We fit both catalytic and reverse catalytic models to serological data to estimate the force of infection and the rate of waning immunity, and to detect periods of sustained transmission. For serotypes SAT2, SAT3, and type A, a model assuming life-long immunity fit better. For serotypes SAT1 and type O, the better-fit model suggests that immunity may wane over time. Our analysis further indicates that type O has the greatest force of infection and the longest duration of immunity. Estimates for the force of infection were time-varying and indicated that serotypes SAT1 and O displayed endemic dynamics, serotype A displayed epidemic dynamics, and SAT2 and SAT3 did not sustain local chains of transmission. Since these results were obtained from the same population at the same time, they highlight important differences in transmission specific to each serotype. They also show that immunity wanes at rates specific to each serotype, which influences patterns of local persistence. Overall, this work shows that viral serotypes can differ significantly in their epidemiological and immunological characteristics. Patterns and processes that drive transmission in endemic settings must consider complex viral dynamics for accurate representation and interpretation.	[Pomeroy, Laura W.; Garabed, Rebecca] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Bjornstad, Ottar N.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Bjornstad, Ottar N.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Bjornstad, Ottar N.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Bjornstad, Ottar N.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Kim, Hyeyoung] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; [Jumbo, Simon Dickmu; Abdoulkadiri, Souley] Lanavet, Lab Natl Vet, Garoua, Cameroon; [Garabed, Rebecca] Ohio State Univ, Publ Hlth Preparedness Infect Dis Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Pomeroy, LW (corresponding author), Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA.	pomeroy.26@osu.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Garabed, Rebecca/0000-0002-8964-3576	Eunice Kennedy Shriver National Institute of Child Health & Human Development [R24-HD058484]; National Science Foundation [DEB-1015908]; Ohio State University Initiative in Population Research; Direct For Biological Sciences [1015908] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD058484] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation(National Science Foundation (NSF)); Ohio State University Initiative in Population Research; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by award R24-HD058484 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (http://www.nichd.nih.gov/Pages/index.aspx), awarded to the Ohio State University Initiative in Population Research and RG, and by award DEB-1015908 from the National Science Foundation (http://www.nsf.gov), awarded to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; ANDERSON R M, 1991; Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289; Boender GJ, 2010, EPIDEMICS-NETH, V2, P36, DOI 10.1016/j.epidem.2010.03.001; Bronsvoort BMDC, 2006, VET REC, V159, P299; Buhnerkempe MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091724; Carpenter TE, 2011, J VET DIAGN INVEST, V23, P26, DOI 10.1177/104063871102300104; CUNLIFFE HR, 1964, CORNELL VET, V54, P501; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; Doran RJ, 2005, PREV VET MED, V70, P133, DOI 10.1016/j.prevetmed.2005.03.002; Ehizibolo DO, 2014, TRANSBOUND EMERG DIS, V61, P500, DOI 10.1111/tbed.12054; Ferrari MJ, 2010, EPIDEMIOL INFECT, V138, P108, DOI 10.1017/S0950268809990173; Garland AJM, 1974, INHIBITORY ACTIVITY; Garner MG, 2005, AUST VET J, V83, P758, DOI 10.1111/j.1751-0813.2005.tb11589.x; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; GRIFFITHS D. A., 1974, Applied Statistics, V23, P330, DOI 10.2307/2347126; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Hens N, 2010, EPIDEMIOL INFECT, V138, P802, DOI 10.1017/S0950268809990781; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Lavine JS, 2012, VACCINE, V30, P544, DOI 10.1016/j.vaccine.2011.11.065; Leforban Y, 1999, VACCINE, V17, P1755, DOI 10.1016/S0264-410X(98)00445-9; Lindstrom T, 2012, J R SOC INTERFACE, V9, P1287, DOI 10.1098/rsif.2011.0625; Long GH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001224; Ludi A, 2016, TRANSBOUND EMERG DIS, V63, pE27, DOI 10.1111/tbed.12227; Muench H., CATALYTIC MODELS EPI, P8928; Njoya A, 1997, WORLD ANIM REV, P12; Profitos JMH, 2013, PASTORALISM, V3, DOI 10.1186/2041-7136-3-8; R Development Core Team, 2012, R LANG ENV STAT COMP; Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111; Rodriguez LL, 2011, EXPERT REV VACCINES, V10, P377, DOI [10.1586/erv.11.4, 10.1586/ERV.11.4]; RStudio, 2014, RSTUDIO INT DEV ENV; Rweyemamu M, 2008, TRANSBOUND EMERG DIS, V55, P57, DOI 10.1111/j.1865-1682.2007.01013.x; Seignobos O., 2000, ATLAS PROVINCE EXTRE; Ster IC, 2012, EPIDEMICS-NETH, V4, P158, DOI 10.1016/j.epidem.2012.07.002; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Tildesley MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1459, DOI 10.1098/rspb.2008.0006; Tildesley MJ, 2012, PREV VET MED, V104, P224, DOI 10.1016/j.prevetmed.2011.11.007; Vernon MC, 2012, PREV VET MED, V105, P110, DOI 10.1016/j.prevetmed.2011.12.016; Ward MP, 2009, PREV VET MED, V91, P55, DOI 10.1016/j.prevetmed.2009.05.005; Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018	42	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136642	10.1371/journal.pone.0136642	http://dx.doi.org/10.1371/journal.pone.0136642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327324	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700051
J	Sablon-Carrazana, M; Fernandez, I; Bencomo, A; Lara-Martinez, R; Rivera-Marrero, S; Dominguez, G; Perez-Perera, R; Jimenez-Garcia, LF; Altamirano-Bustamante, NF; Diaz-Delgado, M; Vedrenne, F; Rivillas-Acevedo, L; Pasten-Hidalgo, K; Segura-Valdez, MD; Islas-Andrade, S; Garrido-Magana, E; Perera-Pintado, A; Prats-Capote, A; Rodriguez-Tanty, C; Altamirano-Bustamante, MM				Sablon-Carrazana, Marquiza; Fernandez, Isaac; Bencomo, Alberto; Lara-Martinez, Reyna; Rivera-Marrero, Suchitil; Dominguez, Guadalupe; Perez-Perera, Rafaela; Felipe Jimenez-Garcia, Luis; Altamirano-Bustamante, Nelly F.; Diaz-Delgado, Massiel; Vedrenne, Fernand; Rivillas-Acevedo, Lina; Pasten-Hidalgo, Karina; de Lourdes Segura-Valdez, Maria; Islas-Andrade, Sergio; Garrido-Magana, Eulalia; Perera-Pintado, Alejandro; Prats-Capote, Anais; Rodriguez-Tanty, Chryslaine; Altamirano-Bustamante, Myriam M.			Drug Development in Conformational Diseases: A Novel Family of Chemical Chaperones that Bind and Stabilise Several Polymorphic Amyloid Structures	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; PROTEIN-STRUCTURE SIMILARITY; TAU AGGREGATION INHIBITORS; PAIRED HELICAL FILAMENTS; SOLID-PHASE SYNTHESIS; PS GRAFT SUPPORTS; FIBRIL FORMATION; MOLECULAR CHAPERONES; GUIDING PRINCIPLES; ALZHEIMERS-DISEASE	The increasing prevalence of conformational diseases, including Alzheimer's disease, type 2 Diabetes Mellitus and Cancer, poses a global challenge at many different levels. It has devastating effects on the sufferers as well as a tremendous economic impact on families and the health system. In this work, we apply a cross-functional approach that combines ideas, concepts and technologies from several disciplines in order to study, in silico and in vitro, the role of a novel chemical chaperones family (NCHCHF) in processes of protein aggregation in conformational diseases. Given that Serum Albumin (SA) is the most abundant protein in the blood of mammals, and Bovine Serum Albumin (BSA) is an off-the-shelf protein available in most labs around the world, we compared the ligandability of BSA: NCHCHF with the interaction sites in the Human Islet Amyloid Polypeptide (hIAPP): NCHCHF, and in the amyloid pharmacophore fragments (A beta 17-42 and A beta 16-21): NCHCHF. We posit that the merging of this interaction sites is a meta-structure of pharmacophore which allows the development of chaperones that can prevent protein aggregation at various states from: stabilizing the native state to destabilizing oligomeric state and protofilament. Furthermore to stabilize fibrillar structures, thus decreasing the amount of toxic oligomers in solution, as is the case with the NCHCHF. The paper demonstrates how a set of NCHCHF can be used for studying and potentially treating the various physiopathological stages of a conformational disease. For instance, when dealing with an acute phase of cytotoxicity, what is needed is the recruitment of cytotoxic oligomers, thus chaperone F, which accelerates fiber formation, would be very useful; whereas in a chronic stage it is better to have chaperones A, B, C, and D, which stabilize the native and fibril structures halting self-catalysis and the creation of cytotoxic oligomers as a consequence of fiber formation. Furthermore, all the chaperones are able to protect and recondition the cerebellar granule cells (CGC) from the cytotoxicity produced by the hIAPP(20-29) fragment or by a low potassium medium, regardless of their capacity for accelerating or inhibiting in vitro formation of fibers. In vivo animal experiments are required to study the impact of chemical chaperones in cognitive and metabolic syndromes.	[Sablon-Carrazana, Marquiza; Bencomo, Alberto; Rivera-Marrero, Suchitil; Perez-Perera, Rafaela; Diaz-Delgado, Massiel; Rodriguez-Tanty, Chryslaine] Ctr Neurociencias Cuba, Dept Neurodiagnost, Havana, Cuba; [Sablon-Carrazana, Marquiza; Fernandez, Isaac; Bencomo, Alberto; Vedrenne, Fernand; Rivillas-Acevedo, Lina; Islas-Andrade, Sergio; Altamirano-Bustamante, Myriam M.] Inst Mexicano Seguro Social, Hosp Cardiol, Unidad Invest Med Enfermedades Metab, Ctr Med Nacl Siglo 21, Mexico City, DF, Mexico; [Fernandez, Isaac] Inst Politecn Nacl, Dept Microbiol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Lara-Martinez, Reyna; Felipe Jimenez-Garcia, Luis; de Lourdes Segura-Valdez, Maria] Univ Nacl Autonoma Mexico, Lab Nanobiol Celular, Dept Biol Celular, Fac Ciencias, Mexico City, DF, Mexico; [Dominguez, Guadalupe] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City, DF, Mexico; [Altamirano-Bustamante, Nelly F.; Pasten-Hidalgo, Karina] Inst Nacl Pediat SS, Serv Endocrinol, Mexico City, DF, Mexico; [Pasten-Hidalgo, Karina] Catedra Conacyt, Mexico City, DF, Mexico; [Garrido-Magana, Eulalia] IMSS, Serv Endocrinol, Hosp Pediat, CMNXXI, Mexico City, DF, Mexico; [Perera-Pintado, Alejandro; Prats-Capote, Anais] Ctr Invest Clin, Havana, Cuba	Instituto Mexicano del Seguro Social; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Mexicano del Seguro Social	Rodriguez-Tanty, C (corresponding author), Ctr Neurociencias Cuba, Dept Neurodiagnost, Havana, Cuba.	chris@cneuro.edu.cu; myriamab@unam.mx	Rivillas-Acevedo, Lina/AAE-8801-2020; /ABI-8453-2020; Altamirano, Myriam/GPW-5376-2022; Rivera, Suchitil/AAI-1632-2021	/0000-0002-9402-4219; Rivera, Suchitil/0000-0002-1186-5734	Mexico's National Council of Science and Technology (CONACYT) [SALUD-2010-C02-151942]; Institute of Science and Technology of Mexico City (ICYTDF); Cuba's National Science and Technology Program (PNCT) [31200]	Mexico's National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Institute of Science and Technology of Mexico City (ICYTDF); Cuba's National Science and Technology Program (PNCT)	Funding for this study was provided by Mexico's National Council of Science and Technology (CONACYT) SALUD-2010-C02-151942, Institute of Science and Technology of Mexico City (ICYTDF), and Cuba's National Science and Technology Program (PNCT, 31200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock JJ, 2013, INT J BIOL MACROMOL, V53, P42, DOI 10.1016/j.ijbiomac.2012.10.030; Bartolini M, 2010, CHEMBIOCHEM, V11, P1018, DOI 10.1002/cbic.200900666; Bhattacharya M, 2011, J PHYS CHEM B, V115, P4195, DOI 10.1021/jp111528c; Blancas S, 2011, NEUROCHEM INT, V58, P934, DOI 10.1016/j.neuint.2011.03.017; Blancas-Mejia LM, 2015, J BIOL CHEM, V290, P4953, DOI 10.1074/jbc.M114.615401; Breinbauer R, 2002, ANGEW CHEM INT EDIT, V41, P2879; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Bulic B, 2007, ANGEW CHEM INT EDIT, V46, P9215, DOI 10.1002/anie.200704051; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Hard T, 2012, J MOL BIOL, V421, P441, DOI 10.1016/j.jmb.2011.12.062; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Holm NK, 2007, BBA-PROTEINS PROTEOM, V1774, P1128, DOI 10.1016/j.bbapap.2007.06.008; Hood CA, 2008, J PEPT SCI, V14, P97, DOI 10.1002/psc.921; Jiang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00857; Juarez J, 2009, J PHYS CHEM B, V113, P10521, DOI 10.1021/jp902224d; Kates SA, 1996, PEPTIDE RES, V9, P106; Kates SA, 1998, BIOPOLYMERS, V47, P365, DOI 10.1002/(SICI)1097-0282(1998)47:5<365::AID-BIP4>3.0.CO;2-8; Khurana R, 2003, BIOPHYS J, V85, P1135, DOI 10.1016/S0006-3495(03)74550-0; Koch MA, 2003, BIOL CHEM, V384, P1265, DOI 10.1515/BC.2003.140; Koch MA, 2005, DRUG DISCOV TODAY, V10, P471, DOI 10.1016/S1359-6446(05)03419-7; Konrat R, 2009, CELL MOL LIFE SCI, V66, P3625, DOI 10.1007/s00018-009-0117-0; Landau M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001080; Larbig G, 2007, CURR ALZHEIMER RES, V4, P315; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Moran J, 1999, J NEUROCHEM, V73, P568, DOI 10.1046/j.1471-4159.1999.0730568.x; Naranjo Y, 2012, MOL BIOSYST, V8, P411, DOI 10.1039/c1mb05367a; Papp E, 2006, HANDB EXP PHARM, V172, P405; Pickhardt A, 2007, CURR ALZHEIMER RES, V4, P397, DOI 10.2174/156720507781788765; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Pickhardt M, 2007, BIOCHEMISTRY-US, V46, P10016, DOI 10.1021/bi700878g; Sablon CM, 2014, Google Patents, Patent No. [WO20141313, 20141313]; Sablon CM, [No title captured], Patent No. [EP2436666B1, 2436666B1]; Sablon CM, 2010, Google Patents, Patent No. [US20120321560, 20120321560]; Sablon CM, 2010, Google Patents, Patent No. [WO2010118706A2, 2010118706]; Sablon CM, [No title captured], Patent No. [WO2010118706A4, 2010118706]; Sablon CM, 2010, Google Patents, Patent No. [EP2436666A2, 2436666]; Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769; Scheibel T, 2006, HANDB EXP PHARM, V172, P199; Seong IS, 2000, FEBS LETT, V477, P224, DOI 10.1016/S0014-5793(00)01808-1; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Tomoyasu T, 2013, J BIOSCI BIOENG, V115, P15, DOI 10.1016/j.jbiosc.2012.08.001; Vetri V, 2011, ARCH BIOCHEM BIOPHYS, V508, P13, DOI 10.1016/j.abb.2011.01.024; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zahn R, 1996, J MOL BIOL, V261, P43, DOI 10.1006/jmbi.1996.0440	52	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135292	10.1371/journal.pone.0135292	http://dx.doi.org/10.1371/journal.pone.0135292			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327208	gold, Green Submitted, Green Published			2022-12-27	WOS:000360437700017
J	Ayepola, OO; Olasupo, NA; Egwari, LO; Becker, K; Schaumburg, F				Ayepola, Olayemi O.; Olasupo, Nurudeen A.; Egwari, Louis O.; Becker, Karsten; Schaumburg, Frieder			Molecular Characterization and Antimicrobial Susceptibility of Staphylococcus aureus Isolates from Clinical Infection and Asymptomatic Carriers in Southwest Nigeria	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; EPIDEMIOLOGY; IDENTIFICATION; PREVALENCE; RESISTANCE; CARRIAGE; STRAINS; TOXIN; AGR	Few reports from Africa suggest that resistance pattern, virulence factors and genotypes differ between Staphylococcus aureus from nasal carriage and clinical infection. We therefore compared antimicrobial resistance, selected virulence factors and genotypes of S. aureus from nasal carriage and clinical infection in Southwest Nigeria. Non-duplicate S. aureus isolates were obtained from infection (n = 217) and asymptomatic carriers (n = 73) during a cross sectional study in Lagos and Ogun States, Nigeria from 2010-2011. Susceptibility testing was performed using Vitek automated systems. Selected virulence factors were detected by PCR. The population structure was assessed using spa typing. The spa clonal complexes (spa-CC) were deduced using the Based Upon Repeat Pattern algorithm (BURP). Resistance was higher for aminoglycosides in clinical isolates while resistances to quinolones and tetracycline were more prevalent in carrier isolates. The Panton-Valentine leukocidin (PVL) was more frequently detected in isolates from infection compared to carriage (80.2 vs 53.4%; p< 0.001, chi(2)-test). Seven methicillin resistant S. aureus isolates were associated with spa types t002, t008, t064, t194, t8439, t8440 and t8441. The predominant spa types among the methicillin-susceptible S. aureus isolates were t084 (65.5%), t2304 (4.4%) and t8435 (4.1%). spa-CC 084 was predominant among isolates from infection (80.3%, n = 167) and was significantly associated with PVL (OR = 7.1, 95% CI: 3.913.2, p< 0.001, chi(2-)test). In conclusion, PVL positive isolates were more frequently detected among isolates from infection compared to carriage and are associated with spa-CC 084.	[Ayepola, Olayemi O.; Egwari, Louis O.] Covenant Univ, Dept Biol Sci, Ota, Ogun State, Nigeria; [Olasupo, Nurudeen A.] Lagos State Univ, Dept Microbiol, Ojo, Lagos State, Nigeria; [Becker, Karsten; Schaumburg, Frieder] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany	Covenant University; Lagos State University; University of Munster	Ayepola, OO (corresponding author), Covenant Univ, Dept Biol Sci, Ota, Ogun State, Nigeria.	ola.ayepola@covenantuniversity.edu.ng	Schaumburg, Frieder/E-4464-2016; Ayepola, Olayemi/C-6922-2016; Olasupo, Nurudeen/CAH-0407-2022; Becker, Karsten/O-2302-2018	Becker, Karsten/0000-0002-6391-1341; Olasupo, Nurudeen/0000-0002-9222-2959	Covenant University; European Molecular Biology Organization (EMBO) [ASTF 18.00-2011]	Covenant University; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	Covenant University www.covenantuniversity.edu.ng OOA, European Molecular Biology Organization (EMBO) www.embo.org ASTF 18.00-2011 OOA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Breurec S, 2011, CLIN MICROBIOL INFEC, V17, P633, DOI 10.1111/j.1469-0691.2010.03320.x; Cremieux AC, 2014, J INFECT DIS, V209, P1773, DOI 10.1093/infdis/jit840; Egyir B, 2015, J GLOB ANTIMICROB RE, V3, P26, DOI 10.1016/j.jgar.2014.11.006; Goerke C, 2005, INT J MED MICROBIOL, V295, P67, DOI [10.1016/j.ijmm.2005.01.004, 10.1016/j.imm.2005.01.004]; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Kaase M, 2008, CLIN MICROBIOL INFEC, V14, P614, DOI 10.1111/j.1469-0691.2008.01997.x; Kaspar U, 2016, ENVIRON MICROBIOL, V18, P2130, DOI 10.1111/1462-2920.12891; Kolawole DO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068721; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kraef C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00060; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Naber KG, 2008, EUR UROL, V54, P1164, DOI 10.1016/j.eururo.2008.05.010; Otto M, 2014, CURR OPIN MICROBIOL, V17, P32, DOI 10.1016/j.mib.2013.11.004; Otto M, 2014, INT J MED MICROBIOL, V304, P164, DOI 10.1016/j.ijmm.2013.11.019; Schaumburg F, 2014, CLIN MICROBIOL INFEC, V20, P589, DOI 10.1111/1469-0691.12690; Schaumburg F, 2013, EPIDEMIOL INFECT, V141, P1717, DOI 10.1017/S0950268812002270; Schaumburg F, 2011, CLIN MICROBIOL INFEC, V17, P1507, DOI 10.1111/j.1469-0691.2011.03534.x; Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4; Shittu A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-286; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9	28	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137531	10.1371/journal.pone.0137531	http://dx.doi.org/10.1371/journal.pone.0137531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348037	gold, Green Published, Green Submitted			2022-12-27	WOS:000360897600053
J	Liao, CT; Fan, KH; Kang, CJ; Lin, CY; Chang, JTC; Tsang, NM; Huang, BS; Chao, YK; Lee, LY; Hsueh, C; Wang, HM; Liau, CT; Hsu, CL; Hsieh, CH; Ng, SH; Lin, CH; Tsao, CK; Fang, TJ; Huang, SF; Chang, KP; Yen, TC				Liao, Chun-Ta; Fan, Kang-Hsing; Kang, Chung-Jan; Lin, Chien-Yu; Chang, Joseph Tung-Chieh; Tsang, Ngan-Ming; Huang, Bing-Shen; Chao, Yin-Kai; Lee, Li-Yu; Hsueh, Chuen; Wang, Hung-Ming; Liau, Chi-Ting; Hsu, Cheng-Lung; Hsieh, Chia-Hsun; Ng, Shu-Hang; Lin, Chih-Hung; Tsao, Chung-Kan; Fang, Tuan-Jen; Huang, Shiang-Fu; Chang, Kai-Ping; Yen, Tzu-Chen			Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ESOPHAGEAL CANCER; PRIMARY-TUMORS; NECK-CANCER; HEAD; SURVIVAL	Objectives Simultaneous second primary tumors (SSPT) are not uncommon in patients with oral cavity squamous cell carcinoma (OSCC) living in areas where the habit of betel quid chewing is widespread. We sought to identify the main prognostic factors in OSCC patients with SSPT and incorporate them into a risk stratification scheme. Methods A total of 1822 consecutive patients with primary OSCC treated between January 1996 and February 2014 were analyzed for the presence of SSPT. The 18-month and 5-year overall survival (OS) rates served as the main outcome measures. Results Of the 1822 patients, 77 (4%) were found to have SSPT (i.e, two malignancies identified within one month of each other). The 18-month and 5-year OS rates in patients without SSPT and with SSPT were 82% and 69%, and 72% and 53%, respectively (p = 0.0063). Patients with SSPT were further divided into patients with either esophageal cancer or hepatocellular carcinoma (eso-HCC subgroup, n = 8) and other tumors (NO eso-HCC subgroup, n = 69). After multivariate analysis, neck nodal extracapsular spread (ECS, n = 18) and the presence of eso-HCC were identified as independent adverse prognostic factors. The 18-month OS rates of SSPT patients with both eso-HCC and ECS (n = 5) vs. the remaining patients (n = 72) were 0% and 78%, respectively (p < 0.0001). Conclusion OSCC patients with neck nodal ECS and esophageal cancer or hepatocellular carcinoma as SSPT have a dismal short-term prognosis.	[Liao, Chun-Ta; Kang, Chung-Jan; Fang, Tuan-Jen; Huang, Shiang-Fu; Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Liao, Chun-Ta; Fan, Kang-Hsing; Kang, Chung-Jan; Lin, Chien-Yu; Chang, Joseph Tung-Chieh; Tsang, Ngan-Ming; Huang, Bing-Shen; Chao, Yin-Kai; Lee, Li-Yu; Hsueh, Chuen; Wang, Hung-Ming; Liau, Chi-Ting; Hsu, Cheng-Lung; Hsieh, Chia-Hsun; Ng, Shu-Hang; Lin, Chih-Hung; Tsao, Chung-Kan; Fang, Tuan-Jen; Huang, Shiang-Fu; Chang, Kai-Ping; Yen, Tzu-Chen] Chang Gung Univ, Taoyuan, Taiwan; [Liao, Chun-Ta; Fan, Kang-Hsing; Kang, Chung-Jan; Lin, Chien-Yu; Chang, Joseph Tung-Chieh; Tsang, Ngan-Ming; Huang, Bing-Shen; Chao, Yin-Kai; Lee, Li-Yu; Hsueh, Chuen; Wang, Hung-Ming; Liau, Chi-Ting; Hsu, Cheng-Lung; Hsieh, Chia-Hsun; Ng, Shu-Hang; Lin, Chih-Hung; Tsao, Chung-Kan; Fang, Tuan-Jen; Huang, Shiang-Fu; Chang, Kai-Ping; Yen, Tzu-Chen] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Taoyuan, Taiwan; [Fan, Kang-Hsing; Lin, Chien-Yu; Chang, Joseph Tung-Chieh; Tsang, Ngan-Ming; Huang, Bing-Shen] Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Chao, Yin-Kai] Chang Gung Mem Hosp, Dept Thorac & Cardiovasc Surg, Taoyuan, Taiwan; [Lee, Li-Yu; Hsueh, Chuen] Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan; [Wang, Hung-Ming; Liau, Chi-Ting; Hsu, Cheng-Lung; Hsieh, Chia-Hsun] Chang Gung Mem Hosp, Dept Med Oncol, Taoyuan, Taiwan; [Ng, Shu-Hang] Chang Gung Mem Hosp, Dept Diagnost Radiol, Taoyuan, Taiwan; [Lin, Chih-Hung; Tsao, Chung-Kan] Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Taoyuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Mol Imaging Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yen, TC (corresponding author), Chang Gung Mem Hosp, Head & Neck Oncol Grp, Taoyuan, Taiwan.	yen1110@adm.cgmh.org.tw	Hsieh, Jason Chia-Hsun/G-5059-2010; Fan, K/GXH-3734-2022; Li-yu, Lee/G-5055-2010; Chao, YinKai/ABE-7827-2020	Hsieh, Jason Chia-Hsun/0000-0002-5547-409X; Hsueh, Chuen/0000-0001-7860-5964; Chao, Yin Kai/0000-0001-8649-8783; Fang, TuanJen/0000-0002-7805-3458; Fan, Kang-Hsing/0000-0002-0910-7803				[Anonymous], 2011, CANC REGISTRY ANN RE; Boute P, 2014, EUR ANN OTORHINOLARY, V131, P283, DOI 10.1016/j.anorl.2013.10.003; Fan KH, 2010, INT J RADIAT ONCOL, V77, P1024, DOI 10.1016/j.ijrobp.2009.06.064; Fukuzawa K, 1999, CANCER LETT, V144, P145, DOI 10.1016/S0304-3835(99)00223-2; Hsu SH, 2013, HEAD NECK-J SCI SPEC, V35, P1801, DOI 10.1002/hed.23242; Liao CT, 2007, ORAL ONCOL, V43, P811, DOI 10.1016/j.oraloncology.2006.10.003; Liao CT, 2013, ORAL ONCOL, V49, P230, DOI 10.1016/j.oraloncology.2012.09.010; Liao CT, 2011, INT J RADIAT ONCOL, V81, P930, DOI 10.1016/j.ijrobp.2010.07.1988; Liao CT, 2009, INT J RADIAT ONCOL, V74, P1054, DOI 10.1016/j.ijrobp.2008.09.045; Liao CT, 2015, J CANC RES PRACT, V2, P103; Lim H, 2015, GUT LIVER, V9, P159, DOI 10.5009/gnl13401; Lin CY, 2010, INT J RADIAT ONCOL, V78, P1011, DOI 10.1016/j.ijrobp.2009.09.074; Morita M, 2013, ANN SURG ONCOL, V20, P2434, DOI 10.1245/s10434-013-2875-z; Qaisi M, 2014, J ORAL MAXIL SURG, V72, P1511, DOI 10.1016/j.joms.2014.03.012; Wang HM, 2004, CANCER-AM CANCER SOC, V101, P1818, DOI 10.1002/cncr.20561	15	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136918	10.1371/journal.pone.0136918	http://dx.doi.org/10.1371/journal.pone.0136918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335067	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400032
J	Sokhi, DS; Oxenham, C; Coates, R; Forbes, M; Gupta, NK; Blackburn, DJ				Sokhi, Dilraj Singh; Oxenham, Chantal; Coates, Rebecca; Forbes, Mhairi; Gupta, Nadi K.; Blackburn, Daniel J.			Four-Stage Audit Demonstrating Increased Uptake of HIV Testing in Acute Neurology Admissions Using Staged Practical Interventions	PLOS ONE			English	Article							MEDICAL ADMISSIONS; CARE; GUIDELINES; UNIT; TRANSMISSION; INFECTION; BARRIERS	Background UK National Guidelines (UKNG) advise HIV testing in clinically indicated neurological presentations. We audited the impact of our practical strategies to increase uptake of HIV testing at a regional acute neurology admissions unit. Methods We audited HIV testing in 4 periods over 2 years: before we designed a UKNG-based "HIV testing in Neurology" protocol ("pre-protocol"); after dissemination of the protocol alone ("post-protocol"); post-protocol dissemination combined with both a tailored departmental admissions clerking proforma to prompt for HIV testing & consenting, and regular focussed tutorials to doctors on HIV testing in neurological patients ("post-proforma"); and finally one year after the post-proforma period ("+1 year"). We also looked at the total number of HIV tests sent from the unit during the two-year period. We assessed significance using Fisher's exact test. Results 47.8% of all acute neurology non-stroke admissions were eligible for HIV testing during all the audit periods. Testing rates were as follows: pre-protocol 21.9%; post-protocol 36.6%; post-proforma 83.3%; and at +1 year 65.4% (p<0.05 for both post-protocol and +1 year when compared to pre-protocol). Documentation of consent for HIV testing improved from 25% to 67.6% with the HIV-tailored clerking proforma. The total number of HIV tests requested from the unit doubled in the post-proforma period compared to pre-protocol ( p<0.05). Conclusion In conclusion: the combination of an HIV testing protocol, a tailored departmental clerking proforma and regular focussed teaching to doctors on indications for HIV testing led to a sustained increase in HIV testing uptake in our regional acute neurology admissions unit.	[Sokhi, Dilraj Singh; Oxenham, Chantal; Coates, Rebecca; Forbes, Mhairi; Blackburn, Daniel J.] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Clin Neurol, Sheffield S10 4JF, S Yorkshire, England; [Gupta, Nadi K.] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Genitourinary Med, Sheffield S10 4JF, S Yorkshire, England; [Blackburn, Daniel J.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Sokhi, DS (corresponding author), Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Clin Neurol, Doctors Off L16, Glossop Rd, Sheffield S10 4JF, S Yorkshire, England.	Dilraj.Sokhi@doctors.net.uk	Blackburn, Daniel J/B-7355-2011	blackburn, daniel/0000-0001-8886-1283				Aghaizu A, 2013, GILL ON DELPECH VC C; Alston C, 2013, CLIN MED, V13, P114, DOI 10.7861/clinmedicine.13-1-114; Anand Kuljeet Singh, 2014, J Int Assoc Provid AIDS Care, V13, P409, DOI 10.1177/2325957414531620; [Anonymous], 2006, 2005 2006 MORT AUD; [Anonymous], 2009, HIV UK 2009 REP; Benjamin LA, 2012, LANCET NEUROL, V11, P878, DOI 10.1016/S1474-4422(12)70205-3; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Buetikofer S., 2014, SWISS MED WKLY, V144, DOI [10.4414/SMW.2014.13961, DOI 10.4414/SMW.2014.13961]; Burns F, 2013, HIV MED, V14, P10, DOI 10.1111/hiv.12056; Casalino E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046437; Chan SY, 2011, INT J STD AIDS, V22, P187, DOI 10.1258/ijsa.2010.010304; Chua AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034663; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Dodd MC, 2013, THORAX, V68, P1072, DOI 10.1136/thoraxjnl-2012-202871; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Ellis S, 2011, CLIN MED, V11, P541, DOI 10.7861/clinmedicine.11-6-541; Socias ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069517; Gendelman HEG, 2011, NEUROLOGY AIDS; Hartney T, 2012, EVIDENCE RESOURCES C; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Health Protection Agency, 2011, TIM TEST HIV EXP HIV; Hickman SJ, 2008, NEURO-OPHTHALMOLOGY, V32, P237, DOI 10.1080/01658100802391905; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lucas SB, 2008, CLIN MED, V8, P250, DOI 10.7861/clinmedicine.8-3-250; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; McLaren JS, 2001, QJM-INT J MED, V94, P615, DOI 10.1093/qjmed/94.11.615; Mitchell L, 2011, INT J STD AIDS, V22, P753, DOI 10.1258/ijsa.2009.009244; Page I, 2011, J ROY COLL PHYS EDIN, V41, P9, DOI 10.4997/JRCPE.2011.103; Palfreeman A., 2008, UKNATIONAL GUIDELINE; Palfreeman A, 2013, SEX TRANSM INFECT, V89, P308, DOI 10.1136/sextrans-2011-050401; Peck L, 2010, QJM-INT J MED, V103, P147, DOI 10.1093/qjmed/hcp185; Perry NH, 2010, HIV MED, V11; Phillips D, 2014, SEX TRANSM INFECT, V90, P185, DOI 10.1136/sextrans-2013-051302; Price H, 2009, INT J STD AIDS, V20, P56, DOI 10.1258/ijsa.2008.008326; Ratcliffe L, 2011, POSTGRAD MED J, V87, P170, DOI 10.1136/pgmj.2010.109801; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Sokhi D, 2013, HIV MED S, V4, P12; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; SOPHID, 2011, SURV PREV HIV INF DI; Thornton AC, 2012, SEX TRANSM INFECT, V88, P601, DOI 10.1136/sextrans-2012-050584; van Sighem A, 2010, AIDS, V24, P1527, DOI 10.1097/QAD.0b013e32833a3946	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0134574	10.1371/journal.pone.0134574	http://dx.doi.org/10.1371/journal.pone.0134574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335351	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000360615400002
J	Aimone, J; Ball, S; King-Casas, B				Aimone, Jason; Ball, Sheryl; King-Casas, Brooks			The Betrayal Aversion Elicitation Task: An Individual Level Betrayal Aversion Measure	PLOS ONE			English	Article							RISK-AVERSION; TRUST; HUMANS	Research on betrayal aversion shows that individuals' response to risk depends not only on probabilities and payoffs, but also on whether the risk includes a betrayal of trust. While previous studies focus on measuring aggregate levels of betrayal aversion, the connection between an individual's own betrayal aversion and other individually varying factors, including risk preferences, are currently unexplored. This paper develops a new task to elicit an individual's level of betrayal aversion that can then be compared to individual characteristics. We demonstrate the feasibility of our new task and show that our aggregate individual results are consistent with previous studies. We then use this classification to ask whether betrayal aversion is correlated with risk aversion. While we find risk aversion and betrayal aversion have no significant relationship, we do observe that risk aversion is correlated with non-social risk preferences, but not the social, betrayal related, risk component of the new task.	[Aimone, Jason] Baylor Univ, Dept Econ, Hankamer Sch Business, Waco, TX 76798 USA; [Aimone, Jason; Ball, Sheryl; King-Casas, Brooks] Virginia Tech, Caril Res Inst, Roanoke, VA 24016 USA; [Ball, Sheryl] Virginia Tech, Dept Econ, Blacksburg, VA USA; [King-Casas, Brooks] Virginia Tech, Dept Psychol, Blacksburg, VA USA; [King-Casas, Brooks] Salem Vet Affairs Med Ctr, Res Serv Line, Salem, VA USA; [King-Casas, Brooks] Virginia Tech, Caril Sch Med, Dept Psychiat, Roanoke, VA USA; [King-Casas, Brooks] VT WFU Sch Biomed Engn & Sci, Blacksburg, VA USA	Baylor University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Salem Veterans Affairs Medical Center; Virginia Polytechnic Institute & State University	Ball, S (corresponding author), Virginia Tech, Caril Res Inst, Roanoke, VA 24016 USA.	sball@vt.edu			VHA ORD grant [D7020R]	VHA ORD grant	The authors acknowledge partial support from VHA ORD grant #D7020R. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2127; Aimone JA, 2013, J ECON BEHAV ORGAN, V89, P1, DOI 10.1016/j.jebo.2013.02.001; Aimone JA, 2012, EXP ECON, V15, P571, DOI 10.1007/s10683-012-9314-z; Aimone JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017725; Akerstrom M., 1991, BETRAYAL BETRAYERS S; Ball S, 2010, J RISK UNCERTAINTY, V41, P167, DOI 10.1007/s11166-010-9105-x; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Birnberg JG, 2011, J MANAG ACOUNT RES, V23, P169, DOI 10.2308/jmar-10087; Bohnet I, 2004, J ECON BEHAV ORGAN, V55, P467, DOI 10.1016/j.jebo.2003.11.004; Bohnet I, 2008, AM ECON REV, V98, P294, DOI 10.1257/aer.98.1.294; Bohnet I, 2010, Q J ECON, V125, P811, DOI 10.1162/qjec.2010.125.2.811; Dave C, 2010, J RISK UNCERTAINTY, V41, P219, DOI 10.1007/s11166-010-9103-z; Eckel CC, 2002, EVOL HUM BEHAV, V23, P281, DOI 10.1016/S1090-5138(02)00097-1; Elangovan AR, 1998, ACAD MANAGE REV, V23, P547, DOI 10.2307/259294; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Gershoff AD, 2011, J CONSUM RES, V38, P140, DOI 10.1086/658883; Gregoire Y, 2008, J ACAD MARKET SCI, V36, P247, DOI 10.1007/s11747-007-0054-0; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Hong K, 2007, J ECON PSYCHOL, V28, P197, DOI 10.1016/j.joep.2006.06.003; Kahnenman D, 1998, J RISK UNCERTAINTY, V49, P61; Koehler JJ, 2003, ORGAN BEHAV HUM DEC, V90, P244, DOI 10.1016/S0749-5978(02)00518-6; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Norman J, 2013, REV LITIGATION, V32, P525; Shnoor B, 2009, AM J TRIAL ADVOC, V33, p71 	25	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137491	10.1371/journal.pone.0137491	http://dx.doi.org/10.1371/journal.pone.0137491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331944	Green Submitted, gold, Green Published			2022-12-27	WOS:000360613800135
J	Crall, JD; Gravish, N; Mountcastle, AM; Combes, SA				Crall, James D.; Gravish, Nick; Mountcastle, Andrew M.; Combes, Stacey A.			BEEtag: A Low-Cost, Image-Based Tracking System for the Study of Animal Behavior and Locomotion	PLOS ONE			English	Article							FLIGHT; IDENTIFICATION; INDIVIDUALS; BUMBLEBEES	A fundamental challenge common to studies of animal movement, behavior, and ecology is the collection of high-quality datasets on spatial positions of animals as they change through space and time. Recent innovations in tracking technology have allowed researchers to collect large and highly accurate datasets on animal spatiotemporal position while vastly decreasing the time and cost of collecting such data. One technique that is of particular relevance to the study of behavioral ecology involves tracking visual tags that can be uniquely identified in separate images or movie frames. These tags can be located within images that are visually complex, making them particularly well suited for longitudinal studies of animal behavior and movement in naturalistic environments. While several software packages have been developed that use computer vision to identify visual tags, these software packages are either (a) not optimized for identification of single tags, which is generally of the most interest for biologists, or (b) suffer from licensing issues, and therefore their use in the study of animal behavior has been limited. Here, we present BEEtag, an opensource, image-based tracking system in Matlab that allows for unique identification of individual animals or anatomical markers. The primary advantages of this system are that it (a) independently identifies animals or marked points in each frame of a video, limiting error propagation, (b) performs well in images with complex backgrounds, and (c) is low-cost. To validate the use of this tracking system in animal behavior, we mark and track individual bumblebees (Bombus impatiens) and recover individual patterns of space use and activity within the nest. Finally, we discuss the advantages and limitations of this software package and its application to the study of animal movement, behavior, and ecology.	[Crall, James D.; Gravish, Nick; Mountcastle, Andrew M.; Combes, Stacey A.] Harvard Univ, Concord Field Stn, Organism & Evolutionary Biol, Bedford, MA 01730 USA; [Gravish, Nick] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Crall, JD (corresponding author), Harvard Univ, Concord Field Stn, Organism & Evolutionary Biol, Bedford, MA 01730 USA.	james.crall@gmail.com		Gravish, Nicholas/0000-0002-9391-2476	NSF GRFP fellowship; NSF CAREER grant [IOS-1253677]; James S. McDonnell foundation; Direct For Biological Sciences [1253677] Funding Source: National Science Foundation	NSF GRFP fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); James S. McDonnell foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by an NSF GRFP fellowship to James Crall and an NSF CAREER grant to Stacey Combes (IOS-1253677). Nick Gravish would like to acknowledge funding from the James S. McDonnell foundation.	ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Atcheson B., 2010, P 15 INT WORKSH VIS, P41; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; Daley MA, 2006, P NATL ACAD SCI USA, V103, P15681, DOI 10.1073/pnas.0601473103; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Dennis RL, 2008, POULTRY SCI, V87, P1939, DOI 10.3382/ps.2007-00311; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; DUDLEY R, 1990, J EXP BIOL, V148, P19; Fiala M, 2005, PROC CVPR IEEE, P590; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Kain J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2908; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Ravi S, 2013, J EXP BIOL, V216, P4299, DOI 10.1242/jeb.090845; Ristroph L, 2009, J EXP BIOL, V212, P1324, DOI 10.1242/jeb.025502; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Sockman KW, 2001, GEN COMP ENDOCR, V122, P205, DOI 10.1006/gcen.2001.7626; Stelzer RJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-93; Wakeling JM, 1997, J EXP BIOL, V200, P543	27	65	65	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136487	10.1371/journal.pone.0136487	http://dx.doi.org/10.1371/journal.pone.0136487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332211	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800058
J	Ketha, H; Singh, RJ; Grebe, SK; Bergstralh, EJ; Rule, AD; Lieske, JC; Kumar, R				Ketha, Hemamalini; Singh, Ravinder J.; Grebe, Stefan K.; Bergstralh, Eric J.; Rule, Andrew D.; Lieske, John C.; Kumar, Rajiv			Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers	PLOS ONE			English	Article							IDIOPATHIC INFANTILE HYPERCALCEMIA; TANDEM MASS-SPECTROMETRY; D 24-HYDROXYLASE GENE; ABSORPTIVE HYPERCALCIURIA; PRIMARY HYPERPARATHYROIDISM; DIAGNOSTIC-CRITERIA; CYP24A1; NEPHROLITHIASIS; MUTATIONS; 1,25-DIHYDROXYVITAMIN-D3	Background Elevated serum 1,25-dihydroxyvitamin D (1,25(OH)(2)D) concentrations have been reported among cohorts of recurrent calcium (Ca) kidney stone-formers and implicated in the pathogenesis of hypercalciuria. Variations in Ca and vitamin D metabolism, and excretion of urinary solutes among first-time male and female Ca stone-formers in the community, however, have not been defined. Methods In a 4-year community-based study we measured serum Ca, phosphorus (P), 25-hydroxyvitamin D (25(OH) D), 1,25(OH)(2)D, 24,25-dihydroxyvitamin D (24,25(OH)(2)D), parathyroid hormone (PTH), and fibroblast growth factor-23 (FGF-23) concentrations in first-time Ca stoneformers and age-and gender frequency-matched controls. Results Serum Ca and 1,25(OH)(2)D were increased in Ca stone-formers compared to controls (P = 0.01 and P = 0.001). Stone-formers had a lower serum 24,25(OH)(2)D/25(OH)D ratio compared to controls (P = 0.008). Serum PTH and FGF-23 concentrations were similar in the groups. Urine Ca excretion was similar in the two groups (P = 0.82). In controls, positive associations between serum 25(OH)D and 24,25(OH)(2)D, FGF-23 and fractional phosphate excretion, and negative associations between serum Ca and PTH, and FGF-23 and 1,25(OH)(2)D were observed. In SF associations between FGF-23 and fractional phosphate excretion, and FGF-23 and 1,25(OH)(2)D, were not observed. 1,25(OH)(2)D concentrations associated more weakly with FGF-23 in SF compared with C (P < 0.05). Conclusions Quantitative differences in serum Ca and 1,25(OH)(2)D and reductions in 24-hydroxylation of vitamin D metabolites are present in first-time SF and might contribute to first-time stone risk.	[Ketha, Hemamalini; Rule, Andrew D.; Lieske, John C.; Kumar, Rajiv] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55902 USA; [Ketha, Hemamalini; Rule, Andrew D.; Lieske, John C.; Kumar, Rajiv] Mayo Clin, Dept Med, Rochester, MN USA; [Ketha, Hemamalini; Singh, Ravinder J.; Grebe, Stefan K.; Lieske, John C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Singh, Ravinder J.; Bergstralh, Eric J.; Rule, Andrew D.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Kumar, Rajiv] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kumar, R (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55902 USA.	rkumar@mayo.edu	Lieske, John/ABA-4829-2020	Ketha, Hemamalini/0000-0002-4720-7485; Kumar, Rajiv/0000-0003-3497-3057	Mayo Clinic O'Brien Urology Research Center [U54 DK100227]; Rare Kidney Stone Consortium [U54DK083908]; NIDDK; National Center for Advancing Translational Sciences (NCATS), NIH Training Grant [T32 DK007013, R21-AR058003, R21-AR060869]; Falk Foundation; Mayo Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060869, R21AR058003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007013, U54DK100227, U54DK083908, P50DK083007] Funding Source: NIH RePORTER	Mayo Clinic O'Brien Urology Research Center; Rare Kidney Stone Consortium; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences (NCATS), NIH Training Grant; Falk Foundation; Mayo Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Mayo Clinic O'Brien Urology Research Center (U54 DK100227), the Rare Kidney Stone Consortium (U54DK083908), a member of the NIH Rare Diseases Clinical Research Network (RDCRN), the NIDDK and the National Center for Advancing Translational Sciences (NCATS), NIH Training Grant T32 DK007013, R21-AR058003, R21-AR060869, a grant from the Falk Foundation, and the Mayo Foundation.	BROADUS AE, 1984, J CLIN ENDOCR METAB, V58, P161, DOI 10.1210/jcem-58-1-161; BROADUS AE, 1980, NEW ENGL J MED, V302, P421, DOI 10.1056/NEJM198002213020801; BROADUS AE, 1984, NEW ENGL J MED, V311, P73, DOI 10.1056/NEJM198407123110201; COE FL, 1992, NEW ENGL J MED, V327, P1141, DOI 10.1056/NEJM199210153271607; COE FL, 1979, NEW ENGL J MED, V300, P337, DOI 10.1056/NEJM197902153000703; Dauber A, 2012, J CLIN ENDOCR METAB, V97, pE268, DOI 10.1210/jc.2011-1972; DELUCA HF, 1983, ANNU REV BIOCHEM, V52, P411, DOI 10.1146/annurev.bi.52.070183.002211; DELUCA HF, 1972, NEW ENGL J MED, V287, P250, DOI 10.1056/NEJM197208032870511; Dinour D, 2013, J UROLOGY, V190, P552, DOI 10.1016/j.juro.2013.02.3188; GARABEDIAN M, 1972, P NATL ACAD SCI USA, V69, P1673, DOI 10.1073/pnas.69.7.1673; Jacobs TP, 2014, J CLIN ENDOCR METAB, V99, P708, DOI 10.1210/jc.2013-3802; KAPLAN RA, 1977, J CLIN INVEST, V59, P756, DOI 10.1172/JCI108696; KUMAR R, 1984, PHYSIOL REV, V64, P478, DOI 10.1152/physrev.1984.64.2.478; KUMAR R, 1978, J BIOL CHEM, V253, P3804; LEMANN J, 1989, J UROLOGY, V141, P715, DOI 10.1016/S0022-5347(17)40993-1; Lieske JC, 2006, KIDNEY INT, V69, P760, DOI 10.1038/sj.ki.5000150; Lieske JC, 2014, CLIN J AM SOC NEPHRO, V9, P943, DOI 10.2215/CJN.08210813; Moe OW, 2005, J AM SOC NEPHROL, V16, P729, DOI 10.1681/ASN.2004100888; Netzel BC, 2011, CLIN CHEM, V57, P431, DOI 10.1373/clinchem.2010.157115; O'Seaghdha CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003796; PAK CYC, 1974, J CLIN INVEST, V54, P387, DOI 10.1172/JCI107774; PAK CYC, 1980, AM J MED, V69, P19, DOI 10.1016/0002-9343(80)90495-7; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Ryan ZC, 2013, P NATL ACAD SCI USA, V110, P6199, DOI 10.1073/pnas.1221255110; Sakhaee K, 2008, CURR OPIN NEPHROL HY, V17, P304, DOI 10.1097/MNH.0b013e3282f8b34d; Sayers J, 2013, OA NEPHROLOGY, V1, p[6, 1]; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Scott P, 1998, J AM SOC NEPHROL, V9, P425; Scott P, 1999, J AM SOC NEPHROL, V10, P1007; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Strathmann FG, 2011, CLIN CHEM, V57, P1279, DOI 10.1373/clinchem.2010.161174; Taylor EN, 2015, CLIN J AM SOC NEPHRO, V10, P667, DOI 10.2215/CJN.07060714; Tebben PJ, 2012, J CLIN ENDOCR METAB, V97, pE423, DOI 10.1210/jc.2011-1935; Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404; Wolf P, 2014, ENDOCR PRACT, V20, pE91, DOI 10.4158/EP13479.CR	36	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137350	10.1371/journal.pone.0137350	http://dx.doi.org/10.1371/journal.pone.0137350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332888	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800126
J	Klijs, B; Scholtens, S; Mandemakers, JJ; Snieder, H; Stolk, RP; Smidt, N				Klijs, Bart; Scholtens, Salome; Mandemakers, Jornt J.; Snieder, Harold; Stolk, Ronald P.; Smidt, Nynke			Representativeness of the LifeLines Cohort Study	PLOS ONE			English	Article							HEALTH; PARTICIPATION; DISEASES; PROFILE; BMI	Background LifeLines is a large prospective population-based three generation cohort study in the north of the Netherlands. Different recruitment strategies were adopted: recruitment of an index population via general practitioners, subsequent inclusion of their family members, and online self-registration. Our aim was to investigate the representativeness of the adult study population at baseline and to evaluate differences in the study population according to recruitment strategy. Methods Demographic characteristics of the LifeLines study population, recruited between 2006-2013, were compared with the total adult population in the north of the Netherlands as registered in the Dutch population register. Socioeconomic characteristics, lifestyle, chronic diseases, and general health were further compared with participants of the Permanent Survey of Living Conditions within the region (2005-2011, N = 6,093). Differences according to recruitment strategy were assessed. Results Compared with the population of the north of the Netherlands, LifeLines participants were more often female, middle aged, married, living in a semi-urban place and Dutch native. Adjusted for differences in demographic composition, in LifeLines a smaller proportion had a low educational attainment (5% versus 14%) or had ever smoked (54% versus 66%). Differences in the prevalence of various chronic diseases and low general health scores were mostly smaller than 3%. The age profiles of the three recruitment groups differed due to age related inclusion criteria of the recruitment groups. Other differences according to recruitment strategy were small. Conclusions Our results suggest that, adjusted for differences in demographic composition, the LifeLines adult study population is broadly representative for the adult population of the north of the Netherlands. The recruitment strategy had a minor effect on the level of representativeness. These findings indicate that the risk of selection bias is low and that risk estimates in LifeLines can be generalized to the general population.	[Klijs, Bart; Snieder, Harold; Stolk, Ronald P.; Smidt, Nynke] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Scholtens, Salome; Stolk, Ronald P.] LifeLines Cohort Study & Biobank, Groningen, Netherlands; [Mandemakers, Jornt J.] Wageningen Univ, Sociol Consumpt & Households, NL-6700 AP Wageningen, Netherlands	University of Groningen; Wageningen University & Research	Klijs, B (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	b.klijs01@umcg.nl	Mandemakers, Jornt/N-5591-2016	Mandemakers, Jornt/0000-0002-1718-6599; Stolk, Ronald/0000-0002-0518-1205; Scholtens, Salome/0000-0002-0651-5203	Dutch government; Netherlands Organization of Scientific Research NWO; northern Netherlands Collaboration of Provinces (SNN); European fund for regional development; Dutch Ministry of economic affairs; Pieken in de Delta; Province of Groningen; Province of Drenthe; Target project, BBMRI-NL; University of Groningen; University Medical Center Groningen, The Netherlands	Dutch government; Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); northern Netherlands Collaboration of Provinces (SNN); European fund for regional development(European Commission); Dutch Ministry of economic affairs(Ministry of Economic Affairs, Netherlands); Pieken in de Delta; Province of Groningen; Province of Drenthe; Target project, BBMRI-NL; University of Groningen; University Medical Center Groningen, The Netherlands(Netherlands Government)	LifeLines has been funded by a number of public sources, notably the Dutch government, the Netherlands Organization of Scientific Research NWO, the northern Netherlands Collaboration of Provinces (SNN), European fund for regional development, Dutch Ministry of economic affairs, Pieken in de Delta, Provinces of Groningen and Drenthe, the Target project, BBMRI-NL, the University of Groningen, and the University Medical Center Groningen, The Netherlands.	Bak HJ, 2001, SOC SCI QUART, V82, P779, DOI 10.1111/0038-4941.00059; Banks Emily, 2012, BMC Res Notes, V5, P655, DOI 10.1186/1756-0500-5-655; Courtenay WH, 2002, J HEALTH PSYCHOL, V7, P219, DOI 10.1177/1359105302007003216; Ebrahim S, 2013, INT J EPIDEMIOL, V42, P1022, DOI 10.1093/ije/dyt105; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Harris ML, 2015, AM J EPIDEMIOL, V181, P737, DOI 10.1093/aje/kwv006; Hutchings S, 2014, OCCUP ENV MED S1, V71; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Jockel KH, 2013, EUR J EPIDEMIOL, V28, P223, DOI 10.1007/s10654-013-9782-2; Klerk M, 2005, NATL OVERVIEW LIVING; Klijs B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025325; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504; Messer KL, 2006, INT UROL NEPHROL, V38, P255, DOI 10.1007/s11255-006-0018-1; Nohr EA, 2013, INT J EPIDEMIOL, V42, P1016, DOI 10.1093/ije/dyt102; PUTNAM RD, 1995, PS, V28, P664, DOI 10.2307/420517; Rothman KJ., 2012, EPIDEMIOLOGY INTRO; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Scholtens S., 2014, INT J EPIDEMIOL; Shahar E, 1996, ANN EPIDEMIOL, V6, P498, DOI 10.1016/S1047-2797(96)00104-4; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith BH, 2013, INT J EPIDEMIOL, V42, P689, DOI 10.1093/ije/dys084; Stang A, 2014, INT J EPIDEMIOL, V43, P630, DOI 10.1093/ije/dyt263; Statistics Netherlands, 2005, PERM SURV LIV COND; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; The Netherlands Institute for Social Research, 2006, ELD REP 2006 CHANG L; van Echtelt P, 2010, JOBLESS EXISTENCE ME; van Lenthe FJ, 2014, INT J EPIDEMIOL, V43, P721, DOI 10.1093/ije/dyt040; Visscher TLS, 2006, OBESITY, V14, P2054, DOI 10.1038/oby.2006.240; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wuijts F, 2011, REPRT SNAPSHOT QUALI	32	167	167	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137203	10.1371/journal.pone.0137203	http://dx.doi.org/10.1371/journal.pone.0137203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333164	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800109
J	Koester, DC; Freeman, EW; Brown, JL; Wildt, DE; Terrell, KA; Franklin, AD; Crosier, AE				Koester, Diana C.; Freeman, Elizabeth W.; Brown, Janine L.; Wildt, David E.; Terrell, Kimberly A.; Franklin, Ashley D.; Crosier, Adrienne E.			Motile Sperm Output by Male Cheetahs (Acinonyx jubatus) Managed Ex Situ Is Influenced by Public Exposure and Number of Care-Givers	PLOS ONE			English	Article							FREE-RANGING CHEETAHS; NORTH-AMERICAN ZOOS; CAT FELIS-CATUS; DOMESTIC CAT; REPRODUCTIVE TRAITS; EJACULATE TRAITS; SEASONAL-CHANGES; STRESS; SPERMATOZOA; PITUITARY	The collective cheetah (Acinonyx jubatus) population in zoological institutions has never been self-sustaining because of challenges in natural reproduction. A retrospective analysis of North American zoo-breeding records has revealed that >90% of litters produced since 2003 occurred in facilities 'off-display' from the public. We examined seminal, endocrine, and behavioral traits of 29 adult male cheetahs that were: 1) managed in public exhibit or off-display facilities; 2) maintained by different numbers of cheetah-specific care-givers; and 3) living adjacent to varying numbers of adult conspecifics. Cheetahs housed off-display produced more total motile sperm/ejaculate (P = 0.04) than on-exhibit males. This finding was mirrored in our laboratory's historical records where two-fold more total motile sperm (P < 0.01) were measured in ejaculates from individuals with no public exposure (n = 43) compared to on-exhibit (n = 116) counterparts. Males at institutions with <= 3 care-givers also produced more total motile sperm/ejaculate (P < 0.03) and spent more time behaviorally active (P < 0.01) than at facilities using >3 care-givers. Exposure to high numbers of conspecifics within the same institution did not impact (P > 0.05) seminal traits, and presence of the public, care-giver number, or animals/facility had no influence (P > 0.05) on androgen or glucocorticoid excretion or other behavioral metrics. Findings indicate that male cheetahs are sensitive to general public exposure and too many care-givers, resulting in compromised motile sperm output/ejaculate with mechanism of action unrelated to altered androgen or glucocorticoid excretion.	[Koester, Diana C.; Freeman, Elizabeth W.; Brown, Janine L.; Wildt, David E.; Terrell, Kimberly A.; Franklin, Ashley D.; Crosier, Adrienne E.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA; [Koester, Diana C.] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Freeman, Elizabeth W.] George Mason Univ, New Century Coll, Fairfax, VA 22030 USA; [Terrell, Kimberly A.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Franklin, Ashley D.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; George Mason University; George Mason University; Tulane University; University System of Maryland; University of Maryland College Park	Koester, DC (corresponding author), Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA 22630 USA.	KoesterD@si.edu	Franklin, Ashley D/J-3069-2015	Franklin, Ashley D/0000-0002-0818-5156	William H. Donner Foundation Inc.; Smithsonian Pre-doctoral Research Fellowship Program; George Mason University Presidential Scholar Award in the Department of Environmental Science and Policy	William H. Donner Foundation Inc.; Smithsonian Pre-doctoral Research Fellowship Program; George Mason University Presidential Scholar Award in the Department of Environmental Science and Policy	This research was supported by the William H. Donner Foundation Inc., the Smithsonian Pre-doctoral Research Fellowship Program, and the George Mason University Presidential Scholar Award in the Department of Environmental Science and Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; Aitken-Palmer C, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099044; Baker K, 2013, J ZOO AQUAR RES, V1, P35; Bartos L, 1998, COMP BIOCHEM PHYS A, V120, P373, DOI 10.1016/S1095-6433(98)10038-7; Brown JL, 2001, J REP FER S, P71; BROWN JL, 1991, J REPROD FERTIL, V91, P29; CARLSTEAD K, 1993, ZOO BIOL, V12, P321, DOI 10.1002/zoo.1430120403; Carlstead K, 2009, ZOO BIOL, V28, P589, DOI 10.1002/zoo.20289; Caro T., 1994, CHEETAHS SERENGETI P; CARO TM, 1987, ETHOLOGY, V74, P52; CARO TM, 1993, ZOO BIOL, V12, P19, DOI 10.1002/zoo.1430120105; Christofoletti MD, 2010, EUR J WILDLIFE RES, V56, P561, DOI 10.1007/s10344-009-0350-8; Comizzoli P, 2009, REPROD DOMEST ANIM, V44, P47, DOI 10.1111/j.1439-0531.2009.01373.x; Crosier AE, 2007, REPROD FERT DEVELOP, V19, P370, DOI 10.1071/RD06057; Crosier AE, 2011, BIOL REPROD, V85, P243, DOI 10.1095/biolreprod.110.089417; Crosier AE, 2006, CRYOBIOLOGY, V52, P169, DOI 10.1016/j.cryobiol.2005.10.011; Dalmau A, 2007, J WILDLIFE MANAGE, V71, P190, DOI 10.2193/2005-492; DONOGHUE AM, 1992, BIOL REPROD, V46, P1047, DOI 10.1095/biolreprod46.6.1047; Durant S, ACINONYX JUBATUS IUC; EATON R L, 1970, Journal of Wildlife Management, V34, P56, DOI 10.2307/3799492; Ganan N, 2010, REPRODUCTION, V139, P275, DOI 10.1530/REP-09-0259; Grafen A., 2002, MODERN STAT LIFE SCI; Graham LH, 1996, ZOO BIOL, V15, P71, DOI 10.1002/(SICI)1098-2361(1996)15:1<71::AID-ZOO7>3.0.CO;2-9; Grisham J, 2013, CHEETAH ACINONYX JUB; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; HOWARD JG, 1990, J ANDROL, V11, P204; Howard JG, 1997, BIOL REPROD, V56, P1059, DOI 10.1095/biolreprod56.4.1059; Jasnow AM, 2001, HORM BEHAV, V40, P428, DOI 10.1006/hbeh.2001.1708; JOHNSTON LA, 1994, J REPROD FERTIL, V102, P229; Jurke MH, 1997, ZOO BIOL, V16, P133, DOI 10.1002/(SICI)1098-2361(1997)16:2<133::AID-ZOO4>3.0.CO;2-B; KASSON BG, 1985, J BIOL CHEM, V260, P5302; Kwon WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054192; LAURENSON MK, 1993, ZOO BIOL, V12, P31, DOI 10.1002/zoo.1430120106; LINDBURG DG, 1993, ZOO BIOL, V12, P97, DOI 10.1002/zoo.1430120109; Linklater WL, 2010, ANIM CONSERV, V13, P104, DOI 10.1111/j.1469-1795.2009.00308.x; Marker L, 2012, INT CHEETAH STUDBOOK; Marker LL, 2008, J ZOOL, V274, P226, DOI 10.1111/j.1469-7998.2007.00375.x; MARKERKRAUS L, 1993, ZOO BIOL, V12, P5, DOI 10.1002/zoo.1430120104; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; MASON JW, 1956, SCIENCE, V124, P983, DOI 10.1126/science.124.3229.983; MEIDAN R, 1985, ENDOCRINOLOGY, V116, P416, DOI 10.1210/endo-116-1-416; Munson L, 2005, J WILDLIFE DIS, V41, P542, DOI 10.7589/0090-3558-41.3.542; Munson L, 1999, J ZOO WILDLIFE MED, V30, P342; MUNSON L, 1993, ZOO BIOL, V12, P105, DOI 10.1002/zoo.1430120110; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Neubauer K, 2004, BIOL REPROD, V71, P1517, DOI 10.1095/biolreprod.104.031062; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; OBRIEN SJ, 1983, SCIENCE, V221, P459, DOI 10.1126/science.221.4609.459; OBRIEN SJ, 1987, P NATL ACAD SCI USA, V84, P508, DOI 10.1073/pnas.84.2.508; OSKINA IN, 1992, COMP BIOCHEM PHYS A, V101, P665, DOI 10.1016/0300-9629(92)90341-M; Pukazhenthi B, 2000, CRYOBIOLOGY, V40, P139, DOI 10.1006/cryo.2000.2233; Pukazhenthi BS, 2001, J REP FER S, P423; Pukazhenthi BS, 2006, THERIOGENOLOGY, V66, P112, DOI 10.1016/j.theriogenology.2006.03.020; PURI S, 1985, ARCH ANDROLOGY, V14, P263, DOI 10.3109/01485018508988309; Quirke T, 2012, APPL ANIM BEHAV SCI, V142, P189, DOI 10.1016/j.applanim.2012.09.007; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; ROTH TL, 1995, J EXP ZOOL, V271, P323, DOI 10.1002/jez.1402710410; Scott LV, 1998, LIFE SCI, V62, P1985, DOI 10.1016/S0024-3205(98)00027-7; SLIWA L, 1994, ARCH ANDROLOGY, V33, P145; Smith RF, 2002, DOMEST ANIM ENDOCRIN, V23, P75, DOI 10.1016/S0739-7240(02)00147-9; Sokal R. R., 2012, BIOMETRY; Swanson WF, 1996, J ZOO WILDLIFE MED, V27, P234; Terio KA, 2004, J WILDLIFE DIS, V40, P259, DOI 10.7589/0090-3558-40.2.259; Terrell KA, 2012, CRYOBIOLOGY, V64, P110, DOI 10.1016/j.cryobiol.2011.12.006; Terrell KA, 2010, BIOL REPROD, V83, P833, DOI 10.1095/biolreprod.110.085639; Uschold-Schmidt N, 2012, PSYCHONEUROENDOCRINO, V37, P1676, DOI 10.1016/j.psyneuen.2012.02.015; Vick MM, 2012, STRESS, V15, P52, DOI 10.3109/10253890.2011.578267; Wells A, 2004, J ZOO WILDLIFE MED, V35, P8, DOI 10.1638/02-084; Wielebnowski N, 1998, ZOO BIOL, V17, P193, DOI 10.1002/(SICI)1098-2361(1998)17:3<193::AID-ZOO4>3.0.CO;2-4; Wielebnowski N, 1996, ZOO BIOL, V15, P353, DOI 10.1002/(SICI)1098-2361(1996)15:4<353::AID-ZOO1>3.0.CO;2-A; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; Wielebnowski NC, 2002, ANIM CONSERV, V5, P291, DOI 10.1017/S1367943002004043; Wielebnowski NC, 1999, ZOO BIOL, V18, P335, DOI 10.1002/(SICI)1098-2361(1999)18:4<335::AID-ZOO8>3.0.CO;2-X; Wildt David E., 1997, International Zoo Yearbook, V35, P164, DOI 10.1111/j.1748-1090.1997.tb01207.x; WILDT DE, 1983, BIOL REPROD, V29, P1019, DOI 10.1095/biolreprod29.4.1019; WILDT DE, 1987, NATURE, V329, P328, DOI 10.1038/329328a0; WILDT DE, 1988, BIOL REPROD, V38, P245, DOI 10.1095/biolreprod38.2.245; WILDT DE, 1993, ZOO BIOL, V12, P45, DOI 10.1002/zoo.1430120107; WILDT DE, 1987, BIOL REPROD, V36, P351, DOI 10.1095/biolreprod36.2.351; Wildt DE, 2012, ASS ZOOS AQUARIU AUG; Wingfield JC, 2013, ANIM BEHAV, V85, P1127, DOI 10.1016/j.anbehav.2013.02.018; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016; Ziegler-Meeks, 2009, HUSBANDRY MANUAL CHE	84	22	22	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135847	10.1371/journal.pone.0135847	http://dx.doi.org/10.1371/journal.pone.0135847			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332582	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800042
J	Lemaire, M; Silva, LFN; Lemarie, CA; Bolt, AM; Molina, MF; Krohn, RM; Smits, JE; Lehoux, S; Mann, KK				Lemaire, Maryse; Silva, Luis Fernando Negro; Lemarie, Catherine A.; Bolt, Alicia M.; Molina, Manuel Flores; Krohn, Regina M.; Smits, Judit E.; Lehoux, Stephanie; Mann, Koren K.			Arsenic Exposure Increases Monocyte Adhesion to the Vascular Endothelium, a Pro-Atherogenic Mechanism	PLOS ONE			English	Article							KAPPA-B ACTIVATION; DRINKING-WATER; ATHEROSCLEROTIC LESIONS; PLATELETS TRIGGERS; REACTIVE OXYGEN; PLASMA-LEVELS; P-SELECTIN; EXPRESSION; VCAM-1; INTEGRIN	Epidemiological studies have shown that arsenic exposure increases atherosclerosis, but the mechanisms underlying this relationship are unknown. Monocytes, macrophages and platelets play an important role in the initiation of atherosclerosis. Circulating monocytes and macrophages bind to the activated vascular endothelium and migrate into the subendothelium, where they become lipid-laden foam cells. This process can be facilitated by platelets, which favour monocyte recruitment to the lesion. Thus, we assessed the effects of low-to-moderate arsenic exposure on monocyte adhesion to endothelial cells, platelet activation and platelet-monocyte interactions. We observed that arsenic induces human monocyte adhesion to endothelial cells in vitro. These findings were confirmed ex vivo using a murine organ culture system at concentrations as low as 10 ppb. We found that both cell types need to be exposed to arsenic to maximize monocyte adhesion to the endothelium. This adhesion process is specific to monocyte/endothelium interactions. Hence, no effect of arsenic on platelet activation or platelet/leukocyte interaction was observed. We found that arsenic increases adhesion of mononuclear cells via increased CD29 binding to VCAM-1, an adhesion molecule found on activated endothelial cells. Similar results were observed in vivo, where arsenic-exposed mice exhibit increased VCAM-1 expression on endothelial cells and increased CD29 on circulating monocytes. Interestingly, expression of adhesion molecules and increased binding can be inhibited by antioxidants in vitro and in vivo. Together, these data suggest that arsenic might enhance atherosclerosis by increasing monocyte adhesion to endothelial cells, a process that is inhibited by antioxidants.	[Lemaire, Maryse; Bolt, Alicia M.; Molina, Manuel Flores; Mann, Koren K.] McGill Univ, Lady Davis Inst Med Res, Dept Oncol, Montreal, PQ, Canada; [Silva, Luis Fernando Negro; Lemarie, Catherine A.] McGill Univ, Dept Med, Lady Davis Inst Med Res, Div Expt Med, Montreal, PQ, Canada; [Lemarie, Catherine A.; Lehoux, Stephanie] McGill Univ, Dept Med, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Krohn, Regina M.; Smits, Judit E.] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada	Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; University of Calgary	Mann, KK (corresponding author), McGill Univ, Lady Davis Inst Med Res, Dept Oncol, Montreal, PQ, Canada.	koren.mann@mcgill.ca	Smits, Judit/E-8225-2012	Lemarie, Catherine/0000-0002-3897-4287; Smits, Judit/0000-0001-5341-4088	Canadian Institutes of Health Research [MOP-115000, CIHR 102498, MFE-120914]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research [KKM: MOP-115000; SL: CIHR 102498]. ML is supported by a fellowship from the Canadian Institutes of Health Research [MFE-120914].	Abernathy CO, 2003, J NUTR, V133, p1536S, DOI 10.1093/jn/133.5.1536S; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; ATSDR, 2006, TOX PROF ARS FED PRO; Barchowsky A, 1996, FREE RADICAL BIO MED, V21, P783, DOI 10.1016/0891-5849(96)00174-8; Barchowsky A, 1999, FREE RADICAL BIO MED, V27, P1405, DOI 10.1016/S0891-5849(99)00186-0; BARDY N, 1995, CIRC RES, V77, P684, DOI 10.1161/01.RES.77.4.684; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021; Bunderson M, 2004, TOXICOL APPL PHARM, V201, P32, DOI 10.1016/j.taap.2004.04.008; Chen Y, 2007, ENVIRON HEALTH PERSP, V115, P1415, DOI 10.1289/ehp.10277; Cook-Mills JM, 2005, ANTIOXID REDOX SIGNA, V15; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; de Almeida MC, 2000, MEM I OSWALDO CRUZ, V95, P221, DOI 10.1590/S0074-02762000000200014; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; ENGEL RR, 1994, ARCH ENVIRON HEALTH, V49, P418, DOI 10.1080/00039896.1994.9954996; Eriksson EE, 2001, FASEB J, V15, P1149, DOI 10.1096/fj.00-0537com; Gailer J, 2000, CHEM RES TOXICOL, V13, P1135, DOI 10.1021/tx000050h; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; HAWRYLOWICZ CM, 1991, J EXP MED, V174, P785, DOI 10.1084/jem.174.4.785; HealthCanada, 2006, GUID CAN DRINK WAT Q; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Hossain E, 2013, TOXICOL APPL PHARM, V273, P651, DOI 10.1016/j.taap.2013.10.012; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Huo Y, 2001, ACTA PHYSIOL SCAND, V173, P35, DOI 10.1046/j.1365-201X.2001.00882.x; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Huo YQ, 2000, CIRC RES, V87, P153, DOI 10.1161/01.RES.87.2.153; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Medrano MJ, 2010, ENVIRON RES, V110, P448, DOI 10.1016/j.envres.2009.10.002; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Krohn RM, 2015, J NUTR BIOC IN PRESS; Lee MY, 2002, TOXICOL APPL PHARM, V179, P83, DOI 10.1006/taap.2001.9356; Lemaire M, 2014, TOXICOL SCI, V142, P477, DOI 10.1093/toxsci/kfu197; Lemaire M, 2011, TOXICOL SCI, V122, P211, DOI 10.1093/toxsci/kfr097; Lemarie A, 2006, J IMMUNOL, V177, P3019, DOI 10.4049/jimmunol.177.5.3019; Lemarie CA, 2003, CIRC RES, V93, P207, DOI 10.1161/01.RES.0000086942.13523.88; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550; Moon KA, 2013, ANN INTERN MED, V159, P649, DOI 10.7326/0003-4819-159-10-201311190-00719; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289; Peter K, 1999, Thromb Haemost, V82 Suppl 1, P38; Puig-Kroger A, 2000, J IMMUNOL, V165, P4338, DOI 10.4049/jimmunol.165.8.4338; Riou S, 2007, CIRC RES, V100, P1226, DOI 10.1161/01.RES.0000265231.59354.2c; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Shih PT, 1999, CIRC RES, V84, P345, DOI 10.1161/01.RES.84.3.345; Simeonova PP, 2003, ENVIRON HEALTH PERSP, V111, P1744, DOI 10.1289/ehp.6332; Smith KR, 2001, AM J PHYSIOL-LUNG C, V280, pL442, DOI 10.1152/ajplung.2001.280.3.L442; Srivastava RK, 2013, TOXICOL APPL PHARM, V272, P879, DOI 10.1016/j.taap.2013.08.004; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; Werr J, 2000, J LEUKOCYTE BIOL, V68, P553; WHO W, 2008, GUID DRINK WAT QUAL, P306; Wu F, 2012, AM J EPIDEMIOL, V175, P1252, DOI 10.1093/aje/kwr464; Yuan Y, 2013, RADIAT RES, V179, P62, DOI 10.1667/RR3119.1	64	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136592	10.1371/journal.pone.0136592	http://dx.doi.org/10.1371/journal.pone.0136592			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332580	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800062
J	Titmarsh, HF; Gow, AG; Kilpatrick, S; Cartwright, JA; Milne, EM; Philbey, AW; Berry, J; Handel, I; Mellanby, RJ				Titmarsh, Helen F.; Gow, Adam G.; Kilpatrick, Scott; Cartwright, Jennifer A.; Milne, Elspeth M.; Philbey, Adrian W.; Berry, Jacqueline; Handel, Ian; Mellanby, Richard J.			Low Vitamin D Status Is Associated with Systemic and Gastrointestinal Inflammation in Dogs with a Chronic Enteropathy	PLOS ONE			English	Article							SERUM 25(OH)D CONCENTRATIONS; CONGESTIVE-HEART-FAILURE; C-REACTIVE PROTEIN; D SUPPLEMENTATION; 25-HYDROXYVITAMIN D; HYPOVITAMINOSIS D; BOWEL-DISEASE; PROINFLAMMATORY CYTOKINES; 1,25-DIHYDROXYVITAMIN D-3; OXIDATIVE STRESS	Introduction Vitamin D deficiency, as assessed by serum concentrations of 25 hydroxyvitamin D (25 (OH)D), has been linked to the development of over-zealous and inappropriate inflammation in humans. However, the relationship between vitamin D status and inflammation in dogs is ill-defined. Chronic enteropathies (CE) are frequently diagnosed in client owned dogs, have a wide range of serum 25(OH)D concentrations, and represent a spontaneous model in which to probe the relationship between vitamin D and inflammation. The hypothesis of this study was that vitamin D status would be negatively associated with systemic and gastrointestinal inflammation in dogs with a CE. The aim of this study was to examine the relationship between serum 25(OH)D concentrations and markers of systemic and gastrointestinal inflammation in a cohort of dogs with CE. Methods and Materials Serum 25(OH)D concentrations, together with neutrophil, monocyte, eosinophil and lymphocyte counts, duodenal histopathology scores, serum IL-2, IL-6, IL-8 and TNF alpha concentrations and were measured in 39 dogs with histologically confirmed CE. A linear regression model examined the relationship between serum 25(OH)D status and measures of inflammation. Results Serum 25(OH)D concentrations were negatively associated with neutrophil and monocyte counts, duodenal histopathology scores and serum IL-2 and IL-8 concentrations. Dogs with low serum 25(OH)D concentrations typically had an inflammatory signature characterised by high monocyte and neutrophil numbers together with low lymphocyte numbers. There is a need to establish whether low vitamin D status is a cause or consequence of inflammation.	[Titmarsh, Helen F.; Gow, Adam G.; Kilpatrick, Scott; Cartwright, Jennifer A.; Milne, Elspeth M.; Philbey, Adrian W.; Handel, Ian; Mellanby, Richard J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland; [Titmarsh, Helen F.; Gow, Adam G.; Kilpatrick, Scott; Cartwright, Jennifer A.; Milne, Elspeth M.; Philbey, Adrian W.; Handel, Ian; Mellanby, Richard J.] Univ Edinburgh, Roslin Inst, Roslin EH25 9RG, Midlothian, Scotland; [Berry, Jacqueline] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Royal Infirm, Vitamin Res Lab D,Endocrinol & Diabet,Inst Human, Manchester M13 9WL, Lancs, England	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Manchester	Mellanby, RJ (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9RG, Midlothian, Scotland.	Richard.Mellanby@ed.ac.uk	Gow, Adam/H-6623-2019	Gow, Adam/0000-0002-4297-8870; Kilpatrick, Scott/0000-0002-1469-757X; Mellanby, Richard John/0000-0002-3467-7007	Wellcome Trust Intermediate Clinical Fellowship	Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust)	Richard Mellanby is supported by a Wellcome Trust Intermediate Clinical Fellowship.	Abou-Raya A, 2013, J RHEUMATOL, V40, P265, DOI 10.3899/jrheum.111594; Alvarez JA, 2013, EUR J CLIN NUTR, V67, P264, DOI 10.1038/ejcn.2012.217; Bang UC, 2011, ENDOCR RES, V36, P135, DOI 10.3109/07435800.2011.554937; Barker T, 2013, EUR J APPL PHYSIOL, V113, P1523, DOI 10.1007/s00421-012-2582-7; Barth JH, 2012, ANN CLIN BIOCHEM, V49, P399, DOI 10.1258/acb.2011.011195; Bellia A, 2013, INTERN EMERG MED, V8, P33, DOI 10.1007/s11739-011-0559-x; Berry J, 2000, 25 HYDROXYVITAMIN D, P797; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cannell JJ, 2014, DERM-ENDOCRINOL, V6, DOI 10.4161/19381980.2014.983401; Carlson Nathan, 2013, Perm J, V17, P19, DOI 10.7812/TPP/13-007; Chambers ES, 2014, IMMUNOLOGY, V143, P52, DOI 10.1111/imm.12289; Charrad M, 2014, J STAT SOFTW, V61, P1; Chen YZ, 2014, INFLAMM BOWEL DIS, V20, P1910, DOI 10.1097/MIB.0000000000000158; Christakos S, 2003, J CELL BIOCHEM, V88, P695, DOI 10.1002/jcb.10423; Codoner-Franch P, 2012, J PEDIATR-US, V161, P848, DOI 10.1016/j.jpeds.2012.04.046; Czifra G, 2014, RHEUMATOL INT, V34, P717, DOI 10.1007/s00296-013-2751-y; Day MJ, 2008, J COMP PATHOL, V138, pS1, DOI 10.1016/j.jcpa.2008.01.001; Cavalcante IGD, 2015, EXP GERONTOL, V66, P10, DOI 10.1016/j.exger.2015.03.011; De Vita F, 2014, AGE, V36, DOI 10.1007/s11357-014-9694-4; Di Filippo P, 2015, INT ARCH ALLERGY IMM, V166, P91, DOI 10.1159/000371350; Friis H, 2008, J NUTR, V138, P2474, DOI 10.3945/jn.108.094979; Froicu M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-5; Garg M, 2013, INFLAMM BOWEL DIS, V19, P2634, DOI 10.1097/01.MIB.0000436957.77533.b2; Gerber B, 2003, AM J VET RES, V64, P1161, DOI 10.2460/ajvr.2003.64.1161; Gow AG, 2011, J SMALL ANIM PRACT, V52, P410, DOI 10.1111/j.1748-5827.2011.01082.x; Grzanka A, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-2; Harishankar M, 2014, INT IMMUNOPHARMACOL, V23, P148, DOI 10.1016/j.intimp.2014.08.021; Henriksen VT, 2014, MED HYPOTHESES, V82, P134, DOI 10.1016/j.mehy.2013.11.020; Hidaka M, 2013, EUR J PHARMACOL, V721, P305, DOI 10.1016/j.ejphar.2013.09.014; Hopkins MH, 2011, CANCER PREV RES, V4, P1645, DOI 10.1158/1940-6207.CAPR-11-0105; Jeong MS, 2014, ANN DERMATOL, V26, P296, DOI 10.5021/ad.2014.26.3.296; Karim Y, 2013, INT IMMUNOPHARMACOL, V17, P693, DOI 10.1016/j.intimp.2013.08.010; Khoo AL, 2011, CYTOKINE, V55, P294, DOI 10.1016/j.cyto.2011.04.016; Kilpatrick S, 2014, VET J, V200, P197, DOI 10.1016/j.tvjl.2014.01.007; Korf H, 2012, IMMUNOBIOLOGY, V217, P1292, DOI 10.1016/j.imbio.2012.07.018; Kraus MS, 2014, J VET INTERN MED, V28, P109, DOI 10.1111/jvim.12239; Laird E, 2014, J CLIN ENDOCR METAB, V99, P1807, DOI 10.1210/jc.2013-3507; Li YC, 2015, J STEROID BIOCHEM, V148, P179, DOI 10.1016/j.jsbmb.2015.01.011; Maechler M., 2015, CLUSTER ANAL BASICS; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; Matilainen JM, 2010, J STEROID BIOCHEM, V121, P142, DOI 10.1016/j.jsbmb.2010.03.020; MAWER EB, 1985, CLIN SCI, V68, P135, DOI 10.1042/cs0680135; MAWER EB, 1990, CLIN CHIM ACTA, V190, P199, DOI 10.1016/0009-8981(90)90174-Q; MAZZUCCHELLI L, 1994, AM J PATHOL, V144, P997; Mellanby RJ, 2005, J SMALL ANIM PRACT, V46, P345, DOI 10.1111/j.1748-5827.2005.tb00331.x; Nissou MF, 2014, J ALZHEIMERS DIS, V42, P789, DOI 10.3233/JAD-140411; Patel S, 2007, ARTHRITIS RHEUM, V56, P2143, DOI 10.1002/art.22722; Peterson CA, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-10; Poudel-Tandukar K, 2013, AIDS RES HUM RETROV, V29, P528, DOI [10.1089/aid.2012.0120, 10.1089/AID.2012.0120]; Prietl B, 2013, NUTRIENTS, V5, P2502, DOI 10.3390/nu5072502; Raftery T, 2015, DIGEST DIS SCI, V60, P2427, DOI 10.1007/s10620-015-3620-1; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Robinson AB, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000011; Rosa CT, 2013, J VET INTERN MED, V27, P1159, DOI 10.1111/jvim.12161; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Selting KA, 2016, VET COMP ONCOL, V14, P295, DOI 10.1111/vco.12101; Shih EM, 2016, PEDIATR DIABETES, V17, P36, DOI 10.1111/pedi.12238; Sinha-Hikim I, 2015, HORM METAB RES, V47, P280, DOI 10.1055/s-0034-1383652; Spoo JW, 2015, J VET INTERN MED, V29, P519, DOI 10.1111/jvim.12546; Stubbs JR, 2010, J AM SOC NEPHROL, V21, P353, DOI 10.1681/ASN.2009040451; SWAIN SL, 1991, CURR OPIN IMMUNOL, V3, P304, DOI 10.1016/0952-7915(91)90028-Y; Szkaradkiewicz A, 2009, ARCH IMMUNOL THER EX, V57, P291, DOI 10.1007/s00005-009-0031-z; Team RC, 2014, LANG ENV STAT COMP R; Waldron JL, 2013, J CLIN PATHOL, V66, P620, DOI 10.1136/jclinpath-2012-201301; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Yang LL, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.1; Zhu Y, 2005, EUR J IMMUNOL, V35, P217, DOI 10.1002/eji.200425491	68	33	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137377	10.1371/journal.pone.0137377	http://dx.doi.org/10.1371/journal.pone.0137377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333093	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800128
J	Browne, M; Thomson, P; Rockloff, MJ; Pennycook, G				Browne, Matthew; Thomson, Patricia; Rockloff, Matthew Justus; Pennycook, Gordon			Going against the Herd: Psychological and Cultural Factors Underlying the 'Vaccination Confidence Gap'	PLOS ONE			English	Article							ALTERNATIVE MEDICINE USE; COGNITIVE REFLECTION; COMPLEMENTARY/ALTERNATIVE MEDICINE; ATTITUDES; IMMUNIZATION; PARENTS; PREVALENCE; COVERAGE; CHILDREN; DECISION	By far the most common strategy used in the attempt to modify negative attitudes toward vaccination is to appeal to evidence-based reasoning. We argue, however, that focusing on science comprehension is inconsistent with one of the key facts of cognitive psychology: Humans are biased information processors and often engage in motivated reasoning. On this basis, we hypothesised that negative attitudes can be explained primarily by factors unrelated to the empirical evidence for vaccination; including some shared attitudes that also attract people to complementary and alternative medicine (CAM). In particular, we tested psychosocial factors associated with CAM endorsement in past research; including aspects of spirituality, intuitive (vs analytic) thinking styles, and the personality trait of openness to experience. These relationships were tested in a cross-sectional, stratified CATI survey (N = 1256, 624 Females). Whilst educational level and thinking style did not predict vaccination rejection, psychosocial factors including: preferring CAM to conventional medicine (OR.49, 95% CI.36-.66), endorsement of spirituality as a source of knowledge (OR.83, 95% CI.71-.96), and openness (OR.86, 95% CI.74-.99), all predicted negative attitudes to vaccination. Furthermore, for 9 of the 12 CAMs surveyed, utilisation in the last 12 months was associated with lower levels of vaccination endorsement. From this we suggest that vaccination scepticism appears to be the outcome of a particular cultural and psychological orientation leading to unwillingness to engage with the scientific evidence. Vaccination compliance might be increased either by building general confidence and understanding of evidence-based medicine, or by appealing to features usually associated with CAM, e.g. 'strengthening your natural resistance to disease'.	[Browne, Matthew; Rockloff, Matthew Justus] Cent Queensland Univ, Sch Human Hlth & Social Sci, Bundaberg, Qld 4670, Australia; [Pennycook, Gordon] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada; [Thomson, Patricia] Univ Stirling, Sch Hlth Sci, Stirling FK9 4LA, Scotland	Central Queensland University; University of Waterloo; University of Stirling	Browne, M (corresponding author), Cent Queensland Univ, Sch Human Hlth & Social Sci, Univ Dr, Bundaberg, Qld 4670, Australia.	m.browne@cqu.edu.au	Pennycook, Gordon/AAD-6631-2019	Pennycook, Gordon/0000-0003-1344-6143; Browne, Matthew/0000-0002-2668-6229				AJZEN I, 1986, BASIC APPL SOC PSYCH, V7, P259, DOI 10.1207/s15324834basp0704_2; ASCH DA, 1994, MED DECIS MAKING, V14, P118, DOI 10.1177/0272989X9401400204; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Australian Bureau of Statistics, 2011, CENSUS OF POPULATION; Australian Government Department of Health, 2013, NATIONAL IMMUNISATIO; Ball LK, 1998, PEDIATRICS, V101, P453, DOI 10.1542/peds.101.3.453; Barnes Patricia M, 2004, Adv Data, P1; Bean SJ, 2011, VACCINE, V29, P1874, DOI 10.1016/j.vaccine.2011.01.003; BENNETT P, 1992, HEALTH EDUC RES, V7, P341, DOI 10.1093/her/7.3.341; Beyerstein BL, 2001, ACAD MED, V76, P230, DOI 10.1097/00001888-200103000-00009; Boon H, 2000, J CLIN ONCOL, V18, P2515, DOI 10.1200/JCO.2000.18.13.2515; Briones R, 2012, HEALTH COMMUN, V27, P478, DOI 10.1080/10410236.2011.610258; Browne M, 2014, EUR J SOC PSYCHOL, V44, P736, DOI 10.1002/ejsp.2059; Campitelli G, 2010, JUDGM DECIS MAK, V5, P182; Carlisle E, 2005, SHAPE REASON, P205; Cokely ET, 2009, JUDGM DECIS MAK, V4, P20; Covello VT, 1991, ACCEPTABLE EVIDENCE, P66; Downs JS, 2008, VACCINE, V26, P1595, DOI 10.1016/j.vaccine.2008.01.011; Egede LE, 2002, DIABETES CARE, V25, P324, DOI 10.2337/diacare.25.2.324; Ellison CG, 2012, PREV MED, V54, P9, DOI 10.1016/j.ypmed.2011.08.029; Ernst E, 2001, VACCINE, V20, pS90, DOI 10.1016/S0264-410X(01)00290-0; Ernst E, 1997, EUR J PEDIATR, V156, P513, DOI 10.1007/s004310050650; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Furnham A, 2007, BRIT J HEALTH PSYCH, V12, P229, DOI 10.1348/135910706X100593; Garrow D, 2006, DIABETES CARE, V29, P15, DOI 10.2337/diacare.29.01.06.dc05-1448; Gellin BG, 2000, PEDIATRICS, V106, P1097, DOI 10.1542/peds.106.5.1097; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Gust DA, 2004, PEDIATRICS, V114, pE16, DOI 10.1542/peds.114.1.e16; HALPER J, 1981, PEDIATRICS, V68, P407; Hildreth KD, 2007, SOCIOL INQ, V77, P76, DOI 10.1111/j.1475-682X.2007.00178.x; Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177; Jones L, 2010, PREV MED, V50, P148, DOI 10.1016/j.ypmed.2009.12.001; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kaptchuk TJ, 1998, ANN INTERN MED, V129, P1061, DOI 10.7326/0003-4819-129-12-199812150-00011; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; Koehler DJ, 2010, MEM COGNITION, V38, P667, DOI 10.3758/MC.38.6.667; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Lehrke P, 2001, VACCINE, V19, P4859, DOI 10.1016/S0264-410X(01)00180-3; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Liberali JM, 2012, J BEHAV DECIS MAKING, V25, P361, DOI 10.1002/bdm.752; MacLennan AH, 2002, PREV MED, V35, P166, DOI 10.1006/pmed.2002.1057; Pennycook G, 2012, COGNITION, V123, P335, DOI 10.1016/j.cognition.2012.03.003; Piedmont RL., 2014, ENCYCL QUAL LIFE WEL, P2282; Poethko-Muller C, 2009, VACCINE, V27, P2563, DOI 10.1016/j.vaccine.2009.02.009; Population Research Laboratory, 2012, QUEENSLAND SOCIAL SU; Prislin R, 1998, AM J PUBLIC HEALTH, V88, P1821, DOI 10.2105/AJPH.88.12.1821; Quandt SA, 2009, J ALTERN COMPLEM MED, V15, P331, DOI 10.1089/acm.2008.0521; Ritov I., 1990, Journal of Behavioral Decision Making, V3, P263, DOI 10.1002/bdm.3960030404; Salmon DA, 2005, ARCH PEDIAT ADOL MED, V159, P470, DOI 10.1001/archpedi.159.5.470; Salmon DA, 2004, PEDIATRICS, V113, pE552, DOI 10.1542/peds.113.6.e552; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; Smith PJ, 2011, PUBLIC HEALTH REP, V126, P135, DOI 10.1177/00333549111260S215; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Stokley S, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-6; Swami V, 2014, COGNITION, V133, P572, DOI 10.1016/j.cognition.2014.08.006; Toplak ME, 2014, THINK REASONING, V20, P147, DOI 10.1080/13546783.2013.844729; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; Wilson K, 2004, VACCINE, V22, P329, DOI 10.1016/j.vaccine.2003.08.014; Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018	62	112	113	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0132562	10.1371/journal.pone.0132562	http://dx.doi.org/10.1371/journal.pone.0132562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26325522	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700004
J	Stanturf, JA; Goodrick, SL; Warren, ML; Charnley, S; Stegall, CM				Stanturf, John A.; Goodrick, Scott L.; Warren, Melvin L., Jr.; Charnley, Susan; Stegall, Christie M.			Social Vulnerability and Ebola Virus Disease in Rural Liberia	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; ADAPTIVE CAPACITY; STOPPING RULES; NUMBER; RETENTION; HEALTH; LEVEL	The Ebola virus disease (EVD) epidemic that has stricken thousands of people in the three West African countries of Liberia, Sierra Leone, and Guinea highlights the lack of adaptive capacity in post-conflict countries. The scarcity of health services in particular renders these populations vulnerable to multiple interacting stressors including food insecurity, climate change, and the cascading effects of disease epidemics such as EVD. However, the spatial distribution of vulnerable rural populations and the individual stressors contributing to their vulnerability are unknown. We developed a Social Vulnerability Classification using census indicators and mapped it at the district scale for Liberia. According to the Classification, we estimate that districts having the highest social vulnerability lie in the north and west of Liberia in Lofa, Bong, Grand Cape Mount, and Bomi Counties. Three of these counties together with the capital Monrovia and surrounding Montserrado and Margibi counties experienced the highest levels of EVD infections in Liberia. Vulnerability has multiple dimensions and a classification developed from multiple variables provides a more holistic view of vulnerability than single indicators such as food insecurity or scarcity of health care facilities. Few rural Liberians are food secure and many cannot reach a medical clinic in <80 minutes. Our results illustrate how census and household survey data, when displayed spatially at a sub-county level, may help highlight the location of the most vulnerable households and populations. Our results can be used to identify vulnerability hotspots where development strategies and allocation of resources to address the underlying causes of vulnerability in Liberia may be warranted. We demonstrate how social vulnerability index approaches can be applied in the context of disease outbreaks, and our methods are relevant elsewhere.	[Stanturf, John A.; Goodrick, Scott L.; Stegall, Christie M.] US Forest Serv, Ctr Forest Disturbance Sci, Athens, GA 30602 USA; [Warren, Melvin L., Jr.] US Forest Serv, Ctr Bottomland Hardwoods Res, Oxford, MS USA; [Charnley, Susan] US Forest Serv, Goods Serv & Values Program, Portland, OR USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Stanturf, JA (corresponding author), US Forest Serv, Ctr Forest Disturbance Sci, Athens, GA 30602 USA.	jstanturf@fs.fed.us	Stanturf, John A./M-4171-2019	Stanturf, John A./0000-0002-6828-9459	Liberia Mission; US Congress; US Agency, for International Development through the US Forest Service Office of International Programs	Liberia Mission; US Congress; US Agency, for International Development through the US Forest Service Office of International Programs(United States Agency for International Development (USAID))	Funding for travel was provided to JAS, SLG, and MLW by the Liberia Mission, US Agency, for International Development through the US Forest Service Office of International Programs. All other funding was internal Forest Service appropriated funding from the US Congress. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abson DJ, 2012, APPL GEOGR, V35, P515, DOI 10.1016/j.apgeog.2012.08.004; [Anonymous], 2014, R LANG ENV STAT COMP; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bandalos DL, 2009, STATISTICAL AND METHODOLOGICAL MYTHS AND URBAN LEGENDS: DOCTRINE, VERITY AND FABLE IN THE ORGANIZATIONAL AND SOCIAL SCIENCES, P61; Bartkowiak A., 1991, APPL STOCH MOD DATA, V55, P64; Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056; Beauducel A., 2001, METHODS PSYCHOL RES, V6, P141; Boko M, 2007, IPCC WGII 4 ASSESSME; Brooks N, 2005, GLOBAL ENVIRON CHANG, V15, P151, DOI 10.1016/j.gloenvcha.2004.12.006; Bruce B, 2004, LIBERIA CHALLENGES P; Cangelosi R, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-2; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Charrad M, 2014, J STAT SOFTW, V61, P1; Collier P, 2013, J CONFLICT RESOLUT, V57, P65, DOI 10.1177/0022002712464847; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Cutter SL, 2008, P NATL ACAD SCI USA, V105, P2301, DOI 10.1073/pnas.0710375105; Dixon R. K., 2003, Mitigation and Adaptation Strategies for Global Change, V8, P93, DOI 10.1023/A:1026001626076; Ellis S, 2007, THE MASK OF ANARCHY; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Fekete A, 2012, NAT HAZARDS, V61, P1161, DOI 10.1007/s11069-011-9973-7; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; FERRE L, 1995, COMPUT STAT DATA AN, V19, P669, DOI 10.1016/0167-9473(94)00020-J; Frazier TG, 2014, APPL GEOGR, V51, P158, DOI 10.1016/j.apgeog.2014.04.004; Government of Liberia, 2007, COMPR ASS AGR SECT, V2; Government of Liberia, 2008, LIB VIS ACC EC GROWT; Government of Liberia, 2009, 2008 POP HOUS CENS F; Government of Liberia, 2010, STAT FOOD NUTR INS L; Hahn MB, 2009, GLOBAL ENVIRON CHANG, V19, P74, DOI 10.1016/j.gloenvcha.2008.11.002; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hegre H, 2009, J CONFLICT RESOLUT, V53, P598, DOI 10.1177/0022002709336459; Hinkel J, 2011, GLOBAL ENVIRON CHANG, V21, P198, DOI 10.1016/j.gloenvcha.2010.08.002; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Independent Evaluation Group, 2013, LIB COUNTR PROGR EV; Independent Evaluation Group, 2012, LIBERIA WORLD BANK G; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Johnson Sirleaf E, 2014, BBC NEWSHOUR    1019; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kelly PM, 2000, CLIMATIC CHANGE, V47, P325, DOI 10.1023/A:1005627828199; Kieh GeorgeKlay., 2009, INT J WORLD PEACE, V26, P7; MacNeil A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001546; Organization for Economic Cooperation and Development, 2001, DAC GUID POV RED; Oxford Poverty and Human Development Initiative, 2014, LIB COUNTR BRIEF MUL; Patil VH, 2008, J BUS RES, V61, P162, DOI 10.1016/j.jbusres.2007.05.008; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Peterson AT, 2007, J MAMMAL, V88, P1544, DOI 10.1644/06-MAMM-A-280R1.1; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Pourrut X, 2005, MICROBES INFECT, V7, P1005, DOI 10.1016/j.micinf.2005.04.006; Reaves EJ, 2014, MMWR-MORBID MORTAL W, V63, P959; Saez AM, 2015, EMBO MOL MED, V7, P17, DOI 10.15252/emmm.201404792; Salehyan I, 2006, INT ORGAN, V60, P335, DOI 10.1017/S0020818306060103; Sokal R.R., 2012, BIOMETRY; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th edition.; Thomas MR, 2015, EC IMPACT EBOLA SUBS; Tsimpo C, 2012, POVERTY POLICY RESPO, P60; United Nations, 2014, HUM DEV REP 2014; Varpilah ST, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-11; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wisner B., 2004, AT RISK; Wolf S, 2013, INT J CLIM CHANG STR, V5, P54, DOI 10.1108/17568691311299363; World Health Organization, 2015, EBOL RESP ROADM SIT; Zebardast E, 2013, NAT HAZARDS, V65, P1331, DOI 10.1007/s11069-012-0412-1	61	31	32	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137208	10.1371/journal.pone.0137208	http://dx.doi.org/10.1371/journal.pone.0137208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26325519	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700103
J	Trebotic, LK; Klimek, P; Thomas, A; Fenzl, A; Leitner, K; Springer, S; Kiefer, FW; Kautzky-Willer, A				Trebotic, Lana Kosi; Klimek, Peter; Thomas, Anita; Fenzl, Anna; Leitner, Karoline; Springer, Stefanie; Kiefer, Florian W.; Kautzky-Willer, Alexandra			Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus	PLOS ONE			English	Article							BETA-CELL PROLIFERATION; TRIGLYCERIDE-METABOLISM; GLUCOSE; HOMEOSTASIS; RESISTANCE; ANGPTL3; OBESITY; WOMEN; RISK; 1ST	Aims/hypothesis Betatrophin has recently been introduced as a novel hormone and promotor of beta cell proliferation and improved glucose tolerance in mouse models of insulin resistance. In obese and diabetic humans altered levels were reported and a role in pathophysiology of metabolic diseases was therefore hypothesized. However its release and regulation in women with gestational diabetes mellitus (GDM), as well as its associations with markers of obesity, glucose and lipid metabolism during pregnancy still remain unclear. Methods Circulating betatrophin was quantified in 21 women with GDM and 19 pregnant body mass index-matched women with normal glucose tolerance (NGT) as well as 10 healthy age-matched non-pregnant women by enzyme-linked immunosorbent assay. Additionally we performed radioimmunassay (RIA) to confirm the results. Results Betatrophin concentrations measured by ELISA were significantly higher in GDM than in NGT (29.3 +/- 4.4 ng/ml vs. 18.1 +/- 8.7 ng/ml, p<0.001) which was confirmed by RIA. Betatrophin did not correlate with BMI or insulin resistance but showed a weak association with leptin levels in pregnancy and negative relationship with fasting C-peptide levels in all women. Moreover it correlated significantly with lipid parameters including triglycerides and total cholesterol in pregnancy, as well as estrogen, progesteron and birth weight. Conclusions/interpretation Circulating betatrophin concentrations are dramatically increased in pregnancy and are significantly higher in GDM versus pregnant NGT. In the light of the previously reported role in lipid metabolism, betatrophin may represent a novel endocrine regulator of lipid alterations in pregnancy. However additional studies are needed to elucidate whether hormonal factors, such as estrogen, control the production of betatrophin and if targeting betatrophin could hold promise in the fight against metabolic disease.	[Trebotic, Lana Kosi; Thomas, Anita; Fenzl, Anna; Leitner, Karoline; Kiefer, Florian W.; Kautzky-Willer, Alexandra] Med Univ Vienna, Dept Med 3, Gender Med Unit, Clin Div Endocrinol & Metab, Vienna, Austria; [Springer, Stefanie] Med Univ Vienna, Clin Div Gynaecol & Obstret, Vienna, Austria; [Klimek, Peter] Med Univ Vienna, Sect Sci Complex Syst, CEMSIIS, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Kautzky-Willer, A (corresponding author), Med Univ Vienna, Dept Med 3, Gender Med Unit, Clin Div Endocrinol & Metab, Vienna, Austria.	alexandra.kautzky-willer@meduniwien.ac.at	Klimek, Peter/AAC-2723-2019	Klimek, Peter/0000-0003-1187-6713; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Thomas, Anita/0000-0002-1679-3098; Kiefer, Florian/0000-0003-2191-025X	FFG, Vienna, Austria	FFG, Vienna, Austria	Initial funding for this research was provided by FFG, Vienna, Austria.	Bao W, 2015, METABOLISM, V64, P756, DOI 10.1016/j.metabol.2015.01.013; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Ebert T, 2015, EUR J ENDOCRINOL, V173, P1, DOI 10.1530/EJE-14-0815; Fenzl A, 2014, DIABETOLOGIA, V57, P1204, DOI 10.1007/s00125-014-3208-x; GABBE SG, 1986, NEW ENGL J MED, V315, P1025, DOI 10.1056/NEJM198610163151609; Gomez-Ambrosi J, 2014, J CLIN ENDOCR METAB, V99, pE2004, DOI 10.1210/jc.2014-1568; Gusarova V, 2014, CELL, V159, P691, DOI 10.1016/j.cell.2014.09.027; Harreiter J, 2014, WOMENS HEALTH, V10, P91, DOI [10.2217/WHE.13.69, 10.2217/whe.13.69]; Harville EW, 2011, EPIDEMIOLOGY, V22, P724, DOI 10.1097/EDE.0b013e318225c960; Herrera E, 2010, BEST PRACT RES CL EN, V24, P515, DOI 10.1016/j.beem.2010.05.006; Hu H, 2014, DIABETES CARE, V37, P2718, DOI 10.2337/dc14-0602; Jiao Y, 2014, DIABETES, V63, P1283, DOI 10.2337/db13-1435; Kalter-Leibovici O, 2012, DIABETIC MED, V29, P748, DOI 10.1111/j.1464-5491.2011.03516.x; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kugelberg Elisabeth, 2013, Nat Rev Endocrinol, V9, P379, DOI 10.1038/nrendo.2013.98; Lickert H, 2013, CELL METAB, V18, P5, DOI 10.1016/j.cmet.2013.06.006; Mankuta D, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-58; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Tokumoto S, 2015, DIABETIC MED, V32, P653, DOI 10.1111/dme.12696; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Wawrusiewicz-Kurylonek N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131171; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Yilmaz H, 2015, EXP CLIN ENDOCR DIAB, V123, P376, DOI 10.1055/s-0035-1549888; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038; Zhang Y, 2006, PHYSIOL BEHAV, V88, P249, DOI 10.1016/j.physbeh.2006.05.038	28	45	48	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136701	10.1371/journal.pone.0136701	http://dx.doi.org/10.1371/journal.pone.0136701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325425	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700058
J	Melmaiee, K; Anderson, M; Elavarthi, S; Guenzi, A; Canaan, P				Melmaiee, Kalpalatha; Anderson, Michael; Elavarthi, Sathya; Guenzi, Arron; Canaan, Patricia			Transcriptional Analysis of Resistance to Low Temperatures in Bermudagrass Crown Tissues	PLOS ONE			English	Article							PLANT COLD-ACCLIMATION; ARABIDOPSIS-THALIANA; FREEZING TOLERANCE; GENE-EXPRESSION; DEHYDRIN EXPRESSION; OPHIOSPHAERELLA-HERPOTRICHA; SEEDED BERMUDAGRASS; SIGNALING PATHWAYS; CAMELLIA-SINENSIS; RESPONSE PATHWAY	Bermudagrass (Cynodon dactylon L pers.) is one of the most geographically adapted and utilized of the warm-season grasses. However, bermudagrass adaptation to the Northern USA is limited by freeze damage and winterkill. Our study provides the first large-scale analyses of gene expression in bermudagrass regenerative crown tissues during cold acclimation. We compared gene expression patterns in crown tissues from highly cold tolerant "MSU" and susceptible "Zebra" genotypes exposed to near-freezing temperatures. Suppressive subtractive hybridization was used to isolate putative cold responsive genes Approximately, 3845 transcript sequences enriched for cold acclimation were deposited in the GenBank. A total of 4589 ESTs (3184 unigenes) including 744 ESTs associated with the bermudagrass disease spring dead spot were printed on microarrays and hybridized with cold acclimated complementary Deoxyribonucleic acid (cDNA). A total of 587 differentially expressed unigenes were identified in this study. Of these only 97 (17%) showed significant NCBI matches. The overall expression pattern revealed 40% more down- than up-regulated genes, which was particularly enhanced in MSU compared to Zebra. Among the up-regulated genes 68% were uniquely expressed in MSU (36%) or Zebra (32%). Among the down-regulated genes 40% were unique to MSU, while only 15% to Zebra. Overall expression intensity was significantly higher in MSU than in Zebra (p value <= 0.001) and the overall number of genes expressed at 28 days was 2.7 fold greater than at 2 days. These changes in expression patterns reflect the strong genotypic and temporal response to cold temperatures. Additionally, differentially expressed genes from this study can be utilized for developing molecular markers in bermudagrass and other warm season grasses for enhancing cold hardiness.	[Melmaiee, Kalpalatha; Anderson, Michael; Elavarthi, Sathya; Guenzi, Arron] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Canaan, Patricia] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Anderson, M (corresponding author), Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA.	michael.anderson@okstate.edu	Anderson, Michael/I-3309-2019	Anderson, Michael/0000-0002-2319-2282; Elavarthi, Sathya/0000-0002-6719-4669	 [200312-253]; Office of Integrative Activities [1301765] Funding Source: National Science Foundation	; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by www.usga.org (200312-253).	Alonso AP, 2007, METAB ENG, V9, P419, DOI 10.1016/j.ymben.2007.06.002; Anderson J, 2002, CROP SCI, V42, P975, DOI 10.2135/cropsci2002.0975; ANDERSON JA, 1988, HORTSCIENCE, V23, P748; Anderson JA, 2002, CROP SCI, V42, P190, DOI 10.2135/cropsci2002.0190; Anderson JV, 2005, PLANT CELL ENVIRON, V28, P1567, DOI 10.1111/j.1365-3040.2005.01393.x; Artus NN, 1996, P NATL ACAD SCI USA, V93, P13404, DOI 10.1073/pnas.93.23.13404; Ayoubi P, 2002, NUCLEIC ACIDS RES, V30, P4761, DOI 10.1093/nar/gkf585; Baird JH, 1998, PLANT DIS, V82, P771, DOI 10.1094/PDIS.1998.82.7.771; Baud S, 2004, J EXP BOT, V55, P397, DOI 10.1093/jxb/erh047; Benedict C, 2006, PLANT PHYSIOL, V141, P1219, DOI 10.1104/pp.106.083527; Choi DW, 1999, THEOR APPL GENET, V98, P1234, DOI 10.1007/s001220051189; Daher Z, 2010, PROTEOMICS, V10, P2123, DOI 10.1002/pmic.200900345; de los Reyes BG, 2001, THEOR APPL GENET, V103, P297, DOI 10.1007/s001220100569; Degenkolbe T, 2012, PLANT J, V72, P972, DOI 10.1111/tpj.12007; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fujiki Y, 2000, PLANT PHYSIOL, V124, P1139, DOI 10.1104/pp.124.3.1139; Gatschet MJ, 1996, CROP SCI, V36, P712, DOI 10.2135/cropsci1996.0011183X003600030032x; GATSCHET MJ, 1994, J AM SOC HORTIC SCI, V119, P477, DOI 10.21273/JASHS.119.3.477; Giolo M, 2013, HORTSCIENCE, V48, P780, DOI 10.21273/HORTSCI.48.6.780; Gulick PJ, 2005, GENOME, V48, P913, DOI 10.1139/g05-039; Guy C, 2006, PHYSIOL PLANTARUM, V126, P1, DOI [10.1111/j.1399-3054.2006.00628.x, 10.1111/j.1399-3054.2005.00628.x]; HARLAN J R, 1970, East African Agricultural and Forestry Journal, V36, P220; HARLAN JR, 1969, CROP SCI, V9, P774, DOI 10.2135/cropsci1969.0011183X000900060031x; Hewezi T, 2006, J EXP BOT, V57, P3109, DOI 10.1093/jxb/erl080; Hur J, 2004, PLANT SCI, V167, P417, DOI 10.1016/j.plantsci.2004.04.009; Ismail AM, 1999, P NATL ACAD SCI USA, V96, P13566, DOI 10.1073/pnas.96.23.13566; Isopp H, 2000, PLANT CELL ENVIRON, V23, P597, DOI 10.1046/j.1365-3040.2000.00583.x; Ivashuta S, 2002, PLANT J, V31, P615, DOI 10.1046/j.1365-313X.2002.01383.x; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Jarzabek M, 2009, CRYOBIOLOGY, V58, P268, DOI 10.1016/j.cryobiol.2009.01.007; JOHNSTON RA, 1975, CROP SCI, V15, P445, DOI 10.2135/cropsci1975.0011183X001500030050x; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Kobayashi F, 2005, J EXP BOT, V56, P887, DOI 10.1093/jxb/eri081; Koehler G., 2007, Current Topics in Phytochemistry, Volume 8, P73; Kojima M, 2007, PLANT SCI, V172, P36, DOI 10.1016/j.plantsci.2006.07.009; KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupas AN, 2006, J STRUCT BIOL, V156, P1, DOI 10.1016/j.jsb.2006.07.009; Melmaiee K, 2007, FUNCTIONAL GENOMICS; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Oh SA, 1996, PLANT MOL BIOL, V30, P739, DOI 10.1007/BF00019008; Oliveira IC, 1997, PLANT PHYSIOL BIOCH, V35, P185; Ouellet F., 2013, COLD ACCLIMATION FRE; Parmentier-Line CM, 2002, PLANT SCI, V162, P273, DOI 10.1016/S0168-9452(01)00563-5; Pinhero RG, 2007, PHYSIOL PLANTARUM, V130, P230, DOI 10.1111/j.1399-3054.2007.00911.x; RESTREPOHARTWIG MA, 1994, J VIROL, V68, P2388, DOI 10.1128/JVI.68.4.2388-2397.1994; Rorat T, 2006, CELL MOL BIOL LETT, V11, P536, DOI 10.2478/s11658-006-0044-0; Samala S, 1998, CROP SCI, V38, P188, DOI 10.2135/cropsci1998.0011183X003800010031x; Sandve SR, 2011, PLANT SCI, V180, P69, DOI 10.1016/j.plantsci.2010.07.011; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Sidebottom C, 2000, NATURE, V406, P256, DOI 10.1038/35018639; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Stitt M, 2002, CURR OPIN PLANT BIOL, V5, P199, DOI 10.1016/S1369-5266(02)00258-3; Strand A, 2003, PLANT CELL ENVIRON, V26, P523, DOI 10.1046/j.1365-3040.2003.00983.x; Strand A, 1997, PLANT J, V12, P605, DOI 10.1046/j.1365-313X.1997.00605.x; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Tao DL, 1998, CRYOBIOLOGY, V37, P38, DOI 10.1006/cryo.1998.2096; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; VONKAMPEN J, 1995, PLANTA, V197, P528, DOI 10.1007/BF00196675; Vyas D, 2005, PLANT PHYSIOL BIOCH, V43, P383, DOI 10.1016/j.plaphy.2005.02.016; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xiao HG, 2006, PLANT CELL REP, V25, P968, DOI 10.1007/s00299-006-0151-4; Yu Jing, 2005, Acta Genetica Sinica, V32, P789; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289; Zhang XL, 2008, J EXP BOT, V59, P4045, DOI 10.1093/jxb/ern245; Zhang XZ, 2008, J AM SOC HORTIC SCI, V133, P542, DOI 10.21273/JASHS.133.4.542; Zhang XZ, 2006, CROP SCI, V46, P2598, DOI 10.2135/cropsci2006.02.0108; Zhang XZ, 2011, CROP SCI, V51, P838, DOI 10.2135/cropsci2010.06.0345; Zhang Y, 2006, CROP SCI, V46, P497, DOI 10.2135/cropsci2004.0572; Zhang Y, 2006, PHYSIOL MOL PLANT P, V68, P105, DOI 10.1016/j.pmpp.2006.07.003	76	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136433	10.1371/journal.pone.0136433	http://dx.doi.org/10.1371/journal.pone.0136433			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348040	gold, Green Submitted, Green Published			2022-12-27	WOS:000360897600008
J	Narwani, A; Alexandrou, MA; Herrin, J; Vouaux, A; Zhou, C; Oakley, TH; Cardinale, BJ				Narwani, Anita; Alexandrou, Markos A.; Herrin, James; Vouaux, Alaina; Zhou, Charles; Oakley, Todd H.; Cardinale, Bradley J.			Common Ancestry Is a Poor Predictor of Competitive Traits in Freshwater Green Algae	PLOS ONE			English	Article							PHYLOGENETIC LIMITING SIMILARITY; PHYTOPLANKTON RESPONSES; EVOLUTIONARY HISTORY; RESOURCE COMPETITION; SPECIES INTERACTIONS; COMMUNITY ECOLOGY; FUNCTIONAL TRAITS; RELATEDNESS; DIVERSITY; PATTERNS	Phytoplankton species traits have been used to successfully predict the outcome of competition, but these traits are notoriously laborious to measure. If these traits display a phylogenetic signal, phylogenetic distance (PD) can be used as a proxy for trait variation. We provide the first investigation of the degree of phylogenetic signal in traits related to competition in freshwater green phytoplankton. We measured 17 traits related to competition and tested whether they displayed a phylogenetic signal across a molecular phylogeny of 59 species of green algae. We also assessed the fit of five models of trait evolution to trait variation across the phylogeny. There was no significant phylogenetic signal for 13 out of 17 ecological traits. For 7 traits, a non-phylogenetic model provided the best fit. For another 7 traits, a phylogenetic model was selected, but parameter values indicated that trait variation evolved recently, diminishing the importance of common ancestry. This study suggests that traits related to competition in freshwater green algae are not generally well-predicted by patterns of common ancestry. We discuss the mechanisms by which the link between phylogenetic distance and phenotypic differentiation may be broken.	[Narwani, Anita] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, CH-8600 Dubendorf, Switzerland; [Alexandrou, Markos A.; Oakley, Todd H.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Narwani, Anita; Herrin, James; Vouaux, Alaina; Zhou, Charles; Cardinale, Bradley J.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of California System; University of California Santa Barbara; University of Michigan System; University of Michigan	Narwani, A (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, BU-G11 Uberlandstr 133, CH-8600 Dubendorf, Switzerland.	anita.narwani@eawag.ch	Cardinale, Bradley J/I-7076-2013	Oakley, Todd/0000-0002-4478-915X; Narwani, Anita/0000-0003-4561-0163	US National Science Foundation [DEB-1046121]; Division Of Environmental Biology [1046307, 1046121] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the US National Science Foundation's DIMENSIONS of Biodiversity program grant to BJC and THO (DEB-1046121) (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503446). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2009, P NATL ACAD SCI USA, V106, P18067, DOI 10.1073/pnas.0904862106; Alexandrou MA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1745; Becks L, 2012, ECOL LETT, V15, P492, DOI 10.1111/j.1461-0248.2012.01763.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019363; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cahill JF, 2008, PERSPECT PLANT ECOL, V10, P41, DOI 10.1016/j.ppees.2007.10.001; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cooper N, 2010, J EVOLUTION BIOL, V23, P2529, DOI 10.1111/j.1420-9101.2010.02144.x; Cottingham KL, 1998, ECOL APPL, V8, P508, DOI 10.2307/2641090; Dybzinski R, 2007, AM NAT, V170, P305, DOI 10.1086/519857; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Edwards KF, 2013, ECOLOGY, V94, P1626, DOI 10.1890/12-1459.1; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Faith DP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0011; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fritschie KJ, 2014, ECOLOGY, V95, P1407, DOI 10.1890/13-0986.1; Fritz SA, 2010, P ROY SOC B-BIOL SCI, V277, P2435, DOI 10.1098/rspb.2010.0030; Gerhold P, 2015, FUNCT ECOL, V29, P600, DOI 10.1111/1365-2435.12425; Godoy O, 2014, ECOL LETT, V17, P836, DOI 10.1111/ele.12289; GROVER JP, 1989, LIMNOL OCEANOGR, V34, P341, DOI 10.4319/lo.1989.34.2.0341; GROVER JP, 1994, AM NAT, V143, P258, DOI 10.1086/285603; GROVER JP, 1989, LIMNOL OCEANOGR, V34, P349, DOI 10.4319/lo.1989.34.2.0349; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hertz PE, 2013, EVOLUTION, V67, P2101, DOI 10.1111/evo.12072; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Huisman J, 2001, AM NAT, V157, P488, DOI 10.1086/319929; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Huisman J, 2001, ECOL LETT, V4, P408, DOI 10.1046/j.1461-0248.2001.00256.x; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Jones LE, 2009, PHILOS T R SOC B, V364, P1579, DOI 10.1098/rstb.2009.0004; Kelly S, 2014, DIVERS DISTRIB, V20, P600, DOI 10.1111/ddi.12188; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Klausmeier CA, 2008, ECOL RES, V23, P479, DOI 10.1007/s11284-008-0470-8; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Litchman E, 2010, HYDROBIOLOGIA, V653, P15, DOI 10.1007/s10750-010-0341-5; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Loladze I, 2011, ECOL LETT, V14, P244, DOI 10.1111/j.1461-0248.2010.01577.x; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Low-Decarie E, 2011, GLOBAL CHANGE BIOL, V17, P2525, DOI 10.1111/j.1365-2486.2011.02402.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P1340, DOI 10.1111/j.1462-2920.2009.01860.x; Martiny AC, 2009, P NATL ACAD SCI USA, V106, P10787, DOI 10.1073/pnas.0902532106; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; Mouquet N, 2012, BIOL REV, V87, P769, DOI 10.1111/j.1469-185X.2012.00224.x; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Nakov T, 2014, LIMNOL OCEANOGR, V59, P79, DOI 10.4319/lo.2014.59.1.0079; Narwani A, 2013, ECOL LETT, V16, P1373, DOI 10.1111/ele.12182; Ndiribe C, 2014, J PLANT ECOL, V7, P439, DOI 10.1093/jpe/rtt064; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perronne R, 2014, PLANT ECOL EVOL, V147, P165, DOI 10.5091/plecevo.2014.885; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; Roncal J, 2012, BIOL J LINN SOC, V106, P528, DOI 10.1111/j.1095-8312.2012.01879.x; Savage JA, 2012, ECOLOGY, V93, pS138, DOI 10.1890/11-0406.1; Schwaderer AS, 2011, LIMNOL OCEANOGR, V56, P589, DOI 10.4319/lo.2011.56.2.0589; Seppala J, 1998, HYDROBIOLOGIA, V363, P207; Smith KL, 2011, EVOLUTION, V65, P976, DOI 10.1111/j.1558-5646.2010.01211.x; Sommer U, 1995, LIMNOL OCEANOGR, V40, P1271, DOI 10.4319/lo.1995.40.7.1271; SOMMER U, 1984, LIMNOL OCEANOGR, V29, P633, DOI 10.4319/lo.1984.29.3.0633; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Tan JQ, 2012, ECOLOGY, V93, P1164, DOI 10.1890/11-1557.1; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; TILMAN D, 1981, ECOLOGY, V62, P802, DOI 10.2307/1937747; Tilman D., 1982, Monographs in Population Biology, pi; Venail PA, 2014, J ECOL, V102, P1288, DOI 10.1111/1365-2745.12271; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Yoshida T, 2007, PLOS BIOL, V5, P1868, DOI 10.1371/journal.pbio.0050235; Young JN, 2012, PHILOS T R SOC B, V367, P483, DOI 10.1098/rstb.2011.0145	84	17	18	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137085	10.1371/journal.pone.0137085	http://dx.doi.org/10.1371/journal.pone.0137085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348482	Green Submitted, Green Published, gold			2022-12-27	WOS:000360897600020
J	Guan, WJ; Gao, YH; Li, HM; Yuan, JJ; Chen, RC; Zhong, NS				Guan, Wei-jie; Gao, Yong-hua; Li, Hui-min; Yuan, Jing-jing; Chen, Rong-chang; Zhong, Nan-shan			Impacts of Co-Existing Chronic Rhinosinusitis on Disease Severity and Risks of Exacerbations in Chinese Adults with Bronchiectasis	PLOS ONE			English	Article							CYSTIC FIBROSIS BRONCHIECTASIS; QUALITY-OF-LIFE; SINONASAL DISEASE; UNITED AIRWAYS; NASAL POLYPS; GUANGZHOU	Background Mounting evidence supports the notion of "one airway, one disease." Objective To determine whether chronic rhinosinusitis (CRS) poses adverse impacts on Chinese adults with bronchiectasis. Methods We enrolled 148 consecutive adults with clinically stable bronchiectasis. CRS diagnosed based on the 2012 (EPOS)-O-3 criteria. We systematically evaluated the bronchiectasis etiology, radiology, lung function, sputum bacteriology, airway inflammatory biomarkers, Bronchiectasis Severity Index, cough sensitivity and healthcare resource utilization. All patients were prospectively followed-up for 1 year to examine the frequency of bronchiectasis exacerbations (BEs). Results Forty-seven patients (31.8%) were diagnosed as having CRS. Bronchiectasis etiologies did not vary statistically between CRS and no-CRS group. There was a trend towards non-statistically higher Bronchiectasis Severity Index [6.4 +/- 3.4 vs. 5.0(6.0), P = 0.19], a higher proportion of patients with BEs needing hospitalization before enrollment (48.9% vs. 29.7%, P = 0.13), poorer FVC [78.2 +/- 19.8% vs. 82.2(16.8)%, P = 0.54] and FEV1 [68.2 +/- 24.8% vs. 74.8(21.2)%, P = 0.29], a higher prevalence of Pseudomonas aeruginosa isolated (36.2% vs. 26.7%, P = 0.27) or colonized in sputum (36.2% vs. 21.8%, P = 0.12) and greater capsaicin cough sensitivity [C2: 3.9(123.0) mu mol/L vs. 11.7(123.0) mu mol/L, P = 0.81; C5: 62.5(996.0) mu mol/L vs. 250.0(973.0) mu mol/L, P = 0.32]. Patients with CRS had significantly greater risks of experiencing BEs during follow-up (P = 0.02 for negative binominal regression test). Conclusion Chinese adults with bronchiectasis appear to have a lower prevalence of CRS than that in western countries. There was a trend towards greater adverse impacts on bronchiectasis in patients with CRS. Studies with greater sample sizes might help to resolve this issue. In future clinical practice, physicians should be vigilant to the screening of concomitant CRS in bronchiectasis so as to better improve patient's healthcare. Our findings may be of clinical significance in that proper treatment of upper airway symptoms due to CRS will be the prevention of infection or re-infection of the tracheobronchial tree, which should be addressed for the future management of bronchiectasis.	[Guan, Wei-jie; Li, Hui-min; Yuan, Jing-jing; Chen, Rong-chang; Zhong, Nan-shan] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis,Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China; [Gao, Yong-hua] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Zhengzhou 450052, Henan, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Zhengzhou University	Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis,Natl Clin Res Ctr Resp Dis, Guangzhou, Guangdong, Peoples R China.	chenrc@vip.163.com; nanshan@vip.163.com	Guan, Wei-jie/K-8257-2019		Changjiang Scholars and Innovative Research Team in University [ITR0961]; National Key Technology R&D Program of the 12th National Five-year Development Plan [2012BAI05B01]; National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer [2013BAI09B09]; National Natural Science Foundation [81400010]; Scientific Research Projects for Medical Doctors and Researchers from Overseas, Guangzhou Medical University [2014C21]	Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Technology R&D Program of the 12th National Five-year Development Plan(National Key Technology R&D Program); National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Projects for Medical Doctors and Researchers from Overseas, Guangzhou Medical University	Profs. Zhong and Chen declared that they had received Changjiang Scholars and Innovative Research Team in University ITR0961, The National Key Technology R&D Program of the 12th National Five-year Development Plan 2012BAI05B01 and National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer No. 2013BAI09B09. All other authors declared no potential conflict of interest. Dr. Guan has received National Natural Science Foundation No. 81400010 and 2014 Scientific Research Projects for Medical Doctors and Researchers from Overseas, Guangzhou Medical University No. 2014C21. None of the funding sources had any role in the study.	Angrill J, 2002, THORAX, V57, P15, DOI 10.1136/thorax.57.1.15; Barker AF, 2014, LANCET RESP MED, V2, P738, DOI 10.1016/S2213-2600(14)70165-1; Bilton D, 2014, THORAX, V69, P1073, DOI 10.1136/thoraxjnl-2014-205587; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Brodt AM, 2014, EUR RESPIR J, V44, P382, DOI 10.1183/09031936.00018414; Chalmers JD, 2015, EUR RESPIR J, V45, P1446, DOI 10.1183/09031936.00119114; Chalmers JD, 2014, AM J RESP CRIT CARE, V189, P576, DOI 10.1164/rccm.201309-1575OC; Chalmers JD, 2012, AM J RESP CRIT CARE, V186, P657, DOI 10.1164/rccm.201203-0487OC; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Guan WJ, 2015, INT J TUBERC LUNG D, V19, P610, DOI 10.5588/ijtld.14.0613; Guan WJ, 2015, RESPIROLOGY, V20, P739, DOI 10.1111/resp.12528; Guan WJ, 2015, ANN AM THORAC SOC, V12, P657, DOI 10.1513/AnnalsATS.201406-280OC; Guan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113057; Guilemany JM, 2006, RESP MED, V100, P1997, DOI 10.1016/j.rmed.2006.02.016; Guilemany JM, 2009, ALLERGY, V64, P1524, DOI 10.1111/j.1398-9995.2009.02011.x; Guilemany JM, 2009, ALLERGY, V64, P790, DOI 10.1111/j.1398-9995.2008.01892.x; Liu YP, 2015, RESPIROLOGY, V20, P312, DOI 10.1111/resp.12452; Loebinger MR, 2009, THORAX, V64, P1096, DOI 10.1136/thx.2008.112870; Guilemany JM, 2011, RESP MED, V105, P44, DOI 10.1016/j.rmed.2010.10.019; Metaxas EI, 2015, CAN RESPIR J, V22, P163, DOI 10.1155/2015/783682; Mutalithas K, 2008, RESP MED, V102, P1140, DOI 10.1016/j.rmed.2008.03.011; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Philpott CM, 2008, J LARYNGOL OTOL, V122, P11, DOI 10.1017/S0022215107009140; Quittner AL, 2015, THORAX, V70, P12, DOI 10.1136/thoraxjnl-2014-205918; Taylor SL, 2015, ANN AM THORAC SOC, V12, P701, DOI 10.1513/AnnalsATS.201411-513OC; Tsang KWT, 1998, AM J RESP CRIT CARE, V158, P723, DOI 10.1164/ajrccm.158.3.9710090; Wilkinson M, 2014, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD001289.PUB2; Wu QB, 2014, RESPIROLOGY, V19, P321, DOI 10.1111/resp.12233	28	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137348	10.1371/journal.pone.0137348	http://dx.doi.org/10.1371/journal.pone.0137348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340660	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200049
J	Hong, HM; Liu, YY; Zhang, HT; Xiao, JH; Li, XH; Wang, SP				Hong, Hanming; Liu, Yanyan; Zhang, Haitao; Xiao, Jinghua; Li, Xianghua; Wang, Shiping			Small RNAs and Gene Network in a Durable Disease Resistance Gene-Mediated Defense Responses in Rice	PLOS ONE			English	Article							ORYZAE PV. ORYZAE; XANTHOMONAS-ORYZAE; RECEPTOR KINASE; BROAD-SPECTRUM; MICRORNAS; EXPRESSION; IDENTIFICATION; IMMUNITY; SEQUENCES; XA3/XA26	Accumulating data have suggested that small RNAs (sRNAs) have important functions in plant responses to pathogen invasion. However, it is largely unknown whether and how sRNAs are involved in the regulation of rice responses to the invasion of Xanthomonas oryzae pv. oryzae (Xoo), which causes bacterial blight, the most devastating bacterial disease of rice worldwide. We performed simultaneous genome-wide analyses of the expression of sRNAs and genes during early defense responses of rice to Xoo mediated by a major disease resistance gene, Xa3/Xa26, which confers durable and race-specific qualitative resistance. A large number of sRNAs and genes showed differential expression in Xa3/Xa26-mediated resistance. These differentially expressed sRNAs include known microRNAs (miRNAs), unreported miRNAs, and small interfering RNAs. The candidate genes, with expression that was negatively correlated with the expression of sRNAs, were identified, indicating that these genes may be regulated by sRNAs in disease resistance in rice. These results provide a new perspective regarding the putative roles of sRNA candidates and their putative target genes in durable disease resistance in rice.	[Hong, Hanming; Liu, Yanyan; Zhang, Haitao; Xiao, Jinghua; Li, Xianghua; Wang, Shiping] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res Wuhan, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Wang, SP (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res Wuhan, Wuhan 430070, Peoples R China.	swang@mail.hzau.edu.cn			National Natural Science Foundation of China [31471757]; National Program of High Technology Development of China [2012AA10A303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of High Technology Development of China(National High Technology Research and Development Program of China)	This work was supported by the grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (31471757) and the National Program of High Technology Development of China (www.863.gov.cn) (2012AA10A303). The funders had no role in study design, data cellection and analysis, decision to publish, or preparation of the manuscript.	Campo S, 2013, NEW PHYTOL, V199, P212, DOI 10.1111/nph.12292; Cao YL, 2007, GENETICS, V177, P523, DOI 10.1534/genetics.107.075176; Chen HL, 2002, PHYTOPATHOLOGY, V92, P750, DOI 10.1094/PHYTO.2002.92.7.750; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Deng HQ, 2012, PLANT PHYSIOL, V158, P876, DOI 10.1104/pp.111.191379; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; [Gao Juejing 高觉婧], 2010, [分子植物育种, Molecular Plant Breeding], V8, P420; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Guo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116175; He ZH, 1998, PLANT J, V14, P55, DOI 10.1046/j.1365-313X.1998.00092.x; Hu KM, 2008, MOL PLANT, V1, P786, DOI 10.1093/mp/ssn039; Iqbal MJ, 2009, CURR ISSUES MOL BIOL, V11, pI11; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katiyar-Agarwal S, 2007, GENE DEV, V21, P3123, DOI 10.1101/gad.1595107; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kou Y, 2013, TRANSLATIONAL GENOMI, P11; Kou YJ, 2010, SCI CHINA LIFE SCI, V53, P1263, DOI 10.1007/s11427-010-4081-6; Kou YJ, 2010, CURR OPIN PLANT BIOL, V13, P181, DOI 10.1016/j.pbi.2009.12.010; Langenbach C, 2013, NEW PHYTOL, V198, P536, DOI 10.1111/nph.12155; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2013, PLANT GENETICS GENOM, V5, P161, DOI DOI 10.1007/978-1-4614-7903-1_11; Li HJ, 2012, MOL PLANT, V5, P281, DOI 10.1093/mp/ssr079; Li H, 2009, PLANT MOL BIOL, V69, P337, DOI 10.1007/s11103-008-9430-5; Li Y, 2014, PLANT PHYSIOL, V164, P1077, DOI 10.1104/pp.113.230052; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Pelaez P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00343; Peng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061029; Peng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054148; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Seo JK, 2013, MOL PLANT MICROBE IN, V26, P617, DOI 10.1094/MPMI-10-12-0255-IA; Shen JQ, 2010, MOL GENET GENOMICS, V284, P477, DOI 10.1007/s00438-010-0581-0; Snead NM, 2010, WIRES RNA, V1, P117, DOI 10.1002/wrna.14; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; Wang GN, 2006, PLANT MOL BIOL, V60, P437, DOI 10.1007/s11103-005-4770-x; Xiao J, 2013, PLANT PHYSIOL, V163, P1868, DOI 10.1104/pp.113.226019; Xiao WF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004603; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang HT, 2013, CURR OPIN PLANT BIOL, V16, P188, DOI 10.1016/j.pbi.2013.02.008; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	59	15	15	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137360	10.1371/journal.pone.0137360	http://dx.doi.org/10.1371/journal.pone.0137360			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335702	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400053
J	Suzuki, Y; Tamesue, D; Asahi, K; Ishikawa, Y				Suzuki, Yuhei; Tamesue, Dai; Asahi, Kentaro; Ishikawa, Yoshiki			Grit and Work Engagement: A Cross-Sectional Study	PLOS ONE			English	Article							PERSEVERANCE; PERFORMANCE; VALIDATION; PASSION	Grit, defined as perseverance of effort and consistency of interest, has attracted attention as a predictor of success in various fields beyond IQ and the Big Five personality dimension of Conscientiousness. The purpose of the current study was to examine previously uninvestigated questions regarding grit using a cross-sectional design among a large number of working adults in Japan. First, we tested geographical generalizability of associations between grit and orientations towards happiness by comparing previous studies in the U.S. and the current study in Japan. It was confirmed that orientation towards meaning rather than orientation towards engagement had a stronger positive correlation with grit in our sample of Japanese people. This result is inconsistent with previous studies in the U.S. Furthermore, the Big Five dimension of Openness to Experience was newly confirmed as having a positive association with grit. Second, we examined the association between grit and work engagement, which is considered as an outcome indicator for work performance. In this analysis, grit was a strong predictor for work performance as well as academic performance.	[Tamesue, Dai] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan; [Asahi, Kentaro] Beach Life JAPAN, Chuo Ku, Tokyo, Japan; [Ishikawa, Yoshiki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Ishikawa, Y (corresponding author), Campus H,Shibuya Ku, Tokyo, Japan.	ishikun@gmail.com			Campus for H., Inc.	Campus for H., Inc.	This study was funded by Campus for H., Inc. Co-authors Yuhei Suzuki and Yoshiki Ishikawa were employed by Campus for H., Inc. at the time of the study. Campus for H., Inc. provided support in the form of salaries for authors YS and YI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bakker AB, 2010, WORK ENGAGEMENT: A HANDBOOK OF ESSENTIAL THEORY AND RESEARCH, P1; BARRICK MR, 1991, PERS PSYCHOL, V44, P1, DOI 10.1111/j.1744-6570.1991.tb00688.x; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; Duckworth AL, 2009, J PERS ASSESS, V91, P166, DOI 10.1080/00223890802634290; Hartigan J.A., 1989, FAIRNESS EMPLOYMENT; Hiruma F, 2012, WASEDA COMMER REV, V433, P1; Holland J. L, 1997, MAKING VOCATIONAL CH; HOLLAND JL, 1959, J COUNS PSYCHOL, V6, P35, DOI 10.1037/h0040767; Kumano Michiko, 2011, Shinrigaku Kenkyu, V81, P619; Ministry of Education Culture Sports Science and Technology Ministry of Health Labour and Welfare of Japan, 2002, ETH GUID EP RES; Namikawa Tsutomu, 2012, Shinrigaku Kenkyu, V83, P91; Nye CD, 2012, PERSPECT PSYCHOL SCI, V7, P384, DOI 10.1177/1745691612449021; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Peterson C., 2005, J HAPPINESS STUD, V6, P25, DOI [https://doi.org/10.1007/s10902-004-1278-z, DOI 10.1007/S10902-004-1278-Z]; Schaufeli WB, 2002, J HAPPINESS STUD, V3, P71, DOI DOI 10.1023/A:1015630930326; Schaufeli WB, 2006, EDUC PSYCHOL MEAS, V66, P701, DOI 10.1177/0013164405282471; Schmidt FL, 2004, J PERS SOC PSYCHOL, V86, P162, DOI 10.1037/0022-3514.86.1.162; Shimazu A, 2008, APPL PSYCHOL-INT REV, V57, P510, DOI 10.1111/j.1464-0597.2008.00333.x; Sugimura K, 2012, NEW DIR CHILD ADOLES, V138, P123, DOI 10.1002/cad.20025; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Tsuno K, 2009, IND HEALTH, V47, P640, DOI 10.2486/indhealth.47.640; Von Culin KR, 2014, J POSIT PSYCHOL, V9, P306, DOI 10.1080/17439760.2014.898320; Wada S, 1996, JPN J PSYCHOL, V67, P61, DOI 10.4992/jjpsy.67.61; Yoshizu J., 2013, JPN J RES EMOT, V20, P12, DOI [10.4092/jsre.20.12, DOI 10.2132/PERSONALITY.24.167, DOI 10.4092/JSRE.20.12]	24	52	52	5	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137501	10.1371/journal.pone.0137501	http://dx.doi.org/10.1371/journal.pone.0137501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ5AJ	26335001	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400063
J	Costa-Silva, GJ; Rodriguez, MS; Roxo, FF; Foresti, F; Oliveira, C				Costa-Silva, Guilherme J.; Rodriguez, Monica S.; Roxo, Fabio F.; Foresti, Fausto; Oliveira, Claudio			Using Different Methods to Access the Difficult Task of Delimiting Species in a Complex Neotropical Hyperdiverse Group	PLOS ONE			English	Article							SILURIFORMES LORICARIIDAE; CHARACIFORMES CHARACIDAE; RINELORICARIA SILURIFORMES; DNA BARCODE; BASIN; RIVER; SPECIATION; DIVERSITY; TAXONOMY; MODEL	The genus Rineloricaria is a Neotropical freshwater fish group with a long and problematic taxonomic history, attributed to the large number of species and the pronounced similarity among them. In the present work, taxonomic information and different molecular approaches were used to identify species boundaries and characterize independent evolutionary units. We analyzed 228 samples assembled in 53 distinct morphospecies. A general mixed yule-coalescent (GMYC) analysis indicated the existence of 70 entities, while BOLD system analyses showed the existence of 56 distinct BINs. When we used a new proposed integrative taxonomy approach, mixing the results obtained by each analysis, we identified 73 OTUs. We suggest that Rineloricaria probably has some complexity in the known species and several species not formally described yet. Our data suggested that other hyperdiverse fish groups with wide distributions can be further split into many new evolutionary taxonomic units.	[Costa-Silva, Guilherme J.; Roxo, Fabio F.; Foresti, Fausto; Oliveira, Claudio] Univ Estadual Paulista, Dept Morfol, Lab Biol Genet Peixes, Botucatu, SP, Brazil; [Rodriguez, Monica S.] Univ Fed Vicosa, Rio Paranaiba, MG, Brazil	Universidade Estadual Paulista; Universidade Federal de Vicosa	Costa-Silva, GJ (corresponding author), Univ Estadual Paulista, Dept Morfol, Lab Biol Genet Peixes, Botucatu, SP, Brazil.	costasilvagj@gmail.com	Oliveira, Claudio/D-7713-2012; Fapesp, Biota/F-8655-2017	Oliveira, Claudio/0000-0002-7010-8880; Fapesp, Biota/0000-0002-9887-8449	Brazilian agency FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo) [proc. 2014/05051-5, proc. 2007/04071-2]; Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [proc. 441347/2014-2]	Brazilian agency FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Brazilian agencies FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo, proc. 2014/05051-5 to FFR, proc. 2007/04071-2 to GJCS) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, proc. 441347/2014-2 to FFR).	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Baldwin CC, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.79.1045; Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Bellafronte E, 2013, NEOTROP ICHTHYOL, V11, P497, DOI 10.1590/S1679-62252013000300003; Benine RC, 2009, NEOTROP ICHTHYOL, V7, P161, DOI 10.1590/S1679-62252009000200005; Covain R, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1462.1.1; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Queiroz L. J., 2013, PEIXES RIO MADEIRA; Drummond AJ, 2010, GENEIOUS; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EVERS H.G., 2005, CATFISH ATLAS, V1; Fichberg I, 2008, NEOTROP ICHTHYOL, V6, P347, DOI 10.1590/S1679-62252008000300008; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fricke R, 2014, CATALOG FISHES ONLIN; Ghazzi MS, 2008, IHERINGIA SER ZOOL, V98, P100, DOI 10.1590/S0073-47212008000100014; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Ingenito LFS, 2008, NEOTROP ICHTHYOL, V6, P355, DOI 10.1590/S1679-62252008000300009; Kashiwagi T, 2012, MOL PHYLOGENET EVOL, V64, P212, DOI 10.1016/j.ympev.2012.03.020; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; Liao YC, 2011, ZOOTAXA, P32; Marques DF, 2013, NEOTROP ICHTHYOL, V11, P459, DOI 10.1590/S1679-62252013000200015; Mayr E, 1940, AM NAT, V74, P249, DOI 10.1086/280892; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; Menezes NA, 2007, PEIXES AGUA DOCE MAT; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2014, TRACER BEAST; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Reis RE, 1983, IHERINGIA SER ZOOL, V80, P61; Reis Roberto E., 2001, Ichthyological Exploration of Freshwaters, V12, P319; Rodriguez MS, 2008, NEOTROP ICHTHYOL, V6, P367, DOI 10.1590/S1679-62252008000300010; Rodriguez MS, 2008, COPEIA, P333, DOI 10.1643/CI-06-218; Roxo FF, 2012, ZOOTAXA, P1; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Smith PJ, 2011, J FISH BIOL, V78, P355, DOI 10.1111/j.1095-8649.2010.02846.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Vera-Alcaraz HS, 2012, NEOTROP ICHTHYOL, V10, P285, DOI 10.1590/S1679-62252012000200006; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia X, 2009, PHYLOGENETIC HDB PRA, V2, P611, DOI [10.1017/CBO9780511819049.022, DOI 10.1017/CBO9780511819049.022]; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3	50	47	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135075	10.1371/journal.pone.0135075	http://dx.doi.org/10.1371/journal.pone.0135075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332320	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800019
J	Sergentanis, TN; Tsivgoulis, G; Perlepe, C; Ntanasis-Stathopoulos, I; Tzanninis, IG; Sergentanis, IN; Psaltopoulou, T				Sergentanis, Theodoros N.; Tsivgoulis, Georgios; Perlepe, Christina; Ntanasis-Stathopoulos, Ioannis; Tzanninis, Ioannis-Georgios; Sergentanis, Ioannis N.; Psaltopoulou, Theodora			Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; GROWTH-FACTOR-I; CANCER-RISK; INTRACRANIAL MENINGIOMA; HORMONE; ASSOCIATION; RECEPTORS; EXPOSURE; COHORT; WOMEN	Objective This meta-analysis aims to examine the association between being overweight/obese and risk of meningiomas and gliomas as well as overall brain/central nervous system (CNS) tumors. Study Design Potentially eligible publications were sought in PubMed up to June 30, 2014. Randomeffects meta-analysis and dose-response meta-regression analysis was conducted. Cochran Q statistic, I-squared and tau-squared were used for the assessment of between-study heterogeneity. The analysis was performed using Stata/SE version 13 statistical software. Results A total of 22 studies were eligible, namely 14 cohort studies (10,219 incident brain/CNS tumor cases, 1,319 meningioma and 2,418 glioma cases in a total cohort size of 10,143,803 subjects) and eight case-control studies (1,009 brain/CNS cases, 1,977 meningioma cases, 1,265 glioma cases and 8,316 controls). In females, overweight status/obesity was associated with increased risk for overall brain/CNS tumors (pooled RR = 1.12, 95% CI: 1.03-1.21, 10 study arms), meningiomas (pooled RR = 1.27, 95% CI: 1.13-1.43, 16 study arms) and gliomas (pooled RR = 1.17, 95% CI: 1.03-1.32, six arms). Obese (BMI>30 kg/m(2)) females seemed particularly aggravated in terms of brain/CNS tumor (pooled RR = 1.19, 95% CI: 1.05-1.36, six study arms) and meningioma risk (pooled RR = 1.48, 95% CI: 1.28-1.71, seven arms). In males, overweight/obesity status correlated with increased meningioma risk (pooled RR = 1.58, 95% CI: 1.22-2.04, nine study arms), whereas the respective association with overall brain/CNS tumor or glioma risk was not statistically significant. Dose-response meta-regression analysis further validated the findings. Conclusion Our findings highlight obesity as a risk factor for overall brain/CNS tumors, meningiomas and gliomas among females, as well as for meningiomas among males.	[Sergentanis, Theodoros N.; Perlepe, Christina; Ntanasis-Stathopoulos, Ioannis; Tzanninis, Ioannis-Georgios; Psaltopoulou, Theodora] Natl Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Tsivgoulis, Georgios] Natl Univ Athens, Sch Med, Attikon Univ Hosp, Dept Neurol 2, Athens, Greece; [Sergentanis, Ioannis N.] Hop Cantonal Univ Geneva, Hop Psychiat, Geneva, Switzerland	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; University of Geneva	Psaltopoulou, T (corresponding author), Natl Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece.	tpsaltop@med.uoa.gr	Tsivgoulis, Georgios/AAD-5360-2020; Psaltopoulou, Theodora/AAA-6878-2020; Tsivgoulis, Georgios/AAD-7467-2019; Ntanasis-Stathopoulos, Ioannis/AAD-3692-2019; Sergentanis, Theodoros N./AAD-8303-2019	Tsivgoulis, Georgios/0000-0002-0640-3797; Psaltopoulou, Theodora/0000-0002-1404-9716; Ntanasis-Stathopoulos, Ioannis/0000-0002-6328-9783; Sergentanis, Theodoros N./0000-0002-9355-5528				Aghi MK, 2007, NEUROSURGERY, V61, P754, DOI 10.1227/01.NEU.0000298903.63635.E3; Benson VS, 2008, BRIT J CANCER, V99, P185, DOI 10.1038/sj.bjc.6604445; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Cabaniols C, 2011, J NEURO-ONCOL, V103, P307, DOI 10.1007/s11060-010-0388-1; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Claus EB, 2013, J NEUROSURG, V118, P649, DOI 10.3171/2012.9.JNS12811; Claus EB, 2011, J NEUROSURG, V115, P1072, DOI 10.3171/2011.6.JNS11129; Cowppli-Bony A, 2011, CANCER CAUSE CONTROL, V22, P697, DOI 10.1007/s10552-011-9742-7; Crosbie EJ, 2010, CANCER EPIDEM BIOMAR, V19, P3119, DOI 10.1158/1055-9965.EPI-10-0832; Custer B, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-152; Custer BS, 2002, CANCER, V94, P1626, DOI 10.1002/cncr.10410; Discacciati A, 2012, ANN ONCOL, V23, P1665, DOI 10.1093/annonc/mdr603; Edlinger M, 2012, J HYPERTENS, V30, P290, DOI 10.1097/HJH.0b013e32834e9176; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Friend KE, 2001, GROWTH HORM IGF RES, V11, P84, DOI 10.1054/ghir.2000.0183; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holick CN, 2007, AM J CLIN NUTR, V85, P877, DOI 10.1093/ajcn/85.3.877; Il'yasova D, 2005, CANCER CAUSE CONTROL, V16, P383, DOI 10.1007/s10552-004-5025-x; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; Ismail K, 1998, EUR J ANAESTH, V15, P106, DOI 10.1097/00003643-199801000-00019; Jhawar BS, 2003, J NEUROSURG, V99, P848, DOI 10.3171/jns.2003.99.5.0848; Johnson DR, 2011, NEURO-ONCOLOGY, V13, P1011, DOI 10.1093/neuonc/nor081; Kicinski M, 2015, STAT MED, V34, P2781, DOI 10.1002/sim.6525; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; KURIHARA M, 1989, J NEUROSURG, V71, P538, DOI 10.3171/jns.1989.71.4.0538; Lee E, 2006, INT J CANCER, V119, P1152, DOI 10.1002/ijc.21950; Lichtman MA, 2010, ONCOLOGIST, V15, P1083, DOI 10.1634/theoncologist.2010-0206; Linos E, 2007, JNCI-J NATL CANCER I, V99, P1544, DOI 10.1093/jnci/djm170; Little MP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1147; Little RB, 2013, CANCER CAUSE CONTROL, V24, P1025, DOI 10.1007/s10552-013-0178-0; LONGSTRETH WT, 1993, CANCER, V72, P639, DOI 10.1002/1097-0142(19930801)72:3<639::AID-CNCR2820720304>3.0.CO;2-P; Mandelzweig L, 2009, CANCER CAUSE CONTROL, V20, P1927, DOI 10.1007/s10552-009-9386-z; Michaud DS, 2011, CANCER PREV RES, V4, P1385, DOI 10.1158/1940-6207.CAPR-11-0014; Mittlbock M, 2006, STAT MED, V25, P4321, DOI 10.1002/sim.2692; Moore SC, 2009, CANCER RES, V69, P8349, DOI 10.1158/0008-5472.CAN-09-1669; Mullan RJ, 2009, J CLIN EPIDEMIOL, V62, P138, DOI 10.1016/j.jclinepi.2008.08.002; Navas-Acien A, 2002, AM J IND MED, V42, P214, DOI 10.1002/ajim.10107; Ning Y, 2010, OBES REV, V11, P19, DOI 10.1111/j.1467-789X.2009.00613.x; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Omulecka A, 2006, FOLIA NEUROPATHOL, V44, P111; Pan SY, 2004, AM J EPIDEMIOL, V159, P259, DOI 10.1093/aje/kwh041; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Samanic C, 2004, CANCER CAUSE CONTROL, V15, P35, DOI 10.1023/B:CACO.0000016573.79453.ba; Samanic C, 2006, CANCER CAUSE CONTROL, V17, P901, DOI 10.1007/s10552-006-0023-9; Sanson M, 2000, ACTA NEUROCHIR, V142, P493, DOI 10.1007/s007010050462; Schildkraut JM, 2014, J NEUROSURG, V120, P820, DOI 10.3171/2013.12.JNS131170; Sergentanis TN, 2013, EUR J CANCER, V49, P642, DOI 10.1016/j.ejca.2012.08.028; Shao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090167; Trichopoulos D., 2008, TXB CANC EPIDEMIOLOG; Umansky F, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/5/E7; Wiedmann M, 2013, BRIT J CANCER, V109, P289, DOI 10.1038/bjc.2013.304; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3; Wolin KY, 2010, ONCOLOGIST, V15, P556, DOI 10.1634/theoncologist.2009-0285; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yin D, 2005, NEUROL RES, V27, P27, DOI 10.1179/016164105X18151	63	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136974	10.1371/journal.pone.0136974	http://dx.doi.org/10.1371/journal.pone.0136974			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332834	gold, Green Submitted, Green Published			2022-12-27	WOS:000360613800085
J	Wei, L; Xiang, XG; Wang, YZ; Li, ZY				Wei, Lai; Xiang, Xiao-guo; Wang, Yin-zheng; Li, Zhen-yu			Phylogenetic Relationships and Evolution of the Androecia in Ruteae (Rutaceae)	PLOS ONE			English	Article							COMPARATIVE FLORAL STRUCTURE; CLADISTIC-ANALYSIS; ONTOGENY; AURANTIOIDEAE; CLASSIFICATION; SUBFAMILIES; ORANGE; LEGUMINOSAE; SYSTEMATICS; MORPHOLOGY	Ruta, which belongs to tribe Ruteae, is the type genus of the subfamily Rutoideae and the family Rutaceae. Molecular systematic studies have shown that the genera in Ruteae are closer related to Aurantioideae than to most other genera of Rutoideae, some of the genera traditionally placed in Ruteae have been shown to be nested within the Aurantioideae clade, but the diagnostic characters for determining new patterns in the relationship are poor. In this study, we investigated the floral development of Boenninghausenia in Ruteae (sensu stricto), Haplophyllum in the basal position of Aurantioideae and Murraya in traditional Aurantioideae using scanning electron microscopy. The androecium of Boenninghausenia is obdiplostemony. As androecia in other genera within Ruteae (s.s.) are also obdiplostemonous, reconstruction of the ancestral state indicates that obdiplostemony is an ancestral character in this clade. Because the androecia of Haplophyllum and Murraya are also obdiplostemonous, obdiplostemony is also an ancestral character in Aurantioideae clade. The ancestral state reconstruction indicates this character can serve as a synapomorphy of the Ruteae-Aurantioideae clade. The results of our work also shed light on the evolution of the androecium in Rutaceae, as the obdiplostemony of this group is clearly derived from haplostemony in the ancestral genera in Rutaceae and has develop into polyandry by increasing antepetalous stamens.	[Wei, Lai] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Wei, Lai; Xiang, Xiao-guo; Wang, Yin-zheng; Li, Zhen-yu] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Botany, CAS	Wang, YZ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	wangyz@ibcas.ac.cn; Lizy@ibcas.ac.cn			National Natural Science Foundation of China [31200149]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Natural Science Foundation of China (Grant no. 31200149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, ANTHER FORM FUNCTION; Appelhans MS, 2011, ANN BOT-LONDON, V107, P1259, DOI 10.1093/aob/mcr076; Appelhans MS, 2012, J BIOGEOGR, V39, P1235, DOI 10.1111/j.1365-2699.2012.02686.x; Bayer RJ, 2009, AM J BOT, V96, P668, DOI 10.3732/ajb.0800341; Bayly MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072493; Bello MA, 2008, ANN BOT-LONDON, V101, P1491, DOI [10.1093/aob/mcm228, 10.1093/aob/mcn073]; Caris P, 2006, PLANT SYST EVOL, V257, P223, DOI 10.1007/s00606-005-0373-x; Chase MW, 1999, AM J BOT, V86, P1191, DOI 10.2307/2656983; Corner E. J. H., 1976, SEEDS DICOTYLEDONS; Cronquist A, 1993, INTEGRATE SYSTEM CLA; DA SILVA MFGF, 1988, PLANT SYST EVOL, V161, P97; DECRAENE LPR, 1995, BOT J LINN SOC, V118, P193, DOI 10.1016/S0024-4074(05)80002-6; Decraene LPR, 1996, AM J BOT, V83, P201, DOI 10.2307/2445939; Dickson A, 1865, T BOT SOC EDINBURG, V8, P86; Endress PK, 2006, ADV BOT RES, V44, P1, DOI 10.1016/S0065-2296(06)44001-5; Endress PK, 2010, ANN BOT-LONDON, V106, P687, DOI 10.1093/aob/mcq171; Endress PK, 2000, INT J PLANT SCI, V161, pS237, DOI 10.1086/317571; Engler A, 1896, DIA NATURLICHEN PFLA; Engler H.G.A., 1931, NATURLICHEN PFLANZEN, P187; Erbar C, 1997, INT J PLANT SCI, V158, pS49, DOI 10.1086/297506; Gonzalez FA, 2010, AM J BOT, V97, P191, DOI 10.3732/ajb.0900194; GREGOR HJ, 1989, PLANT SYST EVOL, V162, P251, DOI 10.1007/BF00936920; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Kaplan D. R., 1984, CLADISTICS PERSPECTI, P51; Kirchoff BK, 2003, INT J PLANT SCI, V164, P505, DOI 10.1086/375421; Kubitzki K., 2011, V10, P276; Leins P., 2010, FLOWER FRUIT MORPHOL; LORD EM, 1985, BOT GAZ, V146, P320, DOI 10.1086/337531; Maddison WP, 2019, MESQUITE MODULAR SYS; Manafzadeh S, 2014, J BIOGEOGR, V41, P366, DOI 10.1111/jbi.12185; Matthews ML, 2012, BOT J LINN SOC, V170, P299, DOI [10.1111/j.1095-8339.2012.01299.x, 10.1111/j.1095-8339.20]; Matthews ML, 2005, BOT J LINN SOC, V149, P129, DOI 10.1111/j.1095-8339.2005.00445.x; Matthews ML, 2001, ANN BOT-LONDON, V88, P439, DOI 10.1006/anbo.2001.1494; MOORE J. A., 1936, New Phytologist, V35, P318, DOI 10.1111/j.1469-8137.1936.tb06885.x; Morton CM, 2003, AM J BOT, V90, P1463, DOI 10.3732/ajb.90.10.1463; Morton CM, 2014, ANN MO BOT GARD, V99, P620, DOI 10.3417/2010034; Mou FJ, 2012, J SYST EVOL, V50, P460, DOI 10.1111/j.1759-6831.2012.00193.x; Poon WS, 2007, SYST BOT, V32, P837, DOI 10.1600/036364407783390692; Ronse De Craene LP., 2010, FLORAL DIAGRAMS AID; Salvo G, 2008, MOL PHYLOGENET EVOL, V49, P736, DOI 10.1016/j.ympev.2008.09.004; Samuel R, 2001, PLANT BIOLOGY, V3, P77, DOI 10.1055/s-2001-11747; Scott KD, 2000, PLANT SYST EVOL, V223, P15, DOI 10.1007/BF00985324; Sehr EM, 2009, INT J PLANT SCI, V170, P845, DOI 10.1086/599074; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Stebbins G. L., 1973, BREVIORA, V418, P1; Stuessy T.F., 2009, PLANT TAXONOMY SYSTE; THORNE RF, 1992, BOT REV, V58, P225, DOI 10.1007/BF02858611; Tucker SC, 2000, INT J PLANT SCI, V161, P537, DOI 10.1086/314278; Tucker SC, 2005, INT J PLANT SCI, V166, P557, DOI 10.1086/429848; Wei L, 2012, PLANT BIOLOGY, V14, P190, DOI 10.1111/j.1438-8677.2011.00475.x; Xu FX, 2010, ANN BOT-LONDON, V106, P591, DOI 10.1093/aob/mcq158; Zhou QY, 2006, INT J PLANT SCI, V167, P201, DOI 10.1086/498352; Zhou QY, 2002, AUST J BOT, V50, P633, DOI 10.1071/BT02015	53	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137190	10.1371/journal.pone.0137190	http://dx.doi.org/10.1371/journal.pone.0137190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332986	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800107
J	Allen, A; Breadon, E; Byrne, A; Mallon, T; Skuce, R; Groussaud, P; Dainty, A; Graham, J; Jones, K; Pollock, L; Whatmore, A				Allen, Adrian; Breadon, Eleanor; Byrne, Andrew; Mallon, Thomas; Skuce, Robin; Groussaud, Pauline; Dainty, Amanda; Graham, Judith; Jones, Kerri; Pollock, Lorraine; Whatmore, Adrian			Molecular Epidemiology of Brucella abortus in Northern Ireland-1991 to 2012	PLOS ONE			English	Article							TANDEM-REPEAT MARKERS; UNITED-STATES; IDENTIFICATION; OUTBREAK; MELITENSIS; MANAGEMENT; DIVERSITY; EVOLUTION; CATTLE; LEVEL	Background Brucellosis is the most common bacterial zoonoses worldwide. Bovine brucellosis caused by Brucella abortus has far reaching animal health and economic impacts at both the local and national levels. Alongside traditional veterinary epidemiology, the use of molecular typing has recently been applied to inform on bacterial population structure and identify epidemiologically-linked cases of infection. Multi-locus variable number tandem repeat VNTR analysis (MLVA) was used to investigate the molecular epidemiology of a well-characterised Brucella abortus epidemic in Northern Ireland involving 387 herds between 1991 and 2012. Results MLVA identified 98 unique B. abortus genotypes from disclosing isolates in the 387 herds involved in the epidemic. Clustering algorithms revealed the relatedness of many of these genotypes. Combined with epidemiological information on chronology of infection and geographic location, these genotype data helped to identify 7 clonal complexes which underpinned the outbreak over the defined period. Hyper-variability of some VNTR loci both within herds and individual animals led to detection of multiple genotypes associated with single outbreaks. However with dense sampling, these genotypes could still be associated with specific clonal complexes thereby permitting inference of epidemiological links. MLVA-based epidemiological monitoring data were congruent with an independent classical veterinary epidemiology study carried out in the same territory. Conclusions MLVA is a useful tool in ongoing disease surveillance of B. abortus outbreaks, especially when combined with accurate epidemiological information on disease tracings, geographical clustering of cases and chronology of infection.	[Allen, Adrian; Breadon, Eleanor; Byrne, Andrew; Mallon, Thomas; Skuce, Robin; Jones, Kerri; Pollock, Lorraine] Agri Food & Biosci Inst AFBI, AFBI Stormont, Belfast, Antrim, North Ireland; [Skuce, Robin] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Groussaud, Pauline; Dainty, Amanda; Whatmore, Adrian] Anim & Plant Hlth Agcy APHA, Dept Bacteriol, OIE WHO FAO Reference Lab Brucellosis, Addlestone, Surrey, England; [Graham, Judith] Vet Serv, Dept Agr & Rural Dev, Belfast, Antrim, North Ireland	Agri-Food & Biosciences Institute; Queens University Belfast; Animal & Plant Health Agency UK; Food & Agriculture Organization of the United Nations (FAO)	Allen, A (corresponding author), Agri Food & Biosci Inst AFBI, AFBI Stormont, Belfast, Antrim, North Ireland.	Adrian.Allen@afbini.gov.uk	Byrne, Andrew/N-3894-2015; Allen, Adrian R/C-6242-2009; Whatmore, Adrian M/C-7744-2011	Byrne, Andrew/0000-0003-0296-4586; Whatmore, Adrian M/0000-0003-4218-156X	Department of Agriculture and Rural Development, Northern Ireland; Department of Environment, Food and Rural Affairs (DEFRA) [SE0311, SE0313, SB1400]	Department of Agriculture and Rural Development, Northern Ireland; Department of Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department of Agriculture and Rural Development, Northern Ireland www.dardni.gov.uk, and the Department of Environment, Food and Rural Affairs (DEFRA) under projects SE0311, SE0313 and SB1400 www.	Abernethy DA, 2011, PREV VET MED, V98, P223, DOI 10.1016/j.prevetmed.2010.11.002; Abernethy DA, 2006, VET REC, V158, P717, DOI 10.1136/vr.158.21.717; Adone R, 2013, REV SCI TECH OIE, V32, P199; Alton G. G., 1988, TECHNIQUES BRUCELLOS, P13; Alvarez J, 2011, RES VET SCI, V90, P208, DOI 10.1016/j.rvsc.2010.05.028; Biek R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003008; Bricker BJ, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-15; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Crawford R. P., 1990, Animal brucellosis., P131; Aparicio ED, 2013, REV SCI TECH OIE, V32, P53; Dixon P.M., 2002, ENCY ENV, VVolume 3, P1796, DOI DOI 10.1002/9780470057339.VAR046; Dorneles EMS, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-186; Foster JT, 2009, J BACTERIOL, V191, P2864, DOI 10.1128/JB.01581-08; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Godfroid J, 2013, REV SCI TECH OIE, V32, P27; Gwida M, 2012, COMP IMMUNOL MICROB, V35, P181, DOI 10.1016/j.cimid.2011.12.012; Gyuranecz M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-76; Higgins J, 2012, APPL ENVIRON MICROB, V78, P3674, DOI 10.1128/AEM.00045-12; Houston R, 2001, REV SCI TECH OIE, V20, P652, DOI 10.20506/rst.20.2.1293; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Kilic S, 2011, J CLIN MICROBIOL, V49, P3276, DOI 10.1128/JCM.02538-10; Kulakov YK, 2010, VACCINE, V28, pF41, DOI 10.1016/j.vaccine.2010.03.051; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Leiser OP, 2013, VET MICROBIOL, V166, P1, DOI 10.1016/j.vetmic.2013.02.025; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Poester FP, 2013, REV SCI TECH OIE, V32, P105; Ragan V, 2013, REV SCI TECH OIE, V32, P189; Reyes JF, 2012, INFECT GENET EVOL, V12, P811, DOI 10.1016/j.meegid.2011.05.018; Scholz HC, 2013, REV SCI TECH OIE, V32, P149; Scott JC, 2007, APPL ENVIRON MICROB, V73, P7331, DOI 10.1128/AEM.00976-07; Skuce RA, 2010, VET REC, V167, P684, DOI 10.1136/vr.c5108; Spratt BG, 2004, FEMS MICROBIOL LETT, V241, P129, DOI 10.1016/j.femsle.2004.11.015; Stringer LA, 2008, PREV VET MED, V84, P72, DOI 10.1016/j.prevetmed.2007.11.005; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wattam AR, 2014, J BACTERIOL, V196, P920, DOI 10.1128/JB.01091-13; Whatmore AM, 2006, J CLIN MICROBIOL, V44, P1982, DOI 10.1128/JCM.02039-05; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001	39	15	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136721	10.1371/journal.pone.0136721	http://dx.doi.org/10.1371/journal.pone.0136721			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325586	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700059
J	Deere, JA; Coulson, T; Smallegange, IM				Deere, Jacques A.; Coulson, Tim; Smallegange, Isabel M.			Life History Consequences of the Facultative Expression of a Dispersal Life Stage in the Phoretic Bulb Mite (Rhizoglyphus robini)	PLOS ONE			English	Article							TRADE-OFFS; QUANTITATIVE-ANALYSIS; MALE MORPHS; BEHAVIOR; FLIGHT; EVOLUTION; DIMORPHISM; PHYSIOLOGY; GROWTH; ACARI	Life history traits play an important role in population dynamics and correlate, both positively and negatively, with dispersal in a wide range of taxa. Most invertebrate studies on trade-offs between life history traits and dispersal have focused on dispersal via flight, yet much less is known about how life history trade-offs influence species that disperse by other means. In this study, we identify effects of investing in dispersal morphology (dispersal expression) on life history traits in the male dimorphic bulb mite (Rhizoglyphus robini). This species has a facultative juvenile life stage (deutonymph) during which individuals can disperse by phoresy. Further, adult males are either fighters (which kill other mites) or benign scramblers. Here, in an experiment, we investigate the effects of investing in dispersal on size at maturity, sex and male morph ratio, and female lifetime reproductive success. We show that life history traits correlate negatively with the expression of the dispersal stage. Remarkably, all males that expressed the dispersal life stage developed into competitive fighters and none into scramblers. This suggests that alternative, male reproductive strategies and dispersal should not be viewed in isolation but considered concurrently.	[Deere, Jacques A.; Coulson, Tim] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Deere, Jacques A.; Smallegange, Isabel M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam IBED, Amsterdam, Netherlands	University of Oxford; University of Amsterdam	Deere, JA (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	j.a.deere@uva.nl	Deere, Jacques/I-4721-2019; Coulson, Tim/AAL-8148-2021; Smallegange, Isabel M./A-8198-2010	Deere, Jacques/0000-0001-6736-2223; Coulson, Tim/0000-0001-9371-9003; Smallegange, Isabel M./0000-0001-6218-7358	European Research Council Advanced Grant [249872]; MacGillavry Fellowship from the University of Amsterdam; Meer vrouwelijke onderzoekers als universitair docent (MEERVOUD) grant [836.13.001]; Netherlands Organisation for Scientific Research (NWO) [864.13.005]; Natural Environment Research Council [NE/K014218/1, NE/I023783/2, 1136795, NE/I023791/2, NE/E015921/1, NE/I023783/1, NE/G004390/2, NE/H007148/2, NE/I023791/1, NE/G004390/1, 1221700, NE/H007148/1] Funding Source: researchfish; NERC [NE/I023791/2, NE/G004390/2, NE/H007148/2, NE/G004390/1, NE/I023783/2, NE/I023791/1, NE/K014218/1, NE/E015921/1, NE/I023783/1] Funding Source: UKRI	European Research Council Advanced Grant(European Research Council (ERC)); MacGillavry Fellowship from the University of Amsterdam; Meer vrouwelijke onderzoekers als universitair docent (MEERVOUD) grant; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the European Research Council Advanced Grant, grant no. 249872 (http://erc.europa.eu/) to TC, a MacGillavry Fellowship from the University of Amsterdam (http://www.uva.nl/en) to IS, a Meer vrouwelijke onderzoekers als universitair docent (MEERVOUD) grant no. 836.13.001 to IS, and a VIDI grant no. 864.13.005 from the Netherlands Organisation for Scientific Research (NWO) (http://www.nwo.nl/en) to IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton TG, 2005, P ROY SOC B-BIOL SCI, V272, P1351, DOI 10.1098/rspb.2005.3081; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bystrom P, 2004, OIKOS, V104, P109, DOI 10.1111/j.0030-1299.2004.12759.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Coulson T, 2010, J ANIM ECOL, V79, P1226, DOI 10.1111/j.1365-2656.2010.01734.x; Diaz A, 2000, EXP APPL ACAROL, V24, P85, DOI 10.1023/A:1006304300657; DIXON AFG, 1993, J ANIM ECOL, V62, P182, DOI 10.2307/5492; Fadamiro HY, 1996, J INSECT BEHAV, V9, P339, DOI 10.1007/BF02213876; Friedenberg NA, 2003, ECOL LETT, V6, P953, DOI 10.1046/j.1461-0248.2003.00524.x; Fronhofer EA, 2014, EVOLUTION, V68, P1838, DOI 10.1111/evo.12339; Gade G, 2002, PHYSIOL ENTOMOL, V27, P51, DOI 10.1046/j.1365-3032.2002.00268.x; GERSON U, 1983, ACAROLOGIA, V24, P439; GROSS MR, 1991, ECOLOGY, V72, P1180, DOI 10.2307/1941091; Hanski I, 2006, J ANIM ECOL, V75, P91, DOI 10.1111/j.1365-2656.2005.01024.x; Hector KL, 2012, J ANIM ECOL, V81, P583, DOI 10.1111/j.1365-2656.2011.01942.x; HOUCK MA, 1991, ANNU REV ENTOMOL, V36, P611, DOI 10.1146/annurev.en.36.010191.003143; Huss M, 2013, FRESHWATER BIOL, V58, P1416, DOI 10.1111/fwb.12138; Le Galliard JF, 2012, MOL ECOL, V21, P505, DOI 10.1111/j.1365-294X.2011.05410.x; Leigh DM, 2014, EXP APPL ACAROL, V64, P159, DOI 10.1007/s10493-014-9822-y; LI JB, 1994, HEREDITY, V72, P10, DOI 10.1038/hdy.1994.2; Lukasik P, 2010, BEHAV ECOL, V21, P270, DOI 10.1093/beheco/arp186; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Min KJ, 2004, J INSECT PHYSIOL, V50, P531, DOI 10.1016/j.jinsphys.2004.03.009; Nichols J., 2001, DISPERSAL; NISHIGAKI J, 1991, APPL ENTOMOL ZOOL, V26, P255, DOI 10.1303/aez.26.255; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Perez-Mendoza J, 2011, J ECON ENTOMOL, V104, P443, DOI 10.1603/EC10430; R Core Team, 2021, R LANGUAGE ENV STAT; RADWAN J, 1995, HEREDITY, V74, P669, DOI 10.1038/hdy.1995.91; Radwan J, 2000, ETHOLOGY, V106, P53, DOI 10.1046/j.1439-0310.2000.00498.x; RANKIN MA, 1992, ANNU REV ENTOMOL, V37, P533, DOI 10.1146/annurev.en.37.010192.002533; ROFF D, 1977, J ANIM ECOL, V46, P443, DOI 10.2307/3822; ROFF DA, 1991, AM ZOOL, V31, P243; Roff Derek, 2002, pi; Ronce O, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P119; Smallegange IM, 2012, J EVOLUTION BIOL, V25, P972, DOI 10.1111/j.1420-9101.2012.02490.x; Smallegange IM, 2014, AM NAT, V183, P784, DOI 10.1086/675817; Smallegange IM, 2011, ECOLOGY, V92, P755, DOI 10.1890/09-2069.1; Smallegange IM, 2011, NATURWISSENSCHAFTEN, V98, P339, DOI 10.1007/s00114-011-0773-4; Smallegange IM, 2011, EVOL ECOL, V25, P857, DOI 10.1007/s10682-010-9446-6; Stacey P.B., 1990, COOPERATIVE BREEDING; Stearns S.C., 1992, pi; Stevens VM, 2014, ECOL LETT, V17, P1039, DOI 10.1111/ele.12303; Stevens VM, 2012, ECOL LETT, V15, P74, DOI 10.1111/j.1461-0248.2011.01709.x; Stillwell RC, 2010, P ROY SOC B-BIOL SCI, V277, P3819, DOI 10.1098/rspb.2010.0895; Yano S, 2002, EXP APPL ACAROL, V27, P1, DOI 10.1023/A:1021518221031; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	50	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136872	10.1371/journal.pone.0136872	http://dx.doi.org/10.1371/journal.pone.0136872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325395	Green Submitted, gold, Green Published			2022-12-27	WOS:000360437700069
J	He, SL; Yang, Y; Morrell, PL; Yi, TS				He, Shui-Lian; Yang, Yang; Morrell, Peter L.; Yi, Ting-Shuang			Nucleotide Sequence Diversity and Linkage Disequilibrium of Four Nuclear Loci in Foxtail Millet (Setaria italica)	PLOS ONE			English	Article							L. P. BEAUV.; SCALE GENOTYPING APPLICATIONS; GENOME-WIDE ASSOCIATION; POPULATION-STRUCTURE; GENETIC DIVERSITY; MOLECULAR DIVERSITY; COMMON MILLET; ORYZA-SATIVA; RECOMBINATION; WILD	Foxtail millet (Setaria italica (L.) Beauv) is one of the earliest domesticated grains, which has been cultivated in northern China by 8,700 years before present (YBP) and across Eurasia by 4,000 YBP. Owing to a small genome and diploid nature, foxtail millet is a tractable model crop for studying functional genomics of millets and bioenergy grasses. In this study, we examined nucleotide sequence diversity, geographic structure, and levels of linkage disequilibrium at four nuclear loci (ADH1, G3PDH, IGS1 and TPI1) in representative samples of 311 landrace accessions across its cultivated range. Higher levels of nucleotide sequence and haplotype diversity were observed in samples from China relative to other sampled regions. Genetic assignment analysis classified the accessions into seven clusters based on nucleotide sequence polymorphisms. Intralocus LD decayed rapidly to half the initial value within similar to 1.2 kb or less.	[He, Shui-Lian; Yang, Yang; Yi, Ting-Shuang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, China Southwestern Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [He, Shui-Lian] Yunnan Agr Univ, Landscape & Hort Coll, Kunming, Yunnan, Peoples R China; [Morrell, Peter L.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Yunnan Agricultural University; University of Minnesota System; University of Minnesota Twin Cities	Yi, TS (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, China Southwestern Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China.	tingshuangyi@mail.kib.ac.cn	Morrell, Peter/E-2059-2011	Morrell, Peter/0000-0001-6282-1582	Talent Project of Yunnan Province [2011CI042]; Research Foundation for Doctoral Program of Yunnan Agriculture University	Talent Project of Yunnan Province; Research Foundation for Doctoral Program of Yunnan Agriculture University	This study was supported by grants from the Talent Project of Yunnan Province (Project No. 2011CI042) and the Research Foundation for Doctoral Program of Yunnan Agriculture University.	Andolfatto P, 2000, GENETICS, V156, P257; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Austin DF, 2006, ECON BOT, V60, P143, DOI 10.1663/0013-0001(2006)60[143:FMSPFI]2.0.CO;2; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073514; Bakker EG, 2006, MOL ECOL, V15, P1405, DOI 10.1111/j.1365-294X.2006.02884.x; Benabdelmouna A, 2001, THEOR APPL GENET, V103, P668, DOI 10.1007/s001220100596; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; d'Ennequin ML, 2000, THEOR APPL GENET, V100, P1061, DOI 10.1007/s001220051387; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; Doyle J. J., 1987, PHYTOCHEM B, P11; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ERLAND S, 1994, NEW PHYTOL, V126, P525, DOI 10.1111/j.1469-8137.1994.tb04251.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fukunaga K, 1997, THEOR APPL GENET, V95, P751, DOI 10.1007/s001220050621; Fukunaga K, 2002, GENET RESOUR CROP EV, V49, P95, DOI 10.1023/A:1013852007770; Gao M, 1988, ACTA AGRON SIN, V14, P132; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; JUSUF M, 1985, THEOR APPL GENET, V71, P385, DOI 10.1007/BF00251177; KAWASE M, 1982, THEOR APPL GENET, V63, P117, DOI 10.1007/BF00303690; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; KIHARA H., 1942, Bot. Mag., V56, P62; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kossover O, 2009, J HERED, V100, P432, DOI 10.1093/jhered/esp014; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; LI HW, 1945, J AM SOC AGRON, V37, P32; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Li Y, 1996, GENET RESOUR CROP EV, V43, P377, DOI 10.1007/BF00132958; Li Y, 1998, GENET RESOUR CROP EV, V45, P279, DOI 10.1023/A:1008600123509; Lin JZ, 2002, GENETICS, V162, P2007; Liu ZL, 2014, CROP SCI, V54, P659, DOI 10.2135/cropsci2012.11.0646; Liu ZL, 2011, CROP SCI, V51, P1655, DOI 10.2135/cropsci2010.11.0643; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Martin G, 2006, GENETICS, V172, P593, DOI 10.1534/genetics.104.039982; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Muthamilarasan M, 2014, DNA RES, V21, P41, DOI 10.1093/dnares/dst039; Nasu H, 2007, VEG HIST ARCHAEOBOT, V16, P481, DOI 10.1007/s00334-006-0068-4; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Pritchard JK, 2000, GENETICS, V155, P945; Rakshit S, 2007, THEOR APPL GENET, V114, P731, DOI 10.1007/s00122-006-0473-1; RAO KEP, 1987, ECON BOT, V41, P108, DOI 10.1007/BF02859358; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Ross-Ibarra J, 2007, J EVOLUTION BIOL, V20, P800, DOI 10.1111/j.1420-9101.2006.01275.x; SAKAMOTO S, 1987, JARQ-JPN AGR RES Q, V21, P84; Schontz D, 1998, PLANT BREEDING, V117, P231, DOI 10.1111/j.1439-0523.1998.tb01931.x; Schontz D, 1999, PLANT BREEDING, V118, P190, DOI 10.1046/j.1439-0523.1999.118002190.x; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Song BH, 2009, GENETICS, V181, P1021, DOI 10.1534/genetics.108.095364; Sun X., 2009, SEED WORLD, V4, P47; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Till-Bottraud I, 1992, THEOR APPL GENET, V83, P940, DOI 10.1007/BF00232954; Toleno DM, 2007, BIOINFORMATICS, V23, P1807, DOI 10.1093/bioinformatics/btm260; Turrill WB, 1926, NATURE, V118, P392, DOI 10.1038/118392a0; Vetriventhan M, 2014, EUPHYTICA, V196, P423, DOI 10.1007/s10681-013-1044-6; Wachowiak W, 2009, TREE GENET GENOMES, V5, P117, DOI 10.1007/s11295-008-0188-3; Wall JD, 1999, GENET RES, V74, P65, DOI 10.1017/S0016672399003870; Wang CF, 2012, G3-GENES GENOM GENET, V2, P769, DOI 10.1534/g3.112.002907; Wang CF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-90; WANG RL, 1995, AM J BOT, V82, P308, DOI 10.2307/2445576; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yadav CB, 2014, DNA RES; Yang XY, 2012, P NATL ACAD SCI USA, V109, P3726, DOI 10.1073/pnas.1115430109; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78	83	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137088	10.1371/journal.pone.0137088	http://dx.doi.org/10.1371/journal.pone.0137088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325578	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700092
J	Afroz, T; Luo, ML; Beisel, CL				Afroz, Taliman; Luo, Michelle L.; Beisel, Chase L.			Impact of Residual Inducer on Titratable Expression Systems	PLOS ONE			English	Article							P-BAD PROMOTER; ESCHERICHIA-COLI; GENE-EXPRESSION; ARABAD PROMOTER; RIBOSWITCHES; RNAS; TRANSPORTER; PROTEIN	Inducible expression systems are widely employed for the titratable control of gene expression, yet molecules inadvertently present in the growth medium or synthesized by the host cells can alter the response profile of some of these systems. Here, we explored the quantitative impact of these residual inducers on the apparent response properties of inducible systems. Using a simple mathematical model, we found that the presence of residual inducer shrinks the apparent dynamic range and causes the apparent Hill coefficient to converge to one. We also found that activating systems were more sensitive than repressing systems to the presence of residual inducer and the response parameters were most heavily dependent on the original Hill coefficient. Experimental interrogation of common titratable systems based on an L-arabinose inducible promoter or a thiamine pyrophosphate-repressing riboswitch in Escherichia coli confirmed the predicted trends. We finally found that residual inducer had a distinct effect on "all-or-none" systems, which exhibited increased sensitivity to the added inducer until becoming fully induced. Our findings indicate that residual inducer or repressor alters the quantitative response properties of titratable systems, impacting their utility for scientific discovery and pathway engineering.	[Afroz, Taliman; Luo, Michelle L.; Beisel, Chase L.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Beisel, CL (corresponding author), N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	cbeisel@ncsu.edu	Beisel, Chase L/D-4823-2015	Beisel, Chase L/0000-0003-0650-9943	National Institutes of Health [1R56AI103557-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI103557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (1R56AI103557-01A1 to CLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz T, 2015, ACS SYNTH BIOL, V4, P141, DOI 10.1021/sb400162z; Afroz T, 2014, MOL MICROBIOL, V93, P1093, DOI 10.1111/mmi.12695; Afroz T, 2013, CHEM ENG SCI, V103, P79, DOI 10.1016/j.ces.2013.02.017; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Beisel CL, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.62; Brautaset T, 2009, MICROB BIOTECHNOL, V2, P15, DOI 10.1111/j.1751-7915.2008.00048.x; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Lakaye B, 2004, J BIOL CHEM, V279, P17142, DOI 10.1074/jbc.M313569200; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; LOBELL RB, 1990, SCIENCE, V250, P528, DOI 10.1126/science.2237403; Mandin P, 2009, MOL MICROBIOL, V72, P551, DOI 10.1111/j.1365-2958.2009.06665.x; Mizuguchi H, 2002, J GENE MED, V4, P240, DOI 10.1002/jgm.261; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Qi L, 2012, NUCLEIC ACIDS RES, V40, P5775, DOI 10.1093/nar/gks168; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Sharma V, 2008, J AM CHEM SOC, V130, P16310, DOI 10.1021/ja805203w; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Topp S, 2010, APPL ENVIRON MICROB, V76, P7881, DOI 10.1128/AEM.01537-10; VOGLER AP, 1989, J BACTERIOL, V171, P6586, DOI 10.1128/jb.171.12.6586-6592.1989; WEICKERT MJ, 1993, MOL MICROBIOL, V10, P245, DOI 10.1111/j.1365-2958.1993.tb01950.x; Wieland M, 2009, ANGEW CHEM INT EDIT, V48, P2715, DOI 10.1002/anie.200805311; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145	31	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137421	10.1371/journal.pone.0137421	http://dx.doi.org/10.1371/journal.pone.0137421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348036	Green Submitted, Green Published, gold			2022-12-27	WOS:000360897600044
J	Imohl, M; van der Linden, M				Imoehl, Matthias; van der Linden, Mark			Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013	PLOS ONE			English	Article							MACROLIDE RESISTANCE; EMM TYPES; INFECTIONS; DISEASE; PHENOTYPES	A nationwide laboratory-based surveillance study of invasive S. pyogenes infections was conducted in Germany. Invasive isolates (n = 1,281) were obtained between 2003 and 2013. All isolates were susceptible to penicillin, cefotaxime and vancomycin. Tetracycline showed the highest rate of resistant or intermediate resistant isolates with 9.8%, followed by macrolides (4.0%), trimethoprim/sulfamethoxazole (SXT) (1.9%), levofloxacin (1.3%), chloramphenicol (0.9%) and clindamycin (0.7%). The most prominent trends were the appearance of levofloxacin non-susceptible isolates since 2011, and an increase of SXT non-susceptibility since 2012.	[Imoehl, Matthias] Univ Hosp RWTH Aachen, Inst Med Microbiol, Aachen, Germany; Univ Hosp RWTH Aachen, Natl Reference Ctr Streptococci, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Imohl, M (corresponding author), Univ Hosp RWTH Aachen, Inst Med Microbiol, Aachen, Germany.	mimoehl@ukaachen.de	Imöhl, Matthias/P-5014-2014; van der Linden, Mark/B-9305-2009	Imöhl, Matthias/0000-0002-8372-0251; van der Linden, Mark/0000-0002-6574-4313	European Commission's Directorate-General for Research's Fifth Framework Programme [QLK2.CT.2002.01398]	European Commission's Directorate-General for Research's Fifth Framework Programme	This study was supported, in part, by the European Commission's Directorate-General for Research's Fifth Framework Programme (QLK2.CT.2002.01398). All other resources used were supplied by the RWTH Aachen Universitiy and the Robert Koch-Institut.	Bley C, 2011, INT J ANTIMICROB AG, V37, P425, DOI 10.1016/j.ijantimicag.2011.01.019; Bowen AC, 2012, J CLIN MICROBIOL, V50, P4067, DOI 10.1128/JCM.02195-12; BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390, DOI 10.1001/jama.1993.03500030088038; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Clinical and Laboratory Standards Institute, 2014, PERF STAND ANT SUSC; Creti R, 2007, J CLIN MICROBIOL, V45, P2249, DOI 10.1128/JCM.00513-07; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; EUCAST, 2014, BREAKP TABL INT MICS; Friaes A, 2013, INT J MED MICROBIOL, V303, P505, DOI 10.1016/j.ijmm.2013.07.004; Giovanetti E, 1999, ANTIMICROB AGENTS CH, V43, P1935, DOI 10.1128/AAC.43.8.1935; Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x; Lamagni T L, 2005, Euro Surveill, V10, P179; Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07; Martin J, 2011, EURO SURVEILL, V16; Meehan M, 2013, EUROSURVEILLANCE, P18; Meisal R, 2010, J CLIN MICROBIOL, V48, P842, DOI 10.1128/JCM.01312-09; Montes M, 2011, EUR J CLIN MICROBIOL, V30, P1295, DOI 10.1007/s10096-011-1226-x; Nir-Paz R, 2006, INT J ANTIMICROB AG, V28, P313, DOI 10.1016/j.ijantimicag.2006.07.005; Plainvert C, 2012, CLIN MICROBIOL INFEC, V18, P702, DOI 10.1111/j.1469-0691.2011.03624.x; PODBIELSKI A, 1991, MED MICROBIOL IMMUN, V180, P213; SEPPALA H, 1993, J ANTIMICROB CHEMOTH, V32, P885, DOI 10.1093/jac/32.6.885; Siljander T, 2010, EUR J CLIN MICROBIOL, V29, P1229, DOI 10.1007/s10096-010-0989-9; Silva-Costa C, 2015, EXPERT REV ANTI-INFE, V13, P615, DOI 10.1586/14787210.2015.1023292; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Szczypa K, 2006, J CLIN MICROBIOL, V44, P3975, DOI 10.1128/JCM.01163-06; Vikerfors A, 2009, SCAND J INFECT DIS, V41, P823, DOI 10.3109/00365540903179749; Weisblum B, 1998, DRUG RESIST UPDATE, V1, P29, DOI 10.1016/S1368-7646(98)80212-4; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Zakikhany K, 2011, EUROSURVEILLANCE, P16	29	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137313	10.1371/journal.pone.0137313	http://dx.doi.org/10.1371/journal.pone.0137313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340445	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200047
J	Xie, NZ; Du, QS; Li, JX; Huang, RB				Xie, Neng-Zhong; Du, Qi-Shi; Li, Jian-Xiu; Huang, Ri-Bo			Exploring Strong Interactions in Proteins with Quantum Chemistry and Examples of Their Applications in Drug Design	PLOS ONE			English	Article							CATION-PI INTERACTIONS; DENSITY-FUNCTIONAL THEORY; COUPLED-CLUSTER SINGLES; INTERACTION ENERGIES; HEPATITIS-C; VIRUS P7; BINDING; MODEL; INHIBITORS; CHANNEL	Objectives Three strong interactions between amino acid side chains (salt bridge, cation-p, and amide bridge) are studied that are stronger than (or comparable to) the common hydrogen bond interactions, and play important roles in protein-protein interactions. Methods Quantum chemical methods MP2 and CCSD(T) are used in calculations of interaction energies and structural optimizations. Results The energies of three types of amino acid side chain interactions in gaseous phase and in aqueous solutions are calculated using high level quantum chemical methods and basis sets. Typical examples of amino acid salt bridge, cation-p, and amide bridge interactions are analyzed, including the inhibitor design targeting neuraminidase (NA) enzyme of influenza A virus, and the ligand binding interactions in the HCV p7 ion channel. The inhibition mechanism of the M2 proton channel in the influenza A virus is analyzed based on strong amino acid interactions. Conclusion (1) The salt bridge interactions between acidic amino acids (Glu(-) and Asp(-)) and alkaline amino acids (Arg(+), Lys(+) and His(+)) are the strongest residue-residue interactions. However, this type of interaction may be weakened by solvation effects and broken by lower pH conditions. (2) The cation-interactions between protonated amino acids (Arg(+), Lys(+) and His(+)) and aromatic amino acids (Phe, Tyr, Trp and His) are 2.5 to 5-fold stronger than common hydrogen bond interactions and are less affected by the solvation environment. (3) The amide bridge interactions between the two amide-containing amino acids (Asn and Gln) are three times stronger than hydrogen bond interactions, which are less influenced by the pH of the solution. (4) Ten of the twenty natural amino acids are involved in salt bridge, or cation-, or amide bridge interactions that often play important roles in protein-protein, protein-peptide, protein-ligand, and protein-DNA interactions.	[Xie, Neng-Zhong; Du, Qi-Shi; Li, Jian-Xiu; Huang, Ri-Bo] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, Nanning 530007, Guangxi, Peoples R China; [Li, Jian-Xiu; Huang, Ri-Bo] Guangxi Univ, Life Sci & Biotechnol Coll, Nanning 530004, Guangxi, Peoples R China; [Du, Qi-Shi] Gordon Life Sci Inst, Belmont, MA 02478 USA	Guangxi University; Gordon Life Science Institute	Du, QS (corresponding author), Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, 98 Daling Rd, Nanning 530007, Guangxi, Peoples R China.	duqishi@foxmail.com; rbhuang@gxas.ac.cn			National Science Foundation of China (NSFC) [31370716, 31360207]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (NSFC http://www.nsfc.gov.cn/) to QSD (31370716) and the National Science Foundation of China (NSFC http://www.nsfc.gov.cn/) to RBH (31360207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amovilli C, 1998, ADV QUANTUM CHEM, V32, P227, DOI 10.1016/S0065-3276(08)60416-5; ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Barrett GC, 1998, AMINO ACIDS PEPTIDES, P48; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Charbonneau DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076675; Cheng JG, 2008, SCI CHINA SER B, V51, P768, DOI 10.1007/s11426-008-0087-3; Chu XK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002608; Cossi M, 1998, J CHEM PHYS, V109, P6246, DOI 10.1063/1.477265; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; DITCHFIELD R, 1971, J CHEM PHYS, V54, P724, DOI 10.1063/1.1674902; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Du QS, 2007, J CHEM THEORY COMPUT, V3, P1665, DOI 10.1021/ct700026d; Du QS, 2007, BIOCHEM BIOPH RES CO, V362, P525, DOI 10.1016/j.bbrc.2007.08.025; Du QS, 2012, J CHEM INF MODEL, V52, P996, DOI 10.1021/ci300066y; Du QS, 2012, J MOL GRAPH MODEL, V34, P38, DOI 10.1016/j.jmgm.2011.12.002; Du QS, 2012, J COMPUT CHEM, V33, P153, DOI 10.1002/jcc.21951; Du QS, 2006, J COMPUT CHEM, V27, P685, DOI 10.1002/jcc.20369; Du QS, 2005, J CHEM INF MODEL, V45, P347, DOI 10.1021/ci049707l; Eldar-Finkelman H, 2009, CURR PHARM DESIGN, V15, P2463, DOI 10.2174/138161209788682253; Foresman JB, 1996, J PHYS CHEM-US, V100, P16098, DOI 10.1021/jp960488j; Foster TL, 2011, HEPATOLOGY, V54, P79, DOI 10.1002/hep.24371; Gold V., 2014, COMPENDIUM CHEM TERM, V528; Gresh N, 2004, J COMPUT CHEM, V25, P823, DOI 10.1002/jcc.20012; Grunenberg J, 2004, J AM CHEM SOC, V126, P16310, DOI 10.1021/ja046282a; Gu RX, 2011, J AM CHEM SOC, V133, P10817, DOI 10.1021/ja1114198; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; Jensen F, 2007, INTRO COMPUTATIONAL, P159; Jurecka P, 2006, PHYS CHEM CHEM PHYS, V8, P1985, DOI 10.1039/b600027d; Jurecka P, 2007, J COMPUT CHEM, V28, P555, DOI 10.1002/jcc.20570; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Keskin O, 2008, CURR PHARM BIOTECHNO, V9, P67, DOI 10.2174/138920108783955191; Kober L, 2013, BIOTECHNOL BIOENG, V110, P1164, DOI 10.1002/bit.24776; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LEE TJ, 1988, CHEM PHYS LETT, V150, P406, DOI 10.1016/0009-2614(88)80427-5; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Marshall MS, 2009, J PHYS CHEM A, V113, P13438, DOI 10.1021/jp906086x; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; Mihm U, 2006, ANTIVIR THER, V11, P507; Morgado C, 2007, PHYS CHEM CHEM PHYS, V9, P448, DOI 10.1039/b615263e; Nagy PI, 2010, J PHYS CHEM B, V114, P16436, DOI 10.1021/jp103313s; Nayek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093862; Nelson D.L., 2008, PRINCIPLES BIOCH; Nissink JWM, 2002, PROTEINS, V49, P457, DOI 10.1002/prot.10232; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Pielak RM, 2011, BBA-BIOMEMBRANES, V1808, P522, DOI 10.1016/j.bbamem.2010.04.015; PURVIS GD, 1982, J CHEM PHYS, V76, P1910, DOI 10.1063/1.443164; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Roy D, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4755990; Scalmani G., 2016, GAUSSIAN 09; Scheiner S, 1997, J AM CHEM SOC, p[119, 12952]; Scheraga HA, 2007, ANNU REV PHYS CHEM, V58, P57, DOI 10.1146/annurev.physchem.58.032806.104614; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; SCUSERIA GE, 1989, J CHEM PHYS, V90, P3700, DOI 10.1063/1.455827; SCUSERIA GE, 1988, J CHEM PHYS, V89, P7382, DOI 10.1063/1.455269; Silva PJ, 2012, THEORETICAL CHEMISTR, V132, P1307; Smith BJ, 2001, PROTEIN SCI, V10, P689, DOI 10.1110/ps.41801; StGelais C, 2009, J VIROL, V83, P7970, DOI 10.1128/JVI.00521-09; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tomii K, 1996, PROTEIN ENG, V9, P27, DOI 10.1093/protein/9.1.27; van Mourik T, 2002, J CHEM PHYS, V116, P9620, DOI 10.1063/1.1476010; von Lilienfeld OA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.153004; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Wang Q, 2013, P NATL ACAD SCI USA, V110, P20545, DOI 10.1073/pnas.1312788110; Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768	73	31	31	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137113	10.1371/journal.pone.0137113	http://dx.doi.org/10.1371/journal.pone.0137113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339784	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200021
J	Itakura, Y; Kohsaka, H; Ohyama, T; Zlatic, M; Pulver, SR; Nose, A				Itakura, Yuki; Kohsaka, Hiroshi; Ohyama, Tomoko; Zlatic, Marta; Pulver, Stefan R.; Nose, Akinao			Identification of Inhibitory Premotor Interneurons Activated at a Late Phase in a Motor Cycle during Drosophila Larval Locomotion	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; SYNAPTIC-TRANSMISSION; FLUORESCENT PROTEINS; PATTERN GENERATORS; NEURAL CIRCUITS; CENTRAL NEURONS; SPINAL-CORD; BODY-WALL; GLUTAMATE; ORGANIZATION	Rhythmic motor patterns underlying many types of locomotion are thought to be produced by central pattern generators (CPGs). Our knowledge of how CPG networks generate motor patterns in complex nervous systems remains incomplete, despite decades of work in a variety of model organisms. Substrate borne locomotion in Drosophila larvae is driven by waves of muscular contraction that propagate through multiple body segments. We use the motor circuitry underlying crawling in larval Drosophila as a model to try to understand how segmentally coordinated rhythmic motor patterns are generated. Whereas muscles, motoneurons and sensory neurons have been well investigated in this system, far less is known about the identities and function of interneurons. Our recent study identified a class of glutamatergic premotor interneurons, PMSIs (period-positive median segmental interneurons), that regulate the speed of locomotion. Here, we report on the identification of a distinct class of glutamatergic premotor interneurons called Glutamatergic Ventro-Lateral Interneurons (GVLIs). We used calcium imaging to search for interneurons that show rhythmic activity and identified GVLIs as interneurons showing wave-like activity during peristalsis. Paired GVLIs were present in each abdominal segment A1-A7 and locally extended an axon towards a dorsal neuropile region, where they formed GRASP-positive putative synaptic contacts with motoneurons. The interneurons expressed vesicular glutamate transporter (vGluT) and thus likely secrete glutamate, a neurotransmitter known to inhibit motoneurons. These anatomical results suggest that GVLIs are premotor interneurons that locally inhibit motoneurons in the same segment. Consistent with this, optogenetic activation of GVLIs with the red-shifted channelrhodopsin, CsChrimson ceased ongoing peristalsis in crawling larvae. Simultaneous calcium imaging of the activity of GVLIs and motoneurons showed that GVLIs' wave-like activity lagged behind that of motoneurons by several segments. Thus, GVLIs are activated when the front of a forward motor wave reaches the second or third anterior segment. We propose that GVLIs are part of the feedback inhibition system that terminates motor activity once the front of the motor wave proceeds to anterior segments.	[Itakura, Yuki; Kohsaka, Hiroshi; Nose, Akinao] Univ Tokyo, Dept Complex Sci & Engn, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Ohyama, Tomoko; Zlatic, Marta; Pulver, Stefan R.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Nose, Akinao] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; Howard Hughes Medical Institute; University of Tokyo	Pulver, SR (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	pulvers@janelia.hhmi.org; nose@k.u-tokyo.ac.jp	Kohsaka, Hiroshi/AAT-4177-2021	Kohsaka, Hiroshi/0000-0003-1087-9680; Zlatic, Marta/0000-0002-3149-2250; Pulver, Stefan/0000-0001-5170-7522; Itakura, Yuki/0000-0001-7513-0529	MEXT/JSPS KAKENHI Grant [22115002, 221S0003, 15H04255]; Janelia Research Campus (Howard Hughes Medical Institute)	MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Janelia Research Campus (Howard Hughes Medical Institute)	This work was supported by a MEXT/JSPS KAKENHI Grant Numbers, 22115002 (to A.N.) and 221S0003 (to A.N. and Y.I.), and 15H04255 (to A.N.). The work was also supported by Janelia Research Campus (Howard Hughes Medical Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; [Anonymous], 1983, ANIMAL BEHAV, V31, P282; Berni J, 2012, CURR BIOL, V22, P1861, DOI 10.1016/j.cub.2012.07.048; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; Esengil H, 2008, MOL BIOSYST, V4, P300, DOI 10.1039/b718447f; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Gjorgjieva J, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00024; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; GRILLNER S, 1974, EXP BRAIN RES, V20, P459; Heckscher ES, 2012, J NEUROSCI, V32, P12460, DOI 10.1523/JNEUROSCI.0222-12.2012; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Iyengar BG, 2011, GENES BRAIN BEHAV, V10, P883, DOI 10.1111/j.1601-183X.2011.00729.x; Iyengar BG, 2006, J COMP NEUROL, V499, P583, DOI 10.1002/cne.21133; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kitamoto T, 2002, J NEUROGENET, V16, P205, DOI 10.1080/01677060216295; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kohsaka H, 2014, CURR BIOL, V24, P2632, DOI 10.1016/j.cub.2014.09.026; Lahiri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023180; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Landgraf M, 2003, DEV BIOL, V260, P207, DOI 10.1016/S0012-1606(03)00215-X; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li HH, 2014, CELL REP, V8, P897, DOI 10.1016/j.celrep.2014.06.065; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Liu WW, 2013, P NATL ACAD SCI USA, V110, P10294, DOI 10.1073/pnas.1220560110; MacKay-Lyons M, 2002, PHYS THER, V82, P69, DOI 10.1093/ptj/82.1.69; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marley Richard, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot065656; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nern A, 2011, P NATL ACAD SCI USA, V108, P14198, DOI 10.1073/pnas.1111704108; Nose A, 1997, DEVELOPMENT, V124, P1433; Ohyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071706; Parmentier ML, 1996, J NEUROSCI, V16, P6687; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Rohrbough J, 2002, J NEUROPHYSIOL, V88, P847, DOI 10.1152/jn.2002.88.2.847; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; Skinner FK, 1998, CURR OPIN NEUROBIOL, V8, P725, DOI 10.1016/S0959-4388(98)80114-1; Suster ML, 2002, NATURE, V416, P174, DOI 10.1038/416174a; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; WALLEN P, 1984, J PHYSIOL-LONDON, V347, P225, DOI 10.1113/jphysiol.1984.sp015063; WILSON DM, 1961, J EXP BIOL, V38, P471; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	61	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136660	10.1371/journal.pone.0136660	http://dx.doi.org/10.1371/journal.pone.0136660			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335437	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400019
J	Venkataraman, K; Tan, LSM; Bautista, DCT; Griva, K; Zuniga, YLM; Amir, M; Lee, YS; Lee, J; Tai, ES; Khoo, EYH; Wee, HL				Venkataraman, Kavita; Tan, Luor Shyuan Maudrene; Bautista, Dianne Carrol Tan; Griva, Konstadina; Zuniga, Yasmin Laura Marie; Amir, Mohamed; Lee, Yung Seng; Lee, Jeannette; Tai, E. Shyong; Khoo, Eric Yin Hao; Wee, Hwee Lin			Psychometric Properties of the Problem Areas in Diabetes (PAID) Instrument in Singapore	PLOS ONE			English	Article							EMOTIONAL DISTRESS; INTRAINDIVIDUAL CHANGES; CONTROLLED-TRIAL; SCALE; VALIDITY; VERSION; RELIABILITY	Background Emotional distress is an important dimension in diabetes, and several instruments have been developed to measure this aspect. The Problem Areas in Diabetes (PAID) scale is one such instrument which has demonstrated validity and reliability in Western populations, but its psychometric properties in Asian populations have not been examined. Methods This was a secondary analysis of data from patients with Type 2 diabetes mellitus recruited through convenience sampling from a diabetes specialist outpatient clinic in Singapore. The following psychometric properties were assessed: Construct validity through confirmatory factor analysis (CFA) and Rasch analysis, concurrent validity through correlation with related scales (Kessler Psychological Distress Scale, Diabetes Health Profile-psychological distress, Audit of Diabetes Dependent Quality of Life), reliability through assessment of internal consistency and floor and ceiling effects, and sensitivity by estimating effect sizes for known clinical and social functioning groups. Results 203 patients with mean age of 45 +/- 12 years were analysed. None of the previously published model structures achieved a good fit on CFA. On Rasch analysis, four items showed poor fit and were removed. The abridged 16-item PAID mapped to a single latent trait, with a high degree of internal consistency (Cronbach alpha 0.95), but significant floor effect (24.6% scoring at floor). Both 20-item and 16-item PAID scores were moderately correlated with scores of related scales, and sensitive to differences in clinical and social functioning groups, with large effect sizes for glycemic control and diabetes related complications, nephropathy and neuropathy. Conclusion The abridged 16-item PAID measures a single latent trait of emotional distress due to diabetes whereas the 20-item PAID appears to measures more than one latent trait. However, both the 16-item and 20-item PAID versions are valid, reliable and sensitive for use among Singaporean patients with diabetes.	[Venkataraman, Kavita; Tan, Luor Shyuan Maudrene; Lee, Jeannette; Tai, E. Shyong; Wee, Hwee Lin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Venkataraman, Kavita; Tan, Luor Shyuan Maudrene; Lee, Jeannette; Tai, E. Shyong; Wee, Hwee Lin] Natl Univ Hlth Syst, Singapore, Singapore; [Bautista, Dianne Carrol Tan] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore; [Bautista, Dianne Carrol Tan] Singapore Clin Res Inst, Singapore, Singapore; [Griva, Konstadina; Amir, Mohamed] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Zuniga, Yasmin Laura Marie; Tai, E. Shyong; Khoo, Eric Yin Hao] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Lee, Yung Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore; [Lee, Yung Seng] Natl Univ Singapore Hosp, Khoo Teck Puat Natl Univ, Childrens Med Inst, Singapore 117548, Singapore; [Lee, Yung Seng] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Wee, Hwee Lin] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Singapore Clinical Research Institute; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Khoo, EYH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore.	eric_khoo@nuhs.edu.sg; phawhl@nus.edu.sg	Lee, Yung Seng/F-2169-2014; Khoo, Eric YH/K-1146-2013; Venkataraman, Kavita/Q-8956-2019; Wee, Hwee Lin/D-4126-2012; Griva, Konstadina/A-6549-2018	Lee, Yung Seng/0000-0002-1253-0557; Venkataraman, Kavita/0000-0002-3139-6998; Wee, Hwee Lin/0000-0002-7150-1801; GRIVA, KONSTADINA/0000-0001-8173-5663; Tai, E Shyong/0000-0003-2929-8966	Ministry of Education Singapore Academic Research Fund Tier 1 [FY2011-FRC3-007]	Ministry of Education Singapore Academic Research Fund Tier 1(Ministry of Education, Singapore)	This work was supported by a grant from the Ministry of Education Singapore Academic Research Fund Tier 1 (Grant No. FY2011-FRC3-007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181; Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010; Arzaghi SM., 2011, IRAN J DIABETES LIPI, V10, P1; Boone WJ, 2014, RASCH ANAL HUMAN SCI; Cohen J.E., 1988, STAT POWER ANAL BEHA; Department of Statistics S, 2013, KEY HOUS INC TRENDS; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Fayers P., 2007, QUALITY LIFE ASSESSM; Graue M, 2012, INT J NURS STUD, V49, P174, DOI 10.1016/j.ijnurstu.2011.08.007; Gross CC, 2007, DIABETES RES CLIN PR, V76, P455, DOI 10.1016/j.diabres.2006.09.022; Hermanns N, 2006, DIABETOLOGIA, V49, P469, DOI 10.1007/s00125-005-0094-2; Huang MF, 2010, DIABETES CARE, V33, P38, DOI 10.2337/dc09-0768; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lam CLK, 2005, QUAL LIFE RES, V14, P539, DOI 10.1007/s11136-004-0704-3; M OH, 2011, NAT HLTH SURV 2010 S; Meadows K, 1996, QUAL LIFE RES, V5, P242, DOI 10.1007/BF00434746; Miller ST, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-70; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Phan TP, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000012; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Sigurdardottir AK, 2008, INT J NURS STUD, V45, P526, DOI 10.1016/j.ijnurstu.2006.10.008; Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305; Statistics Do, 2011, CENS POP 2010 STAT R; Vileikyte L, 2004, DIABETES-METAB RES, V20, pS13, DOI 10.1002/dmrr.437; Wee HL, 2006, PHARMACOECONOMICS, V24, P673, DOI 10.2165/00019053-200624070-00006; Welch G, 2003, DIABETIC MED, V20, P69, DOI 10.1046/j.1464-5491.2003.00832.x; Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760; Wyrwich KW, 1999, MED CARE, V37, P469, DOI 10.1097/00005650-199905000-00006; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2	30	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136759	10.1371/journal.pone.0136759	http://dx.doi.org/10.1371/journal.pone.0136759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ5AJ	26336088	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400025
J	Cracco, E; Van Durme, K; Braet, C				Cracco, Emiel; Van Durme, Kim; Braet, Caroline			Validation of the FEEL-KJ: An Instrument to Measure Emotion Regulation Strategies in Children and Adolescents	PLOS ONE			English	Article							PSYCHOPATHOLOGY; QUESTIONNAIRE	Although the field of emotion regulation in children and adolescents is growing, there is need for age-adjusted measures that assess a large variety of strategies. An interesting instrument in this respect is the FEEL-KJ because it measures 7 adaptive and 5 maladaptive emotion regulation strategies in response to three different emotions. However, the FEEL-KJ has not yet been validated extensively. Therefore, the current study aims to test the internal structure and validity of the FEEL-KJ in a large sample of Dutch-speaking Belgian children and adolescents (N = 1102, 8-18 years old). The investigation of the internal structure confirms earlier reports of a two-factor structure with Adaptive and Maladaptive Emotion Regulation as overarching categories. However, it also suggests that the two-factor model is more complex than what was previously assumed. The evaluation of the FEEL-KJ validity furthermore provides evidence for its construct and external validity. In sum, the current study confirms that the FEEL-KJ is a valuable and reliable measure of emotion regulation strategies in children and adolescents.	[Cracco, Emiel] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Van Durme, Kim; Braet, Caroline] Univ Ghent, Dept Dev Personal & Social Psychol, B-9000 Ghent, Belgium	Ghent University; Ghent University	Cracco, E (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	emiel.cracco@ugent.be		Braet, Caroline/0000-0003-2458-287X; Cracco, Emiel/0000-0003-4043-5992	Research Foundation Flanders Grant [FWO14/ASP/050]; Ghent University Special Research Funds [B/11527/02-BOF10/DOC/392]	Research Foundation Flanders Grant; Ghent University Special Research Funds	This research was supported by the Research Foundation Flanders Grant FWO14/ASP/050 awarded to the first author and by the Ghent University Special Research Funds Grant B/11527/02-BOF10/DOC/392 awarded to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela JRZ, 2002, J ABNORM CHILD PSYCH, V30, P515, DOI 10.1023/A:1019873015594; Achenbach T. M, 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Aldao A, 2010, BEHAV RES THER, V48, P974, DOI 10.1016/j.brat.2010.06.002; Barrett K. C., 1987, HDB INFANT DEV, P555, DOI DOI 10.1177/0272431613483005; Billings A G, 1981, J Behav Med, V4, P139, DOI 10.1007/BF00844267; Braet C, 2014, COGNITIVE THER RES, V38, P493, DOI 10.1007/s10608-014-9616-x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Czaja J, 2009, INT J EAT DISORDER, V42, P356, DOI 10.1002/eat.20630; de Boo GM, 2009, COGNITIVE THER RES, V33, P1, DOI 10.1007/s10608-007-9135-0; Eschenbeck H, 2012, EUR J PSYCHOL ASSESS, V28, P32, DOI 10.1027/1015-5759/a000088; FOLKMAN S, 1988, J PERS SOC PSYCHOL, V54, P466, DOI 10.1037/0022-3514.54.3.466; Frijda N.H., 1986, EMOTIONS; Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6; Garnefski N, 2007, EUR CHILD ADOLES PSY, V16, P1, DOI 10.1007/s00787-006-0562-3; Garner D.M., 1991, EATING DISORDER INVE; Grob A., 2005, FRAGEBOGEN ERHEBUNG; Gross J. J., 2006, EMOTION REGULATION C, P13, DOI [10.1037/11468-001, DOI 10.1037/11468-001]; Gross J.J., 2014, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Gullone E, 2012, PSYCHOL ASSESSMENT, V24, P409, DOI 10.1037/a0025777; Hannesdottir DK, 2007, CLIN CHILD FAM PSYCH, V10, P275, DOI 10.1007/s10567-007-0024-6; Harter S, 1988, SELF PERCEPTIO UNPUB; Hayduk L. A., 1987, STRUCTURAL EQUATION; Hollingshead A. B., 1975, 4 FACTOR INDEX UNPUB; Kim J, 2010, J CHILD PSYCHOL PSYC, V51, P706, DOI 10.1111/j.1469-7610.2009.02202.x; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Kovacs M, 2008, CHILD DEV PERSPECT, V2, P149, DOI 10.1111/j.1750-8606.2008.00057.x; Neumann A, 2010, ASSESSMENT, V17, P138, DOI 10.1177/1073191109349579; Offord DR, 1996, J AM ACAD CHILD PSY, V35, P1078, DOI 10.1097/00004583-199608000-00019; R Core Team, 2021, R LANGUAGE ENV STAT; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Saarni C., 2006, HDB CHILD PSYCHOL SO, P226, DOI 10.1002/9780470147658.chpsy0305; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Shaver Phillip R, 2002, Attach Hum Dev, V4, P133, DOI 10.1080/14616730210154171; Smolak Linda, 2004, Body Image, V1, P15, DOI 10.1016/S1740-1445(03)00008-1; Southam-Gerow MA, 2002, CLIN PSYCHOL REV, V22, P189, DOI 10.1016/S0272-7358(01)00087-3; Thompson R A, 1994, Monogr Soc Res Child Dev, V59, P25, DOI 10.2307/1166137; Williamson D. A., 1995, HDB ASSESSMENT METHO, P347; Zeman J, 2002, J CLIN CHILD ADOLESC, V31, P393, DOI 10.1207/153744202760082658; Zeman J, 2001, J NONVERBAL BEHAV, V25, P187, DOI 10.1023/A:1010623226626; Zeman J, 1996, DEV PSYCHOL, V32, P842, DOI 10.1037/0012-1649.32.5.842; Zeman J, 2006, J DEV BEHAV PEDIATR, V27, P155, DOI 10.1097/00004703-200604000-00014	46	43	43	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137080	10.1371/journal.pone.0137080	http://dx.doi.org/10.1371/journal.pone.0137080			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331845	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800094
J	Hakimzadeh, N; Nossent, AY; van der Laan, AM; Schirmer, SH; de Ronde, MWJ; Pinto-Sietsma, SJ; van Royen, N; Quax, PHA; Hoefer, IE; Piek, JJ				Hakimzadeh, Nazanin; Nossent, A. Yael; van der Laan, Anja M.; Schirmer, Stephan H.; de Ronde, Maurice W. J.; Pinto-Sietsma, Sara-Joan; van Royen, Niels; Quax, Paul H. A.; Hoefer, Imo E.; Piek, Jan J.			Circulating MicroRNAs Characterizing Patients with Insufficient Coronary Collateral Artery Function	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; NEUROTROPHIC FACTOR; VASCULAR INTEGRITY; HEART-FAILURE; BLOOD-FLOW; ARTERIOGENESIS; EXPRESSION; DISEASE; PROLIFERATION; ANGIOGENESIS	Background Coronary collateral arteries function as natural bypasses in the event of coronary obstruction. The degree of collateral network development significantly impacts the outcome of patients after an acute myocardial infarction (AMI). MicroRNAs (miRNAs, miRs) have arisen as biomarkers to identify heterogeneous patients, as well as new therapeutic targets in cardiovascular disease. We sought to identify miRNAs that are differentially expressed in chronic total occlusion (CTO) patients with well or poorly developed collateral arteries. Methods and Results Forty-one CTO patients undergoing coronary angiography and invasive assessment of their coronary collateralization were dichotomized based on their collateral flow index (CFI). After miRNA profiling was conducted on aortic plasma, four miRNAs were selected for validation by real-time quantitative reverse transcription polymerase chain reaction in patients with low (CFI<0.39) and high (CFI>0.39) collateral artery capacity. We confirmed significantly elevated levels of miR423-5p (p<0.05), miR10b (p<0.05), miR30d (p<0.05) and miR126 (p<0.001) in patients with insufficient collateral network development. We further demonstrated that each of these miRNAs could serve as circulating biomarkers to discriminate patients with low collateral capacity (p<0.01 for each miRNA). We also determined significantly greater expression of miR30d (p<0.05) and miR126 (p<0.001) in CTO patients relative to healthy controls. Conclusion The present study identifies differentially expressed miRNAs in patients with high versus low coronary collateral capacity. We have shown that these miRNAs can function as circulating biomarkers to discriminate between patients with insufficient or sufficient collateralization. This is the first study to identify miRNAs linked to coronary collateral vessel function in humans.	[Hakimzadeh, Nazanin] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Nossent, A. Yael; Quax, Paul H. A.] Univ Med Ctr, Dept Surg, Leiden, Netherlands; [Nossent, A. Yael; Quax, Paul H. A.] Univ Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [van der Laan, Anja M.; Piek, Jan J.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Schirmer, Stephan H.] Univ Saarland, Dept Cardiol, Klin Innere Med 3, Homburg, Germany; [de Ronde, Maurice W. J.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [van Royen, Niels] Vrije Univ Amsterdam Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Hoefer, Imo E.] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Saarland University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center	Piek, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.piek@amc.uva.nl	van Royen, Niels/Q-1097-2017; SJ, Pinto-Sietsma/AAI-3207-2021; Quax, Paul/ABD-5294-2020; Quax, Paul/W-8520-2019	Quax, Paul/0000-0002-6853-5760; Nossent, Anne Yael/0000-0002-2155-4286	CTMM, Center for Translational Molecular Medicine, project EMINENCE [01C-204]; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Heart foundation and Netherlands Organization for Scientific Research [Veni 916.12.041]; Biomedical Materials institute [P1.03 PENT]	CTMM, Center for Translational Molecular Medicine, project EMINENCE; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Dutch Heart foundation and Netherlands Organization for Scientific Research; Biomedical Materials institute	This work was performed within the framework of CTMM, Center for Translational Molecular Medicine (www.ctmm.nl), project EMINENCE (grant 01C-204). This research also forms part of the Project P1.03 PENT of the research program of the Biomedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. Financial contributions of the Dutch Heart foundation and Netherlands Organization for Scientific Research (AYN: Veni 916.12.041) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Condorelli G, 2014, J AM COLL CARDIOL, V63, P2177, DOI 10.1016/j.jacc.2014.01.050; Dimmeler S, 2013, EMBO MOL MED, V5, P180, DOI 10.1002/emmm.201201986; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; Elsman P, 2004, EUR HEART J, V25, P854, DOI 10.1016/j.ehj.2004.03.005; Epstein SE, 2012, CIRCULATION, V125, P3211, DOI 10.1161/CIRCULATIONAHA.111.079038; Faber JE, 2014, ARTERIOSCL THROM VAS, V34, P1854, DOI 10.1161/ATVBAHA.114.303929; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Goldraich LA, 2014, BIOMARKERS, V19, P135, DOI 10.3109/1354750X.2013.870605; Hakimzadeh N, 2013, NETH HEART J, V21, P144, DOI 10.1007/s12471-013-0376-0; Hakimzadeh N, 2013, CURR CARDIOL REV; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jiang H, 2011, BIOCHEM BIOPH RES CO, V415, P99, DOI 10.1016/j.bbrc.2011.10.020; Kocaman SA, 2008, ATHEROSCLEROSIS, V197, P753, DOI 10.1016/j.atherosclerosis.2007.07.010; Koh W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S6; KOLIBASH AJ, 1982, AM J CARDIOL, V50, P230; Kurotobi T, 2004, J AM COLL CARDIOL, V44, P28, DOI 10.1016/j.jacc.2003.11.066; Li X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.430; Meier P, 2007, CIRCULATION, V116, P975, DOI 10.1161/CIRCULATIONAHA.107.703959; Nazari-Jahantigh M, 2012, THROMB HAEMOSTASIS, V107, P611, DOI 10.1160/TH11-12-0826; PIJLS NHJ, 1995, J AM COLL CARDIOL, V25, P1522, DOI 10.1016/0735-1097(95)00111-G; Raffort J, 2015, DIABETOLOGIA; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Schirmer SH, 2008, CIRC RES, V102, P1286, DOI 10.1161/CIRCRESAHA.108.171827; Schirmer SH, 2010, J BIOL CHEM, V285, P34677, DOI 10.1074/jbc.M110.164350; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; van der Hoeven NW, 2013, HEART, V99, P1100, DOI 10.1136/heartjnl-2013-304006; van der Laan AM, 2012, EUR HEART J, V33, P1076, DOI 10.1093/eurheartj/ehr220; van Solingen C, 2013, CURR VASC PHARM; van Solingen C, 2009, J CELL MOL MED, V13, P1577, DOI 10.1111/j.1582-4934.2008.00613.x; Varendi K, 2014, CELL MOL LIFE SCI; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Welten SMJ, 2014, CIRC RES, V115, P696, DOI 10.1161/CIRCRESAHA.114.304747	34	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137035	10.1371/journal.pone.0137035	http://dx.doi.org/10.1371/journal.pone.0137035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331273	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800090
J	Nazareth, TM; Machado, G				Nazareth, Tais M.; Machado, Glauco			Egg Production Constrains Chemical Defenses in a Neotropical Arachnid	PLOS ONE			English	Article							TRADE-OFFS; ECOLOGICAL IMMUNOLOGY; EVOLUTIONARY ECOLOGY; PHASMID INSECT; REPRODUCTION; COSTS; HARVESTMAN; OPILIONES; PREDATION; SIZE	Female investment in large eggs increases the demand for fatty acids, which are allocated for yolk production. Since the biosynthetic pathway leading to fatty acids uses the same precursors used in the formation of polyketides, allocation trade-offs are expected to emerge. Therefore, egg production should constrain the investment in chemical defenses based on polyketides, such as benzoquinones. We tested this hypothesis using the harvestman Acutiosoma longipes, which produces large eggs and releases benzoquinones as chemical defense. We predicted that the amount of secretion released by ovigerous females (OFs) would be smaller than that of non-ovigerous females (NOF). We also conducted a series of bioassays in the field and in the laboratory to test whether egg production renders OFs more vulnerable to predation. OFs produce less secretion than NOFs, which is congruent with the hypothesis that egg production constrains the investment in chemical defenses. Results of the bioassays show that the secretion released by OFs is less effective in deterring potential predators (ants and spiders) than the secretion released by NOFs. In conclusion, females allocate resources to chemical defenses in a way that preserves a primary biological function related to reproduction. However, the trade-off between egg and secretion production makes OFs vulnerable to predators. We suggest that egg production is a critical moment in the life of harvestman females, representing perhaps the highest cost of reproduction in the group.	[Nazareth, Tais M.] Univ Sao Paulo, Programa Posgrad Ecol, Dept Ecol, Inst Biociencias, BR-05508900 Sao Paulo, SP, Brazil; [Machado, Glauco] Univ Sao Paulo, LAGE, Dept Ecol, Inst Biociencias, BR-05508900 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Machado, G (corresponding author), Univ Sao Paulo, LAGE, Dept Ecol, Inst Biociencias, Rua Matao,Trav 14,321, BR-05508900 Sao Paulo, SP, Brazil.	glaucom@ib.usp.br	Machado, Glauco/D-6983-2012		Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [11/50800-8, 99/05446-8, 02/00381-0, 12/50229-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors were supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (TMN: 11/50800-8; GM: 99/05446-8; 02/00381-0; 12/50229-1) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	[Anonymous], 1981, CHEM DEFENSES ARTHRO; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; BERENBAUM MR, 1995, P NATL ACAD SCI USA, V92, P2, DOI 10.1073/pnas.92.1.2; BOWNES M, 1986, ANNU REV ENTOMOL, V31, P507, DOI 10.1146/annurev.en.31.010186.002451; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Buzatto BA, 2007, J ANIM ECOL, V76, P937, DOI 10.1111/j.1365-2656.2007.01273.x; Buzatto BA, 2011, EVOL ECOL, V25, P331, DOI 10.1007/s10682-010-9431-0; Cox RM, 2010, FUNCT ECOL, V24, P1262, DOI 10.1111/j.1365-2435.2010.01756.x; Dziminski MA, 2009, FUNCT ECOL, V23, P164, DOI 10.1111/j.1365-2435.2008.01480.x; Eisner T, 1997, J EXP BIOL, V200, P2493; Eisner T., 2005, SECRET WEAPONS DEFEN; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; French SS, 2007, FUNCT ECOL, V21, P1115, DOI 10.1111/j.1365-2435.2007.01311.x; French SS, 2009, INTEGR COMP BIOL, V49, P246, DOI 10.1093/icb/icp032; Gilbert JDJ, 2010, AM NAT, V176, P212, DOI 10.1086/653661; Gnaspini P, 1996, J ZOOL, V239, P417, DOI 10.1111/j.1469-7998.1996.tb05933.x; Gnaspini Pedro, 2007, P455; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; HARVELL CD, 1986, AM NAT, V128, P810, DOI 10.1086/284607; Helfman G.S., 1990, Advances in the Study of Behavior, V19, P249, DOI 10.1016/S0065-3454(08)60205-3; Higginson AD, 2011, J ANIM ECOL, V80, P384, DOI 10.1111/j.1365-2656.2010.01786.x; HILL CS, 1985, J CHEM ECOL, V11, P1083, DOI 10.1007/BF01020677; Ivanisevic J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028059; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Kreiter N, 1996, J ARACHNOL, V24, P24; Kreiter NA, 2001, OECOLOGIA, V127, P417, DOI 10.1007/s004420000607; Machado G, 2000, J NAT HIST, V34, P587, DOI 10.1080/002229300299453; Machado G, 2005, J CHEM ECOL, V31, P2519, DOI 10.1007/s10886-005-7611-0; Machado G, 1998, J ZOOL, V246, P359, DOI 10.1111/j.1469-7998.1998.tb00166.x; Machado Glauco, 2007, P414; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MCCAULEY DE, 1986, AM NAT, V127, P112, DOI 10.1086/284472; MEINWALD J, 1966, SCIENCE, V151, P79, DOI 10.1126/science.151.3706.79; Moreno-Garcia M, 2013, B ENTOMOL RES, V103, P127, DOI 10.1017/S000748531200048X; Morgan ED, 2004, BIOSYNTHESIS INSECTS; Morrongiello JR, 2012, J ANIM ECOL, V81, P806, DOI 10.1111/j.1365-2656.2012.01961.x; Neilson EH, 2013, TRENDS PLANT SCI, V18, P250, DOI 10.1016/j.tplants.2013.01.001; Pankewitz F, 2008, BIOL REV, V83, P209, DOI 10.1111/j.1469-185X.2008.00040.x; Polis GA, 1998, ECOLOGY, V79, P2560, DOI 10.1890/0012-9658(1998)079[2560:PAAMCO]2.0.CO;2; Bascunan-Garcia AP, 2010, J INSECT PHYSIOL, V56, P204, DOI 10.1016/j.jinsphys.2009.10.005; Requena GS, 2015, OIKOS, V124, P372, DOI 10.1111/oik.01641; Requena GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046701; Rocha DFO, 2013, MOLECULES, V18, P11429, DOI 10.3390/molecules180911429; Roff Derek, 2002, pi; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Smiseth PT, 2012, EVOLUTION OF PARENTAL CARE, P1; Stahlschmidt ZR, 2013, FUNCT ECOL, V27, P800, DOI 10.1111/1365-2435.12071; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Stearns S.C., 1992, pi; Tomaino-Gomes GA, 2008, THESIS U ESTADUAL CA; Trougakos LP, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P3; Williams TD, 2005, BIOSCIENCE, V55, P39, DOI 10.1641/0006-3568(2005)055[0039:MUTCOE]2.0.CO;2; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x	53	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134908	10.1371/journal.pone.0134908	http://dx.doi.org/10.1371/journal.pone.0134908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331946	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800015
J	Sevane, N; Canon, J; Gil, I; Dunner, S				Sevane, Natalia; Canon, Javier; Gil, Ignacio; Dunner, Susana			Transcriptomic Characterization of Innate and Acquired Immune Responses in Red-Legged Partridges (Alectoris rufa): A Resource for Immunoecology and Robustness Selection	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISEASE RESISTANCE; ANTIBODY-RESPONSE; VIRUS; MODEL; WILD; DIFFERENTIATION; RESPONSIVENESS; ORGANIZATION; EXPRESSION	Present and future challenges for wild partridge populations include the resistance against possible disease transmission after restocking with captive-reared individuals, and the need to cope with the stress prompted by new dynamic and challenging scenarios. Selection of individuals with the best immune ability may be a good strategy to improve general immunity, and hence adaptation to stress. In this study, non-infectious challenges with phytohemagglutinin (PHA) and sheep red blood cells allowed the classification of red-legged partridges (Alectoris rufa) according to their overall immune responses (IR). Skin from the area of injection of PHA and spleen, both from animals showing extreme high and low IR, were selected to investigate the transcriptional profiles underlying the different ability to cope with pathogens and external aggressions. RNA-seq yielded 97 million raw reads from eight sequencing libraries and approximately 84% of the processed reads were mapped to the reference chicken genome. Differential expression analysis identified 1488 up- and 107 down-regulated loci in individuals with high IR versus low IR. Partridges displaying higher innate IR show an enhanced activation of host defence gene pathways complemented with a tightly controlled desensitization that facilitates the return to cellular homeostasis. These findings indicate that the immune system ability to respond to aggressions (either diseases or stress produced by environmental changes) involves extensive transcriptional and post-transcriptional regulations, and expand our understanding on the molecular mechanisms of the avian immune system, opening the possibility of improving disease resistance or robustness using genome assisted selection (GAS) approaches for increased IR in partridges by using genes such as AVN or BF2 as markers. This study provides the first transcriptome sequencing data of the Alectoris genus, a resource for molecular ecology that enables integration of genomic tools in further studies.	[Sevane, Natalia; Canon, Javier; Gil, Ignacio; Dunner, Susana] Univ Complutense, Fac Vet, Dept Prod Anim, E-28040 Madrid, Spain	Complutense University of Madrid	Sevane, N (corresponding author), Univ Complutense, Fac Vet, Dept Prod Anim, E-28040 Madrid, Spain.	nsevane@ucm.es	Cañón, Javier/M-5704-2018; Sevane, Natalia/R-1920-2018; Dunner, Susana/H-3124-2015	Cañón, Javier/0000-0003-1137-0958; Sevane, Natalia/0000-0003-4766-6291; 	Centre for Industrial Technological Development (CDTI) [IDI-2011-0754]; European Social Fund [PTQ-11-04753]	Centre for Industrial Technological Development (CDTI); European Social Fund(European Social Fund (ESF))	This project was founded by the Centre for Industrial Technological Development (CDTI) (IDI-2011-0754). NS is recipient of an INNCORPORA-Torres Quevedo contract (PTQ-11-04753) funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaansen-Tennekes R, 2009, POULTRY SCI, V88, P1879, DOI 10.3382/ps.2009-00150; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2009417 SEC EUR COMM; Apostolova MD, 2002, J BIOL CHEM, V277, P34471, DOI 10.1074/jbc.M205827200; BirdLife International. Alectoris rufa, AL RUF IUCN RED LIST; Biscarini F, 2010, ANIM GENET, V41, P26, DOI 10.1111/j.1365-2052.2009.01960.x; Bonneaud C, 2011, P NATL ACAD SCI USA, V108, P7899, DOI 10.1073/pnas.1018580108; Bovenhuis H, 2002, POULTRY SCI, V81, P309, DOI 10.1093/ps/81.3.309; Brodeur JF, 2009, J IMMUNOL, V182, P4844, DOI 10.4049/jimmunol.0803679; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Chazara O, 2011, MOL IMMUNOL, V48, P1263, DOI 10.1016/j.molimm.2011.03.009; Cogliani C, 2011, MICROBE, V6, P274, DOI DOI 10.1128/MICROBE.6.274.1; Cotter PF, 2005, POULTRY SCI, V84, P220, DOI 10.1093/ps/84.2.220; D'Souza SJA, 2002, J BIOL CHEM, V277, P10626, DOI 10.1074/jbc.M111956200; Davison F, 2008, AVIAN IMMUNOLOGY, P1; Fang ZH, 2006, HISTOL HISTOPATHOL, V21, P403, DOI 10.14670/HH-21.403; Garaud S, 2008, J IMMUNOL, V181, P2010, DOI 10.4049/jimmunol.181.3.2010; Goff L.A., 2012, R PACKAGE VERSION 2; Grasman KA, 2010, METHODS MOL BIOL, V598, P387, DOI 10.1007/978-1-60761-401-2_25; Haertel E, 2014, SEMIN IMMUNOL, V26, P321, DOI 10.1016/j.smim.2014.01.005; Hangalapura BN, 2004, POULTRY SCI, V83, P765, DOI 10.1093/ps/83.5.765; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaiser P, 2008, DEV BIOLOGICALS, V132, P57, DOI 10.1159/000317144; Kaiser P, 2010, AVIAN PATHOL, V39, P309, DOI 10.1080/03079457.2010.508777; Kaufman J, 2008, AVIAN IMMUNOLOGY, P159, DOI 10.1016/B978-012370634-8.50011-1; Kaufman J, 2013, MOL IMMUNOL, V55, P159, DOI 10.1016/j.molimm.2012.10.030; Keestra AM, 2010, J IMMUNOL, V185, P460, DOI 10.4049/jimmunol.0901921; Kondo T, 2012, BIOCHEM BIOPH RES CO, V422, P501, DOI 10.1016/j.bbrc.2012.05.028; KUNNAS TA, 1992, ENDOCRINOLOGY, V130, P3421, DOI 10.1210/en.130.6.3421; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lei W, 2014, J THORAC DIS, V6, P979, DOI 10.3978/j.issn.2072-1439.2014.06.34; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Libri V, 2008, J IMMUNOL, V181, P5847, DOI 10.4049/jimmunol.181.9.5847; Lu JV, 2014, SEMIN CELL DEV BIOL, V35, P33, DOI 10.1016/j.semcdb.2014.07.003; Luo CL, 2014, INFECT GENET EVOL, V21, P351, DOI 10.1016/j.meegid.2013.12.004; Luo J, 2014, POULTRY SCI, V93, P848, DOI 10.3382/ps.2013-03624; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; Meitern R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-533; Millan J, 2004, J WILDLIFE MANAGE, V68, P701, DOI 10.2193/0022-541X(2004)068[0701:ACOTHF]2.0.CO;2; Millan J., 2009, Wildlife Biology in Practice, V5, P70; Ontiveros D, 2000, BIOL CONSERV, V93, P19, DOI 10.1016/S0006-3207(99)00117-2; Owen JP, 2008, IMMUNOGENETICS, V60, P621, DOI 10.1007/s00251-008-0314-2; Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; RANE SG, 1994, ONCOGENE, V9, P2415; *SAS I INC, 2009, STAT AN SAS STAT SOF; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sild E, 2011, BRAIN BEHAV IMMUN, V25, P1349, DOI 10.1016/j.bbi.2011.03.020; Smith J, 2015, J VIROL, V89, P2469, DOI 10.1128/JVI.02828-14; Starnes T, 2006, EXP HEMATOL, V34, P1101, DOI 10.1016/j.exphem.2006.05.015; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Strbo N, 2014, ADV WOUND CARE, V3, P492, DOI 10.1089/wound.2012.0435; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Traver D, 2003, ADV IMMUNOL, V81, P253; Villanua D, 2007, J HELMINTHOL, V81, P101, DOI 10.1017/S0022149X07251211; Villanua D, 2008, EUR J WILDLIFE RES, V54, P199, DOI 10.1007/s10344-007-0130-2; Walker BA, 2011, P NATL ACAD SCI USA, V108, P8396, DOI 10.1073/pnas.1019496108; Wang WH, 2015, J APPL GENET, V56, P365, DOI 10.1007/s13353-014-0269-y; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Webster LMI, 2011, MOL ECOL, V20, P920, DOI 10.1111/j.1365-294X.2010.04906.x; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wolf M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00213	69	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136776	10.1371/journal.pone.0136776	http://dx.doi.org/10.1371/journal.pone.0136776			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331304	gold, Green Published			2022-12-27	WOS:000360613800070
J	Bischof, J; Muller, S; Borufka, L; Asghari, F; Moller, S; Holzhuter, SA; Nizze, H; Ibrahim, SM; Jaster, R				Bischof, Julia; Mueller, Sarah; Borufka, Luise; Asghari, Farahnaz; Moeller, Steffen; Holzhueter, Stephanie-Anna; Nizze, Horst; Ibrahim, Saleh M.; Jaster, Robert			Quantitative Trait Locus Analysis Implicates CD4(+)/CD44(high) Memory T Cells in the Pathogenesis of Murine Autoimmune Pancreatitis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DIAGNOSTIC-CRITERIA; JAPANESE POPULATION; MRL/MP-MOUSE; SUSCEPTIBILITY; INFLAMMATION; RISK; GENE; IDENTIFICATION; POLYMORPHISMS	The mouse strain MRL/MpJ is prone to spontaneously develop autoimmune pancreatitis (AIP). To elucidate the genetic control towards the development of the phenotype and to characterize contributions of immunocompetent cell types, MRL/MpJ mice were interbred with three additional strains (BXD2/TYJ, NZM2410/J, CAST/EIJ) for four generations in an advanced intercross line. Cellular phenotypes were determined by flow cytometric quantification of splenic leukocytes and complemented by the histopathological evaluation of pancreatic lesions. An Illumina SNP array was used for genotyping. QTL analyses were performed with the R implementation of HAPPY. Out of 41 leukocyte subpopulations (B cells, T cells and dendritic cells), only three were significantly associated with AIP: While CD4(+)/CD44(high) memory T cells and CD4(+)/CD69(+) T helper (Th) cells correlated positively with the disease, the cytotoxic T cell phenotype CD8(+)/CD44(low) showed a negative correlation. A QTL for AIP on chromosome 2 overlapped with QTLs for CD4(+)/CD44(high) and CD8(+)/CD44(high) memory T cells, FoxP3(+)/CD4(+) and FoxP3(+)/CD8(+) regulatory T cells (Tregs), and CD8(+)/CD69(+) cytotoxic T cells. On chromosome 6, overlapping QTLs for AIP and CD4(+)/IL17(+) Th17 cells and again FoxP3(+)/CD8(+) Tregs were observed. In conclusion, CD4(+)/CD44(high) memory T cells are the only leukocyte subtype that could be linked to AIP both by correlation studies and from observed overlapping QTL. The potential role of this cell type in the pathogenesis of AIP warrants further investigations.	[Bischof, Julia; Asghari, Farahnaz; Moeller, Steffen; Ibrahim, Saleh M.] Med Univ Lubeck, Dept Dermatol, D-23562 Lubeck, Germany; [Mueller, Sarah; Borufka, Luise; Asghari, Farahnaz; Jaster, Robert] Univ Rostock, Med Ctr, Div Gastroenterol, Dept Med 2, D-18057 Rostock, Germany; [Holzhueter, Stephanie-Anna; Nizze, Horst] Univ Rostock, Med Ctr, Inst Pathol, D-18057 Rostock, Germany	University of Lubeck; University of Rostock; University of Rostock	Jaster, R (corresponding author), Univ Rostock, Med Ctr, Div Gastroenterol, Dept Med 2, E Heydemann Str 6, D-18057 Rostock, Germany.	jaster@med.uni-rostock.de	Möller, Steffen/B-5368-2013; Ibrahim, Saleh/AAO-9541-2020	Möller, Steffen/0000-0002-7187-4683; Ibrahim, Saleh/0000-0001-7827-2290; Bischof, Julia/0000-0002-6672-6571; Asghari, Farahnaz/0000-0003-3847-5514	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany [DFG EXC306/1, IB 24/9-1, JA 819/5-1]	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de/en/index.jsp), 53170 Bonn, Germany; grants DFG EXC306/1 and IB 24/9-1 to Saleh Ibrahim and JA 819/5-1 to Robert Jaster. The funder had no role in study design, data collection, analysis and interpretation, decision to publish, and preparation of the manuscript.	Aparisi L, 2005, GUT, V54, P703, DOI 10.1136/gut.2004.047142; Asghari F, 2011, J MED GENET, V48, P557, DOI 10.1136/jmg.2011.089730; Bang SY, 2010, ARTHRITIS RHEUM-US, V62, P369, DOI 10.1002/art.27272; Chang MC, 2007, CLIN CHEM, V53, P1700, DOI 10.1373/clinchem.2007.085951; Chang MC, 2014, J GASTROEN HEPATOL, V29, P2038, DOI 10.1111/jgh.12649; Devarajan P, 2013, IMMUNOL RES, V57, P12, DOI 10.1007/s12026-013-8448-1; Emmrich J, 2012, CURR PHARM DESIGN, V18, P4542, DOI 10.2174/138161212802502134; Fitzner B, 2009, PANCREATOLOGY, V9, P233, DOI 10.1159/000199434; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hart PA, 2015, GASTROENTEROLOGY, V149, P39, DOI 10.1053/j.gastro.2015.03.010; Hart PA, 2013, GUT, V62, P1607, DOI 10.1136/gutjnl-2012-302886; KANNO H, 1992, CLIN EXP IMMUNOL, V89, P68; Kawa S, 2002, GASTROENTEROLOGY, V122, P1264, DOI 10.1053/gast.2002.33022; Kawakami N, 2005, J IMMUNOL, V175, P69, DOI 10.4049/jimmunol.175.1.69; Kloppel G, 2010, J GASTROENTEROL, V45, P787, DOI 10.1007/s00535-010-0265-x; Lohr JM, 2010, AM J GASTROENTEROL, V105, P2060, DOI 10.1038/ajg.2010.141; Ludwig RJ, 2012, J INVEST DERMATOL, V132, P1409, DOI 10.1038/jid.2011.466; Miyoshi H, 2008, PANCREAS, V36, P133, DOI 10.1097/MPA.0b013e3181577553; Moller S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S5; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; Okada Y, 2014, LUPUS, V23, P1112, DOI 10.1177/0961203314536249; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Ota M, 2011, DIS MARKERS, V31, P223, DOI [10.3233/DMA-2011-0820, 10.1155/2011/264747]; Park DH, 2008, GASTROENTEROLOGY, V134, P440, DOI 10.1053/j.gastro.2007.11.023; Ranea LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075611; Sattler A, 2009, BLOOD, V113, P1948, DOI 10.1182/blood-2008-02-139147; Schwaiger T, 2014, GUT, V63, P494, DOI 10.1136/gutjnl-2012-303635; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Sorg H, 2008, AM J PHYSIOL-GASTR L, V295, pG1274, DOI 10.1152/ajpgi.90341.2008; Umemura T, 2006, GUT, V55, P1367, DOI 10.1136/gut.2006.095059; Umemura T, 2008, AM J GASTROENTEROL, V103, P588, DOI 10.1111/j.1572-0241.2007.01750.x; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Yamamoto M, 2005, RHEUMATOLOGY, V44, P227, DOI 10.1093/rheumatology/keh447; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Zhang LZ, 2011, PANCREAS, V40, P1172, DOI 10.1097/MPA.0b013e318233bec5	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136298	10.1371/journal.pone.0136298	http://dx.doi.org/10.1371/journal.pone.0136298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325540	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700037
J	Potas, JR; de Castro, NG; Maddess, T; de Souza, MN				Potas, Jason Robert; de Castro, Newton Goncalves; Maddess, Ted; de Souza, Marcio Nogueira			Waveform Similarity Analysis: A Simple Template Comparing Approach for Detecting and Quantifying Noisy Evoked Compound Action Potentials	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; CAT; AXONS	Experimental electrophysiological assessment of evoked responses from regenerating nerves is challenging due to the typical complex response of events dispersed over various latencies and poor signal-to-noise ratio. Our objective was to automate the detection of compound action potential events and derive their latencies and magnitudes using a simple cross-correlation template comparison approach. For this, we developed an algorithm called Waveform Similarity Analysis. To test the algorithm, challenging signals were generated in vivo by stimulating sural and sciatic nerves, whilst recording evoked potentials at the sciatic nerve and tibialis anterior muscle, respectively, in animals recovering from sciatic nerve transection. Our template for the algorithm was generated based on responses evoked from the intact side. We also simulated noisy signals and examined the output of the Waveform Similarity Analysis algorithm with imperfect templates. Signals were detected and quantified using Waveform Similarity Analysis, which was compared to event detection, latency and magnitude measurements of the same signals performed by a trained observer, a process we called Trained Eye Analysis. The Waveform Similarity Analysis algorithm could successfully detect and quantify simple or complex responses from nerve and muscle compound action potentials of intact or regenerated nerves. Incorrectly specifying the template outperformed Trained Eye Analysis for predicting signal amplitude, but produced consistent latency errors for the simulated signals examined. Compared to the trained eye, Waveform Similarity Analysis is automatic, objective, does not rely on the observer to identify and/or measure peaks, and can detect small clustered events even when signal-to-noise ratio is poor. Waveform Similarity Analysis provides a simple, reliable and convenient approach to quantify latencies and magnitudes of complex waveforms and therefore serves as a useful tool for studying evoked compound action potentials in neural regeneration studies.	[Potas, Jason Robert; Maddess, Ted] Australian Natl Univ, John Curtin Sch Med Res, Dept Neurosci, Canberra, ACT 2601, Australia; [Potas, Jason Robert] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Potas, Jason Robert; de Castro, Newton Goncalves] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil; [de Souza, Marcio Nogueira] Univ Fed Rio de Janeiro, COPPE, Biomed Engn Program, BR-21945 Rio De Janeiro, RJ, Brazil	Australian National University; John Curtin School of Medical Research; Australian National University; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Potas, JR (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Neurosci, Canberra, ACT 2601, Australia.	jason.potas@anu.edu.au	Souza, Marcio N/I-3683-2012; Maddess, Teddy L/A-3200-2008; Castro, Newton/AGX-7014-2022; Potas, Jason/B-1327-2011; Souza, Marcio N/G-8547-2017; Castro, Newton G/C-3263-2009	Souza, Marcio N/0000-0001-9409-3786; Maddess, Teddy L/0000-0003-4591-3658; Castro, Newton/0000-0001-9570-7428; Potas, Jason/0000-0002-1973-8211; Souza, Marcio N/0000-0001-9409-3786; Castro, Newton G/0000-0001-9570-7428	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JP was supported with a postdoctoral fellowship from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109; BAKER M, 1992, J PHYSIOL-LONDON, V451, P539, DOI 10.1113/jphysiol.1992.sp019178; Fugleholm K, 2000, J PERIPHER NERV SYST, V5, P82, DOI 10.1046/j.1529-8027.2000.00008.x; FUGLEHOLM K, 1994, J NEUROSCI, V14, P2659; Kim S, 2007, J NEUROSCI METH, V165, P165, DOI 10.1016/j.jneumeth.2007.05.033; Krarup C, 2004, MUSCLE NERVE, V29, P465, DOI 10.1002/mus.10524; Moldovan M, 2006, BRAIN, V129, P2471, DOI 10.1093/brain/awl184; Sorensen J, 2001, BRAIN RES, V903, P185, DOI 10.1016/S0006-8993(01)02441-6; Vleggeert-Lankamp CLAM, 2007, J NEUROSURG, V107, P1168, DOI 10.3171/JNS-07/12/1168; Walbeehm ET, 2003, J PERIPHER NERV SYST, V8, P108, DOI 10.1046/j.1529-8027.2003.03014.x; Yadav R, 2011, IEEE ENG MED BIO, P7545, DOI 10.1109/IEMBS.2011.6091860; Zhang PM, 2004, J NEUROSCI METH, V135, P55, DOI 10.1016/j.jneumeth.2003.12.001	13	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136992	10.1371/journal.pone.0136992	http://dx.doi.org/10.1371/journal.pone.0136992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325291	Green Submitted, gold, Green Published			2022-12-27	WOS:000360437700079
J	Xiao, CF; Robertson, RM				Xiao, Chengfeng; Robertson, R. Meldrum			Locomotion Induced by Spatial Restriction in Adult Drosophila	PLOS ONE			English	Article							OPEN-FIELD ARENA; LAYING HENS; BEHAVIOR; STEREOTYPIES; MELANOGASTER; MUTANTS; WHITE; SEROTONIN; DOPAMINE; WELFARE	Drosophila adults display an unwillingness to enter confined spaces but the behaviors induced by spatial restriction in Drosophila are largely unknown. We developed a protocol for high-throughput analysis of locomotion and characterized features of locomotion in a restricted space. We observed intense and persistent locomotion of flies in small circular arenas (diameter 1.27 cm), whereas locomotion was greatly reduced in large circular arenas (diameter 3.81 cm). The increased locomotion induced by spatial restriction was seen in male flies but not female flies, indicating sexual dimorphism of the response to spatial restriction. In large arenas, male flies increased locomotion in arenas previously occupied by male but not female individuals. In small arenas, such pre-conditioning had no effect on male flies, which showed intense and persistent locomotion similar to that seen in fresh arenas. During locomotion with spatial restriction, wildtype Canton-S males traveled slower and with less variation in speed than the mutant w1118 carrying a null allele of white gene. In addition, wildtype flies showed a stronger preference for the boundary than the mutant in small arenas. Genetic analysis with a series of crosses revealed that the white gene was not associated with the phenotype of boundary preference in wildtype flies.	[Xiao, Chengfeng; Robertson, R. Meldrum] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Robertson, RM (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	robertrm@queensu.ca	Robertson, Robert M/B-2482-2009; Xiao, Chengfeng/B-1432-2014	Robertson, Robert M/0000-0002-2666-7861; Xiao, Chengfeng/0000-0002-2301-1365	RGPIN [40930-09]; Natural Sciences and Engineering Research Council of Canada (NSERC)	RGPIN; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by RGPIN 40930-09, the Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN SH, 1978, SCIENCE, V201, P373, DOI 10.1126/science.566471; ADAMS MR, 1988, LAB ANIM SCI, V38, P279; Balcombe JP, 2006, LAB ANIM-UK, V40, P217, DOI 10.1258/002367706777611488; BAXTER MR, 1994, VET REC, V134, P614, DOI 10.1136/vr.134.24.614; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; BURNET B, 1988, HEREDITY, V61, P111, DOI 10.1038/hdy.1988.96; Chen A, 2013, GENETICS, V193, P159, DOI 10.1534/genetics.112.142042; COLE BJ, 1995, ANIM BEHAV, V50, P1317, DOI 10.1016/0003-3472(95)80047-6; Colomb Julien, 2014, F1000Res, V3, P176, DOI 10.12688/f1000research.4263.2; Colomb J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042247; CONNOLLY K, 1967, ANIM BEHAV, V15, P149, DOI 10.1016/S0003-3472(67)80026-5; CRASKE MG, 1992, BEHAV RES THER, V30, P569, DOI 10.1016/0005-7967(92)90002-X; EWING ARTHUR W., 1963, ANIMAL BEHAVIOUR, V11, P369, DOI 10.1016/S0003-3472(63)80128-1; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; Gross AN, 2012, BEHAV BRAIN RES, V234, P61, DOI 10.1016/j.bbr.2012.06.007; HOTTA Y, 1976, P NATL ACAD SCI USA, V73, P4154, DOI 10.1073/pnas.73.11.4154; JENSEN P, 1984, APPL ANIM BEHAV SCI, V12, P93, DOI 10.1016/0168-1591(84)90099-6; Kain JS, 2012, P NATL ACAD SCI USA, V109, P19834, DOI 10.1073/pnas.1211988109; Krushinski LV, 1962, ANIMAL BEHAV ITS NOR; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P345, DOI 10.1016/j.neubiorev.2010.02.004; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; Liu LZ, 2007, GENETICS, V175, P1197, DOI 10.1534/genetics.106.068411; Maimon G, 2008, CURR BIOL, V18, P464, DOI 10.1016/j.cub.2008.02.054; Manoli DS, 2013, CURR OPIN NEUROBIOL, V23, P330, DOI 10.1016/j.conb.2013.04.005; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; MASON GJ, 1991, BEHAV PROCESS, V25, P103, DOI 10.1016/0376-6357(91)90013-P; Mendes CS, 2013, ELIFE, V2, DOI 10.7554/eLife.00231; MILLER RE, 1969, SCIENCE, V165, P1027, DOI 10.1126/science.165.3897.1027; Pendleton RG, 2002, BEHAV GENET, V32, P89, DOI 10.1023/A:1015279221600; PIRROTTA V, 1984, EMBO J, V3, P563, DOI 10.1002/j.1460-2075.1984.tb01847.x; Riemensperger T, 2013, CELL REP, V5, P952, DOI 10.1016/j.celrep.2013.10.032; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Shields Sara, 2013, Animals (Basel), V3, P386, DOI 10.3390/ani3020386; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Soibam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046570; Soibam B, 2012, BRAIN BEHAV, V2, P97, DOI 10.1002/brb3.36; Tactacan GB, 2009, POULTRY SCI, V88, P698, DOI 10.3382/ps.2008-00369; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; van Swinderen B, 2006, J NEUROBIOL, V66, P1195, DOI 10.1002/neu.20300	47	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135825	10.1371/journal.pone.0135825	http://dx.doi.org/10.1371/journal.pone.0135825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351842	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800017
J	Alex, A; Li, AR; Zeng, XX; Tate, RE; McKee, ML; Capen, DE; Zhang, Z; Tanzi, RE; Zhou, C				Alex, Aneesh; Li, Airong; Zeng, Xianxu; Tate, Rebecca E.; McKee, Mary L.; Capen, Diane E.; Zhang, Zhan; Tanzi, Rudolph E.; Zhou, Chao			A Circadian Clock Gene, Cry, Affects Heart Morphogenesis and Function in Drosophila as Revealed by Optical Coherence Microscopy	PLOS ONE			English	Article							CARDIAC DYSFUNCTION; EXPRESSION; CRYPTOCHROME; PHOTORECEPTOR; TOMOGRAPHY; RHYTHMS; DISEASE; PROTEIN; SYSTEM; LEADS	Circadian rhythms are endogenous, entrainable oscillations of physical, mental and behavioural processes in response to local environmental cues such as daylight, which are present in the living beings, including humans. Circadian rhythms have been related to cardiovascular function and pathology. However, the role that circadian clock genes play in heart development and function in a whole animal in vivo are poorly understood. The Drosophila cryptochrome (dCry) is a circadian clock gene that encodes a major component of the circadian clock negative feedback loop. Compared to the embryonic stage, the relative expression levels of dCry showed a significant increase (>100-fold) in Drosophila during the pupa and adult stages. In this study, we utilized an ultrahigh resolution optical coherence microscopy (OCM) system to perform non-invasive and longitudinal analysis of functional and morphological changes in the Drosophila heart throughout its post-embryonic lifecycle for the first time. The Drosophila heart exhibited major morphological and functional alterations during its development. Notably, heart rate (HR) and cardiac activity period (CAP) of Drosophila showed significant variations during the pupa stage, when heart remodeling took place. From the M-mode (2D + time) OCM images, cardiac structural and functional parameters of Drosophila at different developmental stages were quantitatively determined. In order to study the functional role of dCry on Drosophila heart development, we silenced dCry by RNAi in the Drosophila heart and mesoderm, and quantitatively measured heart morphology and function in those flies throughout its development. Silencing of dCry resulted in slower HR, reduced CAP, smaller heart chamber size, pupal lethality and disrupted posterior segmentation that was related to increased expression of a posterior compartment protein, wingless. Collectively, our studies provided novel evidence that the circadian clock gene, dCry, plays an essential role in heart morphogenesis and function.	[Alex, Aneesh; Zeng, Xianxu; Zhou, Chao] Lehigh Univ, Dept Elect & Comp Engn, Bethlehem, PA 18015 USA; [Alex, Aneesh; Zeng, Xianxu; Zhou, Chao] Lehigh Univ, Ctr Photon & Nanoelect, Bethlehem, PA 18015 USA; [Li, Airong; Tate, Rebecca E.; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02129 USA; [Li, Airong; Tate, Rebecca E.; Tanzi, Rudolph E.] Harvard Univ, Sch Med, Boston, MA 02129 USA; [Zeng, Xianxu; Zhang, Zhan] Zhengzhou Univ, Affiliated Hosp 3, Dept Pathol, Zhengzhou 450000, Henan, Peoples R China; [McKee, Mary L.; Capen, Diane E.] Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02115 USA; [McKee, Mary L.; Capen, Diane E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Zhou, Chao] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Zhengzhou University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Lehigh University	Tanzi, RE (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Genet & Aging Res Unit, Boston, MA 02129 USA.	tanzi@helix.mgh.harvard.edu; chaozhou@lehigh.edu	Zhou, Chao/A-1327-2007; Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Alex, Aneesh/0000-0001-8652-307X; Zhou, Chao/0000-0002-8679-3413	National Institutes of Health [R00EB010071, R15EB019704, R03AR063271, R01AG014713, R01MH060009]; National Science Foundation [1455613]; Cure Alzheimer's Fund; Massachusetts General Hospital ECOR Award; Boston Area Diabetes and Endocrinology Research Centre [DK 57521]; Centre for the Study of Inflammatory Bowel Disease [DK 43351]; Lehigh University Start-up Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R15EB019704, R00EB010071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014713, P50AG005134] Funding Source: NIH RePORTER; Direct For Biological Sciences [1455613] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Cure Alzheimer's Fund; Massachusetts General Hospital ECOR Award; Boston Area Diabetes and Endocrinology Research Centre; Centre for the Study of Inflammatory Bowel Disease; Lehigh University Start-up Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Lehigh University Start-up Fund, National Institutes of Health [R00EB010071 to C.Z., R15EB019704 to C.Z. and A.L., R03AR063271 to A.L., and R01AG014713 and R01MH060009 to R.E. Tanzi], National Science Foundation [1455613 to C.Z. and A. L.], the Cure Alzheimer's Fund [to R.E. Tanzi], and a Massachusetts General Hospital ECOR Award [to A.L.]. The Microscopy Core Facility at the MGH Program in Membrane Biology receives support from the Boston Area Diabetes and Endocrinology Research Centre [DK 57521] and the Centre for the Study of Inflammatory Bowel Disease [DK 43351]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AD, 2003, OPT LETT, V28, P2064, DOI 10.1364/OL.28.002064; Alayari NN, 2009, JOVE-J VIS EXP, pe1423, DOI DOI 10.3791/1423; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Boppart SA, 1997, P NATL ACAD SCI USA, V94, P4256, DOI 10.1073/pnas.94.9.4256; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Curran KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002749; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Dolezelova E, 2007, GENETICS, V177, P329, DOI 10.1534/genetics.107.076513; Drexler W, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-540-77550-8; Dulcis D, 2005, J NEUROSCI, V25, P271, DOI 10.1523/JNEUROSCI.2906-04.2005; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Eisenberg LM, 2006, DEV BIOL, V293, P305, DOI 10.1016/j.ydbio.2006.02.014; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; FERCHER AF, 1995, OPT COMMUN, V117, P43, DOI 10.1016/0030-4018(95)00119-S; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Ha M, 2005, J OCCUP HEALTH, V47, P89, DOI 10.1539/joh.47.89; HIDALGO A, 1994, CURR BIOL, V4, P1087, DOI 10.1016/S0960-9822(00)00247-5; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Ishikawa T, 1999, GENES CELLS, V4, P57, DOI 10.1046/j.1365-2443.1999.00237.x; IZATT JA, 1994, OPT LETT, V19, P590, DOI 10.1364/OL.19.000590; Layalle S, 2011, DEVELOPMENT, V138, P2315, DOI 10.1242/dev.057059; Lefta M, 2012, AM J PHYSIOL-HEART C, V303, pH475, DOI 10.1152/ajpheart.00238.2012; Leibetseder V, 2009, CHRONOBIOL INT, V26, P621, DOI 10.1080/07420520902924939; Li A, 2011, CURR ALZHEIMER RES, V8, P313, DOI 10.2174/156720511795563746; Li AR, 2013, HUM MOL GENET, V22, P3798, DOI 10.1093/hmg/ddt230; Liu LB, 2011, NAT MED, V17, P1010, DOI 10.1038/nm.2409; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Monier B, 2005, DEVELOPMENT, V132, P5283, DOI 10.1242/dev.02091; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Paternostro G, 2001, CIRC RES, V88, P1053, DOI 10.1161/hh1001.090857; Peterson LM, 2012, BIOMED OPT EXPRESS, V3, P3022, DOI 10.1364/BOE.3.003022; Portaluppi F, 2012, SLEEP MED REV, V16, P151, DOI 10.1016/j.smrv.2011.04.003; Rizki T.M., 1978, P397; Slama K., 2010, EUROPEAN J ENTOMOLOG; Slama L, 2005, J INSECT PHYSIOL, V51, P489, DOI 10.1016/j.jinsphys.2004.11.016; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; STURTEVANT MA, 1995, DEVELOPMENT, V121, P785; Sullivan W, 2008, DROSOPHILA PROTOCOLS; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; Tsai MT, 2013, J BIOPHOTONICS, V6, P708, DOI 10.1002/jbio.201200164; Udo R, 2004, BIOCHEM BIOPH RES CO, V318, P893, DOI 10.1016/j.bbrc.2004.04.113; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174; Yazdanfar S, 1997, OPT EXPRESS, V1, P424, DOI 10.1364/OE.1.000424; Yelbuz TM, 2002, CIRCULATION, V106, P2771, DOI 10.1161/01.CIR.0000042672.51054.7B; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005; Zeitouni B, 2007, PLOS GENET, V3, P1907, DOI 10.1371/journal.pgen.0030174; Zhou C, 2010, CANCER RES, V70, P10071, DOI 10.1158/0008-5472.CAN-10-2968; Zikova M, 2003, P NATL ACAD SCI USA, V100, P12189, DOI 10.1073/pnas.2133156100	58	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137236	10.1371/journal.pone.0137236	http://dx.doi.org/10.1371/journal.pone.0137236			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348211	gold, Green Published, Green Submitted			2022-12-27	WOS:000360897600027
J	Pant, SD; Karlskov-Mortensen, P; Jacobsen, MJ; Cirera, S; Kogelman, LJA; Bruun, CS; Mark, T; Jorgensen, CB; Grarup, N; Appel, EVR; Galjatovic, EAA; Hansen, T; Pedersen, O; Guerin, M; Huby, T; Lesnik, P; Meuwissen, THE; Kadarmideen, HN; Fredholm, M				Pant, Sameer D.; Karlskov-Mortensen, Peter; Jacobsen, Mette J.; Cirera, Susanna; Kogelman, Lisette J. A.; Bruun, Camilla S.; Mark, Thomas; Jorgensen, Claus B.; Grarup, Niels; Appel, Emil V. R.; Galjatovic, Ehm A. A.; Hansen, Torben; Pedersen, Oluf; Guerin, Maryse; Huby, Thierry; Lesnik, Philipppe; Meuwissen, Theo H. E.; Kadarmideen, Haja N.; Fredholm, Merete			Comparative Analyses of QTLs Influencing Obesity and Metabolic Phenotypes in Pigs and Humans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; LINKAGE DISEQUILIBRIUM; ADIPOSE-TISSUE; CHOLESTEROL; GENE; RECEPTOR; ALPHA; LOCI; EXPRESSION	The pig is a well-known animal model used to investigate genetic and mechanistic aspects of human disease biology. They are particularly useful in the context of obesity and metabolic diseases because other widely used models (e.g. mice) do not completely recapitulate key pathophysiological features associated with these diseases in humans. Therefore, we established a F2 pig resource population (n = 564) designed to elucidate the genetics underlying obesity and metabolic phenotypes. Segregation of obesity traits was ensured by using breeds highly divergent with respect to obesity traits in the parental generation. Several obesity and metabolic phenotypes were recorded (n = 35) from birth to slaughter (242 +/- 48 days), including body composition determined at about two months of age (63 +/- 10 days) via dual-energy x-ray absorptiometry (DXA) scanning. All pigs were genotyped using Illumina Porcine 60k SNP Beadchip and a combined linkage disequilibrium-linkage analysis was used to identify genome-wide significant associations for collected phenotypes. We identified 229 QTLs which associated with adiposity-and metabolic phenotypes at genome-wide significant levels. Subsequently comparative analyses were performed to identify the extent of overlap between previously identified QTLs in both humans and pigs. The combined analysis of a large number of obesity phenotypes has provided insight in the genetic architecture of the molecular mechanisms underlying these traits indicating that QTLs underlying similar phenotypes are clustered in the genome. Our analyses have further confirmed that genetic heterogeneity is an inherent characteristic of obesity traits most likely caused by segregation or fixation of different variants of the individual components belonging to cellular pathways in different populations. Several important genes previously associated to obesity in human studies, along with novel genes were identified. Altogether, this study provides novel insight that may further the current understanding of the molecular mechanisms underlying human obesity.	[Pant, Sameer D.; Karlskov-Mortensen, Peter; Jacobsen, Mette J.; Cirera, Susanna; Kogelman, Lisette J. A.; Bruun, Camilla S.; Mark, Thomas; Jorgensen, Claus B.; Kadarmideen, Haja N.; Fredholm, Merete] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Copenhagen, Denmark; [Grarup, Niels; Appel, Emil V. R.; Galjatovic, Ehm A. A.; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Guerin, Maryse; Huby, Thierry; Lesnik, Philipppe] Integrat Biol Atherosclerosis Team, INSERM, UMR S 1166, F-75013 Paris, France; [Guerin, Maryse; Huby, Thierry; Lesnik, Philipppe] Univ Paris 06, Sorbonne Univ, Integrat Biol Atherosclerosis Team, UMR S 1166, F-75013 Paris, France; [Guerin, Maryse; Huby, Thierry; Lesnik, Philipppe] Hop La Pitie Salpetriere, Inst Cardiometab & Nutr ICAN, Paris, France; [Meuwissen, Theo H. E.] Norwegian Univ Life Sci, Inst Anim & Agr Sci, As, Norway	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Norwegian University of Life Sciences	Kadarmideen, HN (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Copenhagen, Denmark.	hajak@sund.ku.dk; mf@sund.ku.dk	Pant, Sameer Dinkar/D-1448-2017; Karlskov-Mortensen, Peter/C-3030-2013; Grarup, Niels/K-2807-2015; Lesnik, Philippe/AAD-7393-2020; Kogelman, Lisette/Y-5883-2019; Guerin, Maryse/N-5794-2017; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Cirera, Susanna/K-8540-2017; Lesnik, Philippe F/F-7803-2011; Huby, Thierry/E-6768-2017; HUBY, Thierry/N-4820-2019; Jorgensen, Claus B./GXH-7925-2022	Pant, Sameer Dinkar/0000-0002-0672-4478; Karlskov-Mortensen, Peter/0000-0002-2491-2763; Grarup, Niels/0000-0001-5526-1070; Lesnik, Philippe/0000-0002-6909-7715; Pedersen, Oluf/0000-0002-3321-3972; Huby, Thierry/0000-0001-6634-551X; HUBY, Thierry/0000-0001-6634-551X; Jorgensen, Claus B./0000-0003-4749-5306; Fredholm, Merete/0000-0002-3563-7648; Kogelman, Lisette/0000-0001-9782-7810; Kadarmideen, Haja/0000-0001-6294-382X; Cirera, Susanna/0000-0001-8105-1579; Jacobsen, Mette Juul/0000-0001-9264-7554; GUERIN, Maryse/0000-0003-0150-1360	Ministry of Science and Technology; Danish Council for Strategic Research [0603-00457B]; Danish Research Council for Independent Research [DFF 1335-00127]; EU-FP7 Marie Curie Actions-Career Integration Grant [CIG293511]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Research Council for Independent Research(Det Frie Forskningsrad (DFF)); EU-FP7 Marie Curie Actions-Career Integration Grant	This study was supported by a grant from the Ministry of Science and Technology to the "UNIK Project for Food Fitness and Pharma for Health", by the Danish Council for Strategic Research to the BioChild project (0603-00457B), and by the Danish Research Council for Independent Research (DFF 1335-00127). HNK was supported by EU-FP7 Marie Curie Actions-Career Integration Grant (CIG293511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Arai A, 2002, J BIOL CHEM, V277, P24453, DOI 10.1074/jbc.M202216200; Arner P, 2005, DIABETOLOGIA, V48, P2203, DOI 10.1007/s00125-005-1956-3; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bitsch F, 2003, ANAL BIOCHEM, V323, P139, DOI 10.1016/j.ab.2003.08.029; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chang YC, 2010, OBESITY, V18, P7, DOI 10.1038/oby.2009.198; Chen GJ, 2012, EUR J HUM GENET, V20, P463, DOI 10.1038/ejhg.2011.206; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Ding H, 2012, INT SCI INDEX, V6; Edwards DRV, 2013, HUM GENET, V132, P323, DOI 10.1007/s00439-012-1246-3; Estrada IA, 2012, CIRC RES, V111, P1166, DOI 10.1161/CIRCRESAHA.112.275743; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gilmour AR, 2009, ASREML USER GUIDE RE; GUERIN M, 1994, ARTERIOSCLER THROMB, V14, P199, DOI 10.1161/01.ATV.14.2.199; Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Irvin MR, 2011, PHARMACOGENET GENOM, V21, P798, DOI 10.1097/FPC.0b013e32834b68f9; Johansen T, 2001, COMPARATIVE MED, V51, P150; Johansson A, 2010, OBESITY, V18, P803, DOI 10.1038/oby.2009.359; JONES DP, 1971, J CLIN INVEST, V50, P259, DOI 10.1172/JCI106490; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Kempen KPG, 1998, EUR J CLIN INVEST, V28, P1030; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kogelman Lisette J. A., 2013, Frontiers in Genetics, V4, P29, DOI 10.3389/fgene.2013.00029; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lowe JK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000365; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Melen E, 2013, CLIN EXP ALLERGY, V43, P463, DOI 10.1111/cea.12054; Melka MG, 2012, J CLIN ENDOCR METAB, V97, pE145, DOI 10.1210/jc.2011-1801; Meuwissen T, 2010, GENETICS, V185, P1441, DOI 10.1534/genetics.110.113936; Nofer JR, 2003, J BIOL CHEM, V278, P53055, DOI 10.1074/jbc.M305673200; Pathak P, 2013, J BIOL CHEM, V288, P37154, DOI 10.1074/jbc.M113.485987; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Soleimani M, 2013, KIDNEY INT, V84, P657, DOI 10.1038/ki.2013.138; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang KS, 2012, GENE, V500, P80, DOI 10.1016/j.gene.2012.03.046; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willson TM, 2002, STRUCTURE, V10, P1605, DOI 10.1016/S0969-2126(02)00916-4; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101; Zou LY, 2013, FASEB J, V27	57	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137356	10.1371/journal.pone.0137356	http://dx.doi.org/10.1371/journal.pone.0137356			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348622	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000360897600039
J	Leigh-Brown, S; Goncalves, A; Thybert, D; Stefflova, K; Watt, S; Flicek, P; Brazma, A; Marioni, JC; Odom, DT				Leigh-Brown, Sarah; Goncalves, Angela; Thybert, David; Stefflova, Klara; Watt, Stephen; Flicek, Paul; Brazma, Alvis; Marioni, John C.; Odom, Duncan T.			Regulatory Divergence of Transcript Isoforms in a Mammalian Model System	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; HOUSE MOUSE; POLYADENYLATION; GENOME; EVOLUTION; DNA; TISSUES; BINDING; CIS	Phenotypic differences between species are driven by changes in gene expression and, by extension, by modifications in the regulation of the transcriptome. Investigation of mammalian transcriptome divergence has been restricted to analysis of bulk gene expression levels and gene-internal splicing. Using allele-specific expression analysis in inter-strain hybrids of Mus musculus, we determined the contribution of multiple cellular regulatory systems to transcriptome divergence, including: alternative promoter usage, transcription start site selection, cassette exon usage, alternative last exon usage, and alternative polyadenylation site choice. Between mouse strains, a fifth of genes have variations in isoform usage that contribute to transcriptomic changes, half of which alter encoded amino acid sequence. Virtually all divergence in isoform usage altered the post-transcriptional regulatory instructions in gene UTRs. Furthermore, most genes with isoform differences between strains contain changes originating from multiple regulatory systems. This result indicates widespread cross-talk and coordination exists among different regulatory systems. Overall, isoform usage diverges in parallel with and independently to gene expression evolution, and the cis and trans regulatory contribution to each differs significantly.	[Leigh-Brown, Sarah; Odom, Duncan T.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England; [Goncalves, Angela; Thybert, David; Flicek, Paul; Brazma, Alvis; Marioni, John C.] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Goncalves, Angela; Watt, Stephen; Odom, Duncan T.] Wellcome Trust Sanger Inst, Cambridge, England; [Stefflova, Klara] CALTECH, Div Biol, Pasadena, CA 91125 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; California Institute of Technology	Marioni, JC (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	marioni@ebi.ac.uk; Duncan.odom@cruk.cam.ac.uk		Flicek, Paul/0000-0002-3897-7955; Odom, Duncan/0000-0001-6201-5599; Brazma, Alvis/0000-0001-5988-7409; Thybert, David/0000-0001-7806-7318; Barsi, Klara/0000-0001-9338-0468; Marioni, John/0000-0001-9092-0852; Goncalves, Angela/0000-0002-3890-7658	European Research Council; EMBO Young Investigators Program; Hutchinson Whampoa; Cancer Research UK; University of Cambridge; European Molecular Biology Laboratory; Wellcome Trust [WT095908, WT098051]; European Commission [261123]; Cancer Research UK [20412, 15603] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); EMBO Young Investigators Program(European Molecular Biology Organization (EMBO)); Hutchinson Whampoa; Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); European Molecular Biology Laboratory; Wellcome Trust(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK)	This work was supported by the European Research Council (DTO) (http://erc.europa.eu/); EMBO Young Investigators Program (DTO) (http://www.embo.org/funding-awards/young-investigators); Hutchinson Whampoa (DTO) (http://www.hutchison-whampoa.com/en/global/home.php); Cancer Research UK (DTO, SLB, KS, SW) (http://www.cancerresearchuk.org/); University of Cambridge (SLB, KS, DTO, AG) (http://www.cam.ac.uk/); European Molecular Biology Laboratory (AG, DT, AB, PF, JCM) (http://www.embl.org/); Wellcome Trust WT095908 and WT098051 (DT, PF, DTO) (http://www.wellcome.ac.uk/); and FP7 HEALTH grant from the European Commission GEUVADIS grant agreement 261123 (AG, AB) (http://www.geuvadis.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Since performing the experimental work and writing this manuscript, SLB has taken paid employment at Abcam, a Biotech firm selling reagents to research scientists. Abcam had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bartolomei MS, 2011, COLD SPRING HARB PER, V3; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Evsyukova I, 2013, RNA, V19, P103, DOI 10.1261/rna.035410.112; Gao QS, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145970; Geraldes A, 2011, MOL ECOL, V20, P4722, DOI 10.1111/j.1365-294X.2011.05285.x; Goncalves A, 2012, GENOME RES, V22, P2376, DOI 10.1101/gr.142281.112; Gonzalez-Porta M, 2012, GENOME RES, V22, P528, DOI 10.1101/gr.121947.111; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Le Sommer C, 2005, MOL CELL BIOL, V25, P9595, DOI 10.1128/MCB.25.21.9595-9607.2005; Li Y, 2010, GENETICS, V186, P405, DOI 10.1534/genetics.110.119677; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Mahony S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r84; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; McManus CJ, 2014, GENOME RES, V24, P786, DOI 10.1101/gr.161521.113; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Reyes A, 2013, P NATL ACAD SCI USA, V110, P15377, DOI 10.1073/pnas.1307202110; Rigo F, 2009, RNA, V15, P823, DOI 10.1261/rna.1409209; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Voolstra C, 2007, GENOME RES, V17, P42, DOI 10.1101/gr.5683806; Waks Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.32; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	53	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137367	10.1371/journal.pone.0137367	http://dx.doi.org/10.1371/journal.pone.0137367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339903	Green Published, Green Accepted, gold			2022-12-27	WOS:000360688200052
J	Li, Y; Zhang, Q; Zhang, FF; Liu, RX; Liu, H; Chen, F				Li, Yue; Zhang, Qian; Zhang, Fangfei; Liu, Ruoxi; Liu, He; Chen, Feng			Analysis of the Microbiota of Black Stain in the Primary Dentition	PLOS ONE			English	Article							DENTAL-CARIES; PRIMARY TEETH; SCHOOLCHILDREN; PREVALENCE; CHILDREN; PERIODONTITIS; BACTERIA	Black tooth stain is a characteristic extrinsic discoloration commonly seen on the cervical enamel following the contour of the gingiva. To investigate the relationship between black tooth stain and the oral microbiota, we used 16S rRNA gene sequencing to compare the microbial composition of dental plaque and saliva among caries-free children with and without black stain. Dental plaque and saliva, as well as black stain, were sampled from 10 children with and 15 children without black stain. Data were analyzed using the pipeline tool MOTHUR. Student's t-test was used to compare alpha diversities and the Mann-Whitney U test to compare the relative abundances of the microbial taxa. A total of 10 phyla, 19 classes, 32 orders, 61 families and 102 genera were detected in these samples. Shannon and Simpson diversity were found to be significantly lower in saliva samples of children with black stain. Microbial diversity was reduced in the black stain compared to the plaque samples. Actinomyces, Cardiobacterium, Haemophilus, Corynebacterium, Tannerella and Treponema were more abundant and Campylobacter less abundant in plaque samples of children with black stain. Principal component analysis demonstrated clustering among the dental plaque samples from the control group, while the plaque samples from the black stain group were not and appeared to cluster into two subgroups. Alterations in oral microbiota may be associated with the formation of black stain.	[Li, Yue; Zhang, Fangfei; Liu, He] Peking Univ, Sch Stomatol, Dept Pediat Dent, Beijing 100871, Peoples R China; [Zhang, Qian; Liu, Ruoxi; Chen, Feng] Peking Univ, Sch Stomatol, Cent Lab, Beijing 100871, Peoples R China	Peking University; Peking University	Liu, H (corresponding author), Peking Univ, Sch Stomatol, Dept Pediat Dent, Beijing 100871, Peoples R China.	heliu69@126.com; moleculecf@gmail.com			National Natural Science Foundation of China [81200762]; Peking University School of Stomatology [PKUSS20110301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking University School of Stomatology	This work was funded by the National Natural Science Foundation of China (81200762 to FC) and Peking University School of Stomatology (PKUSS20110301 to FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Franca-Pinto CC, 2012, CARIES RES, V46, P170, DOI 10.1159/000337280; Martin JMG, 2013, PEDIATR INT, V55, P355, DOI 10.1111/ped.12066; Gasparetto André, 2003, Braz. Dent. J., V14, P157, DOI 10.1590/S0103-64402003000300003; Han XY, 2005, J CLIN MICROBIOL, V43, P2370, DOI 10.1128/JCM.43.5.2370-2374.2005; Heinrich-Weltzien R, 2014, CARIES RES, V48, P118, DOI 10.1159/000353469; Heinrich-Weltzien R, 2009, COMMUNITY DENT ORAL, V37, P182, DOI 10.1111/j.1600-0528.2008.00458.x; Hutchison CA, 2007, NUCLEIC ACIDS RES, V35, P6227, DOI 10.1093/nar/gkm688; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; Koch MJ, 2001, J DENT CHILD, V68, P353; Li Y, 2014, ISME J, V8, P1879, DOI 10.1038/ismej.2014.28; MELLANBY M, 1957, BRIT MED J, V2, P318, DOI 10.1136/bmj.2.5040.318; Murphy TF, 2003, CURR OPIN INFECT DIS, V16, P129, DOI 10.1097/00001432-200304000-00009; Pushpanjali K, 2004, Oral Health Prev Dent, V2, P33; REID JS, 1976, J DENT RES, V55, P1130, DOI 10.1177/00220345760550062401; REID JS, 1977, J DENT RES, V56, P895, DOI 10.1177/00220345770560081001; Ronay V, 2011, ORAL HLTH PREV DENT, V9, P37; Saba C, 2006, J Clin Pediatr Dent, V30, P219; Sakai VT, 2007, INT J PAEDIATR DENT, V17, P192, DOI 10.1111/j.1365-263X.2006.00813.x; Sarkonen N, 2001, J CLIN MICROBIOL, V39, P3955, DOI 10.1128/JCM.39.11.3955-3961.2001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sela MN, 2001, CRIT REV ORAL BIOL M, V12, P399, DOI 10.1177/10454411010120050301; SLOTS J, 1974, SCAND J DENT RES, V82, P484; Soukos NS, 2005, ANTIMICROB AGENTS CH, V49, P1391, DOI 10.1128/AAC.49.4.1391-1396.2005; Tek M, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-25; Tomita S, 2013, MICROB PATHOGENESIS, V61-62, P11, DOI 10.1016/j.micpath.2013.04.006; Tsuzukibashi O, 2014, J MICROBIOL METH, V104, P67, DOI 10.1016/j.mimet.2014.06.005; Unno T, 2015, J MICROBIOL BIOTECHN	27	24	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137030	10.1371/journal.pone.0137030	http://dx.doi.org/10.1371/journal.pone.0137030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340752	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200020
J	Salmasi, S; Khan, TM; Hong, YH; Ming, LC; Wong, TW				Salmasi, Shahrzad; Khan, Tahir Mehmood; Hong, Yet Hoi; Ming, Long Chiau; Wong, Tin Wui			Medication Errors in the Southeast Asian Countries: A Systematic Review	PLOS ONE			English	Review							ADMINISTRATION ERRORS; CARE; HOSPITALS; SINGAPORE; HEALTH	Background Medication error (ME) is a worldwide issue, but most studies on ME have been undertaken in developed countries and very little is known about ME in Southeast Asian countries. This study aimed systematically to identify and review research done on ME in Southeast Asian countries in order to identify common types of ME and estimate its prevalence in this region. Methods The literature relating to MEs in Southeast Asian countries was systematically reviewed in December 2014 by using; Embase, Medline, Pubmed, ProQuest Central and the CINAHL. Inclusion criteria were studies (in any languages) that investigated the incidence and the contributing factors of ME in patients of all ages. Results The 17 included studies reported data from six of the eleven Southeast Asian countries: five studies in Singapore, four in Malaysia, three in Thailand, three in Vietnam, one in the Philippines and one in Indonesia. There was no data on MEs in Brunei, Laos, Cambodia, Myanmar and Timor. Of the seventeen included studies, eleven measured administration errors, four focused on prescribing errors, three were done on preparation errors, three on dispensing errors and two on transcribing errors. There was only one study of reconciliation error. Three studies were interventional. Discussion The most frequently reported types of administration error were incorrect time, omission error and incorrect dose. Staff shortages, and hence heavy workload for nurses, doctor/nurse distraction, and misinterpretation of the prescription/medication chart, were identified as contributing factors of ME. There is a serious lack of studies on this topic in this region which needs to be addressed if the issue of ME is to be fully understood and addressed.	[Salmasi, Shahrzad; Khan, Tahir Mehmood] Monash Univ Malaysia, Sch Pharm, Sunway City, Selangor, Malaysia; [Hong, Yet Hoi] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Ming, Long Chiau] Univ Teknol MARA, Fac Pharm, Brain Degenerat & Therapeut Grp, Pharmaceut & Life Sci CoRe, Puncak Alam, Selangor, Malaysia; [Wong, Tin Wui] Univ Teknol MARA, Nondestruct Biomed & Pharmaceut Res Ctr, iPROMISE, Puncak Alam, Selangor, Malaysia	Universiti Malaya; Universiti Teknologi MARA; Universiti Teknologi MARA	Khan, TM (corresponding author), Monash Univ Malaysia, Sch Pharm, Sunway City, Selangor, Malaysia.	tahir.mehmood@monash.edu; ming.long@bath.edu	Khan, Yusra Habib/AFK-9024-2022; HONG, YET HOI/B-5229-2010; Wong, Tin Wui/B-8668-2012; Ming, L C/J-5210-2015; Khan, Tahir/ABA-6714-2021	Khan, Yusra Habib/0000-0002-9479-6147; HONG, YET HOI/0000-0003-2739-580X; Wong, Tin Wui/0000-0002-9131-6937; Ming, L C/0000-0002-6971-1383; Salmasi, Shahrzad/0000-0003-1330-3388; Khan, Tahir/0000-0003-0081-1957	Research Acculturation Grant Scheme (RAGS), Malaysia [RAGS/2013/UITM/SKK02/5, SKK02/3]; Monash University Malaysia, Universiti Teknologi MARA, Ministry of Education, Malaysia	Research Acculturation Grant Scheme (RAGS), Malaysia; Monash University Malaysia, Universiti Teknologi MARA, Ministry of Education, Malaysia	This work was supported by Research Acculturation Grant Scheme (RAGS), Malaysia (RAGS/2013/UITM/SKK02/5, SKK02/3). The authors would like to express their gratitude to Monash University Malaysia, Universiti Teknologi MARA, Ministry of Education, Malaysia for financial support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Dellemin Che, 2004, Malays J Med Sci, V11, P52; Alsulami Z, 2013, EUR J CLIN PHARMACOL, V69, P995, DOI 10.1007/s00228-012-1435-y; Anderson Stuart, 2002, J Interprof Care, V16, P391, DOI 10.1080/1356182021000008337; Aronson JK, 2009, BRIT J CLIN PHARMACO, V67, P599, DOI 10.1111/j.1365-2125.2009.03415.x; Biswas P, 2013, J PHARMACOL PHARMACO, V4, pS7, DOI 10.4103/0976-500X.120941; Cheung KC, 2009, BRIT J CLIN PHARMACO, V67, P676, DOI 10.1111/j.1365-2125.2009.03428.x; Chongsuvivatwong V, 2011, LANCET, V377, P429, DOI 10.1016/S0140-6736(10)61507-3; Choo J, 2014, NURS HEALTH SCI, V16, P245, DOI 10.1111/nhs.12078; Choo J, 2013, NURS HEALTH SCI, V15, P101, DOI 10.1111/j.1442-2018.2012.00706.x; Chua SS, 2009, J CLIN PHARM THER, V34, P215, DOI 10.1111/j.1365-2710.2008.00997.x; Chua SS, 2010, EUR J PEDIATR, V169, P603, DOI 10.1007/s00431-009-1084-z; Ernawati DK, 2014, THER CLIN RISK MANAG, V10, P413, DOI 10.2147/TCRM.S61687; Fahimi F, 2009, ARCH IRAN MED, V12, P173; Gautam Parshotam Lal, 2013, J Anaesthesiol Clin Pharmacol, V29, P293, DOI 10.4103/0970-9185.117037; Hashim J., 2012, HLTH HEALTHCARE SYST; Nguyen HT, 2014, BMJ QUAL SAF, V23, P319, DOI 10.1136/bmjqs-2013-002357; Nguyen HT, 2014, NURS RES, V63, P68, DOI 10.1097/NNR.0000000000000010; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Iyer US, 2011, ANAESTH INTENS CARE, V39, P1151; Kaboli PJ, 2006, ARCH INTERN MED, V166, P955, DOI 10.1001/archinte.166.9.955; Keers RN, 2013, ANN PHARMACOTHER, V47, P237, DOI 10.1345/aph.1R147; Kirk RC, 2005, DRUG SAFETY, V28, P817, DOI 10.2165/00002018-200528090-00006; Kohn L. T., 2000, ERR IS HUMAN BUILDIN, V6; Nguyen HT, ERRORS MED IN PRESS; Nosek RA, 2005, ADV PATIENT SAFETY R, V4, P361; Nwokike J, 2013, COMP ANAL PHARMACOVI; Ong W M, 2013, Med J Malaysia, V68, P52; Patel I, 2010, INDIAN J PHARM SCI, V72, P539, DOI 10.4103/0250-474X.78518; Valdez LP, 2013, NURS EDUC TODAY, V33, P222, DOI 10.1016/j.nedt.2012.01.001; Rothschild JM, 2010, ANN EMERG MED, V55, P513, DOI 10.1016/j.annemergmed.2009.10.012; Sangtawesin Varaporn, 2003, J Med Assoc Thai, V86 Suppl 3, pS570; Sanguansak T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000539; Smetzer JL, 2007, MED ERRORS; Thanoo Hintong MD, 2005, J MED ASS THAI, V88, P118; U.S. Food and Drug Administration, 2015, MED ERR; United Nations Statistic Division, COMP MAC CONT REG GE; United Nations' Department of Economic and Social Affairs, WORLD POP PROSP 2012; World Health Organization (WHO), 2014, REP LEARN SYST MED E; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Yi SB, 2013, INT J HEALTH CARE Q, V26, P31, DOI 10.1108/09526861311288622; Yoelao D, 2014, INT J BEHAV SCI, V9, P53, DOI 10.14456/ijbs.2014.5	41	60	64	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136545	10.1371/journal.pone.0136545	http://dx.doi.org/10.1371/journal.pone.0136545			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ6BA	26340679	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200009
J	Xing, JJ; Liu, XF; Xiong, XM; Huang, L; Lao, CY; Yang, M; Gao, S; Huang, QY; Yang, W; Zhu, YF; Zhang, DH				Xing, Ji-Juan; Liu, Xiu-Fen; Xiong, Xiao-Ming; Huang, Li; Lao, Cheng-Yi; Yang, Mei; Gao, Shan; Huang, Qiong-Yan; Yang, Wei; Zhu, Yun-Feng; Zhang, Di-Hua			Effects of Combined Spinal-Epidural Analgesia during Labor on Postpartum Electrophysiological Function of Maternal Pelvic Floor Muscle: A Randomized Controlled Trial	PLOS ONE			English	Article							PRESSURE MEASUREMENTS; VAGINAL DELIVERY; REDUCE; RISK; PAIN	Objective Combined spinal-epidural analgesia (CSEA) is sometimes used for difficult births, but whether it contributes to postpartum pelvic muscle disorder is unclear. This randomized controlled trial examined whether CSEA given during labor affects the electrophysiological index of postpartum pelvic floor muscle function. Methods A consecutive sample of primiparous women who delivered vaginally at term were randomly assigned to a CSEA group (n = 143) and control group (n = 142) between June 2013 and June 2014. All were assessed 6-8 weeks later for electrophysiological function of pelvic floor muscle. Results The two groups were similar in the degree of muscle strength, muscle fatigue, and pelvic dynamic pressure of pelvic floor muscle. The CSEA and control groups showed similar proportions of women with normal muscle strength (score >= 4) in type I pelvic fibers (23.1% vs. 14.1%, P = 0.051) and type II pelvic fibers (28.0% vs. 24.6%, P = 0.524). The groups also contained similar proportions of women who showed no fatigue in type I fibers (54.5% vs. 48.6%, P = 0.315) or type II fibers (88.8% vs. 87.3%, P = 0.699). Similarly low proportions of women in the CSEA group and control group showed normal pelvic dynamic pressure 11.2% vs. 7.7%, P = 0.321). However, women in the CSEA group spent significantly less time in labor than those in the control group (7.25 vs. 9.52 h, P <0.001). Conclusions CSEA did not affect the risk of postpartum pelvic muscle disorder in this cohort of primiparous women who gave birth vaginally. A significant shorter duration of labour was observed in the CSEA-group.	[Xing, Ji-Juan; Lao, Cheng-Yi; Huang, Qiong-Yan; Yang, Wei; Zhu, Yun-Feng] Maternal & Child Hlth Hosp Nanning City, Dept Anesthesia, Nanning 530011, Peoples R China; [Liu, Xiu-Fen; Huang, Li] Peking Univ, Affiliated Hosp 1, Pain Management Dept, Beijing 100034, Peoples R China; [Xiong, Xiao-Ming] Maternal & Child Hlth Hosp Nandan Cty, Dept Obstet & Gynecol, Hechi 547200, Peoples R China; [Yang, Mei; Gao, Shan] Maternal & Child Hlth Hosp Nanning City, Matern Care Dept, Nanning 530011, Peoples R China; [Zhang, Di-Hua] Maternal & Child Hlth Hosp Nanning City, Child Care Dept, Nanning 530011, Peoples R China	Peking University	Zhu, YF (corresponding author), Maternal & Child Hlth Hosp Nanning City, Dept Anesthesia, Nanning 530011, Peoples R China.	xingjijuan123@163.com; 1069052046@qq.com			Scientific and Technological Key Project of Nanning City [20133189]	Scientific and Technological Key Project of Nanning City	This work was supported by the Scientific and Technological Key Project of Nanning City (no. 20133189).	Ashton-Miller JA, 2009, ANNU REV BIOMED ENG, V11, P163, DOI 10.1146/annurev-bioeng-061008-124823; BO K, 1990, NEUROUROL URODYNAM, V9, P479, DOI 10.1002/nau.1930090504; BO K, 1992, NEUROUROL URODYNAM, V11, P107, DOI 10.1002/nau.1930110205; Bo K, 1990, NEUROUROL URODYNAM, V9, P395; Caroci AD, 2010, J CLIN NURS, V19, P2424, DOI 10.1111/j.1365-2702.2010.03289.x; Costantini S, 2006, ULTRASOUND OBST GYN, V27, P183, DOI 10.1002/uog.2663; Ding T, 2014, ANESTH ANALG, V119, P383, DOI 10.1213/ANE.0000000000000107; Feng BB, 2013, CLIN EXP OBSTET GYN, V40, P574; Frawley HC, 2006, INT UROGYNECOL J, V17, P365, DOI 10.1007/s00192-005-0016-3; Gambling D, 2013, ANESTH ANALG, V116, P636, DOI 10.1213/ANE.0b013e31827e4e29; Gou WL, 2003, DELIVERY; Handa VL, 2011, OBSTET GYNECOL, V118, P777, DOI 10.1097/AOG.0b013e3182267f2f; Long Yan, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P808; Lovett RW, 1916, J AMER MED ASSOC, V66, P729; Memon H, 2012, CURR OPIN OBSTET GYN, V24, P349, DOI 10.1097/GCO.0b013e328357628b; Oliveira LS, 2014, SAO PAULO MED J, V132, P231, DOI 10.1590/1516-3180.2014.1324710; Panayi DC, 2009, CURR OPIN OBSTET GYN, V21, P97, DOI 10.1097/GCO.0b013e328321e44b; Qaseem A, 2006, ANN INTERN MED, V144, P575, DOI 10.7326/0003-4819-144-8-200604180-00008; Rofaeel A, 2007, CAN J ANAESTH, V54, P15, DOI 10.1007/BF03021894; Salvesen KA, 2004, BMJ-BRIT MED J, V329, P378, DOI 10.1136/bmj.38163.724306.3A; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shan XM, 2012, CHIN J CLIN OBSTET G, V13, P92; Simmons SW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003401.pub2; Simmons Scott W, 2012, Cochrane Database Syst Rev, V10, pCD003401, DOI 10.1002/14651858.CD003401.pub3; Singh N, 2014, ANN CARD ANAESTH, V17, P177, DOI 10.4103/0971-9784.129892; Torrisi G, 2012, EUR J OBSTET GYN R B, V160, P110, DOI 10.1016/j.ejogrb.2011.10.010; Tsen LC, 1999, ANESTHESIOLOGY, V91, P920, DOI 10.1097/00000542-199910000-00010; Van de Velde M, 2004, ANESTH ANALG, V98, P1153, DOI 10.1213/01.ANE.0000101980.34587.66; Wang SS, 2014, CONT MED, V20, P97; Wisner KL, 2014, ANESTH ANALG, V119, P219, DOI 10.1213/ANE.0000000000000322; Yao ZC, 2014, NURS PRAC RES, V11, P6	31	8	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137267	10.1371/journal.pone.0137267	http://dx.doi.org/10.1371/journal.pone.0137267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340002	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200043
J	Beiderwellen, K; Geraldo, L; Ruhlmann, V; Heusch, P; Gomez, B; Nensa, F; Umutlu, L; Lauenstein, TC				Beiderwellen, Karsten; Geraldo, Llanos; Ruhlmann, Verena; Heusch, Philipp; Gomez, Benedikt; Nensa, Felix; Umutlu, Lale; Lauenstein, Thomas C.			Accuracy of [F-18] FDG PET/MRI for the Detection of Liver Metastases	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; WHOLE-BODY; GADOBENATE DIMEGLUMINE; INITIAL-EXPERIENCE; HEPATIC METASTASES; COLORECTAL-CANCER; LESIONS; MRI; PET/CT; CT	Background The aim of this study was to compare the diagnostic accuracy of [F-18] FDG-PET/MRI with PET/CT for the detection of liver metastases. Methods 32 patients with solid malignancies underwent [18F] FDG-PET/CT and subsequent PET/MRI of the liver. Two readers assessed both datasets regarding lesion characterization (benign, indeterminate, malignant), conspicuity and diagnostic confidence. An imaging follow-up (mean interval: 185 +/- 92 days) and/-or histopathological specimen served as standards of reference. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated for both modalities. Accuracy was determined by calculating the area under the receiver operating characteristic (ROC) curve. Values of conspicuity and diagnostic confidence were compared using Wilcoxon-signed-rank test. Results The standard of reference revealed 113 liver lesions in 26 patients (malignant: n = 45; benign: n = 68). For PET/MRI a higher accuracy (PET/CT: 82.4%; PET/MRI: 96.1%; p<0.001) as well as sensitivity (67.8% vs. 92.2%, p<0.01) and NPV (82.0% vs. 95.1%, p<0.05) were observed. PET/MRI offered higher lesion conspicuity (PET/CT: 2.0 +/- 1.1 [median: 2; range 0-3]; PET/MRI: 2.8 +/- 0.5 [median: 3; range 0-3]; p<0.001) and diagnostic confidence (PET/CT: 2.0 +/- 0.8 [median: 2; range: 1-3]; PET/MRI 2.6 +/- 0.6 [median: 3; range: 1-3]; p<0.001). Furthermore, PET/MRI enabled the detection of additional PET-negative metastases (reader 1: 10; reader 2: 12). Conclusions PET/MRI offers higher diagnostic accuracy compared to PET/CT for the detection of liver metastases.	[Beiderwellen, Karsten; Nensa, Felix; Umutlu, Lale; Lauenstein, Thomas C.] Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Geraldo, Llanos] Univ Hosp Santa Creu & St Pau, Dept Nucl Med, Barcelona, Spain; [Ruhlmann, Verena; Gomez, Benedikt] Univ Duisburg Essen, Univ Hosp Essen, Clin Nucl Med, Essen, Germany; [Heusch, Philipp] Univ Dusseldorf, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany	University of Duisburg Essen; University of Duisburg Essen; Heinrich Heine University Dusseldorf	Beiderwellen, K (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	karsten.beiderwellen@uk-essen.de		Nensa, Felix/0000-0002-5811-7100				Antoch G, 2004, J CLIN ONCOL, V22, P4357, DOI 10.1200/JCO.2004.08.120; Antoch G, 2003, JAMA-J AM MED ASSOC, V290, P3199, DOI 10.1001/jama.290.24.3199; Beiderwellen K, 2013, EUR J RADIOL, V82, pE669, DOI 10.1016/j.ejrad.2013.07.027; Benoist S, 2009, ANN SURG ONCOL, V16, P2385, DOI 10.1245/s10434-009-0492-7; Catalano OA, 2013, RADIOLOGY, V269, P857, DOI 10.1148/radiol.13131306; Chan VO, 2012, IRISH J MED SCI, V181, P499, DOI 10.1007/s11845-012-0805-x; Chan WL, 2011, J MED IMAG RADIAT ON, V55, P379, DOI 10.1111/j.1754-9485.2011.02287.x; Donati OF, 2013, EUR J RADIOL, V82, P822, DOI 10.1016/j.ejrad.2012.12.005; Donati OF, 2010, J NUCL MED, V51, P692, DOI 10.2967/jnumed.109.068510; Fernandez FG, 2004, ANN SURG, V240, P438, DOI 10.1097/01.sla.0000138076.72547.b1; Frankel TL, 2012, J GASTROINTEST ONCOL, V3, P11, DOI 10.3978/j.issn.2078-6891.2012.002; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Holzapfel K, 2012, ABDOM IMAGING, V37, P74, DOI 10.1007/s00261-011-9758-1; Holzapfel K, 2010, EUR J RADIOL, V76, P89, DOI 10.1016/j.ejrad.2009.05.014; Khalil HI, 2005, RADIOLOGY, V235, P872, DOI 10.1148/radiol.2353041099; Kiefer A, 2011, NUKLEARMED-NUCL MED, V50, P147, DOI 10.3413/nukmed-0364; Kim YK, 2004, EUR RADIOL, V14, P5, DOI 10.1007/s00330-003-2115-1; Kim YK, 2011, CLIN RADIOL, V66, P489, DOI 10.1016/j.crad.2010.09.007; Lee JW, 2011, MOL IMAGING BIOL, V13, P565, DOI 10.1007/s11307-010-0394-x; Mentha G, 2013, SEMIN LIVER DIS, V33, P262, DOI 10.1055/s-0033-1351785; Morana G, 2011, INVEST RADIOL, V46, P225, DOI 10.1097/RLI.0b013e3181feee3a; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Petersein J, 2000, RADIOLOGY, V215, P727, DOI 10.1148/radiology.215.3.r00jn14727; Reiner CS, 2014, EUR J NUCL MED MOL I, V41, P649, DOI 10.1007/s00259-013-2654-x; Scharitzer M, 2013, EUR RADIOL, V23, P2187, DOI 10.1007/s00330-013-2824-z; Schwartz LH, 1999, RADIOLOGY, V210, P71, DOI 10.1148/radiology.210.1.r99ja0371; Seo HJ, 2011, INVEST RADIOL, V46, P548, DOI 10.1097/RLI.0b013e31821a2163; Sutherland LM, 2006, ARCH SURG-CHICAGO, V141, P181, DOI 10.1001/archsurg.141.2.181; Tajima T, 2012, JPN J RADIOL, V30, P648, DOI 10.1007/s11604-012-0105-4; Tatsumi M, 2011, INT J CLIN ONCOL, V16, P408, DOI 10.1007/s10147-011-0202-x; Wetter A, 2013, INVEST RADIOL, V48, P256, DOI 10.1097/RLI.0b013e318282c654; Yang DM, 2011, BRIT J RADIOL, V84, P319, DOI 10.1259/bjr/50130643	33	41	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137285	10.1371/journal.pone.0137285	http://dx.doi.org/10.1371/journal.pone.0137285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335246	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400049
J	Bronzwaer, ASGT; Ouweneel, DM; Stok, WJ; Westerhof, BE; van Lieshout, JJ				Bronzwaer, Anne-Sophie G. T.; Ouweneel, Dagmar M.; Stok, Wim J.; Westerhof, Berend E.; van Lieshout, Johannes J.			Arterial Pressure Variation as a Biomarker of Preload Dependency in Spontaneously Breathing Subjects - A Proof of Principle	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; PREDICTING FLUID RESPONSIVENESS; STROKE VOLUME VARIATION; PULSE PRESSURE; CARDIAC-OUTPUT; CENTRAL HYPOVOLEMIA; CRITICALLY-ILL; TIDAL VOLUME; HEAD-UP; TILT	Objective Pulse (PPV) and systolic pressure variation (SPV) quantify variations in arterial pressure related to heart-lung interactions and have been introduced as biomarkers of preload dependency to guide fluid treatment in mechanically ventilated patients. However, respiratory intrathoracic pressure changes during spontaneous breathing are considered too small to affect preload and stroke volume sufficiently for the detection by PPV and/or SPV. This study addressed the effects of paced breathing and/or an external respiratory resistance on PPV and SPV in detecting preload dependency in spontaneously breathing subjects. Methods In 10 healthy subjects, hemodynamic and respiratory parameters were evaluated during progressive central hypovolemia (head-up tilt). Breathing conditions were varied by manipulating breathing frequency and respiratory resistance. Subjects responding with a reduction in stroke volume index >= 15% were classified as having developed preload dependency. The ability for PPV and SPV to predict preload dependency was expressed by the area under the ROC curve (AUC). Results A breathing frequency at 6/min increased the PPV (16 +/- 5% vs. 10 +/- 3%, p<0.001) and SPV (9 +/- 3% vs. 5 +/- 2%, p<0.001) which was further enhanced by an expiratory resistance (PPV: 19 +/- 3%, p = 0.025 and SPV: 10 +/- 2%, p = 0.047). These respiratory modifications, compared to free breathing, enhanced the predictive value of PPV with higher accuracy (AUC: 0.92 vs. 0.46). Conclusion Under conditions of progressive central hypovolemia, the application of an external respiratory resistance at a breathing frequency of 6/min enhanced PPV and SPV and is worth further study for detection of preload dependency from arterial pressure variations in non-ventilated subjects.	[Bronzwaer, Anne-Sophie G. T.; van Lieshout, Johannes J.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Ouweneel, Dagmar M.] Univ Amsterdam, Acad Med Ctr, AMC Heart Ctr, NL-1105 AZ Amsterdam, Netherlands; [Stok, Wim J.; van Lieshout, Johannes J.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands; [Bronzwaer, Anne-Sophie G. T.; Ouweneel, Dagmar M.; Stok, Wim J.; Westerhof, Berend E.; van Lieshout, Johannes J.] Univ Amsterdam, Acad Med Ctr, Ctr Heart Failure Res, Lab Clin Cardiovasc Physiol, NL-1105 AZ Amsterdam, Netherlands; [Westerhof, Berend E.] Edwards Lifesci BMEYE, Amsterdam, Netherlands; [van Lieshout, Johannes J.] Univ Nottingham, Sch Med, MRC Arthrit Res UK Ctr Musculoskeletal Ageing Res, Queens Med Ctr,Sch Life Sci, Nottingham, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Edwards Lifesciences; University of Nottingham	van Lieshout, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands.	j.j.vanlieshout@amc.uva.nl	Van Lieshout, Johannes/P-5499-2019; van Lieshout, Johannes J/B-6674-2011	Van Lieshout, Johannes/0000-0002-3646-2122; van Lieshout, Johannes J/0000-0002-3646-2122; Ouweneel, Dagmar/0000-0003-3857-7000				Bartels SA, 2011, J CLIN MONIT COMPUT, V25, P315, DOI 10.1007/s10877-011-9310-4; Bendjelid K, 2003, INTENS CARE MED, V29, P352, DOI 10.1007/s00134-002-1615-9; Bogert LWJ, 2010, ANAESTHESIA, V65, P1119, DOI 10.1111/j.1365-2044.2010.06511.x; Bronzwaer ASGT, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00157; Bundgaard-Nielsen M, 2009, BR J ANAESTH; Convertino VA, 2007, CRIT CARE MED, V35, P1145, DOI 10.1097/01.CCM.0000259464.83188.2C; Dahl MK, 2009, CRIT CARE, V13, DOI 10.1186/cc7760; De Backer D, 2005, INTENS CARE MED, V31, P517, DOI 10.1007/s00134-005-2586-4; De Backer D, 2009, ANESTHESIOLOGY, V110, P1092, DOI 10.1097/ALN.0b013e31819db2a1; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Gisolf J, 2004, AVIAT SPACE ENVIR MD, V75, P1086; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harms MPM, 2003, EXP PHYSIOL, V88, P611, DOI 10.1113/eph8802580; Heenen S, 2006, CRIT CARE, V10, DOI 10.1186/cc4970; Hofer Christoph K, 2011, Acta Anaesthesiol Taiwan, V49, P59, DOI 10.1016/j.aat.2011.05.001; Idris AH, 2007, RESP CARE, V52, P177; Jans O, 2012, BRIT J ANAESTH, V108, P436, DOI 10.1093/bja/aer403; Kim HK, 2008, CRIT CARE MED, V36, P2858, DOI 10.1097/CCM.0b013e3181865aea; Lansdorp B, 2011, BRJ ANAESTH; LENFANT C, 1967, J APPL PHYSIOL, V22, P675, DOI 10.1152/jappl.1967.22.4.675; Marik PE, 2009, CRIT CARE MED, V37, P2642, DOI 10.1097/CCM.0b013e3181a590da; MATZEN S, 1991, CLIN PHYSIOL, V11, P411, DOI 10.1111/j.1475-097X.1991.tb00813.x; Michard F, 2002, CHEST, V121, P2000, DOI 10.1378/chest.121.6.2000; Michard F, 2000, AM J RESP CRIT CARE, V162, P134, DOI 10.1164/ajrccm.162.1.9903035; Monnet X, 2007, CURR OPIN CRIT CARE, V13, P549, DOI 10.1097/MCC.0b013e3282ec68b2; MORENO AH, 1967, AM J PHYSIOL, V213, P455, DOI 10.1152/ajplegacy.1967.213.2.455; Muller L, 2010, INTENS CARE MED, V36, P496, DOI 10.1007/s00134-009-1686-y; Pinsky MR, 2007, CURR OPIN CRIT CARE, V13, P528, DOI 10.1097/MCC.0b013e3282efad97; Preisman S, 2005, BRIT J ANAESTH, V95, P746, DOI 10.1093/bja/aei262; PRIBAN IP, 1963, J PHYSIOL-LONDON, V166, P425, DOI 10.1113/jphysiol.1963.sp007114; Secher N H, 2011, CLIN FLUID THERAPY P, P166; Shum HP, 2011, J CRIT CARE, V26, P613, DOI 10.1016/j.jcrc.2011.02.008; Soubrier S, 2007, INTENS CARE MED, V33, P1117, DOI 10.1007/s00134-007-0644-9; Vallee F, 2009, INTENS CARE MED, V35, P1004, DOI 10.1007/s00134-009-1478-4; van Lieshout JJ, 2005, ACTA ANAESTH SCAND, V49, P1287, DOI 10.1111/j.1399-6576.2005.00841.x; Westerdahl E, 2001, J REHABIL MED, V33, P79; Zollei E, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-40	37	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137364	10.1371/journal.pone.0137364	http://dx.doi.org/10.1371/journal.pone.0137364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335939	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400055
J	Janganan, TK; Chen, GY; Chen, DL; Menino, JF; Rodrigues, F; Borges-Walmsley, MI; Walmsley, AR				Janganan, Thamarai K.; Chen, Gongyou; Chen, Daliang; Menino, Joao F.; Rodrigues, Fernando; Borges-Walmsley, Maria I.; Walmsley, Adrian R.			A G beta protein and the TupA Co-Regulator Bind to Protein Kinase A Tpk2 to Act as Antagonistic Molecular Switches of Fungal Morphological Changes	PLOS ONE			English	Article							TRANSCRIPTIONAL CO-REPRESSOR; CANDIDA-ALBICANS SFL1; KELCH-REPEAT PROTEINS; STALK-LIKE STRUCTURES; SACCHAROMYCES-CEREVISIAE; CYCLIC-AMP; G-ALPHA; ADENYLATE-CYCLASE; PARACOCCIDIOIDES-BRASILIENSIS; COUPLED RECEPTOR	The human pathogenic fungus Paracoccidioides brasiliensis (Pb) undergoes a morphological transition from a saprobic mycelium to pathogenic yeast that is controlled by the cAMP-signaling pathway. There is a change in the expression of the G beta-protein PbGpb1, which interacts with adenylate cyclase, during this morphological transition. We exploited the fact that the cAMP-signaling pathway of Saccharomyces cerevisiae does not include a G beta-protein to probe the functional role of PbGpb1. We present data that indicates that PbGpb1 and the transcriptional regulator PbTupA both bind to the PKA protein PbTpk2. PbTPK2 was able to complement a TPK2 Delta strain of S. cerevisiae, XPY5a/alpha, which was defective in pseudohyphal growth. Whilst PbGPB1 had no effect on the parent S. cerevisiae strain, MLY61a/alpha, it repressed the filamentous growth of XPY5a/alpha transformed with PbTPK2, behaviour that correlated with a reduced expression of the floculin FLO11. In vitro, PbGpb1 reduced the kinase activity of PbTpk2, suggesting that inhibition of PbTpk2 by PbGpb1 reduces the level of expression of Flo11, antagonizing the filamentous growth of the cells. In contrast, expressing the co-regulator PbTUPA in XPY5a/alpha cells transformed with PbTPK2, but not untransformed cells, induced hyperfilamentous growth, which could be antagonized by co-transforming the cells with PbGPB1. PbTUPA was unable to induce the hyperfilamentous growth of a FLO8 Delta strain, suggesting that PbTupA functions in conjunction with the transcription factor Flo8 to control Flo11 expression. Our data indicates that P. brasiliensis PbGpb1 and PbTupA, both of which have WD/beta-propeller structures, bind to PbTpk2 to act as antagonistic molecular switches of cell morphology, with PbTupA and PbGpb1 inducing and repressing filamentous growth, respectively. Our findings define a potential mechanism for controlling the morphological switch that underpins the virulence of dimorphic fungi.	[Janganan, Thamarai K.; Chen, Gongyou; Chen, Daliang; Borges-Walmsley, Maria I.; Walmsley, Adrian R.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Menino, Joao F.; Rodrigues, Fernando] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Menino, Joao F.] Univ Minho, ICVS PT Govt Associate Lab 3Bs, Braga, Portugal	Durham University; Universidade do Minho; Universidade do Minho	Borges-Walmsley, MI (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	i.borgeswalmsley@me.com	Janganan, Thamarai/AAQ-8705-2020; CHEN, Gongyou/AAA-9694-2019; Rodrigues, Fernando/T-5299-2018	CHEN, Gongyou/0000-0003-1979-2880; Rodrigues, Fernando/0000-0001-8436-9398; Menino, Joao/0000-0003-3778-1747	Wellcome Trust [069445]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Wellcome Trust 069445, and GC and DC were the recipients of Wellcome Trust travelling fellowships. (Wellcome.ac.uk.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Bahn YS, 2007, EUKARYOT CELL, V6, P2376, DOI 10.1128/EC.00318-07; Barrales RR, 2008, GENETICS, V178, P145, DOI 10.1534/genetics.107.081315; Batlle M, 2003, J CELL SCI, V116, P701, DOI 10.1242/jcs.00266; Bauer J, 2007, EUKARYOT CELL, V6, P1736, DOI 10.1128/EC.00236-07; Baum S, 2004, BIOCHEM J, V380, P823, DOI 10.1042/BJ20031962; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Borba CD, 2002, MYCOSES, V45, P174, DOI 10.1046/j.1439-0507.2002.00752.x; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; Cao F, 2006, MOL BIOL CELL, V17, P295, DOI 10.1091/mbc.E05-06-0502; Chen DL, 2007, MOL MICROBIOL, V65, P761, DOI 10.1111/j.1365-2958.2007.05824.x; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Conlan RS, 1999, J BIOL CHEM, V274, P205, DOI 10.1074/jbc.274.1.205; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Engelberg D, 1998, J BACTERIOL, V180, P3992, DOI 10.1128/JB.180.15.3992-3996.1998; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Garcia-Sanchez S, 2005, MOL BIOL CELL, V16, P2913, DOI 10.1091/mbc.E05-01-0071; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; Goes T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003173; GOLD S, 1994, GENE DEV, V8, P2805, DOI 10.1101/gad.8.23.2805; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Grosse C, 2008, APPL ENVIRON MICROB, V74, P4923, DOI 10.1128/AEM.00470-08; Harashima T, 2002, MOL CELL, V10, P163, DOI 10.1016/S1097-2765(02)00569-5; Hirschman JE, 1999, MOL CELL BIOL, V19, P7705; Hoffman CS, 2005, EUKARYOT CELL, V4, P495, DOI 10.1128/EC.4.3.495-503.2005; Hwang CS, 2003, MOL MICROBIOL, V47, P1029, DOI 10.1046/j.1365-2958.2003.03353.x; Ivey FD, 2005, P NATL ACAD SCI USA, V102, P6108, DOI 10.1073/pnas.0502270102; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; Kennedy EJ, 2008, J BIOL CHEM, V283, P1084, DOI 10.1074/jbc.M704028200; Khalaf RA, 2001, GENETICS, V157, P1503; Kido M, 2002, J BIOL CHEM, V277, P3117, DOI 10.1074/jbc.M109526200; Klein BS, 2007, CURR OPIN MICROBIOL, V10, P314, DOI 10.1016/j.mib.2007.04.002; Klosterman SJ, 2007, ADV GENET, V57, P1, DOI 10.1016/S0065-2660(06)57001-4; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; Lee N, 2003, ANNU REV PHYTOPATHOL, V41, P399, DOI 10.1146/annurev.phyto.41.052002.095728; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Li Y, 2007, EUKARYOT CELL, V6, P2112, DOI 10.1128/EC.00199-07; Liebmann B, 2004, INFECT IMMUN, V72, P5193, DOI 10.1128/IAI.72.9.5193-5203.2004; Liu H, 2007, EMBO J, V26, P690, DOI 10.1038/sj.emboj.7601536; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Lorenz MC, 1997, EMBO J, V16, P7008, DOI 10.1093/emboj/16.23.7008; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; MBONYI K, 1990, MOL CELL BIOL, V10, P4518, DOI 10.1128/MCB.10.9.4518; MEDOFF J, 1981, J BACTERIOL, V145, P1452, DOI 10.1128/JB.145.3.1452-1455.1981; Menino Joao F, 2012, Methods Mol Biol, V845, P187, DOI 10.1007/978-1-61779-539-8_12; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Pan XW, 2000, CURR OPIN MICROBIOL, V3, P567, DOI 10.1016/S1369-5274(00)00142-9; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Pan XW, 1999, MOL CELL BIOL, V19, P4874; PARIS S, 1985, MYCOPATHOLOGIA, V92, P115, DOI 10.1007/BF00444093; Peeters T, 2007, TRENDS BIOCHEM SCI, V32, P547, DOI 10.1016/j.tibs.2007.09.011; Peeters T, 2006, P NATL ACAD SCI USA, V103, P13034, DOI 10.1073/pnas.0509644103; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; SASS P, 1986, P NATL ACAD SCI USA, V83, P9303, DOI 10.1073/pnas.83.24.9303; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Scherz R, 2001, J BACTERIOL, V183, P5402, DOI 10.1128/JB.183.18.5402-5413.2001; Sezen B, 2009, GENE DEV, V23, P1559, DOI 10.1101/gad.524209; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Slessareva JE, 2006, SCIENCE, V314, P1412, DOI 10.1126/science.1134041; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; Storlazzi A, 1999, Mol Cell Biol Res Commun, V2, P172, DOI 10.1006/mcbr.1999.0169; THEVELEIN JM, 1985, J GEN MICROBIOL, V131, P3199; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Todd RB, 2003, MOL MICROBIOL, V48, P85, DOI 10.1046/j.1365-2958.2003.03426.x; Torres I, 2014, FEMS YEAST RES, V14, P270, DOI 10.1111/1567-1364.12099; Tudisca V, 2010, EUR J CELL BIOL, V89, P339, DOI 10.1016/j.ejcb.2009.08.005; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; UNO I, 1985, P NATL ACAD SCI USA, V82, P7855, DOI 10.1073/pnas.82.23.7855; Valerius O, 2007, MOL CELL PROTEOMICS, V6, P1968, DOI 10.1074/mcp.M700184-MCP200; Versele M, 1999, EMBO J, V18, P5577, DOI 10.1093/emboj/18.20.5577; Versele M, 2001, EMBO REP, V2, P574, DOI 10.1093/embo-reports/kve132; WILSON RB, 1988, MOL CELL BIOL, V8, P505, DOI 10.1128/MCB.8.1.505; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200; Zhao W, 2006, INFECT IMMUN, V74, P4865, DOI 10.1128/IAI.00565-06; ZOLLER MJ, 1988, J BIOL CHEM, V263, P9142	99	1	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136866	10.1371/journal.pone.0136866	http://dx.doi.org/10.1371/journal.pone.0136866			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334875	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000360615400030
J	Junek, T; Vymyslicka, PJ; Hozdecka, K; Hejcmanova, P				Junek, Tomas; Vymyslicka, Pavla Junkova; Hozdecka, Katerina; Hejcmanova, Pavla			Application of Spatial and Closed Capture-Recapture Models on Known Population of the Western Derby Eland (Taurotragus derbianus derbianus) in Senegal	PLOS ONE			English	Article							CAMERA-TRAP; DENSITY-ESTIMATION; ABUNDANCE; SIZE; WILDLIFE; DESIGNS; BIASES; RANGE	Camera trapping with capture-recapture analyses has provided estimates of the abundances of elusive species over the last two decades. Closed capture-recapture models (CR) based on the recognition of individuals and incorporating natural heterogeneity in capture probabilities are considered robust tools; however, closure assumption is often questionable and the use of an M-h jackknife estimator may fail in estimations of real abundance when the heterogeneity is high and data is sparse. A novel, spatially explicit capture-recapture (SECR) approach based on the location-specific capture histories of individuals overcomes the limitations of closed models. We applied both methods on a closed population of 16 critically endangered Western Derby elands in the fenced 1,060-ha Fathala reserve, Senegal. We analyzed the data from 30 cameras operating during a 66-day sampling period deployed in two densities in grid and line arrays. We captured and identified all 16 individuals in 962 trap-days. Abundances were estimated in the programs CAPTURE (models M-0, Mh and Mh Chao) and R, package secr (basic Null and Finite mixture models), and compared with the true population size. We specified 66 days as a threshold in which SECR provides an accurate estimate in all trapping designs within the 7-times divergent density from 0.004 to 0.028 camera trap/ha. Both SECR models showed uniform tendency to overestimate abundance when sampling lasted shorter with no major differences between their outputs. Unlike the closed models, SECR performed well in the line patterns, which indicates promising potential for linear sampling of properly defined habitats of non-territorial and identifiable herbivores in dense wooded savanna conditions. The CR models provided reliable estimates in the grid and we confirmed the advantage of Mh Chao estimator over Mh jackknife when data appeared sparse. We also demonstrated the pooling of trapping occasions with an increase in the capture probabilities, avoiding violation of results.	[Junek, Tomas; Vymyslicka, Pavla Junkova] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague 16521 6, Suchdol, Czech Republic; [Hozdecka, Katerina; Hejcmanova, Pavla] Czech Univ Life Sci Prague, Fac Trop AgriSci, Dept Anim Sci & Food Proc, Prague 16521 6, Suchdol, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Junek, T (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Kamycka 129, Prague 16521 6, Suchdol, Czech Republic.	tjunek@fzp.czu.cz	Hejcmanová, Pavla/AAD-4910-2021; Vymyslická, Pavla Jůnková/ABH-9466-2020	Hejcmanová, Pavla/0000-0001-9547-4302; Vymyslická, Pavla Jůnková/0000-0001-6915-1876	grant CIGA [20134220]; Czech University of Life Sciences Prague; Postdok CZU [CZ.1.07/2.3.00/30.0040]; Czech University of Life Sciences Prague (CIGA) [20134217]	grant CIGA; Czech University of Life Sciences Prague; Postdok CZU; Czech University of Life Sciences Prague (CIGA)	The project was financially supported by the grant CIGA, reg. No. 20134220 (principal investigator Tomas Junek), provided by the Czech University of Life Sciences Prague and Postdok CZU (ESF and MEYS CZ.1.07/2.3.00/30.0040), principal investigator Pavla Junkova Vymyslicka, provided by the Czech University of Life Sciences Prague (http://www.czu.cz/en/), and Grant of Czech University of Life Sciences Prague (CIGA, reg. number 20134217, principal investigator Pavla Junkova Vymyslicka). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anile S, 2014, J ZOOL, V293, P252, DOI 10.1111/jzo.12141; [Anonymous], 1991, USERS GUIDE INTERACT; Barnes RFW, 1999, MAMMAL REV, V29, P175, DOI 10.1046/j.1365-2907.1999.00044.x; Barrier NF, 2013, APPL PHOTOGRAPHIC CA, V8, P388; Bengsen AJ, 2011, J WILDLIFE MANAGE, V75, P1222, DOI 10.1002/jwmg.132; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Brandlova K., 2013, W DERBY ELAND TAUROT; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; Burton AC, 2011, BIOL CONSERV, V144, P2344, DOI 10.1016/j.biocon.2011.06.014; Cassey P, 1999, ENVIRONMETRICS, V10, P261, DOI 10.1002/(SICI)1099-095X(199905/06)10:3<261::AID-ENV351>3.0.CO;2-O; CHAO A, 1989, BIOMETRICS, V45, P427, DOI 10.2307/2531487; Chao A, 1987, ESTIMATING POPULATIO; Cooch E, 2009, PROGRAM MARK GENTLE, P1; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Dumond M, 2015, WILDLIFE SOC B, V9999, P1; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford MG, 2011, ECOLOGY, V92, P2202, DOI 10.1890/11-0332.1; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Gerber BD, 2015, ECOL APPL, V25, P695, DOI 10.1890/14-0960.1; Gompper M, 2006, WILDLIFE SOC, V34; Harmsen BJ, 2011, POPUL ECOL, V53, P253, DOI 10.1007/s10144-010-0211-z; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Heilbrun RD, 2006, WILDLIFE SOC B, V34, P69, DOI 10.2193/0091-7648(2006)34[69:EBAUAT]2.0.CO;2; Henschel P, 2010, CATNEWS, P2006; Henschel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083500; HILLMAN JC, 1988, AFR J ECOL, V26, P135, DOI 10.1111/j.1365-2028.1988.tb00964.x; Howe EJ, 2013, POPUL ECOL, V55, P595, DOI 10.1007/s10144-013-0389-y; Ivan JS, 2013, ECOLOGY, V94, P817, DOI 10.1890/12-0102.1; Jachmann H, 2002, J APPL ECOL, V39, P841, DOI 10.1046/j.1365-2664.2002.00752.x; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Kelly MJ, 2008, J MAMMAL, V89, P408, DOI 10.1644/06-MAMM-A-424R.1; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Kolackova K, 2011, WILDLIFE BIOL, V17, P299, DOI 10.2981/10-019; Larrucea ES, 2007, J WILDLIFE MANAGE, V71, P1682, DOI 10.2193/2006-407; Li XY, 2014, POPUL ECOL, V56, P251, DOI 10.1007/s10144-013-0405-2; Maffei L, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P119, DOI 10.1007/978-4-431-99495-4_8; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; Marques TA, 2012, J ORNITHOL, V152, pS445, DOI 10.1007/s10336-010-0535-7; MENKENS GE, 1988, ECOLOGY, V69, P1952, DOI 10.2307/1941172; Nezerkova P, 2004, SOIL CONSERVATION; Nezerkova-Hejcmanova P, 2005, BELG J BOT, V138, P119; O'Brien TG, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P71, DOI 10.1007/978-4-431-99495-4_6; Ogutu JO, 2006, J ZOOL, V269, P149, DOI 10.1111/j.1469-7998.2006.00055.x; Ogutu JO, 2012, BIODIVERS CONSERV, V21, P1033, DOI 10.1007/s10531-012-0239-9; Otis DL., 1982, CAPTURE RECAPTURE RE; Redfern JV, 2002, S AFR J SCI, V98, P455; Renaud PC, 2006, INVENTAIRE AERIEN TE, P74; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Royle JA, 2013, ECOLOGY, V94, P287, DOI 10.1890/12-0413.1; Schipper J., 2007, SMALL CARNIVORE CONS, V36, P38; Sharma RK, 2010, ANIM CONSERV, V13, P94, DOI 10.1111/j.1469-1795.2009.00305.x; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Tchamba MN, 1996, BIOL CONSERV, V75, P35, DOI 10.1016/0006-3207(95)00040-2; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Treves A, 2010, BIOL CONSERV, V143, P521, DOI 10.1016/j.biocon.2009.11.025; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2; Vanderhoff E. Natasha, 2011, Mastozool. neotrop., V18, P271; Wallace R. B., 2003, Mastozoologia Neotropical, V10, P133; Wang SW, 2009, BIOL CONSERV, V142, P606, DOI 10.1016/j.biocon.2008.11.023; Weingarth K, 2012, WALDOKOLOGIE LANDSCH, P1	63	7	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136525	10.1371/journal.pone.0136525	http://dx.doi.org/10.1371/journal.pone.0136525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334997	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400015
J	Rennung, M; Goritz, AS				Rennung, Miriam; Goeritz, Anja S.			Facing Sorrow as a Group Unites. Facing Sorrow in a Group Divides	PLOS ONE			English	Article							EMOTION; MOOD; INFORMATION; SOLIDARITY; JUDGMENTS; AROUSAL; MODEL; SELF; BIAS; CONSTRUCTION	Collective gatherings foster group cohesion through providing occasion for emotional sharing among participants. However, prior studies have failed to disentangle two processes that are involved in emotional sharing: 1) focusing shared attention on the same emotion-eliciting event and 2) actively sharing one's experiences and disclosing one's feelings to others. To date, it has remained untested if shared attention influences group cohesion independent of active emotional sharing. Our experiment investigated the effect of shared versus individual attention on cohesion in groups of strangers. We predicted that differences in group cohesion as called forth by shared vs. individual attention are most pronounced when experiencing highly arousing negative affect, in that the act of experiencing intensely negative affect with others buffers negative affect's otherwise detrimental effect on group cohesion. Two-hundred sixteen participants were assembled in groups of 3 to 4 people to either watch an emotion-eliciting film simultaneously on a common screen or to watch the same emotion-eliciting film clip on a laptop in front of each group member using earphones. The film clips were chosen to elicit either highly arousing negative affect or one of three other affective states representing the other poles in Russel's Circumplex model of affect. We examined self-reported affective and cognitive group cohesion and a behavioral measure of group cohesion. Results support our buffer-hypothesis, in that experiencing intense negative affect in unison leads to higher levels of group cohesion than experiencing this affect individually despite the group setting. The present study demonstrates that shared attention to intense negative emotional stimuli affects group cohesion independently of active emotional sharing.	[Rennung, Miriam; Goeritz, Anja S.] Univ Freiburg, Dept Occupat & Consumer Psychol, D-79085 Freiburg, Germany	University of Freiburg	Rennung, M (corresponding author), Univ Freiburg, Dept Occupat & Consumer Psychol, D-79085 Freiburg, Germany.	miriam.rennung@psychologie.uni-freiburg.de		Goritz, Anja/0000-0002-4638-0489	German Research Foundation (DFG) [GO 1107/13-1]; Albert Ludwigs University Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work was supported by research Grant GO 1107/13-1 to Anja Goritz from the German Research Foundation (DFG): www.dfg.de. The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg.	Aron A, 2000, J PERS SOC PSYCHOL, V78, P273, DOI 10.1037/0022-3514.78.2.273; ARONSON E, 1959, J ABNORM SOC PSYCH, V59, P177, DOI 10.1037/h0047195; ASHFORTH BE, 1995, HUM RELAT, V48, P97, DOI 10.1177/001872679504800201; Barsade SG, 2002, ADMIN SCI QUART, V47, P644, DOI 10.2307/3094912; Barsade SG, 1998, RES MANAG GRP TEAM, V1, P81; Bartel CA, 2000, ADMIN SCI QUART, V45, P197, DOI 10.2307/2667070; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; BILLIG M, 1973, EUR J SOC PSYCHOL, V3, P27, DOI 10.1002/ejsp.2420030103; BOLLEN KA, 1990, SOC FORCES, V69, P479, DOI 10.2307/2579670; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cameron JE, 2004, SELF IDENTITY, V3, P239, DOI 10.1080/13576500444000047; CLARK MS, 1983, SOC PSYCHOL QUART, V46, P31, DOI 10.2307/3033658; Clore G.L., 1994, HDB SOCIAL COGNITION, P323; Collins R, 2004, SOCIOL THEOR, V22, P53, DOI 10.1111/j.1467-9558.2004.00204.x; Collins R, 2005, INTERACTION RITUAL C; Collins Randall, 2010, MICROSOCIOLOGY RELIG; DEMEIJER M, 1989, J NONVERBAL BEHAV, V13, P247, DOI 10.1007/BF00990296; Dion KL., 2000, GROUP DYN-THEOR RES, V4, P7, DOI [10.1037/1089-2699.4.1.7, DOI 10.1037/1089-2699.4.1.7]; Douglas SP, 2007, J INT MARKETING, V15, P30, DOI 10.1509/jimk.15.1.030; Dunlop WL, 2011, GROUP DYN-THEOR RES, V15, P258, DOI 10.1037/a0023642; Dunn JR, 2005, J PERS SOC PSYCHOL, V88, P736, DOI 10.1037/0022-3514.88.5.736; Durkheim Emile, 1912, FORMES ELEMENTAIRES; ERBER R, 1991, J EXP SOC PSYCHOL, V27, P480, DOI 10.1016/0022-1031(91)90005-Q; FORGAS JP, 1990, EUR J SOC PSYCHOL, V20, P441, DOI 10.1002/ejsp.2420200506; FORGAS JP, 1995, PSYCHOL BULL, V117, P39, DOI 10.1037/0033-2909.117.1.39; FORGAS JP, 1987, J PERS SOC PSYCHOL, V53, P53, DOI 10.1037/0022-3514.53.1.53; Forgas JP, 2001, ORGAN BEHAV HUM DEC, V86, P3, DOI 10.1006/obhd.2001.2971; FORGAS JP, 1988, AUST J PSYCHOL, V40, P125, DOI 10.1080/00049538808259077; Gaertner L, 1998, EUR J SOC PSYCHOL, V28, P963, DOI 10.1002/(SICI)1099-0992(1998110)28:6<963::AID-EJSP905>3.0.CO;2-S; Gill SP, 2012, AI SOC, V27, P111, DOI 10.1007/s00146-011-0362-2; Goldenberg A, 2014, J PERS SOC PSYCHOL, V107, P581, DOI 10.1037/a0037462; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Hawdon J, 2011, SOC FORCES, V89, P1363, DOI 10.1093/sf/89.4.1363; Hayes AF, 2015, MULTIVAR BEHAV RES, V50, P1, DOI 10.1080/00273171.2014.962683; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; ISEN AM, 1970, J PERS SOC PSYCHOL, V15, P294, DOI 10.1037/h0029610; Johnson KJ, 2005, PSYCHOL SCI, V16, P875, DOI 10.1111/j.1467-9280.2005.01631.x; Kelly JR, 2001, ORGAN BEHAV HUM DEC, V86, P99, DOI 10.1006/obhd.2001.2974; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Klep A, 2011, EUR J SOC PSYCHOL, V41, P312, DOI 10.1002/ejsp.775; Kokal I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027272; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; Kuppens P, 2013, PSYCHOL BULL, V139, P917, DOI 10.1037/a0030811; Lavelle JJ, 2016, J BUS ETHICS, V136, P43, DOI 10.1007/s10551-014-2500-5; Lodewijkx HFM, 2005, SMALL GR RES, V36, P237, DOI 10.1177/1046496404272381; Nelson DW, 2009, J POSIT PSYCHOL, V4, P53, DOI 10.1080/17439760802357859; Nummenmaa L, 2014, NEUROIMAGE, V102, P498, DOI 10.1016/j.neuroimage.2014.07.063; Nummenmaa L, 2012, P NATL ACAD SCI USA, V109, P9599, DOI 10.1073/pnas.1206095109; Paez D, 2015, J PERS SOC PSYCHOL, V108, P711, DOI 10.1037/pspi0000014; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Pinel EC, 2006, J PERS SOC PSYCHOL, V90, P243, DOI 10.1037/0022-3514.90.2.243; Reddish P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071182; Rime B, 2007, J SOC ISSUES, V63, P307, DOI 10.1111/j.1540-4560.2007.00510.x; Rime B, 2009, EMOT REV, V1, P60, DOI 10.1177/1754073908097189; ROSS L, 1977, J EXP SOC PSYCHOL, V13, P279, DOI 10.1016/0022-1031(77)90049-X; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Schachter S, 1959, STANFORD STUDIES PSY, V1; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Seashore S., 1954, GROUP COHESIVENESS I; Shaw JC, 2003, J APPL PSYCHOL, V88, P444, DOI 10.1037/0021-9010.88.3.444; Singh S. N., 1989, PSYCHOL MARKET, V6, P1; Spoor JR, 2004, GROUP PROCESS INTERG, V7, P398, DOI 10.1177/1368430204046145; Storbeck J, 2008, SOC PERSONAL PSYCHOL, V2, P1824, DOI 10.1111/j.1751-9004.2008.00138.x; Swann WB, 2012, PSYCHOL REV, V119, P441, DOI 10.1037/a0028589; von Scheve C, 2013, EMOT REV, V5, P406, DOI 10.1177/1754073913484170; Wegge J, 2012, STRESS HEALTH, V28, P123, DOI 10.1002/smi.1412; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; Whelan DC, 2012, SOC PSYCHOL PERS SCI, V3, P430, DOI 10.1177/1948550611425194; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Woosnam KM, 2010, J TRAVEL RES, V49, P365, DOI 10.1177/0047287509346858; Xygalatas D, 2013, PSYCHOL SCI, V24, P1602, DOI 10.1177/0956797612472910	75	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136750	10.1371/journal.pone.0136750	http://dx.doi.org/10.1371/journal.pone.0136750			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ5AJ	26335924	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400023
J	Ahuja, P; Nair, S; Narayan, S; Gratzl, M				Ahuja, Punkaj; Nair, Sumitha; Narayan, Sreenath; Gratzl, Miklos			Functional Imaging of Chemically Active Surfaces with Optical Reporter Microbeads	PLOS ONE			English	Article							SCANNING ELECTROCHEMICAL MICROSCOPY; SINGLE LIVING CELLS; SELECTIVE OPTODES; PEBBLE SENSORS; FABRICATION; VISUALIZATION; DIOXIDE; PROBE; IONS	We have developed a novel approach to allow for continuous imaging of concentration fields that evolve at surfaces due to release, uptake, and mass transport of molecules, without significant interference of the concentration fields by the chemical imaging itself. The technique utilizes optical "reporter" microbeads immobilized in a thin layer of transparent and inert hydrogel on top of the surface. The hydrogel has minimal density and therefore diffusion in and across it is like in water. Imaging the immobilized microbeads over time provides quantitative concentration measurements at each location where an optical reporter resides. Using image analysis in post-processing these spatially discrete measurements can be transformed into contiguous maps of the dynamic concentration field across the entire surface. If the microbeads are small enough relative to the dimensions of the region of interest and sparsely applied then chemical imaging will not noticeably affect the evolution of concentration fields. In this work colorimetric optode microbeads a few micrometers in diameter were used to image surface concentration distributions on the millimeter scale.	[Ahuja, Punkaj; Nair, Sumitha; Narayan, Sreenath; Gratzl, Miklos] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University	Gratzl, M (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	miklos.gratzl@case.edu						Amemiya S, 2006, ANAL BIOANAL CHEM, V386, P458, DOI 10.1007/s00216-006-0510-6; Atamanchuk D, 2014, LIMNOL OCEANOGR-METH, V12, P63, DOI 10.4319/lom.2014.12.63; BALDINI F, 1992, SENSOR ACTUAT B-CHEM, V7, P752, DOI 10.1016/0925-4005(92)80398-H; Bard A. J., 2012, SCANNING ELECTROCHEM, V2nd; BARD AJ, 1989, ANAL CHEM, V61, P132, DOI 10.1021/ac00177a011; Black M, 2005, MEAS SCI TECHNOL, V16, P174, DOI 10.1088/0957-0233/16/1/023; Buhlmann P, 1998, CHEM REV, V98, P1593, DOI 10.1021/cr970113+; Bychkova V, 2009, ANAL CHEM, V81, P2325, DOI 10.1021/ac8024619; Clark HA, 1999, ANAL CHEM, V71, P4831, DOI 10.1021/ac990629o; Conn P.M., 2012, IMAGING SPECTROSCOPI; Crank J, 2009, MATH DIFFUSION; Cussler E.L., 1997, DIFFUSION MASS TRANS; DELBIANCO A, 1993, SENSOR ACTUAT B-CHEM, V11, P347, DOI 10.1016/0925-4005(93)85274-E; DICKERT FL, 1988, ANAL CHEM, V60, P1377, DOI 10.1021/ac00165a005; ENGSTROM RC, 1989, ANAL CHEM, V61, pA1099, DOI 10.1021/ac00194a002; Grime JMA, 2008, P NATL ACAD SCI USA, V105, P14277, DOI 10.1073/pnas.0803720105; Institute of Electrical and Electronics Engineers, 1998, AUT FAC GEST REC 199; Kim G, 2010, ANAL CHEM, V82, P2165, DOI 10.1021/ac9024544; KURATLI M, 1994, ANAL CHEM, V66, P85, DOI 10.1021/ac00073a016; KURATLI M, 1993, ANAL CHEM, V65, P3473, DOI 10.1021/ac00071a023; LEE CM, 1990, P NATL ACAD SCI USA, V87, P1740, DOI 10.1073/pnas.87.5.1740; LEE DT, 1980, INT J COMPUT INF SCI, V9, P219, DOI 10.1007/BF00977785; Lee YEK, 2009, WIRES NANOMED NANOBI, V1, P98, DOI 10.1002/wnan.2; Liu B, 2000, P NATL ACAD SCI USA, V97, P9855, DOI 10.1073/pnas.97.18.9855; *MATHW INC, 2003, MATLAB; Moding Everett, 2009, Journal of Sensors, DOI 10.1155/2009/235158; Pahler M, 2011, CHEMPHYSCHEM, V12, P2798, DOI 10.1002/cphc.201100428; Pust SE, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105709; Rudd NC, 2005, ANAL CHEM, V77, P6205, DOI 10.1021/ac050800y; Samson E, 2003, MATER STRUCT, V36, P156, DOI 10.1007/BF02479554; SCHANTZ EJ, 1962, BIOCHEMISTRY-US, V1, P658, DOI 10.1021/bi00910a019; Sheth Disha B., MULTIELECTRODE PLATF; Si D, 2012, ANAL CHEM, V84, P978, DOI 10.1021/ac202521e; Suzuki K, 2002, ANAL CHEM, V74, P5766, DOI 10.1021/ac0259414; Tohda K, 2006, ANAL SCI, V22, P383, DOI 10.2116/analsci.22.383; Torisawa YS, 2005, ONCOL REP, V13, P1107; WEST SJ, 1992, ANAL CHEM, V64, P533, DOI 10.1021/ac00029a016; Yasukawa T, 2000, ELECTROANAL, V12, P653, DOI 10.1002/1521-4109(200005)12:9<653::AID-ELAN653>3.0.CO;2-S	38	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136970	10.1371/journal.pone.0136970	http://dx.doi.org/10.1371/journal.pone.0136970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332766	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800084
J	Hoefler, A; Athenstaedt, U; Corcoran, K; Ebner, F; Ischebeck, A				Hoefler, Andreas; Athenstaedt, Ursula; Corcoran, Katja; Ebner, Franz; Ischebeck, Anja			Coping with Self-Threat and the Evaluation of Self-Related Traits: An fMRI Study	PLOS ONE			English	Article							ESTEEM; ACTIVATION; ATTENTION; VALENCE	A positive view of oneself is important for a healthy lifestyle. Self-protection mechanisms such as suppressing negative self-related information help us to maintain a positive view of ourselves. This is of special relevance when, for instance, a negative test result threatens our positive self-view. To date, it is not clear which brain areas support self-protective mechanisms under self-threat. In the present functional magnetic resonance imaging (fMRI) study the participants (N = 46) received a (negative vs. positive) performance test feedback before entering the scanner. In the scanner, the participants were instructed to ascribe personality traits either to themselves or to a famous other. Our results showed that participants responded slower to negative self-related traits compared to positive self-related traits. High self-esteem individuals responded slower to negative traits compared to low self-esteem individuals following a self-threat. This indicates that high self-esteem individuals engage more in self-enhancing strategies after a threat by inhibiting negative self-related information more successfully than low self-esteem individuals. This behavioral pattern was mirrored in the fMRI data as dACC correlated positively with trait self-esteem. Generally, ACC activation was attenuated under threat when participants evaluated self-relevant traits and even more for negative self-related traits. We also found that activation in the ACC was negatively correlated with response times, indicating that greater activation of the ACC is linked to better access (faster response) to positive self-related traits and to impaired access (slower response) to negative self-related traits. These results confirm the ACC function as important in managing threatened self-worth but indicate differences in trait self-esteem levels. The fMRI analyses also revealed a decrease in activation within the left Hippocampus and the right thalamus under threat. This indicates that a down-regulation of activation in these regions might also serve as coping mechanism in dealing with self-threat.	[Hoefler, Andreas; Athenstaedt, Ursula; Corcoran, Katja; Ischebeck, Anja] Graz Univ, Dept Psychol, Graz, Austria; [Ischebeck, Anja] BioTechMed Graz, Neurosci, Graz, Austria; [Ebner, Franz] Med Univ Graz, Dept Neuroradiol, Graz, Austria	University of Graz; Medical University of Graz	Hoefler, A (corresponding author), Graz Univ, Dept Psychol, Graz, Austria.	andreas.hoefler@uni-graz.at		Ischebeck, Anja/0000-0002-3493-2848; Corcoran, Katja/0000-0003-1838-9141				Alicke M. D., 2011, HDB SELF ENHANCEMENT; Altstotter-Gleich C., 2000, MOGLICHKEITEN OPERAT; Beer J. S., 2011, HDB SELF ENHANCEMENT, P49; Brett M, 2001, NEUROIMAGE, V13, pS85; D'Argembeau A, 2005, BRIT J PSYCHOL, V96, P457, DOI 10.1348/000712605X53218; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fazio R. H., 1990, J PERS SOC PSYCHOL, V50, P229; Ferring D, 1996, DIAGNOSTICA, V42, P284; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Hosoda M, 2000, PERCEPT MOTOR SKILL, V90, P1283, DOI 10.2466/PMS.90.3.1283-1294; Hughes BL, 2013, J COGNITIVE NEUROSCI, V25, P613, DOI 10.1162/jocn_a_00343; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Korn CW, 2012, J NEUROSCI, V32, P16832, DOI 10.1523/JNEUROSCI.3016-12.2012; Krendl AC, 2008, PSYCHOL SCI, V19, P168, DOI 10.1111/j.1467-9280.2008.02063.x; Leary MR, 2009, PERS SOC PSYCHOL REV, V13, P151, DOI 10.1177/1088868309342595; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; MARKUS H, 1986, J PERS SOC PSYCHOL, V51, P858, DOI 10.1037/0022-3514.51.4.858; MARKUS H, 1977, J PERS SOC PSYCHOL, V35, P63, DOI 10.1037/0022-3514.35.2.63; McGregor I, 2006, PSYCHOL INQ, V17, P299, DOI 10.1080/10478400701366977; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Pauly K, 2013, SOC COGN AFFECT NEUR, V8, P878, DOI 10.1093/scan/nss086; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Peukert D., 2010, BIOSPEKTRUM, V16, P639; Portas CM, 1998, J NEUROSCI, V18, P8979; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Sedikides C, 2009, SOC PERSONAL PSYCHOL, V3, P1055, DOI 10.1111/j.1751-9004.2009.00220.x; Sheldon KM, 1997, J PERS SOC PSYCHOL, V73, P1380, DOI 10.1037/0022-3514.73.6.1380; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Talairach J., 1988, COPLANAR STEREOTAXIC; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; vanDellen MR, 2011, PERS SOC PSYCHOL REV, V15, P51, DOI 10.1177/1088868310372950; Watson LA, 2008, BRIT J PSYCHOL, V99, P143, DOI 10.1348/000712607X248689; Wheeler C. S., 2007, PERSONALITY SOCIAL P, V11, P324; Wonderlic Inc, 1996, WOND PERS TEST WPT G; Yoshimura S, 2009, BRAIN COGNITION, V69, P218, DOI 10.1016/j.bandc.2008.07.010	42	11	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136027	10.1371/journal.pone.0136027	http://dx.doi.org/10.1371/journal.pone.0136027			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333130	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800048
J	Markhus, MW; Rasinger, JD; Malde, MK; Froyland, L; Skotheim, S; Braarud, HC; Stormark, KM; Graff, IE				Markhus, Maria Wik; Rasinger, Josef Daniel; Malde, Marian Kjellevold; Froyland, Livar; Skotheim, Siv; Braarud, Hanne Cecilie; Stormark, Kjell Morten; Graff, Ingvild Eide			Docosahexaenoic Acid Status in Pregnancy Determines the Maternal Docosahexaenoic Acid Status 3-, 6-and 12 Months Postpartum. Results from a Longitudinal Observational Study	PLOS ONE			English	Article							ESSENTIAL FATTY-ACIDS; ALPHA-LINOLENIC ACID; SEAFOOD CONSUMPTION; FISH CONSUMPTION; DEPRESSION; MOTHERS; RISK; OMEGA-3-FATTY-ACIDS; COGNITION; MERCURY	Background Essential fatty acid status as well as docosahexaenoic acid (DHA, 22: 6n-3) declines during pregnancy and lactation. As a result, the DHA status may not be optimal for child development and may increase the risk for maternal postpartum depression. The objective of this study was to assess changes in thematernal fatty acid status from pregnancy to 12 months postpartum, and to study the impact of seafood consumption on the individual fatty acid status. Methods Blood samples and seafood consumption habits (gestation week 28, and three-, six- and 12 months postpartum) were collected in a longitudinal observational study of pregnant and postpartum women (n = 118). Multilevel linear modeling was used to assess both changes over time in the fatty acid status of red blood cells (RBC), and in the seafood consumption. Results Six fatty acids varied the most (>80%) across the four time points analyzed, including the derivative of the essential a-linoleic acid (ALA, 18: 3n-3), DHA; the essential linoleic acid (LA, 18: 2 n-6); and the LA derivative, arachidonic acid (AA, 20: 4n-6). Over all, a large variation in individuals' DHA-and AA status was observed; however, over the 15-month study period only small inter-individual differences in the longitudinal trajectory of DHA- and AA abundance in the RBC were detected. The median intake of seafood was lower than recommended. Regardless, the total weekly frequency of seafood and eicosapentaenoic acid (EPA, 20: 5n-3)/DHA-supplement intake predicted the maternal level of DHA (mu g/g RBC). Conclusion The period of depletion of the maternal DHA status during pregnancy and lactation, seem to turn to repletion from about six months postpartum towards one year after childbirth, irrespective of RBC concentration of DHA during pregnancy. Seafood and EPA/DHA-supplement intake predicted the DHA levels over time.	[Markhus, Maria Wik; Rasinger, Josef Daniel; Malde, Marian Kjellevold; Froyland, Livar; Graff, Ingvild Eide] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Markhus, Maria Wik] Univ Bergen, Fac Med & Dent, Dept Biomed, Bergen, Norway; [Skotheim, Siv; Braarud, Hanne Cecilie; Stormark, Kjell Morten] Uni Res Hlth, Reg Ctr Child & Youth Mental Hlth & Child Welf, Bergen, Norway	University of Bergen	Markhus, MW (corresponding author), Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway.	maria.wik.markhus@nifes.no	Rasinger, Josef Daniel/AAO-3687-2020; Kjellevold, Marian/C-2973-2012; Kjellevold, Marian/Q-6334-2019; Markhus, Maria Wik/AAL-9055-2021	Kjellevold, Marian/0000-0001-7070-5784; Kjellevold, Marian/0000-0001-7070-5784; Markhus, Maria Wik/0000-0002-0196-5387; Rasinger, Josef Daniel/0000-0002-9424-4414	Ministry of Fisheries and Coastal Affairs, Norway; Regional Centre for Child and Youth Mental Health and Child Welfare, Uni Research Health, Bergen, Norway; Programmstyret i Ernaering, Faculty of Medicine and Dentistry, University of Bergen, Norway	Ministry of Fisheries and Coastal Affairs, Norway; Regional Centre for Child and Youth Mental Health and Child Welfare, Uni Research Health, Bergen, Norway; Programmstyret i Ernaering, Faculty of Medicine and Dentistry, University of Bergen, Norway	Funding provided by Ministry of Fisheries and Coastal Affairs, Norway; Regional Centre for Child and Youth Mental Health and Child Welfare, Uni Research Health, Bergen, Norway; Programmstyret i Ernaering, Faculty of Medicine and Dentistry, University of Bergen, Norway.	Alvheim AR, 2012, OBESITY, V20, P1984, DOI 10.1038/oby.2012.38; Araujo P, 2008, J CHROMATOGR A, V1212, P106, DOI 10.1016/j.chroma.2008.10.006; Bergmann RL, 2008, ANN NUTR METAB, V52, P157, DOI 10.1159/000129651; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Brantsaeter AL, 2009, J NUTR, V139, P1162, DOI 10.3945/jn.109.104968; Burdge G, 2004, CURR OPIN CLIN NUTR, V7, P137, DOI 10.1097/00075197-200403000-00006; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Dahl Lisbeth, 2006, Tidsskr Nor Laegeforen, V126, P309; Dahl L, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-127; De Vriese SR, 2003, LIFE SCI, V73, P3181, DOI 10.1016/j.lfs.2003.02.001; DeLucia C, 2006, J PEDIATR PSYCHOL, V31, P1002, DOI 10.1093/jpepsy/jsj074; European Food Safety Authority, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3835, 10.2903/j.efsa.2014.3595, 10.2903/j.efsa.2014.3761]; FDA, 2014, FISH WHAT PREGN WOM; Field A, 2012, DISCOVERING STAT USI, P957; Freeman MP, 2006, ACTA PSYCHIAT SCAND, V113, P31, DOI 10.1111/j.1600-0447.2005.00660.x; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Hibbeln JR, 1998, LANCET, V351, P1213, DOI 10.1016/S0140-6736(05)79168-6; Hibbeln JR, 2002, J AFFECT DISORDERS, V69, P15, DOI 10.1016/S0165-0327(01)00374-3; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; HORNSTRA G, 1995, EUR J OBSTET GYN R B, V61, P57, DOI 10.1016/0028-2243(95)02153-J; Judge MP, 2011, FASEB J, V25; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; Koletzko B, 2007, BRIT J NUTR, V98, P873, DOI 10.1017/S0007114507764747; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Makrides M, 2003, ASIA PAC J CLIN NU S, V12, pS37; Malde MK, 2012, INT J NURSING MIDWIF, V4, P64; Markhus MW, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.19272; Markhus MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067617; Meyer BJ, 2003, LIPIDS, V38, P391, DOI 10.1007/s11745-003-1074-0; Miles EA, 2011, AM J CLIN NUTR, V94, p1986S, DOI 10.3945/ajcn.110.001636; Min Y, 2000, INT J VITAM NUTR RES, V70, P70, DOI 10.1024/0300-9831.70.2.70; Oken E, 2005, ENVIRON HEALTH PERSP, V113, P1376, DOI 10.1289/ehp.8041; Oken E, 2008, AM J EPIDEMIOL, V167, P1171, DOI 10.1093/aje/kwn034; Otto SJ, 2003, PROSTAG LEUKOTR ESS, V69, P237, DOI 10.1016/S0952-3278(03)00090-5; Otto SJ, 2001, AM J CLIN NUTR, V73, P1074; Otto SJ, 2001, AM J CLIN NUTR, V73, P302; POSTLE AD, 1995, EARLY HUM DEV, V43, P47, DOI 10.1016/0378-3782(95)01663-N; Shek DTL, 2011, THESCIENTIFICWORLDJO, V11, P42, DOI 10.1100/tsw.2011.2; Simopoulos Artemis P., 2009, V99, P1, DOI 10.1159/000192755; Skotheim S, 2013, INFANT BEHAV DEV, V36, P419, DOI 10.1016/j.infbeh.2013.03.009; Su KP, 2008, J CLIN PSYCHIAT, V69, P644, DOI 10.4088/JCP.v69n0418; The Norwegian Directorate of Health, 2012, NORK 3 NAT DIET SURV; The Norwegian Directorate of Health, 2013, UTV NORSK KOSTH 2012; The Norwegian Directorate of Health, 1999, NORK 1997 LANDS KOST; The Norwegian national nutrition council, 2011, DIET ADV PROM PUBL H; van Houwelingen AC, 1999, LIPIDS, V34, pS229, DOI 10.1007/BF02562301; *VKM, 2007, COMPR ASS FISH OTH S; Vlaardingerbroek H, 2004, PROSTAG LEUKOTR ESS, V71, P363, DOI 10.1016/j.plefa.2004.07.002	51	26	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136409	10.1371/journal.pone.0136409	http://dx.doi.org/10.1371/journal.pone.0136409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331947	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800055
J	Takada, T; Nishiwaki, H; Yamamoto, Y; Noguchi, Y; Fukuma, S; Yamazaki, S; Fukuhara, S				Takada, Toshihiko; Nishiwaki, Hiroki; Yamamoto, Yosuke; Noguchi, Yoshinori; Fukuma, Shingo; Yamazaki, Shin; Fukuhara, Shunichi			The Role of Digital Rectal Examination for Diagnosis of Acute Appendicitis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACUTE ABDOMINAL-PAIN; TEST ACCURACY; SUSPECTED APPENDICITIS; HISTORY; SCORE; PERFORMANCE; UTILITY; ADULTS	Background Digital rectal examination (DRE) has been traditionally recommended to evaluate acute appendicitis, although several reports indicate its lack of utility for this diagnosis. No meta-analysis has examined DRE for diagnosis of acute appendicitis. Objectives To assess the role of DRE for diagnosis of acute appendicitis. Data Sources Cochrane Library, PubMed, and SCOPUS from the earliest available date of indexing through November 23, 2014, with no language restrictions. Study Selection Clinical studies assessing DRE as an index test for diagnosis of acute appendicitis. Data Extraction and Synthesis Two independent reviewers extracted study data and assessed the quality, using the Quality Assessment of Diagnostic Accuracy Studies 2 tool. Bivariate random-effects models were used for the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio (DOR) as point estimates with 95% confidence intervals (CI). Main Outcomes and Measures The main outcome measure was the diagnostic performance of DRE for diagnosis of acute appendicitis. Results We identified 19 studies with a total of 7511 patients. The pooled sensitivity and specificity were 0.49 (95% CI 0.42-0.56) and 0.61 (95% CI 0.53-0.67), respectively. The positive and negative likelihood ratios were 1.24 (95% CI 0.97-1.58) and 0.85 (95% CI 0.70-1.02), respectively. The DOR was 1.46 (0.95-2.26). Conclusion and Relevance Acute appendicitis cannot be ruled in or out through the result of DRE. Reconsideration is needed for the traditional teaching that rectal examination should be performed routinely in all patients with suspected appendicitis.	[Takada, Toshihiko; Nishiwaki, Hiroki; Yamamoto, Yosuke; Fukuma, Shingo; Yamazaki, Shin; Fukuhara, Shunichi] Kyoto Univ, Dept Healthcare Epidemiol, Sch Publ Hlth, Grad Sch Med, Kyoto, Japan; [Takada, Toshihiko; Noguchi, Yoshinori; Fukuma, Shingo; Fukuhara, Shunichi] Fukushima Med Univ, Dept Gen Med, Shirakawa Satellite Teaching & Res STAR, Fukushima, Japan; [Nishiwaki, Hiroki; Fukuma, Shingo; Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence CIR, Fukushima, Japan; [Yamamoto, Yosuke; Fukuma, Shingo] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci iACT, Kyoto 606, Japan; [Noguchi, Yoshinori] Japanese Red Cross Nagoya Daini Hosp, Div Gen Internal Med, Nagoya, Aichi, Japan	Kyoto University; Fukushima Medical University; Fukushima Medical University; Kyoto University; Japanese Red Cross Nagoya Daini Hospital	Takada, T (corresponding author), Kyoto Univ, Dept Healthcare Epidemiol, Sch Publ Hlth, Grad Sch Med, Kyoto, Japan.	ttakada@water.ocn.ne.jp	YAMAMOTO, Yosuke/HCH-0666-2022; Nishiwaki, Hiroki/I-5001-2019	Nishiwaki, Hiroki/0000-0001-7365-7685; Fukuma, Shingo/0000-0002-8379-8761				ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; Andersson RE, 1999, WORLD J SURG, V23, P133, DOI 10.1007/PL00013174; Andersson REB, 2004, BRIT J SURG, V91, P28, DOI 10.1002/bjs.4464; Barber MD, 1997, BRIT J SURG, V84, P110; BERRY J, 1984, ANN SURG, V200, P567, DOI 10.1097/00000658-198411000-00002; Birnbaum BA, 2000, RADIOLOGY, V215, P337, DOI 10.1148/radiology.215.2.r00ma24337; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BONELLO JC, 1979, DIS COLON RECTUM, V22, P97, DOI 10.1007/BF02586770; Brewster GS, 2000, WESTERN J MED, V173, P207, DOI 10.1136/ewjm.173.3.207; Brunicardi F, 2014, SCHWARTZS PRINCIPLES, V10e; Chandrasekaran TV, 2014, SURGERY, V32, P413, DOI [10.1016/j.mpsur.2014.06.004, DOI 10.1016/J.MPSUR.2014.06.004]; CHEE C P, 1982, SMJ Singapore Medical Journal, V23, P265; Cobben LPJ, 2000, RADIOLOGY, V215, P349, DOI 10.1148/radiology.215.2.r00ma08349; DAEHLIN L, 1982, ACTA CHIR SCAND, V148, P291; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; DICKSON AP, 1985, ARCH DIS CHILD, V60, P666, DOI 10.1136/adc.60.7.666; DIXON JM, 1991, BRIT MED J, V302, P386, DOI 10.1136/bmj.302.6773.386; DUNNING PG, 1991, ANN ROY COLL SURG, V73, P233; ESKELINEN M, 1995, SCAND J GASTROENTERO, V30, P349, DOI 10.3109/00365529509093289; ESKELINEN M, 1992, THEOR SURG, V7, P86; ESKELINEN M, 1994, SCAND J GASTROENTERO, V29, P59, DOI 10.3109/00365529409090438; ESKELINEN M, 1992, THEOR SURG, V7, P81; ESKELINEN M, 1994, INT J BIOMED COMPUT, V36, P239, DOI 10.1016/0020-7101(94)90059-0; GARCIA JC, 1989, J CHIR-PARIS, V126, P630; Gil V F, 2000, Med Clin (Barc), V114 Suppl 2, P48; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gwynn LK, 2001, J EMERG MED, V21, P119, DOI 10.1016/S0736-4679(01)00353-5; HORATTAS MC, 1990, AM J SURG, V160, P291, DOI 10.1016/S0002-9610(06)80026-7; IRVIN TT, 1989, BRIT J SURG, V76, P1121, DOI 10.1002/bjs.1800761105; IZBICKI JR, 1992, EUR J SURG, V158, P227; Jahn H, 1997, EUR J SURG, V163, P433; Jesudason EC, 1999, BRIT J SURG, V86, P376, DOI 10.1046/j.1365-2168.1999.01066.x; Kessler C, 2012, J EMERG MED, V43, P1196, DOI 10.1016/j.jemermed.2012.06.015; Khoshnood Ardavan, 2014, Lakartidningen, V111, P89; Koudelka J, 1991, Rozhl Chir, V70, P36; Lee H Y, 1993, Med J Malaysia, V48, P17; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Macias DJ, 2000, AM J EMERG MED, V18, P676, DOI 10.1053/ajem.2000.16308; Manimaran N, 2004, ANN ROY COLL SURG, V86, P292, DOI 10.1308/147870804218; Mary EK, 2011, WASHINGTON MANUAL SU, V6th; MURIS JWM, 1993, FAM PRACT, V10, P34, DOI 10.1093/fampra/10.1.34; NASE HW, 1980, AM SURGEON, V46, P504; Ozdogan M, 2005, TURK J SURG, V21, P175; Park JS, 2013, AM SURGEON, V79, P101; Quaas J, 2009, AM J EMERG MED, V27, P1125, DOI 10.1016/j.ajem.2008.08.027; Rehak F, 1984, PRAKT LEK, V10, ps371; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sedlak M, 2008, AM J EMERG MED, V26, P359, DOI 10.1016/j.ajem.2007.06.006; Silen W., 2010, COPES EARLY DIAGNOSI; SMITH PH, 1965, POSTGRAD MED J, V41, P2, DOI 10.1136/pgmj.41.471.2; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	53	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136996	10.1371/journal.pone.0136996	http://dx.doi.org/10.1371/journal.pone.0136996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332867	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800086
J	Gu, YF; Shi, JQ; Cao, P; Yuan, W; Wu, HQ; Yang, LL; Tian, Y; Liang, L				Gu, Yifei; Shi, Jueqian; Cao, Peng; Yuan, Wen; Wu, Huiqiao; Yang, Lili; Tian, Ye; Liang, Lei			Clinical and Imaging Predictors of Surgical Outcome in Multilevel Cervical Ossification of Posterior Longitudinal Ligament: An Analysis of 184 Patients	PLOS ONE			English	Article							MAGNETIC-RESONANCE IMAGES; SIGNAL INTENSITY CHANGES; OPEN-DOOR LAMINOPLASTY; SPONDYLOTIC MYELOPATHY; SPINAL-CORD; FOLLOW-UP; MINOR TRAUMA; PROGNOSTIC-FACTORS; SURGERY; STRATEGY	Objective To investigate the clinical and imaging predictors of surgical outcomes in patients with ossification of the posterior longitudinal ligament (OPLL). Materials and Methods From May 2010 to April 2012, a total of 200 consecutive patients with cervical OPLL were recruited for this study. Of them, 184 patients (130 men and 54 women) who could be tracked for more than 24 months after surgery were finally included for analysis. Their demographic, clinical and radiological data were collected preoperatively. The recovery ratio in terms of JOA score was used to assess the outcome of the patients preoperatively and at 2 years postoperatively. A JOA recovery rate less than 50% was considered a poor outcome. Results Compared with good outcome group, an older mean age at operation, a longer mean duration of symptoms, a lower mean pre-operativer JOA score, and a higher proportion of diabetics were observed in poor outcome group. Patients in poor outcome group were more likely to present kyphotic cervical alignment, smaller mean transverse area of the spinal cord, and intramedullary signal abnormalities. The result of multivariate stepwise logistic regression showed that a longer duration of symptoms and the presence of T1 hypo-intensity intramedullary changes on MRI were significant risk factors of lower JOA recovery ratios. Conclusion A longer duration of symptom, T1 hypointensity on MRI and a history of minor trauma were highly predictive of a poor outcome for patients undergoing surgical treatment of OPLL. Age at operation, the history of diabetes, the preoperative JOA score, the transverse area of the spinal cord and T2 hyper-intensity on MRI were also associated with the prognosis of OPLL.	[Gu, Yifei; Cao, Peng; Yuan, Wen; Wu, Huiqiao; Yang, Lili; Tian, Ye; Liang, Lei] Second Mil Med Univ, Dept Spine Surg, Changzheng Hosp, Shanghai, Peoples R China; [Shi, Jueqian] Shanghai Chest Hosp, Dept Radiol, Shanghai, Peoples R China	Naval Medical University; Shanghai Jiao Tong University	Cao, P (corresponding author), Second Mil Med Univ, Dept Spine Surg, Changzheng Hosp, Shanghai, Peoples R China.	mdpinocao@gmail.com; yuanwen_spine@126.com			Joint Research Project on Major Diseases of Shanghai Health System [2013ZYJB0502]	Joint Research Project on Major Diseases of Shanghai Health System	This study was supported by a grant from the Joint Research Project on Major Diseases of Shanghai Health System (No. 2013ZYJB0502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvin B, 2013, SPINE, V38, P1170, DOI 10.1097/BRS.0b013e31828e23a8; Chatley A, 2009, J NEUROSURG-SPINE, V11, P562, DOI 10.3171/2009.6.SPINE091; Chen Y, 2011, J SPINAL DISORD TECH, V24, P24, DOI 10.1097/BSD.0b013e3181c7e91e; Chiba K, 2006, SPINE, V31, P2998, DOI 10.1097/01.brs.0000250307.78987.6b; Choi S, 2005, J SPINAL DISORD TECH, V18, P309, DOI 10.1097/01.bsd.0000161236.94894.fc; de Rota JJF, 2007, J NEUROSURG-SPINE, V6, P17, DOI 10.3171/spi.2007.6.1.4; Eaton SEM, 2001, LANCET, V358, P35, DOI 10.1016/S0140-6736(00)05268-5; Fujimori T, 2014, SPINE, V39, P58, DOI 10.1097/BRS.0000000000000054; Fujimura Y, 1998, J SPINAL DISORD, V11, P16; Fujiyoshi T, 2008, SPINE, V33, pE990, DOI 10.1097/BRS.0b013e318188b300; GOTO S, 1995, SPINE, V20, P2247, DOI 10.1097/00007632-199510001-00012; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Inamasu J, 2009, J NEUROSURG SCI, V53, P93; Iwasaki M, 2002, J NEUROSURG, V96, P180, DOI 10.3171/spi.2002.96.2.0180; Iwasaki M, 2007, SPINE, V32, P654, DOI 10.1097/01.brs.0000257566.91177.cb; Iwasaki M, 2007, SPINE, V32, P647, DOI 10.1097/01.brs.0000257560.91147.86; Kalb S, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10265; Kato Y, 1998, J NEUROSURG, V89, P217, DOI 10.3171/jns.1998.89.2.0217; KATOH S, 1995, PARAPLEGIA, V33, P330, DOI 10.1038/sc.1995.74; Kim HJ, 2008, J BONE JOINT SURG BR, V90B, P1468, DOI 10.1302/0301-620X.90B11.20632; Lee SE, 2015, GLOB SPINE J, V5, P124, DOI 10.1055/s-0034-1397340; Lee SE, 2013, J NEUROSURG-SPINE, V18, P465, DOI 10.3171/2013.1.SPINE12779; Li H, 2008, EUR SPINE J, V17, P1277, DOI 10.1007/s00586-008-0740-8; Nouri A, 2015, SPINE, V40, P1092, DOI 10.1097/BRS.0000000000000919; Ogawa Y, 2004, J NEUROSURG-SPINE, V1, P168, DOI 10.3171/spi.2004.1.2.0168; OHSHIO I, 1993, SPINE, V18, P1140, DOI 10.1097/00007632-199307000-00005; Papadopoulos CA, 2004, ORTHOPEDICS, V27, P1087; Park YS, 2006, NEUROL MED-CHIR, V46, P231, DOI 10.2176/nmc.46.231; RAMANAUSKAS WL, 1989, J COMPUT ASSIST TOMO, V13, P399, DOI 10.1097/00004728-198905000-00005; Scardino FB, 2010, EUR SPINE J, V19, P699, DOI 10.1007/s00586-009-1267-3; Shedid D, 2007, NEUROSURGERY, V60, P7, DOI 10.1227/01.NEU.0000215430.86569.C4; SIMPSON JM, 1993, J BONE JOINT SURG AM, V75A, P1823, DOI 10.2106/00004623-199312000-00013; Steinmetz MP, 2007, NEUROSURGERY, V60, P90, DOI 10.1227/01.NEU.0000215553.49728.B0; Sun QZ, 2015, J SPINAL DISORD TECH, V28, pE304, DOI 10.1097/BSD.0b013e31828b2b59; Sun QZ, 2012, ORTHOPEDICS, V35, pE403, DOI 10.3928/01477447-20120222-38; Sun QZ, 2011, EUR SPINE J, V20, P1466, DOI 10.1007/s00586-011-1813-7; Tetreault LA, 2013, J BONE JOINT SURG AM, V95A, P1659, DOI 10.2106/JBJS.L.01323; Vedantam A, 2011, J NEUROSURG-SPINE, V15, P660, DOI 10.3171/2011.8.SPINE11452; Wada E, 1999, SPINE, V24, P455, DOI 10.1097/00007632-199903010-00009; Wang XW, 2012, EUR SPINE J, V21, P314, DOI 10.1007/s00586-011-1996-y; Yoo DS, 2010, WORLD NEUROSURG, V73, P50, DOI 10.1016/j.surneu.2009.05.021; Yoon ST, 2013, SPINE, V38, pS232, DOI 10.1097/BRS.0b013e3182a7eb55; Yu FB, 2015, J SPINAL DISORD TECH, V28, P389, DOI 10.1097/BSD.0000000000000031	43	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136042	10.1371/journal.pone.0136042	http://dx.doi.org/10.1371/journal.pone.0136042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327216	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700028
J	Lehndal, L; Agren, J				Lehndal, Lina; Agren, Jon			Herbivory Differentially Affects Plant Fitness in Three Populations of the Perennial Herb Lythrum salicaria along a Latitudinal Gradient	PLOS ONE			English	Article							ENVIRONMENTAL CONTEXT INFLUENCES; PURPLE LOOSESTRIFE; INSECT HERBIVORES; ARABIDOPSIS-LYRATA; DEFENSE EVOLUTION; SIMULATED LEAF; RESISTANCE; TOLERANCE; DAMAGE; ARCHITECTURE	Herbivory can negatively and selectively affect plant fitness by reducing growth, survival and reproductive output, thereby influencing plant population dynamics and evolution. Latitudinal variation in intensity of herbivory is common, but the extent to which it translates into corresponding variation in effects on plant performance is still poorly known. We tested the hypothesis that variation in the fitness-consequences of herbivory mirror differences in intensity of herbivory among three natural populations of the perennial herb Lythrum salicaria along a latitudinal gradient from southern to northernmost Sweden. We documented intensity of herbivory and examined its effect on survival, growth and reproductive output over two years by experimentally removing herbivores with insecticide. The intensity of herbivory and the effects of herbivory on plant fitness were strongest in the southern population, intermediate in the central population and weakest in the northern population. The mean proportion of the leaf area removed ranged from 11% in the southern to 3% in the northern population. Herbivore removal increased plant height 1.5-fold in the southern and 1.2-fold in the central population, the proportion plants flowering 4-fold in the southern and 2-fold in the central population, and seed production per flower 1.6-fold in the southern and 1.2-fold in the central population, but did not affect plant fitness in the northern population. Herbivore removal thus affected the relative fecundity of plants in the three populations: In the control, seed output per plant was 8.6 times higher in the northern population compared to the southern population, whereas after herbivore removal it was 2.5 times higher in the southern population. The results demonstrate that native herbivores may strongly affect the demographic structure of L. salicaria populations and thereby shape geographic patterns of seed production. They further suggest that the strength of herbivore-mediated selection varies among populations and decreases towards the north.	[Lehndal, Lina; Agren, Jon] Uppsala Univ, Plant Ecol & Evolut, Dept Ecol & Genet, Evolutionary Biol Ctr, Uppsala, Sweden	Uppsala University	Lehndal, L (corresponding author), Uppsala Univ, Plant Ecol & Evolut, Dept Ecol & Genet, Evolutionary Biol Ctr, Uppsala, Sweden.	lina.lehndal@ebc.uu.se	Ågren, Jon/E-6093-2011	Ågren, Jon/0000-0001-9573-2463	Svenska Vaxtgeografiska Sallskapet; Regnells botaniska resestipendium; Uddeholms resestipendium; Swedish research Council	Svenska Vaxtgeografiska Sallskapet; Regnells botaniska resestipendium; Uddeholms resestipendium; Swedish research Council(Swedish Research CouncilEuropean Commission)	This study was financially supported by Svenska Vaxtgeografiska Sallskapet, Regnells botaniska resestipendium, and Uddeholms resestipendium to LL and by a grant from the Swedish research Council to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Agren J, 2013, P NATL ACAD SCI USA, V110, P18202, DOI 10.1073/pnas.1301421110; Alonso C, 1996, J ECOL, V84, P495, DOI 10.2307/2261472; [Anonymous], 2014, R LANG ENV STAT COMP; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BLOSSEY B, 1995, BIOL CONTROL, V5, P47, DOI 10.1006/bcon.1995.1006; Castillo G, 2013, ECOL RES, V28, P663, DOI 10.1007/s11284-013-1059-4; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; CRAWLEY MJ, 1989, ANNU REV ENTOMOL, V34, P531, DOI 10.1146/annurev.en.34.010189.002531; Didiano TJ, 2014, J ECOL, V102, P584, DOI 10.1111/1365-2745.12227; Dobzhansky T., 1950, American Scientist, V38, P209; Garcia MB, 2002, AM J BOT, V89, P1295, DOI 10.3732/ajb.89.8.1295; Grevstad FS, 2006, BIOL CONTROL, V39, P1, DOI 10.1016/j.biocontrol.2006.03.007; Hamback PA, 2003, FUNCT ECOL, V17, P87, DOI 10.1046/j.1365-2435.2003.00699.x; Hamback PA, 2000, ECOLOGY, V81, P1784, DOI 10.1890/0012-9658(2000)081[1784:ARIDTP]2.0.CO;2; Heisswolf A, 2005, ECOL ENTOMOL, V30, P299, DOI 10.1111/j.0307-6946.2005.00706.x; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Hunt-Joshi TR, 2004, ECOL APPL, V14, P1574, DOI 10.1890/03-5181; Juenger T, 2005, EVOL ECOL, V19, P79, DOI 10.1007/s10682-004-8090-4; Katovich EJS, 2001, WEED SCI, V49, P190, DOI 10.1614/0043-1745(2001)049[0190:EOGSFO]2.0.CO;2; Knight TM, 2003, AM J BOT, V90, P1207, DOI 10.3732/ajb.90.8.1207; Kolb A, 2007, OIKOS, V116, P864, DOI 10.1111/j.2007.0030-1299.15608.x; Lehndal L, 2015, J EVOLUTION BIOL, V28, P576, DOI 10.1111/jeb.12589; Loe G, 2007, OIKOS, V116, P134, DOI 10.1111/j.2006.0030-1299.15022.x; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Pennings SC, 2005, ECOLOGY, V86, P2310, DOI 10.1890/04-1022; Pennings SC, 2009, ECOLOGY, V90, P183, DOI 10.1890/08-0222.1; Puentes A, 2012, OECOLOGIA, V169, P1033, DOI 10.1007/s00442-012-2276-1; Rasmann S, 2011, ECOL LETT, V14, P476, DOI 10.1111/j.1461-0248.2011.01609.x; Schat M, 2005, ENVIRON ENTOMOL, V34, P906, DOI 10.1603/0046-225X-34.4.906; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Stenberg JA, 2006, OECOLOGIA, V148, P414, DOI 10.1007/s00442-006-0390-7; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; von Euler T, 2014, ECOLOGY, V95, P495, DOI 10.1890/13-0528.1; Wieski K, 2014, ECOGRAPHY, V37, P763, DOI 10.1111/ecog.00498; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044	38	20	21	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135939	10.1371/journal.pone.0135939	http://dx.doi.org/10.1371/journal.pone.0135939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325383	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700025
J	Liu, Q; Li, R; Zhou, RL; Li, J; Gu, Q				Liu, Qing; Li, Rui; Zhou, Renlai; Li, Juan; Gu, Quan			Abnormal Resting-State Connectivity at Functional MRI in Women with Premenstrual Syndrome	PLOS ONE			English	Article							MENSTRUAL-CYCLE PHASE; DISORDER; STRESS; REACTIVITY	Objectives Premenstrual syndrome (PMS) refers to a series of cycling and relapsing physical, emotion and behavior syndromes that occur in the luteal phase and resolve soon after the onset of menses. Although PMS is widely recognized, its neural mechanism is still unclear. Design To address this question, we measured brain activity for women with PMS and women without PMS (control group) using resting-state functional magnetic resonance imaging (rs-fMRI). In addition, the participants should complete the emotion scales (Beck Anxiety Inventory, BAI; Beck Depression Inventory, BDI, before the scanning) as well as the stress perception scale (Visual analog scale for stress, VAS, before and after the scanning). Results The results showed that compared with the control group, the PMS group had decreased connectivity in the middle frontal gyrus (MFG) and theparahippocampalgyrus (PHG), as well as increased connectivity in the left medial/superior temporal gyri (MTG/STG) and pre-centralgyrus within the default mode network (DMN); in addition, the PMS group had higher anxiety and depression scale scores, together with lower stress perception scores. Finally, there were significantly positive correlations between the stress perception scores and functional connectivity in the MFG and cuneus. The BDI scores in the PMS group were correlated negatively with the functional connectivity in the MFG and precuneus and correlated positively with the functional connectivity in the MTG. Conclusion These findings suggest that compared with normal women, women with PMS displayed abnormal stress sensitivity, which was reflected in the decreased and increased functional connectivity within the DMN, blunted stress perception and higher depression.	[Liu, Qing; Zhou, Renlai; Gu, Quan] Beijing Normal Univ, Beijing Key Lab Appl Expt Psychol, Sch Psychol, Beijing 100875, Peoples R China; [Zhou, Renlai] Nanjing Univ, Sch Social & Behav Sci, Dept Psychol, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Qing; Zhou, Renlai; Gu, Quan] Beijing Normal Univ, Res Ctr Emot Regulat, Beijing 100875, Peoples R China; [Zhou, Renlai] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhou, Renlai] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Li, Rui; Li, Juan] Chinese Acad Sci, Inst Psychol, Ctr Aging Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Beijing Normal University; Nanjing University; Beijing Normal University; Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS	Zhou, RL (corresponding author), Beijing Normal Univ, Beijing Key Lab Appl Expt Psychol, Sch Psychol, Beijing 100875, Peoples R China.	rlzhou@nju.edu.cn	liu, qingqing/HHD-0360-2022; Liu, Qing/GWC-9222-2022; Zhou, Renlai/ABA-1226-2021	Zhou, Renlai/0000-0001-7035-7097; li, rui/0000-0002-4101-5415	National Basic Research Program of China [2011CB505101]; key lab open project of Beijing University of Chinese Medicine [2011-SYSKFKT03]; Shangshan funding	National Basic Research Program of China(National Basic Research Program of China); key lab open project of Beijing University of Chinese Medicine; Shangshan funding	The work was funded by the National Basic Research Program of China (No. 2011CB505101) and the key lab open project of Beijing University of Chinese Medicine (2011-SYSKFKT03), as well as the Shangshan funding. The authors would like to express their gratitude for the support of the project.	Bancroft J, 1993, PSYCHOL MED MONO S24; Bannbers E, 2012, J AFFECT DISORDERS, V142, P347, DOI 10.1016/j.jad.2012.04.006; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Brosschot JF, 2010, NEUROSCI BIOBEHAV R, V35, P46, DOI 10.1016/j.neubiorev.2010.01.004; CHAPMAN JP, 1987, J ABNORM PSYCHOL, V96, P89, DOI 10.1037/0021-843X.96.2.89; [陈春萍 Chen Chunping], 2011, [中国科学. 生命科学, Scientia Sinica Vitae], V41, P1049; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Epperson CN, 2007, NEUROPSYCHOPHARMACOL, V32, P2190, DOI 10.1038/sj.npp.1301351; Gingnell M, 2012, HORM BEHAV, V62, P400, DOI 10.1016/j.yhbeh.2012.07.005; Hellhammer J, 2012, PSYCHONEUROENDOCRINO, V37, P119, DOI 10.1016/j.psyneuen.2011.05.012; Hjelmervik H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103492; Ismail KMK, 2005, CURR OBSTET GYNAECOL, V15, P25, DOI DOI 10.1007/S13224-011-0117-5; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; Klatzkin RR, 2014, J PSYCHOSOM RES, V76, P46, DOI 10.1016/j.jpsychores.2013.11.002; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Ossewaarde L, 2010, PSYCHONEUROENDOCRINO, V35, P47, DOI 10.1016/j.psyneuen.2009.08.011; Petersen N, 2014, NEUROIMAGE, V90, P24, DOI 10.1016/j.neuroimage.2013.12.016; Protopopescu X, 2008, J AFFECT DISORDERS, V108, P87, DOI 10.1016/j.jad.2007.09.015; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Wang X., 1999, CHIN MENT HLTH J, V12, P238	20	19	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136029	10.1371/journal.pone.0136029	http://dx.doi.org/10.1371/journal.pone.0136029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26325510	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700026
J	Saito, Y; Fujiwara, T; Ohashi, K; Okitsu, Y; Fukuhara, N; Onishi, Y; Ishizawa, K; Harigae, H				Saito, Yo; Fujiwara, Tohru; Ohashi, Keiichi; Okitsu, Yoko; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Harigae, Hideo			High-Throughput siRNA Screening to Reveal GATA-2 Upstream Transcriptional Mechanisms in Hematopoietic Cells	PLOS ONE			English	Article							GENE-EXPRESSION; STEM; MUTATIONS; CITED2; DIFFERENTIATION; IDENTIFICATION; DEFICIENCY; REGULATORS; NETWORK	Hematopoietic stem cells can self-renew and differentiate into all blood cell types. The transcription factor GATA-2 is expressed in both hematopoietic stem and progenitor cells and is essential for cell proliferation, survival, and differentiation. Recently, evidence from studies of aplastic anemia, MonoMAC syndrome, and lung cancer has demonstrated a mechanistic link between GATA-2 and human pathophysiology. GATA-2-dependent disease processes have been extensively analyzed; however, the transcriptional mechanisms upstream of GATA-2 remain less understood. Here, we conducted high-throughput small-interferingRNA (siRNA) library screening and showed that YN-1, a human erythroleukemia cell line, expressed high levels of GATA-2 following the activation of the hematopoietic-specific 1S promoter. As transient luciferase reporter assay in YN-1 cells revealed the highest promoter activity in the 1S promoter fused with GATA-2 intronic enhancer (+9.9 kb/1S); therefore, we established a cell line capable of stably expressing +9.9 kb/1S-Luciferase. Subsequently, we screened 995 transcription factor genes and revealed that CITED2 acts as a GATA-2 activator in human hematopoietic cells. These results provide novel insights into and further identify the regulatory mechanism of GATA-2.	[Saito, Yo; Fujiwara, Tohru; Ohashi, Keiichi; Okitsu, Yoko; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Harigae, Hideo] Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Fujiwara, Tohru; Harigae, Hideo] Tohoku Univ, Mol Hematol Oncol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Ishizawa, Kenichi] Yamagata Univ, Dept Hematol & Cell Therapy, Fac Med, Yamagata 990, Japan	Tohoku University; Tohoku University; Yamagata University	Harigae, H (corresponding author), Tohoku Univ, Dept Hematol & Rheumatol, Grad Sch Med, Sendai, Miyagi 980, Japan.	harigae@med.tohoku.ac.jp	Fujiwara, Tohru/GOG-9775-2022		KANAE Foundation for the Promotion of Medical Science; Sanofi KK; Chugai Pharmaceutical Co., Ltd.	KANAE Foundation for the Promotion of Medical Science; Sanofi KK; Chugai Pharmaceutical Co., Ltd.	This study was supported by KANAE Foundation for the Promotion of Medical Science (TF) (http://www.kanae-zaidan.com) which receives financial support from Sanofi KK, and by a research grant from Chugai Pharmaceutical Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Cortes-Lavaud X, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.1233.1233; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Ding XL, 2012, STEM CELLS DEV, V21, P121, DOI 10.1089/scd.2010.0539; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; ENDO K, 1993, BRIT J HAEMATOL, V85, P653, DOI 10.1111/j.1365-2141.1993.tb03205.x; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Ezoe S, 2002, BLOOD, V100, P3512, DOI 10.1182/blood-2002-04-1177; Fujimaki S, 2001, BRIT J HAEMATOL, V113, P52, DOI 10.1046/j.1365-2141.2001.02736.x; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara T, 2014, ANN HEMATOL, V93, P1515, DOI 10.1007/s00277-014-2090-4; Fujiwara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040959; Guiu J, 2013, J EXP MED, V210, P71, DOI 10.1084/jem.20120993; Harigae H, 2006, TOHOKU J EXP MED, V210, P1, DOI 10.1620/tjem.210.1; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; Johnson KD, 2012, J CLIN INVEST, V122, P3692, DOI 10.1172/JCI61623; Kamata M, 2014, HAEMATOLOGICA, V99, P1686, DOI 10.3324/haematol.2014.105692; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; KOEFFLER HP, 1980, BLOOD, V56, P265; Korthuis PM, 2015, LEUKEMIA, V29, P625, DOI 10.1038/leu.2014.259; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Moriguchi T, 2014, INT J HEMATOL, V100, P417, DOI 10.1007/s12185-014-1568-0; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Pan XQ, 2000, J BIOCHEM, V127, P105, DOI 10.1093/oxfordjournals.jbchem.a022570; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Sanalkumar R, 2014, P NATL ACAD SCI USA, V111, pE1091, DOI 10.1073/pnas.1400065111; Snow JW, 2011, BLOOD, V117, P4769, DOI 10.1182/blood-2010-10-313031; Snow JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001103; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zeng WH, 2004, BLOOD, V103, P325, DOI 10.1182/blood-2003-02-0490	41	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137079	10.1371/journal.pone.0137079	http://dx.doi.org/10.1371/journal.pone.0137079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325290	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700090
J	Bullone, M; Beauchamp, G; Godbout, M; Martin, JG; Lavoie, JP				Bullone, Michela; Beauchamp, Guy; Godbout, Mireille; Martin, James G.; Lavoie, Jean-Pierre			Endobronchial Ultrasound Reliably Quantifies Airway Smooth Muscle Remodeling in an Equine Asthma Model	PLOS ONE			English	Article							BRONCHIAL WALL; LUNG-FUNCTION; HEAVES; ULTRASONOGRAPHY; DISEASE; HORSES; HYPERTROPHY; HYPERPLASIA; OBSTRUCTION; THICKNESS	Endobronchial ultrasonography (EBUS) revealed differences in the thickness of the layer representing subepithelial tissues (L2) between human asthmatics and controls, but whether this measurement correlates with airway smooth muscle (ASM) remodeling in asthma is unknown. In this study, we sought to determine the ability of EBUS to predict histological ASM remodeling in normal and equine asthmatic airways. We studied 109 isolated bronchi from the lungs of 13 horses. They underwent EBUS examination using a 30 MHz radial probe before being processed for histology. ASM remodeling parameters were evaluated in EBUS images (L2 thickness, L2 area, L2 area/internal perimeter [Pi] and L2 area/Pi(2)) and histological cuts (ASM area/Pi(2)), and compared. EBUS was then performed ex vivo on the lungs of 4 horses with heaves, an asthma-like condition of horses, and 7 controls to determine whether central bronchial remodeling could be detected with this technique. An optimized approach was developed based on data variability within airways, subjects, and groups, and then validated in 7 horses (3 controls, 4 with heaves) that underwent EBUS in vivo. L2 area was significantly associated to ASM area in isolated lungs (p<0.0001), in the absence of significant bias related to the airway size. Bronchial size significantly affected EBUS ASM-related parameters, except for L2 area/Pi(2). L2 area/Pi(2) was increased in the airways of asthmatic horses compared to controls, both ex vivo and in vivo (p<0.05). Bronchial histology confirmed our findings (A(ASM)/Pi(2) was increased in asthmatic horses compared to controls, p<0.05). In both horses with heaves and controls, L2 was composed of ASM for the outer 75% of its thickness and by ECM for the remaining inner 25%. In conclusion, EBUS reliably allows assessment of asthma-associated ASM remodeling of central airways in a non-invasive way.	[Bullone, Michela; Beauchamp, Guy; Godbout, Mireille; Lavoie, Jean-Pierre] Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada; [Martin, James G.] McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada	Universite de Montreal; McGill University	Lavoie, JP (corresponding author), Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada.	jean-pierre.lavoie@umontreal.ca	Bullone, Michela/K-5175-2018	Bullone, Michela/0000-0002-9094-6734; Martin, James/0000-0001-7574-5363	Canadian Institutes of Health [R0017988]; Canadian Foundation for Innovation [29172]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This study was supported by the Canadian Institutes of Health (#R0017988) and by the Canadian Foundation for Innovation (#29172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo BB, 2008, EUR RESPIR J, V32, P61, DOI 10.1183/09031936.00147807; Baba M, 2002, LUNG CANCER-J IASLC, V35, P65, DOI 10.1016/S0169-5002(01)00284-7; Bolliger CT, 2002, EUR RESPIR J, V19, P356, DOI 10.1183/09031936.02.00204602; Bullone M, 2014, J APPL PHYSIOL, V117, P806, DOI 10.1152/japplphysiol.00468.2014; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; EBINA M, 1990, AM REV RESPIR DIS, V141, P1322, DOI 10.1164/ajrccm/141.5_Pt_1.1322; EBINA M, 1990, AM REV RESPIR DIS, V141, P1327, DOI 10.1164/ajrccm/141.5_Pt_1.1327; Elliot JG, 2015, RESPIROLOGY, V20, P66, DOI 10.1111/resp.12384; Ernst A, 2003, CHEST, V123, P1693, DOI 10.1378/chest.123.5.1693; Falcone F, 2003, RESPIRATION, V70, P179, DOI 10.1159/000070066; Herszberg B, 2006, J ALLERGY CLIN IMMUN, V118, P382, DOI 10.1016/j.jaci.2006.03.044; Hirota N, 2013, CHEST, V144, P1026, DOI 10.1378/chest.12-3073; HURTER T, 1992, THORAX, V47, P565, DOI 10.1136/thx.47.7.565; James A, 2000, EUR RESPIR J, V15, P782, DOI 10.1034/j.1399-3003.2000.15d25.x; James AL, 2009, EUR RESPIR J, V34, P1040, DOI 10.1183/09031936.00181608; James AL, 2002, AM J RESP CRIT CARE, V166, P1590, DOI 10.1164/rccm.2108069; James AL, 1988, AM REV RESPIR DIS, V138, P139; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Jones RL, 2014, AM J RESP CELL MOL, V50, P246, DOI 10.1165/rcmb.2013-0029OC; Kaminska M, 2009, J ALLERGY CLIN IMMUN, V124, P45, DOI 10.1016/j.jaci.2009.03.049; Kita T, 2010, J BRONCHOL INTERN PU, V17, P301, DOI 10.1097/LBR.0b013e3181f9f09b; Koblinger K, 2011, J VET INTERN MED, V25, P1118, DOI 10.1111/j.1939-1676.2011.00788.x; Kurimoto N, 1999, CHEST, V115, P1500, DOI 10.1378/chest.115.6.1500; LAMBERT RK, 1993, J APPL PHYSIOL, V74, P2771, DOI 10.1152/jappl.1993.74.6.2771; Leclere M, 2011, RESPIROLOGY, V16, P1027, DOI 10.1111/j.1440-1843.2011.02033.x; Leclere M, 2011, AM J RESP CELL MOL, V45, P181, DOI 10.1165/rcmb.2010-0300OC; Oliver MN, 2007, AM J RESP CELL MOL, V37, P264, DOI 10.1165/rcmb.2006-0418OC; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Robinson NE, 2000, EQUINE VET J, V32, P393, DOI 10.2746/042516400777591147; Setlakwe EL, 2014, AM J PHYSIOL-LUNG C, V307, pL252, DOI 10.1152/ajplung.00019.2014; Shaw TJ, 2004, EUR RESPIR J, V23, P813, DOI 10.1183/09031936.04.00119904; Soja J, 2009, CHEST, V136, P797, DOI 10.1378/chest.08-2759; Sumi Y, 2007, CLIN EXP ALLERGY, V37, P1781, DOI 10.1111/j.1365-2222.2007.02828.x	33	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136284	10.1371/journal.pone.0136284	http://dx.doi.org/10.1371/journal.pone.0136284			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348727	Green Submitted, Green Published, gold			2022-12-27	WOS:000360897600004
J	Caldwell, J; Wang, W; Zandstra, PW				Caldwell, Julia; Wang, Weijia; Zandstra, Peter W.			Proportional-Integral-Derivative (PID) Control of Secreted Factors for Blood Stem Cell Culture	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; GROWTH-FACTOR-BETA; INTERACTION NETWORKS; EXPANSION; RECONSTITUTION; HEMATOPOIESIS	Clinical use of umbilical cord blood has typically been limited by the need to expand hematopoietic stem and progenitor cells (HSPC) ex vivo. This expansion is challenging due to the accumulation of secreted signaling factors in the culture that have a negative regulatory effect on HSPC output. Strategies for global regulation of these factors through dilution have been developed, but do not accommodate the dynamic nature or inherent variability of hematopoietic cell culture. We have developed a mathematical model to simulate the impact of feedback control on in vitro hematopoiesis, and used it to design a proportional-integral-derivative (PID) control algorithm. This algorithm was implemented with a fed-batch bioreactor to regulate the concentrations of secreted factors. Controlling the concentration of a key target factor, TGF-beta 1, through dilution limited the negative effect it had on HSPCs, and allowed global control of other similarly-produced inhibitory endogenous factors. The PID control algorithm effectively maintained the target soluble factor at the target concentration. We show that feedback controlled dilution is predicted to be a more cost effective dilution strategy compared to other open-loop strategies, and can enhance HSPC expansion in short term culture. This study demonstrates the utility of secreted factor process control strategies to optimize stem cell culture systems, and motivates the development of multi-analyte protein sensors to automate the manufacturing of cell therapies.	[Caldwell, Julia; Wang, Weijia; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Zandstra, Peter W.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Zandstra, Peter W.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [Zandstra, Peter W.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Zandstra, PW (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	peter.zandstra@utoronto.ca	Wang, Weijia/O-6061-2017	Wang, Weijia/0000-0002-0270-8366	Leukemia and Lymphoma Society of Canada grant [493946]; Canadian Stem Cell Network grant [492019]; Natural Science and Engineering Research Council Discovery grant [456382]; Ontario Stem Cell Initiative post-doctoral fellowship	Leukemia and Lymphoma Society of Canada grant; Canadian Stem Cell Network grant; Natural Science and Engineering Research Council Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Stem Cell Initiative post-doctoral fellowship	This work was funded by a Leukemia and Lymphoma Society of Canada grant (493946, www.llscanada.org) to PWZ, a Canadian Stem Cell Network grant (492019, www.stemcellnetwork.ca) to PWZ, and a Natural Science and Engineering Research Council Discovery grant (456382, www.nserc-crsng.gc.ca) to PWZ. WW was supported by an Ontario Stem Cell Initiative (www.oirm.ca) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; CASHMAN JD, 1990, BLOOD, V75, P96; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Csaszar E, 2014, BIOTECHNOL BIOENG, V111, P1258, DOI 10.1002/bit.25163; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Durand EM, 2010, CURR OPIN HEMATOL, V17, P308, DOI 10.1097/MOH.0b013e32833a888c; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Fortunel NO, 2000, BLOOD, V96, P2022; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gluckman E, 2009, BONE MARROW TRANSPL, V44, P621, DOI 10.1038/bmt.2009.280; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Kirouac DC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.49; Koller MR, 1998, BONE MARROW TRANSPL, V21, P653, DOI 10.1038/sj.bmt.1701157; Lim M, 2007, BIOTECHNOL ADV, V25, P353, DOI 10.1016/j.biotechadv.2007.02.002; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Madlambayan GJ, 2005, EXP HEMATOL, V33, P1229, DOI 10.1016/j.exphem.2005.05.018; Ming K, 2015, ACS NANO, V9, P3060, DOI 10.1021/nn5072792; Mostafa SS, 2001, EXP HEMATOL, V29, P873, DOI 10.1016/S0301-472X(01)00658-0; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Politikos I, 2014, BLOOD, V124, P3201, DOI 10.1182/blood-2014-07-589176; Prouix C, 2004, BIOTECHNOL BIOENG, V88, P675, DOI 10.1002/bit.20288; Qiao W, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145141; Sage AT, 2014, ACCOUNTS CHEM RES, V47, P2417, DOI 10.1021/ar500130m; Yang H, 2002, STEM CELLS, V20, P320, DOI 10.1634/stemcells.20-4-320; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119	30	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137392	10.1371/journal.pone.0137392	http://dx.doi.org/10.1371/journal.pone.0137392			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348930	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600042
J	Schutt, SD; Fu, JN; Nguyen, H; Bastian, D; Heinrichs, J; Wu, YX; Liu, C; McDonald, DG; Pidala, J; Yu, XZ				Schutt, Steven D.; Fu, Jianing; Nguyen, Hung; Bastian, David; Heinrichs, Jessica; Wu, Yongxia; Liu, Chen; McDonald, Daniel G.; Pidala, Joseph; Yu, Xue-Zhong			Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice	PLOS ONE			English	Article							BRUTONS TYROSINE KINASE; CD4(+) T-CELLS; B-CELLS; DONOR CD4(+); BRONCHIOLITIS OBLITERANS; TRANSCRIPTION FACTOR; CHRONIC GVHD; ACTIVATION; TRANSPLANTS; PHOSPHORYLATION	Bruton's Tyrosine Kinase (BTK) and IL-2 Inducible T-cell Kinase (ITK) are enzymes responsible for the phosphorylation and activation of downstream effectors in the B-cell receptor (BCR) signaling and T cell receptor (TCR) signaling pathways, respectively. Ibrutinib is an FDA-approved potent inhibitor of both BTK and ITK that impairs B-cell and T-cell function. CD4 T cells and B cells are essential for the induction of chronic graft-versus-host disease (cGVHD). We evaluated these targets by testing the ability of Ibrutinib to prevent or ameliorate cGVHD, which is one of the major complications for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). We found that Ibrutinib significantly alleviated cGVHD across four different mouse models, accompanied by increased long-term survival and reduced clinical score. The clinical improvements in Ibrutinib-treated recipients were associated with decreased serum-autoantibodies, costimulatory molecule activation, B-cell proliferation, and glomerulonephritis compared to vehicle controls. Ibrutinib was also able to alleviate the clinical manifestations in acute GVHD (aGVHD), where the recipients were given grafts with or without B cells, suggesting that an inhibitory effect of Ibrutinib on T cells contributes to a reduction in both aGVHD and cGVHD pathogenesis. An effective prophylactic regimen is still lacking to both reduce the incidence and severity of human cGVHD following allo-HSCT. Our study shows that Ibrutinib is an effective prophylaxis against several mouse models of cGVHD with minimal toxicity and could be a promising strategy to combat human cGVHD clinically.	[Schutt, Steven D.; Fu, Jianing; Nguyen, Hung; Bastian, David; Heinrichs, Jessica; Wu, Yongxia; Yu, Xue-Zhong] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Fu, Jianing] Univ S Florida, Canc Biol PhD Program, Tampa, FL USA; [Fu, Jianing] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Liu, Chen] Univ Florida, Pathol Immunol & Lab Med, Gainesville, FL USA; [McDonald, Daniel G.] Med Univ S Carolina, Dept Radiat Oncol, Charleston, SC 29425 USA; [Pidala, Joseph] Univ S Florida, H Lee Moffitt Canc Ctr, Blood & Bone Marrow Transplant Dept, Tampa, FL 33682 USA; [Yu, Xue-Zhong] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of Florida; Medical University of South Carolina; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Medical University of South Carolina	Yu, XZ (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA.	yux@musc.edu	Nguyen, Hung D/AAN-5364-2021; Fu, Jianing/F-4031-2014; Nguyen, Hung/F-9211-2016	Nguyen, Hung D/0000-0001-9416-5137; Fu, Jianing/0000-0003-1500-5405; Nguyen, Hung/0000-0002-7929-4392; Yu, Xue-Zhong/0000-0002-1751-2884; Schutt, Steven/0000-0002-2069-2556	 [CA169116];  [CA143812]; NATIONAL CANCER INSTITUTE [R01CA169116, R01CA143812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118305] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: CA169116, http://www.cancer.gov/; and CA143812, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala A, 2003, INT J EXP PATHOL, V84, P1, DOI 10.1046/j.1365-2613.2003.00235.x; Allen JL, 2014, BLOOD, V123, P2108, DOI 10.1182/blood-2013-10-533562; Anderson BE, 2005, BLOOD, V105, P2227, DOI 10.1182/blood-2004-08-3032; Anderson BE, 2003, J CLIN INVEST, V112, P101, DOI 10.1172/JCI200317601; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; Byrd JC, 2014, NEW ENGL J MED, V371, P213, DOI 10.1056/NEJMoa1400376; Chu YW, 2008, BIOL BLOOD MARROW TR, V14, P365, DOI 10.1016/j.bbmt.2007.12.002; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; DeNucci CC, 2010, J IMMUNOL, V184, P2458, DOI 10.4049/jimmunol.0902407; Huu DL, 2013, BLOOD, V121, P3274, DOI 10.1182/blood-2012-11-465658; Dubovsky JA, 2014, J CLIN INVEST, V124, P4867, DOI 10.1172/JCI75328; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Flynn R, 2014, BLOOD, V123, P3988, DOI 10.1182/blood-2014-03-562231; Fu JN, 2015, J IMMUNOL, V194, P388, DOI 10.4049/jimmunol.1401618; Gibson S, 1996, J IMMUNOL, V156, P2716; Gomez-Rodriguez J, 2014, J EXP MED, V211, P529, DOI 10.1084/jem.20131459; Hata D, 1998, J BIOL CHEM, V273, P10979, DOI 10.1074/jbc.273.18.10979; Jain N, 2013, NAT MED, V19, P1632, DOI 10.1038/nm.3393; Kansu E, 2001, BLOOD, V98, P3868, DOI 10.1182/blood.V98.13.3868; Kapur R, 2008, HAEMATOL-HEMATOL J, V93, P1702, DOI 10.3324/haematol.13311; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Levade M, 2014, BLOOD, V124, P3991, DOI 10.1182/blood-2014-06-583294; Liang Y, 2008, BLOOD, V111, P954, DOI 10.1182/blood-2007-05-089573; Lopez-Herrera G, 2014, J LEUKOCYTE BIOL, V95, P243, DOI 10.1189/jlb.0513307; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Mohamed AJ, 1999, SCAND J IMMUNOL, V49, P113; Ogawa Y, 2003, INVEST OPHTH VIS SCI, V44, P1888, DOI 10.1167/iovs.02-0699; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1034/j.1600-065X.2000.017504.x; Schroeder MA, 2011, DIS MODEL MECH, V4, P318, DOI 10.1242/dmm.006668; SINGH RR, 1995, J EXP MED, V181, P2017, DOI 10.1084/jem.181.6.2017; Socie G, 2014, BLOOD, V124, P374, DOI 10.1182/blood-2014-01-514752; Srinivasan M, 2012, BLOOD, V119, P1570, DOI 10.1182/blood-2011-07-364414; Tschetter JR, 2000, J IMMUNOL, V165, P5987, DOI 10.4049/jimmunol.165.10.5987; US Food & Drug Administration, 2013, HIGHL PRESCR INF; Valenzuela JO, 2009, J CLIN INVEST, V119, P3774, DOI 10.1172/JCI39692; Vogelsang GB, 2001, BLOOD, V97, P1196, DOI 10.1182/blood.V97.5.1196; Weil D, 1997, BLOOD, V90, P4332, DOI 10.1182/blood.V90.11.4332.4332_4332_4340; Westermann J, 2003, LAB INVEST, V83, P459, DOI 10.1097/01.LAB.0000062852.80567.90; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232; Wu T, 2013, J IMMUNOL, V191, P488, DOI 10.4049/jimmunol.1300657; Young JS, 2012, J IMMUNOL, V189, P222, DOI 10.4049/jimmunol.1200677; Yu Y, 2013, EUR J IMMUNOL, V43, P2327, DOI 10.1002/eji.201243282; Yu Y, 2011, BLOOD, V118, P5011, DOI 10.1182/blood-2011-03-340315; Zhang CY, 2006, BLOOD, V107, P2993, DOI 10.1182/blood-2005-09-3623; Zhao DC, 2011, J IMMUNOL, V186, P856, DOI 10.4049/jimmunol.1002195	45	60	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137641	10.1371/journal.pone.0137641	http://dx.doi.org/10.1371/journal.pone.0137641			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348529	gold, Green Published, Green Submitted			2022-12-27	WOS:000360897600056
J	Yang, YQ; Li, X; Yang, SH; Zhou, YL; Dong, C; Ren, J; Sun, XD; Yang, YP				Yang, Yunqiang; Li, Xiong; Yang, Shihai; Zhou, Yanli; Dong, Chao; Ren, Jian; Sun, Xudong; Yang, Yongping			Comparative Physiological and Proteomic Analysis Reveals the Leaf Response to Cadmium-Induced Stress in Poplar (Populus yunnanensis)	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ARABIDOPSIS-THALIANA; OXIDATIVE DAMAGE; ABIOTIC STRESS; PLANTS; DROUGHT; ROOTS; EXPRESSION; TOLERANCE; LEAVES	Excess amounts of heavy metals are important environmental pollutants with significant ecological and nutritional effects. Cdmium (Cd) is of particular concern because of its widespread occurrence and high toxicity. We conducted physiological and proteomic analyses to improve our understanding of the responses of Populus yunnanensis to Cd stress. The plantlets experienced two apparent stages in their response to Cd stress. During the first stage, transiently induced defense-response molecules, photosynthesis-and energy-associated proteins, antioxidant enzymes and heat shock proteins (HSPs) accumulated to enhance protein stability and establish a new cellular homeostasis. This activity explains why plant photosynthetic capability during this period barely changed. During the second stage, a decline of ribulose-1, 5-bisphosphate carboxylase (RuBisCO) and HSP levels led to imbalance of the plant photosynthetic system. Additionally, the expression of Mitogen-activated protein kinase 3 (MPK3), Mitogen-activated protein kinase 6 (MPK6) and a homeobox-leucine zipper protein was higher in the second stage. Higher expression of caffeoyl-CoA O-methyltransferase (CCoAOMT) may regulate plant cell wall synthesis for greater Cd storage. These genes may be candidates for further research and use in genetic manipulation of poplar tolerance to Cd stress.	[Yang, Yunqiang; Li, Xiong; Zhou, Yanli; Dong, Chao; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Key Lab Plant Divers & Biogeog East Asia, Kunming Inst Bot, Kunming 650204, Peoples R China; [Yang, Yunqiang; Li, Xiong; Zhou, Yanli; Dong, Chao; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Plant Germplasm & Genom Ctr, Kunming Inst Bot, Kunming 650201, Peoples R China; [Yang, Yunqiang; Li, Xiong; Zhou, Yanli; Dong, Chao; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Inst Tibetan Plateau Res, Kunming Inst Bot, Kunming 650201, Peoples R China; [Yang, Shihai] Chinese Acad Sci, Key Lab Tibetan Environm Changes & Land Surface P, Inst Tibetan Plateau Res, Beijing 100085, Peoples R China; [Ren, Jian] Yunnan Agr Univ, Dept Grassland Sci, Kunming 650201, Peoples R China; [Li, Xiong; Yang, Shihai; Zhou, Yanli; Dong, Chao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Yunnan Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, XD (corresponding author), Chinese Acad Sci, Key Lab Plant Divers & Biogeog East Asia, Kunming Inst Bot, Kunming 650204, Peoples R China.	sunxundong@mail.kib.ac.cn; yangyp@mail.kib.ac.cn	Yang, Shihai/J-1593-2012; Sun, Xudong/HHN-3905-2022	Yang, Shihai/0000-0002-6497-968X; 	National Natural Science Foundation of China (NSFC) [41271058]; Major State Basic Research Development Program of China [2010CB951704]; National Science Foundation of China [31260167]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (NSFC) (No. 41271058), the Major State Basic Research Development Program of China (Nos. 2010CB951704), and the National Science Foundation of China (No. 31260167).	Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g; Benavides María P., 2005, Braz. J. Plant Physiol., V17, P21, DOI 10.1590/S1677-04202005000100003; Broin M, 2002, PLANT CELL, V14, P1417, DOI 10.1105/tpc.001644; Chen LH, 2011, J EXP BOT, V62, P5037, DOI 10.1093/jxb/err203; Chen Q, 2013, PLANT PHYSIOL BIOCH, V70, P504, DOI 10.1016/j.plaphy.2013.06.015; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa P, 1998, PLANT MOL BIOL, V38, P587, DOI 10.1023/A:1006006132120; Das P, 1997, ENVIRON POLLUT, V98, P29, DOI 10.1016/S0269-7491(97)00110-3; Desikan R, 2005, BIOL SCI SER, P169, DOI 10.1002/9780470988565.ch7; Duan BL, 2008, PHYSIOL PLANTARUM, V134, P257, DOI 10.1111/j.1399-3054.2008.01128.x; Duan BL, 2005, PHYSIOL PLANTARUM, V124, P476, DOI 10.1111/j.1399-3054.2005.00535.x; Gong HJ, 2005, PLANT SCI, V169, P313, DOI 10.1016/j.plantsci.2005.02.023; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Gratao PL, 2009, ENVIRON EXP BOT, V67, P387, DOI 10.1016/j.envexpbot.2009.06.017; Guo CL, 2013, PLANT MOL BIOL REP, V31, P1012, DOI 10.1007/s11105-013-0569-0; Herbette S, 2006, BIOCHIMIE, V88, P1751, DOI 10.1016/j.biochi.2006.04.018; HERNANDEZ JA, 1995, PLANT SCI, V105, P151, DOI 10.1016/0168-9452(94)04047-8; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Jiang H, 2013, CHEMOSPHERE, V91, P1213, DOI 10.1016/j.chemosphere.2013.01.041; Jonak C, 2004, PLANT PHYSIOL, V136, P3276, DOI 10.1104/pp.104.045724; KEY JL, 1981, P NATL ACAD SCI-BIOL, V78, P3526, DOI 10.1073/pnas.78.6.3526; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kieffer P, 2009, J PROTEOME RES, V8, P400, DOI 10.1021/pr800561r; Kieffer P, 2009, J PROTEOMICS, V72, P379, DOI 10.1016/j.jprot.2009.01.014; Kirkham MB, 2006, GEODERMA, V137, P19, DOI 10.1016/j.geoderma.2006.08.024; Li L, 2013, PHYSIOL PLANTARUM, V147, P477, DOI 10.1111/j.1399-3054.2012.01676.x; Li X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107605; Li ZW, 2005, PLANT SOIL, V271, P165, DOI 10.1007/s11104-004-2296-7; Lin CW, 2005, PLANT PHYSIOL BIOCH, V43, P963, DOI 10.1016/j.plaphy.2005.10.001; Liu CP, 2007, BIOL PLANTARUM, V51, P116, DOI 10.1007/s10535-007-0023-y; Liu CF, 2011, PLANT SOIL, V344, P131, DOI 10.1007/s11104-011-0733-y; Liu XM, 2010, PHYTOCHEMISTRY, V71, P614, DOI 10.1016/j.phytochem.2010.01.005; Lombi E, 2002, PLANT PHYSIOL, V128, P1359, DOI 10.1104/pp.010731; Lukacova Z, 2013, PLANT GROWTH REGUL, V70, P89, DOI 10.1007/s10725-012-9781-4; Pietrini F, 2003, PLANT PHYSIOL, V133, P829, DOI 10.1104/pp.103.026518; Pietrzykowska M, 2014, PLANT CELL, V26, P3646, DOI 10.1105/tpc.114.127373; Prasad MNV, 1995, ENVIRON EXP BOT, V35, P525, DOI 10.1016/0098-8472(95)00024-0; Ranocha P, 2002, PLANT PHYSIOL, V129, P145, DOI 10.1104/pp.010988; Raven E L, 2000, Subcell Biochem, V35, P317; Roelofs D, 2008, FUNCT ECOL, V22, P8, DOI 10.1111/j.1365-2435.2007.01312.x; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Schnoor J, 2004, ENVIRON SCI TECHNOL, V38, p53A, DOI 10.1021/es040368m; Senthil KM, 2010, PLANT PHYSIOL BIOCH, V48, P35; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Vincent D, 2005, PLANT PHYSIOL, V137, P949, DOI 10.1104/pp.104.050815; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang XQ, 2009, PLANT PHYSIOL, V149, P1739, DOI 10.1104/pp.108.131714; Weast RC, 1988, CRC HDB CHEM PHYS; Windhof A., 2011, RUBISCO FOLDING OLIG; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu LX, 2013, ENVIRON EXP BOT, V89, P28, DOI 10.1016/j.envexpbot.2012.12.001; Yamaguchi H, 2010, J EXP BOT, V61, P423, DOI 10.1093/jxb/erp313; Yang JL, 2013, NEW PHYTOL, V197, P815, DOI 10.1111/nph.12057; Zhang A, 2010, J EXP BOT, V61, P4399, DOI 10.1093/jxb/erq243; Zhang XL, 2012, RICE SCI, V19, P86, DOI 10.1016/S1672-6308(12)60026-2; Zhao CR, 2010, SOIL SCI PLANT NUTR, V56, P150, DOI 10.1111/j.1747-0765.2009.00440.x; Zhou YQ, 2010, ECOTOXICOLOGY, V19, P69, DOI 10.1007/s10646-009-0389-z	59	23	24	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137396	10.1371/journal.pone.0137396	http://dx.doi.org/10.1371/journal.pone.0137396			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26349064	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600043
J	Etienne, L; Blanchard, E; Boyer, A; Desvignes, V; Gaillard, J; Meunier, JC; Roingeard, P; Hourioux, C				Etienne, Loic; Blanchard, Emmanuelle; Boyer, Audrey; Desvignes, Virginie; Gaillard, Julien; Meunier, Jean-Christophe; Roingeard, Philippe; Hourioux, Christophe			The Replacement of 10 Non-Conserved Residues in the Core Protein of JFH-1 Hepatitis C Virus Improves Its Assembly and Secretion	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; CELL-CULTURE SYSTEM; LIPID DROPLETS; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN; STRUCTURAL PROTEINS; INFECTIOUS VIRUS; VIRAL GENOME; PARTICLES; RNA	Hepatitis C virus (HCV) assembly is still poorly understood. It is thought that trafficking of the HCV core protein to the lipid droplet (LD) surface is essential for its multimerization and association with newly synthesized HCV RNA to form the viral nucleocapsid. We carried out a mapping analysis of several complete HCV genomes of all genotypes, and found that the genotype 2 JFH-1 core protein contained 10 residues different from those of other genotypes. The replacement of these 10 residues of the JFH-1 strain sequence with the most conserved residues deduced fromsequence alignments greatly increased virus production. Confocal microscopy of themodified JFH-1 strain in cell culture showed that themutated JFH-1 core protein, C10M, was presentmostly at the endoplasmic reticulum(ER) membrane, but not at the surface of the LDs, even though its trafficking to these organelles was possible. The non-structural 5A protein of HCV was also redirected to ER membranes and colocalized with the C10Mcore protein. Using a Semliki forest virus vector to overproduce core protein, we demonstrated that the C10M core protein was able to form HCV-like particles, unlike the native JFH-1 core protein. Thus, the substitution of a few selected residues in the JFH-1 core protein modified the subcellular distribution and assembly properties of the protein. These findings suggest that the early steps of HCV assembly occur at the ER membrane rather than at the LD surface. The C10M-JFH-1 strain will be a valuable tool for further studies of HCV morphogenesis.	[Etienne, Loic; Blanchard, Emmanuelle; Boyer, Audrey; Desvignes, Virginie; Meunier, Jean-Christophe; Roingeard, Philippe; Hourioux, Christophe] Univ Tours, Fac Med, INSERM, U966, Tours, France; [Etienne, Loic; Blanchard, Emmanuelle; Boyer, Audrey; Desvignes, Virginie; Gaillard, Julien; Meunier, Jean-Christophe; Roingeard, Philippe; Hourioux, Christophe] CHRU Tours, Tours, France; [Blanchard, Emmanuelle; Gaillard, Julien; Roingeard, Philippe; Hourioux, Christophe] Univ Tours, PPF ASB, Plate Forme Microscopies, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Universite de Tours	Hourioux, C (corresponding author), Univ Tours, Fac Med, INSERM, U966, Tours, France.	hourioux@med.univ-tours.fr			Agence nationale de recherches sur le sida et les hepatites virales; Ligue contre le cancer	Agence nationale de recherches sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); Ligue contre le cancer(Ligue nationale contre le cancer)	This study was supported by the Agence nationale de recherches sur le sida et les hepatites virales, (http://www.anrs.fr/), Ligue contre le cancer, (http://www.ligue-cancer.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Goughoulte M, 2006, J GEN VIROL, V87, P855, DOI 10.1099/vir.0.81664-0; Aizaki H, 2003, VIROLOGY, V314, P16, DOI 10.1016/S0042-6822(03)00383-0; Aoki Y, 1998, VIROLOGY, V250, P140, DOI 10.1006/viro.1998.9361; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Blanchard E, 2003, J VIROL, V77, P10131, DOI 10.1128/JVI.77.18.10131-10138.2003; Blanchard E, 2002, J VIROL, V76, P4073, DOI 10.1128/JVI.76.8.4073-4079.2002; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Boyer A, 2014, J BIOL CHEM, V289, P18904, DOI 10.1074/jbc.M113.538256; Camus G, 2013, J BIOL CHEM, V288, P9915, DOI 10.1074/jbc.M112.434910; Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Galli A, 2013, J GEN VIROL, V94, P2221, DOI 10.1099/vir.0.053868-0; Gawlik K, 2014, IMMUNOL RES, V60, P1, DOI 10.1007/s12026-014-8494-3; Gawlik K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088866; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hourioux C, 2007, GUT, V56, P1302, DOI 10.1136/gut.2006.108647; Hourioux C, 2007, CELL MICROBIOL, V9, P1014, DOI 10.1111/j.1462-5822.2006.00848.x; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Kim S, 2014, HEPATOLOGY, V60, P1838, DOI 10.1002/hep.27197; Lappalainen S, 2013, HUM VACC IMMUNOTHER, V9, P1991, DOI 10.4161/hv.25249; Lee J-Y, 2014, J VIROL; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Lindenbach BD, 2013, CURR TOP MICROBIOL, V369, P199, DOI 10.1007/978-3-642-27340-7_8; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Matsumoto M, 1996, VIROLOGY, V218, P43, DOI 10.1006/viro.1996.0164; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928; OKAMOTO H, 1991, J GEN VIROL, V72, P2697, DOI 10.1099/0022-1317-72-11-2697; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Popescu CI, 2010, BIOL CELL, V102, P63, DOI 10.1042/BC20090125; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; Salloum S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003513; Sharma KK, 2012, NUCLEIC ACIDS RES, V40, P2540, DOI 10.1093/nar/gkr1140; Sharma KK, 2010, NUCLEIC ACIDS RES, V38, P3632, DOI 10.1093/nar/gkq094; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Steinmann E, 2013, J VIROL, V87, P13297, DOI 10.1128/JVI.01708-13; Tan S-L, 2006, ASSEMBLE INTERACT PL; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Vogt DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003302; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	57	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137182	10.1371/journal.pone.0137182	http://dx.doi.org/10.1371/journal.pone.0137182			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339783	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200031
J	Cieslik, M; Czapski, GA; Strosznajder, JB				Cieslik, Magdalena; Czapski, Grzegorz A.; Strosznajder, Joanna B.			The Molecular Mechanism of Amyloid beta 42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial Sirtuins	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; OXIDATIVE STRESS; CELL-DEATH; P53; ALPHA; SIRT1; SPHINGOSINE-1-PHOSPHATE; DEFICIENCY; PATHWAY	Our study focused on the relationship between amyloid beta 1-42 (A beta), sphingosine kinases (SphKs) and mitochondrial sirtuins in regulating cell fate. SphK1 is a key enzyme involved in maintaining sphingolipid rheostat in the brain. Deregulation of the sphingolipid metabolism may play a crucial role in the pathogenesis of Alzheimer's disease (AD). Mitochondrial function and mitochondrial deacetylases, i.e. sirtuins (Sirt3,-4,-5), are also important for cell viability. In this study, we evaluated the interaction between A beta(1-42), SphKs and Sirts in cell survival/death, and we examined several compounds to indicate possible target(s) for a strategy protecting against cytotoxicity of A beta(1-42). PC12 cells were subjected to A beta(1-42) oligomers and SphK inhibitor SKI II for 24-96 h. Our data indicated that A beta(1-42) enhanced SphK1 expression and activity after 24 h, but down-regulated them after 96 h and had no effect on Sphk2. A beta(1-42) and SKI II induced free radical formation, disturbed the balance between pro-and anti-apoptotic proteins and evoked cell death. Simultaneously, up-regulation of anti-oxidative enzymes catalase and superoxide dismutase 2 was observed. Moreover, the total protein level of glycogen synthase kinase-3 beta was decreased. A beta(1-42) significantly increased the level of mitochondrial proteins: apoptosis-inducing factor AIF and Sirt3, -4, -5. By using several pharmacologically active compounds we showed that p53 protein plays a significant role at very early stages of A beta(1-42) toxicity. However, during prolonged exposure to A beta(1-42), the activation of caspases, MEK/ERK, and alterations in mitochondrial permeability transition pores were additional factors leading to cell death. Moreover, SphK product, sphingosine-1-phosphate (S1P), and Sirt activators and antioxidants, resveratrol and quercetin, significantly enhanced viability of cells subjected to A beta(1-42). Our data indicated that p53 protein and inhibition of SphKs may be early key events responsible for cell death evoked by A beta 1-42. We suggest that activation of S1P-dependent signalling and Sirts may offer a promising cytoprotective strategy.	[Cieslik, Magdalena; Czapski, Grzegorz A.; Strosznajder, Joanna B.] Polish Acad Sci, Dept Cellular Signalling, Mossakowski Med Res Ctr, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Strosznajder, JB (corresponding author), Polish Acad Sci, Dept Cellular Signalling, Mossakowski Med Res Ctr, Warsaw, Poland.	jstrosznajder@imdik.pan.pl	Czapski, Grzegorz/D-6151-2016	Strosznajder, Joanna/0000-0002-6213-1212; Czapski, Grzegorz/0000-0002-7541-1571; Cieslik, Magdalena/0000-0002-7604-4371	National Science Centre [2013/09/B/NZ3/01350, 5870/B/PO1/2011/40]	National Science Centre(National Science Centre, Poland)	This study was supported by The National Science Centre (http://www.ncn.gov.pl) Grants 2013/09/B/NZ3/01350 and 5870/B/PO1/2011/40 to J.B.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Asle-Rousta M, 2013, J MOL NEUROSCI, V50, P524, DOI 10.1007/s12031-013-9979-6; Aubry S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120352; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Buizza L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.13; Ceccom J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-12; Cedazo-Minguez A, 2003, J NEUROCHEM, V87, P1152, DOI 10.1046/j.1471-4159.2003.02088.x; Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254; Cieslik M, 2013, NEUROCHEM INT, V62, P626, DOI 10.1016/j.neuint.2013.02.016; Couttas TA, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-9; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Czapski GA, 2011, FEBS LETT, V585, P1243, DOI 10.1016/j.febslet.2011.03.058; Czubowicz K, 2014, MOL NEUROBIOL, V50, P26, DOI 10.1007/s12035-013-8606-4; de Moura MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106028; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Fonteh AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125597; Fornai F, 2007, BRAIN RES, V1129, P174, DOI 10.1016/j.brainres.2006.10.071; Gandy K Alexa Orr, 2013, Handb Exp Pharmacol, P275, DOI 10.1007/978-3-7091-1511-4_14; Gassowska M, 2014, NEUROCHEM RES, V39, P645, DOI 10.1007/s11064-014-1240-3; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Hemmati F, 2013, BEHAV BRAIN RES, V252, P415, DOI 10.1016/j.bbr.2013.06.016; Herskovits AZ, 2013, CELL RES, V23, P746, DOI 10.1038/cr.2013.70; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hooper C, 2007, NEUROSCI LETT, V418, P34, DOI 10.1016/j.neulet.2007.03.026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jesko H, 2014, FOLIA NEUROPATHOL, V52, P70, DOI 10.5114/fn.2014.41745; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Karaca I, 2014, J BIOL CHEM, V289, P16761, DOI 10.1074/jbc.M113.535500; Kazmierczak A, 2011, NEUROCHEM INT, V58, P206, DOI 10.1016/j.neuint.2010.11.018; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim Taehyun, 2011, Int J Alzheimers Dis, V2011, P857368, DOI 10.4061/2011/857368; Kincaid B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00048; Kitagishi Y, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt265; Koczor CA, 2012, AM J PATHOL, V180, P2276, DOI 10.1016/j.ajpath.2012.01.045; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li F, 2012, CURR PHARM DESIGN, V18, P27, DOI 10.2174/138161212798919075; Li NJ, 2010, CLIN BIOCHEM, V43, P992, DOI 10.1016/j.clinbiochem.2010.04.072; MASLIAH E, 1991, J NEUROSCI, V11, P2759; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Nakanishi A, 2015, INT J MOL SCI, V16, P2879, DOI 10.3390/ijms16022879; Nassif M, 2007, NEUROCHEM INT, V50, P229, DOI 10.1016/j.neuint.2006.08.008; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Pyszko J, 2014, MOL NEUROBIOL, V50, P38, DOI 10.1007/s12035-013-8622-4; Pyszko JA, 2014, FOLIA NEUROPATHOL, V52, P260, DOI 10.5114/fn.2014.45567; Sery O, 2013, FOLIA NEUROPATHOL, V51, P1, DOI 10.5114/fn.2013.34190; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Strosznajder JB, 2012, MOL NEUROBIOL, V46, P78, DOI 10.1007/s12035-012-8258-9; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; van Echten-Deckert G, 2014, CELL PHYSIOL BIOCHEM, V34, P148, DOI 10.1159/000362991; Yang Y, 2014, NEUROCHEM RES, V39, P932, DOI 10.1007/s11064-014-1290-6; Yuyama K, 2014, BBA-MOL CELL BIOL L, V1841, P793, DOI 10.1016/j.bbalip.2013.08.002	65	34	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137193	10.1371/journal.pone.0137193	http://dx.doi.org/10.1371/journal.pone.0137193			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334640	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400044
J	Lluch-Senar, M; Cozzuto, L; Cano, J; Delgado, J; Llorens-Rico, V; Pereyre, S; Bebear, C; Serrano, L				Lluch-Senar, Maria; Cozzuto, Luca; Cano, Jaime; Delgado, Javier; Llorens-Rico, Veronica; Pereyre, Sabine; Bebear, Cecile; Serrano, Luis			Comparative "-omics" in Mycoplasma pneumoniae Clinical Isolates Reveals Key Virulence Factors	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; FRAGMENT-LENGTH-POLYMORPHISM; P1 CYTADHESIN GENE; VACUOLATING CYTOTOXIN; GLYCEROL METABOLISM; ANTIGENIC VARIATION; READ ALIGNMENT; CARDS TOXIN; GENOME; INFECTION	The human respiratory tract pathogen M. pneumoniae is one of the best characterized minimal bacterium. Until now, two main groups of clinical isolates of this bacterium have been described ( types 1 and 2), differing in the sequence of the P1 adhesin gene. Here, we have sequenced the genomes of 23 clinical isolates of M. pneumoniae. Studying SNPs, non-synonymous mutations, indels and genome rearrangements of these 23 strains and 4 previously sequenced ones, has revealed new subclasses in the two main groups, some of them being associated with the country of isolation. Integrative analysis of in vitro gene essentiality and mutation rates enabled the identification of several putative virulence factors and antigenic proteins; revealing recombination machinery, glycerol metabolism and peroxide production as possible factors in the genetics and physiology of these pathogenic strains. Additionally, the transcriptomes and proteomes of two representative strains, one from each of the two main groups, have been characterized to evaluate the impact of mutations on RNA and proteins levels. This study has revealed that type 2 strains show higher expression levels of CARDS toxin, a protein recently shown to be one of the major factors of inflammation. Thus, we propose that type 2 strains could be more toxigenic than type 1 strains of M. pneumoniae.	[Lluch-Senar, Maria; Cano, Jaime; Delgado, Javier; Llorens-Rico, Veronica; Serrano, Luis] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [Lluch-Senar, Maria; Cozzuto, Luca; Cano, Jaime; Delgado, Javier; Llorens-Rico, Veronica; Serrano, Luis] UPF, Barcelona, Spain; [Cozzuto, Luca] Ctr Genom Regulat CRG, Bioinformat Unit, Barcelona, Spain; [Pereyre, Sabine; Bebear, Cecile] Univ Bordeaux, INRA, USC Mycoplasmal & Chlamydial Infect Humans EA3671, Bordeaux, France; [Pereyre, Sabine; Bebear, Cecile] Bordeaux Univ Hosp, Dept Bacteriol, Bordeaux, France; [Serrano, Luis] ICREA, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); INRAE; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; ICREA	Lluch-Senar, M (corresponding author), Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Dr Aiguader 88, Barcelona, Spain.	maria.lluch@crg.es; luis.serrano@crg.es	Lloréns-Rico, Verónica/O-1390-2015; , Pereyre/B-5815-2016; Lluch, Maria/ABF-8435-2021; Senar, Maria Lluch/K-7848-2018; Bébéar, Cécile/A-6596-2016; Serrano, Luis/B-3355-2013; Delgado, Javier F/S-1688-2018; Cozzuto, Luca/K-5385-2015	Lloréns-Rico, Verónica/0000-0002-0860-5990; , Pereyre/0000-0003-1757-4206; Senar, Maria Lluch/0000-0001-7568-4353; Serrano, Luis/0000-0002-5276-1392; Bebear, Cecile/0000-0001-6065-2332; Delgado, Javier/0000-0003-1302-5445; Cozzuto, Luca/0000-0003-3194-8892	European Research Council (ERC); European Union's Horizon research and innovation program [634942]; ICREA Funding Source: Custom	European Research Council (ERC)(European Research Council (ERC)); European Union's Horizon research and innovation program; ICREA(ICREA)	This work was supported by the European Research Council (ERC). This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 634942.	Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x; Baseman JB, 1996, AM J RESP CRIT CARE, V154, pS137, DOI 10.1164/ajrccm/154.4_Pt_2.S137; Bebear C, 2011, FUTURE MICROBIOL, V6, P423, DOI [10.2217/fmb.11.18, 10.2217/FMB.11.18]; Becker A, 2015, P NATL ACAD SCI USA, V112, P5165, DOI 10.1073/pnas.1420308112; Benitez AJ, 2012, J CLIN MICROBIOL, V50, P3620, DOI 10.1128/JCM.01755-12; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bose S, 2014, MBIO, V5, DOI 10.1128/mBio.02186-14; BREDT W, 1968, P SOC EXP BIOL MED, V128, P338, DOI 10.3181/00379727-128-33009; Burgos R, 2014, J BACTERIOL, V196, P1608, DOI 10.1128/JB.01385-13; Chalker V, 2012, EUROSURVEILLANCE B E, V17, DOI 22340973; Chalker V, 2011, EURO SURVEILLANCE BU, V16; Chiner E, 2003, An Med Interna, V20, P597; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; DALLO SF, 1990, INFECT IMMUN, V58, P2017, DOI 10.1128/IAI.58.6.2017-2020.1990; Degrange S, 2009, J CLIN MICROBIOL, V47, P914, DOI 10.1128/JCM.01935-08; Dorigo-Zetsma JW, 2001, INFECT IMMUN, V69, P5612, DOI 10.1128/IAI.69.9.5612-5618.2001; Dumke R, 2003, INT J MED MICROBIOL, V292, P513, DOI 10.1078/1438-4221-00231; Dumke R, 2010, EPIDEMIOL INFECT, V138, P1829, DOI 10.1017/S0950268810000622; Dumke R, 2006, J CLIN MICROBIOL, V44, P2567, DOI 10.1128/JCM.00495-06; Eibach D, 2012, EUROSURVEILLANCE B E, V17; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Guell M, 2011, NAT REV MICROBIOL, V9, P658, DOI 10.1038/nrmicro2620; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Jacobs E, 1996, EUR J CLIN MICROBIOL, V15, P38, DOI 10.1007/BF01586183; Kannan TR, 2010, MOL MICROBIOL, V76, P1127, DOI 10.1111/j.1365-2958.2010.07092.x; Kannan TR, 2006, P NATL ACAD SCI USA, V103, P6724, DOI 10.1073/pnas.0510644103; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; Kenri T, 1999, INFECT IMMUN, V67, P4557, DOI 10.1128/IAI.67.9.4557-4562.1999; Krishnakumar R, 2010, APPL ENVIRON MICROB, V76, P5297, DOI 10.1128/AEM.00024-10; Krishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062706; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Lenglet A, 2012, EUROSURVEILLANCE, V17, P2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000679; Lluch-Senar M, 2015, MOL SYST BIOL, V11; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Medina JL, 2012, AM J RESP CELL MOL, V46, P815, DOI 10.1165/rcmb.2011-0135OC; Nilsson AC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-39; Nir-Paz R, 2012, EUROSURVEILLANCE B E, V17; Nisar N, 2007, POSTGRAD MED J, V83, P100, DOI 10.1136/pgmj.2006.049023; Ou Chun-Yen, 2008, Acta Paediatrica Taiwanica, V49, P14; Pereyre S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038585; Polkowska A, 2012, EUROSURVEILLANCE B E, V17; Rasmussen JN, 2010, EUROSURVEILLANCE B E, V15; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Sasaki T, 1996, J CLIN MICROBIOL, V34, P447, DOI 10.1128/JCM.34.2.447-449.1996; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Simmons WL, 2013, MICROBIOL-SGM, V159, P737, DOI 10.1099/mic.0.064782-0; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith LG, 2010, INFECT DIS CLIN N AM, V24, P57, DOI 10.1016/j.idc.2009.10.006; Spuesens EBM, 2010, J CLIN MICROBIOL, V48, P680, DOI 10.1128/JCM.02078-09; Sun HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064607; Szczepanek SM, 2014, INFECT IMMUN, V82, P4915, DOI 10.1128/IAI.02208-14; Techasaensiri C, 2010, AM J RESP CRIT CARE, V182, P797, DOI 10.1164/rccm.201001-0080OC; Thurman KA, 2009, CLIN INFECT DIS, V48, P1244, DOI 10.1086/597775; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Walter ND, 2008, J INFECT DIS, V198, P1365, DOI 10.1086/592281; Warnes G.R., Various R Programming Tools for Plotting Data 2020; Watanabe H, 2014, ALLERGY ASTHMA PROC, V35, P204, DOI 10.2500/aap.2014.35.3742; Wodke JAH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.6; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105; Yus E, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.16; Zhao F, 2013, J CLIN MICROBIOL, V51, P636, DOI 10.1128/JCM.02567-12	71	35	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137354	10.1371/journal.pone.0137354	http://dx.doi.org/10.1371/journal.pone.0137354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335586	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400052
J	Man, JG; Shi, Y; Yu, ZW; Zhang, YL				Man, Jianguo; Shi, Yu; Yu, Zhenwen; Zhang, Yongli			Dry Matter Production, Photosynthesis of Flag Leaves and Water Use in Winter Wheat Are Affected by Supplemental Irrigation in the Huang-Huai-Hai Plain of China	PLOS ONE			English	Article							GRAIN-YIELD; USE EFFICIENCY; LEAF PHOTOSYNTHESIS; DEFICIT IRRIGATION; DURUM-WHEAT; ROOT-GROWTH; BIOMASS ACCUMULATION; SOIL; NITROGEN; MAIZE	Winter wheat is threatened by drought in the Huang-Huai-Hai Plain of China, thus, effective water-saving irrigation practices are urgently required to maintain its high winter wheat production. This study was conducted from 2012 to 2014 to determine how supplemental irrigation (SI) affected soil moisture, photosynthesis, and dry matter (DM) production of winter wheat by measuring the moisture in 0-20 cm (W2), 0-40 cm (W3), and 0-60 cm (W4) soil profiles. Rainfed (W0) and local SI practice (W1, irrigation with 60 mm each at jointing and anthesis) treatments were designed as controls. The irrigation amount for W3 was significantly lower than that for W1 and W4 but higher than that for W2. The soil relative water content (SRWC) in 0-40 cm soil profiles at jointing after SI for W3 was significantly lower than that for W1 and W4 but higher than that for W2. W3 exhibited lower SRWC in 100-140 and 60-140 cm soil profiles at anthesis after SI and at maturity, respectively, but higher root length density in 60-100 cm soil profiles than W1, W2 and W4. Compared with W1, W2 and W4, photosynthetic and transpiration rates and stomatal conductance of flag leaves for W3 were significantly greater during grain filling, particularly at the mid and later stages. The total DM at maturity, DM in grain and leaves, post-anthesis DM accumulation and its contribution to grain and grain filling duration were higher for W3. The 1000-grain weight, grain yield and water use efficiency for W3 were the highest. Therefore, treatment of increasing SRWC in the 0-40 cm soil profiles to 65% and 70% field capacities at jointing and anthesis (W3), respectively, created a suitable soil moisture environment for winter wheat production, which could be considered as a high yield and water-saving treatment in Huang-Huai-Hai Plain, China.	[Man, Jianguo; Shi, Yu; Yu, Zhenwen; Zhang, Yongli] Shandong Agr Univ, Coll Agron, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst, Tai An 271018, Shandong, Peoples R China	Ministry of Agriculture & Rural Affairs; Shandong Agricultural University	Shi, Y (corresponding author), Shandong Agr Univ, Coll Agron, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst, Tai An 271018, Shandong, Peoples R China.	shiyu@sdau.edu.cn			National Natural Science Foundation of China [31401334]; National Agriculture Technology Research System of China [CARS-3-1-19]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Agriculture Technology Research System of China	This work was financially supported by the National Natural Science Foundation of China (31401334) and the National Agriculture Technology Research System of China (CARS-3-1-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 2007, AGR WATER MANAGE, V92, P151, DOI 10.1016/j.agwat.2007.05.010; Arduini I, 2006, EUR J AGRON, V25, P309, DOI 10.1016/j.eja.2006.06.009; Chattaraj S, 2013, FIELD CROP RES, V144, P179, DOI 10.1016/j.fcr.2012.12.009; Dahal K, 2014, ENVIRON EXP BOT, V106, P207, DOI 10.1016/j.envexpbot.2013.11.015; Dong BD, 2011, AGR WATER MANAGE, V99, P103, DOI 10.1016/j.agwat.2011.07.013; Ercoli L, 2008, EUR J AGRON, V28, P138, DOI 10.1016/j.eja.2007.06.002; Fang Q, 2010, AGR WATER MANAGE, V97, P1165, DOI 10.1016/j.agwat.2009.02.012; Gao Y, 2014, AGR WATER MANAGE, V146, P1, DOI 10.1016/j.agwat.2014.07.010; Gardner W. H., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P493; Guo ZJ, 2014, FIELD CROP RES, V166, P102, DOI 10.1016/j.fcr.2014.06.004; Han ZhanJiang, 2010, Acta Agronomica Sinica, V36, P457, DOI 10.3724/SP.J.1006.2010.00457; Hayashi T, 2013, FIELD CROP RES, V152, P27, DOI 10.1016/j.fcr.2013.03.020; Iqbal MA, 2014, AGR WATER MANAGE, V135, P61, DOI 10.1016/j.agwat.2013.12.012; Jalilian J, 2012, FIELD CROP RES, V127, P26, DOI 10.1016/j.fcr.2011.11.001; Khamssi NN, 2012, PHOTOCHEM PHOTOBIOL, V88, P76, DOI 10.1111/j.1751-1097.2011.01008.x; Li CX, 2011, AGR WATER MANAGE, V98, P1789, DOI 10.1016/j.agwat.2011.07.005; Li HJ, 2008, AGR WATER MANAGE, V95, P1271, DOI 10.1016/j.agwat.2008.05.003; Li Q, 2009, PLANT SOIL ENVIRON, V55, P85, DOI 10.17221/315-PSE; Li QQ, 2010, AGR WATER MANAGE, V97, P1676, DOI 10.1016/j.agwat.2010.05.025; Lihua Lv, 2011, Frontiers of Agriculture in China, V5, P556, DOI 10.1007/s11703-011-1149-4; Liu HJ, 2013, IRRIG DRAIN, V62, P37, DOI 10.1002/ird.1712; Liu HJ, 2011, AGR WATER MANAGE, V98, P483, DOI 10.1016/j.agwat.2010.09.006; Liu LiPing, 2012, Journal of Northeast Agricultural University (English Edition), V19, P20, DOI 10.1016/S1006-8104(13)60046-X; Lv GH, 2010, IRRIGATION SCI, V28, P387, DOI 10.1007/s00271-009-0200-1; Masoni A, 2007, EUR J AGRON, V26, P179, DOI 10.1016/j.eja.2006.09.006; Meade KA, 2013, FIELD CROP RES, V151, P92, DOI 10.1016/j.fcr.2013.07.014; National Bureau of Statistics of China, 2013, CHIN STAT YB, V449, P453; Ning P, 2013, FIELD CROP RES, V144, P19, DOI 10.1016/j.fcr.2013.01.020; Ning SR, 2015, FIELD CROP RES, V177, P125, DOI 10.1016/j.fcr.2015.03.012; Qi WZ, 2012, EUR J AGRON, V38, P54, DOI 10.1016/j.eja.2011.12.003; Rajala A, 2009, FIELD CROP RES, V114, P263, DOI 10.1016/j.fcr.2009.08.007; Ram H, 2013, AGR WATER MANAGE, V128, P92, DOI 10.1016/j.agwat.2013.06.011; Saeidi M., 2012, Australian Journal of Crop Science, V6, P1179; Shimono H, 2004, FIELD CROP RES, V89, P71, DOI 10.1016/j.fcr.2004.01.025; Sun QP, 2011, AGR WATER MANAGE, V98, P808, DOI 10.1016/j.agwat.2010.12.007; Sun YY, 2014, FIELD CROP RES, V167, P1, DOI 10.1016/j.fcr.2014.07.002; Wang CY, 2014, FIELD CROP RES, V165, P138, DOI 10.1016/j.fcr.2014.04.011; Wang D, 2013, FIELD CROP RES, V151, P35, DOI 10.1016/j.fcr.2013.07.009; Wang J, 2011, PLANT SOIL, V347, P41, DOI 10.1007/s11104-011-0764-4; Wang RF, 2009, IND CROP PROD, V29, P182, DOI 10.1016/j.indcrop.2008.04.025; Wu WenMing, 2012, Acta Agronomica Sinica, V38, P1088; Xu ZZ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-21; Xue Q, 2003, PLANT SOIL, V257, P151, DOI 10.1023/A:1026230527597; Yang JC, 2004, PLANTA, V220, P331, DOI 10.1007/s00425-004-1338-y; Yang N, 2014, EUR J AGRON, V58, P63, DOI 10.1016/j.eja.2014.05.002; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang BB, 2010, J CEREAL SCI, V52, P263, DOI 10.1016/j.jcs.2010.05.014; Zhang XY, 2008, IRRIGATION SCI, V27, P1, DOI 10.1007/s00271-008-0131-2; Zhang XY, 2011, AGR WATER MANAGE, V98, P1097, DOI 10.1016/j.agwat.2011.02.003; Zhang XY, 2009, FIELD CROP RES, V114, P75, DOI 10.1016/j.fcr.2009.07.006; Zhang XY, 2004, HYDROL PROCESS, V18, P2275, DOI 10.1002/hyp.5533; Zhao DD, 2013, AGR WATER MANAGE, V118, P87, DOI 10.1016/j.agwat.2012.11.019; Zheng CF, 2009, PLANT SCI, V176, P575, DOI 10.1016/j.plantsci.2009.01.015; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	54	30	32	7	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137274	10.1371/journal.pone.0137274	http://dx.doi.org/10.1371/journal.pone.0137274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335019	gold, Green Submitted, Green Published			2022-12-27	WOS:000360615400047
J	Moncrieff, S; Moncan, M; Scialpi, F; Ditzel, M				Moncrieff, Sophie; Moncan, Matthieu; Scialpi, Flavia; Ditzel, Mark			Regulation of hedgehog Ligand Expression by the N-End Rule Ubiquitin-Protein Ligase Hyperplastic Discs and the Drosophila GSK3 beta Homologue, Shaggy	PLOS ONE			English	Article							CUBITUS INTERRUPTUS; SUBSTRATE RECOGNITION; SIGNALING PATHWAYS; STRUCTURAL BASIS; EYE DEVELOPMENT; IMAGINAL DISC; GENE HEDGEHOG; EDD; WINGLESS; DEGRADATION	Hedgehog (Hh) morphogen signalling plays an essential role in tissue development and homeostasis. While much is known about the Hh signal transduction pathway, far less is known about the molecules that regulate the expression of the hedgehog (hh) ligand itself. Here we reveal that Shaggy (Sgg), the Drosophila melanogaster orthologue of GSK3 beta, and the N-end Rule Ubiquitin-protein ligase Hyperplastic Discs (Hyd) act together to co-ordinate Hedgehog signalling through regulating hh ligand expression and Cubitus interruptus (Ci) expression. Increased hh and Ci expression within hyd mutant clones was effectively suppressed by sgg RNAi, placing sgg downstream of hyd. Functionally, sgg RNAi also rescued the adult hyd mutant head phenotype. Consistent with the genetic interactions, we found Hyd to physically interact with Sgg and Ci. Taken together we propose that Hyd and Sgg function to co-ordinate hh ligand and Ci expression, which in turn influences important developmental signalling pathways during imaginal disc development. These findings are important as tight temporal/spatial regulation of hh ligand expression underlies its important roles in animal development and tissue homeostasis. When deregulated, hh ligand family misexpression underlies numerous human diseases (e.g., colorectal, lung, pancreatic and haematological cancers) and developmental defects (e.g., cyclopia and polydactyly). In summary, our Drosophila-based findings highlight an apical role for Hyd and Sgg in initiating Hedgehog signalling, which could also be evolutionarily conserved in mammals.	[Moncrieff, Sophie; Moncan, Matthieu; Scialpi, Flavia; Ditzel, Mark] Univ Edinburgh, MRC Inst Genet & Mol Med, Edinburgh CRUK Canc Res Ctr, Western Gen Hosp, Edinburgh EH4 2XR, Midlothian, Scotland	University of Edinburgh	Ditzel, M (corresponding author), Univ Edinburgh, MRC Inst Genet & Mol Med, Edinburgh CRUK Canc Res Ctr, Western Gen Hosp, Crewe Rd South, Edinburgh EH4 2XR, Midlothian, Scotland.	mark.ditzel@ed.ac.uk			Biotechnology and Biological Science Research Council New Investigator Award [BB/H0128691/1]; Medical Research Council [RA1734]; ERASMUS undergraduate placement award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949] Funding Source: NIH RePORTER; BBSRC [BB/H012869/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H012869/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council New Investigator Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERASMUS undergraduate placement award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Science Research Council New Investigator Award BB/H0128691/1 (MD, FS), the Medical Research Council RA1734 (SM) and an ERASMUS undergraduate placement award (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NE, 2007, CURR OPIN GENET DEV, V17, P287, DOI 10.1016/j.gde.2007.05.005; Baker NE, 2009, DEV BIOL, V335, P356, DOI 10.1016/j.ydbio.2009.09.008; Bejarano F, 2007, EMBO REP, V8, P778, DOI 10.1038/sj.embor.7401003; Benavides M, 2013, BBA-MOL CELL RES, V1833, P21, DOI 10.1016/j.bbamcr.2012.10.007; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; Gradilla AC, 2013, CURR OPIN GENET DEV, V23, P363, DOI 10.1016/j.gde.2013.04.011; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hay-Koren A, 2011, MOL BIOL CELL, V22, P399, DOI 10.1091/mbc.E10-05-0440; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Klein T, 2001, CURR OPIN GENET DEV, V11, P470, DOI 10.1016/S0959-437X(00)00219-7; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Legent Kevin, 2008, V469, P141, DOI 10.1007/978-1-60327-469-2_12; Lim NS, 2006, J BIOL CHEM, V281, P14376, DOI 10.1074/jbc.M600307200; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Matta-Camacho E, 2012, ACTA CRYSTALLOGR F, V68, P1158, DOI 10.1107/S1744309112036937; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; Maurange C, 2002, GENE DEV, V16, P2672, DOI 10.1101/gad.242702; Meissner B, 2013, BLOOD, V121, P3161, DOI 10.1182/blood-2013-01-478834; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; O'Brien PM, 2008, BRIT J CANCER, V98, P1085, DOI 10.1038/sj.bjc.6604281; Ohshima R, 2007, GENES CELLS, V12, P1339, DOI 10.1111/j.1365-2443.2007.01138.x; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Papadopoulou D, 2004, MOL CELL BIOL, V24, P4909, DOI 10.1128/MCB.24.11.4909-4919.2004; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Reid MA, 2013, MOL CELL, V50, P200, DOI 10.1016/j.molcel.2013.02.008; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Royet J, 1997, DEVELOPMENT, V124, P4793; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; Scialpi F, 2015, J BIOL CHEM, V290, P12585, DOI 10.1074/jbc.M114.625673; Smits VA, 2012, CELL CYCLE, V11; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Su H, 2011, MOL CELL, V43, P97, DOI 10.1016/j.molcel.2011.06.013; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; Terriente-Felix A, 2011, DEV BIOL, V350, P382, DOI 10.1016/j.ydbio.2010.12.003; Tokusumi Y, 2010, DEVELOPMENT, V137, P3561, DOI 10.1242/dev.053728; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111	56	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136760	10.1371/journal.pone.0136760	http://dx.doi.org/10.1371/journal.pone.0136760			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334301	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400026
J	Nero, H; Wallen, MB; Franzen, E; Stahle, A; Hagstromer, M				Nero, Hakan; Wallen, Martin Benka; Franzen, Erika; Stahle, Agneta; Hagstromer, Maria			Accelerometer Cut Points for Physical Activity Assessment of Older Adults with Parkinson's Disease	PLOS ONE			English	Article							WEARABLE MONITORS; ENERGY-EXPENDITURE; ACTIVITY INTENSITY; GAIT; CALIBRATION; ACTIGRAPH; VALIDATION; WALKING; PEOPLE; OUTPUT	Objective To define accelerometer cut points for different walking speeds in older adults with mild to moderate Parkinson's disease. Method A volunteer sample of 30 older adults (mean age 73; SD 5.4 years) with mild to moderate Parkinson's disease walked at self-defined brisk, normal, and slow speeds for three minutes in a circular indoor hallway, each wearing an accelerometer around the waist. Walking speed was calculated and used as a reference measure. Through ROC analysis, accelerometer cut points for different levels of walking speed in counts per 15 seconds were generated, and a leave-one-out cross-validation was performed followed by a quadratic weighted Cohen's Kappa, to test the level of agreement between true and cut point-predicted walking speeds. Results Optimal cut points for walking speeds <= 1.0 m/s were <= 328 and <= 470 counts/15 sec; for speeds >1.3 m/s, they were >= 730 and >= 851 counts/15 sec for the vertical axis and vector magnitude, respectively. Sensitivity and specificity were 61%-100% for the developed cut points. The quadratic weighted Kappa showed substantial agreement: kappa = 0.79 (95% CI 0.70-0.89) and. = 0.69 (95% CI 0.56-0.82) for the vertical axis and the vector magnitude, respectively. Conclusions This study provides accelerometer cut points based on walking speed for physical-activity measurement in older adults with Parkinson's disease for evaluation of interventions and for investigating links between physical activity and health.	[Nero, Hakan; Wallen, Martin Benka; Franzen, Erika; Stahle, Agneta; Hagstromer, Maria] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Franzen, Erika] Karolinska Univ Hosp, Dept Phys Therapy, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Nero, H (corresponding author), Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	hakan.nero@ki.se		Franzen, Erika/0000-0001-5520-544X; Hagstromer, Maria/0000-0002-4607-8677	Norrbacka-Eugenia foundation [DNR 817/12]; Swedish Research Council [DNR 521-2010-2483, 522-2010-2566, 521-2013-2525]; Swedish Doctoral School in Health Care Sciences; Ragnhild and Einar Lundstrom memory foundation [DNR LA2013-0028]	Norrbacka-Eugenia foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Doctoral School in Health Care Sciences; Ragnhild and Einar Lundstrom memory foundation	This work was supported by: Norrbacka-Eugenia foundation (MH), DNR 817/12, http://www.norrbacka-eugenia.se/index.html; Swedish Research Council (AS, MH, EF), DNR 521-2010-2483, 522-2010-2566 and 521-2013-2525, http://www.vr.se/; Swedish Doctoral School in Health Care Sciences (MH), http://ki.se/nvs/om-forskarskolan; Ragnhild and Einar Lundstrom memory foundation (HN), DNR LA2013-0028, www.lindhes.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Farias N, 2014, J SCI MED SPORT, V17, P293, DOI 10.1016/j.jsams.2013.07.002; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Bassett DR, 2000, MED SCI SPORT EXER, V32, pS471, DOI 10.1097/00005768-200009001-00006; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Borg G A, 1974, Exerc Sport Sci Rev, V2, P131; Brooks AG, 2005, MED SCI SPORT EXER, V37, P1216, DOI 10.1249/01.mss.0000170074.19649.0e; Butte NF, 2012, MED SCI SPORT EXER, V44, pS5, DOI 10.1249/MSS.0b013e3182399c0e; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Conradsson D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-111; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dijkstra B, 2010, ARCH PHYS MED REHAB, V91, P1272, DOI 10.1016/j.apmr.2010.05.004; Fahn S., 1987, UNIFIED PARKINSONS D; Fares S, 2008, J AM DIET ASSOC, V108, P544, DOI 10.1016/j.jada.2007.12.012; Fazio P, 2013, NEUROL SCI, V34, P435, DOI 10.1007/s10072-012-1017-x; Fisher BE, 2008, ARCH PHYS MED REHAB, V89, P1221, DOI 10.1016/j.apmr.2008.01.013; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Grandas F, 2004, NEUROLOGY, V63, pS8, DOI 10.1212/WNL.63.8_suppl_3.S8; Hall KS, 2013, MED SCI SPORT EXER, V45, P574, DOI 10.1249/MSS.0b013e318276c73c; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrison MB, UPDRS ACTIVITY DAILY; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Johansson E, 2014, PEDIAT OBESITY; John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e; Kozey SL, 2010, MED SCI SPORT EXER, V42, P1776, DOI 10.1249/MSS.0b013e3181d479f2; Lindemann U, 2014, SENSORS-BASEL, V14, P1267, DOI 10.3390/s140101267; Linder J, 2010, MOVEMENT DISORD, V25, P341, DOI 10.1002/mds.22987; Mackintosh KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036919; Matthews CE, 2005, MED SCI SPORT EXER, V37, pS512, DOI 10.1249/01.mss.0000185659.11982.3d; McGibbon CA, 2001, J NEUROPHYSIOL, V85, P1923, DOI 10.1152/jn.2001.85.5.1923; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Miller NE, 2010, J AGING PHYS ACTIV, V18, P158, DOI 10.1123/japa.18.2.158; Moore ST, 2007, GAIT POSTURE, V26, P200, DOI 10.1016/j.gaitpost.2006.09.011; Motl RW, 2009, ARCH PHYS MED REHAB, V90, P1778, DOI 10.1016/j.apmr.2009.03.020; Murphy SL, 2009, PREV MED, V48, P108, DOI 10.1016/j.ypmed.2008.12.001; Nemanich ST, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/141720; Nilsson MH, 2009, ACTA NEUROL SCAND, V120, P331, DOI 10.1111/j.1600-0404.2009.01175.x; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; Paul SS, 2013, MOVEMENT DISORD, V28, P655, DOI 10.1002/mds.25404; Pruitt LA, 2008, J AGING PHYS ACTIV, V16, P416, DOI 10.1123/japa.16.4.416; Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Sirard JR, 2005, J PHYS ACT HEALTH, V2, P345, DOI DOI 10.1123/JPAH.2.3.345; Speelman AD, 2011, NAT REV NEUROL, V7, P528, DOI 10.1038/nrneurol.2011.107; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; van Nimwegen M, 2011, J NEUROL, V258, P2214, DOI 10.1007/s00415-011-6097-7; Viera AJ, 2005, FAM MED, V37, P360; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; Wallen MB, 2014, PHYSIOL MEAS, V35, P2287, DOI 10.1088/0967-3334/35/11/2287; Washburn RA., 1990, J AGING HEALTH, V2, P341, DOI DOI 10.1177/089826439000200304; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de	60	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135899	10.1371/journal.pone.0135899	http://dx.doi.org/10.1371/journal.pone.0135899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332765	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800044
J	Tran, NT; Dawson, A; Meyers, J; Krause, S; Hickling, C				Nguyen-Toan Tran; Dawson, Angela; Meyers, Janet; Krause, Sandra; Hickling, Carina		IAWG Reprod Hlth Crisis	Developing Institutional Capacity for Reproductive Health in Humanitarian Settings: A Descriptive Study	PLOS ONE			English	Article							SERVICES; REFUGEES	Introduction Institutions play a central role in advancing the field of reproductive health in humanitarian settings (RHHS), yet little is known about organizational capacity to deliver RHHS and how this has developed over the past decade. This study aimed to document the current institutional experiences and capacities related to RHHS. Materials and Methods Descriptive study using an online questionnaire tool. Results Respondents represented 82 institutions from 48 countries, of which two-thirds originated from low-and middle-income countries. RHHS work was found not to be restricted to humanitarian agencies (25%), but was also embraced by development organizations (25%) and institutions with dual humanitarian and development mandates (50%). Agencies reported working with refugees (81%), internally-displaced (87%) and stateless persons (20%), in camp-based settings (78%), and in urban (83%) and rural settings (78%). Sixty-eight percent of represented institutions indicated having an RHHS-related policy, 79% an accountability mechanism including humanitarian work, and 90% formal partnerships with other institutions. Seventy-three percent reported routinely appointing RH focal points to ensure coordination of RHHS implementation. There was reported progress in RHHS-related disaster risk reduction (DRR), emergency management and coordination, delivery of the Minimum Initial Services Package (MISP) for RH, comprehensive RH services in post-crisis/recovery situations, gender mainstreaming, and community-based programming. Other reported institutional areas of work included capacity development, program delivery, advocacy/policy work, followed by research and donor activities. Except for abortion-related services, respondents cited improved efforts in advocacy, capacity development and technical support in their institutions for RHHS to address clinical services, including maternal and newborn health, sexual violence prevention and response, HIV prevention, management of sexually-transmitted infections, adolescent RH, and family planning. Approximately half of participants reported that their institutions had experienced an increase in dedicated budget and staff for RHHS, a fifth no change, and 1 in 10 a decrease. The Interagency RH Kits were reportedly the most commonly used supplies to support RHHS implementation. Conclusion The results suggest overall growth in institutional capacity in RHHS over the past decade, indicating that the field has matured and expanded from crisis response to include RHHS into DRR and other elements of the emergency management cycle. It is critical to consolidate the progress to date, address gaps, and sustain momentum.	[Nguyen-Toan Tran; Hickling, Carina] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Dawson, Angela] Univ Technol Sydney, Fac Hlth, WHO Collaborating Ctr, Sydney, NSW 2007, Australia; [Meyers, Janet] Int Med Corps, Washington, DC USA; [Krause, Sandra] Womens Refugee Commiss, New York, NY USA	University of New South Wales Sydney; University of Technology Sydney; World Health Organization	Tran, NT (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.	sandrak@wrcommission.org	Doraiswamy, Sathya/AAN-9348-2020; Tappis, Hannah/F-5005-2011	Doraiswamy, Sathya/0000-0002-4198-8065; Tappis, Hannah/0000-0002-4289-5418; Tran, Nguyen-Toan/0000-0001-7134-7878	US Department of State, Bureau of Population, Refugees and Migration	US Department of State, Bureau of Population, Refugees and Migration	US Department of State, Bureau of Population, Refugees and Migration: http://www.state.gov/j/prm/. The John D. and Catherine T. MacArthur Foundation: http://www.macfound.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin J, 2008, REPROD HEALTH MATTER, V16, P10, DOI 10.1016/S0968-8080(08)31351-2; Butler-McPhee J, 2011, SPRINTING CHANGE SEX; Casey SE, 2015, CONFL HEALTH, V9, DOI 10.1186/1752-1505-9-S1-S3; Creswell JW, 2013, RES DESIGN QUALITATI; Gender-based Violence Area of Responsibility Working Group, 2010, HDB GEND BAS VIOL IN; Hsu J, 2013, LANCET, V381, P1772, DOI 10.1016/S0140-6736(13)60762-X; Humanitarian Accountability Partnership (HAP), 2010, 2010 HAP STAND ACC Q; IASC, 2015, GUID INT GEND BAS VI; Inter-Agency Standing Committee (IASC), 2003, GUID HIV AIDS INT EM; Inter-Agency Standing Committee (IASC), 2006, GEND HDB HUM ACT; Inter-Agency Standing Committee (IASC), 2007, AM PSYCHOL ASS, DOI [DOI 10.1037/E518422011-002, 10.1037/e518422011-002]; Inter-Agency Standing Committee (IASC), 2009, MATR AG ROL RESP ENS; Inter-agency Working Group on Reproductive Health in Crises, 2010, GRAN CONS SEX REPR H; Inter-agency Working Group on Reproductive Health in Crises, 2010, INT FIELD MAN REPR H, P24; Inter-agency Working Group on Reproductive Health in Crises, 1999, INT FIELD MAN REPR H; Internal Displacement Monitoring Center, 2014, GLOB EST 2013 PEOPL; International Centre for Reproductive Health, GEND BAS VIOL HUM SE; International Committee of the Red Cross, 1994, 2020 GLOB NAT DIS AS; International Planned Parenthood Federation United Nations Population Fund University of New South Wales, 2009, SPRINT FAC MAN SRH C; International Rescue Committee, CLIN CAR SEX ASS SUR; IPPF/Women's Refugee Commission, 2008, SYN MISP CHEAT SHEET; Kaplan A., 1999, DEV CAPACITY; Kaplan Allan, 2000, DEV PRACTICE, V10, P517, DOI DOI 10.1080/09614520050116677; Krause S, 2015, CONFL HEALTH, V9, DOI 10.1186/1752-1505-9-S1-S4; Organisation for Economic Co-operation and Development, PAR DECL AID EFF ACC; Patton M. Q., 2001, QUALITATIVE EVALUATI, V3rd; Save the Children/UNFPA, 2009, AD SEX REPR HLTH TOO; Tanabe M, 2015, CONFL HEALTH, V9, DOI 10.1186/1752-1505-9-S1-S2; The Sphere Project, 2000, HUM CHART MIN STAND; United Nations Children's Fund, 2012, LEV TRENDS CHILD MOR; United Nations High Commissioner for Refugees, 2014, 2013 GLOB TRENDS; United Nations High Commissioner for Refugees, 2004, INT GLOB EV REPR HLT; United Nations Population Fund, 2010, INT REPR HLTH KITS; United Nations Secretariat, 2003, UN SECR GEN B SPEC M; WHO UNFPA UNHCR, CLIN MAN RAP SURV; WHO UNICEF, 2013, TRENDS MAT MORT 1990; Women's Refugee Commission, 2006, MISP REPR HLTH CRIS; Women's Refugee Commission, 2013, MISP CERT AN; Women's Refugee Commission, 2012, AD SEX REPR HLTH PRO; Women's Refugee Commission (formerly Women's Commission for Refugee Women and Children), 2008, REPR HLTH COORD GAP; World Health Organization, 2009, HLTH CLUST GUID PRAC; World Health Organization, 2010, UN CENTR EM RESP FUN; World Health Organization, 2012, INT SEX REPR HLTH HL	43	17	17	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137412	10.1371/journal.pone.0137412	http://dx.doi.org/10.1371/journal.pone.0137412			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331474	Green Published, gold			2022-12-27	WOS:000360613800131
J	Olfson, E; Cottrell, CE; Davidson, NO; Gurnett, CA; Heusel, JW; Stitziel, NO; Chen, LS; Hartz, S; Nagarajan, R; Saccone, NL; Bierut, LJ				Olfson, Emily; Cottrell, Catherine E.; Davidson, Nicholas O.; Gurnett, Christina A.; Heusel, Jonathan W.; Stitziel, Nathan O.; Chen, Li-Shiun; Hartz, Sarah; Nagarajan, Rakesh; Saccone, Nancy L.; Bierut, Laura J.			Identification of Medically Actionable Secondary Findings in the 1000 Genomes	PLOS ONE			English	Article							INCIDENTAL FINDINGS; FAMILIAL HYPERCHOLESTEROLEMIA; PATIENT AUTONOMY; VARIANT CLASSIFICATION; ACMG RECOMMENDATIONS; SEQUENCE VARIATION; CLINICAL GENOMICS; MUTATION DATABASE; GENETIC RESEARCH; CANCER	The American College of Medical Genetics and Genomics (ACMG) recommends that clinical sequencing laboratories return secondary findings in 56 genes associated with medically actionable conditions. Our goal was to apply a systematic, stringent approach consistent with clinical standards to estimate the prevalence of pathogenic variants associated with such conditions using a diverse sequencing reference sample. Candidate variants in the 56 ACMG genes were selected from Phase 1 of the 1000 Genomes dataset, which contains sequencing information on 1,092 unrelated individuals from across the world. These variants were filtered using the Human Gene Mutation Database (HGMD) Professional version and defined parameters, appraised through literature review, and examined by a clinical laboratory specialist and expert physician. Over 70,000 genetic variants were extracted from the 56 genes, and filtering identified 237 variants annotated as disease causing by HGMD Professional. Literature review and expert evaluation determined that 7 of these variants were pathogenic or likely pathogenic. Furthermore, 5 additional truncating variants not listed as disease causing in HGMD Professional were identified as likely pathogenic. These 12 secondary findings are associated with diseases that could inform medical follow-up, including cancer predisposition syndromes, cardiac conditions, and familial hypercholesterolemia. The majority of the identified medically actionable findings were in individuals from the European (5/379) and Americas (4/181) ancestry groups, with fewer findings in Asian (2/286) and African (1/246) ancestry groups. Our results suggest that medically relevant secondary findings can be identified in approximately 1% (12/1092) of individuals in a diverse reference sample. As clinical sequencing laboratories continue to implement the ACMG recommendations, our results highlight that at least a small number of potentially important secondary findings can be selected for return. Our results also confirm that understudied populations will not reap proportionate benefits of genomic medicine, highlighting the need for continued research efforts on genetic diseases in these populations.	[Olfson, Emily; Chen, Li-Shiun; Hartz, Sarah; Bierut, Laura J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Cottrell, Catherine E.; Heusel, Jonathan W.; Nagarajan, Rakesh] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Cottrell, Catherine E.; Nagarajan, Rakesh; Saccone, Nancy L.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Gurnett, Christina A.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Dept Med, Div Cardiovasc, St Louis, MO 63110 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO USA; [Nagarajan, Rakesh] Pierian DX, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bierut, LJ (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	laura@wustl.edu	Stitziel, Nathan/AAL-8413-2021; Heusel, Jon/AAC-8050-2021; Hartz, Sarah M/AAD-7662-2020; Cottrell, Cathy/AGG-3565-2022; Bierut, Laura Jean/W-6806-2019; Hartz, Sarah/AAD-4073-2019	Stitziel, Nathan/0000-0002-4963-8211; Cottrell, Cathy/0000-0002-2974-0235; Bierut, Laura Jean/0000-0002-9952-4810; Hartz, Sarah/0000-0002-5429-3799; Gurnett, Christina/0000-0001-9129-315X	National Institutes of Health (NIH) [T32GM07200, UL1TR000448, TL1TR000449, F30AA023685]; NIH [UL1TR000448, P30DK052574, R03HD068649, R01AR067715, K08HL114642, K08DA030398, R01DA038076, K08DA032680, KL2TR000450, R01DA026911, P01CA089392, U19CA148127, P30CA091842, R01DA036583, R01DA025888, U10AA008401]; Buehrle Family Foundation; Gale Family Foundation;  [R01DK56260];  [R01HL38180]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000449, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA032680, R01DA036583] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Buehrle Family Foundation; Gale Family Foundation; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Ms. Olfson was supported by T32GM07200, UL1TR000448, TL1TR000449, and F30AA023685 from the National Institutes of Health (NIH). Dr. Davidson was supported by R01DK56260, R01HL38180 and Digestive Disease Research Core Center P30DK052574 from NIH; the Buehrle Family Foundation (http://buehrlefamilyfoundation.org/), and the Gale Family Foundation for hereditary GI cancer. Dr. Gurnett was supported by R03HD068649 and R01AR067715 from NIH. Dr. Stitziel was supported by K08HL114642 from NIH. Dr. Chen was supported by K08DA030398 and R01DA038076 from NIH. Dr. Hartz was supported by K08DA032680, KL2TR000450, and UL1TR000448 from NIH. Dr. Saccone was supported by R01DA026911 from NIH. Dr. Bierut was supported by P01CA089392, U19CA148127, P30CA091842, R01DA036583, R01DA025888 and U10AA008401 from NIH. The NIH and other funding sources did not have a role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Dr. Nagarajan is the Chief Informatics Officer for Pierian Dx and Drs. Cottrell and Heusel are consultants for Pierian Dx. Pierian Dx provided support in the form of salaries for authors RN, CEC and JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baker M, 2012, NATURE, V491, P171, DOI 10.1038/491171a; Bauce B, 2002, J AM COLL CARDIOL, V40, P341, DOI 10.1016/S0735-1097(02)01946-0; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Beroud C, 2000, HUM MUTAT, V15, P86, DOI 10.1002/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4; Bollinger JM, 2012, GENET MED, V14, P451, DOI 10.1038/gim.2011.66; Cassa CA, 2013, HUM MUTAT, V34, P1216, DOI 10.1002/humu.22375; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Cox MGPJ, 2011, CIRCULATION, V123, P2690, DOI 10.1161/CIRCULATIONAHA.110.988287; Daneshjou R, 2014, BIOCOMPUT-PAC SYM, P229; Ng D, 2013, CIRC-CARDIOVASC GENE, V6, P337, DOI 10.1161/CIRCGENETICS.113.000039; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Garcia-Garcia AB, 2011, ATHEROSCLEROSIS, V218, P423, DOI 10.1016/j.atherosclerosis.2011.07.106; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Green RC, 2013, JAMA-J AM MED ASSOC, V310, P365, DOI 10.1001/jama.2013.41703; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Kirmani S, 1993, GENEREVIEWS R; Klitzman R, 2013, JAMA-J AM MED ASSOC, V310, P369, DOI 10.1001/jama.2013.41709; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuznetsov SG, 2008, NAT MED, V14, P875, DOI 10.1038/nm.1719; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Loeys B. L., 1993, GENEREVIEWS R; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MALKIN D, 1992, NEW ENGL J MED, V326, P1309, DOI 10.1056/NEJM199205143262002; McEwen JE, 2012, ETHICAL CONSIDERATIO; McGuire AL, 2013, SCIENCE, V340, P1047, DOI 10.1126/science.1240156; McNally E, 1993, GENEREVIEWS R; Murphy J, 2008, AM J BIOETHICS, V8, P36, DOI 10.1080/15265160802513093; Napolitano C., 1993, GENEREVIEWS R; Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422; OMIM Online Mendelian Inheritance in Man, 2012, OMIM ONL MEND INH MA; Petrucelli N., 1993, GENE REV, P1993; Piippo K, 2000, J AM COLL CARDIOL, V35, P1919, DOI 10.1016/S0735-1097(00)00636-7; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Ross LF, 2013, JAMA-J AM MED ASSOC, V310, P367, DOI 10.1001/jama.2013.41700; Schneider K., 1993, GENEREVIEWS; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; Stenson Peter D, 2009, Hum Genomics, V4, P69; Stephens K., 1993, GENEREVIEWS; Szabo C, 2000, HUM MUTAT, V16, P123, DOI 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119; Wolf SM, 2012, GENET MED, V14, P355, DOI 10.1038/gim.2012.26; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Youngblom E, 1993, FAMILIAL HYPERCHOLES	59	59	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135193	10.1371/journal.pone.0135193	http://dx.doi.org/10.1371/journal.pone.0135193			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332594	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800022
J	Tas, H; Nguyen, CT; Patel, R; Kim, NH; Kuhlman, TE				Tas, Huseyin; Nguyen, Cac T.; Patel, Ravish; Kim, Neil H.; Kuhlman, Thomas E.			An Integrated System for Precise Genome Modification in Escherichia coli	PLOS ONE			English	Article							SUBTILIS SACB GENE; BACILLUS-SUBTILIS; TETRACYCLINE RESISTANCE; CHROMOSOMAL INTEGRATION; PHIC31 INTEGRASE; DIVISION CYCLE; HUMAN-CELLS; DNA; SELECTION; EXPRESSION	We describe an optimized system for the easy, effective, and precise modification of the Escherichia coli genome. Genome changes are introduced first through the integration of a 1.3 kbp Landing Pad consisting of a gene conferring resistance to tetracycline (tetA) or the ability to metabolize the sugar galactose (galK). The Landing Pad is then excised as a result of double-strand breaks by the homing endonuclease I-SceI, and replaced with DNA fragments bearing the desired change via lambda-Red mediated homologous recombination. Repair of the double strand breaks and counterselection against the Landing Pad (using NiCl2 for tetA or 2-deoxy-galactose for galK) allows the isolation of modified bacteria without the use of additional antibiotic selection. We demonstrate the power of this method to make a variety of genome modifications: the exact integration, without any extraneous sequence, of the lac operon (similar to 6.5 kbp) to any desired location in the genome and without the integration of antibiotic markers; the scarless deletion of ribosomal rm operons (similar to 6 kbp) through either intrachromosomal or oligonucleotide recombination; and the in situ fusion of native genes to fluorescent reporter genes without additional perturbation.	[Tas, Huseyin; Nguyen, Cac T.; Kim, Neil H.; Kuhlman, Thomas E.] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Tas, Huseyin; Kuhlman, Thomas E.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Nguyen, Cac T.; Kim, Neil H.; Kuhlman, Thomas E.] Univ Illinois, Dept Phys, Urbana, IL USA; [Patel, Ravish] Univ Illinois, Dept Mol & Cellular Biol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kuhlman, TE (corresponding author), Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA.	tkuhlman@illinois.edu	TAS, HUSEYIN/AHA-5112-2022	TAS, HUSEYIN/0000-0003-4804-2237	Center for the Physics of Living Cells NSF Physics Frontier Center [PHY 1430124]; Department of Physics at the University of Illinois at Urbana-Champaign; Direct For Mathematical & Physical Scien [1430124] Funding Source: National Science Foundation	Center for the Physics of Living Cells NSF Physics Frontier Center; Department of Physics at the University of Illinois at Urbana-Champaign; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the Center for the Physics of Living Cells NSF Physics Frontier Center (PHY 1430124) and startup funds from the Department of Physics at the University of Illinois at Urbana-Champaign.	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; BREMER H, 1977, J THEOR BIOL, V69, P645, DOI 10.1016/0022-5193(77)90373-3; Bremer H, 1996, ESCHERICHIA COLI SAL, V1, P1553; CALOS MP, 1981, MOL GEN GENET, V183, P559, DOI 10.1007/BF00268783; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Costantino N, 2003, P NATL ACAD SCI USA, V100, P15748, DOI 10.1073/pnas.2434959100; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GAY P, 1983, J BACTERIOL, V153, P1424, DOI 10.1128/JB.153.3.1424-1431.1983; Gomaa AA, 2014, MBIO, V5, DOI 10.1128/mBio.00928-13; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; HELMSTETTER CE, 1968, J MOL BIOL, V31, P507, DOI 10.1016/0022-2836(68)90424-5; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Keravala A, 2006, MOL THER, V13, pS201, DOI 10.1016/j.ymthe.2006.08.596; Kuhlman TE, 2010, BIOENG BUGS, V1, P296, DOI DOI 10.4161/BBUG.1.4.12386; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Kuhlman TE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1193; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Li XT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt1075; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Narayanan K, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng051; Orford M, 2000, Nucleic Acids Res, V28, pE84, DOI 10.1093/nar/28.18.e84; Pelicic V, 1996, J BACTERIOL, V178, P1197, DOI 10.1128/jb.178.4.1197-1199.1996; Podolsky T, 1996, PLASMID, V36, P112, DOI 10.1006/plas.1996.0038; Pohl T, 2007, BIOCHEMISTRY-US, V46, P10694, DOI 10.1021/bi701057t; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Rivero-Muller A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm250; Ryu YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094266; Sabri S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-60; Sekhavati MH, 2013, CELL J, V14, P264; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; St-Pierre F, 2013, ACS SYNTH BIOL, V2, P537, DOI 10.1021/sb400021j; Stringer AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044841; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yu BJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn359; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	52	20	24	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136963	10.1371/journal.pone.0136963	http://dx.doi.org/10.1371/journal.pone.0136963			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332675	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800083
J	Al-Shehri, SS; Knox, CL; Liley, HG; Cowley, DM; Wright, JR; Henman, MG; Hewavitharana, AK; Charles, BG; Shaw, PN; Sweeney, EL; Duley, JA				Al-Shehri, Saad S.; Knox, Christine L.; Liley, Helen G.; Cowley, David M.; Wright, John R.; Henman, Michael G.; Hewavitharana, Amitha K.; Charles, Bruce G.; Shaw, Paul N.; Sweeney, Emma L.; Duley, John A.			Breastmilk-Saliva Interactions Boost Innate Immunity by Regulating the Oral Microbiome in Early Infancy	PLOS ONE			English	Article							XANTHINE-OXIDASE; HYDROGEN-PEROXIDE; LACTOPEROXIDASE SYSTEM; ANTIBACTERIAL PROPERTIES; PHYSIOLOGICAL ROLES; NITRIC-OXIDE; BOVINE-MILK; OXIDOREDUCTASE; NUCLEOTIDES; THIOCYANATE	Introduction Xanthine oxidase (XO) is distributed in mammals largely in the liver and small intestine, but also is highly active in milk where it generates hydrogen peroxide (H2O2). Adult human saliva is low in hypoxanthine and xanthine, the substrates of XO, and high in the lactoperoxidase substrate thiocyanate, but saliva of neonates has not been examined. Results Median concentrations of hypoxanthine and xanthine in neonatal saliva (27 and 19 mu M respectively) were ten-fold higher than in adult saliva (2.1 and 1.7 mu M). Fresh breastmilk contained 27.3 +/- 12.2 mu MH2O2 but mixing baby saliva with breastmilk additionally generated > 40 mu MH2O2, sufficient to inhibit growth of the opportunistic pathogens Staphylococcus aureus and Salmonella spp. Oral peroxidase activity in neonatal saliva was variable but low (median 7 U/L, range 2-449) compared to adults (620 U/L, 48-1348), while peroxidase substrate thiocyanate in neonatal saliva was surprisingly high. Baby but not adult saliva also contained nucleosides and nucleobases that encouraged growth of the commensal bacteria Lactobacillus, but inhibited opportunistic pathogens; these nucleosides/bases may also promote growth of immature gut cells. Transition from neonatal to adult saliva pattern occurred during the weaning period. A survey of saliva from domesticated mammals revealed wide variation in nucleoside/base patterns. Discussion and Conclusion During breast-feeding, baby saliva reacts with breastmilk to produce reactive oxygen species, while simultaneously providing growth-promoting nucleotide precursors. Milk thus plays more than a simply nutritional role in mammals, interacting with infant saliva to produce a potent combination of stimulatory and inhibitory metabolites that regulate early oral- and hence gut-microbiota. Consequently, milk-saliva mixing appears to represent unique biochemical synergism which boosts early innate immunity.	[Al-Shehri, Saad S.; Hewavitharana, Amitha K.; Charles, Bruce G.; Shaw, Paul N.; Duley, John A.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Al-Shehri, Saad S.] Taif Univ, Coll Appl Med Sci, At Taif, Saudi Arabia; [Knox, Christine L.; Sweeney, Emma L.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Fac Hlth, Brisbane, Qld 4001, Australia; [Liley, Helen G.; Cowley, David M.; Henman, Michael G.; Duley, John A.] Mater Res Inst, Mater Hlth Serv, Brisbane, Qld, Australia; [Wright, John R.] Univ Queensland, Sch Vet Sci, Gatton, Australia	University of Queensland; Taif University; Queensland University of Technology (QUT); Mater Health Services; Mater Research; University of Queensland	Al-Shehri, SS (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.	sa.alshehri@tu.edu.sa	Liley, Helen Gwendolin/C-5608-2011; Shaw, Paul N/G-4418-2010; Shaw, Paul/Q-8454-2019; Hewavitharana, Amitha K/A-5533-2008; Cowley, David M/M-9674-2013; Wright, John/D-7974-2013	Liley, Helen Gwendolin/0000-0002-8249-9516; Shaw, Paul N/0000-0001-7154-592X; Shaw, Paul/0000-0001-7154-592X; Hewavitharana, Amitha K/0000-0003-2935-9941; Cowley, David M/0000-0002-4153-934X; Knox, Christine/0000-0003-3997-6812; Sweeney, Emma/0000-0002-3199-6432	National Health and Medical Research Council (Australia) [1043282]; Golden Casket Community Program (Queensland), Mater Children's Hospital Grant [200110]; Taif University, Saudi Arabia; QUT scholarship	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Golden Casket Community Program (Queensland), Mater Children's Hospital Grant; Taif University, Saudi Arabia; QUT scholarship	This project was supported financially by the National Health and Medical Research Council (Australia), Project Grant no. 1043282 [http://www.nhmrc.gov.au/]. The funding was received by JAD. Additional support was received from the Golden Casket Community Program (Queensland), Mater Children's Hospital Grant no. 200110 [https://tatts.com/goldencasket/about/community] by SSA. S. Al-Shehri was a recipient of a PhD scholarship from Taif University, Saudi Arabia, which is greatly acknowledged. ELS was a recipient of a QUT scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; ABADEH S, 1992, BIOCHIM BIOPHYS ACTA, V1117, P25, DOI 10.1016/0304-4165(92)90157-P; Agarwal A, 2011, CRIT REV BIOTECHNOL, V31, P264, DOI 10.3109/07388551.2010.527823; Akinbi H, 2010, J PEDIATR GASTR NUTR, V51, P347, DOI 10.1097/MPG.0b013e3181e07f0a; Al-Kerwi EAA, 2005, ASIA PAC J CLIN NUTR, V14, P428; Al-Shehri S, 2013, J CHROMATOGR B, V931, P140, DOI 10.1016/j.jchromb.2013.05.001; Arsene-Ploetze F, 2006, J BACTERIOL, V188, P4777, DOI 10.1128/JB.00195-06; Benboubetra M, 2004, J DAIRY SCI, V87, P1580, DOI 10.3168/jds.S0022-0302(04)73311-1; Brondino CD, 2006, CURR OPIN CHEM BIOL, V10, P109, DOI 10.1016/j.cbpa.2006.01.034; BROWN AM, 1995, BBA-GEN SUBJECTS, V1245, P248, DOI 10.1016/0304-4165(95)00093-Q; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Delgado S, 2011, FEMS IMMUNOL MED MIC, V62, P225, DOI 10.1111/j.1574-695X.2011.00806.x; El-Chemaly S, 2003, AM J RESP CRIT CARE, V167, P425, DOI 10.1164/rccm.200206-531OC; Fox PF, 2006, INT DAIRY J, V16, P500, DOI 10.1016/j.idairyj.2005.09.013; Gaetani GF, 1996, BLOOD, V87, P1595, DOI 10.1182/blood.V87.4.1595.bloodjournal8741595; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; GOTHEFORS L, 1975, INFECT IMMUN, V11, P1210, DOI 10.1128/IAI.11.6.1210-1215.1975; Graham S, 1996, BRIT J CLIN PHARMACO, V41, P299, DOI 10.1046/j.1365-2125.1996.03116.x; Gritz EC, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00017; Harrison R, 2006, INT DAIRY J, V16, P546, DOI 10.1016/j.idairyj.2005.08.016; Harrison R, 2004, DRUG METAB REV, V36, P363, DOI 10.1081/DMR-120037569; Haukioja A, 2004, J MED MICROBIOL, V53, P855, DOI 10.1099/jmm.0.45548-0; He XS, 2014, ISME J, V8, P564, DOI 10.1038/ismej.2013.172; Heegaard CW, 1997, J PEDIATR GASTR NUTR, V25, P159, DOI 10.1097/00005176-199708000-00006; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Kilstrup M, 2005, FEMS MICROBIOL REV, V29, P555, DOI 10.1016/j.femsre.2005.04.006; Kochanska B, 2000, ACTA BIOCHIM POL, V47, P877; Lahti M, 1999, J CHEM EDUC, V76, P1281; Liao KY, 2011, PEDIATR NEONATOL, V52, P93, DOI 10.1016/j.pedneo.2011.02.012; Maia LB, 2011, J BIOL INORG CHEM, V16, P443, DOI 10.1007/s00775-010-0741-z; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Millar TM, 2002, REDOX REP, V7, P65, DOI 10.1179/135100002125000280; OHLSSON PI, 1986, ACTA CHEM SCAND B, V40, P358, DOI 10.3891/acta.chem.scand.40b-0358; Osterman K L, 2000, J Hum Lact, V16, P297, DOI 10.1177/089033440001600405; Pan Q, 2011, INVEST OPHTH VIS SCI, V52, P1723, DOI 10.1167/iovs.10-5866; Peglow S, 2011, J HEPATO-BIL-PAN SCI, V18, P137, DOI 10.1007/s00534-010-0328-7; REITER B, 1981, ANIM PROD, V32, P297, DOI 10.1017/S0003356100027197; ROBINSON JL, 1980, J DAIRY SCI, V63, P865, DOI 10.3168/jds.S0022-0302(80)83017-7; Rodriguez-Serrano F, 2007, J NUTR, V137, P879, DOI 10.1093/jn/137.4.879; ROTH S, 1987, CELL IMMUNOL, V108, P417, DOI 10.1016/0008-8749(87)90224-3; Shin K, 2001, AM J CLIN NUTR, V73, P984; Silanikove N, 2005, FREE RADICAL BIO MED, V38, P1139, DOI 10.1016/j.freeradbiomed.2004.12.011; Silanikove N, 2007, BIOCHEM BIOPH RES CO, V363, P561, DOI 10.1016/j.bbrc.2007.08.188; Silvestre D, 2008, J HUM LACT, V24, P371, DOI 10.1177/0890334408319158; Stevens CR, 2000, LANCET, V356, P829, DOI 10.1016/S0140-6736(00)02660-X; TENOVUO J, 1976, J DENT RES, V55, P661, DOI 10.1177/00220345760550042001; THOMAS EL, 1994, INFECT IMMUN, V62, P529, DOI 10.1128/IAI.62.2.529-535.1994; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tully D B, 2001, J Hum Lact, V17, P152, DOI 10.1177/089033440101700212; UAUY R, 1994, J NUTR, V124, pS1436, DOI 10.1093/jn/124.suppl_8.1436S; Van Gysel M, 2012, EUR J PEDIATR, V171, P1231, DOI 10.1007/s00431-012-1750-4; Vorbach C, 2003, TRENDS IMMUNOL, V24, P512, DOI 10.1016/S1471-4906(03)00237-0; Wan AKL, 2003, ORAL MICROBIOL IMMUN, V18, P72, DOI 10.1034/j.1399-302X.2003.00044.x; Wang M, 2015, J PEDIAT GASTROENTER; Yamamoto T, 2011, CLIN CHIM ACTA, V412, P1712, DOI 10.1016/j.cca.2011.06.006; Yener FYG, 2009, J FOOD SCI, V74, pM73, DOI 10.1111/j.1750-3841.2009.01057.x	56	54	55	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135047	10.1371/journal.pone.0135047	http://dx.doi.org/10.1371/journal.pone.0135047			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325665	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700016
J	Sokolovska, N; Teytaud, O; Rizkalla, S; Consortium, M; Clement, K; Zucker, JD				Sokolovska, Nataliya; Teytaud, Olivier; Rizkalla, Salwa; Consortium, MicroObese; Clement, Karine; Zucker, Jean-Daniel			Sparse Zero-Sum Games as Stable Functional Feature Selection	PLOS ONE			English	Article							APPROXIMATIONS	In large-scale systems biology applications, features are structured in hidden functional categories whose predictive power is identical. Feature selection, therefore, can lead not only to a problem with a reduced dimensionality, but also reveal some knowledge on functional classes of variables. In this contribution, we propose a framework based on a sparse zero-sum game which performs a stable functional feature selection. In particular, the approach is based on feature subsets ranking by a thresholding stochastic bandit. We provide a theoretical analysis of the introduced algorithm. We illustrate by experiments on both synthetic and real complex data that the proposed method is competitive from the predictive and stability viewpoints.	[Sokolovska, Nataliya; Rizkalla, Salwa; Clement, Karine; Zucker, Jean-Daniel] Hop La Pitie Salpetriere, Assistance Publ Hop Paris, ICAN, Inst Cardiometab & Nutr, Paris, France; [Sokolovska, Nataliya; Rizkalla, Salwa; Clement, Karine; Zucker, Jean-Daniel] Univ Paris 06, Sorbonne Univ, UMR S 1166, ICAN,NutriOm Team, Paris, France; [Sokolovska, Nataliya; Rizkalla, Salwa; Clement, Karine; Zucker, Jean-Daniel] INSERM, UMR S U1166, NutriOm Team, Paris, France; [Teytaud, Olivier] Univ Paris 11, LRI, INRIA Saclay, F-91405 Orsay, France; [Zucker, Jean-Daniel] UMI UMMISCO, Inst Dev Res, Bondy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; Hanoi University of Science & Technology; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Yaounde I	Sokolovska, N (corresponding author), Hop La Pitie Salpetriere, Assistance Publ Hop Paris, ICAN, Inst Cardiometab & Nutr, Paris, France.	nataliya.sokolovska@upmc.fr	Clément, karine/R-1120-2017; ZUCKER, Jean-Daniel/K-3008-2016	ZUCKER, Jean-Daniel/0000-0002-5597-7922; Sokolovska, Nataliya/0000-0001-8841-1725				ALTHOFER I, 1994, LINEAR ALGEBRA APPL, V199, P339, DOI 10.1016/0024-3795(94)90357-3; Althofer I, 1994, ON SPARSE APPROXIMAT; Audibert J-Y, 2010, J MACHINE LEARNING R, V11, P2635; Auer P, 2003, SIAM J COMPUT, V32, P48, DOI 10.1137/S0097539701398375; Auger D, 2014, ACML; Chevaleyre Y, 2013, ICML; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Daskalakis C, 2006, PROCEEDINGS OF THE T; Delage E., 2009, ACM SIGKDD INTL CONF; Dernoncourt D, 2012, CAP; Dessi N, 2013, BIOMED RESEARCH INTE; Fudenberg D., 1991, GAME THEORY; Ganzfried S, 2011, NATIONAL CONFERENCE; Ganzfried S., 2011, AAMAS; Gaudel R, 2010, ICML; GRIGORIADIS MD, 1995, OPER RES LETT, V18, P53, DOI 10.1016/0167-6377(95)00032-0; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; Hofmeister T, 1996, LINEAR ALGEBRA APPL, V240, P9, DOI 10.1016/0024-3795(94)00175-8; Huang J, 2008, STAT SINICA, V18, P1603; Huang KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120317; Kalyanakrishnan S, 2012, ICML; Kalyanaraman S, 2007, LECT NOTES COMPUT SC, V4698, P323; Koller D., 1994, Proceedings of the Twenty-Sixth Annual ACM Symposium on the Theory of Computing, P750, DOI 10.1145/195058.195451; Koller D, 1996, GAME ECON BEHAV, V14, P247, DOI 10.1006/game.1996.0051; Le Chatelier E, 2011, NATURE; LEMKE CE, 1964, J SOC IND APPL MATH, V12, P413, DOI 10.1137/0112033; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Radlinski F., 2008, ICML; Shoham Y., 2009, MULTIAGENT SYSTEMS A; Somol P, 2010, IEEE T PATTERN ANAL, V32, P1921, DOI 10.1109/TPAMI.2010.34; Teytaud O, 2011, LECT NOTES COMPUT SC, V6624, P153, DOI 10.1007/978-3-642-20525-5_16; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Waugh K, 2009, AAMAS; Wen-Bo D, 2012, COMMUNICATIONS IN TH, V58; Zhang HF, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18006	39	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0134683	10.1371/journal.pone.0134683	http://dx.doi.org/10.1371/journal.pone.0134683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325268	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700013
J	Love, BC; Kopec, L; Guest, O				Love, Bradley C.; Kopec, Lukasz; Guest, Olivia			Optimism Bias in Fans and Sports Reporters	PLOS ONE			English	Article							HEALTH; SELF	People are optimistic about their prospects relative to others. However, existing studies can be difficult to interpret because outcomes are not zero-sum. For example, one person avoiding cancer does not necessitate that another person develops cancer. Ideally, optimism bias would be evaluated within a closed formal system to establish with certainty the extent of the bias and the associated environmental factors, such that optimism bias is demonstrated when a population is internally inconsistent. Accordingly, we asked NFL fans to predict how many games teams they liked and disliked would win in the 2015 season. Fans, like ESPN reporters assigned to cover a team, were overly optimistic about their team's prospects. The opposite pattern was found for teams that fans disliked. Optimism may flourish because year-to-year team results are marked by auto-correlation and regression to the group mean (i.e., good teams stay good, but bad teams improve).	[Love, Bradley C.; Kopec, Lukasz] UCL, Expt Psychol, London, England; [Guest, Olivia] Univ Oxford, Expt Psychol, Oxford, England	University of London; University College London; University of Oxford	Love, BC (corresponding author), UCL, Expt Psychol, London, England.	b.love@ucl.ac.uk	Guest, Olivia/M-2116-2013	Guest, Olivia/0000-0002-1891-0972	Leverhulme Trust [RPG-2014-075]; Wellcome Trust [WT106931MA]; Engineering and Physical Sciences Research Council [1224321] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding: This work was supported by the Leverhulme Trust grant RPG-2014-075 (www.leverhulme.ac.uk) and Wellcome Trust Senior Investigator Award WT106931MA (www.wellcome.ac.uk) to BCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1991, PSYCHOL SCI, V2, P396, DOI 10.1111/j.1467-9280.1991.tb00174.x; ARMSTRONG JS, 1980, TECHNOL REV, V82, P18; Bar-Hillel M, 2008, PSYCHON B REV, V15, P278, DOI 10.3758/PBR.15.2.278; BROWN JD, 1986, SOC COGNITION, V4, P353, DOI 10.1521/soco.1986.4.4.353; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Caponecchia C, 2010, J APPL SOC PSYCHOL, V40, P601, DOI 10.1111/j.1559-1816.2010.00589.x; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; DEJOY DM, 1989, ACCIDENT ANAL PREV, V21, P333, DOI 10.1016/0001-4575(89)90024-9; ESPN_Staff, 2014, NFL NAT 2014 NFL REV; Fawcett TW, 2014, TRENDS COGN SCI, V18, P153, DOI 10.1016/j.tics.2013.12.012; Guedj O, 2005, INT J THEOR APPL FIN, V8, P933, DOI 10.1142/S0219024905003281; Harris AJL, 2011, PSYCHOL REV, V118, P135, DOI 10.1037/a0020997; Massey C, 2011, PSYCHOL SCI, V22, P274, DOI 10.1177/0956797610396223; MCKENNA FP, 1993, BRIT J PSYCHOL, V84, P389, DOI 10.1111/j.2044-8295.1993.tb02490.x; PERLOFF LS, 1986, J PERS SOC PSYCHOL, V50, P502, DOI 10.1037/0022-3514.50.3.502; Puri M, 2007, J FINANC ECON, V86, P71, DOI 10.1016/j.jfineco.2006.09.003; Sharot T, 2011, CURR BIOL, V21, pR941, DOI 10.1016/j.cub.2011.10.030; Strunk DR, 2006, BEHAV RES THER, V44, P861, DOI 10.1016/j.brat.2005.07.001; Tindle HA, 2009, CIRCULATION, V120, P656, DOI 10.1161/CIRCULATIONAHA.108.827642; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; WEINSTEIN ND, 1982, J BEHAV MED, V5, P441, DOI 10.1007/BF00845372; Wilson TD, 2000, J PERS SOC PSYCHOL, V78, P821, DOI 10.1037/0022-3514.78.5.821	22	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137685	10.1371/journal.pone.0137685	http://dx.doi.org/10.1371/journal.pone.0137685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26352146	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800108
J	Skinner, B; Guy, SJ				Skinner, Brian; Guy, Stephen J.			A Method for Using Player Tracking Data in Basketball to Learn Player Skills and Predict Team Performance	PLOS ONE			English	Article								Player tracking data represents a revolutionary new data source for basketball analysis, in which essentially every aspect of a player's performance is tracked and can be analyzed numerically. We suggest a way by which this data set, when coupled with a network-style model of the offense that relates players' skills to the team's success at running different plays, can be used to automatically learn players' skills and predict the performance of untested 5-man lineups in a way that accounts for the interaction between players' respective skill sets. After developing a general analysis procedure, we present as an example a specific implementation of our method using a simplified network model. While player tracking data is not yet available in the public domain, we evaluate our model using simulated data and show that player skills can be accurately inferred by a simple statistical inference scheme. Finally, we use the model to analyze games from the 2011 playoff series between the Memphis Grizzlies and the Oklahoma City Thunder and we show that, even with a very limited data set, the model can consistently describe a player's interactions with a given lineup based only on his performance with a different lineup.	[Skinner, Brian] Univ Minnesota, Fine Theoret Phys Inst, Minneapolis, MN 55455 USA; [Skinner, Brian] MIT, Cambridge, MA 02139 USA; [Guy, Stephen J.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Guy, Stephen J.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Massachusetts Institute of Technology (MIT); University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities	Skinner, B (corresponding author), Univ Minnesota, Fine Theoret Phys Inst, Minneapolis, MN 55455 USA.	skinner1@mit.edu; sjguy@cs.umn.edu		Guy, Stephen/0000-0001-8986-5817; Skinner, Brian/0000-0003-0774-3563				Carlin B. P., 2011, BAYESIAN METHODS DAT; Engelmann J., 2011, MIT SLOAN SPORTS AN; Fewell JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047445; Franks A, 2014, ARXIV14050231STAT; Goldsberry K, 2013, MIT SLOAN SPORTS AN; Lowe Z., 2013, 7 WAYS NBAS NEW CAME; Maheswaran R., 2012, P 6 ANN MIT SLOAN SP; Malinowski E., 2011, INSIDE NBAS DATA DRI; Maymin P, 2013, MIT SLOAN SPORTS AN; Miller A., 2014, ARXIV14010942STAT; Oliver D., 2004, BASKETBALL PAPER RUL; Piette J., 2011, MIT SLOAN SPORTS AN, P1; Reich BJ, 2006, AM STAT, V60, P3, DOI 10.1198/000313006X90305; Shirley K., 2007, NEW ENGL S STAT SPOR; Skinner B., 2013, SIGNIFICANCE, V10, P25, DOI [10.1111/j.1740-9713.2013.00662.x, DOI 10.1111/J.1740-9713.2013.00662.X]; Skinner B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030776; Skinner B, 2010, J QUANT ANAL SPORTS, V6, DOI 10.2202/1559-0410.1217; Strumbelj E, 2012, INT J FORECASTING, V28, P532, DOI 10.1016/j.ijforecast.2011.01.004; Weil S., 2011, MIT SLOAN SPORTS AN	19	11	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136393	10.1371/journal.pone.0136393	http://dx.doi.org/10.1371/journal.pone.0136393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351846	Green Published, gold, Green Submitted			2022-12-27	WOS:000360932800035
J	Chen, W; Zheng, HL; Teng, HK; Wang, YL; Zhang, YX; Zhao, CL; Liao, Y				Chen, Wei; Zheng, Huaili; Teng, Houkai; Wang, Yili; Zhang, Yuxin; Zhao, Chuanliang; Liao, Yong			Enhanced Coagulation-Flocculation Performance of Iron-Based Coagulants: Effects of PO43- and SiO32- Modifiers	PLOS ONE			English	Article							SILICATE SULFATE PFSIS; COMPOSITE COAGULANT; FERRIC SULFATE; POLYFERRIC SULFATE; WASTE-WATER; TITANIUM TETRACHLORIDE; DEWATERING PROPERTIES; FLOC CHARACTERISTICS; METAL-SALTS; BEHAVIOR	PO43- and SiO32- are often used as modifier to improve stability and aggregating ability of the iron-base coagulants, however, there are few reports about their detailed comparison between the coagulation performance and mechanisms. In this study, three coagulants-polyferric phosphoric sulfate (PFPS), polysilicon ferric sulfate (PFSS), and polyferric sulfate (PFS) were synthesized; their structure and morphology were characterized by Fourier transformed infrared (FT-IR) spectroscopy, X-ray diffraction (XRD) and Scanning electron microscope (SEM). Alkali titration and Ferron species analysis were employed to investigate the hydrolysis performance and species distribution. Jar test was conducted to measure their coagulation behaviors at different dosage, pH, and temperatures in which the flocs properties were measured. The results showed that a number of new compounds were formed due to the presence of PO43- and SiO32-. Moreover, PFPS and PFSS had similar level in Fe-a as well as Fe-b. Among them, PFPS produced more multi-core iron atoms polymer and content of Fe-b, and the formed flocs were larger and denser. It exhibited superior coagulation performance in terms of turbidity reduction, UV254 removal and residual ferric concentration. Jar test and floc breakage/regrowth experiments indicated other than charge neutrality, the dominated mechanism involved in PFSS was the adsorption between polysilicic acid and solution particle, while PFPS was sweeping, entrapment/adsorption resulting from larger polymer colloid of Fe-P chemistry bond.	[Chen, Wei; Zheng, Huaili; Zhao, Chuanliang; Liao, Yong] Chongqing Univ, State Minist Educ, Three Gorges Reservoir Reg Ecoenvironm, Key Lab, Chongqing 630044, Peoples R China; [Chen, Wei; Zheng, Huaili; Zhao, Chuanliang; Liao, Yong] Chongqing Univ, Natl Ctr Int Res Low Carbon & Green Bldg, Chongqing 630044, Peoples R China; [Teng, Houkai] Tianjin Chem Res & Design Inst, Natl Res Ctr Ind Water Treatment Engn & Technol, Tianjin, Peoples R China; [Wang, Yili] Beijing Forestry Univ, Res Ctr Water Pollut Source Control & Ecoremedia, Beijing, Peoples R China; [Zhang, Yuxin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Chongqing University; Chongqing University; Beijing Forestry University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Chen, W (corresponding author), Chongqing Univ, State Minist Educ, Three Gorges Reservoir Reg Ecoenvironm, Key Lab, Chongqing 630044, Peoples R China.	chenwei0835@foxmail.com; zhl@cqu.edu.cn	Zhang, Yu Xin/D-1524-2009	Zhang, Yu Xin/0000-0003-4698-5645	National Natural Science Foundation of China [21477010]; "Graduate Student Research Innovation Project" of Chongqing University [CYB14045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Graduate Student Research Innovation Project" of Chongqing University	Funding provided by National Natural Science Foundation of China (Project No. 21477010), URLs: http://www.nsfc.gov.cn/, received by Huaili Zheng, contribution to the preparation of manuscript and 2014 "Graduate Student Research Innovation Project" of Chongqing University (Project No. CYB14045), URLs: http://www.nsfc.gov.cn/, received by Wei Chen, contribution to the data collection and analysis.	Bache DH, 1997, WATER SCI TECHNOL, V36, P49, DOI 10.2166/wst.1997.0084; Cheng WP, 2002, CHEMOSPHERE, V47, P963, DOI 10.1016/S0045-6535(02)00052-8; Cotton F. A., 1999, ADV INORGANIC CHEM; Dong HY, 2014, DESALINATION, V335, P102, DOI 10.1016/j.desal.2013.12.018; DOUSMA J, 1978, J COLLOID INTERF SCI, V64, P154, DOI 10.1016/0021-9797(78)90345-4; Duan JM, 2003, ADV COLLOID INTERFAC, V100, P475, DOI 10.1016/S0001-8686(02)00067-2; El Samrani AG, 2004, WATER RES, V38, P756, DOI 10.1016/j.watres.2003.10.002; Fu Y, 2007, J NON-CRYST SOLIDS, V353, P2206, DOI 10.1016/j.jnoncrysol.2007.02.038; Fu Y, 2009, CHEM ENG J, V149, P1, DOI 10.1016/j.cej.2007.03.020; Huang X, 2014, CHEM ENG J, V245, P173, DOI 10.1016/j.cej.2014.02.018; Hussain S, 2013, CHEM ENG J, V225, P394, DOI 10.1016/j.cej.2013.03.119; Istv'an L., 1993, WATER SCI TECHNOL, V27, P242; Jiang JQ, 1998, WATER RES, V32, P930, DOI 10.1016/S0043-1354(97)83364-7; Kang L, 1995, J ENV ENG, V27, P249; KRATOHVIL S, 1967, J COLLOID INTERF SCI, V24, P47, DOI 10.1016/0021-9797(67)90275-5; Lan W, 2009, J HAZARD MATER, V162, P174, DOI 10.1016/j.jhazmat.2008.05.032; Lei GY, 2009, DESALINATION, V247, P518, DOI 10.1016/j.desal.2008.06.026; Li R, 2013, CHEM ENG J, V223, P869, DOI 10.1016/j.cej.2013.03.010; Li R, 2013, DESALINATION, V319, P85, DOI 10.1016/j.desal.2013.03.024; MORRIS JK, 1984, J AM WATER WORKS ASS, V76, P74; Moussas PA, 2008, SEP PURIF TECHNOL, V63, P475, DOI 10.1016/j.seppur.2008.06.009; Moussas PA, 2009, WATER RES, V43, P3511, DOI 10.1016/j.watres.2009.05.015; Mpofu P, 2004, J COLLOID INTERF SCI, V271, P145, DOI 10.1016/j.jcis.2003.09.042; Niu XX, 2011, J ENVIRON SCI-CHINA, V23, P1122, DOI 10.1016/S1001-0742(10)60537-2; Rong HY, 2014, CHEM ENG J, V243, P169, DOI 10.1016/j.cej.2013.12.005; Rong HY, 2013, J HAZARD MATER, V252, P330, DOI 10.1016/j.jhazmat.2013.03.011; Song S, 2006, WATER RES, V40, P364, DOI 10.1016/j.watres.2005.09.046; Sun CZ, 2012, CHEM ENG J, V185, P29, DOI 10.1016/j.cej.2011.04.056; Sun F, 2013, SEP PURIF TECHNOL, V115, P123, DOI 10.1016/j.seppur.2013.05.004; Sun T, 2010, CHEM ENG J, V163, P48, DOI 10.1016/j.cej.2010.07.037; Tang HX, 1994, CHEM WATER WASTEWATE, VIII, P57; Tran T, 2006, J MEMBRANE SCI, V280, P560, DOI 10.1016/j.memsci.2006.02.013; Tzoupanos ND, 2009, COLLOID SURFACE A, V342, P30, DOI 10.1016/j.colsurfa.2009.03.054; Wang DS, 2000, COLLOID SURFACE A, V166, P27, DOI 10.1016/S0927-7757(99)00420-3; Wang DS, 2001, WATER RES, V35, P3418, DOI 10.1016/S0043-1354(01)00034-3; Wang JP, 2013, WATER RES, V47, P2643, DOI 10.1016/j.watres.2013.01.050; Wei JC, 2009, WATER RES, V43, P724, DOI 10.1016/j.watres.2008.11.004; Yang Hai-yan, 2004, J Zhejiang Univ Sci, V5, P721, DOI 10.1631/jzus.2004.0721; Ye CQ, 2007, COLLOID SURFACE A, V294, P163, DOI 10.1016/j.colsurfa.2006.08.005; Yu WZ, 2010, WATER RES, V44, P3959, DOI 10.1016/j.watres.2010.04.032; Zeng K, 2007, HYDROMETALLURGY CHIN; Zhao YX, 2014, DESALINATION, V335, P70, DOI 10.1016/j.desal.2013.12.016; Zhao YX, 2013, CHEM ENG J, V233, P70, DOI 10.1016/j.cej.2013.08.017; Zheng HL, 2011, SPECTROSC SPECT ANAL, V31, P551, DOI 10.3964/j.issn.1000-0593(2011)02-0551-04; Zheng HL, 2013, CHEM ENG J, V234, P318, DOI 10.1016/j.cej.2013.08.098; Zheng HL, 2011, DESALINATION, V269, P148, DOI 10.1016/j.desal.2010.10.054; Zhu GC, 2012, DESALINATION, V285, P315, DOI 10.1016/j.desal.2011.10.019; Zhu GC, 2011, CHEM ENG J, V178, P50, DOI 10.1016/j.cej.2011.10.008; Zouboulis AI, 2008, J HAZARD MATER, V155, P459, DOI 10.1016/j.jhazmat.2007.11.108; Zouboulis AI, 2008, DESALINATION, V224, P307, DOI 10.1016/j.desal.2007.06.012	50	15	15	5	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137116	10.1371/journal.pone.0137116	http://dx.doi.org/10.1371/journal.pone.0137116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339902	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200022
J	Matsunaga, E; Higuchi, Y; Mori, K; Yairo, N; Oka, T; Shinozuka, S; Tashiro, K; Izumi, M; Kuhara, S; Takegawa, K				Matsunaga, Emiko; Higuchi, Yujiro; Mori, Kazuki; Yairo, Nao; Oka, Takuji; Shinozuka, Saki; Tashiro, Kosuke; Izumi, Minoru; Kuhara, Satoru; Takegawa, Kaoru			Identification and Characterization of a Novel Galactofuranose-Specific beta-D-Galactofuranosidase from Streptomyces Species	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASE; UDP-GALACTOPYRANOSE MUTASE; ASPERGILLUS-NIDULANS; GENOME SEQUENCE; NIGER; BIOSYNTHESIS; GALACTOMANNAN; PENICILLIUM; KAWACHII; PROTEIN	beta-D-galactofuranose (Galf) is a component of polysaccharides and glycoconjugates and its transferase has been well analyzed. However, no beta-D-galactofuranosidase (Galf-ase) gene has been identified in any organism. To search for a Galf-ase gene we screened soil samples and discovered a strain, identified as a Streptomyces species by the 16S ribosomal RNA gene analysis, that exhibits Galf-ase activity for 4-nitrophenyl beta-D-galactofuranoside (pNP-beta-D-Galf) in culture supernatants. By draft genome sequencing of the strain, named JHA19, we found four candidate genes encoding Galf-ases. Using recombinant proteins expressed in Escherichia coli, we found that three out of four candidates displayed the activity of not only Galf-ase but also alpha-L-arabinofuranosidase (Araf-ase), whereas the other one showed only the Galf-ase activity. This novel Galf-specific hydrolase is encoded by ORF1110 and has an optimum pH of 5.5 and a Km of 4.4 mM for the substrate pNP-beta-D-Galf. In addition, this enzyme was able to release galactose residue from galactomannan prepared from the filamentous fungus Aspergillus fumigatus, suggesting that natural polysaccharides could be also substrates. By the BLAST search using the amino acid sequence of ORF1110 Galf-ase, we found that there are homolog genes in both prokaryotes and eukaryotes, indicating that Galf-specific Galf-ases widely exist in microorganisms.	[Matsunaga, Emiko; Higuchi, Yujiro; Mori, Kazuki; Yairo, Nao; Tashiro, Kosuke; Kuhara, Satoru; Takegawa, Kaoru] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Oka, Takuji] Sojo Univ, Fac Biotechnol & Life Sci, Dept Appl Microbial Technol, Kumamoto, Japan; [Shinozuka, Saki; Izumi, Minoru] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan	Kyushu University; Sojo University; Okayama University	Takegawa, K (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, 6-10-1 Hakozaki, Fukuoka 812, Japan.	takegawa@agr.kyushu-u.ac.jp	Mori, Kazuki/M-2670-2018	Mori, Kazuki/0000-0003-3238-2472; Higuchi, Yujiro/0000-0001-7309-291X; Oka, Takuji/0000-0002-5691-654X	JSPS [26292054, 26892022]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI (https://www.jsps.go.jp/english/index.html) Grant Numbers 26292054 to K. Takegawa and 26892022 to YH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz S, 2011, FUNGAL GENET BIOL, V48, P896, DOI 10.1016/j.fgb.2011.06.001; Alam MK, 2012, FUNGAL GENET BIOL, V49, P1033, DOI 10.1016/j.fgb.2012.08.010; Chlubnova I, 2012, CARBOHYD RES, V356, P44, DOI 10.1016/j.carres.2012.04.002; COUSIN MA, 1989, J APPL BACTERIOL, V66, P311, DOI 10.1111/j.1365-2672.1989.tb02484.x; Crous JM, 1996, APPL MICROBIOL BIOT, V46, P256, DOI 10.1007/s002530050813; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; El-Ganiny AM, 2010, FUNGAL GENET BIOL, V47, P629, DOI 10.1016/j.fgb.2010.03.002; El-Ganiny AM, 2008, FUNGAL GENET BIOL, V45, P1533, DOI 10.1016/j.fgb.2008.09.008; Engel J, 2009, J BIOL CHEM, V284, P33859, DOI 10.1074/jbc.M109.070219; FLIPPHI MJA, 1993, CURR GENET, V24, P525, DOI 10.1007/BF00351717; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Futagami T, 2011, EUKARYOT CELL, V10, P1586, DOI 10.1128/EC.05224-11; Gielkens M, 1999, MICROBIOL-UK, V145, P735, DOI 10.1099/13500872-145-3-735; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Komachi Y, 2013, MOL MICROBIOL, V90, P1054, DOI 10.1111/mmi.12416; Koseki T, 2003, J BIOSCI BIOENG, V96, P232, DOI 10.1016/S1389-1723(03)80187-1; Kudoh A, 2015, GLYCOBIOLOGY, V25, P74, DOI 10.1093/glycob/cwu091; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; Marino C, 1998, GLYCOBIOLOGY, V8, P901, DOI 10.1093/glycob/8.9.901; Matsumura K, 2004, J BIOSCI BIOENG, V98, P77, DOI 10.1263/jbb.98.77; Morelle W, 2005, EUKARYOT CELL, V4, P1308, DOI 10.1128/EC.4.7.1308-1316.2005; Nikodinovic J, 2003, BIOTECHNIQUES, V35, P932, DOI 10.2144/03355bm05; Peltier P, 2008, CARBOHYD RES, V343, P1897, DOI 10.1016/j.carres.2008.02.010; RAMLI N, 1995, BIOSCI BIOTECH BIOCH, V59, P1856, DOI 10.1271/bbb.59.1856; REISS E, 1979, INFECT IMMUN, V25, P357, DOI 10.1128/IAI.25.1.357-365.1979; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; RIETSCHELBERST M, 1977, J BIOL CHEM, V252, P3219; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; SCHWABE K, 1978, CARBOHYD RES, V67, P541, DOI 10.1016/S0008-6215(00)84146-4; Shi H, 2014, BIOTECHNOL LETT, V36, P1321, DOI 10.1007/s10529-014-1493-6; Tefsen B, 2012, BIOL CHEM, V393, P767, DOI 10.1515/hsz-2012-0134; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; VANBRUGGENVANDERLUGT AW, 1992, J BACTERIOL, V174, P6096; VARELA O, 1986, CARBOHYD RES, V155, P247, DOI 10.1016/S0008-6215(00)90153-8; Wallis GLF, 1999, BBA-GEN SUBJECTS, V1472, P576, DOI 10.1016/S0304-4165(99)00188-9; Wallis GLF, 2001, BBA-GEN SUBJECTS, V1525, P19, DOI 10.1016/S0304-4165(00)00150-1; Wallis GLF, 2001, EUR J BIOCHEM, V268, P4134, DOI 10.1046/j.1432-1327.2001.02322.x; Yuen KY, 2001, J CLIN MICROBIOL, V39, P3830, DOI 10.1128/JCM.39.11.3830-3837.2001; Zhao G, 2014, GENOME ANNOUNC, V2, P100; Zhao GZ, 2012, EUKARYOT CELL, V11, P1178, DOI 10.1128/EC.00160-12	44	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137230	10.1371/journal.pone.0137230	http://dx.doi.org/10.1371/journal.pone.0137230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340350	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200036
J	Mori, J; Kawabata, A; Tang, HM; Tadagaki, K; Mizuguchi, H; Kuroda, K; Mori, Y				Mori, Junko; Kawabata, Akiko; Tang, Huamin; Tadagaki, Kenjiro; Mizuguchi, Hiroyuki; Kuroda, Kazumichi; Mori, Yasuko			Human Herpesvirus-6 U14 Induces Cell-Cycle Arrest in G2/M Phase by Associating with a Cellular Protein, EDD	PLOS ONE			English	Article							ADENOVIRUS VECTORS; HYPERPLASTIC-DISCS; E2F1/RB PATHWAYS; VIRAL ENVELOPE; CODING CONTENT; T-CELLS; HUMAN-HERPESVIRUS-6; GENE; P53; INFECTION	The human herpesvirus-6 (HHV-6) infection induces cell-cycle arrest. In this study, we found that the HHV-6-encoded U14 protein induced cell-cycle arrest at G2/M phase via an association with the cellular protein EDD, a mediator of DNA-damage signal transduction. In the early phase of HHV-6 infection, U14 colocalized with EDD dots in the nucleus, and similar colocalization was also observed in cells transfected with a U14 expression vector. When the carboxyl-terminal region of U14 was deleted, no association of U14 and EDD was observed, and the percentage of cells in G2/M decreased relative to that in cells expressing wild-type U14, indicating that the C-terminal region of U14 and the U14-EDD association are critical for the cell-cycle arrest induced by U14. These results indicate that U14 is a G2/M checkpoint regulator encoded by HHV-6.	[Mori, Junko; Kawabata, Akiko; Tang, Huamin; Mori, Yasuko] Kobe Univ, Grad Sch Med, Div Clin Virol, Kobe, Hyogo 6500017, Japan; [Tang, Huamin] Nanjing Med Univ, Dept Immunol, Nanjing 210029, Jiangsu, Peoples R China; [Tadagaki, Kenjiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Biochem & Mol Biol, Kyoto 6028566, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka 5650871, Japan; [Kuroda, Kazumichi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 1738610, Japan; [Mori, Yasuko] Natl Inst Biomed Innovat, Lab Virol & Vaccinol, Osaka 5670085, Japan	Kobe University; Nanjing Medical University; Kyoto Prefectural University of Medicine; Osaka University; Nihon University; National Institute of Health Sciences - Japan	Mori, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Clin Virol, Kobe, Hyogo 6500017, Japan.	ymori@med.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS).	Ablashi D, 2014, ARCH VIROL, V159, P863, DOI 10.1007/s00705-013-1902-5; Akkapaiboon P, 2004, J VIROL, V78, P7969, DOI 10.1128/JVI.78.15.7969-7983.2004; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Clark DA, 2002, INT J HEMATOL, V76, P246, DOI 10.1007/BF03165124; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; De Bolle L, 2004, FEBS LETT, V560, P25, DOI 10.1016/S0014-5793(04)00035-3; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; Fehr AR, 2013, J VIROL, V87, P8818, DOI 10.1128/JVI.00088-13; GOMPELS UA, 1995, VIROLOGY, V209, P29, DOI 10.1006/viro.1995.1228; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Isegawa Y, 1999, J VIROL, V73, P8053, DOI 10.1128/JVI.73.10.8053-8063.1999; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; Kawabata A, 2012, VIROLOGY, V429, P21, DOI 10.1016/j.virol.2012.03.027; Kawabata K, 2005, MOL THER, V12, P547, DOI 10.1016/j.ymthe.2005.04.015; Kofod-Olsen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059223; Koshizuka T, 2010, VIROLOGY, V405, P280, DOI 10.1016/j.virol.2010.06.016; Li LY, 2014, ARCH VIROL, V159, P365, DOI 10.1007/s00705-013-1826-0; Li LY, 2012, J MED VIROL, V84, P657, DOI 10.1002/jmv.23226; Li LY, 2011, J VIROL, V85, P6774, DOI 10.1128/JVI.02577-10; Ling SY, 2011, J BIOL CHEM, V286, P14972, DOI 10.1074/jbc.M110.182527; Mizuguchi H, 2002, GENE, V285, P69, DOI 10.1016/S0378-1119(02)00410-9; Mlechkovich G, 2007, J VIROL, V81, P13499, DOI 10.1128/JVI.01496-07; Mori Y, 2003, J VIROL, V77, P4992, DOI 10.1128/JVI.77.8.4992-4999.2003; Mori Y, 1998, VIROLOGY, V249, P129, DOI 10.1006/viro.1998.9305; Mori Y, 2003, J VIROL, V77, P2452, DOI 10.1128/JVI.77.4.2452-2458.2003; Mori Y, 2009, CELL MICROBIOL, V11, P1001, DOI 10.1111/j.1462-5822.2009.01312.x; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Nakamura T, 2008, J PROTEOME RES, V7, P1007, DOI 10.1021/pr7005878; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OKUNO T, 1989, J CLIN MICROBIOL, V27, P651, DOI 10.1128/JCM.27.4.651-653.1989; Oster B, 2008, J GEN VIROL, V89, P87, DOI 10.1099/vir.0.83136-0; Oster B, 2005, J VIROL, V79, P1961, DOI 10.1128/JVI.79.3.1961-1965.2005; Oster B, 2008, J GEN VIROL, V89, P1106, DOI 10.1099/vir.0.83262-0; Oster B, 2006, J CLIN VIROL, V37, pS63, DOI 10.1016/S1386-6532(06)70014-2; Ota M, 2014, MICROBIOL IMMUNOL, V58, P119, DOI 10.1111/1348-0421.12121; Reitsma JM, 2011, CELL HOST MICROBE, V9, P103, DOI 10.1016/j.chom.2011.01.006; Sakurai F, 2005, GENE THER, V12, P1424, DOI 10.1038/sj.gt.3302562; Schleimann MH, 2014, VIROLOGY, V452, P254, DOI 10.1016/j.virol.2014.01.028; Sharon E, 2014, P NATL ACAD SCI USA, V111, P451, DOI 10.1073/pnas.1308854110; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Takemoto M, 2005, J VIROL, V79, P13037, DOI 10.1128/JVI.79.20.13037-13046.2005; Takemoto M, 2004, J GEN VIROL, V85, P869, DOI 10.1099/vir.0.19626-0; YAMANISHI K, 1988, LANCET, V1, P1065; Zerr DM, 2005, CLIN INFECT DIS, V40, P932, DOI 10.1086/428060; Zhao RY, 2005, CELL RES, V15, P143, DOI 10.1038/sj.cr.7290279	46	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137420	10.1371/journal.pone.0137420	http://dx.doi.org/10.1371/journal.pone.0137420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340541	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200058
J	Tundup, S; Srivastava, L; Norberg, T; Watford, W; Harn, D				Tundup, Smanla; Srivastava, Leena; Norberg, Thomas; Watford, Wendy; Harn, Donald			A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway	PLOS ONE			English	Article							N-FUCOPENTAOSE-III; HOST IMMUNE-RESPONSES; DC-SIGN; ALTERNATIVE ACTIVATION; DENDRITIC CELLS; KAPPA-B; IN-VIVO; MACROPHAGES; POLARIZATION; RECEPTORS	The milk pentasaccharide LNFPIII has therapeutic action for metabolic and autoimmune diseases and prolongs transplant survival in mice when presented as a neoglycoconjugate. Within LNFPIII is the Lewis(x) trisaccharide, expressed by many helminth parasites. In humans, LNFPIII is found in human milk and also known as stage-specific embryonic antigen-1. LNFPIII-NGC drives alternative activation of macrophages and dendritic cells via NF kappa B activation in a TLR4 dependent mechanism. However, the connection between LNFPIII-NGC activation of APCs, TLR4 signaling and subsequent MAP kinase signaling leading to anti-inflammatory activation of APCs remains unknown. In this study we determined that the innate receptor CD14 was essential for LNFPIII-NGC induction of both ERK and NFkB activation in APCs. Induction of ERK activation by LNFPIII-NGC was completely dependent on CD14/TLR4-Ras-Raf1/TPL2-MEK axis in bone marrow derived dendritic cells (BMDCs). In addition, LNFPIII-NGC preferentially induced the production of Th2 "favoring" chemokines CCL22 and matrix metalloprotease protein-9 in a CD14 dependent manner in BMDCs. In contrast, LNFPIII-NGC induces significantly lower levels of Th1 "favoring" chemokines, MIP1 alpha, MIP1 beta and MIP-2 compared to levels in LPS stimulated cells. Interestingly, NGC of the identical human milk sugar LNnT, minus the alpha 1-3 linked fucose, failed to activate APCs via TLR4/MD2/CD14 receptor complex, suggesting that the alpha 1-3 linked fucose in LNFPIII and not on LNnT, is required for this process. Using specific chemical inhibitors of the MAPK pathway, we found that LNFPIII-NGC induction of CCL22, MMP9 and IL-10 production was dependent on ERK activation. Over all, this study suggests that LNFPIII-NGC utilizes CD14/TLR4-MAPK (ERK) axis in modulating APC activation to produce anti-inflammatory chemokines and cytokines in a manner distinct from that seen for the pro-inflammatory PAMP LPS. These pathways may explain the in vivo therapeutic effect of LNFPIII-NGC treatment for inflammation based diseases.	[Tundup, Smanla; Srivastava, Leena; Watford, Wendy; Harn, Donald] Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA 30602 USA; [Harn, Donald] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Norberg, Thomas] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden; [Tundup, Smanla] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Uppsala University; University of Chicago	Harn, D (corresponding author), Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA 30602 USA.	dharn@uga.edu		Watford, Wendy/0000-0003-4261-5399	National Institute of Health [5R01AI056484]; University of Georgia Research Funds; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056484] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Research Funds; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health (Grant 5R01AI056484 to D.H.), University of Georgia Research Funds, and the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atochina O, 2006, EXP DERMATOL, V15, P461, DOI 10.1111/j.1600-0625.2006.00431.x; Atochina O, 2005, CLIN DIAGN LAB IMMUN, V12, P1041, DOI 10.1128/CDLI.12.9.1041-1049.2005; Atochina O, 2008, IMMUNOLOGY, V125, P111, DOI 10.1111/j.1365-2567.2008.02826.x; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Bhargava P, 2012, NAT MED, V18, P1665, DOI 10.1038/nm.2962; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dutta P, 2010, TRANSPLANTATION, V90, P1071, DOI 10.1097/TP.0b013e3181f8f296; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Gros A, 2012, CLIN CANCER RES, V18, P5212, DOI 10.1158/1078-0432.CCR-12-1108; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; HARN DA, 1987, J IMMUNOL, V138, P1571; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; KO AI, 1990, P NATL ACAD SCI USA, V87, P4159, DOI 10.1073/pnas.87.11.4159; Koning N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00112; Larghi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045279; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Lo SK, 1997, BLOOD, V89, P307, DOI 10.1182/blood.V89.1.307.307_307_314; Lopez-Pelaez M, 2011, EUR J IMMUNOL, V41, P1733, DOI 10.1002/eji.201041101; Martinez FO, 2011, EUR J IMMUNOL, V41, P1531, DOI 10.1002/eji.201141670; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Okano M, 2001, J IMMUNOL, V167, P442, DOI 10.4049/jimmunol.167.1.442; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; SPOONCER E, 1984, J BIOL CHEM, V259, P4792; Srivastava L, 2014, INFECT IMMUN, V82, P1891, DOI 10.1128/IAI.01293-13; Terrazas CA, 2013, FASEB J, V27, P4547, DOI 10.1096/fj.13-228932; Thomas PG, 2005, J IMMUNOL, V175, P2082, DOI 10.4049/jimmunol.175.4.2082; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; Tundup S, 2014, INFECT IMMUN, V82, P3240, DOI 10.1128/IAI.01780-14; Tundup S, 2012, ANN NY ACAD SCI, V1253, pE1, DOI 10.1111/j.1749-6632.2012.06618.x; van Stijn CMW, 2010, MOL IMMUNOL, V47, P1544, DOI 10.1016/j.molimm.2010.01.014; VELUPILLAI P, 1994, P NATL ACAD SCI USA, V91, P18, DOI 10.1073/pnas.91.1.18; Watford WT, 2010, J IMMUNOL, V184, P105, DOI 10.4049/jimmunol.0803730; Zhu B, 2012, CLIN IMMUNOL, V142, P351, DOI 10.1016/j.clim.2011.12.006	37	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137495	10.1371/journal.pone.0137495	http://dx.doi.org/10.1371/journal.pone.0137495			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340260	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200065
J	Villar, M; Ayllon, N; Kocan, KM; Bonzon-Kulichenko, E; Alberdi, P; Blouin, EF; Weisheit, S; Mateos-Hernandez, L; Cabezas-Cruz, A; Bell-Sakyi, L; Vancova, M; Bily, T; Meyer, DF; Sterba, J; Contreras, M; Rudenko, N; Grubhoffer, L; Vazquez, J; de la Fuente, J				Villar, Margarita; Ayllon, Nieves; Kocan, Katherine M.; Bonzon-Kulichenko, Elena; Alberdi, Pilar; Blouin, Edmour F.; Weisheit, Sabine; Mateos-Hernandez, Lourdes; Cabezas-Cruz, Alejandro; Bell-Sakyi, Lesley; Vancova, Marie; Bily, Tomas; Meyer, Damien F.; Sterba, Jan; Contreras, Marinela; Rudenko, Nataliia; Grubhoffer, Libor; Vazquez, Jesus; de la Fuente, Jose			Identification and Characterization of Anaplasma phagocytophilum Proteins Involved in Infection of the Tick Vector, Ixodes scapularis	PLOS ONE			English	Article							IV SECRETION SYSTEM; GENE-EXPRESSION; SURFACE-PROTEINS; DIFFERENTIAL EXPRESSION; CATTLE PATHOGEN; MARGINALE; MEMBRANE; ADHESION; CELLS; HOST	Anaplasma phagocytophilum is an emerging zoonotic pathogen transmitted by Ixodes scapularis that causes human granulocytic anaplasmosis. Here, a high throughput quantitative proteomics approach was used to characterize A. phagocytophilum proteome during rickettsial multiplication and identify proteins involved in infection of the tick vector, I. scapularis. The first step in this research was focused on tick cells infected with A. phagocytophilum and sampled at two time points containing 10-15% and 65-71% infected cells, respectively to identify key bacterial proteins over-represented in high percentage infected cells. The second step was focused on adult female tick guts and salivary glands infected with A. phagocytophilum to compare in vitro results with those occurring during bacterial infection in vivo. The results showed differences in the proteome of A. phagocytophilum in infected ticks with higher impact on protein synthesis and processing than on bacterial replication in tick salivary glands. These results correlated well with the developmental cycle of A. phagocytophilum, in which cells convert from an intracellular reticulated, replicative form to the nondividing infectious dense-core form. The analysis of A. phagocytophilum differentially represented proteins identified stress response (GroEL, HSP70) and surface (MSP4) proteins that were over-represented in high percentage infected tick cells and salivary glands when compared to low percentage infected cells and guts, respectively. The results demonstrated that MSP4, GroEL and HSP70 interact and bind to tick cells, thus playing a role in rickettsia-tick interactions. The most important finding of these studies is the increase in the level of certain bacterial stress response and surface proteins in A. phagocytophilum-infected tick cells and salivary glands with functional implication in tick-pathogen interactions. These results gave a new dimension to the role of these stress response and surface proteins during A. phagocytophilum infection in ticks. Characterization of Anaplasma proteome contributes information on host-pathogen interactions and provides targets for development of novel control strategies for pathogen infection and transmission.	[Villar, Margarita; Ayllon, Nieves; Alberdi, Pilar; Mateos-Hernandez, Lourdes; Cabezas-Cruz, Alejandro; Contreras, Marinela; de la Fuente, Jose] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, SaBio, Ronda Toledo S-N, Ciudad Real 13005, Spain; [Kocan, Katherine M.; Blouin, Edmour F.; de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Bonzon-Kulichenko, Elena; Vazquez, Jesus] Ctr Nacl Invest Cardiovasc, Madrid 28029, Spain; [Weisheit, Sabine; Bell-Sakyi, Lesley] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Weisheit, Sabine; Bell-Sakyi, Lesley] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland; [Weisheit, Sabine; Bell-Sakyi, Lesley] Pirbright Inst, Woking GU24 0NF, Surrey, England; [Cabezas-Cruz, Alejandro] Univ Lille Nord France, Inst Pasteur Lille, CIIL, INSERM,U1019,CNRS,UMR 8204, Lille, France; [Vancova, Marie; Bily, Tomas; Sterba, Jan; Rudenko, Nataliia; Grubhoffer, Libor] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CZ-37005 Ceske Budejovice, Czech Republic; [Vancova, Marie; Bily, Tomas; Grubhoffer, Libor] Univ South Bohemia, Fac Sci, CZ-37005 Ceske Budejovice, Czech Republic; [Meyer, Damien F.] CIRAD, UMR CMAEE, F-97170 Petit Bourg, Guadeloupe, France; [Meyer, Damien F.] INRA, CMAEE UMR1309, F-34398 Montpellier, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater; Centro Nacional de Investigaciones Cardiovasculares (CNIC); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; CIRAD; INRAE	de la Fuente, J (corresponding author), Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, SaBio, Ronda Toledo S-N, Ciudad Real 13005, Spain.	jose_delafuente@yahoo.com	Villar-Rayo, Marga M/J-4155-2012; Rudenko, Natalie/AAD-8980-2021; Bonzon-Kulichenko, Elena/R-4208-2018; Contreras, Marinela/R-4474-2019; Cabezas-Cruz, Alejandro/P-2755-2017; Štěrba, Ján/E-9533-2012; Alberdi, Pilar/K-7788-2014; Hernández, Lourdes Mateos/P-6717-2019; Vazquez, Jesus/B-7697-2015; Vancova, Marie/G-8347-2014; Rudenko, Nataliia/J-8571-2012; Bily, Tomas/AAT-8692-2020; Rojo, Marinela Contreras/AAD-9995-2021; Grubhoffer, Libor/G-9762-2014; Meyer, Damien/G-2607-2013	Villar-Rayo, Marga M/0000-0003-4172-9079; Bonzon-Kulichenko, Elena/0000-0003-0852-7520; Cabezas-Cruz, Alejandro/0000-0002-8660-730X; Štěrba, Ján/0000-0003-1005-1787; Alberdi, Pilar/0000-0002-6999-9735; Hernández, Lourdes Mateos/0000-0001-9566-7710; Vazquez, Jesus/0000-0003-1461-5092; Vancova, Marie/0000-0003-0678-8268; Bily, Tomas/0000-0003-1450-1693; Grubhoffer, Libor/0000-0003-0885-1849; Contreras Rojo, Marinela/0000-0002-1505-5624; Meyer, Damien/0000-0003-2735-176X	MEC, Spain [BFU2011-23896]; European Union [278976]; Postdok BIOGLOBE, Czech Republic [CZ.1.07/2.3.00/30.0032]; European Social Fund; state budget of the Czech Republic; Ministerio de Educacion, Cultura y Deporte, Spain; EU [238511]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001741] Funding Source: researchfish; BBSRC [BBS/E/I/00001741] Funding Source: UKRI	MEC, Spain(Spanish Government); European Union(European Commission); Postdok BIOGLOBE, Czech Republic; European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Ministerio de Educacion, Cultura y Deporte, Spain; EU(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by MEC, Spain, grant BFU2011-23896 (JF), European Union FP7 ANTIGONE project number 278976 (JF) and Postdok BIOGLOBE, Czech Republic CZ.1.07/2.3.00/30.0032 co-financed by the European Social Fund and the state budget of the Czech Republic (JS). N. Ayllon was funded by Ministerio de Educacion, Cultura y Deporte, Spain. S. Weisheit was supported by the POSTICK ITN (Post-graduate training network for capacity building to control ticks and tick-borne diseases) within the FP7-PEOPLE-ITN programme (EU Grant No. 238511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayllon N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005120; Ayllon N, 2013, INFECT IMMUN, V81, P2415, DOI 10.1128/IAI.00194-13; Blouin EF, 2003, VET PARASITOL, V111, P247, DOI 10.1016/S0304-4017(02)00378-3; Brayton KA, 2006, EXPERT REV VACCINES, V5, P95, DOI 10.1586/14760584.5.1.95; de la Fuente J, 2005, CELL MICROBIOL, V7, P549, DOI 10.1111/j.1462-5822.2004.00485.x; de la Fuente J, 2003, VET MICROBIOL, V91, P265, DOI 10.1016/S0378-1135(02)00309-7; de la Fuente J, 2001, INT J PARASITOL, V31, P145, DOI 10.1016/S0020-7519(00)00162-4; de la Fuente J, 2007, GENOMICS, V90, P712, DOI 10.1016/j.ygeno.2007.08.009; de la Fuente J, 2006, PARASITOL RES, V100, P85, DOI 10.1007/s00436-006-0244-6; de la Fuente J, 2010, VET PARASITOL, V167, P175, DOI 10.1016/j.vetpar.2009.09.019; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Galindo RC, 2012, J PROTEOM BIOINFORM, V5, P108, DOI DOI 10.4172/JPB.1000221; Galindo RC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-181; Garcia-Garcia JC, 2004, VET MICROBIOL, V98, P261, DOI 10.1016/j.vetmic.2003.10.021; Ge Y, 2007, J BACTERIOL, V189, P7819, DOI 10.1128/JB.00866-07; Ge Y, 2006, CELL MICROBIOL, V8, P1406, DOI 10.1111/j.1462-5822.2006.00720.x; Goulhen F, 1998, INFECT IMMUN, V66, P5307, DOI 10.1128/IAI.66.11.5307-5313.1998; Hajdusek O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00026; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kocan KM, 2008, FRONT BIOSCI-LANDMRK, V13, P7032, DOI 10.2741/3208; Kocan KM, 2012, TICKS TICK-BORNE DIS, V3, P147, DOI 10.1016/j.ttbdis.2012.01.004; Kocan KM, 2002, EXP APPL ACAROL, V28, P9, DOI 10.1023/A:1025329728269; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Lin MQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00024; Lis K, 2014, TICKS TICK-BORNE DIS, V5, P511, DOI 10.1016/j.ttbdis.2014.03.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; Martinez-Bartolome S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mastronunzio JE, 2012, J BACTERIOL, V194, P2238, DOI 10.1128/JB.06791-11; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Meyer DF, 2013, NUCLEIC ACIDS RES, V41, P9218, DOI 10.1093/nar/gkt718; Multhoff G, 2007, METHODS, V43, P229, DOI 10.1016/j.ymeth.2007.06.006; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Naranjo V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065915; Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h; Niu H, 2006, CELL MICROBIOL, V8, P523, DOI 10.1111/j.1462-5822.2005.00643.x; Nogueira T, 2000, CURR OPIN MICROBIOL, V3, P154, DOI 10.1016/S1369-5274(00)00068-0; Noh SM, 2008, INFECT IMMUN, V76, P2219, DOI 10.1128/IAI.00008-08; Ramabu SS, 2010, INFECT IMMUN, V78, P3047, DOI 10.1128/IAI.00300-10; Reichard MV, 2009, VECTOR-BORNE ZOONOT, V9, P565, DOI 10.1089/vbz.2008.0106; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; SCORPIO A, 1994, J BACTERIOL, V176, P6449, DOI 10.1128/JB.176.21.6449-6456.1994; Severo MS, 2012, FUTURE MICROBIOL, V7, P719, DOI [10.2217/fmb.12.45, 10.2217/FMB.12.45]; Severo MS, 2014, MOL MED MICROBIOLOGY, P2029; Seydlova G, 2012, J APPL MICROBIOL, V112, P765, DOI 10.1111/j.1365-2672.2012.05238.x; Sinclair SH, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00274; Stuen S, 2007, VET RES COMMUN, V31, P79, DOI 10.1007/s11259-007-0071-y; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; Sukumaran B, 2006, J EXP MED, V203, P1507, DOI 10.1084/jem.20060208; Sumner JW, 1997, J CLIN MICROBIOL, V35, P2087, DOI 10.1128/JCM.35.8.2087-2092.1997; Susin MF, 2006, J BACTERIOL, V188, P8044, DOI 10.1128/JB.00824-06; Troese MJ, 2011, INFECT IMMUN, V79, P4696, DOI 10.1128/IAI.05658-11; Villar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089564; Villar Margarita, 2010, Int J Proteomics, V2010, P657261, DOI 10.1155/2010/657261; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhi N, 2002, MOL MICROBIOL, V46, P135, DOI 10.1046/j.1365-2958.2002.03143.x; Zhu HY, 2013, MICROBES INFECT, V15, P172, DOI 10.1016/j.micinf.2012.10.001; Zivkovic Z, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/705034	63	24	25	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137237	10.1371/journal.pone.0137237	http://dx.doi.org/10.1371/journal.pone.0137237			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340562	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200038
J	Bonato, M; Spironelli, C; Lisi, M; Priftis, K; Zorzi, M				Bonato, Mario; Spironelli, Chiara; Lisi, Matteo; Priftis, Konstantinos; Zorzi, Marco			Effects of Multimodal Load on Spatial Monitoring as Revealed by ERPs	PLOS ONE			English	Article							TOP-DOWN MODULATION; ATTENTIONAL LOAD; PERCEPTUAL LOAD; SELECTIVE ATTENTION; POTENTIALS REVEAL; MEMORY LOAD; HUMAN BRAIN; NEGLECT; VISION; RESPONSES	While the role of selective attention in filtering out irrelevant information has been extensively studied, its characteristics and neural underpinnings when multiple environmental stimuli have to be processed in parallel are much less known. Building upon a dual-task paradigm that induced spatial awareness deficits for contralesional hemispace in right hemisphere-damaged patients, we investigated the electrophysiological correlates of multimodal load during spatial monitoring in healthy participants. The position of appearance of briefly presented, lateralized targets had to be reported either in isolation (single task) or together with a concurrent task, visual or auditory, which recruited additional attentional resources (dual-task). This top-down manipulation of attentional load, without any change of the sensory stimulation, modulated the amplitude of the first positive ERP response (P1) and shifted its neural generators, with a suppression of the signal in the early visual areas during both visual and auditory dual tasks. Furthermore, later N2 contralateral components elicited by left targets were particularly influenced by the concurrent visual task and were related to increased activation of the supramarginal gyrus. These results suggest that the right hemisphere is particularly affected by load manipulations, and confirm its crucial role in subtending automatic orienting of spatial attention and in monitoring both hemispaces.	[Bonato, Mario] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Bonato, Mario; Spironelli, Chiara; Lisi, Matteo; Priftis, Konstantinos; Zorzi, Marco] Univ Padua, Dept Gen Psychol, Padua, Italy; [Spironelli, Chiara; Zorzi, Marco] Univ Padua, Ctr Cognit Neurosci, Padua, Italy; [Lisi, Matteo] Univ Paris 05, Lab Psychol Percept, CNRS, UMR 8242, Paris, France; [Zorzi, Marco] IRCSS San Camillo Hosp, Lido Venice, Italy	Ghent University; University of Padua; University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Bonato, M (corresponding author), Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium.	mario.bonato@ugent.be; chiara.spironelli@unipd.it; marco.zorzi@unipd.it	Bonato, Mario/B-4977-2013; Lisi, Matteo/O-6824-2017; Zorzi, Marco/B-7863-2008; Priftis, Konstantinos/B-7862-2008; Spironelli, Chiara/AAC-1701-2021; Spironelli, Chiara/D-1548-2014	Bonato, Mario/0000-0002-2004-9341; Lisi, Matteo/0000-0003-3554-385X; Zorzi, Marco/0000-0002-4651-6390; Priftis, Konstantinos/0000-0002-5215-4621; Spironelli, Chiara/0000-0002-8547-2431; Spironelli, Chiara/0000-0002-8547-2431	Compagnia di San Paolo (Neuroscience Program); University of Padova (Strategic Grant NEURAT); FWO-Pegasus; Marie Curie IEF Fellowship within the 7th European Community Framework Program	Compagnia di San Paolo (Neuroscience Program)(Compagnia di San Paolo); University of Padova (Strategic Grant NEURAT); FWO-Pegasus; Marie Curie IEF Fellowship within the 7th European Community Framework Program	This study was supported by grants from Compagnia di San Paolo (Neuroscience Program) and from the University of Padova (Strategic Grant NEURAT) to MZ. MB was supported by a FWO-Pegasus and by a Marie Curie IEF Fellowship within the 7th European Community Framework Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anticevic A, 2010, NEUROIMAGE, V49, P2638, DOI 10.1016/j.neuroimage.2009.11.008; Arrington CM, 2000, J COGNITIVE NEUROSCI, V12, P106, DOI 10.1162/089892900563975; Bahrami B, 2007, CURR BIOL, V17, P509, DOI 10.1016/j.cub.2007.01.070; Barnhardt J, 2008, NEUROPSYCHOLOGIA, V46, P2071, DOI 10.1016/j.neuropsychologia.2008.02.007; Bartolomeo P, 2002, NEUROSCI BIOBEHAV R, V26, P217, DOI 10.1016/S0149-7634(01)00065-3; Bellgrove MA, 2013, NEUROPSYCHOLOGIA, V51, P1085, DOI 10.1016/j.neuropsychologia.2013.01.019; Bonato M, 2013, BEHAV NEUROL, V26, P179, DOI [10.1155/2013/139812, 10.3233/BEN-2012-129005]; Bonato M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00195; Bonato M, 2012, NEUROPSYCHOLOGY, V26, P20, DOI 10.1037/a0025306; Bonato M, 2010, NEUROPSYCHOLOGIA, V48, P3934, DOI 10.1016/j.neuropsychologia.2010.08.022; Bonato M, 2009, J COGNITIVE NEUROSCI, V21, P745, DOI 10.1162/jocn.2009.21054; Buxbaum LJ, 2012, NEUROPSYCHOLOGY, V26, P430, DOI 10.1037/a0028674; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Dell'Acqua R, 2006, PSYCHOPHYSIOLOGY, V43, P394, DOI 10.1111/j.1469-8986.2006.00411.x; Ding YL, 2014, HUM BRAIN MAPP, V35, P3008, DOI 10.1002/hbm.22381; Fu SM, 2008, NEUROIMAGE, V39, P1345, DOI 10.1016/j.neuroimage.2007.09.068; Fu SM, 2010, BIOL PSYCHOL, V85, P171, DOI 10.1016/j.biopsycho.2010.06.008; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Handy TC, 2001, PSYCHOL SCI, V12, P213, DOI 10.1111/1467-9280.00338; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopfinger JB, 2006, NEUROIMAGE, V31, P774, DOI 10.1016/j.neuroimage.2005.12.049; Kinsbourne M, 1977, Adv Neurol, V18, P41; Klemen J, 2010, J COGNITIVE NEUROSCI, V22, P437, DOI 10.1162/jocn.2009.21204; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Luck S.J., 2005, INTRO EVENT RELATED; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Malhotra P, 2009, BRAIN, V132, P645, DOI 10.1093/brain/awn350; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Marois R, 2000, NEURON, V25, P717, DOI 10.1016/S0896-6273(00)81073-9; O'Connell RG, 2011, CEREB CORTEX, V21, P1056, DOI 10.1093/cercor/bhq178; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 1999, BRAIN, V122, P1731, DOI 10.1093/brain/122.9.1731; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Peers PV, 2006, NEUROPSYCHOLOGIA, V44, P1325, DOI 10.1016/j.neuropsychologia.2006.01.033; Ptak R, 2007, BRAIN, V130, P3211, DOI 10.1093/brain/awm234; R Development Core Team, 2012, R LANG ENV STAT COMP; Rauss K, 2012, HUM BRAIN MAPP, V33, P63, DOI 10.1002/hbm.21193; Rauss K, 2011, NEUROSCI BIOBEHAV R, V35, P1237, DOI 10.1016/j.neubiorev.2010.12.011; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; Recarte MA, 2000, J EXP PSYCHOL-APPL, V6, P31, DOI 10.1037/1076-898X.6.1.31; Rorden C, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.004.2008; Russell C, 2004, NEUROREPORT, V15, P2189, DOI 10.1097/00001756-200410050-00009; Russell C, 2013, CORTEX, V49, P1874, DOI 10.1016/j.cortex.2012.10.005; Santangelo V, 2008, CONSCIOUS COGN, V17, P989, DOI 10.1016/j.concog.2008.02.006; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schluter ND, 2001, NEUROPSYCHOLOGIA, V39, P105, DOI 10.1016/S0028-3932(00)00105-6; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Shulman GL, 2003, J NEUROPHYSIOL, V90, P3384, DOI 10.1152/jn.00343.2003; Silvanto J, 2009, CEREB CORTEX, V19, P327, DOI 10.1093/cercor/bhn091; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor MJ, 2002, CLIN NEUROPHYSIOL, V113, P1903, DOI 10.1016/S1388-2457(02)00309-7; Todd JJ, 2005, PSYCHOL SCI, V16, P965, DOI 10.1111/j.1467-9280.2005.01645.x; van Kessel ME, 2013, J NEUROPSYCHOL, V7, P72, DOI 10.1111/j.1748-6653.2012.02036.x; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Vuilleumier P, 2008, CURR BIOL, V18, P1525, DOI 10.1016/j.cub.2008.08.072; WEBSTER RG, 1964, J EXP PSYCHOL, V68, P269, DOI 10.1037/h0043256; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; WILLIAMS LJ, 1985, HUM FACTORS, V27, P221, DOI 10.1177/001872088502700209	66	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136719	10.1371/journal.pone.0136719	http://dx.doi.org/10.1371/journal.pone.0136719			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335779	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000360615400022
J	Lobo, CLD; do Nascimento, EM; Abelha, R; Queiroz, AMM; Connes, P; Cardoso, GP; Ballas, SK				de Castro Lobo, Clarisse Lopes; do Nascimento, Emilia Matos; Abelha, Renato; Mach Queiroz, Ana Maria; Connes, Philippe; Cardoso, Gilberto Perez; Ballas, Samir K.			Risk Factors of Pulmonary Hypertension in Brazilian Patients with Sickle Cell Anemia	PLOS ONE			English	Article							ERYTHROPOIETIC ACTIVITY; DISEASE; HEART; HYDROXYUREA; HEMOGLOBIN; SURVIVAL	This study was a prospective cross-sectional cohort study of 125 patients with sickle cell anemia (SS) between the ages of 16 to 60 years. Enrolled patients were followed-up prospectively for 15 months. Demographic, clinical, hematological and routine biochemical data were obtained on all patients. Six-minute walk test and Doppler Echocardiography were performed on all patients. A tricuspid regurgitant jet velocity (TRJV) <2.5 m/sec was considered normal, 2.5 <= TRJV <= 3.0 was considered mild-moderate and >3.0 m/sec, severe. Patients with abnormal TRJV were significantly older and more anemic, had significantly higher lactate dehydrogenase (LDH) levels, reticulocyte count and incidence of death. The logistic multimodal model implemented for the 125 patients indicated that age was the covariate that influenced the outcome of normal or abnormal TRJV with a cutoff age of thirty-two years. The survival rate for the group of patients with creatinine (Cr) > 1.0 mg/dL was lower than the group with Cr <= 1 and normal TRJV. A coefficient matrix showed that the LDH values were weakly correlated with the reticulocyte count but strongly correlated with hemoglobin suggesting that the TRJV values were not correlated with the hemolytic rate but with anemia. Ten patients died during the follow-up of whom 7 had TRJV > 2.5 m/sec. Acute chest syndrome was the most common cause of death followed by sepsis. In conclusion, this study shows that patients with SS older than thirty-two years with high LDH, elevated TRJV, severe anemia and Cr > 1 have poor prognosis and may be at risk of having pulmonary hypertension and should undergo RHC.	[de Castro Lobo, Clarisse Lopes; do Nascimento, Emilia Matos; Abelha, Renato; Mach Queiroz, Ana Maria; Ballas, Samir K.] Inst Hematol Arthur de Siqueira Cavalcanti HEMORI, Clin Hematol Div, Rio De Janeiro, RJ, Brazil; [do Nascimento, Emilia Matos] UEZO Ctr Univ Estadual Zona Oeste, Rio De Janeiro, RJ, Brazil; [Connes, Philippe] Univ Lyon 1, Lab CRIS, EA 647, Sect Vasc Biol & Red Blood Cell, F-69622 Villeurbanne, France; [Cardoso, Gilberto Perez] Univ Fed Fluminense, Niteroi, RJ, Brazil; [Ballas, Samir K.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Cardeza Fdn, Philadelphia, PA 19107 USA	Centro Universitario Estadual da Zona Oeste; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidade Federal Fluminense; Jefferson University	Ballas, SK (corresponding author), Inst Hematol Arthur de Siqueira Cavalcanti HEMORI, Clin Hematol Div, Rio De Janeiro, RJ, Brazil.	samir.ballas@jefferson.edu	Connes, Philippe/J-7835-2019	Connes, Philippe/0000-0002-9232-0268	Office of the Secretary of Health for the State of Rio de Janeiro; Brazilian Ministry of Health	Office of the Secretary of Health for the State of Rio de Janeiro; Brazilian Ministry of Health	Grant sponsor: Office of the Secretary of Health for the State of Rio de Janeiro and the Brazilian Ministry of Health.	Appleton CP, 1997, J AM SOC ECHOCARDIOG, V10, P271, DOI 10.1016/S0894-7317(97)70063-4; Ataga KI, 2010, EUR J HAEMATOL, V85, P257, DOI 10.1111/j.1600-0609.2010.01471.x; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Ballas SK, 2013, BLOOD, V121, P243, DOI 10.1182/blood-2012-10-462135; Ballas SK, 2000, HEMOGLOBIN, V24, P277, DOI 10.3109/03630260008993134; Ballas SK, 1999, BRIT J HAEMATOL, V105, P491, DOI 10.1111/j.1365-2141.1999.01339.x; Ballas SK, 2006, TRANSFUSION, V46, P105, DOI 10.1111/j.1537-2995.2006.00679.x; Barnett CF, 2008, JAMA-J AM MED ASSOC, V299, P324, DOI 10.1001/jama.299.3.324; Brugnara C, 1997, AM J CLIN PATHOL, V108, P133; CANCADO R. D., 2007, REV BRAS HEMATOL HEM, V29, P203, DOI DOI 10.1590/S1516-84842007000300002; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Charache S, 1996, MEDICINE, V75, P300, DOI 10.1097/00005792-199611000-00002; Connes P, 2011, CLIN HEMORHEOL MICRO, V49, P151, DOI 10.3233/CH-2011-1465; COX DR, 1972, J R STAT SOC B, V34, P187; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Fonseca GHH, 2012, EUR RESPIR J, V39, P112, DOI 10.1183/09031936.00134410; Ghofrani HA, 2009, J AM COLL CARDIOL, V54, pS108, DOI 10.1016/j.jacc.2009.04.014; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; GUYATT GH, 1985, J CHRON DIS, V38, P517, DOI 10.1016/0021-9681(85)90035-9; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Karazincir S, 2008, DIAGN INTERV RADIOL, V14, P72; Kiba T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-462; Machado RF, 2011, BLOOD, V118, P855, DOI 10.1182/blood-2010-09-306167; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Patel RP, 2004, FREE RADICAL BIO MED, V36, P399, DOI 10.1016/j.freeradbiomed.2003.11.019; R Core Team, 2021, R LANGUAGE ENV STAT; Sachdev V, 2011, CIRCULATION, V124, P1452, DOI 10.1161/CIRCULATIONAHA.111.032920; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P354; Seong C, 1998, BRIT J HAEMATOL, V101, P189, DOI 10.1046/j.1365-2141.1998.00657.x; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Tassi EM, 2014, ARQ BRAS CARDIOL, V102, P456, DOI 10.5935/abc.20140052; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	35	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137539	10.1371/journal.pone.0137539	http://dx.doi.org/10.1371/journal.pone.0137539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335226	Green Submitted, gold, Green Published			2022-12-27	WOS:000360615400065
J	Hirsch, HJ; Gross, I; Pollak, Y; Eldar-Geva, T; Gross-Tsur, V				Hirsch, Harry J.; Gross, Itai; Pollak, Yehuda; Eldar-Geva, Talia; Gross-Tsur, Varda			Irisin and the Metabolic Phenotype of Adults with Prader-Willi Syndrome	PLOS ONE			English	Article							GROWTH-HORMONE TREATMENT; BROWN ADIPOSE-TISSUE; CIRCULATING IRISIN; INSULIN SENSITIVITY; FAT DISTRIBUTION; OBESE SUBJECTS; EXERCISE; HUMANS; CHILDREN; GLUCOSE	Context Hyperphagia, low resting energy expenditure, and abnormal body composition contribute to severe obesity in Prader Willi syndrome (PWS). Irisin, a circulating myokine, stimulates "browning" of white adipose tissue resulting in increased energy expenditure and improved insulin sensitivity. Irisin has not been previously studied in PWS. Objectives Compare plasma and salivary irisin in PWS adults and normal controls. Examine the relationship of irisin to insulin sensitivity and plasma lipids. Design and Study Participants A fasting blood sample for glucose, lipids, insulin, leptin, adinopectin, and irisin was obtained from 22 PWS adults and 54 healthy BMI-matched volunteers. Saliva was collected for irisin assay in PWS and controls. Results Fasting glucose (77 +/- 9 vs 83 +/- 7mg/dl, p = 0.004), insulin (4.1 +/- 2.0 vs 7.9 +/- 4.7 mu U/ml, p<0.001), and triglycerides (74 +/- 34 vs 109 +/- 71mg/dl, p = 0.007) were lower in PWS than in controls. Insulin resistance (HOMA-IR) was lower (0.79 +/- 0.041 vs 1.63 +/- 1.02, p<0.001) and insulin sensitivity (QUICKI) was higher (0.41 +/- 0.04 vs 0.36 +/- 0.03, p<0.001) in PWS. Plasma irisin was similar in both groups, but salivary irisin (64.5 +/- 52.0 vs 33.0 +/- 12.1ng/ml), plasma leptin (33.5 +/- 24.2 vs 19.7 +/- 19.3ng/ml) and plasma adinopectin (13.0 +/- 10.8 vs 7.6 +/- 4.5 mu g/ml) were significantly greater in PWS (p<0.001). In PWS, plasma irisin showed positive Pearson correlations with total cholesterol (r = 0.58, p = 0.005), LDL-cholesterol (r = 0.59, p = 0.004), and leptin (r = 0.43, p = 0.045). Salivary irisin correlated negatively with HDL-cholesterol (r = -0.50, p = 0.043) and positively with LDL-cholesterol (r = 0.51, p = 0.037) and triglycerides (r = 0.50, p = 0.041). Conclusions Salivary irisin was markedly elevated in PWS although plasma irisin was similar to levels in controls. Significant associations with plasma lipids suggest that irisin may contribute to the metabolic phenotype of PWS.	[Hirsch, Harry J.; Pollak, Yehuda; Gross-Tsur, Varda] Shaare Zedek Med Ctr, Israel Multidisciplinary Prader Willi Syndrome Cl, Neuropediat Unit, Dept Pediat, Jerusalem, Israel; [Gross, Itai] Hadassah Hebrew Univ Hosp, Dept Pediat, Jerusalem, Israel; [Pollak, Yehuda] Hebrew Univ Jerusalem, Sch Educ, Jerusalem, Israel; [Eldar-Geva, Talia; Gross-Tsur, Varda] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel; [Eldar-Geva, Talia] Shaare Zedek Med Ctr, Dept Obstet & Gynecol, Reprod Endocrinol & Genet Unit, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Hirsch, HJ (corresponding author), Shaare Zedek Med Ctr, Israel Multidisciplinary Prader Willi Syndrome Cl, Neuropediat Unit, Dept Pediat, Jerusalem, Israel.	hirschmd@gmail.com		Pollak, Yehuda/0000-0002-1293-499X	Mirsky Foundation, Shaare Zedek Medical Center, Jerusalem, Israel	Mirsky Foundation, Shaare Zedek Medical Center, Jerusalem, Israel	This study was funded by the Mirsky Foundation, Shaare Zedek Medical Center, Jerusalem, Israel.	Al-Daghri NM, 2014, EUR J CLIN INVEST, V44, P119, DOI 10.1111/eci.12196; Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Anastasilakis AD, 2014, J CLIN ENDOCR METAB, V99, P3247, DOI 10.1210/jc.2014-1367; Aydin S, 2014, PEPTIDES, V61, P130, DOI 10.1016/j.peptides.2014.09.014; Aydin S, 2013, PEPTIDES, V50, P13, DOI 10.1016/j.peptides.2013.09.011; Aydin S, 2014, PEPTIDES, V56, P141, DOI 10.1016/j.peptides.2014.04.002; Bluher S, 2014, OBESITY, V22, P1701, DOI 10.1002/oby.20739; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Butler MG, 2007, AM J MED GENET A, V143A, P449, DOI 10.1002/ajmg.a.31507; Cassidy SB, 2009, EURO J HUM GENET, V17, P219; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Choi HY, 2014, J CLIN ENDOCR METAB, V99, P2778, DOI 10.1210/jc.2014-1195; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de la Iglesia R, 2014, CLIN ENDOCRINOL, V81, P306, DOI 10.1111/cen.12383; Goldstone AP, 2001, J CLIN ENDOCR METAB, V86, P4330, DOI 10.1210/jc.86.9.4330; Haqq AM, 2011, J CLIN ENDOCR METAB, V96, pE225, DOI 10.1210/jc.2010-1733; Hart PS, 1998, ANN NY ACAD SCI, V842, P125, DOI 10.1111/j.1749-6632.1998.tb09640.x; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lindgren AC, 1999, HORM RES, V51, P157, DOI 10.1159/000023350; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Miller JL, 2011, AM J MED GENET A, V155A, P1040, DOI 10.1002/ajmg.a.33951; Panagiotou G, 2014, METABOLISM, V63, P1265, DOI 10.1016/j.metabol.2014.06.001; Pardo M, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/857270; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Saeves R, 2012, ARCH ORAL BIOL, V57, P1335, DOI 10.1016/j.archoralbio.2012.05.003; Sanchis-Gomar F, 2014, ENDOCRINE, V46, P674, DOI 10.1007/s12020-014-0170-9; Schuster DP, 1996, METABOLISM, V45, P1514, DOI 10.1016/S0026-0495(96)90181-X; Song YQ, 2007, DIABETES CARE, V30, P1747, DOI 10.2337/dc07-0358; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Talebizadeh Z, 2005, CLIN GENET, V67, P230, DOI 10.1111/j.1399-0004.2004.00392.x; Tanaka Y, 2013, AM J MED GENET A, V161A, P27, DOI 10.1002/ajmg.a.35653; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang C, 2015, ENDOCRINE, V49, P90, DOI 10.1007/s12020-014-0458-9; Yan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094235; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	36	20	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136864	10.1371/journal.pone.0136864	http://dx.doi.org/10.1371/journal.pone.0136864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334732	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400029
J	Iqbal, A; Labib, M; Muharemagic, D; Sattar, S; Dixon, BR; Berezovski, MV				Iqbal, Asma; Labib, Mahmoud; Muharemagic, Darija; Sattar, Syed; Dixon, Brent R.; Berezovski, Maxim V.			Detection of Cryptosporidium parvum Oocysts on Fresh Produce Using DNA Aptamers	PLOS ONE			English	Article							EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; CELL-SELEX; GIARDIA; LIGANDS; POLYMERASE; PATHOGENS	There are currently no standard methods for the detection of Cryptosporidium spp., or other protozoan parasites, in foods, and existing methods are often inadequate, with low and variable recovery efficiencies. Food testing is difficult due to the low concentrations of parasites, the difficulty in eluting parasites from some foods, the lack of enrichment methods, and the presence of PCR inhibitors. The main objectives of the present study were to obtain DNA aptamers binding to the oocyst wall of C. parvum, and to use the aptamers to detect the presence of this parasite in foods. DNA aptamers were selected against C. parvum oocysts using SELEX (Systematic Evolution of Ligands by EXponential enrichment). Ten rounds of selection led to the discovery of 14 aptamer clones with high affinities for C. parvum oocysts. For detecting parasite-bound aptamers, a simple electrochemical sensor was employed, which used a gold nanoparticle-modified screen-printed carbon electrode. This aptasensor was fabricated by self-assembling a hybrid of a thiolated ssDNA primer and the anti-C. parvum aptamer. Square wave voltammetry was employed to quantitate C. parvum in the range of 150 to 800 oocysts, with a detection limit of approximately 100 oocysts. The high sensitivity and specificity of the developed aptasensor suggests that this novel method is very promising for the detection and identification of C. parvum oocysts on spiked fresh fruits, as compared to conventional methods such as microscopy and PCR.	[Iqbal, Asma; Dixon, Brent R.] Hlth Canada, Bur Microbial Hazards, Food Directorate, Ottawa, ON K1A 0L2, Canada; [Labib, Mahmoud; Muharemagic, Darija; Berezovski, Maxim V.] Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON, Canada; [Sattar, Syed] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	Health Canada; University of Ottawa; University of Ottawa	Dixon, BR (corresponding author), Hlth Canada, Bur Microbial Hazards, Food Directorate, Ottawa, ON K1A 0L2, Canada.	Brent.Dixon@hc-sc.gc.ca; Maxim.Berezovski@uottawa.ca	Berezovski, Maxim V./N-1247-2019; Berezovski, Maxim V./F-8961-2012; Labib, Mahmoud/P-2267-2014; Labib, Mahmoud/ABB-1104-2021	Berezovski, Maxim V./0000-0003-0514-599X; Berezovski, Maxim V./0000-0003-0514-599X; Labib, Mahmoud/0000-0003-4565-2056; Labib, Mahmoud/0000-0003-4565-2056	Mitacs Elevate Fellowship Program; Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories Program; Natural Sciences and Engineering Research Council of Canada	Mitacs Elevate Fellowship Program; Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the following sources of funding: Mitacs Elevate Fellowship Program for ML; Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories Program for AI; and Natural Sciences and Engineering Research Council of Canada for MVB.	Berezovski MV, 2008, J AM CHEM SOC, V130, P9137, DOI 10.1021/ja801951p; Budu-Amoako E, 2011, J FOOD PROTECT, V74, P1944, DOI 10.4315/0362-028X.JFP-11-107; Chalmers RM, 2013, TRENDS PARASITOL, V29, P237, DOI 10.1016/j.pt.2013.03.001; Chalmers RM, 2012, ANN I SUPER SANITA, V48, P429, DOI 10.4415/ANN_12_04_10; Coklin T, 2011, J VET DIAGN INVEST, V23, P260, DOI 10.1177/104063871102300210; Daniels DA, 2003, P NATL ACAD SCI USA, V100, P15416, DOI 10.1073/pnas.2136683100; Dixon BR, 2011, RAPID DETECTION, CHARACTERIZATION, AND ENUMERATION OF FOODBORNE PATHOGENS, P349; Dixon B.R., 2015, FOODBORNE PARASITES, P317, DOI [10.1016/B978-1-78242-332-4.00013-8, DOI 10.1016/B978-1-78242-332-4.00013-8]; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Labib M, 2014, ADV BIOCHEM ENG BIOT, V140, P155, DOI 10.1007/10_2013_229; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Xiao Y, 2007, NAT PROTOC, V2, P2875, DOI 10.1038/nprot.2007.413	16	35	35	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137455	10.1371/journal.pone.0137455	http://dx.doi.org/10.1371/journal.pone.0137455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334529	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400059
J	King, R; Bird, N; Ramirez-Gonzalez, R; Coghill, JA; Patil, A; Hassani-Pak, K; Uauy, C; Phillips, AL				King, Robert; Bird, Nicholas; Ramirez-Gonzalez, Ricardo; Coghill, Jane A.; Patil, Archana; Hassani-Pak, Keywan; Uauy, Cristobal; Phillips, Andrew L.			Mutation Scanning in Wheat by Exon Capture and Next-Generation Sequencing	PLOS ONE			English	Article							GENOME; DISCOVERY; LENGTH; TOOL	Targeted Induced Local Lesions in Genomes (TILLING) is a reverse genetics approach to identify novel sequence variation in genomes, with the aims of investigating gene function and/or developing useful alleles for breeding. Despite recent advances in wheat genomics, most current TILLING methods are low to medium in throughput, being based on PCR amplification of the target genes. We performed a pilot-scale evaluation of TILLING in wheat by next-generation sequencing through exon capture. An oligonucleotide-based enrichment array covering similar to 2Mbp of wheat coding sequence was used to carry out exon capture and sequencing on three mutagenised lines of wheat containing previously-identified mutations in the TaGA20ox1 homoeologous genes. After testing different mapping algorithms and settings, candidate SNPs were identified by mapping to the IWGSC wheat Chromosome Survey Sequences. Where sequence data for all three homoeologues were found in the reference, mutant calls were unambiguous; however, where the reference lacked one or two of the homoeologues, captured reads from these genes were mis-mapped to other homoeologues, resulting either in dilution of the variant allele frequency or assignment of mutations to the wrong homoeologue. Competitive PCR assays were used to validate the putative SNPs and estimate cut-off levels for SNP filtering. At least 464 high-confidence SNPs were detected across the three mutagenized lines, including the three known alleles in TaGA20ox1, indicating a mutation rate of similar to 35 SNPs per Mb, similar to that estimated by PCR-based TILLING. This demonstrates the feasibility of using exon capture for genome re-sequencing as a method of mutation detection in polyploid wheat, but accurate mutation calling will require an improved genomic reference with more comprehensive coverage of homoeologues.	[King, Robert; Hassani-Pak, Keywan] Rothamsted Res, Computat & Syst Biol Dept, Harpenden AL5 2JQ, Herts, England; [Bird, Nicholas; Ramirez-Gonzalez, Ricardo; Uauy, Cristobal] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Ramirez-Gonzalez, Ricardo] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Coghill, Jane A.] Univ Bristol, Sch Biol Sci, Transcript Facil, Bristol BS8 1UG, Avon, England; [Patil, Archana; Phillips, Andrew L.] Rothamsted Res, Plant Biol & Crop Sci Dept, Harpenden AL5 2JQ, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; The Genome Analysis Centre (TGAC); University of Bristol; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Phillips, AL (corresponding author), Rothamsted Res, Plant Biol & Crop Sci Dept, Harpenden AL5 2JQ, Herts, England.	andy.phillips@rothamsted.ac.uk	Hassani-Pak, Keywan/AAY-5854-2020; king, rob/AAT-3739-2020; Ramírez, Ricardo/H-4808-2019; Uauy, Cristobal/T-4382-2019	Ramírez, Ricardo/0000-0001-5745-7085; Uauy, Cristobal/0000-0002-9814-1770; Hassani-Pak, Keywan/0000-0001-9625-0511	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I000712/1, BB/J003557/1, BB/J004588/1, BBS/E/C/00005202]; Norwich Research Park PhD Studentship; Genome Analysis Centre Funding and Maintenance Grant; Biotechnology and Biological Sciences Research Council [BB/I000712/1, BBS/E/C/00005202, BB/J003557/1, BB/J003743/1, BB/J003913/1, BB/I000607/1, BBS/E/J/000C0628] Funding Source: researchfish; BBSRC [BB/J003557/1, BB/J003913/1, BB/I000607/1, BBS/E/C/00005202, BBS/E/J/000C0628, BB/I000712/1, BB/J003743/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Norwich Research Park PhD Studentship; Genome Analysis Centre Funding and Maintenance Grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants BB/I000712/1, BB/J003557/1, BB/J004588/1 (GRO Institute Strategic Programme Grant to JIC) and BBS/E/C/00005202 (2020 Wheat Institute Strategic Programme Grant to Rothamsted Research) from the UK Biotechnology and Biological Sciences Research Council (BBSRC). RRG is supported by a Norwich Research Park PhD Studentship and by The Genome Analysis Centre Funding and Maintenance Grant.	Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Avila-Arcos MC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00074; Botticella E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-156; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Chen A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003134; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; De Koeyer D, 2010, MOL BREEDING, V25, P67, DOI 10.1007/s11032-009-9309-4; DVORAK J, 1988, GENOME, V30, P680, DOI 10.1139/g88-115; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hazard B, 2012, CROP SCI, V52, P1754, DOI 10.2135/cropsci2012.02.0126; Henry IM, 2014, PLANT CELL, V26, P1382, DOI 10.1105/tpc.113.121590; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; King R, 2015, VARSCAN ALLELE FILTE; King R, 2015, REFERENCE FASTA REDU; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Krasileva KV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r66; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lochlainn SO, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-43; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; Mokry M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq072; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Pearce S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0520-7; Rakszegi M, 2010, EUPHYTICA, V174, P409, DOI 10.1007/s10681-010-0149-4; Ramirez-Gonzalez RH, 2015, POLYMARKER; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Sestili F, 2010, MOL BREEDING, V25, P145, DOI 10.1007/s11032-009-9314-7; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slade AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-69; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Tsai H, 2011, PLANT PHYSIOL, V156, P1257, DOI 10.1104/pp.110.169748; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wilkinson PA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-219; Winfield MO, 2012, PLANT BIOTECHNOL J, V10, P733, DOI 10.1111/j.1467-7652.2012.00713.x	46	44	45	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137549	10.1371/journal.pone.0137549	http://dx.doi.org/10.1371/journal.pone.0137549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335335	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400066
J	Bakoyannis, G; Yiannoutsos, CT				Bakoyannis, Giorgos; Yiannoutsos, Constantin T.			Impact of and Correction for Outcome Misclassification in Cumulative Incidence Estimation	PLOS ONE			English	Article							SAMPLING-BASED APPROACH; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; COMPETING RISKS; FOLLOW-UP; PATIENTS LOST; SCALE-UP; DEATH; SURVIVAL; AFRICA	Cohort studies and clinical trials may involve multiple events. When occurrence of one of these events prevents the observance of another, the situation is called "competing risks". A useful measure in such studies is the cumulative incidence of an event, which is useful in evaluating interventions or assessing disease prognosis. When outcomes in such studies are subject to misclassification, the resulting cumulative incidence estimates may be biased. In this work, we study the mechanism of bias in cumulative incidence estimation due to outcome misclassification. We show that even moderate levels of misclassification can lead to seriously biased estimates in a frequently unpredictable manner. We propose an easy to use estimator for correcting this bias that is uniformly consistent. Extensive simulations suggest that this method leads to unbiased estimates in practical settings. The proposed method is useful, both in settings where misclassification probabilities are known by historical data or can be estimated by other means, and for performing sensitivity analyses when the misclassification probabilities are not precisely known.	[Bakoyannis, Giorgos; Yiannoutsos, Constantin T.] Indiana Univ, Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Yiannoutsos, CT (corresponding author), Indiana Univ, Fairbanks Sch Publ Hlth, Dept Biostat, 410 West 10th St,Suite 3000, Indianapolis, IN 46202 USA.	cyiannou@iupui.edu	Bakoyannis, Giorgos/AAW-8304-2020	Bakoyannis, Giorgos/0000-0002-2789-2497	National Institutes of Health [U01-AI069911, R01-AI102710]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102710, U01AI069911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant U01-AI069911 "East Africa IeDEA Regional Consortium" to CTY, and National Institutes of Health grant R01-AI102710 "Statistical Designs and Methods for Double-Sampling for HIV/AIDS". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1978, SCAND J STAT, V5, P141; Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Bakoyannis G, 2012, STAT METHODS MED RES, V21, P257, DOI 10.1177/0962280210394479; BARRON BA, 1977, BIOMETRICS, V33, P414, DOI 10.2307/2529795; DiCiccio TJ, 1996, STAT SCI, V11, P189; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FLANDERS WD, 1992, EPIDEMIOLOGY, V3, P3, DOI 10.1097/00001648-199201000-00002; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021797; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Gerver SM, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-29; GREENLAND S, 1980, AM J EPIDEMIOL, V112, P564, DOI 10.1093/oxfordjournals.aje.a113025; Ha J, 2012, LIFETIME DATA ANAL, V18, P58, DOI 10.1007/s10985-011-9210-4; Henriques J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031706; Hinchliffe SR, 2013, CANCER EPIDEMIOL, V37, P11, DOI 10.1016/j.canep.2012.08.012; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kiragga AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083524; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; QUADE D, 1980, AM J EPIDEMIOL, V111, P503, DOI 10.1093/oxfordjournals.aje.a112930; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Touloumi G, 2006, JAIDS-J ACQ IMM DEF, V42, P554, DOI 10.1097/01.qai.0000230321.85911.db; Van Rompaye B, 2012, EPIDEMIOLOGY, V23, P194, DOI 10.1097/EDE.0b013e3182454cad; Van Rompaye B, 2010, BIOSTATISTICS, V11, P546, DOI 10.1093/biostatistics/kxq011; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	28	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137454	10.1371/journal.pone.0137454	http://dx.doi.org/10.1371/journal.pone.0137454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331616	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800132
J	Carls, MG; Larsen, ML; Holland, LG				Carls, Mark G.; Larsen, Marie L.; Holland, Larry G.			Spilled Oils: Static Mixtures or Dynamic Weathering and Bioavailability?	PLOS ONE			English	Article							PRINCE-WILLIAM-SOUND; EXXON-VALDEZ OIL; POLYCYCLIC AROMATIC-HYDROCARBONS; SITE-SPECIFIC CONTAMINANTS; CRUDE-OIL; MEMBRANE DEVICES; RAINBOW-TROUT; FISH EMBRYOS; MUSSEL BEDS; PART II	Polynuclear aromatic hydrocarbons (PAHs) from sequestered MV Selendang Ayu oil were biologically available in 2008, 3.6 y after it was spilled along Unalaska Island, Alaska. Thermodynamically driven weathering was the most probable mechanism of organism exposure to PAHs. Alkane and PAH composition in oil changed over time as smaller constituents were preferentially lost, indicative of weathering. In contrast, composition of the largest compounds (biomarkers) including triterpanes, hopanes, and steranes remained unchanged. Smaller molecules (the PAHs) lost from stranded oil were observed in indigenous mussels and passive samplers deployed in July 2008. Concentration and composition of PAHs were significantly different than in a non-oiled reference area and patterns observed in mussels were repeated in passive samplers deployed in three zones (intertidal, subtidal, and water). Thus, hydrocarbons lost from one compartment (sequestered whole oil) were detectable in another (mussels and passive samplers) implying aqueous transfer. Quantities of mobile oil constituents were small, yielding uptake concentrations that are likely inconsequential for mussels, but the sensitivity provided by bioaccumulation and passive sampler uptake ensured that dissolved hydrocarbons were detectable.	[Carls, Mark G.; Larsen, Marie L.; Holland, Larry G.] NOAA, Auke Bay Labs, NMFS, Juneau, AK 99802 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Carls, MG (corresponding author), NOAA, Auke Bay Labs, NMFS, Juneau, AK 99802 USA.	mark.carls@noaa.gov						[Anonymous], 2010, OIL BUDGET CALCULATO; [Anonymous], 2005, ALEUTIANS W COASTAL; Bence AE, 1995, ASTM STP, V1219; BLUMER M, 1973, DEEP-SEA RES, V20, P239, DOI 10.1016/0011-7471(73)90014-4; Boehm PD, 2005, MAR POLLUT BULL, V50, P740, DOI 10.1016/j.marpolbul.2005.02.002; Boehm PD, 2004, ENVIRON TOXICOL CHEM, V23, P2916, DOI 10.1897/03-514.1; Carls MG, 2006, ENVIRON SCI TECHNOL, V40, P4233, DOI 10.1021/es052498g; Carls MG, 2004, T AM FISH SOC, V133, P834, DOI 10.1577/T03-125.1; Carls MG, 2004, ENVIRON TOXICOL CHEM, V23, P1416, DOI 10.1897/03-395; Carls MG, 2004, MAR ENVIRON RES, V57, P359, DOI 10.1016/j.marenvres.2003.11.002; Carls MG, 2001, MAR ENVIRON RES, V51, P167, DOI 10.1016/S0141-1136(00)00103-3; Carls MG, 2007, SELENDANG AYU OIL RI; Carls MG, 2010, HUM ECOL RISK ASSESS, V15, P1084; Dubansky B, 2013, ENVIRON SCI TECHNOL, V47, P5074, DOI 10.1021/es400458p; Dubansky B, 2012, INTEGR COMP BIOL, V52, pE49; Faksness L-G, 2002, STF66A02028 SINTEF A; Farwell AJ, 2006, ENVIRON TOXICOL CHEM, V25, P3266, DOI 10.1897/05-637R1.1; Flint PL, 2009, CHRONIC EXPOSURE SEA; GILFILLAN ES, 1978, J FISH RES BOARD CAN, V35, P630, DOI 10.1139/f78-110; Gundlach ER, 1981, P 1981 OIL SPILL C; Harji RR, 2008, ENVIRON INT, V34, P959, DOI 10.1016/j.envint.2008.02.006; Heintz RA, 1999, ENVIRON TOXICOL CHEM, V18, P494, DOI 10.1002/etc.5620180318; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Larsen ML, 2010, STANDARD OPERATING P; Larsen ML, 2008, STANDARD OPERATING P; Livingstone D.R., 1991, Advances in Comparative and Environmental Physiology, V7, P45; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Marty GD, 1997, CAN J ZOOL, V75, P989, DOI 10.1139/z97-120; Mauseth GS, 2008, 2008 INT OIL SPILL C; Mitra S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049505; Neff JM, 2006, ENVIRON TOXICOL CHEM, V25, P947, DOI 10.1897/05-339R.1; Page DS, 2006, MAR POLLUT BULL, V52, P367, DOI 10.1016/j.marpolbul.2005.08.027; Page DS, 2005, MAR ENVIRON RES, V60, P422, DOI 10.1016/j.marenvres.2005.01.002; Reddy CM, 2002, ENVIRON SCI TECHNOL, V36, P4754, DOI 10.1021/es020656n; Rhodes S, 2005, ECOTOX ENVIRON SAFE, V60, P247, DOI 10.1016/j.ecoenv.2004.08.002; Short JW, 2007, ENVIRON SCI TECHNOL, V41, P1245, DOI 10.1021/es0620033; Short JW, 2008, MAR ENVIRON RES, V66, P487, DOI 10.1016/j.marenvres.2008.08.007; Short JW, 2006, ENVIRON SCI TECHNOL, V40, P3723, DOI 10.1021/es0601134; Short JW, 1997, ENVIRON SCI TECHNOL, V31, P2375, DOI 10.1021/es960985d; Short JW, 2004, ENVIRON SCI TECHNOL, V38, P19, DOI 10.1021/es0348694; Short JW, 1996, AM FISH S S, V18, P140; Springman KR, 2008, MAR ENVIRON RES, V66, P477, DOI 10.1016/j.marenvres.2008.07.001; STEGEMAN JJ, 1978, J FISH RES BOARD CAN, V35, P668, DOI 10.1139/f78-117; Sundberg H, 2006, CAN J FISH AQUAT SCI, V63, P1320, DOI 10.1139/F06-034; TEAL JM, 1992, MAR POLLUT BULL, V24, P607, DOI 10.1016/0025-326X(92)90281-A; TEAL JM, 1984, ENVIRON MANAGE, V8, P27, DOI 10.1007/BF01867871; VANDERMEULEN JH, 1994, CAN J FISH AQUAT SCI, V51, P845, DOI 10.1139/f94-083; VENKATESAN MI, 1988, MAR CHEM, V25, P1, DOI 10.1016/0304-4203(88)90011-4; Wang Z, 2007, OIL SPILL ENVIRONMENTAL FORENSICS: FINGERPRINTING AND SOURCE IDENTIFICATION, P1; Whitehead A, 2013, INTEGR COMP BIOL, V53, P635, DOI 10.1093/icb/ict080; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Zhao MX, 2003, ORG GEOCHEM, V34, P131, DOI 10.1016/S0146-6380(02)00142-0	55	5	5	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134448	10.1371/journal.pone.0134448	http://dx.doi.org/10.1371/journal.pone.0134448			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332909	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800008
J	Carvalho, DS; Andrade, RFS; Pinho, STR; Goes-Neto, A; Lobao, TCP; Bomfim, GC; El-Hani, CN				Carvalho, Daniel S.; Andrade, Roberto F. S.; Pinho, Suani T. R.; Goes-Neto, Aristoteles; Lobao, Thierry C. P.; Bomfim, Gilberto C.; El-Hani, Charbel N.			What are the Evolutionary Origins of Mitochondria? A Complex Network Approach	PLOS ONE			English	Article							ALPHA-PROTEOBACTERIA; COMMUNITY STRUCTURE; COMMON ANCESTOR; ATP SYNTHASE; ORGANELLE; PHYLOGENY	Mitochondria originated endosymbiotically from an Alphaproteobacteria-like ancestor. However, it is still uncertain which extant group of Alphaproteobacteria is phylogenetically closer to the mitochondrial ancestor. The proposed groups comprise the order Rickettsiales, the family Rhodospirillaceae, and the genus Rickettsia. In this study, we apply a new complex network approach to investigate the evolutionary origins of mitochondria, analyzing protein sequences modules in a critical network obtained through a critical similarity threshold between the studied sequences. The dataset included three ATP synthase subunits (4, 6, and 9) and its alphaproteobacterial homologs (b, a, and c). In all the subunits, the results gave no support to the hypothesis that Rickettsiales are closely related to the mitochondrial ancestor. Our findings support the hypothesis that mitochondria share a common ancestor with a clade containing all Alphaproteobacteria orders, except Rickettsiales.	[Carvalho, Daniel S.; Bomfim, Gilberto C.; El-Hani, Charbel N.] Univ Fed Bahia, Dept Gen Biol, Inst Biol, Salvador, BA, Brazil; [Andrade, Roberto F. S.; Pinho, Suani T. R.] Univ Fed Bahia, Gen Phys Dept, Inst Phys, Salvador, BA, Brazil; [Goes-Neto, Aristoteles] State Univ Feira de Santana, Dept Biol Sci, Feira De Santana, BA, Brazil; [Lobao, Thierry C. P.] Univ Fed Bahia, Dept Math, Inst Math, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Estadual de Feira de Santana; Universidade Federal da Bahia	El-Hani, CN (corresponding author), Univ Fed Bahia, Dept Gen Biol, Inst Biol, Salvador, BA, Brazil.	charbel.elhani@gmail.com	El-Hani, Charbel/Q-1364-2019; Andrade, Roberto Fernandes Silva/R-9088-2019; Goes-Neto, Aristoteles/A-6955-2013	Andrade, Roberto Fernandes Silva/0000-0002-9323-1400; Goes-Neto, Aristoteles/0000-0002-7692-6243; Carvalho, Daniel/0000-0001-6590-4287	CNPq [111828/2011-2, 101238/2012-6, 57386/2008-9, 308148/2013-4, 301259/2010-0]; FAPESB [534/2013, PNX 0006/2009]; RFSA; CNPq (INCT-SC); FAPESB/CNPQ [PNX 0016/2009]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); RFSA; CNPq (INCT-SC)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESB/CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DSC has received during the work scientific training grants from CNPq (contract ns. 111828/2011-2 and 101238/2012-6) and master grant from FAPESB (contract n. 534/2013). RFSA, STRP and TCPL are partially supported by FAPESB (contract n. PNX 0006/2009). STRP is also supported by CNPq (INCT-CITECS, contract n. 57386/2008-9), and RFSA, by CNPq (INCT-SC). AGN is supported by CNPq (contract n. 308148/2013-4). CNEH is partially supported by FAPESB/CNPQ (contract n. PNX 0016/2009) and CNPq (contract n. 301259/2010-0).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson SGE, 1999, CURR OPIN MICROBIOL, V2, P535, DOI 10.1016/S1369-5274(99)00013-2; Andrade RFS, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046101; Andrade RFS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001131; Andrade RFS, 2009, INT J BIFURCAT CHAOS, V19, P2677, DOI 10.1142/S0218127409024396; Atteia A, 2009, MOL BIOL EVOL, V26, P1533, DOI 10.1093/molbev/msp068; Bapteste E, 2013, TRENDS GENET, V29, P439, DOI 10.1016/j.tig.2013.05.007; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Chang X, 2010, GENOMICS, V95, P339, DOI 10.1016/j.ygeno.2010.03.006; Esposti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096566; Devenish RJ, 2000, BBA-BIOENERGETICS, V1458, P428, DOI 10.1016/S0005-2728(00)00092-X; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Ferla MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083383; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Goes-Neto A, 2010, BIOSYSTEMS, V101, P59, DOI 10.1016/j.biosystems.2010.04.006; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Gupta RS, 2005, CRIT REV MICROBIOL, V31, P101, DOI 10.1080/10408410590922393; Luo HW, 2013, MBIO, V4, DOI 10.1128/mBio.00373-13; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; McInerney JO, 2014, NAT REV MICROBIOL, V12, P449, DOI 10.1038/nrmicro3271; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nartsissov YR, 2006, J THEOR BIOL, V242, P300, DOI 10.1016/j.jtbi.2006.02.018; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Le PT, 2014, TRENDS MICROBIOL, V22, P147, DOI 10.1016/j.tim.2013.12.006; Rodriguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520; Sallstrom B, 2005, CURR OPIN MICROBIOL, V8, P579, DOI 10.1016/j.mib.2005.08.002; SCHWARTZ RM, 1978, SCIENCE, V199, P395, DOI 10.1126/science.202030; Thiergart T, 2012, GENOME BIOL EVOL, V4, P466, DOI 10.1093/gbe/evs018; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep07949; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zimorski V, 2014, CURR OPIN MICROBIOL, V22, P38, DOI 10.1016/j.mib.2014.09.008	35	14	14	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134988	10.1371/journal.pone.0134988	http://dx.doi.org/10.1371/journal.pone.0134988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332127	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800017
J	Chan, HHL; Siewerdsen, JH; Vescan, A; Daly, MJ; Prisman, E; Irish, JC				Chan, Harley H. L.; Siewerdsen, Jeffrey H.; Vescan, Allan; Daly, Michael J.; Prisman, Eitan; Irish, Jonathan C.			3D Rapid Prototyping for Otolaryngology-Head and Neck Surgery: Applications in Image-Guidance, Surgical Simulation and Patient-Specific Modeling	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; DEMONS DEFORMABLE REGISTRATION; SKULL BASE; MANDIBULAR RECONSTRUCTION; GUIDED SURGERY; C-ARM; ACCURACY; BONE; RELIABILITY; TRACKING	The aim of this study was to demonstrate the role of advanced fabrication technology across a broad spectrum of head and neck surgical procedures, including applications in endoscopic sinus surgery, skull base surgery, and maxillofacial reconstruction. The initial case studies demonstrated three applications of rapid prototyping technology are in head and neck surgery: i) a mono-material paranasal sinus phantom for endoscopy training ii) a multi-material skull base simulator and iii) 3D patient-specific mandible templates. Digital processing of these phantoms is based on real patient or cadaveric 3D images such as CT or MRI data. Three endoscopic sinus surgeons examined the realism of the endoscopist training phantom. One experienced endoscopic skull base surgeon conducted advanced sinus procedures on the high-fidelity multi-material skull base simulator. Ten patients participated in a prospective clinical study examining patient-specific modeling for mandibular reconstructive surgery. Qualitative feedback to assess the realism of the endoscopy training phantom and high-fidelity multi-material phantom was acquired. Conformance comparisons using assessments from the blinded reconstructive surgeons measured the geometric performance between intra-operative and pre-operative reconstruction mandible plates. Both the endoscopy training phantom and the high-fidelity multi-material phantom received positive feedback on the realistic structure of the phantom models. Results suggested further improvement on the soft tissue structure of the phantom models is necessary. In the patient-specific mandible template study, the pre-operative plates were judged by two blinded surgeons as providing optimal conformance in 7 out of 10 cases. No statistical differences were found in plate fabrication time and conformance, with pre-operative plating providing the advantage of reducing time spent in the operation room. The applicability of common model design and fabrication techniques across a variety of otolaryngological sub-specialties suggests an emerging role for rapid prototyping technology in surgical education, procedure simulation, and clinical practice.	[Chan, Harley H. L.; Daly, Michael J.; Irish, Jonathan C.] Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada; [Irish, Jonathan C.] Univ Hlth Network, Dept Surg Oncol, Toronto, ON, Canada; [Daly, Michael J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Vescan, Allan; Irish, Jonathan C.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Vescan, Allan] Mt Sinai Hosp, Dept Otolaryngol, Toronto, ON M5G 1X5, Canada; [Prisman, Eitan] Univ British Columbia, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Johns Hopkins University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of British Columbia	Irish, JC (corresponding author), Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada.	jonathan.irish@uhn.on.ca		Daly, Michael/0000-0002-2217-4146; Prisman, Eitan/0000-0001-7201-6181	TECHNA-Guided Therapeutics (GTx) Program at the University Health Network; Hatch Engineering Fellowship Fund; RACH Fund; Princess Margaret Cancer Foundation; National Institutes of Health [R01-CA127944-02]; NATIONAL CANCER INSTITUTE [R01CA127444] Funding Source: NIH RePORTER	TECHNA-Guided Therapeutics (GTx) Program at the University Health Network; Hatch Engineering Fellowship Fund; RACH Fund; Princess Margaret Cancer Foundation(University of Toronto); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the TECHNA-Guided Therapeutics (GTx) Program at the University Health Network, including The Kevin and Sandra Sullivan Chair in Surgical Oncology, The Hatch Engineering Fellowship Fund, The RACH Fund, The Princess Margaret Cancer Foundation and National Institutes of Health (R01-CA127944-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora H, 2005, ARCH OTOLARYNGOL, V131, P217, DOI 10.1001/archotol.131.3.217; Balachandran R, 2012, INT J COMPUT ASS RAD, V7, P315, DOI 10.1007/s11548-011-0639-4; Balachandran R, 2009, IEEE T BIO-MED ENG, V56, P37, DOI 10.1109/TBME.2008.2002110; Balachandran R, 2008, OTOL NEUROTOL, V29, P1050, DOI 10.1097/MAO.0b013e3181859a08; Barghan S, 2012, AUST DENT J, V57, P109, DOI 10.1111/j.1834-7819.2011.01663.x; Bichlmeier CP, 2008, INT WORKSH AUGM ENV, P45; Bill J S, 2004, Mund Kiefer Gesichtschir, V8, P135, DOI 10.1007/s10006-004-0541-0; Bittner JG, 2010, GASTROINTEST ENDOSC, V71, P357, DOI 10.1016/j.gie.2009.08.033; Blanco RT, 2005, EUR J RADIOL, V56, P130, DOI 10.1016/j.ejrad.2005.03.033; Brown GA, 2002, J ORTHOP TRAUMA, V16, P347, DOI 10.1097/00005131-200205000-00010; Caire F, 2010, STEREOT FUNCT NEUROS, V88, P109, DOI 10.1159/000280823; Chen G, 2010, CHINESE MED J-PEKING, V123, P2576, DOI 10.3760/cma.j.issn.0366-6999.2010.18.016; Cohen A, 2009, ORAL SURG ORAL MED O, V108, P661, DOI 10.1016/j.tripleo.2009.05.023; Daly MJ, 2010, PROC SPIE, V7625, DOI 10.1117/12.844212; Das S, 2008, AM J RHINOL, V22, P166, DOI 10.2500/ajr.2008.22.3152; De Man B, 1999, IEEE T NUCL SCI, V46, P691, DOI 10.1109/23.775600; Desilets DJ, 2011, GASTROINTEST ENDOSC, V73, P861, DOI 10.1016/j.gie.2011.01.063; Dixon BJ, 2011, LARYNGOSCOPE, V121, P2060, DOI 10.1002/lary.22153; Dreiseidler T, 2010, ORAL SURG ORAL MED O, V110, P94, DOI 10.1016/j.tripleo.2010.03.013; El-Beialy AR, 2011, AM J ORTHOD DENTOFAC, V140, P157, DOI 10.1016/j.ajodo.2010.03.030; Enquobahrie A, 2008, INT J COMPUT ASS RAD, V3, P395, DOI 10.1007/s11548-008-0243-4; Fitzpatrick JM, 1998, IEEE T MED IMAGING, V17, P694, DOI 10.1109/42.736021; Garrido BJ, 2011, SPINE J, V11, P331, DOI 10.1016/j.spinee.2011.03.007; Genden E, 1996, AM J OTOLARYNG, V17, P219, DOI 10.1016/S0196-0709(96)90085-X; Gibson A, 2003, APPL OPTICS, V42, P3109, DOI 10.1364/AO.42.003109; Hamming NM, 2009, MED PHYS, V36, P1800, DOI 10.1118/1.3117609; Hanna EY, 2007, ARCH OTOLARYNGOL, V133, P1209, DOI 10.1001/archotol.133.12.1209; Heiland M, 2007, ORAL SURG ORAL MED O, V104, P814, DOI 10.1016/j.tripleo.2007.04.031; Isaacs Seth, 2009, Otolaryngol Clin North Am, V42, P765, DOI 10.1016/j.otc.2009.08.014; Klatt J, 2011, J CRANIO MAXILL SURG, V39, P244, DOI 10.1016/j.jcms.2010.06.009; Labadie RF, 2005, OTOL NEUROTOL, V26, P557, DOI 10.1097/01.mao.0000178117.61537.5b; Labadie RF, 2010, OTOL NEUROTOL, V31, P94, DOI 10.1097/MAO.0b013e3181c2f81a; Labadie RF, 2009, INT J COMPUT ASS RAD, V4, P273, DOI 10.1007/s11548-009-0292-3; Lee JH, 2004, INT J ORAL MAX SURG, V33, P150, DOI 10.1054/ijom.2003.0487; Liang X, 2010, EUR J RADIOL, V75, P265, DOI 10.1016/j.ejrad.2009.03.042; Murayama Y, 2011, NEUROSURGERY, V68, P1427, DOI 10.1227/NEU.0b013e31820b4f1c; Nithiananthan S, 2009, MED PHYS, V36, P4755, DOI 10.1118/1.3223631; Nithiananthan S, 2011, MED PHYS, V38, P1785, DOI 10.1118/1.3555037; Nogueira JF, 2010, BRAZ J OTORHINOLAR, V76, P129, DOI 10.1590/S1808-86942010000100021; Poeschl PW, 2013, CLIN ORAL INVEST, V17, P317, DOI 10.1007/s00784-012-0704-6; Pohlenz P, 2008, J ORAL MAXIL SURG, V66, P324, DOI 10.1016/j.joms.2007.03.032; Pohlenz P, 2007, ORAL SURG ORAL MED O, V103, P412, DOI 10.1016/j.tripleo.2006.05.008; Pohlenz P, 2009, J ORAL MAXIL SURG, V67, P515, DOI 10.1016/j.joms.2008.06.086; Prisman E, 2011, INT FORUM ALLERGY RH, V1, P70, DOI 10.1002/alr.20007; Rabie A, 2011, J CRANIOFAC SURG, V22, P1466, DOI 10.1097/SCS.0b013e31821d1982; Ro EY, 2007, LARYNGOSCOPE, V117, P759, DOI 10.1097/mlg.0b013e318031f0cf; Schafer S, 2010, MED PHYS, V37, P694, DOI 10.1118/1.3284540; Sielhorst T, 2008, J DISP TECHNOL, V4, P451, DOI 10.1109/JDT.2008.2001575; Siewerdsen JH, 2005, PROC SPIE, V5744, P789, DOI 10.1117/12.595690; Singare S, 2004, MED ENG PHYS, V26, P671, DOI 10.1016/j.medengphy.2004.06.001; Timock AM, 2011, AM J ORTHOD DENTOFAC, V140, P734, DOI 10.1016/j.ajodo.2011.06.021; Uneri A, 2012, INT J COMPUT ASS RAD, V7, P159, DOI 10.1007/s11548-011-0636-7; Warren FM, 2007, OTOL NEUROTOL, V28, P325, DOI 10.1097/01.mao.0000253287.86737.2e; Weersink RA, 2011, MED PHYS, V38, P6458, DOI 10.1118/1.3658569; Wise SK, 2008, AM J RHINOL, V22, P635, DOI 10.2500/ajr.2008.22.3242; Woodworth BA, 2008, J LARYNGOL OTOL, V122, P361, DOI 10.1017/S0022215107000485; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zain-Alabdeen EH, 2012, DENTOMAXILLOFAC RAD, V41, P185, DOI [10.1259/dmfr/24985981, 10.1259/dmfr/24985971]	58	56	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136370	10.1371/journal.pone.0136370	http://dx.doi.org/10.1371/journal.pone.0136370			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331717	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800053
J	Esbjorn, BH; Breinholst, S; Niclasen, J; Skovgaard, LF; Lange, K; Reinholdt-Dunne, ML				Esbjorn, Barbara Hoff; Breinholst, Sonja; Niclasen, Janni; Skovgaard, Louise Fabritius; Lange, Katrine; Reinholdt-Dunne, Marie Louise			Identifying the Best-Fitting Factor Structure of the Experience of Close Relations - Revised in a Scandinavian Example	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; VALIDITY; RELIABILITY; VERSION; INTERVIEW; ANXIETY	The aim of this study was to enhance the understanding of cultural and sample differences in the assessment of attachment by examining the factor structure of the Experiences in Close Relationships-Revised (ECR-R). The ECR-R is a self-report measure of adult romantic attachment dimensions. The present study used a Danish sample with the purpose of addressing limitations in previous studies, such as the lack of diversity in cultural background, restricted sample characteristics, and poorly fitting structure models. Participants consisted of 253 parents of children between the ages of 7 and 12 years, 53% being mothers. The parents completed the paper version of the questionnaire. Confirmatory Factor Analyses were carried out to determine whether theoretically and empirically established models including one and two factors would also provide adequate fits in a Danish sample. A previous study using the original ECR suggested that Scandinavian samples may best be described using a five-factor solution. Our results indicated that the one-and two-factor models of the ECR-R did not fit the data well. Exploratory Factor Analysis revealed a five-factor model. Our study provides evidence that further investigation is needed to establish which model may provide the best model fit in the Scandinavian countries.	[Esbjorn, Barbara Hoff; Breinholst, Sonja; Niclasen, Janni; Skovgaard, Louise Fabritius; Lange, Katrine; Reinholdt-Dunne, Marie Louise] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark	University of Copenhagen	Esbjorn, BH (corresponding author), Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.	Barbara.hoff@psy.ku.dk			Egmont Foundation [831-2205]; Helse Foundation [2008A438, 2009A617]; Simon Spies Foundation [004610]	Egmont Foundation; Helse Foundation; Simon Spies Foundation	The study has been supported financially by the Egmont Foundation (grant nr.: 831-2205), Helse Foundation (grant nr.: 2008A438 & 2009A617), and Simon Spies Foundation (grant nr.: 004610). No individuals from any of the foundations played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no conflict of interest.	Alonso-Arbiol I, 2008, EUR J PSYCHOL ASSESS, V24, P9, DOI 10.1027/1015-5759.24.1.9; Bowlby J., 1973, SEPARATION ANXIETY A, V2; Bowlby J., 1980, LOSS SADNESS DEPRESS, V3; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Brennan K.AC.C.L., 1998, ATTACHMENT THEORY CL, P46, DOI DOI 10.1037/T03763-000; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Busonera A, 2014, PSYCHOL REP, V114, P785, DOI 10.2466/03.21.PR0.114k23w9; Byrne B.M., 2012, STRUCTURAL EQUATION; Cameron JJ, 2012, J RES PERS, V46, P472, DOI 10.1016/j.jrp.2012.05.001; Diderichsen A, 2007, PSYKOLOGISKE ARV TI; Ehrenthal Johannes C, 2009, Psychother Psychosom Med Psychol, V59, P215, DOI 10.1055/s-2008-1067425; Esbjorn BH, 2013, BRIT J CLIN PSYCHOL, V52, P394, DOI 10.1111/bjc.12024; Fairchild AJ, 2006, EDUC PSYCHOL MEAS, V66, P116, DOI 10.1177/0013164405278564; Fraley CR, 2000, J PERS SOC PSYCHOL, V78, P350, DOI DOI 10.1037/0022-3514.78.2.350; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; [金艳 JIN Yan], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P242; Kobak R., 2008, HDB ATTACHMENT THEOR, P23; Kooiman CG, 2013, J PERS ASSESS, V95, P217, DOI 10.1080/00223891.2012.740540; Olsson I, 2010, NORD J PSYCHIAT, V64, P340, DOI 10.3109/08039481003728586; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Shmueli-Goetz Y, 2008, DEV PSYCHOL, V44, P939, DOI 10.1037/0012-1649.44.4.939; Sibley CG, 2005, PERS SOC PSYCHOL B, V31, P1524, DOI 10.1177/0146167205276865; Sibley CG, 2004, PERS INDIV DIFFER, V36, P969, DOI 10.1016/S0191-8869(03)00165-X; Tsagarakis M, 2007, EUR J PSYCHOL ASSESS, V23, P47, DOI 10.1027/1015-5759.23.1.47; Wongpakaran T, 2011, SINGAP MED J, V52, P100	25	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137218	10.1371/journal.pone.0137218	http://dx.doi.org/10.1371/journal.pone.0137218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331312	gold, Green Submitted, Green Published			2022-12-27	WOS:000360613800110
J	Heald, SLM; Nusbaum, HC				Heald, Shannon L. M.; Nusbaum, Howard C.			Variability in Vowel Production within and between Days	PLOS ONE			English	Article							TRAINING JAPANESE LISTENERS; R-VERTICAL-BAR; SLEEP; COARTICULATION; CONSOLIDATION; FATIGUE; CONTEXT; SPOKEN	Although the acoustic variability of speech is often described as a problem for phonetic recognition, there is little research examining acoustic-phonetic variability over time. We measured naturally occurring acoustic variability in speech production at nine specific time points (three per day over three days) to examine daily change in production as well as change across days for citation-form vowels. Productions of seven different vowels (/EE/, /IH/, /AH/, /UH/, /AE/, /OO/, /EH/) were recorded at 9AM, 3PM and 9PM over the course of each testing day on three different days, every other day, over a span of five days. Results indicate significant systematic change in F1 and F0 values over the course of a day for each of the seven vowels recorded, whereas F2 and F3 remained stable. Despite this systematic change within a day, however, talkers did not show significant changes in F0, F1, F2, and F3 between days, demonstrating that speakers are capable of producing vowels with great reliability over days without any extrinsic feedback besides their own auditory monitoring. The data show that in spite of substantial day-to-day variability in the specific listening and speaking experiences of these participants and thus exposure to different acoustic tokens of speech, there is a high degree of internal precision and consistency for the production of citation form vowels.	[Heald, Shannon L. M.; Nusbaum, Howard C.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago	Heald, SLM (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	smbowdre@uchicago.edu						Akahane-Yamada R., 1996, P 3 JOINT M AC SOC A; Barrett J, 2002, EXP BRAIN RES, V146, P531, DOI 10.1007/s00221-002-1229-z; Bes F, 2009, SLEEP, V32, P392, DOI 10.1093/sleep/32.3.392; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Boersma P., 1993, IFA P, V17, P97; Boersma P., 2016, PRAAT DOING PHONETIC; Bradlow AR, 1997, J ACOUST SOC AM, V101, P2299, DOI 10.1121/1.418276; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Broughton R. J., 1997, SLEEP RES ONLINE SRO, V1, P166; Butcher A., 1976, J PHONETICS, V4, P59; CATFORD JC, 1970, MOD LANG J, V54, P477, DOI 10.2307/321767; Colquhoun W., 1971, BIOL RHYTHMS HUMAN P, P39; COOPER WE, 1974, J ACOUST SOC AM, V56, P617, DOI 10.1121/1.1903300; Dalby J., 1998, P EUR SPEECH COMM AS, P25; DELATTRE PC, 1955, J ACOUST SOC AM, V27, P769, DOI 10.1121/1.1908024; DIENER HC, 1988, PROG BRAIN RES, V76, P253; Elman JL, 1986, INVARIANCE VARIABILI, P360; ENOKA RM, 1989, J NEUROPHYSIOL, V62, P1344, DOI 10.1152/jn.1989.62.6.1344; Evans BG, 2007, J ACOUST SOC AM, V121, P3814, DOI 10.1121/1.2722209; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; FLANAGAN JL, 1955, J ACOUST SOC AM, V27, P613, DOI 10.1121/1.1907979; FOWLER CA, 1993, LANG SPEECH, V36, P171, DOI 10.1177/002383099303600304; Francis AL, 2002, J EXP PSYCHOL HUMAN, V28, P349, DOI 10.1037//0096-1523.28.2.349; GELFER MP, 1991, J VOICE, V5, P158, DOI 10.1016/S0892-1997(05)80179-1; Gribble PA, 2004, PERCEPT MOTOR SKILL, V99, P1035, DOI 10.2466/pms.99.3.1035-1045; Holt LL, 2000, J ACOUST SOC AM, V108, P710, DOI 10.1121/1.429604; Kostyk BE, 1998, J VOICE, V12, P287, DOI 10.1016/S0892-1997(98)80019-2; Kuhl P. K., 1995, SPEECH PERCEPTION LI, P433; Labov W., 2006, PHONOLOGY SOUND CHAN; LEHISTE I, 1961, J ACOUST SOC AM, V33, P419, DOI 10.1121/1.1908681; Liberman A. M., 1967, MODELS PERCEPTION SP; LINDBLOM B, 1963, J ACOUST SOC AM, V35, P1773, DOI 10.1121/1.1918816; LIVELY SE, 1994, J ACOUST SOC AM, V96, P2076, DOI 10.1121/1.410149; MANN VA, 1980, PERCEPT PSYCHOPHYS, V28, P407, DOI 10.3758/BF03204884; Miller J. L., 1981, PERSPECTIVES STUDY S, P39; Minors DS, 2013, CIRCADIAN RHYTHMS HU; MOON SJ, 1994, J ACOUST SOC AM, V96, P40, DOI 10.1121/1.410492; Nusbaum H., 1997, TALKER VARIABILITY S, P109; OHMAN SEG, 1966, J ACOUST SOC AM, V39, P151, DOI 10.1121/1.1909864; Perkell J, 1997, SPEECH COMMUN, V22, P227, DOI 10.1016/S0167-6393(97)00026-5; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Press W. H., 1992, ART SCI COMPUTING; Purcell DW, 2006, J ACOUST SOC AM, V120, P966, DOI 10.1121/1.2217714; RECASENS D, 1989, SPEECH COMMUN, V8, P293, DOI 10.1016/0167-6393(89)90012-5; REPP BH, 1982, PSYCHOL BULL, V92, P81, DOI 10.1037/0033-2909.92.1.81; STEMPLE JC, 1994, J VOICE, V8, P271, DOI 10.1016/S0892-1997(05)80299-1; Stevens K. N., 1963, J SPEECH HEARING RES; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; STRANGE W, 1989, J ACOUST SOC AM, V85, P2135, DOI 10.1121/1.397863; Traunmuller H, 2000, J ACOUST SOC AM, V107, P3438, DOI 10.1121/1.429414; TULLER B, 1994, J EXP PSYCHOL HUMAN, V20, P3, DOI 10.1037/0096-1523.20.1.3; VANSUMMERS W, 1988, J ACOUST SOC AM, V84, P917, DOI 10.1121/1.396660; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8	53	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136791	10.1371/journal.pone.0136791	http://dx.doi.org/10.1371/journal.pone.0136791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331478	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800071
J	Loevinsohn, M				Loevinsohn, Michael			The 2001-03 Famine and the Dynamics of HIV in Malawi: A Natural Experiment	PLOS ONE			English	Article							POPULATION-BASED SURVEYS; SEXUAL-BEHAVIOR; YOUNG-PEOPLE; PREVALENCE; MIGRATION; AFRICA; SURVEILLANCE; DECLINES; PARTNERSHIPS; REDUCTIONS	Background Food security has deteriorated for many people in developing regions facing high and volatile food prices. Without effective and equitable responses, the situation is likely to worsen due to diminishing access to land and water, competition from non-food uses of agricultural products, and the effects of climate change and variability. Understanding how this will affect the burden and distribution of major diseases such as HIV is critical. This study makes use of the near-experimental conditions created by the Malawi famine to shed new light on this issue. Methods Multilevel, random intercept models were used to relate the change in HIV prevalence at antenatal surveillance sites over the course of the famine to the proportion of rural households requiring food aid in the surrounding district at the famine's peak. Similar models were used to relate this indicator of rural hunger to changes in the composition of the antenatal population. The extent and direction of migration were estimated from a household survey conducted 1-2 years after the famine. Findings At rural sites, the change in HIV prevalence was positively and non-linearly related to the extent of rural hunger (P = 0.016), consistent with contemporary accounts of increased transactional sex and with hunger compromising immune function. At non-rural sites, prevalence declined as rural hunger increased (P = 0.006), concentrated in women who self-identified as farmers (P = 0.010). This finding is consistent with contemporary accounts of migration in search of food and work from villages where HIV risk was lower to towns and cities where it was higher. Corroborating this interpretation, the proportion of farmers in the antenatal population was found to rise at non-rural sites as rural hunger increased in the surrounding district (P = 0.015) whereas the proportion fell with increasing rural hunger at rural sites (P<0.001). The models suggest migrants were predominantly farming women under 25 years (P = 0.010). The household survey confirmed that there was a surge of rural-to-urban migration during the famine, particularly by women under 25 years. Migration to less affected rural areas also increased. Conclusion The Malawi famine appears to have had a substantial effect on HIV's dynamics and demography. Poverty and inequality, commonly considered structural determinants of HIV epidemics, can change rapidly, apparently transmitting their effects with little lag. Epidemic patterns risk being misread if such social and economic change is ignored. Many studies examining HIV prevalence declines have implicated sexual behaviour change but do not appear to have adequately considered the contribution of rural-urban migration. The evidence from Malawi, which links actions that undermined people's food security to changes in the prevalence and distribution of HIV infections, suggests new opportunities for prevention.	Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England	University of Sussex	Loevinsohn, M (corresponding author), Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England.	mloevinsohn@gmail.com			ESRC [ES/I021620/1] Funding Source: UKRI; Economic and Social Research Council [ES/I021620/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2015, AIDS IND SURV; [Anonymous], 2006, AIDS ECOLOGY POVERTY; Bello GA, 2006, SEX TRANSM INFECT, V82, pI9, DOI 10.1136/sti.2005.016030; Bello G, 2011, SEX TRANSM INFECT, V87, P296, DOI 10.1136/sti.2010.043786; Browne W., 2009, MCMC ESTIMATION MLWI; Bryceson D. F, 2004, SOCIAL PATHWAYS HIV; Bryceson DF, 2006, J MOD AFR STUD, V44, P173, DOI 10.1017/S0022278X06001595; Bryceson DF, 2002, WORLD DEV, V30, P725, DOI 10.1016/S0305-750X(02)00006-2; CHRISTIANSEN R, 1984, DEV CHANGE, V15, P125, DOI 10.1111/j.1467-7660.1984.tb00176.x; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Conroy AC, 2006, POVERTY, AIDS AND HUNGER: BREAKING THE POVERTY TRAP IN MALAWI, P1, DOI 10.1057/9780230627703; DECOSAS J, 1995, LANCET, V346, P826, DOI 10.1016/S0140-6736(95)91631-8; Devereux S, 2002, IDS BULL-I DEV STUD, V33, P70, DOI 10.1111/j.1759-5436.2002.tb00046.x; Devereux S, 2003, MALAWI FOOD CRISIS I, DOI 10.1.1.359.6681; Devereux S, 2007, ROUTL STUD DEV ECON, V52, P143; Ellis F, 2003, WORLD DEV, V31, P1495, DOI 10.1016/S0305-750X(03)00111-6; FAO & WFP, 2014, STAT FOOD INS WORLD; Frankenberger T., 2003, LIVELIHOOD EROSION T; Garnett GP, 1996, J INFECT DIS, V174, pS150, DOI 10.1093/infdis/174.Supplement_2.S150; George CK, 2005, SOCIAL CONTEXT ASSES; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Gillespie S, 2009, FOOD SECUR, V1, P261, DOI 10.1007/s12571-009-0027-x; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; Gouws E, 2008, AIDS, V22, pS5, DOI 10.1097/01.aids.0000341773.86500.9d; GREENLAND S, 1987, AM J EPIDEMIOL, V125, P761, DOI 10.1093/oxfordjournals.aje.a114593; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2010, INT J EPIDEMIOL, V39, P1311, DOI 10.1093/ije/dyq055; Haggblade S, 2009, 100 MICH STAT U; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Hargrove JW, 2011, EPIDEMICS-NETH, V3, P88, DOI 10.1016/j.epidem.2011.02.004; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hossain N, 2011, DEV POLICY REV, V29, P565, DOI 10.1111/j.1467-7679.2011.00547.x; Itano N., 2012, CHRISTIAN SCI M 0515; Kamowa O., 2002, LIVING ABYSS HUNGER; Kishor S., 2004, PROFILING DOMESTIC V; Lee J, 2009, ANN ACAD MED SINGAP, V38, P714; Loevinsohn M, 2013, NATURAL EXPT UNDER A; Loevinsohn M, 2012, SEASONALITY, RURAL LIVELIHOODS AND DEVELOPMENT, P56; Lumey LH, 2011, ANNU REV PUBL HEALTH, V32, P237, DOI 10.1146/annurev-publhealth-031210-101230; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Mandala Elias C, 2005, END CHIDYERANO HIST, P165; Michelo C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-279; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Munthali A., 2006, CURRENT ISSUES RURAL, P23; MVAC, 2002, MAL EM FOOD SEC ASS; MVAC, 2003, MAL EM FOOD SEC ASS; National AIDS Commission, 2003, HIV SENT SURV REP 20; National Statistical Office, 2005, INT HOUS SURV 2004 2; National Statistical Office, 1998, POP HOUS CENS FIN RE; National Statistical Office ORC Macro, 2001, MAL DEM HLTH SURV 20; Ngwira N., 2001, HIV AIDS AGR FOOD SE; Pascoe SJS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115290; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; Porter JR., 2014, CLIMATE CHANGE 2014; Potts Deborah, 2012, WHATEVER HAPPENED AF; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; RENEWAL, 2003, HIV AIDS FOOD CRIS S; Rusike J, 2010, FOOD POLICY, V35, P98, DOI 10.1016/j.foodpol.2009.10.004; Sandoy IF, 2006, TROP MED INT HEALTH, V11, P917, DOI 10.1111/j.1365-3156.2006.01629.x; Schabenberger O., 2004, STAT METHODS SPATIAL; Sen A.K., 1981, POVERTY FAMINES; Shah MK, 2002, IMPACT HIV AIDS AGR; Stein Z., 1975, FAMINE HUM DEV DUTCH; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P697, DOI 10.2471/BLT.07.045260; SUSSER M, 1981, AM J CLIN NUTR, V34, P784, DOI 10.1093/ajcn/34.4.784; SUSSER M, 1991, AM J EPIDEMIOL, V133, P635, DOI 10.1093/oxfordjournals.aje.a115939; Tsai AC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001203; Ukoumunne OC, 2001, STAT MED, V20, P417, DOI 10.1002/1097-0258(20010215)20:3<417::AID-SIM802>3.0.CO;2-G; UNAIDS, 2011, WORLD AIDS DAY REP 2; VAC, 2003, ID IMP HIV AIDS FOOD; Vaughan M., 2007, STORY AFRICAN FAMINE; Vermeulen SJ, 2012, ENVIRON SCI POLICY, V15, P136, DOI 10.1016/j.envsci.2011.09.003; von Braun J., 1999, FAMINE AFRICA CAUSES; Walker PT, 2008, SEX TRANSM INFECT, V84, pII42, DOI 10.1136/sti.2008.029975; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; WHO, 2002, CHOL MAL DIS OUTBR R; World Bank, 2007, MAL POV VULN ASS INV; World Food Programme, 2003, 10200 EMOP WORLD FOO; Zulu LC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-285	83	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135108	10.1371/journal.pone.0135108	http://dx.doi.org/10.1371/journal.pone.0135108			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26332405	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800020
J	Lovell, R; Towlson, C; Parkin, G; Portas, M; Vaeyens, R; Cobley, S				Lovell, Ric; Towlson, Chris; Parkin, Guy; Portas, Matt; Vaeyens, Roel; Cobley, Stephen			Soccer Player Characteristics in English Lower-League Development Programmes: The Relationships between Relative Age, Maturation, Anthropometry and Physical Fitness	PLOS ONE			English	Article							YOUTH SOCCER; BIOLOGICAL MATURATION; RUNNING SPEED; SUCCESS; PERFORMANCE; MATURITY; TESTS	The relative age effect (RAE) and its relationships with maturation, anthropometry, and physical performance characteristics were examined across a representative sample of English youth soccer development programmes. Birth dates of 1,212 players, chronologically age-grouped (i.e., U9's-U18's), representing 17 professional clubs (i.e., playing in Leagues 1 & 2) were obtained and categorised into relative age quartiles from the start of the selection year (Q1 = Sep-Nov; Q2 = Dec-Feb; Q3 = Mar-May; Q4 = Jun-Aug). Players were measured for somatic maturation and performed a battery of physical tests to determine aerobic fitness (Multi-Stage Fitness Test [MSFT]), Maximal Vertical Jump (MVJ), sprint (10 & 20m), and agility (T-Test) performance capabilities. Odds ratio's (OR) revealed Q1 players were 5.3 times (95% confidence intervals [CI]: 4.08-6.83) more likely to be selected than Q4's, with a particularly strong RAE bias observed in U9 (OR: 5.56) and U13-U16 squads (OR: 5.45-6.13). Multivariate statistical models identified few between quartile differences in anthropometric and fitness characteristics, and confirmed chronological age-group and estimated age at peak height velocity (APHV) as covariates. Assessment of practical significance using magnitude-based inferences demonstrated body size advantages in relatively older players (Q1 vs. Q4) that were very-likely small (Effect Size [ES]: 0.53-0.57), and likely to very-likely moderate (ES: 0.62-0.72) in U12 and U14 squads, respectively. Relatively older U12-U14 players also demonstrated small advantages in 10m (ES: 0.31-0.45) and 20m sprint performance (ES: 0.36-0.46). The data identify a strong RAE bias at the entry-point to English soccer developmental programmes. RAE was also stronger circa-PHV, and relatively older players demonstrated anaerobic performance advantages during the pubescent period. Talent selectors should consider motor function and maturation status assessments to avoid premature and unwarranted drop-out of soccer players within youth development programmes.	[Lovell, Ric] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia; [Towlson, Chris] Univ Hull, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Parkin, Guy] Profootball Support, Huddersfield, W Yorkshire, England; [Portas, Matt] Univ Teesside, Sport & Exercise Dept, Middlesbrough, Cleveland, England; [Vaeyens, Roel] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Cobley, Stephen] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia	Western Sydney University; University of Hull; University of Teesside; Ghent University; University of Sydney	Lovell, R (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia.	r.lovell@uws.edu.au	Cobley, Stephen P/I-5686-2017; Towlson, Christopher/AAP-9835-2020; Lovell, Ric/I-9973-2019	Cobley, Stephen P/0000-0001-6099-392X; Lovell, Ric/0000-0001-5859-0267; Towlson, Christopher/0000-0001-5960-0324	Pro-football	Pro-football	Pro-football Support provided support in the form of salaries for authors [RL, GP, MP]. GP is the director of the agency (Pro-Football Support) contracted by the clubs in this study to under take anthropometric, somatic maturation and fitness assessments of the players registered with each Football Club. The specific roles of these authors are articulated in the 'author contributions' section.	Augste C, 2011, J SPORT SCI, V29, P983, DOI 10.1080/02640414.2011.574719; Barnsley R.H., 1992, RELAT AGE EFF FOOTBA, V27, P77, DOI [DOI 10.1177/101269029202700105, 10.1177/101269029202700105]; Berthoin S, 1994, J SPORT SCI, V12, P355, DOI 10.1080/02640419408732181; Buchheit M, 2010, INT J SPORTS MED, V31, P818, DOI 10.1055/s-0030-1262838; Butterfield SA, 2004, PERCEPT MOTOR SKILL, V99, P225, DOI 10.2466/pms.99.1.225-234; Carling C, 2009, SCAND J MED SCI SPOR, V19, P3, DOI 10.1111/j.1600-0838.2008.00867.x; Cobley S, 2009, SPORTS MED, V39, P235, DOI 10.2165/00007256-200939030-00005; Deprez D, 2013, INT J SPORTS MED, V34, P897, DOI 10.1055/s-0032-1333262; Deprez D, 2012, INT J SPORTS MED, V33, P987, DOI 10.1055/s-0032-1311654; Deprez DN, 2015, J STRENGTH COND RES, V29, P1692, DOI 10.1519/JSC.0000000000000806; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Helsen WF, 2000, AM J HUM BIOL, V12, P729, DOI 10.1002/1520-6300(200011/12)12:6<729::AID-AJHB2>3.0.CO;2-7; Helsen WF, 1998, AM J HUM BIOL, V10, P791, DOI 10.1002/(SICI)1520-6300(1998)10:6&lt;791::AID-AJHB10&gt;3.0.CO;2-1; Helsen WF, 2005, J SPORT SCI, V23, P629, DOI 10.1080/02640410400021310; Hirose N, 2009, J SPORT SCI, V27, P1159, DOI 10.1080/02640410903225145; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; Malina RM, 2007, BRIT J SPORT MED, V41, P290, DOI 10.1136/bjsm.2006.031294; Malina RM, 2014, J SPORT SCI, V32, P424, DOI 10.1080/02640414.2013.828850; Mendez-Villanueva A, 2011, J SPORT SCI, V29, P477, DOI 10.1080/02640414.2010.536248; Mendez-Villanueva A, 2010, PEDIATR EXERC SCI, V22, P497, DOI 10.1123/pes.22.4.497; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Mujika I, 2009, J SPORT SCI, V27, P1153, DOI 10.1080/02640410903220328; O'Brien TD, 2009, EXP PHYSIOL, V94, P731, DOI 10.1113/expphysiol.2008.045062; Ross WD, 1991, PHYSL TESTING ELITEA, P223; Simmons C, 2001, J SPORT SCI, V19, P677, DOI 10.1080/02640410152475801; Sporis G, 2010, J STRENGTH COND RES, V24, P679, DOI 10.1519/JSC.0b013e3181c4d324; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; Till K., 2010, TALENT DEV EXCELLENC, V2, P193; Vaeyens R, 2005, J SPORT SCI, V23, P747, DOI 10.1080/02640410400022052; Vandendriessche JB, 2012, J SPORT SCI, V30, P1695, DOI 10.1080/02640414.2011.652654	33	102	109	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137238	10.1371/journal.pone.0137238	http://dx.doi.org/10.1371/journal.pone.0137238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331852	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800114
J	Sugiyama, N; Somerville, AD; Schoeninger, MJ				Sugiyama, Nawa; Somerville, Andrew D.; Schoeninger, Margaret J.			Stable Isotopes and Zooarchaeology at Teotihuacan, Mexico Reveal Earliest Evidence of Wild Carnivore Management in Mesoamerica	PLOS ONE			English	Article							CARBON ISOTOPES; BONE; COLLAGEN; DIET; DIAGENESIS; BIOAPATITE; NITROGEN; MAIZE	From Roman gladiatorial combat to Egyptian animal mummies, the capture and manipulation of carnivores was instrumental in helping to shape social hierarchies throughout the ancient world. This paper investigates the historical inflection point when humans began to control animals not only as alimental resources but as ritual symbols and social actors in the New World. At Teotihuacan (A.D. 1-550), one of the largest pre-Hispanic cities, animal remains were integral components of ritual caches expressing state ideology and militarism during the construction of the Moon and the Sun Pyramids. The caches contain the remains of nearly 200 carnivorous animals, human sacrificial victims and other symbolic artifacts. This paper argues the presence of skeletal pathologies of infectious disease and injuries manifest on the carnivore remains show direct evidence of captivity. Stable isotope analysis (delta C-13 and delta N-15) of bones and teeth confirms that some of these carnivores were consuming high levels of C-4 foods, likely reflecting a maize-based anthropocentric food chain. These results push back the antiquity of keeping captive carnivores for ritualistic purposes nearly 1000 years before the Spanish conquistadors described Moctezuma's zoo at the Aztec capital. Mirroring these documents the results indicate a select group of carnivores at Teotihuacan may have been fed maize-eating omnivores, such as dogs and humans. Unlike historical records, the present study provides the earliest and direct archaeological evidence for this practice in Mesoamerica. It also represents the first systematic isotopic exploration of a population of archaeological eagles (n = 24) and felids (n = 29).	[Sugiyama, Nawa] Smithsonian Inst, Dept Anthropol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Somerville, Andrew D.; Schoeninger, Margaret J.] Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California San Diego	Sugiyama, N (corresponding author), Smithsonian Inst, Dept Anthropol, Natl Museum Nat Hist, Washington, DC 20560 USA.	SugiyamaN@si.edu	Somerville, Andrew/AAC-9253-2022	Somerville, Andrew/0000-0003-4839-2739	National Science Foundation Doctoral Dissertation Improvement Grant [BCS-1028851, PI-Richard Meadow]; Fulbright-Hays Doctoral Dissertation Research Abroad Program; Dumbarton Oaks Research Library and Collection	National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); Fulbright-Hays Doctoral Dissertation Research Abroad Program; Dumbarton Oaks Research Library and Collection	The zooarchaeological and isotopic study was completed as part of Sugiyama's dissertation project with support from the National Science Foundation Doctoral Dissertation Improvement Grant (BCS-1028851, PI-Richard Meadow), the Fulbright-Hays Doctoral Dissertation Research Abroad Program, and the William R. Tyler Fellowship from the Dumbarton Oaks Research Library and Collection.	Allitt S, 2008, N AM ARCHAEOL, V29, P343, DOI 10.2190/NA.29.3-4.h; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Beasley MM, 2014, J ARCHAEOL SCI, V46, P16, DOI 10.1016/j.jas.2014.03.008; Benson EP, 1972, CULT FELINE; Blanco Alicia, 2009, AMMVEPE, V20, P29; Bouwman AS, 2008, THESIS CALIFORNIA ST; Clementz MT, 2009, GEOL J, V44, P605, DOI 10.1002/gj.1173; Cortes Hernan, 1971, CARTAS DE RELACION; Cowgill, 1973, URBANIZATION TEOTIHU; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Fuente Bdl, 2006, PINT MUR PREH MEX TE; Garvie-Lok SJ, 2004, J ARCHAEOL SCI, V31, P763, DOI 10.1016/j.jas.2003.10.014; Keeling CD, 1979, ENVIRON INT, V2, P229, DOI [10.1016/0160-4120(79)90005-9, DOI 10.1016/0160-4120(79)90005-9]; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; KRUEGER HW, 1984, ACS SYM SER, V258, P205; Lujan LL, 2014, ANIMALS AND INEQUALITY IN THE ANCIENT WORLD, P33, DOI 10.5876/9781607322863.c002; McKusick CharmionR., 2001, SW BIRDS SACRIFICE, VArizona Archaeologist No. 31; MILLER A. G., 1973, MURAL PAINTING TEOTI; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Nicholson Henry B., 1955, PACIFIC DISCOVERY, V8, P3; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Polaco Oscar J., 1991, FAUNA TEMPLO MAYOR; Rawlings TA, 2010, J ARCHAEOL SCI, V37, P2433, DOI 10.1016/j.jas.2010.05.004; Reitz E. J., 2004, ZOOARCHAEOLOGY; Saunders N. J., 1998, ICONS POWER FELINE S; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schoeninger MJ., 1989, APPL GEOCHEM, V4, P281, DOI DOI 10.1016/0883-2927(89)90030-9; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Somerville AD, 2010, J ANTHROPOL ARCHAEOL, V29, P125, DOI 10.1016/j.jaa.2009.09.003; Stone Elizabeth C., 2007, SETTLEMENT SOC ESSAY, P261; Sugiyama N, 2014, ANIMALS AND INEQUALITY IN THE ANCIENT WORLD, P11, DOI 10.5876/9781607322863.c001; Sugiyama N, 2013, ANTHROPOZOOLOGICA, V48, P467, DOI 10.5252/az2013n2a18; Sugiyama N, 2013, LAT AM ANTIQ, V24, P403, DOI 10.7183/1045-6635.24.4.403; Sugiyama S, 2014, ARQUEOLOGIA MEXICANA, VXXI, P24; Sugiyama S, 2007, ANCIENT MESOAM, V18, P127, DOI 10.1017/S0956536107000065; Sugiyama S, 2007, ANCIENT MESOAM, V18, P109, DOI 10.1017/S0956536107000053; Sugiyama Saburo, 2000, ARQUEOLOGIA, V23, P161; Sugiyama Saburo, 2006, ARQUEOLOGIA HIST CTR, P131; VALADEZ AZUA R, 1993, ANATOMIA CONJUNTO RE, P729; Warinner C, 2013, J ARCHAEOL SCI, V40, P868, DOI 10.1016/j.jas.2012.07.003; Warinner C, 2009, J ARCHAEOL SCI, V36, P1690, DOI 10.1016/j.jas.2009.03.034; White CD, 2001, J ARCHAEOL SCI, V28, P89, DOI 10.1006/jasc.1999.0560; Wright LE, 1996, J ARCHAEOL SCI, V23, P933, DOI 10.1006/jasc.1996.0087	45	26	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135635	10.1371/journal.pone.0135635	http://dx.doi.org/10.1371/journal.pone.0135635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332042	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800036
J	Owusu, R; Asante, KP; Mahama, E; Awini, E; Anyorigiya, T; Dosoo, D; Amu, A; Jakpa, G; Ofei, E; Segbaya, S; Oduro, AR; Gyapong, M; Hodgson, A; Bart-Plange, C; Owusu-Agyei, S				Owusu, Ruth; Asante, Kwaku Poku; Mahama, Emmanuel; Awini, Elizabeth; Anyorigiya, Thomas; Dosoo, David; Amu, Alberta; Jakpa, Gabriel; Ofei, Emmanuel; Segbaya, Sylvester; Oduro, Abraham Rexford; Gyapong, Margaret; Hodgson, Abraham; Bart-Plange, Constance; Owusu-Agyei, Seth			Glucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort Study	PLOS ONE			English	Article							CHLORPROGUANIL-DAPSONE-ARTESUNATE; PLASMODIUM-FALCIPARUM MALARIA; PHASE-III TRIAL; G6PD DEFICIENCY; AFRICAN CHILDREN; DOUBLE-BLIND; NEONATAL-MORTALITY; BIRTH-WEIGHT; ANEMIA; WOMEN	Background Sulphadoxine-Pyrimethamine (SP) is still the only recommended antimalarial for use in intermittent preventive treatment of malaria during pregnancy (IPTp) in some malaria endemic countries including Ghana. SP has the potential to cause acute haemolysis in G6PD deficient people resulting in significant haemoglobin (Hb) drop but there is limited data on post SP-IPTp Hb drop. This study determined the difference, if any in proportions of women with significant acute haemoglobin drop between G6PD normal, partial deficient and full deficient women after SP-IPTp. Methods and Findings Prospectively, 1518 pregnant women who received SP for IPTp as part of their normal antenatal care were enrolled. Their G6PD status were determined at enrollment followed by assessments on days 3, 7,14 and 28 to document any adverse effects and changes in postIPTp haemoglobin (Hb) levels. The three groups were comparable at baseline except for their mean Hb (10.3 g/dL for G6PD normal, 10.8 g/dL for G6PD partial deficient and 10.8 g/dL for G6PD full defect women). The prevalence of G6PD full defect was 2.3% and 17.0% for G6PD partial defect. There was no difference in the proportions with fractional Hb drop >= 20% as compared to their baseline value post SP-IPTp among the 3 groups on days 3, 7, 14. The G6PD full defect group had the highest median fractional drop at day 7. There was a weak negative correlation between G6PD activity and fractional Hb drop. There was no statistical difference between the three groups in the proportions of those who started the study with Hb >= 8g/dl whose Hb level subsequently fell below 8g/dl post-SP IPTp. No study participant required transfusion or hospitalization for severe anaemia. Conclusions There was no significant difference between G6PD normal and deficient women in proportions with significant acute haemoglobin drop post SP-IPTp and lower G6PD enzyme activity was not strongly associated with significant acute drug-induced haemoglobin drop post SP-IPTp but a larger study is required to confirm consistency of findings.	[Owusu, Ruth; Asante, Kwaku Poku; Mahama, Emmanuel; Dosoo, David; Jakpa, Gabriel; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana; [Awini, Elizabeth; Amu, Alberta; Ofei, Emmanuel; Gyapong, Margaret] Dodowa Hlth Res Ctr, Ghana Hlth Serv, Dodowa, Ghana; [Anyorigiya, Thomas; Oduro, Abraham Rexford] Navrongo Hlth Res Ctr, Ghana Hlth Serv, Navrongo, Ghana; [Segbaya, Sylvester] AngloGold Ashanti Malaria Control Program, Obuasi, Ghana; [Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Bart-Plange, Constance] Ghana Hlth Serv, Natl Malaria Control Programme, Korle Bu, Accra, Ghana	Ghana Health Service; Kintampo Health Research Centre; Ghana Health Service; Ghana Health Service; Navrongo Health Research Center; Ghana Health Service; Ghana Health Service	Owusu, R (corresponding author), Komfo Anokye Teaching Hosp, Publ Hlth Unit, Kumasi, Ghana.	ruthowusu1@yahoo.com		Gyapong, Margaret/0000-0002-4818-3497; ODURO, ABRAHAM/0000-0002-4191-7419; Owusu-Agyei, Seth/0000-0002-0807-1781	Global Fund [GHN-405-G04-M]; National Malaria Control Programme, Ghana	Global Fund; National Malaria Control Programme, Ghana	The study was commissioned by the National Malaria Control Programme, Ghana Health Service with funding from the Global Fund. Grant number: GHN-405-G04-M http://portfolio.theglobafund.org/en/Grant/Index/GHN-405-G04-M. The funding was provided to the Ministry of Health/Ghana Health Service and assessed through the National Malaria Control Programme, Ghana. CBP and SS are the authors who were employees of the National Malaria Control Programme at the time of the study. The Global Fund had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Adisa R A, 2011, Niger J Physiol Sci, V26, P207; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; Asa OO, 2008, MATERN CHILD HLTH J, V12, P692, DOI 10.1007/s10995-008-0319-3; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Carter N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-241; CHAN TK, 1976, BRIT MED J, V2, P1227, DOI 10.1136/bmj.2.6046.1227; DODOO ANO, 2005, INT J RISK SAF MED, V17, P13; Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0; Gies S, 2009, TROP MED INT HEALTH, V14, P174, DOI 10.1111/j.1365-3156.2008.02215.x; Glover-Amengor Mary, 2005, Ghana Med J, V39, P102; Johnson MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007246; Luzzatto L, 2014, BRIT J HAEMATOL, V164, P469, DOI 10.1111/bjh.12665; May J, 2000, TROP MED INT HEALTH, V5, P119, DOI 10.1046/j.1365-3156.2000.00529.x; Menendez C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009438; Mockenhaupt FP, 2003, TROP MED INT HEALTH, V8, P118, DOI 10.1046/j.1365-3156.2003.01008.x; Mockenhaupt FP, 2000, T ROY SOC TROP MED H, V94, P477, DOI 10.1016/S0035-9203(00)90057-9; Ofori Mf, 2009, Ghana Med J, V43, P13; Ouedraogo S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-348; Pamba A, 2012, BLOOD, V120, P4123, DOI 10.1182/blood-2012-03-416032; Premji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006682; Schantz-Dunn Julianna, 2009, Rev Obstet Gynecol, V2, P186; Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09; Tiono AB, 2009, AM J TROP MED HYG, V81, P969, DOI 10.4269/ajtmh.2009.09-0351; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2012, UPD WHO POL REC INT; Wilson NO, 2011, AM J TROP MED HYG, V85, P12, DOI 10.4269/ajtmh.2011.10-0512; Youngster I, 2010, DRUG SAFETY, V33, P713, DOI 10.2165/11536520-000000000-00000	28	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136828	10.1371/journal.pone.0136828	http://dx.doi.org/10.1371/journal.pone.0136828			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327623	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700065
J	Yang, S; Lee, BU				Yang, Sejung; Lee, Byung-Uk			Poisson-Gaussian Noise Reduction Using the Hidden Markov Model in Contourlet Domain for Fluorescence Microscopy Images	PLOS ONE			English	Article							ANSCOMBE TRANSFORMATION; INTENSITY ESTIMATION; OPTIMAL INVERSION; WAVELETS	In certain image acquisitions processes, like in fluorescence microscopy or astronomy, only a limited number of photons can be collected due to various physical constraints. The resulting images suffer from signal dependent noise, which can be modeled as a Poisson distribution, and a low signal-to-noise ratio. However, the majority of research on noise reduction algorithms focuses on signal independent Gaussian noise. In this paper, we model noise as a combination of Poisson and Gaussian probability distributions to construct a more accurate model and adopt the contourlet transform which provides a sparse representation of the directional components in images. We also apply hidden Markov models with a framework that neatly describes the spatial and interscale dependencies which are the properties of transformation coefficients of natural images. In this paper, an effective denoising algorithm for Poisson-Gaussian noise is proposed using the contourlet transform, hidden Markov models and noise estimation in the transform domain. We supplement the algorithm by cycle spinning and Wiener filtering for further improvements. We finally show experimental results with simulations and fluorescence microscopy images which demonstrate the improved performance of the proposed approach.	[Yang, Sejung] Ewha Womans Univ, Med Ctr, Ewha Inst Convergence Med, Seoul, South Korea; [Lee, Byung-Uk] Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Lee, BU (corresponding author), Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea.	bulee@ewha.ac.kr		Lee, Byung-Uk/0000-0002-3452-3016	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A3013525, 2012M3A9B6055379, 2013R1A2A2A04015894]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A3013525, 2012M3A9B6055379, and 2013R1A2A2A04015894). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; BAMBERGER RH, 1992, IEEE T SIGNAL PROCES, V40, P882, DOI 10.1109/78.127960; Boulanger J, 2010, IEEE T MED IMAGING, V29, P442, DOI 10.1109/TMI.2009.2033991; BURT PJ, 1983, IEEE T COMMUN, V31, P532, DOI 10.1109/TCOM.1983.1095851; Charles C, 2003, COMPUT STAT DATA AN, V43, P139, DOI 10.1016/S0167-9473(02)00208-6; Coifman R. R., 1995, TRANSLATION INVARIAN, P125, DOI [10.1007/978-1-4612-2544-7, DOI 10.1007/978-1-4612-2544-7_9, 10.1007/978-1-4612-2544-7_9]; Crouse MS, 1998, IEEE T SIGNAL PROCES, V46, P886, DOI 10.1109/78.668544; da Cunha AL, 2006, IEEE T IMAGE PROCESS, V15, P3089, DOI 10.1109/TIP.2006.877507; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; Donoho D. L., 1993, P S APPL MATH, P173; Eslami R, 2003, CONF REC ASILOMAR C, P1982; Fisz M., 1955, C MATH, V3, P138, DOI DOI 10.4064/CM-3-2-138-146; Foi A, 2008, IEEE T IMAGE PROCESS, V17, P1737, DOI 10.1109/TIP.2008.2001399; Fryzlewicz P, 2004, J COMPUT GRAPH STAT, V13, P621, DOI 10.1198/106186004X2697; Giryes R, 2014, IEEE T IMAGE PROCESS, V23, P5057, DOI 10.1109/TIP.2014.2362057; Harmany ZT, 2012, IEEE T IMAGE PROCESS, V21, P1084, DOI 10.1109/TIP.2011.2168410; Jansen M, 2006, J R STAT SOC B, V68, P27, DOI 10.1111/j.1467-9868.2005.00531.x; Kolaczyk ED, 2000, ASTROPHYS J, V534, P490, DOI 10.1086/308718; Kolaczyk ED, 1999, STAT SINICA, V9, P119; LEE JS, 1980, IEEE T PATTERN ANAL, V2, P165, DOI 10.1109/TPAMI.1980.4766994; Lefkimmiatis S, 2009, IEEE T IMAGE PROCESS, V18, P1724, DOI 10.1109/TIP.2009.2022008; Lingenfelter DJ, 2009, P SOC PHOTO-OPT INS, V7246; Lu H, 2004, IEEE T IMAGE PROCESS, V13, P1128, DOI 10.1109/TIP.2003.822606; Luisier F, 2011, IEEE T IMAGE PROCESS, V20, P696, DOI 10.1109/TIP.2010.2073477; Luisier F, 2010, SIGNAL PROCESS, V90, P415, DOI 10.1016/j.sigpro.2009.07.009; Makitalo M, 2014, IEEE T IMAGE PROCESS, V23, P5348, DOI 10.1109/TIP.2014.2363735; Makitalo M, 2013, IEEE T IMAGE PROCESS, V22, P91, DOI 10.1109/TIP.2012.2202675; Makitalo M, 2011, IEEE T IMAGE PROCESS, V20, P2697, DOI 10.1109/TIP.2011.2121085; Makitalo M, 2011, IEEE T IMAGE PROCESS, V20, P99, DOI 10.1109/TIP.2010.2056693; Malfait M, 1997, IEEE T IMAGE PROCESS, V6, P549, DOI 10.1109/83.563320; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Mihcak MK, 1999, IEEE SIGNAL PROC LET, V6, P300, DOI 10.1109/97.803428; Nowak RD, 1999, IEEE T IMAGE PROCESS, V8, P666, DOI 10.1109/83.760334; Po DDY, 2006, IEEE T IMAGE PROCESS, V15, P1610, DOI 10.1109/TIP.2006.873450; Portilla J, 2003, IEEE T IMAGE PROCESS, V12, P1338, DOI 10.1109/TIP.2003.818640; ROBBINS H, 1964, ANN MATH STAT, V35, P1, DOI 10.1214/aoms/1177703729; Simoncelli E. P., 1999, BAYESIAN INFERENCE W, V141, p291 , DOI DOI 10.1007/978-1-4612-0567-8; Starck J.-L., 1998, IMAGE PROCESSING DAT; Starck JL, 2002, IEEE T IMAGE PROCESS, V11, P670, DOI [10.1109/TIP.2002.1014998, 10.1117/12.408568]; STEIN CM, 1981, ANN STAT, V9, P1135, DOI 10.1214/aos/1176345632; Zhang B., 2007, P IEEE INT C IM PROC, V6, P233; Zhang B, 2008, IEEE T IMAGE PROCESS, V17, P1093, DOI 10.1109/TIP.2008.924386	45	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136964	10.1371/journal.pone.0136964	http://dx.doi.org/10.1371/journal.pone.0136964			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352138	Green Published, gold			2022-12-27	WOS:000360932800054
J	Ullah, G; Demuro, A; Parker, I; Pearson, JE				Ullah, Ghanim; Demuro, Angelo; Parker, Ian; Pearson, John E.			Analyzing and Modeling the Kinetics of Amyloid Beta Pores Associated with Alzheimer's Disease Pathology	PLOS ONE			English	Article							AGGREGATED MARKOV-MODELS; INTRACELLULAR A-BETA; IMAGING CA2+ FLUX; ION-CHANNEL; ACETYLCHOLINE-RECEPTOR; INOSITOL TRISPHOSPHATE; CALCIUM; OLIGOMERS; PROTEIN; HYPOTHESIS	Amyloid beta (A beta) oligomers associated with Alzheimer's disease (AD) form Ca2+-permeable plasma membrane pores, leading to a disruption of the otherwise well-controlled intracellular calcium (Ca2+) homeostasis. The resultant up-regulation of intracellular Ca2+ concentration has detrimental implications for memory formation and cell survival. The gating kinetics and Ca2+ permeability of A beta pores are not well understood. We have used computational modeling in conjunction with the ability of optical patch-clamping for massively parallel imaging of Ca2+ flux through thousands of pores in the cell membrane of Xenopus oocytes to elucidate the kinetic properties of A beta pores. The fluorescence time-series data from individual pores were idealized and used to develop data-driven Markov chain models for the kinetics of the A beta pore at different stages of its evolution. Our study provides the first demonstration of developing Markov chain models for ion channel gating that are driven by optical-patch clamp data with the advantage of experiments being performed under close to physiological conditions. Towards the end, we demonstrate the upregulation of gating of various Ca2+ release channels due to A beta pores and show that the extent and spatial range of such up-regulation increases as A beta pores with low open probability and Ca2+ permeability transition into those with high open probability and Ca2+ permeability.	[Ullah, Ghanim] Univ S Florida, Dept Phys, Tampa, FL 33620 USA; [Demuro, Angelo; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Pearson, John E.] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87545 USA	State University System of Florida; University of South Florida; University of California System; University of California Irvine; United States Department of Energy (DOE); Los Alamos National Laboratory	Ullah, G (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	gullah@usf.edu			College of Arts and Sciences at USF; National Institute of Health (USA) [P50-AG16573, R37-GM48071, R01 GM065830]; Mathematical Biosciences Institute at OSU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065830, R37GM048071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016573] Funding Source: NIH RePORTER	College of Arts and Sciences at USF; National Institute of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathematical Biosciences Institute at OSU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a start up grant from College of Arts and Sciences at USF (GU), National Institute of Health (USA) grants P50-AG16573 (AD), R37-GM48071 (IP), and R01 GM065830 (JEP). Part of the work was conducted at the Ohio State University. GU would like to thank the Mathematical Biosciences Institute at OSU for an earlier career award.	Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; BAUER RJ, 1987, BIOPHYS J, V52, P961, DOI 10.1016/S0006-3495(87)83289-7; Berridge MJ, 2011, NEUROCHEM RES, V36, P1149, DOI 10.1007/s11064-010-0371-4; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Bruno WJ, 2013, BIOPHYS J, V105, P68, DOI 10.1016/j.bpj.2013.02.060; Bruno WJ, 2005, P NATL ACAD SCI USA, V102, P6326, DOI 10.1073/pnas.0409110102; Capone R, 2012, BIOCHEMISTRY-US, V51, P776, DOI 10.1021/bi2017427; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2005, J GEN PHYSIOL, V126, P179, DOI 10.1085/jgp.200509331; Demuro A, 2004, BIOL RES, V37, P675, DOI 10.4067/s0716-97602004000400025; Demuro A, 2004, BIOPHYS J, V86, P3250, DOI 10.1016/S0006-3495(04)74373-8; Demuro A, 2003, CELL CALCIUM, V34, P499, DOI 10.1016/S0143-4160(03)00154-4; Demuro A, 2013, J NEUROSCI, V33, P3824, DOI 10.1523/JNEUROSCI.4367-12.2013; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Diaz JC, 2009, P NATL ACAD SCI USA, V106, P3348, DOI 10.1073/pnas.0813355106; Gillman AL, 2014, J PHYS CHEM B, V118, P7335, DOI 10.1021/jp5040954; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hatip FFB, 2010, CURR ALZHEIMER RES, V7, P602; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hirakura Y, 1999, J NEUROSCI RES, V57, P458, DOI 10.1002/(SICI)1097-4547(19990815)57:4<458::AID-JNR5>3.0.CO;2-4; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; KIENKER P, 1989, PROC R SOC SER B-BIO, V236, P269, DOI 10.1098/rspb.1989.0024; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; McQuarrie A. D, 1998, REGRESSION TIME SERI; Milescu LS, 2000, QUB SOFTWARE; Muller M, 2011, P NATL ACAD SCI USA, V108, P13293, DOI 10.1073/pnas.1109297108; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Prangkio P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047261; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Reisert J, 2003, J GEN PHYSIOL, V122, P349, DOI 10.1085/jgp.200308888; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Small DH, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-7; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Ullah G, 2006, BIOPHYS J, V90, P3485, DOI 10.1529/biophysj.105.073460; Ullah G, 2012, J GEN PHYSIOL, V140, P159, DOI 10.1085/jgp.201110753; Ullah G, 2012, CELL CALCIUM, V52, P152, DOI 10.1016/j.ceca.2012.04.018; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Womack MD, 2002, EUR J NEUROSCI, V16, P1214, DOI 10.1046/j.1460-9568.2002.02171.x	50	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137357	10.1371/journal.pone.0137357	http://dx.doi.org/10.1371/journal.pone.0137357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348728	Green Submitted, gold, Green Published			2022-12-27	WOS:000360897600040
J	Krishnan, NP; Nguyen, NQ; Papp-Wallace, KM; Bonomo, RA; van den Akker, F				Krishnan, Nikhil P.; Nguyen, Nhu Q.; Papp-Wallace, Krisztina M.; Bonomo, Robert A.; van den Akker, Focco			Inhibition of Klebsiella beta-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study	PLOS ONE			English	Article							TRANS-ENAMINE INTERMEDIATE; CRYSTAL-STRUCTURE; CLASS-A; CLAVULANIC ACID; BORONIC ACID; COMPLEX; EPIDEMIOLOGY; PNEUMONIAE; INSIGHTS; NXL104	beta-Lactamase inhibition is an important clinical strategy in overcoming beta-lactamase-mediated resistance to beta-lactam antibiotics in Gram negative bacteria. A new beta-lactamase inhibitor, avibactam, is entering the clinical arena and promising to be a major step forward in our antibiotic armamentarium. Avibactam has remarkable broad-spectrum activity in being able to inhibit classes A, C, and some class D beta-lactamases. We present here structural investigations into class A beta-lactamase inhibition by avibactam as we report the crystal structures of SHV-1, the chromosomal penicillinase of Klebsiella pneumoniae, and KPC-2, an acquired carbapenemase found in the same pathogen, complexed with avibactam. The 1.80 angstrom KPC-2 and 1.42 angstrom resolution SHV-1 beta-lactamase avibactam complex structures reveal avibactam covalently bonded to the catalytic S70 residue. Analysis of the interactions and chair-shaped conformation of avibactam bound to the active sites of KPC-2 and SHV-1 provides structural insights into recently laboratory-generated amino acid substitutions that result in resistance to avibactam in KPC-2 and SHV-1. Furthermore, we observed several important differences in the interactions with amino acid residues, in particular that avibactam forms hydrogen bonds to S130 in KPC-2 but not in SHV-1, that can possibly explain some of the different kinetic constants of inhibition. Our observations provide a possible reason for the ability of KPC-2 beta-lactamase to slowly desulfate avibactam with a potential role for the stereochemistry around the N1 atom of avibactam and/or the presence of an active site water molecule that could aid in avibactam desulfation, an unexpected consequence of novel inhibition chemistry.	[Krishnan, Nikhil P.; Nguyen, Nhu Q.; Bonomo, Robert A.; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Papp-Wallace, Krisztina M.; Bonomo, Robert A.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	van den Akker, F (corresponding author), Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	focco.vandenakker@case.edu	Papp-Wallace, Krisztina/L-2923-2019	Papp-Wallace, Krisztina/0000-0002-9976-7898	AstraZeneca; Cleveland Department of Veterans Affairs; Veterans Affairs Career Development Award; Department of Veterans Affairs Merit Review Program [1I01BX001974]; Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center (VISN 10 GRECC); National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01 AI100560, R01 AI063517]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063517, R01AI100560, R01AI072219] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001974] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); Cleveland Department of Veterans Affairs; Veterans Affairs Career Development Award; Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center (VISN 10 GRECC); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a research grant from AstraZeneca (KMP-W, RAB, and FVDA), who also provided the avibactam compound for the study. KMP-W is supported by funds and/or facilities provided by the Cleveland Department of Veterans Affairs and a Veterans Affairs Career Development Award. RAB is supported in part by funds and/or facilities provided by the Cleveland Department of Veterans Affairs, the Department of Veterans Affairs Merit Review Program 1I01BX001974, the Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center (VISN 10 GRECC), and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Numbers R01 AI100560 and R01 AI063517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratu S, 2005, ANTIMICROB AGENTS CH, V49, P3018, DOI 10.1128/AAC.49.7.3018-3020.2005; Bush K, 2013, J INFECT CHEMOTHER, V19, P549, DOI 10.1007/s10156-013-0640-7; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Castanheira M, 2014, MICROB DRUG RESIST, V20, P436, DOI 10.1089/mdr.2013.0181; Deshpande LM, 2006, DIAGN MICR INFEC DIS, V56, P367, DOI 10.1016/j.diagmicrobio.2006.07.004; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Ehmann DE, 2013, J BIOL CHEM, V288, P27960, DOI 10.1074/jbc.M113.485979; Ehmann DE, 2012, P NATL ACAD SCI USA, V109, P11663, DOI 10.1073/pnas.1205073109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endimiani A, 2011, ANTIMICROB AGENTS CH, V55, P82, DOI 10.1128/AAC.01198-10; Endimiani A, 2009, ANTIMICROB AGENTS CH, V53, P3599, DOI 10.1128/AAC.00641-09; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; Ke W, 2012, ANTIMICROB AGENTS CH, V56, P2713, DOI 10.1128/AAC.06099-11; King DT, 2015, ACS INFECT DIS, V1, P175, DOI 10.1021/acsinfecdis.5b00007; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; Lahiri SD, 2015, ACS CHEM BIOL, V10, P591, DOI 10.1021/cb500703p; Lahiri SD, 2013, ANTIMICROB AGENTS CH, V57, P2496, DOI 10.1128/AAC.02247-12; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Livermore DM, 2011, ANTIMICROB AGENTS CH, V55, P390, DOI 10.1128/AAC.00756-10; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padayatti PS, 2006, J AM CHEM SOC, V128, P13235, DOI 10.1021/ja063715w; Padayatti PS, 2004, BIOCHEMISTRY-US, V43, P843, DOI 10.1021/bi035985m; Padayatti PS, 2005, J BIOL CHEM, V280, P34900, DOI 10.1074/jbc.M505333200; Papp-Wallace KM, 2015, ANTIMICROB AGENTS CH, V59, P3710, DOI 10.1128/AAC.04406-14; Petrella S, 2008, ANTIMICROB AGENTS CH, V52, P3725, DOI 10.1128/AAC.00163-08; Rodkey EA, 2012, J AM CHEM SOC, V134, P16798, DOI 10.1021/ja3073676; Rydberg P, 2013, ANGEW CHEM INT EDIT, V52, P993, DOI 10.1002/anie.201206207; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sgrignani J, 2014, BIOCHEMISTRY-US, V53, P5174, DOI 10.1021/bi500589x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winkler ML, 2015, ANTIMICROB AGENTS CH, V59, P3700, DOI 10.1128/AAC.04405-14; Winkler ML, 2013, J MED CHEM, V56, P1084, DOI 10.1021/jm301490d; Xu H, 2012, BIOCHEMISTRY-US, V51, P4551, DOI 10.1021/bi300508r	36	53	55	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136813	10.1371/journal.pone.0136813	http://dx.doi.org/10.1371/journal.pone.0136813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340563	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200018
J	Schick, MA; Baar, W; Bruno, RR; Wollborn, J; Held, C; Schneider, R; Flemming, S; Schlegel, N; Roewer, N; Neuhaus, W; Wunder, C				Schick, Martin Alexander; Baar, Wolfgang; Bruno, Raphael Romano; Wollborn, Jakob; Held, Christopher; Schneider, Reinhard; Flemming, Sven; Schlegel, Nicolas; Roewer, Norbert; Neuhaus, Winfried; Wunder, Christian			Balanced Hydroxyethylstarch (HES 130/0.4) Impairs Kidney Function In-Vivo without Inflammation	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; SEVERE SEPSIS; FLUID RESUSCITATION; INTENSIVE-CARE; STARCH; THERAPY; CRYSTALLOIDS; COLLOIDS; SAFETY; REPLACEMENT	Volume therapy is a standard procedure in daily perioperative care, and there is an ongoing discussion about the benefits of colloid resuscitation with hydroxyethylstarch (HES). In sepsis HES should be avoided due to a higher risk for acute kidney injury (AKI). Results of the usage of HES in patients without sepsis are controversial. Therefore we conducted an animal study to evaluate the impact of 6% HES 130/0.4 on kidney integrity with sepsis or under healthy conditions Sepsis was induced by standardized Colon Ascendens Stent Peritonitis (sCASP). sCASP-group as well as control group (C) remained untreated for 24 h. After 18 h sCASP+HES group (sCASP+VOL) and control+HES (C+VOL) received 50 ml/KG balanced 6% HES (VOL) 130/0.4 over 6h. After 24h kidney function was measured via Inulin- and PAH-Clearance in re-anesthetized rats, and serum urea, creatinine (crea), cystatin C and Neutrophil gelatinase-associated lipocalin (NGAL) as well as histopathology were analysed. In vitro human proximal tubule cells (PTC) were cultured +/- lipopolysaccharid (LPS) and with 0.1-4.0% VOL. Cell viability was measured with XTT-, cell toxicity with LDH-test. sCASP induced severe septic AKI demonstrated divergent results regarding renal function by clearance or creatinine measure focusing on VOL. Soleley HES (C+VOL) deteriorated renal function without sCASP. Histopathology revealed significantly derangements in all HES groups compared to control. In vitro LPS did not worsen the HES induced reduction of cell viability in PTC cells. For the first time, we demonstrated, that application of 50 ml/KG 6% HES 130/0.4 over 6 hours induced AKI without inflammation in vivo. Severity of sCASP induced septic AKI might be no longer susceptible to the way of volume expansion.	[Schick, Martin Alexander; Baar, Wolfgang; Bruno, Raphael Romano; Wollborn, Jakob; Roewer, Norbert; Neuhaus, Winfried; Wunder, Christian] Univ Hosp Wurzburg, Inst Anaesthesia & Crit Care, Wurzburg, Germany; [Baar, Wolfgang; Wollborn, Jakob] Univ Med Ctr Freiburg, Dept Anesthesiol & Intens Care Med, Freiburg, Germany; [Neuhaus, Winfried] Univ Vienna, Dept Med Chem, Vienna, Austria; [Held, Christopher; Schneider, Reinhard] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Flemming, Sven; Schlegel, Nicolas] Univ Wurzburg, Dept Gen Visceral Vasc & Paediat Surg, Dept Surg 1, D-97070 Wurzburg, Germany; [Neuhaus, Winfried] Med Univ Vienna, Inst Med Genet, Vienna, Austria	University of Wurzburg; University of Freiburg; University of Vienna; University of Wurzburg; University of Wurzburg; Medical University of Vienna	Schick, MA (corresponding author), Univ Hosp Wurzburg, Inst Anaesthesia & Crit Care, Wurzburg, Germany.	schick_m@ukw.de	Schick, Martin/ABH-6971-2020; Flemming, Sven/AAA-9950-2020	Flemming, Sven/0000-0002-6304-3169; Neuhaus, Winfried/0000-0002-6552-7183; Bruno, Raphael Romano/0000-0003-3776-3530	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.	Adamson RH, 2004, J PHYSIOL-LONDON, V557, P889, DOI 10.1113/jphysiol.2003.058255; Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Bayer O, 2012, CRIT CARE MED, V40, P2543, DOI 10.1097/CCM.0b013e318258fee7; Bruno RR, 2014, ANESTH ANALG, V119, P570, DOI 10.1213/ANE.0000000000000325; Chen N, 2006, PEDIATR NEPHROL, V21, P160, DOI 10.1007/s00467-005-2105-4; Corrigan G, 1999, AM J PHYSIOL-RENAL, V277, pF312, DOI 10.1152/ajprenal.1999.277.2.F312; Flemming S, 2014, SHOCK, V41, P537, DOI 10.1097/SHK.0000000000000152; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Irwin MG, 2014, ANESTH ANALG, V119, P737, DOI 10.1213/ANE.0000000000000221; Li LX, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0815-y; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Neuhaus W, 2012, ANESTH ANALG, V114, P371, DOI 10.1213/ANE.0b013e3182367a54; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Raghunathan K, 2014, ANESTH ANALG, V119, P731, DOI 10.1213/ANE.0000000000000186; Schick MA BW, 2014, INTENSIVE CARE MED E, V2; Schick MA, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-179; Schick MA, 2012, J PHYSIOL-LONDON, V590, P2693, DOI 10.1113/jphysiol.2012.232116; Schick MA, 2010, INTENS CARE MED, V36, P541, DOI 10.1007/s00134-009-1704-0; Schneider R, 2007, AM J PHYSIOL-RENAL, V292, pF1599, DOI 10.1152/ajprenal.00473.2006; Starling E H, 1896, J Physiol, V19, P312; Stumpner J, 2012, ACTA ANAESTH SCAND, V56, P904, DOI 10.1111/j.1399-6576.2012.02657.x; Van der Linden P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0830-z; Weiskopf RB, 2014, ANESTH ANALG, V119, P509, DOI 10.1213/ANE.0000000000000323; Witt L, 2014, PEDIATR ANESTH, V24, P974, DOI 10.1111/pan.12445; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515; Xu C, 2014, KIDNEY INT, V85, P72, DOI 10.1038/ki.2013.286	27	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137247	10.1371/journal.pone.0137247	http://dx.doi.org/10.1371/journal.pone.0137247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340751	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200040
J	Heishima, K; Mori, T; Sakai, H; Sugito, N; Murakami, M; Yamada, N; Akao, Y; Maruo, K				Heishima, Kazuki; Mori, Takashi; Sakai, Hiroki; Sugito, Nobuhiko; Murakami, Mami; Yamada, Nami; Akao, Yukihiro; Maruo, Kohji			MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis	PLOS ONE			English	Article							CERVICAL-CANCER CELLS; DOWN-REGULATION; NEGATIVE REGULATOR; GROWTH-FACTOR; P53; ANGIOGENESIS; ANGIOSARCOMA; EXPRESSION; MIR-214; BREAST	MicroRNA-214 regulates both angiogenic function in endothelial cells and apoptosis in various cancers. However, the regulation and function of miR-214 is unclear in canine hemangiosarcoma, which is a spontaneous model of human angiosarcoma. The expression and functional roles of miR-214 in canine hemangiosarcoma were presently explored by performing miRNA TaqMan qRT-PCR and transfecting cells with synthetic microRNA. Here, we report that miR-214 was significantly down-regulated in the cell lines used and in clinical samples of canine hemangiosarcoma. Restoration of miR-214 expression reduced cell growth and induced apoptosis in canine hemangiosarcoma cell lines through transcriptional activation of p53-regulated genes although miR-214 had a slight effect of growth inhibition on normal endothelial cells. We identified COP1, which is a critical negative regulator of p53, as a novel direct target of miR-214. COP1 was overexpressed and the specific COP1 knockdown induced apoptosis through transcriptional activation of p53-regulated genes as well as did miR-214-transfection in HSA cell lines. Furthermore, p53 knockdown abolished the miR-214-COP1-mediated apoptosis; thus, miR-214 and COP1 regulated apoptosis through controlling p53 in HSA. In conclusion, miR-214 functioned as a tumor suppressor in canine hemangiosarcoma by inducing apoptosis through recovering the function of p53. miR-214 down-regulation and COP1 overexpression is likely to contribute to tumorigenesis of HSA. Therefore, targeting miR-214-COP1-p53 axis would possibly be a novel effective strategy for treatment of canine hemangiosarcoma and capable of being applied to the development of novel therapeutics for human angiosarcoma.	[Heishima, Kazuki; Mori, Takashi; Sakai, Hiroki; Maruo, Kohji] Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu, Japan; [Heishima, Kazuki; Mori, Takashi; Murakami, Mami; Maruo, Kohji] Gifu Univ, Fac Appl Biol Sci, Dept Vet Clin Oncol, Gifu, Gifu, Japan; [Sakai, Hiroki] Gifu Univ, Fac Appl Biol Sci, Dept Vet Pathol, Gifu, Gifu, Japan; [Sugito, Nobuhiko; Yamada, Nami; Akao, Yukihiro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Gifu, Japan	Gifu University; Gifu University; Gifu University; Gifu University	Mori, T (corresponding author), Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu, Japan.	tmori@gifu-u.ac.jp	Heishima, Kazuki/J-6233-2019	Heishima, Kazuki/0000-0002-4629-8661; Yamada, Nami/0000-0002-1220-0814				Abraham JA, 2007, ANN SURG ONCOL, V14, P1953, DOI 10.1245/s10434-006-9335-y; Anoun S, 2014, TURK J HEMATOL, V31, P408, DOI 10.4274/tjh.2013.0049; Blanchard DK, 2002, AM J SURG, V184, P356, DOI 10.1016/S0002-9610(02)00943-1; Chan LS, 2009, EUR J PHARM SCI, V38, P370, DOI 10.1016/j.ejps.2009.08.008; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; DONNELL RM, 1981, AM J SURG PATHOL, V5, P629, DOI 10.1097/00000478-198110000-00005; DORN CR, 1968, J NATL CANCER I, V40, P295; Dornan D, 2004, CANCER RES, V64, P7226, DOI 10.1158/0008-5472.CAN-04-2601; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Fayette J, 2007, ANN ONCOL, V18, P2030, DOI 10.1093/annonc/mdm381; Gamlem H, 2008, APMIS, V116, P41, DOI 10.1111/j.1600-0463.2008.125m4.x; Goga A, 2007, MOL INTERV, V7, P199, DOI 10.1124/mi.7.4.6; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang HJ, 2014, ONCOTARGET, V5, P2161, DOI 10.18632/oncotarget.1855; Italiano A, 2012, CANCER-AM CANCER SOC, V118, P5878, DOI 10.1002/cncr.27614; Khanna C, 2006, NATURE; Lee YH, 2010, CANCER RES, V70, P8264, DOI 10.1158/0008-5472.CAN-10-0749; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2012, FEBS J, V279, P2393, DOI 10.1111/j.1742-4658.2012.08618.x; Long LM, 2015, ONCOL LETT, V9, P645, DOI 10.3892/ol.2014.2746; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Millau JF, 2009, MUTAT RES-REV MUTAT, V681, P118, DOI 10.1016/j.mrrev.2008.06.002; Misiewicz-Krzeminska I, 2013, HAEMATOLOGICA, V98, P640, DOI 10.3324/haematol.2012.070011; Murai A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-128; Ogilvie GK, 1996, J VET INTERN MED, V10, P379, DOI 10.1111/j.1939-1676.1996.tb02085.x; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Ratert N, 2013, J MOL DIAGN, V15, P695, DOI 10.1016/j.jmoldx.2013.05.008; Rouhani P, 2008, CANCER-AM CANCER SOC, V113, P616, DOI 10.1002/cncr.23571; Sharma T, 2015, FUTURE ONCOL, V11, P349, DOI [10.2217/fon.14.193, 10.2217/FON.14.193]; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; Taniguchi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08647; Tate G, 2007, CANCER GENET CYTOGEN, V178, P160, DOI 10.1016/j.cancergencyto.2007.07.017; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Mil A, 2012, CARDIOVASC RES, V93, P655, DOI 10.1093/cvr/cvs003; vanLeeuwen IS, 1997, CANCER LETT, V111, P173, DOI 10.1016/S0304-3835(96)04529-6; Wang F, 2013, FEBS LETT, V587, P488, DOI 10.1016/j.febslet.2013.01.016; Wang JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118086; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Yamada N, 2014, BBA-GENE REGUL MECH, V1839, P1256, DOI 10.1016/j.bbagrm.2014.09.002; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Yonemaru K, 2007, J VET MED SCI, V69, P271, DOI 10.1292/jvms.69.271; Zhao ZQ, 2012, BMB REP, V45, P641, DOI 10.5483/BMBRep.2012.45.11.097; Zietz C, 1998, AM J PATHOL, V153, P1425, DOI 10.1016/S0002-9440(10)65729-X	51	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137361	10.1371/journal.pone.0137361	http://dx.doi.org/10.1371/journal.pone.0137361			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335793	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400054
J	Lee, YS; Jeng, MJ; Tsao, PC; Soong, WJ; Chou, P				Lee, Yu-Sheng; Jeng, Mei-Jy; Tsao, Pei-Chen; Soong, Wen-Jue; Chou, Pesus			Prognosis and Risk Factors for Congenital Airway Anomalies in Children with Congenital Heart Disease: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; CARDIAC-SURGERY; EXTRACARDIAC ABNORMALITIES; TRACHEOBRONCHIAL ANOMALIES; DIAGNOSIS; MALFORMATIONS; COMPRESSION; OBSTRUCTION; VALIDATION; ACCURACY	The mortality risk associated with congenital airway anomalies (CAA) in children with congenital heart disease (CHD) is unclear. This study aimed to investigate the factors associated with CAA, and the associated mortality risk, among children with CHD. Methods This nationwide, population-based study evaluated 39,652 children with CHD aged 0-5 years between 2000 and 2011, using the Taiwan National Health Insurance Research Database (NHIRD). We performed descriptive, logistic regression, Kaplan-Meier, and Cox regression analyses of the data. Results Among the children with CHD, 1,591 (4.0%) had concomitant CAA. Children with CHD had an increased likelihood of CAA if they were boys (odds ratio [OR], 1.48; 95% confidence interval [CI], 1.33-1.64), infants (OR, 5.42; 95% CI, 4.06-7.24), or had a congenital musculoskeletal anomaly (OR, 3.19; 95% CI, 2.67-3.81), and were typically identified 0-3 years after CHD diagnosis (OR, 1.33; 95% CI 1.17-1.51). The mortality risk was increased in children with CHD and CAA (crude hazard ratio [HR], 2.05; 95% CI, 1.77-2.37), even after adjusting for confounders (adjusted HR, 1.76; 95% CI, 1.51-2.04). Mortality risk also changed by age and sex (adjusted HR and 95% CI are quoted): neonates, infants, and toddlers and preschool children, 1.67 (1.40-2.00), 1.93 (1.47-2.55), and 4.77 (1.39-16.44), respectively; and boys and girls, 1.62 (1.32-1.98) and 2.01 (1.61-2.50), respectively. Conclusion The mortality risk is significantly increased among children with CHD and comorbid CAA. Clinicians should actively seek CAA during the follow-up of children with CHD.	[Lee, Yu-Sheng; Jeng, Mei-Jy; Tsao, Pei-Chen; Soong, Wen-Jue] Taipei Vet Gen Hosp, Dept Pediat, Div Gen Pediat, Taipei, Taiwan; [Lee, Yu-Sheng; Jeng, Mei-Jy; Tsao, Pei-Chen; Soong, Wen-Jue] Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan; [Lee, Yu-Sheng; Chou, Pesus] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Yu-Sheng; Chou, Pesus] Natl Yang Ming Univ, Sch Med, Community Med Res Ctr, Taipei 112, Taiwan; [Jeng, Mei-Jy] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Soong, WJ (corresponding author), Taipei Vet Gen Hosp, Dept Pediat, Div Gen Pediat, Taipei, Taiwan.	wjsoong@vghtpe.gov.tw; pschou@ym.edu.tw			Taipei Veterans General Hospital, Taiwan [V102B-047]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This study was supported by a grant from the Taipei Veterans General Hospital (V102B-047), Taiwan, and YSL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli A, 2013, J CRANIOFAC SURG, V24, P1423, DOI 10.1097/SCS.0b013e3182953b43; Altman KW, 1999, ARCH OTOLARYNGOL, V125, P525, DOI 10.1001/archotol.125.5.525; BACKER CL, 1989, J THORAC CARDIOV SUR, V97, P725; Bernier Pierre-Luc, 2010, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V13, P26, DOI 10.1053/j.pcsu.2010.02.005; Bernstein D, 2011, NELSON TXB PEDIAT, V19th; Bertrand P, 2003, PEDIATR PULM, V36, P137, DOI 10.1002/ppul.10332; Billett J, 2008, HEART, V94, P1194, DOI 10.1136/hrt.2007.122671; Brown JW, 2006, ANN THORAC SURG, V82, P2221, DOI 10.1016/j.athoracsur.2006.07.022; Chen YJ, 2012, ARCH DERMATOL, V148, P103, DOI 10.1001/archdermatol.2011.682; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Connor JA, 2005, PEDIATRICS, V116, P689, DOI 10.1542/peds.2004-2071; Cuneo BF, 2006, CURR OPIN PEDIATR, V18, P490, DOI 10.1097/01.mop.0000245348.52960.11; Gittenberger-de Groot AC, 2013, SEMIN FETAL NEONAT M, V18, P237, DOI 10.1016/j.siny.2013.04.008; Gonzalez JH, 2009, PEDIATR CARDIOL, V30, P269, DOI 10.1007/s00246-008-9331-z; GREENWOOD RD, 1984, CLIN PEDIATR, V23, P145, DOI 10.1177/000992288402300303; GREENWOOD RD, 1975, PEDIATRICS, V55, P485; Guillemaud JP, 2007, ARCH OTOLARYNGOL, V133, P672, DOI 10.1001/archotol.133.7.672; HANNA EJ, 1994, J MED GENET, V31, P858, DOI 10.1136/jmg.31.11.858; Healy F, 2012, PAEDIATR RESPIR REV, V13, P10, DOI 10.1016/j.prrv.2011.01.007; Healy F, 2010, EUR J PEDIATR, V169, P1, DOI 10.1007/s00431-009-1027-8; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Jiao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082826; Kazim R, 1998, J CARDIOTHOR VASC AN, V12, P553, DOI 10.1016/S1053-0770(98)90100-8; Khariwala SS, 2005, ARCH OTOLARYNGOL, V131, P336, DOI 10.1001/archotol.131.4.336; Lee SL, 2002, PEDIATR PULM, V34, P304, DOI 10.1002/ppul.10164; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lyons M, 2012, EARLY HUM DEV, V88, P951, DOI 10.1016/j.earlhumdev.2012.09.001; Massin MM, 2007, ACTA PAEDIATR, V96, P753, DOI 10.1111/j.1651-2227.2007.00275.x; Mehta RP, 2005, LARYNGOSCOPE, V115, P1923, DOI 10.1097/01.mlg.0000172037.49945.2f; MITCHELL SC, 1971, CIRCULATION, V43, P323, DOI 10.1161/01.CIR.43.3.323; Noel CV, 2014, CONGENIT HEART DIS, V9, P294, DOI 10.1111/chd.12138; Pereira KD, 1997, CHEST, V111, P1769, DOI 10.1378/chest.111.6.1769; Pfammatter JP, 2006, ANN THORAC SURG, V81, P1008, DOI 10.1016/j.athoracsur.2005.09.015; Rogers DJ, 2013, JAMA OTOLARYNGOL, V139, P586, DOI 10.1001/jamaoto.2013.3214; Roodpeyma S, 2002, CLIN PEDIATR, V41, P653, DOI 10.1177/000992280204100903; Sivanandam S, 2006, AM J PERINAT, V23, P241, DOI 10.1055/s-2006-939535; STOLL C, 1989, EUR J EPIDEMIOL, V5, P382, DOI 10.1007/BF00144842; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wang CC, 2013, PEDIATR PULM, V48, P587, DOI 10.1002/ppul.22674; Welke KF, 2006, ANN THORAC SURG, V82, P164, DOI 10.1016/j.athoracsur.2006.03.004	41	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137437	10.1371/journal.pone.0137437	http://dx.doi.org/10.1371/journal.pone.0137437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334302	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400058
J	Petrillo, M; Zannoni, GF; Martinelli, E; Anchora, LP; Ferrandina, G; Tropeano, G; Fagotti, A; Scambia, G				Petrillo, Marco; Zannoni, Gian Franco; Martinelli, Enrica; Anchora, Luigi Pedone; Ferrandina, Gabriella; Tropeano, Giovanna; Fagotti, Anna; Scambia, Giovanni			Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer	PLOS ONE			English	Article							RADICAL SURGERY; CONCURRENT CHEMOTHERAPY; RADIATION-THERAPY; PELVIC RADIATION; CARCINOMA; CISPLATIN; STAGE; COMPLICATIONS; HYSTERECTOMY; RADIOTHERAPY	Objective we investigate the prognostic role of pre-treatment ratio between Type 1 (M1) and Type 2 (M2) tumor-associated macrophages (TAMs) in locally advanced cervical cancer (LACC) patients treated with chemoradiation (CT/RT). Methods 84 consecutive LACC patients treated with cisplatin-based CT/RT for a total dose of 50.0 Gy, followed by radical surgery were analysed. Double-staining immunohistochemistry of CD163/p-STAT, CD68/pSTAT1, CD163/c-MAF, and CD68/c-MAF was performed on tumor samples taken at the time of diagnosis. TAMs with CD163+pSTAT1+, or CD68+pSTAT1+ were defined M1; CD163+c-MAF+ or CD68+c-MAF+ defined the M2 phenotype. The number of M1 and M2 cells was counted at low magnification by evaluating for each case the same tumour area. The ratio between M1 and M2 (M1/M2) was finally calculated. Results At diagnosis, we observed a direct correlation between the number of circulating monocytes and of TAMs (p-value = 0.001). Patients with high M1/M2 experienced more frequently complete pathologic response (no residual tumor) to CT/RT, compared to cases with low M1/M2 (55.0% Vs 29.5%; p-value = 0.029). At multivariate analysis M1/M2 (OR = 2.067; p-value = 0.037) emerged as independent predictor of pathologic response to CT/RT. Women with high M1/M2 showed a longer 5-yrs Disease-free (67.2% Vs. 44.3%; p-value = 0.019), and 5-yrs Overall (69.3% Vs. 46.9%; p-value = 0.037) survival, compared to cases with low M1/M2. The presence of a high M1/M2 ratio was independently associated with an unfavourable survival outcome in multivariate analysis. Conclusions polarisation of TAMs toward a M2 phenotype, as reflected by a lower M1/M2 ratio, is an independent predictor of poor response to CT/RT, and shorter survival in LACC.	[Petrillo, Marco; Martinelli, Enrica; Anchora, Luigi Pedone; Ferrandina, Gabriella; Tropeano, Giovanna; Scambia, Giovanni] Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Gynecol Oncol Unit, Rome, Italy; [Petrillo, Marco] Univ Cattolica Sacro Cuore, Dept Oncol, Gynecol Oncol Unit, Fdn John Paul 2, Campobasso, Italy; [Zannoni, Gian Franco] Univ Cattolica Sacro Cuore, Dept Human Pathol, Div Gynecol Pathol, Rome, Italy; [Fagotti, Anna] Univ Perugia, St Maria Hosp, Div Gynecol Oncol, Terni, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Perugia	Petrillo, M (corresponding author), Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, Gynecol Oncol Unit, Rome, Italy.	marco.petrillo@gmail.com	Anchora, Luigi Pedone/AAC-1331-2019; Zannoni, Gian Franco/AAC-4754-2020; Ferrandina, Gabriella/AAA-9083-2019; fagotti, anna AF/K-5233-2018	Anchora, Luigi Pedone/0000-0001-8036-9323; Zannoni, Gian Franco/0000-0002-4473-7560; FERRANDINA, Maria Gabriella/0000-0003-4672-4197; Petrillo, Marco/0000-0003-0306-4328				Allavena P, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24614; Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Benedetti-Panici P, 2003, EUR J CANCER, V39, P2470, DOI 10.1016/S0959-8049(03)00425-8; Cellini N, 2008, AM J CLIN ONCOL-CANC, V31, P280, DOI 10.1097/COC.0b013e31815aff03; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Distefano M, 2005, GYNECOL ONCOL, V99, pS166, DOI 10.1016/j.ygyno.2005.07.074; Ferlay J SH, 2008, GLOBOCAN 2008 V2 0 C; Ferrandina G, 2010, GYNECOL ONCOL, V119, P404, DOI 10.1016/j.ygyno.2010.08.004; Jurado M, 1999, GYNECOL ONCOL, V74, P30, DOI 10.1006/gyno.1999.5424; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keys HM, 1999, NEW ENGL J MED, V340, P1154, DOI 10.1056/NEJM199904153401503; Lee HW, 2013, BBA-REV CANCER, V1835, P170, DOI 10.1016/j.bbcan.2012.12.007; Lee YY, 2012, GYNECOL ONCOL, V124, P92, DOI 10.1016/j.ygyno.2011.09.034; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mazibrada J, 2008, GYNECOL ONCOL, V108, P112, DOI 10.1016/j.ygyno.2007.08.095; McNeil C, 1999, J NATL CANCER I, V91, P500, DOI 10.1093/jnci/91.6.500a; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Rigo A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-273; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; van Steenwijk PJD, 2013, INT J CANCER, V133, P2884, DOI 10.1002/ijc.28309; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Whitney CW, 1999, J CLIN ONCOL, V17, P1339, DOI 10.1200/JCO.1999.17.5.1339; Zannoni GF, 2008, INT J GYNECOL PATHOL, V27, P274, DOI 10.1097/PGP.0b013e31815b1263	30	50	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136654	10.1371/journal.pone.0136654	http://dx.doi.org/10.1371/journal.pone.0136654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335330	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400018
J	Silva, CRE; Borges, FFV; Bernardes, A; Perez, CN; Silva, DDE; Chen-Chen, L				Ribeiro e Silva, Carolina; Veloso Borges, Flavio Fernandes; Bernardes, Aline; Perez, Caridad Noda; de Melo e Silva, Daniela; Chen-Chen, Lee			Genotoxic, Cytotoxic, Antigenotoxic, and Anticytotoxic Effects of Sulfonamide Chalcone Using the Ames Test and the Mouse Bone Marrow Micronucleus Test	PLOS ONE			English	Article							CHEMOPREVENTIVE AGENTS; INDUCED MUTAGENICITY; ACYL SULFONAMIDE; ANTIMUTAGENICITY; ANTIOXIDANT; DERIVATIVES; INHIBITORS; ASSAY; MODULATION; ACTIVATION	Chalcones present several biological activities and sulfonamide chalcone derivatives have shown important biological applications, including antitumor activity. In this study, genotoxic, cytotoxic, antigenotoxic, and anticytotoxic activities of the sulfonamide chalcone N-{4[3-(4-nitrophenyl)prop-2-enoyl]phenyl}benzenesulfonamide (CPN) were assessed using the Salmonella typhimurium reverse mutation test (Ames test) and the mouse bone marrow micronucleus test. The results showed that CPN caused a small increase in the number of histidine revertant colonies in S. typhimurium strains TA98 and TA100, but not statistically significant (p > 0.05). The antimutagenicity test showed that CPN significantly decreased the number of His(+) revertants in strain TA98 at all doses tested (p < 0.05), whereas in strain TA100 this occurred only at doses higher than 50 mu g/plate (p < 0.05). The results of the micronucleus test indicated that CPN significantly increased the frequency of micronucleated polychromatic erythrocytes (MNPCE) at 24 h and 48 h, revealing a genotoxic effect of this compound. Also, a significant decrease in polychromatic/normochromatic erythrocyte ratio (PCE/NCE) was observed at the higher doses of CPN at 24 h and 48 h (p < 0.05), indicating its cytotoxic action. CPN co-administered with mitomycin C (MMC) significantly decreased the frequency of MNPCE at almost all doses tested at 24 h (p < 0.05), showing its antigenotoxic activity, and also presented a small decrease in MNPCE at 48 h (p > 0.05). Additionally, CPN co-administered with MMC significantly increased PCE/NCE ratio at all doses tested, demonstrating its anticytotoxic effect. In summary, CPN presented genotoxic, cytotoxic, antigenotoxic, and anticytotoxic properties.	[Ribeiro e Silva, Carolina; Veloso Borges, Flavio Fernandes; de Melo e Silva, Daniela; Chen-Chen, Lee] Univ Fed Goias, Inst Ciencias Biol, Goiania, Go, Brazil; [Bernardes, Aline; Perez, Caridad Noda] Univ Fed Goias, Inst Quim, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Silva, CRE (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Goiania, Go, Brazil.	crs_bio@hotmail.com	Perez, Caridad C. Noda Noda/M-6704-2013; Chen-Chen, Lee/Q-9797-2019; Chen, Lee Chen/B-1668-2013; Noda-Perez, Caridad/AAO-1659-2021	Perez, Caridad C. Noda Noda/0000-0003-0586-0774; Chen-Chen, Lee/0000-0002-0386-247X; Chen, Lee Chen/0000-0002-0386-247X; Noda-Perez, Caridad/0000-0003-0586-0774; Silva, Daniela de Melo/0000-0003-0362-0988				Andrighetti-Frohner CR, 2007, ACTA CRYSTALLOGR E, V63, pO3275, DOI 10.1107/S1600536807029303; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Cheng JH, 2008, BIOORGAN MED CHEM, V16, P7270, DOI 10.1016/j.bmc.2008.06.031; Claxton LD, 2010, ENVIRON HEALTH PERSP, V118, P1515, DOI 10.1289/ehp.1002336; Damazio RG, 2010, EUR J MED CHEM, V45, P1332, DOI 10.1016/j.ejmech.2009.12.017; Dashwood RH, 2002, MUTAT RES-REV MUTAT, V511, P89, DOI 10.1016/S1383-5742(02)00005-4; Decordier I, 2008, MUTAT RES-GEN TOX EN, V651, P30, DOI 10.1016/j.mrgentox.2007.10.016; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Furtado MA, 2008, MUTAT RES-GEN TOX EN, V657, P150, DOI 10.1016/j.mrgentox.2008.09.003; GUENGERICH FP, 1992, PHARMACOL THERAPEUT, V54, P17; Jawetz E, 1998, MICROBIOLOGIA MED; Kang JE, 2013, MOLECULES, V18, P140, DOI 10.3390/molecules18010140; Kato K, 2011, MUTAT RES-GEN TOX EN, V721, P21, DOI 10.1016/j.mrgentox.2010.11.012; Kim EJ, 2010, BIOORG MED CHEM LETT, V20, P4237, DOI 10.1016/j.bmcl.2010.05.033; KURODA Y, 1992, MUTAT RES, V267, P201, DOI 10.1016/0027-5107(92)90064-9; Lee SA, 2009, HEPATOLOGY, V49, P1316, DOI 10.1002/hep.22777; Luo Y, 2011, BIOORGAN MED CHEM, V19, P6069, DOI 10.1016/j.bmc.2011.08.038; Luo Y, 2011, BIOORGAN MED CHEM, V19, P4730, DOI 10.1016/j.bmc.2011.06.088; MANFREDI JJ, 1984, PHARMACOL THERAPEUT, V25, P83, DOI 10.1016/0163-7258(84)90025-1; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Narayan BH, 2010, FOOD FUNCT, V1, P174, DOI 10.1039/c0fo00102c; Pelczar MJ, 1996, MICROBIOLOGIA CONCEI; POIRIER LA, 1974, BIOCHEM PHARMACOL, V23, P661, DOI 10.1016/0006-2952(74)90631-5; Ramalho SD, 2013, CHEM BIODIVERS, V10, P1999, DOI 10.1002/cbdv.201200344; Seo WD, 2005, BIOORG MED CHEM LETT, V15, P5514, DOI 10.1016/j.bmcl.2005.08.087; Seo WD, 2010, EUR J MED CHEM, V45, P2010, DOI 10.1016/j.ejmech.2010.01.049; Sghaier MB, 2011, S AFR J BOT, V77, P730, DOI 10.1016/j.sajb.2011.03.014; TORIGOE T, 1983, BIOCHEM BIOPH RES CO, V112, P833, DOI 10.1016/0006-291X(83)91693-5; VONLEDEB.M, 1973, MUTAT RES, V19, P109, DOI 10.1016/0027-5107(73)90118-8; Wang SJ, 2010, EUR J MED CHEM, V45, P1250, DOI 10.1016/j.ejmech.2009.12.031; WATERS MD, 1990, MUTAT RES, V238, P57, DOI 10.1016/0165-1110(90)90039-E	32	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137063	10.1371/journal.pone.0137063	http://dx.doi.org/10.1371/journal.pone.0137063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335560	gold, Green Published, Green Submitted			2022-12-27	WOS:000360615400036
J	Seinstra, M; Grzymek, K; Kalenscher, T				Seinstra, Maayke; Grzymek, Katharina; Kalenscher, Tobias			Gender-Specific Differences in the Relationship between Autobiographical Memory and Intertemporal Choice in Older Adults	PLOS ONE			English	Article							DECISION-MAKING; SEX-DIFFERENCES; TEMPORAL-LOBE; EPISODIC MEMORY; TIME PERSPECTIVE; AGE-DIFFERENCES; DISCOUNT RATES; FUTURE; HIPPOCAMPUS; REWARD	As the population of older adults grows, their economic choices will have increasing impact on society. Research on the effects of aging on intertemporal decisions shows inconsistent, often opposing results, indicating that yet unexplored factors might play an essential role in guiding one's choices. Recent studies suggest that episodic future thinking, which is based on the same neural network involved in episodic memory functions, leads to reductions in discounting of future rewards. As episodic memory functioning declines with normal aging, but to greatly variable degrees, individual differences in delay discounting might be due to individual differences in the vitality of this memory system in older adults. We investigated this hypothesis, using a sample of healthy older adults who completed an intertemporal choice task as well as two episodic memory tasks. We found no clear evidence for a relationship between episodic memory performance and delay discounting in older adults. However, when additionally considering gender differences, we found an interaction effect of gender and autobiographical memory on delay discounting: while men with higher memory scores showed less delay discounting, women with higher memory scores tended to discount the future more. We speculate that this gender effect might stem from the gender-specific use of different modal representation formats (i.e. temporal or visual) during assessment of intertemporal choice options.	[Seinstra, Maayke; Grzymek, Katharina; Kalenscher, Tobias] Univ Dusseldorf, Dept Comparat Psychol, Inst Expt Psychol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Seinstra, M (corresponding author), Univ Dusseldorf, Dept Comparat Psychol, Inst Expt Psychol, Dusseldorf, Germany.	Maayke.Seinstra@hhu.de	Kalenscher, Tobias/U-8438-2019	Kalenscher, Tobias/0000-0002-0358-9020				Agarwal S, 2009, BROOKINGS PAP ECO AC, P51, DOI 10.1353/eca.0.0067; AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Anderson CL, 2009, DEV ECON, V47, P123, DOI 10.1111/j.1746-1049.2009.00080.x; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Baller G, 2006, INVENTAR ZUR GEDACHT; Benoit RG, 2011, J NEUROSCI, V31, P6771, DOI 10.1523/JNEUROSCI.6559-10.2011; Boyer P, 2008, TRENDS COGN SCI, V12, P219, DOI 10.1016/j.tics.2008.03.003; Boyle PA, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-48; Brown SBRE, 2009, COGN AFFECT BEHAV NE, V9, P365, DOI 10.3758/CABN.9.4.365; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P197, DOI 10.1162/089892900561832; Cabeza R, 1997, NEURON, V19, P863, DOI 10.1016/S0896-6273(00)80967-8; Chao LW, 2009, JUDGM DECIS MAK, V4, P1; CHUNG SH, 1967, J EXP ANAL BEHAV, V10, P67, DOI 10.1901/jeab.1967.10-67; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Deakin J, 2004, J INT NEUROPSYCH SOC, V10, P590, DOI 10.1017/S1355617704104104; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Denburg NL, 2006, INT J PSYCHOPHYSIOL, V61, P19, DOI 10.1016/j.ijpsycho.2005.10.021; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Eichenbaum H, 2000, CURR BIOL, V10, pR785, DOI 10.1016/S0960-9822(00)00763-6; Eisenhauer JG, 2006, APPL ECON, V38, P1223, DOI 10.1080/00036840500392391; Eppinger B, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0036953; Fink GR, 1996, J NEUROSCI, V16, P4275; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; Harrison GW, 2002, AM ECON REV, V92, P1606, DOI 10.1257/000282802762024674; Haushofer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078597; Henson RNA, 1999, BRAIN, V122, P1367, DOI 10.1093/brain/122.7.1367; Herlitz A, 2008, CURR DIR PSYCHOL SCI, V17, P52, DOI 10.1111/j.1467-8721.2008.00547.x; Irish M, 2012, BRAIN, V135, P2178, DOI 10.1093/brain/aws119; Jacques PLS, 2011, MEMORY, V19, P723, DOI 10.1080/09658211.2010.516266; Jimura K, 2011, BEHAV PROCESS, V87, P253, DOI 10.1016/j.beproc.2011.04.006; Johnson A, 2007, CURR OPIN NEUROBIOL, V17, P692, DOI 10.1016/j.conb.2008.01.003; Kalenscher T, 2008, PROG NEUROBIOL, V84, P284, DOI 10.1016/j.pneurobio.2007.11.004; Kopelman MD, 1997, NEUROPSYCHOLOGIA, V35, P1533, DOI 10.1016/S0028-3932(97)00076-6; Kramer JH, 1997, NEUROPSYCHOLOGY, V11, P577, DOI 10.1037/0894-4105.11.4.577; Kwan D, 2015, HIPPOCAMPUS, V25, P432, DOI 10.1002/hipo.22431; Kwan D, 2013, J EXP PSYCHOL GEN, V142, P1355, DOI 10.1037/a0034001; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lebreton M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001684; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Lin H, 2014, BEHAV NEUROSCI, V128, P12, DOI 10.1037/a0035705; Lockenhoff CE, 2011, PSYCHOL AGING, V26, P274, DOI 10.1037/a0023280; LOGUE AW, 1984, J EXP ANAL BEHAV, V41, P53, DOI 10.1901/jeab.1984.41-53; Lundervold AJ, 2014, SCAND J PSYCHOL, V55, P225, DOI 10.1111/sjop.12114; Maguire EA, 2003, J NEUROSCI, V23, P5302; Maguire EA, 1996, P ROY SOC B-BIOL SCI, V263, P1745, DOI 10.1098/rspb.1996.0255; Maguire EA, 2000, HIPPOCAMPUS, V10, P475; Malkova L, 2003, J NEUROSCI, V23, P1956; Marschner A, 2005, BRAIN RES BULL, V67, P382, DOI 10.1016/j.brainresbull.2005.06.010; MAZUR JE, 1984, J EXP PSYCHOL ANIM B, V10, P426, DOI 10.1037/0097-7403.10.4.426; Mell T, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.034.2009; Mohr PNC, 2010, NEUROSCI BIOBEHAV R, V34, P678, DOI 10.1016/j.neubiorev.2009.05.010; Musch J, 2009, 10 MINUTEN TES UNPUB; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Oberg C, 2002, J INT NEUROPSYCH SOC, V8, P691, DOI 10.1017/S1355617702801424; Ostapczuk M, 2006, THESIS U BONN GERMAN; Ostapczuk M, 2011, Z ARB ORGAN, V55, P1, DOI 10.1026/0932-4089/a000031; Palombo DJ, 2015, HIPPOCAMPUS, V25, P345, DOI 10.1002/hipo.22376; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Piefke M, 2005, ANAT EMBRYOL, V210, P497, DOI 10.1007/s00429-005-0038-0; Piefke M, 2005, HUM BRAIN MAPP, V24, P313, DOI 10.1002/hbm.20092; Piolino P, 2002, MEMORY, V10, P239, DOI 10.1080/09658210143000353; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Read D, 2004, ORGAN BEHAV HUM DEC, V94, P22, DOI 10.1016/j.obhdp.2004.01.002; Reimers S, 2009, PERS INDIV DIFFER, V47, P973, DOI 10.1016/j.paid.2009.07.026; Renoult L, 2012, TRENDS COGN SCI, V16, P550, DOI 10.1016/j.tics.2012.09.003; Rick S, 2008, PHILOS T R SOC B, V363, P3813, DOI 10.1098/rstb.2008.0150; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; Rybash JM, 1999, J GEN PSYCHOL, V126, P85, DOI 10.1080/00221309909595353; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Samanez-Larkin GR, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00126; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Schacter DL, 2007, BEHAV BRAIN SCI, V30, P331, DOI 10.1017/S0140525X07002178; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a; Schroots JJF, 2004, INT J AGING HUM DEV, V58, P69, DOI 10.2190/7A1A-8HCE-0FD9-7CTX; Seidlitz L, 1998, J PERS SOC PSYCHOL, V74, P262, DOI 10.1037/0022-3514.74.1.262; Sozou PD, 2003, P ROY SOC B-BIOL SCI, V270, P1047, DOI 10.1098/rspb.2003.2344; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Suzuki M, 2002, NEUROIMAGE, V17, P1790, DOI 10.1006/nimg.2002.1303; Suzuki WA, 2007, ANN NY ACAD SCI, V1097, P1, DOI 10.1196/annals.1379.007; Tsukiura T, 2002, HUM BRAIN MAPP, V17, P203, DOI 10.1002/hbm.10068; Tulving E, 2001, PHILOS T R SOC B, V356, P1505, DOI 10.1098/rstb.2001.0937; Weiler JA, 2008, LEARN MEMORY, V15, P190, DOI 10.1101/lm.890408; Whelan R, 2009, PSYCHOL REC, V59, P247, DOI 10.1007/BF03395661; Wimmer GE, 2012, SCIENCE, V338, P270, DOI 10.1126/science.1223252; Worthy DA, 2011, PSYCHOL SCI, V22, P1375, DOI 10.1177/0956797611420301; Young KD, 2013, HUM BRAIN MAPP, V34, P3320, DOI 10.1002/hbm.22144	93	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137061	10.1371/journal.pone.0137061	http://dx.doi.org/10.1371/journal.pone.0137061			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ5AJ	26335426	Green Published, gold			2022-12-27	WOS:000360615400035
J	Shin, SH; Huang, M; Kim, SH; Choi, JY				Shin, Seung-Ho; Huang, Mei; Kim, Sung Huhn; Choi, Jae Young			Differential Protein Expression in Congenital and Acquired Cholesteatomas	PLOS ONE			English	Article							DEVELOPING MIDDLE-EAR; TITIN; ORIGIN; CELLS	Congenital cholesteatomas are epithelial lesions that present as an epithelial pearl behind an intact eardrum. Congenital and acquired cholesteatomas progress quite differently from each other and progress patterns can provide clues about the unique origin and pathogenesis of the abnormality. However, the exact pathogenic mechanisms by which cholesteatomas develop remain unknown. In this study, key proteins that directly affect cholesteatoma pathogenesis are investigated with proteomics and immunohistochemistry. Congenital cholesteatoma matrices and retroauricular skin were harvested during surgery in 4 patients diagnosed with a congenital cholesteatoma. Tissue was also harvested from the retraction pocket in an additional 2 patients during middle ear surgery. We performed 2-dimensional (2D) electrophoresis to detect and analyze spots that are expressed only in congenital cholesteatoma and matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF/MS) to separate proteins by molecular weight. Protein expression was confirmed by immunohistochemical staining. The image analysis of 2D electrophoresis showed that 4 congenital cholesteatoma samples had very similar protein expression patterns and that 127 spots were exclusively expressed in congenital cholesteatomas. Of these 127 spots, 10 major spots revealed the presence of titin, forkhead transcription activator homolog (FKH 5-3), plectin 1, keratin 10, and leucine zipper protein 5 by MALDI-TOF/MS analysis. Immunohistochemical staining showed that FKH 5-3 and titin were expressed in congenital cholesteatoma matrices, but not in acquired cholesteatomas. Our study shows that protein expression patterns are completely different in congenital cholesteatomas, acquired cholesteatomas, and skin. Moreover, non-epithelial proteins, including FKH 5-3 and titin, were unexpectedly expressed in congenital cholesteatoma tissue. Our data indicates that congenital cholesteatoma origins may differ from those of acquired cholesteatomas, which originate from retraction pocket epithelia.	[Shin, Seung-Ho] Ewha Womans Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Shin, Seung-Ho] Yonsei Univ, Dept Med, Grad Sch, Seoul 120749, South Korea; [Huang, Mei] Yonsei Univ, Res Ctr Human Nat Def Syst, Coll Med, Seoul 120749, South Korea; [Kim, Sung Huhn; Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea	Ewha Womans University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SH (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.	fledermaus@yuhs.ac; jychoi@yuhs.ac	; Shin, Seung Ho/C-5403-2014	choi, jae young/0000-0001-9493-3458; Kim, Sung Huhn/0000-0003-4408-3066; Shin, Seung Ho/0000-0001-8093-2673	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2013M3A9D5072551]; National Research Foundation of Korea(NRF) - Ministry of Education, Science and Technology [R11-2007-040-02001-0]	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; National Research Foundation of Korea(NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (2013M3A9D5072551) and Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology (grant number) R11-2007-040-02001-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMI K, 1983, LARYNGOSCOPE, V93, P1140; Akimoto R, 2000, ORL J OTO-RHINO-LARY, V62, P257, DOI 10.1159/000027756; Bennett M, 2006, OTOLARYNG CLIN N AM, V39, P1081, DOI 10.1016/j.otc.2006.08.001; Cho SY, 2005, PROTEOMICS, V5, P3386, DOI 10.1002/pmic.200401310; Choi BK, 2003, PROTEOMICS, V3, P1955, DOI 10.1002/pmic.200300558; FRANKEL S, 1993, LARYNGOSCOPE, V103, P1214; FRIEDBERG J, 1994, LARYNGOSCOPE, V104, P1, DOI 10.1288/00005537-199403001-00001; Friedland DR, 2009, OTOL NEUROTOL, V30, P998, DOI 10.1097/MAO.0b013e3181b4e91f; Granzier HL, 2005, ADV PROTEIN CHEM, V71, P89, DOI 10.1016/S0065-3233(04)71003-7; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; HROMAS R, 1993, BLOOD, V81, P2854; Karmody CS, 1998, AM J OTOL, V19, P292; Kotter S, 2014, BIOL CHEM, V395, P1341, DOI 10.1515/hsz-2014-0178; Kojima H, 2001, LARYNGOSCOPE, V111, P867, DOI 10.1097/00005537-200105000-00021; Liu W, 2014, EUR ARCH OTO-RHINO-L, V271, P265, DOI 10.1007/s00405-013-2403-6; Machado C, 2000, J CELL BIOL, V151, P639, DOI 10.1083/jcb.151.3.639; Machado C, 1998, J CELL BIOL, V141, P321, DOI 10.1083/jcb.141.2.321; Macias JD, 2013, LARYNGOSCOPE, V123, pS1, DOI 10.1002/lary.24176; Maniu A, 2014, ROM J MORPHOL EMBRYO, V55, P7; MICHAELS L, 1986, J OTOLARYNGOL, V15, P169; MICHAELS L, 1988, INT J PEDIATR OTORHI, V15, P51, DOI 10.1016/0165-5876(88)90050-X; Mukherjee S, 2014, MOL PHARMACOL, V86, P318, DOI 10.1124/mol.114.093757; Olszewska E, 2013, OTOL NEUROTOL, V34, P266, DOI 10.1097/MAO.0b013e31827c9d8d; Park HR, 2009, ACTA OTO-LARYNGOL, V129, P268, DOI 10.1080/00016480802251591; RUEDI L, 1959, Acta Otolaryngol, V50, P233, DOI 10.3109/00016485909129191; SADE J, 1983, ACTA OTO-LARYNGOL, V96, P119, DOI 10.3109/00016488309132882; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Teed RW, 1936, ARCHIV OTOLARYNGOL, V24, P455; Tuteja G, 2007, CELL, V130, DOI 10.1016/j.cell.2007.09.005; Zastrow MS, 2006, J CELL SCI, V119, P239, DOI 10.1242/jcs.02728	30	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137011	10.1371/journal.pone.0137011	http://dx.doi.org/10.1371/journal.pone.0137011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335306	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400034
J	Yang, J; Farmer, LM; Agyekum, AAA; Elbaz-Younes, I; Hirschi, KD				Yang, Jian; Farmer, Lisa M.; Agyekum, Abia A. A.; Elbaz-Younes, Ismail; Hirschi, Kendal D.			Detection of an Abundant Plant-Based Small RNA in Healthy Consumers	PLOS ONE			English	Article							MICRORNAS; MIRNAS; COMMUNICATION; BACTERIA; DELIVERY; PROTEIN; CANCER; CELLS; PCR	The mechanisms of delivery of plant small RNAs to consumers must be investigated in order to harness this technology to positively impact biotechnology. Two groups have used honeysuckle (Lonicera japonica) feeding regimes to detect a plant-based small RNA, termed MIR2911, in sera. Meanwhile, numerous groups have failed to detect dietary plant-based small RNAs in consumers. Here we catalog levels of MIR2911 in different herbs, and suggest that in particular herb MIR2911 levels are elevated. Feeding these different herb-based diets to mice, we found MIR2911 levels in the sera and urine were associated with dietary intake levels. Abundance was not the sole determinate of apparent RNA bioavailability, as gavage-feeding large-doses of synthetic MIR2911 permitted only small transient increases in serum levels. Dietary MIR2911 were not modified in circulation by association with the host's RNA-induced silencing complex, as the RNA did not co-immunoprecipitate with AGO2. The stability of dietary MIR2911 in circulation differed from synthesized small RNAs, as tail vein administration of various synthetic plant-based small RNAs resulted in rapid clearance. However, synthetic MIR2911 appeared to be more stable than the other plant miRNAs tested. Notably, this uptake of dietary MIR2911 was not related to perturbations in the host's microbiome or gut permeability. We suggest dietary uptake of MIR2911 is commonplace in healthy consumers, and reproducible detection of plant-based small RNAs in consumers depends on dietary abundance, RNA stability and digestion from within the food-matrix.	[Yang, Jian; Farmer, Lisa M.; Agyekum, Abia A. A.; Elbaz-Younes, Ismail; Hirschi, Kendal D.] Baylor Coll Med, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA; [Hirschi, Kendal D.] Texas A&M Univ, Vegetable & Fruit Improvement Ctr, College Stn, TX USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station	Hirschi, KD (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA.	kendalh@bcm.edu	hirschi, kendal/GNP-0351-2022	Elbaz Younes, Ismail/0000-0001-8957-194X	NIH [5T32HD071839-02]; USDA/ARIS [6250-51000-051-00D]; Soy Health Research Program; Dry Bean Health Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD071839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA/ARIS; Soy Health Research Program; Dry Bean Health Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	L.M.F. was supported by a grant from the NIH (5T32HD071839-02). This work was supported by USDA/ARIS 6250-51000-051-00D and funds from the Soy Health and Dry Bean Health Research Programs.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beatty M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-933; Brandl K, 2009, P NATL ACAD SCI USA, V106, P3300, DOI 10.1073/pnas.0813036106; Bryniarski K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122991; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079652; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; FURNER RL, 1975, LAB ANIM SCI, V25, P648; Ghosal A, 2015, MICROBIOLOGYOPEN, V4, P252, DOI 10.1002/mbo3.235; Heneghan HM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2798; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; Ivashuta SI, 2009, FOOD CHEM TOXICOL, V47, P353, DOI 10.1016/j.fct.2008.11.025; Jain K. K., 2008, Current Drug Delivery, V5, P27, DOI 10.2174/156720108783331023; Liang G, 2014, FOOD SCI NUTR, V2, P8; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lukasik A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099963; Marx JO, 2014, J AM ASSOC LAB ANIM, V53, P301; Mlotshwa S, 2015, CELL RES, V25, P521, DOI 10.1038/cr.2015.25; Mu JY, 2014, MOL NUTR FOOD RES, V58, P1561, DOI 10.1002/mnfr.201300729; Nagy-Szakal D, 2011, GUT MICROBES, V2, P178, DOI 10.4161/gmic.2.3.16107; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909; Taylor RS, 2014, TRENDS PLANT SCI, V19, P175, DOI 10.1016/j.tplants.2013.11.008; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WATTS RH, 1971, J CLIN PATHOL, V24, P667, DOI 10.1136/jcp.24.7.667; Witwer KW, 2014, J NUTR, V144, P1880, DOI 10.3945/jn.114.202523; Witwer KW, 2014, BIOESSAYS, V36, P394, DOI 10.1002/bies.201300150; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246; Yamamoto H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/276186; Yang J, 2015, NUTRIENTS, V7, P3184, DOI 10.3390/nu7053184; Yang J, 2015, CELL RES, V25, P517, DOI 10.1038/cr.2015.26; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015; Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79; Zhou Z, 2015, CELL RES, V25, P39, DOI 10.1038/cr.2014.130	42	59	61	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137516	10.1371/journal.pone.0137516	http://dx.doi.org/10.1371/journal.pone.0137516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335106	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400064
J	Blackman, LM; Cullerne, DP; Torrena, P; Taylor, J; Hardham, AR				Blackman, Leila M.; Cullerne, Darren P.; Torrena, Pernelyn; Taylor, Jen; Hardham, Adrienne R.			RNA-Seq Analysis of the Expression of Genes Encoding Cell Wall Degrading Enzymes during Infection of Lupin (Lupinus angustifolius) by Phytophthora parasitica	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; CELLULOSE-BINDING; FUNCTIONAL-CHARACTERIZATION; IMMUNOGOLD LOCALIZATION; RHAMNOGALACTURONAN II; PHYSIOLOGICAL ROLES; GLYCOSIDE HYDROLASE; CALLOSE DEPOSITION; ASPERGILLUS-NIGER; PECTATE-LYASE	RNA-Seq analysis has shown that over 60% (12,962) of the predicted transcripts in the Phytophthora parasitica genome are expressed during the first 60 h of lupin root infection. The infection transcriptomes included 278 of the 431 genes encoding P. parasitica cell wall degrading enzymes. The transcriptome data provide strong evidence of global transcriptional cascades of genes whose encoded proteins target the main categories of plant cell wall components. A major cohort of pectinases is predominantly expressed early but as infection progresses, the transcriptome becomes increasingly dominated by transcripts encoding cellulases, hemicellulases, beta-1,3-glucanases and glycoproteins. The most highly expressed P. parasitica carbohydrate active enzyme gene contains two CBM1 cellulose binding modules and no catalytic domains. The top 200 differentially expressed genes include beta-1,4-glucosidases, beta-1,4-glucanases, beta-1,4-galactanases, a beta-1,3-glucanase, an alpha-1,4-polygalacturonase, a pectin deacetylase and a pectin methylesterase. Detailed analysis of gene expression profiles provides clues as to the order in which linkages within the complex carbohydrates may come under attack. The gene expression profiles suggest that (i) demethylation of pectic homogalacturonan occurs before its deacetylation; (ii) cleavage of the backbone of pectic rhamnogalacturonan I precedes digestion of its side chains; (iii) early attack on cellulose microfibrils by non-catalytic cellulose-binding proteins and enzymes with auxiliary activities may facilitate subsequent attack by glycosyl hydrolases and enzymes containing CBM1 cellulose-binding modules; (iv) terminal hemicellulose backbone residues are targeted after extensive internal backbone cleavage has occurred; and (v) the carbohydrate chains on glycoproteins are degraded late in infection. A notable feature of the P. parasitica infection transcriptome is the high level of transcription of genes encoding enzymes that degrade beta-1,3-glucanases during middle and late stages of infection. The results suggest that high levels of beta-1,3-glucanases may effectively degrade callose as it is produced by the plant during the defence response.	[Blackman, Leila M.; Cullerne, Darren P.; Torrena, Pernelyn; Hardham, Adrienne R.] Australian Natl Univ, Plant Sci Div, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia; [Cullerne, Darren P.; Taylor, Jen] CSIRO, Agr Flagship, Canberra, ACT, Australia	Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Blackman, LM (corresponding author), Australian Natl Univ, Plant Sci Div, Res Sch Biol, Coll Med Biol & Environm, Canberra, ACT, Australia.	leila.blackman@anu.edu.au	Cullerne, Darren/A-7080-2011; Hardham, Adrienne/C-9674-2009; Taylor, Jennifer M/A-1686-2010	Cullerne, Darren/0000-0001-9784-0492; Taylor, Jennifer M/0000-0003-4231-0181	Australian Research Council Discovery Grant [DP110102156]	Australian Research Council Discovery Grant(Australian Research Council)	This research was conducted with the support of the Australian Research Council Discovery Grant DP110102156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Adhikari B. N., 2013, PLoS ONE, V8, pe75072, DOI 10.1371/journal.pone.0075072; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Attard A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-538; Avila M, 2009, MICROBIOL-SGM, V155, P2739, DOI 10.1099/mic.0.027789-0; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Benen JAE, 1999, EUR J BIOCHEM, V259, P577, DOI 10.1046/j.1432-1327.1999.00080.x; Biely P, 2012, BIOTECHNOL ADV, V30, P1575, DOI 10.1016/j.biotechadv.2012.04.010; Blackman LM, 2008, MOL PLANT PATHOL, V9, P495, DOI 10.1111/J.1364-3703.2008.00478.X; Blackman LM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-785; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; BONHOFF A, 1987, PLANTA, V172, P101, DOI 10.1007/BF00403034; Bonnin E, 2008, CARBOHYD POLYM, V74, P411, DOI 10.1016/j.carbpol.2008.03.014; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brito N, 2006, MOL PLANT MICROBE IN, V19, P25, DOI 10.1094/MPMI-19-0025; Brouwer H, 2014, FUNGAL GENET BIOL, V72, P192, DOI 10.1016/j.fgb.2014.08.011; Brunner F, 2002, PHYTOCHEMISTRY, V59, P689, DOI 10.1016/S0031-9422(02)00045-6; Brunner PC, 2013, MOL BIOL EVOL, V30, P1337, DOI 10.1093/molbev/mst041; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Cano-Canchola C, 2000, FUNGAL GENET BIOL, V29, P145, DOI 10.1006/fgbi.2000.1196; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clavaud C, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P387; COOPER RM, 1975, PHYSIOL PLANT PATHOL, V5, P135, DOI 10.1016/0048-4059(75)90017-X; COOPER RM, 1983, BIOCH PLANT PATHOLOG, P101; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; de Vries RP, 2000, CARBOHYD RES, V327, P401, DOI 10.1016/S0008-6215(00)00066-5; De Wet BJM, 2008, APPL MICROBIOL BIOT, V77, P975, DOI 10.1007/s00253-007-1235-y; DEISING H, 1995, CAN J BOT, V73, pS624, DOI 10.1139/b95-304; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Douaiher MN, 2007, PLANT PATHOL, V56, P79, DOI 10.1111/j.1365-3059.2006.01460.x; Douaiher MN, 2007, EUR J PLANT PATHOL, V117, P71, DOI 10.1007/s10658-006-9073-9; DUDLER R, 1990, PLANT MOL BIOL, V14, P415, DOI 10.1007/BF00028777; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Enkerli K, 1997, CAN J BOT, V75, P1509, DOI 10.1139/b97-865; Enkerli K, 1997, CAN J BOT, V75, P1493, DOI 10.1139/b97-864; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Frankova L, 2013, J EXP BOT, V64, P3519, DOI 10.1093/jxb/ert201; Fu HT, 2013, FUNGAL BIOL-UK, V117, P673, DOI 10.1016/j.funbio.2013.07.003; Gan PHP, 2009, MOL GENET GENOMICS, V281, P565, DOI 10.1007/s00438-009-0431-0; Gao DH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-5; Garbe J, 2012, J INNATE IMMUN, V4, P121, DOI 10.1159/000334775; Georgelis N, 2014, CARBOHYD POLYM, V100, P17, DOI 10.1016/j.carbpol.2013.04.094; Grover A, 2012, CRIT REV PLANT SCI, V31, P57, DOI 10.1080/07352689.2011.616043; Hardham AR, 2010, FUNCT PLANT BIOL, V37, P919, DOI 10.1071/FP10073; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Haverkort AJ, 2008, POTATO RES, V51, P47, DOI 10.1007/s11540-008-9089-y; Hayden KJ, 2014, TREE GENET GENOMES, V10, P489, DOI 10.1007/s11295-014-0698-0; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Hurlbert JC, 2001, J BACTERIOL, V183, P2093, DOI 10.1128/JB.183.6.2093-2100.2001; Isshiki A, 2001, MOL PLANT MICROBE IN, V14, P749, DOI 10.1094/MPMI.2001.14.6.749; Jiang RHY, 2012, ANNU REV PHYTOPATHOL, V50, P295, DOI 10.1146/annurev-phyto-081211-172912; Jiang T, 2013, BIOCHEM BIOPH RES CO, V438, P193, DOI 10.1016/j.bbrc.2013.07.051; Jones RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023555; JONES TM, 1972, PHYSIOL PLANT PATHOL, V2, P153, DOI 10.1016/0048-4059(72)90023-9; Kebdani N, 2010, NEW PHYTOL, V185, P248, DOI 10.1111/j.1469-8137.2009.03048.x; KOCH JL, 1989, PLANT PHYSIOL, V91, P816, DOI 10.1104/pp.91.3.816; Kovacs K, 2011, J ENVIRON MANAGE, V92, P1292, DOI 10.1016/j.jenvman.2010.12.018; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Larroque M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-605; Le Berre JY, 2008, NEW PHYTOL, V177, P480, DOI 10.1111/j.1469-8137.2007.02269.x; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Lima PD, 2012, FEMS YEAST RES, V12, P685, DOI 10.1111/j.1567-1364.2012.00819.x; Limberg G, 2000, CARBOHYD RES, V327, P293, DOI 10.1016/S0008-6215(00)00067-7; Liu HL, 2005, MOL PLANT MICROBE IN, V18, P1296, DOI 10.1094/MPMI-18-1296; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; MARTINEZ MJ, 1991, FEMS MICROBIOL LETT, V81, P145, DOI 10.1016/0378-1097(91)90294-K; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; McLeod A, 2003, FUNGAL GENET BIOL, V38, P250, DOI 10.1016/S1087-1845(02)00523-6; Melida H, 2013, EUKARYOT CELL, V12, P194, DOI 10.1128/EC.00288-12; Minic Z, 2008, PLANTA, V227, P723, DOI 10.1007/s00425-007-0668-y; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Nakajima M, 2012, APPL ENVIRON MICROB, V78, P5682, DOI 10.1128/AEM.00483-12; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; Pabst M, 2013, PLANT J, V76, P61, DOI 10.1111/tpj.12271; Parenicova L, 2000, FEBS LETT, V467, P333, DOI 10.1016/S0014-5793(00)01173-X; Pitson SM, 1997, ENZYME MICROB TECH, V21, P182, DOI 10.1016/S0141-0229(96)00263-3; Pogorelko G, 2013, PLANT PHYSIOL, V162, P9, DOI 10.1104/pp.113.214460; Pritchard L, 2014, MOL PLANT PATHOL, V15, P865, DOI 10.1111/mpp.12210; Nguyen QB, 2011, MOL MICROBIOL, V81, P1008, DOI 10.1111/j.1365-2958.2011.07746.x; Robold AV, 1998, CAN J MICROBIOL, V44, P1161, DOI 10.1139/cjm-44-12-1161; Rogers LM, 2000, P NATL ACAD SCI USA, V97, P9813, DOI 10.1073/pnas.160271497; Savory EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035796; SCOTTCRAIG JS, 1990, PLANT CELL, V2, P1191, DOI 10.1105/tpc.2.12.1191; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Selig MJ, 2009, CELLULOSE, V16, P711, DOI 10.1007/s10570-009-9322-0; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Soriano M, 2006, MICROBIOL-SGM, V152, P617, DOI 10.1099/mic.0.28562-0; Stals I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040854; Tamayo-Ramos JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-26; Tenberge KB, 1999, MYCOL RES, V103, P1103, DOI 10.1017/S095375629800820X; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Underwood W, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00085; van Munster JM, 2014, FUNGAL GENET BIOL, V72, P34, DOI 10.1016/j.fgb.2014.04.006; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; Vardakou M., 2004, Innovative Food Science & Emerging Technologies, V5, P107, DOI 10.1016/S1466-8564(03)00044-4; Veneault-Fourrey C, 2014, FUNGAL GENET BIOL, V72, P168, DOI 10.1016/j.fgb.2014.08.007; Vincken JP, 2003, PLANT PHYSIOL, V132, P1781, DOI 10.1104/pp.103.022350; Voigt CA, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P525; Williamson G, 1998, MICROBIOL-SGM, V144, P2011, DOI 10.1099/00221287-144-8-2011; Wu CH, 2008, MOL PLANT MICROBE IN, V21, P480, DOI 10.1094/MPMI-21-4-0480; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Yu YT, 2010, J PHYTOPATHOL, V158, P344, DOI 10.1111/j.1439-0434.2009.01614.x; Zerillo MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072572; Zhao Q, 2014, ANNU REV PHYTOPATHOL, V52, P69, DOI 10.1146/annurev-phyto-082712-102237; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427	122	36	36	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136899	10.1371/journal.pone.0136899	http://dx.doi.org/10.1371/journal.pone.0136899			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332397	gold, Green Submitted, Green Published			2022-12-27	WOS:000360613800080
J	Chen, H; Lin, HT; Zheng, DY; Liu, YH; Chen, WR; Liu, YZ				Chen, Hui; Lin, Haotian; Zheng, Danying; Liu, Yuhua; Chen, Weirong; Liu, Yizhi			Expression of Cytokines, Chmokines and Growth Factors in Patients Undergoing Cataract Surgery with Femtosecond Laser Pretreatment	PLOS ONE			English	Article							POSTERIOR CAPSULE OPACIFICATION; LENS EPITHELIAL-CELLS; MACULAR DEGENERATION; AQUEOUS-HUMOR; PHACOEMULSIFICATION; INFLAMMATION; DISEASE; INTERLEUKIN-1; FAMILY; FLARE	Purpose To describe cytokines, chemokines and growth factors profiles in patients undergoing cataract surgery with femtosecond laser pretreatment and investigate their relationships with the postoperative in vivo inflammation index. Methods Aqueous humor was collected from 22 eyes after femtosecond laser pretreatment and from 22 eyes at the beginning of routine cataract surgery. The levels of 45 inflammation-related mediators were measured using multiplex fluorescent bead-based immunoassays. Laser flare photometry was measured preoperatively and at 1 day, 7 days and 30 days postoperatively. Results Compared with the control group, the femtosecond laser treatment group showed significantly higher aqueous humor levels of fibroblast growth factor (FGF-2), tumor necrosis factor (TNF)-alpha, leukemia inhibitor factor (LIF), interleukin (IL)-1ra and IL-18, and significantly lower aqueous humor levels of IL-9, platelet-derived growth factor (PDGF)-BB, eotaxin and TNF-beta. Postoperative aqueous flare was significantly greater in the manual cataract surgery group at 1 day (p<0.001), 7days (p<0.001) and 30 days (p = 0.002). No correlation was found between the analyzed mediators and the aqueous flare values. Conclusions The expression profiles of cytokines, chemokines and growth factors and the correlations of these profiles with the in vivo inflammatory indexes for patients undergoing cataract surgery with femtosecond laser pretreatment were identified. Our data indicate a disturbance of postoperative inflammation response after femtosecond laser treatment.	[Chen, Hui; Lin, Haotian; Zheng, Danying; Liu, Yuhua; Chen, Weirong; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, WR (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	chenwr_q@aliyun.com; yizhi_liu@aliyun.com	liu, yi/GXE-9662-2022; Chen, Wei/GZK-7348-2022		Fund for National Natural Science Foundation [81300784]; Fund for the Natural Science Foundation of Guangdong Province [S2013040012956]; Ministry of Science and Technology of China Grants (973 program) [2015CB964600]; Guangdong Technology Programs [2013B021800054]; Pearl River Science and Technology New Star [2014J2200060]; Project of Guangzhou City; Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China [2014A030306030]	Fund for National Natural Science Foundation; Fund for the Natural Science Foundation of Guangdong Province; Ministry of Science and Technology of China Grants (973 program); Guangdong Technology Programs; Pearl River Science and Technology New Star; Project of Guangzhou City; Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China	This study was supported by the Fund for National Natural Science Foundation (81300784), the Fund for the Natural Science Foundation of Guangdong Province (S2013040012956), the Ministry of Science and Technology of China Grants (973 program, 2015CB964600), the Guangdong Technology Programs (No. 2013B021800054), the Pearl River Science and Technology New Star (2014J2200060), Project of Guangzhou City, the Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China (2014A030306030). The sponsor of the study had no role in the design of the original study protocol, data collection, data analysis, data interpretation, writing of the report, or decision to submit the manuscript for publication.	Abell RG, 2013, J CATARACT REFR SURG, V39, P1321, DOI 10.1016/j.jcrs.2013.06.009; Alexander JP, 1998, CURR EYE RES, V17, P276, DOI 10.1076/ceyr.17.3.276.5219; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Chamberlain CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071631; Cheng X, 2014, DRUG DISCOV TODAY, V19, P1822, DOI 10.1016/j.drudis.2014.06.029; Chew EY, 2009, OPHTHALMOLOGY, V116, P297, DOI 10.1016/j.ophtha.2008.09.019; Coburn LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082300; Conrad-Hengerer I, 2014, J REFRACT SURG, V30, P222, DOI 10.3928/1081597X-20140321-01; Conrad-Hengerer I, 2012, J CATARACT REFR SURG, V38, P1888, DOI 10.1016/j.jcrs.2012.07.023; Coughlin CM, 1998, J CLIN INVEST, V101, P1441, DOI 10.1172/JCI1555; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; DINARELLO CA, 1991, BLOOD, V77, P1627; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Er H, 2000, OPHTHALMIC SURG LAS, V31, P479; Er H, 2002, EUR J OPHTHALMOL, V12, P183, DOI 10.1177/112067210201200302; Friedman NJ, 2011, J CATARACT REFR SURG, V37, P1189, DOI 10.1016/j.jcrs.2011.04.022; Jiang SH, 2010, BRIT J OPHTHALMOL, V94, P1078, DOI 10.1136/bjo.2009.169052; JOSE PJ, 1994, THE JOURNAL OF EXPER, V179, P881; Kovacs I, 2014, J REFRACT SURG, V30, P154, DOI 10.3928/1081597X-20140217-01; Liu Y, 2004, EYE, V18, P900, DOI 10.1038/sj.eye.6701349; Liu YZ, 2007, J CATARACT REFR SURG, V33, P287, DOI 10.1016/j.jcrs.2006.10.044; Lou BS, 2013, J CATARACT REFR SURG, V39, P250, DOI 10.1016/j.jcrs.2012.07.038; Mansfield KJ, 2004, MOL VIS, V10, P521; Mayer WJ, 2014, AM J OPHTHALMOL, V157, P426, DOI 10.1016/j.ajo.2013.09.017; MCAVOY JW, 1989, DEVELOPMENT, V107, P221; Meacock WR, 2000, BRIT J OPHTHALMOL, V84, P332, DOI 10.1136/bjo.84.3.332; Nagy Z, 2009, J REFRACT SURG, V25, P1053, DOI 10.3928/1081597X-20091117-04; Prada J, 2000, J CATARACT REFR SURG, V26, P114, DOI 10.1016/S0886-3350(99)00266-7; Qiao H, 2007, J LEUKOCYTE BIOL, V81, P1012, DOI 10.1189/jlb.0506342; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Schultz T, 2013, J REFRACT SURG, V29, P742, DOI 10.3928/1081597X-20131021-03; SHAH SM, 1991, BRIT J OPHTHALMOL, V75, P348, DOI 10.1136/bjo.75.6.348; Sharma RK, 2009, MOL VIS, V15, P60; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tanaka T, 2004, MOL VIS, V10, P462; Taravati P, 2012, CURR OPIN OPHTHALMOL, V23, P12, DOI 10.1097/ICU.0b013e32834cd60e	37	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137227	10.1371/journal.pone.0137227	http://dx.doi.org/10.1371/journal.pone.0137227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331724	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800113
J	Langen, CD; White, T; Ikram, MA; Vernooij, MW; Niessen, WJ				Langen, Carolyn D.; White, Tonya; Ikram, M. Arfan; Vernooij, Meike W.; Niessen, Wiro J.			Integrated Analysis and Visualization of Group Differences in Structural and Functional Brain Connectivity: Applications in Typical Ageing and Schizophrenia	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; RESTING-STATE NETWORKS; FMRI DATA; HUMAN CONNECTOME; MOTION ARTIFACT; LOW-FREQUENCY; PARCELLATION; ORGANIZATION; ARCHITECTURE; TUTORIAL	Structural and functional brain connectivity are increasingly used to identify and analyze group differences in studies of brain disease. This study presents methods to analyze uniand bi-modal brain connectivity and evaluate their ability to identify differences. Novel visualizations of significantly different connections comparing multiple metrics are presented. On the global level, "bi-modal comparison plots" show the distribution of uni-and bi-modal group differences and the relationship between structure and function. Differences between brain lobes are visualized using "worm plots". Group differences in connections are examined with an existing visualization, the "connectogram". These visualizations were evaluated in two proof-of-concept studies: (1) middle-aged versus elderly subjects; and (2) patients with schizophrenia versus controls. Each included two measures derived from diffusion weighted images and two from functional magnetic resonance images. The structural measures were minimum cost path between two anatomical regions according to the "Statistical Analysis of Minimum cost path based Structural Connectivity" method and the average fractional anisotropy along the fiber. The functional measures were Pearson's correlation and partial correlation of mean regional time series. The relationship between structure and function was similar in both studies. Uni-modal group differences varied greatly between connectivity types. Group differences were identified in both studies globally, within brain lobes and between regions. In the aging study, minimum cost path was highly effective in identifying group differences on all levels; fractional anisotropy and mean correlation showed smaller differences on the brain lobe and regional levels. In the schizophrenia study, minimum cost path and fractional anisotropy showed differences on the global level and within brain lobes; mean correlation showed small differences on the lobe level. Only fractional anisotropy and mean correlation showed regional differences. The presented visualizations were helpful in comparing and evaluating connectivity measures on multiple levels in both studies.	[Langen, Carolyn D.; Niessen, Wiro J.] Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Radiol, Rotterdam, Netherlands; [Langen, Carolyn D.; Niessen, Wiro J.] Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Med Informat, Rotterdam, Netherlands; [White, Tonya] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Niessen, Wiro J.] Delft Univ Technol, Fac Sci Appl, Imaging Phys, Delft, Netherlands; [Ikram, M. Arfan; Vernooij, Meike W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [White, Tonya; Ikram, M. Arfan; Vernooij, Meike W.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Langen, CD (corresponding author), Erasmus MC, Biomed Imaging Grp Rotterdam, Dept Radiol, Rotterdam, Netherlands.	c.langen@erasmusmc.nl	Ikram, M. Arfan/AAM-5225-2021; White, Tonya/AAU-2226-2021; Vernooij, Meike Willemijn/E-4061-2016	White, Tonya/0000-0003-0271-1896; Niessen, Wiro/0000-0002-5822-1995; Vernooij, Meike/0000-0003-4658-2176	ZonMw TOP [91211021]	ZonMw TOP	This study is financially supported through ZonMw TOP project number: 91211021, awarded to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Angrilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004507; Betzel R.F., 2013, PHYS REV E, V1, P353, DOI [DOI 10.1103/PhysRevE.72.026132, 10.1017/nws.2013.19, DOI 10.1017/NWS.2013.19]; Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Bowman FD, 2012, NEUROIMAGE, V62, P1769, DOI 10.1016/j.neuroimage.2012.05.032; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/nmeth.2482, 10.1038/NMETH.2482]; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Boer R, 2011, NEUROIMAGE, V55, P557, DOI 10.1016/j.neuroimage.2010.12.012; de Reus MA, 2013, NEUROIMAGE, V80, P397, DOI 10.1016/j.neuroimage.2013.03.053; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito A, 2011, BIOL PSYCHIAT, V70, P64, DOI 10.1016/j.biopsych.2011.02.019; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gollub RL, 2013, NEUROINFORMATICS, V11, P367, DOI 10.1007/s12021-013-9184-3; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Hollingshead AB, 2007, AM J PUBLIC HEALTH, V97, P1756; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Ikram MA, 2008, NEUROBIOL AGING, V29, P882, DOI 10.1016/j.neurobiolaging.2006.12.012; Ikram MA, 2011, EUR J EPIDEMIOL, V26, P811, DOI 10.1007/s10654-011-9624-z; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Jbabdi S, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/320195; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kubicki M, 2005, CURR OPIN PSYCHIATR, V18, P121, DOI 10.1097/00001504-200503000-00004; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Margulies DS, 2013, NEUROIMAGE, V80, P445, DOI 10.1016/j.neuroimage.2013.04.111; Nakamura K, 2012, PSYCHIAT RES-NEUROIM, V202, P233, DOI 10.1016/j.pscychresns.2011.09.006; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Pruim RHR, 2015, NEUROIMAGE, V112, P278, DOI 10.1016/j.neuroimage.2015.02.063; Robinson EC, 2010, NEUROIMAGE, V50, P910, DOI 10.1016/j.neuroimage.2010.01.019; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Sripada CS, 2014, P NATL ACAD SCI USA, V111, P14259, DOI 10.1073/pnas.1407787111; STERNBERG S, 1969, AM SCI, V57, P421; Tadayonnejad R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096033; van den Heuvel MP, 2010, HUM BRAIN MAPP, V31, P631, DOI 10.1002/hbm.20893; van Horn JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037454; Varoquaux G, 2013, NEUROIMAGE, V80, P405, DOI 10.1016/j.neuroimage.2013.04.007; Wee CY, 2012, NEUROIMAGE, V59, P2045, DOI 10.1016/j.neuroimage.2011.10.015; White T, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.10.003; White T, 2001, NEUROIMAGE, V13, P577, DOI 10.1006/nimg.2000.0716; White T, 2013, SCHIZOPHRENIA BULL, V39, P1077, DOI 10.1093/schbul/sbs106; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004; Zhu DJ, 2014, NEUROIMAGE, V102, P184, DOI 10.1016/j.neuroimage.2013.09.071; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	69	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137484	10.1371/journal.pone.0137484	http://dx.doi.org/10.1371/journal.pone.0137484			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331844	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800134
J	Langham, GM; Schuetz, JG; Distler, T; Soykan, CU; Wilsey, C				Langham, Gary M.; Schuetz, Justin G.; Distler, Trisha; Soykan, Candan U.; Wilsey, Chad			Conservation Status of North American Birds in the Face of Future Climate Change	PLOS ONE			English	Article							RANGE SHIFTS; MODELS	Human-induced climate change is increasingly recognized as a fundamental driver of biological processes and patterns. Historic climate change is known to have caused shifts in the geographic ranges of many taxa and future climate change is expected to result in even greater redistributions of species. As a result, predicting the impact of climate change on future patterns of biodiversity will greatly aid conservation planning. Using the North American Breeding Bird Survey and Audubon Christmas Bird Count, two of the most comprehensive continental datasets of vertebrates in the world, and correlative distribution modeling, we assessed geographic range shifts for 588 North American bird species during both the breeding and non-breeding seasons under a range of future emission scenarios (SRES A2, A1B, B2) through the end of the century. Here we show that 314 species (53%) are projected to lose more than half of their current geographic range across three scenarios of climate change through the end of the century. For 126 species, loss occurs without concomitant range expansion; whereas for 188 species, loss is coupled with potential to colonize new replacement range. We found no strong associations between projected climate sensitivities and existing conservation prioritizations. Moreover, species responses were not clearly associated with habitat affinities, migration strategies, or climate change scenarios. Our results demonstrate the need to include climate sensitivity into current conservation planning and to develop adaptive management strategies that accommodate shrinking and shifting geographic ranges. The persistence of many North American birds will depend on their ability to colonize climatically suitable areas outside of current ranges and management actions that target climate adaptation.	[Langham, Gary M.] Natl Audubon Soc, Washington, DC 20036 USA; [Schuetz, Justin G.; Distler, Trisha; Soykan, Candan U.; Wilsey, Chad] Natl Audubon Soc, San Francisco, CA USA		Langham, GM (corresponding author), Natl Audubon Soc, Washington, DC 20036 USA.	climatescience@audubon.org		Wilsey, Chad/0000-0002-1448-1445	U.S. Fish and Wildlife Service [F11AP00380/912001-9700]	U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	This work was supported by the U.S. Fish and Wildlife Service (contract #F11AP00380/912001-9700) to GML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Beidleman CA, 2001, COLORADO PARTNERS FL; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Case MJ, 2015, BIOL CONSERV, V187, P127, DOI 10.1016/j.biocon.2015.04.013; Cerovski AM, 2001, WYOMING BIRD CONSERV; Distler T, 2015, J BIOGEOGR, V42, P976, DOI 10.1111/jbi.12479; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dunn EH, 2005, AUK, V122, P338, DOI 10.1642/0004-8038(2005)122[0338:ETSVOT]2.0.CO;2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fink D., 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1.; Fischlin A., 2007, IMPACTS ADAPTATION V, P211; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Garson G. D., 2012, VARIANCE COMPONENTS; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans R.J., DISMO SPECIES DISTRI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, GEOGRAPHIC ANAL MODE; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; IUCN, 2013, IUCN RED LIST THREAT; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Link WA, 2006, CONDOR, V108, P13, DOI 10.1650/0010-5422(2006)108[0013:AHMFRA]2.0.CO;2; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; McDonald KW, 2012, ECOL EVOL, V2, P3052, DOI 10.1002/ece3.410; McKenney DW, 2006, AGR FOREST METEOROL, V138, P69, DOI 10.1016/j.agrformet.2006.03.012; McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI 10.1175/2011BAMS3132.1; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Oksanen J., **DATA OBJECT**; Panjabi A.O., 2012, PARTNERS FLIGHT TECH, V3; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peterson AT, 2009, EPIDEMICS-NETH, V1, P240, DOI 10.1016/j.epidem.2009.11.003; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ridgeway G., 2010, GBM GEN BOOSTED REGR; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Rowland EL, 2011, ENVIRON MANAGE, V47, P322, DOI 10.1007/s00267-010-9608-x; Sauer JR, 2012, N AM BREEDING BIRD S; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schneider SH, 2002, CLIMATE CHANGE OVERV; Schuetz JG, 2015, ECOL APP IN PRESS; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Small-Lorenz SL, 2013, NAT CLIM CHANGE, V3, P91, DOI 10.1038/nclimate1810; Stralberg D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006825; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; U.S. Fish and Wildlife Service, 2008, BIRDS CONS CONC 2008; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Welsh AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052015; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325	53	74	76	1	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135350	10.1371/journal.pone.0135350	http://dx.doi.org/10.1371/journal.pone.0135350			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333202	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800029
J	Xu, J; Xing, XJ; Tian, YS; Peng, RH; Xue, Y; Zhao, W; Yao, QH				Xu, Jing; Xing, Xiao-Juan; Tian, Yong-Sheng; Peng, Ri-He; Xue, Yong; Zhao, Wei; Yao, Quan-Hong			Transgenic Arabidopsis Plants Expressing Tomato Glutathione S-Transferase Showed Enhanced Resistance to Salt and Drought Stress	PLOS ONE			English	Article							OVER-EXPRESSION; ABSCISIC-ACID; HEAVY-METAL; TOLERANCE; GENE; PROLINE; ROLES; OVEREXPRESSION; MECHANISMS; SEEDLINGS	Although glutathione S-transferases (GST, EC 2.5.1.18) are involved in response to abiotic stress, limited information is available regarding gene function in tomato. In this study, a GST gene from tomato, designated LeGSTU2, was cloned and functionally characterized. Expression profile analysis results showed that it was expressed in roots and flowers, and the transcription was induced by salt, osmotic, and heat stress. The gene was then introduced to Arabidopsis by Agrobacterium tumefaciens-mediated transformation. Transgenic Arabidopsis plants were normal in terms of growth and maturity compared with wild-type plants. Transgenic plants also showed an enhanced resistance to salt and osmotic stress induced by NaCl and mannitol. The increased tolerance of transgenic plants was correlated with the changes in proline, malondialdehyde and antioxidative emzymes activities. Our results indicated that the gene from tomato plays a positive role in improving tolerance to salinity and drought stresses in Arabidopsis.	[Xu, Jing; Xing, Xiao-Juan; Tian, Yong-Sheng; Peng, Ri-He; Xue, Yong; Zhao, Wei; Yao, Quan-Hong] Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai 201106, Peoples R China	Shanghai Academy of Agricultural Sciences	Yao, QH (corresponding author), Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai 201106, Peoples R China.	yaoquanhong_sh@126.com			Shanghai Rising-Star Program [14QB1403400]; Shanghai Natural Science Foundation [13ZR1460600]; National Natural Science Foundation [31300237, 31401458]; Youth Talents Growth Plan of Shanghai Academy of Agricultural Sciences [2015-1-26]	Shanghai Rising-Star Program; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Youth Talents Growth Plan of Shanghai Academy of Agricultural Sciences	The research study was sponsored by Shanghai Rising-Star Program [Grant No: 14QB1403400], Shanghai Natural Science Foundation [Grant No: 13ZR1460600] National Natural Science Foundation [Grant No: 31300237, 31401458], and Youth Talents Growth Plan of Shanghai Academy of Agricultural Sciences [Grant No: 2015-1-26]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; BARTLING D, 1993, EUR J BIOCHEM, V216, P579, DOI 10.1111/j.1432-1033.1993.tb18177.x; Bianchi MW, 2002, PHYSIOL PLANTARUM, V116, P96, DOI 10.1034/j.1399-3054.2002.1160112.x; Chen CY, 2007, PLANT PHYSIOL, V145, P1619, DOI 10.1104/pp.107.109876; Chen JH, 2012, PLANT PHYSIOL, V158, P340, DOI 10.1104/pp.111.181875; Chi YH, 2011, DNA RES, V18, P1, DOI 10.1093/dnares/dsq031; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; Dalton DA, 2009, PLANT PHYSIOL, V150, P521, DOI 10.1104/pp.109.136630; Diao GP, 2011, PLANT MOL BIOL REP, V29, P77, DOI 10.1007/s11105-010-0212-2; Dixon David P, 2010, Arabidopsis Book, V8, pe0131, DOI 10.1199/tab.0131; Ezaki B, 2000, PLANT PHYSIOL, V122, P657, DOI 10.1104/pp.122.3.657; Hoque MA, 2010, BIOSCI BIOTECH BIOCH, V74, P2124, DOI 10.1271/bbb.100393; Hu ZL, 2011, BIOL PLANTARUM, V55, P27, DOI 10.1007/s10535-011-0004-z; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Ji W, 2010, BIOTECHNOL LETT, V32, P1173, DOI 10.1007/s10529-010-0269-x; Jiang HW, 2010, PLANT PHYSIOL, V154, P1646, DOI 10.1104/pp.110.159152; Jiang Y, 2007, J EXP BOT, V58, P3591, DOI 10.1093/jxb/erm207; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Kumar S, 2013, J HAZARD MATER, V248, P228, DOI 10.1016/j.jhazmat.2013.01.004; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Le Martret B, 2011, PLANT BIOTECHNOL J, V9, P661, DOI 10.1111/j.1467-7652.2011.00611.x; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Matysik J, 2002, CURR SCI INDIA, V82, P525; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moons A, 2003, FEBS LETT, V553, P427, DOI 10.1016/S0014-5793(03)01077-9; OREGAN BP, 1993, S AFR J BOT, V59, P98, DOI 10.1016/S0254-6299(16)30780-3; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sytykiewicz H, 2011, INT J MOL SCI, V12, P7982, DOI 10.3390/ijms12117982; Takesawa T, 2002, MOL BREEDING, V9, P93, DOI 10.1023/A:1026718308155; Xu J, 2010, PLANTA, V231, P1251, DOI 10.1007/s00425-010-1122-0; Yang GY, 2014, PLANT CELL TISS ORG, V117, P99, DOI 10.1007/s11240-014-0424-5; Yu T, 2003, J PLANT PHYSIOL, V160, P1305, DOI 10.1078/0176-1617-01205; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	39	65	75	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136960	10.1371/journal.pone.0136960	http://dx.doi.org/10.1371/journal.pone.0136960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327625	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700076
J	Zhang, B; Cowden, D; Zhang, F; Yuan, J; Siedlak, S; Abouelsaad, M; Zeng, L; Zhou, XF; O'Toole, J; Das, AS; Kofskey, D; Warren, M; Bian, ZH; Cui, YQ; Tan, T; Kresak, A; Wyza, RE; Petersen, RB; Wang, GX; Kong, QZ; Wang, XL; Sedor, J; Zhu, XW; Zhu, H; Zou, WQ				Zhang, Bo; Cowden, Daniel; Zhang, Fan; Yuan, Jue; Siedlak, Sandra; Abouelsaad, Mai; Zeng, Liang; Zhou, Xuefeng; O'Toole, John; Das, Alvin S.; Kofskey, Diane; Warren, Miriam; Bian, Zehua; Cui, Yuqi; Tan, Tao; Kresak, Adam; Wyza, Robert E.; Petersen, Robert B.; Wang, Gong-Xian; Kong, Qingzhong; Wang, Xinglong; Sedor, John; Zhu, Xiongwei; Zhu, Hua; Zou, Wen-Quan			Prion Protein Protects against Renal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							REGULATED KINASE ACTIVATION; HEME OXYGENASE; NITRIC-OXIDE; CASPASE-3 ACTIVATION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; ISCHEMIA; BRAIN; KIDNEY; TISSUE	The cellular prion protein (PrPC), a protein most noted for its link to prion diseases, has been found to play a protective role in ischemic brain injury. To investigate the role of PrPC in the kidney, an organ highly prone to ischemia/reperfusion (IR) injury, we examined wildtype (WT) and PrPC knockout (KO) mice that were subjected to 30-min of renal ischemia followed by 1, 2, or 3 days of reperfusion. Renal dysfunction and structural damage was more severe in KO than in WT mice. While PrP was undetectable in KO kidneys, Western blotting revealed an increase in PrP in IR-injuredWT kidneys compared to sham-treated kidneys. Compared to WT, KO kidneys exhibited increases in oxidative stress markers heme oxygenase-1, nitrotyrosine, and Ne-(carboxymethyl) lysine, and decreases in mitochondrial complexes I and III. Notably, phosphorylated extracellular signal-regulated kinase (pERK) staining was predominantly observed in tubular cells from KO mice following 2 days of reperfusion, a time at which significant differences in renal dysfunction, histological changes, oxidative stress, and mitochondrial complexes between WT and KO mice were observed. Our study provides the first evidence that PrPC may play a protective role in renal IR injury, likely through its effects on mitochondria and ERK signaling pathways.	[Zhang, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Organ Transplantat, Wuhan 430074, Hubei, Peoples R China; [Cowden, Daniel; Zhang, Fan; Yuan, Jue; Siedlak, Sandra; Abouelsaad, Mai; Zeng, Liang; Das, Alvin S.; Kofskey, Diane; Warren, Miriam; Petersen, Robert B.; Kong, Qingzhong; Wang, Xinglong; Zhu, Xiongwei; Zou, Wen-Quan] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA; [Zhang, Bo; Zhou, Xuefeng; Bian, Zehua; Cui, Yuqi; Tan, Tao] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Zeng, Liang; Wang, Gong-Xian; Zou, Wen-Quan] Nanchang Univ, Affiliated Hosp 1, Dept Urol, Nanchang, Jiangxi, Peoples R China; [Zou, Wen-Quan] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [O'Toole, John; Sedor, John] Case Western Reserve Univ, Kidney Dis Res Ctr, Cleveland, OH 44106 USA; [Petersen, Robert B.; Kong, Qingzhong; Zou, Wen-Quan] Case Western Reserve Univ, Dept Neurol, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Kong, Qingzhong; Zou, Wen-Quan] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Natl Ctr Regenerat Med, Cleveland, OH 44106 USA; [O'Toole, John; Sedor, John] Case Western Reserve Univ, Dept Physiol & Med, Cleveland, OH 44106 USA; [O'Toole, John; Sedor, John] Case Western Reserve Univ, Dept Biophys, Cleveland, OH 44106 USA; [Kresak, Adam; Wyza, Robert E.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Human Tissue Procurement Facil HTPF, Cleveland, OH 44106 USA; [Kresak, Adam; Wyza, Robert E.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Comprehens Canc Ctr Tissue Resources Core, Cleveland, OH 44106 USA; [Zhang, Bo] Minist Hlth, Key Lab, Wuhan, Hubei, Peoples R China; [Zhang, Bo] Minist Educ, Key Lab, Wuhan, Hubei, Peoples R China; [Petersen, Robert B.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Neurosci, Cleveland, OH 44106 USA; [Zhang, Fan] Shandong Univ, Dept Neurosurg, Jinan 250100, Peoples R China; [Zou, Wen-Quan] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Huazhong University of Science & Technology; Case Western Reserve University; Case Western Reserve University Hospital; University System of Ohio; Ohio State University; Nanchang University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Shandong University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhu, XW (corresponding author), Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA.	xiongwei.zhu@case.edu; hua.zhu@osumc.edu; wenquan.zou@case.edu	Zhu, Hua/G-4409-2010; Zhu, Xiongwei/A-9629-2009; Zou, Wenquan/ABF-2875-2020; Zou, Wenquan/GWQ-3489-2022; Cui, Yuqi/U-5914-2017; Das, Alvin S./X-4408-2019	Zhu, Xiongwei/0000-0003-2092-6508; Das, Alvin S./0000-0003-2313-977X; Zhu, Hua/0000-0001-7136-7326	National Institute of Health [NS062787, NS087588]; CJD Foundation; University Hospitals Case Medical Center; American Heart Association [12SDG12070714]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087588, R01NS062787] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CJD Foundation; University Hospitals Case Medical Center; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institute of Health (http://grants.nih.gov/grants/oer.htm) grants number NS062787 and NS087588 to WQZ. Additional funding to WQZ was obtained from the CJD Foundation (http://www.cjdfoundation.org/) and bridge funding from University Hospitals Case Medical Center (http://www.uhhospitals.org/case). HZ received a Scientist Development Grant number 12SDG12070714 from the American Heart Association (http://my.americanheart.org/fundingopportunities). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Adding Case Medical Center, and case (see above).	Alderliesten M, 2007, AM J PATHOL, V171, P452, DOI 10.2353/ajpath.2007.060805; Aragno M, 2003, KIDNEY INT, V64, P836, DOI 10.1046/j.1523-1755.2003.00152.x; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Brown DR, 1998, J NEUROCHEM, V70, P1686; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 2000, BIOCHEM J, V345, P767; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; Tabara LC, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.14; Chatterjee PK, 1999, EXP NEPHROL, V7, P438; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chiao H, 1997, J CLIN INVEST, V99, P1165, DOI 10.1172/JCI119272; Cruthirds DL, 2003, ARCH BIOCHEM BIOPHYS, V412, P27, DOI 10.1016/S0003-9861(03)00039-0; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Goligorsky MS, 2002, KIDNEY INT, V61, P855, DOI 10.1046/j.1523-1755.2002.00233.x; Graner E, 2000, FEBS LETT, V482, P257, DOI 10.1016/S0014-5793(00)02070-6; Heemann U, 2000, AM J PATHOL, V156, P287, DOI 10.1016/S0002-9440(10)64729-3; Jang HS, 2013, BBA-MOL BASIS DIS, V1832, P1998, DOI 10.1016/j.bbadis.2013.07.001; Kaizu T, 2003, KIDNEY INT, V63, P1393, DOI 10.1046/j.1523-1755.2003.00882.x; Khader A, 2014, TRANSPLANTATION, V98, P148, DOI 10.1097/TP.0000000000000194; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x; Li JH, 2011, NEPHROL DIAL TRANSPL, V26, P469, DOI 10.1093/ndt/gfq466; Lo RKH, 2003, J BIOL CHEM, V278, P52154, DOI 10.1074/jbc.M307299200; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Martins VR, 1997, NAT MED, V3, P1376, DOI 10.1038/nm1297-1376; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0; Mitsios N, 2007, J NEUROSCI RES, V85, P602, DOI 10.1002/jnr.21142; Montie HL, 2005, BBA-MOL BASIS DIS, V1741, P314, DOI 10.1016/j.bbadis.2005.04.007; Morimoto K, 2001, KIDNEY INT, V60, P1858, DOI 10.1046/j.1523-1755.2001.01000.x; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Negro A, 2001, MOL CELL NEUROSCI, V17, P521, DOI 10.1006/mcne.2000.0953; Noiri E, 2001, AM J PHYSIOL-RENAL, V281, pF948, DOI 10.1152/ajprenal.0071.2001; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Pat B, 2005, KIDNEY INT, V67, P931, DOI 10.1111/j.1523-1755.2005.00157.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rahman NA, 2009, TRANSPL P, V41, P3603, DOI 10.1016/j.transproceed.2009.04.008; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; Requena JR, 1997, J BIOL CHEM, V272, P17473, DOI 10.1074/jbc.272.28.17473; Ruan YL, 2014, KIDNEY INT, V86, P525, DOI 10.1038/ki.2014.80; Sawe N, 2008, J NEUROSCI RES, V86, P1659, DOI 10.1002/jnr.21604; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Spudich A, 2005, NEUROBIOL DIS, V20, P442, DOI 10.1016/j.nbd.2005.04.002; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Steele AD, 2009, PRION, V3, P240, DOI 10.4161/pri.3.4.10135; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Wei QQ, 2012, AM J PHYSIOL-RENAL, V303, pF1487, DOI 10.1152/ajprenal.00352.2012; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Xiao Xiangzhu, 2014, J Clin Cell Immunol, V5; Xiao XZ, 2009, AM J PATHOL, V174, P1602, DOI 10.2353/ajpath.2009.081045; Yang Y, 2014, NEUROSCI LETT, V568, P44, DOI 10.1016/j.neulet.2014.03.037; Zager RA, 2012, J AM SOC NEPHROL, V23, P1048, DOI 10.1681/ASN.2011121147; Zanetti F, 2014, CARDIOVASC RES, V104, P93, DOI 10.1093/cvr/cvu194; Zhuang SG, 2008, J PHARMACOL EXP THER, V325, P732, DOI 10.1124/jpet.108.136358; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	68	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136923	10.1371/journal.pone.0136923	http://dx.doi.org/10.1371/journal.pone.0136923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327228	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700072
J	Muhly, T; Serrouya, R; Neilson, E; Li, HT; Boutin, S				Muhly, Tyler; Serrouya, Robert; Neilson, Eric; Li, Haitao; Boutin, Stan			Influence of In-Situ Oil Sands Development on Caribou (Rangifer tarandus) Movement	PLOS ONE			English	Article							WOODLAND CARIBOU; ANIMAL MOVEMENT; POPULATIONS; DYNAMICS; PREDATION; SELECTION; BEHAVIOR; WOLVES; MOOSE	In-situ oil sands development (ISD) involves a network of facilities, wells, roads and pipelines to extract and transport subsurface bitumen. This technology is rapidly expanding and there is uncertainty whether ISDs restrict animal movement, leading to increased extinction probabilities for some wide-ranging species. Here we test for effects of simulated future (i.e., 50 years from now) and current ISDs on simulated movements of woodland caribou (Rangifer tarandus), a threatened species across North America. In simulations of future scenarios, we varied the spacing and permeability of ISDs and the presence/absence of protected areas. Permeability was measured as the number of times simulated caribou crossed ISDs with different levels of modelled permeability. We estimated the effects of these factors on caribou step length and annual home range size, key metrics of small and large spatiotemporal scales of movement, respectively. Current caribou crossings of above-ground pipeline features of ISDs were measured using camera traps and compared to expected caribou crossing rates based on present-day caribou movement simulations. Current crossing rates were evaluated within the context of predicted future crossing success rates necessary to maintain caribou step lengths and home ranges. With few exceptions, permeability across ISDs was the main factor affecting caribou movement, more so than spacing between developments or the presence of protected areas. However, minimal permeability (crossing rates of c. 15% to 60%, relative to an undisturbed site was needed to maintain existing home range size and step lengths. The effect of permeability on home range size and step length was non-linear, suggesting that small increases in permeability would provide a disproportionately greater benefit to caribou movement. Our predictions demonstrate that maintaining permeability across ISDs is more important than spacing between leases or including protected areas, and thus provides clear direction for mitigation efforts for features that will exist on the landscape for decades to come.	[Muhly, Tyler; Serrouya, Robert; Li, Haitao] Univ Alberta, Alberta Biodivers Monitoring Inst, Dept Biol Sci, Edmonton, AB, Canada; [Muhly, Tyler] Stantec, Environm Serv, Sidney, BC, Canada; [Neilson, Eric; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta	Serrouya, R (corresponding author), Univ Alberta, Alberta Biodivers Monitoring Inst, Dept Biol Sci, Edmonton, AB, Canada.	Serrouya@ualberta.ca	Boutin, Stan/A-2619-2014	Boutin, Stan/0000-0001-6317-038X	Environmental Monitoring Committee of the Lower Athabasca; Santec	Environmental Monitoring Committee of the Lower Athabasca; Santec	Funding was provided by the Environmental Monitoring Committee of the Lower Athabasca. They helped to set the direction of the research, and approved the scenarios for future in situ developments. They did not influence or comment on the Results or Discussion sections of the Manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Santec provided support in the form of a salary for author TM, (from a contract from ABMI during the submission and review phase to PLOS ONE), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alberta Go, LOW ATH REG PLAN 201; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Beauchesne D, 2014, BIOL CONSERV, V172, P190, DOI 10.1016/j.biocon.2014.03.002; Beyer H. L, 2012, GEOSPATIAL MODELLING; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Canada E., 2012, RECOVERY STRATEGY WO; CURATOLO JA, 1986, CAN FIELD NAT, V100, P218; Dunne BM, 2009, BIOL CONSERV, V142, P332, DOI 10.1016/j.biocon.2008.10.029; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Hervieux D, 2013, CAN J ZOOL, V91, P872, DOI 10.1139/cjz-2013-0123; JOHNSON AR, 1992, LANDSCAPE ECOL, V7, P63, DOI 10.1007/BF02573958; Latham ADM, 2011, J WILDLIFE MANAGE, V75, P204, DOI 10.1002/jwmg.28; Lawhead BE, 2006, LIT REV SYNTHESIS EF; Ltd. GA, 2004, REV WILDL CROSS STRU; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Mcloughlin PD, 2007, ECOLOGY, V88, P3192, DOI 10.1890/06-1974.1; McLoughlin PD, 2003, J WILDLIFE MANAGE, V67, P755, DOI 10.2307/3802682; Meek P, 2012, INTRO CAMERA TRAPPIN; Miller C, 2000, ECOL APPL, V10, P85, DOI 10.1890/1051-0761(2000)010[0085:MTEOFM]2.0.CO;2; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Nams VO, 2006, J ANIM ECOL, V75, P298, DOI 10.1111/j.1365-2656.2006.01047.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105; Scheller RM, 2005, GLOBAL CHANGE BIOL, V11, P307, DOI 10.1111/j.1365-2486.2005.00906.x; Schneider RR, 2010, BIOL CONSERV, V143, P1603, DOI 10.1016/j.biocon.2010.04.002; SEIP DR, 1992, CAN J ZOOL, V70, P1494, DOI 10.1139/z92-206; Serrouya R, 2012, MOL ECOL, V21, P2588, DOI 10.1111/j.1365-294X.2012.05570.x; Shifley SR, 2000, COMPUT ELECTRON AGR, V27, P7, DOI 10.1016/S0168-1699(00)00087-9; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Turchin Peter, 1998; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wittmer HU, 2005, OECOLOGIA, V144, P257, DOI 10.1007/s00442-005-0055-y	36	14	14	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136933	10.1371/journal.pone.0136933	http://dx.doi.org/10.1371/journal.pone.0136933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26349062	gold, Green Published, Green Submitted			2022-12-27	WOS:000360897600016
J	Milani, L; Ghiselli, F; Pecci, A; Maurizii, MG; Passamonti, M				Milani, Liliana; Ghiselli, Fabrizio; Pecci, Andrea; Maurizii, Maria Gabriella; Passamonti, Marco			The Expression of a Novel Mitochondrially-Encoded Gene in Gonadic Precursors May Drive Paternal Inheritance of Mitochondria	PLOS ONE			English	Article							VASA-LIKE GENE; LARGE RIBOSOMAL-RNA; GERM PLASM; UNIPARENTAL INHERITANCE; SMALL MICROMERES; POLAR GRANULES; BLUE MUSSEL; SEA-URCHIN; I-TASSER; PROTEIN	Mitochondria have an active role in germ line development, and their inheritance dynamics are relevant to this process. Recently, a novel protein (RPHM21) was shown to be encoded in sperm by the male-transmitted mtDNA of Ruditapes philippinarum, a species with Doubly Uniparental Inheritance (DUI) of mitochondria. In silico analyses suggested a viral origin of RPHM21, and we hypothesized that the endogenization of a viral element provided sperm mitochondria of R. philippinarum with the ability to invade male germ line, thus being transmitted to the progeny. In this work we investigated the dynamics of germ line development in relation to mitochondrial transcription and expression patterns using qPCR and specific antibodies targeting the germ line marker VASPH (R. philippinarum VASA homolog), and RPHM21. Based on the experimental results we conclude that both targets are localized in the primordial germ cells (PGCs) of males, but while VASPH is detected in all PGCs, RPHM21 appears to be expressed only in a subpopulation of them. Since it has been predicted that RPHM21 might have a role in cell proliferation and migration, we here suggest that PGCs expressing it might gain advantage over others and undertake spermatogenesis, accounting for RPHM21 presence in all spermatozoa. Understanding how foreign sequence endogenization and co-option can modify the biology of an organism is of particular importance to assess the impact of such events on evolution.	[Milani, Liliana; Ghiselli, Fabrizio; Pecci, Andrea; Maurizii, Maria Gabriella; Passamonti, Marco] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy	University of Bologna	Milani, L (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy.	liliana.milani@unibo.it	Milani, Liliana/B-7063-2015; Ghiselli, Fabrizio/D-2260-2010	Milani, Liliana/0000-0001-5052-2075; Ghiselli, Fabrizio/0000-0002-1680-8616	Italian Ministry of Education, Universities and Research "Futuro in Ricerca"; University of Bologna "RFO"; Canziani bequest; Fondazione del Monte	Italian Ministry of Education, Universities and Research "Futuro in Ricerca"; University of Bologna "RFO"; Canziani bequest; Fondazione del Monte	This work was supported by the Italian Ministry of Education, Universities and Research "Futuro in Ricerca 2013" grant to FG, University of Bologna "RFO 2013" funding to MGM, and "Canziani bequest" and "Fondazione del Monte" funding to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikura R, 2001, MECH DEVELOP, V107, P97, DOI 10.1016/S0925-4773(01)00455-5; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; Citorik RJ, 2014, CURR OPIN MICROBIOL, V19, P59, DOI 10.1016/j.mib.2014.05.022; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Delgado M, 2004, SCI MAR, V71; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V320, P592, DOI 10.1016/j.bbrc.2004.06.009; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Ghiselli F, 2013, GENOME BIOL EVOL, V5, P1535, DOI 10.1093/gbe/evt112; Ghiselli F, 2012, MOL BIOL EVOL, V29, P771, DOI 10.1093/molbev/msr248; Ghiselli F, 2011, MOL BIOL EVOL, V28, P949, DOI 10.1093/molbev/msq271; Goic B, 2012, CURR OPIN MICROBIOL, V15, P531, DOI 10.1016/j.mib.2012.06.002; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Gustafson EA, 2010, BIOESSAYS, V32, P626, DOI 10.1002/bies.201000001; HAY B, 1988, DEVELOPMENT, V103, P625; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Hickford DE, 2011, BIOL REPROD, V85, P733, DOI 10.1095/biolreprod.111.091629; Ina S, 2003, GENE EXPR PATTERNS, V3, P635, DOI 10.1016/S1567-133X(03)00111-X; Jones G.G., 1993, MANILA CLAMS HATCHER; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Kobayashi S, 1998, CURR BIOL, V8, P1117, DOI 10.1016/S0960-9822(98)70466-X; KOBAYASHI S, 1993, SCIENCE, V260, P1521, DOI 10.1126/science.7684857; Kotaja N, 2007, MOL CELL BIOL, V8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorsch JR, 2002, CELL, V109, P797, DOI 10.1016/S0092-8674(02)00804-8; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Marracci S, 2007, DEV GENES EVOL, V217, P395, DOI 10.1007/s00427-007-0143-6; Matova N, 2001, DEV BIOL, V231, P291, DOI 10.1006/dbio.2000.0120; Meneghetti F, 2004, AQUACULTURE, V240, P473, DOI 10.1016/j.aquaculture.2004.04.011; Milani L, 2012, J EXP ZOOL PART B, V318; Milani L, 2014, CURR GENET, V60, P163, DOI 10.1007/s00294-014-0420-7; Milani L, 2014, GENOME BIOL EVOL, V6, P391, DOI 10.1093/gbe/evu021; Milani L, 2013, J EXP ZOOL PART B, V320, P442, DOI 10.1002/jez.b.22520; Milani L, 2013, GENOME BIOL EVOL, V5, P1408, DOI 10.1093/gbe/evt101; Milani L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028194; Mitra K, 2013, BIOESSAYS, V35, P955, DOI 10.1002/bies.201300011; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Obata M, 2011, DEV GROWTH DIFFER, V53, P878, DOI 10.1111/j.1440-169X.2011.01294.x; Obata M, 2010, DEV GENES EVOL, V220, P139, DOI 10.1007/s00427-010-0335-3; Ogawa M, 1999, ZOOL SCI, V16, P445, DOI 10.2108/zsj.16.445; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfister D, 2008, DEV BIOL, V319, P146, DOI 10.1016/j.ydbio.2008.02.045; Ponurovsky S. K., 1992, Journal of Shellfish Research, V11, P265; Reunov A, 2000, DEV GROWTH DIFFER, V42, P139; Reunov AA, 2014, ZYGOTE; Reunov A, 2006, ZYGOTE, V14, P231, DOI 10.1017/S0967199406003789; Reunov AA, 2013, ZYGOTE, V21, P95, DOI 10.1017/S0967199411000402; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozen S, 2000, Methods Mol Biol, V132, P365; SKIBINSKI DOF, 1994, NATURE, V368, P817, DOI 10.1038/368817b0; SKIBINSKI DOF, 1994, GENETICS, V138, P801; Styhler S, 1998, DEVELOPMENT, V125, P1569; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thandapani P, EXPRESSION MOUSE AVE; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Venetis C, 2006, P R SOC B, V273, P2483, DOI 10.1098/rspb.2006.3607; Voronina E, 2008, DEV BIOL, V314, P276, DOI 10.1016/j.ydbio.2007.11.039; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; Wilsch-Br Reunova YA, 1997, J CELL BIOL, V139; Yan RH, 2010, J CELL BIOL, V188, P335, DOI 10.1083/jcb.200904040; Yuan YM, 2014, GENE, V545, P15, DOI 10.1016/j.gene.2014.05.017; Yusa Y, 2013, J HERED, V104, P380, DOI 10.1093/jhered/est014; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZOUROS E, 1994, P NATL ACAD SCI USA, V91, P7463, DOI 10.1073/pnas.91.16.7463; ZOUROS E, 1994, NATURE, V368, P818, DOI 10.1038/368818a0; Zouros E, 2013, EVOL BIOL, V40, P1, DOI 10.1007/s11692-012-9195-2	77	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137468	10.1371/journal.pone.0137468	http://dx.doi.org/10.1371/journal.pone.0137468			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339998	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200063
J	Vallejo, MC; Mayinger, P				Vallejo, Milene Carmes; Mayinger, Peter			Delayed Turnover of Unphosphorylated Ssk1 during Carbon Stress Activates the Yeast Hog1 Map Kinase Pathway	PLOS ONE			English	Article							PROTEASOME; PHOSPHORYLATION; DEGRADATION; CASCADE	In Saccharomyces cerevisiae, the Hog1 mitogen-activated protein kinase (MAPK) pathway coordinates the adaptation to osmotic stress and was recently reported to respond to acute changes in glucose levels. Similarly as in osmotic stress, glucose starvation leads to a transient accumulation of Hog1 in the nucleus. However, the kinetics and the mechanism of Hog1 activation are different for these stress conditions. During osmotic shock the activation of Hog1 can be transduced by either the Sho1 or the Sln1/Ypd1/Ssk1 branch. During glucose starvation the phosphorylation of Hog1 is slower and is completely dependent on Ssk1, but independent of Sho1. To characterize the mechanism of activation of Hog1 during carbon stress, we examined the turnover of Ssk1 protein levels upon glucose starvation in the presence of cycloheximide and monitored protein levels by western blotting. Our data demonstrate that unphosphorylated Ssk1 was quickly degraded during exponential growth and after osmotic stress but remained remarkably stable during glucose limitation. We conclude that glucose starvation induces a delay in the turnover of unphosphorylated Ssk1, which is sufficient to activate the Hog1 MAPK pathway. Although unphosphorylated Ssk1 is known to be degraded by the proteasome, its stabilization is apparently not due to changes in cellular localization or decrease in ubiquitination levels during glucose limitation.	[Vallejo, Milene Carmes; Mayinger, Peter] Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97239 USA	Oregon Health & Science University	Mayinger, P (corresponding author), Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97239 USA.	mayinger@ohsu.edu			National Institutes of Health [RO1GM084088]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant RO1GM084088 to PM.	Adams A, 1998, METHODS YEAST GENETI, pxiv; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dihazi H, 2004, J BIOL CHEM, V279, P23961, DOI 10.1074/jbc.M312974200; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Duch A, 2012, FEBS LETT, V586, P2925, DOI 10.1016/j.febslet.2012.07.034; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hickman MJ, 2011, GENETICS, V188, P325, DOI 10.1534/genetics.111.128322; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Lu JMY, 2003, EUKARYOT CELL, V2, P1304, DOI 10.1128/EC.2.6.1304-1314.2003; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Panadero J, 2006, J BIOL CHEM, V281, P4638, DOI 10.1074/jbc.M512736200; Peters LZ, 2013, J CELL BIOL, V201, P663, DOI 10.1083/jcb.201211146; Piao HL, 2012, TRAFFIC, V13, P1522, DOI 10.1111/j.1600-0854.2012.01406.x; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; Sato N, 2003, MOL CELL BIOL, V23, P6662, DOI 10.1128/MCB.23.18.6662-6671.2003; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002	27	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137199	10.1371/journal.pone.0137199	http://dx.doi.org/10.1371/journal.pone.0137199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340004	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200033
J	Pan, XD; Pang, M; Ma, AJ; Wang, K; Zhang, Z; Zhong, QW; Yang, SN				Pan, Xudong; Pang, Meng; Ma, Aijun; Wang, Kun; Zhang, Zhang; Zhong, Qianwei; Yang, Shuna			Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; OSTEOPROTEGERIN; APOPTOSIS; LIGAND; PROLIFERATION; ACTIVATION	Objective To investigate the association of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptors, osteoprotegerin (OPG) and death receptor 5 (DR5) with largeartery atherosclerosis (LAA) stroke and its prognosis. Methods We included patients with LAA stroke (n = 132) according to the TOAST classification system and controls (n = 60). To evaluate the extent and severity of cerebral atherosclerosis, the LAA stroke group was subdivided into 3 subgroups by number of cerebral arteries with atherosclerotic stenosis (>= 50%): single, double and multiple (>= 3). Plasma levels of TRAIL, OPG and DR5 were measured by ELISA. Ordinal logistic regression was used to analyze the association between the plasma levels of TRAIL, OPG, DR5 and the severity of cerebral atherosclerosis. Prognosis was determined by the Modified Rankin Scale at 3 months after stroke. Receiver operating characteristic (ROC) curve was used to evaluated TRAIL as a predictor of prognosis. Results Plasma TRAIL level was significantly lower for LAA patients than controls (P < 0.001), while plasma OPG and DR5 levels were higher (both P < 0.001). Logistic regression analysis revealed that risk of severe cerebral atherosclerosis was reduced significantly with increased plasma level of TRAIL (OR 0.438; 95% CI 0.282-0.681; P < 0.001), whereas increased with high plasma levels of OPG and DR5 (OR 2.707; 95% CI 1.702-4.302, P < 0.001; OR 3.593; 95% CI 1.878-6.869, P < 0.001). Plasma TRAIL level was negatively correlated with the prognosis (r = -0.372, P < 0.001). The optimal cut-off value of TRAIL for prognosis was 848.63 pg/mL. The sensitivity and specificity at this cut-off value were 63.1% and 86.2%, respectively. After adding the plasma TRAIL level into the multivariate model of ROC, the area under the ROC curve was increased from 0.639 to 0.785, but the change was not statistical significant (P = 0.146). Conclusions TRAIL and its receptors OPG and DR5 may be involved in LAA stroke and the plasma level of TRAIL may be a biomarker predicting the severity of cerebral atherosclerosis and the prognosis of LAA stroke.	[Pan, Xudong; Pang, Meng; Ma, Aijun; Wang, Kun; Zhang, Zhang; Zhong, Qianwei; Yang, Shuna] Qingdao Univ, Affiliated Hosp, Dept Neurol, Qingdao 266100, Shandong, Peoples R China	Qingdao University	Ma, AJ (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Neurol, Qingdao 266100, Shandong, Peoples R China.	pangmeng6666@163.com			Shandong Province Natural Science Foundation [ZR2011HM087]	Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province)	XDP was fully supported by a grant from Shandong Province Natural Science Foundation (ZR2011HM087).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alladina SJ, 2005, J VASC RES, V42, P337, DOI 10.1159/000086599; Corallini F, 2008, FRONT BIOSCI-LANDMRK, V13, P135, DOI 10.2741/2665; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Kaplan MJ, 2000, J IMMUNOL, V164, P2897, DOI 10.4049/jimmunol.164.6.2897; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Kim J, 2013, CLIN BIOCHEM, V46, P1036, DOI 10.1016/j.clinbiochem.2013.05.048; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lieb W, 2010, ARTERIOSCL THROM VAS, V30, P1849, DOI 10.1161/ATVBAHA.109.199661; Martin-Ventura JL, 2007, FRONT BIOSCI-LANDMRK, V12, P3656, DOI 10.2741/2342; Mogelvang R, 2012, AM J CARDIOL, V109, P515, DOI 10.1016/j.amjcard.2011.09.043; Mori K, 2010, THROMB RES, V125, P322, DOI 10.1016/j.thromres.2009.11.024; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Sato K, 2006, J EXP MED, V203, P239, DOI 10.1084/jem.20051062; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Secchiero P, 2010, ATHEROSCLEROSIS, V210, P274, DOI 10.1016/j.atherosclerosis.2009.11.005; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Watt V, 2011, ATHEROSCLEROSIS, V215, P348, DOI 10.1016/j.atherosclerosis.2011.01.010; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8	23	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136414	10.1371/journal.pone.0136414	http://dx.doi.org/10.1371/journal.pone.0136414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334877	gold, Green Published, Green Submitted			2022-12-27	WOS:000360615400014
J	Zhao, JC; Liang, X; Xu, K				Zhao, Jichang; Liang, Xiao; Xu, Ke			Competition between Homophily and Information Entropy Maximization in Social Networks	PLOS ONE			English	Article							SMALL-WORLD; EMERGENCE; DYNAMICS	In social networks, it is conventionally thought that two individuals with more overlapped friends tend to establish a new friendship, which could be stated as homophily breeding new connections. While the recent hypothesis of maximum information entropy is presented as the possible origin of effective navigation in small-world networks. We find there exists a competition between information entropy maximization and homophily in local structure through both theoretical and experimental analysis. This competition suggests that a newly built relationship between two individuals with more common friends would lead to less information entropy gain for them. We demonstrate that in the evolution of the social network, both of the two assumptions coexist. The rule of maximum information entropy produces weak ties in the network, while the law of homophily makes the network highly clustered locally and the individuals would obtain strong and trust ties. A toy model is also presented to demonstrate the competition and evaluate the roles of different rules in the evolution of real networks. Our findings could shed light on the social network modeling from a new perspective.	[Zhao, Jichang] Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China; [Liang, Xiao] Chinese Acad Sci, Inst Elect, Key Lab Technol Geospatial Informat Proc & Applic, Beijing, Peoples R China; [Xu, Ke] Beihang Univ, State Key Lab Software Dev Environm, Beijing 100191, Peoples R China	Beihang University; Chinese Academy of Sciences; Institute of Electronics, CAS; Beihang University	Zhao, JC (corresponding author), Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China.	jichang@buaa.edu.cn		Zhao, Jichang/0000-0002-5319-8060	State Key Laboratory of Software Development Environment [SKLSDE-2015ZX-28, SKLSDE-2015ZX-05]; Fundamental Research Funds for the Central Universities [YWF-15-JGXY-011]	State Key Laboratory of Software Development Environment; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was partially supported by the fund of the State Key Laboratory of Software Development Environment (Grant nos. SKLSDE-2015ZX-28 and SKLSDE-2015ZX-05) and the Fundamental Research Funds for the Central Universities (Grant no. YWF-15-JGXY-011). No authors of this paper are employed or contracted by the above funders.	Ahn YY, 2007, P 16 INT C WORLD WID, DOI [DOI 10.1145/1242572.1242685, 10.1145/1242572.1242685]; [Anonymous], [No title captured]; Bao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076027; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Cheng XQ, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10011; Davidsen J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.128701; Dunbar R., 1998, GROOMING GOSSIP EVOL; Goldenberg J, 2009, DISTANCE IS NOT DEAD; Golder SA, 2007, Communities and Technologies 2007, P41, DOI 10.1007/978-1-84628-905-7_3; Granovetter MS, 1974, STRENGTH WEAK TIES; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026107; Hu YQ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.108701; Jin EM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046132; Kibanov M, 2014, SCI CHINA INFORM SCI, V57, DOI 10.1007/s11432-014-5067-y; Kim BJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.045101; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Ma XJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056106; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pollet TV, 2011, CYBERPSYCH BEH SOC N, V14, P253, DOI 10.1089/cyber.2010.0161; Ribeiro B., 2010, P 10 ACM SIGCOMM C I, P390, DOI [10.1145/1879141, DOI 10.1145/1879141.1879192]; Toivonen R, 2006, PHYSICA A, V371, P851, DOI 10.1016/j.physa.2006.03.050; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; Viswanath B, 2009, 2ND ACM SIGCOMM WORKSHOP ON ONLINE SOCIAL NETWORKS (WOSN 09), P37; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang W., 2014, SCI CHINA INFORM SCI, V57, P1, DOI [10.1007/s11432-014-5221-6, DOI 10.1007/S11432-014-5221-6]; Zhang W, 2014, SCI CHINA INFORM SCI, V57, DOI [10.1007/s11432-013-4930-6, 10.1007/s11432-014-5070-3]; Zhao JC, 2014, NEUROCOMPUTING, V142, P343, DOI 10.1016/j.neucom.2014.04.025; Zhao JC, 2012, KNOWL INF SYST, V32, P589, DOI 10.1007/s10115-011-0445-x; Zhao JC, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016105; Zhou HJ, 2005, P NATL ACAD SCI USA, V102, P10052, DOI 10.1073/pnas.0409296102	38	2	2	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136896	10.1371/journal.pone.0136896	http://dx.doi.org/10.1371/journal.pone.0136896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334994	Green Submitted, gold, Green Published			2022-12-27	WOS:000360615400031
J	Tapia-Armijos, MF; Homeier, J; Espinosa, CI; Leuschner, C; de la Cruz, M				Fernanda Tapia-Armijos, Maria; Homeier, Juergen; Ivan Espinosa, Carlos; Leuschner, Christoph; de la Cruz, Marcelino			Deforestation and Forest Fragmentation in South Ecuador since the 1970s-Losing a Hotspot of Biodiversity	PLOS ONE			English	Article							LAND-COVER CLASSIFICATION; HABITAT FRAGMENTATION; TROPICAL DEFORESTATION; PROTECTED AREAS; RAIN-FORESTS; DYNAMICS; PATTERNS; AMAZON; VEGETATION; LANDSCAPE	Deforestation and fragmentation are major components of global change; both are contributing to the rapid loss of tropical forest area with important implications for ecosystem functioning and biodiversity conservation. The forests of South Ecuador are a biological 'hotspot' due to their high diversity and endemism levels. We examined the deforestation and fragmentation patterns in this area of high conservation value using aerial photographs and Aster satellite scenes. The registered annual deforestation rates of 0.75% (1976-1989) and 2.86% (1989-2008) for two consecutive survey periods, the decreasing mean patch size and the increasing isolation of the forest fragments show that the area is under severe threat. Approximately 46% of South Ecuador's original forest cover had been converted by 2008 into pastures and other anthropogenic land cover types. We found that deforestation is more intense at lower elevations (premontane evergreen forest and shrubland) and that the deforestation front currently moves in upslope direction. Improved awareness of the spatial extent, dynamics and patterns of deforestation and forest fragmentation is urgently needed in biologically diverse areas like South Ecuador.	[Fernanda Tapia-Armijos, Maria; Ivan Espinosa, Carlos] Univ Tecn Particular Loja, Dept Ciencias Nat, Secc Ecol & Sistemat, Loja, Ecuador; [Fernanda Tapia-Armijos, Maria; Homeier, Juergen; Leuschner, Christoph] Univ Gottingen, Plant Ecol, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany; [de la Cruz, Marcelino] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Dept Biol & Geol, ESCET, Madrid, Spain	Universidad Tecnica Particular de Loja; University of Gottingen; Universidad Rey Juan Carlos	Tapia-Armijos, MF (corresponding author), Univ Tecn Particular Loja, Dept Ciencias Nat, Secc Ecol & Sistemat, Loja, Ecuador.	mftapia@utpl.edu.ec	Espinosa, Carlos Ivan/AAI-1305-2019; de la Cruz, Marcelino/M-6124-2015; Homeier, Jürgen/G-1662-2011	Espinosa, Carlos Ivan/0000-0002-5330-4505; de la Cruz, Marcelino/0000-0002-9080-4525; Homeier, Jürgen/0000-0001-5676-3267	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT) [PIC 08 - 000139]; Universidad Tecnica Particular de Loja (UTPL); Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID) [A/012436/07, A/021000/08]; German Research Foundation (DFG) [FOR 816, HO 3296/2]	Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT); Universidad Tecnica Particular de Loja (UTPL); Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID); German Research Foundation (DFG)(German Research Foundation (DFG))	This research, MFT and CIE were financially supported by the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT - http://www.educacionsuperior.gob.ec/) - Project PIC 08 - 000139 and the Universidad Tecnica Particular de Loja (UTPL - utpl.edu.ec), MFT was financially supported by the the Secretaria de Educacion Superior, Ciencia, Tecnologia e Innovacion (SENESCYT - http://www.educacionsuperior.gob.ec/) scholarship program 2010, MC was financially supported by the Agencia Espanola de Cooperacion Internacional para el Desarrollo (AECID - http://www.aecid.es/ES) grants A/012436/07 and A/021000/08, MFT and JH were financially supported by the German Research Foundation (DFG - http://www.dfg.de/en/) research unit FOR 816 (project HO 3296/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS M, 2002, ASTER USER HDB ADV S; Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; [Anonymous], 2010, GEOGR BULL; Armenteras D, 2003, BIOL CONSERV, V113, P245, DOI 10.1016/S0006-3207(02)00359-2; Balslev H, 2002, BOT AUTROECUATORIANA; Barthlott W, 2005, NOVA ACT LC, V92, P61; Bendix J, 2006, CLIMATE RES, V30, P133, DOI 10.3354/cr030133; Bendix J., 1992, ERDKUNDE, V46, P118; Brehm G, 2005, J BIOGEOGR, V32, P1621, DOI 10.1111/j.1365-2699.2005.01304.x; Brehm G., 2008, V198, P15; Brodie J, 2012, TRENDS ECOL EVOL, V27, P145, DOI 10.1016/j.tree.2011.09.008; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brummitt N, 2003, CONSERV BIOL, V17, P1442, DOI 10.1046/j.1523-1739.2003.02344.x; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Cayuela L, 2006, FOREST ECOL MANAG, V226, P208; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Chuvieco S. E, 2010, TELEDETECCION AMBIEN; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Cueva J, 2010, COBERTURA VEGETAL US; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Eastman JR, 2012, IDRISI SELVA EDITION; Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017; Ellingson LJ, 2000, FOREST ECOL MANAG, V137, P41, DOI 10.1016/S0378-1127(99)00311-4; Emck P., 2007, THESIS U ERLANGEN NU; Espinosa C. I., 2012, Ecosistemas, V21, P167; Eva HD, 2012, REMOTE SENS-BASEL, V4, P1369, DOI 10.3390/rs4051369; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAO, 2011, STAT WORLDS FOR 2011, P179; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fearnside PM, 2004, ECOL APPL, V14, P982, DOI 10.1890/03-5225; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gottlicher D, 2009, INT J REMOTE SENS, V30, P1867, DOI 10.1080/01431160802541531; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hawbaker TJ, 2006, ECOL APPL, V16, P1222, DOI 10.1890/1051-0761(2006)016[1222:RDHGAL]2.0.CO;2; Homeier J., 2008, V198, P87; Homeier J., 2013, ECOL STUD, V221, P93, DOI DOI 10.1007/978-3-642-38137-9; Homeier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047128; Iniguez-Armijos C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105869; Janzen D.H., 1988, P130; Jokisch BD, 2002, GEOGR REV, V92, P235, DOI 10.2307/4140972; Kauffman JB, 2003, FOREST ECOL MANAG, V176, P1, DOI 10.1016/S0378-1127(02)00227-X; Keating PL, 1998, PHYS GEOGR, V19, P221, DOI 10.1080/02723646.1998.10642648; Knowlton JL, 2011, ECOL APPL, V21, P2974, DOI 10.1890/10-1886.1; Kouki J, 2001, SCAND J FOREST RES, P27, DOI 10.1080/028275801300090564; Lambin E, 2003, ANNU REV ENV RESOUR, V28; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Macedo MN, 2012, P NATL ACAD SCI USA, V109, P1341, DOI 10.1073/pnas.1111374109; Macleod RD, 1998, PHOTOGRAMM ENG REM S, V64, P207; Maldonado N., 2002, BOT NICA AUSTROECUAT, P28; Marquette CM, 1998, HUM ECOL, V26, P573, DOI 10.1023/A:1018797325069; McGarigal K, 2002, COMPUTER SOFTWARE PR; Mena CF, 2008, PHOTOGRAMM ENG REM S, V74, P737, DOI 10.14358/PERS.74.6.737; Mendoza JE, 2002, LANDSCAPE URBAN PLAN, V59, P147, DOI 10.1016/S0169-2046(02)00012-9; MILLETTE TL, 1995, GLOBAL ENVIRON CHANG, V5, P367, DOI 10.1016/0959-3780(95)00071-U; Ministerio del Ambiente del Ecuador, 2010, RES BIOSF EC LUG EXC; Ministerio del Ambiente del Ecuador Sistema de Clasificacion de los Ecosistemas del Ecuador Continental, 2012, SUBS PATR NAT, P136; Noske NM, 2008, BASIC APPL ECOL, V9, P4, DOI 10.1016/j.baae.2007.06.014; PALA V, 1995, PHOTOGRAMM ENG REM S, V61, P935; Pan WKY, 2004, AGR ECOSYST ENVIRON, V101, P117, DOI 10.1016/j.agee.2003.09.022; Peters T, 2013, ECOSYSTEM SERVICES B, V221, P19, DOI [10.1007/978-3-642-38137-9_2, DOI 10.1007/978-3-642-38137-9_2]; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Riano D, 2003, IEEE T GEOSCI REMOTE, V41, P1056, DOI 10.1109/TGRS.2003.811693; Richter M., 2003, ERDKUNDE, V57, P161, DOI DOI 10.3112/ERDKUNDE.2003.03.01; RodriguezMahecha J. V, 2004, HOTSPOTS REVISITED E, P80; Rudel TK, 2002, ANN ASSOC AM GEOGR, V92, P87, DOI 10.1111/1467-8306.00281; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schowengerdt RA, 2007, REMOTE SENSING: MODELS AND METHODS FOR IMAGE PROCESSING, 3RD EDITION, P1; Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Sierra R, 1998, HUM ECOL, V26, P135, DOI 10.1023/A:1018753018631; Sierra R, 2000, APPL GEOGR, V20, P1, DOI 10.1016/S0143-6228(99)00014-4; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Southgate D., 1990, Staff Paper - Department of Agricultural and Applied Economics, University of Minnesota; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Tabarelli M, 2010, CONSERV BIOL, V24, P1654, DOI 10.1111/j.1523-1739.2010.01529.x; Tapia-Armijos MF, 2011, COBERTURA VEGETAL US; Thies B, 2012, J LAND USE SCI, P1; Torracchi E, 2000, AVANCES ANALISIS ESP, P275; Toutin T, 2004, INT J REMOTE SENS, V25, P1893, DOI 10.1080/0143116031000101611; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Valencia R., 2000, LIBRO ROJO PLANTAS E; Vina A, 2004, AMBIO, V33, P118, DOI 10.1639/0044-7447(2004)033[0118:SCDAOD]2.0.CO;2; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Weigend M, 2002, BOT REV, V68, P38, DOI 10.1663/0006-8101(2002)068[0038:OOTBOT]2.0.CO;2; Weigend Maximilian, 2004, Rev. peru biol., V11, P127; Werner Florian A., 2005, Ecotropica (Bonn), V11, P21; Wolf K, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003876; Wunder S, 2000, EC DEFORESTATION EXA; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Young AG, 2000, CONSERV BIOL SER, V4, P335	98	129	141	1	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0133701	10.1371/journal.pone.0133701	http://dx.doi.org/10.1371/journal.pone.0133701			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332681	gold, Green Published			2022-12-27	WOS:000360613800005
J	Hu, XX; Fu, L; Li, Y; Lin, ZB; Liu, X; Wang, JF; Chen, YX; Wang, ZP; Zhang, X; Ou, ZJ; Ou, JS				Hu, Xiao-Xia; Fu, Li; Li, Yan; Lin, Ze-Bang; Liu, Xiang; Wang, Jing-Feng; Chen, Yang-Xin; Wang, Zhi-Ping; Zhang, Xi; Ou, Zhi-Jun; Ou, Jing-Song			The Cardioprotective Effect of Vitamin E (Alpha-Tocopherol) Is Strongly Related to Age and Gender in Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; E SUPPLEMENTATION; CORONARY-DISEASE; HEART-DISEASE; E CONSUMPTION; RAT HEARTS; RISK	Vitamin E (VitE) only prevented cardiovascular diseases in some patients and the mechanisms remain unknown. VitE levels can be affected by aging and gender. We hypothesize that age and gender can influence VitE's cardioprotective effect. Mice were divided into 4 groups according to age and gender, and each group of mice were divided into a control group and a VitE group. The mice were administered water or VitE for 21 days; Afterward, the cardiac function and myocardial infarct size and cardiomyocyte apoptosis were measured after myocardial ischemia reperfusion(MI/R). VitE may significantly improved cardiac function in young male mice and aged female mice by enhancing ERK1/2 activity and reducing JNK activity. Enhanced expression of HSP90 and Bcl-2 were also seen in young male mice. No changes in cardiac function and cardiac proteins were detected in aged male mice and VitE was even liked to exert a reverse effect in cardiac function in young mice by enhancing JNK activity and reducing Bcl-2 expression. Those effects were in accordance with the changes of myocardial infarction size and cardiomyocyte apoptosis in each group of mice. VitE may reduce MI/R injury by inhibiting cardiomyocyte apoptosis in young male mice and aged female mice but not in aged male mice. VitE was possibly harmful for young female mice, shown as increased cardiomyocyte apoptosis after MI/R. Thus, we speculated that the efficacy of VitE in cardiac protection was associated with age and gender.	[Hu, Xiao-Xia; Fu, Li; Li, Yan; Lin, Ze-Bang; Liu, Xiang; Wang, Zhi-Ping; Zhang, Xi; Ou, Jing-Song] Sun Yat Sen Univ, Affiliated Hosp 1, Div Cardiac Surg, Guangzhou 510080, Guangdong, Peoples R China; [Hu, Xiao-Xia; Fu, Li; Li, Yan; Lin, Ze-Bang; Liu, Xiang; Wang, Zhi-Ping; Zhang, Xi; Ou, Zhi-Jun; Ou, Jing-Song] Sun Yat Sen Univ, sAffiliated Hosp 1, Key Lab Assisted Circulat, Minist Hlth, Guangzhou 510080, Guangdong, Peoples R China; [Hu, Xiao-Xia; Fu, Li; Li, Yan; Lin, Ze-Bang; Liu, Xiang; Ou, Zhi-Jun; Ou, Jing-Song] Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Engn Lab Diag & Treatment Vasc Dis, Guangzhou 510080, Guangdong, Peoples R China; [Ou, Zhi-Jun] Sun Yat Sen Univ, Affiliated Hosp 1, Div Hypertens & Vasc Dis, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Jing-Feng; Chen, Yang-Xin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou 510120, Guangdong, Peoples R China; [Wang, Jing-Feng; Chen, Yang-Xin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Arrhythmia & Electrophysio, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Ou, ZJ (corresponding author), Sun Yat Sen Univ, sAffiliated Hosp 1, Key Lab Assisted Circulat, Minist Hlth, Guangzhou 510080, Guangdong, Peoples R China.	Zhijunou@163.com; oujs@mail.sysu.edu.cn	wang, jing/GRS-7509-2022; Fu, Liwu/AAE-8835-2020		National Natural Science Foundation of China [30971261, 81170271, 81370370, 81325001]; Changjiang Scholars Program from Ministry of Education of China; Guangdong Pearl River Scholars Program; Program of National Key Clinical Specialties; Sun Yat-Sen University Clinical Research 5010 Program; Ministry of Human Resources and Social Security of China; Guangdong Natural Science Fund Committee, China [S2011010004378]; Guangzhou Government for Scientific Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changjiang Scholars Program from Ministry of Education of China; Guangdong Pearl River Scholars Program; Program of National Key Clinical Specialties; Sun Yat-Sen University Clinical Research 5010 Program; Ministry of Human Resources and Social Security of China; Guangdong Natural Science Fund Committee, China; Guangzhou Government for Scientific Research Foundation	This study was supported by the National Natural Science Foundation of China (30971261, 81170271, 81370370 and Distinguished Young Scholar 81325001), the Changjiang Scholars Program from Ministry of Education of China, the Guangdong Pearl River Scholars Program, the Program of National Key Clinical Specialties, the Sun Yat-Sen University Clinical Research 5010 Program, the Science and Technology Research for the Returned Overseas Chinese Scholars from the Ministry of Human Resources and Social Security of China (2011), the Guangdong Natural Science Fund Committee, China (S2011010004378) and the Guangzhou Government for Scientific Research Foundation for Returned Overseas Chinese Scholars.	Altavilla D, 2000, CARDIOVASC RES, V47, P515, DOI 10.1016/S0008-6363(00)00124-3; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Chae CU, 2012, CIRC-HEART FAIL, V5, P176, DOI 10.1161/CIRCHEARTFAILURE.111.963793; Coombes JS, 2000, ACTA PHYSIOL SCAND, V169, P261, DOI 10.1046/j.1365-201x.2000.00740.x; Coombes JS, 2000, INT J VITAM NUTR RES, V70, P293, DOI 10.1024/0300-9831.70.6.293; Das J, 2011, BIOCHEM PHARMACOL, V81, P891, DOI 10.1016/j.bcp.2011.01.008; Du Y, 2005, LIFE SCI, V77, P2770, DOI 10.1016/j.lfs.2005.03.027; Hak AE, 2003, CIRCULATION, V108, P802, DOI 10.1161/01.CIR.0000084546.82738.89; Jeong JJ, 2009, FOOD CHEM TOXICOL, V47, P1569, DOI 10.1016/j.fct.2009.03.044; Kamzalov S, 2004, EXP GERONTOL, V39, P1199, DOI 10.1016/j.exger.2004.04.007; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Liao XL, 2013, J CARDIOVASC PHARM, V61, P430, DOI 10.1097/FJC.0b013e318288a68d; Mohanty I, 2004, BASIC CLIN PHARMACOL, V94, P184, DOI 10.1111/j.1742-7843.2004.pto940405.x; Mukherjee S, 2008, BBA-MOL BASIS DIS, V1782, P498, DOI 10.1016/j.bbadis.2008.05.002; Ou ZJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1131, DOI 10.1152/ajpendo.00107.2010; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Rodrigo R, 2012, INTERACT CARDIOV TH, V15, P209, DOI 10.1093/icvts/ivs154; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Traber MG, 2007, AM J CLIN NUTR, V85, p293S, DOI 10.1093/ajcn/85.1.293S; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Vardi M, 2013, J LIPID RES, V54, P2307, DOI 10.1194/jlr.R026641; Yang F, 2011, J HEART LUNG TRANSPL, V30, P928, DOI 10.1016/j.healun.2011.04.001; Yang JH, 2014, CELL STRESS CHAPERON, V19, P33, DOI 10.1007/s12192-013-0432-0; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zhao Y, 2007, CANCER LETT, V247, P345, DOI 10.1016/j.canlet.2006.05.015	26	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137405	10.1371/journal.pone.0137405	http://dx.doi.org/10.1371/journal.pone.0137405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331272	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800130
J	Lee, WH; Schaffner-Reckinger, E; Tsoukatos, DC; Aylward, K; Moussis, V; Tsikaris, V; Trypou, P; Egot, M; Baruch, D; Kieffer, N; Bachelot-Loza, C				Lee, Wen Hwa; Schaffner-Reckinger, Elisabeth; Tsoukatos, Demokritos C.; Aylward, Kelly; Moussis, Vassilios; Tsikaris, Vassilios; Trypou, Paraskevi; Egot, Marion; Baruch, Dominique; Kieffer, Nelly; Bachelot-Loza, Christilla			Inhibition of alpha IIb beta 3 Ligand Binding by an alpha IIb Peptide that Clasps the Hybrid Domain to the beta I Domain of beta 3	PLOS ONE			English	Article							PLATELET INTEGRIN ALPHA(IIB)BETA(3); GLYCOPROTEIN-IIB; CONFORMATIONAL-CHANGES; FIBRINOGEN BINDING; STRUCTURAL BASIS; CELL-ADHESION; ACTIVATION; RECEPTOR; ALPHA-V-BETA-3; AGGREGATION	Agonist-stimulated platelet activation triggers conformational changes of integrin alpha IIb beta 3, allowing fibrinogen binding and platelet aggregation. We have previously shown that an octapeptide, (p1)YMESRADR(8), corresponding to amino acids 313-320 of the beta-ribbon extending from the beta-propeller domain of alpha IIb, acts as a potent inhibitor of platelet aggregation. Here we have performed in silico modelling analysis of the interaction of this peptide with alpha IIb beta 3 in its bent and closed (not swing-out) conformation and show that the peptide is able to act as a substitute for the beta-ribbon by forming a clasp restraining the beta 3 hybrid and beta I domains in a closed conformation. The involvement of species-specific residues of the beta 3 hybrid domain (E356 and K384) and the beta 1 domain (E297) as well as an intrapeptide bond (pE315-pR317) were confirmed as important for this interaction by mutagenesis studies of alpha IIb beta 3 expressed in CHO cells and native or substituted peptide inhibitory studies on platelet functions. Furthermore, NMR data corroborate the above results. Our findings provide insight into the important functional role of the alpha IIb beta-ribbon in preventing integrin alpha IIb beta 3 head piece opening, and highlight a potential new therapeutic approach to prevent integrin ligand binding.	[Lee, Wen Hwa] Univ Oxford, SGC, Oxford, England; [Schaffner-Reckinger, Elisabeth; Kieffer, Nelly] Univ Luxembourg, Lab Biol & Physiol Integree, CNRS, GDRE ITI, Luxembourg, Luxembourg; [Tsoukatos, Demokritos C.; Moussis, Vassilios; Tsikaris, Vassilios; Trypou, Paraskevi] Univ Ioannina, Dept Chem, Sect Organ Chem & Biochem, Ioannina, Greece; [Aylward, Kelly; Egot, Marion; Baruch, Dominique; Bachelot-Loza, Christilla] INSERM, UMR S 1140, Fac Pharm, Paris, France; [Aylward, Kelly; Egot, Marion; Baruch, Dominique; Bachelot-Loza, Christilla] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Kieffer, Nelly] Jiao Tong Univ, Sch Med, CNRS LIA 124, Sino French Res Ctr Life Sci & Genom, Shanghai 200030, Peoples R China	University of Oxford; University of Luxembourg; University of Ioannina; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Shanghai Jiao Tong University	Bachelot-Loza, C (corresponding author), INSERM, UMR S 1140, Fac Pharm, Paris, France.	christilla.bachelot-loza@parisdescartes.fr	Lee, Wen Hwa/G-1250-2013; Tsikaris, Vassilios/AAM-6235-2021; Baruch, Dominique/ABA-1791-2020; baruch, dominique/F-8189-2013; Lee, Wen Hwa/GZA-8183-2022	Lee, Wen Hwa/0000-0002-4098-5225; Baruch, Dominique/0000-0003-2835-5500; Lee, Wen Hwa/0000-0002-4098-5225; Bachelot-Loza, Christilla/0000-0002-6264-902X; Moussis, Vassilios/0000-0003-0658-8637	"Programme Egide Platon" of the Ministry of Foreign Affairs, France; Joint Research and Technology Program of the General Secretariat for Research and Technology, Greece; Region Ile-de-France (CORDDIM); AbbVie [1097737]; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust	"Programme Egide Platon" of the Ministry of Foreign Affairs, France; Joint Research and Technology Program of the General Secretariat for Research and Technology, Greece; Region Ile-de-France (CORDDIM)(Region Ile-de-France); AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was generously supported by "Programme Egide Platon" of the Ministry of Foreign Affairs, France and the Joint Research and Technology Program of the General Secretariat for Research and Technology, Greece; M.E. is supported by the Region Ile-de-France (CORDDIM). The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Armstrong PC, 2012, THROMB HAEMOSTASIS, V107, P808, DOI 10.1160/TH11-10-0727; Atherton E., 1990, SOLID PHASE PEPTIDE; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Biris N, 2003, EUR J BIOCHEM, V270, P3760, DOI 10.1046/j.1432-1033.2003.03762.x; Bledzka K, 2013, CIRC RES, V112, P1189, DOI 10.1161/CIRCRESAHA.112.300570; CARRELL NA, 1985, J BIOL CHEM, V260, P1743; Cheng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081609; Choi WS, 2013, BLOOD, V122, P4165, DOI 10.1182/blood-2013-04-499194; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Derrick JM, 1997, BIOCHEM J, V325, P309, DOI 10.1042/bj3250309; FRELINGER AL, 1988, J BIOL CHEM, V263, P12397; HARFENIST EJ, 1988, BLOOD, V71, P132; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; Kamata T, 2010, J BIOL CHEM, V285, P38428, DOI 10.1074/jbc.M110.139667; Kok RJ, 2002, BIOCONJUGATE CHEM, V13, P128, DOI 10.1021/bc015561+; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Legendre P, 2006, J THROMB HAEMOST, V4, P236, DOI 10.1111/j.1538-7836.2005.01653.x; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mitchell WB, 2007, BLOOD, V109, P3725, DOI 10.1182/blood-2006-11-058420; Mitsios JV, 2004, EUR J BIOCHEM, V271, P855, DOI 10.1111/j.1432-1033.2004.03990.x; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Papamichael ND, 2009, J PHARMACOL EXP THER, V329, P634, DOI 10.1124/jpet.108.150086; Pearce AC, 2004, BIOCHEM J, V378, P193, DOI 10.1042/BJ20031298; PFAFF M, 1994, J BIOL CHEM, V269, P20233; Provasi D, 2009, PROTEINS, V77, P477, DOI 10.1002/prot.22463; Rand ML, 1999, THROMB HAEMOSTASIS, V82, P1680; SAMANEN J, 1991, J MED CHEM, V34, P3114, DOI 10.1021/jm00114a022; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Stanica RM, 2008, J PEPT SCI, V14, P1195, DOI 10.1002/psc.1060; Stewart JM, 1984, PRINCIPLES PEPTIDE S; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Vijayan KV, 2003, FEBS LETT, V540, P41, DOI 10.1016/S0014-5793(03)00170-4; Vomund AN, 2008, BIOCHEMISTRY-US, V47, P11616, DOI 10.1021/bi8015108; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	41	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134952	10.1371/journal.pone.0134952	http://dx.doi.org/10.1371/journal.pone.0134952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332040	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800016
J	Townhill, BL; Maxwell, D; Engelhard, GH; Simpson, SD; Pinnegar, JK				Townhill, Bryony L.; Maxwell, David; Engelhard, Georg H.; Simpson, Stephen D.; Pinnegar, John K.			Historical Arctic Logbooks Provide Insights into Past Diets and Climatic Responses of Cod	PLOS ONE			English	Article							GADUS-MORHUA; NORWEGIAN COD; LIFE-HISTORY; FISH STOCKS; SEA; DYNAMICS; CAPELIN; GROWTH; SHIFTS; ZOOPLANKTON	Gadus morhua (Atlantic cod) stocks in the Barents Sea are currently at levels not seen since the 1950s. Causes for the population increase last century, and understanding of whether such large numbers will be maintained in the future, are unclear. To explore this, we digitised and interrogated historical cod catch and diet datasets from the Barents Sea. Seventeen years of catch data and 12 years of prey data spanning 1930-1959 cover unexplored spatial and temporal ranges, and importantly capture the end of a previous warm period, when temperatures were similar to those currently being experienced. This study aimed to evaluate cod catch per unit effort and prey frequency in relation to spatial, temporal and environmental variables. There was substantial spatio-temporal heterogeneity in catches through the time series. The highest catches were generally in the 1930s and 1940s, although at some localities more cod were recorded late in the 1950s. Generalized Additive Models showed that environmental, spatial and temporal variables are all valuable descriptors of cod catches, with the highest occurring from 15-45 degrees E longitude and 73-77 degrees N latitude, at bottom temperatures between 2 and 4 degrees C and at depths between 150 and 250 m. Cod diets were highly variable during the study period, with frequent changes in the relative frequencies of different prey species, particularly Mallotus villosus (capelin). Environmental variables were particularly good at describing the importance of capelin and Clupea harengus (herring) in the diet. These new analyses support existing knowledge about how the ecology of the region is controlled by climatic variability. When viewed in combination with more recent data, these historical relationships will be valuable in forecasting the future of Barents Sea fisheries, and in understanding how environments and ecosystems may respond.	[Townhill, Bryony L.; Maxwell, David; Engelhard, Georg H.; Pinnegar, John K.] Ctr Environm Fisheries & Aquaculture Sci Cefas, Lowestoft, Suffolk, England; [Simpson, Stephen D.] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter, Devon, England	Centre for Environment Fisheries & Aquaculture Science; University of Exeter	Townhill, BL (corresponding author), Ctr Environm Fisheries & Aquaculture Sci Cefas, Lowestoft, Suffolk, England.	bryony.townhill@cefas.co.uk		Pinnegar, John/0000-0001-5061-9520; Engelhard, Georg H./0000-0002-7821-7029; Simpson, Stephen/0000-0002-4856-6164	Cefas Seedcorn [DP332]; NERC Fellowship [NE/J500616/2]; Natural Environment Research Council [NE/J500616/2] Funding Source: researchfish; NERC [NE/J500616/2] Funding Source: UKRI	Cefas Seedcorn; NERC Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Work was funded by Cefas Seedcorn grant number DP332 entitled Trawling Through Time DM. Funding was provided to SS through a NERC Fellowship (NE/J500616/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenorov VK, 1946, GIDROMETEOIXDAT, P1; Beaugrand G, 2002, MAR ECOL PROG SER, V232, P197, DOI 10.3354/meps232197; Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beverton R., 1965, INT COMMISSION NW AT, V6, P225; BEVERTON RJH, 1994, ICES MAR SC, V198, P482; Blacker RW, 1957, MINISTRY AGR FISHERI, VII; Bogstad B, 2013, MAR BIOL RES, V9, P895, DOI 10.1080/17451000.2013.775451; Boitsov VD, 2012, ICES J MAR SCI, V69, P833, DOI 10.1093/icesjms/fss075; Brander KM, 2010, J FISH BIOL, V77, P1899, DOI 10.1111/j.1095-8649.2010.02782.x; Brown WW, 1946, HULL B MARINE BIOL, V3; Cefas, CEF FISH STOM REC 20; Corlett J., 1965, Special Publications International Commission for the Northwest Atlantic Fisheries, V6, P373; DALPADADO P, 1991, POLAR RES, V10, P443, DOI 10.1111/j.1751-8369.1991.tb00665.x; Dalpadado P, 1996, MAR ECOL PROG SER, V144, P175, DOI 10.3354/meps144175; Dolgov AV, 2007, IMR PINRO REPORT SER, P44; Drinkwater KF, 2011, PROG OCEANOGR, V90, P47, DOI 10.1016/j.pocean.2011.02.006; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Ellingsen IH, 2008, CLIMATIC CHANGE, V87, P155, DOI 10.1007/s10584-007-9369-6; Engelhard GH, 2014, GLOBAL CHANGE BIOL, V20, P2473, DOI 10.1111/gcb.12513; Engelhard GH, 2011, ICES J MAR SCI, V68, P1090, DOI 10.1093/icesjms/fsr031; Engelhard GH, 2011, ICES J MAR SCI, V68, P580, DOI 10.1093/icesjms/fsq183; Furevik T., 2002, FISKEN HAVET; Genner MJ, 2010, GLOBAL CHANGE BIOL, V16, P517, DOI 10.1111/j.1365-2486.2009.02027.x; Gjosaeter H, 1998, SARSIA, V83, P453, DOI 10.1080/00364827.1998.10420445; Godo OR, 2003, FISH FISH, V4, P121, DOI 10.1046/j.1467-2979.2003.00112.x; GRAHAM M., 1953, ARCTIC, V6, P252; HARVEY JOHN, 1965, INT COMM NORTHWEST ATLANTIC FISH SPEC PUBLICATION, V6, P869; Helle K, 1999, ICES J MAR SCI, V56, P15, DOI 10.1006/jmsc.1998.0427; Helle K, 2002, ENVIRON BIOL FISH, V65, P341, DOI 10.1023/A:1020581415071; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; Hjort J, 1914, CONSEIL PERMANENT IN; Huse G, 2008, CLIMATIC CHANGE, V87, P177, DOI 10.1007/s10584-007-9347-z; Hylen A, 2002, ICES MARINE SCI S, V215, P534; ICES, 2014, ADV JUN 2014 ECOREGI; ICES, 1949, RAPP PROC VERB REUN; ICES, 2014, ICES REP ARCT FISH W; Jensen ADS, 1939, BIOL MEDDELELSER, VXIV, P8; Johannesen E, NW ATL FISH ORG SCI; Johannesen E, 2012, MAR ECOL PROG SER, V458, P181, DOI 10.3354/meps09818; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Keup-Thiel E, 2006, BOREAL ENVIRON RES, V11, P329; Kjesbu OS, 2014, P NATL ACAD SCI USA, V111, P3478, DOI 10.1073/pnas.1316342111; Lee A., 1956, Polar Record, V8, P109; Orlova EL, 2005, ICES J MAR SCI, V62, P1281, DOI 10.1016/j.icesjms.2005.05.020; Orlova EL, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2014.00074; Ottersen G, 2014, ICES J MAR SCI, V71, P2064, DOI 10.1093/icesjms/fsu037; Ottersen G, 2013, MAR ECOL PROG SER, V480, P205, DOI 10.3354/meps10249; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinnegar J. K., 2014, DAPSTOM INTEGRATED D; Prozorkevich D, 2013, IMR PINRO JOINT REPO, V4, P38; R Core Team, 2021, R LANGUAGE ENV STAT; Rose GA, 2004, CAN J FISH AQUAT SCI, V61, P1553, DOI 10.1139/F04-173; SAETERSDAL G, 1987, FISH RES, V5, P253; Sagarin R, 2001, SCIENCE, V294, P811, DOI 10.1126/science.1064218; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Steffensen E, 1969, METEORLOGISKE ANN, V5, P263; Stempniewicz L, 2007, DEEP-SEA RES PT II, V54, P2934, DOI 10.1016/j.dsr2.2007.08.012; Stenevik EK, 2007, MAR POLICY, V31, P19, DOI 10.1016/j.marpol.2006.05.001; Stiansen JE, 2006, JOINT PINRO IMR REPO; Sundby S, 2008, ICES J MAR SCI, V65, P953, DOI 10.1093/icesjms/fsn085; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Wang HY, 2014, MAR ECOL PROG SER, V514, P217, DOI 10.3354/meps10943; Wood S, 2014, MIXED GAM COMPUTATIO; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Yamanouchi T, 2011, POLAR SCI, V5, P53, DOI 10.1016/j.polar.2010.10.002; Yaragina NA, 2009, MAR BIOL RES, V5, P75, DOI 10.1080/17451000802512739; Zatsepin VI, 1939, FISHERIES RES BOARD, V1064; Zubov MN, 1948, THE CTR ARCTIC	68	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135418	10.1371/journal.pone.0135418	http://dx.doi.org/10.1371/journal.pone.0135418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331271	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000360613800030
J	Bosse, G; Abels, W; Mtatifikolo, F; Ngoli, B; Neuner, B; Wernecke, KD; Spies, C				Bosse, Goetz; Abels, Wiltrud; Mtatifikolo, Ferdinand; Ngoli, Baltazar; Neuner, Bruno; Wernecke, Klaus-Dieter; Spies, Claudia			Perioperative Care and the Importance of Continuous Quality Improvement-A Controlled Intervention Study in Three Tanzanian Hospitals	PLOS ONE			English	Article							ANESTHETIC-RELATED MORTALITY; INTEGRATED MANAGEMENT; DEVELOPING-COUNTRIES; PATIENT SAFETY; HEALTH-CARE; CHECKLIST; SURGERY; GUIDELINES; STRATEGY; SYSTEM	Introduction Surgical services are increasingly seen to reduce death and disability in Sub-Saharan Africa, where hospital-based mortality remains alarmingly high. This study explores two implementation approaches to improve the quality of perioperative care in a Tanzanian hospital. Effects were compared to a control group of two other hospitals in the region without intervention. Methods All hospitals conducted quality assessments with a Hospital Performance Assessment Tool. Changes in immediate outcome indicators after one and two years were compared to final outcome indicators such as Anaesthetic Complication Rate and Surgical Case Fatality Rate. Results Immediate outcome indicators for Preoperative Care in the intervention hospital improved (52.5% in 2009; 84.2% in 2011, p<0.001). Postoperative Inpatient Care initially improved to then decline again (63.3% in 2009; 70% in 2010; 58.6% in 2011). In the control group, preoperative care declined from 50.8% (2009) to 32.8% (2011, p <0.001), while postoperative care did not significantly change. Anaesthetic Complication Rate in the intervention hospital declined (1.89% before intervention; 0.96% after intervention, p = 0.006). Surgical Case Fatality Rate in the intervention hospital declined from 5.67% before intervention to 2.93% after intervention (p<0.0010). Surgical Case Fatality Rate in the control group was 4% before intervention and 3.8% after intervention (p = 0.411). Anaesthetic Complication Rate in the control group was not available. Discussion Immediate outcome indicators initially improved, while at the same time final outcome declined (Surgical Case Fatality, Anaesthetic Complication Rate). Compared to the control group, final outcome improved more in the intervention hospital, although the effect was not significant over the whole study period. Documentation of final outcome indicators seemed inconsistent. Immediate outcome indicators seem more helpful to steer the Continuous Quality Improvement program. Conclusion Specific interventions as part of Continuous Quality Improvement might lead to sustainable improvement of the quality of care, if embedded in a multi-faceted approach.	[Bosse, Goetz; Abels, Wiltrud; Neuner, Bruno; Spies, Claudia] Charite, Dept Anaesthesiol & Intens Care Med, Campus Charite Mitte, D-13353 Berlin, Germany; [Bosse, Goetz; Abels, Wiltrud; Neuner, Bruno; Spies, Claudia] Charite, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Mtatifikolo, Ferdinand] Bombo Reg Hosp, Tanga City, Tanga Region, Tanzania; [Ngoli, Baltazar] Giz Deutsch Gesell Int Zusammenarbeit GmbH, TGPSH, Component Leader Qual Improvement, Dar Es Salaam, Tanzania; [Wernecke, Klaus-Dieter] Charite, D-13353 Berlin, Germany; [Wernecke, Klaus-Dieter] Sostana GmbH, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sostana GmbH	Bosse, G (corresponding author), Charite, Dept Anaesthesiol & Intens Care Med, Campus Charite Mitte, D-13353 Berlin, Germany.	goetz.bosse@charite.de	Spies, Claudia/AAJ-5412-2020	Spies, Claudia/0000-0002-1062-0495	European ESTHER Alliance [81130201]; GIZ Deutsche Gesellschaft fur Internationale Zusammenarbeit GmbH	European ESTHER Alliance; GIZ Deutsche Gesellschaft fur Internationale Zusammenarbeit GmbH	The development project out of which the present study evolved was funded by the European ESTHER Alliance. Number of the GIZ Esther Project Phase 1 was 81130201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In the framework of a development cooperation, GIZ Deutsche Gesellschaft fur Internationale Zusammenarbeit GmbH provided support in the form of a grant for CS and salaries for B. Ngoli, as well as personal fees and per diems for GB and WA during their working periods in Tanzania, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong I A, 2001, Qual Manag Health Care, V9, P1; Aveling EL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003039; Ayieko P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001018; Bae JY, 2011, B WORLD HEALTH ORGAN, V89, P395, DOI 10.2471/BLT.11.088229; Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Barbour V, 2008, PLOS MED, V5, P1165, DOI 10.1371/journal.pmed.0050182; Belizan M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-243; Bosse G, 2011, East Afr J Public Health, V8, P199; Bosse G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065428; de Vries EN, 2009, QUAL SAF HEALTH CARE, V18, P121, DOI 10.1136/qshc.2008.027524; de Vries EN, 2012, BMJ QUAL SAF, V21, P503, DOI 10.1136/bmjqs-2011-000347; Deming W, 1982, OUT CRISIS; Deming W E, 1990, J Soc Health Syst, V2, P74; Donabedian A, 1980, Med Care Rev, V37, P653; Donabedian A., 1980, EXPLORATION QUALITY; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Grol R BR, 2004, QUALITY IMPROVEMENT; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; HEYWOOD AJ, 1989, ANN ROY COLL SURG, V71, P354; Hulscher MEJL, 2013, BMJ QUAL SAF, V22, P19, DOI 10.1136/bmjqs-2011-000651; IOM, 2000, ERR IS HUMAN BUILDIN; Kelley E, 2001, INT J HEALTH PLAN M, V16, P195, DOI 10.1002/hpm.632; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; Maman AFOB, 2005, TROP DOCT, V35, P220, DOI 10.1258/004947505774938666; Naimoli JF, 2006, INT J QUAL HEALTH C, V18, P134, DOI 10.1093/intqhc/mzi097; NORDBERG E, 1990, E AFR MED J, V67, pSS1; Ozgediz D, 2008, PLOS MED, V5, P850, DOI 10.1371/journal.pmed.0050121; Peabody JW, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1293; Penoyar T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000369; Pollach G, 2013, LANCET, V381, P199, DOI 10.1016/S0140-6736(13)60080-X; Reerink IH, 1996, INT J QUAL HEALTH C, V8, P131, DOI 10.1093/intqhc/8.2.131; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Schlack WS, 2010, CURR OPIN ANESTHESIO, V23, P754, DOI 10.1097/ACO.0b013e3283400b26; Spiegel DA, 2007, LANCET, V370, P1013, DOI 10.1016/S0140-6736(07)61457-3; Teixeira PGR, 2013, J TRAUMA ACUTE CARE, V75, P717, DOI 10.1097/TA.0b013e31829d27b6; Umar Nasir, 2009, Qual Manag Health Care, V18, P295, DOI 10.1097/QMH.0b013e3181bee28d; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Weiser TG, 2009, LANCET, V374, P1113, DOI 10.1016/S0140-6736(09)61161-2; World Health Organization, 2009, WHO GUID SAF SURG 20; Yii MK, 2002, BRIT J SURG, V89, P110, DOI 10.1046/j.0007-1323.2001.01979.x	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136156	10.1371/journal.pone.0136156	http://dx.doi.org/10.1371/journal.pone.0136156			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327392	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700030
J	Kong, LN; Guo, Y; Qin, B; Peng, X; Zhu, WF				Kong, Ling-Na; Guo, Ying; Qin, Bo; Peng, Xin; Zhu, Wen-Fen			Development of Self-Management Indicators for Chronic Hepatitis B Patients on Antiviral Therapy: Results of a Chinese Delphi Panel Survey	PLOS ONE			English	Article							VIRUS INFECTION; DISEASE; INSTRUMENT; ADHERENCE; HISTORY; PEOPLE	Objective This study aimed to develop a set of indicators that could be used to measure and monitor the self-management performance for chronic hepatitis B (CHB) patients on antiviral therapy in China. Methods A two-round Delphi study via e-mail correspondence was conducted, with a group of 30 Chinese experts. The Delphi questionnaire consisted of 53 indicators identified from a literature review. Experts rated and scored the importance of indicators on a five-point Likert scale. Consensus was considered to be reached if a median score in the top tertile (4-5) and >= 80% of panel ratings in the top tertile (4-5) after Round 2. The included indicators were validated with a group of 106 CHB patients. Results The response rates for the first and second rounds were 90.9% (n=30) and 86.7% (n=26), respectively. Three new indicators were suggested in the first round. 55 indicators were included in the second round after modified. 45 (81.8%) indicators achieved on the level of consensus, all of which had an inter-quartile range of 1 or below. The final set included 4 domains and 45 indicators which were well accepted and understandable by CHB patients. Conclusion This Delphi study produced a set of 45 self-management indicators for CHB patients on antiviral therapy in China. These indicators could be used to measure and monitor the patients' self-management performance, with the goal of improving the quality of life in this population.	[Kong, Ling-Na; Qin, Bo] Chongqing Univ, Dept Infect Dis, Affiliated Hosp Chongqing Med 1, Chongqing 630044, Peoples R China; [Kong, Ling-Na; Zhu, Wen-Fen] Chongqing Med Univ, Coll Nursing, Chongqing, Peoples R China; [Guo, Ying] Harbin Med Univ, Dept Internal Med, Outpatient Dept, Affiliated Hosp 2, Harbin, Peoples R China; [Peng, Xin] Jilin Univ, Sch Nursing, Changchun 130023, Peoples R China	Chongqing University; Chongqing Medical University; Harbin Medical University; Jilin University	Qin, B (corresponding author), Chongqing Univ, Dept Infect Dis, Affiliated Hosp Chongqing Med 1, Chongqing 630044, Peoples R China.	cqqinbo@126.com						Aronson BD, 2012, AM J PHARM EDUC, V76, DOI 10.5688/ajpe767125; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Bonner JE, 2012, J VIRAL HEPATITIS, V19, P316, DOI 10.1111/j.1365-2893.2011.01550.x; Cai SF, 2012, CHI MOD MED, V19, P144; Chen KH, 2008, J ADV NURS, V64, P595, DOI 10.1111/j.1365-2648.2008.04821.x; Cooke GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5429; Corbin J. S A, 1988, UNENDING WORK AND CA; Dalkey NC, 1969, THE DELPHI METHOD AN; Deane KHO, 2003, BRIT J OCCUPATIONAL, V66, P247, DOI DOI 10.1177/030802260306600603; Foundation DH, 2009, CHRONIC HEPATITIS B; Fry M, 2012, PSYCHOL HEALTH, V27, P460, DOI 10.1080/08870446.2011.592982; Fung J, 2011, J ANTIMICROB CHEMOTH, V66, P2715, DOI 10.1093/jac/dkr388; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Giang L, 2012, WORLD J HEPATOL, V4, P43, DOI 10.4254/wjh.v4.i2.43; Groessl EJ, 2011, J VIRAL HEPATITIS, V18, P358, DOI 10.1111/j.1365-2893.2010.01328.x; Groessl EJ, 2008, J GEN INTERN MED, V23, P1959, DOI 10.1007/s11606-008-0790-y; Kamezaki H, 2013, INT J MED SCI, V10, P567, DOI 10.7150/ijms.5795; Kleynen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100227; Li H, 2014, INT J NURS STUD, V51, P208, DOI 10.1016/j.ijnurstu.2013.05.012; Li HX, 2008, CHIN J PRACL NURS, V24, P43; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lin CW, 2013, J HEPATOL, V58, P730, DOI 10.1016/j.jhep.2012.11.045; Lin CC, 2008, RES NURS HEALTH, V31, P370, DOI 10.1002/nur.20258; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Maarsingh OR, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-12; McGinn CA, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-105; Palter VN, 2011, AM J SURG, V201, P251, DOI 10.1016/j.amjsurg.2010.01.031; Petersen J, 2012, EXPERT REV GASTROENT, V6, P683, DOI [10.1586/egh.12.52, 10.1586/EGH.12.52]; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Shen J, 2012, CHIN NURS SCI, V26, P1963; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Stevens Bonnie, 2006, BMC Pediatr, V6, P1, DOI 10.1186/1471-2431-6-1; Stoller EP, 2009, AM J HEALTH BEHAV, V33, P376, DOI 10.5993/AJHB.33.4.4; Tolsgaard MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057687; Xu W., 2011, J NURS SCI, V26, P38; YANG J, 2013, J APPL MATH, DOI DOI 10.1155/2013/; Yang YF, 2009, NURS J CHIN PLA, V26, P27; Zhang CH, 2013, RESP CARE, V58, P1931, DOI 10.4187/respcare.02269; Zhao X, 2013, PHYSIOLOGICAL AND SU	40	13	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0134125	10.1371/journal.pone.0134125	http://dx.doi.org/10.1371/journal.pone.0134125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26327606	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700010
J	Paul, M; Iyengar, K; Essen, B; Gemzell-Danielsson, K; Iyengar, SD; Bring, J; Soni, S; Klingberg-Allvin, M				Paul, Mandira; Iyengar, Kirti; Essen, Birgitta; Gemzell-Danielsson, Kristina; Iyengar, Sharad D.; Bring, Johan; Soni, Sunita; Klingberg-Allvin, Marie			Acceptability of Home-Assessment Post Medical Abortion and Medical Abortion in a Low-Resource Setting in Rajasthan, India. Secondary Outcome Analysis of a Non-Inferiority Randomized Controlled Trial	PLOS ONE			English	Article							SIMPLIFIED FOLLOW-UP; PREGNANCY TEST; MISOPROSTOL; FEASIBILITY; MIFEPRISTONE; CARE; ULTRASOUND; HEALTH; WOMEN	Background Studies evaluating acceptability of simplified follow-up after medical abortion have focused on high-resource or urban settings where telephones, road connections, and modes of transport are available and where women have formal education. Objective To investigate women's acceptability of home-assessment of abortion and whether acceptability of medical abortion differs by in-clinic or home-assessment of abortion outcome in a low-resource setting in India. Design Secondary outcome of a randomised, controlled, non-inferiority trial. Setting Outpatient primary health care clinics in rural and urban Rajasthan, India. Population Women were eligible if they sought abortion with a gestation up to 9 weeks, lived within defined study area and agreed to follow-up. Women were ineligible if they had known contraindications to medical abortion, haemoglobin < 85mg/l and were below 18 years. Methods Abortion outcome assessment through routine clinic follow-up by a doctor was compared with home-assessment using a low-sensitivity pregnancy test and a pictorial instruction sheet. A computerized random number generator generated the randomisation sequence (1: 1) in blocks of six. Research assistants randomly allocated eligible women who opted for medical abortion (mifepristone and misoprostol), using opaque sealed envelopes. Blinding during outcome assessment was not possible. Main Outcome Measures Women's acceptability of home-assessment was measured as future preference of follow-up. Overall satisfaction, expectations, and comparison with previous abortion experiences were compared between study groups. Results 731 women were randomized to the clinic follow-up group (n = 353) or home-assessment group (n = 378). 623 (85%) women were successfully followed up, of those 597 (96%) were satisfied and 592 (95%) found the abortion better or as expected, with no difference between study groups. The majority, 355 (57%) women, preferred home-assessment in the event of a future abortion. Significantly more women, 284 (82%), in the home-assessment group preferred home-assessment in the future, as compared with 188 (70%) of women in the clinic follow-up group, who preferred clinic follow-up in the future (p < 0.001). Conclusion Home-assessment is highly acceptable among women in low-resource, and rural, settings. The choice to follow-up an early medical abortion according to women's preference should be offered to foster women's reproductive autonomy.	[Paul, Mandira] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Iyengar, Kirti; Essen, Birgitta; Gemzell-Danielsson, Kristina; Klingberg-Allvin, Marie] Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Karolinska Univ Hosp, Stockholm, Sweden; [Iyengar, Kirti; Iyengar, Sharad D.; Soni, Sunita] ARTH, Udaipur, Rajasthan, India; [Bring, Johan] Statisticon, Stockholm, Sweden; [Klingberg-Allvin, Marie] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden	Uppsala University; Karolinska Institutet; Karolinska University Hospital; Statisticon AB; Dalarna University	Paul, M (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	mandira.paul@kbh.uu.se	Paul, Mandira/AAW-3415-2021	Klingberg-Allvin, Marie/0000-0002-8947-2949; Essen, Birgitta/0000-0002-2900-2849	Swedish Research Council [2011-3525]; Swedish International Development Agency (SIDA); Statisticon	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Agency (SIDA); Statisticon(Statisticon AB)	The Swedish Research Council (grant#2011-3525) and the Swedish International Development Agency (SIDA) funded the study. Statisticon provided support in the form of a salary for author JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	[Anonymous], 2013, SPECIAL B MAT MORTAL, P1; Blum J, 2012, CONTRACEPTION, V86, P757, DOI 10.1016/j.contraception.2012.06.005; Bracken H, 2014, CONTRACEPTION, V90, P29, DOI 10.1016/j.contraception.2014.03.016; Bracken H, 2010, INT J GYNECOL OBSTET, V108, P228, DOI 10.1016/j.ijgo.2009.09.027; Cameron ST, 2012, CONTRACEPTION, V86, P67, DOI 10.1016/j.contraception.2011.11.010; Creanga AA, 2008, CONTRACEPTION, V78, P500, DOI 10.1016/j.contraception.2008.07.010; Dao B, 2007, BJOG-INT J OBSTET GY, V114, P1368, DOI 10.1111/j.1471-0528.2007.01468.x; Elul B, 2010, HEALTH CARE WOMEN IN, V32, P72, DOI 10.1080/07399332.2010.529212; Fiala C, 2004, CONTRACEPTION, V70, P387, DOI 10.1016/j.contraception.2004.06.005; Fiala C, 2003, EUR J OBSTET GYN R B, V109, P190, DOI 10.1016/S0301-2115(03)00012-5; Gomperts R, 2014, CONTRACEPTION, V89, P129, DOI 10.1016/j.contraception.2013.11.005; Grossman D, 2004, OBSTET GYNECOL, V103, P738, DOI 10.1097/01.AOG.0000115511.14004.19; Grossman D, 2011, CONTRACEPTION, V83, P504, DOI 10.1016/j.contraception.2010.08.023; Hirve SS, 2004, REPROD HEALTH MATTER, V12, P114, DOI 10.1016/S0968-8080(04)24017-4; Honkanen H, 2004, BJOG-INT J OBSTET GY, V111, P715, DOI 10.1111/j.1471-0528.2004.00153.x; IIPS, 2010, DISTR LEV HOUS FAC S; India Office of the registrar General and Census Commissioner India: Census of India, 2011, RAJ POP CENS DAT 201; Iyengar K, 2015, LANCET GLOB HEALTH, V3, pE537, DOI 10.1016/S2214-109X(15)00150-3; Jejeebhoy SJ, 2012, INT PERSPECT SEX R H, V38, P133, DOI 10.1363/3813312; Johnston HB, 2002, ABORTION PRACTICE IN; Kallner HK, 2010, HUM REPROD, V25, P1153, DOI 10.1093/humrep/deq037; Kallner HK, 2012, CONTRACEPTION, V85, P394, DOI 10.1016/j.contraception.2011.08.009; Karki C, 2009, INT J GYNECOL OBSTET, V106, P39, DOI 10.1016/j.ijgo.2009.02.007; Kopp Kallner H, 2014, BJOG, P1; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; Michie L, 2014, CONTRACEPTION, V89, P440, DOI 10.1016/j.contraception.2014.01.010; National Rural Health Mission Ministry of Health and Family Welfare, 2010, COMPR AB CAR TRAIN S; Ngoc NTN, 2014, OBSTET GYNECOL, V123, P88, DOI 10.1097/AOG.0000000000000050; Obrist B, 2007, PLOS MED, V4, P1584, DOI 10.1371/journal.pmed.0040308; Okonofua F, 2014, INT J GYNECOL OBSTET, V125, P49, DOI 10.1016/j.ijgo.2013.10.009; Oppegaard KS, 2014, LANCET, V6736, P1; Paul M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-98; Renner R, 2012, WHO CAN PROVIDE EFFE, P1; Saghaei Mahmood, 2004, BMC Med Res Methodol, V4, P26, DOI 10.1186/1471-2288-4-26; Schulz KF, 2010, LANCET, V375, P1144, DOI 10.1016/S0140-6736(10)60413-8; Sedgh G, 2007, LANCET, V370, P1338, DOI 10.1016/S0140-6736(07)61575-X; Tamang A, 2012, INT J GYNECOL OBSTET, V118, pS52, DOI 10.1016/j.ijgo.2012.05.011; Tran NT, 2010, INT J GYNECOL OBSTET, V109, P209, DOI 10.1016/j.ijgo.2010.01.012; WINIKOFF B, 1995, FAM PLANN PERSPECT, V27, P142, DOI 10.2307/2136257; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.	41	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0133354	10.1371/journal.pone.0133354	http://dx.doi.org/10.1371/journal.pone.0133354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327217	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700006
J	Yang, J; Zhou, S; Gu, JJ; Guo, MF; Xia, HH; Liu, YZ				Yang, Jing; Zhou, Sheng; Gu, Jianjun; Guo, Minfei; Xia, Honghui; Liu, Yizhi			UPR Activation and the Down-Regulation of alpha-Crystallin in Human High Myopia-Related Cataract Lens Epithelium	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSCRIPTION FACTOR; RISK-FACTORS; ATF6; CHAPERONE; RESISTANCE; CLEAVAGE; DISEASES	Purpose To investigate the expression of alpha A- and alpha B-crystallin and the unfolded protein response in the lens epithelium of patients with high myopia-related cataracts. Methods and Materials The central portion of the human anterior lens capsule together with the adhering epithelial cells, approximately 5 mm in diameter, were harvested and processed within two hours after cataract surgery from high myopia-related (spherical equivalent >=-10.00 diopters) and age-related cataract patients or from high myopia but non-cataractous patients (tissue were collected from ocular trauma patients with high myopia and lens trauma). Anterior lens samples from fresh cadaver normal human eyes were used as normal control (collected within 6 hours from death). Real-time PCR was performed to detect the mRNA levels of alpha-crystallins as well as unfolded protein response (UPR)-related GRP78, spliced-XBP1, ATF4 and ATF6. Western blot analysis was used to determine the protein level of alpha-crystallin, GRP78, p-IRE1 alpha, p-eIF2 alpha and ATF6. Results In the lens epithelium of the high myopia-related cataract group and the age related cataract group, the mRNA and soluble protein expression of alpha A- and alpha B-crystallin were both decreased; additionally, the protein levels of ATF6, p-eIF2 alpha and p-IRE1 alpha and the gene expression levels of spliced XBP1, GRP78, ATF6 and ATF4 were greatly increased relative to the normal control. Conclusion These results suggest the significant loss of soluble alpha-crystallin and the activation of the UPR in the lens epithelium of patients with high myopia-related cataract, which may be associated with the cataractogenesis of high myopia-related cataract.	[Yang, Jing; Zhou, Sheng; Gu, Jianjun; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Sheng] First Peoples Hosp Foshan, Dept Ophthalmol, Foshan, Guangdong, Peoples R China; [Guo, Minfei] Huichang Cty Peoples Hosp, Dept Ophthalmol, Ganzhou, Jiangxi, Peoples R China; [Xia, Honghui] Zhaoqing Gaoyao Peoples Hosp, Dept Ophthalmol, Zhaoqing, Guangdong, Peoples R China	Sun Yat Sen University	Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yizhi_liu@aliyun.com	liu, yi/GXE-9662-2022		Chinese State Key Laboratory of Ophthalmology grant [303060202400402001]	Chinese State Key Laboratory of Ophthalmology grant	Funding: This study was supported by the Chinese State Key Laboratory of Ophthalmology grant (No. 303060202400402001) received by Dr. Jing Yang.	Akal A, 2014, INT J OPHTHALMOL-CHI, V7, P828, DOI 10.3980/j.issn.2222-3959.2014.05.16; Alemayehu H, 2014, PEDIATR SURG INT, V30, P649, DOI 10.1007/s00383-014-3513-y; Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Boelens WC, 2014, PROG BIOPHYS MOL BIO, V115, P3, DOI 10.1016/j.pbiomolbio.2014.02.005; Fernandez-Buenaga R, 2013, EYE, V27, P795, DOI 10.1038/eye.2013.95; Foufelle F, 2007, M S-MED SCI, V23, P291, DOI 10.1051/medsci/2007233291; Halliday M, 2014, NEUROPHARMACOLOGY, V76, P169, DOI 10.1016/j.neuropharm.2013.08.034; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hegde SM, 2014, INVEST OPHTH VIS SCI, V55, P6398, DOI 10.1167/iovs.14-14623; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Kaufman BJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1178, DOI 10.1001/archopht.1996.01100140378001; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Lazar C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00433; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Luo K, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/328791; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Park SW, 2013, SEMIN IMMUNOPATHOL, V35, P351, DOI 10.1007/s00281-013-0370-z; PERKINS ES, 1984, BRIT J OPHTHALMOL, V68, P293, DOI 10.1136/bjo.68.5.293; Praveen MR, 2010, EYE, V24, P686, DOI 10.1038/eye.2009.137; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; WEALE R, 1980, BRIT J OPHTHALMOL, V64, P311, DOI 10.1136/bjo.64.5.311; Yadav Raj Kumar, 2014, J Cancer Prev, V19, P75, DOI 10.15430/JCP.2014.19.2.75; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Younan C, 2002, INVEST OPHTH VIS SCI, V43, P3625; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhu GY, 2015, J CELL PHYSIOL, V230, P1413, DOI 10.1002/jcp.24923; Zhu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081900	39	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137582	10.1371/journal.pone.0137582	http://dx.doi.org/10.1371/journal.pone.0137582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351848	gold, Green Submitted, Green Published			2022-12-27	WOS:000360932800098
J	Vadyvaloo, V; Hinz, AK				Vadyvaloo, Viveka; Hinz, Angela K.			A LysR-Type Transcriptional Regulator, RovM, Senses Nutritional Cues Suggesting that It Is Involved in Metabolic Adaptation of Yersinia pestis to the Flea Gut	PLOS ONE			English	Article							BORNE TRANSMISSION; BIOFILM FORMATION; VIRULENCE; EVOLUTION; MOTILITY; GENES; PSEUDOTUBERCULOSIS; EXPRESSION; INFECTION; VECTOR	Yersinia pestis has evolved as a clonal variant of Yersinia pseudotuberculosis to cause flea-borne biofilm-mediated transmission of the bubonic plague. The LysR-type transcriptional regulator, RovM, is highly induced only during Y. pestis infection of the flea host. RovM homologs in other pathogens regulate biofilm formation, nutrient sensing, and virulence; including in Y. pseudotuberculosis, where RovM represses the major virulence factor, RovA. Here the role that RovM plays during flea infection was investigated using a Y. pestis KIM6+ strain deleted of rovM, Delta rovM. The Delta rovM mutant strain was not affected in characteristic biofilm gut blockage, growth, or survival during single infection of fleas. Nonetheless, during a co-infection of fleas, the Delta rovM mutant exhibited a significant competitive fitness defect relative to the wild type strain. This competitive fitness defect was restored as a fitness advantage relative to the wild type in a Delta rovM mutant complemented in trans to over-express rovM. Consistent with this, Y. pestis strains, producing elevated transcriptional levels of rovM, displayed higher growth rates, and differential ability to form biofilm in response to specific nutrients in comparison to the wild type. In addition, we demonstrated that rovA was not repressed by RovM in fleas, but that elevated transcriptional levels of rovM in vitro correlated with repression of rovA under specific nutritional conditions. Collectively, these findings suggest that RovM likely senses specific nutrient cues in the flea gut environment, and accordingly directs metabolic adaptation to enhance flea gut colonization by Y. pestis.	[Vadyvaloo, Viveka; Hinz, Angela K.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University	Vadyvaloo, V (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	viveka@vetmed.wsu.edu						Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Blumer C, 2005, MICROBIOL-SGM, V151, P3287, DOI 10.1099/mic.0.28098-0; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chouikha I, 2012, CURR OPIN MICROBIOL, V15, P239, DOI 10.1016/j.mib.2012.02.003; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Erickson DL, 2007, CELL MICROBIOL, V9, P2658, DOI 10.1111/j.1462-5822.2007.00986.x; Erickson DL, 2006, J BACTERIOL, V188, P1113, DOI 10.1128/JB.188.3.1113-1119.2006; Harris SJ, 1998, MOL MICROBIOL, V28, P705, DOI 10.1046/j.1365-2958.1998.00825.x; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Heroven AK, 2007, ADV EXP MED BIOL, V603, P156; Heroven AK, 2006, MOL MICROBIOL, V62, P1469, DOI 10.1111/j.1365-2958.2006.05458.x; Hinnebusch BJ, 2012, YERSINIA: SYSTEMS BIOLOGY AND CONTROL, P1; Hinnebusch BJ, 1998, J INFECT DIS, V178, P1406, DOI 10.1086/314456; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Jones RT, 2013, ISME J, V7, P224, DOI 10.1038/ismej.2012.95; Jones RT, 2012, J MED ENTOMOL, V49, P492, DOI 10.1603/ME11244; Joyce SA, 2003, MOL MICROBIOL, V47, P1445, DOI 10.1046/j.1365-2958.2003.03389.x; Lawrenz MB, 2007, J BACTERIOL, V189, P5963, DOI 10.1128/JB.00528-07; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Osborne SE, 2009, P NATL ACAD SCI USA, V106, P3982, DOI 10.1073/pnas.0811669106; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Perez JC, 2009, P NATL ACAD SCI USA, V106, P4319, DOI 10.1073/pnas.0810343106; Perry RD, 2004, J BACTERIOL, V186, P1638, DOI 10.1128/JB.186.6.1638-1647.2004; Quade N, 2011, ACTA CRYSTALLOGR D, V67, P81, DOI 10.1107/S0907444910049681; Rempe KA, 2012, J BACTERIOL, V194, P2036, DOI 10.1128/JB.06568-11; Richards GR, 2008, J BACTERIOL, V190, P4870, DOI 10.1128/JB.00358-08; Richards GR, 2009, CELL MICROBIOL, V11, P1025, DOI 10.1111/j.1462-5822.2009.01322.x; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Sebbane F, 2004, INFECT IMMUN, V72, P7334, DOI 10.1128/IAI.72.12.7334-7337.2004; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; SELZER G, 1983, CELL, V32, P119, DOI 10.1016/0092-8674(83)90502-0; Spinner JL, 2013, INFECT IMMUN, V81, P4041, DOI 10.1128/IAI.00648-13; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Surgey N, 1996, J BACTERIOL, V178, P1593, DOI 10.1128/jb.178.6.1593-1599.1996; Tanikawa T, 2006, MICROBIOL IMMUNOL, V50, P587, DOI 10.1111/j.1348-0421.2006.tb03833.x; Vadyvaloo V, 2015, MICROBIOL-SGM, V161, P1198, DOI 10.1099/mic.0.000082; Vadyvaloo V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000783	41	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137508	10.1371/journal.pone.0137508	http://dx.doi.org/10.1371/journal.pone.0137508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348850	gold, Green Published, Green Submitted			2022-12-27	WOS:000360897600050
J	Lelieveld, IM; Bottcher, A; Hennermann, JB; Beck, M; Fellgiebel, A				Lelieveld, Irene M.; Boettcher, Anna; Hennermann, Julia B.; Beck, Michael; Fellgiebel, Andreas			Eight-Year Follow-Up of Neuropsychiatric Symptoms and Brain Structural Changes in Fabry Disease	PLOS ONE			English	Article							WHITE-MATTER LESIONS; ALPHA-GALACTOSIDASE; DEPRESSION; MUTATIONS; GENE; HIPPOCAMPUS	Brain structural alterations and neuropsychiatric symptoms have been described repeatedly in Fabry disease, yet cognitive deficits have been shown to be only mild. Here, we aimed to investigate neuropsychiatric symptoms and brain structure longitudinally. We expected no clinically relevant increase of neuropsychiatric symptoms in parallel to increased brain structural alterations. We assessed 14 Fabry patients (46.1 +/- 10.8 years) who had participated in our investigation eight years ago. Patients engaged in neuropsychiatric testing, as well as structural magnetic resonance imaging and angiography to determine white matter lesions, hippocampal volume, and the diameter of the larger intracranial arteries. While Fabry patients did not differ on cognitive performance, they showed progressive and significant hippocampal volume loss over the 8-year observation period. White matter lesions were associated with older age and higher white matter lesion load at baseline, but did not reach statistical significance when comparing baseline to follow-up. Likewise, intracranial artery diameters did not increase significantly. None of the imaging parameters were associated with the neuropsychiatric parameters. Depression frequency reduced from 50% at baseline to 21% at follow-up, but it did not reach significance. This investigation demonstrates clinical stability in cognitive function, while pronounced hippocampal atrophy is apparent throughout the 8 years. Our middle-aged Fabry patients appeared to compensate successfully for progressive hippocampal volume loss. The hippocampal volume decline indicates brain regional neuronal involvement in Fabry disease.	[Lelieveld, Irene M.; Boettcher, Anna; Fellgiebel, Andreas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychiat & Psychotherapy, D-55122 Mainz, Germany; [Hennermann, Julia B.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Pediat & Adolescent Med, Villa Metab, D-55122 Mainz, Germany; [Beck, Michael] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Human Genet, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Lelieveld, IM (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychiat & Psychotherapy, D-55122 Mainz, Germany.	irene.lelieveld@unimedizin-mainz.de			Shire; Genzyme; Actelion	Shire; Genzyme(Sanofi-AventisGenzyme Corporation); Actelion	The authors of this manuscript have the following competing interests: Michael Beck and Julia Hennermann received unrestricted grants, honoraria and travel support from Shire, Genzyme and Actelion. Andreas Fellgiebel received unrestricted grants, honoraria, and travel support from Shire and Genzyme. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ashton-Prolla P, 2000, J INVEST MED, V48, P227; Barnes J, 2009, NEUROBIOL AGING, V30, P1711, DOI 10.1016/j.neurobiolaging.2008.01.010; Bolsover FE, 2014, J INHERIT METAB DIS, V37, P177, DOI 10.1007/s10545-013-9643-x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Davies JP, 1996, EUR J HUM GENET, V4, P219; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; ENG CM, 1994, HUM MOL GENET, V3, P1795, DOI 10.1093/hmg/3.10.1795; ENG CM, 1993, AM J HUM GENET, V53, P1186; Fellgiebel A, 2012, J INHERIT METAB DIS, V35, P363, DOI 10.1007/s10545-011-9390-9; Fellgiebel A, 2011, CEREBROVASC DIS, V31, P294, DOI 10.1159/000322558; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Godin O, 2009, CEREBROVASC DIS, V28, P177, DOI 10.1159/000226117; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; Hamilton M, 1986, ASSESSMENT DEPRESSIO, P143, DOI [10.1007/9783642704864_14, 10.1007/978-3-642-70486-4_14, DOI 10.1007/978-3-642-70486-4_14]; Hurting C., 2000, WMS R WECHSLER GEDAC; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KAYE EM, 1988, ANN NEUROL, V23, P505, DOI 10.1002/ana.410230513; Maletic V, 2007, INT J CLIN PRACT, V61, P2030, DOI 10.1111/j.1742-1241.2007.01602.x; MEANEY C, 1994, HUM MOL GENET, V3, P1019, DOI 10.1093/hmg/3.6.1019; Okeda R, 2008, NEUROPATHOLOGY, V28, P532, DOI 10.1111/j.1440-1789.2008.00883.x; Pfefferbaum A, 2013, NEUROIMAGE, V65, P176, DOI 10.1016/j.neuroimage.2012.10.008; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Radbruch L, 1999, J PAIN SYMPTOM MANAG, V18, P180, DOI 10.1016/S0885-3924(99)00064-0; Reitan R.M., 1979, TRAIL MAKING TEST MA; Rey A, 1964, LEXAMEN CLINIQUE PSY; Salat DH, 2014, NEUROSCIENCE, V276, P174, DOI 10.1016/j.neuroscience.2013.11.041; Schafer Ellen, 2005, Hum Mutat, V25, P412; Schermuly I, 2011, EUR J NEUROL, V18, P347, DOI 10.1111/j.1468-1331.2010.03155.x; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tuttolomondo A, 2013, CURR PHARM DESIGN, V19, P6014, DOI 10.2174/13816128113199990387; Uceyler N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087054; Villablanca JP, 2006, INVEST RADIOL, V41, P799, DOI 10.1097/01.rli.0000242835.00032.f5; Wang L, 2014, J PSYCHIATR RES, V56, P56, DOI 10.1016/j.jpsychires.2014.05.005; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; Yalcin I, 2014, CURR OPIN ANESTHESIO, V27, P520, DOI 10.1097/ACO.0000000000000116; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028	39	22	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137603	10.1371/journal.pone.0137603	http://dx.doi.org/10.1371/journal.pone.0137603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340726	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200070
J	Ben Messaoud, N; Katzarova, I; Lopez, JM				Ben Messaoud, Nabil; Katzarova, Ilina; Lopez, Jose M.			Basic Properties of the p38 Signaling Pathway in Response to Hyperosmotic Shock	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; GENE-EXPRESSION; TRANSDUCTION PATHWAY; EPITHELIAL-CELLS; MAP-KINASES; STRESS; APOPTOSIS; CASCADE; YEAST; PHOSPHORYLATION	Some properties of signaling systems, like ultrasensitivity, hysteresis (a form of biochemical memory), and all-or-none responses at a single cell level, are important to understand the regulation of irreversible processes. Xenopus oocytes are a suitable cell model to study these properties. The p38 MAPK (mitogen-activated protein kinase) pathway is activated by different stress stimuli, including osmostress, and regulates multiple biological processes, from immune response to cell cycle. Recently, we have reported that activation of p38 and JNK regulate osmostress-induced apoptosis in Xenopus oocytes and that sustained activation of p38 accelerates cytochrome c release and caspase-3 activation. However, the signaling properties of p38 in response to hyperosmotic shock have not been studied. Here we show, using Xenopus oocytes as a cell model, that hyperosmotic shock activates the p38 signaling pathway with an ultrasensitive and bimodal response in a time-dependent manner, and with low hysteresis. At a single cell level, p38 activation is not well correlated with cytochrome c release 2 h after hyperosmotic shock, but a good correlation is observed at 4 h after treatment. Interestingly, cytochrome c microinjection induces p38 phosphorylation through caspase-3 activation, and caspase inhibition reduces p38 activation induced by osmostress, indicating that a positive feedback loop is engaged by hyperosmotic shock. To know the properties of the stress protein kinases activated by hyperosmotic shock will facilitate the design of computational models to predict cellular responses in human diseases caused by perturbations in fluid osmolarity.	[Ben Messaoud, Nabil; Katzarova, Ilina; Lopez, Jose M.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Bioquim,Inst Neurociencies, E-08193 Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona	Lopez, JM (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Bioquim,Inst Neurociencies, E-08193 Barcelona, Spain.	josemanuel.lopez@uab.cat	Lopez, Jose M/D-1654-2011; Lopez, Jose/AAF-3798-2020	Lopez, Jose M/0000-0002-4104-6262; Lopez, Jose/0000-0002-4104-6262	Spanish Ministerio de Economia y Competitividad [BFU2009-10765, BFU2010-15978]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Spanish Ministerio de Economia y Competitividad (grant numbers BFU2009-10765 and BFU2010-15978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Bagowski CP, 2001, J BIOL CHEM, V276, P1459, DOI 10.1074/jbc.M008050200; Bellou S, 2009, AM J PHYSIOL-CELL PH, V297, pC1477, DOI 10.1152/ajpcell.00058.2009; Ben Messaoud N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124482; Bhuyan AK, 2001, CELL DEATH DIFFER, V8, P63, DOI 10.1038/sj.cdd.4400773; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 1996, EMBO J, V15, P4156, DOI 10.1002/j.1460-2075.1996.tb00790.x; Cuenda A, 1998, BIOCHEM J, V333, P11, DOI 10.1042/bj3330011; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Deak JC, 1998, P NATL ACAD SCI USA, V95, P5595, DOI 10.1073/pnas.95.10.5595; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Ito T, 2005, AM J PHYSIOL-REG I, V289, pR432, DOI 10.1152/ajpregu.00027.2004; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lopez Jose M, 2010, Commun Integr Biol, V3, P146; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Martianez T, 2009, J BIOL CHEM, V284, P23902, DOI 10.1074/jbc.M109.026054; Mitono H, 2005, J APPL PHYSIOL, V99, P902, DOI 10.1152/japplphysiol.00156.2005; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tomlinson DR, 1999, DIABETOLOGIA, V42, P1271, DOI 10.1007/s001250051439; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Wang L, 2011, J BIOL CHEM, V286, P1951, DOI 10.1074/jbc.M110.166009; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416	38	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0135249	10.1371/journal.pone.0135249	http://dx.doi.org/10.1371/journal.pone.0135249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335493	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400003
J	Halder, B; Singh, S; Thakur, SS				Halder, Babli; Singh, Shruti; Thakur, Suman S.			Withania somnifera Root Extract Has Potent Cytotoxic Effect against Human Malignant Melanoma Cells	PLOS ONE			English	Article							CANCER; MICE; SKIN; CARCINOMA; LEAVES; LINES	In Ayurveda, Withania somnifera is commonly known as Ashwagandha, its roots are specifically used in medicinal and clinical applications. It possesses numerous therapeutic actions which include anti-inflammatory, sedative, hypnotic and narcotic. Extracts from this plant have been reported for its anticancer properties. In this study we evaluated for the first time, the cytotoxic effect of Withania root extract on human malignant melanoma A375 cells. The crude extract of Withania was tested for cytotoxicity against A375 cells by MTT assay. Cell morphology of treated A375 cells was visualized through phase contrast as well as fluorescence microscopy. Agarose gel electrophoresis was used to check DNA fragmentation of the crude extract treated cells. Crude extract of Withania root has the potency to reduce viable cell count in dose as well as time dependent manner. Morphological change of the A375 cells was also observed in treated groups in comparison to untreated or vehicle treated control. Apoptotic body and nuclear blebbing were observed in DAPI stained treated cells under fluorescence microscope. A ladder of fragmented DNA was noticed in treated cells. Thus it might be said that the crude water extract of Withania somnifera has potent cytotoxic effect on human malignant melanoma A375 cells.	[Halder, Babli; Singh, Shruti; Thakur, Suman S.] CCMB, CSIR, Telengana 500007, India	Council of Scientific & Industrial Research (CSIR) - India	Thakur, SS (corresponding author), CCMB, CSIR, Uppal Rd, Telengana 500007, India.	sst@ccmb.res.in		Thakur, Suman/0000-0001-5928-8836	Department of Biotechnology, India; Council of Scientific and Industrial Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors are thankful to the Department of Biotechnology, India and Council of Scientific and Industrial Research, India for funding.	Aggarwal BB, 2006, EXPERT OPIN THER TAR, V10, P87, DOI 10.1517/14728222.10.1.87; Ahmad M, 2005, HUM EXP TOXICOL, V24, P137, DOI 10.1191/0906327105ht209oa; Bhattacharya A, 2001, J ETHNOPHARMACOL, V74, P1, DOI 10.1016/S0378-8741(00)00309-3; Bhattacharya S K, 1997, Indian J Exp Biol, V35, P236; Bone K, 1996, MONOGRAPHS W HERBAL; BREKHMAN II, 1969, ANNU REV PHARMACOLOG, V9, P419, DOI 10.1146/annurev.pa.09.040169.002223; Chatterjee A, 1995, NEW DELHI PUBLICATIO, V4, P208; Chatterjee A., 1995, TREATISE INDIAN MED, V4, P208; Davis L, 2002, J EXP CLIN CANC RES, V21, P585; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Jerant AF, 2000, AM FAM PHYSICIAN, V62, P357; Kaur K, 2004, FOOD CHEM TOXICOL, V42, P2015, DOI 10.1016/j.fct.2004.07.015; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Mathur S, 2004, PHYTOMEDICINE, V11, P452, DOI 10.1016/j.phymed.2003.05.004; Muralikrishnan G, 2010, IMMUNOL INVEST, V39, P688, DOI 10.3109/08820139.2010.487083; Nagashayana N, 2000, J NEUROL SCI, V176, P124, DOI 10.1016/S0022-510X(00)00329-4; Prakash J, 2002, NUTR CANCER, V42, P91, DOI 10.1207/S15327914NC421_12; Singh B, 2001, PHYTOTHER RES, V15, P311, DOI 10.1002/ptr.858; SINGH N, 1982, International Journal of Crude Drug Research, V20, P29; SINGH N, 1986, International Journal of Crude Drug Research, V24, P90; Singh N, 1986, ANN NAT ACAD IND MED, V2, P14; Singh N, 1976, P IND PHARM SOC, V17; Singh SP, 1979, P 11 ANN C IND PHARM, V11, P65; Yadav B, 2010, INDIAN J PHARM SCI, V72, P659, DOI 10.4103/0250-474X.78543; Yang ES, 2011, CHEM-BIOL INTERACT, V190, P9, DOI 10.1016/j.cbi.2011.01.015; Yu YK, 2010, BIOCHEM PHARMACOL, V79, P542, DOI 10.1016/j.bcp.2009.09.017	27	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137498	10.1371/journal.pone.0137498	http://dx.doi.org/10.1371/journal.pone.0137498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334881	gold, Green Published, Green Submitted			2022-12-27	WOS:000360615400062
J	Thurman, JM; Wong, M; Renner, B; Frazer-Abel, A; Giclas, PC; Joy, MS; Jalal, D; Radeva, MK; Gassman, J; Gipson, DS; Kaskel, F; Friedman, A; Trachtman, H				Thurman, Joshua M.; Wong, Maria; Renner, Brandon; Frazer-Abel, Ashley; Giclas, Patricia C.; Joy, Melanie S.; Jalal, Diana; Radeva, Milena K.; Gassman, Jennifer; Gipson, Debbie S.; Kaskel, Frederick; Friedman, Aaron; Trachtman, Howard			Complement Activation in Patients with Focal Segmental Glomerulosclerosis	PLOS ONE			English	Article							ALTERNATIVE PATHWAY; CONTRIBUTES; PRODUCTS; CHILDREN; DISEASE; SAMPLES; PLASMA	Background Recent pre-clinical studies have shown that complement activation contributes to glomerular and tubular injury in experimental FSGS. Although complement proteins are detected in the glomeruli of some patients with FSGS, it is not known whether this is due to complement activation or whether the proteins are simply trapped in sclerotic glomeruli. We measured complement activation fragments in the plasma and urine of patients with primary FSGS to determine whether complement activation is part of the disease process. Study Design Plasma and urine samples from patients with biopsy-proven FSGS who participated in the FSGS Clinical Trial were analyzed. Setting and Participants We identified 19 patients for whom samples were available from weeks 0, 26, 52 and 78. The results for these FSGS patients were compared to results in samples from 10 healthy controls, 10 patients with chronic kidney disease (CKD), 20 patients with vasculitis, and 23 patients with lupus nephritis. Outcomes Longitudinal control of proteinuria and estimated glomerular filtration rate (eGFR). Measurements Levels of the complement fragments Ba, Bb, C4a, and sC5b-9 in plasma and urine. Results Plasma and urine Ba, C4a, sC5b-9 were significantly higher in FSGS patients at the time of diagnosis than in the control groups. Plasma Ba levels inversely correlated with the eGFR at the time of diagnosis and at the end of the study. Plasma and urine Ba levels at the end of the study positively correlated with the level of proteinuria, the primary outcome of the study. Limitations Limited number of patients with samples from all time-points. Conclusions The complement system is activated in patients with primary FSGS, and elevated levels of plasma Ba correlate with more severe disease. Measurement of complement fragments may identify a subset of patients in whom the complement system is activated. Further investigations are needed to confirm our findings and to determine the prognostic significance of complement activation in patients with FSGS.	[Thurman, Joshua M.; Wong, Maria; Renner, Brandon; Joy, Melanie S.; Jalal, Diana] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Frazer-Abel, Ashley; Giclas, Patricia C.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Radeva, Milena K.; Gassman, Jennifer] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Gipson, Debbie S.] Univ Michigan, CS Mott Childrens Hosp, Dept Pediat, Ann Arbor, MI 48109 USA; [Kaskel, Frederick] Childrens Hosp Montefiore, Albert Einstein Coll Med, Dept Pediat, Bronx, NY USA; [Friedman, Aaron] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Trachtman, Howard] NYU Langone Med Ctr, NYU Sch Med, Dept Pediat, New York, NY 10016 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; Cleveland Clinic Foundation; University of Michigan System; University of Michigan; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; University of Minnesota System; University of Minnesota Twin Cities; New York University; NYU Langone Medical Center	Trachtman, H (corresponding author), NYU Langone Med Ctr, NYU Sch Med, Dept Pediat, New York, NY 10016 USA.	howard.trachtman@nyumc.org	Trachtman, Howard/GSE-2340-2022	Thurman, Joshua Michael/0000-0002-3476-9956; Trachtman, Howard/0000-0001-7447-9489; Jalal, Diana/0000-0002-1975-8650; Gipson, Debbie/0000-0003-4473-9045	NIH-NIDDK [RO1-DK076690, U01-DK063385, DK063490, DK063455, DK063549]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK063490, U01DK063549, U01DK063455, U01DK063385, R01DK076690] Funding Source: NIH RePORTER	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH-NIDDK RO1-DK076690 (JT), NIH-NIDDK U01-DK063385, NIH-NIDDK DK063490, NIH-NIDDK DK063455, and NIH-NIDDK DK063549 (HT, MR, JG, DG, FK, AF).	Chua JS, 2015, J AM SOC NEPHROL; Chun MJ, 2004, J AM SOC NEPHROL, V15, P2169, DOI 10.1097/01.ASN.0000135051.62500.97; Cosio FG, 1996, CLIN NEPHROL, V45, P146; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; DAHA MR, 1976, J IMMUNOL, V117, P630; Daina E, 2012, NEW ENGL J MED, V366, P1161, DOI 10.1056/NEJMc1112273; Fernandez-Fresnedo G, 2009, CLIN J AM SOC NEPHRO, V4, P1317, DOI 10.2215/CJN.00570109; GEPHARDT GN, 1986, ARCH PATHOL LAB MED, V110, P902; Gipson DS, 2011, KIDNEY INT, V80, P868, DOI 10.1038/ki.2011.195; Gipson DS, 2011, KIDNEY INT, V79, P678, DOI 10.1038/ki.2010.485; Gou SJ, 2013, KIDNEY INT, V83, P129, DOI 10.1038/ki.2012.313; HABIB R, 1988, PEDIATR NEPHROL, V2, P402, DOI 10.1007/BF00853431; HEBERT LA, 1991, KIDNEY INT, V39, P811, DOI 10.1038/ki.1991.102; Kiffel J, 2011, ADV CHRONIC KIDNEY D, V18, P332, DOI 10.1053/j.ackd.2011.03.005; Korbet SM, 2012, J AM SOC NEPHROL, V23, P1769, DOI 10.1681/ASN.2012040389; Lenderink AM, 2007, AM J PHYSIOL-RENAL, V293, pF555, DOI 10.1152/ajprenal.00403.2006; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; MOLLNES TE, 1988, CLIN EXP IMMUNOL, V73, P484; Morita Y, 2000, J AM SOC NEPHROL, V11, P700, DOI 10.1681/ASN.V114700; Nangaku M, 1999, J AM SOC NEPHROL, V10, P2323; NEWMAN WJ, 1976, MEDICINE, V55, P67, DOI 10.1097/00005792-197601000-00004; PERRIN LH, 1975, J CLIN INVEST, V56, P165, DOI 10.1172/JCI108065; Pfeifer PH, 1999, CLIN CHEM, V45, P1190; Pickering MC, 2013, KIDNEY INT, V84, P1079, DOI 10.1038/ki.2013.377; Renner B, 2013, J AM SOC NEPHROL, V24, P1849, DOI 10.1681/ASN.2012111064; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Salinas-Carmona MC, 2009, AUTOIMMUNITY, V42, P537, DOI 10.1080/08916930903019119; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Sethna C, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/389542; Strassheim D, 2013, J AM SOC NEPHROL, V24, P393, DOI 10.1681/ASN.2012020187; Sun QQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036654; Thurman JM, 2009, CLIN J AM SOC NEPHRO, V4, P1920, DOI 10.2215/CJN.02730409; Turnberg D, 2006, J IMMUNOL, V177, P4094, DOI 10.4049/jimmunol.177.6.4094; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wei CL, 2012, J AM SOC NEPHROL, V23, P2051, DOI 10.1681/ASN.2012030302; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411	36	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136558	10.1371/journal.pone.0136558	http://dx.doi.org/10.1371/journal.pone.0136558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335102	gold, Green Published, Green Submitted			2022-12-27	WOS:000360615400016
J	van der Waal, D; den Heeten, GJ; Pijnappel, RM; Schuur, KH; Timmers, JMH; Verbeek, ALM; Broeders, MJM				van der Waal, Danielle; den Heeten, Gerard J.; Pijnappel, Ruud M.; Schuur, Klaas H.; Timmers, Johanna M. H.; Verbeek, Andre L. M.; Broeders, Mireille J. M.			Comparing Visually Assessed BI-RADS Breast Density and Automated Volumetric Breast Density Software: A Cross-Sectional Study in a Breast Cancer Screening Setting	PLOS ONE			English	Article							MAMMOGRAPHIC DENSITY; RISK-FACTORS; AGREEMENT; VARIABILITY; CATEGORIES; PATTERNS; REPRODUCIBILITY; CLASSIFICATION; RELIABILITY; INDEX	Introduction The objective of this study is to compare different methods for measuring breast density, both visual assessments and automated volumetric density, in a breast cancer screening setting. These measures could potentially be implemented in future screening programmes, in the context of personalised screening or screening evaluation. Materials and Methods Digital mammographic exams (N = 992) of women participating in the Dutch breast cancer screening programme (age 50-75y) in 2013 were included. Breast density was measured in three different ways: BI-RADS density (5th edition) and with two commercially available automated software programs (Quantra and Volpara volumetric density). BI-RADS density (ordinal scale) was assessed by three radiologists. Quantra (v1.3) and Volpara (v1.5.0) provide continuous estimates. Different comparison methods were used, including Bland-Altman plots and correlation coefficients (e.g., intraclass correlation coefficient [ICC]). Results Based on the BI-RADS classification, 40.8% of the women had 'heterogeneously or extremely dense' breasts. The median volumetric percent density was 12.1% (IQR: 9.6-16.5) for Quantra, which was higher than the Volpara estimate (median 6.6%, IQR: 4.4-10.9). The mean difference between Quantra and Volpara was 5.19% (95% CI: 5.04-5.34) (ICC: 0.64). There was a clear increase in volumetric percent dense volume as BI-RADS density increased. The highest accuracy for predicting the presence of BI-RADS c+d (heterogeneously or extremely dense) was observed with a cut-off value of 8.0% for Volpara and 13.8% for Quantra. Conclusion Although there was no perfect agreement, there appeared to be a strong association between all three measures. Both volumetric density measures seem to be usable in breast cancer screening programmes, provided that the required data flow can be realized.	[van der Waal, Danielle; Verbeek, Andre L. M.; Broeders, Mireille J. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 ED Nijmegen, Netherlands; [den Heeten, Gerard J.; Pijnappel, Ruud M.; Schuur, Klaas H.; Timmers, Johanna M. H.; Broeders, Mireille J. M.] Dutch Reference Ctr Screening, Nijmegen, Netherlands; [den Heeten, Gerard J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Pijnappel, Ruud M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	van der Waal, D (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 ED Nijmegen, Netherlands.	Danielle.vanderWaal@radboudumc.nl	van der Waal, Daniëlle/A-1386-2016; Broeders, Mireille JM/C-8820-2015; Verbeek, A.L.M./H-8103-2014	van der Waal, Daniëlle/0000-0002-5850-8814; Broeders, Mireille JM/0000-0002-8741-8148; Verbeek, A.L.M./0000-0002-2319-5002; Pijnappel, Ruud/0000-0002-6912-9414				Altman D.G., 1991, PRACTICAL STAT MED R, DOI [DOI 10.1002/SIM.4780101015, 10.1002/sim.4780101015]; Assi V, 2012, NAT REV CLIN ONCOL, V9, P33, DOI 10.1038/nrclinonc.2011.173; Berg WA, 2000, AM J ROENTGENOL, V174, P1769, DOI 10.2214/ajr.174.6.1741769; Bernardi D, 2012, RADIOL MED, V117, P519, DOI 10.1007/s11547-011-0777-3; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Brand JS, 2014, CANCER EPIDEM BIOMAR, V23, P1764, DOI 10.1158/1055-9965.EPI-13-1219; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Ciatto S, 2006, BREAST, V15, P44, DOI 10.1016/j.breast.2005.04.019; Ciatto S, 2005, BREAST, V14, P269, DOI 10.1016/j.breast.2004.12.004; Ciatto S, 2012, BREAST, V21, P503, DOI 10.1016/j.breast.2012.01.005; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Eng A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0439-1; Fleiss JL., 2003, STAT METHODS RATES P; Garrido-Estepa M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-485; Gram IT, 1997, EUR J RADIOL, V24, P131, DOI 10.1016/S0720-048X(96)01138-2; Gubern-Merida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085952; Gweon HM, 2013, AM J ROENTGENOL, V201, P692, DOI 10.2214/AJR.12.10197; Hartman K, 2008, LECT NOTES COMPUT SC, V5116, P33, DOI 10.1007/978-3-540-70538-3_5; Highnam R, 2010, INT WORKSH DIG MAMM, P651; Jeffreys M, 2010, LECT NOTES COMPUT SC, V6136, P408, DOI 10.1007/978-3-642-13666-5_55; Kerlikowske K, 2007, NEW ENGL J MED, V356, P297, DOI 10.1056/NEJMe068244; Ko SY, 2014, KOREAN J RADIOL, V15, P313, DOI 10.3348/kjr.2014.15.3.313; Kopans DB, 2008, RADIOLOGY, V246, P348, DOI 10.1148/radiol.2461070309; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lokate M, 2010, CANCER EPIDEM BIOMAR, V19, P3096, DOI 10.1158/1055-9965.EPI-10-0703; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Morrish OW, 2015, RADIOLOGY; Ng KH, 2012, LANCET ONCOL, V13, P334, DOI 10.1016/S1470-2045(12)70093-1; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Ooms EA, 2007, BREAST, V16, P568, DOI 10.1016/j.breast.2007.04.007; Park IH, 2014, ANN SURG ONCOL; Ray KM, 2015, AM J ROENTGENOL, V204, P257, DOI 10.2214/AJR.14.13558; Redondo A, 2012, BRIT J RADIOL, V85, P1465, DOI 10.1259/bjr/21256379; Regini E, 2014, RADIOL MED, V119, P741, DOI 10.1007/s11547-014-0390-3; Schetter SE, 2014, BREAST CANCER RES TR, V146, P355, DOI 10.1007/s10549-014-3031-6; Schmachtenberg C, 2015, ACAD RADIOL; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Seo JM, 2013, CLIN RADIOL, V68, P690, DOI 10.1016/j.crad.2013.01.011; Sickles E., 2013, ACR BIRADS ATLAS BRE, VVolume 5; Skippage P, 2013, BREAST J, V19, P79, DOI 10.1111/tbj.12046; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829; van Engeland S, 2006, IEEE T MED IMAGING, V25, P273, DOI 10.1109/TMI.2005.862741; van Gils CH, 1998, EUR J EPIDEMIOL, V14, P315, DOI 10.1023/A:1007423824675; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081653; WOLFE JN, 1976, AM J ROENTGENOL, V126, P1130, DOI 10.2214/ajr.126.6.1130; Yaffe MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2102	47	50	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136667	10.1371/journal.pone.0136667	http://dx.doi.org/10.1371/journal.pone.0136667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335569	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400020
J	Buehring, GC; Shen, HM; Jensen, HM; Jin, DL; Hudes, M; Block, G				Buehring, Gertrude Case; Shen, Hua Min; Jensen, Hanne M.; Jin, Diana L.; Hudes, Mark; Block, Gladys			Exposure to Bovine Leukemia Virus Is Associated with Breast Cancer: A Case-Control Study	PLOS ONE			English	Article							RISK; DNA; CELLS; MILK; IDENTIFICATION; PASTEURIZATION; IRRADIATION; ENVIRONMENT; INFECTION; REPAIR	Background Age, reproductive history, hormones, genetics, and lifestyle are known risk factors for breast cancer, but the agents that initiate cellular changes from normal to malignant are not understood. We previously detected bovine leukemia virus (BLV), a common oncogenic virus of cattle, in the breast epithelium of humans. The objective of this study was to determine whether the presence of BLV DNA in human mammary epithelium is associated with breast cancer. Methods This was a case-control study of archival formalin fixed paraffin embedded breast tissues from 239 donors, received 2002-2008 from the Cooperative Human Tissue Network. Case definition as breast cancer versus normal (women with no history of breast cancer) was established through medical records and examination of tissues by an anatomical pathologist. Breast exposure to BLV was determined by in situ-PCR detection of a biomarker, BLV DNA, localized within mammary epithelium. Results The frequency of BLV DNA in mammary epithelium from women with breast cancer (59%) was significantly higher than in normal controls (29%) (multiply-adjusted odds ratio = 3.07, confidence interval = 1.66-5.69, p = .0004, attributable risk = 37%). In women with premalignant breast changes the frequency of BLV DNA was intermediate (38%) between that of women with breast cancer and normal controls (p for trend < .001). Conclusions Among the specimens in this study, the presence of amplified BLV DNA was significantly associated with breast cancer. The odds ratio magnitude was comparable to those of well-established breast cancer risk factors related to reproductive history, hormones, and lifestyle and was exceeded only by risk factors related to genetics (familial breast cancer), high dose ionizing radiation, and age. These findings have the potential for primary and secondary prevention of breast cancer.	[Buehring, Gertrude Case; Shen, Hua Min; Jin, Diana L.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Jensen, Hanne M.] Univ Calif Davis, Dept Pathol & Lab Med, Davis Med Ctr, Sacramento, CA 95817 USA; [Hudes, Mark] Univ Calif Berkeley, Atkins Ctr Weight & Hlth, Berkeley, CA 94720 USA; [Block, Gladys] Univ Calif Berkeley, Sch Publ Hlth, Div Community Hlth & Human Dev, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Buehring, GC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.	buehring@berkeley.edu	Block, Gladys/E-3304-2010	Block, Gladys/0000-0001-6722-930X	Breast Cancer Research Program of the University of California [6PB-0075]; Department of Defense Breast Cancer Research Program (DAMD) [17-02-1-0320]	Breast Cancer Research Program of the University of California; Department of Defense Breast Cancer Research Program (DAMD)(United States Department of Defense)	This study was funded by a grant (#6PB-0075) from the Breast Cancer Research Program of the University of California to GCB and a grant from the Department of Defense Breast Cancer Research Program (DAMD 17-02-1-0320) to GCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, CANC FACTS FIG 2015; APHIS, 2008, BOV LEUK VIR BLV US; APHIS Veterinary Service Center for Epidemiology and Animal Health USDA, 1999, BOV LEUK VIR BLV US; ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; Barba M, 2006, CANCER CAUSE CONTROL, V17, P395, DOI 10.1007/s10552-005-0481-5; BAUMGARTENER L, 1976, J AM VET MED ASSOC, V169, P1189; Bondy Melissa L., 2003, Cancer, V97, P230, DOI 10.1002/cncr.11018; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; BRINTON LA, 1983, BRIT J CANCER, V47, P757, DOI 10.1038/bjc.1983.128; Buehring GC, 2003, AIDS RES HUM RETROV, V19, P1105, DOI 10.1089/088922203771881202; BUEHRING GC, 1994, LAB INVEST, V71, P359; Buehring GC, 2014, EMERG INFECT DIS, V20, P772, DOI 10.3201/eid2005.131298; Carlson Laurie Winn, 2001, CATTLE INFORMAL SOCI; CARROLL KK, 1968, CAN MED ASSOC J, V98, P590; Chartsbin, CURR WORLDW TOT MILK; Chu TY, 1999, GENE CHROMOSOME CANC, V24, P127, DOI 10.1002/(SICI)1098-2264(199902)24:2<127::AID-GCC5>3.0.CO;2-8; CHUNG YS, 1986, AUST VET J, V63, P379, DOI 10.1111/j.1751-0813.1986.tb02908.x; Clamp A, 2002, LANCET ONCOL, V3, P611, DOI 10.1016/S1470-2045(02)00875-6; Clarke CA, 2012, JNCI-J NATL CANCER I, V104, P1094, DOI 10.1093/jnci/djs264; Clemons M, 2000, CANCER TREAT REV, V26, P291, DOI 10.1053/ctrv.2000.0174; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Coyle YM, 2004, BREAST CANCER RES TR, V84, P273, DOI 10.1023/B:BREA.0000019964.33963.09; de Parseval N, 2005, CYTOGENET GENOME RES, V110, P318, DOI 10.1159/000084964; Dong JY, 2011, BREAST CANCER RES TR, V127, P23, DOI 10.1007/s10549-011-1467-5; Duncan RB, 2005, J VET DIAGN INVEST, V17, P190, DOI 10.1177/104063870501700217; FERRER JF, 1981, SCIENCE, V213, P1014, DOI 10.1126/science.6267692; Fitzgibbons PL, 1998, ARCH PATHOL LAB MED, V122, P1053; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Globcan, EST AG STAND BREAST; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; Heaphy CM, 2009, BREAST CANCER RES TR, V118, P229, DOI 10.1007/s10549-009-0504-0; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kamihira S, 2005, CLIN LAB HAEMATOL, V27, P235, DOI 10.1111/j.1365-2257.2005.00698.x; Kao SY, 1999, J VIROL, V73, P4299, DOI 10.1128/JVI.73.5.4299-4304.1999; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; Lairmore MD, 2014, ANNU REV ANIM BIOSCI, V2, P189, DOI 10.1146/annurev-animal-022513-114117; Lee LC, 2012, CAN VET J, V53, P283; Lundgren B, 1977, CANCER, V40, P722; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Murakami H, 2011, VIRUS RES, V156, P107, DOI 10.1016/j.virusres.2011.01.004; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Nuovo GJ, 1996, PCR SITU HYBRIDIZATI, P193; Park HU, 2006, ONCOGENE, V25, P438, DOI 10.1038/sj.onc.1209059; Philpott SM, 1999, J NATL CANCER I, V91, P933, DOI 10.1093/jnci/91.11.933; RADKE K, 1992, MICROB PATHOGENESIS, V12, P319, DOI 10.1016/0882-4010(92)90095-6; Reyes RA, 1996, J VIROL, V70, P4961, DOI 10.1128/JVI.70.8.4961-4965.1996; Robert-Guroff M, 2000, VITAL BACTERIAL PARA, P475; Salmons B, 2013, INT J CANCER, V133, P1530, DOI 10.1002/ijc.28210; SCHWARTZ I, 1994, VET RES, V25, P521; Sellers TA, 2008, CANCER CAUSE CONTROL, V19, P805, DOI 10.1007/s10552-008-9143-8; Singletary SE, 2003, ANN SURG, V237, P474, DOI 10.1097/00000658-200304000-00007; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; TRICHOPOULOS D, 1972, JNCI-J NATL CANCER I, V48, P605; Van Der Maaten M J, 1975, Bibl Haematol, P360; VONFOURNIER D, 1980, CANCER-AM CANCER SOC, V45, P2198; Wise LA, 2009, CANCER CAUSE CONTROL, V20, P1083, DOI 10.1007/s10552-009-9332-0; Zhao XR, 2007, GENOMICS, V89, P502, DOI 10.1016/j.ygeno.2006.12.007	59	85	89	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134304	10.1371/journal.pone.0134304	http://dx.doi.org/10.1371/journal.pone.0134304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332838	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800007
J	Dong, XB; Dai, GS; Ulgiati, S; Na, RS; Zhang, XS; Kang, MY; Wang, XC				Dong, Xiaobin; Dai, Guangshuo; Ulgiati, Sergio; Na, Risu; Zhang, Xinshi; Kang, Muyi; Wang, Xuechao			On the Relationship between Economic Development, Environmental Integrity and Well-Being: The Point of View of Herdsmen in Northern China Grassland	PLOS ONE			English	Article							ECOSYSTEM SERVICES; INNER-MONGOLIA; DEGRADATION; DRIVERS; ECOLOGY; SCIENCE	Inner Mongolia is among the most important regions in terms of contribution to the socioeconomic development of China. Furthermore, its grassland is a major ecological barrier for Northern China. The present study evaluates the changes in ecosystem services availability and human wellbeing based on a survey on864 herdsmen of the grassland and 20 governmental officials. The survey provided the following results: (1) The supporting and provisioning services of the grassland have recently declined, thus affecting the herdsmen's wellbeing. The intensity of grazing, coal exploitation and tourism development heavily limits the availability of ecosystem services, among which provisioning ones are perceived as the most important. Below a certain threshold, grazing and mining are likely to promote the improvement of herdsmen's wellbeing, while trespassing that point, the enhancement of the herdsmen's living standards is curbed. (2) The herdsmen's cultural exchange, health conditions and social relations are better now than before; however, the threats on herdsmen's health and safety have increased. (3) A better income is among the most urgent herdsmen's needs. Livestock revenues did not increase at the same rate as the damage to the grassland and human risk exposure did. (4) The governmental ecological compensation policy did not entirely solve the problem of grassland desertification and environmental degradation, although it is also true that the degree of implementation and effectiveness of government policies is related to the still insufficient herdsmen's understanding and acceptance of these policies.	[Dong, Xiaobin; Dai, Guangshuo; Zhang, Xinshi; Kang, Muyi; Wang, Xuechao] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Dong, Xiaobin; Dai, Guangshuo; Zhang, Xinshi; Kang, Muyi; Wang, Xuechao] Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China; [Ulgiati, Sergio] Parthenope Univ, Dept Sci & Technol, I-80133 Naples, Italy; [Na, Risu] Xilinguol Vocat Coll, Xilinhot 026000, Peoples R China	Beijing Normal University; Beijing Normal University; Parthenope University Naples	Dong, XB (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	xbdong@bnu.edu.cn; dgsh@mailbnu.edu.cn	Ulgiati, Sergio/ABE-9420-2020; Wang, Xue-Chao/J-5860-2019	Wang, Xue-Chao/0000-0003-4431-0900; Ulgiati, Sergio/0000-0001-6159-4947	National Natural Science Foundation of China [41030535, 41271549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (41030535, 41271549).	[Anonymous], 2011, STAT YB XIL; Balmford A., 2008, EC ECOSYSTEMS BIODIV; BARNES JI, 2003, EC RETURNS LAND USE; Cai X, 2005, THESIS CHINESE ACAD; Cao SX, 2007, AMBIO, V36, P409, DOI 10.1579/0044-7447(2007)36[409:DBSAEC]2.0.CO;2; Cao Xin, 2006, Zhiwu Shengtai Xuebao, V30, P268; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Cheng S, 2013, J MUC NATL SCI EDITI, V22, P23; Costanza R, 1997, NATURES SERVICE SOC; Cox ME, 2006, ECOL SOC, V11; Dai SF, 2002, INT J COAL GEOL, V51, P237, DOI 10.1016/S0166-5162(02)00098-8; Dai SF, 2010, INT J COAL GEOL, V81, P320, DOI 10.1016/j.coal.2009.03.005; Daw T, 2011, ENVIRON CONSERV, V38, P370, DOI 10.1017/S0376892911000506; Deacon H. J., 1978, S AFRICAN ARCHAEOLOG, V33, P39, DOI DOI 10.2307/3888251; Deutsch L, 2003, ECOL ECON, V44, P205, DOI 10.1016/S0921-8009(02)00274-4; Dong XB, 2014, ENERG POLICY, V67, P767, DOI [10.1, 10.1016/j.enpol.2013.11.038]; Du G, 2009, INT J COAL GEOL, V78, P16, DOI 10.1016/j.coal.2008.10.004; Ellis JE, 1992, GRASSLANDS GRASSLAND, P9; Environmental Protection Agency, 1997, SPEC REP ENV END DIS; [冯亚芬 FENG Yafen], 2009, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V23, P181; Finkelman RB, 2002, INT J COAL GEOL, V50, P425, DOI 10.1016/S0166-5162(02)00125-8; Folke C, 1996, ECOL APPL, V6, P1018, DOI 10.2307/2269584; Guhn M., 2010, ED REPORT CANADIAN I; Hill K., 2005, VALUE HIGHER ED INDI; Hirschberg JG, 1998, DEP EC WORKING PAPER, V654; Hoffmann C, 2008, CATENA, V75, P182, DOI 10.1016/j.catena.2008.06.003; Jiang Ye, 2010, Chinese Journal of Plant Ecology, V34, P1132, DOI 10.3773/j.issn.1005-264x.2010.10.002; Junquera B, 2001, RESOUR CONSERV RECY, V33, P51, DOI 10.1016/S0921-3449(01)00057-X; Le Maitre DC, 2007, FRONT ECOL ENVIRON, V5, P261, DOI 10.1890/1540-9295(2007)5[261:LESAWR]2.0.CO;2; Le Maitre DC., 2008, ADV SUSTAINABILITY S, P339; Levinson A, 2012, J PUBLIC ECON, V96, P869, DOI 10.1016/j.jpubeco.2012.06.007; Ling F, 2013, HAIHE WATER RESOURCE, V1, P16; Liu X, 2011, NO ENV, V23, P65; Liu Z, 2006, METEOROLOGICAL SCI I, V1, P27; Lu F, 2012, THESIS INNER MONGOLI; Millennium Ecosystem Assessment, 2005, EC HUM WELLB BIOD SY; Millennium Ecosystem Assessment, 2005, MILL EC ASS SER; Ni T, 2011, 60 PERCENT ORDINARY; Normile D, 2007, SCIENCE, V317, P314, DOI 10.1126/science.317.5836.314; Qiao G, 2004, J INNER MONGOLIA FIN, V2, P44; Rahaman T, 2005, 200506 WIDER UN U; Robinson DT, 2012, COMPUT ENVIRON URBAN, V36, P164, DOI 10.1016/j.compenvurbsys.2011.10.002; Rodriguez JP, 2006, ECOL SOC, V11; Shackleton C., 2008, LINKS ECOSYSTEM SERV; Shi JG, 2010, CHINESE AGR SCI B, V26, P318; Smith LM, 2013, ECOL INDIC, V28, P79, DOI 10.1016/j.ecolind.2012.02.032; Smyth R, 2008, ECOL ECON, V68, P547, DOI 10.1016/j.ecolecon.2008.05.017; Sneath D, 1998, SCIENCE, V281, P1147, DOI 10.1126/science.281.5380.1147; Summers JK, 2012, AMBIO, V41, P327, DOI 10.1007/s13280-012-0256-7; The Economics of Ecosystems and Biodiversity (TEEB), 2009, CLIM ISS UPD; Tong Chuan, 2006, Shengtaixue Zazhi, V25, P259; Van Landeghem B, 2012, J ECON BEHAV ORGAN, V81, P571, DOI 10.1016/j.jebo.2011.08.001; Wainger LA, 2004, ENVIRON MONIT ASSESS, V94, P69, DOI 10.1023/B:EMAS.0000016880.31332.e1; Wang G, 2013, ECOLOGICAL EC, V2, P89; Wang H, 2012, J ANHUI AGR SCI, V40, P7839; Wang Ming-jun, 2010, Shengtaixue Zazhi, V29, P862; Wendland KJ, 2010, ECOL ECON, V69, P2093, DOI 10.1016/j.ecolecon.2009.01.002; Wu JG, 2013, LANDSCAPE ECOL, V28, P999, DOI 10.1007/s10980-013-9894-9; XIE G.D., 2001, J NATURAL RESOURCES, V16, P47, DOI DOI 10.3321/J.ISSN:1000-3037.2001.01.009; Yang Y, 2008, CENTRAL S FOREST INV, V27, P58; Yu S, 2007, W RES, V21, P51; Zhang D, 2005, THESIS CHINA U MININ; [赵士洞 ZHAO Shidong], 2006, [地球科学进展, Advance in Earth Sciences], V21, P895; Zhao YouYi, 2008, Acta Prataculturae Sinica, V17, P143; Zhou G, 2002, NE CHINA TRANSECT NE	65	25	28	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134786	10.1371/journal.pone.0134786	http://dx.doi.org/10.1371/journal.pone.0134786			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331721	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800013
J	Gaimster, H; Summers, D				Gaimster, Hannah; Summers, David			Regulation of Indole Signalling during the Transition of E. coli from Exponential to Stationary Phase	PLOS ONE			English	Article							ESCHERICHIA-COLI; CATABOLITE REPRESSION; TRYPTOPHANASE; EXPRESSION; ACIDS	During the transition from exponential to stationary phase E. coli produces a substantial quantity of the small, aromatic signalling molecule indole. In LB medium the supernatant indole concentration reaches a maximum of 0.5-1 mM. At this concentration indole has been implicated in many processes inducing acid resistance and the modulation of virulence. It has recently been shown that cell-associated indole transiently reaches a very high concentration (approx. 60 mM) during stationary phase entry, presumably because indole is being produced more rapidly than it can leave the cell. It is proposed that this indole pulse inhibits growth and cell division, causing the culture to enter stationary phase before nutrients are completely exhausted, with benefits for survival in long-term stationary phase. This study asks how E. coli cells rapidly upregulate indole production during stationary phase entry and why the indole pulse has a duration of only 10-15 min. We find that at the start of the pulse tryptophanase synthesis is triggered by glucose depletion and that this is correlates with the up-regulation of indole synthesis. The magnitude and duration of the resulting indole pulse are dependent upon the availability of exogenous tryptophan. Indole production stops when all the available tryptophan is depleted and the cell-associated indole equilibrates with the supernatant.	[Gaimster, Hannah; Summers, David] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge	Gaimster, H (corresponding author), UEA, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	h.gaimster@uea.ac.uk		Gaimster, Hannah/0000-0002-8593-0746	Biotechnology and Biological Sciences Research Council [PCAG-EJNF]; Biotechnology and Biological Sciences Research Council [BB/F002912/1] Funding Source: researchfish; BBSRC [BB/F002912/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	HG was funded by a Biotechnology and Biological Sciences Research Council Doctoral Training Grant studentship (http://www.bbsrc.ac.uk/home/home.aspx), grant number PCAG-EJNF.	BOTSFORD JL, 1971, J BACTERIOL, V105, P303, DOI 10.1128/JB.105.1.303-312.1971; Chant EL, 2007, MOL MICROBIOL, V63, P35, DOI 10.1111/j.1365-2958.2006.05481.x; Chimerel C, 2012, BIOCH BIOPHYSICA ACT, V1818; DEELEY MC, 1981, J BACTERIOL, V147, P787, DOI 10.1128/JB.147.3.787-796.1981; Di Martino P, 2003, CAN J MICROBIOL, V49, P443, DOI 10.1139/W03-056; Field CM, 2011, J THEOR BIOL, V291, P119, DOI 10.1016/j.jtbi.2011.09.006; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gaimster H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093168; Gong F, 2002, J BIOL CHEM, V277, P17095, DOI 10.1074/jbc.M201213200; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Hirakawa H, 2010, MICROB PATHOGENESIS, V49, P90, DOI 10.1016/j.micpath.2010.05.002; ISAACS H, 1994, MICROBIOL-UK, V140, P2125, DOI 10.1099/13500872-140-8-2125; KAZARINOFF MN, 1980, J BIOL CHEM, V255, P6228; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Li G, 2013, MICROBIOL-SGM, V159, P402, DOI 10.1099/mic.0.064139-0; NEWTON WA, 1965, J BIOL CHEM, V240, P1211; SUMMERS DK, 1993, MOL MICROBIOL, V8, P1031, DOI 10.1111/j.1365-2958.1993.tb01648.x; Walters M, 2006, INT J MED MICROBIOL, V296, P125, DOI 10.1016/j.ijmm.2006.01.041; Winzer K, 2002, CURR OPIN MICROBIOL, V5, P216, DOI 10.1016/S1369-5274(02)00304-1; Wyeth FJS, 1919, BIOCHEM J, V13, P10, DOI 10.1042/bj0130010; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991	21	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136691	10.1371/journal.pone.0136691	http://dx.doi.org/10.1371/journal.pone.0136691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332864	Green Published, gold			2022-12-27	WOS:000360613800066
J	Mori, Y; Yoshino, Y; Ochi, S; Yamazaki, K; Kawabe, K; Abe, M; Kitano, T; Ozaki, Y; Yoshida, T; Numata, S; Mori, T; Iga, J; Kuroda, N; Ohmori, T; Ueno, S				Mori, Yoko; Yoshino, Yuta; Ochi, Shinichiro; Yamazaki, Kiyohiro; Kawabe, Kentaro; Abe, Masao; Kitano, Tomoji; Ozaki, Yuki; Yoshida, Taku; Numata, Shusuke; Mori, Takaaki; Iga, Junichi; Kuroda, Norio; Ohmori, Tetsuro; Ueno, Shu-ichi			TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia	PLOS ONE			English	Article							QUANTITATIVE PCR; ASSOCIATION; DEMENTIA; DAP12; NEURODEGENERATION; ACTIVATION; PROTEIN; VARIANT; P.R47H; BLOOD	TREM2 and TYROBP are causal genes for Nasu-Hakola disease (NHD), a rare autosomal recessive disease characterized by bone lesions and early-onset progressive dementia. TREM2 forms a receptor signaling complex with TYROBP, which triggers the activation of immune responses in macrophages and dendritic cells, and the functional polymorphism of TREM2 is reported to be associated with neurodegenerative disorders such as Alzheimer's disease (AD). The objective of this study was to reveal the involvement of TYROBP and TREM2 in the pathophysiology of AD and schizophrenia. Methods: We investigated the mRNA expression level of the 2 genes in leukocytes of 26 patients with AD and 24 with schizophrenia in comparison with age-matched controls. Moreover, we performed gene association analysis between these 2 genes and schizophrenia. Results: No differences were found in TYROBP mRNA expression in patients with AD and schizophrenia; however, TREM2 mRNA expression was increased in patients with AD and schizophrenia compared with controls (P < 0.001). There were no genetic associations of either gene with schizophrenia in Japanese patients. Conclusion: TREM2 expression in leukocytes is elevated not only in AD but also in schizophrenia. Inflammatory processes involving TREM2 may occur in schizophrenia, as observed in neurocognitive disorders such as AD. TREM2 expression in leukocytes may be a novel biomarker for neurological and psychiatric disorders.	[Mori, Yoko; Yoshino, Yuta; Ochi, Shinichiro; Yamazaki, Kiyohiro; Kawabe, Kentaro; Abe, Masao; Kitano, Tomoji; Ozaki, Yuki; Yoshida, Taku; Mori, Takaaki; Iga, Junichi; Ueno, Shu-ichi] Ehime Univ, Grad Sch Med, Dept Neuropsychiat Mol & Funct, Toon, Ehime, Japan; [Numata, Shusuke; Ohmori, Tetsuro] Univ Tokushima, Course Integrated Brain Sci, Inst Hlth Biosci, Dept Psychiat,Med Informat,Grad Sch, Tokushima 770, Japan; [Kuroda, Norio] Kuroda Hosp, Masaki, Ehime, Japan	Ehime University; Tokushima University	Mori, Y (corresponding author), Ehime Univ, Grad Sch Med, Dept Neuropsychiat Mol & Funct, Toon, Ehime, Japan.	yoko-m@m.ehime-u.ac.jp	Kawabe, Kentaro/AAC-6933-2022; Ochi, Shinichiro/S-3318-2019; Iga, Jun-ichi/I-1650-2019	Kawabe, Kentaro/0000-0002-6569-7828; Ochi, Shinichiro/0000-0003-2263-3477; Iga, Jun-ichi/0000-0003-4409-3096	Japanese Ministry of Health, Labour and Welfare; Japanese Ministry of Education, Culture, Sports, Science and Technology; Ehime Graduate University of Medicine's Good Practice Fund; Grants-in-Aid for Scientific Research [15K09809] Funding Source: KAKEN	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ehime Graduate University of Medicine's Good Practice Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Health and Labor Science Research Grant from the Japanese Ministry of Health, Labour and Welfare; a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology; and the Ehime Graduate University of Medicine's Good Practice Fund.	Al-Hakeim HK, 2015, J AFFECT DISORDERS, V182, P106, DOI 10.1016/j.jad.2015.04.044; Avramopoulos D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116696; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Carrol ED, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-20; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Colonna M, 2003, J CLIN INVEST, V111, P313, DOI 10.1172/JCI200317745; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Dickerson F, 2013, SCHIZOPHR RES, V143, P198, DOI 10.1016/j.schres.2012.10.041; Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Giraldo M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.02.016; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Hu N, 2014, J ALZHEIMERS DIS, V38, P497, DOI 10.3233/JAD-130854; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kiialainen A, 2005, NEUROBIOL DIS, V18, P314, DOI 10.1016/j.nbd.2004.09.007; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lue LF, 2015, BRAIN PATHOL, V25, P469, DOI 10.1111/bpa.12190; Masel J, 2011, CURR BIOL, V21, pR837, DOI 10.1016/j.cub.2011.08.007; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miyashita A, 2014, J ALZHEIMERS DIS, V41, P1031, DOI 10.3233/JAD-140225; Monji A, 2013, PROG NEURO-PSYCHOPH, V42, P115, DOI 10.1016/j.pnpbp.2011.12.002; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paradowska-Gorycka A, 2013, HUM IMMUNOL, V74, P730, DOI 10.1016/j.humimm.2013.02.003; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi N, 2013, NEUROBIOL DIS, V53, P49, DOI 10.1016/j.nbd.2012.11.001; Uranova NA, 2011, SCHIZOPHR RES TREAT, V2011, DOI 10.1155/2011/325789; Watanabe S, 2015, J PSYCHIATR RES, V66-67, P1, DOI 10.1016/j.jpsychires.2015.03.004	35	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136835	10.1371/journal.pone.0136835	http://dx.doi.org/10.1371/journal.pone.0136835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332043	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800076
J	Niehaus, AJ; Mlisana, K; Gandhi, NR; Mathema, B; Brust, JCM				Niehaus, Abraham J.; Mlisana, Koleka; Gandhi, Neel R.; Mathema, Barun; Brust, James C. M.			High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR CHARACTERIZATION; ETHIONAMIDE; STRAINS	Background Drug-resistant tuberculosis (TB) remains extremely difficult to treat because there are often few remaining active medications and limited diagnostic options to detect resistance. Resistance to isoniazid is typically caused by mutations in either katG or the inhA promoter. inhA mutations confer low-level resistance to isoniazid and cross-resistance to ethionamide while katG mutations confer high-level isoniazid resistance and no cross-resistance. Line Probe Assays (LPAs) that detect mutations in katG and inhA are currently performed on all positive TB cultures in KwaZulu-Natal province, South Africa, but the frequency of inhA mutations in drug-resistant TB patients has not been examined. Methods We sought to determine the proportion of patients who could potentially benefit from high-dose isoniazid and who may be resistant to ethionamide. We reviewed 994 LPA (Hain MTBDRplus) results at the TB reference laboratory in KwaZulu-Natal to determine the frequency of mutations in either katG or the inhA promoter. We stratified these results by drug-resistance category (i.e., MDR-TB, pre-XDR-TB, and XDR-TB) as determined by phenotypic drug-susceptibility testing. Results Among MDR-and XDR-TB isolates, the prevalence of inhA mutations without a concurrent katG mutation was 14.8% and 10.3% respectively. The prevalence of inhA mutations with OR without a katG mutation was 30.3% and 82.8%, respectively. Conclusion More than 10% of patients with MDR- and XDR-TB may benefit from high-dose isoniazid. Although ethionamide is empirically included in all MDR- and XDR-TB regimens, nearly a third of MDR-TB patients and a majority of XDR-TB patients likely have resistance to ethionamide. Laboratories performing line probe assays should report specific band patterns so that clinicians may adjust treatment regimens accordingly.	[Niehaus, Abraham J.; Mlisana, Koleka] Natl Hlth Lab Serv, Dept Med Microbiol, Durban, South Africa; [Niehaus, Abraham J.; Mlisana, Koleka] Univ KwaZulu Natal, Durban, South Africa; [Gandhi, Neel R.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Gandhi, Neel R.] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Gandhi, Neel R.] Emory Univ, Dept Med, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Mathema, Barun] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Brust, James C. M.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Brust, James C. M.] Montefiore Med Ctr, Bronx, NY 10467 USA	University of Kwazulu Natal; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Columbia University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Brust, JCM (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	jcmbrust@gmail.com	Niehaus, Abraham/AAD-3483-2022; Niehaus, Abraham/B-4918-2010; Mlisana, Koleka/N-6204-2013	Niehaus, Abraham/0000-0002-2793-1855; Niehaus, Abraham/0000-0002-2793-1855; Mlisana, Koleka/0000-0002-8436-3268; Mathema, Barun/0000-0003-2772-479X	Albert Einstein College of Medicine Center for Global Health; National Institutes of Health [K23AI083088, K24AI114444]; Einstein-Montefiore Center for AIDS Research [P30 AI051519]; Emory Center for AIDS Research [P30 AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, K23AI083088, K24AI114444, R01AI089349, P30AI051519, R01AI087465] Funding Source: NIH RePORTER	Albert Einstein College of Medicine Center for Global Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein-Montefiore Center for AIDS Research; Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a pilot grant from the Albert Einstein College of Medicine Center for Global Health. JCMB and NRG are each supported by the National Institutes of Health (K23AI083088 and K24AI114444, respectively). Additional support for this study was provided by the Einstein-Montefiore and Emory Centers for AIDS Research (P30 AI051519 and P30 AI050409, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate D, 2014, INT J TUBERC LUNG D, V18, P946, DOI 10.5588/ijtld.13.0926; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Chihota VN, 2012, J CLIN MICROBIOL, V50, P995, DOI 10.1128/JCM.05832-11; Conradie F, 2014, SAMJ S AFR MED J, V104, P164, DOI 10.7196/SAMJ.7263; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2014, EMERG INFECT DIS, V20, P426, DOI 10.3201/eid2003.131083; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Herrera L, 2004, INT J ANTIMICROB AG, V23, P572, DOI 10.1016/j.ijantimicag.2003.09.032; Jagielski T, 2014, J ANTIMICROB CHEMOTH, V69, P2369, DOI 10.1093/jac/dku161; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P139; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Muller B, 2011, INT J TUBERC LUNG D, V15, P344; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; Varghese B, 2014, MICROBIAL DRUG RESIS; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; World Health Organization, 2014, WHOHTMTB201408; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	19	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135003	10.1371/journal.pone.0135003	http://dx.doi.org/10.1371/journal.pone.0135003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332235	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800018
J	Wu, WJ; Gu, SP; Sun, C; He, W; Xie, XH; Li, X; Ye, WD; Qin, CL; Chen, YP; Xiao, J; Liu, C				Wu, Weijie; Gu, Shuping; Sun, Cheng; He, Wei; Xie, Xiaohua; Li, Xihai; Ye, Wenduo; Qin, Chunlin; Chen, Yiping; Xiao, Jing; Liu, Chao			Altered FGF Signaling Pathways Impair Cell Proliferation and Elevation of Palate Shelves	PLOS ONE			English	Article							CRANIAL NEURAL CREST; SECONDARY PALATE; CLEFT-PALATE; GROWTH-FACTOR; TRANSCRIPTION FACTOR; MAMMALIAN PALATE; MICE; MORPHOGENESIS; TOOTH; PALATOGENESIS	In palatogenesis, palatal shelves are patterned along the mediolateral axis as well as the anteroposterior axis before the onset of palatal fusion. Fgf10 specifically expressed in lateral mesenchyme of palate maintains Shh transcription in lateral epithelium, while Fgf7 activated in medial mesenchyme by Dlx5, suppressed the expansion of Shh expression to medial epithelium. How FGF signaling pathways regulate the cell behaviors of developing palate remains elusive. In our study, we found that when Fgf8 is ectopically expressed in the embryonic palatal mesenchyme, the elevation of palatal shelves is impaired and the posterior palatal shelves are enlarged, especially in the medial side. The palatal deformity results from the drastic increase of cell proliferation in posterior mesenchyme and decrease of cell proliferation in epithelium. The expression of mesenchymal Fgf10 and epithelial Shh in the lateral palate, as well as the Dlx5 and Fgf7 transcription in the medial mesenchyme are all interrupted, indicating that the epithelial-mesenchymal interactions during palatogenesis are disrupted by the ectopic activation of mesenchymal Fgf8. Besides the altered Fgf7, Fgf10, Dlx5 and Shh expression pattern, the reduced Osr2 expression domain in the lateral mesenchyme also suggests an impaired mediolateral patterning of posterior palate. Moreover, the ectopic Fgf8 expression up-regulates pJak1 throughout the palatal mesenchyme and pErk in the medial mesenchyme, but down-regulates pJak2 in the epithelium, suggesting that during normal palatogenesis, the medial mesenchymal cell proliferation is stimulated by FGF/Erk pathway, while the epithelial cell proliferation is maintained through FGF/Jak2 pathway.	[Wu, Weijie] Shanghai Zhongshan Hosp, Dept Stomatol, Shanghai, Peoples R China; [Wu, Weijie; Gu, Shuping; Sun, Cheng; He, Wei; Li, Xihai; Ye, Wenduo; Chen, Yiping; Liu, Chao] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Wu, Weijie; Gu, Shuping; Sun, Cheng; He, Wei; Li, Xihai; Ye, Wenduo; Chen, Yiping; Liu, Chao] Tulane Univ, Sch Sci & Engn, New Orleans, LA 70118 USA; [Xie, Xiaohua; Qin, Chunlin; Liu, Chao] Baylor Coll Dent, Texas A&M Hlth Sci Ctr, Dept Biomed Sci, Dallas, TX 75246 USA; [He, Wei] Zunyi Med Univ, Affiliated Stomatol Hosp, Dept Oral & Maxillofacial Surg, Zunyi, Peoples R China; [Xie, Xiaohua] Harbin Med Univ, Affiliated Hosp 2, Inst Hard Tissue Dev & Regenerat, Dept Endodont, Harbin, Peoples R China; [Li, Xihai] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fuzhou, Peoples R China; [Xiao, Jing; Liu, Chao] Dalian Med Univ, Coll Stomatol, Dept Oral Biol, Dalian, Peoples R China	Fudan University; Tulane University; Tulane University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Zunyi Medical University; Harbin Medical University; Fujian University of Traditional Chinese Medicine; Dalian Medical University	Xiao, J (corresponding author), Dalian Med Univ, Coll Stomatol, Dept Oral Biol, Dalian, Peoples R China.	xiaoj@dlmedu.edu.cn; cliu@bcd.tamhsc.edu			National Institutes of Health [R01 DE14044, R01 DE022549]; National Science Foundation of China [81271120]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014044, R01DE022549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was provided by the National Institutes of Health Grants (R01 DE14044) to Y.C., National Institutes of Health Grants (R01 DE022549) to C.Q., and the National Science Foundation of China Research Grant (No. 81271120) to J.X.	Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Almaidhan A, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-3; Bellmunt J, 2013, NAT REV CLIN ONCOL, V10, P557, DOI 10.1038/nrclinonc.2013.155; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Dudas M, 2007, ACTA HISTOCHEM, V109, P1, DOI 10.1016/j.acthis.2006.05.009; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Gao Y, 2009, DEV BIOL, V328, P200, DOI 10.1016/j.ydbio.2009.01.008; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Gu SP, 2008, MECH DEVELOP, V125, P729, DOI 10.1016/j.mod.2008.04.003; Gu SP, 2008, DEV DYNAM, V237, P1509, DOI 10.1002/dvdy.21534; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; He FL, 2011, DEV BIOL, V350, P511, DOI 10.1016/j.ydbio.2010.12.021; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hosokawa R, 2009, J EXP ZOOL PART B, V312B, P343, DOI 10.1002/jez.b.21274; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Lan Y, 2007, GENESIS, V45, P618, DOI 10.1002/dvg.20334; Lan Y, 2009, DEVELOPMENT, V136, P1387, DOI 10.1242/dev.028167; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Li JY, 2011, DEVELOPMENT, V138, P1977, DOI 10.1242/dev.061341; Li Q, 2007, INT J DEV BIOL, V51, P167, DOI 10.1387/ijdb.062212ql; Lin CX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003231; Liu WJ, 2008, DEVELOPMENT, V135, P3959, DOI 10.1242/dev.025304; Matsumura K, 2011, BIOCHEM BIOPH RES CO, V404, P1076, DOI 10.1016/j.bbrc.2010.12.116; Pantalacci S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-116; PRESNELL JK, 1997, HUMASONS ANIMAL TISS; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Snyder-Warwick AK, 2010, P NATL ACAD SCI USA, V107, P2515, DOI 10.1073/pnas.0913985107; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wang C, 2013, J BIOL CHEM, V288, P22174, DOI 10.1074/jbc.M113.463620; Welsh IC, 2009, DEV BIOL, V336, P53, DOI 10.1016/j.ydbio.2009.09.028; Xiong W, 2009, DEV BIOL, V330, P131, DOI 10.1016/j.ydbio.2009.03.021; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhou J, 2013, DEVELOPMENT, V140, P4709, DOI 10.1242/dev.099028	42	17	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136951	10.1371/journal.pone.0136951	http://dx.doi.org/10.1371/journal.pone.0136951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332583	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800082
J	Yang, ZY; Dong, WJ; Xiu, JF; Dai, RF; Chou, JM				Yang, Zhiyong; Dong, Wenjie; Xiu, Jinfeng; Dai, Rufeng; Chou, Jieming			Structural Path Analysis of Fossil Fuel Based CO2 Emissions: A Case Study for China	PLOS ONE			English	Article							INPUT-OUTPUT-ANALYSIS; REGIONAL CONSUMPTION ACTIVITIES; GLOBAL ENVIRONMENTAL-IMPACT; INTERNATIONAL-TRADE; RESPONSIBILITY; DECOMPOSITION; POLLUTION; CONSUMER; PRODUCER; IMPORTS	Environmentally extended input-output analysis (EEIOA) has long been used to quantify global and regional environmental impacts and to clarify emission transfers. Structural path analysis (SPA), a technique based on EEIOA, is especially useful for measuring significant flows in this environmental-economic system. This paper constructs an imports-adjusted single-region input-output (SRIO) model considering only domestic final use elements, and it uses the SPA technique to highlight crucial routes along the production chain in both final use and sectoral perspectives. The results indicate that future mitigation policies on household consumption should change direct energy use structures in rural areas, cut unreasonable demand for power and chemical products, and focus on urban areas due to their consistently higher magnitudes than rural areas in the structural routes. Impacts originating from government spending should be tackled by managing onsite energy use in 3 major service sectors and promoting cleaner fuels and energy-saving techniques in the transport sector. Policies on investment should concentrate on sectoral interrelationships along the production chain by setting up standards to regulate upstream industries, especially for the services, construction and equipment manufacturing sectors, which have high demand pulling effects. Apart from the similar methods above, mitigating policies in exports should also consider improving embodied technology and quality in manufactured products to achieve sustainable development. Additionally, detailed sectoral results in the coal extraction industry highlight the onsite energy use management in large domestic companies, emphasize energy structure rearrangement, and indicate resources and energy safety issues. Conclusions based on the construction and public administration sectors reveal that future mitigation in secondary and tertiary industries should be combined with upstream emission intensive industries in a systematic viewpoint to achieve sustainable development. Overall, SPA is a useful tool in empirical studies, and it can be used to analyze national environmental impacts and guide future mitigation policies.	[Yang, Zhiyong; Dong, Wenjie; Xiu, Jinfeng; Dai, Rufeng; Chou, Jieming] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Yang, Zhiyong; Dong, Wenjie; Dai, Rufeng; Chou, Jieming] Beijing Normal Univ Zhuhai, Future Earth Res Inst, Zhuhai, Guangdong, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University Zhuhai	Chou, JM (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	choujm@bnu.edu.cn			National Basic Program for Global Change Research of China [2012CB9557]; National Natural Science Foundation of China [41175125, 41330527]; National level Major Incubation Project of Guangdong Province, China [2014GKXM058]	National Basic Program for Global Change Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National level Major Incubation Project of Guangdong Province, China	This work is funded by the National Basic Program for Global Change Research of China (2012CB9557, http://www.973.gov.cn/Default_3.aspx), the National Natural Science Foundation of China (41175125 and 41330527, http://www.nsfc.gov.cn/), and the National level Major Incubation Project of Guangdong Province, China (2014GKXM058, http://govinfonew.nlc.gov.cn/gdfz/govShow2015-016143086-TC0000000004.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew R, 2009, ECON SYST RES, V21, P311, DOI 10.1080/09535310903541751; Arto I, 2014, ECOL ECON, V97, P93, DOI 10.1016/j.ecolecon.2013.11.005; Atkinson G, 2011, GLOBAL ENVIRON CHANG, V21, P563, DOI 10.1016/j.gloenvcha.2010.11.009; Bai Y., 2015, XIJINPING ACTIVELY P; Boden T. A., 2013, GLOBAL REGIONAL NATL, DOI [10.3334/CDIAC/00001_V2013, DOI 10.3334/CDIAC/00001_V2013]; DEFOURNY J, 1984, ECON J, V94, P111, DOI 10.2307/2232220; EIA, US EN INF ADM INT EN; Fan Y, 2007, ECOL ECON, V62, P683, DOI 10.1016/j.ecolecon.2006.08.016; Gallego B., 2005, ECON SYST RES, V17, P365, DOI [10.1080/ 09535310500283492, 10.1080/09535310500283492, DOI 10.1080/09535310500283492]; GCEC, 2014, NEW CLIM EC GLOB REP, P42; General Administration of Customs of the People's Republic of China (GAC), 2021, CHIN CUST STAT DAT; Guan DB, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/2/024010; Guan D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036540; Guan D, 2008, GLOBAL ENVIRON CHANG, V18, P626, DOI 10.1016/j.gloenvcha.2008.08.001; Hertwich EG, 2010, MULTIREGIONAL INPUT; Huang YA, 2009, ECON SYST RES, V21, P217, DOI 10.1080/09535310903541348; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Kan HD, 2009, ENVIRON HEALTH PERSP, V117, pA187, DOI 10.1289/ehp.12737; Kanemoto K, 2014, GLOBAL ENVIRON CHANG, V24, P52, DOI 10.1016/j.gloenvcha.2013.09.008; Kanemoto K, 2012, ENVIRON SCI TECHNOL, V46, P172, DOI 10.1021/es202239t; Le Quere C, 2014, EARTH SYST SCI DATA, V6, P235, DOI 10.5194/essd-6-235-2014; Lenzen M., 2003, Structural Change and Economic Dynamics, V14, P1, DOI 10.1016/S0954-349X(02)00025-5; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Lenzen M, 2002, J CLEAN PROD, V10, P545, DOI 10.1016/S0959-6526(02)00007-0; Lenzen M., 2004, ECON SYST RES, V16, P391, DOI [DOI 10.1080/0953531042000304272, 10.1080/0953531042000304272]; Lenzen M, 2007, ECOL ECON, V61, P27, DOI 10.1016/j.ecolecon.2006.05.018; Lenzen M, 2007, ECOL MODEL, V200, P334, DOI 10.1016/j.ecolmodel.2006.07.041; Lenzen M, 2013, ECOL ECON, V94, P78, DOI 10.1016/j.ecolecon.2013.06.018; Lenzen M, 2010, ECOL ECON, V70, P261, DOI 10.1016/j.ecolecon.2010.04.005; Marques A, 2013, ECOL ECON, V89, P162, DOI 10.1016/j.ecolecon.2013.02.020; Marques A, 2012, ECOL ECON, V84, P57, DOI 10.1016/j.ecolecon.2012.09.010; Miller RE, 2009, INPUT OUTPUT ANAL FD, P69; Minx JC, 2009, ECON SYST RES, V21, P187, DOI 10.1080/09535310903541298; Nakamura D, 2014, CHINA US AGREE LIMIT; NBSC, NAT BUR STAT CHIN 20; NBSC, 2007, INPUT OUTPUT TABLES; NBSC, 2008, EN STAT YB CHINA; Oshita Y, 2012, ENERG ECON, V34, P1041, DOI 10.1016/j.eneco.2011.08.013; Peters G, 2006, CONSTRUCTION CHINESE, p[1501, 3]; Peters G.P., 2006, ECON SYST RES, V18, P155, DOI DOI 10.1080/09535310600653008; Peters GP, 2007, ENVIRON SCI TECHNOL, V41, P5939, DOI 10.1021/es070108f; Peters GP, 2006, J IND ECOL, V10, P89, DOI 10.1162/jiec.2006.10.3.89; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Rodrigues J, 2008, ECOL ECON, V66, P533, DOI 10.1016/j.ecolecon.2007.12.010; Rodrigues J, 2006, ECOL ECON, V59, P256, DOI 10.1016/j.ecolecon.2005.10.002; Rypdal K., 2006, 2006 IPCC GUIDELINES; Sheng B, 2002, POLITICAL EC ANAL CH, P480; Shui B, 2006, ENERG POLICY, V34, P4063, DOI 10.1016/j.enpol.2005.09.010; Song L, 2012, RISING CHINA GLOBAL, P71; Song R, 2015, GHG PROTOCOL TOOL EN; Sonis M, 1997, REG SCI URBAN ECON, V27, P325, DOI 10.1016/S0166-0462(96)02165-5; Su B, 2013, ENERG POLICY, V56, P83, DOI 10.1016/j.enpol.2013.01.041; Tans P, EARTH SYSTEM RES LA; Treloar G.J., 1997, EC SYSTEMS RES, V9, P375, DOI [DOI 10.1080/09535319700000032, 10.1080/09535319700000032]; Treloar G.J., 2001, CONSTR MANAG ECON, V19, P49, DOI [10.1080/014461901452076, DOI 10.1080/014461901452076]; Tukker A, 2013, ENVIRON SCI TECHNOL, V47, P1775, DOI 10.1021/es303217f; Turner K, 2007, ECOL ECON, V62, P37, DOI 10.1016/j.ecolecon.2006.12.002; UNSD, UN STAST DIV; Waugh FV, 1950, ECONOMETRICA, V18, P142, DOI 10.2307/1907265; Weber CL, 2008, ENERG POLICY, V36, P3572, DOI 10.1016/j.enpol.2008.06.009; Wiedmann T, 2007, ECOL ECON, V61, P15, DOI 10.1016/j.ecolecon.2006.12.003; Wiedmann T, 2009, ECOL ECON, V69, P211, DOI 10.1016/j.ecolecon.2009.08.026; Wood R, 2009, ENERG ECON, V31, P335, DOI 10.1016/j.eneco.2008.11.003; Yang ZY, 2015, J CLEAN PROD, V103, P793, DOI 10.1016/j.jclepro.2014.03.053; Zhang M, 2009, ECOL ECON, V68, P2122, DOI 10.1016/j.ecolecon.2009.02.005; Zhang YG, 2013, ENERG ECON, V40, P967, DOI 10.1016/j.eneco.2013.05.025; Zhang YG, 2012, ENVIRON RESOUR ECON, V51, P371, DOI 10.1007/s10640-011-9503-9; Zhang YG, 2009, ECOL ECON, V68, P2399, DOI 10.1016/j.ecolecon.2009.03.014	68	27	29	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135727	10.1371/journal.pone.0135727	http://dx.doi.org/10.1371/journal.pone.0135727			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332222	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800038
J	Chen, WQ; Xu, XY; Wang, LJ; Bai, G; Xiang, WP				Chen, Wenqi; Xu, Xiaoyan; Wang, Lingjuan; Bai, Ge; Xiang, Wenpei			Low Expression of Mfn2 Is Associated with Mitochondrial Damage and Apoptosis of Ovarian Tissues in the Premature Ovarian Failure Model	PLOS ONE			English	Article							DYNAMICS; CELLS; INSUFFICIENCY; ATRESIA; FUSION; GENES; ATP	Background This study aimed to construct a working model for detecting the mitochondrial damage and expression of Mfn2. It furthermore explored the pathogenesis of premature ovarian failure (POF) induced by cisplatin. Method Forty young female mice were divided randomly into two groups. The first was the treatment group intraperitoneally administered cisplatin (1.5mg/kg). The untreated control group was likewise injected with physiological saline for 10 days. One month later, we observed the ovarian weight and morphological changes, particularly the development of follicles and concentration of sex hormones. Immunohistochemistry and western blotting were used to measure the two groups. We later evaluated ovarian cell apoptosis with TUNEL and analyzed Bcl-2 and Bax levels. We used transmission electron microscopy in order to observe the ultrastructure of ovarian cells. The phosphomolybdic acid colorimetric method was used to measure the ATP content in the ovarian tissue. Finally, the mitochondrial membrane potential of ovarian cells was detected with JC-1 dye. Results The cisplatin resulted in a decline of body weight, reduced ovarian weight significantly, and resulted in disorders of the extrous cycle. The follicles' number decreased within the tissue's stromal hyperplasia. Moreover, E-2 levels were reduced, and elevated gonadotropin levels were observed. However, Mfn2 was present in the cell's cytoplasm in both groups. Nevertheless, the Mfn2 levels and the expression of Bcl-2 were significantly decreased (p<0.05), but the expression of Bax and the apoptosis index (AI) was increased. In addition, the ATP levels (35.2 +/- 5.7 mu mol/g) of the control group were significantly higher (13.5 +/- 3.8 mu mol/g). Lastly, an obvious impairment of mitochondrial function and structure was observed. Conclusion The intreperitoneal injection of cisplatin, when administered for 10 days, establishes a POF model. Thus, the above results suggest that lower expression of Mfn2 may be involved in the mechanism of premature ovarian failure by affecting both the mitochondria's energy metabolism and its apoptosis. This decides the termination of the follicles' development.	[Chen, Wenqi; Wang, Lingjuan; Bai, Ge; Xiang, Wenpei] Huazhong Univ Sci & Technol, Family Planning Res Inst, Tongji Med Coll, Wuhan 430030, Peoples R China; [Xu, Xiaoyan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Obstet & Gynecol, Tongji Med Coll, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xiang, WP (corresponding author), Huazhong Univ Sci & Technol, Family Planning Res Inst, Tongji Med Coll, Wuhan 430030, Peoples R China.	wpxiang2010@gmail.com			Fundamental Research Funds for the Central Universities	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by "the Fundamental Research Funds for the Central Universities".	Abed RMM, 2012, INDIAN J MICROBIOL, V52, P88, DOI 10.1007/s12088-011-0239-6; Bonomi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042423; Cha KY, 2005, FERTIL STERIL, V84, P1712, DOI 10.1016/j.fertnstert.2005.06.036; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Duarte A, 2012, PLOS ONE, V7, P1; Escobar-Henriques M, 2013, BBA-MOL CELL RES, V1833, P162, DOI 10.1016/j.bbamcr.2012.07.016; Givvimani S, 2015, INT J CARDIOL, V187, P325, DOI 10.1016/j.ijcard.2015.03.352; Guo JQ, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-18; Jin M, 2012, SCI CHINA LIFE SCI, V55, P677, DOI 10.1007/s11427-012-4355-2; Li D, 2013, ANIM REPROD SCI, V137, P205, DOI 10.1016/j.anireprosci.2012.11.011; Li Lin, 2009, Zhonghua Fu Chan Ke Za Zhi, V44, P191; Lin PF, 2012, MOL REPROD DEV, V79, P423, DOI 10.1002/mrd.22045; Liu C, 2014, BIOCHEM BIOPH RES CO, V450, P500, DOI 10.1016/j.bbrc.2014.06.005; Liu JB, 2014, MOL CELLS, V37, P865, DOI 10.14348/molcells.2014.0145; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nasrallah CM, 2014, NAT REV ENDOCRINOL, V10, P650, DOI 10.1038/nrendo.2014.160; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Munoz JP, 2013, EMBO J, V32, P2348, DOI 10.1038/emboj.2013.168; Pang W, 2013, PLACENTA, V34, P613, DOI 10.1016/j.placenta.2013.03.013; Paradies G, 2015, ARCH TOXICOL, V89, P923, DOI 10.1007/s00204-015-1475-z; Ray Wilson Z, 2012, Hand (N Y), V7, P59, DOI 10.1007/s11552-011-9378-9; Scorrano L, 2013, EUR J CLIN INVEST, V43, P886, DOI 10.1111/eci.12135; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sullivan SD, 2011, SEMIN REPROD MED, V29, P283, DOI 10.1055/s-0031-1280914; Tarazona AM, 2006, REPROD DOMEST ANIM, V41, P5, DOI 10.1111/j.1439-0531.2006.00615.x; Tian Y, 2015, CELL BIOL INT, V39, P584, DOI 10.1002/cbin.10426; Tsujimoto Y, 1997, CELL DEATH DIFFER, V4, P429, DOI 10.1038/sj.cdd.4400262; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Verma S, 2015, J BIOMOL STRUCT DYN, V33, P1094, DOI 10.1080/07391102.2014.931823; Vidoni S, 2013, ANTIOXID REDOX SIGN, V19, P379, DOI 10.1089/ars.2012.4800; Vujovic S, 2012, SRP ARK CELOK LEK, V140, P806, DOI 10.2298/SARH1212806V; Wakai T, 2014, MOL HUM REPROD, V20, P1090, DOI 10.1093/molehr/gau064; Wang Q, 2010, PLOS ONE, V28; Welt CK, 2008, CLIN ENDOCRINOL, V68, P499, DOI 10.1111/j.1365-2265.2007.03073.x; Yucebilgin MS, 2004, AUST NZ J OBSTET GYN, V44, P6, DOI 10.1111/j.1479-828X.2004.00143.x; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Zhang G, 2015, REPROD DOMEST ANIM, V50, P465, DOI 10.1111/rda.12514; Zhao N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125680	38	15	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136421	10.1371/journal.pone.0136421	http://dx.doi.org/10.1371/journal.pone.0136421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327438	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700041
J	Molaei, G; Armstrong, PM; Abadam, CF; Akaratovic, KI; Kiser, JP; Andreadis, TG				Molaei, Goudarz; Armstrong, Philip M.; Abadam, Charles F.; Akaratovic, Karen I.; Kiser, Jay P.; Andreadis, Theodore G.			Vector-Host Interactions of Culiseta melanura in a Focus of Eastern Equine Encephalitis Virus Activity in Southeastern Virginia	PLOS ONE			English	Article							WEST-NILE-VIRUS; POTENTIAL MOSQUITO VECTORS; FIELD-COLLECTED MOSQUITOS; MARYLAND FRESHWATER SWAMP; UPSTATE NEW-YORK; FEEDING PATTERNS; ENCEPHALOMYELITIS VIRUS; UNITED-STATES; WILD BIRDS; MASSACHUSETTS	Eastern equine encephalitis virus (EEEV) causes a highly pathogenic mosquito-borne zoonosis that is responsible for sporadic outbreaks of severe illness in humans and equines in the eastern USA. Culiseta (Cs.) melanura is the primary vector of EEEV in most geographic regions but its feeding patterns on specific avian and mammalian hosts are largely unknown in the mid-Atlantic region. The objectives of our study were to: 1) identify avian hosts of Cs. melanura and evaluate their potential role in enzootic amplification of EEEV, 2) assess spatial and temporal patterns of virus activity during a season of intense virus transmission, and 3) investigate the potential role of Cs. melanura in epidemic/epizootic transmission of EEEV to humans and equines. Accordingly, we collected mosquitoes at 55 sites in Suffolk, Virginia in 2013, and identified the source of blood meals in engorged mosquitoes by nucleotide sequencing PCR products of the mitochondrial cytochrome b gene. We also examined field-collected mosquitoes for evidence of infection with EEEV using Vector Test, cell culture, and PCR. Analysis of 188 engorged Cs. melanura sampled from April through October 2013 indicated that 95.2%, 4.3%, and 0.5% obtained blood meals from avian, mammalian, and reptilian hosts, respectively. American Robin was the most frequently identified host for Cs. melanura (42.6% of blood meals) followed by Northern Cardinal (16.0%), European Starling (11.2%), Carolina Wren (4.3%), and Common Grackle (4.3%). EEEV was detected in 106 mosquito pools of Cs. melanura, and the number of virus positive pools peaked in late July with 22 positive pools and a Maximum Likelihood Estimation (MLE) infection rate of 4.46 per 1,000 mosquitoes. Our findings highlight the importance of Cs. melanura as a regional EEEV vector based on frequent feeding on virus-competent bird species. A small proportion of blood meals acquired from mammalian hosts suggests the possibility that this species may occasionally contribute to epidemic/epizootic transmission of EEEV.	[Molaei, Goudarz; Armstrong, Philip M.; Andreadis, Theodore G.] Connecticut Agr Expt Stn, Ctr Vector Biol & Zoonot Dis, New Haven, CT 06504 USA; [Abadam, Charles F.; Akaratovic, Karen I.; Kiser, Jay P.] Suffolk Mosquito Control, Dept Publ Works, Suffolk, VA USA	Connecticut Agricultural Experiment Station	Molaei, G (corresponding author), Connecticut Agr Expt Stn, Ctr Vector Biol & Zoonot Dis, New Haven, CT 06504 USA.	Goudarz.Molaei@ct.gov	Armstrong, Philip/GWU-8253-2022	Akaratovic, Karen/0000-0001-6999-9818	Division of Mosquito Control, City of Suffolk's Department of Public Works, VA; Centers for Disease Control and Prevention [U50/CCU6806-01-1]; USDA NIFA [1043]	Division of Mosquito Control, City of Suffolk's Department of Public Works, VA; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USDA NIFA(United States Department of Agriculture (USDA))	Funding for this research was provided in part by the Division of Mosquito Control, City of Suffolk's Department of Public Works, VA; Laboratory Capacity for Infectious Diseases Cooperative Agreement Number U50/CCU6806-01-1 from the Centers for Disease Control and Prevention issued to CAES, and USDA NIFA Multi-state Research Project 1043.	Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Armstrong PM, 2012, VECTOR-BORNE ZOONOT, V12, P872, DOI 10.1089/vbz.2012.1008; Armstrong PM, 2010, EMERG INFECT DIS, V16, P1869, DOI 10.3201/eid1612.100640; BAST TF, 1973, AM J TROP MED HYG, V22, P109, DOI 10.4269/ajtmh.1973.22.109; CARTER V, 1977, WATER RESOUR BULL, V13, P1; Cleckner HL, 2011, REMOTE SENS-BASEL, V3, P2663, DOI 10.3390/rs3122663; Cohen SB, 2009, AM J TROP MED HYG, V81, P452, DOI 10.4269/ajtmh.2009.81.452; Conover WJ, 1980, PRACTICAL NONPARAMET, p[369, 494]; CRANS WJ, 1994, J MED ENTOMOL, V31, P711, DOI 10.1093/jmedent/31.5.711; DALRYMPLE JM, 1972, AM J EPIDEMIOL, V96, P129, DOI 10.1093/oxfordjournals.aje.a121439; EDMAN JD, 1971, J MED ENTOMOL, V8, P687, DOI 10.1093/jmedent/8.6.687; EMORD DE, 1984, J MED ENTOMOL, V21, P395, DOI 10.1093/jmedent/21.4.395; Estep LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057879; Estep LK, 2011, AM J TROP MED HYG, V84, P718, DOI 10.4269/ajtmh.2011.10-0586; Heckscher Christopher M., 2000, Northeastern Naturalist, V7, P113, DOI 10.1656/1092-6194(2000)007[0113:FDBOTG]2.0.CO;2; Howard JJ, 2004, J MED ENTOMOL, V41, P1090, DOI 10.1603/0022-2585-41.6.1090; HUTTO RL, 1995, CONSERV BIOL, V9, P1041, DOI [10.1046/j.1523-1739.1995.9051041.x, 10.1046/j.1523-1739.1995.9051033.x-i1]; Joseph SR, 1969, U MD AGR EXP STN B, VA-161, P1; KOMAR N, 1994, ANN NY ACAD SCI, V740, P157, DOI 10.1111/j.1749-6632.1994.tb19866.x; Komar N, 1999, AM J TROP MED HYG, V60, P387, DOI 10.4269/ajtmh.1999.60.387; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Loftin KC, 2006, J ENVIRON HEALTH, V68, P33; LORD RD, 1970, AM J EPIDEMIOL, V92, P73, DOI 10.1093/oxfordjournals.aje.a121181; MAIN AJ, 1988, AM J TROP MED HYG, V38, P208, DOI 10.4269/ajtmh.1988.38.208; Martin K, 1973, THESIS U ALBERTA EDM; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Molaei G, 2008, J MED ENTOMOL, V45, P1143, DOI 10.1603/0022-2585(2008)45[1143:HPOPMV]2.0.CO;2; Molaei G, 2006, J MED ENTOMOL, V43, P1088, DOI 10.1603/0022-2585(2006)43[1088:IOAAMB]2.0.CO;2; Molaei G, 2006, AM J TROP MED HYG, V75, P1140, DOI 10.4269/ajtmh.2006.75.1140; Molaei G, 2013, VECTOR-BORNE ZOONOT, V13, P312, DOI 10.1089/vbz.2012.1099; Morris C. D., 1988, The arboviruses: epidemiology and ecology. Volume III., P1; MORRIS CD, 1975, AM J TROP MED HYG, V24, P986, DOI 10.4269/ajtmh.1975.24.986; NASCI RS, 1981, J MED ENTOMOL, V18, P493, DOI 10.1093/jmedent/18.6.493; Nasci RS, 1996, J AM MOSQUITO CONTR, V12, P167; Poole A, BIRDS N AM ONLINE; REITER P, 1987, J AM MOSQUITO CONTR, V3, P325; Sallabanks R, 1995, ANN REPORT SUS UNPUB; SAUGSTAD ES, 1972, AM J EPIDEMIOL, V96, P114, DOI 10.1093/oxfordjournals.aje.a121437; Scott T. W., 1989, Advances in Virus Research, V37, P277, DOI 10.1016/S0065-3527(08)60838-6; Slaff M, 1989, PUBLICATIONS; Tenbroeck C, 1935, J EXP MED, V62, P677, DOI 10.1084/jem.62.5.677; Vaidyanathan R, 1997, J MED ENTOMOL, V34, P346, DOI 10.1093/jmedent/34.3.346	42	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136743	10.1371/journal.pone.0136743	http://dx.doi.org/10.1371/journal.pone.0136743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327226	Green Published, gold			2022-12-27	WOS:000360437700061
J	Ye, M; Yang, TL; Qing, P; Lei, X; Qiu, J; Liu, GY				Ye, Ming; Yang, Tianliang; Qing, Peng; Lei, Xu; Qiu, Jiang; Liu, Guangyuan			Changes of Functional Brain Networks in Major Depressive Disorder: A Graph Theoretical Analysis of Resting-State fMRI	PLOS ONE			English	Article							DEFAULT-MODE-NETWORK; DRUG-NAIVE; MODULAR ORGANIZATION; MEDICATION-NAIVE; NEURAL ACTIVITY; CONNECTIVITY; 1ST-EPISODE; METAANALYSIS; MRI; CINGULATE	Recent developments in graph theory have heightened the need for investigating the disruptions in the topological structure of functional brain network in major depressive disorder (MDD). In this study, we employed resting-state functional magnetic resonance imaging (fMRI) and graph theory to examine the whole-brain functional networks among 42 MDD patients and 42 healthy controls. Our results showed that compared with healthy controls, MDD patients showed higher local efficiency and modularity. Furthermore, MDD patients showed altered nodal centralities of many brain regions, including hippocampus, temporal cortex, anterior cingulate gyrus and dorsolateral prefrontal gyrus, mainly located in default mode network and cognitive control network. Together, our results suggested that MDD was associated with disruptions in the topological structure of functional brain networks, and provided new insights concerning the pathophysiological mechanisms of MDD.	[Ye, Ming; Qing, Peng] Southwest Univ, Fac Comp & Informat Sci, Chongqing, Peoples R China; [Ye, Ming; Liu, Guangyuan] Southwest Univ, Coll Elect & Informat Engn, Chongqing, Peoples R China; [Yang, Tianliang; Lei, Xu; Qiu, Jiang] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Yang, Tianliang; Lei, Xu; Qiu, Jiang] Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China	Southwest University - China; Southwest University - China; Southwest University - China	Lei, X (corresponding author), Southwest Univ, Fac Psychol, Chongqing, Peoples R China.	xlei@swu.edu.cn; liugy@swu.edu.cn		Liu, Guangyuan/0000-0002-8058-5947	National Natural Science Foundation of China [61472330]; Fundamental Research Funds for the Central Universities [XDJK2012C023, SWU111047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was funded by the National Natural Science Foundation of China (61472330) and the Fundamental Research Funds for the Central Universities (XDJK2012C023 and SWU111047).	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cullen KR, 2009, NEUROSCI LETT, V460, P227, DOI 10.1016/j.neulet.2009.05.022; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; Ebert D, 1996, BIOL PSYCHIAT, V39, P1044, DOI 10.1016/0006-3223(95)00320-7; First M. B., 1997, STRUCTURED CLIN INTE; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Gotlib IH, 2008, CURR DIR PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-8721.2008.00567.x; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2012, J PSYCHIATR RES, V46, P1366, DOI 10.1016/j.jpsychires.2012.07.003; Guo WB, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000560; Guo WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091102; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; Hamilton JP, 2011, NEUROBIOLOGY DEPRESS, P57, DOI DOI 10.1201/B11232-4; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Jin CW, 2011, NEUROSCI LETT, V503, P105, DOI 10.1016/j.neulet.2011.08.017; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Leistedt SJJ, 2009, HUM BRAIN MAPP, V30, P2207, DOI 10.1002/hbm.20662; Lisiecka D, 2011, INT J NEUROPSYCHOPH, V14, P521, DOI 10.1017/S1461145710001513; Liu Chun-Hong, 2012, PLoS One, V7, pe48181, DOI 10.1371/journal.pone.0048181; Liu F, 2013, J AFFECT DISORDERS, V146, P401, DOI 10.1016/j.jad.2012.10.001; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039516; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lord A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041282; Mayberg HS, 2014, RECIPROCAL LIMBIC CO, V156, P675; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Singh MK, 2013, BIOL PSYCHIAT, V74, P777, DOI 10.1016/j.biopsych.2013.03.005; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096505; Tagliazucchi E, 2013, NEUROIMAGE, V70, P327, DOI 10.1016/j.neuroimage.2012.12.073; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang L, 2014, PSYCHOL MED, V44, P1417, DOI 10.1017/S0033291713002031; Wang L, 2012, J AFFECT DISORDERS, V142, P6, DOI 10.1016/j.jad.2012.04.013; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wei XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114603; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	63	85	90	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0133775	10.1371/journal.pone.0133775	http://dx.doi.org/10.1371/journal.pone.0133775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327292	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700007
J	Zhang, Y; Zhang, J; Zhu, SY; Du, CH; Zhang, W				Zhang, Ye; Zhang, Jun; Zhu, Shenyue; Du, Changhui; Zhang, Wei			Prevalence and Predictors of Somatic Symptoms among Child and Adolescents with Probable Posttraumatic Stress Disorder: A Cross-Sectional Study Conducted in 21 Primary and Secondary Schools after an Earthquake	PLOS ONE			English	Article							WORLD-TRADE-CENTER; UNEXPLAINED PHYSICAL SYMPTOMS; PATIENT HEALTH QUESTIONNAIRE; CHRONIC-FATIGUE-SYNDROME; NEW-YORK-CITY; PSYCHIATRIC-DISORDERS; PSYCHOLOGICAL TRAUMA; WENCHUAN EARTHQUAKE; TERRORIST ATTACKS; CHRONIC PAIN	Purpose To explore the prevalence rates and predictors of somatic symptoms among child and adolescent survivors with probable posttraumatic stress disorder (PTSD) after an earthquake. Methods A total of 3053 students from 21 primary and secondary schools in Baoxing County were administered the Patient Health Questionnaire-13 (PHQ-13), a short version of PHQ-15 without the two items about sexuality and menstruation, the Children's Revised Impact of Event Scale (CRIES), and the self-made Earthquake-Related Experience Questionnaire 3 months after the Lushan earthquake. Results Among child and adolescent survivors, the prevalence rates of all somatic symptoms were higher in the probable PTSD group compared with the controls. The most frequent somatic symptoms were trouble sleeping (83.2%), feeling tired or having low energy (74.4%), stomach pain (63.2%), dizziness (58.1%), and headache (57.7%) in the probable PTSD group. Older age, having lost family members, having witnessed someone get seriously injured, and having witnessed someone get buried were predictors for somatic symptoms among child and adolescent survivors with probable PTSD. Conclusions Somatic symptoms among child and adolescent earthquake survivors with probable PTSD in schools were common, and predictors of these somatic symptoms were identified. These findings may help those providing psychological health programs to find the child and adolescent students with probable PTSD who are at high risk of somatic symptoms in schools after an earthquake in China.	[Zhang, Ye; Zhang, Jun; Zhang, Wei] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu 610064, Sichuan, Peoples R China; [Zhu, Shenyue] Baoxing Cty Educ Bur, Educ Supervis Dept, Yaan, Sichuan, Peoples R China; [Du, Changhui] Chengdu Ctr Dis Control, Sci & Educ Informat Dept, Chengdu, Sichuan, Peoples R China	Sichuan University	Zhang, J (corresponding author), Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu 610064, Sichuan, Peoples R China.	zh2000jun2000@163.com; weizhang27@163.com		Zhang, Ye/0000-0002-6715-7884	Post-disaster Emergency Program of Sichuan University [2013SCU190]	Post-disaster Emergency Program of Sichuan University	This research was supported by the Post-disaster Emergency Program of Sichuan University (Grant number. 2013SCU190). The funders had no role in study design, data collection and analysis.	Afari N, 2014, PSYCHOSOM MED, V76, P2, DOI 10.1097/PSY.0000000000000010; Andreski P, 1998, PSYCHIAT RES, V79, P131, DOI 10.1016/S0165-1781(98)00026-2; Asmundson GJG, 2009, DEPRESS ANXIETY, V26, P888, DOI 10.1002/da.20600; Boscarino JA, 1999, ANN BEHAV MED, V21, P227, DOI 10.1007/BF02884839; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Burton C, 2003, BRIT J GEN PRACT, V53, P231; Cheng YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096644; Drossman DA, 1998, PSYCHOSOM MED, V60, P258, DOI 10.1097/00006842-199805000-00007; Egger HL, 1999, J AM ACAD CHILD PSY, V38, P852, DOI 10.1097/00004583-199907000-00015; Eglinton R, 2011, PSYCHIAT RES, V188, P245, DOI 10.1016/j.psychres.2011.04.012; Escobar JI, 2002, ENVIRON HEALTH PERSP, V110, P631, DOI 10.1289/ehp.02110s4631; Fagan J, 2003, PSYCHOSOM MED, V65, P993, DOI 10.1097/01.PSY.0000097334.48556.5F; Fu Y, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-1; Germain A, 2008, SLEEP MED REV, V12, P185, DOI 10.1016/j.smrv.2007.09.003; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Gureje Oye, 2008, Curr Psychiatry Rep, V10, P318, DOI 10.1007/s11920-008-0051-0; Hensley L, 2008, J CLIN CHILD ADOLESC, V37, P542, DOI 10.1080/15374410802148186; Interian A, 2006, PSYCHOSOMATICS, V47, P392, DOI 10.1176/appi.psy.47.5.392; [景璐石 Jing Lushi], 2010, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V19, P654; Katon W, 2001, ANN INTERN MED, V134, P917, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00017; Kulich R J, 2000, Curr Rev Pain, V4, P36; Lee S, 2011, J PSYCHOSOM RES, V71, P69, DOI 10.1016/j.jpsychores.2011.01.016; Li JH, 2011, AM J GASTROENTEROL, V106, P1933, DOI 10.1038/ajg.2011.300; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Maher MJ, 2006, CNS DRUGS, V20, P567, DOI 10.2165/00023210-200620070-00003; Mason HJ, 2000, AM J GASTROENTEROL, V95, P2852, DOI 10.1016/S0002-9270(00)01105-9; McGeary D, 2011, J CLIN PSYCHOL MED S, V18, P155, DOI 10.1007/s10880-011-9236-5; Munyandamutsa N, 2012, SOC PSYCH PSYCH EPID, V47, P1753, DOI 10.1007/s00127-012-0494-9; Nater UM, 2011, PSYCHIAT RES, V189, P318, DOI 10.1016/j.psychres.2011.07.015; Osorio C, 2012, MIL MED, V177, P957, DOI 10.7205/MILMED-D-12-00024; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Paras ML, 2009, JAMA-J AM MED ASSOC, V302, P550, DOI 10.1001/jama.2009.1091; Peres JFP, 2009, CURR PAIN HEADACHE R, V13, P350, DOI 10.1007/s11916-009-0057-2; Perrin S, 2005, BEHAV COGN PSYCHOTH, V33, P487, DOI 10.1017/S1352465805002419; Poikolainen K, 2000, ARCH DIS CHILD, V83, P388, DOI 10.1136/adc.83.5.388; Roelofs K, 2007, CLIN PSYCHOL REV, V27, P798, DOI 10.1016/j.cpr.2007.07.004; Ross Colin A, 2005, J Child Sex Abus, V14, P27, DOI 10.1300/J070v14n01_02; Ruchkin V, 2014, J YOUTH ADOLESCENCE, V43, P834, DOI 10.1007/s10964-013-9966-9; Sareen J, 2007, PSYCHOSOM MED, V69, P242, DOI 10.1097/PSY.0b013e31803146d8; Savas LS, 2009, ALIMENT PHARM THER, V29, P115, DOI 10.1111/j.1365-2036.2008.03847.x; SCHWARZ ED, 1994, PSYCHIAT CLIN N AM, V17, P311; Sharp Timothy J, 2004, Curr Pain Headache Rep, V8, P111, DOI 10.1007/s11916-004-0024-x; Spinhoven P, 2006, PSYCHOSOM MED, V68, P605, DOI 10.1097/01.psy.0000222367.88642.de; Staab JP, 2006, CURR OPIN NEUROL, V19, P41, DOI 10.1097/01.wco.0000198102.95294.1f; Stam R, 1997, GUT, V40, P704, DOI 10.1136/gut.40.6.704; Sun XY, 2014, INT J BEHAV MED, V21, P730, DOI 10.1007/s12529-013-9377-z; Tang BH, 2014, PSYCHIAT RES, V220, P384, DOI 10.1016/j.psychres.2014.07.050; Tang BH, 2013, LANCET, V381, P1984, DOI 10.1016/S0140-6736(13)61201-5; Taylor DC, 1996, J AM ACAD CHILD PSY, V35, P491, DOI 10.1097/00004583-199604000-00015; Toblin RL, 2012, J AFFECT DISORDERS, V136, P469, DOI 10.1016/j.jad.2011.10.048; Wu KK, 2003, SOC PSYCH PSYCH EPID, V38, P94, DOI 10.1007/s00127-003-0611-x; Ying LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089401; Zhou XB, 2013, COMPR PSYCHIAT, V54, P493, DOI 10.1016/j.comppsych.2012.12.010; Zhou XB, 2013, SOC PSYCH PSYCH EPID, V48, P907, DOI 10.1007/s00127-012-0596-4; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	55	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137101	10.1371/journal.pone.0137101	http://dx.doi.org/10.1371/journal.pone.0137101			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26327455	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700096
J	Shitara, H; Shimoyama, D; Sasaki, T; Hamano, N; Ichinose, T; Yamamoto, A; Kobayashi, T; Osawa, T; Iizuka, H; Hanakawa, T; Tsushima, Y; Takagishi, K				Shitara, Hitoshi; Shimoyama, Daisuke; Sasaki, Tsuyoshi; Hamano, Noritaka; Ichinose, Tsuyoshi; Yamamoto, Atsushi; Kobayashi, Tsutomu; Osawa, Toshihisa; Iizuka, Haku; Hanakawa, Takashi; Tsushima, Yoshito; Takagishi, Kenji			The Neural Correlates of Shoulder Apprehension: A Functional MRI Study	PLOS ONE			English	Article							HUMAN AMYGDALA; EXTINCTION; HUMANS; FEAR; HIPPOCAMPUS; INSTABILITY; KNOWLEDGE; MONKEYS	Although shoulder apprehension is an established clinical finding and is important for the prevention of shoulder dislocation, how this subjective perception is evoked remains unclear. We elucidated the functional neuroplasticity associated with apprehension in patients with recurrent anterior shoulder instability (RSI) using functional magnetic resonance imaging (fMRI). Twelve healthy volunteers and 14 patients with right-sided RSI performed a motor imagery task and a passive shoulder motion task. Brain activity was compared between healthy participants and those with RSI and was correlated with the apprehension intensity reported by participants after each task. Compared to healthy volunteers, participants with RSI exhibited decreased brain activity in the motor network, but increased activity in the hippocampus and amygdala. During the passive motion task, participants with RSI exhibited decreased activity in the left premotor and primary motor/somatosensory areas. Furthermore, brain activity was correlated with apprehension intensity in the left amygdala and left thalamus during the motor imagery task (memory-induced), while a correlation between apprehension intensity and brain activity was found in the left prefrontal cortex during the passive motion task (instability-induced). Our findings provide insight into the pathophysiology of RSI by identifying its associated neural alterations. We elucidated that shoulder apprehension was induced by two different factors, namely instability and memory.	[Shitara, Hitoshi; Shimoyama, Daisuke; Sasaki, Tsuyoshi; Hamano, Noritaka; Ichinose, Tsuyoshi; Yamamoto, Atsushi; Iizuka, Haku; Takagishi, Kenji] Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gunma, Japan; [Kobayashi, Tsutomu] Takasaki Univ Hlth & Welf, Dept Phys Therapy, Takasaki, Gunma, Japan; [Osawa, Toshihisa] Natl Hosp Org, Takasaki Gen Med Ctr, Dept Orthopaed Surg, Takasaki, Gunma, Japan; [Hanakawa, Takashi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Dept Adv Neuroimaging, Kodaira, Tokyo, Japan; [Tsushima, Yoshito] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 371, Japan	Gunma University; National Center for Neurology & Psychiatry - Japan; Gunma University	Shitara, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gunma, Japan.	hshitara@gunma-u.ac.jp	一ノ瀬, 剛/HDM-5592-2022; Shitara, Hitoshi/AAS-7991-2020; Hanakawa, Takashi/AEU-7951-2022	Shitara, Hitoshi/0000-0003-3547-0718; 	Nakatomi foundation Grand for medical and pharmacological research	Nakatomi foundation Grand for medical and pharmacological research	This work was supported by Nakatomi foundation Grand for medical and pharmacological research (https://www.nakatomi.or.jp/en/index.html), Award number: None; Recipient: Hitoshi Shitara. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1995, J NEUROSCI, V15, P5879; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Carel C, 2000, J CEREBR BLOOD F MET, V20, P478, DOI 10.1097/00004647-200003000-00006; Dodson CC, 2008, ORTHOP CLIN N AM, V39, P507, DOI 10.1016/j.ocl.2008.06.001; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; HALGREN E, 1978, BRAIN, V101, P83, DOI 10.1093/brain/101.1.83; Haller S, 2014, AM J NEURORADIOL, V35, P691, DOI 10.3174/ajnr.A3738; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hirnstein M, 2011, NEUROPSYCHOLOGIA, V49, P29, DOI 10.1016/j.neuropsychologia.2010.10.028; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; Jobe F W, 1989, Orthop Rev, V18, P963; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; Ketter TA, 1996, ARCH GEN PSYCHIAT, V53, P59; Kluver H, 1997, J NEUROPSYCH CLIN N, V9, P606; Lorey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020368; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Owens BD, 2014, AM J SPORT MED, V42, P2591, DOI 10.1177/0363546514551149; Owens BD, 2011, ORTHOPEDICS, V34, P460, DOI 10.3928/01477447-20110427-21; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; ROWE C R, 1961, Clin Orthop, V20, P40; ROWE CR, 1981, J BONE JOINT SURG AM, V63, P863, DOI 10.2106/00004623-198163060-00001; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Walch G, 1996, J BONE JOINT SURG BR, V78B, P670, DOI 10.1302/0301-620X.78B4.0780670; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009; Whalen PJ, 1998, J NEUROSCI, V18, P411	28	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137387	10.1371/journal.pone.0137387	http://dx.doi.org/10.1371/journal.pone.0137387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351854	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800080
J	Arminjon, M; Chamseddine, A; Kopta, V; Paunovic, A; Mohr, C				Arminjon, Mathieu; Chamseddine, Amer; Kopta, Vladimir; Paunovic, Aleksandar; Mohr, Christine			Are We Modular Lying Cues Detectors? The Answer Is "Yes, Sometimes"	PLOS ONE			English	Article							FACIAL FEATURES; EVOLUTION; ACCURACY; TRUSTWORTHINESS; INTERNET; FACES	We quickly form first impressions about newly encountered people guiding our subsequent behaviour (approach, avoidance). Such instant judgments might be innate and automatic, being performed unconsciously and independently to other cognitive processes. Lying detection might be subject to such a modular process. Unfortunately, numerous studies highlighted problems with lying detection paradigms such as high error rates and learning effects. Additionally, humans should be motivated doing both detecting others' lies and disguising own lies. Disguising own lies might even be more challenging than detecting other people's lies. Thus, when trying to disguise cheating behaviour, liars might display a mixture of disguising (fake) trust cues and uncontrolled lying cues making the interpretation of the expression difficult (perceivers are guessing). In two consecutive online studies, we tested whether seeing an increasing amount (range 0-4) of lying cues (LC) and non-lying cues (NLC) on a standard face results in enhanced guessing behaviour (studies 1 and 2) and that enhanced guessing is accompanied by slower responding (study 2). Results showed that pronounced guessing and slowest responding occurred for faces with an intermediate number and not with the highest number of LC and NLC. In particular, LC were more important than NLC to uncertain lying decisions. Thus, only a few LC may interfere with automatic processing of lying detection (irrespective of NLC), probably because too little lying cue information is yet available.	[Arminjon, Mathieu] Univ Geneva, Dept Psychiat, Agalma Fdn, Geneva, Switzerland; [Chamseddine, Amer] Ecole Polytech Fed Lausanne, Dependable Syst Lab, CH-1015 Lausanne, Switzerland; [Kopta, Vladimir] Ecole Polytech Fed Lausanne, Lab Elect & Elect Engn, CH-1015 Lausanne, Switzerland; [Paunovic, Aleksandar] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci I&C, CH-1015 Lausanne, Switzerland; [Mohr, Christine] Fac Social & Polit Sci, Inst Psychol, CH-1015 Lausanne, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Arminjon, M (corresponding author), Univ Geneva, Dept Psychiat, Agalma Fdn, Geneva, Switzerland.	Mathieu.Arminjon@unige.ch	Arminjon, Mathieu/GQQ-9159-2022	/0000-0003-2254-8555; Mohr, Christine/0000-0002-3720-7115				Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Bond CF, 2006, PERS SOC PSYCHOL REV, V10, P214, DOI 10.1207/s15327957pspr1003_2; Bonnefon JF, 2013, J EXP PSYCHOL GEN, V142, P143, DOI 10.1037/a0028930; Buller DB, 1996, COMMUN THEOR, V6, P203, DOI 10.1111/j.1468-2885.1996.tb00127.x; Cabin RJ., 2000, B ECOL SOC AM, V81, P246, DOI [DOI 10.2307/20168454, 10.2307/20168454]; CHENG PW, 1989, COGNITION, V33, P285, DOI 10.1016/0010-0277(89)90031-0; Chiappe D., 2004, EVOLUTIONARY PSYCHOL, V2, P108, DOI DOI 10.1177/147470490400200117; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P163; Cosmides L., 2005, HDB EVOLUTIONARY PSY, P584; De Neys W, 2013, BIOL LETT, V9, P143; De Neys W, 2015, J ECON PSYCHOL, V47, P17, DOI 10.1016/j.joep.2015.01.002; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; EKMAN P, 1991, J NONVERBAL BEHAV, V15, P125, DOI 10.1007/BF00998267; Ekman P, 1999, PSYCHOL SCI, V10, P263, DOI 10.1111/1467-9280.00147; Fodor J, 1983, MODULARITY MIND; FRANK RH, 1993, ETHOL SOCIOBIOL, V14, P247, DOI 10.1016/0162-3095(93)90020-I; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Kovacs-Balint Z, 2013, BRIT J PSYCHOL, V104, P563, DOI 10.1111/bjop.12007; Lewis I, 2009, AUST J PSYCHOL, V61, P107, DOI 10.1080/00049530802105865; Little AC, 2013, PERS INDIV DIFFER, V54, P507, DOI 10.1016/j.paid.2012.10.018; MANDERSCHEID LV, 1965, J FARM ECON, V47, P1381, DOI 10.2307/1236396; Manson JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082531; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Okubo M, 2012, J NONVERBAL BEHAV, V36, P217, DOI 10.1007/s10919-012-0134-9; Paas F, 2003, EDUC PSYCHOL-US, V38, P63, DOI 10.1207/S15326985EP3801_8; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Schaller M., 2008, 1 IMPRESSIONS, P15; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Sell A, 2003, ENCY COGNITIVE SCI, P47; Skitka LJ, 2006, ANNU REV PSYCHOL, V57, P529, DOI 10.1146/annurev.psych.57.102904.190048; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Tognetti A, 2013, EVOL HUM BEHAV, V34, P427, DOI 10.1016/j.evolhumbehav.2013.08.002; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Lier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053827; Vanneste S, 2007, EVOL HUM BEHAV, V28, P272, DOI 10.1016/j.evolhumbehav.2007.02.005; Verplaetse J, 2007, EVOL HUM BEHAV, V28, P260, DOI 10.1016/j.evolhumbehav.2007.04.006; von Hippel W, 2011, BEHAV BRAIN SCI, V34, DOI 10.1017/S0140525X10001354	40	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136418	10.1371/journal.pone.0136418	http://dx.doi.org/10.1371/journal.pone.0136418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ8YQ	26349057	Green Published, gold			2022-12-27	WOS:000360897600007
J	Utsunomiya, YT; Ribeiro, ES; Quintal, APN; Sangalli, JR; Gazola, VR; Paula, HB; Trinconi, CM; Lima, VMF; Perri, SHV; Taylor, JF; Schnabel, RD; Sonstegard, TS; Garcia, JF; Nunes, CM				Utsunomiya, Yuri T.; Ribeiro, Erica S.; Quintal, Amanda P. N.; Sangalli, Juliano R.; Gazola, Valquiria R.; Paula, Henrique B.; Trinconi, Cristiana M.; Lima, Valeria M. F.; Perri, Silvia H. V.; Taylor, Jeremy F.; Schnabel, Robert D.; Sonstegard, Tad S.; Garcia, Jose F.; Nunes, Caris M.			Genome-Wide Scan for Visceral Leishmaniasis in Mixed-Breed Dogs Identifies Candidate Genes Involved in T Helper Cells and Macrophage Signaling	PLOS ONE			English	Article							CANINE LEISHMANIASIS; INTERFERON; GAMMA; AREA	We conducted a genome-wide scan for visceral leishmaniasis in mixed-breed dogs from a highly endemic area in Brazil using 149,648 single nucleotide polymorphism (SNP) markers genotyped in 20 cases and 28 controls. Using a mixed model approach, we found two candidate loci on canine autosomes 1 and 2. The positional association on chromosome 2 mapped to a predicted DNAse sensitive site in CD14+ monocytes that serve as a cis-regulatory element for the expression of interleukin alpha receptors 2 (IL2RA) and 15 (IL15RA). Both interleukins were previously found to lead to protective T helper 1 cell (Th1) response against Leishmania spp. in humans and mice. The associated marker on chromosome 1 was located between two predicted transcription factor binding sites regulating the expression of the transducin-like enhancer of split 1 gene (TLE1), an important player in Notch signaling. This pathway is critical for macrophage activity and CD4+ T cell differentiation into Th1 and T helper 2. Together, these findings suggest that the human and mouse model for protective response against Leishmania spp., which involves Th1 and macrophage modulation by interleukins 2, 15, gamma interferon and Notch signaling, may also hold for the canine model.	[Utsunomiya, Yuri T.; Garcia, Jose F.] UNESP Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Med Vet Prevent & Reprod Anim, Sao Paulo, Brazil; [Ribeiro, Erica S.; Quintal, Amanda P. N.; Sangalli, Juliano R.; Gazola, Valquiria R.; Paula, Henrique B.; Trinconi, Cristiana M.; Lima, Valeria M. F.; Perri, Silvia H. V.; Garcia, Jose F.; Nunes, Caris M.] UNESP Univ Estadual Paulista, Fac Med Vet Aracatuba, Dept Apoio Saude & Prod Anim, Sao Paulo, Brazil; [Taylor, Jeremy F.; Schnabel, Robert D.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Sonstegard, Tad S.] USDA ARS, Anim Genom & Improvement Lab, Beltsville, MD USA	Universidade Estadual Paulista; Universidade Estadual Paulista; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA)	Nunes, CM (corresponding author), UNESP Univ Estadual Paulista, Fac Med Vet Aracatuba, Dept Apoio Saude & Prod Anim, Sao Paulo, Brazil.	caris@fmva.unesp.br	Sangalli, Juliano Rodrigues/C-1834-2013; Nunes, Caris M/R-9337-2016; de Melo Trinconi Tronco, Cristiana/N-5208-2015; de Lima, Valéria M.F./B-7867-2013; Utsunomiya, Yuri Tani T/K-5214-2013	Nunes, Caris M/0000-0002-5463-3845; de Melo Trinconi Tronco, Cristiana/0000-0003-3493-7339; de Lima, Valéria M.F./0000-0002-0954-5045; Utsunomiya, Yuri Tani T/0000-0002-6526-8337	Sao Paulo Research Foundation (FAPESP) [2014/01095-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	YTU is supported by a scholarship from the Sao Paulo Research Foundation (FAPESP-http://www.fapesp.br/) (process 2014/01095-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; Altet L, 2002, INFECT IMMUN, V70, P2763, DOI 10.1128/IAI.70.6.2763-2771.2002; Auderset F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002560; CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209; D'Agostino P, 2004, SCAND J IMMUNOL, V60, P609, DOI 10.1111/j.0300-9475.2004.01522.x; de Lima VMF, 2005, PESQUISA VET BRASIL, V25, P215, DOI 10.1590/S0100-736X2005000400005; Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518; Franca-Silva JC, 2003, VET PARASITOL, V111, P161, DOI 10.1016/S0304-4017(02)00351-5; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Larabee JL, 2013, J BIOL CHEM, V288, P21526, DOI 10.1074/jbc.M113.465120; Milano S, 2002, CLIN EXP IMMUNOL, V127, P360, DOI 10.1046/j.1365-2249.2002.01749.x; Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005; Quilez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035349; Quinnell RJ, 2003, IMMUNOGENETICS, V55, P23, DOI 10.1007/s00251-003-0545-1; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; RODGERS MR, 1990, EXP PARASITOL, V71, P267, DOI 10.1016/0014-4894(90)90031-7; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Robert E, 2005, J HERED, V96, P755, DOI 10.1093/jhered/esi111; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; World Health Organization, 2010, CONTR LEISHM REP M W	20	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136749	10.1371/journal.pone.0136749	http://dx.doi.org/10.1371/journal.pone.0136749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348501	Green Submitted, Green Published, gold			2022-12-27	WOS:000360897600011
J	Verma, V; Mallik, L; Hariadi, RF; Sivaramakrishnan, S; Skiniotis, G; Joglekar, AP				Verma, Vikash; Mallik, Leena; Hariadi, Rizal F.; Sivaramakrishnan, Sivaraj; Skiniotis, Georgios; Joglekar, Ajit P.			Using Protein Dimers to Maximize the Protein Hybridization Efficiency with Multisite DNA Origami Scaffolds	PLOS ONE			English	Article							KINETOCHORE-MICROTUBULE ATTACHMENT; NANOSCALE SHAPES; FOLDING DNA; NANOSTRUCTURES; ARCHITECTURE; PURIFICATION; COMPLEX	DNA origami provides a versatile platform for conducting 'architecture-function' analysis to determine how the nanoscale organization of multiple copies of a protein component within a multi-protein machine affects its overall function. Such analysis requires that the copy number of protein molecules bound to the origami scaffold exactly matches the desired number, and that it is uniform over an entire scaffold population. This requirement is challenging to satisfy for origami scaffolds with many protein hybridization sites, because it requires the successful completion of multiple, independent hybridization reactions. Here, we show that a cleavable dimerization domain on the hybridizing protein can be used to multiplex hybridization reactions on an origami scaffold. This strategy yields nearly 100% hybridization efficiency on a 6-site scaffold even when using low protein concentration and short incubation time. It can also be developed further to enable reliable patterning of a large number of molecules on DNA origami for architecture-function analysis.	[Verma, Vikash; Hariadi, Rizal F.; Sivaramakrishnan, Sivaraj; Joglekar, Ajit P.] Univ Michigan, Sch Med, Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Mallik, Leena; Skiniotis, Georgios] Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI USA; [Mallik, Leena; Skiniotis, Georgios] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Joglekar, AP (corresponding author), Univ Michigan, Sch Med, Cell & Dev Biol, Ann Arbor, MI 48109 USA.	ajitj@umich.edu	Verma, Vikash/AAU-6550-2020; Mallik, Leena/AAM-4619-2020	Verma, Vikash/0000-0003-2371-4164; Joglekar, Ajit/0000-0002-0607-5332; Hariadi, Rizal/0000-0001-7840-859X; Skiniotis, Georgios/0000-0003-0238-7846	National Institute of General Medical Sciences [R01-GM105948]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105948] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant R01-GM105948 to APJ.	Aravamudhan P, 2015, NAT CELL BIOL, V17, P868, DOI 10.1038/ncb3179; Aravamudhan P, 2014, CURR BIOL, V24, P1437, DOI 10.1016/j.cub.2014.05.014; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Hariadi RF, 2014, P NATL ACAD SCI USA, V111, P4091, DOI 10.1073/pnas.1315923111; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lin CX, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1070; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050; Meyer R, 2015, SMALL, V11, P2669, DOI 10.1002/smll.201403544; Mutch SA, 2007, BIOPHYS J, V92, P2926, DOI 10.1529/biophysj.106.101428; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Shaw A, 2015, ACS NANO, V9, P4968, DOI 10.1021/nn507035g; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]	18	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137125	10.1371/journal.pone.0137125	http://dx.doi.org/10.1371/journal.pone.0137125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348722	Green Submitted, Green Published, gold			2022-12-27	WOS:000360897600022
J	Alshabanat, A; Zafari, Z; Albanyan, O; Dairi, M; FitzGerald, JM				Alshabanat, A.; Zafari, Z.; Albanyan, O.; Dairi, M.; FitzGerald, J. M.			Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; LUNG-DISEASE; CLINICAL PHENOTYPES; NEVER-SMOKERS; FOLLOW-UP; PREVALENCE; BURDEN; INFLAMMATION; NONSMOKERS	Background The combination of asthma and chronic obstructive pulmonary disease (COPD), or ACOS is a recently defined syndrome. The epidemiology of the condition is poorly described and previous research has suggested ACOS is associated with worse outcomes than either condition alone. We therefore decided to complete a systematic review of the published literature. Methods This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A structured search was performed in the PubMed, Embase, and Medline databases up to Feb 2015 to identify studies reporting incidence, prevalence, health care utilization, morbidity, or mortality in COPD and asthma. Results A total of 19 studies were included in the present study. The pooled prevalence of overlap among COPD was 27% (95% CI: 0.16-0.38, p<0.0001) and 28% (95% CI: 0.09-0.47, p = 0.0032) in the population and hospital-based studies, respectively. We found no significant difference between ACOS and COPD in terms of gender, smoking status, lung function and 6mWD. However, in comparison to subject with only COPD, ACOS subjects were significantly younger, had higher BMI, healthcare utilization, and lower HRQoL. Conclusion ACOS is a common condition that exists in a substantial proportion of subjects with COPD. ACOS represents a distinct clinical phenotype with more frequent exacerbations, hospitalization, worse health-related quality of life, and higher healthcare costs than either disease alone. There is a critical need to better define the management and treatment of this syndrome.	[Alshabanat, A.] Univ British Columbia, Dept Expt Med, Vancouver, BC V5Z 1M9, Canada; [Zafari, Z.; FitzGerald, J. M.] Vancouver Coastal Hlth Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Albanyan, O.] King Fahad Specialist Hosp, Dept Med, Dammam, Saudi Arabia; [Dairi, M.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [FitzGerald, J. M.] Univ British Columbia, Fac Med, IHLH, Vancouver, BC, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia	Alshabanat, A (corresponding author), Lung Ctr, 2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.	Abalshabanat@gmail.com	albanyan, omar/GQH-4369-2022					Andersen H, 2013, CLIN RESPIR J, V7, P342, DOI 10.1111/crj.12013; [Anonymous], 2014, ASTHMA; Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; Blanchette CM, 2008, J MANAGE CARE PHARM, V14, P176, DOI 10.18553/jmcp.2008.14.2.176; Bridevaux PO, 2010, EUR RESPIR J, V36, P1259, DOI 10.1183/09031936.00004110; Danielsson P, 2012, CLIN RESPIR J, V6, P120, DOI 10.1111/j.1752-699X.2011.00257.x; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Diaz-Guzman E, 2011, COPD, V8, P400, DOI 10.3109/15412555.2011.611200; Fabbri LM, 2003, AM J RESP CRIT CARE, V167, P418, DOI 10.1164/rccm.200203-183OC; Fu JJ, 2014, ALLERGY ASTHMA IMMUN, V6, P316, DOI 10.4168/aair.2014.6.4.316; Gershon A, 2012, J ALLERGY CLIN IMMUN, V129, P679, DOI 10.1016/j.jaci.2011.11.014; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Global Initiative for Asthma (GINA), 2014, GLOB STRAT ASTHM MAN; GOLD, 2011, GLOB STRAT DIAGN MAN; Hagstad S, 2012, RESP MED, V106, P980, DOI 10.1016/j.rmed.2012.03.010; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Jeffery Peter K, 2004, Proc Am Thorac Soc, V1, P176, DOI 10.1513/pats.200402-009MS; Johannessen A, 2005, INT J TUBERC LUNG D, V9, P926; Jyrki-Tapani Kotaniemi, 2005, COPD, V2, P331; Kauppi P, 2011, J ASTHMA, V48, P279, DOI 10.3109/02770903.2011.555576; Lamprecht B, 2008, RESP MED, V102, P1833, DOI 10.1016/j.rmed.2008.07.007; Lim HS, 2014, ANN ALLERG ASTHMA IM, V113, P652, DOI 10.1016/j.anai.2014.08.021; Izquierdo-Alonso JL, 2013, RESP MED, V107, P724, DOI 10.1016/j.rmed.2013.01.001; Lundback B, 2009, COPD, V6, P263, DOI 10.1080/15412550903061483; Magnussen H, 2008, RESP MED, V102, P50, DOI 10.1016/j.rmed.2007.08.003; Mapel Douglas W, 2007, COPD, V4, P127, DOI 10.1080/15412550701341111; Marsh SE, 2008, THORAX, V63, P761, DOI 10.1136/thx.2007.089193; Martinez FJ, 2005, POSTGRAD MED, V117, P19, DOI 10.3810/pgm.2005.03.1593; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Methvin JN, 2009, CHEST, V135, P102, DOI 10.1378/chest.08-1315; Meyer PA, 2002, CHEST, V122, P2003, DOI 10.1378/chest.122.6.2003; Miravitiles M, 2013, EUR RESPIR J, V41, P1252, DOI 10.1183/09031936.00118912; Miravitlles M, 2013, RESP MED, V107, P1053, DOI 10.1016/j.rmed.2013.03.007; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Panizza JA, 2006, INTERN MED J, V36, P773, DOI 10.1111/j.1445-5994.2006.01214.x; Pereira LMP, 2007, INT J TUBERC LUNG D, V11, P1026; Rhee CK, 2014, COPD, V11, P163, DOI 10.3109/15412555.2013.831061; Shahab L, 2006, THORAX, V61, P1043, DOI 10.1136/thx.2006.064410; Shaya FT, 2008, CHEST, V134, P14, DOI 10.1378/chest.07-2317; Shirtcliffe P, 2012, INTERN MED J, V42, P83, DOI 10.1111/j.1445-5994.2010.02238.x; Silva GE, 2004, CHEST, V126, P59, DOI 10.1378/chest.126.1.59; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; Soriano JB, 2002, EUR RESPIR J, V20, P819, DOI 10.1183/09031936.02.00301302; Vasankari TM, 2010, EUR RESPIR J, V36, P766, DOI 10.1183/09031936.00178109; Wells G.A., NEWCASTLE OTTAWA SCA; Zhou Y, 2009, EUR RESPIR J, V33, P509, DOI 10.1183/09031936.00084408	46	172	174	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136065	10.1371/journal.pone.0136065	http://dx.doi.org/10.1371/journal.pone.0136065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336076	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400008
J	Dupe, A; Dumas, C; Papadopoulou, B				Dupe, Aurelien; Dumas, Carole; Papadopoulou, Barbara			Differential Subcellular Localization of Leishmania Alba-Domain Proteins throughout the Parasite Development	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; RNA-BINDING PROTEIN; TRYPANOSOMA-BRUCEI; GENE-EXPRESSION; PROTEOMIC ANALYSIS; SACCHAROMYCES-CEREVISIAE; PLASMODIUM-FALCIPARUM; ARGININE METHYLATION; CRYSTAL-STRUCTURE; AMASTIGOTE FORMS	Alba-domain proteins are RNA-binding proteins found in archaea and eukaryotes and recently studied in protozoan parasites where they play a role in the regulation of virulence factors and stage-specific proteins. This work describes in silico structural characterization, cellular localization and biochemical analyses of Alba-domain proteins in Leishmania infantum. We show that in contrast to other protozoa, Leishmania have two Alba-domain proteins, LiAlba1 and LiAlba3, representative of the Rpp20- and the Rpp25-like eukaryotic subfamilies, respectively, which share several sequence and structural similarities but also important differences with orthologs in other protozoa, especially in sequences targeted for post-translational modifications. LiAlba1 and LiAlba3 proteins form a complex interacting with other RNA-binding proteins, ribosomal subunits, and translation factors as supported by co-immunoprecipitation and sucrose gradient sedimentation analysis. A higher co-sedimentation of Alba proteins with ribosomal subunits was seen upon conditions of decreased translation, suggesting a role of these proteins in translational repression. The Leishmania Alba-domain proteins display differential cellular localization throughout the parasite development. In the insect promastigote stage, Alba proteins co-localize predominantly to the cytoplasm but they translocate to the nucleolus and the flagellum upon amastigote differentiation in the mammalian host and are found back to the cytoplasm once amastigote differentiation is completed. Heat-shock, a major signal of amastigote differentiation, triggers Alba translocation to the nucleolus and the flagellum. Purification of the Leishmania flagellum confirmed LiAlba3 enrichment in this organelle during amastigote differentiation. Moreover, partial characterization of the Leishmania flagellum proteome of promastigotes and differentiating amastigotes revealed the presence of other RNA-binding proteins, as well as differences in the flagellum composition between these two parasite lifestages. Shuttling of Alba-domain proteins between the cytoplasm and the nucleolus or the flagellum throughout the parasite life cycle suggests that these RNA-binding proteins participate in several distinct regulatory pathways controlling developmental gene expression in Leishmania.	[Papadopoulou, Barbara] Univ Laval, CHU Quebec Res Ctr, Res Ctr Infect Dis, Quebec City, PQ, Canada; Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ, Canada	Laval University; Laval University	Papadopoulou, B (corresponding author), Univ Laval, CHU Quebec Res Ctr, Res Ctr Infect Dis, Quebec City, PQ, Canada.	barbara.papadopoulou@crchul.ulaval.ca			Canadian Institutes of Health Research (CIHR) Strategic Training Program [STP-53924]; CIHR [MOP-12182]; 'Fonds de Recherche du Quebec-Nature et Technologies' (FRQNT)	Canadian Institutes of Health Research (CIHR) Strategic Training Program(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); 'Fonds de Recherche du Quebec-Nature et Technologies' (FRQNT)	AD was a recipient of doctoral fellowships from the Canadian Institutes of Health Research (CIHR) Strategic Training Program STP-53924 and the Centre for Host-Parasite Interactions (CHPI) supported by the 'Fonds de Recherche du Quebec-Nature et Technologies' (FRQNT). This study was supported by the CIHR operating grant MOP-12182 awarded to BP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; Alves LR, 2010, GENE, V452, P72, DOI 10.1016/j.gene.2009.12.009; Alzate JF, 2006, APOPTOSIS, V11, P161, DOI 10.1007/s10495-006-4570-z; Aravind L, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r64; Baron DM, 2007, J CELL SCI, V120, P478, DOI 10.1242/jcs.03352; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Burkard GS, 2013, MOL MICROBIOL, V88, P827, DOI 10.1111/mmi.12227; Casanova M, 2008, CELL DEATH DIFFER, V15, P1910, DOI 10.1038/cdd.2008.132; Cassola A, 2009, J BIOL CHEM, V284, P35015, DOI 10.1074/jbc.M109.031633; Chene A, 2012, NUCLEIC ACIDS RES, V40, P3066, DOI 10.1093/nar/gkr1215; Chou CC, 2003, J BACTERIOL, V185, P4066, DOI 10.1128/JB.185.14.4066-4073.2003; Choudhary MK, 2009, MOL CELL PROTEOMICS, V8, P1579, DOI 10.1074/mcp.M800601-MCP200; Clayton CE, 2014, MOL BIOCHEM PARASIT, V195, P96, DOI 10.1016/j.molbiopara.2014.06.005; Cloutier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035085; Lima TDD, 2010, EUKARYOT CELL, V9, P1484, DOI 10.1128/EC.00148-10; Daniels JP, 2010, MICROBIOL MOL BIOL R, V74, P552, DOI 10.1128/MMBR.00024-10; Dastidar EG, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-5; Dupe A, 2014, MOL MICROBIOL, V91, P548, DOI 10.1111/mmi.12478; Ferreira TR, 2014, MOL MICROBIOL, V94, P1085, DOI 10.1111/mmi.12819; Foucher AL, 2006, J PROTEOME RES, V5, P1741, DOI 10.1021/pr060081j; Gissot M, 2013, J MOL BIOL, V425, P1287, DOI 10.1016/j.jmb.2013.01.039; Gluenz E, 2010, CURR OPIN MICROBIOL, V13, P473, DOI 10.1016/j.mib.2010.05.008; Goetz SC, 2009, METHOD CELL BIOL, V94, P199, DOI 10.1016/S0091-679X(08)94010-3; Goyal M, 2012, NUCLEIC ACIDS RES, V40, P1174, DOI 10.1093/nar/gkr821; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; Hem S, 2010, PROTEOMICS, V10, P3868, DOI 10.1002/pmic.201000305; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kohl L, 2005, INT REV CYTOL, V244, P227, DOI 10.1016/S0074-7696(05)44006-1; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Kramer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-283; Kumarevel T, 2008, PROTEINS, V71, P1156, DOI 10.1002/prot.21807; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; Lefebvre M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076380; Lott K, 2013, J PROTEOMICS, V91, P210, DOI 10.1016/j.jprot.2013.07.010; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Mani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022463; Marchini FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025381; Morales MA, 2010, P NATL ACAD SCI USA, V107, P8381, DOI 10.1073/pnas.0914768107; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024184; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019920; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Padmanabhan PK, 2012, CELL DEATH DIFFER, V19, P1972, DOI 10.1038/cdd.2012.85; PAPADOPOULOU B, 1992, EMBO J, V11, P3601, DOI 10.1002/j.1460-2075.1992.tb05444.x; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Prajapati SC, 2011, FEBS J, V278, P3256, DOI 10.1111/j.1742-4658.2011.08275.x; Ramirez CA, 2013, J PROTEOMICS, V94, P124, DOI 10.1016/j.jprot.2013.09.008; Raymond F, 2012, NUCLEIC ACIDS RES, V40, P1131, DOI 10.1093/nar/gkr834; Robello C, 2000, EXP PARASITOL, V94, P129, DOI 10.1006/expr.1999.4485; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; Ruan JP, 2007, MOL BIOCHEM PARASIT, V155, P66, DOI 10.1016/j.molbiopara.2007.05.008; Sbicego S, 2003, EUKARYOT CELL, V2, P560, DOI 10.1128/EC.2.3.560-568.2003; Schmidt-Arras D, 2011, J PROTEOMICS, V74, P1644, DOI 10.1016/j.jprot.2011.03.024; Sereno D, 2006, PARASITOL RES, V100, P1, DOI 10.1007/s00436-006-0280-2; Sereno D, 1997, ANTIMICROB AGENTS CH, V41, P972, DOI 10.1128/AAC.41.5.972; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Tull D, 2004, MOL BIOL CELL, V15, P4775, DOI 10.1091/mbc.E04-06-0457; Verma JK, 2014, PHYTOCHEMISTRY, V100, P16, DOI 10.1016/j.phytochem.2014.01.015; Welting TJM, 2007, RNA, V13, P65, DOI 10.1261/rna.237807; Yoffe Y, 2004, RNA, V10, P1764, DOI 10.1261/rna.7520404; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zheng WP, 2013, EUR J MED CHEM, V59, P132, DOI 10.1016/j.ejmech.2012.11.014; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313; Zinoviev A, 2011, NUCLEIC ACIDS RES, V39, P8404, DOI 10.1093/nar/gkr555	83	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137243	10.1371/journal.pone.0137243	http://dx.doi.org/10.1371/journal.pone.0137243			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334886	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400046
J	Fereshtehnejad, SM; Shafieesabet, M; Farhadi, F; Hadizadeh, H; Rahmani, A; Naderi, N; Khaefpanah, D; Shahidi, GA; Delbari, A; Lokk, J				Fereshtehnejad, Seyed-Mohammad; Shafieesabet, Mahdiyeh; Farhadi, Farzaneh; Hadizadeh, Hasti; Rahmani, Arash; Naderi, Nader; Khaefpanah, Dena; Shahidi, Gholam Ali; Delbari, Ahmad; Lokk, Johan			Heterogeneous Determinants of Quality of Life in Different Phenotypes of Parkinson's Disease	PLOS ONE			English	Article							NUTRITIONAL-STATUS; SYMPTOMS; DEPRESSION; NONMOTOR	Objectives Health-related quality of life (HRQoL) is considered a very important outcome indicator in patients with Parkinson's disease (PD). A broad list of motor and non-motor features have been shown to affect HRQoL in PD, however, there is a dearth of information about the complexity of interrelationships between determinants of HRQoL in different PD phenotypes. We aimed to find independent determinates and the best structural model for HRQoL, also to investigate the heterogeneity in HRQoL between PD patients with different phenotypes regarding onset-age, progression rate and dominant symptom. Methods A broad spectrum of demographic, motor and non-motor characteristics were collected in 157 idiopathic PD patients, namely comorbidity profile, nutritional status, UPDRS (total items), psychiatric symptoms (depression, anxiety), fatigue and psychosocial functioning through physical examination, validated questionnaires and scales. Structural equation model (SEM) and multivariate regressions were applied to find determinants of Parkinson's disease summary index (PDSI) and different domains of HRQoL (PDQ-39). Results Female sex, anxiety, depression and UPDRS-part II scores were the significant independent determinants of PDSI. A structural model consisting of global motor, global non-motor and co-morbidity indicator as three main components was able to predict 89% of the variance in HRQoL. In older-onset and slow-progression phenotypes, the motor domain showed smaller contribution on HRQoL and the majority of its effects were mediated through non-motor features. Comorbidity component was a significant determinant of HRQoL only among older-onset and non-tremor-dominant PD patients. Fatigue was not a significant indicator of non-motor component to affect HRQoL in rapid-progression PD. Conclusions Our findings showed outstanding heterogeneities in the pattern and determinants of HRQoL among PD phenotypes. These factors should be considered during the assessments and developing personalized interventions to improve HRQOL in PD patients with different phenotypes or prominent feature.	[Fereshtehnejad, Seyed-Mohammad; Delbari, Ahmad; Lokk, Johan] Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad; Khaefpanah, Dena] Iran Univ Med Sci, FCRDC, Firoozgar Hosp, Tehran, Iran; [Shafieesabet, Mahdiyeh; Farhadi, Farzaneh; Hadizadeh, Hasti; Rahmani, Arash; Naderi, Nader] Iran Univ Med Sci, MSRC, Fac Med, Tehran, Iran; [Rahmani, Arash] Iran Univ Med Sci, Mental Hlth Res Ctr, Tehran Inst Psychiat, Sch Behav Sci & Mental Hlth, Tehran, Iran; [Shahidi, Gholam Ali] Iran Univ Med Sci, Fac Med, Dept Neurol, Movement Disorders Clin, Tehran, Iran; [Delbari, Ahmad] Univ Social Welf & Rehabil, Iranian Res Ctr Aging, Tehran, Iran; [Lokk, Johan] Karolinska Univ Hosp, Dept Geriatr Med, Stockholm, Sweden	Karolinska Institutet; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Karolinska Institutet; Karolinska University Hospital	Fereshtehnejad, SM (corresponding author), Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden.	sm.fereshtehnejad@ki.se	rahmani, arash/AAL-5457-2020; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Hadizadeh, Hasti/H-9613-2018; Delbari, Ahmad/D-8560-2017	rahmani, arash/0000-0002-2948-3478; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Hadizadeh, Hasti/0000-0002-2099-6859; Shahidi, Gholam Ali/0000-0002-3889-4973				Akbar U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124541; Berganzo K, 2014, NEUROLOGIA; Fereshtehnejad SM, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/260684; Fereshtehnejad SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091153; Fereshtehnejad SM, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/935429; Gasparoli E, 2002, NEUROL SCI, V23, pS77, DOI 10.1007/s100720200078; Ghazi L, 2015, ECOL FOOD NUTR, V54, P342, DOI 10.1080/03670244.2014.994743; Hancock G.R., 2003, J MOD APPL STAT METH, V2, P293, DOI [DOI 10.22237/JMASM/1067644980, DOI 10.22237/jmasm/1067644980]; Hinnell C, 2012, MOVEMENT DISORD, V27, P236, DOI 10.1002/mds.23961; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jones JD, 2015, J NEUROPSYCH CLIN N, V27, P213, DOI 10.1176/appi.neuropsych.13120380; Kasten M, 2012, MOVEMENT DISORD, V27, P754, DOI 10.1002/mds.24999; 홍석경, 2002, [Journal of the Korean Neurological Association, 대한신경과학회지], V20, P227; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; Lee J, 2015, WESTERN J NURS RES, V37, P1062, DOI 10.1177/0193945914528588; Li HJ, 2010, MOVEMENT DISORD, V25, P2740, DOI 10.1002/mds.23368; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Montazeri Ali, 2003, Health Qual Life Outcomes, V1, P14, DOI 10.1186/1477-7525-1-14; Nojomi M, 2010, J RES MED SCI, V15, P63; Qin ZH, 2009, PARKINSONISM RELAT D, V15, P767, DOI 10.1016/j.parkreldis.2009.05.011; Quelhas R, 2009, J NEUROPSYCH CLIN N, V21, P413, DOI 10.1176/appi.neuropsych.21.4.413; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; Rodriguez-Violante M, 2013, ARCH MED RES, V44, P110, DOI 10.1016/j.arcmed.2013.01.005; Sheard JM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0212-1; Shearer J, 2012, J NEUROL, V259, P462, DOI 10.1007/s00415-011-6202-y; Sieber BA, 2014, ANN NEUROL, V76, P469, DOI 10.1002/ana.24261; Soh SE, 2013, QUAL LIFE RES, V22, P1543, DOI 10.1007/s11136-012-0289-1; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Visser M, 2008, J NEUROL, V255, P1580, DOI 10.1007/s00415-008-0994-4; Winter Y, 2010, J NEUROL, V257, P638, DOI 10.1007/s00415-009-5389-7; Wu Y, 2014, J NEUROL SCI, V340, P144, DOI 10.1016/j.jns.2014.03.014; Zhao YJ, 2008, EUR J NEUROL, V15, P737, DOI 10.1111/j.1468-1331.2008.02178.x	33	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137081	10.1371/journal.pone.0137081	http://dx.doi.org/10.1371/journal.pone.0137081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335773	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400038
J	Gan, P; Xie, Y; Duan, WJ; Deng, Q; Yu, XL				Gan, Pei; Xie, Yan; Duan, Wenjie; Deng, Qing; Yu, Xiuli			Rumination and Loneliness Independently Predict Six-Month Later Depression Symptoms among Chinese Elderly in Nursing Homes	PLOS ONE			English	Article							PRIMARY-CARE; RISK-FACTORS; PREVALENCE; COMMUNITY; DISORDERS; RESIDENTS; QUALITY; ROLES; SCALE; MOOD	Background Previous studies conducted in Western countries independently demonstrated that loneliness and rumination are remarkable risk factors of depression among the elderly in both community and nursing homes. However, knowledge on the relationship between these three constructs among the elderly in Eastern countries is scarce. The current study aims to determine the relationship between loneliness, rumination, and depression among Chinese elderly in nursing homes. Methods A total of 71 elderly participants with an average age of 82.49 years completed this six-month longitudinal study. Physical reports indicated that none of the participants were clinically depressed before the study. At Time 1, their loneliness and rumination were measured using UCLA-8 Loneliness Scale and Ruminative Responses Scale. Six months later, the participants completed the Center for Epidemiologic Studies Depression Scale to assess depressive symptoms (Time 2). Results Multiple regression analysis revealed that both loneliness and rumination at Time 1 were the predictors of depression symptoms at Time 2 among the Chinese elderly in nursing homes. However, in the mediation analysis using PROCESS, the indirect effect between loneliness at Time 1 and depression symptoms at Time 2 was insignificant. Conclusions Results suggest that previous loneliness and rumination thinking are predictors of future depression symptoms among the Chinese elderly in nursing homes. However, the insignificant mediation further suggests that the differences between loneliness and rumination should be explored in future studies. Findings have important implications for mental health professionals in nursing homes in China.	[Gan, Pei; Xie, Yan; Deng, Qing; Yu, Xiuli] Chongqing Med Univ, Affiliated Hosp 1, Qinggang Senior Care Ctr, Chongqing, Peoples R China; [Duan, Wenjie] City Univ Hong Kong, Dept Appl Social Sci, Hong Kong, Hong Kong, Peoples R China	Chongqing Medical University; City University of Hong Kong	Xie, Y (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Qinggang Senior Care Ctr, Chongqing, Peoples R China.	zhourushui123@163.com; duan.w@outlook.com	Duan, Wenjie/C-8722-2016	Duan, Wenjie/0000-0002-1251-3685	National Key Clinical Specialties Construction Program of China (Nursing) [MOF-MOHRSS[2010]305]	National Key Clinical Specialties Construction Program of China (Nursing)	This study was supported by National Key Clinical Specialties Construction Program of China (Nursing, MOF-MOHRSS[2010]305).	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Asnani MR, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-40; Aylaz R, 2012, ARCH GERONTOL GERIAT, V55, P548, DOI 10.1016/j.archger.2012.03.006; Azam WMYWM, 2013, ASIA-PAC PSYCHIAT, V5, P134, DOI 10.1111/appy.12061; Barcelos-Ferreira R, 2013, J AFFECT DISORDERS, V150, P616, DOI 10.1016/j.jad.2013.02.024; Boorsma M, 2012, AM J GERIAT PSYCHIAT, V20, P932, DOI 10.1097/JGP.0b013e31825d08ac; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Casey DA, 2012, ASIA-PAC PSYCHIAT, V4, P160, DOI 10.1111/j.1758-5872.2012.00191.x; Cole MG, 1999, AM J PSYCHIAT, V156, P1182; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; DiTommaso E, 2004, EDUC PSYCHOL MEAS, V64, P99, DOI 10.1177/0013164403258450; Duan WJ, 2012, RES SOCIAL WORK PRAC, V22, P680, DOI 10.1177/1049731512450074; GUPTA R, 2001, J MENTAL HLTH AGING, V7, P257; Hansen NB, 2013, J HEALTH PSYCHOL, V18, P198, DOI 10.1177/1359105312440299; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; HAYS RD, 1987, J PERS ASSESS, V51, P69, DOI 10.1207/s15327752jpa5101_6; Ingersoll-Dayton B, 2010, AGING MENT HEALTH, V14, P439, DOI 10.1080/13607860903483136; JONES WH, 1985, J PERS SOC PSYCHOL, V48, P1503, DOI 10.1037/0022-3514.48.6.1503; Jongenelis K, 2004, J AFFECT DISORDERS, V83, P135, DOI 10.1016/j.jad.2004.06.001; Liu LJ, 2016, J HEALTH PSYCHOL, V21, P750, DOI 10.1177/1359105314536941; McCusker J, 2005, J AM GERIATR SOC, V53, P1344, DOI 10.1111/j.1532-5415.2005.53404.x; Mechakra-Tahiri S, 2009, INT J GERIATR PSYCH, V24, P1226, DOI 10.1002/gps.2250; Mehta M, 2008, INT J GERIATR PSYCH, V23, P238, DOI 10.1002/gps.1868; NOLENHOEKSEMA S, 1991, J PERS SOC PSYCHOL, V61, P115, DOI 10.1037/0022-3514.61.1.115; Olivera J, 2008, INT J GERIATR PSYCH, V23, P915, DOI 10.1002/gps.2004; Ostbye T, 2004, CHRONIC DIS CANADA, V26, P93; Park J, 2013, J HEALTH PSYCHOL, V18, P226, DOI 10.1177/1359105312439731; Rabins PV, 1996, J GERONTOL A-BIOL, V51, pM319, DOI 10.1093/gerona/51A.6.M319; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RUSSELL D, 1978, J PERS ASSESS, V42, P290, DOI 10.1207/s15327752jpa4203_11; Smith JM, 2009, CLIN PSYCHOL REV, V29, P116, DOI 10.1016/j.cpr.2008.10.003; Sutcliffe C, 2007, AM J GERIAT PSYCHIAT, V15, P708, DOI 10.1097/JGP.0b013e3180381537; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Tsai FJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-567; Tucker RP, 2013, PERS INDIV DIFFER, V55, P606, DOI 10.1016/j.paid.2013.05.013; Underwood M, 2013, LANCET, V382, P41, DOI 10.1016/S0140-6736(13)60649-2; Vanhalst J, 2012, J PSYCHOL, V146, P259, DOI 10.1080/00223980.2011.555433; von Hippel W, 2008, COGNITIVE THER RES, V32, P474, DOI 10.1007/s10608-006-9034-9; Wang GY, 2011, INT J GERIATR PSYCH, V26, P1162, DOI 10.1002/gps.2656; WILSON D, 1992, J PERS ASSESS, V59, P72, DOI 10.1207/s15327752jpa5901_7; Yuen ANY, 2014, PSYCHO-ONCOLOGY, V23, P412, DOI 10.1002/pon.3433; YUM JO, 1988, COMMUN MONOGR, V55, P374, DOI 10.1080/03637758809376178; Zawadzki MJ, 2013, HEALTH PSYCHOL, V32, P212, DOI 10.1037/a0029007	44	33	35	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137176	10.1371/journal.pone.0137176	http://dx.doi.org/10.1371/journal.pone.0137176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ5AJ	26334298	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400042
J	Mori, S; Kodaira, M; Ito, A; Okazaki, M; Kawaguchi, N; Hamada, Y; Takada, Y; Matsuura, N				Mori, Seiji; Kodaira, Moe; Ito, Ayano; Okazaki, Mika; Kawaguchi, Naomasa; Hamada, Yoshinosuke; Takada, Yoshikazu; Matsuura, Nariaki			Enhanced Expression of Integrin alpha v beta 3 Induced by TGF-beta Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-beta-Induced Epithelia-lMesenchymal Transition (EMT) in Mammary Epithelial Cells	PLOS ONE			English	Article							TERNARY COMPLEX-FORMATION; FIBROBLAST GROWTH-FACTORS; HUMAN LUNG FIBROBLASTS; MESENCHYMAL TRANSITION; RECEPTOR IGF1R; DIRECT BINDING; CANCER; INDUCTION; TGF-BETA-1; COOPERATION	Epithelial-to-mesenchymal transition (EMT) plays a critical role in cancer metastasis, and is regulated by growth factors such as transforming growth factor beta (TGF-beta) and fibroblast growth factors (FGF) secreted from the stromal and tumor cells. However, the role of growth factors in EMT has not been fully established. Several integrins are upregulated by TGF-beta 1 during EMT. Integrins are involved in growth factor signaling through integrin-growth factor receptor crosstalk. We previously reported that FGF1 directly binds to integrin alpha v beta 3 and the interaction was required for FGF1 functions such as cell proliferation and migration. We studied the role of alpha v beta 3 induced by TGF-beta on TGF-beta-induced EMT. Here, we describe that FGF1 augmented EMT induced by TGF-beta 1 in MCF10A and MCF12A mammary epithelial cells. TGF-beta 1 markedly amplified integrin alpha v beta 3 and FGFR1 (but not FGFR2). We studied if the enhancing effect of FGF1 on TGF-beta 1-induced EMT requires enhanced levels of both integrin alpha v beta 3 expression and FGFR1. Knockdown of beta 3 suppressed the enhancement by FGF1 of TGF-beta 1-induced EMT in MCF10A cells. Antagonists to FGFR suppressed the enhancing effect of FGF1 on EMT. Integrin-binding defective FGF1 mutant did not augment TGF-beta 1-induced EMT in MCF10A cells. These findings suggest that enhanced integrin alpha v beta 3 expression in addition to enhanced FGFR1 expression is critical for FGF1 to augment TGF-beta 1-induced EMT in mammary epithelial cells.	[Mori, Seiji; Kodaira, Moe; Ito, Ayano; Okazaki, Mika; Kawaguchi, Naomasa; Hamada, Yoshinosuke; Matsuura, Nariaki] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Mol Pathol, Suita, Osaka 5650871, Japan; [Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Biochem, Sacramento, CA 95817 USA; [Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Mol Med, Sacramento, CA 95817 USA; [Takada, Yoshikazu] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Translat Med, Taipei 11031, Taiwan	Osaka University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Taipei Medical University	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu; matsuura@sahs.med.osaka-u.ac.jp		takada, yoshikazu/0000-0001-5481-9589	Japan Society for the Promotion of Science [26460471]; NIH [CA13015, DOD W81XWH-10-1-0312]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Grant-in-Aid for Scientific Research (Grant No. 26460471) from the Japan Society for the Promotion of Science (to SM and NM) and NIH CA13015 and DOD W81XWH-10-1-0312 (to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Billottet C, 2004, MOL BIOL CELL, V15, P4725, DOI 10.1091/mbc.E04-04-0336; Billottet C, 2008, J CELL BIOCHEM, V104, P826, DOI 10.1002/jcb.21667; Blatchford DR, 1999, J CELL PHYSIOL, V181, P304, DOI 10.1002/(SICI)1097-4652(199911)181:2<304::AID-JCP12>3.0.CO;2-5; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Feng X, 2013, 2013 IEEE 7TH INTERNATIONAL CONFERENCE ON SOFTWARE SECURITY AND RELIABILITY - COMPANION (SERE-C), P1, DOI 10.1109/SERE-C.2013.24; Finlay GA, 2000, J BIOL CHEM, V275, P27650; Fischer ANM, 2007, ONCOGENE, V26, P3395, DOI 10.1038/sj.onc.1210121; Fujita M, 2013, J BIOL CHEM, V288, P19593, DOI 10.1074/jbc.M113.470872; Fujita M, 2013, J BIOL CHEM, V288, P3059, DOI 10.1074/jbc.M112.412536; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Gotzmann J, 2006, ONCOGENE, V25, P3170, DOI 10.1038/sj.onc.1209083; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Hollestelle A, 2013, BREAST CANCER RES TR, V138, P47, DOI 10.1007/s10549-013-2415-3; Hong JP, 2013, INT J MOL MED, V31, P1436, DOI 10.3892/ijmm.2013.1337; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Mamuya FA, 2012, J CELL MOL MED, V16, P445, DOI 10.1111/j.1582-4934.2011.01419.x; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mori S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057927; Moustakas A, 2012, SEMIN CANCER BIOL, V22, P446, DOI 10.1016/j.semcancer.2012.04.002; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; Ramos C, 2006, AM J PHYSIOL-LUNG C, V291, pL871, DOI 10.1152/ajplung.00019.2006; Ramos C, 2010, AM J PHYSIOL-LUNG C, V299, pL222, DOI 10.1152/ajplung.00070.2010; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Shukla MN, 2009, AM J RESP CELL MOL, V40, P643, DOI 10.1165/rcmb.2008-0217OC; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; Turner C, 2010, J THEOR BIOL, V265, P329, DOI 10.1016/j.jtbi.2010.05.024; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yamaji S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010273	50	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137486	10.1371/journal.pone.0137486	http://dx.doi.org/10.1371/journal.pone.0137486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334633	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400060
J	Su, Z; Mao, YP; OuYang, PY; Tang, J; Xie, FY				Su, Zhen; Mao, Yan-Ping; OuYang, Pu-Yun; Tang, Jie; Xie, Fang-Yun			Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic Impact	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INTENSITY-MODULATED RADIOTHERAPY; TUMOR-RELATED LEUKOCYTOSIS; PREOPERATIVE LEUKOCYTOSIS; ENDOMETRIAL CARCINOMA; PRETREATMENT LEUKOCYTOSIS; LEUKEMOID REACTION; CERVICAL-CANCER; BLADDER-CANCER; POOR-PROGNOSIS	Background This study aimed to evaluate initial hyperleukocytosis and neutrophilia as prognostic indicators in patients with nasopharyngeal carcinoma. Methods A retrospective analysis of 5,854 patients identified from a cohort of 6,035 patients diagnosed with nasopharyngeal carcinoma was performed with initial hyperleukocytosis and neutrophilia analyzed as prognostic factors. Multivariate Cox proportional hazards analyses were applied. Results Hyperleukocytosis was observed in 508 patients (8.7%). Multivariate analysis showed that initial hyperleukocytosis was an independent predictor of death (HR 1.40, 95% CI 1.15-1.70, p = 0.001), progression (HR 1.25, 95% CI 1.06-1.47, p = 0.007) and, marginally, distant metastasis (HR 1.21, 95% CI 0.97-1.52, p = 0.088). Neutrophilia was also an independent predictor of death (HR 1.46, 95% CI 1.18-1.81, p = 0.001), progression (HR 1.31, 95% CI 1.10-1.56, p = 0.003), and distant metastasis (HR 1.29, 95% CI 1.02-1.65, p = 0.036), after adjusting for prognostic factors and excluding hyperleukocytosis. Conclusion Initial hyperleukocytosis and neutrophilia were independent, poor prognostic factors and may be convenient and useful biological markers for survival of patients with nasopharyngeal carcinoma.	[Su, Zhen; Mao, Yan-Ping; OuYang, Pu-Yun; Tang, Jie; Xie, Fang-Yun] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Xie, FY (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.	xiefy@sysucc.org.cn						Adham M, 2012, CHIN J CANCER, V31, P185, DOI 10.5732/cjc.011.10328; Banerjee R, 2013, DIS COLON RECTUM, V56, P1036, DOI 10.1097/DCR.0b013e31829ab0d4; Brandau S, 2013, SEMIN CANCER BIOL, V23, P139, DOI 10.1016/j.semcancer.2013.02.008; Brandau S, 2013, SEMIN CANCER BIOL, V23, P171, DOI 10.1016/j.semcancer.2013.02.007; Cerny J, 2012, HEMATOL ONCOL CLIN N, V26, P303, DOI 10.1016/j.hoc.2012.01.001; Cetin B, 2012, ASIAN PAC J CANCER P, V13, P1059, DOI 10.7314/APJCP.2012.13.3.1059; Chakraborty A, 2006, UROLOGY, V68, P208, DOI 10.1016/j.urology.2006.01.046; Chen L, 2012, RADIOTHER ONCOL, V104, P331, DOI 10.1016/j.radonc.2011.10.009; Chen YW, 2014, BRIT J ORAL MAX SURG, V52, P425, DOI 10.1016/j.bjoms.2014.02.014; Coppin CML, 1996, J CLIN ONCOL, V14, P2901, DOI 10.1200/JCO.1996.14.11.2901; CVITKOVIC E, 1993, J CLIN ONCOL, V11, P2434, DOI 10.1200/JCO.1993.11.12.2434; Donskov F, 2013, SEMIN CANCER BIOL, V23, P200, DOI 10.1016/j.semcancer.2013.02.001; Dumitru CA, 2011, INT J CANCER, V129, P859, DOI 10.1002/ijc.25991; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Granger JM, 2009, CANCER-AM CANCER SOC, V115, P3919, DOI 10.1002/cncr.24480; Gutschalk CM, 2006, CANCER RES, V66, P8026, DOI 10.1158/0008-5472.CAN-06-0158; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Hirai K, 2001, J DERMATOL SCI, V25, P179, DOI 10.1016/S0923-1811(00)00131-6; [黄腾波 Huang Tengbo], 2002, [中华医学遗传学杂志, Chinese Journal of Medical Genetics], V19, P134; Imai Y, 2005, J GASTROEN HEPATOL, V20, P287, DOI 10.1111/j.1440-1746.2004.03575.x; Kasuga I, 2001, CANCER-AM CANCER SOC, V92, P2399, DOI 10.1002/1097-0142(20011101)92:9<2399::AID-CNCR1588>3.0.CO;2-W; Kohne CH, 2002, ANN ONCOL, V13, P308, DOI 10.1093/annonc/mdf034; Kus AB, 2014, INT J PEDIATR OTORHI, V78, P885, DOI 10.1016/j.ijporl.2014.02.016; Leung TW, 2005, HEAD NECK-J SCI SPEC, V27, P555, DOI 10.1002/hed.20189; Luomaranta A, 2013, GYNECOL ONCOL, V129, P28, DOI 10.1016/j.ygyno.2013.01.008; Ma J, 2007, CLIN CANCER RES, V13, P1445, DOI 10.1158/1078-0432.CCR-06-2059; Mabuchi S, 2012, INT J GYNECOL CANCER, V22, P1545, DOI 10.1097/IGC.0b013e31826ea0eb; Mabuchi S, 2011, GYNECOL ONCOL, V122, P25, DOI 10.1016/j.ygyno.2011.03.037; Maione P, 2009, LUNG CANCER, V66, P8, DOI 10.1016/j.lungcan.2009.02.022; Negrier S, 2002, ANN ONCOL, V13, P1460, DOI 10.1093/annonc/mdf257; OuYang PY, 2013, ANN ONCOL, V24, P2136, DOI 10.1093/annonc/mdt146; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Pfister DG, 2014, J NATL COMPR CANC NE, V12, P1454, DOI 10.6004/jnccn.2014.0142; Qiu MZ, 2010, TUMOR BIOL, V31, P633, DOI 10.1007/s13277-010-0079-8; Queen MM, 2005, CANCER RES, V65, P8896, DOI 10.1158/0008-5472.CAN-05-1734; Rutkowski P, 2007, J CANCER RES CLIN, V133, P589, DOI 10.1007/s00432-007-0202-4; Shamamian P, 2001, J CELL PHYSIOL, V189, P197, DOI 10.1002/jcp.10014; Shin JH, 2014, CARDIOVASC DRUG THER, V28, P211, DOI 10.1007/s10557-014-6519-8; So KA, 2014, GYNECOL ONCOL, V132, P551, DOI 10.1016/j.ygyno.2014.01.010; Strell C, 2010, EXP CELL RES, V316, P138, DOI 10.1016/j.yexcr.2009.09.003; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Worley MJ, 2013, INT J GYNECOL CANCER, V23, P312, DOI 10.1097/IGC.0b013e31827da21b; Worley MJ, 2012, GYNECOL ONCOL, V125, P561, DOI 10.1016/j.ygyno.2012.03.043; Wu F, 2014, RADIOTHER ONCOL, V112, P106, DOI 10.1016/j.radonc.2014.05.005; Yang XD, 2014, WORLD J GASTROENTERO, V20, P1074, DOI 10.3748/wjg.v20.i4.1074	46	13	13	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136752	10.1371/journal.pone.0136752	http://dx.doi.org/10.1371/journal.pone.0136752			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336064	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400024
J	Zhang, JT; Ren, W; An, PL; Pan, ZH; Wang, LW; Dong, ZQ; He, D; Yang, J; Pan, SF; Tian, HQ				Zhang, Jingting; Ren, Wei; An, Pingli; Pan, Zhihua; Wang, Liwei; Dong, Zhiqiang; He, Di; Yang, Jia; Pan, Shufen; Tian, Hanqin			Responses of Crop Water Use Efficiency to Climate Change and Agronomic Measures in the Semiarid Area of Northern China	PLOS ONE			English	Article							NITROGEN-FERTILIZATION; WINTER-WHEAT; YIELD; SOIL; PHOTOSYNTHESIS; RESILIENCE; VARIETIES; CULTIVAR; IMPACTS; WEATHER	It has long been concerned how crop water use efficiency (WUE) responds to climate change. Most of existing researches have emphasized the impact of single climate factor but have paid less attention to the effect of developed agronomic measures on crop WUE. Based on the long-term field observations/experiments data, we investigated the changing responses of crop WUE to climate variables (temperature and precipitation) and agronomic practices (fertilization and cropping patterns) in the semi-arid area of northern China (SAC) during two periods, 1983-1999 and 2000-2010 (drier and warmer). Our results suggest that crop WUE was an intrinsical system sensitive to climate change and agronomic measures. Crops tend to reach the maximum WUE (WUEmax) in warm-dry environment while reach the stable minimum WUE (WUEmin) in warm-wet environment, with a difference between WUEmax and WUEmin ranging from 29.0%-55.5%. Changes in temperature and precipitation in the past three decades jointly enhanced crop WUE by 8.1%-30.6%. Elevated fertilizer and rotation cropping would increase crop WUE by 5.6-11.0% and 19.5-92.9%, respectively. These results indicate crop has the resilience by adjusting WUE, which is not only able to respond to subsequent periods of favorable water balance but also to tolerate the drought stress, and reasonable agronomic practices could enhance this resilience. However, this capacity would break down under impact of climate changes and unconscionable agronomic practices (e.g. excessive N/P/K fertilizer or traditional continuous cropping). Based on the findings in this study, a conceptual crop WUE model is constructed to indicate the threshold of crop resilience, which could help the farmer develop appropriate strategies in adapting the adverse impacts of climate warming.	[Zhang, Jingting; An, Pingli; Pan, Zhihua; Wang, Liwei; Dong, Zhiqiang; He, Di] China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China; [Zhang, Jingting; An, Pingli; Pan, Zhihua; Wang, Liwei; Dong, Zhiqiang] Minist Agr Field Sci Observat Hohhot, Key Ecol & Environm Expt Stn, Wuchuan 011705, Hohhot, Peoples R China; [Ren, Wei] Univ Kentucky, Dept Plant & Soil Sci, Coll Agr Food & Environm, Lexington, KY 40506 USA; [Ren, Wei; Yang, Jia; Pan, Shufen; Tian, Hanqin] Auburn Univ, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA	China Agricultural University; University of Kentucky; Auburn University System; Auburn University	An, PL (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China.	anpl@cau.edu.cn	Yang, Jia/A-6483-2012; Ren, Wei/I-4048-2014; Ren, Wei/G-8317-2016; Tian, Hanqin/A-6484-2012	Yang, Jia/0000-0003-2019-9603; Ren, Wei/0000-0002-4840-4835; Tian, Hanqin/0000-0002-1806-4091; pan, shufen/0000-0001-7920-1427	National Natural Science Foundation of China [41271110, 41371232]; National Basic Research Program of China [2012CB956204]; National Non-profit Research Foundation for Meteorology [GYHY201506016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Non-profit Research Foundation for Meteorology	The National Natural Science Foundation of China (41271110, 41371232), the National Basic Research Program of China (2012CB956204) and the National Non-profit Research Foundation for Meteorology (GYHY201506016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; An CB, 2006, QUATERNARY SCI REV, V25, P351, DOI 10.1016/j.quascirev.2005.03.013; [Anonymous], 1965, RES PAP; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Chen C, 2010, AGRON J, V102, P1037, DOI 10.2134/agronj2009.0505; Chen C, 2010, AGR WATER MANAGE, V97, P1175, DOI 10.1016/j.agwat.2008.11.012; [陈拓 Chen Tuo], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P83; Du X, 2010, AGR SCI CHINA, V9, P1183, DOI 10.1016/S1671-2927(09)60206-6; Fan JL, 2007, CLIN CHANGE MIDDLE F, V3, P91; Fu BJ, 2003, CATENA, V54, P197, DOI 10.1016/S0341-8162(03)00065-1; Fu CB, 2001, CHINESE SCI BULL, V46, P1199, DOI 10.1007/BF02900602; Gaiser T, 2004, PLANT SOIL, V263, P165, DOI 10.1023/B:PLSO.0000047733.98854.9f; Gao JuLin, 2007, Acta Agronomica Sinica, V33, P455; Gong DY, 2004, J ARID ENVIRON, V59, P771, DOI 10.1016/j.jaridenv.2004.02.006; Gouveia AC, 2009, TREES-STRUCT FUNCT, V23, P267, DOI 10.1007/s00468-008-0274-z; Habtegebrial K, 2007, SOIL TILL RES, V94, P55, DOI 10.1016/j.still.2006.07.002; Halitligil MB, 2000, BIOL FERT SOILS, V31, P175, DOI 10.1007/s003740050642; He D, 2013, FRONT EARTH SCI-PRC, V7, P417, DOI 10.1007/s11707-013-0381-z; Ji Lanzhu, 2005, Ying Yong Sheng Tai Xue Bao, V16, P408; Jiang GM, 2000, ACTA BOT SIN, V42, P855; [李春梅 Li Chunmei], 2002, [水土保持学报, Journal of soil and water conservation], V16, P68; Liu YA, 2010, GLOBAL CHANGE BIOL, V16, P2287, DOI 10.1111/j.1365-2486.2009.02077.x; Loader NJ, 1995, HOLOCENE, V5, P457, DOI 10.1177/095968369500500408; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Ma ZG, 2006, CHINESE SCI BULL, V51, P2913, DOI 10.1007/s11434-006-2159-0; Maltais-Landry G, 2012, AGRON J, V104, P301, DOI 10.2134/agronj2011.0220; Mei XR, 2013, J INTEGR AGR, V12, P1243, DOI 10.1016/S2095-3119(13)60437-2; Monson RK, 2010, OECOLOGIA, V162, P491, DOI 10.1007/s00442-009-1465-z; Moosavi S. G., 2014, Annual Research & Review in Biology, V4, P2318, DOI 10.9734/ARRB/2014/9261; Ogaya R, 2003, ENVIRON EXP BOT, V50, P137, DOI 10.1016/S0098-8472(03)00019-4; Pan Zhihua, 2003, J CHINA AGR RESOURCE, V24, P37; Picotte JJ, 2007, OECOLOGIA, V153, P821, DOI 10.1007/s00442-007-0794-z; Ponton S, 2006, GLOBAL CHANGE BIOL, V12, P294, DOI 10.1111/j.1365-2486.2005.01103.x; Ren GY, 2012, ADV ATMOS SCI, V29, P958, DOI 10.1007/s00376-012-1200-2; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; SCHLESER GH, 1990, J EXP BOT, V41, P565, DOI 10.1093/jxb/41.5.565; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Slafer GA, GENETIC IMPROVEMENT, P1; Stepowski J, 1996, EFFECT DIFFERENT FER; Tao FL, 2014, AGR FOREST METEOROL, V189, P91, DOI 10.1016/j.agrformet.2014.01.013; Tao FL, 2012, EUR J AGRON, V43, P201, DOI 10.1016/j.eja.2012.07.005; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Walker B, 2004, ECOL SOC, V9; Wang J, 2012, CLIMATIC CHANGE, V113, P825, DOI 10.1007/s10584-011-0385-1; Wells N, 2004, J CLIMATE, V17, P2335, DOI 10.1175/1520-0442(2004)017&lt;2335:ASPDSI&gt;2.0.CO;2; Wildy DT, 2004, PLANT SOIL, V262, P111, DOI 10.1023/B:PLSO.0000037030.61945.0d; Xiao DP, CONTRIBUTIONS CULTIV; Xiao GJ, 2013, AGR ECOSYST ENVIRON, V181, P108, DOI 10.1016/j.agee.2013.09.019; [杨利民 Yang Limin], 2007, [生态学报, Acta Ecologica Sinica], V27, P16; Zhang LiFeng, 2002, Agricultural Sciences in China, V1, P76; Zhang XY, 2013, EUR J AGRON, V50, P52, DOI 10.1016/j.eja.2013.05.005; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; [赵风华 ZHAO FengHua], 2008, [地理科学进展, Progress in Geography], V27, P32; Zheng TC, 2011, FIELD CROP RES, V122, P225, DOI 10.1016/j.fcr.2011.03.015; Zou T, 2010, ECOL RES, V25, P185, DOI 10.1007/s11284-009-0642-1	55	17	18	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137409	10.1371/journal.pone.0137409	http://dx.doi.org/10.1371/journal.pone.0137409			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336098	gold, Green Published, Green Submitted			2022-12-27	WOS:000360615400057
J	Claisse, JT; Pondella, DJ; Love, M; Zahn, LA; Williams, CM; Bull, AS				Claisse, Jeremy T.; Pondella, Daniel J.; Love, Milton, II; Zahn, Laurel A.; Williams, Chelsea M.; Bull, Ann S.			Impacts from Partial Removal of Decommissioned Oil and Gas Platforms on Fish Biomass and Production on the Remaining Platform Structure and Surrounding Shell Mounds	PLOS ONE			English	Article							OFFSHORE PETROLEUM PLATFORMS; SECONDARY PRODUCTION; SPATIAL-PATTERNS; CALIFORNIA OIL; ASSEMBLAGES; GROWTH; TEMPERATURE; VARIABILITY; RECRUITMENT; CHANNEL	When oil and gas platforms become obsolete they go through a decommissioning process. This may include partial removal (from the surface to 26 m depth) or complete removal of the platform structure. While complete removal would likely eliminate most of the existing fish biomass and associated secondary production, we find that the potential impacts of partial removal would likely be limited on all but one platform off the coast of California. On average 80% of fish biomass and 86% of secondary fish production would be retained after partial removal, with above 90% retention expected for both metrics on many platforms. Partial removal would likely result in the loss of fish biomass and production for species typically found residing in the shallow portions of the platform structure. However, these fishes generally represent a small proportion of the fishes associated with these platforms. More characteristic of platform fauna are the primarily deeper-dwelling rockfishes (genus Sebastes). "Shell mounds" are biogenic reefs that surround some of these platforms resulting from an accumulation of mollusk shells that have fallen from the shallow areas of the platforms mostly above the depth of partial removal. We found that shell mounds are moderately productive fish habitats, similar to or greater than natural rocky reefs in the region at comparable depths. The complexity and areal extent of these biogenic habitats, and the associated fish biomass and production, will likely be reduced after either partial or complete platform removal. Habitat augmentation by placing the partially removed platform superstructure or some other additional habitat enrichment material (e.g., rock boulders) on the seafloor adjacent to the base of partially removed platforms provides additional options to enhance fish production, potentially mitigating reductions in shell mound habitat.	[Claisse, Jeremy T.; Pondella, Daniel J.; Zahn, Laurel A.; Williams, Chelsea M.] Occidental Coll, Dept Biol, Vantuna Res Grp, Los Angeles, CA 90041 USA; [Love, Milton, II] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Bull, Ann S.] Bur Ocean Energy Management, Pacific Reg, Environm Sci Sect, Camarillo, CA USA	Occidental College; University of California System; University of California Santa Barbara	Claisse, JT (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	jtclaisse@cpp.edu			United States Department of the Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington, District of Columbia [M12AC00003]	United States Department of the Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington, District of Columbia	Funding was provided by the United States Department of the Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington, District of Columbia under Agreement Number M12AC00003.	Ajemian MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126354; Benke AC, 2010, RIVER RES APPL, V26, P36, DOI 10.1002/rra.1290; Bernstein BB, 2010, EVALUATING ALTERNATI; Blanchette CA, 2007, J EXP MAR BIOL ECOL, V340, P126, DOI 10.1016/j.jembe.2006.09.022; Bomkamp RE, 2004, MAR BIOL, V146, P201, DOI 10.1007/s00227-004-1413-8; Bram JB, 2005, J EXP MAR BIOL ECOL, V317, P223, DOI 10.1016/j.jembe.2004.12.003; BULL AS, 1994, B MAR SCI, V55, P1086; Carlisle J. G., 1964, CALIF DEP FISH GAME, V124, P93; Chapman DW, 1968, METHODS ASSESSMENT F, P182; Claisse JT, 2014, P NATL ACAD SCI USA, V111, P15462, DOI 10.1073/pnas.1411477111; Fowler AM, 2014, OCEAN COAST MANAGE, V87, P20, DOI 10.1016/j.ocecoaman.2013.10.019; Fowler AM, 2015, P NATL ACAD SCI USA, V112, pE102, DOI 10.1073/pnas.1422274112; Gallaway BJ, 2009, REV FISH SCI, V17, P48, DOI 10.1080/10641260802160717; Gislason H, 2010, FISH FISH, V11, P149, DOI 10.1111/j.1467-2979.2009.00350.x; Haddon M., 2011, MODELING QUANTITATIV, V2nd; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Helvey M, 2002, ICES J MAR SCI, V59, pS266, DOI 10.1006/jmsc.2002.1226; Holbrook SJ, 2000, ECOLOGICAL ISSUES RE, P1; IVLEV VS, 1966, J FISH RES BOARD CAN, V23, P1727, DOI 10.1139/f66-160; Kamimura Y, 2011, AQUAT ECOL, V45, P367, DOI 10.1007/s10452-011-9360-1; Langhamer O, 2012, SCI WORLD J, DOI 10.1100/2012/386713; Love M. S., 2002, ROCKFISHES NE PACIFI; Love MS, 2006, FISH B-NOAA, V104, P542; Love MS, 2012, B MAR SCI, V88, P863, DOI 10.5343/bms.2011.1101; Love M, 2009, ENVIRON BIOL FISH, V84, P55, DOI 10.1007/s10641-008-9389-8; Love MS, 2006, FISH B-NOAA, V104, P383; LOVE MS, 1991, ENVIRON BIOL FISH, V30, P225, DOI 10.1007/BF02296891; Love MS, 1999, B MAR SCI, V65, P497; Love MS, 2003, OCS STUD MMS; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; Martin CJB, 2010, MAR COAST FISH, V2, P180, DOI 10.1577/C09-037.1; MBC, 1987, OCS STUD MMS, P1; MMS, 2003, FIN REP ASS PHYS CHA, P1; O'Leary M, 2010, RECOLUTIONS GEOMETRY; Page HM, 2007, MAR ECOL PROG SER, V344, P245, DOI 10.3354/meps06929; PAGE HM, 1987, J EXP MAR BIOL ECOL, V111, P159, DOI 10.1016/0022-0981(87)90053-0; Parente V, 2006, ENERG POLICY, V34, P1992, DOI 10.1016/j.enpol.2005.02.008; Scarborough Bull A., 1993, DIVING SCI, P117; Scarborough-Bull A, 2008, AM FISH S S, V49, P899; Schroeder DM, 2004, OCEAN COAST MANAGE, V47, P21, DOI 10.1016/j.ocecoaman.2004.03.002; Stephen CD, 1990, FISHERY MANAGEMENT P, V3; Waters T.F., 1977, Advances in Ecological Research, V10, P91, DOI 10.1016/S0065-2504(08)60235-4; Wilson JR, 2008, ESTUAR COAST SHELF S, V79, P483, DOI 10.1016/j.ecss.2008.05.001; Wilson JC, 2009, WIND ENERGY, V12, P203, DOI 10.1002/we.324	44	34	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135812	10.1371/journal.pone.0135812	http://dx.doi.org/10.1371/journal.pone.0135812			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332384	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800040
J	Komatsu, T; Dacheux, D; Kreppel, F; Nagata, K; Wodrich, H				Komatsu, Tetsuro; Dacheux, Denis; Kreppel, Florian; Nagata, Kyosuke; Wodrich, Harald			A Method for Visualization of Incoming Adenovirus Chromatin Complexes in Fixed and Living Cells	PLOS ONE			English	Article							TEMPLATE-ACTIVATING FACTOR; PROTEIN-VII; CORE PROTEINS; EARLY PHASE; FACTOR-I; DNA; TRANSCRIPTION; REPLICATION; EXPRESSION; RESOLUTION	Inside the adenovirus virion, the genome forms a chromatin-like structure with viral basic core proteins. Core protein VII is the major DNA binding protein and was shown to remain associated with viral genomes upon virus entry even after nuclear delivery. It has been suggested that protein VII plays a regulatory role in viral gene expression and is a functional component of viral chromatin complexes in host cells. As such, protein VII could be used as a maker to track adenoviral chromatin complexes in vivo. In this study, we characterize a new monoclonal antibody against protein VII that stains incoming viral chromatin complexes following nuclear import. Furthermore, we describe the development of a novel imaging system that uses Template Activating Factor-I (TAF-I/SET), a cellular chromatin protein tightly bound to protein VII upon infection. This setup allows us not only to rapidly visualize protein VII foci in fixed cells but also to monitor their movement in living cells. These powerful tools can provide novel insights into the spatio-temporal regulation of incoming adenoviral chromatin complexes.	[Komatsu, Tetsuro; Dacheux, Denis; Wodrich, Harald] Univ Bordeaux, MFP CNRS UMR 5234, Microbiol Fondamentale & Pathogenicite, F-33076 Bordeaux, France; [Komatsu, Tetsuro; Nagata, Kyosuke] Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Dacheux, Denis] Bordeaux INP, MCMP, UMR 5234, F-33000 Bordeaux, France; [Kreppel, Florian] Univ Ulm, Dept Gene Therapy, D-89081 Ulm, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Tsukuba; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Ulm University	Wodrich, H (corresponding author), Univ Bordeaux, MFP CNRS UMR 5234, Microbiol Fondamentale & Pathogenicite, F-33076 Bordeaux, France.	harald.wodrich@u-bordeaux.fr	Dacheux, Denis/AGF-5359-2022; Wodrich, Harald/P-1777-2019	Wodrich, Harald/0000-0002-4764-1708; DACHEUX, Denis/0000-0002-9956-4839; Komatsu, Tetsuro/0000-0003-3963-8792	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Equipe FRM 2011 Projet [DEQ20110421299]; CNRS/University of Bordeaux	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Equipe FRM 2011 Projet; CNRS/University of Bordeaux(Centre National de la Recherche Scientifique (CNRS))	This work was in part supported by grants from the Equipe FRM 2011 Projet DEQ20110421299 (HW) and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KN) and by institutional funding (CNRS/University of Bordeaux to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURG JL, 1983, J VIROL, V46, P749, DOI 10.1128/JVI.46.3.749-755.1983; Cassany A, 2015, J VIROL, V89, P1719, DOI 10.1128/JVI.02639-14; CHATTERJEE PK, 1986, EMBO J, V5, P1633, DOI 10.1002/j.1460-2075.1986.tb04406.x; Giberson AN, 2012, NUCLEIC ACIDS RES, V40, P2369, DOI 10.1093/nar/gkr1076; Glotzer JB, 2001, J VIROL, V75, P2421, DOI 10.1128/JVI.75.5.2421-2434.2001; Greber UF, 1997, EMBO J, V16, P5998, DOI 10.1093/emboj/16.19.5998; Haruki H, 2006, J VIROL, V80, P794, DOI 10.1128/JVI.80.2.794-801.2006; Haruki H, 2003, FEBS LETT, V555, P521, DOI 10.1016/S0014-5793(03)01336-X; Johnson JS, 2004, J VIROL, V78, P6459, DOI 10.1128/JVI.78.12.6459-6468.2004; Kato K, 2007, NUCLEIC ACIDS RES, V35, P705, DOI 10.1093/nar/gkl1077; Kawase H, 1996, GENES CELLS, V1, P1045, DOI 10.1046/j.1365-2443.1996.d01-223.x; Komatsu T, 2011, NUCLEIC ACIDS RES, V39, P889, DOI 10.1093/nar/gkq783; Kreppel F, 2002, HUM GENE THER, V13, P1151, DOI 10.1089/104303402320138934; Martinez R, 2015, J VIROL, V89, P2121, DOI 10.1128/JVI.02257-14; Martinez R, 2013, METHODS MOL BIOL, V1064, P211, DOI 10.1007/978-1-62703-601-6_15; Miyaji-Yamaguchi M, 1999, J MOL BIOL, V290, P547, DOI 10.1006/jmbi.1999.2898; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Okuwaki M, 2001, J MOL BIOL, V311, P41, DOI 10.1006/jmbi.2001.4812; Puntener D, 2011, J VIROL, V85, P481, DOI 10.1128/JVI.01571-10; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Schreiner S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002549; Wang IH, 2013, CELL HOST MICROBE, V14, P468, DOI 10.1016/j.chom.2013.09.004; Wodrich H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000808; Xue YM, 2005, J VIROL, V79, P2474, DOI 10.1128/JVI.79.4.2474-2483.2005	27	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137102	10.1371/journal.pone.0137102	http://dx.doi.org/10.1371/journal.pone.0137102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332038	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800096
J	Shah, J; Mark, O; Weltman, H; Barcelo, N; Lo, W; Wronska, D; Kakkilaya, S; Rao, A; Bhat, ST; Sinha, R; Omar, S; O'bare, P; Moro, M; Gilman, RH; Harris, N				Shah, Jyotsna; Mark, Olivia; Weltman, Helena; Barcelo, Nicolas; Lo, Wai; Wronska, Danuta; Kakkilaya, Srinivas; Rao, Aravinda; Bhat, Shalia T.; Sinha, Ruchi; Omar, Sabah; O'bare, Peter; Moro, Manuel; Gilman, Robert H.; Harris, Nick			Fluorescence In Situ Hybridization (FISH) Assays for Diagnosing Malaria in Endemic Areas	PLOS ONE			English	Article							NUCLEIC-ACID PROBES; BLOOD SMEAR; IDENTIFICATION; PCR	Malaria is a responsible for approximately 600 thousand deaths worldwide every year. Appropriate and timely treatment of malaria can prevent deaths but is dependent on accurate and rapid diagnosis of the infection. Currently, microscopic examination of the Giemsa stained blood smears is the method of choice for diagnosing malaria. Although it has limited sensitivity and specificity in field conditions, it still remains the gold standard for the diagnosis of malaria. Here, we report the development of a fluorescence in situ hybridization (FISH) based method for detecting malaria infection in blood smears and describe the use of an LED light source that makes the method suitable for use in resource-limited malaria endemic countries. The Plasmodium Genus (P-Genus) FISH assay has a Plasmodium genus specific probe that detects all five species of Plasmodium known to cause the disease in humans. The P. falciparum (PF) FISH assay and P. vivax (PV) FISH assay detect and differentiate between P. falciparum and P. vivax respectively from other Plasmodium species. The FISH assays are more sensitive than Giemsa. The sensitivities of P-Genus, PF and PV FISH assays were found to be 98.2%, 94.5% and 98.3%, respectively compared to 89.9%, 83.3% and 87.9% for the detection of Plasmodium, P. falciparum and P. vivax by Giemsa staining respectively.	[Shah, Jyotsna; Mark, Olivia; Weltman, Helena; Barcelo, Nicolas; Harris, Nick] ID FISH Technol Inc, Palo Alto, CA 94303 USA; [Shah, Jyotsna; Mark, Olivia; Weltman, Helena; Lo, Wai; Wronska, Danuta; Harris, Nick] IGeneX Inc, Palo Alto, CA USA; [Kakkilaya, Srinivas; Rao, Aravinda] Nova Meditech Pvt Ltd, Mangalore, India; [Bhat, Shalia T.; Sinha, Ruchi] Kasturba Med Coll Hosp, Mangalore, India; [Omar, Sabah] Kenya Govt Med Res Ctr, Nairobi, Kenya; [O'bare, Peter] Walter Reed Project, Kisumu, Kenya; [Moro, Manuel] NIH, Bethesda, MD 20892 USA; [Gilman, Robert H.] Johns Hopkins Univ, Baltimore, MD USA	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Kenya Medical Research Institute; National Institutes of Health (NIH) - USA; Johns Hopkins University	Shah, J (corresponding author), ID FISH Technol Inc, Palo Alto, CA 94303 USA.	jyotsna@aol.com	Lo, Wai U/J-3053-2019; Bhat, Shaila/AAX-8692-2020	Lo, Wai U/0000-0002-2182-0222; 	NIH SBIR Phase I and Phase II Grants [A1056785]; ID-FISH Technology Inc.; IGeneX Inc.; Nova Meditech Pvt. Ltd.	NIH SBIR Phase I and Phase II Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ID-FISH Technology Inc.; IGeneX Inc.; Nova Meditech Pvt. Ltd.	This study was supported by NIH SBIR Phase I and Phase II Grants # A1056785. ID-FISH Technology Inc.' and 'IGeneX Inc.' provided support in the form of salaries for authors HW, DW and OM and Nova Meditech Pvt. Ltd. provided support in the form of salaries for authors AR and SK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amand ALS, 2005, J CLIN MICROBIOL, V43, P5369, DOI 10.1128/JCM.43.10.5369-5371.2005; [Anonymous], 2007, CDC MALARIA RAPID DI; Baiden F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034073; Bjorkman A, 2010, CLIN INFECT DIS, V51, P512, DOI 10.1086/655689; CDC, 2012, MMWR-MORBID MORTAL W, P1; Cullen KA, 2012, CDC MORBIDITY MORTAL, V63; DeLong E.F., 1990, DIAGN CLIN TEST, V28, P41; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Graczyk TK, 2003, AM J TROP MED HYG, V68, P228, DOI 10.4269/ajtmh.2003.68.228; Joanny F, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-234; Johnston SP, 2006, J CLIN MICROBIOL, V44, P1087, DOI 10.1128/JCM.44.3.1087-1089.2006; Lee JH, 2014, J CLIN MICROBIOL, V52, P3784, DOI 10.1128/JCM.01797-14; Lefmann M, 2006, J CLIN MICROBIOL, V44, P3760, DOI 10.1128/JCM.01435-06; Machado A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-82; Meatherall B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-377; Ndao M, 2004, J CLIN MICROBIOL, V42, P2694, DOI 10.1128/JCM.42.6.2694-2700.2004; Ramasamy R, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00123; Rigby S, 2002, J CLIN MICROBIOL, V40, P2182, DOI 10.1128/JCM.40.6.2182-2186.2002; Shah J. S., 1999, 39 INT C ANT AG CHEM; Shah JS, 1996, CLIN DIAGN LAB IMMUN, V3, P119, DOI 10.1128/CDLI.3.1.119-127.1996; Shah JS, US Patent, Patent No. [6,165,723, 6165723]; St Amand AL, 2005, J CLIN MICROBIOL, V43, P1505, DOI 10.1128/JCM.43.4.1505-1514.2005; Stender H, 1999, J CLIN MICROBIOL, V37, P2760, DOI 10.1128/JCM.37.9.2760-2765.1999; Stender H., 1999, INT J TUBERC LUNG D, V9, P830; Tangpukdee N, 2009, KOREAN J PARASITOL, V47, P93, DOI 10.3347/kjp.2009.47.2.93; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	28	15	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136726	10.1371/journal.pone.0136726	http://dx.doi.org/10.1371/journal.pone.0136726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333092	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800068
J	Smith, JD; Ell, SW				Smith, J. David; Ell, Shawn W.			One Giant Leap for Categorizers: One Small Step for Categorization Theory	PLOS ONE			English	Article							MODELING INDIVIDUAL-DIFFERENCES; MULTIPLE SYSTEMS; CLASSIFICATION; IMPLICIT; INTERFERENCE; ATTENTION; MEMORY; SINGLE	We explore humans' rule-based category learning using analytic approaches that highlight their psychological transitions during learning. These approaches confirm that humans show qualitatively sudden psychological transitions during rule learning. These transitions contribute to the theoretical literature contrasting single vs. multiple category-learning systems, because they seem to reveal a distinctive learning process of explicit rule discovery. A complete psychology of categorization must describe this learning process, too. Yet extensive formal-modeling analyses confirm that a wide range of current (gradient-descent) models cannot reproduce these transitions, including influential rule-based models (e.g., COVIS) and exemplar models (e.g., ALCOVE). It is an important theoretical conclusion that existing models cannot explain humans' rule-based category learning. The problem these models have is the incremental algorithm by which learning is simulated. Humans descend no gradient in rule-based tasks. Very different formal-modeling systems will be required to explain humans' psychology in these tasks. An important next step will be to build a new generation of models that can do so.	[Smith, J. David] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Ell, Shawn W.] Univ Maine, Dept Psychol, Orono, ME 04469 USA; [Ell, Shawn W.] Maine Grad Sch Biomed Sci & Engn, Orono, ME USA	University System of Georgia; Georgia State University; University of Maine System; University of Maine Orono	Smith, JD (corresponding author), Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA.	psysmith@buffalo.edu			NICHD [HD-060563, HD-061455]; NSF [BCS-0956993, BCS-1349737]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061455, P01HD060563] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1349737] Funding Source: National Science Foundation	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	The preparation of this article was supported by Grant HD-060563 from NICHD, Grant HD-061455 from NICHD, Grant BCS-0956993 from NSF, and Grant BCS-1349737 from NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 2006, PSYCHOL LEARN MOTIV, V46, P1, DOI 10.1016/S0079-7421(06)46001-1; Ashby FG, 2011, ANN NY ACAD SCI, V1224, P147, DOI 10.1111/j.1749-6632.2010.05874.x; Ashby FG, 2010, NEUROBIOL LEARN MEM, V94, P1, DOI 10.1016/j.nlm.2010.03.001; Ashby FG, 2001, TRENDS COGN SCI, V5, P204, DOI 10.1016/S1364-6613(00)01624-7; Ashby FG, 2005, TRENDS COGN SCI, V9, P83, DOI 10.1016/j.tics.2004.12.003; ASHBY FG, 1994, PERCEPT PSYCHOPHYS, V55, P11, DOI 10.3758/BF03206876; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Ashby FG, 1999, PSYCHON B REV, V6, P363, DOI 10.3758/BF03210826; Ashby FG, 2002, PSYCHON B REV, V9, P175, DOI 10.3758/BF03196275; Ashby FG, PSYCHONOMIC IN PRESS; Bartlema A, 2014, J MATH PSYCHOL, V59, P132, DOI 10.1016/j.jmp.2013.12.002; Bower GH, 1964, STUDIES MATH PSYCHOL; Cohen AL, 2008, PSYCHON B REV, V15, P692, DOI 10.3758/PBR.15.4.692; Dunn JC, 2012, J EXP PSYCHOL LEARN, V38, P840, DOI 10.1037/a0027867; Ell SW, 2006, PERCEPT PSYCHOPHYS, V68, P1013, DOI 10.3758/BF03193362; Ell SW, 2004, PERCEPT PSYCHOPHYS, V66, P1318, DOI 10.3758/BF03195001; Erickson MA, 1998, J EXP PSYCHOL GEN, V127, P107, DOI 10.1037/0096-3445.127.2.107; ESTES WK, 1956, PSYCHOL BULL, V53, P134, DOI 10.1037/h0045156; Feldman J, 2000, NATURE, V407, P630, DOI 10.1038/35036586; HAYES KJ, 1953, PSYCHOL REV, V60, P269, DOI 10.1037/h0056308; HAYKIN S, 1994, NEURAL NETWORKS; Keri S, 2003, BRAIN RES REV, V43, P85, DOI 10.1016/S0165-0173(03)00204-2; KNOWLTON BJ, 1993, SCIENCE, V262, P1747, DOI 10.1126/science.8259522; Kruschke JK, 1999, J EXP PSYCHOL LEARN, V25, P1083, DOI 10.1037/0278-7393.25.5.1083; Kruschke JK, 2001, J MATH PSYCHOL, V45, P812, DOI 10.1006/jmps.2000.1354; KRUSCHKE JK, 1992, PSYCHOL REV, V99, P22, DOI 10.1037/0033-295X.99.1.22; Lee MD, 2005, PSYCHON B REV, V12, P605, DOI 10.3758/BF03196751; Lee MD, 2010, COGNITION IN FLUX, P387; Maddox WT, 1999, PERCEPT PSYCHOPHYS, V61, P354, DOI 10.3758/BF03206893; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Murphy G. L., 2002, BIG BOOK CONCEPTS; Navarro DJ, 2006, J MATH PSYCHOL, V50, P101, DOI 10.1016/j.jmp.2005.11.006; Newell BR, 2010, MEM COGNITION, V38, P563, DOI 10.3758/MC.38.5.563; Nosofsky RM, 2000, PSYCHON B REV, V7, P375; NOSOFSKY RM, 1994, PSYCHOL REV, V101, P53, DOI 10.1037/0033-295X.101.1.53; Nosofsky RM, 2005, MEM COGNITION, V33, P1256, DOI 10.3758/BF03193227; Nosofsky RM, 2002, PSYCHON B REV, V9, P169, DOI 10.3758/BF03196274; Reed R., 1999, NEURAL SMITHING, DOI 10.7551/mitpress/4937.001.0001; Rosseel Y, 2002, J MATH PSYCHOL, V46, P178, DOI 10.1006/jmps.2001.1379; Rouder JN, NEW HANDBOO IN PRESS; Schmittmann VD, 2006, NEUROPSYCHOLOGIA, V44, P2079, DOI 10.1016/j.neuropsychologia.2005.12.011; Seger CA, 2010, ANNU REV NEUROSCI, V33, P203, DOI 10.1146/annurev.neuro.051508.135546; Smith JD, 2008, J EXP PSYCHOL GEN, V137, P390, DOI 10.1037/0096-3445.137.2.390; Smith JD, 2014, PSYCHOL SCI, V25, P447, DOI 10.1177/0956797613509112; Smith JD, 2012, NEUROSCI BIOBEHAV R, V36, P2355, DOI 10.1016/j.neubiorev.2012.09.003; Smith JD, 2010, J EXP PSYCHOL-ANIM B, V36, P54, DOI 10.1037/a0015892; Smith JD, 1998, J EXP PSYCHOL LEARN, V24, P1411, DOI 10.1037/0278-7393.24.6.1411; Stanton RD, 2007, MEM COGNITION, V35, P1747, DOI 10.3758/BF03193507	49	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137334	10.1371/journal.pone.0137334	http://dx.doi.org/10.1371/journal.pone.0137334			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26332587	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800122
J	Chang, JS; Kuo, HP; Chang, KLB; Kong, ZL				Chang, Jenq-Sheng; Kuo, Hsiang-Ping; Chang, Ke Liang B.; Kong, Zwe-Ling			Apoptosis of Hepatocellular Carcinoma Cells Induced by Nanoencapsulated Polysaccharides Extracted from Antrodia Camphorata	PLOS ONE			English	Article							CHITOSAN NANOPARTICLES; SILICA NANOPARTICLES; GENE-EXPRESSION; DRUG-DELIVERY; TOXICITY; GROWTH; MITOCHONDRIA; INDUCTION; CHEMISTRY; NECROSIS	Antrodia camphorata is a well-known medicinal mushroom in Taiwan and has been studied for decades, especially with focus on anti-cancer activity. Polysaccharides are the major bioactive compounds reported with anti-cancer activity, but the debates on how they target cells still remain. Research addressing the encapsulation of polysaccharides from A. camphorata extract (ACE) to enhance anti-cancer activity is rare. In this study, ACE polysaccharides were nano-encapsulated in chitosan-silica and silica (expressed as ACE/CS and ACE/S, respectively) to evaluate the apoptosis effect on a hepatoma cell line (Hep G2). The results showed that ACE polysaccharides, ACE/CS and ACE/S all could damage the Hep G2 cell membrane and cause cell death, especially in the ACE/CS group. In apoptosis assays, DNA fragmentation and sub-G(1) phase populations were increased, and the mitochondrial membrane potential decreased significantly after treatments. ACE/CS and ACE/S could also increase reactive oxygen species (ROS) generation, induce Fas/APO-1 (apoptosis antigen 1) expression and elevate the proteolytic activities of caspase-3, caspase-8 and caspase-9 in Hep G2 cells. Unsurprisingly, ACE/CS induced a similar apoptosis mechanism at a lower dosage (ACE polysaccharides = 13.2 mu g/mL) than those of ACE/S (ACE polysaccharides = 21.2 mu g/mL) and ACE polysaccharides (25 mu g/mL). Therefore, the encapsulation of ACE polysaccharides by chitosan-silica nanoparticles may provide a viable approach for enhancing anti-tumor efficacy in liver cancer cells.	[Chang, Jenq-Sheng; Kuo, Hsiang-Ping; Chang, Ke Liang B.; Kong, Zwe-Ling] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan	National Taiwan Ocean University	Kong, ZL (corresponding author), Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan.	kongzl@mail.ntou.edu.tw	Kong, Zwe-Ling/E-8763-2013; Kong, Zwe-Ling/AAB-5328-2019; Kong, Zwe-Ling/AAB-5261-2019	Kong, Zwe-Ling/0000-0002-4877-6524; Kong, Zwe-Ling/0000-0002-4877-6524; 	Ministry of Science and technology [NSC 97-2313-B-019-006-MY3, NSC 97-2221-E-019-001]	Ministry of Science and technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Science Council Taiwan, which was renamed to the Ministry of Science and technology since 2014. Grant numbers were NSC 97-2313-B-019-006-MY3 (for Z. L. Kong) and NSC 97-2221-E-019-001 (for K. L. B. Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbe C, 2004, ADV MATER, V16, P1959, DOI 10.1002/adma.200400771; Bodnar M, 2005, BIOMACROMOLECULES, V6, P2521, DOI 10.1021/bm0502258; Borchers AT, 2008, EXP BIOL MED, V233, P259, DOI 10.3181/0708-MR-227; Borchers AT, 2004, EXP BIOL MED, V229, P393, DOI 10.1177/153537020422900507; Cai XJ, 2011, CYTOTECHNOLOGY, V63, P319, DOI 10.1007/s10616-011-9366-5; Carolina A, 2013, CAN J VET RES, V77, P136; Chang JS, 2007, ENVIRON SCI TECHNOL, V41, P2064, DOI 10.1021/es062347t; Chang JS, 2006, CHEM MATER, V18, P702, DOI 10.1021/cm052161d; Chou CT, 2013, AMINO ACIDS, V45, P811, DOI 10.1007/s00726-013-1524-y; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Coradin T, 2003, CHEMBIOCHEM, V4, P251, DOI 10.1002/cbic.200390044; Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009; Geethangili M, 2011, EVIDENCE BASED COMPL, V2011; Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284; Hseu YC, 2004, NUTR CANCER, V48, P189, DOI 10.1207/s15327914nc4802_9; Hsiao G, 2003, J AGR FOOD CHEM, V51, P3302, DOI 10.1021/jf021159t; Hsu YL, 2005, CANCER LETT, V221, P77, DOI 10.1016/j.canlet.2004.08.012; Huang GJ, 2012, FOOD CHEM, V132, P709, DOI 10.1016/j.foodchem.2011.11.004; Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2; Kong ZL, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1945-2; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; Latchoumycandane C, 2012, J BIOL CHEM, V287, P17693, DOI 10.1074/jbc.M111.300012; Lee IH, 2002, FEMS MICROBIOL LETT, V209, P63, DOI 10.1111/j.1574-6968.2002.tb11110.x; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin LN, 2010, CYTOTECHNOLOGY, V62, P377, DOI 10.1007/s10616-010-9295-8; Liu JJ, 2004, TOXICOL APPL PHARM, V201, P186, DOI 10.1016/j.taap.2004.05.016; Lozano MV, 2008, BIOMACROMOLECULES, V9, P2186, DOI 10.1021/bm800298u; Maes Michael, 2012, Inflammopharmacology, V20, P127, DOI 10.1007/s10787-011-0111-7; Mi FL, 2007, BIOMACROMOLECULES, V8, P892, DOI 10.1021/bm060998b; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Peng CC, 2007, J ETHNOPHARMACOL, V109, P93, DOI 10.1016/j.jep.2006.07.009; Shim W, 2012, ACS NANO, V6, P7665, DOI 10.1021/nn301113f; Slowing II, 2007, ADV FUNCT MATER, V17, P1225, DOI 10.1002/adfm.200601191; Song TY, 2003, J AGR FOOD CHEM, V51, P1571, DOI 10.1021/jf0209701; Tepper CG, 2000, EXP CELL RES, V260, P9, DOI 10.1006/excr.2000.4990; Wang GJ, 2003, LIFE SCI, V73, P2769, DOI 10.1016/S0024-3205(03)00669-6; Wang X, 2008, CA-CANCER J CLIN, V58, P97, DOI 10.3322/CA.2007.0003; Yang HL, 2006, CANCER LETT, V231, P215, DOI 10.1016/j.canlet.2005.02.004; Zhang H, 2004, BIOMACROMOLECULES, V5, P2461, DOI 10.1021/bm0496211	42	16	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136782	10.1371/journal.pone.0136782	http://dx.doi.org/10.1371/journal.pone.0136782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327534	Green Submitted, gold, Green Published			2022-12-27	WOS:000360437700064
J	Liu, YN; Kujawinski, EB				Liu, Yina; Kujawinski, Elizabeth B.			Chemical Composition and Potential Environmental Impacts of Water-Soluble Polar Crude Oil Components Inferred from ESI FT-ICR MS	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; POLYCYCLIC AROMATIC-HYDROCARBONS; ELECTROSPRAY-IONIZATION; HORIZON OIL; MASS-SPECTROMETRY; SOLUBILITY ENHANCEMENT; NSO COMPOUNDS; EXXON-VALDEZ; FUEL-OIL; TOXICITY	Polar petroleum components enter marine environments through oil spills and natural seepages each year. Lately, they are receiving increased attention due to their potential toxicity to marine organisms and persistence in the environment. We conducted a laboratory experiment and employed state-of-the-art Fourier-transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) to characterize the polar petroleum components within two operationally-defined seawater fractions: the water-soluble fraction (WSF), which includes only water-soluble molecules, and the water-accommodated fraction (WAF), which includes WSF and microscopic oil droplets. Our results show that compounds with higher heteroatom (N, S, O) to carbon ratios (NSO:C) than the parent oil were selectively partitioned into seawater in both fractions, reflecting the influence of polarity on aqueous solubility. WAF and WSF were compositionally distinct, with unique distributions of compounds across a range of hydrophobicity. These compositional differences will likely result in disparate impacts on environmental health and organismal toxicity, and thus highlight the need to distinguish between these often-interchangeable terminologies in toxicology studies. We use an empirical model to estimate hydrophobicity character for individual molecules within these complex mixtures and provide an estimate of the potential environmental impacts of different crude oil components.	[Liu, Yina; Kujawinski, Elizabeth B.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Liu, YN (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	yina.liu@whoi.edu	Liu, Yina/C-1522-2017	Liu, Yina/0000-0002-3485-7542	Gulf of Mexico Research Initiative (GOMRI) Project [161684]	Gulf of Mexico Research Initiative (GOMRI) Project	This study is funded by the Gulf of Mexico Research Initiative (GOMRI) Project # 161684 to Dr. Elizabeth B. Kujawinski.	Aeppli C, 2012, ENVIRON SCI TECHNOL, V46, P8799, DOI 10.1021/es3015138; Akaishi FM, 2004, ARCH ENVIRON CON TOX, V46, P244, DOI 10.1007/s00244-003-2260-1; Alkindi AYA, 1996, J FISH BIOL, V49, P1291; ANDERSON JW, 1974, MAR BIOL, V27, P75, DOI 10.1007/BF00394763; Arnot JA, 2006, ENVIRON REV, V14, P257, DOI 10.1139/a06-005; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; Bellas J, 2013, CHEMOSPHERE, V90, P1103, DOI 10.1016/j.chemosphere.2012.09.015; Bhatia MP, 2010, GEOCHIM COSMOCHIM AC, V74, P3768, DOI 10.1016/j.gca.2010.03.035; Bianchi TS, 2014, ENVIRON SCI TECHNOL, V48, P9288, DOI 10.1021/es501547b; BOEHM P D, 1974, Marine Pollution Bulletin, V5, P101, DOI 10.1016/0025-326X(74)90256-2; BOEHM PD, 1976, ESTUAR COAST MAR SCI, V4, P93, DOI 10.1016/0302-3524(76)90010-4; BOEHM PD, 1973, GEOCHIM COSMOCHIM AC, V37, P2459, DOI 10.1016/0016-7037(73)90292-5; BOYLAN DB, 1971, NATURE, V230, P44, DOI 10.1038/230044a0; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Carls MG, 2008, AQUAT TOXICOL, V88, P121, DOI 10.1016/j.aquatox.2008.03.014; CHIOU CT, 1986, ENVIRON SCI TECHNOL, V20, P502, DOI 10.1021/es00147a010; CHIOU CT, 1987, ENVIRON SCI TECHNOL, V21, P1231, DOI 10.1021/es00165a012; Corilo YE, 2013, ANAL CHEM, V85, P9064, DOI 10.1021/ac401604u; Diercks AR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045046; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Dubinsky EA, 2013, ENVIRON SCI TECHNOL, V47, P10860, DOI 10.1021/es401676y; GIRLING AE, 1989, CHEMOSPHERE, V19, P1635, DOI 10.1016/0045-6535(89)90507-9; GRIFFIN LF, 1977, APPL ENVIRON MICROB, V33, P1092, DOI 10.1128/AEM.33.5.1092-1096.1977; Gutierrez T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067717; Hughey CA, 2004, ORG GEOCHEM, V35, P863, DOI 10.1016/j.orggeochem.2004.02.008; Hughey CA, 2002, ORG GEOCHEM, V33, P743, DOI 10.1016/S0146-6380(02)00038-4; Incardona JP, 2013, AQUAT TOXICOL, V142, P303, DOI 10.1016/j.aquatox.2013.08.011; Incardona JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030116; JAFFE R, 1991, ENVIRON POLLUT, V69, P237, DOI 10.1016/0269-7491(91)90147-O; Jones D.L, 2017, FATHOM TOOLBOX MATLA; Ke L, 2009, CHEMOSPHERE, V76, P1102, DOI 10.1016/j.chemosphere.2009.04.022; Kennedy CJ, 2005, J EXP MAR BIOL ECOL, V323, P43, DOI 10.1016/j.jembe.2005.02.021; Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027; Kujawinski EB, 2002, ENVIRON FORENSICS, V3, P207, DOI 10.1006/enfo.2002.0109; Kujawinski EB, 2006, ANAL CHEM, V78, P4363, DOI 10.1021/ac0600306; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Kujawinski EB, 2009, GEOCHIM COSMOCHIM AC, V73, P4384, DOI 10.1016/j.gca.2009.04.033; Lubcke-von Varel U, 2011, ENVIRON SCI TECHNOL, V45, P2384, DOI 10.1021/es103381y; Marshall AG, 2008, P NATL ACAD SCI USA, V105, P18090, DOI 10.1073/pnas.0805069105; Mason OU, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00332; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; McKenna AM, 2014, ENERG FUEL, V28, P2454, DOI 10.1021/ef5002452; McKenna AM, 2013, ENVIRON SCI TECHNOL, V47, P7530, DOI 10.1021/es305284t; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Meharg AA, 1998, ENVIRON POLLUT, V99, P29, DOI 10.1016/S0269-7491(97)00180-2; Melbye AG, 2009, ENVIRON TOXICOL CHEM, V28, P1815, DOI 10.1897/08-545.1; Meylan WM, 1999, ENVIRON TOXICOL CHEM, V18, P664, DOI 10.1002/etc.5620180412; MEYLAN WM, 1995, J PHARM SCI-US, V84, P83, DOI 10.1002/jps.2600840120; Meylan WM, 1996, ENVIRON TOXICOL CHEM, V15, P100, DOI 10.1002/etc.5620150205; National Research Council, 2003, OIL SEA INP FAT EFF; Ohwada K, 2003, MAR POLLUT BULL, V47, P78, DOI 10.1016/S0025-326X(03)00112-7; Peacock EE, 2005, ENVIRON FORENSICS, V6, P273, DOI 10.1080/15275920500194480; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Ray PZ, 2014, J HAZARD MATER, V280, P636, DOI 10.1016/j.jhazmat.2014.08.059; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Reemtsma T, 2010, J MASS SPECTROM, V45, P382, DOI 10.1002/jms.1722; ROSSI SS, 1976, ENVIRON POLLUT, V10, P9, DOI 10.1016/0013-9327(76)90091-4; Ryerson T.B., 2012, P NATL ACAD SCI; Singer MM, 2000, MAR POLLUT BULL, V40, P1007, DOI 10.1016/S0025-326X(00)00045-X; Sleighter RL, 2008, MAR CHEM, V110, P140, DOI 10.1016/j.marchem.2008.04.008; Soule MCK, 2010, ORG GEOCHEM, V41, P725, DOI 10.1016/j.orggeochem.2010.05.017; Southam AD, 2007, ANAL CHEM, V79, P4595, DOI 10.1021/ac062446p; Stanford LA, 2007, ENVIRON SCI TECHNOL, V41, P2696, DOI 10.1021/es0624063; Tanaka S, 1997, ANAL CHIM ACTA, V337, P351, DOI 10.1016/S0003-2670(96)00422-9; Tejeda-Agredano MC, 2014, ENVIRON POLLUT, V184, P435, DOI 10.1016/j.envpol.2013.09.031; US EPA, 2012, EST PROGR INT SUIT M, V167; Wandruszka RV, 2000, GEOCHEM T, V1, P1, DOI [10.1186/1467-4866-1-10, DOI 10.1186/1467-4866-1-10]	68	33	33	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136376	10.1371/journal.pone.0136376	http://dx.doi.org/10.1371/journal.pone.0136376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327219	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700039
J	Kostylev, M; Otwell, AE; Richardson, RE; Suzuki, Y				Kostylev, Maxim; Otwell, Anne E.; Richardson, Ruth E.; Suzuki, Yo			Cloning Should Be Simple: Escherichia coli DH5 alpha-Mediated Assembly of Multiple DNA Fragments with Short End Homologies	PLOS ONE			English	Article							PCR PRODUCTS; IN-VIVO; SACCHAROMYCES-CEREVISIAE; DIRECT TRANSFORMATION; CAS SYSTEMS; RECOMBINATION; YEAST; EXPRESSION; EXTENSION; PATHWAYS	Numerous DNA assembly technologies exist for generating plasmids for biological studies. Many procedures require complex in vitro or in vivo assembly reactions followed by plasmid propagation in recombination-impaired Escherichia coli strains such as DH5 alpha, which are optimal for stable amplification of the DNA materials. Here we show that despite its utility as a cloning strain, DH5 alpha retains sufficient recombinase activity to assemble up to six double-stranded DNA fragments ranging in size from 150 bp to at least 7 kb into plasmids in vivo. This process also requires surprisingly small amounts of DNA, potentially obviating the need for upstream assembly processes associated with most common applications of DNA assembly. We demonstrate the application of this process in cloning of various DNA fragments including synthetic genes, preparation of knockout constructs, and incorporation of guide RNA sequences in constructs for clustered regularly interspaced short palindromic repeats (CRISPR) genome editing. This consolidated process for assembly and amplification in a widely available strain of E. coli may enable productivity gain across disciplines involving recombinant DNA work.	[Kostylev, Maxim; Suzuki, Yo] J Craig Venter Inst, Dept Synthet Biol & Bioenergy, La Jolla, CA 92037 USA; [Otwell, Anne E.] Cornell Univ, Dept Microbiol, Ithaca, NY USA; [Richardson, Ruth E.] Cornell Univ, Sch Civil & Environm Engn, Ithaca, NY 14853 USA	J. Craig Venter Institute; Cornell University; Cornell University	Kostylev, M (corresponding author), J Craig Venter Inst, Dept Synthet Biol & Bioenergy, La Jolla, CA 92037 USA.	mkostyle@jcvi.org; ysuzuki@jcvi.org	Ibrahim, Essam Hassan/G-1960-2018; Richardson, Ruth E/B-8265-2017	Ibrahim, Essam Hassan/0000-0003-0130-2257; 	US Department of Energy [DE-EE0006109, DE-SC0006644]	US Department of Energy(United States Department of Energy (DOE))	This work was supported by the US Department of Energy DE-EE0006109 to YS (http://energy.gov/eere/office-energy-efficiency-renewableenergy); US Department of Energy DE-SC0006644 to RER (http://genomicscience.energy.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Cao PG, 2014, PLASMID, V76, P40, DOI 10.1016/j.plasmid.2014.09.002; Chayot R, 2010, P NATL ACAD SCI USA, V107, P2141, DOI 10.1073/pnas.0906355107; Colloms SD, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1101; Degryse E, 1996, GENE, V170, P45, DOI 10.1016/0378-1119(95)00858-6; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jacobus AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119221; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Koskela EV, 2015, MOL BIOTECHNOL, V57, P233, DOI 10.1007/s12033-014-9817-2; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Labunskyy VM, 2014, G3-GENES GENOM GENET, V4, P1183, DOI 10.1534/g3.114.010868; Lanza AM, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-33; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lovett ST, 2002, GENETICS, V160, P851; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Maniatis T., 1982, MOL CLONING; Mitchell LA, 2015, NUCLEIC ACIDS RES, V43, P6620, DOI 10.1093/nar/gkv466; Noskov V, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e8; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Smith C, 1993, PCR Methods Appl, V2, P328, DOI 10.1101/gr.2.4.328; Suzuki Y, 2011, NAT METHODS, V8, P159, DOI 10.1038/NMETH.1550; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Thomason Lynn C, 2014, Curr Protoc Mol Biol, V106, DOI 10.1002/0471142727.mb0116s106; Wang RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057943; Wright MS, 2014, ANTIMICROB AGENTS CH, V58, P4961, DOI 10.1128/AAC.00125-14; You C, 2012, APPL ENVIRON MICROB, V78, P1593, DOI 10.1128/AEM.07105-11; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	40	66	69	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137466	10.1371/journal.pone.0137466	http://dx.doi.org/10.1371/journal.pone.0137466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348330	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600046
J	Levin, II; Zonana, DM; Burt, JM; Safran, RJ				Levin, Iris I.; Zonana, David M.; Burt, John M.; Safran, Rebecca J.			Performance of Encounternet Tags: Field Tests of Miniaturized Proximity Loggers for Use on Small Birds	PLOS ONE			English	Article							SOCIAL NETWORK ANALYSIS; TEMPORAL DYNAMICS; BEHAVIOR; ATTACHMENT; QUALITY	Proximity logging is a new tool for understanding social behavior as it allows for accurate quantification of social networks. We report results from field calibration and deployment tests of miniaturized proximity tags (Encounternet), digital transceivers that log encounters between tagged individuals. We examined radio signal behavior in relation to tag attachment (tag, tag on bird, tag on saline-filled balloon) to understand how radio signal strength is affected by the tag mounting technique used for calibration tests. We investigated inter-tag and inter-receiver station variability, and in each calibration test we accounted for the effects of antennae orientation. Additionally, we used data from a live deployment on breeding barn swallows (Hirundo rustica erythrogaster) to analyze the quality of the logs, including reciprocal agreement in dyadic logs. We evaluated the impact (in terms of mass changes) of tag attachment on the birds. We were able to statistically distinguish between RSSI values associated with different close-proximity (<5m) tag-tag distances regardless of antennae orientation. Inter-tag variability was low, but we did find significant inter-receiver station variability. Reciprocal agreement of dyadic logs was high and social networks were constructed from proximity tag logs based on two different RSSI thresholds. There was no evidence of significant mass loss in the time birds were wearing tags. We conclude that proximity loggers are accurate and effective for quantifying social behavior. However, because RSSI and distance cannot be perfectly resolved, data from proximity loggers are most appropriate for comparing networks based on specific RSSI thresholds. The Encounternet system is flexible and customizable, and tags are now light enough for use on small animals (<50g).	[Levin, Iris I.; Zonana, David M.; Safran, Rebecca J.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Burt, John M.] Encounternet LLC, Portland, OR USA; [Burt, John M.] Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	University of Colorado System; University of Colorado Boulder; University of Washington; University of Washington Seattle	Levin, II (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	Iris.Levin@colorado.edu		Zonana, David/0000-0002-1599-8913	University of Colorado; National Science Foundation [1306059]	University of Colorado; National Science Foundation(National Science Foundation (NSF))	Funding for this research was provided by a University of Colorado Innovative Seed Grant award. I. Levin was supported by a National Science Foundation Postdoctoral Research Fellowship No. 1306059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082316; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Blonder B, 2012, METHODS ECOL EVOL, V3, P958, DOI 10.1111/j.2041-210X.2012.00236.x; Boyland NK, 2013, BEHAV ECOL SOCIOBIOL, V67, P1877, DOI 10.1007/s00265-013-1622-6; Bridge ES, 2013, J FIELD ORNITHOL, V84, P121, DOI 10.1111/jofo.12011; Castles M, 2014, ANIM BEHAV, V96, P59, DOI 10.1016/j.anbehav.2014.07.023; Cross PC, 2013, ECOLOGY, V94, P2076, DOI 10.1890/12-2086.1; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Drewe JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039068; Fair J., 2010, ORNITHOLOGICAL COUNC; Farine DR, 2015, ANIM BEHAV, V104, pE1, DOI 10.1016/j.anbehav.2014.11.019; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Hobson EA, 2013, ANIM BEHAV, V85, P83, DOI 10.1016/j.anbehav.2012.10.010; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Krause J, 2011, TRENDS ECOL EVOL, V26, P5, DOI 10.1016/j.tree.2010.10.004; Kuznetsova A, 2014, LMER TEST TESTS RAND; Meise K, 2013, AQUAT BIOL, V18, P81, DOI 10.3354/ab00492; Mennill DJ, 2012, METHODS ECOL EVOL, V3, P663, DOI 10.1111/j.2041-210X.2012.00206.x; Naef-Daenzer B, 2005, J EXP BIOL, V208, P4063, DOI 10.1242/jeb.01870; Naef-Daenzer B, 2007, J AVIAN BIOL, V38, P404, DOI 10.1111/j.2007.0908-8857.03863.x; Patison KP, 2010, APPL ANIM BEHAV SCI, V128, P10, DOI 10.1016/j.applanim.2010.10.001; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Ralls K, 2013, J MAMMAL, V94, P1185, DOI 10.1644/13-MAMM-A-057.1; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Rutz C, 2015, METHODS ECOL EVOL, V6, P656, DOI 10.1111/2041-210X.12370; Rutz C, 2012, CURR BIOL, V22, pR669, DOI 10.1016/j.cub.2012.06.037; Ryder TB, 2012, BIOL LETTERS, V8, P917, DOI 10.1098/rsbl.2012.0536; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Snijders L, 2014, ANIM BEHAV, V98, P95, DOI 10.1016/j.anbehav.2014.09.029; Vitousek MN, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0539; Walrath R, 2011, WILDLIFE SOC B, V35, P452, DOI 10.1002/wsb.76; Watson-Haigh NS, 2012, IEEE SENS J, V12, P1611, DOI 10.1109/JSEN.2011.2175215; Weber N, 2013, CURR BIOL, V23, pR915, DOI 10.1016/j.cub.2013.09.011; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020	38	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137242	10.1371/journal.pone.0137242	http://dx.doi.org/10.1371/journal.pone.0137242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348329	gold, Green Published, Green Submitted			2022-12-27	WOS:000360897600028
J	Shao, YZ; Wei, R; Zhang, XC; Xiang, QP				Shao, Yizhen; Wei, Ran; Zhang, Xianchun; Xiang, Qiaoping			Molecular Phylogeny of the Cliff Ferns (Woodsiaceae: Polypodiales) with a Proposed Infrageneric Classification	PLOS ONE			English	Article							EUPOLYPOD II FERNS; RBCL NUCLEOTIDE-SEQUENCES; F REGION SEQUENCES; GENE-SEQUENCES; ATHYRIACEAE; INFERENCE; INSIGHTS; MRBAYES	The cliff fern family Woodsiaceae has experienced frequent taxonomic changes at the familial and generic ranks since its establishment. The bulk of its species were placed in Woodsia, while Cheilanthopsis, Hymenocystis, Physematium, and Protowoodsia are segregates recognized by some authors. Phylogenetic relationships among the genera of Woodsiaceae remain unclear because of the extreme morphological diversity and inadequate taxon sampling in phylogenetic studies to date. In this study, we carry out comprehensive phylogenetic analyses of Woodsiaceae using molecular evidence from four chloroplast DNA markers (atpA, matK, rbcL and trnL-F) and covering over half the currently recognized species. Our results show three main clades in Woodsiaceae corresponding to Physematium (clade I), Cheilanthopsis-Protowoodsia (clade II) and Woodsia s.s. (clade III). In the interest of preserving monophyly and taxonomic stability, a broadly defined Woodsia including the other segregates is proposed, which is characterized by the distinctive indument and inferior indusia. Therefore, we present a new subgeneric classification of the redefined Woodsia based on phylogenetic and ancestral state reconstructions to better reflect the morphological variation, geographic distribution pattern, and evolutionary history of the genus. Our analyses of the cytological character evolution support multiple aneuploidy events that have resulted in the reduction of chromosome base number from 41 to 33, 37, 38, 39 and 40 during the evolutionary history of the cliff ferns.	[Shao, Yizhen; Wei, Ran; Zhang, Xianchun; Xiang, Qiaoping] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China; [Shao, Yizhen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiang, QP (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China.	qpxiang@ibcas.ac.cn	WEI, RAN/M-1994-2018	WEI, RAN/0000-0001-7393-9965; Xiang, Qiao-Ping/0000-0003-3028-7244	National Natural Science Foundation of China [31370260, 31170199]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31370260, 31170199).	ALSTON A. H. G., 1956, TAXON, V5, P23, DOI 10.2307/1216940; Brown DFM, 1964, NOVA HEDWIGIA S, V16, P1; Brown R., 1810, PRODROMUS FLORAE NOV; CHING R. C., 1954, ACTA PHYTOTAXONOMICA, V3, P93; CHING RC, 1978, ACTA PHYTOTAX SINICA, V16, P1; Ching RC., 1940, SUNYATSENIA, V5, P1; Christenhusz MJM, 2011, PHYTOTAXA, V19, P7, DOI 10.11646/phytotaxa.19.1.2; Christensen C., 1938, MANUAL PTERIDOLOGY, P522, DOI [10.1007/978-94-017-6111-6_20, DOI 10.1007/978-94-017-6111-6_20]; Copeland EB, 1947, GENERA FILICUM; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; Flora of North America Editorial Committee, 1993, FLORA N AM N MEXICO, V2, P270; Hall T.A., 1999, BIOEDIT USER FRIENDL; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Hasebe M, 1995, AM FERN J, V85, P134, DOI 10.2307/1547807; Hieronymus G., 1920, NOTIZBLATT BOT GARTE, V7, P406, DOI [10.2307/3994377, DOI 10.2307/3994377]; HOLTTUM RE, 1949, BIOL REV, V24, P267, DOI 10.1111/j.1469-185X.1949.tb00577.x; Hooker W. J., 1846, SPECIES FILICUM, V1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Kaulfuss GF, 1829, FLORA, V12, P341; KRAMER KU, 1990, PTERIDOPHYTES GYMNOS, P130; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Kurita S., 1965, J JAP BOT, V40, P358; Larsson A., 2014, THESIS; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lovis JD, 1977, ADV BOT RES, V4, P229, DOI DOI 10.1016/S0065-2296(08)60371-7; Ma YL, 1983, THESIS CAS BEIJING; Maddison WP, 2011, MESQUITE MODULAR SYS; Manton I., 1950, PROBLEMS CYTOLOGY EV; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Mickel J, 2004, PTERIDOPHYTES MEXI 1, P686; Murakami N, 1999, AM FERN J, V89, P232, DOI 10.2307/1547233; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, TRACER V1 5; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rothfels CJ, 2012, TAXON, V61, P515, DOI 10.1002/tax.613003; Rothfels CJ, 2012, SYST BIOL, V61, P490, DOI 10.1093/sysbio/sys001; Sano R, 2000, MOL PHYLOGENET EVOL, V15, P403, DOI 10.1006/mpev.1999.0708; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Shmakov AI, 2003, PTERIDOLOGY IN THE NEW MILLENNIUM, P49; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Smith AR, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P417, DOI 10.1017/CBO9780511541827.017; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stolze RG, 1994, FLORA ECUADOR, V49, P101; Sundue MA, 2014, ANN BOT-LONDON, V113, P35, DOI 10.1093/aob/mct247; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tagawa M, 1972, COLOURED ILLUSTRATIO; Tagawa M, 1937, ACTA PHYTOTAXONOMICA, V6, P251; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tryon R. M., 1982, FERNS ALLIED PLANTS; Wang L, 2010, MOL PHYLOGENET EVOL, V54, P211, DOI 10.1016/j.ympev.2009.08.032; Wang Ma-Li, 2008, Bulletin of Botanical Research, V28, P175; Wang ML, 2002, ACTA PHYTOTAXON SIN, V41, P416; WEI R, 2010, ACTA BOT YUNNAN, V17, P46; Wei R, 2013, TAXON, V62, P441, DOI 10.12705/623.8; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Wu SH, 1999, FLORA REIPUBLICAE PO, V4, P166; WU SK, 1991, FERN FAMILIES GENERA; Zhang GM, 2013, FLORA CHINA, V2-3, P397	61	7	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136318	10.1371/journal.pone.0136318	http://dx.doi.org/10.1371/journal.pone.0136318			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348852	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600005
J	Strube-Bloss, MF; Brown, A; Spaethe, J; Schmitt, T; Rossler, W				Strube-Bloss, Martin F.; Brown, Austin; Spaethe, Johannes; Schmitt, Thomas; Roessler, Wolfgang			Extracting the Behaviorally Relevant Stimulus: Unique Neural Representation of Farnesol, a Component of the Recruitment Pheromone of Bombus terrestris	PLOS ONE			English	Article							OLFACTORY OUTPUT NEURONS; ANTENNAL LOBE; MORPHOLOGICAL CHARACTERIZATION; ACQUISITION MEMORY; FLORAL SCENTS; HONEY-BEE; DROSOPHILA; ODOR; RESPONSES; ORGANIZATION	To trigger innate behavior, sensory neural networks are pre-tuned to extract biologically relevant stimuli. Many male-female or insect-plant interactions depend on this phenomenon. Especially communication among individuals within social groups depends on innate behaviors. One example is the efficient recruitment of nest mates by successful bumblebee foragers. Returning foragers release a recruitment pheromone in the nest while they perform a 'dance' behavior to activate unemployed nest mates. A major component of this pheromone is the sesquiterpenoid farnesol. How farnesol is processed and perceived by the olfactory system, has not yet been identified. It is much likely that processing farnesol involves an innate mechanism for the extraction of relevant information to trigger a fast and reliable behavioral response. To test this hypothesis, we used population response analyses of 100 antennal lobe (AL) neurons recorded in alive bumblebee workers under repeated stimulation with four behaviorally different, but chemically related odorants (geraniol, citronellol, citronellal and farnesol). The analysis identified a unique neural representation of the recruitment pheromone component compared to the other odorants that are predominantly emitted by flowers. The farnesol induced population activity in the AL allowed a reliable separation of farnesol from all other chemically related odor stimuli we tested. We conclude that the farnesol induced population activity may reflect a predetermined representation within the AL-neural network allowing efficient and fast extraction of a behaviorally relevant stimulus. Furthermore, the results show that population response analyses of multiple single AL-units may provide a powerful tool to identify distinct representations of behaviorally relevant odors.	[Strube-Bloss, Martin F.; Spaethe, Johannes; Schmitt, Thomas; Roessler, Wolfgang] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Theodor Boveri Inst Biosci, Bioctr, D-97074 Wurzburg, Germany; [Brown, Austin] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Wurzburg; University of Arizona	Strube-Bloss, MF (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Theodor Boveri Inst Biosci, Bioctr, Hubland, D-97074 Wurzburg, Germany.	martin.strube-bloss@uni-wuerzburg.de	Spaethe, Johannes/B-8826-2014; Rössler, Wolfgang/E-9526-2019	Rössler, Wolfgang/0000-0002-5195-8214; Strube-Bloss, Martin Fritz/0000-0001-8264-7534; Spaethe, Johannes/0000-0002-0734-2869	University of Arizona [HHMI 52001427]; DFG [SPP 1392, RO 1177/5-2]; German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation; University of Wurzburg	University of Arizona; DFG(German Research Foundation (DFG)); German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation(German Research Foundation (DFG)); University of Wurzburg	Austin Brown was funded by the HHMI 52001427 through the BRAVO! program of the University of Arizona. Further support was provided by the DFG Priority Program SPP 1392 "Integrative Analysis of Olfaction" (RO 1177/5-2 to WR). Martin Strube-Bloss was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. This publication was funded by the German Research Foundation and the University of Wurzburg in the funding program Open Access Publishing.	Abel R, 2001, J COMP NEUROL, V437, P363, DOI 10.1002/cne.1289; Acebes A, 2001, J NEUROSCI, V21, P6264, DOI 10.1523/JNEUROSCI.21-16-06264.2001; Ayasse M, 2014, ANNU REV ENTOMOL, V59, P299, DOI 10.1146/annurev-ento-011613-161949; Bergman P, 1997, J CHEM ECOL, V23, P1235, DOI 10.1023/B:JOEC.0000006461.69512.33; Beyaert I, 2010, ANIM BEHAV, V79, P1077, DOI 10.1016/j.anbehav.2010.02.001; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Brill MF, 2014, JOVE-J VIS EXP, DOI 10.3791/51750; Carcaud J, 2015, J NEUROSCI, V35, P4157, DOI 10.1523/JNEUROSCI.0734-14.2015; Chaffiol A, 2014, CHEM SENSES, V39, P451, DOI 10.1093/chemse/bju017; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dani FR, 2005, CHEM SENSES, V30, P477, DOI 10.1093/chemse/bji040; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Deisig N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033159; Dornhaus A, 2003, J COMP PHYSIOL A, V189, P47, DOI 10.1007/s00359-002-0374-y; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FONTA C, 1984, J CHEM ECOL, V10, P1157, DOI 10.1007/BF00988546; FREE JB, 1981, PHYSIOL ENTOMOL, V6, P263, DOI 10.1111/j.1365-3032.1981.tb00270.x; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; Galizia CG, 2004, J COMP PHYSIOL A, V190, P21, DOI 10.1007/s00359-003-0469-0; Grabe V, 2015, J COMP NEUROL, V523, P530, DOI 10.1002/cne.23697; Granero AM, 2005, NATURWISSENSCHAFTEN, V92, P371, DOI 10.1007/s00114-005-0002-0; HANSSON BS, 1991, J COMP NEUROL, V312, P264, DOI 10.1002/cne.903120209; Heinbockel T, 2013, J COMP PHYSIOL A, V199, P929, DOI 10.1007/s00359-013-0842-6; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hong EJ, 2015, NEURON, V85, P573, DOI 10.1016/j.neuron.2014.12.040; Hussaini SA, 2009, LEARN MEMORY, V16, P698, DOI 10.1101/lm.1578409; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Junker RR, 2010, PLANT SIGNAL BEHAV, V5, P1014, DOI 10.4161/psb.5.8.12289; Junker RR, 2010, ANN BOT-LONDON, V105, P777, DOI 10.1093/aob/mcq045; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; Kleineidam CJ, 2005, CHEM SENSES, V30, P383, DOI 10.1093/chemse/bji033; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; KNUDSEN JT, 1993, PHYTOCHEMISTRY, V33, P253, DOI 10.1016/0031-9422(93)85502-I; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Laissue PP, 1999, J COMP NEUROL, V405, P543; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; McCormick AC, 2014, PLANT CELL ENVIRON, V37, P1909, DOI 10.1111/pce.12287; Meier R, 2008, NEURAL NETWORKS, V21, P1085, DOI 10.1016/j.neunet.2008.06.019; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Muller D, 2002, J COMP PHYSIOL A, V188, P359, DOI 10.1007/s00359-002-0310-1; Namiki S, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.001.2008; Nawrot M, 1999, J NEUROSCI METH, V94, P81, DOI 10.1016/S0165-0270(99)00127-2; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Pamir E, 2011, LEARN MEMORY, V18, P733, DOI 10.1101/lm.2232711; Pregitzer P, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00042; Rossler W, 2011, ARTHROPOD STRUCT DEV, V40, P349, DOI 10.1016/j.asd.2010.12.001; Ronderos DS, 2014, J NEUROSCI, V34, P3959, DOI 10.1523/JNEUROSCI.4582-13.2014; ROSPARS JP, 1992, CELL TISSUE RES, V270, P205, DOI 10.1007/BF00328007; Roussel E, 2014, CURR BIOL, V24, P561, DOI 10.1016/j.cub.2014.01.063; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Schiestl FP, 2000, BEHAV ECOL SOCIOBIOL, V48, P303, DOI 10.1007/s002650000241; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Silbering AF, 2008, J NEUROSCI, V28, P13075, DOI 10.1523/JNEUROSCI.2973-08.2008; Sommerlandt FMJ, 2014, APIDOLOGIE, V45, P106, DOI 10.1007/s13592-013-0227-4; Stollhoff N, 2005, J NEUROSCI, V25, P4485, DOI 10.1523/JNEUROSCI.0117-05.2005; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Strube-Bloss MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050322; Strube-Bloss MF, 2011, J NEUROSCI, V31, P3129, DOI 10.1523/JNEUROSCI.2583-10.2011; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Thai L, 1999, P NATL ACAD SCI USA, V96, P13080, DOI 10.1073/pnas.96.23.13080; Tinbergen, 1951, STUDY INSTINCT; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1; Zube C, 2008, J COMP NEUROL, V506, P425, DOI 10.1002/cne.21548	77	9	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137413	10.1371/journal.pone.0137413	http://dx.doi.org/10.1371/journal.pone.0137413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340263	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200055
J	Telldahl, Y				Telldahl, Ylva			Ageing Cattle: The Use of Radiographic Examinations on Cattle Metapodials from Eketorp Ringfort on the Island of Oland in Sweden	PLOS ONE			English	Article							BONE DIAGENESIS; DENSITY; CALCIUM; AGE; REPRESENTATION; LACTATION; PATTERNS; EXERCISE; GROWTH; SHEEP	In this paper conventional X-ray analysis of cattle metapodials is used to study the age structure of slaughtered cattle at Eketorp ringfort on the island of Oland, Sweden. The X-ray analyses suggest that several animals in both phases were slaughtered aged 4-8 years. More oxen/bulls than cows reached the advanced age of over 8 years, yet in phase III more oxen/bulls seem to have been slaughtered between the ages of 2 and 8 years. These differences may reflect a change in demand for meat related to the character of the site. The results also show a correlation between metapodials with a pathology connected to biomechanical stress and older animals. This suggests that male cattle were used both in meat production and as draught animals. Asymmetry in male metatarsals such as distal broadening of the lateral part of the medial trochlea was visible on the X-ray images. The bone element also indicates a denser outer cortex of the medial diaphysis in comparison to the inner medulla. This could be the result of repetitive mechanical stress. Two metatarsals from cows were documented with distal asymmetry indicating that cows were also used as working animals. Bone elements with changes in the articular surfaces were more common in metapodials from cows with an X-ray age of over 3-4 years. These results highlighted the slaughter age difference between oxen/bulls and cows, enabling a better understanding of animal husbandry and the selection of draught cattle at Eketorp ringfort.	Stockholm Univ, Osteoarchaeol Res Lab, Dept Archaeol & Class Studies, S-10691 Stockholm, Sweden	Stockholm University	Telldahl, Y (corresponding author), Stockholm Univ, Osteoarchaeol Res Lab, Dept Archaeol & Class Studies, Lilla Frescativagen 7, S-10691 Stockholm, Sweden.	ytelldahl@gmail.com						Albarella U., 1997, ANTHROPOZOOLOGICA, V25-6, P37; Bartosiewicz L, 1993, INT J OSTEOARCHAEOL, P69; BARTOSIEWICZ L., 1997, ANTHROPOZOOLOGICA, V25-26, P57; Bartosiewicz L., 1997, DRAUGHT CATTLE THEIR; Bartosiewicz L., 2008, DOCUMENTA ARCHAEOBIO, P153; BEHRENSMEYER A K, 1975, Bulletin of the Museum of Comparative Zoology, V146, P473; Bendrey R, 2007, INT J OSTEOARCHAEOL, V17, P207, DOI 10.1002/oa.875; BENZIE D., 1959, JOUR AGRIC SCI, V52, P1, DOI 10.1017/S0021859600035620; Binford L. R., 1977, THEORY BUILDING ARCH; Bjomhag G, 1994, SVENSKA HUSDJUR FRAN, P75; Boessneck J, 1979, BEFESTIGUNG SIEDLUNG; Borg K, 1999, EKETORP 3 MEDELTIDSA; BRAITHWAITE GD, 1983, BRIT J NUTR, V50, P711, DOI 10.1079/BJN19830143; BURT JK, 1968, J AM VET MED ASSOC, V152, P168; CERVENY C, 1980, ACTA VET BRNO, V49, P11, DOI 10.2754/avb198049010011; CHILD AM, 1995, STUD CONSERV, V40, P19, DOI 10.2307/1506608; CHILIBECK PD, 1995, SPORTS MED, V19, P103, DOI 10.2165/00007256-199519020-00003; Columella LJM, 2009, DE RE RUSTICA; Cuijpers AGFM, 2009, THESIS AMSTERDAM; Ends von DW, 1984, J ARCHAEOL SCI, P765; Farquharson MJ, 1997, J ARCHAEOL SCI, V24, P765, DOI 10.1006/jasc.1996.0158; Fernandez-Jalvo Y, 2010, PALAEOGEOGR PALAEOCL, V288, P62, DOI 10.1016/j.palaeo.2009.12.016; Field RAGW, 1999, PROFESSIONAL ANIMAL, P169; Gifford-Gonzalez D., 1989, BONE MODIFICATION, P179, DOI DOI 10.1002/1097-0185(20001215)261:6237::AID-AR10063.0.CO;2-N; GORDON CC, 1981, AM ANTIQUITY, V46, P566, DOI 10.2307/280601; Grant A., 1982, BAR BRIT SERIES, V109, P91; Habermehl K. H., 1975, ALTERSBESTIMMUNG BEI, V2; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; Herschend F., 2009, EARLY IRON AGE S SCA; Hiney KM, 2004, J ANIM SCI, V82, P1612; Holdar CG, 1976, EKETORP FORTIFICATIO, P1001; Horst RL, 1997, J DAIRY SCI, V80, P1269, DOI 10.3168/jds.S0022-0302(97)76056-9; Jans MME, 2004, J ARCHAEOL SCI, V31, P87, DOI 10.1016/j.jas.2003.07.007; Johannsen N., 2011, PRESENT HUMAN ANIMAL, P12; Karr LP, 2015, INT J OSTEOARCHAEOL, V25, P201, DOI 10.1002/oa.2275; Kaufmann RK, 2001, PNAS, V108, P11790; Knowlton KF, 2002, J DAIRY SCI, V85, P1227, DOI 10.3168/jds.S0022-0302(02)74186-6; Konigsson LK, 1968, HOLOCENE HIST GREAT; Kratochvil Z, 1988, PAMATKY ARCHAEOLOGIC, P456; KREUTZER LA, 1992, J ARCHAEOL SCI, V19, P271, DOI 10.1016/0305-4403(92)90017-W; Lam YM, 1999, AM ANTIQUITY, V64, P343, DOI 10.2307/2694283; LAMBERT JB, 1985, J ARCHAEOL SCI, V12, P85, DOI 10.1016/0305-4403(85)90053-6; LUICK JR, 1957, J NUTR, V61, P597; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Madgwick R, 2012, INT J OSTEOARCHAEOL, V22, P509, DOI 10.1002/oa.1274; MARSHALL F, 1991, J ARCHAEOL SCI, V18, P149, DOI 10.1016/0305-4403(91)90044-P; Muggli E, 2011, VET J, V188, P295, DOI 10.1016/j.tvjl.2010.05.016; Myrdal J., 1991, KONTINUITETENS DYNAM; Nasman U, 1976, EKETORP FORTIFICATIO, P45; Nielsen-Marsh C, 2000, HUMAN OSTEOLOGY ARCH, P439; Nord AG, 2005, J NORDIC ARCHAEOLOGI, V15, P77; OSORO K, 1992, J ANIM SCI, V70, P1661, DOI 10.2527/1992.7061661x; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; PALSSON H, 1952, J AGR SCI-CAMBRIDGE, V42, P1, DOI 10.1017/S0021859600058718; Paral V, 2004, ACTA VET BRNO, V73, P413, DOI 10.2754/avb200473040413; Popkin PRW, 2012, J ARCHAEOL SCI, V39, P1775, DOI 10.1016/j.jas.2012.01.018; Prummel W., 1987, ARCHAEOZOOLOGIA, V2, P11; Reitz E.J., 2008, ZOOARCHAEOLOGY; Salesse K, 2014, PALAEOGEOGR PALAEOCL, V416, P43, DOI 10.1016/j.palaeo.2014.07.021; Shackelford L, 2013, J ARCHAEOL SCI, V40, P4170, DOI 10.1016/j.jas.2013.06.006; Silver A, 1969, SCI ARCHAEOLOGY; Sisson S, 1956, ANATOMY DOMESTIC ANI; Smith CI, 2007, J ARCHAEOL SCI, V34, P1485, DOI 10.1016/j.jas.2006.11.006; Smith R. N., 1956, Veterinary Record, V68, P257; Sterba O, 2004, ACTA VET BRNO, V73, P405, DOI 10.2754/avb200473040405; Symmons R, 2005, J ARCHAEOL SCI, V32, P1691, DOI 10.1016/j.jas.2005.05.011; Telldahl Y, 2012, J ARCHAEOL SCI, V39, P121, DOI 10.1016/j.jas.2011.09.009; Telldahl Y, 2012, INT J PALEOPATHOL, V2, P208, DOI 10.1016/j.ijpp.2012.09.002; Telldahl Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020748; TERNOUTH JH, 1990, TROP GRASSLANDS, V24, P159; Truemann CNG, 2004, J ARCHAEOL SCI, P721; Tschirvinsky N, 1909, ANN I POLYTECHNIQUE, P1; Turner-Walker G., 2008, ADV HUMAN PALAEOPATH, P1; Vretemark M, 1994, SVENSKA HUSDJUR FRAN, V5, P55; WILLIAMS SN, 1991, J ANIM SCI, V69, P1243; Zaki ME, 2009, INT J OSTEOARCHAEOL, V19, P78, DOI 10.1002/oa.978	76	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137109	10.1371/journal.pone.0137109	http://dx.doi.org/10.1371/journal.pone.0137109			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336086	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400041
J	Fukuhara, H; Kureishi, M; Khoda, T; Inoue, K; Tanaka, T; Iketani, K; Orita, M; Inoue, K; Shuin, T				Fukuhara, Hideo; Kureishi, Mitsuhiro; Khoda, Takeo; Inoue, Katsushi; Tanaka, Tohru; Iketani, Kohei; Orita, Masahiro; Inoue, Keiji; Shuin, Taro			The Utility of a Flexible Fluorescence-Cystoscope with a Twin Mode Monitor for the 5-Aminolevulinic Acid-Mediated Photodynamic Diagnosis of Bladder Cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; INTRAVESICAL THERAPY; ENDOSCOPY; LESIONS; TUMORS	Objectives To evaluate the diagnostic value of a new photodynamic diagnosis (PDD) system using 5aminolevulinic acid (ALA) for the diagnosis of bladder tumors. To validate whether falsepositive findings caused by tangent effects in PDD can be resolved, we compared diagnostic accuracies between the new PDD system and a conventional PDD system. Patients and Methods Among 30 transurethral bladder biopsies, 15 cases received ALA-PDD using rigid fluorescence cystoscopy (conventional PDD system), and flexible fluorescence cystoscopy with a twin mode monitor (new PDD system) was used in a separate set of 15 cases. To evaluated the usefulness of ALA-PDD, diagnostic accuracies were retrospectively compared between the conventional PDD system and the new PDD system. Results Of 207 specimens from 30 cases, we obtained 110 specimens using the conventional PDD system and 97 specimens using the new PDD system. Of these samples, we selected 30 distal bladder specimens each from both the conventional PDD system and the new PDD system. The overall sensitivity, specificity and false-positive rate for the new PDD system were 100%, 82.6%, and 17.4%, respectively. Those of the conventional PDD system were 83.3%, 66.2% and 33.8%, respectively. The overall false-positive rate of the new PDD system improved to 16.4% when compared with the conventional PDD system. Furthermore, the false-positive rate of the new PDD system in distal bladder samples improved to 11.8%. The overall AUC of the new PDD system was significantly greater compared with that of the conventional PDD system (P<0.05). We obtained similar significant results in the distal bladder samples (P<0.05). All procedures were well tolerated by all patients without any severe adverse events. Conclusion Flexible cystoscopy had a significantly higher specificity and improved incidence of tangent effects when compared with conventional methods. This preliminary study suggests that the new PDD system using 5-aminolevulinic acid may be more useful than the conventional PDD system.	[Fukuhara, Hideo; Inoue, Keiji; Shuin, Taro] Kochi Med Sch, Dept Urol, Nankoku, Kochi 7838505, Japan; [Kureishi, Mitsuhiro; Iketani, Kohei; Orita, Masahiro] HOYA Corp, R&D Ctr, Akishima, Tokyo 1968510, Japan; [Khoda, Takeo; Inoue, Katsushi; Tanaka, Tohru] SBI Pharmaceut Co Ltd, Tokyo 1066020, Japan	Kochi University; SBI Pharmaceuticals	Inoue, K (corresponding author), Kochi Med Sch, Dept Urol, Nankoku, Kochi 7838505, Japan.	keiji@kochi-u.ac.jp			HOYA Corporation Pharmaceutical Company; SBI Pharmaceutical Company	HOYA Corporation Pharmaceutical Company; SBI Pharmaceutical Company	The funder (HOYA Corporation and SBI Pharmaceuticals Company) provided support for HF, IK, and TS.	[Anonymous], 2004, EFSA J, V1, P1; Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Divisi D, 2010, INTERACT CARDIOV TH, V11, P740, DOI 10.1510/icvts.2010.242123; Draga ROP, 2010, EUR UROL, V57, P655, DOI 10.1016/j.eururo.2009.09.037; Draga ROP, 2009, UROLOGY, V74, P851, DOI 10.1016/j.urology.2009.04.095; Filbeck T, 1999, UROLOGY, V53, P77, DOI 10.1016/S0090-4295(98)00430-0; Frimberger D, 2001, UROLOGY, V58, P372, DOI 10.1016/S0090-4295(01)01222-5; Grimbergen MCM, 2003, EUR UROL, V44, P51, DOI 10.1016/S0302-2838(03)00210-0; Hungerhuber E, 2007, UROLOGY, V69, P260, DOI 10.1016/j.urology.2006.10.015; Inoue K, 2012, CANCER-AM CANCER SOC, V118, P1062, DOI 10.1002/cncr.26378; Inoue Keiji, 2006, Nihon Hinyokika Gakkai Zasshi, V97, P719; Japan Urological Association, 2001, GEN RUL CLIN PATH ST; Jemal A., 2010, CA-CANCER J CLIN, V60, P277, DOI DOI 10.3322/caac.20073; Junker K, 2002, INT J ONCOL, V20, P647; Karl A, 2014, J CLIN TRIALS, p[4, 190]; Koenig F, 1999, BJU INT, V83, P129, DOI 10.1046/j.1464-410X.1999.00917.x; KRIEGMAIR M, 1994, UROLOGY, V44, P836, DOI 10.1016/S0090-4295(94)80167-3; Kriegmair M, 1996, J UROLOGY, V155, P105, DOI 10.1016/S0022-5347(01)66559-5; Lee R, 2000, UROL CLIN N AM, V27, P1, DOI 10.1016/S0094-0143(05)70229-9; Loidl W, 2005, EUR UROL, V47, P323, DOI 10.1016/j.eururo.2004.10.025; Matsuda T, 2011, JPN J CLIN ONCOL, V41, P139, DOI 10.1093/jjco/hyq169; Miyoshi N, 2002, JAP SOC LASER MED, V23, P81; Riedl CR, 1999, J ENDOUROL, V13, P755, DOI 10.1089/end.1999.13.755; Witjes JA, 2005, EUR UROL, V47, P319, DOI 10.1016/j.eururo.2004.09.017; Zaak D, 2002, CANCER-AM CANCER SOC, V95, P1234, DOI 10.1002/cncr.10821; Zaak D, 2001, UROLOGY, V57, P690, DOI 10.1016/S0090-4295(00)01053-0	26	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136416	10.1371/journal.pone.0136416	http://dx.doi.org/10.1371/journal.pone.0136416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332041	Green Submitted, gold, Green Published			2022-12-27	WOS:000360613800056
J	Gilman, CA; Imburgia, MJ; Bartlett, MD; King, DR; Crosby, AJ; Irschick, DJ				Gilman, Casey A.; Imburgia, Michael J.; Bartlett, Michael D.; King, Daniel R.; Crosby, Alfred J.; Irschick, Duncan J.			Geckos as Springs: Mechanics Explain Across-Species Scaling of Adhesion	PLOS ONE			English	Article							CLINGING ABILITY; HABITAT USE; MORPHOLOGY; REPTILIA; FORCE; PERFORMANCE; BEARING; PAD	One of the central controversies regarding the evolution of adhesion concerns how adhesive force scales as animals change in size, either among or within species. A widely held view is that as animals become larger, the primary mechanism that enables them to climb is increasing pad area. However, prior studies show that much of the variation in maximum adhesive force remains unexplained, even when area is accounted for. We tested the hypothesis that maximum adhesive force among pad-bearing gecko species is not solely dictated by toepad area, but also depends on the ratio of toepad area to gecko adhesive system compliance in the loading direction, where compliance (C) is the change in extension (Delta) relative to a change in force (F) while loading a gecko's adhesive system (C = d Delta/dF). Geckos are well-known for their ability to climb on a range of vertical and overhanging surfaces, and range in mass from several grams to over 300 grams, yet little is understood of the factors that enable adhesion to scale with body size. We examined the maximum adhesive force of six gecko species that vary in body size (similar to 2-100 g). We also examined changes between juveniles and adults within a single species (Phelsuma grandis). We found that maximum adhesive force and toepad area increased with increasing gecko size, and that as gecko species become larger, their adhesive systems become significantly less compliant. Additionally, our hypothesis was supported, as the best predictor of maximum adhesive force was not toepad area or compliance alone, but the ratio of toepad area to compliance. We verified this result using a synthetic "model gecko" system comprised of synthetic adhesive pads attached to a glass substrate and a synthetic tendon (mechanical spring) of finite stiffness. Our data indicate that increases in toepad area as geckos become larger cannot fully account for increased adhesive abilities, and decreased compliance must be included to explain the scaling of adhesion in animals with dry adhesion systems.	[Gilman, Casey A.; Irschick, Duncan J.] Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA; [Imburgia, Michael J.; Bartlett, Michael D.; King, Daniel R.; Crosby, Alfred J.] Univ Massachusetts, Polymer Sci & Engn Dept, Amherst, MA 01003 USA; [Irschick, Duncan J.] Univ Massachusetts, Dept Biol, Amherst, MA USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Crosby, AJ (corresponding author), Univ Massachusetts, Polymer Sci & Engn Dept, Amherst, MA 01003 USA.	crosby@mail.pse.umass.edu; irschick@bio.umass.edu	King, Daniel/K-6804-2019; Bartlett, Michael/A-7061-2017	King, Daniel/0000-0002-1377-5556; Bartlett, Michael/0000-0002-7391-5135; Crosby, Alfred/0000-0001-8850-8869	Human Frontiers Science Program [RGP -0034-2012]; HFSP	Human Frontiers Science Program(Human Frontier Science Program); HFSP(Human Frontier Science Program)	This work was supported by Human Frontiers Science Program grant to D. Irschick, A. Crosby and W. Federle (RGP -0034-2012, www.hfsp.org). HFSP provided funding and the authors have shown them the data in the form of a presentation in the summer of 2014 at a meeting; however, they have not participated in any aspect of the science.	Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100; Autumn K, 2006, AM SCI, V94, P124, DOI 10.1511/2006.58.124; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Autumn K, 2008, PHILOS T R SOC A, V366, P1575, DOI 10.1098/rsta.2007.2173; BARQUINS M, 1983, J APPL POLYM SCI, V28, P2647, DOI 10.1002/app.1983.070280816; Bartlett MD, 2013, LANGMUIR, V29, P11022, DOI 10.1021/la4013526; Bartlett MD, 2012, ADV FUNCT MATER, V22, P4985, DOI 10.1002/adfm.201201344; Bartlett MD, 2012, ADV MATER, V24, P1078, DOI 10.1002/adma.201104191; Bauer A.M., 1986, P363; BAUER AM, 1988, CAN J ZOOL, V66, P1583, DOI 10.1139/z88-231; Bergmann PJ, 2005, J EXP ZOOL PART A, V303A, P785, DOI 10.1002/jez.a.210; Creton C, 2007, MRS BULL, V32, P466, DOI 10.1557/mrs2007.79; Elstrott J, 2004, BIOL J LINN SOC, V83, P389, DOI 10.1111/j.1095-8312.2004.00402.x; ERNST V, 1966, J MORPHOL, V120, P233, DOI 10.1002/jmor.1051200303; Federle W, 2006, J R SOC INTERFACE, V3, P689, DOI 10.1098/rsif.2006.0135; Gamble C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039429, 10.1371/journal.pone.0035982]; Gillies AG, 2014, J EXP BIOL, V217, P283, DOI 10.1242/jeb.092015; Gorb SN, 1998, P ROY SOC B-BIOL SCI, V265, P747, DOI 10.1098/rspb.1998.0356; Huber G, 2005, BIOL LETTERS, V1, P2, DOI 10.1098/rsbl.2004.0254; Irschick DJ, 2005, BIOL J LINN SOC, V85, P211, DOI 10.1111/j.1095-8312.2005.00486.x; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Irschick DJ, 2006, J COMP PHYSIOL A, V192, P1169, DOI 10.1007/s00359-006-0145-2; Jeong HE, 2009, NANO TODAY, V4, P335, DOI 10.1016/j.nantod.2009.06.004; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; King DR, 2014, ADV MATER, V26, P4345, DOI 10.1002/adma.201306259; Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968; Meiri S, 2010, J ZOOL, V281, P218, DOI 10.1111/j.1469-7998.2010.00696.x; Peattie AM, 2007, P NATL ACAD SCI USA, V104, P18595, DOI 10.1073/pnas.0707591104; Russell A.P., 1976, Linnean Soc Symp Ser, V3, P217; Russell AP, 2014, ACTA ZOOL-STOCKHOLM, V95, P299, DOI 10.1111/azo.12028; Russell AP, 2002, INTEGR COMP BIOL, V42, P1154, DOI 10.1093/icb/42.6.1154; RUSSELL AP, 1986, CAN J ZOOL, V64, P948, DOI 10.1139/z86-144; Sameoto D, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/10/103001; Scherge M., 2001, BIOL MICRO NANOTRIBO; Webster NB, 2009, ACTA ZOOL-STOCKHOLM, V90, P18, DOI 10.1111/j.1463-6395.2008.00324.x; WILLIAMS EE, 1982, SCIENCE, V215, P1509, DOI 10.1126/science.215.4539.1509	37	26	26	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134604	10.1371/journal.pone.0134604	http://dx.doi.org/10.1371/journal.pone.0134604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331621	gold, Green Submitted, Green Published			2022-12-27	WOS:000360613800012
J	Prause, N; Park, J; Leung, S; Miller, G				Prause, Nicole; Park, Jaymie; Leung, Shannon; Miller, Geoffrey			Women's Preferences for Penis Size: A New Research Method Using Selection among 3D Models	PLOS ONE			English	Article							UNITED-STATES; LENGTHENING PROCEDURES; CATEGORY KNOWLEDGE; SEXUAL HEALTH; HUMAN VAGINA; CONDOM USE; YOUNG MEN; INTERCOURSE; EXPERIENCE; DIMENSIONS	Women's preferences for penis size may affect men's comfort with their own bodies and may have implications for sexual health. Studies of women's penis size preferences typically have relied on their abstract ratings or selecting amongst 2D, flaccid images. This study used haptic stimuli to allow assessment of women's size recall accuracy for the first time, as well as examine their preferences for erect penis sizes in different relationship contexts. Women (N = 75) selected amongst 33, 3D models. Women recalled model size accurately using this method, although they made more errors with respect to penis length than circumference. Women preferred a penis of slightly larger circumference and length for one-time (length = 6.4 inches/16.3 cm, circumference = 5.0 inches/12.7 cm) versus long-term (length = 6.3 inches/16.0 cm, circumference = 4.8 inches/12.2 cm) sexual partners. These first estimates of erect penis size preferences using 3D models suggest women accurately recall size and prefer penises only slightly larger than average.	[Prause, Nicole; Park, Jaymie; Leung, Shannon] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90089 USA; [Miller, Geoffrey] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	University of California System; University of California Los Angeles; University of New Mexico	Prause, N (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90089 USA.	nicole.prause@gmail.com	Miller, Geoffrey/C-4145-2008	Miller, Geoffrey/0000-0002-6026-5372; Leung, Shannon/0000-0002-0855-3780				Althof SE, 2003, UROLOGY, V61, P888, DOI 10.1016/S0090-4295(03)00041-4; Anderson Sarah L, 2008, J Forensic Leg Med, V15, P306, DOI 10.1016/j.jflm.2007.12.007; Armstrong EA, 2012, AM SOCIOL REV, V77, P435, DOI 10.1177/0003122412445802; Awwad Z, 2005, INT J IMPOT RES, V17, P191, DOI 10.1038/sj.ijir.3901272; Backman K, TINKERCAD; Barnhart KT, 2006, HUM REPROD, V21, P1618, DOI 10.1093/humrep/del022; Baskin LS, 1997, J UROLOGY, V158, P1113, DOI 10.1016/S0022-5347(01)64400-8; Berman JR, 2000, EUR UROL, V38, P20, DOI 10.1159/000020247; Boas M, 2006, EUR J ENDOCRINOL, V154, P125, DOI 10.1530/eje.1.02066; Brody S, 2010, J SEX MED, V7, P2774, DOI 10.1111/j.1743-6109.2009.01469.x; Bunzeck N, 2012, HUM BRAIN MAPP, V33, P1309, DOI 10.1002/hbm.21288; Cheng PS, 2001, HORM RES, V55, P278, DOI 10.1159/000050013; Choi IH, 2011, ASIAN J ANDROL, V13, P710, DOI 10.1038/aja.2011.75; Crosby RA, 2013, J PRIM PREV, V34, P109, DOI 10.1007/s10935-013-0294-3; Dixson BJ, 2007, AM J HUM BIOL, V19, P88, DOI 10.1002/ajhb.20584; Dixson BJ, 2014, EVOL HUM BEHAV, V35, P73, DOI 10.1016/j.evolhumbehav.2013.10.003; Eisenman Russell, 2001, BMC Womens Health, V1, P1, DOI 10.1186/1472-6874-1-1; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Eschenbach DA, 2001, J INFECT DIS, V183, P913, DOI 10.1086/319251; Evans S, 2008, PHYSIOL BEHAV, V93, P783, DOI 10.1016/j.physbeh.2007.11.033; Fennell J, 2014, CONTRACEPTION, V89, P264, DOI 10.1016/j.contraception.2013.11.012; FISHER WA, 1983, J SEX RES, V19, P377, DOI 10.1080/00224498309551199; Francken AB, 2002, EUR UROL, V42, P426, DOI 10.1016/S0302-2838(02)00396-2; Furr KD, 1991, ANNALS OF SEX RESEAR, V4, P265; Gaissert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043062; Gaissert N, 2010, J VISION, V10, DOI 10.1167/10.11.2; Gebhard P, 1979, THE KINSEY DATA MARG; Grov C, 2010, ARCH SEX BEHAV, V39, P788, DOI 10.1007/s10508-008-9439-5; Herbenick D, 2014, J SEX MED, V11, P93, DOI 10.1111/jsm.12244; Herbenick D, 2013, J SEX MED, V10, P1516, DOI 10.1111/jsm.12124; Hoeken Z, 2012, REPLICATORG; Johnston L, 2014, PSYCHOLOGY OF MEN MA; Johnston L, 2014, PSYCHOL MEN MASCULIN, V15, P225, DOI 10.1037/a0033264; Jonason PK, 2011, J SEX RES, V48, P486, DOI 10.1080/00224499.2010.497984; Kang DH, 2012, AESTHET PLAST SURG, V36, P813, DOI 10.1007/s00266-012-9891-4; Khan S, 2012, BJU INT, V109, P740, DOI 10.1111/j.1464-410X.2011.10338.x; Kissinger P, 2013, SEX TRANSM INFECT, V89, pA38, DOI 10.1136/sextrans-2013-051184.0119; Kvalem I. L., 2014, CYBERPSYCHOLOGY, V8, DOI [10.5817/CP2014-4-4, DOI 10.5817/CP2014-4-4]; Lang P. J., 2008, TECHNICAL REPORT A 8; Lawrance KA, 1995, PERS RELATIONSHIP, V2, P267, DOI 10.1111/j.1475-6811.1995.tb00092.x; Lawson R, 2014, ATTEN PERCEPT PSYCHO, V76, P541, DOI 10.3758/s13414-013-0559-1; Lee AJ, 2014, EVOL HUM BEHAV, V35, P193, DOI 10.1016/j.evolhumbehav.2014.01.003; Li NP, 2006, J PERS SOC PSYCHOL, V90, P468, DOI 10.1037/0022-3514.90.3.468; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; LOCKE SD, 1995, J SOC BEHAV PERS, V10, P255; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; Mautz BS, 2013, P NATL ACAD SCI USA, V110, P6925, DOI 10.1073/pnas.1219361110; Mondaini N, 2002, INT J IMPOT RES, V14, P283, DOI 10.1038/sj.ijir.3900887; Nabil N, 2013, UROL INT, V90, P465, DOI 10.1159/000347044; Norman JF, 2011, ATTEN PERCEPT PSYCHO, V73, P908, DOI 10.3758/s13414-010-0053-y; Nugteren HM, 2010, J SEX MARITAL THER, V36, P109, DOI 10.1080/00926230903554438; Nummenmaa L, 2012, ARCH SEX BEHAV, V41, P1439, DOI 10.1007/s10508-012-9911-0; Pendergrass PB, 2003, GYNECOL OBSTET INVES, V55, P110, DOI 10.1159/000070184; Peter J, 2014, COMPUT HUM BEHAV, V36, P297, DOI 10.1016/j.chb.2014.03.071; Ponchietti R, 2001, EUR UROL, V39, P183, DOI 10.1159/000052434; Prah P, 2014, SEX TRANSM INFECT, V90, P90, DOI 10.1136/sextrans-2013-051360; RICHTERS J, 1995, VENEREOLOGY, V8, P77; Royer HR, 2013, J PEDIATR ADOL GYNEC, V26, P109, DOI 10.1016/j.jpag.2012.11.007; Schneider T, 2001, UROLOGY, V57, P314, DOI 10.1016/S0090-4295(00)00925-0; Sengezer M, 2002, ANN PLAS SURG, V48, P381; Shah J, 2002, BJU INT, V90, P586, DOI 10.1046/j.1464-410X.2002.02974.x; Siminoski K, 1993, ANN SEX RES, V6, P231, DOI DOI 10.1007/BF00849563; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; Simpson VJ, 2014, ARCH SEX BEHAV, V43, P1367, DOI 10.1007/s10508-014-0289-z; SOPER DE, 1991, CONTRACEPTION, V44, P21, DOI 10.1016/0010-7824(91)90103-M; Soylemez H, 2012, INT J IMPOT RES, V24, P126, DOI 10.1038/ijir.2011.53; Spector IP, 1996, J SEX MARITAL THER, V22, P175; Stulhofer A, 2006, ARCH SEX BEHAV, V35, P5, DOI 10.1007/s10508-006-8989-7; Tiggemann M, 2008, J HEALTH PSYCHOL, V13, P1163, DOI 10.1177/1359105308095971; Udelson D, 1999, INT J IMPOT RES, V11, P327, DOI 10.1038/sj.ijir.3900443; Vardi Y, 2000, UROLOGY, V56, P1035, DOI 10.1016/S0090-4295(00)00850-5; Veale D, 2014, J SEX MED, V11, P84, DOI 10.1111/jsm.12294; Wallen K, 2011, HORM BEHAV, V59, P780, DOI 10.1016/j.yhbeh.2010.12.004; Wallraven C, 2014, PSYCHON B REV, V21, P995, DOI 10.3758/s13423-013-0577-y; Wallraven C, 2014, PSYCHON B REV, V21, P976, DOI 10.3758/s13423-013-0563-4; WEIS DL, 1985, ARCH SEX BEHAV, V14, P421, DOI 10.1007/BF01542003; Wessells H, 1996, J UROLOGY, V156, P995, DOI 10.1016/S0022-5347(01)65682-9; Yildirim I, 2013, COGNITION, V126, P135, DOI 10.1016/j.cognition.2012.08.005; Zink T, 2010, J EMERG MED, V39, P113, DOI 10.1016/j.jemermed.2008.08.024	80	26	26	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0133079	10.1371/journal.pone.0133079	http://dx.doi.org/10.1371/journal.pone.0133079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26332467	Green Submitted, gold, Green Published			2022-12-27	WOS:000360613800003
J	Ueyama, T; Donishi, T; Ukai, S; Yamamoto, Y; Ishida, T; Tamagawa, S; Hotomi, M; Shinosaki, K; Yamanaka, N; Kaneoke, Y				Ueyama, Takashi; Donishi, Tomohiro; Ukai, Satoshi; Yamamoto, Yuta; Ishida, Takuya; Tamagawa, Shunji; Hotomi, Muneki; Shinosaki, Kazuhiro; Yamanaka, Noboru; Kaneoke, Yoshiki			Alterations of Regional Cerebral Blood Flow in Tinnitus Patients as Assessed Using Single-Photon Emission Computed Tomography	PLOS ONE			English	Article							SCORE IMAGING-SYSTEM; ALZHEIMERS-DISEASE; SPECT; PERFUSION; DISCRIMINATION; STIMULATION; MECHANISMS; ANATOMY; NETWORK; CORTEX	Tinnitus is the perception of phantom sound without an external auditory stimulus. Using neuroimaging techniques, such as positron emission tomography, electroencephalography, magnetoencephalography, and functional magnetic resonance imaging (fMRI), many studies have demonstrated that abnormal functions of the central nervous system are closely associated with tinnitus. In our previous research, we reported using resting-state fMRI that several brain regions, including the rectus gyrus, cingulate gyrus, thalamus, hippocampus, caudate, inferior temporal gyrus, cerebellar hemisphere, and medial superior frontal gyrus, were associated with tinnitus distress and loudness. To reconfirm these results and probe target regions for repetitive transcranial magnetic stimulation (rTMS), we investigated the regional cerebral blood flow (rCBF) between younger tinnitus patients (<60 years old) and the age-matched controls using single-photon emission computed tomography and easy Z-score imaging system. Compared with that of controls, the rCBF of tinnitus patients was significantly lower in the bilateral medial superior frontal gyri, left middle occipital gyrus and significantly higher in the bilateral cerebellar hemispheres and vermis, bilateral middle temporal gyri, right fusiform gyrus. No clear differences were observed between tinnitus patients with normal and impaired hearing. Regardless of the assessment modality, similar brain regions were identified as characteristic in tinnitus patients. These regions are potentially involved in the pathophysiology of chronic subjective tinnitus.	[Ueyama, Takashi; Yamamoto, Yuta] Wakayama Med Univ, Grad Sch, Dept Anat & Cell Biol, Wakayama, Japan; [Donishi, Tomohiro; Ishida, Takuya; Kaneoke, Yoshiki] Wakayama Med Univ, Grad Sch, Dept Syst Neurophysiol, Wakayama, Japan; [Ukai, Satoshi; Shinosaki, Kazuhiro] Wakayama Med Univ, Grad Sch, Dept Neuropsychiat, Wakayama, Japan; [Tamagawa, Shunji; Hotomi, Muneki; Yamanaka, Noboru] Wakayama Med Univ, Grad Sch, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Wakayama Medical University	Ueyama, T (corresponding author), Wakayama Med Univ, Grad Sch, Dept Anat & Cell Biol, Wakayama, Japan.	tueyama@wakayama-med.ac.jp	Yamamoto, Yuta/R-1143-2019	Yamamoto, Yuta/0000-0001-5225-6989; Ukai, Satoshi/0000-0002-9776-8379	Grants-in-Aid for Scientific Research [24590895, 15K19291] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; Bauer CA, 2013, HEARING RES, V295, P130, DOI 10.1016/j.heares.2012.03.009; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burton H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-3; Chan Yvonne, 2009, Discov Med, V8, P133; Elgoyhen AB, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00001; Farhadi M, 2010, J CEREBR BLOOD F MET, V30, P864, DOI 10.1038/jcbfm.2009.254; Fujii K, 2011, J EPIDEMIOL, V21, P299, DOI 10.2188/jea.JE20100124; Gardner A, 2002, NUCL MED COMMUN, V23, P429, DOI 10.1097/00006231-200205000-00002; Geven LI, 2014, NEUROSCIENCE, V256, P117, DOI 10.1016/j.neuroscience.2013.10.015; Husain FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026639; Husain FT, 2011, BRAIN RES, V1369, P74, DOI 10.1016/j.brainres.2010.10.095; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Kanetaka H, 2004, EUR J NUCL MED MOL I, V31, P975, DOI 10.1007/s00259-004-1491-3; Kleinjung T, 2005, OTOLARYNG HEAD NECK, V132, P566, DOI 10.1016/j.otohns.2004.09.134; Langguth B, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00015; Laureano MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087839; Lockwood AH, 1999, CEREB CORTEX, V9, P65, DOI 10.1093/cercor/9.1.65; Mahmoudian Saeid, 2013, Int Tinnitus J, V18, P20, DOI 10.5935/0946-5448.20130004; Mahmoudian S, 2012, J RES MED SCI, V17, P242; Matsuda H, 2007, AM J NEURORADIOL, V28, P731; Matsuda H, 2004, NUCL MED COMMUN, V25, P67, DOI 10.1097/00006231-200401000-00010; Matsuda H, 2007, J NUCL MED, V48, P1289, DOI 10.2967/jnumed.106.037218; Matsuda H, 2007, NUCL MED COMMUN, V28, P199, DOI 10.1097/MNM.0b013e328013eb8b; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; Mizumura Sunao, 2006, Radiat Med, V24, P545, DOI 10.1007/s11604-006-0056-8; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Pastor MA, 2008, J NEUROPHYSIOL, V100, P1699, DOI 10.1152/jn.01156.2007; Pastor MA, 2002, J NEUROSCI, V22, P10501; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sataloff RT, 1996, AM J OTOL, V17, P909; Shulman, 1995, Int Tinnitus J, V1, P13; Siedentopf CM, 2007, NEUROSCI LETT, V411, P189, DOI 10.1016/j.neulet.2006.08.049; Takahashi S, 2015, NEUROCASE, V21, P339, DOI 10.1080/13554794.2014.893000; Tunkel D. E., 2014, OTOLARYNG HEAD NE S2, V151, pS1, DOI DOI 10.1177/0194599814545325; Ueyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067778; Vesterager V, 1997, BRIT MED J, V314, P728, DOI 10.1136/bmj.314.7082.728; Yamamoto Y, 2015, PHYSL GENOMICS; Yonekura Y, 1996, Ann Nucl Med, V10, P177	43	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137291	10.1371/journal.pone.0137291	http://dx.doi.org/10.1371/journal.pone.0137291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332128	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800117
J	Amat-ur-Rasool, H; Ahmed, M				Amat-ur-Rasool, Hafsa; Ahmed, Mehboob			Designing Second Generation Anti-Alzheimer Compounds as Inhibitors of Human Acetylcholinesterase: Computational Screening of Synthetic Molecules and Dietary Phytochemicals	PLOS ONE			English	Article							CHOLINESTERASE-INHIBITORS; TORPEDO-CALIFORNICA; DRUG-DELIVERY; DISEASE; GALANTHAMINE; ALKALOIDS; COMPLEX; PLANTS; WEB	Alzheimer's disease (AD), a big cause of memory loss, is a progressive neurodegenerative disorder. The disease leads to irreversible loss of neurons that result in reduced level of acetylcholine neurotransmitter (ACh). The reduction of ACh level impairs brain functioning. One aspect of AD therapy is to maintain ACh level up to a safe limit, by blocking acetylcholinesterase (AChE), an enzyme that is naturally responsible for its degradation. This research presents an in-silico screening and designing of hAChE inhibitors as potential anti-Alzheimer drugs. Molecular docking results of the database retrieved (synthetic chemicals and dietary phytochemicals) and self-drawn ligands were compared with Food and Drug Administration (FDA) approved drugs against AD as controls. Furthermore, computational ADME studies were performed on the hits to assess their safety. Human AChE was found to be most approptiate target site as compared to commonly used Torpedo AChE. Among the tested dietry phytochemicals, berberastine, berberine, yohimbine, sanguinarine, elemol and naringenin are the worth mentioning phytochemicals as potential anti-Alzheimer drugs The synthetic leads were mostly dual binding site inhibitors with two binding subunits linked by a carbon chain i.e. second generation AD drugs. Fifteen new heterodimers were designed that were computationally more efficient inhibitors than previously reported compounds. Using computational methods, compounds present in online chemical databases can be screened to design more efficient and safer drugs against cognitive symptoms of AD.	[Amat-ur-Rasool, Hafsa; Ahmed, Mehboob] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan; [Amat-ur-Rasool, Hafsa] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan	University of Punjab; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab	Ahmed, M (corresponding author), Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan.	mehboob.mmg@pu.edu.pk	Ahmed, Mehboob/M-1936-2019	Ahmed, Mehboob/0000-0002-6363-9050; Amat Ur Rasool, D. Hafsa/0000-0001-9664-3796				Abascal K, 2002, ALTERNATIVE COMPLEME, V8, P284; Alzheimer's Disease International, DEM STAT 2015; Amat-ur-Rasool H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119854; [Anonymous], 2012, CONSUMER REPORTS; ASHANI Y, 1992, BIOCHEM BIOPH RES CO, V184, P719, DOI 10.1016/0006-291X(92)90649-6; Bartolucci C, 2001, PROTEINS, V42, P182, DOI 10.1002/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO;2-1; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Boado RJ, 1998, J PHARM SCI-US, V87, P1308, DOI 10.1021/js9800836; Cavalli A, 2008, J MED CHEM, V51, P347, DOI 10.1021/jm7009364; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; Cummings JL, 2002, JAMA-J AM MED ASSOC, V287, P2335, DOI 10.1001/jama.287.18.2335; DAVIES P, 1976, LANCET, V2, P1403; Duke J, DR DUKES PHYTOCHEMIC; Dvir H, 2002, BIOCHEMISTRY-US, V41, P10810, DOI 10.1021/bi020151+; FARNSWORTH NR, 1967, J PHARM SCI-US, V56, P23, DOI 10.1002/jps.2600560104; Giacobini E, 1998, NEUROCHEM INT, V32, P413, DOI 10.1016/S0197-0186(97)00124-1; Greenblatt HM, 1999, FEBS LETT, V463, P321, DOI 10.1016/S0014-5793(99)01637-3; Grutzendler J, 2001, DRUGS, V61, P41, DOI 10.2165/00003495-200161010-00005; Heinrich M, 2004, J ETHNOPHARMACOL, V92, P147, DOI 10.1016/j.jep.2004.02.012; Heo HJ, 2004, DEMENT GERIATR COGN, V17, P151, DOI 10.1159/000076349; Hoffmann D., 2003, MED HERBALISM SCI PR; Holland D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042325; Houghton PJ, 2006, NAT PROD REP, V23, P181, DOI 10.1039/b508966m; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Iversen L, 1977, SYNAPSES, P137; Jann MW, 2000, PHARMACOTHERAPY, V20, P1, DOI 10.1592/phco.20.1.1.34664; Ji HF, 2011, MOLECULES, V16, P6732, DOI 10.3390/molecules16086732; Kaduszkiewicz H, 2005, BMJ-BRIT MED J, V331, P321, DOI 10.1136/bmj.331.7512.321; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim J, 2010, J NEUROCHEM, V112, P1415, DOI 10.1111/j.1471-4159.2009.06562.x; Kryger G, 1999, STRUCTURE, V7, P297, DOI 10.1016/S0969-2126(99)80040-9; KUTCHAN TM, 1995, PLANT CELL, V7, P1059, DOI 10.2307/3870057; Lanctot Krista L, 2009, Ther Adv Neurol Disord, V2, P163, DOI 10.1177/1756285609102724; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Mendelsohn LD, 2004, J CHEM INF COMP SCI, V44, P2225, DOI 10.1021/ci040123t; Monte MM, 2006, J MOL NEUROSCI, V30, P85; Mroue MA, 1996, J NAT PROD, V59, P890, DOI 10.1021/np960070c; Mukherjee PK, 2007, PHYTOTHER RES, V21, P1142, DOI 10.1002/ptr.2224; NIA, ALZH DIS ALZH BAS 20; Potestio R, 2010, NUCLEIC ACIDS RES, V38, pW41, DOI 10.1093/nar/gkq293; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schulz V, 2003, PHYTOMEDICINE, V10, P74, DOI 10.1078/1433-187X-00302; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Winblad B, 2004, ALZ DIS ASSOC DIS, V18, pS2, DOI 10.1097/01.wad.0000127495.10774.a4; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086	46	23	24	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136509	10.1371/journal.pone.0136509	http://dx.doi.org/10.1371/journal.pone.0136509			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325402	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700047
J	Barennes, H; Frichittavong, A; Gripenberg, M; Koffi, P				Barennes, Hubert; Frichittavong, Amphonexay; Gripenberg, Marissa; Koffi, Paulin			Evidence of High Out of Pocket Spending for HIV Care Leading to Catastrophic Expenditure for Affected Patients in Lao People's Democratic Republic	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; HEALTH EXPENDITURE; FINANCIAL BURDEN; ARV TREATMENT; HIV/AIDS; COSTS; THERAPY; ACCESS; SERVICES; BARRIERS	Background The scaling up of antiviral treatment (ART) coverage in the past decade has increased access to care for numerous people living with HIV/AIDS (PLWHA) in low-resource settings. Out-of-pocket payments (OOPs) represent a barrier for healthcare access, adherence and ART effectiveness, and can be economically catastrophic for PLWHA and their family. We evaluated OOPs of PLWHA attending outpatient and inpatient care units and estimated the financial burden for their households in the Lao People's Democratic Republic. We assumed that such OOPs may result in catastrophic health expenses in this context with fragile economical balance and low health insurance coverage. Methods We conducted a cross-sectional survey of a randomized sample of routine outpatients and a prospective survey of consecutive new inpatients at two referral hospitals (Setthathirat in the capital city, Savannaket in the province). After obtaining informed consent, PLWHA were interviewed using a standardized 82-item questionnaire including information on socio-economic characteristics, disease history and coping strategies. All OOPs occurring during a routine visit or a hospital stay were recorded. Household capacity-to-pay (overall income minus essential expenses), direct and indirect OOPs, OOPs per outpatient visit and per inpatient stay as well as catastrophic spending (greater than or equal to 40% of the capacity-to-pay) were calculated. A multivariate analysis of factors associated with catastrophic spending was conducted. Results A total of 320 PLWHA [280 inpatients and 40 outpatients; 132 (41.2%) defined as poor, and 269 (84.1%) on ART] were enrolled. Monthly median household income, essential expenses and capacity-to-pay were US$147.0 (IQR: 86-242), $126 (IQR: 82-192) and $14 (IQR: 19-80), respectively. At the provincial hospital OOPs were higher during routine visits, but three fold lower during hospitalization than in the central hospital ($21.0 versus $18.5 and $110.8 versus $329.8 respectively (p<0.01). The most notable OOPs were related to transportation and to loss of income. A total of 150 patients (46.8%; 95% CI: 41.3-52.5) were affected by catastrophic health expenses; 36 outpatients (90.0%; 95% CI: 76.3-97.2) and 114 inpatients (40.7%; 95% CI: 34.9-46.7). A total of 141 (44.0%) patients had contracted loans, and 127 (39.6%) had to sell some of their assets. In the multivariate analysis, being of Lao Loum ethnic group (Coef. -1.4; p = 0.04); being poor (Coef. -1.0; p = 0.01) and living more than 100 km away from the hospital (Coef. -1.0; p = 0.002) were positively associated with catastrophic spending. Conversely being in the highest wealth quartile (Coef. 1.6; p<0.001), living alone (Coef. 1.1; p = 0.04), attending the provincial hospital (Coef. 1.0; p = 0.002), and being on ART (Coef. 1.2; p = 0.003), were negatively associated with catastrophic spending. Conclusion PLWHA's households face catastrophic OOPs that are not directly attributable to the cost of ART or to follow-up tests, particularly during a hospitalization period. Transportation, distance to healthcare and time spent at the health facility are the major contributors for OOPs and for indirect opportunity costs. Being on ART and attending the provincial hospital were associated with a lower risk of catastrophic spending. Decentralization of care, access to ART and alleviation of OOPs are crucial factors to successfully decrease the household burden of HIV-AIDS expenses.	[Barennes, Hubert; Frichittavong, Amphonexay; Koffi, Paulin] Inst Francophonie Med Trop, Viangchan, Laos; [Barennes, Hubert; Gripenberg, Marissa] Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia; [Barennes, Hubert] Agence Natl Rech VIH & Ies Hepatites, Phnom Penh, Cambodia; [Barennes, Hubert] Univ Bordeaux, Ctr INSERM U897 Epidemiol Biostat, ISPED, Bordeaux, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Barennes, H (corresponding author), Inst Francophonie Med Trop, Viangchan, Laos.	barenneshub@yahoo.fr						Akkhavong K, 2014, LAO PEOPLES DEMOCRAT, P1; Angeletti C, 2014, HIV MED, V15, P165, DOI 10.1111/hiv.12097; Anh DT, 2014, J ACQUIR IMMUNE DEFI; Araujo DV, 2013, SCI WORLD J, DOI 10.1155/2013/864962; Barennes H, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0300-9; Beauliere A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011213; Bikilla AD, 2009, COST EFF RESOUR ALLO, V7, P6, DOI DOI 10.1186/1478-7547-7-6; Bila Blandine, 2008, Sante, V18, P187; Boufkhed S, 2014, Bull Soc Pathol Exot, V107, P292, DOI 10.1007/s13149-014-0374-5; Boyer S, 2009, B WORLD HEALTH ORGAN, V87, P279, DOI 10.2471/BLT.07.049643; Broughton E, 2014, NURS RES PRACT, V2014, DOI 10.1155/2014/232046; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Choi JW, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0675-1; Duraisamy P, 2006, AIDS CARE, V18, P121, DOI 10.1080/09540120500159359; Hansana V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-617; Minh VH, 2013, SOC SCI MED, V96, P258, DOI 10.1016/j.socscimed.2012.11.028; Kitajima T, 2003, AIDS, V17, P2375, DOI 10.1097/00002030-200311070-00013; Kouanda S, 2010, AIDS CARE, V22, P1146, DOI 10.1080/09540121003605047; Lao Ministry of Health, 2015, LAO NAT HLTH ACC REP, P2; Lao Ministry of Health, 2013, SECT REF FRAM LAO PD, P2; Lao Ministry of Health, 2015, HLTH FIN ST IN PRESS, P2; Lao PDR Ministry of Health, 2014, KEY FEAT OFF SOC HLT, P1; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Nguyen LT, 2014, CLINICOECONOMIC OUTC, V6, P101, DOI 10.2147/CEOR.S57028; Lopera MM, 2011, AIDS CARE, V23, P1602, DOI 10.1080/09540121.2011.579938; Minh HV, 2015, PROGR UNIVERSAL HLTH; Moon S, 2008, AIDS CARE, V20, P984, DOI 10.1080/09540120701768446; Morineau G, 2009, AIDS PATIENT CARE ST, V23, P669, DOI 10.1089/apc.2008.0241; Ngorsuraches S, 2015, APPL HEALTH ECON HEA, V13, P389, DOI 10.1007/s40258-015-0165-6; Paboriboune P, 2012, FIELD ACTION SCI REP; Pannarunothai S, 1997, SOC SCI MED, V44, P1781, DOI 10.1016/S0277-9536(96)00287-0; Pinto AD, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18055; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Prakongsai P, 2009, ADV HEALTH ECON HEAL, V21, P57, DOI 10.1108/S0731-2199(2009)0000021006; Rajagopalan N, 2009, AM J INFECT DIS, V5, P219, DOI 10.3844/ajidsp.2009.219.224; Richter LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086225; The World Bank, 2015, WORLD BANK LAO PDR; Thuan NBT, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-283; Tran BX, 2013, TROP MED INT HEALTH, V18, P212, DOI 10.1111/tmi.12032; UNAIDS, 2013, LAO PDR COUNTR REP P, P1; Van Damme W, 2004, TROP MED INT HEALTH, V9, P273, DOI 10.1046/j.1365-3156.2003.01194.x; Vun MC, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18905; World Bank: Vientiane Office, 2015, GOV EXP HLTH LAO PDR; World Organization for Animal Health (OIE), 2015, LANDSCAPE HIV RAPID, P1; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yiengprugsawan Vasoontara, 2010, Australas epidemiol, V17, P24; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007; Zhou F, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-6	49	25	25	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136664	10.1371/journal.pone.0136664	http://dx.doi.org/10.1371/journal.pone.0136664			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26327558	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700053
J	Bennett, S; Singh, S; Rodriguez, D; Ozawa, S; Singh, K; Chhabra, V; Dhingra, N				Bennett, Sara; Singh, Suneeta; Rodriguez, Daniela; Ozawa, Sachiko; Singh, Kriti; Chhabra, Vibha; Dhingra, Neeraj			Transitioning a Large Scale HIV/AIDS Prevention Program to Local Stakeholders: Findings from the Avahan Transition Evaluation	PLOS ONE			English	Article							SUSTAINABILITY; PEPFAR	Background Between 2009-2013 the Bill and Melinda Gates Foundation transitioned its HIV/AIDS prevention initiative in India from being a stand-alone program outside of government, to being fully government funded and implemented. We present an independent prospective evaluation of the transition. Methods The evaluation drew upon (1) a structured survey of transition readiness in a sample of 80 targeted HIV prevention programs prior to transition; (2) a structured survey assessing institutionalization of program features in a sample of 70 targeted intervention (TI) programs, one year post-transition; and (3) case studies of 15 TI programs. Findings Transition was conducted in 3 rounds. While the 2009 transition round was problematic, subsequent rounds were implemented more smoothly. In the 2011 and 2012 transition rounds, Avahan programs were well prepared for transition with the large majority of TI program staff trained for transition, high alignment with government clinical, financial and managerial norms, and strong government commitment to the program. One year post transition there were significant program changes, but these were largely perceived positively. Notable negative changes were: limited flexibility in program management, delays in funding, commodity stock outs, and community member perceptions of a narrowing in program focus. Service coverage outcomes were sustained at least six months post-transition. Interpretation The study suggests that significant investments in transition preparation contributed to a smooth transition and sustained service coverage. Notwithstanding, there were substantive program changes post-transition. Five key lessons for transition design and implementation are identified.	[Bennett, Sara; Rodriguez, Daniela; Ozawa, Sachiko] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Singh, Suneeta; Singh, Kriti; Chhabra, Vibha] Amaltas Consulting Pvt Ltd, New Delhi 110016, India; [Dhingra, Neeraj] Govt India, Dept Aids Control, Minist Hlth & Family Welf, New Delhi 110001, India	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bennett, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	sbennett@jhu.edu	Singh, Kriti/ABE-3814-2020; Ozawa, Sachiko/Z-4944-2019	Ozawa, Sachiko/0000-0001-7608-9038; bennett, sara/0000-0001-8094-8798	Bill and Melinda Gates Foundation [OPPGH5190]; Amaltas Consulting Pvt. Ltd.	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Amaltas Consulting Pvt. Ltd.	This study was funded by grant # OPPGH5190 from the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org). Foundation staff advised the study team, but did not substantively affect the study design, instruments, interpretation of data or decision to publish. Two staff members of the Foundation reviewed the manuscript, and some of the comments were incorporated depending on whether the research team perceived them to be of relevant and accurate. The authors confirm that Amaltas Consulting Pvt. Ltd. provided support in the form of salaries for authors SS, KS and VC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2010, AV COMM MIN PROGR HI; [Anonymous], 2010, DEP AIDS CONTR ANN R; Bennett S, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7360; Brundage SC., 2011, TERRA NOVA ACHIEVE S; Collins C, 2013, LANCET GLOB HEALTH, V1, pE319, DOI 10.1016/S2214-109X(13)70092-5; Fox Ashley M, 2011, J Int AIDS Soc, V14 Suppl 2, pS5, DOI 10.1186/1758-2652-14-S2-S5; Goosby E, 2012, JAIDS-J ACQ IMM DEF, V60, pS158, DOI 10.1097/QAI.0b013e31825d057c; Government of India, 2009, MEM COOP NAT AIDS CO; Government of India, 2006, MEM COOP NAT AIDS CO; Gruen RL, 2008, LANCET, V372, P1579, DOI 10.1016/S0140-6736(08)61659-1; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Kavanagh MM, 2014, JAIDS-J ACQ IMM DEF, V65, P247, DOI 10.1097/QAI.0000000000000093; Mabuchi S, 2012, INT J HLTH PLANN MAN; National AIDS Control Organization, 2006, NAT AIDS CONTR PROGR; Scheirer MA, 2005, AM J EVAL, V26, P320, DOI 10.1177/1098214005278752; Scheirer MA, 2011, AM J PUBLIC HEALTH, V101, P2059, DOI 10.2105/AJPH.2011.300193; Sgaier SK, 2013, HEALTH AFFAIR, V32, P1265, DOI 10.1377/hlthaff.2012.0646; Stirman SW, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-17; The World Bank, 2013, IMPL COMPL RES REP C; Tran NT, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-44; UNAIDS, 2012, COUNTR OWN SUST AIDS; Verma R, 2010, SEX TRANSM INFECT, V86, pI76, DOI 10.1136/sti.2009.039115	22	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136177	10.1371/journal.pone.0136177	http://dx.doi.org/10.1371/journal.pone.0136177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327591	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700032
J	Braun, FCM; van den Brandt, J; Thomas, S; Lange, S; Schrank, J; Gand, C; Przybylski, GK; Schmoeckel, K; Broker, BM; Schmidt, CA; Grabarczyk, P				Braun, Floriane C. M.; van den Brandt, Jens; Thomas, Soeren; Lange, Sandra; Schrank, Juliane; Gand, Claudia; Przybylski, Grzegorz K.; Schmoeckel, Katrin; Broeker, Barbara M.; Schmidt, Christian A.; Grabarczyk, Piotr			In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; DENDRITIC CELLS; UBIQUITIN; ACTIVATION; INDUCTION; RECEPTOR; TNFAIP3	A20 is an ubiquitin-editing enzyme that ensures the transient nature of inflammatory signaling pathways induced by cytokines like TNF-alpha and IL-1 or pathogens via Toll-like receptor (TLR) pathways. It has been identified as a negative regulator of dendritic cell (DC) maturation and attenuator of their immunostimulatory properties. Ex vivo A20-depleted dendritic cells showed enhanced expression of pro-inflammatory cytokines and costimulatory molecules, which resulted in hyperactivation of tumor-infiltrating T lymphocytes and inhibition of regulatory T cells. In the present study, we demonstrate that a synthetic molecule consisting of a CpG oligonucleotide TLR9 agonist linked to A20-specific siRNAs silences its expression in TLR9(+) mouse dendritic cells in vitro and in vivo. In the B16 mouse melanoma tumor model, silencing of A20 enhances the CpG-triggered induction of NF kappa B activity followed by elevated expression of IL-6, TNF-alpha and IL-12. This leads to potentiated antitumor immune responses manifested by increased numbers of tumor-specific cytotoxic T cells, high levels of tumor cell apoptosis and delayed tumor growth. Our findings confirm the central role of A20 in controlling the immunostimulatory potency of DCs and provide a strategy for simultaneous A20 silencing and TLR activation in vivo.	[Braun, Floriane C. M.; Thomas, Soeren; Lange, Sandra; Schrank, Juliane; Gand, Claudia; Przybylski, Grzegorz K.; Schmidt, Christian A.; Grabarczyk, Piotr] Univ Med Greifswald, Clin Internal Med C, Dept Mol Hematol, Greifswald, Germany; [van den Brandt, Jens] Ernst Moritz Arndt Univ Greifswald, Cent Core, Greifswald, Germany; [van den Brandt, Jens] Ernst Moritz Arndt Univ Greifswald, Res Facil Lab Anim, Greifswald, Germany; [Przybylski, Grzegorz K.] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland; [Schmoeckel, Katrin; Broeker, Barbara M.] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany	Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Ernst Moritz Arndt Universitat Greifswald	Grabarczyk, P (corresponding author), Univ Med Greifswald, Clin Internal Med C, Dept Mol Hematol, Greifswald, Germany.	pgrabarczyk@yahoo.com	Bröker, Barbara M/O-4850-2015	Bröker, Barbara M/0000-0002-5020-8542; Przybylski, Grzegorz/0000-0001-5783-1567; Lange, Sandra/0000-0003-0725-3652	German Jose Carreras Leukemia Foundation [DJCLS F 12/04]; Research Association for Molecular Medicine, University of Greifswald, Germany	German Jose Carreras Leukemia Foundation; Research Association for Molecular Medicine, University of Greifswald, Germany	The work was supported by the following: German Jose Carreras Leukemia Foundation (DJCLS F 12/04), FCMB, https://www.carrerasstiftung.de/; and Research Association for Molecular Medicine, University of Greifswald, Germany, FCMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breckpot K, 2009, J IMMUNOL, V182, P860, DOI 10.4049/jimmunol.182.2.860; Chanudet E, 2009, J PATHOL, V217, P420, DOI 10.1002/path.2466; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Fleshman JW., 2000, PORT SITE WOUND RECU; Giordano M, 2014, P NATL ACAD SCI USA, V111, P11115, DOI 10.1073/pnas.1406259111; Gray RC, 2007, J LEUKOCYTE BIOL, V81, P1075, DOI 10.1189/jlb.1006606; Herrmann A, 2014, J CLIN INVEST, V124, P2977, DOI 10.1172/JCI73174; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Katsuda M, 2011, INT J ONCOL, V39, P1295, DOI 10.3892/ijo.2011.1146; Kim R, 2006, CANCER RES, V66, P5527, DOI 10.1158/0008-5472.CAN-05-4128; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lippens S, 2011, CELL DEATH DIFFER, V18, P1845, DOI 10.1038/cdd.2011.55; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Martin F, 2011, NAT GENET, V43, P822, DOI 10.1038/ng.916; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rahman SMA, 2010, BIOORGAN MED CHEM, V18, P3474, DOI 10.1016/j.bmc.2010.03.076; Santulli-Marotto S, 2003, CANCER RES, V63, P7483; Siders WM, 2003, MOL THER, V7, P498, DOI 10.1016/S1525-0016(03)00044-3; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Snead NM, 2013, NUCLEIC ACIDS RES, V41, P6209, DOI 10.1093/nar/gkt200; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wooldridge James E., 2003, Current Opinion in Oncology, V15, P440, DOI 10.1097/00001622-200311000-00006; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	35	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135444	10.1371/journal.pone.0135444	http://dx.doi.org/10.1371/journal.pone.0135444			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327508	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700020
J	Gsell, M; Fankl, A; Klug, L; Mascher, G; Schmidt, C; Hrastnik, C; Zellnig, G; Daum, G				Gsell, Martina; Fankl, Ariane; Klug, Lisa; Mascher, Gerald; Schmidt, Claudia; Hrastnik, Claudia; Zellnig, Guenther; Daum, Guenther			A Yeast Mutant Deleted of GPH1 Bears Defects in Lipid Metabolism	PLOS ONE			English	Article							PHOSPHATIDYLSERINE DECARBOXYLASE ACTIVITY; CROSS-PATHWAY REGULATION; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID BIOSYNTHESIS; GLYCOGEN-PHOSPHORYLASE; PHOSPHATIDYLETHANOLAMINE; GENE; METHYLATION; IDENTIFICATION; MEMBRANE	In a previous study we demonstrated up-regulation of the yeast GPH1 gene under conditions of phosphatidylethanolamine (PE) depletion caused by deletion of the mitochondrial (M) phosphatidylserine decarboxylase 1 (PSD1) (Gsell et al., 2013, PLoS One. 8(10): e77380. doi: 10.1371/journal.pone.0077380). Gph1p has originally been identified as a glycogen phosphorylase catalyzing degradation of glycogen to glucose in the stationary growth phase of the yeast. Here we show that deletion of this gene also causes decreased levels of phosphatidylcholine (PC), triacylglycerols and steryl esters. Depletion of the two non-polar lipids in Delta gph1 strain leads to lack of lipid droplets, and decrease of the PC level results in instability of the plasma membrane. In vivo labeling experiments revealed that formation of PC via both pathways of biosynthesis, the cytidine diphosphate (CDP)choline and the methylation route, is negatively affected by a.gph1 mutation, although expression of genes involved is not down regulated. Altogether, Gph1p besides its function as a glycogen mobilizing enzyme appears to play a regulatory role in yeast lipid metabolism.	[Gsell, Martina; Fankl, Ariane; Klug, Lisa; Mascher, Gerald; Schmidt, Claudia; Hrastnik, Claudia; Daum, Guenther] Graz Univ Technol, Inst Biochem, NaWi Graz, A-8010 Graz, Austria; [Zellnig, Guenther] Karl Franzens Univ Graz, Inst Plant Sci, NaWi Graz, Graz, Austria	Graz University of Technology; University of Graz	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, NaWi Graz, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at			Austrian Science Fund FWF [21429]; Austrian Science Fund FWF (DK Molecular Enzymology) [W901-B05]; Austrian Science Fund (FWF) [P 26133, W 901] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund FWF (DK Molecular Enzymology); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund FWF (project 21429 and DK Molecular Enzymology W901-B05 to GD).	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARSON MA, 1984, J BIOL CHEM, V259, P6267; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; DAUM G, 1982, J BIOL CHEM, V257, P3028; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Favre C, 2008, FREE RADICAL BIO MED, V45, P1446, DOI 10.1016/j.freeradbiomed.2008.08.021; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gsell M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077380; HAID A, 1983, METHOD ENZYMOL, V96, P192; HARDY TA, 1993, J BIOL CHEM, V268, P23799; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HWANG PK, 1989, MOL CELL BIOL, V9, P1659, DOI 10.1128/MCB.9.4.1659; INOKOSHI J, 1994, MOL GEN GENET, V244, P90, DOI 10.1007/BF00280191; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kim NR, 2013, APPL MICROBIOL BIOT, V97, P8227, DOI 10.1007/s00253-013-4985-8; KODAKI T, 1987, J BIOL CHEM, V262, P15428; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGRAW P, 1989, GENETICS, V122, P317; Nebauer R, 2007, FEBS J, V274, P6180, DOI 10.1111/j.1742-4658.2007.06138.x; Patton-Vogt J, 2007, BBA-MOL CELL BIOL L, V1771, P337, DOI 10.1016/j.bbalip.2006.04.013; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Ploier B, 2013, J BIOL CHEM, V288, P36061, DOI 10.1074/jbc.M113.509927; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; SUMMERS EF, 1988, GENETICS, V120, P909; Takahashi T, 2001, MOL GENET GENOMICS, V265, P1112, DOI 10.1007/s004380100510; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Usher J, 2009, APPL ENVIRON MICROB, V75, P4573, DOI 10.1128/AEM.00351-09; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; Voelker DR, 2000, BBA-MOL CELL BIOL L, V1486, P97, DOI 10.1016/S1388-1981(00)00051-2; Wilson WA, 2010, CAN J MICROBIOL, V56, P408, DOI [10.1139/W10-027, 10.1139/w10-027]; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	52	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136957	10.1371/journal.pone.0136957	http://dx.doi.org/10.1371/journal.pone.0136957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327557	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700075
J	Horicks, F; Van Den Steen, G; Houben, S; Englert, Y; Demeestere, I				Horicks, Florence; Van Den Steen, Geraldine; Houben, Sarah; Englert, Yvon; Demeestere, Isabelle			Folliculogenesis Is Not Fully Inhibited during GnRH Analogues Treatment in Mice Challenging Their Efficiency to Preserve the Ovarian Reserve during Chemotherapy in This Model	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; FOLLICLE-STIMULATING-HORMONE; LHRH ANTAGONIST CETRORELIX; LUTEINIZING-HORMONE; FERTILITY PRESERVATION; INDUCED GONADOTOXICITY; POSTMENOPAUSAL WOMEN; CANCER-PATIENTS; MOUSE OVARIES; FOLLOW-UP	As many chemotherapy regimens induce follicular depletion, fertility preservation became a major concern in young cancer patients. By maintaining follicles at the resting stage, gonadotropin-releasing hormone analogues (GnRHa) were proposed as an ovarian-protective option during chemotherapy. However, their efficacy and mechanisms of action remain to be elucidated. Mice were dosed with cyclophosphamide (Cy, 100-500mg/kg i.p) to quantify follicular depletion and evaluate apoptosis at different times. We observed a dose-dependent depletion of the follicular reserve within 24 hours after Cy injection with a mean follicular loss of 45% at the dose of 200mg/kg. Apoptosis occurs in the granulosa cells of growing follicles within 12 hours after Cy treatment, while no apoptosis was detected in resting follicles suggesting that chemotherapy acutely affects both resting and growing follicles through different mechanisms. We further tested the ability of both GnRH agonist and antagonist to inhibit oestrus cycles, follicular growth and FSH secretion in mice and to protect ovarian reserve against chemotherapy. Although GnRHa were efficient to disrupt oestrus cycles, they failed to inhibit follicular development, irrespective of the doses and injection sites (sc or im). Around 20% of healthy growing follicles were still observed during GnRHa treatment and serum FSH levels were not reduced either by antagonist or agonist. GnRHa had no effect on Cy-induced follicular damages. Thus, we showed that GnRHa were not as efficient at inhibiting the pituitary-gonadal axis in mice as in human. Furthermore, the acute depletion of primordial follicles observed after chemotherapy does not support the hypothesis that the ovary may be protected by gonadotropin suppression.	[Horicks, Florence; Van Den Steen, Geraldine; Houben, Sarah; Englert, Yvon; Demeestere, Isabelle] Univ Libre Bruxelles, Res Lab Human Reprod, Brussels, Belgium; [Englert, Yvon; Demeestere, Isabelle] Free Univ Brussels, Erasme Hosp, Dept Gynecol & Obstet, B-1050 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Horicks, F (corresponding author), Univ Libre Bruxelles, Res Lab Human Reprod, Brussels, Belgium.	fhoricks@ulb.ac.be		Demeestere, Isabelle/0000-0002-3192-6565; Houben, Sarah/0000-0002-9363-8016	Belgian grant [FNRS-Televie 7.4621.14]; Le Fonds Emile DEFAY; Belgian 'Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA) [18101/18102]	Belgian grant; Le Fonds Emile DEFAY; Belgian 'Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Belgian grant FNRS-Televie 7.4621.14 and 'Le Fonds Emile DEFAY'; FH is a research fellow supported by the Belgian 'Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture' (FRIA) 18101/18102; and ID is a research associate at the 'Fonds National pour la Recherche Scientifique' (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATAYA K, 1995, BIOL REPROD, V52, P365, DOI 10.1095/biolreprod52.2.365; ATAYA KM, 1985, CANCER RES, V45, P3651; BOKSER L, 1990, BRIT J CANCER, V61, P861, DOI 10.1038/bjc.1990.192; Browne HN, 2011, FERTIL STERIL, V96, P180, DOI 10.1016/j.fertnstert.2011.04.008; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; CHAPMAN RM, 1981, BLOOD, V58, P849; COUZINET B, 1991, CLIN ENDOCRINOL, V34, P477, DOI 10.1111/j.1365-2265.1991.tb00328.x; Danforth DR, 2005, FERTIL STERIL, V83, P1333, DOI 10.1016/j.fertnstert.2004.12.030; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Decanter C, 2014, FERTIL STERIL, V102, P483, DOI 10.1016/j.fertnstert.2014.05.014; Del Mastro L, 2014, CANCER TREAT REV, V40, P675, DOI 10.1016/j.ctrv.2013.12.001; Demeestere I, 2012, OBSTET GYNECOL INT, V2012, DOI DOI 10.1155/2012/961232; Demeestere I, 2013, J CLIN ONCOL, V31, P903, DOI 10.1200/JCO.2012.42.8185; Desmeules P, 2006, TOXICOL SCI, V90, P500, DOI 10.1093/toxsci/kfj086; Detti L, 2014, FERTIL STERIL, V101, P1157, DOI 10.1016/j.fertnstert.2013.12.028; Ezoe K, 2014, REPROD BIOL, V14, P238, DOI 10.1016/j.repbio.2014.04.007; GLODE LM, 1981, LANCET, V1, P1132; Gosden RG, 1997, HUM REPROD, V12, P2483, DOI 10.1093/humrep/12.11.2483; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Hasky N, 2015, HUM REPROD, V30, P1089, DOI 10.1093/humrep/dev037; Hayden C, 2008, EUR J ENDOCRINOL, V159, pS17, DOI 10.1530/EJE-08-0354; Horvath JE, 2002, P NATL ACAD SCI USA, V99, P15048, DOI 10.1073/pnas.232579499; Huang YH, 2009, GYNECOL ONCOL, V112, P409, DOI 10.1016/j.ygyno.2008.09.044; Hutt K., 2014, TALK WORLD C REPR BI; Kalich-Philosoph L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005402; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Kiesel LA, 2002, CLIN ENDOCRINOL, V56, P677, DOI 10.1046/j.1365-2265.2002.01291.x; Kovacs M, 2001, P NATL ACAD SCI USA, V98, P12197, DOI 10.1073/pnas.211442598; Lemos CNCD, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-51; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; MATIKAINEN T, 1992, J CLIN ENDOCR METAB, V75, P820, DOI 10.1210/jc.75.3.820; Matsuo Go, 2007, Kurume Medical Journal, V54, P25, DOI 10.2739/kurumemedj.54.25; Meirow D, 2000, MOL CELL ENDOCRINOL, V169, P123, DOI 10.1016/S0303-7207(00)00365-8; Meirow D, 2004, HUM REPROD, V19, P1294, DOI 10.1093/humrep/deh257; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; MONTZ FJ, 1991, CANCER RES, V51, P2124; Moore HCF, 2015, NEW ENGL J MED, V372, P923, DOI 10.1056/NEJMoa1413204; Morgan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070117; Oktem O, 2007, CANCER RES, V67, P10159, DOI 10.1158/0008-5472.CAN-07-2042; Razzano A, 2014, GYNECOL ENDOCRINOL, V30, P822, DOI 10.3109/09513590.2014.944153; Roness H, 2013, CELL CYCLE, V12, P3245, DOI 10.4161/cc.26358; Roti ECR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042293; SHARPE KL, 1990, ENDOCRINOLOGY, V127, P25, DOI 10.1210/endo-127-1-25; Singh P, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-26; Sobinoff AP, 2012, TOXICOL SCI, V128, P258, DOI 10.1093/toxsci/kfs137; Tan SJ, 2010, EUR J OBSTET GYN R B, V149, P182, DOI 10.1016/j.ejogrb.2009.12.028; Turner NH, 2013, ANN ONCOL, V24, P2224, DOI 10.1093/annonc/mdt196; van Casteren JIJ, 2000, BIOL REPROD, V62, P886, DOI 10.1095/biolreprod62.4.886; Zhao XJ, 2010, GYNECOL ONCOL, V118, P69, DOI 10.1016/j.ygyno.2010.03.021	49	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137164	10.1371/journal.pone.0137164	http://dx.doi.org/10.1371/journal.pone.0137164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325271	Green Submitted, gold, Green Published			2022-12-27	WOS:000360437700101
J	Markovic-Lipkovski, J; Zivotic, M; Muller, CA; Tampe, B; Cirovic, S; Vjestica, J; Tomanovic, N; Zeisberg, M; Muller, GA				Markovic-Lipkovski, Jasmina; Zivotic, Maja; Mueller, Claudia A.; Tampe, Bjoern; Cirovic, Sanja; Vjestica, Jelena; Tomanovic, Nada; Zeisberg, Michael; Mueller, Gerhard A.			Variable Expression of Neural Cell Adhesion Molecule Isoforms in Renal Tissue: Possible Role in Incipient Renal Fibrosis	PLOS ONE			English	Article							STRUCTURAL BASIS; NCAM; FGFR1; MYOFIBROBLASTS; IDENTIFICATION; REGENERATION; FIBROBLASTS; ACTIVATION; MECHANISMS; BINDING	Rare neural cell adhesion molecule (NCAM) positive cells have been previously described within the normal human adult kidney interstitium, speculating that they could increase in the interstitium with incipient interstitial renal fibrosis (IRF). In the present study, among 93 biopsy samples of various kidney diseases, NCAM(+) interstitial cells were detected in 62.4% cases. An increased number of NCAM(+) cells was significantly observed only in incipient IRF compared to normal renal tissues and advanced IRF stages (p<0.001), independently of underlying diseases (p = 0.657). All three major NCAM isoforms' RT-PCR bands were visible either in normal or in kidneys with incipient IRF, albeit their mRNA expression levels measured by qRT-PCR were different. Applying qRT-PCR on pure NCAM(+) cells population, obtained by laser capture microdissection, significant mRNA over-expression of NCAM(140kD) isoform was found in NCAM(+) cells within incipient IRF (p = 0.004), while NCAM(120kD) and NCAM(180kD) isoforms were not changed significantly (p = 0.750; p = 0.704; respectively). Simultaneously, qRT-PCR also showed significant aSMA (p = 0.014) and SLUG (p = 0.004) mRNAs up-regulation within the NCAM(+) cells of incipient IRF, as well as highly decreased matrix metalloproteinases (MMP) -2 and -9 mRNAs (p = 0.028; p = 0.036; respectively). However, using double immunofluorescence MMP-9 could still be detectable on the protein level in rare NCAM(+) cells within the incipient IRF. Further characterization of NCAM(+) cells by double immunofluorescent labeling revealed their association with molecules involved in fibrosis. Fibroblast growth factor receptor 1 (FGFR1) and alpha 5 beta 1 integrin were extensively expressed on NCAM(+) cells within the incipient IRF areas, whereas human epididymis protein-4 (HE4) was found to be present in few NCAM(+) cells of both normal and interstitium with incipient fibrosis. Heterogeneity of NCAM(+) interstitial cells in normal and incipient IRF, concerning molecules related to fibrosis and variable expression of NCAM isoforms, could suggest diverse role of NCAM(+) cells in homeostasis and in regulation of renal fibrosis in diseased kidneys.	[Markovic-Lipkovski, Jasmina; Zivotic, Maja; Cirovic, Sanja; Vjestica, Jelena; Tomanovic, Nada] Univ Belgrade, Fac Med, Inst Pathol, Belgrade, Serbia; [Mueller, Claudia A.] Univ Tubingen, ZMF, Sect Transplantat Immunol & Immunohematol, Univ Med Clin, Tubingen, Germany; [Mueller, Claudia A.; Tampe, Bjoern; Zeisberg, Michael; Mueller, Gerhard A.] Univ Gottingen, Med Ctr, Dept Nephrol & Rheumatol, D-37073 Gottingen, Germany	University of Belgrade; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Gottingen	Markovic-Lipkovski, J (corresponding author), Univ Belgrade, Fac Med, Inst Pathol, Belgrade, Serbia.	acal@matf.bg.ac.rs	Tampe, Björn/ABA-6091-2021; Zivotic, Maja/N-9508-2017	Tampe, Björn/0000-0002-4357-9863; Zivotic, Maja/0000-0002-5833-6661	Alexander von Humboldt Foundation; DAAD Foundation [451-03-01858/2013-09/6]; Ministry of Education, Science and Technological Development of the Republic of Serbia [OI 175047]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); DAAD Foundation(Deutscher Akademischer Austausch Dienst (DAAD)); Ministry of Education, Science and Technological Development of the Republic of Serbia	The authors are grateful to Alexander von Humboldt Foundation, DAAD Foundation (bilateral PPP-DAAD project between Serbia and Germany, number 451-03-01858/2013-09/6) and Ministry of Education, Science and Technological Development of the Republic of Serbia (project OI 175047), for the major financial support necessary for material and reagents during research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzhor E, 2013, AM J PATHOL, V183, P1621, DOI 10.1016/j.ajpath.2013.07.034; Chhikara N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047672; Cirovic S, 2014, INT J CLIN EXP PATHO, V7, P1402; Salgado AD, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/849684; Diestel S, 2005, J NEUROCHEM, V95, P1777, DOI 10.1111/j.1471-4159.2005.03475.x; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Harari-Steinberg O, 2013, EMBO MOL MED, V5, P1556, DOI 10.1002/emmm.201201584; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; KLEIN G, 1988, DEVELOPMENT, V102, P749; Kochoyan A, 2008, PROTEIN SCI, V17, P1698, DOI 10.1110/ps.035964.108; LeBleu VS, 2013, NAT MED, V19, P227, DOI 10.1038/nm.2989; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Lindquist JA, 2013, NEPHROL DIAL TRANSPL, V28, P2678, DOI 10.1093/ndt/gft247; Lv SS, 2014, DIABETES VASC DIS RE, V11, P251, DOI 10.1177/1479164114531300; Markovic-Lipkovski J, 2007, NEPHROL DIAL TRANSPL, V22, P1558, DOI 10.1093/ndt/gfm006; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Mikami S, 2011, LAB INVEST, V91, P1443, DOI 10.1038/labinvest.2011.111; Norman JT, 1999, EXP NEPHROL, V7, P167; Souma T, 2016, J AM SOC NEPHROL, V27, P428, DOI 10.1681/ASN.2014121184; Strutz F, 2006, NEPHROL DIAL TRANSPL, V21, P3368, DOI 10.1093/ndt/gfl199; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tur MK, 2013, AM J PATHOL, V182, P1205, DOI 10.1016/j.ajpath.2012.12.027; Vansthertem D, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/193259; Zeisberg M, 2015, CLIN J AM SOC NEPHRO, V10, P1831, DOI 10.2215/CJN.00640114; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	29	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137028	10.1371/journal.pone.0137028	http://dx.doi.org/10.1371/journal.pone.0137028			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327314	gold, Green Submitted, Green Published			2022-12-27	WOS:000360437700084
J	Oberwahrenbrock, T; Weinhold, M; Mikolajczak, J; Zimmermann, H; Paul, F; Beckers, I; Brandt, AU				Oberwahrenbrock, Timm; Weinhold, Maria; Mikolajczak, Janine; Zimmermann, Hanna; Paul, Friedemann; Beckers, Ingeborg; Brandt, Alexander U.			Reliability of Intra-Retinal Layer Thickness Estimates	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; MULTIPLE-SCLEROSIS; GANGLION-CELL; PLEXIFORM LAYER; NEUROMYELITIS-OPTICA; SEGMENTATION; PATHOLOGY; NEURITIS; DISEASE	Purpose Measurement of intra-retinal layer thickness using optical coherence tomography (OCT) has become increasingly prominent in multiple sclerosis (MS) research. Nevertheless, the approaches used for determining the mean layer thicknesses vary greatly. Insufficient data exist on the reliability of different thickness estimates, which is crucial for their application in clinical studies. This study addresses this lack by evaluating the repeatability of different thickness estimates. Methods Studies that used intra-retinal layer segmentation of macular OCT scans in patients with MS were retrieved from PubMed. To investigate the repeatability of previously applied layer estimation approaches, we generated datasets of repeating measurements of 15 healthy subjects and 13 multiple sclerosis patients using two OCT devices (Cirrus HD-OCT and Spectralis SD-OCT). We calculated each thickness estimate in each repeated session and analyzed repeatability using intra-class correlation coefficients and coefficients of repeatability. Results We identified 27 articles, eleven of them used the Spectralis SD-OCT, nine Cirrus HD-OCT, two studies used both devices and two studies applied RTVue-100. Topcon OCT-1000, Stratus OCT and a research device were used in one study each. In the studies that used the Spectralis, ten different thickness estimates were identified, while thickness estimates of the Cirrus OCT were based on two different scan settings. In the simulation dataset, thickness estimates averaging larger areas showed an excellent repeatability for all retinal layers except the outer plexiform layer (OPL). Conclusions Given the good reliability, the thickness estimate of the 6 mm-diameter area around the fovea should be favored when OCT is used in clinical research. Assessment of the OPL was weak in general and needs further investigation before OPL thickness can be used as a reliable parameter.	[Oberwahrenbrock, Timm; Mikolajczak, Janine; Zimmermann, Hanna; Paul, Friedemann; Brandt, Alexander U.] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Weinhold, Maria; Beckers, Ingeborg] Beuth Univ Appl Sci, Opt & Laser Technol Lab, Berlin, Germany; [Paul, Friedemann] Charite, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Oberwahrenbrock, T (corresponding author), Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany.	timm.oberwahrenbrock@charite.de	Paul, Friedemann/ABF-9415-2020	paul, friedemann/0000-0002-6378-0070; Zimmermann, Hanna/0000-0002-0276-8051	Berlin Institute for Applied Sciences (IFAF); German Research Society (DFG) [Exc. 257]	Berlin Institute for Applied Sciences (IFAF); German Research Society (DFG)(German Research Foundation (DFG))	This study was supported by a grant from the Berlin Institute for Applied Sciences (IFAF) to IB and a grant from the German Research Society (DFG, Exc. 257) to FP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Balk LJ, 2014, MULT SCLER J, V20, P1198, DOI 10.1177/1352458513518626; Balk LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048222; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brandt AU, 2016, RETINA-J RET VIT DIS, V36, P366, DOI 10.1097/IAE.0000000000000700; Brandt AU, 2014, NEUROLOGY, V83, P73, DOI 10.1212/WNL.0000000000000545; Choi SS, 2008, INVEST OPHTH VIS SCI, V49, P2103, DOI 10.1167/iovs.07-0980; Davies EC, 2011, J NEURO-OPHTHALMOL, V31, P260, DOI 10.1097/WNO.0b013e318221b434; Drexler W, 2001, NAT MED, V7, P502, DOI 10.1038/86589; Fernandes DB, 2013, OPHTHALMOLOGY, V120, P387, DOI 10.1016/j.ophtha.2012.07.066; Gabilondo I, 2013, J NEUROL NEUROSUR PS, V84, P824, DOI 10.1136/jnnp-2012-304854; Garas A, 2011, EUR J OPHTHALMOL, V21, P473, DOI 10.5301/EJO.2010.5844; Garcia-Martin E, 2014, OPHTHALMOLOGY, V121, P573, DOI 10.1016/j.ophtha.2013.09.035; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kaufhold F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071145; Kaushik M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078341; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Narayanan D, 2014, MULT SCLER J, V20, P1331, DOI 10.1177/1352458514523498; Oberwahrenbrock T, 2013, MULT SCLER J, V19, P1887, DOI 10.1177/1352458513489757; Oberwahrenbrock T, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/530305; Otani T, 2011, RETINA-J RET VIT DIS, V31, P497, DOI 10.1097/IAE.0b013e3181ed8dae; Ouyang YL, 2013, GRAEF ARCH CLIN EXP, V251, P2311, DOI 10.1007/s00417-013-2308-5; Park KA, 2014, ACTA OPHTHALMOL, V92, pE57, DOI 10.1111/aos.12215; Ratchford JN, 2013, NEUROLOGY, V80, P47, DOI 10.1212/WNL.0b013e31827b1a1c; Roth NM, 2014, MOVEMENT DISORD, V29, P1163, DOI 10.1002/mds.25896; Saidha S, 2013, JAMA NEUROL, V70, P34, DOI 10.1001/jamaneurol.2013.573; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Saidha S, 2011, MULT SCLER J, V17, P1449, DOI 10.1177/1352458511418630; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Schippling S, 2015, MULT SCLER J, V21, P163, DOI 10.1177/1352458514538110; Schneider E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066151; Seigo MA, 2012, J NEUROL, V259, P2119, DOI 10.1007/s00415-012-6466-x; Seyer LA, 2013, J NEUROL, V260, P2362, DOI 10.1007/s00415-013-6978-z; Sotirchos ES, 2013, NEUROLOGY, V80, P1406, DOI 10.1212/WNL.0b013e31828c2f7a; Sotirchos ES, 2013, CURR EYE RES, V38, P224, DOI 10.3109/02713683.2012.722243; Sriram P, 2012, INVEST OPHTH VIS SCI, V53, P1271, DOI 10.1167/iovs.11-8732; Stricker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023024; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Tatrai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030922; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Tugcu B, 2013, J NEUROL SCI, V335, P182, DOI 10.1016/j.jns.2013.09.027; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; Zimmermann H, 2013, MULT SCLER J, V19, P443, DOI 10.1177/1352458512457844	47	67	67	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137316	10.1371/journal.pone.0137316	http://dx.doi.org/10.1371/journal.pone.0137316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26349053	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000360897600034
J	Ramaprasad, ASE; Singh, S; Gajendra, PSR; Venkatesan, S				Ramaprasad, Azhagiya Singam Ettayapuram; Singh, Sandeep; Gajendra, Raghava P. S.; Venkatesan, Subramanian			AntiAngioPred: A Server for Prediction of Anti-Angiogenic Peptides	PLOS ONE			English	Article							CANCER; DATABASE; THROMBOSPONDIN-1; IDENTIFICATION; COLLAGEN; FAMILY; LOGO	The process of angiogenesis is a vital step towards the formation of malignant tumors. Antiangiogenic peptides are therefore promising candidates in the treatment of cancer. In this study, we have collected anti-angiogenic peptides from the literature and analyzed the residue preference in these peptides. Residues like Cys, Pro, Ser, Arg, Trp, Thr and Gly are preferred while Ala, Asp, Ile, Leu, Val and Phe are not preferred in these peptides. There is a positional preference of Ser, Pro, Trp and Cys in the N terminal region and Cys, Gly and Arg in the C terminal region of anti-angiogenic peptides. Motif analysis suggests the motifs "CG-G", "TC", "SC", "SP-S", etc., which are highly prominent in anti-angiogenic peptides. Based on the primary analysis, we developed prediction models using different machine learning based methods. The maximum accuracy and MCC for amino acid composition based model is 80.9% and 0.62 respectively. The performance of the models on independent dataset is also reasonable. Based on the above study, we have developed a user-friendly web server named "AntiAngioPred" for the prediction of anti-angiogenic peptides.	[Ramaprasad, Azhagiya Singam Ettayapuram; Venkatesan, Subramanian] CSIR, Cent Leather Res Inst, Chem Lab, Madras, Tamil Nadu, India; [Singh, Sandeep; Gajendra, Raghava P. S.] Inst Microbial Technol, CSIR, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Venkatesan, S (corresponding author), CSIR, Cent Leather Res Inst, Chem Lab, Madras, Tamil Nadu, India.	subbu@clri.res.in	singam, Ettayapuram Ramapras Azhagiya/D-3824-2011; Raghava, Gajendra/B-1717-2009; Raghava, Gajendra P.S./AAA-2413-2022; Ramaprasad, Azhagiya Singam Ettayapuram/L-7343-2019	singam, Ettayapuram Ramapras Azhagiya/0000-0003-4978-286X; Raghava, Gajendra P.S./0000-0002-8902-2876; Ramaprasad, Azhagiya Singam Ettayapuram/0000-0003-4978-286X; Singh, Sandeep/0000-0001-5361-4303	DBT; CSIR	DBT(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by DBT (http://www.dbtindia.nic.in/) and CSIR (http://www.csir.res.in/).	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; [Anonymous], 2001, RANDOM FORESTS MACHI; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; BREM S, 1972, J NATL CANCER I, V48, P347; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Gautam A, 2014, NUCLEIC ACIDS RES, V42, pD444, DOI 10.1093/nar/gkt1008; Gautam A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas015; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; Kapoor P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035187, DOI 10.1371/J0URNAL.P0NE.0035187]; Karagiannis ED, 2008, P NATL ACAD SCI USA, V105, P13775, DOI 10.1073/pnas.0803241105; Kohn E C, 1998, Angiogenesis, V2, P25, DOI 10.1023/A:1009046208807; Koskimaki JE, 2009, NEOPLASIA, V11, P1285, DOI 10.1593/neo.09620; Kumar R, 2015, NUCLEIC ACIDS RES, V43, pD956, DOI 10.1093/nar/gku1141; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Maeshima Y, 2000, J BIOL CHEM, V275, P23745, DOI 10.1074/jbc.C000186200; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Mark Hall EF, 2009, SIGKDD EXPLORATIONS, P11; Mehta Divya, 2014, Database (Oxford), V2014, DOI 10.1093/database/bau051; Nyberg P, 2008, EXP CELL RES, V314, P3292, DOI 10.1016/j.yexcr.2008.08.011; Oka Y, 2008, CURR MED CHEM, V15, P3052, DOI 10.2174/092986708786848631; Osborne S, New peptide analogues acting as NK-2 receptor antagonists| are useful as analgesics, anti-angiogenic agents for treating e. g. rheumatoid arthritis or tumours, for appetite suppression or treating psychosis patent, Patent No. [US5554644-A, 5554644]; Pilla L, 2009, EXPERT OPIN BIOL TH, V9, P1043, DOI 10.1517/14712590903085109; Quinlan R., 1993, PROGRAMS MACHINE LEA; Rosca EV, 2011, CURR PHARM BIOTECHNO, V12, P1101; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Scholkopf B BC, 1999, MAKING LARGE SCALE S; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Sulochana KN, 2007, CURR PHARM DESIGN, V13, P2074; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thundimadathil Jyothi, 2012, J Amino Acids, V2012, P967347, DOI 10.1155/2012/967347; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; Tyagi A, 2015, NUCLEIC ACIDS RES, V43, pD837, DOI 10.1093/nar/gku892; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Van Dorpe S, 2012, BRAIN STRUCT FUNCT, V217, P687, DOI 10.1007/s00429-011-0375-0; Waghu FH, 2014, NUCLEIC ACIDS RES, V42, pD1154, DOI 10.1093/nar/gkt1157; Wu CH, 2003, COMPUT BIOL CHEM, V27, P37, DOI 10.1016/S1476-9271(02)00098-1; Wynendaele E, 2013, NUCLEIC ACIDS RES, V41, pD655, DOI 10.1093/nar/gks1137; Xu Y, 2012, J INT MED RES, V40, P1217, DOI 10.1177/147323001204000401	40	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136990	10.1371/journal.pone.0136990	http://dx.doi.org/10.1371/journal.pone.0136990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335203	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400033
J	Jao, I; Kombe, F; Mwalukore, S; Bull, S; Parker, M; Kamuya, D; Molyneux, S; Marsh, V				Jao, Irene; Kombe, Francis; Mwalukore, Salim; Bull, Susan; Parker, Michael; Kamuya, Dorcas; Molyneux, Sassy; Marsh, Vicki			Research Stakeholders' Views on Benefits and Challenges for Public Health Research Data Sharing in Kenya: The Importance of Trust and Social Relations	PLOS ONE			English	Article							EXPERIENCES; PERSPECTIVE; ISSUES	Background There is increasing recognition of the importance of sharing research data within the international scientific community, but also of the ethical and social challenges this presents, particularly in the context of structural inequities and varied capacity in international research. Public involvement is essential to building locally responsive research policies, including on data sharing, but little research has involved stakeholders from low-to-middle income countries. Methods Between January and June 2014, a qualitative study was conducted in Kenya involving sixty stakeholders with varying experiences of research in a deliberative process to explore views on benefits and challenges in research data sharing. In-depth interviews and extended small group discussions based on information sharing and facilitated debate were used to collect data. Data were analysed using Framework Analysis, and charting flow and dynamics in debates. Findings The findings highlight both the opportunities and challenges of communicating about this complex and relatively novel topic for many stakeholders. For more and less research-experienced stakeholders, ethical research data sharing is likely to rest on the development and implementation of appropriate trust-building processes, linked to local perceptions of benefits and challenges. The central nature of trust is underpinned by uncertainties around who might request what data, for what purpose and when. Key benefits perceived in this consultation were concerned with the promotion of public health through science, with legitimate beneficiaries defined differently by different groups. Important challenges were risks to the interests of study participants, communities and originating researchers through stigmatisation, loss of privacy, impacting autonomy and unfair competition, including through forms of intentional and unintentional 'misuse' of data. Risks were also seen for science. Discussion Given background structural inequities in much international research, building trust in this low-to-middle income setting includes ensuring that the interests of study participants, primary communities and originating researchers will be promoted as far as possible, as well as protected. Important ways of building trust in data sharing include involving the public in policy development and implementation, promoting scientific collaborations around data sharing and building close partnerships between researchers and government health authorities to provide checks and balances on data sharing, and promote near and long-term translational benefits.	[Jao, Irene; Kombe, Francis; Mwalukore, Salim; Kamuya, Dorcas; Molyneux, Sassy; Marsh, Vicki] Kenya Med Res Inst Wellcome Trust, Res Programme, Hlth Syst & Res Eth Dept, Kilifi, Kenya; [Bull, Susan; Parker, Michael; Kamuya, Dorcas] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford, England; [Molyneux, Sassy; Marsh, Vicki] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England	Kenya Medical Research Institute; University of Oxford; University of Oxford	Marsh, V (corresponding author), Kenya Med Res Inst Wellcome Trust, Res Programme, Hlth Syst & Res Eth Dept, Kilifi, Kenya.	vmarsh@kemri-wellcome.org	Molyneux, Catherine/HGB-8464-2022	Molyneux, Catherine/0000-0001-9522-416X; Kombe, Francis/0000-0003-0390-2336; Jao, Irene/0000-0002-6645-510X; Bull, Susan/0000-0002-9730-091X	Wellcome Trust, Public Health Research Data Forum [096527]; Wellcome Trust Strategic Award [096527]; Wellcome Trust funding [092654/Z/10/A]; Wellcome Trust Fellowship [WT085418]	Wellcome Trust, Public Health Research Data Forum(Wellcome Trust); Wellcome Trust Strategic Award(Wellcome Trust); Wellcome Trust funding(Wellcome Trust); Wellcome Trust Fellowship(Wellcome Trust)	This research was funded by the Wellcome Trust Strategic Award 096527, on behalf of the Public Health Research Data Forum. The Forum brings together more than 20 health research funders, who are committed to increasing the availability of health research data in ways that are equitable, ethical and efficient, and will accelerate improvements in public health (www.wellcome.ac.uk/publichealthdata). The Kenya Medical Research Institute provided support to the research. VM, IJ, SB, MP and SM are supported by a Wellcome Trust Strategic Award to the Global Health Bioethics Network (096527). VM is supported by Wellcome Trust funding (092654/Z/10/A). SM is supported by a Wellcome Trust Fellowship (WT085418). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abelson J, 2003, SOC SCI MED, V57, P239, DOI 10.1016/S0277-9536(02)00343-X; [Anonymous], 2014, PLOS J; Benatar SR, 2010, J MED ETHICS, V36, P194, DOI 10.1136/jme.2009.032672; Bull S, 2015, JERHRE IN PRESS, V10; Bull S, 2015, J EMPIRICAL IN PRESS, V10; Burgess Michael M, 2004, J Bioeth Inq, V1, P4, DOI 10.1007/BF02448901; Cheah P, 2015, JERHRE IN PRESS, V10; Cheah P, 2015, J EMPIRICAL IN PRESS, V10; Coady SA, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-201; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Denny S, 2015, JERHRE IN PRESS, V10; Denny SG, 2015, J EMPIRICAL IN PRESS, V10; ESRC, 2010, RES DAT POL 2010; Foster MW, 2007, NAT REV GENET, V8, P633, DOI 10.1038/nrg2124; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Green J, 2007, QUALITATIVE METHODS; Hate K, 2015, J EMPIRICAL IN PRESS, V10; Hate K, 2015, JERHRE IN PRESS, V10; Hawkins AK, 2010, NEW GENET SOC, V29, P311, DOI 10.1080/14636778.2010.507487; IJsselmuiden CB, 2010, GLOB PUBLIC HEALTH, V5, P154, DOI 10.1080/17441690903436599; Jao I, 2015, J EMPIRICAL IN PRESS, V10; Kamuya DM, 2013, DEV WORLD BIOETH, V13, P10, DOI 10.1111/dewb.12014; Kamuya DM, 2013, DEV WORLD BIOETH, V13, P1, DOI 10.1111/dewb.12009; Marsh V, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-41; Marsh VM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-13; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; Merson L, 2015, J EMPIRICAL IN PRESS, V10; Merson L, 2015, JERHRE IN PRESS, V10; Molster C, 2013, HEALTH EXPECT, V16, P211, DOI 10.1111/j.1369-7625.2011.00701.x; Molyneux S, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-13; MRC, 2014, MRC DAT SHAR 2014; National Institutes of Health, 2014, NIH DAT SHAR POL 201; Nature, 2014, NATURE; Njue M, 2015, PLOS ONE; Parker M, 2007, PRINCIPLES HLTH CARE; Parker M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000143; Parkin David, 1991, SACRED VOID SPATIAL; Pearce N, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-107; Pisani E, 2010, B WORLD HEALTH ORGAN, V88, P462, DOI 10.2471/BLT.09.074393; Pisani E, 2010, LANCET, V375, P703, DOI 10.1016/S0140-6736(09)61486-0; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Rani Manju, 2011, J Evid Based Med, V4, P204, DOI 10.1111/j.1756-5391.2011.01161.x; Rani M, 2012, B WORLD HEALTH ORGAN, V90, P932, DOI 10.2471/BLT.12.105908; Sankoh O, 2011, LANCET, V378, P401, DOI 10.1016/S0140-6736(11)61211-7; Science, SCIENCE; Tangcharoensathien V, 2010, B WORLD HEALTH ORGAN, V88, P468, DOI 10.2471/BLT.10.079129; Tindana P, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-76; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; Virtual Kenya, VIRT KEN 2011; Wellcome Trust, 2010, POL DAT MAN SHAR 201	50	25	25	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135545	10.1371/journal.pone.0135545	http://dx.doi.org/10.1371/journal.pone.0135545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331716	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800033
J	Sun, YB; Jiang, CQ; Cheng, KK; Zhang, WS; Leung, GM; Lam, TH; Schooling, CM				Sun, Yangbo; Jiang, Chao Qiang; Cheng, Kar Keung; Zhang, Wei Sen; Leung, Gabriel M.; Lam, Tai Hing; Schooling, C. Mary			Nut Consumption and Cardiovascular Risk in Older Chinese: The Guangzhou Biobank Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MEDITERRANEAN DIET; PREVENTION; HEALTH; MORTALITY; WOMEN	Objectives In Western contexts nut consumption is associated with better health. We examined the associations of nut consumption with cardiovascular disease risk in the non-Western setting of Southern China. Methods In the Guangzhou Biobank Cohort Study we used multivariable linear regression to examine the associations of baseline nut (mainly peanuts) consumption (none (n = 6688), <3 portions/week (n = 2596) and >= 3 portions/week (n = 2444)) with follow-up assessment of Framingham cardiovascular disease score (excluding smoking) and its components in older Chinese (>= 50 years) (follow-up 57.8%). Results Nut consumption was not associated with Framingham score (>= 3 portions/week compared to none: 0.02 95% confidence interval (CI) -0.11 to 0.15), systolic blood pressure (-0.66 mmHg 95% CI -1.94, 0.62), diastolic blood pressure (-0.69 mmHg 95% CI -1.44, 0.07), HDL-cholesterol (-0.01 mmol/L 95% CI -0.02, 0.005), LDL-cholesterol (-0.01 mmol/L 95% CI -0.05, 0.02) or fasting glucose (0.04 mmol/L 95% CI -0.02, 0.09), adjusted for baseline values, energy intake, age, sex, phase of recruitment, socio-economic position, lifestyle and baseline health status. Conclusions Observations concerning the benefits of nut consumption may be contextually specific, perhaps depending on the type of nut consumed.	[Sun, Yangbo; Leung, Gabriel M.; Lam, Tai Hing; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Jiang, Chao Qiang; Zhang, Wei Sen] Guangzhou 12 Hosp, Guangzhou, Guangdong, Peoples R China; [Cheng, Kar Keung] Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham, W Midlands, England; [Schooling, C. Mary] CUNY, Sch Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Birmingham; City University of New York (CUNY) System	Lam, TH (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hkucc.hku.hk	Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Cheng, Kar/0000-0002-1516-1857; Schooling, Mary/0000-0001-9933-5887; Lam, Tai Hing/0000-0002-2033-9971; Leung, Gabriel/0000-0002-2503-6283	University of Hong Kong Foundation for Development and Research, Hong Kong; University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Committee, Guangzhou, China; University of Birmingham, Birmingham, United Kingdom; Bureau of Guangzhou Science and Technology [2012J5100041, 2013J4100031]	University of Hong Kong Foundation for Development and Research, Hong Kong(University of Hong Kong); University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Committee, Guangzhou, China; University of Birmingham, Birmingham, United Kingdom; Bureau of Guangzhou Science and Technology	This work was supported by the University of Hong Kong Foundation for Development and Research, Hong Kong; The University of Hong Kong University Research Committee Strategic Research Theme Public Health, Hong Kong; Guangzhou Public Health Bureau, and Guangzhou Science and Technology Committee, Guangzhou, China; and The University of Birmingham, Birmingham, United Kingdom. Key technology collaboration project funded by the Bureau of Guangzhou Science and Technology (Grant 2012J5100041; 2013J4100031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; [Anonymous], 2013, BMJ BRIT MED J; [Anonymous], 2014, AM HEART ASS DIET LI; Blomhoff R, 2006, BRIT J NUTR, V96, pS52, DOI 10.1017/BJN20061864; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; Colpo E, 2013, J NUTR METAB, V2013, P1; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Elhayany A, 2010, DIABETES OBES METAB, V12, P204, DOI 10.1111/j.1463-1326.2009.01151.x; Ellsworth JL, 2001, NUTR METAB CARDIOVAS, V11, P372; Elwell-Sutton T, 2011, J EPIDEMIOL COMMUN H, V65, pA331, DOI 10.1136/jech.2011.142976l.25; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416; Freudenheim JL, 1999, AM J CLIN NUTR, V69, p1315S; Goff D. C., 2013, CIRCULATION; Gonzalez CA, 2006, BRIT J NUTR, V96, pS87, DOI 10.1017/BJN20061868; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; Hsu-Hage B H, 1992, Asia Pac J Clin Nutr, V1, P211; Institute of Nutrition and Food Safety China CDC, 2002, CHIN FOOD COMP 2002, V1; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; Kris-Etherton PN, 2008, J NUTR, V138, p1746S; Li SC, 2011, METABOLISM, V60, P474, DOI 10.1016/j.metabol.2010.04.009; Li TY, 2009, J NUTR, V139, P1333, DOI 10.3945/jn.108.103622; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Luo C, 2014, AM J CLIN NUTR, V100, P256, DOI 10.3945/ajcn.113.076109; Ma L, 2014, THROMB RES; Martinez-Lapiscina EH, 2010, NUTR METAB CARDIOVAS, V20, P359, DOI 10.1016/j.numecd.2009.04.013; Mejia SB, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004660; Nouran MG, 2010, PUBLIC HEALTH NUTR, V13, P1581, DOI 10.1017/S1368980009992837; Sabate J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2006, ARCH INTERN MED, V166, P1498, DOI 10.1001/archinte.166.14.1498; Schuitemaker GE, 2001, EUR J CLIN PHARMACOL, V56, P857, DOI 10.1007/s002280000247; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Shi ZQ, 2014, NUTR METAB CARDIOVAS, V24, P1262, DOI 10.1016/j.numecd.2014.06.009; Villegas R, 2008, AM J CLIN NUTR, V87, P162, DOI 10.1093/ajcn/87.1.162; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yun-Qi Weng JY, 2014, EXP CLIN CARDIOL, V20, P3770; Zhou DH, 2014, AM J CLIN NUTR, V100, P270, DOI 10.3945/ajcn.113.079152	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137178	10.1371/journal.pone.0137178	http://dx.doi.org/10.1371/journal.pone.0137178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332759	Green Published, gold			2022-12-27	WOS:000360613800104
J	Valacca, C; Tassone, E; Mignatti, P				Valacca, Cristina; Tassone, Evelyne; Mignatti, Paolo			TIMP-2 Interaction with MT1-MMP Activates the AKT Pathway and Protects Tumor Cells from Apoptosis	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; GROWTH-PROMOTING ACTIVITY; BREAST-CARCINOMA CELLS; TISSUE INHIBITOR; EXTRACELLULAR-MATRIX; COLORECTAL-CANCER; ENDOTHELIAL-CELLS; BLADDER-CANCER; SIGNALING AXIS; EXPRESSION	Membrane-type 1 matrix metalloproteinase (MT1-MMP), a transmembrane proteinase with an extracellular catalytic domain and a short cytoplasmic tail, degrades a variety of extracellular matrix (ECM) components. In addition, MT1-MMP activates intracellular signaling through proteolysis-dependent and independent mechanisms. We have previously shown that binding of tissue inhibitor of metalloproteinases-2 (TIMP-2) to MT1-MMP controls cell proliferation and migration, as well as tumor growth in vivo by activating the Ras-extracellular signal regulated kinase-1 and -2 (ERK1/2) pathway through a mechanism that requires the cytoplasmic but not the proteolytic domain of MT1-MMP. Here we show that in MT1-MMP expressing cells TIMP-2 also induces rapid and sustained activation of AKT in a dose-and time-dependent manner and by a mechanism independent of the proteolytic activity of MT1-MMP. Fibroblast growth factor receptor-1 mediates TIMP-2 induction of ERK1/2 but not of AKT activation; however, Ras activation is necessary to transduce the TIMP-2-activated signal to both the ERK1/2 and AKT pathways. ERK1/2 and AKT activation by TIMP-2 binding to MT1-MMP protects tumor cells from apoptosis induced by serum starvation. Conversely, TIMP-2 upregulates apoptosis induced by three-dimensional type I collagen in epithelial cancer cells. Thus, TIMP-2 interaction with MT1-MMP provides tumor cells with either pro-or anti-apoptotic signaling depending on the extracellular environment and apoptotic stimulus.	[Valacca, Cristina; Tassone, Evelyne] NYU, Sch Med, Dept Cardiothorac Surg, New York, NY USA; [Mignatti, Paolo] NYU, Sch Med, Dept Med, New York, NY 10018 USA; [Mignatti, Paolo] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; New York University	Mignatti, P (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10018 USA.	mignap01@nyumc.org		Tassone, Evelyne/0000-0003-0631-007X; Mignatti, Paolo/0000-0002-8157-457X	 [R01 CA136715-0101];  [3R01CA136715-03S1]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA136715] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by R01 CA136715-0101 and 3R01CA136715-03S1 (http://www.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal E, 2013, CELL SIGNAL, V25, P1711, DOI 10.1016/j.cellsig.2013.03.025; Annabi B, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-8; Baker EA, 2006, BRIT J ORAL MAX SURG, V44, P482, DOI 10.1016/j.bjoms.2005.10.005; Baker EA, 2000, BRIT J SURG, V87, P1215, DOI 10.1046/j.1365-2168.2000.01531.x; Belkaid A, 2007, NEOPLASIA, V9, P332, DOI 10.1593/neo.07142; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chan KM, 2012, DEV CELL, V22, P1176, DOI 10.1016/j.devcel.2012.04.014; CORCORAN ML, 1995, J BIOL CHEM, V270, P13453, DOI 10.1074/jbc.270.22.13453; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Grignon DJ, 1996, CANCER RES, V56, P1654; HAYAKAWA T, 1994, CELL STRUCT FUNCT, V19, P109, DOI 10.1247/csf.19.109; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hoegy SE, 2001, J BIOL CHEM, V276, P3203, DOI 10.1074/jbc.M008157200; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Kanayama H, 1998, CANCER, V82, P1359, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1359::AID-CNCR20>3.0.CO;2-4; Katz M, 2007, BIOCH BIOPHYS ACTA; Larsen MB, 2005, SCAND J IMMUNOL, V61, P449, DOI 10.1111/j.1365-3083.2005.01585.x; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Lehti K, 2009, J CELL SCI, V122, P126, DOI 10.1242/jcs.035279; Liu YL, 2010, BONE, V47, P916, DOI 10.1016/j.bone.2010.07.022; LUO BH, 2007, ANN REV IMMUNOL; Maquoi E, 2012, ONCOGENE, V31, P480, DOI 10.1038/onc.2011.249; Murawaki Y, 1999, CLIN CHIM ACTA, V281, P109, DOI 10.1016/S0009-8981(98)00215-0; MURPHY AN, 1993, J CELL PHYSIOL, V157, P351, DOI 10.1002/jcp.1041570219; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Olex AL, 2014, GENE, V542, P38, DOI 10.1016/j.gene.2014.03.022; Onguchi T, 2009, AM J PATHOL, V174, P1564, DOI 10.2353/ajpath.2009.080452; Pasieka Zbigniew, 2004, Endocr Regul, V38, P57; Proulx-Bonneau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021511; Ree AH, 1997, CLIN CANCER RES, V3, P1623; Remacle A, 2000, INT J CANCER, V89, P118, DOI 10.1002/(SICI)1097-0215(20000320)89:2<118::AID-IJC3>3.0.CO;2-8; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Ruokolainen H, 2006, MODERN PATHOL, V19, P208, DOI 10.1038/modpathol.3800506; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Sina A, 2010, J CELL COMMUN SIGNAL, V4, P31, DOI 10.1007/s12079-009-0084-0; Soulie P, 2005, ONCOGENE, V24, P1689, DOI 10.1038/sj.onc.1208360; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Sugiyama N, 2010, P NATL ACAD SCI USA, V107, P15786, DOI 10.1073/pnas.0914459107; Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011; Tassone E, 2014, J CELL PHYSL; Theret N, 1998, AM J PATHOL, V153, P945, DOI 10.1016/S0002-9440(10)65636-2; Ueno H, 1997, CANCER RES, V57, P2055; Uhich D, 2004, PLAST RECONSTR SURG, V114, P229, DOI 10.1097/01.PRS.0000129079.19089.6C; Valente P, 1998, INT J CANCER, V75, P246, DOI 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B; VISSCHER DW, 1994, INT J CANCER, V59, P339, DOI 10.1002/ijc.2910590308; Yamashita K, 1996, FEBS LETT, V396, P103, DOI 10.1016/0014-5793(96)01066-6; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231; Zucker S, 1998, INT J CANCER, V75, P780, DOI 10.1002/(SICI)1097-0215(19980302)75:5<780::AID-IJC19>3.0.CO;2-A; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	56	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136797	10.1371/journal.pone.0136797	http://dx.doi.org/10.1371/journal.pone.0136797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331622	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800072
J	Watanabe, S; Ohbayashi, R; Kanesaki, Y; Saito, N; Chibazakura, T; Soga, T; Yoshikawa, H				Watanabe, Satoru; Ohbayashi, Ryudo; Kanesaki, Yu; Saito, Natsumi; Chibazakura, Taku; Soga, Tomoyoshi; Yoshikawa, Hirofumi			Intensive DNA Replication and Metabolism during the Lag Phase in Cyanobacteria	PLOS ONE			English	Article							PRINCIPAL SIGMA-FACTOR; SP STRAIN PCC7942; GROWTH-PHASE; ESCHERICHIA-COLI; STATIONARY-PHASE; CHLAMYDOMONAS-REINHARDTII; CHLOROPLAST DIVISION; SYNCHRONOUS GROWTH; PLASTID NUCLEOIDS; GENE-EXPRESSION	Unlike bacteria such as Escherichia coli and Bacillus subtilis, several species of freshwater cyanobacteria are known to contain multiple chromosomal copies per cell, at all stages of their cell cycle. We have characterized the replication of multi-copy chromosomes in the cyanobacterium Synechococcus elongatus PCC 7942 (hereafter Synechococcus 7942). In Synechococcus 7942, the replication of multi-copy chromosome is asynchronous, not only among cells but also among multi-copy chromosomes. This suggests that DNA replication is not tightly coupled to cell division in Synechococcus 7942. To address this hypothesis, we analysed the relationship between DNA replication and cell doubling at various growth phases of Synechococcus 7942 cell culture. Three distinct growth phases were characterised in Synechococcus 7942 batch culture: lag phase, exponential phase, and arithmetic ( linear) phase. The chromosomal copy number was significantly higher during the lag phase than during the exponential and linear phases. Likewise, DNA replication activity was higher in the lag phase cells than in the exponential and linear phase cells, and the lag phase cells were more sensitive to nalidixic acid, a DNA gyrase inhibitor, than cells in other growth phases. To elucidate physiological differences in Synechococcus 7942 during the lag phase, we analysed the metabolome at each growth phase. In addition, we assessed the accumulation of central carbon metabolites, amino acids, and DNA precursors at each phase. The results of these analyses suggest that Synechococcus 7942 cells prepare for cell division during the lag phase by initiating intensive chromosomal DNA replication and accumulating metabolites necessary for the subsequent cell division and elongation steps that occur during the exponential growth and linear phases.	[Watanabe, Satoru; Ohbayashi, Ryudo; Chibazakura, Taku; Yoshikawa, Hirofumi] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan; [Ohbayashi, Ryudo; Yoshikawa, Hirofumi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan; [Kanesaki, Yu] Tokyo Univ Agr, Genome Res Ctr, Tokyo, Japan; [Saito, Natsumi; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Tokyo University of Agriculture; Japan Science & Technology Agency (JST); Tokyo University of Agriculture; Keio University	Yoshikawa, H (corresponding author), Tokyo Univ Agr, Dept Biosci, Tokyo, Japan.	hiyoshik@nodai.ac.jp	Ohbayashi, Ryudo/AAZ-4841-2020; Kanesaki, Yu/J-3817-2017	Kanesaki, Yu/0000-0003-3537-9789; Ohbayashi, Ryudo/0000-0001-6359-0122	MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1311017]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24780082, 25850056]; Grants-in-Aid for Scientific Research [25850056] Funding Source: KAKEN	MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017 (S1311017) to Tokyo University of Agriculture (HY) in the study data collection and analysis (http://www.mext.go.jp/component/a_menu/education/detail/__icsFiles/afieldfile/2013/07/11/1267810_6. pdf); Grants-in-Aid 24780082 from the Ministry of Education, Culture, Sports, Science and Technology of Japan to YK in the study data collection and analysis (https://kaken.nii.ac.jp/d/p/24780082.en.html), and Grants-in-Aid 25850056 from the Ministry of Education, Culture, Sports, Science and Technology of Japan to SW in the study data collection and analysis (https://kaken.nii.ac.jp/d/p/25850056.en.html).	Asayama M, 1996, J BIOCHEM, V120, P752; BAUMGARTNER BJ, 1989, PLANT PHYSIOL, V89, P1011, DOI 10.1104/pp.89.3.1011; BENDICH AJ, 1987, BIOESSAYS, V6, P279, DOI 10.1002/bies.950060608; Berla BM, 2012, APPL ENVIRON MICROB, V78, P5448, DOI 10.1128/AEM.01174-12; BINDER BJ, 1995, APPL ENVIRON MICROB, V61, P708, DOI 10.1128/AEM.61.2.708-717.1995; BOFFEY SA, 1979, PLANT PHYSIOL, V64, P502, DOI 10.1104/pp.64.3.502; BROEDEL SE, 1991, GENE, V109, P71, DOI 10.1016/0378-1119(91)90590-8; CASTENHOLZ RW, 1988, METHOD ENZYMOL, V167, P68; Chen AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047837; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; CUTLER RG, 1966, J BACTERIOL, V91, P469, DOI 10.1128/JB.91.2.469-476.1966; DEMARSAC NT, 1993, FEMS MICROBIOL LETT, V104, P119; FERRETTI JJ, 1968, J BACTERIOL, V95, P1400, DOI 10.1128/JB.95.4.1400-1406.1968; Foster JS, 2007, ARCH MICROBIOL, V187, P265, DOI 10.1007/s00203-006-0193-6; Fuszard Matthew A, 2013, Aquat Biosyst, V9, P5, DOI 10.1186/2046-9063-9-5; Gerhardt P., 1994, METHODS GEN MOL BACT, P224; Griese M, 2011, FEMS MICROBIOL LETT, V323, P124, DOI 10.1111/j.1574-6968.2011.02368.x; Hein S, 2013, RNA BIOL, V10, P852, DOI 10.4161/rna.24160; Imamura S, 2006, J BIOL CHEM, V281, P2668, DOI 10.1074/jbc.M509639200; Jain IH, 2012, P NATL ACAD SCI USA, V109, P13638, DOI 10.1073/pnas.1211144109; Kabeya Y, 2013, PLANT PHYSIOL, V161, P2102, DOI 10.1104/pp.113.216291; KUROIWA T, 1991, INT REV CYTOL, V128, P1; LAMPPA GK, 1980, PLANTA, V148, P437, DOI [10.1007/BF00552656, 10.1007/BF02395311]; MANN N, 1974, J GEN MICROBIOL, V83, P399; MIYAMURA S, 1986, PROTOPLASMA, V133, P66, DOI 10.1007/BF01293188; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Nimura K, 2001, J BACTERIOL, V183, P1320, DOI 10.1128/JB.183.4.1320-1328.2001; de Alda JAGO, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5937; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ohbayashi R, 2013, FEMS MICROBIOL LETT, V344, P138, DOI 10.1111/1574-6968.12166; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Powikrowska M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00424; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Saito N, 2009, J BIOL CHEM, V284, P16442, DOI 10.1074/jbc.M109.002089; Sakai A, 2004, INT REV CYTOL, V238, P59, DOI 10.1016/S0074-7696(04)38002-2; Sato M, 2007, J BACTERIOL, V189, P3751, DOI 10.1128/JB.01722-06; Schneider D, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-39; Sen A, 2000, ARCH MICROBIOL, V173, P352, DOI 10.1007/s002030000153; SHEHATA TE, 1970, J BACTERIOL, V103, P789, DOI 10.1128/JB.103.3.789-792.1970; Suzuki S, 2004, J BIOL CHEM, V279, P13234, DOI 10.1074/jbc.M313358200; TANAKA K, 1992, BIOCHIM BIOPHYS ACTA, V1132, P94, DOI 10.1016/0167-4781(92)90060-D; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; Wang JD, 2009, NAT REV MICROBIOL, V7, P822, DOI 10.1038/nrmicro2202; Watanabe S, 2012, MOL MICROBIOL, V83, P856, DOI 10.1111/j.1365-2958.2012.07971.x; Yehudai-Resheff S, 2007, PLANT CELL, V19, P1023, DOI 10.1105/tpc.106.045427	46	28	31	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136800	10.1371/journal.pone.0136800	http://dx.doi.org/10.1371/journal.pone.0136800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331851	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800074
J	Zhang, Y; Shi, JL; Liu, LP; Gao, ZH; Che, JX; Shao, DY; Liu, YL				Zhang, Yan; Shi, Junling; Liu, Laping; Gao, Zhenhong; Che, Jinxin; Shao, Dongyan; Liu, Yanlin			Bioconversion of Pinoresinol Diglucoside and Pinoresinol from Substrates in the Phenylpropanoid Pathway by Resting Cells of Phomopsis sp.XP-8	PLOS ONE			English	Article							BREAST-CANCER RISK; MAMMALIAN LIGNANS; PLANT LIGNANS; BIOTRANSFORMATION; (+)-PINORESINOL; ENTEROLACTONE; PHENYLALANINE; BIOSYNTHESIS; METABOLISM	Pinoresinol diglucoside (PDG) and pinoresinol (Pin) are normally produced by plant cells via the phenylpropanoid pathway. This study reveals the existence of a related pathway in Phomopsis sp. XP-8, a PDG-producing fungal strain isolated from the bark of the Tu-chung tree (Eucommiaulmoides Oliv.). After addition of 0.15 g/L glucose to Phomopsis sp. XP-8, PDG and Pin formed when phenylalanine, tyrosine, leucine, cinnamic acid, and p-coumaric acid were used as the substrates respectively. No PDG formed in the absence of glucose, but Pin was detected after addition of all these substrates except leucine. In all systems in the presence of glucose, production of PDG and/or Pin and the accumulation of phenylalanine, cinnamic acid, or p-coumaric acid correlated directly with added substrate in a time- and substrate concentration-dependent manner. After analysis of products produced after addition of each substrate, the mass flow sequence for PDG and Pin biosynthesis was defined as: glucose to phenylalanine, phenylalanine to cinnamic acid, then to p-coumaric acid, and finally to Pin or PDG. During the bioconversion, the activities of four key enzymes in the phenylpropanoid pathway were also determined and correlated with accumulation of their corresponding products. PDG production by Phomopsis sp. exhibits greater efficiency and cost effectiveness than the currently-used plant-based system and will pave the way for large scale production of PDG and/or Pin for medical applications.	[Zhang, Yan; Liu, Laping; Gao, Zhenhong; Che, Jinxin] Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi Provinc, Peoples R China; [Shi, Junling; Shao, Dongyan] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, 127 Youyi West Rd, Xian 710072, Shaanxi Provinc, Peoples R China; [Liu, Yanlin] Northwest A&F Univ, Coll Enol, Yangling 712100, Shaanxi Provinc, Peoples R China	Northwest A&F University - China; Northwestern Polytechnical University; Northwest A&F University - China	Shi, JL (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, 127 Youyi West Rd, Xian 710072, Shaanxi Provinc, Peoples R China.	sjlshi2004@aliyun.com			National Natural Science Foundation of China (NSFC) [31201408]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC) No. 31201408.	Adlercreutz H, 2002, LANCET ONCOL, V3, P364, DOI 10.1016/S1470-2045(02)00777-5; Charles JS, 1976, J AM CHEM SOC, V98, P5412; Charles JS, 1978, US Patent, Patent No. [4:103-106, 4103106]; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Donnez D, 2009, TRENDS BIOTECHNOL, V27, P706, DOI 10.1016/j.tibtech.2009.09.005; During A, 2012, J NUTR, V142, P1798, DOI 10.3945/jn.112.162453; Eudes A, 2014, CURR OPIN BIOTECH, V26, P189, DOI 10.1016/j.copbio.2014.01.002; Heinonen S, 2001, J AGR FOOD CHEM, V49, P3178, DOI 10.1021/jf010038a; Horn-Ross PL, 2001, AM J EPIDEMIOL, V154, P434, DOI 10.1093/aje/154.5.434; Horn-Ross PL, 2003, J NATL CANCER I, V95, P1158, DOI 10.1093/jnci/djg015; Jeandet P, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/579089; Kanehisa Laboratories, 2015, BIOS PLANT SEC MET R; Kaul S, 2012, PHYTOCHEM REV, V11, P487, DOI 10.1007/s11101-012-9260-6; Khan W, 2003, J PLANT PHYSIOL, V160, P859, DOI 10.1078/0176-1617-00905; Luo LF, 2010, J ETHNOPHARMACOL, V129, P238, DOI 10.1016/j.jep.2010.03.019; Marienhagen J, 2013, J BIOTECHNOL, V163, P166, DOI 10.1016/j.jbiotec.2012.06.001; Redmile-Gordon MA, 2013, SOIL BIOL BIOCHEM, V67, P166, DOI 10.1016/j.soilbio.2013.08.017; Ro DK, 2004, J BIOL CHEM, V279, P2600, DOI 10.1074/jbc.M309951200; Saleem M, 2005, NAT PROD REP, V22, P696, DOI 10.1039/b514045p; Satake H, 2013, J AGR FOOD CHEM, V61, P11721, DOI 10.1021/jf4007104; Shi JL, 2012, APPL MICROBIOL BIOT, V93, P1475, DOI 10.1007/s00253-011-3613-8; Suzuki S, 2007, J WOOD SCI, V53, P273, DOI 10.1007/s10086-007-0892-x; Umezawa T., 2005, KAGAKU SEIBUTSU, V43, P461; Wikul A, 2012, BIOORG MED CHEM LETT, V22, P5215, DOI 10.1016/j.bmcl.2012.06.068; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Xiao JB, 2009, ARCH BIOL SCI, V61, P811, DOI 10.2298/ABS0904811X; Xie J, 2013, BREAST CANCER RES TR, V139, P801, DOI 10.1007/s10549-013-2586-y; Xie LH, 2003, CHEM PHARM BULL, V51, P508, DOI 10.1248/cpb.51.508; Zhang JH, 2013, APPL MICROBIOL BIOT, V97, P9941, DOI 10.1007/s00253-013-5212-3; Zhang Y, 2015, APPL MICROBIOL BIOT, V99, P4629, DOI 10.1007/s00253-015-6491-7	30	8	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137066	10.1371/journal.pone.0137066	http://dx.doi.org/10.1371/journal.pone.0137066			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331720	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800093
J	Hill, MD; Martin, RH; Palesch, YY; Moy, CS; Tamariz, D; Ryckborst, KJ; Jones, EB; Weisman, D; Pettigrew, C; Ginsberg, MD				Hill, Michael D.; Martin, Renee H.; Palesch, Yuko Y.; Moy, Claudia S.; Tamariz, Diego; Ryckborst, Karla J.; Jones, Elizabeth B.; Weisman, David; Pettigrew, Creed; Ginsberg, Myron D.			Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial	PLOS ONE			English	Article							MARKED NEUROPROTECTIVE EFFICACY; FOCAL CEREBRAL-ISCHEMIA; LOCAL VASCULAR DYNAMICS; TROPONIN-T; MYOCARDIAL-INFARCTION; DOSE-ESCALATION; RAT MODEL; THERAPY; THROMBOLYSIS; FIBRINOGEN	Background Albumin treatment of ischemic stroke was associated with cardiopulmonary adverse events in previous studies and a low incidence of intracranial hemorrhage. We sought to describe the neurological and cardiopulmonary adverse events in the ALIAS Part 2 Multicenter Trial. Methods Ischemic stroke patients, aged 18-83 and a baseline NIHSS >= 6, were randomized to treatment with ALB or saline control within 5 hours of stroke onset. Neurological adverse events included symptomatic intracranial hemorrhage, hemicraniectomy, neurological deterioration and neurological death. Cardiopulmonary adverse events included pulmonary edema/congestive heart failure, acute coronary syndromes, atrial fibrillation, pneumonia and pulmonary thromboembolism. Results Among 830 patients, neurological and cardiopulmonary adverse events were not differentially associated with poor outcome between ALB and saline control subjects. The rate of symptomatic intracranial hemorrhage in the first 24h was low overall (2.9%, 24/830) but more common in the ALB treated subjects (RR = 2.4, CI95 1.01-5.8). The rate of pulmonary edema/CHF in the first 48h was 7.9% (59/830) and was more common among ALB treated subjects (RR = 10.7, CI95 4.3-26.6); this complication was expected and was satisfactorily managed with mandated diuretic administration and intravenous fluid guidelines. Troponin elevations in the first 48h were common, occurring without ECG change or cardiac symptoms in 52 subjects (12.5%). Conclusions ALB therapy was associated with an increase in symptomatic ICH and pulmonary edema/congestive heart failure but this did not affect final outcomes. Troponin elevation occurs routinely in the first 48 hours after acute ischemic stroke.	[Hill, Michael D.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Hill, Michael D.] Univ Calgary, Dept Med, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada; [Hill, Michael D.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Radiol, Calgary, AB, Canada; [Hill, Michael D.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Community Hlth Sci, Calgary, AB, Canada; [Martin, Renee H.; Palesch, Yuko Y.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Moy, Claudia S.] NINDS, Off Clin Res, NIH, Bethesda, MD 20892 USA; [Tamariz, Diego; Ginsberg, Myron D.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Ryckborst, Karla J.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Jones, Elizabeth B.] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA; [Weisman, David] Abington Neurol Associates, Abington, PA USA; [Pettigrew, Creed] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Pettigrew, Creed] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	University of Calgary; University of Calgary; University of Calgary; University of Calgary; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Miami; University of Calgary; University of Texas System; University of Texas Health Science Center Houston; University of Kentucky; University of Kentucky	Hill, MD (corresponding author), Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada.	michael.hill@ucalgary.ca	Hill, Michael D/C-9073-2012	Hill, Michael D/0000-0002-6269-1543; Pettigrew, Luther Creed/0000-0001-7878-5803	National Institute of Neurological Disorders and Stroke, National Institutes of Health [U01NS040406, U01NS054630, U01NS056975, U10NS058967]; Alberta Innovates [201300690] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS040406, U10NS058967, U01NS054630, U01NS056975] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alberta Innovates; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by cooperative agreements from the National Institute of Neurological Disorders and Stroke, National Institutes of Health (U01NS040406, University of Miami; U01NS054630, Medical University of South Carolina; U01NS056975, University of Michigan; U10NS058967, University of Kentucky).	Anders B, 2013, CEREBROVASC DIS, V36, P211, DOI 10.1159/000353875; Beaulieu-Boire I, 2013, J STROKE CEREBROVASC, V22, P978, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.008; Belayev L, 2005, STROKE, V36, P326, DOI 10.1161/01.STR.0000152949.31366.3d; Belayev L, 1998, STROKE, V29, P2587, DOI 10.1161/01.STR.29.12.2587; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Blackshear JL, 2011, CIRCULATION, V123, P2571, DOI 10.1161/CIRCULATIONAHA.110.008250; DeFazio RA, 2012, J CEREBR BLOOD F MET, V32, P2012, DOI 10.1038/jcbfm.2012.102; Diringer MN, 2010, STROKE, V41, P48, DOI 10.1161/STROKEAHA.109.561712; Ginsberg M., 2004, PHARM CEREBRAL ISCHE, P421; Ginsberg MD, 2005, STROKE, V36, P420; Ginsberg MD, 2006, STROKE, V37, P2100, DOI 10.1161/01.STR.0000231388.72646.05; Ginsberg MD, 2013, LANCET NEUROL, V12, P1049, DOI 10.1016/S1474-4422(13)70223-0; Ginsberg MD, 2011, STROKE, V42, P119, DOI 10.1161/STROKEAHA.110.596072; Ginsberg MD, 2010, STROKE, V41, pE228; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hanna J, 2013, SCAND J CLIN LAB INV, V73, P553, DOI 10.3109/00365513.2013.821710; Hill MD, 2007, INT J STROKE, V2, P214, DOI 10.1111/j.1747-4949.2007.00143.x; Hill MD, 2011, STROKE, V42, P1621, DOI 10.1161/STROKEAHA.110.610980; Jensen JK, 2012, EUR NEUROL, V68, P287, DOI 10.1159/000341340; Katsanos AH, 2013, INT J CARDIOL, V167, P328, DOI 10.1016/j.ijcard.2012.06.107; Kral M, 2013, AM J CARDIOL, V112, P117, DOI 10.1016/j.amjcard.2013.02.067; Nielsen VG, 2005, ACTA ANAESTH SCAND, V49, P1163, DOI 10.1111/j.1399-6576.2005.00733.x; Nimmagadda A, 2008, STROKE, V39, P198, DOI 10.1161/STROKEAHA.107.495598; Park HP, 2008, STROKE, V39, P1556, DOI 10.1161/STROKEAHA.107.502195; Skhirtladze K, 2014, BRIT J ANAESTH, V112, P255, DOI 10.1093/bja/aet348; Song HS, 2008, J CLIN NEUROL, V4, P75, DOI 10.3988/jcn.2008.4.2.75; Weimar C, 2010, INT J STROKE, V5, P103, DOI 10.1111/j.1747-4949.2010.00414.x	28	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0131390	10.1371/journal.pone.0131390	http://dx.doi.org/10.1371/journal.pone.0131390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325387	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700003
J	Rover, C; Nicholas, R; Straube, S; Friede, T				Roever, Christian; Nicholas, Richard; Straube, Sebastian; Friede, Tim			Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression	PLOS ONE			English	Review							DISABILITY STATUS SCALE; MULTIPLE-SCLEROSIS; CLINICAL-TRIALS; RATES; SURROGATE; TRENDS	Background Recent systematic reviews of randomised controlled trials (RCTs) in relapsing multiple sclerosis (RMS) revealed a decrease in placebo annualized relapse rates (ARR) over the past two decades. Furthermore, regression to the mean effects were observed in ARR and MRI lesion counts. It is unclear whether disease progression measured by the expanded disability status scale (EDSS) exhibits similar features. Methods A systematic review of RCTs in RMS was conducted extracting data on EDSS and baseline characteristics. The logarithmic odds of disease progression were modelled to investigate time trends. Random-effects models were used to account for between-study variability; all investigated models included trial duration as a predictor to correct for unequal study durations. Meta-regressions were conducted to assess the prognostic value of a number of study-level baseline variables. Results The systematic literature search identified 39 studies, including a total of 19,714 patients. The proportion of patients in placebo controls experiencing a disease progression decreased over the years (p<0.001). Meta-regression identified associated covariates including the size of the study and its duration that in part explained the time trend. Progression probabilities tended to be lower in the second year of a study compared to the first year with a reduction of 28% in progression odds from year 1 to year 2 (p = 0.017). Conclusion EDSS disease progression exhibits similar behaviour over time as the ARR and point to changes in trial characteristics over the years. This needs to be considered in comparisons between historical and recent trials.	[Roever, Christian; Friede, Tim] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [Nicholas, Richard] Imperial Coll Healthcare NHS Trust, London, England; [Straube, Sebastian] Univ Alberta, Div Prevent Med, Edmonton, AB T6G 2T4, Canada	University of Gottingen; Imperial College London; University of Alberta	Friede, T (corresponding author), Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany.	tim.friede@med.uni-goettingen.de	Röver, Christian/H-4892-2019; Friede, Tim/ABF-1132-2021; Straube, Sebastian/E-1937-2016	Röver, Christian/0000-0002-6911-698X; Friede, Tim/0000-0001-5347-7441; Straube, Sebastian/0000-0001-7862-0398	NIHR Biomedical Research Centre	NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	RN is grateful for support from the NIHR Biomedical Research Centre. The authors received no specific funding for this work.	Aalen O O, 1994, Stat Methods Med Res, V3, P227, DOI 10.1177/096228029400300303; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; CHMP, 2015, EMACHMP7718152011; Hobart J, 2004, MULT SCLER J, V10, P41, DOI 10.1191/1352458504ms983oa; Hyun JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129243; Inusah S, 2010, MULT SCLER J, V16, P1414, DOI 10.1177/1352458510379246; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kicinski M, 2015, STAT MED, V34, P2781, DOI 10.1002/sim.6525; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Nicholas R, 2012, MULT SCLER J, V18, P1290, DOI 10.1177/1352458511435715; Nicholas R, 2011, MULT SCLER J, V17, P1211, DOI 10.1177/1352458511406309; NOSEWORTHY JH, 1990, NEUROLOGY, V40, P971, DOI 10.1212/WNL.40.6.971; Ontaneda D, 2012, MULT SCLER J, V18, P1520, DOI 10.1177/1352458512441689; Petkau J, 2008, MULT SCLER J, V14, P770, DOI 10.1177/1352458507088104; Rudick RA, 2013, LANCET NEUROL, V12, P628, DOI 10.1016/S1474-4422(13)70108-X; Rukhin AL, 2000, J STAT PLAN INFER, V83, P319, DOI 10.1016/S0378-3758(99)00098-1; Sormani MP, 2013, MULT SCLER J, V19, P605, DOI 10.1177/1352458512460605; Steinvorth SM, 2013, MULT SCLER J, V19, P1580, DOI 10.1177/1352458513481009; Stellmann JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116559; Stellmann JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050347; Thompson AJ, 1998, J NEUROL, V245, P189, DOI 10.1007/s004150050204; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03	23	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137052	10.1371/journal.pone.0137052	http://dx.doi.org/10.1371/journal.pone.0137052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327532	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700086
J	Bruchmann, M; Thaler, K; Vorberg, D				Bruchmann, Maximilian; Thaler, Kathrin; Vorberg, Dirk			Visible Persistence of Single-Transient Random Dot Patterns: Spatial Parameters Affect the Duration of Fading Percepts	PLOS ONE			English	Article							VISUAL PERSISTENCE; CORTICAL DYNAMICS; STIMULUS-DURATION; NEURAL DYNAMICS; GANGLION-CELLS; LUMINANCE; ONSET; SEGREGATION; INFORMATION; COMPLETION	Visible persistence refers to the continuation of visual perception after the physical termination of a stimulus. We studied an extreme case of visible persistence by presenting two matrices of randomly distributed black and white pixels in succession. On the transition from one matrix to the second, the luminance polarity of all pixels within a disk- or annulus-shaped area reversed, physically creating a single second-order transient signal. This transient signal produces the percept of a disk or an annulus with an abrupt onset and a gradual offset. To study the nature of this fading percept we varied spatial parameters, such as the inner and the outer diameter of annuli (Experiment I) and the radius and eccentricity of disks (Experiment III), and measured the duration of visible persistence by having subjects adjust the synchrony of the onset of a reference stimulus with the onset or the offset of the fading percept. We validated this method by comparing two modalities of the reference stimuli (Experiment I) and by comparing the judgments of fading percepts with the judgments of stimuli that actually fade in luminance contrast (Experiment II). The results show that (i) irrespective of the reference modality, participants are able to precisely judge the on- and the offsets of the fading percepts, (ii) auditory reference stimuli lead to higher visible persistence durations than visual ones, (iii) visible persistence duration increases with the thickness of annuli and the diameter of disks, but decreases with the diameter of annuli, irrespective of stimulus eccentricity. These effects cannot be explained by stimulus energy, which suggests that more complex processing mechanisms are involved. Seemingly contradictory effects of disk and annulus diameter can be unified by assuming an abstract filling-in mechanism that speeds up with the strength of the edge signal and takes more time the larger the stimulus area is.	[Bruchmann, Maximilian] Univ Munster, Inst Med Psychol & Syst Neurosci, D-48149 Munster, Germany; [Thaler, Kathrin] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Vorberg, Dirk] Univ Munster, Dept Psychol, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster	Bruchmann, M (corresponding author), Univ Munster, Inst Med Psychol & Syst Neurosci, D-48149 Munster, Germany.	Maximilian.Bruchmann@uni-muenster.de			German Research Foundation [BR3832/1-2]	German Research Foundation(German Research Foundation (DFG))	MB received funding from the the German Research Foundation (www.dfg.de), grant number: BR3832/1-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRINGTON KF, 1994, VISION RES, V34, P3371, DOI 10.1016/0042-6989(94)90071-X; BOWEN RW, 1974, VISION RES, V14, P295, DOI 10.1016/0042-6989(74)90079-0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; DILOLLO V, 1995, PSYCHOL BULL, V118, P223, DOI 10.1037/0033-2909.118.2.223; DILOLLO V, 1977, NATURE, V267, P241, DOI 10.1038/267241a0; EFRON R, 1970, NEUROPSYCHOLOGIA, V8, P37, DOI 10.1016/0028-3932(70)90024-2; EFRON R, 1970, NEUROPSYCHOLOGIA, V8, P57, DOI 10.1016/0028-3932(70)90025-4; EFRON R, 1970, PERCEPT PSYCHOPHYS, V8, P231, DOI 10.3758/BF03210211; Ferber S, 2005, NEUROPSYCHOLOGIA, V43, P41, DOI 10.1016/j.neuropsychologia.2004.06.020; Ferber S, 2003, CEREB CORTEX, V13, P716, DOI 10.1093/cercor/13.7.716; Francis G, 1996, PERCEPTION, V25, P543, DOI 10.1068/p250543; Francis G, 1999, SPATIAL VISION, V12, P31, DOI 10.1163/156856899X00021; FRANCIS G, 1994, VISION RES, V34, P1089, DOI 10.1016/0042-6989(94)90012-4; Francis G, 1996, PERCEPT PSYCHOPHYS, V58, P1103, DOI 10.3758/BF03206836; GRONER M T, 1988, Spatial Vision, V3, P293, DOI 10.1163/156856888X00177; Grossberg S, 1999, VISION RES, V39, P3796, DOI 10.1016/S0042-6989(99)00095-4; GROSSBERG S, 1985, PSYCHOL REV, V92, P173, DOI 10.1037/0033-295X.92.2.173; IKEDA H, 1972, J PHYSIOL-LONDON, V227, P769, DOI 10.1113/jphysiol.1972.sp010058; IRWIN DE, 1986, J EXP PSYCHOL HUMAN, V12, P343, DOI 10.1037/0096-1523.12.3.343; Kleiner M, 2007, PERCEPTION, V36, P14; KLING SC, 1983, B PSYCHONOMIC SOC, V21, P435, DOI 10.3758/BF03330001; LOFTUS GR, 1992, J EXP PSYCHOL HUMAN, V18, P530, DOI 10.1037/0096-1523.18.2.530; Loftus GR, 1998, COGNITIVE PSYCHOL, V35, P135, DOI 10.1006/cogp.1998.0678; LONG GM, 1985, PERCEPT PSYCHOPHYS, V38, P381, DOI 10.3758/BF03207167; LONG GM, 1981, VISION RES, V21, P1387, DOI 10.1016/0042-6989(81)90244-3; LOVEGROVE WJ, 1984, VISION RES, V24, P255, DOI 10.1016/0042-6989(84)90128-7; MEYER GE, 1988, CAN J PSYCHOL, V42, P479, DOI 10.1037/h0084201; PARADISO MA, 1991, VISION RES, V31, P1221, DOI 10.1016/0042-6989(91)90047-9; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; REGAN D, 1986, Spatial Vision, V1, P305, DOI 10.1163/156856886X00106; REGAN D, 1984, J OPT SOC AM A, V1, P433, DOI 10.1364/JOSAA.1.000433; Sackur J, 2011, J VISION, V11, DOI 10.1167/11.4.10; SHIOIRI S, 1992, VISION RES, V32, P943, DOI 10.1016/0042-6989(92)90037-J; SPERLING G, 1967, ACTA PSYCHOL, V27, P285, DOI 10.1016/0001-6918(67)90070-4; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; WILSON JTL, 1981, PERCEPT PSYCHOPHYS, V30, P353, DOI 10.3758/BF03206150; WILSON JTL, 1983, VISION RES, V23, P1699, DOI 10.1016/0042-6989(83)90186-4; Wong YJ, 2009, J NEUROPHYSIOL, V102, P3461, DOI 10.1152/jn.00243.2009; YEOMANS JM, 1985, PERCEPT PSYCHOPHYS, V37, P163, DOI 10.3758/BF03202852	43	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137091	10.1371/journal.pone.0137091	http://dx.doi.org/10.1371/journal.pone.0137091			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348616	gold, Green Published, Green Submitted			2022-12-27	WOS:000360897600021
J	Mejean, C; Morzel, M; Neyraud, E; Issanchou, S; Martin, C; Bozonnet, S; Urbano, C; Schlich, P; Hercberg, S; Peneau, S; Feron, G				Mejean, Caroline; Morzel, Martine; Neyraud, Eric; Issanchou, Sylvie; Martin, Christophe; Bozonnet, Sophie; Urbano, Christine; Schlich, Pascal; Hercberg, Serge; Peneau, Sandrine; Feron, Gilles			Salivary Composition Is Associated with Liking and Usual Nutrient Intake	PLOS ONE			English	Article							PROTEIN PROFILES; SODIUM-CHLORIDE; LIFE-STYLE; TASTE PREFERENCES; FAT PERCEPTION; DIETARY-SODIUM; BITTER TASTE; URIC-ACID; FOOD; CONSUMPTION	Salivary flow and composition have an impact on flavor perception. However, very few studies have explored the relationship between saliva, individual liking and usual dietary intake. The aim of our study was to evaluate the association of salivary flow and composition with both a liking for fat, saltiness and sweetness and the usual nutrient intake in an adult French population. Liking for fat, saltiness, and sweetness were inferred from liking scores obtained during hedonic tests on 32 food products among 282 French adults participating in the Nutrinet-Sante Study. Before assessing liking, resting saliva was collected. Standard biochemical analyses were performed to assess specific component concentrations and enzymatic activities. Dietary data were collected using three web-based 24h records. Relationships between salivary flow and composition, sensory liking and nutrient intake were assessed using linear regression. Total antioxidant capacity was positively associated with simple carbohydrate intake (beta = 31.3, 95% CI = 1.58; 60.99) and inversely related to complex carbohydrate consumption (beta = -52.4, 95% CI = -87.51; -19.71). Amylolysis was positively associated with both total (beta = 0.20, 95% CI = 0.01; 0.38) and simple carbohydrate intake (beta = 0.21, 95% CI = 0.01; 0.39). Salivary flow was positively associated with liking for fat (beta = 0.14, 95% CI = 0.03; 0.25). Proteolysis was positively associated with liking for saltiness and for fat (beta = 0.31, 95% CI = 0.02; 0.59; beta = 0.28, 95% CI = 0.01; 0.56, respectively). Amylolysis was inversely associated with liking for sweetness (beta = -10.13, 95% CI = -19.51; -0.75). Carbonic anhydrase 6 was inversely associated with liking for saltiness (beta = -46.77, 95% CI = -86.24; -7.30). Saliva does not substantially vary according to a usual diet, except for carbohydrate intake, whereas the specific association between salivary flow/composition and sensory liking suggests the influence of saliva characteristics in food acceptance.	[Mejean, Caroline; Hercberg, Serge; Peneau, Sandrine] Univ Paris 07, Univ Paris 05,COMUE, Univ Paris 13,U1125,Cnam,EREN,Sorbonne Paris Cite, Ctr Epidemiol & Stat Paris Nord,Inserm,U1153,Inra, F-93017 Bobigny, France; [Morzel, Martine; Neyraud, Eric; Issanchou, Sylvie; Martin, Christophe; Urbano, Christine; Schlich, Pascal; Feron, Gilles] CNRS, Ctr Sci Gout & Alimentat, UMR6265, F-21000 Dijon, France; [Morzel, Martine; Neyraud, Eric; Issanchou, Sylvie; Martin, Christophe; Urbano, Christine; Schlich, Pascal; Feron, Gilles] INRA, Ctr Sci Gout & Alimentat, UMR1324, F-21000 Dijon, France; [Morzel, Martine; Neyraud, Eric; Issanchou, Sylvie; Martin, Christophe; Urbano, Christine; Schlich, Pascal; Feron, Gilles] Univ Bourgogne, Ctr Sci Gout & Alimentat, UMR, F-21000 Dijon, France; [Bozonnet, Sophie] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Bozonnet, Sophie] INRA, UMR792, Ingn Syst Biol & Proc, F-31400 Toulouse, France; [Bozonnet, Sophie] CNRS, UMR5504, F-31400 Toulouse, France; [Hercberg, Serge] Hop Avicenne, Dept Publ Hlth, F-93300 Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Mejean, C (corresponding author), Univ Paris 07, Univ Paris 05,COMUE, Univ Paris 13,U1125,Cnam,EREN,Sorbonne Paris Cite, Ctr Epidemiol & Stat Paris Nord,Inserm,U1153,Inra, F-93017 Bobigny, France.	c.mejean@uren.smbh.univ-paris13.fr	Serge, Hercberg/F-3038-2017; HERCBERG, Serge/B-4429-2008; Peneau, Sandrine/F-2701-2017; Neyraud, Eric/L-2296-2017; Schlich, Pascal/AAM-1384-2020; Schlich, Pascal/O-6869-2015; FERON, Gilles/AAW-8714-2020; Schlich, Pascal/AES-0066-2022	Serge, Hercberg/0000-0002-3168-1350; HERCBERG, Serge/0000-0002-3168-1350; Peneau, Sandrine/0000-0002-3463-0989; Neyraud, Eric/0000-0001-7060-1336; Schlich, Pascal/0000-0001-7919-5135; Morzel, Martine/0000-0002-3589-3641; Bozonnet, Sophie/0000-0001-5091-2209; Feron, Gilles/0000-0002-9522-9654	French National Research Agency (Agence Nationale de la Recherche) in the context of the Programme de Recherche "Alimentation et Industries Alimentaires" (Epipref project) [ANR-08-ALIA-006]; INRA' Metaprogramme Did'It (Diet Impact and Determinants Interactions and Transitions); Regional Council of Burgundy France (PARI Agral 1); FEDER (European Funding for Regional Economical Development); Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	French National Research Agency (Agence Nationale de la Recherche) in the context of the Programme de Recherche "Alimentation et Industries Alimentaires" (Epipref project)(French National Research Agency (ANR)); INRA' Metaprogramme Did'It (Diet Impact and Determinants Interactions and Transitions); Regional Council of Burgundy France (PARI Agral 1)(Region Bourgogne-Franche-Comte); FEDER (European Funding for Regional Economical Development); Ministere de la Sante (DGS); Institut de Veille Sanitaire (InVS); Institut National de la Prevention et de l'Education pour la Sante (INPES); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut de Recherche en Sante Publique (IRESP); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique (INRA); Conservatoire National des Arts et Metiers (CNAM); Universite Paris 13	This work was supported by the French National Research Agency (Agence Nationale de la Recherche) in the context of the 2008 Programme de Recherche "Alimentation et Industries Alimentaires" (Epipref project, ANR-08-ALIA-006), by the INRA' Metaprogramme Did'It (Diet Impact and Determinants Interactions and Transitions), and by the Regional Council of Burgundy France (PARI Agral 1) and the FEDER (European Funding for Regional Economical Development). The Nutrinet-Sante study is supported by the following institutions: Ministere de la Sante (DGS), Institut de Veille Sanitaire (InVS), Institut National de la Prevention et de l'Education pour la Sante (INPES), Fondation pour la Recherche Medicale (FRM), Institut de Recherche en Sante Publique (IRESP), Institut National de la Sante et de la Recherche Medicale (INSERM), Institut National de la Recherche Agronomique (INRA), Conservatoire National des Arts et Metiers (CNAM) and Universite Paris 13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actis AB, 2005, ARCH ORAL BIOL, V50, P1, DOI 10.1016/j.archoralbio.2004.08.001; [Anonymous], 2003, DIET NUTR PREV CHRON; Anwesha Sarkar, 2012, Food oral processing: fundamentals of eating and sensory perception, P111; Arnault N., 2013, TABLE COMPOSITION AL; Battino M, 2002, J CLIN PERIODONTOL, V29, P189, DOI 10.1034/j.1600-051X.2002.290301x.x; BERTINO M, 1982, AM J CLIN NUTR, V36, P1134, DOI 10.1093/ajcn/36.6.1134; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Brussaard JH, 2002, EUR J CLIN NUTR, V56, pS89, DOI 10.1038/sj.ejcn.1601432; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; CHRISTENSEN CM, 1986, ARCH ORAL BIOL, V31, P825, DOI 10.1016/0003-9969(86)90136-6; Cox CL, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-68; da Costa G, 2008, J CHEM ECOL, V34, P376, DOI 10.1007/s10886-007-9413-z; DINICOLANTONIO R, 1984, CLIN EXP PHARMACOL P, V11, P335, DOI 10.1111/j.1440-1681.1984.tb00273.x; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Dsamou M, 2012, CHEM SENSES, V37, P87, DOI 10.1093/chemse/bjr070; Feeney EL, 2014, PHYSIOL BEHAV, V128, P148, DOI 10.1016/j.physbeh.2014.02.013; Feron G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093113; Ferry ALS, 2006, J AGR FOOD CHEM, V54, P8869, DOI 10.1021/jf061607n; Gorelik S, 2007, ARCH BIOCHEM BIOPHYS, V458, P236, DOI 10.1016/j.abb.2006.12.006; Harthoorn LF, 2008, EUR J APPL PHYSIOL, V102, P601, DOI 10.1007/s00421-007-0622-5; Harthoorn LF, 2009, INT J FOOD SCI NUTR, V60, P637, DOI 10.3109/09637480802039814; Henkin RI, 1999, AM J MED SCI, V318, P380, DOI 10.1097/00000441-199912000-00005; Henkin RI, 1999, AM J MED SCI, V318, P392, DOI 10.1097/00000441-199912000-00006; Hercberg S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-242; JOHANSSON G, 1994, ARCH ORAL BIOL, V39, P283, DOI 10.1016/0003-9969(94)90118-X; Karjalainen S, 2011, J DENT RES, V90, P868, DOI 10.1177/0022034511405328; Khan NA, 2009, BBA-MOL CELL BIOL L, V1791, P149, DOI 10.1016/j.bbalip.2009.01.001; Lampure A, 2015, J NUTR, V145, P587, DOI 10.3945/jn.114.201269; Lampure A, 2014, BRIT J NUTR, V112, P1353, DOI 10.1017/S0007114514002050; Lesschaeve I, 2005, AM J CLIN NUTR, V81, p330S, DOI 10.1093/ajcn/81.1.330S; Liem DG, 2004, CHEM SENSES, V29, P713, DOI 10.1093/chemse/bjh077; Mandel AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013352; Marsh P D, 1994, Adv Dent Res, V8, P263; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; Mejean C, 2011, BRIT J NUTR, V105, P776, DOI 10.1017/S0007114510004174; Mela DJ, 2001, OBES RES, V9, p249S, DOI 10.1038/oby.2001.127; MINAH GE, 1985, ARCH ORAL BIOL, V30, P397, DOI 10.1016/0003-9969(85)90066-4; Mitchell M, 2013, FOOD QUAL PREFER, V28, P356, DOI 10.1016/j.foodqual.2012.11.002; Mobini S, 2007, APPETITE, V48, P20, DOI 10.1016/j.appet.2006.05.017; Morzel M, 2014, EUR J PEDIATR, V173, P575, DOI 10.1007/s00431-013-2216-z; Morzel M, 2011, ARCH ORAL BIOL, V56, P634, DOI 10.1016/j.archoralbio.2010.12.015; Morzel M, 2012, J PROTEOMICS, V75, P3665, DOI 10.1016/j.jprot.2012.04.028; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Mounayar R, 2013, CHEMOSENS PERCEPT, V6, P118, DOI 10.1007/s12078-013-9152-1; Nachtsheim R, 2014, FOOD QUAL PREFER, V32, P173, DOI 10.1016/j.foodqual.2013.10.009; Nachtsheim R, 2013, FOOD QUAL PREFER, V29, P137, DOI 10.1016/j.foodqual.2013.03.011; Nagler RM, 2002, FREE RADICAL BIO MED, V32, P268, DOI 10.1016/S0891-5849(01)00806-1; Neyraud E, 2006, J PROTEOME RES, V5, P2474, DOI 10.1021/pr060189z; Neyraud E, 2012, ARCH ORAL BIOL, V57, P556, DOI 10.1016/j.archoralbio.2011.09.016; PANGBORN RM, 1982, AM J CLIN NUTR, V35, P510, DOI 10.1093/ajcn/35.3.510; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Piombino P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085611; Poette J, 2014, FLAVOUR FRAG J, V29, P39, DOI 10.1002/ffj.3177; Quintana M, 2009, CHEMOSENS PERCEPT, V2, P133, DOI 10.1007/s12078-009-9048-2; REISER S, 1989, AM J CLIN NUTR, V49, P832, DOI 10.1093/ajcn/49.5.832; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Silletti E, 2007, J COLLOID INTERF SCI, V313, P485, DOI 10.1016/j.jcis.2007.05.030; Silletti E, 2010, ARCH ORAL BIOL, V55, P268, DOI 10.1016/j.archoralbio.2010.02.004; SKINNER A, 1984, ARCH ORAL BIOL, V29, P323, DOI 10.1016/0003-9969(84)90106-7; SPIELMAN AI, 1990, J DENT RES, V69, P838, DOI 10.1177/00220345900690030101; SQUIRES BT, 1953, J PHYSIOL-LONDON, V119, P153, DOI 10.1113/jphysiol.1953.sp004835; TEOW BH, 1985, CLIN EXP HYPERTENS A, V7, P1681, DOI 10.3109/10641968509073618; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Westman EC, 2002, AM J MED, V113, P30, DOI 10.1016/S0002-9343(02)01129-4; World Health Organization, 1995, PHYS STAT US INT ANT	67	45	47	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137473	10.1371/journal.pone.0137473	http://dx.doi.org/10.1371/journal.pone.0137473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340090	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200064
J	Mureddu, M; Caldarelli, G; Chessa, A; Scala, A; Damiano, A				Mureddu, Mario; Caldarelli, Guido; Chessa, Alessandro; Scala, Antonio; Damiano, Alfonso			Green Power Grids: How Energy from Renewable Sources Affects Networks and Markets	PLOS ONE			English	Article							RESERVE MARKETS; ELECTRICITY; SYSTEMS; OPERATIONS; DEMAND	The increasing attention to environmental issues is forcing the implementation of novel energy models based on renewable sources. This is fundamentally changing the configuration of energy management and is introducing new problems that are only partly understood. In particular, renewable energies introduce fluctuations which cause an increased request for conventional energy sources to balance energy requests at short notice. In order to develop an effective usage of low-carbon sources, such fluctuations must be understood and tamed. In this paper we present a microscopic model for the description and for the forecast of short time fluctuations related to renewable sources in order to estimate their effects on the electricity market. To account for the inter-dependencies in the energy market and the physical power dispatch network, we use a statistical mechanics approach to sample stochastic perturbations in the power system and an agent based approach for the prediction of the market players' behavior. Our model is data-driven; it builds on one-dayahead real market transactions in order to train agents' behaviour and allows us to deduce the market share of different energy sources. We benchmarked our approach on the Italian market, finding a good accordance with real data.	[Mureddu, Mario] Univ Cagliari, Dipartimento Fis, Cagliari, Italy; [Mureddu, Mario; Caldarelli, Guido; Chessa, Alessandro; Scala, Antonio; Damiano, Alfonso] IMT Inst Adv Studies, Lucca, Italy; [Mureddu, Mario] Jacobs Univ Bremen, Dept Phys & Earth Sci, D-28759 Bremen, Germany; [Caldarelli, Guido; Scala, Antonio] ISC, Rome, Italy; [Caldarelli, Guido; Scala, Antonio] London Inst Math Sci, London, England; [Caldarelli, Guido; Chessa, Alessandro] Linkalab, Cagliari, Italy; [Damiano, Alfonso] Univ Cagliari, Dipartimento Ingn Elettr & Elettron, Cagliari, Italy	University of Cagliari; IMT School for Advanced Studies Lucca; Jacobs University; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); University of Cagliari	Damiano, A (corresponding author), IMT Inst Adv Studies, Lucca, Italy.	alfio@diee.unica.it	Scala, Antonio/H-9153-2019; Scala, Antonio/A-2098-2012; Scala, Antonio/GRS-5823-2022; Caldarelli, Guido/AAB-8206-2022; Caldarelli, Guido/A-5274-2010	Scala, Antonio/0000-0002-3414-2686; Scala, Antonio/0000-0002-3414-2686; Mureddu, Mario/0000-0002-9908-9599; Caldarelli, Guido/0000-0001-9377-3616	FET Open Project SIMPOL "Financial Systems Simulation and Policy Modelling" [610704]; IP Project MULTIPLEX [317532]; EU FET project DOLFINS [640772]; Progetto di Interesse Nazionale "CrisisLab"; U.S. Department of the Defense, Defense Threat Reduction Agency [HDTRA1-11-1-0048]; EU project CI2C [HOME/2013/CIPS/AG/4000005013]	FET Open Project SIMPOL "Financial Systems Simulation and Policy Modelling"; IP Project MULTIPLEX; EU FET project DOLFINS; Progetto di Interesse Nazionale "CrisisLab"; U.S. Department of the Defense, Defense Threat Reduction Agency; EU project CI2C	GC acknowledges partial support from FET Open Project SIMPOL "Financial Systems Simulation and Policy Modelling" nr. 610704. AS and GC acknowledge partial support from IP Project MULTIPLEX nr 317532 and from EU FET project DOLFINS nr 640772. AS, MM and AC acknowledge partial support from Progetto di Interesse Nazionale "CrisisLab." GC acknowledges partial support from U.S. Department of the Defense, Defense Threat Reduction Agency, grant HDTRA1-11-1-0048. AS acknowledges partial support from EU HOME/2013/CIPS/AG/4000005013 project CI2C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EH, 2000, IEEE T POWER SYST, V15, P228, DOI 10.1109/59.852126; Bouffard F., 2006, 2006 IEEE Power Engineering Society General Meeting; Bouffard F, 2008, IEEE T POWER SYST, V23, P306, DOI 10.1109/TPWRS.2008.919318; Bunn DW, 2001, IEEE T EVOLUT COMPUT, V5, P493, DOI 10.1109/4235.956713; Contreras J, 2003, IEEE T POWER SYST, V18, P1014, DOI 10.1109/TPWRS.2002.804943; D'Agostino G, 2014, NETWORKS NETWOKS LAS; David AK, 2000, 2000 IEEE POWER ENGINEERING SOCIETY SUMMER MEETING, CONFERENCE PROCEEDINGS, VOLS 1-4, P2168, DOI 10.1109/PESS.2000.866982; Doherty R, 2005, IEEE T POWER SYST, V20, P587, DOI 10.1109/TPWRS.2005.846206; Facchini A, 2014, 14 IAEE EN C ROM NOV; Gao F, 2010, ELECTR POW SYST RES, V80, P9, DOI 10.1016/j.epsr.2009.07.007; GME, 2014, GEST MERC EN; Guo JH, 2003, IEEE T POWER SYST, V18, P665, DOI 10.1109/TPWRS.2003.811012; Joos G, 2000, 2000 IEEE POWER ENGINEERING SOCIETY SUMMER MEETING, CONFERENCE PROCEEDINGS, VOLS 1-4, P1762, DOI 10.1109/PESS.2000.868792; Kiviluoma J, 2012, IEEE T SUSTAIN ENERG, V3, P769, DOI 10.1109/TSTE.2012.2209210; Klobasa M, 2010, IET RENEW POWER GEN, V4, P55, DOI 10.1049/iet-rpg.2008.0086; Li FX, 2012, IEEE T SUSTAIN ENERG, V3, P455, DOI 10.1109/TSTE.2012.2190115; Mashhour E, 2011, IEEE T POWER SYST, V26, P949, DOI 10.1109/TPWRS.2010.2070884; Morales JM, 2010, IEEE T POWER SYST, V25, P554, DOI 10.1109/TPWRS.2009.2036810; Nicolaisen J, 2001, IEEE T EVOLUT COMPUT, V5, P504, DOI 10.1109/4235.956714; Nogales FJ, 2002, IEEE T POWER SYST, V17, P342, DOI 10.1109/TPWRS.2002.1007902; Pahwa Sakshi, 2014, Sci Rep, V4, P3694, DOI 10.1038/srep03694; Pentapalli M., 2008, COMP STUDY ROTH EREV; Rastegar MA, 2009, 2009 6TH INTERNATIONAL CONFERENCE ON THE EUROPEAN ENERGY MARKET, P516; Scala Antonio, 2013, Critical Information Infrastructures Security. 7th International Workshop, CRITIS 2012. Revised Selected Papers: LNCS 7722, P71, DOI 10.1007/978-3-642-41485-5_7; Shaaban MF, 2013, IEEE T POWER SYST, V28, P639, DOI 10.1109/TPWRS.2012.2213309; Song HL, 2000, IEEE T POWER SYST, V15, P618, DOI 10.1109/59.867150; Song HL, 2002, IEEE T POWER SYST, V17, P73, DOI 10.1109/59.982195; Vrakopoulou M, 2013, IEEE T POWER SYST, V28, P3885, DOI 10.1109/TPWRS.2013.2272546; Zimmerman RD, 2011, IEEE T POWER SYST, V26, P12, DOI 10.1109/TPWRS.2010.2051168	29	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0135312	10.1371/journal.pone.0135312	http://dx.doi.org/10.1371/journal.pone.0135312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335705	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000360615400005
J	Bonilha, L; Gleichgerrcht, E; Fridriksson, J; Rorden, C; Breedlove, JL; Nesland, T; Paulus, W; Helms, G; Focke, NK				Bonilha, Leonardo; Gleichgerrcht, Ezequiel; Fridriksson, Julius; Rorden, Chris; Breedlove, Jesse L.; Nesland, Travis; Paulus, Walter; Helms, Gunther; Focke, Niels K.			Reproducibility of the Structural Brain Connectome Derived from Diffusion Tensor Imaging	PLOS ONE			English	Article							TRACTOGRAPHY; NETWORKS; RECONSTRUCTION; CONNECTIVITY; VARIABILITY; RELIABILITY; DISORDERS; EPILEPSY; DISEASE; MR	Rationale Disruptions of brain anatomical connectivity are believed to play a central role in several neurological and psychiatric illnesses. The structural brain connectome is typically derived from diffusion tensor imaging (DTI), which may be influenced by methodological factors related to signal processing, MRI scanners and biophysical properties of neuroanatomical regions. In this study, we evaluated how these variables affect the reproducibility of the structural connectome. Methods Twenty healthy adults underwent 3 MRI scanning sessions (twice in the same MRI scanner and a third time in a different scanner unit) within a short period of time. The scanning sessions included similar T1 weighted and DTI sequences. Deterministic or probabilistic tractography was performed to assess link weight based on the number of fibers connecting gray matter regions of interest (ROI). Link weight and graph theory network measures were calculated and reproducibility was assessed through intra-class correlation coefficients, assuming each scanning session as a rater. Results Connectome reproducibility was higher with data from the same scanner. The probabilistic approach yielded larger reproducibility, while the individual variation in the number of tracked fibers from deterministic tractography was negatively associated with reproducibility. Links connecting larger and anatomically closer ROIs demonstrated higher reproducibility. In general, graph theory measures demonstrated high reproducibility across scanning sessions. Discussion Anatomical factors and tractography approaches can influence the reproducibility of the structural connectome and should be factored in the interpretation of future studies. Our results demonstrate that connectomemapping is a largely reproducible technique, particularly as it relates to the geometry of network architecture measured by graph theory methods.	[Bonilha, Leonardo; Gleichgerrcht, Ezequiel; Breedlove, Jesse L.; Nesland, Travis] Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA; [Fridriksson, Julius] Univ S Carolina, Dept Commun Sci & Disorders, Columbia, SC 29208 USA; [Rorden, Chris] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; [Paulus, Walter] Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Helms, Gunther] Univ Gottingen, MR Res, Dept Cognit Neurol, D-37073 Gottingen, Germany; [Focke, Niels K.] Univ Tubingen, Dept Neurol Epileptol, Tubingen, Germany; [Focke, Niels K.] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Gottingen; University of Gottingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bonilha, L (corresponding author), Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA.	bonilha@musc.edu	Focke, Niels/AAO-7012-2020; Helms, Gunther/A-9114-2010; Paulus, Walter/A-3544-2009	Helms, Gunther/0000-0002-1371-5123; Paulus, Walter/0000-0001-5549-8377; Breedlove, Jesse/0000-0002-8665-1204	National Institute on Deafness and Other Communication Disorders (NIDCD) [DC014021]; American Heart Association (AHA) [5SFDRN26030003]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014021] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported in part by the National Institute on Deafness and Other Communication Disorders (NIDCD), grant number DC014021 (LB) and by the American Heart Association (AHA), grant number 5SFDRN26030003 (LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Besseling RMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034125; Buchanan CR, 2014, NEUROIMAGE, V86, P231, DOI 10.1016/j.neuroimage.2013.09.054; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Deco G, 2014, NEURON, V84, P892, DOI 10.1016/j.neuron.2014.08.034; Duda JT, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00046; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Garyfallidis E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00175; Gerhard Stephan, 2011, Front Neuroinform, V5, P3, DOI 10.3389/fninf.2011.00003; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Kaiser M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00484; Lee CY, 2014, BRAIN RES, V1588, P73, DOI 10.1016/j.brainres.2014.09.002; Leergaard TB, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00014; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Magnotta VA, 2012, BRAIN CONNECT, V2, P345, DOI 10.1089/brain.2012.0112; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Osborne J.W., 2008, BEST PRACT QUANT MET, DOI DOI 10.4135/9781412995627.D18; Quan MN, 2013, SCHIZOPHR RES, V145, P1, DOI 10.1016/j.schres.2012.11.028; Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2013, NEUROIMAGE, V80, P53, DOI 10.1016/j.neuroimage.2013.03.023; Sporns O, 2012, NEUROIMAGE, V62, P881, DOI 10.1016/j.neuroimage.2011.08.085; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	41	59	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135247	10.1371/journal.pone.0135247	http://dx.doi.org/10.1371/journal.pone.0135247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332788	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800024
J	Del Chierico, F; Vernocchi, P; Petrucca, A; Paci, P; Fuentes, S; Pratico, G; Capuani, G; Masotti, A; Reddel, S; Russo, A; Vallone, C; Salvatori, G; Buffone, E; Signore, F; Rigon, G; Dotta, A; Miccheli, A; de Vos, WM; Dallapiccola, B; Putignani, L				Del Chierico, Federica; Vernocchi, Pamela; Petrucca, Andrea; Paci, Paola; Fuentes, Susana; Pratico, Giulia; Capuani, Giorgio; Masotti, Andrea; Reddel, Sofia; Russo, Alessandra; Vallone, Cristina; Salvatori, Guglielmo; Buffone, Elsa; Signore, Fabrizio; Rigon, Giuliano; Dotta, Andrea; Miccheli, Alfredo; de Vos, Willem M.; Dallapiccola, Bruno; Putignani, Lorenza			Phylogenetic and Metabolic Tracking of Gut Microbiota during Perinatal Development	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; PRETERM INFANTS; GENE-EXPRESSION; DELIVERY MODE; DIVERSITY; BACTERIAL; FECES; COMMUNITIES; SUCCESSION; ECOLOGY	The colonization and development of gut microbiota immediately after birth is highly variable and depends on several factors, such as delivery mode and modality of feeding during the first months of life. A cohort of 31 mother and neonate pairs, including 25 at-term caesarean (CS) and 6 vaginally (V) delivered neonates (DNs), were included in this study and 121 meconium/faecal samples were collected at days 1 through 30 following birth. Operational taxonomic units (OTUs) were assessed in 69 stool samples by phylogenetic microarray HITChip and inter- and intra-individual distributions were established by inter-OTUs correlation matrices and OTUs co-occurrence or co-exclusion networks. H-1-NMR metabolites were determined in 70 stool samples, PCA analysis was performed on 55 CS DNs samples, and metabolome/OTUs co-correlations were assessed in 45 CS samples, providing an integrated map of the early microbiota OTUs-metabolome. A microbiota "core" of OTUs was identified that was independent of delivery mode and lactation stage, suggesting highly specialized communities that act as seminal colonizers of microbial networks. Correlations among OTUs, metabolites, and OTUs-metabolites revealed metabolic profiles associated with early microbial ecological dynamics, maturation of milk components, and host physiology.	[Del Chierico, Federica; Vernocchi, Pamela; Petrucca, Andrea; Reddel, Sofia; Russo, Alessandra; Putignani, Lorenza] Bambino Gesu Pediat Hosp, IRCCS, Unit Metagen, Rome, Italy; [Vernocchi, Pamela] Univ Bologna, Interdipartimental Ctr Ind Res CIRI AGRIFOOD, Alma Mater Studiorum, Bologna, Italy; [Petrucca, Andrea] St Andrea Hosp, Dept Diagnost Sci, Rome, Italy; [Paci, Paola] CNR, Inst Syst Anal & Informat Antonio Ruberti, Rome, Italy; [Fuentes, Susana; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Pratico, Giulia; Capuani, Giorgio; Miccheli, Alfredo] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy; [Masotti, Andrea] Bambino Gesu Pediat Hosp, IRCCS, Rome, Italy; [Vallone, Cristina; Signore, Fabrizio; Rigon, Giuliano] San Camillo Hosp, Dept Obstet & Gyneacol, Rome, Italy; [Salvatori, Guglielmo; Dotta, Andrea] Bambino Gesu Pediat Hosp, Dept Neonatol, IRCCS, Rome, Italy; [Buffone, Elsa] San Camillo Hosp, Dept Neonatol, Rome, Italy; [de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland; [Dallapiccola, Bruno] Bambino Gesu Pediat Hosp, IRCCS, Sci Directorate, Rome, Italy; [Putignani, Lorenza] Bambino Gesu Pediat Hosp, IRCCS, Unit Parasitol, Rome, Italy	IRCCS Bambino Gesu; University of Bologna; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Consiglio Nazionale delle Ricerche (CNR); Wageningen University & Research; Sapienza University Rome; IRCCS Bambino Gesu; IRCCS Bambino Gesu; University of Helsinki; University of Helsinki; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Putignani, L (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Unit Metagen, Rome, Italy.	lorenza.putignani@opbg.net	Putignani, Lorenza/K-3409-2016; Del Chierico, Federica/J-4373-2016; Masotti, Andrea/D-5306-2009; Capuani, Giorgio/B-7738-2015; Del Chierico, Federica/AAS-4078-2020; Vernocchi, Pamela/K-2534-2016; Pratico, Giulia/B-4824-2015	Putignani, Lorenza/0000-0003-0134-2830; Del Chierico, Federica/0000-0002-4204-4736; Masotti, Andrea/0000-0002-2511-5088; Capuani, Giorgio/0000-0002-6992-2578; Del Chierico, Federica/0000-0002-4204-4736; Vernocchi, Pamela/0000-0001-8007-5632; Pratico, Giulia/0000-0003-4604-8838	Ministry of Health, Ricerca Corrente Bambino Gesu Children's Hospital; Netherlands Organization for Scientific Research (NWO)	Ministry of Health, Ricerca Corrente Bambino Gesu Children's Hospital; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a grant from the Ministry of Health, Ricerca Corrente (RC201302P002991) Bambino Gesu Children's Hospital and Spinoza and Gravity grants to WMdV of the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Avershina E, 2014, FEMS MICROBIOL ECOL, V87, P280, DOI 10.1111/1574-6941.12223; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; BENNO Y, 1986, MICROBIOL IMMUNOL, V30, P521, DOI 10.1111/j.1348-0421.1986.tb02978.x; Brasili E, 2013, J NUTR, V143, P1549, DOI 10.3945/jn.113.177105; CATASSI C, 1995, J PEDIATR GASTR NUTR, V21, P383, DOI 10.1097/00005176-199511000-00003; Chassard C, 2014, CURR OPIN BIOTECH, V26, P141, DOI 10.1016/j.copbio.2013.12.012; Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63; Chisholm RA, 2010, P NATL ACAD SCI USA, V107, P15821, DOI 10.1073/pnas.1009387107; Chow J, 2014, J PROTEOME RES, V13, P2534, DOI 10.1021/pr500011w; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005; Del Chierico F, 2012, J PROTEOMICS, V75, P4580, DOI 10.1016/j.jprot.2012.02.018; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Duggan Christopher G, 2008, NUTR PEDIAT BASIC SC; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fouhy F, 2012, GUT MICROBES, V3, P203, DOI 10.4161/gmic.20169; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Gueimonde M, 2006, J PEDIATR GASTR NUTR, V42, P166, DOI 10.1097/01.mpg.0000189346.25172.fd; He Y, 2014, MUCOSAL IMMUNOL, V7, P1326, DOI 10.1038/mi.2014.20; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jacobs DM, 2008, NMR BIOMED, V21, P615, DOI 10.1002/nbm.1233; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Jahan-Mihan A, 2011, NUTRIENTS, V3, P574, DOI 10.3390/nu3050574; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jeraldo P, 2012, P NATL ACAD SCI USA, V109, P9692, DOI 10.1073/pnas.1206721109; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Joseph H, MECH SUCCESSION NATU; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Khodayar-Pardo P, 2014, J PERINATOL, V34, P599, DOI 10.1038/jp.2014.47; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Lahti L, 2011, IEEE ACM T COMPUT BI, V8, P217, DOI 10.1109/TCBB.2009.38; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Le Gall G, 2011, J PROTEOME RES, V10, P4208, DOI 10.1021/pr2003598; Lindahl Paul A., 2009, V6, P133, DOI [10.1039/BK9781847559159-00133, 10.1039/9781847559159-00133]; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MacFarlane G.T., 1991, LARGE INTESTINE PHYS, P51; Macfarlane GT, 1997, SCAND J GASTROENTERO, V32, P3, DOI 10.1080/00365521.1997.11720708; Madan JC, 2012, CURR OPIN PEDIATR, V24, P753, DOI 10.1097/MOP.0b013e32835a1ac8; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069621; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matschiavelli N, 2012, J BACTERIOL, V194, P5377, DOI 10.1128/JB.00881-12; Matthews TJ, 2014, ECOL EVOL, V4, P2263, DOI 10.1002/ece3.1092; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Miller TL, 1996, APPL ENVIRON MICROB, V62, P1589, DOI 10.1128/AEM.62.5.1589-1592.1996; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Mondot S, 2013, DIGEST DIS, V31, P278, DOI 10.1159/000354678; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Nauta AJ, 2013, AM J CLIN NUTR, V98, p586S, DOI 10.3945/ajcn.112.039644; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Park HK, 2005, J MICROBIOL, V43, P345; Pettersson J, 2008, BIOL PHARM BULL, V31, P1192, DOI 10.1248/bpb.31.1192; Pfefferle Petra Ina, 2014, F1000Prime Rep, V6, P11, DOI 10.12703/P6-11; Putignani L, 2014, PEDIATR RES, V76, P2, DOI 10.1038/pr.2014.49; Ragsdale SW, 2006, CHEM REV, V106, P3317, DOI 10.1021/cr0503153; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; RASMUSSEN HS, 1988, SCAND J GASTROENTERO, V23, P178, DOI 10.3109/00365528809103964; Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x; Salonen A, 2013, J NUTR, V143, P1549, DOI [10.3945/jn.113.177105, DOI 10.3945/JN.113.177105]; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; SAVAGE DC, 1972, AM J CLIN NUTR, V25, P1372; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sellitto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033387; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Valles Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004406; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9; Zaneveld J, 2008, CURR OPIN CHEM BIOL, V12, P109, DOI 10.1016/j.cbpa.2008.01.015	89	63	63	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137347	10.1371/journal.pone.0137347	http://dx.doi.org/10.1371/journal.pone.0137347			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332837	gold, Green Published			2022-12-27	WOS:000360613800125
J	Mumtaz, Z; Levay, AV; Bhatti, A				Mumtaz, Zubia; Levay, Adrienne V.; Bhatti, Afshan			Successful Community Midwives in Pakistan: An Asset-Based Approach	PLOS ONE			English	Article							HEALTH WORKER MOTIVATION; COGNITIVE-ABILITY; ADVERSE IMPACT	In response to the low levels of skilled birth attendance in rural Pakistan, the government introduced a new cadre of community midwives (CMWs) in 2006. Assessments to-date have found that these CMWs have yet to emerge as significant providers for a number of sociocultural, geographic and financial reasons. However, a small number of CMWs have managed to establish functional practices in the private sector in conservative, infrastructure- challenged rural contexts. With an objective to highlight "what are the successful CMWs doing right given their context?" this paper adopts an asset-based approach to explore the experiences of the Pakistani CMWs who have managed to overcome the barriers and practice. We drew upon ethnographic data that was collected as part of a larger mixed methods study conducted in 2011-2012 in districts Jhelum and Layyah, Pakistan. Thirty eight CMWs, 45 other health care providers, 20 policymakers, 78 women, 35 husbands and 23 older women were interviewed. CMW clinics and practices were observed. Our data showed that only eight 8 out of 38 CMWs sampled were active providers. Poverty as a push factor to work and intrinsic individual-level characteristics that enabled the CMWs to respond successfully to the demands of the midwifery profession in the private sector emerged as the two key themes. Household poverty pushed the CMWs to work in this perceived low-status occupation. Their families supported them since they became the breadwinners. The successful CMWs also had an intrinsic sense of what was required to establish a private practice; they exhibited professionalism, had strong business sense and provided respectful maternity care. The study provides insight into how the program might improve its functioning by adapting its recruitment criteria to ensure selection of right candidates.	[Mumtaz, Zubia; Levay, Adrienne V.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Bhatti, Afshan] Real Med Fdn Pakistan, Islamabad, Pakistan	University of Alberta	Mumtaz, Z (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	zubia.mumtaz@ualberta.ca			Research and Advocacy Fund Pakistan [U0AC-01-2305-092]	Research and Advocacy Fund Pakistan	Funding for this research was awarded to ZM from Research and Advocacy Fund Pakistan http://www.rafpakistan.org, and Research and Advocacy Pakistan Project #U0AC-01-2305-092.	Ahmed FE, 2004, NATL WOMANS STUD ASS, V16, P35; Avis JM, 2002, J BUS PSYCHOL, V17, P87, DOI 10.1023/A:1016200317002; Beaulieu LJ., 2002, MAPPING ASSETS YOUR; Bender J, 2014, US MILITARY IS NOT R; Bowser D, 2010, EXPLORING EVIDENCE D; Brooks F, 2013, CRIT PUBLIC HEALTH, V23, P127, DOI 10.1080/09581596.2013.783687; Campbell M., 2002, PRIMER DOING I ETHNO; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; David F, 1993, Philipp Popul J, V9, P12; Evans R., 2007, J CHILDREN POVERTY, V13, P21, DOI DOI 10.1080/10796120601171211; Eycon Private Ltd, 2014, BAS SURV REP INT MAT, P137; Family Care International, 2003, CAR SEEK PREGN DEL P; Foot J., 2010, GLASS HALF FULL ASSE; Franco LM, 2004, SOC SCI MED, V58, P343, DOI 10.1016/S0277-9536(03)00203-X; Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6; Frank KI, 2006, J PLAN LIT, V20, P351, DOI 10.1177/0885412205286016; Government of Pakistan, 2006, PC 1 NATL MAT; Government of Pakistan Pakistan Bureau of Statistics, 2014, DISTR GLANC LAYYAH; Granger Robert C, 2002, New Dir Youth Dev, P149; Haines A, 2007, LANCET, V370, P911, DOI 10.1016/S0140-6736(07)61423-8; Hammersley M, 1998, READING ETHNOGRAPHIC; Health & Care Professions Council, 2011, PROF HEALTHC PROF; IFAD, 2007, SUST LIV APPR; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Khan, 2009, J EC SOCIAL RES, V11, P77; Khosla N., 2009, J INT WOMENS STUDIES, V11, P289; Kironde S, 2002, AFR HEALTH SCI, V2, P72; Kretzman J.P., 1993, BUILDING COMMUNITIES; Lindstrom B, 2010, 2010 HLTH ASSETS GLO; Mathauer I, 2006, HUM RESOUR HEALTH, V4, P14; Mayan M, 2009, ESSENTIALS QUALITATI, P85; Meyer JP, 2004, J APPL PSYCHOL, V89, P991, DOI 10.1037/0021-9010.89.6.991; Ministry of Planning Development and Reform, 2013, PAK MILL DEV GOALS R; Morgan Antony, 2007, Promot Educ, VSuppl 2, P17; Mumtaz Z, 2015, BJOG-INT J OBSTET GY, V122, P249, DOI 10.1111/1471-0528.13112; Mumtaz Z, BMC HLTH RE IN PRESS; Mumtaz Z, 2013, ARE COMMUNITY MIDWIV; National Institute of Population Studies, 2013, PAK DEM HLTH SURV 20; Newman DA, 2009, J APPL PSYCHOL, V94, P298, DOI 10.1037/a0013472; Njuki R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-660; O'Leary T, 2006, SECC; OLeary T., 2011, APPRECIATING ASSETS; Pakistan Bureau of Statistics, 2015, DISTR GLANC JHEL; Rangel CB, 2014, GUARDIAN COMMENT IS; Rigor Mayan M., 2009, ESSENTIALS QUALITATI, P100; Ryan-Nicholls Kimberley D, 2009, Nurse Res, V16, P70; Sanchez EL, 2013, NBC LATINO NEWS; Simpson L., 2003, Community Development Journal, V38, P277, DOI 10.1093/cdj/38.4.277; Tuckett Anthony G, 2005, Nurse Res, V13, P29; WALT G, 1989, SOC SCI MED, V29, P599, DOI 10.1016/0277-9536(89)90179-2; Warren C, 2008, OBSTET FISTULA CAN C; Warren C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-177; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Zurn P., 2005, NURSE RETENTION RECR	55	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135302	10.1371/journal.pone.0135302	http://dx.doi.org/10.1371/journal.pone.0135302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26333067	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800027
J	Gaertner, J; Weingartner, V; Lange, S; Hausner, E; Gerhardus, A; Simon, ST; Voltz, R; Becker, G; Schmacke, N				Gaertner, Jan; Weingaertner, Vera; Lange, Stefan; Hausner, Elke; Gerhardus, Ansgar; Simon, Steffen T.; Voltz, Raymond; Becker, Gerhild; Schmacke, Norbert			The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review	PLOS ONE			English	Review							RANDOMIZED PHASE-II; CELL LUNG-CANCER; ADVANCED PANCREATIC-CANCER; RECURRENT GLIOBLASTOMA; SYMPTOM BURDEN; OUTCOME MEASURES; CHEMOTHERAPY; MULTICENTER; GEMCITABINE; COMBINATION	Background Randomized controlled trials (RCTs) are important sources of information on the benefits and harms patients may expect from treatment options. The aim of this structured literature review by the German Institute for Quality and Efficiency in Health Care was to explore whether and how the end-of-life (EoL) situation of patients with advanced cancer is considered in RCTs investigating anti-cancer treatments. Methods Our journal pool comprised 19 medical journals, namely five preselected key general medical journals as well as 14 specialist journals (mainly cancer) identified via a scoping search. We systematically searched these journals in MEDLINE to identify RCTs investigating anticancer treatments for the following four cancer types: glioblastoma, lung cancer (stage IIIb-IV), malignant melanoma (stage IV), and pancreatic cancer (search via OVID; November 2012). We selected a representative sample of 100 publications, that is, the 25 most recent publications for each cancer type. EoL was defined as a life expectancy of <= two years. We assessed the information provided on (1) the descriptions of the terminal stage of the disease, (2) the therapeutic goal (i.e. the intended therapeutic benefit of the intervention studied), (3) the study endpoints assessed, (4) the authors' concluding appraisal of the intervention's effects, and (5) the terminology referring to the patients' EoL situation. Results Median survival was <= one year for each of the four cancer types. Descriptions of the terminal stage of the disease were ambiguous or lacking in 29/100 publications. One or more therapeutic goals were mentioned in 51/100 publications; these goals were patient-relevant in 38 publications (survival alone: 30/38; health-related quality of life (HRQoL) or HRQoL and survival: 6/38; symptom control or symptom control and survival: 2/38). Primary end-points included survival (50%), surrogates (44%), and safety (3%). Patient-reported outcomes (PROs) were assessed in 36/100 RCTs. The implications of treatment-related harms for the patients were discussed in 22/100 appraisals. Terminology referring to the patients' EoL situation (e.g. "terminal") was scarce, whereas terms suggesting control of the disease (e.g. "cancer control") were common. Conclusions The EoL situation of patients with advanced cancer should be more carefully considered in clinical trials. Although the investigation and robust reporting of PROs is a prerequisite for informed decision-making in healthcare, they are rarely defined as endpoints and HRQoL is rarely mentioned as a therapeutic goal. Suggestions for improving standards for study design and reporting are presented.	[Gaertner, Jan; Becker, Gerhild] Univ Med Ctr Freiburg, Dept Palliat Care, Freiburg, Germany; [Gaertner, Jan; Becker, Gerhild] Palliat Care Ctr Excellence Baden Wurttemberg, Baden, Switzerland; [Weingaertner, Vera; Simon, Steffen T.; Voltz, Raymond] Univ Hosp Cologne, Dept Palliat Med, Cologne, Germany; [Lange, Stefan; Hausner, Elke] Inst Qual & Efficiency Hlth Care IQWiG, Cologne, Germany; [Gerhardus, Ansgar; Schmacke, Norbert] Univ Bremen, Inst Publ Hlth & Nursing Res IPP, D-28359 Bremen, Germany; [Gerhardus, Ansgar; Schmacke, Norbert] Univ Bremen, Hlth Sci Bremen, D-28359 Bremen, Germany; [Simon, Steffen T.; Voltz, Raymond] Ctr Integrated Oncol CIO Cologne Bonn, Cologne, Germany; [Simon, Steffen T.; Voltz, Raymond] Univ Hosp Cologne, Clin Trials Unit BMBF 01KN1106, Cologne, Germany	University of Freiburg; University of Cologne; University of Bremen; University of Bremen; University of Cologne; University of Cologne	Gaertner, J (corresponding author), Univ Med Ctr Freiburg, Dept Palliat Care, Freiburg, Germany.	jan.gaertner@uniklinik-freiburg.de	Gerhardus, Ansgar/L-9746-2018	Gerhardus, Ansgar/0000-0003-3637-7419; Becker, Gerhild/0000-0001-9060-0285; Gaertner, Jan/0000-0002-1176-3164; Gaertner, Jan/0000-0002-8824-7117	Institute for Quality and Efficiency in Health Care (IQWiG) [GA12-01]; German Cancer Aid (Deutsche Krebshilfe e.V.); Federal Ministry of Education and Research [BMBF01KN0706]	Institute for Quality and Efficiency in Health Care (IQWiG); German Cancer Aid (Deutsche Krebshilfe e.V.)(Deutsche Krebshilfe); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Institute for Quality and Efficiency in Health Care (IQWiG, GA12-01). Neither the funder itself nor any individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Department of Palliative Medicine, University Hospital of Cologne, is supported by the German Cancer Aid (Deutsche Krebshilfe e.V.) as well as by the Federal Ministry of Education and Research (BMBF01KN0706) which both had no role in the design, conduction or analysis of the study, the decision to publish, or the preparation of the manuscript.	Ahmed S, 2012, MED CARE, V50, P1060, DOI 10.1097/MLR.0b013e318268aaff; Amdal CD, 2013, ACTA ONCOL, V52, P679, DOI 10.3109/0284186X.2012.731521; American Cancer Society, 2013, 2015 GOALS AM CANC S; Barbera L, 2010, CANCER-AM CANCER SOC, V116, P5767, DOI 10.1002/cncr.25681; Basch E, 2012, J CLIN ONCOL, V30, P4249, DOI 10.1200/JCO.2012.42.5967; Brettschneider Christian, 2011, GMS Health Technol Assess, V7, pDoc01, DOI 10.3205/hta000092; Buckner JC, 2006, J CLIN ONCOL, V24, P3871, DOI 10.1200/JCO.2005.04.6979; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Cherny N, 2011, SEMIN ONCOL, V38, P351, DOI 10.1053/j.seminoncol.2011.03.002; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Cleeland CS, 2013, CANCER-AM CANCER SOC, V119, P411, DOI 10.1002/cncr.27744; Colucci G, 2010, J CLIN ONCOL, V28, P1645, DOI 10.1200/JCO.2009.25.4433; European Association for Palliative Care (EAPC), DEFINITION OF PALLIA; European countries, 2014, PALLIATIVE MED, V28, P101, DOI [10.1177/0269216313488989, DOI 10.1177/0269216313488989]; European Medicines Agency (EMA), 2013, GUID EV ANT MED PROD; European Organisation for Research and Treatment of Cancer (EORTC Quality of Life Department), 2015, EORTC QUALITY OF LIF; Food and Drug Administration UDoHaHS Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Devices and Radiological Health (CDRH), 2009, GUID IND PAT REP OUT; Functional Assessment of Chronic Illness Therapy (FACIT.org), 2015, QUEST; Ghimire S, 2013, LUNG, V191, P313, DOI 10.1007/s00408-013-9479-z; Gilbert MR, 2012, J NEURO-ONCOL, V106, P147, DOI 10.1007/s11060-011-0650-1; Gondek K, 2007, J CLIN ONCOL, V25, P5087, DOI 10.1200/JCO.2007.11.3845; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Iyer S, 2014, SUPPORT CARE CANCER, V22, P181, DOI 10.1007/s00520-013-1959-4; Iyer S, 2013, LUNG CANCER, V81, P288, DOI 10.1016/j.lungcan.2013.03.008; Kim IH, 2011, J NEURO-ONCOL, V103, P595, DOI 10.1007/s11060-010-0427-y; Kohler M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h796; Levy MH, 2012, J NATL COMPR CANC NE, V10, P1284, DOI 10.6004/jnccn.2012.0132; Mapi Research Trust, 2014, PRODQOLID PAT REP OU; McDermott DF, 2008, J CLIN ONCOL, V26, P2178, DOI 10.1200/JCO.2007.14.8288; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Nakai Y, 2012, BRIT J CANCER, V106, P1934, DOI 10.1038/bjc.2012.183; National Cancer Institute, NCI FACT SHEET TARG; National Institute for Health and Clinical Excellence, APPR LIF EXT END LIF; National Institutes of Health, 2009, COMM FUND STRAT PLAN; Patient-Centered Outcomes Research Institute (PCORI), 2012, PAT CTR OUTC RES 201; Rainbird K, 2009, BRIT J CANCER, V101, P759, DOI 10.1038/sj.bjc.6605235; Ranson M, 2007, J CLIN ONCOL, V25, P2540, DOI 10.1200/JCO.2007.10.8217; Reardon DA, 2011, J NEURO-ONCOL, V103, P371, DOI 10.1007/s11060-010-0403-6; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Reeve B, 2013, QUAL LIFE RES, V22, P1889, DOI 10.1007/s11136-012-0344-y; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Schildmann J, 2013, ONCOLOGIST, V18, P90, DOI 10.1634/theoncologist.2012-0206; Seal BS, 2013, VALUE HEALTH, V16, P872, DOI 10.1016/j.jval.2013.03.1628; Smith TJ, 2012, J CLIN ONCOL, V30, P880, DOI 10.1200/JCO.2011.38.5161; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Teunissen SCCM, 2007, J PAIN SYMPTOM MANAG, V34, P94, DOI 10.1016/j.jpainsymman.2006.10.015; US Department of Health and Human Services, 2013, 2012 ANN PROGR REP C; Wick W, 2010, J CLIN ONCOL, V28, P1168, DOI 10.1200/JCO.2009.23.2595; Wieseler B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8141; Worldwide Palliative Care Alliance and World Health Organization, 2014, GLOB ATL PALL CAR EN; Yoo C, 2009, BRIT J CANCER, V101, P1658, DOI 10.1038/sj.bjc.6605374	54	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136640	10.1371/journal.pone.0136640	http://dx.doi.org/10.1371/journal.pone.0136640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327232	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700050
J	Saritas-Yildirim, B; Pliner, HA; Ochoa, A; Silva, EM				Saritas-Yildirim, Banu; Pliner, Hannah A.; Ochoa, Angelica; Silva, Elena M.			Genome-Wide Identification and Expression of Xenopus F-Box Family of Proteins	PLOS ONE			English	Article							CELL-CYCLE; UBIQUITIN LIGASES; DNA-DAMAGE; DEGRADATION; SCF; DATABASE; SEL-10; NOTCH; DIFFERENTIATION; HYBRIDIZATION	Protein degradation via the multistep ubiquitin/26S proteasome pathway is a rapid way to alter the protein profile and drive cell processes and developmental changes. Many key regulators of embryonic development are targeted for degradation by E3 ubiquitin ligases. The most studied family of E3 ubiquitin ligases is the SCF ubiquitin ligases, which use F-box adaptor proteins to recognize and recruit target proteins. Here, we used a bioinformatics screen and phylogenetic analysis to identify and annotate the family of F-box proteins in the Xenopus tropicalis genome. To shed light on the function of the F-box proteins, we analyzed expression of F-box genes during early stages of Xenopus development. Many F-box genes are broadly expressed with expression domains localized to diverse tissues including brain, spinal cord, eye, neural crest derivatives, somites, kidneys, and heart. All together, our genome-wide identification and expression profiling of the Xenopus F-box family of proteins provide a foundation for future research aimed to identify the precise role of F-box dependent E3 ubiquitin ligases and their targets in the regulatory circuits of development.	[Saritas-Yildirim, Banu; Pliner, Hannah A.; Ochoa, Angelica; Silva, Elena M.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA	Georgetown University	Silva, EM (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.	elena.silva@georgetown.edu	; Pliner, Hannah Andersen/F-3608-2015	Klymkowsky, Mike/0000-0001-5816-9771; Ochoa, Angelica/0000-0003-0615-1654; Pliner, Hannah Andersen/0000-0003-1484-6501	National Institutes of Health [HD060698]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD060698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health #HD060698 to EMS, http://www.nichd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asada S, 2008, INT J MOL MED, V22, P95; Boix-Perales H, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-27; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fotovati A, 2011, J ANAT, V218, P668, DOI 10.1111/j.1469-7580.2011.01370.x; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Galli F, 2010, J CELL SCI, V123, P2423, DOI 10.1242/jcs.061010; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harper JW, 2012, MOL CELL PROTEOMICS, V11, P1541, DOI 10.1074/mcp.R112.021154; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Jia LJ, 2009, PIGM CELL MELANOMA R, V22, P518, DOI 10.1111/j.1755-148X.2009.00611.x; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Karpinka JB, 2015, NUCLEIC ACIDS RES, V43, pD756, DOI 10.1093/nar/gku956; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Kuiken HJ, 2012, J CELL MOL MED, V16, P2140, DOI 10.1111/j.1582-4934.2012.01524.x; Lander R, 2011, J CELL BIOL, V194, P17, DOI 10.1083/jcb.201012085; Liu J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000527; Matsuda Y, 2015, CYTOGENET GENOME RES, V145, P187, DOI 10.1159/000381292; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Pontius J, 2003, NCBI HDB BETHESDA NA; RAMBAUT A, 2006, FIGTREE; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Saritas-Yildirim B, 2014, GENESIS, V52, P287, DOI 10.1002/dvg.22771; Snyder JL, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-15; Uno Y, 2013, HEREDITY, V111, P430, DOI 10.1038/hdy.2013.65; Vernon AE, 2006, DEVELOPMENT, V133, P3359, DOI 10.1242/dev.02504; von Arnim A G, 2001, Sci STKE, V2001, ppe2, DOI 10.1126/stke.2001.97.pe2; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001	42	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136929	10.1371/journal.pone.0136929	http://dx.doi.org/10.1371/journal.pone.0136929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327321	gold, Green Submitted, Green Published			2022-12-27	WOS:000360437700073
J	Shrestha, A; Carraro, G; El Agha, E; Mukhametshina, R; Chao, CM; Rizvanov, A; Barreto, G; Bellusci, S				Shrestha, Amit; Carraro, Gianni; El Agha, Elie; Mukhametshina, Regina; Chao, Cho-Ming; Rizvanov, Albert; Barreto, Guillermo; Bellusci, Saverio			Generation and Validation of miR-142 Knock Out Mice	PLOS ONE			English	Article							LUNG DEVELOPMENT; MICRORNAS; DIFFERENTIATION; CELLS; P300	microRNA-142 (miR-142) is an important regulator of many biological processes and associated signaling pathways during embryonic development, homeostasis and disease. The miR-142 hairpin gives rise to the "guide strand" miR-142-3p and the sister "passenger" strand miR-142-5p. miR-142-3p has been shown to play critical, non-redundant functions in the development of the hematopoietic lineage. We have recently reported that miR-142-3p is critical for the control of Wnt signaling in the mesenchyme of the developing lung. miR-142-5p has been proposed to control adaptive growth in cardiomyocytes postnatally and its increase is associated with extensive apoptosis and cardiac dysfunction in a murine heart failure model. Using homologous recombination, we now report the generation and validation of miR-142-null mice. miR-142-null mice show a significant decrease in th expression levels of both the 3p and 5p isoforms. The expression of Bzrap1, a gene immediately flanking miR-142 is not altered while the expression of a long non-coding RNA embedded within the miR-142 gene is decreased. miR-142-null newborn pups appear normal and are normally represented indicating absence of embryonic lethality. At embryonic day 18.5, miR-142-null lungs display increased Wnt signaling associated with the up-regulation of Apc and p300, two previously reported targets of miR-142-3p and -5p, respectively. Adult miR-142-null animals display impaired hematopoietic lineage formation identical to previously reported miR-142 gene trap knockdown mice. We report, for the first time, the homologous recombination-based miR-142-null mice that will be useful for the scientific community working on the diverse biological functions of miR-142.	[Shrestha, Amit; El Agha, Elie; Mukhametshina, Regina; Chao, Cho-Ming; Bellusci, Saverio] Univ Giessen, Excellence Cluster Cardiopulm Syst, German Ctr Lung Res, Giessen, Hessen, Germany; [Shrestha, Amit; El Agha, Elie; Mukhametshina, Regina; Chao, Cho-Ming; Bellusci, Saverio] Marburg Lung Ctr, Giessen, Hessen, Germany; [Carraro, Gianni] Cedars Sinai Med Ctr, Lung & Regenerat Med Inst, Dept Med, Los Angeles, CA 90048 USA; [Rizvanov, Albert; Bellusci, Saverio] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Barreto, Guillermo] Max Planck Inst, LOEWE Res Grp Lung Canc Epigenet, Bad Nauheim, Germany; [Bellusci, Saverio] Univ So Calif, Keck Sch Med, Saban Res Inst Childrens Hosp Los Angeles, Dev Biol Program,Div Surg, Los Angeles, CA 90033 USA	Justus Liebig University Giessen; Cedars Sinai Medical Center; Kazan Federal University; Max Planck Society; Children's Hospital Los Angeles; University of Southern California	Bellusci, S (corresponding author), Univ Giessen, Excellence Cluster Cardiopulm Syst, German Ctr Lung Res, Giessen, Hessen, Germany.	Saverio.Bellusci@innere.med.uni-giessen.de	Chao, Cho-Ming/GVT-4288-2022; Rizvanov, Albert/H-4486-2013; Barreto, Guillermo/U-5718-2017	Rizvanov, Albert/0000-0002-9427-5739; Barreto, Guillermo/0000-0002-7777-4712; Carraro, Gianni/0000-0003-0824-7692; El Agha, Elie/0000-0001-7504-3417	Deutsche Forschungsgemeinschaft [BE4443/4-1, BE4443/6-1]; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz; Universtat Klinikum Giessen Marburg; University of Giessen Marburg Lung Center; competitive growth of Kazan Federal University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz; Universtat Klinikum Giessen Marburg; University of Giessen Marburg Lung Center; competitive growth of Kazan Federal University	SB was supported by grants from the Deutsche Forschungsgemeinschaft (BE4443/4-1 and BE4443/6-1), Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz, the Universtat Klinikum Giessen Marburg, the University of Giessen Marburg Lung Center, as well as the program of competitive growth of Kazan Federal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Carraro G, 2014, DEVELOPMENT, V141, P1272, DOI 10.1242/dev.105908; Chapnik E, 2014, ELIFE, V3, DOI 10.7554/eLife.01964; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chiou GY, 2013, MOL CELL, V52, P693, DOI 10.1016/j.molcel.2013.11.009; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fan HB, 2014, BLOOD, V124, P1320, DOI 10.1182/blood-2013-12-545012; Herriges MJ, 2014, GENE DEV, V28, P1363, DOI 10.1101/gad.238782.114; Isobe T, 2014, ELIFE, V3, DOI 10.7554/eLife.01977; Kaduthanam S, 2013, LUNG CANCER, V80, P223, DOI 10.1016/j.lungcan.2013.01.013; Kramer NJ, 2015, BLOOD, V125, P3720, DOI 10.1182/blood-2014-10-603951; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Nimmo R, 2013, DEV CELL, V26, P237, DOI 10.1016/j.devcel.2013.06.023; Sharma S, 2012, EMBO MOL MED, V4, P617, DOI 10.1002/emmm.201200234; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Trobaugh DW, 2014, NATURE, V506, P245, DOI 10.1038/nature12869; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494	19	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136913	10.1371/journal.pone.0136913	http://dx.doi.org/10.1371/journal.pone.0136913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327117	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700071
J	Suzuki, H; Misaki, M; Krueger, F; Bodurka, J				Suzuki, Hideo; Misaki, Masaya; Krueger, Frank; Bodurka, Jerzy			Neural Responses to Truth Telling and Risk Propensity under Asymmetric Information	PLOS ONE			English	Article							THEORY-OF-MIND; DECISION-MAKING; FUNCTIONAL CONNECTIVITY; BASOLATERAL AMYGDALA; SOCIAL INFORMATION; PREFRONTAL CORTEX; TRUST; BRAIN; AUTISM; TRUSTWORTHINESS	Trust is multi-dimensional because it can be characterized by subjective trust, trust antecedent, and behavioral trust. Previous research has investigated functional brain responses to subjective trust (e.g., a judgment of trustworthiness) or behavioral trust (e.g., decisions to trust) in perfect information, where all relevant information is available to all participants. In contrast, we conducted a novel examination of the patterns of functional brain activity to a trust antecedent, specifically truth telling, in asymmetric information, where one individual has more information than others, with the effect of varying risk propensity. We used functional magnetic resonance imaging (fMRI) and recruited 13 adults, who played the Communication Game, where they served as the "Sender" and chose either truth telling (true advice) or lie telling (false advice) regarding the best payment allocation for their partner. Our behavioral results revealed that subjects with recreational high risk tended to choose true advice. Moreover, fMRI results yielded that the choices of true advice were associated with increased cortical activation in the anterior rostral medial and frontopolar prefrontal cortices, middle frontal cortex, temporoparietal junction, and precuneus. Furthermore, when we specifically evaluated a role of the bilateral amygdala as the region of interest (ROI), decreased amygdala response was associated with high risk propensity, regardless of truth telling or lying. In conclusion, our results have implications for how differential functions of the cortical areas may contribute to the neural processing of truth telling.	[Suzuki, Hideo; Misaki, Masaya; Bodurka, Jerzy] Laureate Inst Brain Res, Tulsa, OK 74136 USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Bodurka, Jerzy] Univ Oklahoma, Coll Engn, Norman, OK 73019 USA	Laureate Institute for Brain Research, Inc.; George Mason University; University of Oklahoma System; University of Oklahoma - Norman	Bodurka, J (corresponding author), Laureate Inst Brain Res, Tulsa, OK 74136 USA.	jbodurka@laureateinstitute.org	Misaki, Masaya/H-3042-2013	Misaki, Masaya/0000-0002-6829-4311	Laureate Institute for Brain Research; William K. Warren Foundation	Laureate Institute for Brain Research; William K. Warren Foundation	This research was supported by the Laureate Institute for Brain Research and the William K. Warren Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; Ahn HN, 2001, J COUNS PSYCHOL, V48, P251, DOI 10.1037//0022-0167.48.3.251; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Baas D, 2008, NEUROIMAGE, V40, P719, DOI 10.1016/j.neuroimage.2007.12.039; Bachevalier J, 1997, EXP BRAIN RES, V115, P430, DOI 10.1007/PL00005713; Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bodurka J, 2004, MAGNET RESON MED, V51, P165, DOI 10.1002/mrm.10693; Bohnet I, 2004, J ECON BEHAV ORGAN, V55, P467, DOI 10.1016/j.jebo.2003.11.004; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Broekhof E, 2015, J AUTISM DEV DISORD, V45, P2035, DOI 10.1007/s10803-015-2363-3; Burnett S, 2009, J COGNITIVE NEUROSCI, V21, P1736, DOI 10.1162/jocn.2009.21121; Burnett S, 2009, EUR J NEUROSCI, V29, P1294, DOI 10.1111/j.1460-9568.2009.06674.x; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; Cook KS, 2005, SOC PSYCHOL QUART, V68, P121, DOI 10.1177/019027250506800202; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CRAWFORD VP, 1982, ECONOMETRICA, V50, P1431, DOI 10.2307/1913390; Crowley TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012835; Das TK, 2004, J BUS PSYCHOL, V19, P85, DOI 10.1023/B:JOBU.0000040274.23551.1b; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; De Jong BA, 2012, J APPL PSYCHOL, V97, P391, DOI 10.1037/a0026483; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Dirks KT, 1999, J APPL PSYCHOL, V84, P445, DOI 10.1037/0021-9010.84.3.445; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; First M., 2010, STRUCTURED CLIN INTE; Freeman JB, 2014, J NEUROSCI, V34, P10573, DOI 10.1523/JNEUROSCI.5063-13.2014; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Greene JD, 2009, P NATL ACAD SCI USA, V106, P12506, DOI 10.1073/pnas.0900152106; Hansen M. H., 2002, INT FOOD AGRIBUS MAN, V5, P41, DOI [10.1016/s1096-7508(02)00069-1, DOI 10.1016/S1096-7508(02)00069-1]; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Hooker CI, 2011, J ABNORM PSYCHOL, V120, P98, DOI 10.1037/a0020630; Jaarsma P, 2012, MED HEALTH CARE PHIL, V15, P271, DOI 10.1007/s11019-011-9363-7; Joe GW, 2001, PSYCHIATR SERV, V52, P1223, DOI 10.1176/appi.ps.52.9.1223; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Koscik TR, 2011, NEUROPSYCHOLOGIA, V49, P602, DOI 10.1016/j.neuropsychologia.2010.09.023; Krueger F, 2008, PHILOS T R SOC B, V363, P3859, DOI 10.1098/rstb.2008.0165; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Krupnick JL, 1996, J CONSULT CLIN PSYCH, V64, P532, DOI 10.1037/0022-006X.64.3.532; Lambert MJ, 1994, ENCYCL PSYCHOTHER, P143; LaPorta R, 1997, AM ECON REV, V87, P333; Ledley DR, 2010, MAKING COGNITIVE BEH, V2nd; Li CSR, 2009, ALCOHOL CLIN EXP RES, V33, P740, DOI 10.1111/j.1530-0277.2008.00891.x; Lissek S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002023; Luborsky L, 1997, NIDA Res Monogr, V165, P233; Lusher D, 2014, SMALL GR RES, V45, P3, DOI 10.1177/1046496413510362; Mahy CEV, 2014, DEV COGN NEUROS-NETH, V9, P68, DOI 10.1016/j.dcn.2014.01.002; Moretto G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00593; NAYYAR PR, 1990, STRATEGIC MANAGE J, V11, P513, DOI 10.1002/smj.4250110703; O'Nions E, 2014, DEVELOPMENTAL SCI, V17, P786, DOI 10.1111/desc.12167; Orsini CA, 2015, J NEUROSCI, V35, P1368, DOI 10.1523/JNEUROSCI.3586-14.2015; PARKS CD, 1995, J CONFLICT RESOLUT, V39, P718, DOI 10.1177/0022002795039004006; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P289, DOI 10.1016/j.neuropsychologia.2008.07.018; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rode J, 2010, GAME ECON BEHAV, V68, P325, DOI 10.1016/j.geb.2009.05.008; Safran J. D., 2000, NEGOTIATING THERAPEU; Said CP, 2009, J COGNITIVE NEUROSCI, V21, P519, DOI 10.1162/jocn.2009.21041; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Soane E, 2010, J RISK RES, V13, P303, DOI 10.1080/13669870902987024; Sommer M, 2007, NEUROIMAGE, V35, P1378, DOI 10.1016/j.neuroimage.2007.01.042; Staples DS, 2008, INFORM SYST J, V18, P617, DOI 10.1111/j.1365-2575.2007.00244.x; Talairach J., 1988, COPLANAR STEREOTAXIC; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P303, DOI 10.1093/scan/nsn033; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; van Honk J, 2013, P NATL ACAD SCI USA, V110, P2506, DOI 10.1073/pnas.1217316110; Volz KG, 2005, BRAIN RES BULL, V67, P403, DOI 10.1016/j.brainresbull.2005.06.011; Weller JA, 2011, J BEHAV DECIS MAKING, V24, P180, DOI 10.1002/bdm.677; Whalen PJ, 2007, TRENDS COGN SCI, V11, P499, DOI 10.1016/j.tics.2007.08.016; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Yan PS, 2009, AM J DRUG ALCOHOL AB, V35, P284, DOI 10.1080/00952990902968569; Younga L, 2008, NEUROIMAGE, V40, P1912, DOI 10.1016/j.neuroimage.2008.01.057	87	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137014	10.1371/journal.pone.0137014	http://dx.doi.org/10.1371/journal.pone.0137014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ2NK	26325581	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700081
J	Tu, T; Meng, K; Luo, HY; Turunen, O; Zhang, LJ; Cheng, YL; Su, XY; Ma, R; Shi, PJ; Wang, YR; Yang, PL; Yao, B				Tu, Tao; Meng, Kun; Luo, Huiying; Turunen, Ossi; Zhang, Lujia; Cheng, Yanli; Su, Xiaoyun; Ma, Rui; Shi, Pengjun; Wang, Yaru; Yang, Peilong; Yao, Bin			New Insights into the Role of T3 Loop in Determining Catalytic Efficiency of GH28 Endo-Polygalacturonases	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; ACTIVE-SITE; MOLECULAR-DYNAMICS; ASPERGILLUS-NIGER; CRYSTAL-STRUCTURE; ENDOPOLYGALACTURONASE II; CONFORMATIONAL-CHANGES; PECTIN METHYLESTERASE; STRUCTURAL INSIGHTS; GLYCOSIDE HYDROLASE	Intramolecular mobility and conformational changes of flexible loops have important roles in the structural and functional integrity of proteins. The Achaetomium sp. Xz8 endo-polygalacturonase (PG8fn) of glycoside hydrolase (GH) family 28 is distinguished for its high catalytic activity (28,000 U/mg). Structure modeling indicated that PG8fn has a flexible T3 loop that folds partly above the substrate in the active site, and forms a hydrogen bond to the substrate by a highly conserved residue Asn94 in the active site cleft. Our research investigates the catalytic roles of Asn94 in T3 loop which is located above the catalytic residues on one side of the substrate. Molecular dynamics simulation performed on the mutant N94A revealed the loss of the hydrogen bond formed by the hydroxyl group at O34 of pentagalacturonic acid and the crucial ND2 of Asn94 and the consequent detachment and rotation of the substrate away from the active site, and that on N94Q caused the substrate to drift away from its place due to the longer side chain. In line with the simulations, site-directed mutagenesis at this site showed that this position is very sensitive to amino acid substitutions. Except for the altered K-m values from 0.32 (wild type PG8fn) to 0.75-4.74 mg/ml, all mutants displayed remarkably lowered kcat (similar to 3-20,000 fold) and kcat/Km (similar to 8-187,500 fold) values and significantly increased Delta(Delta G) values (5.92-33.47 kJ/mol). Taken together, Asn94 in the GH28 T3 loop has a critical role in positioning the substrate in a correct way close to the catalytic residues.	[Tu, Tao; Meng, Kun; Luo, Huiying; Cheng, Yanli; Su, Xiaoyun; Ma, Rui; Shi, Pengjun; Wang, Yaru; Yang, Peilong; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China; [Turunen, Ossi] Aalto Univ, Sch Chem Technol, Dept Biotechnol & Chem Technol, FI-00076 Aalto, Finland; [Zhang, Lujia] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Aalto University; East China University of Science & Technology	Yao, B (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China.	binyao@caas.cn	Turunen, Ossi/HHN-4776-2022; Zhang, Lujia/ABI-3724-2020	Zhang, Lujia/0000-0003-3566-917X	Recommended International Advanced Agricultural Science and Technology Plan of China (948 program) [2014-S1]; National High Technology Research and Development Program of China (863 program) [2012AA022208, 2013AA102803]	Recommended International Advanced Agricultural Science and Technology Plan of China (948 program); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China)	This work was supported by the Recommended International Advanced Agricultural Science and Technology Plan of China (948 program, grant no. 2014-S1) and the National High Technology Research and Development Program of China (863 program, grant nos. 2012AA022208 and 2013AA102803).	Abbott DW, 2008, MICROBIOL MOL BIOL R, V72, P301, DOI 10.1128/MMBR.00038-07; Abbott DW, 2007, J MOL BIOL, V368, P1215, DOI 10.1016/j.jmb.2007.02.083; Arab-Jaziri F, 2012, FEBS J, V279, P3598, DOI 10.1111/j.1742-4658.2012.08720.x; Bonivento D, 2008, PROTEINS, V70, P294, DOI 10.1002/prot.21610; Cho SW, 2001, J MOL BIOL, V311, P863, DOI 10.1006/jmbi.2001.4919; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Federici L, 2001, P NATL ACAD SCI USA, V98, P13425, DOI 10.1073/pnas.231473698; Guilfoyle AP, 2014, FEBS J, V281, P2254, DOI 10.1111/febs.12779; Gupta S, 2008, BIORESOURCE TECHNOL, V99, P937, DOI 10.1016/j.biortech.2007.03.009; Gutierrez-Fernandez J, 2014, J STRUCT BIOL, V187, P215, DOI 10.1016/j.jsb.2014.07.007; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jayani RS, 2005, PROCESS BIOCHEM, V40, P2931, DOI 10.1016/j.procbio.2005.03.026; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Karimaki J, 2004, PROTEIN ENG DES SEL, V17, P861, DOI 10.1093/protein/gzh099; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mercadante D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087581; Mercadante D, 2013, BIOPHYS J, V104, P1731, DOI 10.1016/j.bpj.2013.02.049; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Muilu J, 1998, PROTEINS, V31, P434; Okoniewska M, 2000, BIOCHEM J, V349, P169, DOI 10.1042/0264-6021:3490169; Paes G, 2007, PROTEIN ENG DES SEL, V20, P15, DOI 10.1093/protein/gzl049; Paes G, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201207001; Paes G, 2012, BIOTECHNOL ADV, V30, P564, DOI 10.1016/j.biotechadv.2011.10.003; Pages S, 2000, J BIOL CHEM, V275, P29348, DOI 10.1074/jbc.M910112199; Pickersgill R, 1998, J BIOL CHEM, V273, P24660, DOI 10.1074/jbc.273.38.24660; Pollet A, 2009, PROTEINS, V77, P395, DOI 10.1002/prot.22445; Santa H, 2005, BBA-PROTEINS PROTEOM, V1749, P65, DOI 10.1016/j.bbapap.2005.02.007; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Sharma N, 2013, REV ENVIRON SCI BIO, V12, P45, DOI 10.1007/s11157-012-9276-9; Shimizu T, 2002, BIOCHEMISTRY-US, V41, P6651, DOI 10.1021/bi025541a; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tu T, 2014, APPL MICROBIOL BIOT, V98, P5019, DOI 10.1007/s00253-014-5533-x; Tu T, 2013, FOOD CHEM, V141, P2974, DOI 10.1016/j.foodchem.2013.05.132; van Pouderoyen G, 2003, FEBS LETT, V554, P462, DOI 10.1016/S0014-5793(03)01221-3; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Vieira DS, 2012, J MOL MODEL, V18, P1473, DOI 10.1007/s00894-011-1172-7; Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z; Wan Q, 2014, ACTA CRYSTALLOGR D, V70, P11, DOI 10.1107/S1399004713023626	45	15	17	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135413	10.1371/journal.pone.0135413	http://dx.doi.org/10.1371/journal.pone.0135413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327390	Green Published, gold			2022-12-27	WOS:000360437700019
J	Zhou, J; Xu, WZ; Wong, JWC; Yong, XY; Yan, BH; Zhang, XY; Jia, HH				Zhou, Jun; Xu, Weizhong; Wong, Jonathan W. C.; Yong, Xiaoyu; Yan, Binghua; Zhang, Xueying; Jia, Honghua			Ultrasonic and Thermal Pretreatments on Anaerobic Digestion of Petrochemical Sludge: Dewaterability and Degradation of PAHs	PLOS ONE			English	Article							WASTE-ACTIVATED-SLUDGE; EXTRACELLULAR POLYMERIC SUBSTANCES; URBAN SLUDGE; BIODEGRADATION; REMOVAL; MATRIX; FLOCS; EPS	Effects of different pretreatment methods on sludge dewaterability and polycyclic aromatic hydrocarbons (PAHs) degradation during petrochemical sludge anaerobic digestion were studied. Results showed that the total biogas production volume in the thermal pretreatment system was 4 and 5 times higher than that in the ultrasound pretreatment and in the control system, and the corresponding volatile solid removal efficiencies reached 28%, 15%, and 8%. Phenanthrene, paranaphthalene, fluoranthene, benzofluoranthene, and benzopyrene removal rates reached 43.3%, 55.5%, 30.6%, 42.9%, and 41.7%, respectively, in the thermal pretreatment system, which were much higher than those in the ultrasound pretreatment and in the control system. Moreover, capillary suction time (CST) of sludge increased after pretreatment, and then reduced after 20 days of anaerobic digestion, indicating that sludge dewaterability was greatly improved after anaerobic digestion. The decrease of protein and polysaccharide in the sludge could improve sludge dewaterability during petrochemical sludge anaerobic digestion. This study suggested that thermal pretreatment might be a promising enhancement method for petrochemical sludge solubilization, thus contributing to degradation of the PAHs, biogas production, and improvement of dewaterability during petrochemical sludge anaerobic digestion.	[Zhou, Jun; Yong, Xiaoyu; Jia, Honghua] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Xu, Weizhong; Zhang, Xueying] Nanjing Tech Univ, Coll Environm, Nanjing, Jiangsu, Peoples R China; [Wong, Jonathan W. C.] Hong Kong Baptist Univ, Sinoforest Appl Res Ctr Pearl River Delta Environ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Yan, Binghua] Chinese Acad Sci, Qingdao Inst Bioenergy & Bio Proc Technol, Lab Waste Valorisat & Water Reuse, Qingdao, Peoples R China	Nanjing Tech University; Nanjing Tech University; Hong Kong Baptist University; Chinese Academy of Sciences	Zhang, XY (corresponding author), Nanjing Tech Univ, Coll Environm, Nanjing, Jiangsu, Peoples R China.	xueyingzhang@njtech.edu.cn; hhjia@njtech.edu.cn	Yan, Binghua/ACD-0393-2022; Yong, Xiao-Yu/HGD-7622-2022; Yong, Xiao-Yu/M-5203-2013	Yan, Binghua/0000-0003-3255-6559; Yong, Xiao-Yu/0000-0001-7267-6067	National Basic Research Program of China [2013CB733500]; National Natural Science Foundation of China [21307058, 21207065]; Jiangsu Province Science Foundation for Youths [BK20130931]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [13KJB610006]; Chinese Academy of Environmental and Application of Microbial Key Laboratory Fund Project [KLCAS-2013-05]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Science Foundation for Youths; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Environmental and Application of Microbial Key Laboratory Fund Project	This work was supported by the National Basic Research Program of China (2013CB733500), the National Natural Science Foundation of China (No. 21307058; 21207065), the Jiangsu Province Science Foundation for Youths (No. BK20130931), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 13KJB610006), and the Chinese Academy of Environmental and Application of Microbial Key Laboratory Fund Project (KLCAS-2013-05).	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Appels L, 2008, PROG ENERG COMBUST, V34, P755, DOI 10.1016/j.pecs.2008.06.002; Barret M, 2012, PEDOSPHERE, V22, P508, DOI 10.1016/S1002-0160(12)60035-6; Barret M, 2010, WATER RES, V44, P3797, DOI 10.1016/j.watres.2010.04.031; Bernal-Martinez A, 2005, PROCESS BIOCHEM, V40, P3244, DOI 10.1016/j.procbio.2005.03.028; Bernal-Martinez A, 2007, CHEMOSPHERE, V68, P1013, DOI 10.1016/j.chemosphere.2007.02.019; Bonten LTC, 1999, CHEMOSPHERE, V38, P3627, DOI 10.1016/S0045-6535(98)00574-8; Bougrier C, 2008, CHEM ENG J, V139, P236, DOI 10.1016/j.cej.2007.07.099; Burgess JE, 2008, WATER SA, V34, P343; Chen JL, 2014, BIOTECHNOL ADV, V32, P1523, DOI 10.1016/j.biotechadv.2014.10.005; Chen YG, 2001, WATER RES, V35, P2615, DOI 10.1016/S0043-1354(00)00565-0; FROLUND B, 1995, APPL MICROBIOL BIOT, V43, P755, DOI 10.1007/s002530050481; Gao YZ, 2004, CHEMOSPHERE, V55, P1169, DOI 10.1016/j.chemosphere.2004.01.037; Gaudy A.F., 1962, IND WATER WASTES, V7, P17; Guo JB, 2014, CHEMOSPHERE, V101, P66, DOI 10.1016/j.chemosphere.2013.12.007; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Houghton JI, 2001, WATER SCI TECHNOL, V44, P373, DOI 10.2166/wst.2001.0792; Li XY, 2007, WATER RES, V41, P1022, DOI 10.1016/j.watres.2006.06.037; Liu XM, 2010, ENVIRON SCI TECHNOL, V44, P4355, DOI 10.1021/es9016766; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma XY, 2013, EXP THERM FLUID SCI, V48, P238, DOI 10.1016/j.expthermflusci.2013.03.006; Mahmoud A, 2011, WATER RES, V45, P2795, DOI 10.1016/j.watres.2011.02.029; Neyens E, 2004, J HAZARD MATER, V106, P83, DOI 10.1016/j.jhazmat.2003.11.014; Novak JT, 2003, WATER RES, V37, P3136, DOI 10.1016/S0043-1354(03)00171-4; Nzila A, 2013, ENVIRON POLLUT, V178, P474, DOI 10.1016/j.envpol.2013.03.042; Pilli S, 2011, ULTRASON SONOCHEM, V18, P1, DOI 10.1016/j.ultsonch.2010.02.014; Rani RU, 2014, ULTRASON SONOCHEM, V21, P1065, DOI 10.1016/j.ultsonch.2013.11.007; Rani RU, 2012, BIORESOURCE TECHNOL, V126, P107, DOI 10.1016/j.biortech.2012.09.027; Ruiz B, 2014, WASTE MANAGE, V34, P2063, DOI 10.1016/j.wasman.2014.06.026; Tiehm A, 2001, WATER RES, V35, P2003, DOI 10.1016/S0043-1354(00)00468-1; Yeom IT, 2002, WATER SCI TECHNOL, V46, P421, DOI 10.2166/wst.2002.0641; Yu GH, 2008, ENVIRON SCI TECHNOL, V42, P7944, DOI 10.1021/es8016717; Yu GH, 2007, APPL MICROBIOL BIOT, V77, P605, DOI 10.1007/s00253-007-1204-5; Yu GH, 2010, J HAZARD MATER, V175, P510, DOI 10.1016/j.jhazmat.2009.10.035; Yu GH, 2010, WATER RES, V44, P797, DOI 10.1016/j.watres.2009.10.021; Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102688	36	8	10	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136162	10.1371/journal.pone.0136162	http://dx.doi.org/10.1371/journal.pone.0136162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327510	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700031
J	Kingston, ACN; Wardill, TJ; Hanlon, RT; Cronin, TW				Kingston, Alexandra C. N.; Wardill, Trevor J.; Hanlon, Roger T.; Cronin, Thomas W.			An Unexpected Diversity of Photoreceptor Classes in the Longfin Squid, Doryteuthis pealeii	PLOS ONE			English	Article							SEPIA-OFFICINALIS; CEPHALOPODS; CUTTLEFISH; RETINOCHROME; CAMOUFLAGE; LIGHT; SKIN; COLORATION; MORPHOLOGY; RHODOPSIN	Cephalopods are famous for their ability to change color and pattern rapidly for signaling and camouflage. They have keen eyes and remarkable vision, made possible by photoreceptors in their retinas. External to the eyes, photoreceptors also exist in parolfactory vesicles and some light organs, where they function using a rhodopsin protein that is identical to that expressed in the retina. Furthermore, dermal chromatophore organs contain rhodopsin and other components of phototransduction (including retinochrome, a photoisomerase first found in the retina), suggesting that they are photoreceptive. In this study, we used a modified whole-mount immunohistochemical technique to explore rhodopsin and retinochrome expression in a number of tissues and organs in the longfin squid, Doryteuthis pealeii. We found that fin central muscles, hair cells (epithelial primary sensory neurons), arm axial ganglia, and sucker peduncle nerves all express rhodopsin and retinochrome proteins. Our findings indicate that these animals possess an unexpected diversity of extraocular photoreceptors and suggest that extraocular photoreception using visual opsins and visual phototransduction machinery is far more widespread throughout cephalopod tissues than previously recognized.	[Kingston, Alexandra C. N.; Cronin, Thomas W.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; [Wardill, Trevor J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Hanlon, Roger T.] Marine Biol Lab, Woods Hole, MA 02543 USA	University System of Maryland; University of Maryland Baltimore County; University of Cambridge; Marine Biological Laboratory - Woods Hole	Kingston, ACN (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	anahm1@umbc.edu	Hanlon, Roger T/Q-8687-2016	Hanlon, Roger T/0000-0003-0004-5674; Wardill, Trevor/0000-0002-2049-113X	Office of Naval Research Basic Research Challenge [N00014-10-0989]; Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship [BB/L024667/1]; Air Force Office of Scientific Research [FA9550-09-0346, FA9550-12-1-0321]; Biotechnology and Biological Sciences Research Council [BB/L024667/1] Funding Source: researchfish; BBSRC [BB/L024667/1] Funding Source: UKRI	Office of Naval Research Basic Research Challenge; Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Office of Naval Research Basic Research Challenge grant number N00014-10-0989 to TWC and RTH and a Biotechnology and Biological Sciences Research Council (BBSRC) David Phillips Fellowship BB/L024667/1 to TJW. The authors gratefully acknowledge support from the Air Force Office of Scientific Research via grants numbered FA9550-09-0346 to RTH. and FA9550-12-1-0321 to TWC.	Allen JJ, 2009, J COMP PHYSIOL A, V195, P547, DOI 10.1007/s00359-009-0430-y; BUDELMANN BU, 1988, J COMP PHYSIOL A, V164, P1, DOI 10.1007/BF00612711; Chiao CC, 2010, J EXP BIOL, V213, P187, DOI 10.1242/jeb.030247; CLONEY RA, 1983, AM ZOOL, V23, P581, DOI 10.1093/icb/23.3.581; Cobb CS, 1998, J MOLLUS STUD, V64, P111, DOI 10.1093/mollus/64.1.111; Gartner W, 2000, HDB BIOL PHYS; Gonzalez-Bellido P. T., 2012, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.PR0T069625; HANLON RT, 1988, PHILOS T ROY SOC B, V320, P437, DOI 10.1098/rstb.1988.0087; HARA T, 1976, J GEN PHYSIOL, V67, P791, DOI 10.1085/jgp.67.6.791; HARA T, 1980, J GEN PHYSIOL, V75, P1, DOI 10.1085/jgp.75.1.1; Jones BW, 2004, MAR BIOL, V144, P1151, DOI 10.1007/s00227-003-1285-3; KIER WM, 1989, J ZOOL, V217, P23, DOI 10.1111/j.1469-7998.1989.tb02472.x; Kingston ACN, 2015, J EXPT BIOL; Mackie GO, 2008, TISSUE CELL, V40, P21, DOI 10.1016/j.tice.2007.08.005; Mathger LM, 2007, J EXP BIOL, V210, P2657, DOI 10.1242/jeb.004382; Mathger LM, 2009, J EXP BIOL, V212, P2133, DOI 10.1242/jeb.020800; MESSENGER JB, 1974, J ZOOL, V174, P387; ROWELL CHF, 1966, J EXP BIOL, V44, P589; SAIBIL H, 1987, J CELL BIOL, V105, P19, DOI 10.1083/jcb.105.1.19; SANTI PA, 1975, TISSUE CELL, V7, P689, DOI 10.1016/0040-8166(75)90037-3; Shigeno S, 2002, J MORPHOL, V254, P65, DOI 10.1002/jmor.10020; SPERLING L, 1975, J GEN PHYSIOL, V65, P235, DOI 10.1085/jgp.65.2.235; Sperling L, 1973, BIOL BULL, V145, P456; Sumbre G, 2001, SCIENCE, V293, P1845, DOI 10.1126/science.1060976; Tong D, 2009, P NATL ACAD SCI USA, V106, P9836, DOI 10.1073/pnas.0904571106; Wardill TJ, 2012, P ROY SOC B-BIOL SCI, V279, P4243, DOI 10.1098/rspb.2012.1374; YOUNG RE, 1973, PAC SCI, V27, P1; Zylinski S, 2011, CURR BIOL, V21, P1937, DOI 10.1016/j.cub.2011.10.014	28	16	16	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0135381	10.1371/journal.pone.0135381	http://dx.doi.org/10.1371/journal.pone.0135381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351853	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800008
J	Ranjbar, M; Rotondi, MA; Ardern, CI; Kuk, JL				Ranjbar, Mahsa; Rotondi, Michael A.; Ardern, Chris I.; Kuk, Jennifer L.			Urinary Biomarkers of Polycyclic Aromatic Hydrocarbons Are Associated with Cardiometabolic Health Risk	PLOS ONE			English	Article							METABOLIC SYNDROME; UNITED-STATES; HEART-DISEASE; LUNG-CANCER; EXPOSURE; WORKERS; POPULATION; DIAGNOSIS; PAHS	Background Polycyclic aromatic hydrocarbons (PAH) are both man-made and naturally occurring environmental pollutants that may be related to cardiometabolic health risk. Objective To determine whether PAH is associated with obesity in the adult population and to examine whether urinary concentrations of PAH metabolites are associated with differences in how obesity relates to 3 or more risk factors for the metabolic syndrome (3RFMetS), type 2 diabetes (T2D), hypertension, and dyslipidemia. Methods A total of 4765 adult participants from the 2001-2008 National Health and Nutrition Examination Survey were examined. The association between 8 urinary hydroxylated PAH metabolites, obesity, and health were examined using weighted logistic regressions adjusting for age, sex, ethnicity, PIR, smoking status, and urinary creatinine. Results There was a positive dose-dependent association between obesity and 2-phenanthrene quintiles (P trend < 0.0001). Contrarily, higher quintiles of 1-naphthalene were associated with lower risk of obesity (P trend = 0.0004). For a given BMI, those in the highest quintile of 2-naphthalene, 2-fluorene, 3-fluorene and 2-phenanthrene had a 66-80% greater likelihood of 3RFMetS (P <= 0.05) compared to low levels. Higher quintiles of 1-naphthalene, 2-naphthalene, 2-phenanthrene and 1-pyrene were associated with a 78-124% greater likelihood of T2D (P <= 0.05) compared to low levels while high 1-naphthalene, 2-naphthalene, 2-fluorene, 3-fluorene and 2-phenanthrene were associated with a 38-68% greater likelihood of dyslipidemia (P <= 0.05) compared to lower levels. Finally, 2-naphthalene and 2-phenanthrene were positively associated with hypertension (P trend = 0.008 and P trend = 0.02 respectively). Conclusions PAH is related to obesity and the expression of a number of obesity-related cardiometabolic health risk factors. Future research is needed to bring to light the mechanistic pathways related to these findings.	[Ranjbar, Mahsa; Rotondi, Michael A.; Ardern, Chris I.; Kuk, Jennifer L.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada	York University - Canada	Kuk, JL (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	jennkuk@yorku.ca			Canadian Institute for Health Research Grant [131594]	Canadian Institute for Health Research Grant(Canadian Institutes of Health Research (CIHR))	This study was supported by a Canadian Institute for Health Research Grant 131594 (http://www.cihr-irsc.gc.ca/e/37788.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry, 1995, TOX PROF POL AR HYDR; Alshaarawy O, 2014, OCCUP ENVIRON MED, V71, P437, DOI 10.1136/oemed-2013-101987; Alshaarawy O, 2013, ENVIRON RES, V126, P98, DOI 10.1016/j.envres.2013.07.006; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; [Anonymous], 2004, NIH PUBLICATION; Armstrong B, 2004, ENVIRON HEALTH PERSP, V112, P970, DOI 10.1289/ehp.6895; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; BONASSI S, 1989, INT J CANCER, V44, P648, DOI 10.1002/ijc.2910440415; Bosetti C, 2007, ANN ONCOL, V18, P431, DOI 10.1093/annonc/mdl172; Buratti M, 2007, BIOMARKERS, V12, P221, DOI 10.1080/13547500601100110; Burstyn I, 2005, EPIDEMIOLOGY, V16, P744, DOI 10.1097/01.ede.0000181310.65043.2f; CDC, 2009, 4 CDCP; CDC, 2012, LAB PROC MAN MON POL; COSTANTINO JP, 1995, J OCCUP ENVIRON MED, V37, P597, DOI 10.1097/00043764-199505000-00009; Curfs DMJ., 2005, FASEB J; Everett CJ, 2010, ENVIRON RES, V110, P79, DOI 10.1016/j.envres.2009.09.010; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hecht SS, 2002, CARCINOGENESIS, V23, P907, DOI 10.1093/carcin/23.6.907; Li Z, 2010, J ENVIRON MONITOR, V12, P1110, DOI 10.1039/c000689k; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; MCLAUGHLIN JK, 1992, BRIT J IND MED, V49, P167; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; OBANA H, 1981, B ENVIRON CONTAM TOX, V27, P23, DOI 10.1007/BF01610981; Patel CJ, 2012, INT J EPIDEMIOL, V41, P828, DOI 10.1093/ije/dys003; Raaschou-Nielsen O, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-67; Rundle A, 2012, AM J EPIDEMIOL, V175, P1163, DOI 10.1093/aje/kwr455; Scinicariello F, 2013, ENV HLTH PERSPECT; St Helen G, 2012, CHEM RES TOXICOL, V25, P952, DOI 10.1021/tx300043k; The NIDDK National Diabetes Information, 2011, NAT DIAB STAT 2011; Vaananen V, 2003, J ENVIRON MONITOR, V5, P739, DOI 10.1039/b304096h; Xu XH, 2013, SCI TOTAL ENVIRON, V461, P341, DOI 10.1016/j.scitotenv.2013.04.089; Xu XH, 2010, SCI TOTAL ENVIRON, V408, P4943, DOI 10.1016/j.scitotenv.2010.07.034; Yang LL, 2014, ENVIRON POLLUT, V195, P24, DOI 10.1016/j.envpol.2014.08.012	33	48	49	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137536	10.1371/journal.pone.0137536	http://dx.doi.org/10.1371/journal.pone.0137536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340343	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200066
J	Schmidt, D; Germano, AMC; Milani, TL				Schmidt, Daniel; Germano, Andresa M. C.; Milani, Thomas L.			Aspects of Dynamic Balance Responses: Inter- and Intra-Day Reliability	PLOS ONE			English	Article							DIRECTIONAL SENSITIVITY; POSTURAL CONTROL; TEST-RETEST; PLATFORM; AGE; PROPRIOCEPTION; PERFORMANCE; STRENGTH; VALIDITY; REFLEXES	The Posturomed device is used as a scientific tool to quantify human dynamic balance ability due to unexpected perturbations, and as a training device. Consequently, the question arises whether such measurements are compromised by learning effects. Therefore, this study aimed to analyze inter- and intra-day reliability of dynamic balance responses using the Posturomed. Thirty healthy young subjects participated (24.3 +/- 3.2 years). The Posturomed was equipped with a triggering mechanism to enable unexpected, horizontal platform perturbations. A force platform was used to quantify Center of Pressure (COP) excursions for two time intervals: interval 1 (0-70 ms post perturbation) and interval 2 (71-260 ms post perturbation). Dynamic balance tests were performed in single leg stances in medio-lateral and anterior-posterior perturbation directions. Inter- and intra-day reliability were assessed descriptively using Bland-Altman plots and inferentially using tests for systematic error and intra-class-correlations. With regard to the mean COP excursions for every subject and all intervals, some cases revealed significant differences between measurement sessions, however, none were considered relevant. Furthermore, intra class correlation coefficients reflected high magnitudes, which leads to the assumption of good relative reliability. However, analyzing inter- and intra-day reliability using Bland-Altman plots revealed one exception: intra-day comparisons for the anterior-posterior direction in interval 2, which points towards possible learning effects. In summary, results reflected good overall reliability with the exception of certain intra-day comparisons in the anterior-posterior perturbation direction, which could indicate learning effects in those particular conditions.	[Schmidt, Daniel; Germano, Andresa M. C.; Milani, Thomas L.] Tech Univ Chemnitz, Dept Human Locomot, Inst Human Movement Sci & Hlth, Chemnitz, Saxony, Germany	Technische Universitat Chemnitz	Schmidt, D (corresponding author), Tech Univ Chemnitz, Dept Human Locomot, Inst Human Movement Sci & Hlth, Chemnitz, Saxony, Germany.	daniel.schmidt@hsw.tu-chemnitz.de		Schmidt, Daniel/0000-0001-6730-4621				Allum JHJ, 2002, J PHYSIOL-LONDON, V542, P643, DOI 10.1113/jphysiol.2001.015644; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bedard M, 2000, EXP AGING RES, V26, P353, DOI 10.1080/036107300750015741; Benvenuti F, 1999, ARCH PHYS MED REHAB, V80, P278, DOI 10.1016/S0003-9993(99)90138-7; Bloem BR, 2000, EXP BRAIN RES, V130, P375, DOI 10.1007/s002219900259; Boeer J, 2010, SPORTVERLETZ SPORTSC, V24, P40, DOI 10.1055/s-0029-1245184; Bower KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115282; Bruhn S, 2004, INT J SPORTS MED, V25, P56; Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Carpenter MG, 1999, EXP BRAIN RES, V129, P93, DOI 10.1007/s002210050940; Condron JE, 2002, J AM GERIATR SOC, V50, P157, DOI 10.1046/j.1532-5415.2002.50022.x; Corriveau H, 2001, ARCH PHYS MED REHAB, V82, P80, DOI 10.1053/apmr.2001.18678; Crisan AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120573; Granacher U, 2009, INT J SPORTS MED, V30, P652, DOI 10.1055/s-0029-1224178; Hilberg T, 2001, HAEMOPHILIA, V7, P582, DOI 10.1046/j.1365-2516.2001.00563.x; Hirschmuller A, 2011, INJURY, V42, P1135, DOI 10.1016/j.injury.2010.09.040; Hulsdunker T, 2015, NEUROSCI LETT, V592, P1, DOI 10.1016/j.neulet.2015.02.049; Kiss RM, 2011, MED ENG PHYS, V33, P1160, DOI 10.1016/j.medengphy.2011.04.017; Kiss RM, 2010, J ELECTROMYOGR KINES, V20, P1052, DOI 10.1016/j.jelekin.2010.06.005; Kramer A, 2014, ARCH PHYS MED REHAB, V95, P1803, DOI 10.1016/j.apmr.2014.04.020; Latash M.L., 2008, NEUROPHYSIOLOGICAL B, V3rd ed.; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; MOORE SP, 1988, EXP BRAIN RES, V73, P648, DOI 10.1007/BF00406624; Muller MLTM, 2004, J BIOMECH, V37, P1573, DOI 10.1016/j.jbiomech.2004.01.004; Muller O, 2004, BIOMED TECH, V49, P56, DOI 10.1515/BMT.2004.011; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Nevill AM, 1997, BRIT J SPORT MED, V31, P314, DOI 10.1136/bjsm.31.4.314; Patel P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12247; Perry SD, 2000, BRAIN RES, V877, P401, DOI 10.1016/S0006-8993(00)02712-8; Pfusterschmied J, 2013, EUR J SPORT SCI, V13, P49, DOI 10.1080/17461391.2011.583991; SAMSON M, 1996, GAIT POSTURE, V4, P252; Santos MJ, 2010, J ELECTROMYOGR KINES, V20, P388, DOI 10.1016/j.jelekin.2009.06.006; Schlee G, 2009, CLIN NEUROPHYSIOL, V120, P1548, DOI 10.1016/j.clinph.2009.06.010; Schwab MJ, 2008, J CHIROPR MED, V7, P146, DOI 10.1016/j.jcm.2008.06.001; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Smith GV., 2000, J STROKE CEREBROVASC, V9, P238, DOI DOI 10.1053/JSCD.2000.16607; STELMACH GE, 1989, J GERONTOL, V44, pB100, DOI 10.1093/geronj/44.4.B100; Taube W, 2007, ACTA PHYSIOL, V189, P347, DOI 10.1111/j.1748-1716.2007.01665.x; Taube W, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00972; Traub R.E., 1991, EDUC MEAS-ISSUES PRA, V10, P37, DOI [10.1111/j.1745-3992.1991.tb00183.x, DOI 10.1111/J.1745-3992.1991.TB00183.X]; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Vincent J., 1994, STAT KINESIOLOGY; Vrieling AH, 2008, GAIT POSTURE, V28, P222, DOI 10.1016/j.gaitpost.2007.12.002; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	47	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136551	10.1371/journal.pone.0136551	http://dx.doi.org/10.1371/journal.pone.0136551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340753	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200010
J	Tanaka, T; Kitajima, Y; Miyake, S; Yanagihara, K; Hara, H; Nishijima-Matsunobu, A; Baba, K; Shida, M; Wakiyama, K; Nakamura, J; Noshiro, H				Tanaka, Tomokazu; Kitajima, Yoshihiko; Miyake, Shuusuke; Yanagihara, Kazuyoshi; Hara, Hiromitsu; Nishijima-Matsunobu, Aki; Baba, Koichi; Shida, Masaaki; Wakiyama, Kota; Nakamura, Jun; Noshiro, Hirokazu			The Apoptotic Effect of HIF-1 alpha Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; INDUCIBLE FACTOR-1; PLASMA-MEMBRANE; EXPRESSION; HIF-1; GROWTH; GENE; INDUCTION; TRANSLOCATION; DEHYDROGENASE	Gastric cancer grows under a hypoxic environment. HIF-1 alpha is known to play an important role in controlling the production of reactive oxygen species (ROS) in the mitochondria under hypoxic conditions. We previously established HIF-1 alpha knockdown (KD) cells and control (SC) cells in the 58As9 gastric cancer cell line. In this study, we revealed that KD cells, but not SC cells, induced apoptosis under conditions of hypoxia (1% O-2) due to excessive production of ROS. A quantitative RT-PCR analysis demonstrated that the expressions of ten genes, which are involved in the control mechanisms of ROS (including the Warburg effect, mitophagy, electron transport chain [ETC] modification and ROS scavenging), were regulated by HIF-1 alpha. Moreover, the promotion of glucose uptake by glucose plus insulin (GI) treatment enhanced the apoptotic effect, which was accompanied by further ROS production in hypoxic KD cells. A Western blot analysis showed that the membranous expression of GLUT1 in KD cells was elevated by glucose and/or insulin treatments, indicating that the GI-induced glucose uptake is mediated by the increased translocation of GLUT1 on the cell membrane. Finally, the anti-tumor effect of HIF-1 alpha knockdown (KD) plus GI was evaluated using a tumor xenograft model, where a hypoxic environment naturally exists. As a result, the GI treatment strongly inhibited the growth of the KD tumors whereby cell apoptosis was highly induced in comparison to the control treatment. In contrast, the growth of the SC tumors expressing HIF-1 alpha was not affected by the GI treatment. Taken together, the results suggest that HIF-1 alpha inhibition plus GI may be an ideal therapy, because the apoptosis due to the destruction of ROS homeostasis is specifically induced in gastric cancer that grows under a hypoxic environment, but not in the normal tissue under the aerobic conditions.	[Tanaka, Tomokazu; Kitajima, Yoshihiko; Miyake, Shuusuke; Baba, Koichi; Shida, Masaaki; Wakiyama, Kota; Nakamura, Jun; Noshiro, Hirokazu] Saga Univ, Fac Med, Dept Surg, Saga 840, Japan; [Kitajima, Yoshihiko] NHO Higashisaga Hosp, Dept Surg, Miyaki Town, Saga, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; [Hara, Hiromitsu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Immunol, Kagoshima 890, Japan; [Nishijima-Matsunobu, Aki] Akita Univ, Grad Sch Med, Dept Mol & Tumor Pathol, Hondo, Akita, Japan	Saga University; National Cancer Center - Japan; Kagoshima University; Akita University	Kitajima, Y (corresponding author), Saga Univ, Fac Med, Dept Surg, Saga 840, Japan.	kitajiy@hosp.go.jp	Nakamura, Jun/AAT-3274-2021	MIYAKE, SHUUSUKE/0000-0002-3148-2087; Nakamura, Jun/0000-0002-3167-3908				Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Burroughs SK, 2013, FUTURE MED CHEM, V5, P553, DOI [10.4155/fmc.13.17, 10.4155/FMC.13.17]; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Comerford KM, 2002, CANCER RES, V62, P3387; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Hara S, 2006, ORAL ONCOL, V42, P593, DOI 10.1016/j.oraloncology.2005.10.016; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HAUSDORFF SF, 1995, J BIOL CHEM, V270, P12965, DOI 10.1074/jbc.270.22.12965; Hayashi M, 2004, J ENDOCRINOL, V183, P145, DOI 10.1677/joe.1.05599; Ide T, 2006, INT J CANCER, V119, P2750, DOI 10.1002/ijc.22178; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jean JC, 2006, AM J PHYSIOL-LUNG C, V291, pL950, DOI 10.1152/ajplung.00087.2006; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kitajima Yoshihiko, 2013, Cancers (Basel), V5, P15, DOI 10.3390/cancers5010015; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Micucci C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105550; Miyake S, 2013, INT J ONCOL, V43, P1431, DOI 10.3892/ijo.2013.2068; Nagle DG, 2006, CURR DRUG TARGETS, V7, P355, DOI 10.2174/138945006776054979; Nakamura J, 2010, INT J CANCER, V127, P1158, DOI 10.1002/ijc.25129; Ohman T, 1999, AM J RESP CELL MOL, V21, P119, DOI 10.1165/ajrcmb.21.1.3521; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Poellinger L, 2004, CURR OPIN GENET DEV, V14, P81, DOI 10.1016/j.gde.2003.12.006; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rohwer N, 2010, CANCER BIOL THER, V10, P383, DOI 10.4161/cbt.10.4.12850; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Stoeltzing O, 2004, JNCI-J NATL CANCER I, V96, P946, DOI 10.1093/jnci/djh168; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vander Heiden MG, 2009, J ENDOCRINOL, V324, P1029, DOI [10.1126/science.1160809, DOI 10.1126/SCIENCE.1160809]; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yang CM, 2001, J CLIN INVEST, V107, P1311, DOI 10.1172/JCI12274; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zou P, 2015, ONCOTARGET, V6, P5860, DOI 10.18632/oncotarget.3333	41	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137257	10.1371/journal.pone.0137257	http://dx.doi.org/10.1371/journal.pone.0137257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339797	gold, Green Submitted, Green Published			2022-12-27	WOS:000360688200041
J	Tardy, C; Goffinet, M; Boubekeur, N; Cholez, G; Ackermann, R; Sy, G; Keyserling, C; Lalwani, N; Paolini, JF; Dasseux, JL; Barbaras, R; Baron, R				Tardy, Claudine; Goffinet, Marine; Boubekeur, Nadia; Cholez, Guy; Ackermann, Rose; Sy, Gavin; Keyserling, Constance; Lalwani, Narendra; Paolini, John F.; Dasseux, Jean-Louis; Barbaras, Ronald; Baron, Rudi			HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE(-/-) Mice: Evidence of ABCA1 Down-Regulation	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; CASSETTE TRANSPORTER 1; TRANSINTESTINAL CHOLESTEROL EXCRETION; PRE-BETA; TANGIER-DISEASE; CAROTID-ARTERY; APOA-I; EFFLUX; RABBITS	Objective CER-001 is a novel engineered HDL-mimetic comprised of recombinant human apoA-I and charged phospholipids that was designed to mimic the beneficial properties of nascent pre-beta HDL. In this study, we have evaluated the dose-dependent regulation of ABCA1 expression in vitro and in vivo in the presence of CER-001 and native HDL (HDL3). Methods and Results CER-001 induced cholesterol efflux from J774 macrophages in a dose-dependent manner similar to natural HDL. A strong down-regulation of the ATP-binding cassette A1 (ABCA1) transporter mRNA (-50%) as well as the ABCA1 membrane protein expression (-50%) was observed at higher doses of CER-001 and HDL3 compared to non-lipidated apoA-I. In vivo, in an apoE(-/-) mouse "flow cessation model," in which the left carotid artery was ligatured to induce local inflammation, the inhibition of atherosclerotic plaque burden progression in response to a dose-range of every-other-day CER-001 or HDL in the presence of a high-fat diet for two weeks was assessed. We observed a U-shaped dose-response curve: inhibition of the plaque total cholesterol content increased with increasing doses of CER-001 or HDL3 up to a maximum inhibition (-51%) at 5 mg/kg; however, as the dose was increased above this threshold, a progressively less pronounced inhibition of progression was observed, reaching a complete absence of inhibition of progression at doses of 20 mg/kg and over. ABCA1 protein expression in the same atherosclerotic plaque was decreased by-45% and-68% at 50 mg/kg for CER-001 and HDL respectively. Conversely, a-12% and 0% decrease in ABCA1 protein expression was observed at the 5 mg/kg dose for CER-001 and HDL respectively. Conclusions These data demonstrate that high doses of HDL and CER-001 are less effective at slowing progression of atherosclerotic plaque in apoE(-/-) mice compared to lower doses, following a U-shaped dose-response curve. A potential mechanism for this phenomenon is supported by the observation that high doses of HDL and CER-001 induce a rapid and strong down-regulation of ABCA1 both in vitro and in vivo. In conclusion, maximally efficient HDL- or CER-001-mediated cholesterol removal from atherosclerotic plaque is achieved by maximizing macrophage-mediated efflux from the plaque while minimizing dose-dependent down-regulation of ABCA1 expression. These observations may help define the optimal dose of HDL mimetics for testing in clinical trials of atherosclerotic burden regression.	[Tardy, Claudine; Goffinet, Marine; Boubekeur, Nadia; Cholez, Guy; Keyserling, Constance; Paolini, John F.; Dasseux, Jean-Louis; Barbaras, Ronald; Baron, Rudi] Cerenis Therapeut SA, Labege, France; [Ackermann, Rose; Sy, Gavin; Lalwani, Narendra] Cerenis Therapeut Inc, Ann Arbor, MI USA		Barbaras, R (corresponding author), Cerenis Therapeut SA, Labege, France.	barbaras@cerenis.com	Tardy, Claudine/AAE-5026-2019; Tardy, Claudine/G-2737-2017	Tardy, Claudine/0000-0002-5292-0672; 	Cerenis Therapeutics	Cerenis Therapeutics	Cerenis Therapeutics provided support in the form of salaries for authors (All), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AMELI S, 1994, CIRCULATION, V90, P1935, DOI 10.1161/01.CIR.90.4.1935; Attie AD, 2001, J LIPID RES, V42, P1717; BADIMON JJ, 1989, LAB INVEST, V60, P455; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; BARBARAS R, 1986, BIOCHIM BIOPHYS ACTA, V888, P143, DOI 10.1016/0167-4889(86)90015-7; Bleck G. T., 2006, BIOPROCESS J, V5, P36; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BOTHAM KM, 1995, PROG LIPID RES, V34, P71, DOI 10.1016/0163-7827(94)00007-9; BRAVO E, 1994, BBA-LIPID LIPID MET, V1215, P93, DOI 10.1016/0005-2760(94)90096-5; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brown WV, 2010, J CLIN LIPIDOL, V4, P5, DOI 10.1016/j.jacl.2009.12.005; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Duverger N, 1996, CIRCULATION, V94, P713, DOI 10.1161/01.CIR.94.4.713; Frikke-Schmidt R, 2004, J CLIN INVEST, V114, P1343, DOI 10.1172/JCI200420361; Godin D, 2000, CIRCULATION, V102, P2861; ISHIDA BY, 1987, J LIPID RES, V28, P778; Ivan E, 2002, CIRCULATION, V105, P2686, DOI 10.1161/01.CIR.0000016825.17448.11; Jaspard B, 1996, BIOCHEMISTRY-US, V35, P1352, DOI 10.1021/bi950938i; Joyce C, 2003, ARTERIOSCL THROM VAS, V23, P965, DOI 10.1161/01.ATV.0000055194.85073.FF; Kootte RS, 2014, EFFECT OF INFUSION O; Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429; Kuo MS, 2008, J LIPID RES, V49, P1353, DOI 10.1194/jlr.D700037-JLR200; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; Le May C, 2013, ARTERIOSCL THROM VAS, V33, P1484, DOI 10.1161/ATVBAHA.112.300263; Lee JMS, 2010, EXPERT REV CARDIOVAS, V8, P1325, DOI 10.1586/ERC.10.108; Lessner SM, 2004, ARTERIOSCL THROM VAS, V24, P2123, DOI 10.1161/01.ATV.0000141840.27300.fd; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; O'Connor PM, 1998, J LIPID RES, V39, P670; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Sakr SW, 1999, BBA-MOL CELL BIOL L, V1438, P85, DOI 10.1016/S1388-1981(99)00041-4; Schaefer EJ, 2014, CURR OPIN LIPIDOL, V25, P194, DOI 10.1097/MOL.0000000000000074; SCHWARTZ CC, 1978, SCIENCE, V200, P62, DOI 10.1126/science.204996; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Soderlund S, 2005, J LIPID RES, V46, P1643, DOI 10.1194/jlr.M400480-JLR200; SOMA MR, 1995, CIRC RES, V76, P405, DOI 10.1161/01.RES.76.3.405; Tardif JC, 2014, EUR HEART J, V35, P3277, DOI 10.1093/eurheartj/ehu171; Tarling EJ, 2013, CURR OPIN LIPIDOL, V24, P138, DOI 10.1097/MOL.0b013e32835da122; Tietge UJF, 2013, ARTERIOSCL THROM VAS, V33, P1452, DOI 10.1161/ATVBAHA.113.301562; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang SP, 2013, J LIPID RES, V54, P2858, DOI 10.1194/jlr.M041541; Watanabe H, 2006, ARTERIOSCL THROM VAS, V26, P897, DOI 10.1161/01.ATV.0000209577.04246.c0	44	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137584	10.1371/journal.pone.0137584	http://dx.doi.org/10.1371/journal.pone.0137584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335690	gold, Green Published, Green Submitted			2022-12-27	WOS:000360615400069
J	Barratt, DT; Klepstad, P; Dale, O; Kaasa, S; Somogyi, AA				Barratt, Daniel T.; Klepstad, Pal; Dale, Ola; Kaasa, Stein; Somogyi, Andrew A.			Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl	PLOS ONE			English	Article							MINI-MENTAL-STATE; PRIMARY-CARE; ASSOCIATION; PHARMACOKINETICS; MECHANISM; DEMENTIA; SURGERY; QUALITY; OPIOIDS; MYD88	Common adverse symptoms of cancer and chemotherapy are a major health burden; chief among these is pain, with opioids including transdermal fentanyl the mainstay of treatment. Innate immune activation has been implicated generally in pain, opioid analgesia, cognitive dysfunction, and sickness type symptoms reported by cancer patients. We aimed to determine if genetic polymorphisms in neuroimmune activation pathways alter the serum fentanyl concentration-response relationships for pain control, cognitive dysfunction, and other adverse symptoms, in cancer pain patients. Cancer pain patients (468) receiving transdermal fentanyl were genotyped for 31 single nucleotide polymorphisms in 19 genes: CASP1, BDNF, CRP, LY96, IL6, IL1B, TGFB1, TNF, IL10, IL2, TLR2, TLR4, MYD88, IL6R, OPRM1, ARRB2, COMT, STAT6 and ABCB1. Lasso and backward stepwise generalised linear regression were used to identify non-genetic and genetic predictors, respectively, of pain control (average Brief Pain Inventory < 4), cognitive dysfunction (Mini-Mental State Examination <= 23), sickness response and opioid adverse event complaint. Serum fentanyl concentrations did not predict between-patient variability in these outcomes, nor did genetic factors predict pain control, sickness response or opioid adverse event complaint. Carriers of the MYD88 rs6853 variant were half as likely to have cognitive dysfunction (11/111) than wild-type patients (69/325), with a relative risk of 0.45 (95% CI: 0.27 to 0.76) when accounting for major non-genetic predictors (age, Karnofsky functional score). This supports the involvement of innate immune signalling in cognitive dysfunction, and identifies MyD88 signalling pathways as a potential focus for predicting and reducing the burden of cognitive dysfunction in cancer pain patients.	[Barratt, Daniel T.; Somogyi, Andrew A.] Univ Adelaide, Sch Med, Discipline Pharmacol, Adelaide, SA, Australia; [Klepstad, Pal] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Klepstad, Pal; Dale, Ola] St Olavs Univ Hosp, Dept Anaesthesiol & Intens Care Med, Trondheim, Norway; [Dale, Ola; Kaasa, Stein] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, European Palliat Care Res Ctr, N-7034 Trondheim, Norway; [Somogyi, Andrew A.] Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia; [Barratt, Daniel T.; Somogyi, Andrew A.] Univ Adelaide, Ctr Personalised Canc Med, Adelaide, SA, Australia	University of Adelaide; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Royal Adelaide Hospital; University of Adelaide	Barratt, DT (corresponding author), Univ Adelaide, Sch Med, Discipline Pharmacol, Adelaide, SA, Australia.	daniel.barratt@adelaide.edu.au		Barratt, Daniel/0000-0001-6261-353X	Norwegian Research Council; European Union [037777]; National Health and Medical Research Council of Australia [1011521]; EPOS study	Norwegian Research Council(Research Council of NorwayEuropean Commission); European Union(European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); EPOS study	The Norwegian Research Council and the European Union's 6th framework (Contract No. 037777; http://www.forskningsradet.no/en/Home_page/1177315753906; PK OD SK) and the National Health and Medical Research Council of Australia (Project Grant 1011521; https://www.nhmrc.gov.au/; AAS) financially supported the EPOS study.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Barratt DT, 2014, PHARMACOGENET GENOM, V24, P185, DOI 10.1097/FPC.0000000000000032; Capparelli R, 2013, GENES IMMUN, V14, P504, DOI 10.1038/gene.2013.48; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cleeland CS, 2000, SEMIN RADIAT ONCOL, V10, P175, DOI 10.1053/srao.2000.6590; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Deguine Jacques, 2014, F1000Prime Rep, V6, P97, DOI 10.12703/P6-97; Dhiman N, 2008, VACCINE, V26, P1731, DOI 10.1016/j.vaccine.2008.01.017; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Fayers PM, 2005, J PAIN SYMPTOM MANAG, V30, P41, DOI 10.1016/j.jpainsymman.2005.05.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galvan A, 2012, PHARMACOGENOMICS J, V12, P412, DOI 10.1038/tpj.2011.27; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Gunma University Hospital Department of Anesthesiology, PREV EFF MIN POST CO; Hutchinson MR, 2011, PHARMACOL REV, V63, P772, DOI 10.1124/pr.110.004135; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Iracleous P, 2010, INT J GERIATR PSYCH, V25, P23, DOI 10.1002/gps.2293; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Ji RR, 2014, NAT REV DRUG DISCOV, V13, P533, DOI 10.1038/nrd4334; KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; Klepstad P, 2005, PALLIATIVE MED, V19, P477, DOI 10.1191/0269216305pm1054oa; Klepstad P, 2011, PAIN, V152, P1139, DOI 10.1016/j.pain.2011.01.040; Klepstad P, 2003, PALLIATIVE MED, V17, P679, DOI 10.1191/0269216303pm835oa; Kurita GP, 2011, J CLIN ONCOL, V29, P1297, DOI 10.1200/JCO.2010.32.6884; Lee BN, 2004, NEUROIMMUNOMODULAT, V11, P279, DOI 10.1159/000079408; Lonie JA, 2009, INT J GERIATR PSYCH, V24, P902, DOI 10.1002/gps.2208; Lu SM, 2015, BRAIN BEHAV IMMUN, V44, P221, DOI 10.1016/j.bbi.2014.10.011; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Milne A, 2008, INT PSYCHOGERIATR, V20, P911, DOI 10.1017/S1041610208007394; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Moksnes K, 2008, EUR J CLIN PHARMACOL, V64, P497, DOI 10.1007/s00228-007-0444-8; Mulholland CV, 2014, J MOL NEUROSCI, V52, P497, DOI 10.1007/s12031-013-0201-7; Mystakidou K, 2007, PSYCHO-ONCOLOGY, V16, P352, DOI 10.1002/pon.1090; R Core Team, 2021, R LANGUAGE ENV STAT; Ripamonti CI, 2012, ANN ONCOL, V23, P294, DOI 10.1093/annonc/mds360; Shulman KI, 2006, INT PSYCHOGERIATR, V18, P281, DOI 10.1017/S1041610205002693; Skaer TL, 2014, J PAIN RES, V7, P495, DOI 10.2147/JPR.S36446; Somogyi AA, 2007, CLIN PHARMACOL THER, V81, P429, DOI 10.1038/sj.clpt.6100095; Stevens CW, 2013, BRIT J PHARMACOL, V168, P1421, DOI 10.1111/bph.12028; Tassinari D, 2011, PALLIATIVE MED, V25, P478, DOI 10.1177/0269216311404274; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Venables WN., 2002, MODERN APPL STAT S 4; Wang Y, 2013, MOL MED REP, V7, P1137, DOI 10.3892/mmr.2013.1322; WHO, 2013, WHOS PAIN LADD AD	46	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137179	10.1371/journal.pone.0137179	http://dx.doi.org/10.1371/journal.pone.0137179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332828	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800105
J	Pollegioni, P; Woeste, KE; Chiocchini, F; Del Lungo, S; Olimpieri, I; Tortolano, V; Clark, J; Hemery, GE; Mapelli, S; Malvolti, ME				Pollegioni, Paola; Woeste, Keith E.; Chiocchini, Francesca; Del Lungo, Stefano; Olimpieri, Irene; Tortolano, Virginia; Clark, Jo; Hemery, Gabriel E.; Mapelli, Sergio; Malvolti, Maria Emilia			Ancient Humans Influenced the Current Spatial Genetic Structure of Common Walnut Populations in Asia	PLOS ONE			English	Article							JUGLANS-REGIA L.; MULTIPLE-REGRESSION; CROP DOMESTICATION; DIVERSITY; HISTORY; TECHNOLOGY; SOFTWARE; PATTERNS; CAUCASUS; DISTANCE	Common walnut (Juglans regia L) is an economically important species cultivated worldwide for its wood and nuts. It is generally accepted that J. regia survived and grew spontaneously in almost completely isolated stands in its Asian native range after the Last Glacial Maximum. Despite its natural geographic isolation, J. regia evolved over many centuries under the influence of human management and exploitation. We evaluated the hypothesis that the current distribution of natural genetic resources of common walnut in Asia is, at least in part, the product of ancient anthropogenic dispersal, human cultural interactions, and afforestation. Genetic analysis combined with ethno-linguistic and historical data indicated that ancient trade routes such as the Persian Royal Road and Silk Road enabled long-distance dispersal of J. regia from Iran and Trans-Caucasus to Central Asia, and from Western to Eastern China. Ancient commerce also disrupted the local spatial genetic structure of autochthonous walnut populations between Tashkent and Samarkand (Central-Eastern Uzbekistan), where the northern and central routes of the Northern Silk Road converged. A significant association between ancient language phyla and the genetic structure of walnut populations is reported even after adjustment for geographic distances that could have affected both walnut gene flow and human commerce over the centuries. Beyond the economic importance of common walnut, our study delineates an alternative approach for understanding how the genetic resources of long-lived perennial tree species may be affected by the interaction of geography and human history.	[Pollegioni, Paola; Chiocchini, Francesca; Olimpieri, Irene; Tortolano, Virginia; Malvolti, Maria Emilia] CNR, Inst Agroenvironm & Forest Biol, Porano, Terni, Italy; [Woeste, Keith E.] Purdue Univ, Dept Forestry & Nat Resources, US Forest Serv, USDA,Hardwood Tree Improvement & Regenerat Ctr, W Lafayette, IN 47907 USA; [Del Lungo, Stefano] CNR, Inst Archaeol & Monumental Heritage, Potenza, Italy; [Clark, Jo] Earth Trust, Abingdon, Oxon, England; [Hemery, Gabriel E.] Sylva Fdn, Little Wittenham, Oxon, England; [Mapelli, Sergio] CNR, Inst Agr Biol & Biotechnol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); United States Forest Service; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR)	Pollegioni, P (corresponding author), CNR, Inst Agroenvironm & Forest Biol, Porano, Terni, Italy.	paola.pollegioni@ibaf.cnr.it	Del+Lungo, Stefano/AAK-9915-2021; Hemery, Gabriel/AAX-9424-2020	Hemery, Gabriel/0000-0002-0839-9293; Chiocchini, Francesca/0000-0002-5122-8756; DEL LUNGO, Stefano/0000-0001-7326-462X	European Community in the framework of the Seventh Framework Programme under the Marie Curie Actions COFUND project "I-MOVE" [267232, 206405]	European Community in the framework of the Seventh Framework Programme under the Marie Curie Actions COFUND project "I-MOVE"	This study was supported by the European Community in the framework of the Seventh Framework Programme under the Marie Curie Actions COFUND project "I-MOVE" (N. 267232) Grant number 206405.	Aradhya MK, 2005, DARWINS HARVEST ORIG, P143; Ashuri Y., 2006, MINORITY LANGUAGES C, V1, P12; Aubaile F., 2012, REV ETHNOECOLOGIE, V1, P1; Beer R, 2008, QUATERNARY SCI REV, V27, P621, DOI 10.1016/j.quascirev.2007.11.012; Belle EMS, 2007, AM J PHYS ANTHROPOL, V133, P1137, DOI 10.1002/ajpa.20622; Bocharnikov V, 2012, WORLD FORESTS, V12, P251, DOI 10.1007/978-94-007-2144-9_7; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bucci G, 2007, MOL ECOL, V16, P2137, DOI 10.1111/j.1365-294X.2007.03275.x; CARRION JS, 1992, J BIOGEOGR, V19, P623, DOI 10.2307/2845705; Christian D, 2000, J WORLD HIST, V11, P1, DOI 10.1353/jwh.2000.0004; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Dehghan B., 2009, Journal of Applied Horticulture (Lucknow), V11, P56; DI COSMO N., 1999, CAMBRIDGE HIST ANCIE, P885, DOI DOI 10.1017/CHOL9780521470308.015; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Djamali M., PALEORIENT, V36, P175, DOI [DOI 10.3406/PALEO.2010.5394, 10.3406/paleo.2010.5394]; Dwyer AM, 2007, PHONOLOGY 1, V37, P1; Dwyer AM, 2005, POL STUD, V15, P1; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Francis G, 2006, STANFORD PROGRAM INT; French David, 1998, IRAN, V36, P15; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2010, WORLD ARCHAEOL, V42, P13, DOI 10.1080/00438240903429680; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Gunn BF, 2010, AM J BOT, V97, P660, DOI 10.3732/ajb.0900114; Gupta AK, 2004, CURR SCI INDIA, V87, P54; Hasandust M, 2000, NAMEYE FARHANGESTAN, V4, P135; Hemery GE, 2005, FORESTRY, V78, P121, DOI 10.1093/forestry/cpi012; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Janick J, 2003, ACTA HORTIC, P19, DOI 10.17660/ActaHortic.2003.620.1; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Khanazarov A. A., 2003, Schweizerische Zeitschrift fur Forstwesen, V154, P226, DOI 10.3188/szf.2003.0226; Laufer B., 1919, MUS NAT HIST PUBL201, V15, P185; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Maffi L, 2005, ANNU REV ANTHROPOL, V34, P599, DOI 10.1146/annurev.anthro.34.081804.120437; Mani BR, 2008, PRAGDHARA, V18, P229; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; Marston JM, 2009, J ARCHAEOL SCI, V36, P2192, DOI 10.1016/j.jas.2009.06.002; McGranahan G., 1991, ACTA HORTIC, V290, P907, DOI [10.17660/ActaHortic.1991.290.20, DOI 10.17660/ACTAHORTIC.1991.290.20]; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; Molnar TJ, 2011, ANN REP N NUT GROW A, V101, P56; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Pollegioni P, 2014, TREE GENET GENOMES, V10, P1027, DOI 10.1007/s11295-014-0740-2; Pritchard JK, 2000, GENETICS, V155, P945; Rong- Ting X, 1990, ACTA HORTIC, V284, P353; Ruhlen M., 1991, GUIDE WORLDS LANGUAG, V1; Sims-Williams Nicholas, 1996, CINA IRAN ALESSANDRO, P45; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Turnbull JW, 2009, ENCY LIFE SUPPORT SY, VII, P48; Vahdati K, 2014, ACTA HORTIC, V1032, P19; Warnock P, 1991, ANATOLIAN STUDIES, V41, P107, DOI DOI 10.2307/3642933; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westengen OT, 2014, P NATL ACAD SCI USA, V111, P14100, DOI 10.1073/pnas.1401646111; Wiesehofer Josef., 2001, ANCIENT PERSIA 550 B; Wilkinson KN, 2012, J FIELD ARCHAEOL, V37, P20, DOI 10.1179/0093469011Z.0000000002; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101; Zohary D., 2000, DOMESTICATION PLANTS, DOI 10.1006/anbo.2001.1505	62	33	36	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135980	10.1371/journal.pone.0135980	http://dx.doi.org/10.1371/journal.pone.0135980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CQ4ZT	26332919	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800046
J	Roth, M; Zhao, F; Zhong, J; Lardinois, D; Tamm, M				Roth, Michael; Zhao, Feng; Zhong, Jun; Lardinois, Didier; Tamm, Michael			Serum IgE Induced Airway Smooth Muscle Cell Remodeling Is Independent of Allergens and Is Prevented by Omalizumab	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEINS; ASTHMA; PROLIFERATION; EXPRESSION	Background Airway wall remodeling in allergic asthma is reduced after treatment with humanized anti-IgE-antibodies. We reported earlier that purified IgE, without the presence of allergens, is sufficient to induce airway wall remodeling due to airway smooth muscle cell (ASMC) activity deposing extracellular matrix. Objective We postulate that IgE contained in serum of allergic asthma patients, in the absence of allergens, stimulates ASMC remodeling activities and can be prevented by anti-IgE antibodies. Methods Isolated human ASMC were exposed to serum obtained from: (i) healthy controls, or patients with (ii) allergic asthma, (iii) non-allergic asthma, and (iv) atopic non-asthma patients. Proliferation and the deposition of collagens and fibronectin were determined after 3 and 5 days. Results Serum from patients with allergies significantly stimulated: (i) ASMC proliferation, (ii) deposition of collagen type-I (48 hours) and (iii) of fibronectin (24 hours). One hour pre-incubation with Omalizumab prevented these three effects of allergic serum, but had no significant effect on serum from healthy donors or non-allergic asthma patients. Interestingly, the addition of allergens did not further increase any of the IgE effects. Conclusion and Clinical Relevance Our data provides experimental evidence that the beneficial effect of Omalizumab on airway wall remodeling and improved lung function may be due to its direct action on IgE bound ASMC.	[Roth, Michael; Zhao, Feng; Zhong, Jun] Univ Basel, Pulm Cell Res, Dept Biomed, Basel, Switzerland; [Roth, Michael; Tamm, Michael] Univ Basel Hosp, Dept Internal Med, Pneumol, CH-4031 Basel, Switzerland; [Zhao, Feng] 4th Mil Med Univ, Xijing Hosp, Dept Resp Dis, Xian, Peoples R China; [Lardinois, Didier] Univ Basel Hosp, Dept Thorac Surg, CH-4031 Basel, Switzerland	University of Basel; University of Basel; Air Force Military Medical University; University of Basel	Roth, M (corresponding author), Univ Basel, Pulm Cell Res, Dept Biomed, Basel, Switzerland.	michael.roth@usb.ch	Roth, Michael/H-8657-2019	Roth, Michael/0000-0002-8139-2821	Novartis Pharma Schweiz AG [CIGE025A]	Novartis Pharma Schweiz AG	MT received support from Novartis Pharma Schweiz AG, CIGE025A, an unrestricted research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2002, BIODRUGS, V16, P380; Baena-Cagnani CE, 2015, CURR OPIN ALLERGY CL; Barnes N, 2013, J ASTHMA, V50, P529, DOI 10.3109/02770903.2013.790419; Chan YC, 2014, J ALLERGY CLIN IMMUN, V134, P1394, DOI 10.1016/j.jaci.2014.06.029; Chang TW, 2007, ADV IMMUNOL, V93, P63, DOI 10.1016/S0065-2776(06)93002-8; Girodet PO, 2011, PHARMACOL THERAPEUT, V130, P325, DOI 10.1016/j.pharmthera.2011.02.001; Halayko AJ, 2003, RESP PHYSIOL NEUROBI, V137, P209, DOI 10.1016/S1569-9048(03)00148-4; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Hoshino M, 2012, RESPIRATION, V83, P520, DOI 10.1159/000334701; Humbert M, 2014, J ALLER CL IMM-PRACT, V2, P525, DOI 10.1016/j.jaip.2014.03.010; Jesudason EC, 2009, THORAX, V64, P541, DOI 10.1136/thx.2008.107094; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Lambers C, 2014, BIOCHEM PHARMACOL, V91, P400, DOI 10.1016/j.bcp.2014.07.026; Lambrecht BN, 2013, EUR J IMMUNOL, V43, P3125, DOI 10.1002/eji.201343730; Nam YH, 2012, J INVEST ALLERG CLIN, V22, P20; Ozgur ES, 2013, J ASTHMA, V50, P687, DOI 10.3109/02770903.2013.792348; Plopper CG, 2007, TOXICOL PATHOL, V35, P97, DOI 10.1080/01926230601132030; Prakash YS, 2013, AM J PHYSIOL-LUNG C, V305, pL912, DOI 10.1152/ajplung.00259.2013; Rabe KF, 2011, ALLERGY, V66, P1142, DOI 10.1111/j.1398-9995.2011.02617.x; Redhu NS, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-41; Redhu NS, 2013, PULM PHARMACOL THER, V26, P86, DOI 10.1016/j.pupt.2012.04.004; Riccio AM, 2012, INT J IMMUNOPATH PH, V25, P475, DOI 10.1177/039463201202500217; Roth M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056015; Roth M, 2010, ANN ALLERG ASTHMA IM, V104, P152, DOI 10.1016/j.anai.2009.11.022; Schieck M, 2014, J ALLERGY CLIN IMMUN, V133, P888, DOI 10.1016/j.jaci.2013.08.048; Schulman ES, 2001, AM J RESP CRIT CARE, V164, pS6, DOI 10.1164/ajrccm.164.supplement_1.2103025; Tajiri T, 2014, ANN ALLERG ASTHMA IM, V113, P470, DOI 10.1016/j.anai.2014.06.004; Ward JE, 2008, EUR RESPIR J, V32, P362, DOI 10.1183/09031936.00119307; Yamauchi Eri, 2008, Allergol Int, V57, P73, DOI 10.2332/allergolint.O-06-481	31	35	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136549	10.1371/journal.pone.0136549	http://dx.doi.org/10.1371/journal.pone.0136549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332463	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800061
J	Uehara, I				Uehara, Izumi			Developmental Changes in Memory-Related Linguistic Skills and Their Relationship to Episodic Recall in Children	PLOS ONE			English	Article							AGE-RELATED-CHANGES; LONG-TERM RECALL; AUTOBIOGRAPHICAL MEMORY; MEDICAL EMERGENCIES; CHILDHOOD AMNESIA; JAPANESE CHILDREN; RECOGNITION; ADOLESCENTS; REMEMBER; WORDS	This longitudinal study of nine children examined two issues concerning infantile amnesia: the time at which memories for events experienced before the age of 3-4 years disappear from consciousness and whether this timing of memory loss is related to the development of specific aspects of episodic and autobiographical memory. This study followed children from infancy to early childhood and examined the central role of three verbal-cognitive milestones related to autobiographical memory: the age at which children begin to report autobiographical memories using the past tense (Milestone 1); the age at which they begin to verbally acknowledge past events (Milestone 2); and the age at which they begin to spontaneously use memory-related verbs (Milestone 3). As expected, memories of events that occurred before 3-4 years of age were affected by infantile amnesia. Achievement of these milestones followed almost the same developmental progression: Milestone 1 (1 year; 10 months (1; 10) to 3 years; 4 months (3; 4)) was followed by Milestones 2 (3; 1 to 4; 0) and 3 (3; 5 to 4; 4). Milestone 2 was typically related to the onset of infantile amnesia, whereas Mile-stone 1 occurred during the period for which the children became amnesic as they aged. These data suggest that linguistic meta-cognitive awareness of personal memory is the key feature in infantile amnesia.	Ochanomizu Univ, Dept Psychol, Bunkyo Ku, Tokyo 112, Japan	Ochanomizu University	Uehara, I (corresponding author), Ochanomizu Univ, Dept Psychol, Bunkyo Ku, Tokyo 112, Japan.	uehara.izumi@ocha.ac.jp			MEXT [19730457]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by MEXT KAKENHI Grant Number 19730457. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer PJ, 2007, PSYCHOL SCI, V18, P910, DOI 10.1111/j.1467-9280.2007.01999.x; Bauer PJ, 2014, MEMORY, V22, P907, DOI 10.1080/09658211.2013.854806; Bauer PJ, 2014, J EXP PSYCHOL GEN, V143, P597, DOI 10.1037/a0033307; BAUER PJ, 1995, J EXP CHILD PSYCHOL, V59, P260, DOI 10.1006/jecp.1995.1012; Cherney ID, 2003, INFANT CHILD DEV, V12, P89, DOI 10.1002/icd.267; Cleveland ES, 2008, APPL COGNITIVE PSYCH, V22, P127, DOI 10.1002/acp.1359; Cleveland ES, 2005, DEV PSYCHOL, V41, P376, DOI 10.1037/0012-1649.41.2.376; Clubb PA, 1993, BIENN M SOC RES CHIL; Conway MA, 1997, J EXP PSYCHOL GEN, V126, P393, DOI 10.1037/0096-3445.126.4.393; EISENBERG AR, 1985, DISCOURSE PROCESS, V8, P177, DOI 10.1080/01638538509544613; FIVUSH R, 1987, COGNITIVE DEV, V2, P393, DOI 10.1016/S0885-2014(87)80015-1; Freud S., 1953, STANDARD EDITION COM, V6; Fujinaga T, 1992, HUMAN DEV RES, V8, P27; HAMOND NR, 1991, COGNITIVE DEV, V6, P433, DOI 10.1016/0885-2014(91)90048-I; Hayne H, 2004, J EXP CHILD PSYCHOL, V89, P127, DOI 10.1016/j.jecp.2004.06.002; Howe ML, 1997, PSYCHOL REV, V104, P499, DOI 10.1037/0033-295X.104.3.499; Iwata M, 1999, JAPANESE J DEV PSYCH, V10, P110; Jack F, 2009, CHILD DEV, V80, P496, DOI 10.1111/j.1467-8624.2009.01274.x; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Koyazu T, 1991, IMAGO, V7, P89; LYON TD, 1994, CHILD DEV, V65, P1357, DOI 10.2307/1131503; MINAMI M, 1996, 1 LANGUAGE, V0016; Morris G, 2007, CHILD DEV, V78, P448, DOI 10.1111/j.1467-8624.2007.01008.x; MULLEN MK, 1994, COGNITION, V52, P55, DOI 10.1016/0010-0277(94)90004-3; Naito M, 2006, INT J BEHAV DEV, V30, P290, DOI 10.1177/0165025406063622; Nelson K, 2003, MEMORY, V11, P125, DOI 10.1080/741938203; Nelson K, 2004, NARRATIVE ANAL STUDY, P87, DOI [10.4135/9781412985246, DOI 10.4135/9781412985246]; Nelson K., 1989, NARRATIVES CRIB; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; PERNER J, 1995, J EXP CHILD PSYCHOL, V59, P516, DOI 10.1006/jecp.1995.1024; Perner J, 2007, INFANT CHILD DEV, V16, P471, DOI 10.1002/icd.517; Peterson C, 2005, MEMORY, V13, P622, DOI 10.1080/09658210444000278; Peterson C, 2001, APPL COGNITIVE PSYCH, V15, pS7, DOI 10.1002/acp.832; Peterson C, 1999, DEV PSYCHOL, V35, P1493, DOI 10.1037/0012-1649.35.6.1493; Peterson C, 1998, DEV PSYCHOL, V34, P1059, DOI 10.1037/0012-1649.34.5.1059; Peterson C, 2007, APPL COGNITIVE PSYCH, V21, P1057, DOI 10.1002/acp.1314; Peterson C, 2011, CHILD DEV, V82, P1092, DOI 10.1111/j.1467-8624.2011.01597.x; PILLEMER DB, 1989, ADV CHILD DEV BEHAV, V21, P297, DOI 10.1016/S0065-2407(08)60291-8; Reese E, 2007, CHILD DEV, V78, P1153, DOI 10.1111/j.1467-8624.2007.01058.x; RoveeCollier C, 1997, PSYCHOL REV, V104, P467, DOI 10.1037/0033-295X.104.3.467; RUBIN DC, 1982, J VERB LEARN VERB BE, V21, P21, DOI 10.1016/S0022-5371(82)90423-6; Simcock G, 2003, DEV PSYCHOL, V39, P805, DOI 10.1037/0012-1649.39.5.805; Simcock G, 2002, PSYCHOL SCI, V13, P225, DOI 10.1111/1467-9280.00442; Solter A, 2008, INFANT CHILD DEV, V17, P593, DOI 10.1002/icd.570; Sonoda N, 1996, JAPANESE J DEV PSYCH, V7, P159; Tager-Flusberg H, 1989, DEV LANGUAGE, P135; Toyama K, 2007, JPN J EDUC PSYCHOL, V55, P359, DOI 10.5926/jjep1953.55.3_359; Tustin K, 2010, DEV PSYCHOL, V46, P1049, DOI 10.1037/a0020105; Uehara I, 1999, PERCEPT MOTOR SKILL, V89, P1029, DOI 10.2466/PMS.89.7.1029-1035; Uehara I, 1998, JPN J EDUC PSYCHOL, V46, P271, DOI 10.5926/jjep1953.46.3_271; Uehara I, 2000, PSYCHOL REP, V87, P837, DOI 10.2466/pr0.2000.87.3.837; Uehara I., 2014, OCHANOMIZU U STUDIES, V10, P111; Uehara I., 2004, B FACULTY HUMAN STUD, V1, P1; Van Abbema DL, 2005, MEMORY, V13, P829, DOI 10.1080/09658210444000430; Wang Q, 2006, CHILD DEV, V77, P1794, DOI 10.1111/j.1467-8624.2006.00974.x; Weist RM, 2008, LANG LEARN DEV, V4, P291, DOI 10.1080/15475440802293490; Wetzler S. E., 1986, AUTOBIOGRAPHICAL MEM, P191, DOI [DOI 10.1017/CBO9780511558313.017, 10.1017/CBO9780511558313.017]	57	4	4	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137220	10.1371/journal.pone.0137220	http://dx.doi.org/10.1371/journal.pone.0137220			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331479	gold, Green Submitted, Green Published			2022-12-27	WOS:000360613800111
J	Yu, ZC; Tang, BL; Zhao, DL; Pang, XH; Qin, QL; Zhou, BC; Zhang, XY; Chen, XL; Zhang, YZ				Yu, Zi-Chao; Tang, Bai-Lu; Zhao, Dian-Li; Pang, Xiuhua; Qin, Qi-Long; Zhou, Bai-Cheng; Zhang, Xi-Ying; Chen, Xiu-Lan; Zhang, Yu-Zhong			Development of a Cold-Adapted Pseudoalteromonas Expression System for the Pseudoalteromonas Proteins Intractable for the Escherichia coli System	PLOS ONE			English	Article							SP SM9913; HALOPLANKTIS TAC-125; EFFICIENT PRODUCTION; ECOLOGICAL ROLES; GENETIC SYSTEM; STRATEGIES; VECTOR; STRAIN; EXOPOLYSACCHARIDE; CHAPERONINS	Although the Escherichia coli expression system is the most commonly used expression system, some proteins are still difficult to be expressed by this system, such as proteins with high thermolability and enzymes that cannot mature by autoprocessing. Therefore, it is necessary to develop alternative expression systems. In this study, a cold-adapted Pseudoalteromonas expression system was developed. A shuttle vector was constructed, and a conjugational transfer system between E. coli and psychrophilic strain Pseudoalteromonas sp. SM20429 was established. Based on the shuttle vector, three reporter vectors were constructed to compare the strength of the cloned promoters at low temperature. The promoter of xylanase gene from Pseudoalteromonas sp. BSi20429 was chosen due to its high activity at 10-15 degrees C. An expression vector pEV containing the chosen promoter, multiple cloning sites and a His tag was constructed for protein expression and purification. With pEV as expression vector and SM20429 as the host, a cold-adapted protease, pseudoalterin, which cannot be maturely expressed in E. coli, was successfully expressed as an active extracellular enzyme when induced by 2% oat spelt xylan at 15 degrees C for 48 h. Recombinant pseudoalterin purified from the culture by Ni affinity chromatography had identical N-terminal sequence, similar molecular mass and substrate specificity as the native pseudoalterin. In addition, another two cold-adapted enzymes were also successfully expressed by this system. Our results indicate that this cold-adapted Pseudoalteromonas expression system will provide an alternative choice for protein expression, especially for the Pseudoalteromonas proteins intractable for the E. coli system.	[Yu, Zi-Chao; Tang, Bai-Lu; Zhao, Dian-Li; Pang, Xiuhua; Qin, Qi-Long; Zhang, Xi-Ying; Chen, Xiu-Lan; Zhang, Yu-Zhong] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Yu, Zi-Chao; Tang, Bai-Lu; Zhao, Dian-Li; Qin, Qi-Long; Zhou, Bai-Cheng; Zhang, Xi-Ying; Chen, Xiu-Lan; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Chen, XL (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	cxl0423@sdu.edu.cn			National Natural Science Foundation of China [31290230, 31290231, 91228210, 41176130, 41106161]; Hi-Tech Research and Development Program of China [2012AA092105, 2012AA092103]; China Ocean Mineral Resources R & D Association (COMRA) Special Foundation [DY125-15- T-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Ocean Mineral Resources R & D Association (COMRA) Special Foundation	The work was supported by the National Natural Science Foundation of China (grants 31290230, 31290231, 91228210, 41176130 and 41106161), the Hi-Tech Research and Development Program of China (2012AA092105, 2012AA092103), the China Ocean Mineral Resources R & D Association (COMRA) Special Foundation (DY125-15- T-05). Independent Innovation Foundation of Shandong University (2012GN019, 2012ZD028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman JP, 2007, MAR DRUGS, V5, P220, DOI 10.3390/md20070017; Chen XL, 2003, MAR BIOL, V143, P989, DOI 10.1007/s00227-003-1128-2; Cui ZS, 2008, ENVIRON MICROBIOL, V10, P2138, DOI 10.1111/j.1462-2920.2008.01637.x; Cusano AM, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-40; Dlugolecka A, 2008, PROTEIN EXPRES PURIF, V62, P179, DOI 10.1016/j.pep.2008.07.006; Ferrer M, 2004, MOL MICROBIOL, V53, P167, DOI 10.1111/j.1365-2958.2004.04077.x; Ferrer M, 2004, APPL ENVIRON MICROB, V70, P4499, DOI 10.1128/AEM.70.8.4499-4504.2004; Ferrer M, 2003, NAT BIOTECHNOL, V21, P1266, DOI 10.1038/nbt1103-1266; GELLISSEN G, 2005, PRODUCTION RECOMBINA; Georgiou G, 1996, CURR OPIN BIOTECH, V7, P190, DOI 10.1016/S0958-1669(96)80012-7; Gouka RJ, 1997, APPL MICROBIOL BIOT, V47, P1, DOI 10.1007/s002530050880; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Hoyoux A, 2001, APPL ENVIRON MICROB, V67, P1529, DOI 10.1128/AEM.67.4.1529-1535.2001; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KAWAMURA T, 1979, J BIOL CHEM, V254, P8457; Khow Orawan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P159, DOI 10.1016/S2221-1691(11)60213-X; KOPETZKI E, 1989, MOL GEN GENET, V216, P149, DOI 10.1007/BF00332244; Kruger Nicholas J., 1996, P15, DOI 10.1007/978-1-60327-259-9_4; Liu SB, 2013, APPL ENVIRON MICROB, V79, P224, DOI 10.1128/AEM.01801-12; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Madonna S, 2006, EXTREMOPHILES, V10, P41, DOI 10.1007/s00792-005-0470-3; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Papa R, 2007, J BIOTECHNOL, V127, P199, DOI 10.1016/j.jbiotec.2006.07.003; Qin GK, 2007, MICROBIOL-SGM, V153, P1566, DOI 10.1099/mic.0.2006/003327-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; Tanner ME, 2002, ACCOUNTS CHEM RES, V35, P237, DOI 10.1021/ar000056y; Wood T.M., 1988, METHOD ENZYMOL, P160; Wu JW, 2011, APPL MICROBIOL BIOT, V92, P253, DOI 10.1007/s00253-011-3532-8; Yu ZC, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-13; Zhao DL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-30; Zhao HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405076; Zhou MY, 2009, MICROB ECOL, V58, P582, DOI 10.1007/s00248-009-9506-z	36	8	8	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137384	10.1371/journal.pone.0137384	http://dx.doi.org/10.1371/journal.pone.0137384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333173	gold, Green Submitted, Green Published			2022-12-27	WOS:000360613800129
J	Calkins, TL; Piermarini, PM				Calkins, Travis L.; Piermarini, Peter M.			Pharmacological and Genetic Evidence for Gap Junctions as Potential New Insecticide Targets in the Yellow Fever Mosquito, Aedes aegypti	PLOS ONE			English	Article							RENAL TUBULES; ANOPHELES-GAMBIAE; CHANNELS; CELLS; COMMUNICATION; PERMEABILITY; EXPRESSION; INNEXINS; SEIZURES	The yellow fever mosquito Aedes aegypti is an important vector of viral diseases that impact global health. Insecticides are typically used to manage mosquito populations, but the evolution of insecticide resistance is limiting their effectiveness. Thus, identifying new molecular and physiological targets in mosquitoes is needed to facilitate insecticide discovery and development. Here we test the hypothesis that gap junctions are valid molecular and physiological targets for new insecticides. Gap junctions are intercellular channels that mediate direct communication between neighboring cells and consist of evolutionarily distinct proteins in vertebrate (connexins) and invertebrate (innexins) animals. We show that the injection of pharmacological inhibitors of gap junctions (i.e., carbenoxolone, meclofenamic acid, or mefloquine) into the hemolymph of adult female mosquitoes elicits dose-dependent toxic effects, with mefloquine showing the greatest potency. In contrast, when applied topically to the cuticle, carbenoxolone was the only inhibitor to exhibit full efficacy. In vivo urine excretion assays demonstrate that both carbenoxolone and mefloquine inhibit the diuretic output of adult female mosquitoes, suggesting inhibition of excretory functions as part of their mechanism of action. When added to the rearing water of 1st instar larvae, carbenoxolone and meclofenamic acid both elicit dose-dependent toxic effects, with meclofenamic acid showing the greatest potency. Injecting a double-stranded RNA cocktail against innexins into the hemolymph of adult female mosquitoes knock down whole-animal innexin mRNA expression and decreases survival of the mosquitoes. Taken together these data indicate that gap junctions may provide novel molecular and physiological targets for the development of insecticides.	[Calkins, Travis L.; Piermarini, Peter M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA	University System of Ohio; Ohio State University	Piermarini, PM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	piermarini.1@osu.edu	Piermarini, Peter/AAO-5666-2021	Piermarini, Peter/0000-0003-1020-5774	National Institutes of Health [R03DK090186]; Mosquito Research Foundation [2014-03]; Ohio Agricultural Research and Development Center SEEDS [2014-078]; Ohio Mosquito Control Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK090186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mosquito Research Foundation; Ohio Agricultural Research and Development Center SEEDS; Ohio Mosquito Control Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, R03DK090186, http://www.nih.gov/; Mosquito Research Foundation, 2014-03, http://www.mosquitoresearch.org/; Ohio Agricultural Research and Development Center SEEDS, 2014-078, oardc.osu.edu/seeds; Ohio Mosquito Control Association, Grant-In-Aid, http://www.ohiomosquito.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anava S, 2009, INSECT BIOCHEM MOLEC, V39, P224, DOI 10.1016/j.ibmb.2008.12.002; Beyenbach KW, 2011, ACTA PHYSIOL, V202, P387, DOI 10.1111/j.1748-1716.2010.02195.x; Calkins TL, 2015, COMP BIOCHEM PHYS B, V183, P11, DOI 10.1016/j.cbpb.2014.11.013; Cao FL, 1998, J CELL SCI, V111, P31; Carlen PL, 2000, BRAIN RES REV, V32, P235, DOI 10.1016/S0165-0173(99)00084-3; CDC, 2015, CHIK VIR US; CDC, 2013, W NIL VIR PREV CONTR; Connors BW, 2012, EPILEPSY CURR, V12, P66, DOI 10.5698/1535-7511-12.2.66; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; Drake LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015578; Giuliani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069212; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lu HL, 2011, INSECT BIOCHEM MOLEC, V41, P135, DOI 10.1016/j.ibmb.2010.10.003; Luo KJ, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0106; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Nachman RJ, 1997, PEPTIDES, V18, P53, DOI 10.1016/S0196-9781(96)00233-1; Ning N, 2013, HUM EXP TOXICOL, V32, P1164, DOI 10.1177/0960327112472997; Phelan P, 2001, BIOESSAYS, V23, P388, DOI 10.1002/bies.1057; Piermarini PM, 2014, GEN COMP ENDOCR, V203, P43, DOI 10.1016/j.ygcen.2013.11.020; Piermarini PM, 2011, AM J PHYSIOL-REG I, V301, pR1318, DOI 10.1152/ajpregu.00223.2011; Piermarini PM, 2010, AM J PHYSIOL-REG I, V298, pR642, DOI 10.1152/ajpregu.00729.2009; Powers AM, 2015, J GEN VIROL, V96, P1, DOI 10.1099/vir.0.070136-0; Pridgeon JW, 2009, J MED ENTOMOL, V46, P335, DOI 10.1603/033.046.0219; Ramsay JA, 1953, J EXP BIOL; Raphemot R, 2014, INSECT BIOCHEM MOLEC, V51, P10, DOI 10.1016/j.ibmb.2014.05.002; Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905; Revuelta L, 2009, INSECT BIOCHEM MOLEC, V39, P913, DOI 10.1016/j.ibmb.2009.11.001; Rozen S, 1998, PRIMER3; Sangaletti R, 2014, AM J PHYSIOL-CELL PH, V307, pC966, DOI 10.1152/ajpcell.00246.2014; Srinivas M, 2003, MOL PHARMACOL, V63, P1389, DOI 10.1124/mol.63.6.1389; SWENSON KI, 1989, CELL, V57, P145, DOI 10.1016/0092-8674(89)90180-3; Thailayil J, 2011, P NATL ACAD SCI USA, V108, P13677, DOI 10.1073/pnas.1104738108; Tice CM, 2001, PEST MANAG SCI, V57, P3, DOI 10.1002/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; Weng XH, 2008, J EXP BIOL, V211, P409, DOI 10.1242/jeb.011213; WHO, 2014, YELL FEV, P1; Zhou XX, 2009, PESTIC BIOCHEM PHYS, V93, P77, DOI 10.1016/j.pestbp.2008.11.007	37	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137084	10.1371/journal.pone.0137084	http://dx.doi.org/10.1371/journal.pone.0137084			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325403	gold, Green Submitted, Green Published			2022-12-27	WOS:000360437700091
J	Inselman, WM; Datta, S; Jenks, JA; Jensen, KC; Grovenburg, TW				Inselman, Will M.; Datta, Shubham; Jenks, Jonathan A.; Jensen, Kent C.; Grovenburg, Troy W.			Buteo Nesting Ecology: Evaluating Nesting of Swainson's Hawks in the Northern Great Plains	PLOS ONE			English	Article							WEST-NILE-VIRUS; SITE SELECTION; HABITAT USE; POPULATIONS; SURVIVAL; PRODUCTIVITY; INFECTION; VALLEY; COVER	Swainson's hawks (Buteo swainsoni) are long-distance migratory raptors that nest primarily in isolated trees located in areas of high grassland density. In recent years, anthropogenic conversion of grassland habitat has raised concerns about the status of the breeding population in the northern Great Plains. In 2013, we initiated a study to investigate the influence of extrinsic factors influencing Swainson's hawk nesting ecology in north-central South Dakota and south-central North Dakota. Using ground and aerial surveys, we located and monitored nesting Swainson's hawk pairs: 73 in 2013 and 120 in 2014. We documented 98 successful breeding attempts that fledged 163 chicks; 1.52 and 1.72 fledglings per successful nest in 2013 and 2014, respectively. We used Program MARK to evaluate the influence of land cover on nest survival. The top model, SDist2Farm+%Hay, indicated that nest survival (fledging at least one chick) decreased as nests were located farther from farm sites and as the percent of hay cover increased within 1200-m of the nest site (34.4%; 95% CI = 27.6%-42.3%). We used logistic regression analysis to evaluate the influence of landscape variables on nest-site selection; Swainson's hawks selected for nest sites located closer to roads. We suggest that tree belts associated with farm sites, whether occupied or not, provide critical breeding sites for Swainson's hawks. Additionally, poor breeding success may be related to the late migratory behavior of this species which requires them to occupy marginal habitat due to other raptors occupying the most suitable habitat prior to Swainson's hawks arriving to the breeding grounds.	[Inselman, Will M.; Datta, Shubham; Jenks, Jonathan A.; Jensen, Kent C.; Grovenburg, Troy W.] S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA	South Dakota State University	Inselman, WM (corresponding author), S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA.	will.inselman@sdstate.edu	Jenks, Jonathan A/B-7321-2009		Agriculture Experiment Station at South Dakota State University; North Dakota Department of Game and Fish, State Wildlife Grant [T-36-R]	Agriculture Experiment Station at South Dakota State University; North Dakota Department of Game and Fish, State Wildlife Grant	Funding for this study was provided by the Agriculture Experiment Station at South Dakota State University and the North Dakota Department of Game and Fish, State Wildlife Grant T-36-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN DE, 1995, J RAPTOR RES, V29, P158; BABCOCK KW, 1995, J RAPTOR RES, V29, P193; Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; BECHARD MJ, 1982, CONDOR, V84, P153, DOI 10.2307/1367658; BECHARD MJ, 1990, J FIELD ORNITHOL, V61, P159; BEDNARZ JC, 1988, CONDOR, V90, P311, DOI 10.2307/1368559; Beyer H. L, 2012, GEOSPATIAL MODELLING; Briggs CW, 2011, J WILDLIFE MANAGE, V75, P1307, DOI 10.1002/jwmg.167; Bryce SA., 1996, ECOREGIONS N DAKOTA; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Datta Shubham, 2015, Prairie Naturalist, V47, P38; Devries JH, 2003, J WILDLIFE MANAGE, V67, P551, DOI 10.2307/3802713; ENGLAND AS, 1995, J RAPTOR RES, V29, P179; ESRI, 2011, ARCGIS DESKT REL 10; Fair J., 2010, ORNITHOLOGICAL COUNC; Fyfe R.W., 1976, Occasional Pap Can Wildl Serv, VNo. 23, P1; GILMER DS, 1984, CONDOR, V86, P12, DOI 10.2307/1367335; Hagen SK, 2005, N DAKOTA COMPREHENSI; HANSEN RW, 1995, J RAPTOR RES, V29, P166; Hosmer DW, 2013, APPL LOGISTIC REGRES, V398; HOUSTON CS, 1995, J RAPTOR RES, V29, P198; Inselman WM., 2015, THESIS S DAKOTA STAT; Johnson MD, 2008, WEST N AM NATURALIST, V68, P444, DOI 10.3398/1527-0904-68.4.444; Johnston CA, 2013, WETLANDS, V33, P175, DOI 10.1007/s13157-012-0365-x; LOKEMOEN JT, 1976, CONDOR, V78, P464, DOI 10.2307/1367095; McConnell S, 2008, WILSON J ORNITHOL, V120, P708, DOI 10.1676/07-048.1; Nemeth N, 2006, J WILDLIFE DIS, V42, P1, DOI 10.7589/0090-3558-42.1.1; Neter J., 1996, APPL LINEAR STAT MOD; Nishida C, 2013, J RAPTOR RES, V47, P377, DOI 10.3356/JRR-12-16.2; North Dakota State Climate Office, 2010, 30 YEAR AV 1981 2010; R Core Team, 2020, R LANG ENV STAT COMP; ROTHFELS M, 1983, CAN J ZOOL, V61, P60, DOI 10.1139/z83-006; SCHMUTZ JK, 1980, CAN J ZOOL, V58, P1075, DOI 10.1139/z80-151; SCHMUTZ JK, 1987, J RANGE MANAGE, V40, P438, DOI 10.2307/3899606; SCHMUTZ JK, 1989, CONDOR, V91, P362, DOI 10.2307/1368315; SMALLWOOD KS, 1995, J RAPTOR RES, V29, P172; South Dakota Department of Game Fish and Parks, 2005, S DAK ALL BIRD CONS; Stout WE, 2005, AVIAN DIS, V49, P371, DOI 10.1637/7335-012805R1.1; U.S. Fish and Wildlife Service, 2011, BIRDS MAN CONC 2011; United States Department of Agriculture, 2010, USDA S DAK ANN STAT; United States Department of Agriculture, 2014, CONS PROGR REP STAT; USDA National Agricultrual Statistics Service, 2014, CROPL DAT LAYER; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WOODBRIDGE B, 1995, J RAPTOR RES, V29, P202; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	45	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137045	10.1371/journal.pone.0137045	http://dx.doi.org/10.1371/journal.pone.0137045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327440	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700085
J	Jobst, BJ; Wielputz, MO; Triphan, SMF; Anjorin, A; Ley-Zaporozhan, J; Kauczor, HU; Biederer, J; Ley, S; Sedlaczek, O				Jobst, Bertram J.; Wielpuetz, Mark O.; Triphan, Simon M. F.; Anjorin, Angela; Ley-Zaporozhan, Julia; Kauczor, Hans-Ulrich; Biederer, Juergen; Ley, Sebastian; Sedlaczek, Oliver			Morpho-Functional 1H-MRI of the Lung in COPD: Short-Term Test-Retest Reliability	PLOS ONE			English	Article							OBSTRUCTIVE-PULMONARY-DISEASE; QUANTITATIVE COMPUTED-TOMOGRAPHY; CYSTIC-FIBROSIS; PROTON MRI; PERFUSION; EMPHYSEMA; CT; AGREEMENT; DYSFUNCTION; CAPABILITY	Purpose Non-invasive end-points for interventional trials and tailored treatment regimes in chronic obstructive pulmonary disease (COPD) for monitoring regionally different manifestations of lung disease instead of global assessment of lung function with spirometry would be valuable. Proton nuclear magnetic resonance imaging (1H-MRI) allows for a radiation-free assessment of regional structure and function. The aim of this study was to evaluate the short-term reproducibility of a comprehensive morpho-functional lungMRI protocol in COPD. Materials and Methods 20 prospectively enrolled COPD patients (GOLD I-IV) underwent 1H-MRI of the lung at 1.5T on two consecutive days, including sequences for morphology, 4D contrast-enhanced perfusion, and respiratory mechanics. Image quality and COPD-related morphological and functional changes were evaluated in consensus by three chest radiologists using a dedicated MRI-based visual scoring system. Test-retest reliability was calculated per each individual lung lobe for the extent of large airway (bronchiectasis, wall thickening, mucus plugging) and small airway abnormalities (tree in bud, peripheral bronchiectasis, mucus plugging), consolidations, nodules, parenchymal defects and perfusion defects. The presence of tracheal narrowing, dystelectasis, pleural effusion, pulmonary trunk ectasia, right ventricular enlargement and, finally, motion patterns of diaphragma and chest wall were addressed. Results Median global scores [10(Q1:8.00; Q3:16.00) vs. 11(Q1:6.00; Q3:15.00)] as well as category subscores were similar between both timepoints, and kappa statistics indicated "almost perfect" global agreement (kappa = 0.86, 95% CI = 0.81-0.91). Most subscores showed at least "substantial" agreement of MRI1 and MRI2 (kappa = 0.64-1.00), whereas the agreement for the diagnosis of dystelectasis/effusion (kappa = 0.42, 95% CI = 0.00-0.93) was "moderate" and of tracheal abnormalities (kappa = 0.21, 95% CI = 0.00-0.75) "fair". Most MRI acquisitions showed at least diagnostic quality at MRI1 (276 of 278) and MRI2 (259 of 264). Conclusion Morpho-functional 1H-MRI can be obtained with reproducible image quality and high short-term test-retest reliability for COPD-related morphological and functional changes of the lung. This underlines its potential value for the monitoring of regional lung characteristics in COPD trials.	[Jobst, Bertram J.; Wielpuetz, Mark O.; Triphan, Simon M. F.; Anjorin, Angela; Ley-Zaporozhan, Julia; Kauczor, Hans-Ulrich; Biederer, Juergen; Ley, Sebastian; Sedlaczek, Oliver] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Jobst, Bertram J.; Wielpuetz, Mark O.; Triphan, Simon M. F.; Anjorin, Angela; Ley-Zaporozhan, Julia; Kauczor, Hans-Ulrich; Biederer, Juergen; Ley, Sebastian; Sedlaczek, Oliver] Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Jobst, Bertram J.; Wielpuetz, Mark O.; Anjorin, Angela; Kauczor, Hans-Ulrich; Sedlaczek, Oliver] Heidelberg Univ, Dept Diagnost & Intervent Radiol Nucl Med, Thoraxklin, Heidelberg, Germany; [Triphan, Simon M. F.] Res Ctr Magnet Resonance Bavaria MRB, Wurzburg, Germany; [Ley-Zaporozhan, Julia] Univ Hosp Munich, Inst Clin Radiol, Munich, Germany; [Biederer, Juergen] Cty Hosp Gross Gerau, Dept Radiol, Radiol Darmstadt, Gross Gerau, Germany; [Ley, Sebastian] Surg Hosp Dr Rinecker, Dept Diagnost & Intervent Radiol, Munich, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Wurzburg; University of Munich	Jobst, BJ (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.	bertram.jobst@med.uni-heidelberg.de	Kauczor, Hans-Ulrich/AAU-5955-2021; Wielpütz, Mark Oliver/ADP-0499-2022; Ley, Sebastian/I-3426-2013; Wielpuetz, Mark/ABE-1790-2020; Kauczor, HU/AAX-6033-2021	Wielpütz, Mark Oliver/0000-0001-6962-037X; Ley, Sebastian/0000-0001-9269-2670; Wielpuetz, Mark/0000-0001-6962-037X; 	Competence Network on Asthma/COPD (ASCONET) through a grant from the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) of the federal government of Germany [01GI0870]	Competence Network on Asthma/COPD (ASCONET) through a grant from the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) of the federal government of Germany	This work has been supported by the Competence Network on Asthma/COPD (ASCONET) through a grant from the Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) of the federal government of Germany (01GI0870, www.bmbf.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflict of interest with regard to the study at hand.	Barr R Graham, 2011, Proc Am Thorac Soc, V8, P522, DOI 10.1513/pats.201101-008MW; Biederer J, 2012, INSIGHTS IMAGING, V3, P355, DOI 10.1007/s13244-011-0146-8; Biederer J, 2012, INSIGHTS IMAGING, V3, P373, DOI 10.1007/s13244-011-0142-z; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coxson Harvey O, 2008, Proc Am Thorac Soc, V5, P940, DOI 10.1513/pats.200806-057QC; Coxson HO, 2005, ACAD RADIOL, V12, P1457, DOI 10.1016/j.acra.2005.08.013; Dournes G, 2015, RADIOLOGY, V276, P258, DOI 10.1148/radiol.15141655; Eichinger M, 2006, EUR RADIOL, V16, P2147, DOI 10.1007/s00330-006-0257-7; Eichinger M, 2012, EUR J RADIOL, V81, P1321, DOI 10.1016/j.ejrad.2011.02.045; Fan L, 2013, EUR RADIOL, V23, P1234, DOI 10.1007/s00330-012-2729-2; GAY SB, 1994, INVEST RADIOL, V29, P848, DOI 10.1097/00004424-199409000-00009; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Henderson AC, 2007, RESP PHYSIOL NEUROBI, V155, P234, DOI 10.1016/j.resp.2006.05.009; Hopkins SR, 2012, J APPL PHYSIOL, V113, P328, DOI 10.1152/japplphysiol.00320.2012; Hueper K, 2013, INVEST RADIOL, V48, P223, DOI 10.1097/RLI.0b013e318281057d; Iwasawa T, 2000, J THORAC IMAG, V15, P191, DOI 10.1097/00005382-200007000-00007; Iwasawa T, 2002, EUR RESPIR J, V19, P225, DOI 10.1183/09031936.02.00044602; Johnson KM, 2013, MAGN RESON MED, V70, P1241, DOI 10.1002/mrm.24570; Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Ley-Zaporozhan J, 2007, EUR J RADIOL, V63, P76, DOI 10.1016/j.ejrad.2007.01.020; Ley-Zaporozhan J, 2010, J MAGN RESON IMAGING, V32, P1340, DOI 10.1002/jmri.22376; Ley-Zaporozhan J, 2010, EUR J RADIOL, V73, P43, DOI 10.1016/j.ejrad.2008.09.029; Ley-Zaporozhan J, 2008, MAGN RESON IMAGING C, V16, P291, DOI 10.1016/j.mric.2008.02.014; Lynch DA, RADIOLOGY IN PRESS; Miller GW, 2014, NMR BIOMED, V27, P1542, DOI 10.1002/nbm.3156; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; Puderbach M, 2007, INVEST RADIOL, V42, P715, DOI 10.1097/RLI.0b013e318074fd81; Puderbach M, 2007, EUR RADIOL, V17, P716, DOI 10.1007/s00330-006-0373-4; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sergiacomi G, 2003, IN VIVO, V17, P319; Sommer G, 2014, EUR J RADIOL, V83, P600, DOI 10.1016/j.ejrad.2013.11.012; Suga K, 1999, JMRI-J MAGN RESON IM, V10, P510, DOI 10.1002/(SICI)1522-2586(199910)10:4<510::AID-JMRI3>3.0.CO;2-G; Tan RT, 1998, CHEST, V113, P1250, DOI 10.1378/chest.113.5.1250; Thieme SF, 2012, EUR J RADIOL, V81, P360, DOI 10.1016/j.ejrad.2010.11.037; van der Meer RW, 2005, RADIOLOGY, V235, P798, DOI 10.1148/radiol.2353040593; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; Wielputz M, 2012, DIAGN INTERV RADIOL, V18, P344, DOI 10.4261/1305-3825.DIR.5365-11.0; Wielputz MO, 2014, AM J RESP CRIT CARE, V189, P956, DOI 10.1164/rccm.201309-1659OC; Wielputz MO, 2014, RESPIRATION, V87, P294, DOI 10.1159/000357448; Xia Y, 2014, COPD, V11, P510, DOI 10.3109/15412555.2014.948990	42	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137282	10.1371/journal.pone.0137282	http://dx.doi.org/10.1371/journal.pone.0137282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327295	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700106
J	Nielsen, MA; Resende, M; de Jongh, WA; Ditlev, SB; Mordmuller, B; Houard, S; Ndam, NT; Agerbaek, MO; Hamborg, M; Massougbodji, A; Issifou, S; Strobaek, A; Poulsen, L; Leroy, O; Kremsner, PG; Chippaux, JP; Luty, AJF; Deloron, P; Theander, TG; Dyring, C; Salanti, A				Nielsen, Morten A.; Resende, Mafalda; de Jongh, Willem A.; Ditlev, Sisse B.; Mordmueller, Benjamin; Houard, Sophie; Ndam, Nicaise Tuikue; Agerbaek, Mette O.; Hamborg, Mette; Massougbodji, Achille; Issifou, Saddou; Strobaek, Anette; Poulsen, Lars; Leroy, Odile; Kremsner, Peter G.; Chippaux, Jean-Philippe; Luty, Adrian J. F.; Deloron, Philippe; Theander, Thor G.; Dyring, Charlotte; Salanti, Ali			The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine	PLOS ONE			English	Article							VARIANT SURFACE-ANTIGENS; CHONDROITIN SULFATE-A; INFECTED ERYTHROCYTES; PREGNANCY; ADHESION; PARASITES; EPITOPES; INSIGHT; DOMAINS; TARGETS	The disease caused by Plasmodium falciparum (Pf) involves different clinical manifestations that, cumulatively, kill hundreds of thousands every year. Placental malaria (PM) is one such manifestation in which Pf infected erythrocytes (IE) bind to chondroitin sulphate A (CSA) through expression of VAR2CSA, a parasite-derived antigen. Protection against PM is mediated by antibodies that inhibit binding of IE in the placental intervillous space. VAR2CSA is a large antigen incompatible with large scale recombinant protein expression. Vaccines based on sub-units encompassing the functionally constrained receptor-binding domains may, theoretically, circumvent polymorphisms, reduce the risk of escape-mutants and induce cross-reactive antibodies. However, the sub-unit composition and small differences in the borders, may lead to exposure of novel immuno-dominant antibody epitopes that lead to non-functional antibodies, and furthermore influence the folding, stability and yield of expression. Candidate antigens from the pre-clinical development expressed in High-Five insect cells using the baculovirus expression vector system were transitioned into the Drosophila Schneider-2 cell (S2) expression-system compliant with clinical development. The functional capacity of antibodies against antigens expressed in High-Five cells or in S2 cells was equivalent. This enabled an extensive down-selection of S2 insect cell-expressed antigens primarily encompassing the minimal CSA-binding region of VAR2CSA. In general, we found differential potency of inhibitory antibodies against antigens with the same borders but of different var2csa sequences. Likewise, we found that subtle size differences in antigens of the same sequence gave varying levels of inhibitory antibodies. The study shows that induction of a functional response against recombinant subunits of the VAR2CSA antigen is unpredictable, demonstrating the need for large-scale screening in order to identify antigens that induce a broadly strain-transcending antibody response.	[Nielsen, Morten A.; Resende, Mafalda; Ditlev, Sisse B.; Agerbaek, Mette O.; Hamborg, Mette; Theander, Thor G.; Salanti, Ali] Univ Copenhagen, Ctr Med Parasitol, Dept Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nielsen, Morten A.; Resende, Mafalda; Ditlev, Sisse B.; Agerbaek, Mette O.; Hamborg, Mette; Theander, Thor G.; Salanti, Ali] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [de Jongh, Willem A.; Strobaek, Anette; Poulsen, Lars; Dyring, Charlotte] SCION DTU Sci Pk, Biotechnol ExpreS2, Horsholm, Denmark; [Mordmueller, Benjamin; Kremsner, Peter G.] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Mordmueller, Benjamin; Kremsner, Peter G.] Ctr Rech Med Lambarene, Lambarene, Gabon; [Houard, Sophie; Leroy, Odile] Univ Klinikum Heidelberg, European Vaccine Initiat, Heidelberg, Germany; [Ndam, Nicaise Tuikue; Chippaux, Jean-Philippe; Luty, Adrian J. F.; Deloron, Philippe] Inst Rech Dev, Mere & Enfant Face Infect Trop UMR216, Paris, France; [Ndam, Nicaise Tuikue; Chippaux, Jean-Philippe; Luty, Adrian J. F.; Deloron, Philippe] Univ Paris 05, PRES Sorbonne Paris Cite, Paris, France; [Massougbodji, Achille; Issifou, Saddou; Chippaux, Jean-Philippe; Luty, Adrian J. F.] Univ Abomey Calavi, Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin	University of Copenhagen; Rigshospitalet; University of Copenhagen; Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi	Nielsen, MA (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Dept Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark.	mortenn@sund.ku.dk	Mordmüller, Benjamin/A-5749-2010; Theander, Thor/F-6714-2015; Deloron, Philippe/G-6305-2010; Luty, Adrian/CAH-2547-2022	Mordmüller, Benjamin/0000-0001-9101-2768; Theander, Thor/0000-0002-3509-7514; Deloron, Philippe/0000-0003-4705-2484; Poulsen, Lars/0000-0001-9106-8956; Luty, Adrian John Frederick/0000-0001-8830-3425; Tuikue Ndam, Nicaise/0000-0003-2646-2513; Chippaux, Jean-Philippe/0000-0002-1976-8568; Salanti, Ali/0000-0003-2207-5575; Ditlev, Sisse Bolm/0000-0003-4417-9711; Agerbaek, Mette Orskov/0000-0001-5865-2034; Nielsen, Morten Agertoug/0000-0003-2668-4992	European Union [304815]; Danish Advanced Technology Foundation [005-2011-1]; Expres2ion Biotechnologies	European Union(European Commission); Danish Advanced Technology Foundation; Expres2ion Biotechnologies	The research leading to these results has received funding from the European Union Seventh Framework Programme, FP7-HEALTH-2012-INNOVATION under grant agreement no 304815 (http://ec.europa.eu/research/fp7/index_en.cfm?pg=health) and the Danish Advanced Technology Foundation under grant number 005-2011-1 (http://innovationsfonden.dk/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Expres2ion Biotechnologies provided support in the form of salaries for authors [WAdeJ, AS, LP, CD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000398; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Beeson JG, 2007, AM J TROP MED HYG, V77, P22, DOI 10.4269/ajtmh.2007.77.22; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Ditlev SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043663; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2013, INFECT IMMUN, V81, P487, DOI 10.1128/IAI.01106-12; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Halbroth BR, 2015, ADV PARASIT, V88, P1, DOI 10.1016/bs.apar.2015.03.001; Lambert LH, 2014, INFECT IMMUN, V82, P4842, DOI 10.1128/IAI.02097-14; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Ndam NT, 2015, EMERG INFECT DIS, V21, P813, DOI 10.3201/eid2105.141626; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oleinikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031011; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; The malERA Consultative Group on Vaccine, 2011, PLOS MED, V8, DOI [10.1371/journal.pmed.1000398, DOI 10.1371/J0URNAL.PMED.1000398]; Tutterrow YL, 2012, INFECT IMMUN, V80, P1479, DOI 10.1128/IAI.00071-12; WHO, 2013, WHO MAL VACC TECHN R; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715	30	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135406	10.1371/journal.pone.0135406	http://dx.doi.org/10.1371/journal.pone.0135406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327283	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700018
J	Kolb, P; Wallich, R; Nassal, M				Kolb, Philipp; Wallich, Reinhard; Nassal, Michael			Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; SURFACE PROTEIN; CORE PROTEIN; CRYSTAL-STRUCTURE; DISPLAY; SALP15; ANTIGEN; IDENTIFICATION; COMPLEMENT; EXPRESSION	Ticks are vectors for various, including pathogenic, microbes. Tick saliva contains multiple anti-host defense factors that enable ticks their bloodmeals yet also facilitate microbe transmission. Lyme disease-causing borreliae profit specifically from the broadly conserved tick histamine release factor (tHRF), and from cysteine-rich glycoproteins represented by Salp15 from Ixodes scapularis and Iric-1 from Ixodes ricinus ticks which they recruit to their outer surface protein C (OspC). Hence these tick proteins are attractive targets for anti-tick vaccines that simultaneously impair borrelia transmission. Main obstacles are the tick proteins immunosuppressive activities, and for Salp15 orthologs, the lack of efficient recombinant expression systems. Here, we exploited the immune-enhancing properties of hepatitis B virus core protein (HBc) derived capsid-like particles (CLPs) to generate, in E. coli, nanoparticulate vaccines presenting tHRF and, as surrogates for the barely soluble wild-type proteins, cysteine-free Salp15 and Iric-1 variants. The latter CLPs were exclusively accessible in the less sterically constrained SplitCore system. Mice immunized with tHRF CLPs mounted a strong anti-tHRF antibody response. CLPs presenting cysteine-free Salp15 and Iric-1 induced antibodies to wild-type, including glycosylated, Salp15 and Iric-1. The broadly distributed epitopes included the OspC interaction sites. In vitro, the anti-Salp15 antibodies interfered with OspC binding and enhanced human complement-mediated killing of Salp15 decorated borreliae. A mixture of all three CLPs induced high titered antibodies against all three targets, suggesting the feasibility of combination vaccines. These data warrant in vivo validation of the new candidate vaccines' protective potential against tick infestation and Borrelia transmission.	[Kolb, Philipp; Nassal, Michael] Univ Hosp Freiburg, Internal Med Mol Biol 2, D-79106 Freiburg, Germany; [Kolb, Philipp] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Wallich, Reinhard] Univ Heidelberg Hosp, Inst Immunol, D-69120 Heidelberg, Germany	University of Freiburg; University of Freiburg; Ruprecht Karls University Heidelberg	Nassal, M (corresponding author), Univ Hosp Freiburg, Internal Med Mol Biol 2, Hugstetter Str 55, D-79106 Freiburg, Germany.	nassal2@ukl.uni-freiburg.de	Kolb, Philipp/AAE-4007-2021; Nassal, Michael/U-4529-2019	Kolb, Philipp/0000-0001-7935-217X; Nassal, Michael/0000-0003-2204-9158	Deutsche Forschungsgemeinschaft; German Research Foundation (DFG); Albert Ludwigs University Freiburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This study was supported by Deutsche Forschungsgemeinschaft (URL: http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Acunzo J, 2014, CANCER TREAT REV, V40, P760, DOI 10.1016/j.ctrv.2014.02.007; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; BreitnerRuddock S, 1997, MED MICROBIOL IMMUN, V185, P253, DOI 10.1007/s004300050038; Calderon-Perez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085514; Dai JF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001205; Dai JF, 2009, CELL HOST MICROBE, V6, P482, DOI 10.1016/j.chom.2009.10.006; Daub H, 2002, J VIROL, V76, P8124, DOI 10.1128/JVI.76.16.8124-8137.2002; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Desel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053531; Embers ME, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00006; Estrada-Pena A, 2014, ANTIVIR RES, V108, P104, DOI 10.1016/j.antiviral.2014.05.016; Fehr T, 1998, P NATL ACAD SCI USA, V95, P9477, DOI 10.1073/pnas.95.16.9477; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Hovius JW, 2008, J INFECT DIS, V198, P1189, DOI 10.1086/591917; Hovius JWR, 2007, VECTOR-BORNE ZOONOT, V7, P296, DOI 10.1089/vbz.2006.0624; Ibanez LI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059081; Juncadella IJ, 2007, FEMS IMMUNOL MED MIC, V49, P433, DOI 10.1111/j.1574-695X.2007.00223.x; Koniger C, 2014, P NATL ACAD SCI USA, V111, pE4244, DOI 10.1073/pnas.1409986111; Kolb P., 2015, VIRAL NANOTECHNOLOGY, P187; Kolb P, 2015, FEBS OPEN BIO, V5, P42, DOI 10.1016/j.fob.2014.12.002; Konig S, 1998, J VIROL, V72, P4997; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Kung F, 2013, FUTURE MICROBIOL, V8, P41, DOI [10.2217/FMB.12.121, 10.2217/fmb.12.121]; Lee BO, 2009, J IMMUNOL, V182, P6670, DOI 10.4049/jimmunol.0803683; Li H, 1997, P NATL ACAD SCI USA, V94, P3584, DOI 10.1073/pnas.94.8.3584; Mason LMK, 2014, TRENDS PARASITOL, V30, P95, DOI 10.1016/j.pt.2013.12.003; Merino O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00030; Mulenga A, 2005, EXP APPL ACAROL, V37, P215, DOI 10.1007/s10493-005-3261-8; Nassal M, 2005, EUR J IMMUNOL, V35, P655, DOI 10.1002/eji.200425449; NASSAL M, 1988, GENE, V66, P279, DOI 10.1016/0378-1119(88)90364-2; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, INT J MED MICROBIOL, V298, P135, DOI 10.1016/j.ijmm.2007.08.002; Nguyen VD, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-1; Porterfield JZ, 2010, J VIROL, V84, P7174, DOI 10.1128/JVI.00586-10; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Riedl P, 2002, J IMMUNOL, V168, P4951, DOI 10.4049/jimmunol.168.10.4951; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Schuijt TJ, 2011, TRENDS PARASITOL, V27, P40, DOI 10.1016/j.pt.2010.06.006; Schuijt TJ, 2008, INFECT IMMUN, V76, P2888, DOI 10.1128/IAI.00232-08; Skamel C, 2006, J BIOL CHEM, V281, P17474, DOI 10.1074/jbc.M513571200; Skrastina D, 2008, VACCINE, V26, P1972, DOI 10.1016/j.vaccine.2008.02.030; Sominskaya I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075938; Steven AC, 2005, ADV VIRUS RES, V64, P125, DOI 10.1016/S0065-3527(05)64005-5; Ulrich R, 1998, ADV VIRUS RES, V50, P141, DOI 10.1016/S0065-3527(08)60808-8; Vogel M, 2005, PROTEINS, V58, P478, DOI 10.1002/prot.20312; Walker A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00005; Walker A, 2008, J BIOL CHEM, V283, P33508, DOI 10.1074/jbc.M805211200; Wang JW, 2013, EXPERT REV VACCINES, V12, P129, DOI [10.1586/erv.12.151, 10.1586/ERV.12.151]; Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121; Wikel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00337; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zhao QJ, 2013, TRENDS BIOTECHNOL, V31, P654, DOI 10.1016/j.tibtech.2013.09.002; Zlotnick A, 1997, P NATL ACAD SCI USA, V94, P9556, DOI 10.1073/pnas.94.18.9556; Zuckert WR, 2004, INFECT IMMUN, V72, P1463, DOI 10.1128/IAI.72.3.1463-1469.2004	58	9	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136180	10.1371/journal.pone.0136180	http://dx.doi.org/10.1371/journal.pone.0136180			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352137	gold, Green Submitted, Green Published			2022-12-27	WOS:000360932800027
J	You, D; Kim, Y; Jang, MJ; Lee, C; Jeong, IG; Cho, YM; Hwang, JJ; Hong, JH; Ahn, H; Kim, CS				You, Dalsan; Kim, Yunlim; Jang, Myoung Jin; Lee, Chunwoo; Jeong, In Gab; Cho, Yong Mee; Hwang, Jung Jin; Hong, Jun Hyuk; Ahn, Hanjong; Kim, Choung-Soo			KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ARSENIC TRIOXIDE AS2O3; DOWN-REGULATION; UP-REGULATION; STEM-CELLS; LINES; INDUCTION; TELOMERE; MITOXANTRONE; PREDNISONE	We investigated the effects of KML001 (NaAsO2, sodium metaarsenite, Kominox), an orally bioavailable arsenic compound, on the growth and death of human prostate cancer cells and its mechanism of action. Growth inhibition was assessed by cytotoxicity assays in the presence or absence of inhibitor of apoptosis, inhibitor of autophagy or antioxidant N-Acetyl-(L)-cysteine to study mechanism of cell death induced by KML001 in PC3, DU145 and LNCaP prostate cancer cell lines. Electron microscopy, flow cytometry and Western blotting were used to study apoptotic and autophagic mechanisms. The DU145 xenograft model was used to determine the efficacy of KML001 in vivo. KML001 decreased the viability of cells and increased the percentage of annexin V-positive cells dose-dependently in prostate cancer cells, and LNCaP cells were more sensitive to KML001 than PC3 or DU145 cells. Electron microscopy revealed typical apoptotic characters and autophagic vacuoles in cells treated with KML001. Exposure to KML001 in prostate cancer cells induced apoptosis and autophagy in a time-and dose-dependent manner. KML001 induced dose-dependent accumulation of reactive oxygen species, and scavenging the reactive oxygen species with N-Acetyl-(L)-cysteine reduced LC3 and cleaved poly (ADP-ribose) polymerase. KML001 significantly inhibited tumor growth in the DU145 xenograft model. In addition, significant decrease of proliferation and significant increases of apoptosis and autophagy were observed in KML001-treated tumors than in vehicle-treated tumors. Exposure of human prostate cancer cells to KML001 induced both apoptosis and autophagic cell death via oxidative stress pathway. And KML001 had an antiproliferative effect on DU145 cells in xenograft mice.	[You, Dalsan; Kim, Yunlim; Lee, Chunwoo; Jeong, In Gab; Hong, Jun Hyuk; Ahn, Hanjong; Kim, Choung-Soo] Univ Ulsan, Coll Med, Dept Urol, Asan Med Ctr, Seoul, South Korea; [Jang, Myoung Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Cho, Yong Mee] Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea; [Hwang, Jung Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center	Kim, CS (corresponding author), Univ Ulsan, Coll Med, Dept Urol, Asan Med Ctr, Seoul, South Korea.	cskim@amc.seoul.kr	Hwang, Jung Jin/F-3424-2014		Korea Health Technology RD Project; Ministry of Health Welfare [A062254, A102059]	Korea Health Technology RD Project; Ministry of Health Welfare	Funding: This study was supported by grants of the Korea Health Technology R&D Project and Ministry of Health & Welfare (A062254 and A102059).	Alemany M, 2000, LEUKEMIA LYMPHOMA, V38, P153, DOI 10.3109/10428190009060329; Aronson S M, 1994, R I Med, V77, P233; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Glienke W, 2006, LEUKEMIA LYMPHOMA, V47, P1629, DOI 10.1080/10428190600625398; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kanzawa T, 2003, CANCER RES, V63, P2103; Kim Y, 2013, AUTOPHAGY, V9, P2126, DOI 10.4161/auto.26308; Kim Y, 2014, ANTI-CANCER DRUG, V25, P53, DOI 10.1097/CAD.0000000000000013; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Miller WH, 2002, CANCER RES, V62, P3893; Murgo AJ, 2001, ONCOLOGIST, V6, P22, DOI 10.1634/theoncologist.6-suppl_2-22; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Phatak P, 2008, CLIN CANCER RES, V14, P4593, DOI 10.1158/1078-0432.CCR-07-4572; Poonepalli A, 2005, CANCER RES, V65, P10977, DOI 10.1158/0008-5472.CAN-05-2336; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Rosenblatt AE, 2009, MOL ENDOCRINOL, V23, P412, DOI 10.1210/me.2008-0235; Sauer H, 2005, ANTIOXID REDOX SIGN, V7, P1423, DOI 10.1089/ars.2005.7.1423; Shen SS, 2012, AUTOPHAGY, V8, P1, DOI 10.4161/auto.8.1.16618; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; So A, 2005, WORLD J UROL, V23, P1, DOI 10.1007/s00345-004-0473-1; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Wei YM, 2001, ACTA PHARMACOL SIN, V22, P725; You D, 2013, UROLOGY, V81, P104, DOI 10.1016/j.urology.2012.08.046; Zhang B, 2012, MOL PHARMACOL, V82, P310, DOI 10.1124/mol.111.076752; Zhang Y, 2005, EUR J PHARMACOL, V516, P1, DOI 10.1016/j.ejphar.2005.04.022	31	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137589	10.1371/journal.pone.0137589	http://dx.doi.org/10.1371/journal.pone.0137589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352139	Green Submitted, Green Published, gold			2022-12-27	WOS:000360932800099
J	Liu, LK; Lee, WJ; Chen, LY; Hwang, AC; Lin, MH; Peng, LN; Chen, LK				Liu, Li-Kuo; Lee, Wei-Ju; Chen, Liang-Yu; Hwang, An-Chun; Lin, Ming-Hsien; Peng, Li-Ning; Chen, Liang-Kung			Association between Frailty, Osteoporosis, Falls and Hip Fractures among Community-Dwelling People Aged 50 Years and Older in Taiwan: Results from I-Lan Longitudinal Aging Study	PLOS ONE			English	Article							DENSITY-MEASUREMENT; PREVALENCE; MORTALITY; ADULTS; MEN; POPULATION; DISABILITY; OBESITY; DEFINITION; SARCOPENIA	Background Association of frailty with adverse clinical outcomes has been reported in Western countries, but data from the Asian population are scarce. This study aimed to evaluate the epidemiology of frailty among community-dwelling middle-aged and elderly population and to explore its association with musculoskeletal health in Taiwan. Methods I-Lan Longitudinal Aging Study (ILAS) data were retrieved for this study. Frailty was defined by the Fried's criteria; a comparison of demographic characteristics, physical performance, and body composition, including skeletal muscle mass and bone mineral density (BMD), as well as recent falls, history of hip fractures and the functional status of subjects with different frailty statuses were accomplished. Results Overall, the data of 1,839 participants (mean age: 63.9 +/- 9.3 years, male 47.5%) were obtained for analysis. The prevalence of pre-frailty was 42.3% in men and 38.8% in women, whereas the prevalence of frailty was 6.9% and 6.7% in men and women, respectively. Frailty was significantly associated with older age, the male gender, larger waist circumference, lower skeletal muscle index, lower hip BMD, poorer physical function, poorer nutritional status, and poorer cognitive function. Also, frailty was significantly associated with osteoporosis (OR: 7.73, 95% CI: 5.01-11.90, p<0.001), history of hip fractures (OR: 8.66, 95% CI: 2.47-30.40, p = 0.001), and recent falls (O.R: 2.53, 95% CI: 1.35-4.76, p = 0.004). Conclusions Frailty and pre-frailty, in Taiwan, was closely associated with recent falls, history of hip fractures and osteoporosis among community-dwelling people 50 years of age and older. Furthermore, frailty intervention programs should take an integrated approach towards strengthening both and muscle mass, as well as prevention of falls.	[Liu, Li-Kuo; Lee, Wei-Ju; Chen, Liang-Yu; Hwang, An-Chun; Lin, Ming-Hsien; Peng, Li-Ning; Chen, Liang-Kung] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan; [Lee, Wei-Ju; Chen, Liang-Yu; Hwang, An-Chun; Peng, Li-Ning] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Liu, Li-Kuo; Chen, Liang-Yu; Hwang, An-Chun; Lin, Ming-Hsien; Peng, Li-Ning; Chen, Liang-Kung] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, I Lan County, Taiwan; [Lee, Wei-Ju] Taipei Vet Gen Hosp, Yuanshan Branch, Dept Family Med, Taipei, I Lan County, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Chen, LK (corresponding author), Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan.	lkchen2@vghtpe.gov.tw	Lee, Wei-Ju/AAK-1549-2021	Lee, Wei-Ju/0000-0003-4326-333X; Chen, Liang-Kung/0000-0002-2387-8508	Ministry of Science and Technology of Taiwan [MOST 103-2633-B-400-002]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (MOST 103-2633-B-400-002).	Abbatecola AM, 2004, J AM GERIATR SOC, V52, P399, DOI 10.1111/j.1532-5415.2004.52112.x; Ahmed N, 2007, AM J MED, V120, P748, DOI 10.1016/j.amjmed.2006.10.018; Blain H, 2014, JOINT BONE SPINE, V81, P403, DOI 10.1016/j.jbspin.2014.01.020; Cawthon PM, 2007, J AM GERIATR SOC, V55, P1216, DOI 10.1111/j.1532-5415.2007.01259.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CY, 2010, ARCH GERONTOL GERIAT, V50, pS43, DOI 10.1016/S0167-4943(10)70012-1; Chen LK, 2012, J CLIN GERONTOL GERI, V3, P3, DOI 10.1016/j.jcgg.2011.12.003; Chen LK, 2013, J CLIN GERONTOL GERI, V4, P97, DOI 10.1016/j.jcgg.2013.05.001; Cheung EYN, 2012, OSTEOPOROSIS INT, V23, P871, DOI 10.1007/s00198-011-1647-5; Cooper C, 2012, OSTEOPOROSIS INT, V23, P1839, DOI 10.1007/s00198-012-1913-1; Crepaldi G, 2005, J Endocrinol Invest, V28, P66; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Delgado C, 2013, J RENAL NUTR, V23, P356, DOI 10.1053/j.jrn.2013.02.010; Fang X, 2012, J NUTR HEALTH AGING, V16, P903, DOI 10.1007/s12603-012-0368-6; Folstein MF, 1075, J PSYCHIATR RES, V12, P189; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Frisoli A, 2011, BONE, V48, P952, DOI 10.1016/j.bone.2010.12.025; Gobbens RJ, 2010, NURS OUTLOOK, V58, P76, DOI 10.1016/j.outlook.2009.09.005; Goulet EDB, 2009, EXP GERONTOL, V44, P740, DOI 10.1016/j.exger.2009.08.008; Guigoz Y, 2006, J NUTR HEALTH AGING, V10, P466; Han D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-95, 10.1186/1471-2164-15-477]; HEBERT R, 1988, AGE AGEING, V17, P293, DOI 10.1093/ageing/17.5.293; Hirani V, 2013, J GERONTOL A-BIOL, V68, P1112, DOI 10.1093/gerona/glt059; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; Jurschik P, 2012, ARCH GERONTOL GERIAT, V55, P625, DOI 10.1016/j.archger.2012.07.002; Jung HW, 2014, J AM GERIATR SOC, V62, P2110, DOI 10.1111/jgs.13107; Jung HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087958; Lin CC, 2013, J AM GERIATR SOC, V61, P292, DOI 10.1111/jgs.12103; Liou Yiing Mei, 2008, J Nurs Res, V16, P252; Liu LK, 2014, GERIATR GERONTOL INT, V14, P36, DOI 10.1111/ggi.12208; Liu LK, 2013, GERIATR GERONTOL INT, V13, P964, DOI 10.1111/ggi.12040; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Moreira VG, 2013, CLINICS, V68, P979, DOI 10.6061/clinics/2013(07)15; Morley JE, 2004, J GERONTOL A-BIOL, V59, P924; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Newton JL, 2003, AGE AGEING, V32, P497, DOI 10.1093/ageing/afg062; Qu Ning-ning, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P265; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rolland Y, 2008, J NUTR HEALTH AGING, V12, P335; Shah K, 2012, J AM GERIATR SOC, V60, P545, DOI 10.1111/j.1532-5415.2011.03819.x; Shamliyan T, 2013, AGEING RES REV, V12, P719, DOI 10.1016/j.arr.2012.03.001; Shimada H, 2013, J AM MED DIR ASSOC, V14, P518, DOI 10.1016/j.jamda.2013.03.010; Sternberg SA, 2014, OSTEOPOROSIS INT, V25, P763, DOI 10.1007/s00198-013-2471-x; Strandberg TE, 2013, AM J EPIDEMIOL, V178, P1452, DOI 10.1093/aje/kwt157; Tom SE, 2013, J AM GERIATR SOC, V61, P327, DOI 10.1111/jgs.12146; van Iersel MB, 2006, J AM GERIATR SOC, V54, P728, DOI 10.1111/j.1532-5415.2006.00668_14.x; Womack JA, 2013, CLIN INFECT DIS, V56, P1498, DOI 10.1093/cid/cit056; Wong YYE, 2013, J CLIN ENDOCR METAB, V98, P3821, DOI 10.1210/jc.2013-1702; Yamada M, 2011, J CLIN GERONTOL GERI, V2, P42, DOI 10.1016/j.jcgg.2011.02.004	51	63	69	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136968	10.1371/journal.pone.0136968	http://dx.doi.org/10.1371/journal.pone.0136968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ8YQ	26348034	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600017
J	Willeke, P; Schluter, B; Sauerland, C; Becker, H; Reuter, S; Jacobi, A; Schotte, H				Willeke, P.; Schlueter, B.; Sauerland, C.; Becker, H.; Reuter, S.; Jacobi, A.; Schotte, H.			Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; NEUTROPHIL EXTRACELLULAR TRAPS; RHEUMATOLOGY 1990 CRITERIA; WEGENERS-GRANULOMATOSIS; ENVIRONMENTAL EXPOSURES; AUTOIMMUNE-DISEASES; NASAL COLONIZATION; CLASSIFICATION; EPIDEMIOLOGY; MRSA	Objective To investigate the association of farm exposure and the development of ANCA-associated vasculitis (AAV). Methods One hundred eighty-nine well defined patients with AAV (n = 119 with granulomatosis with polyangiitis [GPA], n = 48 with microscopic polyangiitis [MPA], n = 22 patients with eosinophilic granulomatosis with polyangiitis [EGPA]) and 190 controls (n = 119 patients with rheumatoid arthritis, n = 71 with large vessel vasculitis) were interrogated using a structured questionnaire. Factors investigated were occupation, farm exposure, contact to different livestock, participation in harvesting, residence next to a farm, MRSA status, and contact to domestic pets at disease onset or ever before. The odds ratio (OR) and 95% confidence interval [95% CI] were calculated for each item. Results Univariate analysis revealed a strong association of AAV with regular farm exposure; OR 3.44 [95% CI 1.43-8.27]. AAV was also associated with regular contact to cattle 4.30 (1.43-8.27), pigs 2.75 (1.12-6.75) and MRSA carriage 3.38 (1.11-10.3). This association was stronger in the subgroup of GPA patients. OR in this group for farm exposure was 4.97; [2.02-12.2], for cattle 6.71 [95% CI 2.19-20.7], for pigs 4.34 [1.75-10.9], and MRSA carriage 5.06 [1.62-15.8]). There was no significant association of MPA or EGPA with these parameters. Conclusion A significant association between farm exposure or farm animal exposure and AAV especially in the subgroup of patients with GPA has been identified. This suggests that these entities are distinct and have different triggers for the immune process.	[Willeke, P.; Becker, H.; Reuter, S.; Schotte, H.] Univ Hosp Munster, Sect Rheumatol & Clin Immunol, Dept Med D, Munster, Germany; [Schlueter, B.] Univ Hosp Munster, Ctr Lab Med, Munster, Germany; [Sauerland, C.] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Jacobi, A.] Brandenburg Med Sch, Div Rheumatol & Clin Immunol, Neuruppin, Germany	University of Munster; University of Munster; University of Munster	Willeke, P (corresponding author), Univ Hosp Munster, Sect Rheumatol & Clin Immunol, Dept Med D, Munster, Germany.	willeke.peter@uni-muenster.de	Sauerland, Maria Cristina/A-4154-2014					ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Beaudreuil S, 2005, KIDNEY INT, V67, P1961, DOI 10.1111/j.1523-1755.2005.00295.x; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Carruthers DM, 1996, BRIT J RHEUMATOL, V35, P142; Chen M, 2010, AUTOIMMUN REV, V9, pA293, DOI 10.1016/j.autrev.2009.10.008; Cooper GS, 2002, INT IMMUNOPHARMACOL, V2, P303, DOI 10.1016/S1567-5769(01)00181-3; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Dimola S, 1999, ANTICANCER RES, V19, P3889; Duna GE, 1998, CLIN EXP RHEUMATOL, V16, P669; Hogan SL, 2007, CLIN J AM SOC NEPHRO, V2, P290, DOI 10.2215/CJN.03501006; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kallenberg CGM, 2013, AM J KIDNEY DIS, V62, P1176, DOI 10.1053/j.ajkd.2013.05.009; Knight A, 2010, ANN RHEUM DIS, V69, P737, DOI 10.1136/ard.2009.107953; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761; Konstantinov KN, 2015, AUTOIMMUN REV, V14, P201, DOI 10.1016/j.autrev.2014.10.020; Lane SE, 2003, ARTHRITIS RHEUM-US, V48, P814, DOI 10.1002/art.10830; Laudien M, 2010, CLIN EXP RHEUMATOL, V28, pS51; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; Lee JHM, 2007, ANN RHEUM DIS, V66, P278, DOI 10.1136/ard.2006.056226; Lidar M, 2009, ANN NY ACAD SCI, V1173, P649, DOI 10.1111/j.1749-6632.2009.04641.x; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Lutalo PMK, 2014, J AUTOIMMUN, V48-49, P94, DOI 10.1016/j.jaut.2014.01.028; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Mahr AD, 2006, CLIN EXP RHEUMATOL, V24, pS82; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; Miller FW, 2012, J AUTOIMMUN, V39, P259, DOI 10.1016/j.jaut.2012.05.002; Millet A, 2013, ANN RHEUM DIS, V72, P1273, DOI 10.1136/annrheumdis-2013-203255; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P1827, DOI 10.1136/ard.2008.101279; Mutneja R, 2013, CHEST J, V144, p354A; Ntatsaki E, 2010, RHEUM DIS CLIN N AM, V36, P447, DOI 10.1016/j.rdc.2010.04.002; Ohlsson SM, 2014, CLIN EXP IMMUNOL, DOI [10.1111/cei.12555, DOI 10.1111/CEI.12555]; Oporto B, 2007, J APPL MICROBIOL, V103, P977, DOI 10.1111/j.1365-2672.2007.03328.x; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Rondina MT, 2013, CIRC RES, V112, P1506, DOI 10.1161/CIRCRESAHA.113.300512; Salvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593	38	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137196	10.1371/journal.pone.0137196	http://dx.doi.org/10.1371/journal.pone.0137196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339905	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200032
J	Yan, WF; van Serooskerken, EV				Yan, Wanfeng; van Serooskerken, Edgar van Tuyll			Forecasting Financial Extremes: A Network Degree Measure of Super-Exponential Growth	PLOS ONE			English	Article							REAL-ESTATE BUBBLE; VISIBILITY GRAPH; PREDICTION; INDEXES	Investors in stock market are usually greedy during bull markets and scared during bear markets. The greed or fear spreads across investors quickly. This is known as the herding effect, and often leads to a fast movement of stock prices. During such market regimes, stock prices change at a super-exponential rate and are normally followed by a trend reversal that corrects the previous overreaction. In this paper, we construct an indicator to measure the magnitude of the super-exponential growth of stock prices, by measuring the degree of the price network, generated from the price time series. Twelve major international stock indices have been investigated. Error diagram tests show that this new indicator has strong predictive power for financial extremes, both peaks and troughs. By varying the parameters used to construct the error diagram, we show the predictive power is very robust. The new indicator has a better performance than the LPPL pattern recognition indicator.	[Yan, Wanfeng; van Serooskerken, Edgar van Tuyll] Banque Pictet & Cie SA, Route Acacias 60, CH-1211 Geneva 73, Switzerland		Yan, WF (corresponding author), Banque Pictet & Cie SA, Route Acacias 60, CH-1211 Geneva 73, Switzerland.	wanfeng.yan@gmail.com			Banque Pictet Cie SA	Banque Pictet Cie SA	We acknowledge financial support from the Banque Pictet & Cie SA.	GELFAND IM, 1976, PHYS EARTH PLANET IN, V11, P227, DOI 10.1016/0031-9201(76)90067-4; Jiang ZQ, 2010, J ECON BEHAV ORGAN, V74, P149, DOI 10.1016/j.jebo.2010.02.007; Johansen A, 1999, INT J MOD PHYS C, V10, P563, DOI 10.1142/S0129183199000437; Johansen A., 2000, INT J THEOR APPL FIN, V2, P219, DOI [DOI 10.1142/S0219024900000115, 10.1142/S0219024900000115]; Johansen A., 1999, J RISK, V1, P5, DOI DOI 10.21314/JOR.1999.014; Johansen A., 1999, J RISK, V12, P91; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Liu C, 2010, PHYSICA A, V389, P2675, DOI 10.1016/j.physa.2010.02.043; Molchan GM, 1997, PURE APPL GEOPHYS, V149, P233, DOI 10.1007/BF00945169; MOLCHAN GM, 1992, J GEOPHYS RES-SOL EA, V97, P4823, DOI 10.1029/91JB03095; Qian MC, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/33/335002; Sornette D, 2006, INT J FORECASTING, V22, P153, DOI 10.1016/j.ijforecast.2005.02.004; Sornette D, 2003, WHY STOCK MARKETS CRASH: CRITICAL EVENTS IN COMPLEX FINANCIAL SYSTEMS, P1; Sornette D., 2002, Quantitative Finance, V2, P468, DOI 10.1088/1469-7688/2/6/306; Sornette D, 2009, PHYSICA A, V388, P1571, DOI 10.1016/j.physa.2009.01.011; Yan W, 2012, IJPAM, V1, P59; Yan WF, 2012, PHYSICA A, V391, P1361, DOI 10.1016/j.physa.2011.09.019; Yan WF, 2012, PHYSICA A, V391, P180, DOI 10.1016/j.physa.2011.07.013; Zhou WX, 2008, PHYSICA A, V387, P243, DOI 10.1016/j.physa.2007.08.059; Zhou WX, 2009, PHYSICA A, V388, P869, DOI 10.1016/j.physa.2008.11.041; Zhou WX, 2006, PHYSICA A, V361, P297, DOI 10.1016/j.physa.2005.06.098; Zhou WX, 2003, PHYSICA A, V329, P249, DOI 10.1016/S0378-4371(03)00600-9	22	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0128908	10.1371/journal.pone.0128908	http://dx.doi.org/10.1371/journal.pone.0128908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ6BA	26339793	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200001
J	Yang, G; Cheng, QL; Liu, S; Zhao, JH				Yang, Guang; Cheng, Qingli; Liu, Sheng; Zhao, Jiahui			The Role of Bone Marrow Cells in the Phenotypic Changes Associated with Diabetic Nephropathy	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STROMAL CELLS	The aim of our study was to investigate the role of bone marrow cells in the phenotypic changes that occur in diabetic nephropathy. Bone marrow cells were obtained from either streptozotocin-induced diabetic or untreated control C3H/He mice and transplanted into control C3H/He mice. Eight weeks after bone marrow cell transplantation, renal morphologic changes and clinical parameters of diabetic nephropathy, including the urine albumin/creatinine ratio and glucose tolerance, were measured in vivo. Expression levels of the genes encoding alpha 1 type IV collagen and transforming growth factor-beta 1 in the kidney were assayed. Our results demonstrated that glucose tolerance was normal in the recipients of bone marrow transplants from both diabetic and control donors. However, compared with recipients of the control bone marrow transplant, the urinary albumin/creatinine ratio, glomerular size, and the mesangial/glomerular area ratio increased 3.3-fold (p < 0.01), 1.23-fold (p < 0.01), and 2.13-fold (p < 0.001), respectively, in the recipients of the diabetic bone marrow transplant. Expression levels of the genes encoding glomerular a1 type IV collagen and transforming growth factor-beta 1 were also significantly increased (p < 0.01) in the recipients of the diabetic bone marrow transplant. Our data suggest that bone marrow cells from the STZ-induced diabetic mice can confer a diabetic phenotype to recipient control mice without the presence of hyperglycemia.	[Yang, Guang; Cheng, Qingli; Liu, Sheng; Zhao, Jiahui] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Cheng, QL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China.	qlcheng64@163.com		Yang, Guang/0000-0001-5075-401X	National Natural Science Foundation of China [81170312, 30772296]; National Natural Science Foundation of Beijing [7122163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (81170312, 30772296) (http://www.nsfc.gov.cn), and the National Natural Science Foundation of Beijing (7122163) (http://www.bjkw.gov.cn/n8785584/index.html) granted to QC. The funders had participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Ben Nasr M, 2015, ACTA DIABETOL; Bernardi S, 2012, EXP DIABETES RES, DOI 10.1155/2012/872504; Cornacchia F, 2001, J CLIN INVEST, V108, P1649; Cramer C, 2010, STEM CELLS DEV, V19, P1875, DOI 10.1089/scd.2010.0009; Doria A, 2012, SEMIN NEPHROL, V32, P437, DOI 10.1016/j.semnephrol.2012.07.006; Ezquer F, 2009, BIOL BLOOD MARROW TR, V15, P1354, DOI 10.1016/j.bbmt.2009.07.022; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Fiorina P, 2014, J AM SOC NEPHROL, V25, P1415, DOI 10.1681/ASN.2013050518; Guang Y, 2015, ZHONGHUA LINCHUANG Y, V15, P246; Hasan M J, 2015, Mymensingh Med J, V24, P18; KAKU K, 1988, DIABETES, V37, P707, DOI 10.2337/diabetes.37.6.707; Kume S, 2005, J BONE MINER RES, V20, P1647, DOI 10.1359/JBMR.050514; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Loeffler I, 2012, AM J PHYSIOL-RENAL, V303, pF733, DOI 10.1152/ajprenal.00212.2012; MACKAY K, 1988, KIDNEY INT, V33, P677, DOI 10.1038/ki.1988.53; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stolzing A, 2012, STEM CELLS DEV, V21, P2718, DOI 10.1089/scd.2011.0406; Stolzing A, 2010, CELLS TISSUES ORGANS, V191, P453, DOI 10.1159/000281826; Thum T, 2007, DIABETES, V56, P666, DOI 10.2337/db06-0699; Volarevic V, 2011, STEM CELLS, V29, P5, DOI 10.1002/stem.556; Volarevic V, 2010, AUTOIMMUNITY, V43, P255, DOI 10.3109/08916930903305641; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zheng F, 2004, DIABETES, V53, P2420, DOI 10.2337/diabetes.53.9.2420	26	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137245	10.1371/journal.pone.0137245	http://dx.doi.org/10.1371/journal.pone.0137245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340671	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200039
J	Malone, CD; Olson, ES; Mattrey, RF; Jiang, T; Tsien, RY; Nguyen, QT				Malone, Christopher D.; Olson, Emilia S.; Mattrey, Robert F.; Jiang, Tao; Tsien, Roger Y.; Nguyen, Quyen T.			Tumor Detection at 3 Tesla with an Activatable Cell Penetrating Peptide Dendrimer (ACPPD-Gd), alpha T1 Magnetic Resonance (MR) Molecular Imaging Agent	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2 ACTIVITY; ACTIVITY IN-VIVO; BREAST-CANCER; NONINVASIVE DETECTION; CONTRAST AGENT; MOUSE MODEL; FLUORESCENCE; PROGRESSION; METASTASIS; SWITCH	Purpose The ability to detect small malignant lesions with magnetic resonance imaging (MRI) is limited by inadequate accumulations of Gd with standard chelate agents. To date, no T1-targeted agents have proven superiority to Gd chelates in their ability to detect small tumors at clinically relevant field strengths. Activatable cell-penetrating peptides and their Gd-loaded dendrimeric form (ACPPD-Gd) have been shown to selectively accumulate in tumors. In this study we compared the performance of ACPPD-Gd vs. untargeted Gd chelates to detect small tumors in rodent models using a clinical 3T-MR system. Materials and Methods This study was approved by the Institutional-Animal Care-and-Use Committee. 2 of 4 inguinal breast fat pads of 16 albino-C57BL/6mice were inoculated with tumor Py8119 cells and the other 2 with saline at random. MRI at 3T was performed at 4, 9, and 14 days after inoculation on 8 mice 24-hours after injection of 0.036mmol Gd/kg (ACPPD-Gd), and before and 2- 3 minutes after 0.1 mmol/kg gadobutrol on the other 8 mice. T1-weighted (T1w) tumor signal normalized to muscle, was compared among the non-contrast, gadobutrol, and ACPPD-Gd groups using ANOVA. Experienced and trainee readers blinded to experimental conditions assessed for the presence of tumor in each of the 4 breast regions. Receiver operator characteristic (ROC) curves and area-under-curve (AUC) values were constructed and analyzed. Results Tumors >= 1mm(3) were iso-intense to muscle without contrast on T1w sequences. They enhanced diffusely and homogeneously by 57 +/- 20% (p<0.001) 24 hours after ACPPD-Gd and by 25 +/- 13% (p<0.001) immediately after gadobutrol. The nearly 2-fold difference was similar for small tumors (1-5mm(3)) (45 +/- 19% vs. 19 +/- 18%, p = 0.03). ACPPD-Gd tended to improve tumor detection by an experienced reader (AUC 0.98 vs 0.91) and significantly more for a trainee (0.93 vs. 0.82, p = 0.02) compared to gadobutrol. This improvement was more pronounced when obvious tumors (>5mm(3)) were removed from the ROC analysis for both the experienced observer (0.96 vs. 0.86) and more so for the trainee (0.86 vs. 0.69, p = 0.04). Conclusion ACPPD-Gd enhances MMP-expressing tumors of any size at 3T 24 hours after administration, improving their detection by blinded observers when compared to non-contrast and contrast groups given commercial Gd-chelates and imaged during the equilibrium phase.	[Malone, Christopher D.; Olson, Emilia S.; Mattrey, Robert F.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Jiang, Tao; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, San Diego, CA 92103 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92103 USA; [Nguyen, Quyen T.] Univ Calif San Diego, Dept Otolaryngol Head & Neck Surg, San Diego, CA 92103 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Malone, CD (corresponding author), Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.	cmalone@ucsd.edu			National Institutes of Health (NIH)/National Cancer Institute [5R01CA158448]; NIH in vivo cellular and molecular imaging centers (ICMIC) [P50-CA128346]; NIH [5T32EB005970-07]; Radiological Society of North America (RSNA) [RR1361]; Howard Hughes Medical Institute; Burroughs Wellcome Fund - CAMS; NATIONAL CANCER INSTITUTE [P50CA128346, R01CA158448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005970] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH in vivo cellular and molecular imaging centers (ICMIC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radiological Society of North America (RSNA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund - CAMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported in part by National Institutes of Health (NIH)/National Cancer Institute grant 5R01CA158448, www.cancer.gov, (RYT); NIH in vivo cellular and molecular imaging centers (ICMIC) P50-CA128346, http://imaging.cancer.gov/programsandresources/specializedinitiatives/icmicp50 (RFM, RYT); NIH 5T32EB005970-07 (ESO, RFM, CDM); Radiological Society of North America (RSNA) RR1361, http://www.rsna.org/research_resident_grant.aspx (CDM); Howard Hughes Medical Institute, http://www.hhmi.org (TJ, RYT); Burroughs Wellcome Fund - CAMS, http://www.bwfund.org/grant-programs/biomedicalsciences/career-awards-medical-scientists, (QTN).	Aguilera TA, 2009, INTEGR BIOL, V1, P371, DOI 10.1039/b904878b; Artacho-Cordon F, 2012, SURG ONCOL, V21, pE143, DOI 10.1016/j.suronc.2012.06.001; Biswas T, 2014, CANCER LETT, V346, P129, DOI 10.1016/j.canlet.2013.12.018; Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368; Burden-Gulley SM, 2013, TRANSL ONCOL, V6, P329, DOI 10.1593/tlo.12490; Chatterji M, 2010, MAGN RESON IMAGING C, V18, P207, DOI 10.1016/j.mric.2010.02.011; Chen S, STROKE UNPUB; Coumans FAW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-283; Crisp JL, 2014, MOL CANCER THER, V13, P1514, DOI 10.1158/1535-7163.MCT-13-1067; Eng J, 2015, ROC ANAL WEB BASED C; Fang JM, 2000, P NATL ACAD SCI USA, V97, P3884, DOI 10.1073/pnas.97.8.3884; Hanaoka K, 2008, MAGN RESON IMAGING, V26, P608, DOI 10.1016/j.mri.2007.11.002; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kircher MF, 2012, RADIOLOGY, V263, P633, DOI 10.1148/radiol.12102394; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lebel R, 2008, MAGN RESON MED, V60, P1056, DOI 10.1002/mrm.21741; Lepage M, 2007, MOL IMAGING, V6, P393, DOI 10.2310/7290.2007.00035; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Pais A, 2011, CANCER RES, V71, P7387, DOI 10.1158/0008-5472.CAN-11-1226; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Savariar EN, 2013, CANCER RES, V73, P855, DOI 10.1158/0008-5472.CAN-12-2969; Shazeeb MS, 2011, CANCER RES, V71, P2230, DOI 10.1158/0008-5472.CAN-10-1139; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; Turnbull LW, 2009, NMR BIOMED, V22, P28, DOI 10.1002/nbm.1273; Turpeenniemi-Hujanen T, 2005, BIOCHIMIE, V87, P287, DOI 10.1016/j.biochi.2005.01.014	31	12	12	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137104	10.1371/journal.pone.0137104	http://dx.doi.org/10.1371/journal.pone.0137104			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336058	Green Published, gold			2022-12-27	WOS:000360615400040
J	Ahmadizar, F; Onland-Moret, NC; de Boer, A; Liu, G; Maitland-van der Zee, AH				Ahmadizar, Fariba; Onland-Moret, N. Charlotte; de Boer, Anthonius; Liu, Geoffrey; Maitland-van der Zee, Anke H.			Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							PHASE-III TRIAL; METASTATIC COLORECTAL-CANCER; CELL LUNG-CANCER; SURROGATE END-POINTS; OXALIPLATIN-BASED CHEMOTHERAPY; ENDOTHELIAL GROWTH-FACTOR; PROGRESSION-FREE SURVIVAL; DOUBLE-BLIND; 1ST-LINE THERAPY; PLUS BEVACIZUMAB	Aim To evaluate the efficacy and safety of bevacizumab in the adjuvant cancer therapy setting within different subset of patients. Methods & Design/Results PubMed, EMBASE, Cochrane and Clinical trials.gov databases were searched for English language studies of randomized controlled trials comparing bevacizumab and adjuvant therapy with adjuvant therapy alone published from January 1966 to 7th of May 2014. Progression free survival, overall survival, overall response rate, safety and quality of life were analyzed using random-or fixed-effects models according to the PRISMA guidelines. We obtained data from 44 randomized controlled trials (30,828 patients). Combining bevacizumab with different adjuvant therapies resulted in significant improvement of progression free survival (log hazard ratio, 0.87; 95% confidence interval (CI), 0.84-0.89), overall survival (log hazard ratio, 0.96; 95% CI, 0.94-0.98) and overall response rate (relative risk, 1.46; 95% CI: 1.33-1.59) compared to adjuvant therapy alone in all studied tumor types. In subgroup analyses, there were no interactions of bevacizumab with baseline characteristics on progression free survival and overall survival, while overall response rate was influenced by tumor type and bevacizumab dose (p-value: 0.02). Although bevacizumab use resulted in additional expected adverse drug reactions except anemia and fatigue, it was not associated with a significant decline in quality of life. There was a trend towards a higher risk of several side effects in patients treated by high-dose bevacizumab compared to the lowdose e.g. all grade proteinuria (9.24; 95% CI: 6.60-12.94 vs. 2.64; 95% CI: 1.29-5.40). Conclusions Combining bevacizumab with different adjuvant therapies provides a survival benefit across all major subsets of patients, including by tumor type, type of adjuvant therapy, and duration and dose of bevacizumab therapy. Though bevacizumab was associated with increased risks of some adverse drug reactions such as hypertension and bleeding, anemia and fatigue were improved by the addition of bevacizumab.	[Ahmadizar, Fariba; de Boer, Anthonius; Maitland-van der Zee, Anke H.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht Inst Pharmaceut Sci UIPS, Utrecht, Netherlands; [Onland-Moret, N. Charlotte] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Liu, Geoffrey] Princess Margaret Hosp, Dept Med, Div Med Oncol & Hematol, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Liu, Geoffrey] Univ Toronto, Toronto, ON, Canada; [Liu, Geoffrey] Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada	Utrecht University; Utrecht University; Utrecht University Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto	Maitland-van der Zee, AH (corresponding author), Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht Inst Pharmaceut Sci UIPS, Utrecht, Netherlands.	A.H.Maitland@uu.nl	Liu, Geoffrey/N-4421-2016; Onland-Moret, N. Charlotte/G-9185-2011; Maitland-van der Zee, Anke/I-9572-2016	Onland-Moret, N. Charlotte/0000-0002-2360-913X; Maitland-van der Zee, Anke/0000-0002-0414-3442; Liu, Geoffrey/0000-0002-2603-7296				Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Allegra CJ, 2011, J CLIN ONCOL, V29, P11, DOI 10.1200/JCO.2010.30.0855; Amit L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051780; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Beauchemin C, 2014, ONCOTARGETS THER, V7, P1101, DOI 10.2147/OTT.S63302; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Bower JE, 2014, NAT REV CLIN ONCOL, V11, P597, DOI 10.1038/nrclinonc.2014.127; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Brufsky AM, 2011, J CLIN ONCOL, V29, P4286, DOI 10.1200/JCO.2010.34.1255; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Cameron D, 2013, LANCET ONCOL, V14, P933, DOI 10.1016/S1470-2045(13)70335-8; Cunningham D, 2013, LANCET ONCOL, V14, P1077, DOI 10.1016/S1470-2045(13)70154-2; Davis S., 2012, REV STUDIES EXAMININ; de Gramont A, 2012, LANCET ONCOL, V13, P1225, DOI 10.1016/S1470-2045(12)70509-0; Dotan E, 2012, J GASTROINTEST CANC; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Foster NR, 2011, CANCER-AM CANCER SOC, V117, P1262, DOI 10.1002/cncr.25526; Geiger-Gritsch S, 2010, ONCOLOGIST, V15, P1179, DOI 10.1634/theoncologist.2009-0155; Gianni L, 2013, J CLIN ONCOL, V31, P1719, DOI 10.1200/JCO.2012.44.7912; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Guan Zhong-Zhen, 2011, Chin J Cancer, V30, P682, DOI 10.5732/cjc.011.10188; Hainsworth JD, 2014, CL LYMPH MYELOM LEUK, V14, P277, DOI 10.1016/j.clml.2014.02.010; Hang XF, 2011, EUR J CLIN PHARMACOL, V67, P613, DOI 10.1007/s00228-010-0988-x; Hapani S, 2009, LANCET ONCOL, V10, P559, DOI 10.1016/S1470-2045(09)70112-3; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kelly WK, 2012, J CLIN ONCOL, V30, P1534, DOI 10.1200/JCO.2011.39.4767; Kemeny NE, 2011, J CLIN ONCOL, V29, P884, DOI 10.1200/JCO.2010.32.5977; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kindler HL, 2012, J CLIN ONCOL, V30, P2509, DOI 10.1200/JCO.2011.41.5869; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Martin M, 2011, LANCET ONCOL, V12, P369, DOI 10.1016/S1470-2045(11)70037-7; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mourad JJ, 2008, ANN ONCOL, V19, P927, DOI 10.1093/annonc/mdm550; Niho S, 2012, LUNG CANCER, V76, P362, DOI 10.1016/j.lungcan.2011.12.005; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Ranpura V, 2010, AM J HYPERTENS, V23, P460, DOI 10.1038/ajh.2010.25; Ranpura V, 2010, ACTA ONCOL, V49, P287, DOI 10.3109/02841860903524396; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schutz FA, 2010, ANN ONCOL; Schutz FAB, 2011, EUR J CANCER, V47, P1161, DOI 10.1016/j.ejca.2011.03.005; Sher A, 2011, ACTA ONCOL, V50, P997, DOI 10.3109/0284186X.2011.581689; Sherrill B, 2012, ONCOTARGETS THER, V5, P287, DOI 10.2147/OTT.S36683; Spigel DR, 2011, J CLIN ONCOL, V29, P2215, DOI 10.1200/JCO.2010.29.3423; Stathopoulos GP, 2010, ONCOLOGY-BASEL, V78, P376, DOI 10.1159/000320520; Su Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035629; Sutton A.J., 2000, METHODS METAANALYSIS; Tang PA, 2007, J CLIN ONCOL, V25, P4562, DOI 10.1200/JCO.2006.08.1935; Tebbutt N, 2009, EJC SUPPL, V7, P321, DOI 10.1016/S1359-6349(09)71096-1; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vale CL, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1798; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Wang Yaning, 2004, Angiogenesis, V7, P335, DOI 10.1007/s10456-004-8272-2; Wu SH, 2010, J AM SOC NEPHROL, V21, P1381, DOI 10.1681/ASN.2010020167; Yang JC, 2003, J CLIN ONCOL, V21, P3127, DOI 10.1200/JCO.2003.02.122; Yang K, 2010, CLIN DRUG INVEST, V30, P229, DOI 10.2165/11532260-000000000-00000; Ye Q, 2013, ARCH GYNECOL OBSTET, V288, P655, DOI 10.1007/s00404-013-2820-1; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039	72	17	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136324	10.1371/journal.pone.0136324	http://dx.doi.org/10.1371/journal.pone.0136324			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331473	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800051
J	Gowda, RN; Redfern, R; Frikeche, J; Pinglay, S; Foster, JW; Lema, C; Cope, L; Chakravarti, S				Gowda, Ranjita N.; Redfern, Rachel; Frikeche, Jihane; Pinglay, Sudarshan; Foster, James William; Lema, Carolina; Cope, Leslie; Chakravarti, Shukti			Functions of Peptidoglycan Recognition Proteins (Pglyrps) at the Ocular Surface: Bacterial Keratitis in Gene-Targeted Mice Deficient in Pglyrp-2,-3 and-4	PLOS ONE			English	Article							INNATE IMMUNITY; CORNEA; INFLAMMATION; NEUTROPHILS; EXPRESSION; RECEPTORS; DEFENSE	Purpose Functions of antimicrobial peptidoglycan recognition proteins (Pglyrp1-4) at the ocular surface are poorly understood. Earlier, we reported an antibacterial role for Pglyrp-1 in Pseudomonas aeruginosa keratitis. Here we investigated functions of three other related genes Pglyrp-2, -3 and -4 in a mouse model of P. aeruginosa keratitis. Methods Wild type (WT) and each of the Pglyrp-null genotypes were challenged with P. aeruginosa keratitis. The eyes were scored in a blinded manner 24 and 48h post infection. Viable bacterial counts and inflammatory factors (IL-12, TNF-alpha, IFN-gamma, CCL2, IL-6 and IL-10) were measured in whole eye homogenates using cytometric bead arrays. Expressions of Pglyrp-1-4, mouse beta defensins (mBD)-2,-3, cathelicidin-related antimicrobial peptide (CRAMP) were determined by qRTPCR in total RNA extracts of uninfected and infected eyes of WT and each of the Pglyrp-null mouse types. Results The Pglyrp-2(-/-) mice showed reduced disease and lower induction of pro-inflammatory TNF-alpha (p = 0.02) than WT or the other Pglyrp null mice. Viable bacterial yield was significantly lower in the Pglyrp-2(-/-) (p = 0.0007) and the Pglyrp-4(-/-) (p = 0.098) mice. With regards to expression of these antimicrobial genes, Pglyrp-2 expression was induced after infection in WT mice. Pglyrp-3 expression was low before and after infection in WT mice, while Pglyrp-4 expression was slightly elevated after infection in WT, Pglyrp-2 and -3 null mice. Pglyrp-1 expression was slightly elevated after infection in all genotypes without statistical significance. Transcripts for antimicrobial peptides mBD2, mBD3 and CRAMP were elevated in infected Pglyrp-2(-/-) males without statistical significance. Conclusions Efficient resolution of keratitis in the Pglyrp-2(-/-) mice may be due to a reduced pro-inflammatory microenvironment and synergistic antibacterial activities of defensins, CRAMP and Pglyrp-1. Therefore, in ocular infections the pro-inflammatory functions of Pglyrp-2 must be regulated to benefit the host.	[Gowda, Ranjita N.; Frikeche, Jihane; Pinglay, Sudarshan; Foster, James William; Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Redfern, Rachel; Lema, Carolina] Univ Houston, Coll Optometry, Ocular Surface Inst, Houston, TX USA; [Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA; [Chakravarti, Shukti] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Cope, Leslie] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Houston System; University of Houston; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Chakravarti, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	schakra1@jhmi.edu	Foster, James/AAK-2225-2020; Lema, Carolina/AFK-5176-2022; Lema, Carolina/AAG-3773-2022	Foster, James/0000-0002-8500-7994; Pinglay, Sudarshan/0000-0002-8781-1476; FRIKECHE, Jihane/0000-0003-1291-6908	National Eye Institute of the National Institutes of Health (NIH) [EY021585]; National Institutes of Health [EY11654, EY023628, P30-CAOO6973]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R56EY011654, R01EY023628, R21EY021585, R01EY011654] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health (NIH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by SC grant number EY021585 from National Eye Institute (https://www.nei.nih.gov) of the National Institutes of Health (NIH)(http://www.nih.gov/); SC grant number EY11654 from National Institutes of Health (http://www.nih.gov/); RR grant number EY023628 from National Institutes of Health (http://www.nih.gov/) and P30-CAOO6973 (LC) from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dziarski R, 2003, BLOOD, V102, P689, DOI 10.1182/blood-2002-12-3853; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Ghosh A, 2009, INVEST OPHTH VIS SCI, V50, P4185, DOI 10.1167/iovs.08-3040; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P5220, DOI 10.1167/iovs.03-0229; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Ma P, 2010, EXP EYE RES, V90, P130, DOI 10.1016/j.exer.2009.09.021; McDermott Alison M, 2004, Ocul Surf, V2, P229; McDermott AM, 2003, INVEST OPHTH VIS SCI, V44, P1859, DOI 10.1167/iovs.02-0787; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Wang HT, 2005, INFECT IMMUN, V73, P7216, DOI 10.1128/IAI.73.11.7216-7225.2005; Wu F, 2008, EXP EYE RES, V87, P214, DOI 10.1016/j.exer.2008.06.001; Zaidi TS, 2010, INVEST OPHTH VIS SCI, V51, P2085, DOI 10.1167/iovs.09-4139; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	19	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137129	10.1371/journal.pone.0137129	http://dx.doi.org/10.1371/journal.pone.0137129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332373	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800100
J	Hardy, JL; Nelson, RA; Thomason, ME; Sternberg, DA; Katovich, K; Farzin, F; Scanlon, M				Hardy, Joseph L.; Nelson, Rolf A.; Thomason, Moriah E.; Sternberg, Daniel A.; Katovich, Kiefer; Farzin, Faraz; Scanlon, Michael			Enhancing Cognitive Abilities with Comprehensive Training: A Large, Online, Randomized, Active-Controlled Trial	PLOS ONE			English	Article							WORKING-MEMORY; EXECUTIVE FUNCTION; BRAIN PLASTICITY; OLDER-ADULTS; INTELLIGENCE; IMPROVEMENT; KNOWLEDGE; CHILDREN; PROGRAM; SKILLS	Background A variety of studies have demonstrated gains in cognitive ability following cognitive training interventions. However, other studies have not shown such gains, and questions remain regarding the efficacy of specific cognitive training interventions. Cognitive training research often involves programs made up of just one or a few exercises, targeting limited and specific cognitive endpoints. In addition, cognitive training studies typically involve small samples that may be insufficient for reliable measurement of change. Other studies have utilized training periods that were too short to generate reliable gains in cognitive performance. Methods The present study evaluated an online cognitive training program comprised of 49 exercises targeting a variety of cognitive capacities. The cognitive training program was compared to an active control condition in which participants completed crossword puzzles. All participants were recruited, trained, and tested online (N = 4,715 fully evaluable participants). Participants in both groups were instructed to complete one approximately 15-minute session at least 5 days per week for 10 weeks. Results Participants randomly assigned to the treatment group improved significantly more on the primary outcome measure, an aggregate measure of neuropsychological performance, than did the active control group (Cohen's d effect size = 0.255; 95% confidence interval = [0.198, 0.312]). Treatment participants showed greater improvements than controls on speed of processing, short-term memory, working memory, problem solving, and fluid reasoning assessments. Participants in the treatment group also showed greater improvements on self-reported measures of cognitive functioning, particularly on those items related to concentration compared to the control group (Cohen's d = 0.249; 95% confidence interval = [0.191, 0.306]). Conclusion Taken together, these results indicate that a varied training program composed of a number of tasks targeted to different cognitive functions can show transfer to a wide range of untrained measures of cognitive performance.	[Hardy, Joseph L.; Sternberg, Daniel A.; Katovich, Kiefer; Farzin, Faraz; Scanlon, Michael] Lumos Labs, Dept Res & Dev, San Francisco, CA 94105 USA; [Nelson, Rolf A.] Wheaton Coll, Dept Psychol, Norton, MA 02766 USA; [Thomason, Moriah E.] Wayne State Univ, Merrill Palmer Skillman Inst Child & Family Dev, Detroit, MI USA; [Thomason, Moriah E.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Sternberg, DA (corresponding author), Lumos Labs, Dept Res & Dev, San Francisco, CA 94105 USA.	daniel@lumoslabs.com	Nelson, Rolf/AAU-4874-2020; Thomason, Moriah E/AAW-9511-2021	Thomason, Moriah/0000-0001-9745-1147	Lumos Labs, Inc.	Lumos Labs, Inc.	No external funding contributed to this research; Lumos Labs, Inc. funded the research through the development of its software tools and through the employment of JLH, DAS, KK, FF and MS and through the consulting services of RAN. The specific roles of these authors are articulated in the "Author Contributions" section. Other members of the company contributed suggestions and ideas during the design of the study and preparation of the manuscript, and provided support and advice to the authors during the process of submitting the manuscript for publication. Lumos Labs had no other role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Legal approval for publication before submission of the manuscript was obtained from Lumos Labs.	Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; BADDELEY AD, 1968, PSYCHON SCI, V10, P341; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Ball K, 2010, J AM GERIATR SOC, V58, P2107, DOI 10.1111/j.1532-5415.2010.03138.x; Bavelier D, 2012, ANNU REV NEUROSCI, V35, P391, DOI 10.1146/annurev-neuro-060909-152832; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Blom G., 1958, STAT ESTIMATES TRANS; Boot WR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00226; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Csikszentmihalyi M., 1991, FLOW PSYCHOL OPTIMAL; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; David P, BRAIN HLTH RES STUDY; DELOCHE G, 1994, J CLIN EXP NEUROPSYC, V16, P195, DOI 10.1080/01688639408402631; Evans JJ, 2002, SCHOOL PSYCHOL REV, V31, P246; Finn M, 2011, BRAIN IMPAIR, V12, P187; Floyd RG, 2003, PSYCHOL SCHOOLS, V40, P155, DOI 10.1002/pits.10083; Green CS, 2014, PSYCHOL RES-PSYCH FO, V78, P756, DOI 10.1007/s00426-013-0535-3; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hardy J, 2013, SCI LUMOSITY VERSION; HUNTER JE, 1986, J VOCAT BEHAV, V29, P340, DOI 10.1016/0001-8791(86)90013-8; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Kesler S, 2013, CLIN BREAST CANCER, V13, P299, DOI 10.1016/j.clbc.2013.02.004; Kesler SR, 2011, NEUROPSYCHOL REHABIL, V21, P433, DOI 10.1080/09602011.2011.578446; Kesler SR, 2011, BRAIN INJURY, V25, P101, DOI 10.3109/02699052.2010.536194; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Landau SM, 2011, NEUROBIOL AGING, V32, P1207, DOI 10.1016/j.neurobiolaging.2009.07.002; Mackey AP, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00032; Mayas J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092269; Mayo Clinic Staff, MEM LOSS 7 TIPS IMPR; McClelland MM, 2013, EARLY CHILD RES Q, V28, P314, DOI 10.1016/j.ecresq.2012.07.008; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Owsley C, 2002, GERONTOLOGY, V48, P254, DOI 10.1159/000058360; Pillai JA, 2011, J INT NEUROPSYCH SOC, V17, P1006, DOI 10.1017/S1355617711001111; Rattray B, 2013, J SCI MED SPORT, V16, P567, DOI 10.1016/j.jsams.2012.12.007; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Scanlon M., 2011, MENSA RES J, V42, P13, DOI DOI 10.1371/JOURNAL.PONE.0134467; Schmiedek F, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00027; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Sternberg DA, 2013, SOC NEUR M SAN DIEG; Tartaglione EV, 2013, AM ASS STUD LIV DIS; Wechsler D., 2008, WECHSLER ADULT INTEL; Wolinsky FD, 2006, J GERONTOL A-BIOL, V61, P1324, DOI 10.1093/gerona/61.12.1324; Wolinsky FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061624; Woollett K, 2011, CURR BIOL, V21, P2109, DOI 10.1016/j.cub.2011.11.018; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	51	79	80	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0134467	10.1371/journal.pone.0134467	http://dx.doi.org/10.1371/journal.pone.0134467			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26333022	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800009
J	Nishiyama, K; Nakashima, H; Ikarashi, M; Kinoshita, M; Nakashima, M; Aosasa, S; Seki, S; Yamamoto, J				Nishiyama, Kiyoshi; Nakashima, Hiroyuki; Ikarashi, Masami; Kinoshita, Manabu; Nakashima, Masahiro; Aosasa, Suefumi; Seki, Shuhji; Yamamoto, Junji			Mouse CD11b(+)Kupffer Cells Recruited from Bone Marrow Accelerate Liver Regeneration after Partial Hepatectomy	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; KILLER T-CELLS; KUPFFER CELLS; ALPHA-GALACTOSYLCERAMIDE; MONOCYTE CHEMOATTRACTANT; HEPATOCYTE PROLIFERATION; GADOLINIUM CHLORIDE; HEPATIC-FIBROSIS; INNATE IMMUNITY; EARLY PHASE	TNF and Fas/FasL are vital components, not only in hepatocyte injury, but are also required for hepatocyte regeneration. Liver F4/80(+)Kupffer cells are classified into two subsets; resident radio-resistant CD68(+)cells with phagocytic and bactericidal activity, and recruited radio-sensitive CD11b(+)cells with cytokine-producing capacity. The aim of this study was to investigate the role of these Kupffer cells in the liver regeneration after partial hepatectomy (PHx) in mice. The proportion of Kupffer cell subsets in the remnant liver was examined in C57BL/6 mice by flow cytometry after PHx. To examine the role of CD11b(+)Kupffer cells/Mf, mice were depleted of these cells before PHx by non-lethal 5 Gy irradiation with or without bone marrow transplantation (BMT) or the injection of a CCR2 (MCP-1 receptor) antagonist, and liver regeneration was evaluated. Although the proportion of CD68(+)Kupffer cells did not significantly change after PHx, the proportion of CD11b(+)Kupffer cells/Mf and their FasL expression was greatly increased at three days after PHx, when the hepatocytes vigorously proliferate. Serum TNF and MCP-1 levels peaked one day after PHx. Irradiation eliminated the CD11b(+)Kupffer cells/Mf for approximately two weeks in the liver, while CD68(+)Kupffer cells, NK cells and NKT cells remained, and hepatocyte regeneration was retarded. However, BMT partially restored CD11b(+)Kupffer cells/Mf and recovered the liver regeneration. Furthermore, CCR2 antagonist treatment decreased the CD11b(+)Kupffer cells/Mf and significantly inhibited liver regeneration. The CD11b(+)Kupffer cells/Mf recruited from bone marrow by the MCP-1 produced by CD68(+)Kupffer cells play a pivotal role in liver regeneration via the TNF/FasL/Fas pathway after PHx.	[Nishiyama, Kiyoshi; Aosasa, Suefumi; Yamamoto, Junji] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan; [Nakashima, Hiroyuki; Ikarashi, Masami; Kinoshita, Manabu; Nakashima, Masahiro; Seki, Shuhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama 3598513, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan	Seki, S (corresponding author), Natl Def Med Coll, Dept Immunol & Microbiol, Namiki 3-2, Tokorozawa, Saitama 3598513, Japan.	btraums@ndmc.ac.jp			National Defense Medical College; JSPS KAKENHI Grant [25460508]; Takeda Science Foundation	National Defense Medical College; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grant-in-aid for Special Research Program from the National Defense Medical College, JSPS KAKENHI Grant Number 25460508, and Takeda Science Foundation to NH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Biswas SK, 2002, J INTERF CYTOK RES, V22, P527, DOI 10.1089/10799900252982007; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Boulton RA, 1998, J HEPATOL, V29, P271, DOI 10.1016/S0168-8278(98)80013-5; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Cherney RJ, 2008, J MED CHEM, V51, P721, DOI 10.1021/jm701488f; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; DIEHL AM, 1994, AM J PHYSIOL-GASTR L, V267, pG552, DOI 10.1152/ajpgi.1994.267.4.G552; Diehl AM, 1996, J GASTROEN HEPATOL, V11, P466, DOI 10.1111/j.1440-1746.1996.tb00292.x; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; GALLIGANI L, 1979, TOXICOL APPL PHARM, V48, P131, DOI 10.1016/S0041-008X(79)80015-0; Higgins GM, 1931, ARCH PATHOL, V12, P186; Ikarashi M, 2013, J LEUKOCYTE BIOL, V94, P1325, DOI 10.1189/jlb.0313144; Inui T, 2005, J HEPATOL, V43, P670, DOI 10.1016/j.jhep.2005.02.027; Inui T, 2002, J IMMUNOL, V169, P6127, DOI 10.4049/jimmunol.169.11.6127; ITOH H, 1988, J IMMUNOL, V141, P315; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kawabata T, 2008, HEPATOLOGY, V48, P1586, DOI 10.1002/hep.22489; Kinoshita M, 2005, SHOCK, V23, P65, DOI 10.1097/01.shk.0000144423.40270.96; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kobayashi E, 1995, ONCOL RES, V7, P529; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Louis H, 1998, HEPATOLOGY, V28, P1607, DOI 10.1002/hep.510280621; Mei Y, 2011, HEPATOLOGY, V54, P1777, DOI 10.1002/hep.24560; Meijer C, 2000, LIVER, V20, P66, DOI 10.1034/j.1600-0676.2000.020001066.x; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Minagawa M, 2000, HEPATOLOGY, V31, P907, DOI 10.1053/he.2000.5850; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Nakagawa R, 2001, J IMMUNOL, V166, P6578, DOI 10.4049/jimmunol.166.11.6578; Nakashima H, 2006, GASTROENTEROLOGY, V131, P1573, DOI 10.1053/j.gastro.2006.08.028; Nakashima H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049339; Nakashima H, 2008, HEPATOLOGY, V48, P1979, DOI 10.1002/hep.22561; Nakashima M, 2012, J LEUKOCYTE BIOL, V91, P537, DOI 10.1189/jlb.0411214; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Ogasawara K, 1998, J IMMUNOL, V160, P3522; Rai RM, 1996, AM J PHYSIOL-GASTR L, V270, pG909, DOI 10.1152/ajpgi.1996.270.6.G909; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seki S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868345; Takehara T, 1998, HEPATOLOGY, V27, P1643, DOI 10.1002/hep.510270625; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Webber EM, 1998, HEPATOLOGY, V28, P1226, DOI 10.1002/hep.510280509; Yamada Y, 1998, HEPATOLOGY, V28, P959, DOI 10.1002/hep.510280410; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yang YP, 2003, J HEPATOL, V39, P200, DOI 10.1016/S0168-8278(03)00229-0; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056; Zimmers TA, 2003, HEPATOLOGY, V38, P326, DOI 10.1053/jhep.2003.50318	51	40	43	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136774	10.1371/journal.pone.0136774	http://dx.doi.org/10.1371/journal.pone.0136774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333171	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800069
J	Phay, M; Kim, HH; Yoo, S				Phay, Monichan; Kim, Hak Hee; Yoo, Soonmoon			Dynamic Change and Target Prediction of Axon-Specific MicroRNAs in Regenerating Sciatic Nerve	PLOS ONE			English	Article							MESSENGER-RNA; PERIPHERAL-NERVE; PROTEIN-SYNTHESIS; INJURED NERVE; LOCALIZATION; NEURONS; DISORDERS; SYSTEM; DEGRADATION; REPERTOIRE	Injury to axons in the peripheral nervous system induces rapid and local regenerative responses to form a new growth cone, and to generate a retrogradely transporting injury signal. The evidence for essential roles of intra-axonal protein synthesis during regeneration is now compelling. MicroRNA (miRNA) has recently been recognized as a prominent player in post-transcriptional regulation of axonal protein synthesis. Here, we directly contrast temporal changes of miRNA levels in the sciatic nerve following injury, as compared to those in an uninjured nerve using deep sequencing. Small RNAs (<200 nucleotides in length) were fractionated from the proximal nerve stumps to improve the representation of differential miRNA levels. Of 141 axoplasmic miRNAs annotated, 63 rat miRNAs showed significantly differential levels at five time points following injury, compared to an uninjured nerve. The differential changes in miRNA levels responding to injury were processed for hierarchical clustering analyses, and used to predict target mRNAs by Targetscan and miRanda. By overlapping these predicted targets with 2,924 axonally localizing transcripts previously reported, the overlapping set of 214 transcripts was further analyzed by the Gene Ontology enrichment and Ingenuity Pathway Analyses. These results suggest the possibility that the potential targets for these miRNAs play key roles in numerous neurological functions involved in ER stress response, cytoskeleton dynamics, vesicle formation, and neurodegeneration and-regeneration. Finally, our results suggest that miRNAs could play a direct role in regenerative response and may be manipulated to promote regenerative ability of injured nerves.	[Phay, Monichan; Kim, Hak Hee; Yoo, Soonmoon] Alfred I DuPont Hosp Children, Nemours Biomed Res, Wilmington, DE 19803 USA; [Phay, Monichan] Univ Delaware, Dept Biol Sci, Delaware, NE USA	Nemours Alfred I. duPont Hospital for Children; University of Delaware	Yoo, S (corresponding author), Alfred I DuPont Hosp Children, Nemours Biomed Res, Wilmington, DE 19803 USA.	yoo@medsci.udel.edu		Yoo, Soonmoon/0000-0002-1645-6809	National Institutes of Health [P20-GM103464, R21-NS085691]; Delaware INBRE Core Center Access Award from an Institutional Development Award (IDeA) Network of Biomedical Research Excellence program (INBRE) of the National Institutes of Health [P20-GM103446]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464, P20GM103446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Delaware INBRE Core Center Access Award from an Institutional Development Award (IDeA) Network of Biomedical Research Excellence program (INBRE) of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by awards from the National Institutes of Health (P20-GM103464 and R21-NS085691 to SY). This project was also partially supported by Delaware INBRE Core Center Access Award (SY) from an Institutional Development Award (IDeA) Network of Biomedical Research Excellence program (INBRE; P20-GM103446) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Christensen M, 2009, NEUROSCI LETT, V466, P55, DOI 10.1016/j.neulet.2009.04.043; Donnelly CJ, 2011, EMBO J, V30, P4665, DOI 10.1038/emboj.2011.347; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; Khudayberdiev SA, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00043; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Liu NK, 2011, PHYSIOL GENOMICS, V43, P571, DOI 10.1152/physiolgenomics.00168.2010; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Merianda TT, 2013, J NEUROSCI, V33, P13735, DOI 10.1523/JNEUROSCI.0962-13.2013; Merianda TT, 2013, J CELL SCI, V126, P90, DOI 10.1242/jcs.107268; Murashov AK, 2007, FASEB J, V21, P656, DOI 10.1096/fj.06-6155com; Nakanishi K, 2010, SPINAL CORD, V48, P192, DOI 10.1038/sc.2009.89; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perry RB, 2012, NEURON, V75, P294, DOI 10.1016/j.neuron.2012.05.033; Rishal I, 2010, J VIS EXP; Rishal I, 2010, DEV NEUROBIOL, V70, P126, DOI 10.1002/dneu.20755; Toth CC, 2009, J NEUROPATH EXP NEUR, V68, P326, DOI 10.1097/NEN.0b013e31819ac71b; Twiss JL, 2000, NEUROBIOL DIS, V7, P416, DOI 10.1006/nbdi.2000.0293; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Weinberg MS, 2009, HUM MOL GENET, V18, pR27, DOI 10.1093/hmg/ddp070; Willis DE, 2011, J NEUROSCI, V31, P14481, DOI 10.1523/JNEUROSCI.2950-11.2011; Yu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024612; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zhou SL, 2011, NEUROSCI LETT, V494, P89, DOI 10.1016/j.neulet.2011.02.064	32	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137461	10.1371/journal.pone.0137461	http://dx.doi.org/10.1371/journal.pone.0137461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331719	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800133
J	Potter, A; Mills, DS				Potter, Alice; Mills, Daniel Simon			Domestic Cats (Felis silvestris catus) Do Not Show Signs of Secure Attachment to Their Owners	PLOS ONE			English	Article							AINSWORTHS STRANGE SITUATION; SEPARATION ANXIETY SYNDROME; BEHAVIOR; DOGS; RESPONSES; STRESS	The Ainsworth Strange Situation Test (SST) has been widely used to demonstrate that the bond between both children and dogs to their primary carer typically meets the requirements of a secure attachment (i.e. the carer being perceived as a focus of safety and security in otherwise threatening environments), and has been adapted for cats with a similar claim made. However methodological problems in this latter research make the claim that the cat-owner bond is typically a secure attachment, operationally definable by its behaviour in the SST, questionable. We therefore developed an adapted version of the SST with the necessary methodological controls which include a full counterbalance of the procedure. A cross-over design experiment with 20 cat-owner pairs (10 each undertaking one of the two versions of the SST first) and continuous focal sampling was used to record the duration of a range of behavioural states expressed by the cats that might be useful for assessing secure attachment. Since data were not normally distributed, non-parametric analyses were used on those behaviours shown to be reliable across the two versions of the test (which excluded much cat behaviour). Although cats vocalised more when the owner rather the stranger left the cat with the other individual, there was no other evidence consistent with the interpretation of the bond between a cat and its owner meeting the requirements of a secure attachment. These results are consistent with the view that adult cats are typically quite autonomous, even in their social relationships, and not necessarily dependent on others to provide a sense of security and safety. It is concluded that alternative methods need to be developed to characterise the normal psychological features of the cat-owner bond.	[Potter, Alice; Mills, Daniel Simon] Lincoln Univ, Anim Behav Cognit & Welf Grp, Sch Life Sci, Lincoln, Lincs, England	University of Lincoln	Mills, DS (corresponding author), Lincoln Univ, Anim Behav Cognit & Welf Grp, Sch Life Sci, Lincoln, Lincs, England.	dmills@lincoln.ac.uk						Ainsworth M., 1978, PATTERNS ATTACHMENT; Bateson P, 2000, DOMESTIC CAT BIOL IT, P232; Bernstein P.L., 2007, HUMAN CAT RELATIONSH, P47, DOI [10.1007/978-1-4020-3227-1_3, DOI 10.1007/978-1-4020-3227-1_3, 10.1007/978-1-4020-3227-13, DOI 10.1007/978-1-4020-3227-13]; BOWLBY J, 1958, INT J PSYCHOANAL, V39, P350; Bowlby J., 1969, ATTACHMENT LOSS, V1, P177; Bradshaw JWS, 1999, APPL ANIM BEHAV SCI, V63, P251, DOI 10.1016/S0168-1591(99)00007-6; CARLSTEAD K, 1993, APPL ANIM BEHAV SCI, V38, P143, DOI 10.1016/0168-1591(93)90062-T; Cassidy J, 1999, HDB ATTACHMENT THEOR, P3; CROWELL S., 2007, TRANSCENDENTAL HEIDE, P1; Crowell-Davis SL, 2004, J FELINE MED SURG, V6, P19, DOI 10.1016/j.jfms.2003.09.013; CrowellDavis SL, 1997, VET CLIN N AM-SMALL, V27, P549, DOI 10.1016/S0195-5616(97)50054-4; Downey H, 2008, J BUS RES, V61, P434, DOI 10.1016/j.jbusres.2007.07.015; Edwards C, 2007, J VET BEHAV, V2, P119, DOI 10.1016/j.jveb.2007.06.004; European Pet Food Industry Federation, 2010, FACTS FIG 2010; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Heidenberger E, 1997, APPL ANIM BEHAV SCI, V52, P345, DOI 10.1016/S0168-1591(96)01134-3; Jones B, 2003, DESIGN ANAL CROSS OV, V2nd, P13; Jongman EC, 2007, J VET BEHAV, V2, P193, DOI 10.1016/j.jveb.2007.09.003; Karsh E, 1984, PET CONNECTION ITS I, P207; Kessler MR, 1999, ANIM WELFARE, V8, P259; Ley JM, 2012, THE CAT, P191; Lowe SE, 2002, ANTHROZOOS, V15, P69, DOI 10.2752/089279302786992702; Macdonald David W., 2000, P95; Martin P., 1993, MEASURING BEHAV, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Mendl M, 2000, DOMESTIC CAT BIOL IT, P193; Mertens C., 1991, Anthrozoos, V4, P214, DOI 10.2752/089279391787057062; Mertens C., 1989, Anthrozoos, V2, P83, DOI 10.2752/089279389787058109; Mills DS, 2013, STRESS PHEROMONATHER, P159; Natoli E, 2001, BEHAV PROCESS, V53, P137, DOI 10.1016/S0376-6357(00)00145-5; Palestrini C, 2005, APPL ANIM BEHAV SCI, V94, P75, DOI 10.1016/j.applanim.2005.02.005; Palmer R, 2008, APPL ANIM BEHAV SCI, V109, P306, DOI 10.1016/j.applanim.2007.04.002; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Parthasarathy V, 2006, J VET BEHAV, V1, P109, DOI 10.1016/j.jveb.2006.09.005; Pet Food Manufacturers Association, 2010, PET POP 2008 2011; PODBERSCEK AL, 1991, APPL ANIM BEHAV SCI, V31, P119, DOI 10.1016/0168-1591(91)90159-U; Prato-Previde E, 2003, BEHAVIOUR, V140, P225, DOI 10.1163/156853903321671514; Ricci E, 2011, J VET BEHAV, V6, P91; Schwartz S, 2003, J AM VET MED ASSOC, V222, P1526, DOI 10.2460/javma.2003.222.1526; Schwartz S, 2002, J AM VET MED ASSOC, V220, P1028, DOI 10.2460/javma.2002.220.1028; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Topal J, 1998, J COMP PSYCHOL, V112, P219, DOI 10.1037/0735-7036.112.3.219; Turner D. C., 2000, The domestic cat: the biology of its behaviour., P193; van IJzendoorn MH, 2009, DEV PSYCHOBIOL, V51, P173, DOI 10.1002/dev.20356; Wedl M, 2011, BEHAV PROCESS, V86, P58, DOI 10.1016/j.beproc.2010.09.001; Weinfield N. S., 1999, HDB ATTACHMENT THEOR, P68; White JM, 2010, J VET BEHAV, V5, P47; ZASLOFF RL, 1994, PSYCHOL REP, V74, P747, DOI 10.2466/pr0.1994.74.3.747	47	22	23	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135109	10.1371/journal.pone.0135109	http://dx.doi.org/10.1371/journal.pone.0135109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332470	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000360613800021
J	Lee, ACH; Lam, JKY; Shiu, SWM; Wong, Y; Betteridge, DJ; Tan, KCB				Lee, Alan C. H.; Lam, Joanne K. Y.; Shiu, Sammy W. M.; Wong, Ying; Betteridge, D. John; Tan, Kathryn C. B.			Serum Level of Soluble Receptor for Advanced Glycation End Products Is Associated with A Disintegrin And Metalloproteinase 10 in Type 1 Diabetes	PLOS ONE			English	Article							A-SECRETASE; RAGE; ADAM10; CLEAVAGE; BIOLOGY; IDENTIFICATION; INSULIN; DISEASE; FORM	Background The receptor for advanced glycation end products (RAGE) is involved in the pathogenesis of diabetic complications, and soluble forms of the receptor (sRAGE) can counteract the detrimental action of the full-length receptor by acting as decoy. Soluble RAGE is produced by alternative splicing [endogenous secretory RAGE (esRAGE)] and/or by proteolytic cleavage of the membrane-bound receptor. We have investigated the role of A Disintegrin And Metalloproteinase 10 (ADAM10) in the ectodomain shedding of RAGE. Methods Constitutive and insulin-induced shedding of RAGE in THP-1 macrophages by ADAM10 was evaluated using an ADAM10-specific metalloproteinase inhibitor. Serum ADAM10 level was measured in type 1 diabetes and control subjects, and the association with serum soluble RAGE was determined. Serum total sRAGE and esRAGE were assayed by ELISA and the difference between total sRAGE and esRAGE gave an estimated measure of soluble RAGE formed by cleavage (cRAGE). Results RAGE shedding (constitutive and insulin-induced) was significantly reduced after inhibition of ADAM10 in macrophages, and insulin stimulated ADAM10 expression and activity. Diabetic subjects have higher serum total sRAGE and esRAGE (p<0.01) than controls, and serum ADAM10 was also increased (p<0.01). Serum ADAM10 correlated with serum cRAGE in type 1 diabetes (r = 0.40, p<0.01) and in controls (r = 0.31. p<0.01) but no correlations were seen with esRAGE. The association remained significant after adjusting for age, gender, BMI, smoking status and HbA1c. Conclusion Our data suggested that ADAM10 contributed to the shedding of RAGE. Serum ADAM10 level was increased in type 1 diabetes and was a significant determinant of circulating cRAGE.	[Lee, Alan C. H.; Lam, Joanne K. Y.; Shiu, Sammy W. M.; Wong, Ying; Tan, Kathryn C. B.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Betteridge, D. John] Royal Free, Dept Med, London, England; [Betteridge, D. John] UCL, Sch Med, London W1N 8AA, England	University of Hong Kong; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; UCL Medical School	Tan, KCB (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.	kcbtan@hkucc.hku.hk			Hong Kong Research Grants Council Research Fund [HKU777712M]	Hong Kong Research Grants Council Research Fund(Hong Kong Research Grants Council)	Supported by the Hong Kong Research Grants Council Research Fund (HKU777712M awarded to KCBT).	Barlovic DP, 2011, CLIN SCI, V121, P43, DOI 10.1042/CS20100501; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Endres K, 2012, CURR ALZHEIMER RES, V9, P157, DOI 10.2174/156720512799361664; Galichet A, 2008, BIOCHEM BIOPH RES CO, V370, P1, DOI 10.1016/j.bbrc.2008.02.163; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Lam JKY, 2013, DIABETIC MED, V30, P702, DOI 10.1111/dme.12166; Metz VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041823; Postina R, 2012, J NEUROCHEM, V120, P46, DOI 10.1111/j.1471-4159.2011.07459.x; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Quade-Lyssy P, 2013, J LIPID RES, V54, P3052, DOI 10.1194/jlr.M038968; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Tam HL, 2010, ATHEROSCLEROSIS, V209, P173, DOI 10.1016/j.atherosclerosis.2009.08.031; Tousseyn Thomas, 2006, Birth Defects Research, V78, P24, DOI 10.1002/bdrc.20066; Vazzana N, 2009, INTERN EMERG MED, V4, P389, DOI 10.1007/s11739-009-0300-1; Vingtdeux V, 2012, J NEUROCHEM, V120, P34, DOI 10.1111/j.1471-4159.2011.07477.x	20	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137330	10.1371/journal.pone.0137330	http://dx.doi.org/10.1371/journal.pone.0137330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325204	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700111
J	Li, LL; Garibaldi, JM; He, DJ; Wang, ML				Li, Longlong; Garibaldi, Jonathan M.; He, Dongjian; Wang, Meili			Semi-Supervised Fuzzy Clustering with Feature Discrimination	PLOS ONE			English	Article							FEATURE-SELECTION; CLASSIFICATION; ALGORITHMS; INFORMATION	Semi-supervised clustering algorithms are increasingly employed for discovering hidden structure in data with partially labelled patterns. In order to make the clustering approach useful and acceptable to users, the information provided must be simple, natural and limited in number. To improve recognition capability, we apply an effective feature enhancement procedure to the entire data-set to obtain a single set of features or weights by weighting and discriminating the information provided by the user. By taking pairwise constraints into account, we propose a semi-supervised fuzzy clustering algorithm with feature discrimination (SFFD) incorporating a fully adaptive distance function. Experiments on several standard benchmark data sets demonstrate the effectiveness of the proposed method.	[Li, Longlong; He, Dongjian] Northwest A & F Univ, Coll Mech & Elect Engn, Yangling 712100, Shaanxi, Peoples R China; [Li, Longlong] Shaanxi Polytech Inst, Coll Informat Engn, Xianyang 712100, Shaanxi, Peoples R China; [Garibaldi, Jonathan M.] Univ Nottingham, Sch Comp Sci, IMA Grp, Nottingham NG8 1BB, England; [Wang, Meili] Northwest A & F Univ, Coll Informat Engn, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Shaanxi Polytechnic Institute; University of Nottingham; Northwest A&F University - China	He, DJ (corresponding author), Northwest A & F Univ, Coll Mech & Elect Engn, Yangling 712100, Shaanxi, Peoples R China.	hdj168@nwsuaf.edu.cn		Garibaldi, Jonathan/0000-0002-9690-7074	National High-tech Research and Development Program (863 program) [2013AA10230402]; National Natural Science Foundation [61402374]; Chinese Scholarship Council; Research Foundation of Shaanxi Polytechnic Institute [ZK11-34]; Medical Research Council [MR/N005953/1] Funding Source: researchfish; MRC [MR/N005953/1] Funding Source: UKRI	National High-tech Research and Development Program (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council); Research Foundation of Shaanxi Polytechnic Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is partially supported by the National High-tech Research and Development Program (863 program: 2013AA10230402), National Natural Science Foundation (61402374), Chinese Scholarship Council and Research Foundation of Shaanxi Polytechnic Institute under Grant No. ZK11-34.	Bar-Hillel AB, 2005, J MACH LEARN RES, V6, P937; Basu AB S., 2002, P 19 INT C MACH LEAR, P19; Basu S, 2004, SIAM PROC S, P333; Basu S, 2004, P 10 ACM SIGKDD INT, P59, DOI DOI 10.1145/1014052.1014062; Benediktsson JA, 1997, INT J REMOTE SENS, V18, P727, DOI 10.1080/014311697218728; Bensaid A. M., 1996, Fourth European Congress on Intelligent Techniques and Soft Computing Proceedings, EUFIT '96, P1402; Cai WL, 2007, PATTERN RECOGN, V40, P825, DOI 10.1016/j.patcog.2006.07.011; Davidson I, 2005, LECT NOTES ARTIF INT, V3721, P59; Dy JG, 2004, J MACH LEARN RES, V5, P845; Dy JG, 2003, IEEE T PATTERN ANAL, V25, P373, DOI 10.1109/TPAMI.2003.1182100; Eschrich S, 2003, IEEE T FUZZY SYST, V11, P262, DOI 10.1109/TFUZZ.2003.809902; Filipovych R, 2011, NEUROIMAGE, V54, P2185, DOI 10.1016/j.neuroimage.2010.09.074; Frigui H, 2004, PATTERN RECOGN, V37, P567, DOI 10.1016/j.patcog.2003.08.002; Frigui H, 2000, NINTH IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS (FUZZ-IEEE 2000), VOLS 1 AND 2, P158, DOI 10.1109/FUZZY.2000.838651; Gabrys B, 2004, INT J APPROX REASON, V35, P251, DOI 10.1016/j.ijar.2003.08.005; Gabrys B, 2002, J VLSI SIG PROC SYST, V32, P67, DOI 10.1023/A:1016315401940; Gabrys B, 2000, IEEE T NEURAL NETWOR, V11, P769, DOI 10.1109/72.846747; GATH I, 1989, IEEE T PATTERN ANAL, V11, P773, DOI 10.1109/34.192473; Grira N, 2008, PATTERN RECOGN, V41, P1834, DOI 10.1016/j.patcog.2007.10.004; Kang BY, 2010, BIOINFORMATICS, V26, P1384, DOI 10.1093/bioinformatics/btq133; Kenji K, 1992, P 9 INT WORKSH MACH, P249, DOI DOI 10.1016/B978-1-55860-247-2.50037-1; KIRA K, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P129; Kulis B, 2009, MACH LEARN, V74, P1, DOI 10.1007/s10994-008-5084-4; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; Pedrycz W, 1997, IEEE T SYST MAN CY B, V27, P787, DOI 10.1109/3477.623232; Pedrycz W, 2002, PATTERN RECOGN, V35, P825, DOI 10.1016/S0031-3203(01)00102-9; Tang W, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P707; Tari L, 2009, J BIOMED INFORM, V42, P74, DOI 10.1016/j.jbi.2008.05.009; Wagstaff K., 2021, P 18 INT C MACH LEAR, P577, DOI DOI 10.1109/TPAMI.2002.1017616; Wang F, 2009, IEEE T KNOWL DATA EN, V21, P1665, DOI 10.1109/TKDE.2009.40; WANG PH, 1983, SIAM REV, V25, P442; Wettschereck D, 1997, ARTIF INTELL REV, V11, P273, DOI 10.1023/A:1006593614256; WINDHAM MP, 1982, IEEE T PATTERN ANAL, V4, P357, DOI 10.1109/TPAMI.1982.4767266; Yan BJ, 2006, LECT NOTES COMPUT SC, V4212, P521; Yasunori E, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS, VOLS 1-3, P1119, DOI 10.1109/FUZZY.2009.5277177; Yin XS, 2010, PATTERN RECOGN, V43, P1320, DOI 10.1016/j.patcog.2009.11.005; Zhang DQ, 2007, PROCEEDINGS OF THE SEVENTH SIAM INTERNATIONAL CONFERENCE ON DATA MINING, P629; Zhang DQ, LECTURE NOTES IN COM, P1229; Zhang HX, 2009, KNOWL-BASED SYST, V22, P477, DOI 10.1016/j.knosys.2009.06.009; Zhao HF, 2010, THIRD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING: WKDD 2010, PROCEEDINGS, P195, DOI 10.1109/WKDD.2010.123; Zhao Z, 2007, PROCEEDINGS OF THE SEVENTH SIAM INTERNATIONAL CONFERENCE ON DATA MINING, P641; Zhu SZ, 2010, KNOWL-BASED SYST, V23, P883, DOI 10.1016/j.knosys.2010.06.003	42	7	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0131160	10.1371/journal.pone.0131160	http://dx.doi.org/10.1371/journal.pone.0131160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325272	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700002
J	Takahara, K; Minami, K; Yoshikawa, Y; Takai, T; Ibuki, N; Hirano, H; Nomi, H; Kawabata, S; Kiyama, S; Miyatake, SI; Kuroiwa, T; Suzuki, M; Kirihata, M; Azuma, H				Takahara, Kiyoshi; Minami, Koichiro; Yoshikawa, Yuki; Takai, Tomoaki; Ibuki, Naokazu; Hirano, Hajime; Nomi, Hayahito; Kawabata, Shinji; Kiyama, Satoshi; Miyatake, Shin-Ichi; Kuroiwa, Toshihiko; Suzuki, Minoru; Kirihata, Mitsunori; Azuma, Haruhito			The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model	PLOS ONE			English	Article							PARA-BORONOPHENYLALANINE; MALIGNANT-MELANOMA; RECURRENT HEAD; BRAIN-TUMOR; RADIATION; DELIVERY; CELLS	Purpose Boron neutron capture therapy (BNCT) is a selective radiation treatment for tumors that preferentially accumulate drugs carrying the stable boron isotope, B-10. BNCT has been evaluated clinically as an alternative to conventional radiation therapy for the treatment of brain tumors, and more recently, recurrent advanced head and neck cancer. Here we investigated the effect of BNCT on prostate cancer (PCa) using an in vivo mouse xenograft model that we have developed. Materials and Methods Mice bearing the xenotransplanted androgen-independent human PCa cell line, PC3, were divided into four groups: Group 1: untreated controls; Group 2: Boronophenylalanine (BPA); Group 3: neutron; Group 4: BPA-mediated BNCT. We compared xenograft growth among these groups, and the body weight and any motility disturbance were recorded. Immunohistochemical (IHC) studies of the proliferation marker, Ki-67, and TUNEL staining were performed 9 weeks after treatment. Results The in vivo studies demonstrated that BPA-mediated BNCT significantly delayed tumor growth in comparison with the other groups, without any severe adverse events. There was a significant difference in the rate of freedom from gait abnormalities between the BPA-mediated BNCT group and the other groups. The IHC studies revealed that BNCT treatment significantly reduced the number of Ki-67-positive cells in comparison with the controls (mean +/- SD 6.9 +/- 1.5 vs 12.7 +/- 4.0, p<0.05), while there was no difference in the number of apoptotic cells, suggesting that BPA-mediated BNCT reduced PCa progression without affecting apoptosis at 9 weeks post-treatment. Conclusions This study has provided the first preclinical proof-of-principle data to indicate that BPA-mediated BNCT reduces the in vivo growth of PCa. Although further studies will be necessary, BNCT might be a novel potential treatment for PCa.	[Takahara, Kiyoshi; Minami, Koichiro; Yoshikawa, Yuki; Takai, Tomoaki; Ibuki, Naokazu; Hirano, Hajime; Nomi, Hayahito; Kiyama, Satoshi; Azuma, Haruhito] Osaka Med Coll, Fac Med, Dept Urol, Osaka, Japan; [Kawabata, Shinji; Miyatake, Shin-Ichi; Kuroiwa, Toshihiko] Osaka Med Coll, Dept Neurosurg, Osaka, Japan; [Suzuki, Minoru] Kyoto Univ, Inst Res Reactor, Radiat Oncol & Particle Radiat Oncol Res Ctr, Osaka 59004, Japan; [Kirihata, Mitsunori] Osaka Prefecture Univ, Res Ctr Boron Neutron Capture Therapy, Res Org 21st Century, Sakai, Osaka 591, Japan	Osaka Medical College; Osaka Medical College; Kyoto University; Osaka Metropolitan University	Takahara, K (corresponding author), Osaka Med Coll, Fac Med, Dept Urol, Osaka, Japan.	uro037@poh.osaka-med.ac.jp	Kawabata, Shinji/ABD-9354-2020	Kawabata, Shinji/0000-0001-5007-5279; Kirihata, Mitsunori/0000-0002-4183-9107	Grants-in-Aid for Scientific Research [26462192] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Barth RF, 2005, CLIN CANCER RES, V11, P3987, DOI 10.1158/1078-0432.CCR-05-0035; CODERRE JA, 1992, RADIAT RES, V129, P290, DOI 10.2307/3578028; CODERRE JA, 1990, CANCER RES, V50, P138; Coderre JA, 2003, TECHNOL CANCER RES T, V2, P355, DOI 10.1177/153303460300200502; Coderre JA, 1999, RADIAT RES, V151, P1, DOI 10.2307/3579742; FARR LE, 1954, AM J ROENTGENOL, V71, P279; Gifford I, 2014, INT J RADIAT BIOL, V90, P480, DOI 10.3109/09553002.2014.901579; Gleave M, 1999, CLIN CANCER RES, V5, P2891; HATANAKA H, 1994, INT J RADIAT ONCOL, V28, P1061, DOI 10.1016/0360-3016(94)90479-0; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kabalka GW, 1997, J NUCL MED, V38, P1762; Kabalka GW, 2003, J NEURO-ONCOL, V62, P187, DOI 10.1007/BF02699944; Kato I, 2009, APPL RADIAT ISOTOPES, V67, pS37, DOI 10.1016/j.apradiso.2009.03.103; Kawabata S, 2009, J RADIAT RES, V50, P51, DOI 10.1269/jrr.08043; Masunaga S, 2001, INT J RADIAT ONCOL, V51, P828, DOI 10.1016/S0360-3016(01)01695-9; Masunaga SI, 2014, EXP THER MED, V8, P291, DOI 10.3892/etm.2014.1704; MISHIMA Y, 1989, LANCET, V2, P388; Miyata S, 2011, NEUROSURGERY, V68, P1380, DOI 10.1227/NEU.0b013e31820b52aa; Miyatake SI, 2009, J NEURO-ONCOL, V91, P199, DOI 10.1007/s11060-008-9699-x; Moss RL, 2014, APPL RADIAT ISOTOPES, V88, P2, DOI 10.1016/j.apradiso.2013.11.109; Nigg DW, 1997, J NEURO-ONCOL, V33, P93, DOI 10.1023/A:1005777416716; SARIS SC, 1992, CANCER RES, V52, P4672; Schinazi RF, 2004, NUCLEOS NUCLEOT NUCL, V23, P291, DOI 10.1081/NCN-120027836; Sharifi N, 2010, ENDOCR-RELAT CANCER, V17, pR305, DOI 10.1677/ERC-10-0187; SOLOWAY AH, 1967, J MED CHEM, V10, P714, DOI 10.1021/jm00316a042; Suzuki M, 2014, J RADIAT RES, V55, P146, DOI 10.1093/jrr/rrt098; Wittig A, 2000, RADIAT RES, V153, P173, DOI 10.1667/0033-7587(2000)153[0173:MOTOPB]2.0.CO;2; Yasui L, 2012, APPL RADIAT ISOTOPES, V70, P6, DOI 10.1016/j.apradiso.2011.07.001	28	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136981	10.1371/journal.pone.0136981	http://dx.doi.org/10.1371/journal.pone.0136981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325195	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700078
J	Wang, XK; Huang, Y; Jastaneiah, S; Majumdar, S; Kang, JU; Yiu, SC; Stark, W; Elisseeff, JH				Wang, Xiaokun; Huang, Yong; Jastaneiah, Sabah; Majumdar, Shoumyo; Kang, Jin U.; Yiu, Samuel C.; Stark, Walter; Elisseeff, Jennifer H.			Protective Effects of Soluble Collagen during Ultraviolet-A Crosslinking on Enzyme-Mediated Corneal Ectatic Models	PLOS ONE			English	Article							PROGRESSIVE KERATOCONUS; BIOMECHANICAL CHANGES; TEAR FILM; RIBOFLAVIN; PROTEOGLYCANS; RABBIT; RIBOFLAVIN/ULTRAVIOLET; TOPOGRAPHY; INHIBITOR; FIBRILS	Collagen crosslinking is a relatively new treatment for structural disorders of corneal ectasia, such as keratoconus. However, there is a lack of animal models of keratoconus, which has been an obstacle for carefully analyzing the mechanisms of crosslinking and evaluating new therapies. In this study, we treated rabbit eyes with collagenase and chondroitinase enzymes to generate ex vivo corneal ectatic models that simulate the structural disorder of keratoconus. The models were then used to evaluate the protective effect of soluble collagen in the UVA crosslinking system. After enzyme treatment, the eyes were exposed to riboflavin/UVA crosslinking with and without soluble type I collagen. Corneal morphology, collagen ultrastructure, and thermal stability were evaluated before and after crosslinking. Enzyme treatments resulted in corneal curvature changes, collagen ultrastructural damage, decreased swelling resistance and thermal stability, which are similar to what is observed in keratoconus eyes. UVA crosslinking restored swelling resistance and thermal stability, but ultrastructural damage were found in the crosslinked ectatic corneas. Adding soluble collagen during crosslinking provided ultrastructural protection and further enhanced the swelling resistance. Therefore, UVA crosslinking on the ectatic model mimicked typical clinical treatment for keratoconus, suggesting that this model replicates aspects of human keratoconus and could be used for investigating experimental therapies and treatments prior to translation.	[Wang, Xiaokun; Yiu, Samuel C.; Stark, Walter; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Huang, Yong; Kang, Jin U.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Jastaneiah, Sabah] King Khalid Eye Specialist Hosp, Ophthalmol, Riyadh, Saudi Arabia; [Majumdar, Shoumyo; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; King Khaled Eye Specialist Hospital; Johns Hopkins University; Johns Hopkins University	Elisseeff, JH (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.	jhe@jhu.edu	Elisseeff, Jennifer/A-3324-2010; Wang, Xiaokun/D-7461-2018; WANG, XIAOKUN/GQR-1904-2022	Elisseeff, Jennifer/0000-0002-5066-1996; Wang, Xiaokun/0000-0003-1992-4951; 	KKESH-WEI Affiliation Research Grant; Research to Prevent Blindness Jules Stein Professorship	KKESH-WEI Affiliation Research Grant; Research to Prevent Blindness Jules Stein Professorship(Research to Prevent Blindness (RPB))	Funding was provided by KKESH-WEI Affiliation Research Grant, and Research to Prevent Blindness Jules Stein Professorship.	Achur RN, 2004, BBA-PROTEINS PROTEOM, V1701, P109, DOI 10.1016/j.bbapap.2004.06.007; Ahn CS, 1999, CORNEA, V18, P194, DOI 10.1097/00003226-199903000-00009; Akhtar S, 2008, ACTA OPHTHALMOL, V86, P764, DOI 10.1111/j.1755-3768.2007.01142.x; Akhtar S, 2013, MOL VIS, V19, P1526; Almubrad T, 2011, MOL VIS, V17, P2283; Ambekar R, 2011, J MECH BEHAV BIOMED, V4, P223, DOI 10.1016/j.jmbbm.2010.09.014; Angunawela RI, 2009, J CATARACT REFR SURG, V35, P606, DOI 10.1016/j.jcrs.2008.11.050; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; Chakravarti S, 2006, DEV DYNAM, V235, P2493, DOI 10.1002/dvdy.20868; Collier SA, 2001, CLIN EXP OPHTHALMOL, V29, P340, DOI 10.1046/j.1442-9071.2001.d01-17.x; Dhawan S, 2011, J OPHTHALMOL, V2011, P1; Dong J, 2013, INT J OPHTHALMOL-CHI, V6, P584, DOI 10.3980/j.issn.2222-3959.2013.05.05; Gokhale NS, 2011, CORNEA, V30, P1495, DOI 10.1097/ICO.0b013e31820687f7; Gokhale NS, 2010, CORNEA, V29, P117, DOI 10.1097/ICO.0b013e3181a06c31; Goldich Y, 2012, CORNEA, V31, P609, DOI 10.1097/ICO.0b013e318226bf4a; Grewal DS, 2009, J CATARACT REFR SURG, V35, P425, DOI 10.1016/j.jcrs.2008.11.046; Gwon A, ANIMAL MODELS EYE RE, P192; Hayes S, 2013, PLOS ONE, P8; Hayes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052860; Henriquez MA, 2011, CORNEA, V30, P281, DOI 10.1097/ICO.0b013e3181eeaea1; Holladay JT, 2009, J REFRACT SURG, V25, pS958, DOI 10.3928/1081597X-20090915-11; Holopainen JM, 2011, AM J OPHTHALMOL, V152, P533, DOI 10.1016/j.ajo.2011.03.023; Hong CW, 2012, INVEST OPHTH VIS SCI, V53, P2321, DOI 10.1167/iovs.11-9327; Hovakimyan M, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/406850; IHALAINEN A, 1986, EUR J CLIN INVEST, V16, P78, DOI 10.1111/j.1365-2362.1986.tb01311.x; Im E, 2007, EXP EYE RES, V84, P383, DOI 10.1016/j.exer.2006.05.017; Johnson RD, 2011, CORNEA, V30, P516, DOI 10.1097/ICO.0b013e3181f0579e; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; KENNEY MC, 1989, BIOCHEM BIOPH RES CO, V161, P353, DOI 10.1016/0006-291X(89)91604-5; Kling S, 2010, INVEST OPHTH VIS SCI, V51, P3961, DOI 10.1167/iovs.09-4536; Koller T, 2009, J CATARACT REFR SURG, V35, P1358, DOI 10.1016/j.jcrs.2009.03.035; Lim LS, 2011, ARCH OPHTHALMOL-CHIC, V129, P360, DOI 10.1001/archophthalmol.2011.23; Lin YK, 2006, FOOD CHEM, V99, P244, DOI 10.1016/j.foodchem.2005.06.053; Mackiewicz Z, 2006, CORNEA, V25, P603, DOI 10.1097/01.ico.0000208820.32614.00; MAEDA N, 1994, INVEST OPHTH VIS SCI, V35, P2749; MAGUIRE LJ, 1989, AM J OPHTHALMOL, V108, P107, DOI 10.1016/0002-9394(89)90001-9; Mazzotta C, 2007, CLIN EXP OPHTHALMOL, V35, P580, DOI 10.1111/j.1442-9071.2007.01536.x; McCall AS, 2010, INVEST OPHTH VIS SCI, V51, P129, DOI 10.1167/iovs.09-3738; Michelacci YM, 2003, BRAZ J MED BIOL RES, V36, P1037, DOI 10.1590/S0100-879X2003000800009; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; Ojeda JL, 2001, J ANAT, V199, P567, DOI 10.1046/j.1469-7580.2001.19950567.x; Patey A, 1984, Cornea, V3, P119; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Raiskup F, 2013, OCUL SURF, V11, P65, DOI 10.1016/j.jtos.2013.01.002; Raiskup F, 2009, J REFRACT SURG, V25, pS824, DOI 10.3928/1081597X-20090813-12; Redbrake C, 1997, CURR EYE RES, V16, P405, DOI 10.1076/ceyr.16.5.405.7044; Sandali O, 2013, OPHTHALMOLOGY, V120, P2403, DOI 10.1016/j.ophtha.2013.05.027; SAWAGUCHI S, 1990, EXP EYE RES, V50, P549, DOI 10.1016/0014-4835(90)90044-U; SAWAGUCHI S, 1994, INVEST OPHTH VIS SCI, V35, P4008; Smith VA, 2000, EUR J OPHTHALMOL, V10, P215, DOI 10.1177/112067210001000305; Sorkin N, 2014, OPHTHALMOLOGICA, V232, P10, DOI 10.1159/000357979; Tahzib NG, 2011, NED TIJDSCHR GENEES, V155, pA3304; Valdez-Garcia Jorge E, 2015, BMC Res Notes, V8, P28, DOI 10.1186/s13104-015-0995-1; Vinciguerra P, 2012, AM J OPHTHALMOL, V154, P520, DOI 10.1016/j.ajo.2012.03.020; Vinciguerra P, 2009, OPHTHALMOLOGY, V116, P369, DOI 10.1016/j.ophtha.2008.09.048; Wilson SE, 2000, CORNEA, V19, P417, DOI 10.1097/00003226-200007000-00001; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2004, CORNEA, V23, P43, DOI 10.1097/00003226-200401000-00008; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2008, CORNEA, V27, P353, DOI 10.1097/ICO.0b013e31815cf66a; Wollensak G, 2006, CURR OPIN OPHTHALMOL, V17, P356, DOI 10.1097/01.icu.0000233954.86723.25; Zhou LL, 1998, INVEST OPHTH VIS SCI, V39, P1117	62	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136999	10.1371/journal.pone.0136999	http://dx.doi.org/10.1371/journal.pone.0136999			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325407	Green Submitted, gold, Green Published			2022-12-27	WOS:000360437700080
J	Wang, XF; Liu, YG				Wang, Xiaofeng; Liu, Yiguang			Accurate and Fast Convergent Initial-Value Belief Propagation for Stereo Matching	PLOS ONE			English	Article							ADAPTIVE SUPPORT-WEIGHT	The belief propagation (BP) algorithm has some limitations, including ambiguous edges and textureless regions, and slow convergence speed. To address these problems, we present a novel algorithm that intrinsically improves both the accuracy and the convergence speed of BP. First, traditional BP generally consumes time due to numerous iterations. To reduce the number of iterations, inspired by the crucial importance of the initial value in nonlinear problems, a novel initial-value belief propagation (IVBP) algorithm is presented, which can greatly improve both convergence speed and accuracy. Second,. the majority of the existing research on BP concentrates on the smoothness term or other energy terms, neglecting the significance of the data term. In this study, a self-adapting dissimilarity data term (SDDT) is presented to improve the accuracy of the data term, which incorporates an additional gradient-based measure into the traditional data term, with the weight determined by the robust measure-based control function. Finally, this study explores the effective combination of local methods and global methods. The experimental results have demonstrated that our method performs well compared with the state-of-the-art BP and simultaneously holds better edge-preserving smoothing effects with fast convergence speed in the Middlebury and new 2014 Middlebury datasets.	[Wang, Xiaofeng; Liu, Yiguang] Sichuan Univ, Coll Comp Sci, Vis & Image Proc Lab, Chengdu 610064, Peoples R China; [Wang, Xiaofeng] Chongqing Univ Sci & Technol, Coll Math & Phys Sci, Chongqing, Peoples R China	Sichuan University; Chongqing University of Science & Technology	Liu, YG (corresponding author), Sichuan Univ, Coll Comp Sci, Vis & Image Proc Lab, Chengdu 610064, Peoples R China.	liuyg@scu.edu.cn	Liu, Yiguang/C-6404-2011		National Natural Science Foundation of China [61571313, 61173182, 61411130133]; Sichuan Province [2014HH0048, 2014HH0025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province	This work was supported in part by the National Natural Science Foundation of China under Grant 61571313, Grant 61173182, and Grant 61411130133 and in part by the Sichuan Province under Grant 2014HH0048 and Grant 2014HH0025.	Barzigar N, 2012, J VISUAL COMMUNICATI, V24, P137; Brown MZ, 2003, IEEE T PATTERN ANAL, V25, P993, DOI 10.1109/TPAMI.2003.1217603; Felzenszwalb PF, 2006, INT J COMPUT VISION, V70, P41, DOI 10.1007/s11263-006-7899-4; Gu Z, 2008, PATTERN RECOGN LETT, V29, P1230, DOI 10.1016/j.patrec.2008.01.032; He KM, 2010, LECT NOTES COMPUT SC, V6311, P1; Hong L, 2004, PROC CVPR IEEE, P74; Hosni A, 2009, IEEE IMAGE PROC, P2093, DOI 10.1109/ICIP.2009.5414478; Jung HY, 2011, IEEE I CONF COMP VIS, P1211, DOI 10.1109/ICCV.2011.6126371; Klaus A, 2006, INT C PATT RECOG, P15; Kowalczuk J, 2013, IEEE T CIRC SYST VID, V23, P94, DOI 10.1109/TCSVT.2012.2203200; Larsen ES, 2007, IEEE I CONF COMP VIS, P1440; Li G., 2006, IEEE COMP SOC C, P2355; Liang Wang, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3033, DOI 10.1109/CVPR.2011.5995480; Mei TC, 2015, APPL OPTICS, V54, P3372, DOI 10.1364/AO.54.003372; Mei X, 2011, PROC CVPR IEEE, P1257; Min DB, 2013, IEEE T PATTERN ANAL, V35, P2539, DOI 10.1109/TPAMI.2013.15; Montserrat T, 2009, IEEE IMAGE PROC, P2353, DOI 10.1109/ICIP.2009.5413610; Mozerov MG, 2015, IEEE T IMAGE PROCESS, V24, P1153, DOI 10.1109/TIP.2015.2395820; Neilson D, 2011, IEEE T PATTERN ANAL, V33, P2147, DOI 10.1109/TPAMI.2011.67; Pugeault N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010663; Rhemann C, 2011, PROC CVPR IEEE, DOI 10.1109/CVPR.2011.5995372; Sato H, 2015, SWARM EVOL COMPUT, V23, P1, DOI 10.1016/j.swevo.2015.02.002; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Su QL, 2015, IEEE T SIGNAL PROCES, V63, P1144, DOI 10.1109/TSP.2015.2389755; Sun J, 2005, PROC CVPR IEEE, P399; Sun J, 2003, IEEE T PATTERN ANAL, V25, P787, DOI 10.1109/TPAMI.2003.1206509; Tappen MF, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P900; Woodford O, 2008, IEEE COMP SOC C COMP, P900; Wu PF, 2015, IEEE T MED IMAGING, V34, P1321, DOI 10.1109/TMI.2015.2388699; Yang Q, 2008, BMVC, V1, P924; Yang Q., 2006, PROC BR MACH VIS C, P989, DOI [10.5244/c.20.101, DOI 10.5244/C.20.101]; Yang QX, 2010, PROC CVPR IEEE, P1458, DOI 10.1109/CVPR.2010.5539797; Yang QX, 2009, PROC CVPR IEEE, P557, DOI 10.1109/CVPRW.2009.5206542; Yang QX, 2009, IEEE T PATTERN ANAL, V31, P492, DOI 10.1109/TPAMI.2008.99; Yoon KJ, 2006, IEEE T PATTERN ANAL, V28, P650, DOI 10.1109/TPAMI.2006.70; Zabih R., 1994, P 3 EUR C COMP VIS, P150; Zitnick CL, 2007, INT J COMPUT VISION, V75, P49, DOI 10.1007/s11263-006-0018-8	37	0	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137530	10.1371/journal.pone.0137530	http://dx.doi.org/10.1371/journal.pone.0137530			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26349063	gold, Green Submitted, Green Published			2022-12-27	WOS:000360897600052
J	Raschle, NM; Menks, WM; Fehlbaum, LV; Tshomba, E; Stadler, C				Raschle, Nora Maria; Menks, Willeke Martine; Fehlbaum, Lynn Valerie; Tshomba, Ebongo; Stadler, Christina			Structural and Functional Alterations in Right Dorsomedial Prefrontal and Left Insular Cortex Co-Localize in Adolescents with Aggressive Behaviour: An ALE Meta-Analysis	PLOS ONE			English	Article							GRAY-MATTER VOLUME; ANTISOCIAL PERSONALITY-DISORDER; BRAIN STRUCTURE ABNORMALITIES; CALLOUS-UNEMOTIONAL TRAITS; ANTERIOR CINGULATE CORTEX; PURE CONDUCT DISORDER; NEURAL RESPONSES; LIKELIHOOD ESTIMATION; CORTICAL THICKNESS; DECISION-MAKING	Recent neuroimaging work has suggested that aggressive behaviour (AB) is associated with structural and functional brain abnormalities in processes subserving emotion processing and regulation. However, most neuroimaging studies on AB to date only contain relatively small sample sizes. To objectively investigate the consistency of previous structural and functional research in adolescent AB, we performed a systematic literature review and two coordinate-based activation likelihood estimation meta-analyses on eight VBM and nine functional neuroimaging studies in a total of 783 participants (408 [224AB/184 controls] and 375 [215 AB/160 controls] for structural and functional analysis respectively). We found 19 structural and eight functional foci of significant alterations in adolescents with AB, mainly located within the emotion processing and regulation network (including orbitofrontal, dorsomedial prefrontal and limbic cortex). A subsequent conjunction analysis revealed that functional and structural alterations co-localize in right dorsomedial prefrontal cortex and left insula. Our results are in line with meta-analytic work as well as structural, functional and connectivity findings to date, all of which make a strong point for the involvement of a network of brain areas responsible for emotion processing and regulation, which is disrupted in AB. Increased knowledge about the behavioural and neuronal underpinnings of AB is crucial for the development of novel and implementation of existing treatment strategies. Longitudinal research studies will have to show whether the observed alterations are a result or primary cause of the phenotypic characteristics in AB.	[Raschle, Nora Maria; Menks, Willeke Martine; Fehlbaum, Lynn Valerie; Tshomba, Ebongo; Stadler, Christina] Psychiat Univ Clin Basel, Dept Child & Adolescent Psychiat, Basel, Switzerland	University of Basel	Raschle, NM (corresponding author), Psychiat Univ Clin Basel, Dept Child & Adolescent Psychiat, Basel, Switzerland.	nora.raschle@upkbs.ch	Stadler, Christina/H-3971-2014; Menks, Willeke/ABD-7239-2021	Stadler, Christina/0000-0003-2178-0635				Afif A, 2007, BRAIN STRUCT FUNCT, V212, P335, DOI 10.1007/s00429-007-0161-1; Anderson NE, 2014, RESTOR NEUROL NEUROS, V32, P103, DOI 10.3233/RNN-139001; Association AP, 2013, DIAGNOSTIC AND STATI; Bar KJ, 2013, ACTA PSYCHIAT SCAND, V127, P269, DOI 10.1111/j.1600-0447.2012.01896.x; Banaschewski T, 2005, DEVELOPMENTAL SCI, V8, P132, DOI 10.1111/j.1467-7687.2005.00400.x; Banaschewski T, 2003, J CHILD PSYCHOL PSYC, V44, P356, DOI 10.1111/1469-7610.00127; Bardone AM, 1998, J AM ACAD CHILD PSY, V37, P594, DOI 10.1097/00004583-199806000-00009; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Berkout OV, 2011, AGGRESS VIOLENT BEH, V16, P503, DOI 10.1016/j.avb.2011.06.001; Beyer F, 2014, CEREB CORTEX; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Blair RJR, 2014, NEW ENGL J MED, V371, P2207, DOI 10.1056/NEJMra1315612; Blair RJR, 2003, BRIT J PSYCHIAT, V182, P5, DOI 10.1192/bjp.182.1.5; Bobes MA, 2013, SOC COGN AFFECT NEUR, V8, P928, DOI 10.1093/scan/nss101; Boccardi M, 2011, PSYCHIAT RES-NEUROIM, V193, P85, DOI 10.1016/j.pscychresns.2010.12.013; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Cappadocia MC, 2009, CLIN PSYCHOL REV, V29, P506, DOI 10.1016/j.cpr.2009.06.001; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; Crowe SL, 2008, DEV PSYCHOPATHOL, V20, P1145, DOI 10.1017/S0954579408000540; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; Dalwani M, 2011, DRUG ALCOHOL DEPEN, V118, P295, DOI 10.1016/j.drugalcdep.2011.04.006; Dalwani MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126368; Dalwani MS, 2014, DRUG ALCOHOL DEPEN, V134, P242, DOI 10.1016/j.drugalcdep.2013.10.009; Dandreaux DM, 2009, J ABNORM CHILD PSYCH, V37, P375, DOI 10.1007/s10802-008-9261-5; Davidson RJ, 2000, PSYCHOL BULL, V126, P890, DOI 10.1037/0033-2909.126.6.890; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011; Decety J, 2013, JAMA PSYCHIAT, V70, P638, DOI 10.1001/jamapsychiatry.2013.27; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Derbyshire S W, 2000, Curr Rev Pain, V4, P467; Dolan MC, 2010, CRIM BEHAV MENT HEAL, V20, P199, DOI 10.1002/cbm.771; Dolan MC, 2009, BIOL PSYCHIAT, V66, P570, DOI 10.1016/j.biopsych.2009.03.019; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Ducharme S, 2011, BIOL PSYCHIAT, V70, P283, DOI 10.1016/j.biopsych.2011.03.015; Dupont S, 2003, SURG RADIOL ANAT, V25, P113, DOI 10.1007/s00276-003-0103-4; Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Ermer E, 2012, J ABNORM PSYCHOL, V121, P649, DOI 10.1037/a0026371; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Euler F, 2014, J ABNORM CHILD PSYCH; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fahim C, 2011, AGGRESSIVE BEHAV, V37, P326, DOI 10.1002/ab.20396; Fairchild G, 2014, J AM ACAD CHILD PSY, V53, P677, DOI 10.1016/j.jaac.2014.02.009; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P924, DOI 10.1111/jcpp.12102; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P86, DOI 10.1111/j.1469-7610.2012.02617.x; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Finger EC, 2011, AM J PSYCHIAT, V168, P152, DOI 10.1176/appi.ajp.2010.10010129; Finger EC, 2012, PSYCHIAT RES-NEUROIM, V202, P239, DOI 10.1016/j.pscychresns.2011.11.002; Frick PJ, 2009, DEV PSYCHOPATHOL, V21, P1111, DOI 10.1017/S0954579409990071; Fusar-Poli P, 2011, NEUROSCI BIOBEHAV R, V35, P1175, DOI 10.1016/j.neubiorev.2010.12.005; Gao Y, 2009, CAN J PSYCHIAT, V54, P813, DOI 10.1177/070674370905401204; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Garavan H, 2010, BRAIN STRUCT FUNCT, V214, P593, DOI 10.1007/s00429-010-0259-8; Gasquoine PG, 2014, NEUROPSYCHOL REV, V24, P77, DOI 10.1007/s11065-014-9246-9; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Glenn AL, 2009, MOL PSYCHIATR, V14, P5, DOI 10.1038/mp.2008.104; Glenn AL, 2008, PSYCHIAT CLIN N AM, V31, P463, DOI 10.1016/j.psc.2008.03.004; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Haney-Caron E, 2014, J PSYCHIATR RES, V48, P111, DOI 10.1016/j.jpsychires.2013.09.015; Herpertz SC, 2008, J CHILD PSYCHOL PSYC, V49, P781, DOI 10.1111/j.1469-7610.2008.01905.x; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Hyatt CJ, 2012, BIOL PSYCHIAT, V72, P207, DOI 10.1016/j.biopsych.2011.11.017; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Irwin W, 1996, NEUROREPORT, V7, P1765, DOI 10.1097/00001756-199607290-00014; Jiang W, 2013, NEUROSCIENCE, V244, P90, DOI 10.1016/j.neuroscience.2013.03.055; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Kensinger EA, 2006, COGN AFFECT BEHAV NE, V6, P110, DOI 10.3758/CABN.6.2.110; Kiehl KA, 2001, BIOL PSYCHIAT, V50, P677, DOI 10.1016/S0006-3223(01)01222-7; Klein RG, 1997, ARCH GEN PSYCHIAT, V54, P1073; Koenigsberg HW, 2009, PSYCHIAT RES-NEUROIM, V172, P192, DOI 10.1016/j.pscychresns.2008.07.010; Kollndorfer K, 2013, NEUROSCI BIOBEHAV R, V37, P2699, DOI 10.1016/j.neubiorev.2013.09.005; Lahey BB, 2005, J CONSULT CLIN PSYCH, V73, P389, DOI 10.1037/0022-006X.73.3.389; Laird AR, 2010, NEUROIMAGE, V51, P677, DOI 10.1016/j.neuroimage.2010.02.048; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Li TQ, 2005, ANN NY ACAD SCI, V1064, P184, DOI 10.1196/annals.1340.034; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Linkersdorfer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043122; Liu HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089790; Lockwood PL, 2013, CURR BIOL, V23, P901, DOI 10.1016/j.cub.2013.04.018; Loeber R, 2000, J AM ACAD CHILD PSY, V39, P1468, DOI 10.1097/00004583-200012000-00007; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Manoliu A, 2014, FRONTIERS IN HUMAN N, V7; Manoliu A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00216; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; Marsh AA, 2013, J CHILD PSYCHOL PSYC, V54, P900, DOI 10.1111/jcpp.12063; Marsh AA, 2011, PSYCHIAT RES-NEUROIM, V194, P279, DOI 10.1016/j.pscychresns.2011.07.008; Mathews VP, 2005, J COMPUT ASSIST TOMO, V29, P287, DOI 10.1097/01.rct.0000162822.46958.33; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; McEwen BS, 2003, MENT RETARD DEV D R, V9, P149, DOI 10.1002/mrdd.10074; Mitchell DGV, 2007, NEUROIMAGE, V34, P1299, DOI 10.1016/j.neuroimage.2006.10.012; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Motzkin JC, 2011, J NEUROSCI, V31, P17348, DOI 10.1523/JNEUROSCI.4215-11.2011; Nguyen TN, 2010, AUST NZ J PSYCHIAT, V44, P766, DOI 10.3109/00048674.2010.495054; Nunn K, 2011, MED HYPOTHESES, V76, P353, DOI 10.1016/j.mehy.2010.10.038; O'Nions E, 2014, DEVELOPMENTAL SCI, V17, P786, DOI 10.1111/desc.12167; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Passamonti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048789; Passamonti L, 2010, ARCH GEN PSYCHIAT, V67, P729, DOI 10.1001/archgenpsychiatry.2010.75; Pawliczek CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078503; Pedersen W, 2011, J ADOLESCENCE, V34, P1025, DOI 10.1016/j.adolescence.2010.11.005; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Prehn K, 2013, SOC NEUROSCI-UK, V8, P136, DOI 10.1080/17470919.2012.686923; Raemaekers M, 2012, NEUROIMAGE, V60, P717, DOI 10.1016/j.neuroimage.2011.11.061; Raine A, 2000, ARCH GEN PSYCHIAT, V57, P119, DOI 10.1001/archpsyc.57.2.119; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Ravens-Sieberer U, 2008, EUR CHILD ADOLES PSY, V17, P22, DOI 10.1007/s00787-008-1003-2; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rowe R, 2010, J CHILD PSYCHOL PSYC, V51, P688, DOI 10.1111/j.1469-7610.2009.02199.x; Rubia K, 2008, AM J PSYCHIAT, V165, P889, DOI 10.1176/appi.ajp.2008.07071084; Rubia K, 2011, BIOL PSYCHIAT, V69, pE69, DOI 10.1016/j.biopsych.2010.09.023; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Sarkar S, 2013, PSYCHOL MED, V43, P401, DOI 10.1017/S003329171200116X; Schmidt-Wilcke T, 2010, NEUROIMAGE, V51, P1234, DOI 10.1016/j.neuroimage.2010.03.042; Schwindt GC, 2009, NEUROIMAGE, V45, P181, DOI 10.1016/j.neuroimage.2008.11.024; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; Sebastian CL, 2014, PSYCHOL MED, V44, P99, DOI 10.1017/S0033291713000482; Sebastian CL, 2012, ARCH GEN PSYCHIAT, V69, P814, DOI 10.1001/archgenpsychiatry.2011.2070; Selvaraj S, 2012, BIPOLAR DISORD, V14, P135, DOI 10.1111/j.1399-5618.2012.01000.x; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Stadler C, 2007, J PSYCHIATR RES, V41, P410, DOI 10.1016/j.jpsychires.2006.01.006; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Sterzer P, 2005, BIOL PSYCHIAT, V57, P7, DOI 10.1016/j.biopsych.2004.10.008; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Sterzer P, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.035.2009; Stevens MC, 2012, J PSYCHIATR NEUROSCI, V37, P389, DOI 10.1503/jpn.110148; Sui J, 2014, NEUROIMAGE, V102, P11, DOI 10.1016/j.neuroimage.2013.09.044; Tang YN, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105272, 10.1371/journal.pone.0086363]; Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Honk Jack, 2006, Cogn Neuropsychiatry, V11, P285, DOI 10.1080/13546800500233728; Viding Essi, 2014, Curr Top Behav Neurosci, V17, P395, DOI 10.1007/7854_2013_266; Viding E, 2012, DEV PSYCHOPATHOL, V24, P969, DOI 10.1017/S095457941200048X; Vloet TD, 2008, BEHAV SCI LAW, V26, P99, DOI 10.1002/bsl.794; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wallace GL, 2014, J AM ACAD CHILD PSY, V53, P456, DOI 10.1016/j.jaac.2013.12.008; Waller R, 2012, J CHILD PSYCHOL PSYC, V53, P946, DOI 10.1111/j.1469-7610.2012.02550.x; Whalen PJ, 1998, J NEUROSCI, V18, P411; White SF, 2013, AM J PSYCHIAT, V170, P315, DOI 10.1176/appi.ajp.2012.12060840; White SF, 2012, DEV PSYCHOPATHOL, V24, P1105, DOI 10.1017/S0954579412000569; Wu DX, 2011, NEURAL REGEN RES, V6, P1965, DOI 10.3969/j.issn.1673-5374.2011.25.008; Yeh PH, 2009, BIOL PSYCHIAT, V65, p241S; Zald DH, 2007, ANN NY ACAD SCI, V1121, P395, DOI 10.1196/annals.1401.012; Zhang JB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/673165; Zhang JB, 2014, J AM ACAD CHILD PSY, V53, P466, DOI 10.1016/j.jaac.2013.12.015	166	32	33	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136553	10.1371/journal.pone.0136553	http://dx.doi.org/10.1371/journal.pone.0136553			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339798	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200011
J	Vanithamani, S; Shanmughapriya, S; Narayanan, R; Raja, V; Kanagavel, M; Sivasankari, K; Natarajaseenivasan, K				Vanithamani, Shanmugam; Shanmughapriya, Santhanam; Narayanan, Ramasamy; Raja, Veerapandian; Kanagavel, Murugesan; Sivasankari, Karikalacholan; Natarajaseenivasan, Kalimuthusamy			Lipopolysaccharide Specific Immunochromatography Based Lateral Flow Assay for Serogroup Specific Diagnosis of Leptospirosis in India	PLOS ONE			English	Article							SERODIAGNOSIS; IMMUNOGLOBULIN; ANTIBODY; ANTIGEN	Background Leptospirosis is a re-emerging infectious disease that is under-recognized due to low-sensitivity and cumbersome serological tests. MAT is the gold standard test and it is the only serogroup specific test used till date. Rapid reliable alternative serogroup specific tests are needed for surveillance studies to identify locally circulating serogroups in the study area. Methods/Principal Findings In the present investigation the serological specificity of leptospiral lipopolysaccharides (LPS) was evaluated by enzyme linked immunosorbent assay (ELISA), dot blot assay and rapid immunochromatography based lateral flow assay (ICG-LFA). Sera samples from 120 MAT positive cases, 174 cases with febrile illness other than leptospirosis, and 121 seronegative healthy controls were evaluated for the diagnostic sensitivity and specificity of the developed assays. LPS was extracted from five locally predominant circulating serogroups including: Australis (27.5%), Autumnalis (11.7%), Ballum (25.8%), Grippotyphosa (12.5%), Pomona (10%) and were used as antigens in the diagnostics to detect IgM antibodies in patients' sera. The sensitivity observed by IgM ELISA and dot blot assay using various leptospiral LPS was >90% for homologous sera. Except for Ballum LPS, no other LPS showed cross-reactivity to heterologous sera. An attempt was made to develop LPS based ICG-LFA for rapid and sensitive serogroup specific diagnostics of leptospirosis. The developed ICG-LFA showed sensitivity in the range between 93 and 100% for homologous sera. The Wilcoxon analysis showed LPS based ICG-LFA did not differ significantly from the gold standard MAT (P>0.05). Conclusion The application of single array of LPS for serogroup specific diagnosis is first of its kind. The developed assay could potentially be evaluated and employed for as MAT alternative.	[Vanithamani, Shanmugam; Shanmughapriya, Santhanam; Narayanan, Ramasamy; Raja, Veerapandian; Kanagavel, Murugesan; Sivasankari, Karikalacholan; Natarajaseenivasan, Kalimuthusamy] Bharathidasan Univ, Dept Microbiol, Ctr Excellence Life Sci, Med Microbiol Lab, Tiruchirappalli 620024, India	Bharathidasan University	Natarajaseenivasan, K (corresponding author), Bharathidasan Univ, Dept Microbiol, Ctr Excellence Life Sci, Med Microbiol Lab, Tiruchirappalli 620024, India.	natarajaseenivasan@rediffmail.com	Veerapandian, Raja/AAJ-1425-2020; Murugesan, Kanagavel/K-2006-2019	Veerapandian, Raja/0000-0003-1118-0038; Murugesan, Kanagavel/0000-0003-3334-5358	Indian Council of Medical Research (ICMR) and Department of Biotechnology, Ministry of Science and Technology, New Delhi [5/3/3/3/2007-ECD-I, BT/PR6872/MED/14/892/2005]; Indian Council of Medical Research (ICMR)	Indian Council of Medical Research (ICMR) and Department of Biotechnology, Ministry of Science and Technology, New Delhi; Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	The research was funded by Indian Council of Medical Research (ICMR) and Department of Biotechnology, Ministry of Science and Technology, New Delhi (ICMR Grant No: 5/3/3/3/2007-ECD-I; DBT Grant No. BT/PR6872/MED/14/892/2005). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279; Gouveia EL, 2008, EMERG INFECT DIS, V14, P757; Hull-Jackson C, 2006, J CLIN MICROBIOL, V44, P1853, DOI 10.1128/JCM.44.5.1853-1855.2006; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7; Natarajaseenivasan K., 2012, WORLD J VACCINE, P85; Prabhakaran SG, 2014, J PUBLIC HEALTH-HEID, V22, P323, DOI 10.1007/s10389-014-0611-1; Priya CG, 2003, J MED MICROBIOL, V52, P667, DOI 10.1099/jmm.0.05120-0; Raja V, 2015, CRIT REV MICROBIOL, V41, P1, DOI 10.3109/1040841X.2013.787387; Ramadass P, 1999, VET MICROBIOL, V70, P137, DOI 10.1016/S0378-1135(99)00133-9; Sehgal S C, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 2, P170; Sehgal SC, 1999, T ROY SOC TROP MED H, V93, P161, DOI 10.1016/S0035-9203(99)90293-6; Sehgal SC, 1997, INDIAN J MED RES, V106, P504; Shim WB, 2006, J AGR FOOD CHEM, V54, P9728, DOI 10.1021/jf0620057; TERPSTRA WJ, 1985, J GEN MICROBIOL, V131, P377; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Toyokawa T, 2011, EXPERT REV ANTI-INFE, V9, P111, DOI [10.1586/eri.10.151, 10.1586/ERI.10.151]; Trueba G A, 1990, J Vet Diagn Invest, V2, P323; Vijayachari P, 2001, INDIAN J MED RES, V114, P99; Vijayachari P, 2002, EPIDEMIOL INFECT, V129, P617, DOI 10.1017/S0950268802007537; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Widiyanti D, 2013, CLIN VACCINE IMMUNOL, V20, P683, DOI 10.1128/CVI.00756-12; Winslow WE, 1997, J CLIN MICROBIOL, V35, P1938, DOI 10.1128/JCM.35.8.1938-1942.1997	28	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137130	10.1371/journal.pone.0137130	http://dx.doi.org/10.1371/journal.pone.0137130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340095	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200024
J	Clemens, KK; Shariff, S; Liu, KA; Hramiak, I; Mahon, JL; McArthur, E; Garg, AX				Clemens, Kristin K.; Shariff, Salimah; Liu, Kuan; Hramiak, Irene; Mahon, Jeffrey L.; McArthur, Eric; Garg, Amit X.			Trends in Antihyperglycemic Medication Prescriptions and Hypoglycemia in Older Adults: 2002-2013	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ROSIGLITAZONE; MONOTHERAPY; THERAPY; COMPLICATIONS; HYPERGLYCEMIA; PIOGLITAZONE; METFORMIN; ONTARIO; EVENTS	Background Over the last decade, several new antihyperglycemic medications have been introduced including those associated with a lower hypoglycemia risk. We aimed to investigate how these medications are being prescribed to older adults in our region. Methods We conducted population-based cross-sectional analyses of older adults (mean age 75 years) with treated diabetes in Ontario, Canada from 2002 until 2013, to examine the percentage prescribed insulin, sulphonylureas, alpha-glucosidase inhibitors, metformin, thiazolidinediones, meglitinides, and dipeptidyl peptidase-4 inhibitors. Over the study period, we also examined their hospital encounters for hypoglycemia (emergency room or inpatient encounter). Results The mean age of treated patients increased slightly over the study quarters and the proportion that were women declined. With the exception of chronic kidney disease, cancer, dementia, and neuropathy, the percentage with a comorbidity appeared to decline. The percentage of treated patients prescribed metformin, gliclazide and dipeptidyl peptidase-4 inhibitors increased as did combination therapy. Glyburide and thiazolidinedione prescriptions declined, and insulin use remained stable. In those with newly treated diabetes, the majority were prescribed metformin, with smaller percentages prescribed insulin and other oral agents. Although the absolute number of treated patients with a hypoglycemia encounter increased until mid-2006 and then decreased, the overall percentage with an encounter declined over the study period (0.8% with an event in the first quarter, 0.4% with an event in the last quarter). Conclusions Antihyperglycemic medications with safer profiles are being increasingly prescribed to older adults. In this setting there has been a decrease in the percentage of treated patients with a hospital encounter for hypoglycemia.	[Clemens, Kristin K.; Garg, Amit X.] Univ Western Ontario, Dept Med, London, ON, Canada; [Shariff, Salimah; Liu, Kuan; McArthur, Eric; Garg, Amit X.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Hramiak, Irene; Mahon, Jeffrey L.] Univ Western Ontario, Dept Med, Div Endocrinol, London, ON, Canada; [Mahon, Jeffrey L.; Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada	Western University (University of Western Ontario); University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario)	Clemens, KK (corresponding author), Univ Western Ontario, Dept Med, London, ON, Canada.	kclemens2008@meds.uwo.ca	Clemens, Kristin K/K-8898-2016; Garg, Amit X/G-3295-2011; Hramiak, Irene/G-3305-2011; Mahon, Jeff/G-3324-2011	Shariff, Salimah/0000-0002-1219-6763	Ontario Ministry of Health; Long-term Care (MOHLTC); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute (LHRI); Adam Linton Chair in Kidney Health Analytics	Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Long-term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute (LHRI); Adam Linton Chair in Kidney Health Analytics	This project was conducted at the Institute for Clinical Evaluative Sciences (ICES) Western Site. ICES is funded by an annual grant from the Ontario Ministry of Health and Long-term Care (MOHLTC). Core funding for ICES Western is provided by the Academic Medical Organization of Southwestern Ontario (AMOSO), the Schulich School of Medicine and Dentistry (SSMD), Western University, and the Lawson Health Research Institute (LHRI). Dr. Amit Garg was supported by the Adam Linton Chair in Kidney Health Analytics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions, results, and conclusions are those of the authors, and no endorsement by ICES, AMOSO, SSMD, LHRI or the MOHLTC is intended or should be inferred. Parts of this material are based upon data and information compiled and provided by the Canadian Institute for Health Information (CIHI). However the analysis, conclusions, opinions and statements expressed herein are those of the authors and not necessarily CIHI.	Baviera M, 2011, DIABETES RES CLIN PR, V93, P123, DOI 10.1016/j.diabres.2011.05.004; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Bronskill S, 2010, AGING ONTARIO ICES C; Cohen A, 2010, DIABETES CARE, V33, P823, DOI 10.2337/dc09-1834; Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Doucet J, 2011, CURR MED RES OPIN, V27, P863, DOI 10.1185/03007995.2011.554532; Filion KB, 2009, PHARMACOEPIDEM DR S, V18, P973, DOI 10.1002/pds.1802; Foster PD, 2013, DIABETIC MED, V30, P1209, DOI 10.1111/dme.12214; Garber AJ, 2002, DIABETES OBES METAB, V4, P201, DOI 10.1046/j.1463-1326.2002.00211.x; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hampp C, 2014, DIABETES CARE, V37, P1367, DOI 10.2337/dc13-2289; Harper W, 2013, CANADIAN DIABETES AS; Hashim S, 2013, J POPUL THER CLIN PH, V20, pE238; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Huang ES, 2013, JAMA INTERN MED, P251; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Lipska KJ, 2014, JAMA INTERN MED, V174, P1116, DOI 10.1001/jamainternmed.2014.1824; Meinelly G, 2013, CANADIAN DIABETES AS; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Rathmann W, 2007, DIABETES CARE, V30, P848, DOI 10.2337/dc06-2000; Rosenstock J, 2006, DIABETES OBES METAB, V8, P650, DOI 10.1111/j.1463-1326.2006.00659.x; Rosenstock J, 2013, DIABETES OBES METAB, V15, P906, DOI 10.1111/dom.12102; Rosenstock J, 2006, DIABETES OBES METAB, V8, P49, DOI 10.1111/j.1463-1326.2005.00541.x; Statistics Canada website, 2014, STAT CAN POP SEX AG; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; vanStaa T, 1997, J CLIN EPIDEMIOL, V50, P735, DOI 10.1016/S0895-4356(97)00024-3; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Zaharan NL, 2014, IRISH J MED SCI, V183, P311, DOI 10.1007/s11845-013-1011-1	34	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137596	10.1371/journal.pone.0137596	http://dx.doi.org/10.1371/journal.pone.0137596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335938	Green Submitted, Green Published, gold			2022-12-27	WOS:000360615400071
J	Conchuir, SO; Barlow, KA; Pache, RA; Ollikainen, N; Kundert, K; O'Meara, MJ; Smith, CA; Kortemme, T				Conchuir, Shane O.; Barlow, Kyle A.; Pache, Roland A.; Ollikainen, Noah; Kundert, Kale; O'Meara, Matthew J.; Smith, Colin A.; Kortemme, Tanja			A Web Resource for Standardized Benchmark Datasets, Metrics, and Rosetta Protocols for Macromolecular Modeling and Design	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; STRUCTURE PREDICTION; BINDING-ENERGY; HOT-SPOTS; SIMULATION; INFORMATION; STABILITY; EVOLUTION; DATABASE; DENSITY	The development and validation of computational macromolecular modeling and design methods depend on suitable benchmark datasets and informative metrics for comparing protocols. In addition, if a method is intended to be adopted broadly in diverse biological applications, there needs to be information on appropriate parameters for each protocol, as well as metrics describing the expected accuracy compared to experimental data. In certain disciplines, there exist established benchmarks and public resources where experts in a particular methodology are encouraged to supply their most efficient implementation of each particular benchmark. We aim to provide such a resource for protocols inmacromolecularmodeling and design. We present a freely accessible web resource (https://kortemmelab.ucsf.edu/benchmarks) to guide the development of protocols for protein modeling and design. The site provides benchmark datasets and metrics to compare the performance of a variety of modeling protocols using different computational samplingmethods and energy functions, providing a "best practice" set of parameters for each method. Each benchmark has an associated downloadable benchmark capture archive containing the input files, analysis scripts, and tutorials for running the benchmark. The capturesmay be run with any suitable modeling method; we supply command lines for running the benchmarks using the Rosetta software suite. We have compiled initial benchmarks for the resource spanning three key areas: prediction of energetic effects of mutations, protein design, and protein structure prediction, each with associated state-of-the-art modeling protocols. With the help of the wider macromolecular modeling community, we hope to expand the variety of benchmarks included on the website and continue to evaluate new iterations of currentmethods as they become available.	[Conchuir, Shane O.; Pache, Roland A.; Smith, Colin A.; Kortemme, Tanja] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94143 USA; [Conchuir, Shane O.; Pache, Roland A.; Smith, Colin A.; Kortemme, Tanja] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Barlow, Kyle A.; Ollikainen, Noah; Smith, Colin A.; Kortemme, Tanja] Univ Calif San Francisco, Grad Program Bioinformat, San Francisco, CA 94143 USA; [Kundert, Kale; Kortemme, Tanja] Univ Calif San Francisco, Grad Program Biophys, San Francisco, CA 94143 USA; [O'Meara, Matthew J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barlow, KA (corresponding author), Univ Calif San Francisco, Grad Program Bioinformat, San Francisco, CA 94143 USA.	kb@kylebarlow.com; kortemme@cgl.ucsf.edu	Smith, Colin A/E-5713-2012; Kortemme, Tanja/AAN-3180-2021	Smith, Colin A/0000-0002-4651-167X; Barlow, Kyle/0000-0002-9787-0066; Kortemme, Tanja/0000-0002-8494-680X; Pache, Roland/0000-0002-4723-6729; O'Meara, Matthew/0000-0002-3128-5331	National Science Foundation (NSF) [DBI-1262182]; National Institutes of Health (NIH) [R01GM098101]; Achievement Awards for College Scientists (ARCS) Scholarship; Direct For Biological Sciences [1262182] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098101, R01GM110089, T32GM067547, T32GM008284] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Awards for College Scientists (ARCS) Scholarship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Science Foundation (NSF) to TK (NSF DBI-1262182), the National Institutes of Health (NIH) (NIH R01GM098101), and an Achievement Awards for College Scientists (ARCS) Scholarship to KAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley D, 2004, COMPUTER LANGUAGE BE; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Calpini A, 2003, GREAT WIN32 COMPUTER; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Coutsias EA, 2004, J COMPUT CHEM, V25, P510, DOI 10.1002/jcc.10416; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darnell SJ, 2008, NUCLEIC ACIDS RES, V36, pW265, DOI 10.1093/nar/gkn346; Dickson RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011082; Dokholyan NV, 2001, J MOL BIOL, V312, P289, DOI 10.1006/jmbi.2001.4949; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ernst A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000416; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Janin J, 2007, STRUCTURE, V15, P755, DOI 10.1016/j.str.2007.06.007; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Mintseris J, 2005, PROTEINS, V60, P214, DOI 10.1002/prot.20560; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; O'Meara MJ, 2015, J CHEM THEORY COMPUT, V11, P609, DOI 10.1021/ct500864r; Ollikainen N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003313; Ollikainen N, 2013, METHOD ENZYMOL, V523, P61, DOI 10.1016/B978-0-12-394292-0.00004-7; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Sellers BD, 2008, PROTEINS, V72, P959, DOI 10.1002/prot.21990; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Smith CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020451; Smith CA, 2010, J MOL BIOL, V402, P460, DOI 10.1016/j.jmb.2010.07.032; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063090; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Yona G, 2002, J MOL BIOL, V315, P1257, DOI 10.1006/jmbi.2001.5293; Zhao SW, 2011, PROTEINS, V79, P2920, DOI 10.1002/prot.23129; Zhu K, 2006, PROTEINS, V65, P438, DOI 10.1002/prot.21040; Zhu XL, 2011, PROTEINS, V79, P2671, DOI 10.1002/prot.23094	52	44	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0130433	10.1371/journal.pone.0130433	http://dx.doi.org/10.1371/journal.pone.0130433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335248	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400001
J	Muldoon, KM; Goodman, SM				Muldoon, Kathleen M.; Goodman, Steven M.			Primates as Predictors of Mammal Community Diversity in the Forest Ecosystems of Madagascar	PLOS ONE			English	Article							NATURELLE-INTEGRALE-DANDOHAHELA; CROSS-TAXON CONGRUENCE; SPECIES RICHNESS; INDICATOR GROUPS; CONSERVATION PRIORITIES; BIODIVERSITY HOTSPOTS; SUBFOSSIL OCCURRENCE; HUMID FORESTS; RESERVE; BIOGEOGRAPHY	The geographic distribution of species is the typical metric for identifying priority areas for conservation. Since most biodiversity remains poorly studied, a subset of charismatic species, such as primates, often stand as surrogates for total biodiversity. A central question is therefore, how effectively do primates predict the pooled species richness of other mammalian taxa? We used lemurs as indicator species to predict total non-primate mammal community richness in the forest ecosystems of Madagascar. We combine environmental and species occurrence data to ascertain the extent to which primate diversity can predict (1) non-primate mammal alpha-diversity (species richness), (2) non-primate complementarity, and (3) non-primate beta-diversity (species turnover). Our results indicate that primates are effective predictors of non-primate mammal community diversity in the forest ecosystems of Madagascar after controlling for habitat. When individual orders of mammals are considered, lemurs effectively predict the species richness of carnivorans and rodents (but not afrosoricids), complementarity of rodents (but not carnivorans or afrosoricids), and all individual components of beta-diversity. We conclude that lemurs effectively predict total non-primate community richness. However, surrogate species alone cannot achieve complete representation of biodiversity.	[Muldoon, Kathleen M.] Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ 85308 USA; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA; [Goodman, Steven M.] Assoc Vahatra, Antananarivo, Madagascar	Midwestern University; Field Museum of Natural History (Chicago)	Muldoon, KM (corresponding author), Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ 85308 USA.	kmuldo@midwestern.edu			Conservation International; John D. and Catherine T. MacArthur Foundation; National Science Foundation [DEB 05-16313]; Volkswagen Foundation; World Wide Fund for Nature	Conservation International; John D. and Catherine T. MacArthur Foundation; National Science Foundation(National Science Foundation (NSF)); Volkswagen Foundation(Volkswagen); World Wide Fund for Nature	This work was supported by Conservation International, John D. and Catherine T. MacArthur Foundation, National Science Foundation (DEB 05-16313), Volkswagen Foundation, and World Wide Fund for Nature.	Allnutt TF, 2008, CONSERV LETT, V1, P173, DOI 10.1111/j.1755-263X.2008.00027.x; Andriamialisoa F., 2003, P1; Andrianjakarivelo V, 2005, ACTA THERIOL, V50, P537, DOI 10.1007/BF03192647; Avenant NL, 2000, S AFR J WILDL RES, V30, P26; Balmford A, 1995, CONSERV BIOL, V9, P1539, DOI 10.1046/j.1523-1739.1995.09061539.x; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; BROWN JH, 1971, ECOLOGY, V52, P305, DOI 10.2307/1934589; Burgess N.D., 2004, TERRESTRIAL ECOREGIO; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Carleton Michael D., 2000, Fieldiana Zoology, V97, P231; Cohen J., 1983, APPL MULTIPLE REGRES; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Crowley BE, 2011, AM J PRIMATOL, V73, P25, DOI 10.1002/ajp.20817; Dewar RE, 2013, P NATL ACAD SCI USA, V110, P12583, DOI 10.1073/pnas.1306100110; Dollar L, 2007, DEV PRIMATOL-PROG PR, P63, DOI 10.1007/978-0-387-34810-0_3; EMMONS LH, 1999, PRIMATE COMMUNITIES, P171, DOI DOI 10.1017/CBO9780511542381.011; Faith DP, 2003, ENVIRON SCI POLICY, V6, P311, DOI 10.1016/S1462-9011(03)00044-3; Feistner ATC, 1999, FIELD ZOOL, P269; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Fleishman E, 2005, CONSERV BIOL, V19, P1125, DOI 10.1111/j.1523-1739.2005.00168.x; Fox BJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P19, DOI 10.1046/j.1365-2699.2000.00184.x; Ganzhorn J.U., 1994, P51; Ganzhorn JU, 1998, FOLIA PRIMATOL, V69, P332; Ganzhorn JU, 1997, J ZOOL, V241, P533, DOI 10.1111/j.1469-7998.1997.tb04845.x; Ganzhorn JU, 1999, BIODIVERSITY ECOSYST; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Godfrey Laurie G., 2004, Lemur News, V9, P9; Godfrey LR, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P19; Godfrey LR, AM J PHYS A IN PRESS; GODFREY LR, 1997, NATURAL CHANGE HUMAN, P218; Goodman SM, 2004, INT J PRIMATOL, V25, P331, DOI 10.1023/B:IJOP.0000019155.33815.bf; Goodman SM, 1999, FIELD ZOOL, P187; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Goodman SM, 1999, FIELD ZOOL, P217; Goodman SM, 2001, J NAT HIST, V35, P285, DOI 10.1080/00222930150215387; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman SM, 1996, COLLOQ SEMI, P283; Goodman SM, 1998, FIELDIANA ZOOLOGY, V90, P1; Goodman SM, 2002, BOISSIERA, P359; Goodman SM, 2008, PAYSAGES NATURELS BI, P435; Goodman SM, 1996, FIELDIANA ZOOLOGY, V85, P1; Goodman SM, 2002, AKONNY ALA, V28, P136; Goodman Steven M., 2000, Fieldiana Zoology, V97, P1; Goodman SM, 2006, CR PALEVOL, V5, P953, DOI 10.1016/j.crpv.2006.09.008; Goodman Steven M., 2000, Fieldiana Zoology, V97, P201; Goodman Steven M., 1998, Fieldiana Zoology, V90, P139; Goodman Steven M., 2007, P25; Goodman Steven M., 1996, Fieldiana Zoology, V85, P218; Goodman Steven M., 1998, Fieldiana Zoology, V90, P201; Grelle CEV, 2002, BIOL CONSERV, V108, P101, DOI 10.1016/S0006-3207(02)00094-0; Groves C, 2001, EVOL ANTHROPOL, V10, P192, DOI 10.1002/evan.10005; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hawkins AFA, 1999, FIELD ZOOL, P175; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; IBM Corporation, 2014, IBM SPSS STAT WIND V; Irwin MT, 2009, ANIM CONSERV, V12, P220, DOI 10.1111/j.1469-1795.2009.00243.x; Kelley Elizabeth A., 2007, Primate Conservation, V22, P71, DOI 10.1896/052.022.0105; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kistler L, 2015, J HUM EVOL, V79, P45, DOI 10.1016/j.jhevol.2014.06.016; KOTLER BP, 1988, ANNU REV ECOL SYST, V19, P281, DOI 10.1146/annurev.es.19.110188.001433; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kremen C, 1999, CONSERV BIOL, V13, P1055, DOI 10.1046/j.1523-1739.1999.98374.x; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lawler JJ, 2008, ANIM CONSERV, V11, P270, DOI 10.1111/j.1469-1795.2008.00176.x; Lehman SM, 2006, AM J PHYS ANTHROPOL, V129, P232, DOI 10.1002/ajpa.20241; Lomolino MV, 2010, BIOGEOGRAPHY; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Lund MP, 2002, ANIM CONSERV, V5, P163, DOI 10.1017/S1367943002002226; Magurren AE, 2004, MEASURING BIOL DIVER; Manne LL, 2003, ANIM CONSERV, V6, P291, DOI 10.1017/S1367943003003354; MANTEL N, 1967, CANCER RES, V27, P209; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Markolf M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-216; Mittermeier R.A., 2010, LEMURS MADAGASCAR; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; MITTERMEIER RA, 2006, LEMURS MADAGASCAR; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Mittermeier RA, 1994, LEMURS MADAGASCAR; Moat J., 2007, ATLAS VEGETATION MAD; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Muldoon KM, 2007, AM J PHYS ANTHROPOL, V134, P152, DOI 10.1002/ajpa.20651; Muldoon KM, 2010, J HUM EVOL, V58, P338, DOI 10.1016/j.jhevol.2010.01.005; Muldoon KM, 2010, J BIOGEOGR, V37, P1144, DOI 10.1111/j.1365-2699.2010.02276.x; Muldoon KM, 2009, J MAMMAL, V90, P1111, DOI 10.1644/08-MAMM-A-242.1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Negi HR, 2002, BIOL CONSERV, V105, P143, DOI 10.1016/S0006-3207(01)00158-6; Nicoll ME, 2003, NATURAL HIST MADAGAS, P1432; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Perez VR, 2005, J HUM EVOL, V49, P722, DOI 10.1016/j.jhevol.2005.08.004; Prendergast JR, 1997, ECOGRAPHY, V20, P210, DOI 10.1111/j.1600-0587.1997.tb00363.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Randrianandianina B.N., 2003, P1423; Revell LJ, 2006, MULTIMANTEL PROGRAM; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rodriguez J, 2006, J BIOGEOGR, V33, P291, DOI 10.1111/j.1365-2699.2005.01397.x; Ryan TM, 2008, P NATL ACAD SCI USA, V105, P10699, DOI 10.1073/pnas.0805195105; Sarkar S, 2006, ACTA BIOTHEOR, V54, P133, DOI 10.1007/s10441-006-8259-z; Schmid Jutta, 1998, Fieldiana Zoology, V90, P227; SCHROPFER R, 1991, ACTA THERIOL, V36, P109, DOI 10.4098/AT.arch.91-7; Sebastiao H, 2009, ECOL INDIC, V9, P160, DOI 10.1016/j.ecolind.2008.03.002; Smith Andrew P., 1997, P415; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; SMITH RJ, 1980, J THEOR BIOL, V87, P97, DOI 10.1016/0022-5193(80)90222-2; Soarimalala V, 2008, MAMM BIOL, V73, P468, DOI 10.1016/j.mambio.2007.09.002; Sokal R. R., 1981, BIOMETRY; Sterling Eleanor, 2000, Fieldiana Zoology, V97, P265; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; Sussman Robert W., 2003, Primate Conservation, V19, P32; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; van Weerd M, 2010, BIODIVERS CONSERV, V19, P3393, DOI 10.1007/s10531-010-9902-1; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Williams P, 2006, BIOL CONSERV, V128, P253, DOI 10.1016/j.biocon.2005.09.047; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wright P. C., 2003, NATURAL HIST MADAGAS, P1485	117	10	13	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136787	10.1371/journal.pone.0136787	http://dx.doi.org/10.1371/journal.pone.0136787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334525	Green Submitted, gold, Green Published			2022-12-27	WOS:000360615400027
J	Adamson, PC; Huchko, MJ; Moss, AM; Kinkel, HF; Medina-Marino, A				Adamson, Paul C.; Huchko, Megan J.; Moss, Alison M.; Kinkel, Hans F.; Medina-Marino, Andrew			Acceptability and Accuracy of Cervical Cancer Screening Using a Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected Women in South Africa	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; VAGINAL SAMPLES; SPECIMENS; CYTOLOGY	Background HIV increases women's risk for high-risk human papillomavirus (hrHPV) infection and invasive cervical cancer. South Africa has a high HIV prevalence but low cervical cancer screening coverage. Self-collection of cervical specimens and hrHPV testing, including hrHPV messenger-RNA (mRNA) testing, are methods aimed at increasing screening rates. However, data are limited on the acceptability and accuracy of tampon-based self-collection for hrHPV mRNA testing in HIV-infected women. Methods We recruited 325 HIV-infected women seeking care at a government HIV clinic in Pretoria, South Africa. A clinician performed a pelvic examination and obtained an endocervical specimen. Study participants performed self-collection using a tampon. Both clinician-and self-collected specimens were tested for hrHPV mRNA. Acceptability of both collection methods was assessed, the prevalence of hrHPV mRNA in our study population was estimated, test positivity of the two collection methods were compared, and test agreement was assessed by calculating the.-statistic, sensitivity, and specificity. Results Over 90% of women reported no difficulties self-collecting specimens and 82% were willing to perform the tampon-collection at home. Based on clinician-collection specimens, the prevalence of hrHPV mRNA in our study population was 36.7% (95% CI: 31.4%-42.0%). There was no difference in test positivity between clinician-collection, 36.7%, and tampon-collection, 43.5% (p-value = 0.08). Using clinician-collection as the reference test, the sensitivity and specificity for hrHPV mRNA of tampon-collection were 77.4% (95% CI: 69.8-85.0%) and 77.8% (95% CI: 71.9-83.6%), respectively. Conclusions Tampon-based self-collection is acceptable to women and has similar hrHPV mRNA positivity rates as clinician-collection, but has reduced sensitivity and specificity compared to clinician-collection. The hrHPV mRNA prevalence in our study population is high, but similar to other high-risk populations, and highlights the need for improved cervical cancer screening. Further research into the optimal use of tampon-based collection as a cervical cancer screening tool is warranted.	[Adamson, Paul C.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Adamson, Paul C.; Kinkel, Hans F.; Medina-Marino, Andrew] Fdn Profess Dev, Res Unit, Pretoria, Gauteng, South Africa; [Huchko, Megan J.] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Moss, Alison M.] Drs Martin & Partners, Edenvale, Gauteng, South Africa; [Kinkel, Hans F.] Univ Pretoria, Dept Family Med, ZA-0002 Pretoria, Gauteng, South Africa; [Medina-Marino, Andrew] Univ Pretoria, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, Gauteng, South Africa	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pretoria; University of Pretoria	Medina-Marino, A (corresponding author), Fdn Profess Dev, Res Unit, Pretoria, Gauteng, South Africa.	andrewmedinamarino@gmail.com	Huchko, Megan/S-6063-2019; Adamson, Paul/AAR-1405-2020	Adamson, Paul/0000-0002-2776-6458; Kinkel, Hans-Friedemann/0000-0002-5455-9219; , Andrew/0000-0002-0095-4141				Adler David H, 2013, J Immunol Tech Infect Dis, V2, DOI 10.4172/2329-9541.1000113; Adler David H, 2014, Infect Dis Obstet Gynecol, V2014, P498048, DOI 10.1155/2014/498048; Belinson JL, 2003, INT J GYNECOL CANCER, V13, P819, DOI 10.1111/j.1525-1438.2003.13611.x; Bhatla N, 2009, CANCER EPIDEMIOL, V33, P446, DOI 10.1016/j.canep.2009.10.013; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Chernesky M, 2014, SEX TRANSM DIS, V41, P365, DOI 10.1097/OLQ.0000000000000125; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Day MN, 2014, DISTRICT HLTH BAROME; Denny L, 2008, OBSTET GYNECOL, V111, P1380, DOI 10.1097/AOG.0b013e3181743327; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Gen-Probe/Hologic Inc, 2013, APTIMA HPV IN PRESS; Gravitt PE, 2011, INT J CANCER, V129, P517, DOI 10.1002/ijc.25974; Heideman DAM, 2013, J CLIN MICROBIOL, V51, P3653, DOI 10.1128/JCM.01517-13; Holanda F, 2006, INT J GYNECOL OBSTET, V95, P179, DOI 10.1016/j.ijgo.2006.07.012; Johnson DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101255; Jones HE, 2007, J CLIN MICROBIOL, V45, P1679, DOI 10.1128/JCM.02369-06; Kuhn L, 2010, AIDS, V24, P2545, DOI 10.1097/QAD.0b013e32833e163e; Mahomed K, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.189.3454; McDonald AC, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00048; Memon S, 2012, 14 INT AIDS C WASH D; National Department of Health, 2010, CLIN GUID MAN HIV AI; National Department of Health Republic of South Africa, 2000, NAT GUID CERV SCREEN; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Ratnam S, 2011, J CLIN MICROBIOL, V49, P557, DOI 10.1128/JCM.02147-10; Safaeian M, 2007, SEX TRANSM DIS, V34, P429, DOI 10.1097/01.olq.0000243623.67673.22; Sankaranarayanan R, 2014, ANN GLOB HEALTH, V80, P412, DOI 10.1016/j.aogh.2014.09.014; Soerjomataram FJ, 2013, GLOBOCAN 2012 V1 0 C; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Ting J, 2013, SEX TRANSM DIS, V40, P584, DOI 10.1097/OLQ.0b013e31828e5a91; UNAIDS, 2013, AIDSINFO COUNTR FACT; Untiet S, 2014, INT J CANCER, V135, P1911, DOI 10.1002/ijc.28834; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; World Health Organization, 2002, CERVICAL CANC SCREEN; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81	35	23	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137299	10.1371/journal.pone.0137299	http://dx.doi.org/10.1371/journal.pone.0137299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332236	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800118
J	Fournie, G; Goodman, SJ; Cruz, M; Cedeno, V; Velez, A; Patino, L; Millins, C; Gibbons, LM; Fox, MT; Cunningham, AA				Fournie, Guillaume; Goodman, Simon J.; Cruz, Marilyn; Cedeno, Virna; Velez, Alberto; Patino, Leandro; Millins, Caroline; Gibbons, Lynda M.; Fox, Mark T.; Cunningham, Andrew A.			Biogeography of Parasitic Nematode Communities in the Galapagos Giant Tortoise: Implications for Conservation Management	PLOS ONE			English	Article							NORTHERN LESSER ANTILLES; INFECTIOUS-DISEASES; HELMINTH INFECTIONS; ANOLIS LIZARDS; TESTUDO-GRAECA; HOST; WILDLIFE; THREATS; EXTINCT; DIVERSIFICATION	The Galapagos giant tortoise is an icon of the unique, endemic biodiversity of Galapagos, but little is known of its parasitic fauna. We assessed the diversity of parasitic nematode communities and their spatial distributions within four wild tortoise populations comprising three species across three Galapagos islands, and consider their implication for Galapagos tortoise conservation programmes. Coprological examinations revealed nematode eggs to be common, with more than 80% of tortoises infected within each wild population. Faecal samples from tortoises within captive breeding centres on Santa Cruz, Isabela and San Cristobal islands also were examined. Five different nematode egg types were identified: oxyuroid, ascarid, trichurid and two types of strongyle. Sequencing of the 18S small-subunit ribosomal RNA gene from adult nematodes passed with faeces identified novel sequences indicative of rhabditid and ascaridid species. In the wild, the composition of nematode communities varied according to tortoise species, which co-varied with island, but nematode diversity and abundance were reduced or altered in captive-reared animals. Evolutionary and ecological factors are likely responsible for the variation in nematode distributions in the wild. This possible species/island-parasite co-evolution has not been considered previously for Galapagos tortoises. We recommend that conservation efforts, such as the current Galapagos tortoise captive breeding/rearing and release programme, be managed with respect to parasite biogeography and host-parasite co-evolutionary processes in addition to the biogeography of the host.	[Fournie, Guillaume; Goodman, Simon J.; Cruz, Marilyn; Cedeno, Virna; Velez, Alberto; Patino, Leandro; Millins, Caroline; Cunningham, Andrew A.] Galapagos Genet Epidemiol & Pathol Lab, Santa Cruz, Galapagos Islan, Ecuador; [Fournie, Guillaume] Ecole Natl Vet Alfort, Maisons Alfort, France; [Fournie, Guillaume] Royal Vet Coll, Dept Prod & Populat Hlth, Hatfield, Herts, England; [Goodman, Simon J.; Patino, Leandro] Univ Leeds, Sch Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Cedeno, Virna] Concepto Azul, Guayaquil, Ecuador; [Cedeno, Virna] Univ Guayaquil, Biotechnol Program, Guayaquil, Ecuador; [Patino, Leandro; Millins, Caroline; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Gibbons, Lynda M.; Fox, Mark T.] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London, England	Ecole Nationale Veterinaire d'Alfort (ENVA); University of London; University of London Royal Veterinary College; University of Leeds; Zoological Society of London; University of London; University of London Royal Veterinary College	Cunningham, AA (corresponding author), Galapagos Genet Epidemiol & Pathol Lab, Galapagos Natl Pk, Santa Cruz, Galapagos Islan, Ecuador.	a.cunningham@ioz.ac.uk	Cunningham, Andrew A/E-7536-2010	Goodman, Simon/0000-0003-4118-8575; Fournie, Guillaume/0000-0002-6998-1201; Millins, Caroline/0000-0002-2006-092X; Fox, Mark/0000-0003-2545-4036; Patino Patino, Leandro Dario/0000-0002-3081-3120; Velez Pinela, Edgar Alberto/0000-0002-7504-5014	Darwin Initiative for the Survival of Species, Department for the Environment, Food and Rural Affairs, UK Government [162-12-17, EIDPO15]; Royal Society Wolfson Research Merit Award	Darwin Initiative for the Survival of Species, Department for the Environment, Food and Rural Affairs, UK Government; Royal Society Wolfson Research Merit Award(Royal Society of London)	This study was funded by the Darwin Initiative for the Survival of Species, Department for the Environment, Food and Rural Affairs, UK Government (162-12-17, EIDPO15); https://www.gov.uk/government/groups/the-darwin-initiative. A.A.C. is supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albon SD, 2002, P ROY SOC B-BIOL SCI, V269, P1625, DOI 10.1098/rspb.2002.2064; Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson RC, 2000, FAMILY ATRACTIDAE NE, P250; Arneberg P, 1998, AM NAT, V151, P497, DOI 10.1086/286136; Behnke JM, 2001, PARASITOLOGY, V122, pS39, DOI 10.1017/S0031182000016796; Bensted-Smith R, 1999, 1999 ANN REPORT C DA, P17; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bouamer S, 2006, ANN ZOOL, V56, P225; Bursey CR, 2002, J PARASITOL, V88, P320, DOI 10.1645/0022-3395(2002)088[0320:AMNSNA]2.0.CO;2; Butler D, 1996, NATURE, V383, P290, DOI 10.1038/383290a0; Caccone A, 1999, P NATL ACAD SCI USA, V96, P13223, DOI 10.1073/pnas.96.23.13223; Chabaud A. G., 2009, Keys to the nematode parasites of vertebrates: archival volume, P248, DOI 10.1079/9781845935726.0248; Chavarri M, 2012, VET PARASITOL, V187, P491, DOI 10.1016/j.vetpar.2012.02.007; Couch L, 1996, J PARASITOL, V82, P432, DOI 10.2307/3284081; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; De Ley P, 2002, BIOL NEMATODES, P1; DOBSON AP, 1992, OECOLOGIA, V91, P110, DOI 10.1007/BF00317248; DOBSON AP, 1992, OECOLOGIA, V91, P118, DOI 10.1007/BF00317249; Dybdahl MF, 2003, TRENDS ECOL EVOL, V18, P523, DOI 10.1016/S0169-5347(03)00223-4; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Falk BG, 2013, MOL ECOL, V22, P4576, DOI 10.1111/mec.12410; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Garrick RC, 2012, CURR BIOL, V22, pR10, DOI 10.1016/j.cub.2011.12.004; GEIMAN QUENTIN M., 1937, JOUR PARASITOL, V23, P331, DOI 10.2307/3272225; GREGORY RD, 1993, ACTA TROP, V54, P131, DOI 10.1016/0001-706X(93)90059-K; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Inglis WG, 1963, B SOC VENEZ CI NAT, P126; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; Márquez Cruz, 2004, Ecol. apl., V3, P98; Mathews F, 2006, BIOL CONSERV, V131, P338, DOI 10.1016/j.biocon.2006.04.011; McAllister CT, 2010, J PARASITOL, V96, P1021, DOI 10.1645/GE-2514.1; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Mes THM, 2003, VET PARASITOL, V115, P311, DOI 10.1016/S0304-4017(03)00219-X; Milinkovitch MC, 2013, EVOL APPL, V6, P377, DOI 10.1111/eva.12014; Ministry of Agriculture Fisheries and Food, 1986, MAN VET PAR TECHN RE, V418; PACALA SW, 1988, PARASITOLOGY, V96, P197, DOI 10.1017/S0031182000081762; Petter A.J, 1966, EQUILIBRE ESPECES PO; Poulakakis N, 2012, MOL ECOL, V21, P160, DOI 10.1111/j.1365-294X.2011.05370.x; Poulin R, 1996, AM NAT, V147, P287, DOI 10.1086/285851; Powell J, 2006, CURR BIOL, V16, pR144, DOI 10.1016/j.cub.2006.02.050; Pritchard Peter C.H., 1996, Chelonian Research Monographs, V1, P1; QUOY J. R. C., 1824, B SCI NATURELLES GEO, V1, P90; Rataj AV, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-33; Reiczigel J, 2003, STAT MED, V22, P611, DOI 10.1002/sim.1320; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Russello MA, 2005, BIOL LETT-UK, V1, P287, DOI 10.1098/rsbl.2005.0317; SCHAD GA, 1963, NATURE, V198, P404, DOI 10.1038/198404b0; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Sol D, 2003, OECOLOGIA, V135, P542, DOI 10.1007/s00442-003-1223-6; Stanton JM, 1998, AUSTRALAS PLANT PATH, V27, P112, DOI 10.1071/AP98014; STEAR MJ, 1995, INT J PARASITOL, V25, P375, DOI 10.1016/0020-7519(94)00136-C; TOFT CA, 1990, TRENDS ECOL EVOL, V5, P326, DOI 10.1016/0169-5347(90)90179-H; Traversa D, 2005, PARASITOL RES, V98, P14, DOI 10.1007/s00436-005-0019-5; Turtle Taxonomy Working Group, 2012, TURTL WORLD 2012 UPD; WALTON A. C., 1942, PROC HELMINTHOL SOC WASHINGTON, V9, P1; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Wilson K, 1997, PARASITOL TODAY, V13, P33, DOI 10.1016/S0169-4758(96)40009-6	62	8	11	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135684	10.1371/journal.pone.0135684	http://dx.doi.org/10.1371/journal.pone.0135684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332126	Green Accepted, Green Published, gold			2022-12-27	WOS:000360613800037
J	Kalla, JL; Aronow, PM				Kalla, Joshua L.; Aronow, Peter M.			Editorial Bias in Crowd-Sourced Political Information	PLOS ONE			English	Article							NEWS; COMPLETENESS; CITIZENS; ACCURACY; COVERAGE; IMPACT	The Internet has dramatically expanded citizens' access to and ability to engage with political information. On many websites, any user can contribute and edit "crowd-sourced" information about important political figures. One of the most prominent examples of crowdsourced information on the Internet is Wikipedia, a free and open encyclopedia created and edited entirely by users, and one of the world's most accessed websites. While previous studies of crowd-sourced information platforms have found them to be accurate, few have considered biases in what kinds of information are included. We report the results of four randomized field experiments that sought to explore what biases exist in the political articles of this collaborative website. By randomly assigning factually true but either positive or negative and cited or uncited information to the Wikipedia pages of U.S. senators, we uncover substantial evidence of an editorial bias toward positivity on Wikipedia: Negative facts are 36% more likely to be removed by Wikipedia editors than positive facts within 12 hours and 29% more likely within 3 days. Although citations substantially increase an edit's survival time, the editorial bias toward positivity is not eliminated by inclusion of a citation. We replicate this study on the Wikipedia pages of deceased as well as recently retired but living senators and find no evidence of an editorial bias in either. Our results demonstrate that crowd-sourced information is subject to an editorial bias that favors the politically active.	[Kalla, Joshua L.] Univ Calif Berkeley, Charles & Louise Travers Dept Polit Sci, Berkeley, CA 94720 USA; [Aronow, Peter M.] Yale Univ, Dept Polit Sci, New Haven, CT USA; [Aronow, Peter M.] Yale Univ, Dept Biostat, New Haven, CT USA	University of California System; University of California Berkeley; Yale University; Yale University	Kalla, JL (corresponding author), Univ Calif Berkeley, Charles & Louise Travers Dept Polit Sci, Berkeley, CA 94720 USA.	kalla@berkeley.edu						[Anonymous], 2014, TOP SITES US; Arceneaux Kevin., 2013, CHANGING MINDS CHANG; BARTELS LM, 1993, AM POLIT SCI REV, V87, P267, DOI 10.2307/2939040; Benkler Y., 2007, WEALTH NETWORKS SOCI; Bergstrom K., 2011, DONT FEED TROLL SHUT, P16; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Berry CR, 2007, J POLIT, V69, P844, DOI 10.1111/j.1468-2508.2007.00579.x; Brown AR, 2011, PS-POLIT SCI POLIT, V44, P339, DOI 10.1017/S1049096511000199; Clauson KA, 2008, ANN PHARMACOTHER, V42, P1814, DOI 10.1345/aph.1L474; COX DR, 1972, J R STAT SOC B, V34, P187; DellaVigna S, 2007, Q J ECON, V122, P1187, DOI 10.1162/qjec.122.3.1187; Gilens Martin, 2000, J POLIT, V62, P369, DOI [10.1111/0022-3816.00017, DOI 10.1111/0022-3816.00017]; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Gore D, 2013, KEEPING YOUR HLTH PL; Groseclose T, 2005, Q J ECON, V120, P1191, DOI 10.1162/003355305775097542; Herman E.S., 1988, POLITICAL EC MASS ME; Hindman M. S., 2009, MYTH DIGITAL DEMOCRA; Jordan W., 2014, BRIT PEOPLE TRUST WI; Kahn KF, 2002, AM POLIT SCI REV, V96, P381; Lenz GabrielS., 2012, FOLLOW LEADER VOTERS; Levine P., 2002, DEMOCRACYS MOMENT RE, P121; Mill John Stuart, 2002, BASIC WRITINGS JS MI; Miller JM, 2000, AM J POLIT SCI, V44, P301, DOI 10.2307/2669312; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; OKeefe E., 2014, WASHINGTON POST; Puglisi R, J EUR ECON IN PRESS; Samoilenko A, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds20; Sauermann H, 2015, P NATL ACAD SCI USA, V112, P679, DOI 10.1073/pnas.1408907112; Snyder JM, 2010, J POLIT ECON, V118, P355, DOI 10.1086/652903; Williams BA, 2004, AM BEHAV SCI, V47, P1208, DOI 10.1177/0002764203262344; Wired Howe J., 2006, WIRED            JUN	31	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136327	10.1371/journal.pone.0136327	http://dx.doi.org/10.1371/journal.pone.0136327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26331611	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800052
J	Koopman, JE; van der Kaaij, NCW; Buijs, MJ; Elyassi, Y; van der Veen, MH; Crielaard, W; ten Cate, JM; Zaura, E				Koopman, Jessica E.; van der Kaaij, Nicoline C. W.; Buijs, Mark J.; Elyassi, Yassaman; van der Veen, Monique H.; Crielaard, Wim; ten Cate, Jacob M.; Zaura, Egija			The Effect of Fixed Orthodontic Appliances and Fluoride Mouthwash on the Oral Microbiome of Adolescents - A Randomized Controlled Clinical Trial	PLOS ONE			English	Article							SUBGINGIVAL PLAQUE; BACTERIAL COMPOSITION; LONGITUDINAL CHANGES; LESION DEVELOPMENT; BIOFILM FORMATION; PUBERTY; GINGIVITIS; PARAMETERS; REMOVAL; CAVITY	While the aesthetic effect of orthodontic treatment is clear, the knowledge on how it influences the oral microbiota and the consequential effects on oral health are limited. In this randomized controlled clinical trial we investigated the changes introduced in the oral ecosystem, during and after orthodontic treatment with fixed appliances in combination with or without a fluoride mouthwash, of 10-16.8 year old individuals (N = 91). We followed several clinical parameters in time, in combination with microbiome changes using next-generation sequencing of the bacterial 16S rRNA gene. During the course of our study, the oral microbial community displayed remarkable resilience towards the disturbances it was presented with. The effects of the fluoride mouthwash on themicrobial composition were trivial. More pronouncedmicrobial changes were related to gingival health status, orthodontic treatment and time. Periodontal pathogens (e.g. Selenomonas and Porphyromonas) were highest in abundance during the orthodontic treatment, while the health associated Streptococcus, Rothia and Haemophilus gained abundance towards the end and after the orthodontic treatment. Only minor compositional changes remained in the oral microbiome after the end of treatment. We conclude that, provided proper oral hygiene is maintained, changes in the oral microbiome composition resulting from orthodontic treatment are minimal and do not negatively affect oral health.	[Koopman, Jessica E.; Buijs, Mark J.; Elyassi, Yassaman; van der Veen, Monique H.; Crielaard, Wim; ten Cate, Jacob M.; Zaura, Egija] Acad Ctr Dent Amsterdam, Dept Prevent Dent, NL-1066 EA Amsterdam, Netherlands; [van der Kaaij, Nicoline C. W.] Acad Ctr Dent Amsterdam, Dept Orthodont, NL-1066 EA Amsterdam, Netherlands	Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Zaura, E (corresponding author), Acad Ctr Dent Amsterdam, Dept Prevent Dent, NL-1066 EA Amsterdam, Netherlands.	e.zaura@acta.nl	van der Veen, Monique H/B-3719-2014	Zaura, Egija/0000-0003-1432-6194; Koopman, Jessica Edith/0000-0002-7944-7969	Elmex research / Colgate-Palmolive Europe	Elmex research / Colgate-Palmolive Europe	The study was financially supported by Elmex research / Colgate-Palmolive Europe. The authors declare that otherwise no competing interests exist. The involvement of Elmex research / Colgate-Palmolive Europe in this study by financial support had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen WM, 2013, INT J SYST EVOL MICR, V63, P965, DOI 10.1099/ijs.0.041186-0; Choi DS, 2009, ANGLE ORTHOD, V79, P1149, DOI 10.2319/111808-593R.1; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; DELANEY J E, 1986, Pediatric Dentistry, V8, P268; Demling A, 2009, EUR J ORTHODONT, V31, P202, DOI 10.1093/ejo/cjn090; Duran-Pinedo AE, 2014, ISME J, V8, P1659, DOI 10.1038/ismej.2014.23; Fujinaka H, 2013, ARCH MICROBIOL, V195, P371, DOI 10.1007/s00203-013-0883-9; Gerardu VAM, 2003, CARIES RES, V37, P369, DOI 10.1159/000072170; Gong YM, 2011, AM J ORTHOD DENTOFAC, V140, P58, DOI 10.1016/j.ajodo.2010.02.033; GUSBERTI FA, 1990, J CLIN PERIODONTOL, V17, P685, DOI 10.1111/j.1600-051X.1990.tb01054.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112; Hu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056343; Huang S, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-33; Jiang W, 2014, MICROB ECOL, V67, P962, DOI 10.1007/s00248-014-0372-y; John RC, 2011, B ENVIRON CONTAM TOX, V87, P343, DOI 10.1007/s00128-011-0320-1; Kim SH, 2012, ANGLE ORTHOD, V82, P254, DOI 10.2319/030311-156.1; Koopman JE, 2015, MICROB ECOL, V69, P422, DOI 10.1007/s00248-014-0535-x; Kraneveld EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042770; Madlena Melinda, 2012, Oral Health Dent Manag, V11, P57; Mattousch TJH, 2007, EUR J ORTHODONT, V29, P294, DOI 10.1093/ejo/cjm008; MOMBELLI A, 1990, J PERIODONTAL RES, V25, P331, DOI 10.1111/j.1600-0765.1990.tb00924.x; MOORE WEC, 1993, INFECT IMMUN, V61, P2891, DOI 10.1128/IAI.61.7.2891-2898.1993; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Morishita M, 1988, Adv Dent Res, V2, P397; Mysak J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/476068; Nadkarni MA, 2012, EUR J CLIN MICROBIOL, V31, P2989, DOI 10.1007/s10096-012-1651-5; NAKAGAWA S, 1994, J CLIN PERIODONTOL, V21, P658, DOI 10.1111/j.1600-051X.1994.tb00783.x; Ogaard B, 2006, EUR J ORTHODONT, V28, P8, DOI 10.1093/ejo/cji075; Ren YJ, 2014, CLIN ORAL INVEST, V18, P1711, DOI 10.1007/s00784-014-1240-3; Ristic M, 2007, ORTHOD CRANIOFAC RES, V10, P187, DOI 10.1111/j.1601-6343.2007.00396.x; Rosin-Grget Kata, 2013, Acta Med Acad, V42, P179, DOI 10.5644/ama2006-124.85; Soro V, 2014, APPL ENVIRON MICROB, V80, P6480, DOI 10.1128/AEM.01827-14; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Sukontapatipark W, 2001, EUR J ORTHODONT, V23, P475, DOI 10.1093/ejo/23.5.475; Tanner ACR, 2012, J DENT RES, V91, P853, DOI 10.1177/0022034512455031; ten Cate JM, 2013, BRIT DENT J, V214, P161, DOI 10.1038/sj.bdj.2013.162; ten Cate J M Bob, 2009, Adv Dent Res, V21, P8, DOI 10.1177/0895937409335591; Thornberg MJ, 2009, AM J ORTHOD DENTOFAC, V135, P95, DOI 10.1016/j.ajodo.2007.02.057; Torlakovic L, 2013, ACTA ODONTOL SCAND, V71, P1547, DOI 10.3109/00016357.2013.776107; TSURUDA K, 1995, J CLIN PERIODONTOL, V22, P316, DOI 10.1111/j.1600-051X.1995.tb00154.x; van der Kaaij NCW, 2015, EUR J ORAL SCI, V123, P186, DOI 10.1111/eos.12186; van Gastel J, 2008, J PERIODONTOL, V79, P2078, DOI 10.1902/jop.2008.080153 ; van Gastel J, 2011, EUR J ORTHODONT, V33, P15, DOI 10.1093/ejo/cjq032; van Loveren C, 2009, CARIES RES, V43, P462, DOI 10.1159/000264683; Van Loveren C, 2001, CARIES RES, V35, P65, DOI 10.1159/000049114; Vetter-O'Hagen CS, 2012, DEV PSYCHOBIOL, V54, P523, DOI 10.1002/dev.20610; WOJCICKI CJ, 1987, J PERIODONTOL, V58, P219, DOI 10.1902/jop.1987.58.4.219; Wright CJ, 2013, MOL ORAL MICROBIOL, V28, P83, DOI 10.1111/omi.12012; ZACHRISSON BU, 1972, ACTA ODONTOL SCAND, V30, P127, DOI 10.3109/00016357209004597; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	54	41	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137318	10.1371/journal.pone.0137318	http://dx.doi.org/10.1371/journal.pone.0137318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332408	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800120
J	Mascarenhas, R; Pietrzak, M; Smith, RM; Webb, A; Wang, DX; Papp, AC; Pinsonneault, JK; Seweryn, M; Rempala, G; Sadee, W				Mascarenhas, Roshan; Pietrzak, Maciej; Smith, Ryan M.; Webb, Amy; Wang, Danxin; Papp, Audrey C.; Pinsonneault, Julia K.; Seweryn, Michal; Rempala, Grzegorz; Sadee, Wolfgang			Allele-Selective Transcriptome Recruitment to Polysomes Primed for Translation: Protein-Coding and Noncoding RNAs, and RNA Isoforms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PRIMARY BILIARY-CIRRHOSIS; MESSENGER-RNA; GENETIC ARCHITECTURE; EXPRESSION IMBALANCE; SUSCEPTIBILITY LOCI; QUANTITATIVE TRAIT; RISK LOCI; VARIANTS; IDENTIFICATION	mRNA translation into proteins is highly regulated, but the role of mRNA isoforms, noncoding RNAs (ncRNAs), and genetic variants remains poorly understood. mRNA levels on polysomes have been shown to correlate well with expressed protein levels, pointing to polysomal loading as a critical factor. To study regulation and genetic factors of protein translation we measured levels and allelic ratios of mRNAs and ncRNAs (including microRNAs) in lymphoblast cell lines (LCL) and in polysomal fractions. We first used targeted assays to measure polysomal loading of mRNA alleles, confirming reported genetic effects on translation of OPRM1 and NAT1, and detecting no effect of rs1045642 (3435C>T) in ABCB1 (MDR1) on polysomal loading while supporting previous results showing increased mRNA turnover of the 3435T allele. Use of high-throughput sequencing of complete transcript profiles (RNA-Seq) in three LCLs revealed significant differences in polysomal loading of individual RNA classes and isoforms. Correlated polysomal distribution between protein-coding and non-coding RNAs suggests interactions between them. Allele-selective polysome recruitment revealed strong genetic influence for multiple RNAs, attributable either to differential expression of RNA isoforms or to differential loading onto polysomes, the latter defining a direct genetic effect on translation. Genes identified by different allelic RNA ratios between cytosol and polysomes were enriched with published expression quantitative trait loci (eQTLs) affecting RNA functions, and associations with clinical phenotypes. Polysomal RNA-Seq combined with allelic ratio analysis provides a powerful approach to study polysomal RNA recruitment and regulatory variants affecting protein translation.	[Mascarenhas, Roshan; Pietrzak, Maciej; Smith, Ryan M.; Wang, Danxin; Papp, Audrey C.; Pinsonneault, Julia K.; Rempala, Grzegorz; Sadee, Wolfgang] Ohio State Univ, Coll Med, Wexner Med Ctr, Ctr Pharmacogen, Columbus, OH 43210 USA; [Pietrzak, Maciej; Seweryn, Michal; Rempala, Grzegorz] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Webb, Amy] Ohio State Univ, Wexner Med Ctr, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA; [Seweryn, Michal] Univ Lodz, Dept Math & Comp Sci, PL-90131 Lodz, Poland; [Seweryn, Michal; Rempala, Grzegorz] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Sadee, Wolfgang] Ohio State Univ, Wexner Med Ctr, Coll Med, Dept Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Lodz; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Sadee, W (corresponding author), Ohio State Univ, Coll Med, Wexner Med Ctr, Ctr Pharmacogen, Columbus, OH 43210 USA.	Wolfgang.Sadee@osumc.edu	Wang, Danxin/I-5810-2019; Rempala, Grzegorz/C-3576-2013; Pietrzak, Maciej/GNH-5768-2022	Wang, Danxin/0000-0002-7134-3065; Pietrzak, Maciej/0000-0001-5768-7884; Seweryn, Michal/0000-0002-9090-3435	National Institute of General Medical Sciences [U01GM092655]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092655] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (nigms.nih.gov); (Grant No. U01GM092655 to WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058257; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; [Anonymous], 2014, R LANG ENV STAT COMP; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Beilharz Traude H., 2004, Briefings in Functional Genomics & Proteomics, V3, P103, DOI 10.1093/bfgp/3.2.103; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Chen P, 2014, HUM MOL GENET, V23, P6129, DOI 10.1093/hmg/ddu322; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Crosslin DR, 2013, HUM MOL GENET, V22, P2119, DOI 10.1093/hmg/ddt010; Deng XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079629; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Garge N, 2010, MOL CELL PROTEOMICS, V9, P1383, DOI 10.1074/mcp.M900378-MCP200; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Ingolia Nicholas T, 2013, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0418s103; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Johansson A, 2013, P NATL ACAD SCI USA, V110, P4673, DOI 10.1073/pnas.1217238110; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kleijn M, 1998, EUR J BIOCHEM, V253, P531, DOI 10.1046/j.1432-1327.1998.2530531.x; Knight JC, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0092-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3260; Lian Z, 2001, BLOOD, V98, P513, DOI 10.1182/blood.V98.3.513; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Martin JE, 2013, HUM MOL GENET, V22, P4021, DOI 10.1093/hmg/ddt248; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Molotski N, 2012, RNA, V18, P1612, DOI 10.1261/rna.033142.112; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Parts L, 2014, GENOME RES, V24, P1363, DOI 10.1101/gr.170506.113; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Polychronakos C, 2012, J MED GENET, V49, P554, DOI 10.1136/jmedgenet-2012-101199; Porcu E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003266; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Rempala GA, 2013, J MATH BIOL, V67, P1339, DOI 10.1007/s00285-012-0589-7; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sadee W, 2011, CLIN PHARMACOL THER, V89, P355, DOI 10.1038/clpt.2010.314; Sadee W, 2014, HUM GENET, V133, P1199, DOI 10.1007/s00439-014-1476-7; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Smith RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-571; Smith RM, 2013, BIOL PSYCHIAT, V73, P546, DOI 10.1016/j.biopsych.2012.09.028; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Sterne-Weiler T, 2013, GENOME RES, V23, P1615, DOI 10.1101/gr.148585.112; Tebaldi T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-220; Teumer A, 2013, J CLIN PERIODONTOL, V40, P977, DOI 10.1111/jcpe.12154; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turner ST, 2012, HYPERTENSION, V59, P1204, DOI 10.1161/HYP.0b013e31825b30f8; van Heesch S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r6; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang DX, 2011, PHARMACOGENET GENOM, V21, P652, DOI 10.1097/FPC.0b013e3283498ee9; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Webb A, 2013, PHARMACOGENET GENOM, V23, P269, DOI 10.1097/FPC.0b013e32835ff536; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wineinger NE, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-4; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Zhang Y, 2005, J BIOL CHEM, V280, P32618, DOI 10.1074/jbc.M504942200	83	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136798	10.1371/journal.pone.0136798	http://dx.doi.org/10.1371/journal.pone.0136798			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331722	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800073
J	Wood, S; Ross, S; Sauve, R				Wood, Stephen; Ross, Sue; Sauve, Reg			Cesarean Section and Subsequent Stillbirth, Is Confounding by Indication Responsible for the Apparent Association? An Updated Cohort Analysis of a Large Perinatal Database	PLOS ONE			English	Article							UNEXPLAINED STILLBIRTH; ANTEPARTUM STILLBIRTH; RETROSPECTIVE COHORT; 1ST PREGNANCY; 2ND PREGNANCY; RISK; DELIVERY; AGE; POPULATION; OUTCOMES	Background Several studies and a recent meta-analysis have suggested that previous Cesarean section may increase the risk of stillbirth in a subsequent pregnancy. Given the high rates of Cesarean section in contemporary obstetric practice, this is of considerable public health importance. We sought to evaluate the potential that this association is the result of residual confounding bias. Methods A large perinatal database (Alberta Perinatal Health Project) was searched to identify a matched set of first and second births from the years 1992-2006. Data on pregnancy outcomes, demographics and potential confounding factors were obtained. Results The cohort was comprised of 98538 matched first and second births. Multivariate analysis did not reveal an association between previous Cesarean section and stillbirth, OR = 1.38 (0.98, 1.93). Restricting the analysis to a low risk group further attenuated the association, OR = .99 (0.62, 1.52). Analysis of the risk by indication for Cesarean section found that the risk was not increased for previous dystocia, OR = .91 (0.53, 1.55) nor for breech presentation, OR = 1.06 (0.50, 2.28) but only for other indications including non reassuring fetal status and fetal distress, OR = 1.96 (1.29, 2.98). Conclusions The results of our cohort analysis suggest that previous Cesarean section does not cause an increased risk of stillbirth.	[Wood, Stephen; Ross, Sue] Univ Calgary, Dept Obstet & Gynecol & Community Hlth Sci, Calgary, AB, Canada; [Sauve, Reg] Univ Calgary, Canada Dept Pediat & Community Hlth Sci, Calgary, AB, Canada	University of Calgary; University of Calgary	Wood, S (corresponding author), Univ Calgary, Dept Obstet & Gynecol & Community Hlth Sci, Calgary, AB, Canada.	Stephen.wood@albertahealthservices.ca						Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Franz MBL, 2009, ARCH GYNECOLOGY OBST, V279; Gray R, 2007, BJOG-INT J OBSTET GY, V114, P264, DOI 10.1111/j.1471-0528.2006.01249.x; Joseph KS, 2013, CAN MED ASSOC J, V185, pE345, DOI 10.1503/cmaj.121372; KEELING JW, 1989, ARCH DIS CHILD, V64, P1345, DOI 10.1136/adc.64.10_Spec_No.1345; Kennare R, 2007, OBSTET GYNECOL, V109, P270, DOI 10.1097/01.AOG.0000250469.23047.73; Mohangoo AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024727; O Bahtiyar M, 2006, AM J OBSTET GYNECOL, V195, P1373, DOI 10.1016/j.ajog.2006.02.051; O'Neill SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054588; Ohana O, 2011, J MATERN-FETAL NEO M, V24, P1079, DOI 10.3109/14767058.2010.545918; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; Richter R, 2007, EUR J OBSTET GYN R B, V132, P51, DOI 10.1016/j.ejogrb.2006.06.002; Salihu HM, 2006, OBSTET GYNECOL, V107, P383, DOI 10.1097/01.AOG.0000195103.46999.32; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 2007, AM J EPIDEMIOL, V165, P194, DOI 10.1093/aje/kwj354; Surkan PJ, 2004, NEW ENGL J MED, V350, P777, DOI 10.1056/NEJMoa031587; Taylor LK, 2005, MED J AUSTRALIA, V183, P515, DOI 10.5694/j.1326-5377.2005.tb07152.x; Wilson RE, 2008, ARCH GYNECOL OBSTET, V278, P231, DOI 10.1007/s00404-007-0557-4; Wood SL, 2008, BJOG-INT J OBSTET GY, V115, P726, DOI 10.1111/j.1471-0528.2008.01705.x	20	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136272	10.1371/journal.pone.0136272	http://dx.doi.org/10.1371/journal.pone.0136272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331274	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800050
J	Gregoraccl, GB; Soares, ACD; Miranda, MD; Coutinho, R; Thompson, FL				Gregoraccl, Gustavo Bueno; dos Santos Soares, Ana Carolina; Miranda, Milene Dias; Coutinho, Ricardo; Thompson, Fabiano L.			Insights into the Microbial and Viral Dynamics of a Coastal Downwelling-Upwelling Transition	PLOS ONE			English	Article							PHYTOPLANKTON BLOOM; MARINE; METAGENOMES; BACTERIOPLANKTON; PROCHLOROCOCCUS; SYNECHOCOCCUS; ENVIRONMENTS; EXPRESSION; ECOSYSTEM; VIRUSES	Although previous studies have described opposing states in upwelling regions, i.e., the rise of cold nutrient-rich waters and prevalence of surface warm nutrient-poor waters, few have addressed the transition from one state to the other. This study aimed to describe the microbial and viral structure during this transition and was able to obtain the taxonomic and metabolic compositions as well as physical-chemical data. This integrated approach allowed for a better understanding of the dynamics of the downwelling upwelling transition, suggesting that a wealth of metabolic processes and ecological interactions are occurring in the minute fractions of the plankton (femto, pico, nano). These processes and interactions included evidence of microbial predominance during downwelling (with nitrogen recycling and aerobic anoxygenic photosynthesis), different viral predation pressures over primary production in different states (cyanobacteria vs eukaryotes), and a predominance of diatoms and selected bacterial and archaeal groups during upwelling (with the occurrence of a wealth of nitrogen metabolism involving ammonia). Thus, the results provided insights into which microbes, viruses and microbial-mediated processes are probably important in the functioning of upwelling systems.	[Gregoraccl, Gustavo Bueno] UNIFESP Baixada Santista, Dept Ciencias Mar, Santos, SP, Brazil; [Gregoraccl, Gustavo Bueno; dos Santos Soares, Ana Carolina; Miranda, Milene Dias; Thompson, Fabiano L.] Univ Fed Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, RJ, Brazil; [Miranda, Milene Dias] Inst Oswaldo Cruz IOC FIOCRUZ, Lab Virus Resp & Sarampo, Rio De Janeiro, RJ, Brazil; [Coutinho, Ricardo] Inst Estudos Mar Almirante Paulo Moreira IEAPM, Arraial Do Cabo, RJ, Brazil; [Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Lab Sistemas Avancados Gestao Prod SAGE COPPE, Ctr Gestao Tecnol CT2, Rio de Janeiro, RJ, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Thompson, FL (corresponding author), Univ Fed Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, RJ, Brazil.	fabianothompson1@gmail.com	Miranda, Milene/ABD-8472-2021; coutinho, ricardo/AAW-2458-2020	Miranda, Milene/0000-0003-0037-059X; coutinho, ricardo/0000-0001-5430-2176; Thompson, Fabiano/0000-0002-7562-1683; Gregoracci, Gustavo/0000-0001-6896-1068	Brazilian funding agency CAPES; Brazilian funding agency CNPq; Brazilian funding agency FAPERJ	Brazilian funding agency CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian funding agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Financial support by Brazilian funding agencies CAPES, CNPq, and FAPERJ.	Allen LZ, 2012, ISME J, V6, P1403, DOI 10.1038/ismej.2011.201; Alves Junior N, 2014, ARCH MICROBIOL; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; BARLOW RG, 1984, MAR ECOL PROG SER, V16, P121, DOI 10.3354/meps016121; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Carvalho W.F., 2004, BRAZ J OCEANOGR, V52, P35; Cavalcanti GS, 2014, ISME J, V8, P52, DOI 10.1038/ismej.2013.133; Cermeno P, 2005, MAR ECOL PROG SER, V297, P51, DOI 10.3354/meps297051; Clokie MRJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-291; Coelho-Souza SA, 2012, BRAZ J OCEANOGR, V60, P353, DOI 10.1590/S1679-87592012000300008; Cuevasa LA, 2004, DEEP-SEA RES PT II, V51, P2427, DOI 10.1016/j.dsr2.2004.07.026; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; Enav H, 2012, ISME J, V6, P619, DOI 10.1038/ismej.2011.146; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Gifford SM, 2013, ISME J, V7, P281, DOI 10.1038/ismej.2012.96; GONZALEZRODRIGUEZ E, 1992, J PLANKTON RES, V14, P289, DOI 10.1093/plankt/14.2.289; Grasshoff K, 1999, METHODS SEAWATER ANA; Gregoracci GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031408; Guenther M, 2008, MAR ECOL PROG SER, V363, P109, DOI 10.3354/meps07458; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11; Lopez-Perez M, 2013, GENOME BIOL EVOL, V5, P1220, DOI 10.1093/gbe/evt089; LORENZZETTI JA, 1996, INT ARCH PHOTOGRA B7, V31; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Moser Gleyci A. O., 1997, Revista Brasileira de Oceanografia, V45, P11; Ottesen EA, 2013, P NATL ACAD SCI USA, V110, pE488, DOI 10.1073/pnas.1222099110; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Sowell SM, 2011, ISME J, V5, P856, DOI 10.1038/ismej.2010.168; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sun J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023973; Teira E, 2009, ENV MICROBIOL REP, V1, P545, DOI 10.1111/j.1758-2229.2009.00079.x; Thompson FL, 2011, ARCH MICROBIOL, V193, P105, DOI 10.1007/s00203-010-0644-y; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wyatt T, 2014, DEEP-SEA RES PT II, V101, P32, DOI 10.1016/j.dsr2.2012.12.006; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943	42	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137090	10.1371/journal.pone.0137090	http://dx.doi.org/10.1371/journal.pone.0137090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327119	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700093
J	Dhawan, D; Paoloni, M; Shukradas, S; Choudhury, DR; Craig, BA; Ramos-Vara, JA; Hahn, N; Bonney, PL; Khanna, C; Knapp, DW				Dhawan, Deepika; Paoloni, Melissa; Shukradas, Shweta; Choudhury, Dipanwita Roy; Craig, Bruce A.; Ramos-Vara, Jose A.; Hahn, Noah; Bonney, Patty L.; Khanna, Chand; Knapp, Deborah W.			Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; HUMAN BREAST-TUMORS; URINARY-BLADDER; MOLECULAR PORTRAITS; TARGETED THERAPY; LUNG-CANCER; PHASE-III; LAPATINIB; ERLOTINIB; PATHWAYS	More than 160,000 people are expected to die from invasive urothelial carcinoma (iUC) this year worldwide. Research in relevant animal models is essential to improving iUC management. Naturally-occurring canine iUC closely resembles human iUC in histopathology, metastatic behavior, and treatment response, and could provide a relevant model for human iUC. The molecular characterization of canine iUC, however, has been limited. Work was conducted to compare gene expression array results between tissue samples from iUC and normal bladder in dogs, with comparison to similar expression array data from human iUC and normal bladder in the literature. Considerable similarities between enrichment patterns of genes in canine and human iUC were observed. These included patterns mirroring basal and luminal subtypes initially observed in human breast cancer and more recently noted in human iUC. Canine iUC samples also exhibited enrichment for genes involved in P53 pathways, as has been reported in human iUC. This is particularly relevant as drugs targeting these genes/pathways in other cancers could be repurposed to treat iUC, with dogs providing a model to optimize therapy. As part of the validation of the results and proof of principal for evaluating individualized targeted therapy, the overexpression of EGFR in canine bladder iUC was confirmed. The similarities in gene expression patterns between dogs and humans add considerably to the value of naturally-occurring canine iUC as a relevant and much needed animal model for human iUC. Furthermore, the finding of expression patterns that cross different pathologically-defined cancers could allow studies of dogs with iUC to help optimize cancer management across multiple cancer types. The work is also expected to lead to a better understanding of the biological importance of the gene expression patterns, and the potential application of the cross-species comparisons approach to other cancer types as well.	[Dhawan, Deepika; Bonney, Patty L.; Knapp, Deborah W.] Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA; [Dhawan, Deepika; Ramos-Vara, Jose A.; Knapp, Deborah W.] Purdue Univ, Purdue Oncol Sci Ctr, W Lafayette, IN 47907 USA; [Paoloni, Melissa; Khanna, Chand] NCI, CCR Comparat Oncol Program, Ctr Canc Res, Bethesda, MD 20892 USA; [Shukradas, Shweta; Choudhury, Dipanwita Roy] Strand Genom Inc, Dept Bioinformat, San Francisco, CA USA; [Craig, Bruce A.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Ramos-Vara, Jose A.] Purdue Univ, Dept Comparat Pathobiol, Coll Vet Med, W Lafayette, IN 47907 USA; [Hahn, Noah] Johns Hopkins Univ, Sch Med, Dept Oncol & Urol, Baltimore, MD USA; [Knapp, Deborah W.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Johns Hopkins University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Knapp, DW (corresponding author), Purdue Univ, Dept Vet Clin Sci, Coll Vet Med, W Lafayette, IN 47907 USA.	knappd@purdue.edu	Craig, Bruce A/D-5797-2017	Craig, Bruce A/0000-0001-9346-467X	Comparative Oncology Program within the Intramural NCI; Strand Genomics Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER	Comparative Oncology Program within the Intramural NCI; Strand Genomics Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by private donations for bladder cancer research made to the Purdue Comparative Oncology Program. At the time the work was done, MP and CK worked in the National Cancer Institute's Comparative Oncology Program. Additional funding for a portion of this work was provided by the Comparative Oncology Program within the Intramural NCI. Strand Genomics Inc. provided support in the form of salaries for authors SS and DRC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	American Cancer Society, 2015, CANC FIG FACTS; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Choi W, 2014, NAT REV UROL, V11, P400, DOI 10.1038/nrurol.2014.129; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Claperon A, 2014, J HEPATOL, V61, P325, DOI 10.1016/j.jhep.2014.03.033; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Decker B, 2015, MOL CANCER RES MCR; Dhawan D, 2013, UROL ONCOL-SEMIN ORI, V31, P1761, DOI 10.1016/j.urolonc.2012.03.015; Dhawan D, 2013, CANCER RES, V73, P875, DOI 10.1158/0008-5472.CAN-12-2101; Dhawan D, 2010, MOL CANCER THER, V9, P1371, DOI 10.1158/1535-7163.MCT-10-0049; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; Fang ZQ, 2013, GENET MOL RES, V12, P1479, DOI 10.4238/2013.May.6.1; Gala K, 2014, CLIN CANCER RES, V20, P1410, DOI 10.1158/1078-0432.CCR-13-1549; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Gross-Goupil M, 2012, EXPERT OPIN INV DRUG, V21, P1727, DOI 10.1517/13543784.2012.713935; Guan Z, 2013, J CLIN ONCOL; Hahn NM, 2012, J UROLOGY, V187, P302, DOI 10.1016/j.juro.2011.09.010; Hanazono K, 2014, J VET MED SCI JPN SO; Havaleshko DM, 2009, NEOPLASIA, V11, P1185, DOI 10.1593/neo.09898; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Kawaguchi T, 2014, J CLIN ONCOL, V32, P1902, DOI 10.1200/JCO.2013.52.4694; Kim WJ, 2011, MOL MED, V17, P478, DOI 10.2119/molmed.2010.00274; Knapp Deborah W, 2015, Am Soc Clin Oncol Educ Book, pe667, DOI 10.14694/EdBook_AM.2015.35.e667; Knapp DW, 2014, ILAR J, V55, P100, DOI 10.1093/ilar/ilu018; KNAPP DW, 1994, J VET INTERN MED, V8, P273, DOI 10.1111/j.1939-1676.1994.tb03232.x; Knapp DW, 2013, ROW MACEWENS SMALL A; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kurtoglu M, 2015, CLIN GENITOURIN CANC; Lee SM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju151; Li ML, 2014, NAT GENET, V46, P872, DOI 10.1038/ng.3030; Liedberg F, 2008, UROL ONCOL-SEMIN ORI, V26, P17, DOI 10.1016/j.urolonc.2006.08.021; Mason RA, 2009, CARCINOGENESIS, V30, P1155, DOI 10.1093/carcin/bgp077; McHugh LA, 2007, UROLOGY, V69, P390, DOI 10.1016/j.urology.2006.12.003; Metro G, 2006, REV RECENT CLIN TRIA, V1, P1, DOI 10.2174/157488706775246157; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Plimack ER, 2014, PROSPECTS TARGETING; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Renouf DJ, 2014, EUR J CANCER, V50, P1909, DOI 10.1016/j.ejca.2014.04.008; Siegel RL, 2016, CA CANC J CLIN, V2015; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Teply Benjamin A, 2014, J Solid Tumors, V4, P25; Tomao F, 2014, ONCOTARGETS THER, V7, DOI 10.2147/OTT.S68286; Villares GJ, 2007, WORLD J UROL, V25, P573, DOI 10.1007/s00345-007-0202-7; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wulfing C, 2009, CANCER-AM CANCER SOC, V115, P2881, DOI 10.1002/cncr.24337; Yan XL, 2012, BREAST CANCER RES TR, V132, P153, DOI 10.1007/s10549-011-1577-0; Zhang ZF, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-58; Zhu ZW, 2012, ANTI-CANCER AGENT ME, V12, P1081, DOI 10.2174/187152012803529673	49	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136688	10.1371/journal.pone.0136688	http://dx.doi.org/10.1371/journal.pone.0136688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352142	Green Submitted, gold, Green Published			2022-12-27	WOS:000360932800045
J	Bucciardini, R; Fragola, V; Abegaz, T; Lucattini, S; Halifom, A; Tadesse, E; Berhe, M; Pugliese, K; Binelli, A; De Castro, P; Terlizzi, R; Fucili, L; Di Gregorio, M; Mirra, M; Olivieri, E; Teklu, T; Zegeye, T; Haile, A; Vella, S; Abraham, L				Bucciardini, Raffaella; Fragola, Vincenzo; Abegaz, Teshome; Lucattini, Stefano; Halifom, Atakilt; Tadesse, Eskedar; Berhe, Micheal; Pugliese, Katherina; Binelli, Andrea; De Castro, Paola; Terlizzi, Roberta; Fucili, Luca; Di Gregorio, Massimiliano; Mirra, Marco; Olivieri, Erika; Teklu, Tsigemariam; Zegeye, Teame; Haile, Amanuel; Vella, Stefano; Abraham, Loko		CASA-project Health Facilities	Retention in Care of Adult HIV Patients Initiating Antiretroviral Therapy in Tigray, Ethiopia: A Prospective Observational Cohort Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; COMMUNITY-HEALTH WORKERS; TREATMENT PROGRAM; CLINICAL-OUTCOMES; ADHERENCE SUPPORT; DELIVERY; SURVIVAL; GENDER; IMPACT; INCOME	Introduction Although Ethiopia has been scaling up the antiretroviral therapy (ART) services, low retention in care of patients remains one of the main obstacles to treatment success. We report data on retention in care and its associated determinants in Tigray, Ethiopia. Methods We used data from the CASA project, a prospective observational and multi-site study of a cohort of HIV-infected patients who initiated ART for the first time in Tigray. Four participating health facilities (HFs) located in the South of Tigray were considered for this study. Patients were followed for one year after ART initiation. The main outcome measure was represented by the current retention in care, defined as the proportion of patients who were alive and receiving ART at the same HF one year after ART initiation. Patients who started ART between January 1, 2013 and December 31, 2013 were included in this analysis. Patients were followed for one year after ART initiation. The determinants of retention were analysed using univariate and multivariate Cox Proportional Hazards model with robust sandwich estimates to account for within HF correlation. Results The four participating HFs in Tigray were able to retain overall 85.1% of their patients after one year from starting ART. Loss to follow-up (5.5%) and transfers to other HF (6.6) were the main determinant of attrition. A multivariate analysis shows that the factors significantly associated with retention were the type of HF, gender and active TB. Alamata health center was the HF with the highest attrition rate (HR 2.99, 95% CI: 2.77-3.23). Active TB (HR 1.72, 95% CI: 1.23-2.41) and gender (HR 1.64, 95% CI: 1.10-2.56) were also significantly associated with attrition. Conclusions Although Ethiopia has significantly improved access to the ART program, achieving and maintaining a satisfactory long-term retention rate is a future goal. This is difficult because of different retention rates among HFs. Moreover specific interventions should be directed to people of different sex to improve retention in care in male population.	[Bucciardini, Raffaella; Fragola, Vincenzo; Lucattini, Stefano; Pugliese, Katherina; Binelli, Andrea; De Castro, Paola; Terlizzi, Roberta; Fucili, Luca; Di Gregorio, Massimiliano; Mirra, Marco; Olivieri, Erika; Vella, Stefano] Ist Super Sanita, I-00161 Rome, Italy; [Abegaz, Teshome; Tadesse, Eskedar; Berhe, Micheal; Haile, Amanuel; Abraham, Loko] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia; [Halifom, Atakilt; Teklu, Tsigemariam; Zegeye, Teame; CASA-project Health Facilities] Tigray Reg Hlth Bur, Mekelle, Ethiopia	Istituto Superiore di Sanita (ISS); Mekelle University	Bucciardini, R (corresponding author), Ist Super Sanita, Viale Regina Elena 299, I-00161 Rome, Italy.	raffaella.bucciardini@iss.it	Vella, Stefano/GZM-0519-2022; VELLA, STEFANO/ABI-3368-2020; VELLA, STEFANO/V-8440-2019; De Castro, Paola/D-6218-2011	VELLA, STEFANO/0000-0003-2347-5984; De Castro, Paola/0000-0001-8717-9418	Italian Ministry of Health-Department of Prevention and Innovation, Rome, Italy	Italian Ministry of Health-Department of Prevention and Innovation, Rome, Italy	This work was supported by the Italian Ministry of Health-Department of Prevention and Innovation, Rome, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, FEDERAL DEMOCRATIC R; [Anonymous], 2013, MMWR MORB MORTAL WKL; Arem H, 2011, AIDS PATIENT CARE ST, V25, P719, DOI 10.1089/apc.2010.0349; Assefa Yibeltal, 2008, Ethiop Med J, V46, P401; Assefa Y, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-43; Assefa Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-45; Assefa Y, 2012, J HEALTH SERV RES PO, V17, P24, DOI 10.1258/jhsrp.2011.010135; Assefa Y, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-81; Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Central Statistical Agency of Ethiopia, 2011, ETH DEM HLTH SURV; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Etienne M, 2010, TROP MED INT HEALTH, V15, P76, DOI 10.1111/j.1365-3156.2010.02513.x; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Fatti G, 2012, JAIDS-J ACQ IMM DEF, V61, pE50, DOI 10.1097/QAI.0b013e31826a6aee; Federal HIV/AIDS Prevention and Control Office, 2009, ETH MULT HIV AIDS RE; Federal HIV/ AIDS Prevention and Control Office, 2013, MON EV REP 2011 2012; Federal Ministry of Health of Ethiopia, 2010, GUID IMPL HIV AIDS C; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Hart JE, 2010, JAIDS-J ACQ IMM DEF, V54, P167, DOI 10.1097/QAI.0b013e3181d9a330; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; Melaku Z, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1776-4; Ministry of Health (MOH), 2004, ACC ACC HIV AIDS TRE; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; Organization WH, 2012, RET HIV PROGR DEF CH; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Schneider H, 2010, AIDS CARE, V22, P60, DOI 10.1080/09540120903483042; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Tassie JM, 2010, JAIDS-J ACQ IMM DEF, V54, P437, DOI 10.1097/QAI.0b013e3181d73e1b; UNAIDS, 2010, GETT ZER 2011 2015 S; WHO, 2015, COUNTR STAT GLOB HLT; World Health Organisation, 2007, TASK SHIFT RAT RED T; World Health Organization, 2013, CONS GUID ANT DRUGS; World Health Organization, 2011, UN ACC SCAL PRIOR HI; Wouters E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-194; Wright J, 2004, TROP MED INT HEALTH, V9, P559, DOI 10.1111/j.1365-3156.2004.01230.x; Wubshet Mamo, 2012, ISRN AIDS, V2012, P721720, DOI 10.5402/2012/721720	40	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136117	10.1371/journal.pone.0136117	http://dx.doi.org/10.1371/journal.pone.0136117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340271	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200005
J	Johanson, Z; Boisvert, C; Maksimenko, A; Currie, P; Trinajstic, K				Johanson, Zerina; Boisvert, Catherine; Maksimenko, Anton; Currie, Peter; Trinajstic, Kate			Development of the Synarcual in the Elephant Sharks (Holocephali; Chondrichthyes): Implications for Vertebral Formation and Fusion	PLOS ONE			English	Article							SALMON SALMO-SALAR; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; EUROPEAN FISH LARVAE; SKELETAL ANOMALIES; AXIAL SKELETON; CLASSIFICATION; SEGMENTATION; EVOLUTIONARY; COLUMN; INSIGHTS	The synarcual is a structure incorporating multiple elements of two or more anterior vertebrae of the axial skeleton, forming immediately posterior to the cranium. It has been convergently acquired in the fossil group 'Placodermi', in Chondrichthyes (Holocephali, Batoidea), within the teleost group Syngnathiformes, and to varying degrees in a range of mammalian taxa. In addition, cervical vertebral fusion presents as an abnormal pathology in a variety of human disorders. Vertebrae develop from axially arranged somites, so that fusion could result from a failure of somite segmentation early in development, or from later heterotopic development of intervertebral bone or cartilage. Examination of early developmental stages indicates that in the Batoidea and the 'Placodermi', individual vertebrae developed normally and only later become incorporated into the synarcual, implying regular somite segmentation and vertebral development. Here we show that in the holocephalan Callorhinchus milii, uniform and regular vertebral segmentation also occurs, with anterior individual vertebra developing separately with subsequent fusion into a synarcual. Vertebral elements forming directly behind the synarcual continue to be incorporated into the synarcual through growth. This appears to be a common pattern through the Vertebrata. Research into human disorders, presenting as cervical fusion at birth, focuses on gene misexpression studies in humans and other mammals such as the mouse. However, in chondrichthyans, vertebral fusion represents the normal morphology, moreover, taxa such Leucoraja (Batoidea) and Callorhinchus (Holocephali) are increasingly used as laboratory animals, and the Callorhinchus genome has been sequenced and is available for study. Our observations on synarcual development in three major groups of early jawed vertebrates indicate that fusion involves heterotopic cartilage and perichondral bone/mineralised cartilage developing outside the regular skeleton. We suggest that chondrichthyans have potential as ideal extant models for identifying the genes involved in these processes, for application to human skeletal heterotopic disorders.	[Johanson, Zerina] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Boisvert, Catherine; Currie, Peter] Monash Univ, ARMI, Clayton, Vic 3800, Australia; [Maksimenko, Anton] Australian Synchrotron, Clayton, Vic 3168, Australia; [Trinajstic, Kate] Curtin Univ, Dept Environm & Agr, Bentley, WA 6845, Australia; [Trinajstic, Kate] Western Australian Museum, Dept Earth & Planetary Sci, Welshpool, WA 6106, Australia	Natural History Museum London; Australian Regenerative Medicine Institute; Monash University; Curtin University; Western Australian Museum	Johanson, Z (corresponding author), Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London SW7 5BD, England.	z.johanson@nhm.ac.uk	Boisvert, Catherine A/A-9782-2019	Boisvert, Catherine A/0000-0002-0618-7270; Johanson, Zerina/0000-0002-8444-6776; Trinajstic, Kate/0000-0002-6519-6396; Currie, Peter/0000-0001-8874-8862	Australian Research Council [DP110101127]; National Health and Medical Research Council [APP1041885]; Australian Synchrotron [23435]; State Government of Victoria; Australian Federal Government; ARC; Victorian State; Australian Government	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Synchrotron; State Government of Victoria; Australian Federal Government(Australian Government); ARC(Australian Research Council); Victorian State; Australian Government(Australian GovernmentCGIAR)	This work was funded through an Australian Research Council grant to KT, CB and ZJ (QE II to KT and Discovery project number DP110101127), and the National Health and Medical Research Council grant to PDC (Australia, Principal Research Fellowship APP1041885). The specimen of Campbellodus was scanned at the Australian Synchrotron under user grant #23435. The Australian Regenerative Medicine Institute is supported by funds from the State Government of Victoria and the Australian Federal Government. The elephant shark facility was funded via ARC grants and the help of the Australian Regenerative Medicine Institute, supported by grants from the Victorian State and Australian Government. Filtration equipment was provided at cost from Advanced Aquarium Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2009, TRENDS GENET, V25, P74, DOI 10.1016/j.tig.2008.11.006; Argot C, 2003, J MORPHOL, V255, P279, DOI 10.1002/jmor.10062; Arratia G, 2001, J MORPHOL, V250, P101, DOI 10.1002/jmor.1062; Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bensimon-Brito A, 2012, EVOL DEV, V14, P116, DOI 10.1111/j.1525-142X.2011.00526.x; Bertin L, 1958, TRAITE ZOOL, V13, P2204; BLOT J, 1980, B MUS NATL HIST NAT, V2, P339; Boglione C, 2013, REV AQUACULT, V5, pS99, DOI 10.1111/raq.12015; Boglione C, 2013, REV AQUACULT, V5, pS121, DOI 10.1111/raq.12016; Boisvert CA, 2015, ZOO BIOL, V34, P94, DOI 10.1002/zoo.21183; Buckley D, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-17; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Christ B, 1998, ANAT EMBRYOL, V197, P1; Claeson KM, 2011, J MORPHOL, V272, P1444, DOI 10.1002/jmor.10996; Cole NJ, 2007, DEV DYNAM, V236, P2421, DOI 10.1002/dvdy.21268; Culbert AL, 2014, STEM CELLS, V32, P1289, DOI 10.1002/stem.1633; Didier DA, 1998, J MORPHOL, V236, P25; Didier DA, 1995, AM MUS NOVIT, V3119, P1; Dittmann K, 2014, ARTHRITIS RHEUMATOL, V66, P831, DOI 10.1002/art.38325; Eckalbar WL, 2012, WIRES DEV BIOL, V1, P401, DOI 10.1002/wdev.34; Fisher S, 2003, DEV BIOL, V264, P64, DOI 10.1016/S0012-1606(03)00399-3; FOREY PL, 1986, ZOOL J LINN SOC-LOND, V86, P43, DOI 10.1111/j.1096-3642.1986.tb01807.x; Gadow H., 1933, THE EVOLUTION OF THE; Galliari FC, 2010, MAMM BIOL, V75, P326, DOI 10.1016/j.mambio.2009.03.014; Goodrich ES, 1958, STUDIES ON THE STRUC; Graham A, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-24; Hatt RT, 1931, B AM MUS NAT HIST, V63, P599; Hughes DST, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-30; James HF, 2009, AUK, V126, P862, DOI 10.1525/auk.2009.08194; Johanson Z, 2013, ZOOMORPHOLOGY, V132, P95, DOI 10.1007/s00435-012-0169-9; Johanson Z, 2010, INT J DEV BIOL, V54, P71, DOI 10.1387/ijdb.072508zj; Khonsari RH, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-27; Lelievre H, 2009, J VERTEBR PALEONTOL, V29, P584, DOI 10.1671/039.029.0233; LIM TM, 1987, DEVELOPMENT, V100, P525; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Mara A, 2007, TRENDS CELL BIOL, V17, P593, DOI 10.1016/j.tcb.2007.09.005; Maroto M, 2012, DEVELOPMENT, V139, P2453, DOI 10.1242/dev.069310; Maxwell EE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-265; Miao JL, 2012, GENES GENET SYST, V87, P213, DOI 10.1266/ggs.87.213; Miles R. S, 1977, Linnean Soc Symp Ser, VNo. 4, P123; Miyake T., 1988, THESIS, VI; Monsoro-Burq AH, 2005, INT J DEV BIOL, V49, P301, DOI 10.1387/ijdb.041953am; MONSOROBURQ AH, 1994, P NATL ACAD SCI USA, V91, P10435, DOI 10.1073/pnas.91.22.10435; Moran MM, 2015, J MAMM EVOL, V22, P93, DOI 10.1007/s10914-014-9256-7; Morin-Kensicki EM, 2002, DEVELOPMENT, V129, P3851; Neyt C, 2000, NATURE, V408, P82, DOI 10.1038/35040549; Offiah A, 2010, AM J MED GENET A, V152A, P1357, DOI 10.1002/ajmg.a.33361; Pedersen ME, 2011, FISH PHYSIOL BIOCHEM, V37, P821, DOI 10.1007/s10695-011-9480-5; Piekarski N, 2014, J MORPHOL, V275, P141, DOI 10.1002/jmor.20204; Pinheiro FL, 2011, ACTA PALAEONTOL POL, V56, P567, DOI 10.4202/app.2010.0057; Rashid DJ, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-25; Rios AC, 2011, NATURE, V473, P532, DOI 10.1038/nature09970; Scaal Martin, 2006, Anat Embryol (Berl), V211 Suppl 1, P9, DOI 10.1007/s00429-006-0127-8; Schaffer AA, 2005, SPINE, V30, P1379, DOI 10.1097/01.brs.0000166619.22832.2c; Schartl M, 2014, DIS MODEL MECH, V7, P181, DOI 10.1242/dmm.012245; Stensi/ E.A., 1969, TRAITE PALEONTOL, V4, P71; TAYLOR W R, 1985, Cybium, V9, P107; Varela-Lasheras I, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-11; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wake MH, 1979, HYMANS COMPARATIVE V; Watanabe Y, 1998, DEVELOPMENT, V125, P2631; Witten PE, 2006, AQUACULTURE, V258, P164, DOI 10.1016/j.aquaculture.2006.05.005; Witten PE, 2009, AQUACULTURE, V295, P6, DOI 10.1016/j.aquaculture.2009.06.037; Witten PE, 2005, DIS AQUAT ORGAN, V64, P237, DOI 10.3354/dao064237; Wyffels Jennifer, 2014, F1000Res, V3, P191, DOI 10.12688/f1000research.4996.1; Ytteborg Elisabeth, 2010, BMC Physiology, V10, P12, DOI 10.1186/1472-6793-10-12; Ytteborg Elisabeth, 2010, BMC Physiology, V10, P13, DOI 10.1186/1472-6793-10-13	68	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0135138	10.1371/journal.pone.0135138	http://dx.doi.org/10.1371/journal.pone.0135138			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339918	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200002
J	Liu, Z; Ding, S; Kropachev, K; Lei, J; Amin, S; Broyde, S; Geacintov, NE				Liu, Zhi; Ding, Shuang; Kropachev, Konstantin; Lei, Jia; Amin, Shantu; Broyde, Suse; Geacintov, Nicholas E.			Resistance to Nucleotide Excision Repair of Bulky Guanine Adducts Opposite Abasic Sites in DNA Duplexes and Relationships between Structure and Function	PLOS ONE			English	Article							NMR SOLUTION STRUCTURES; SOLUTION CONFORMATION; DIOL EPOXIDE; MODIFIED DEOXYGUANOSINE; DAMAGE RECOGNITION; BASE DISPLACEMENT; QUALITY-CONTROL; DELETION SITE; LESION; INTERCALATION	The nucleotide excision repair of certain bulky DNA lesions is abrogated in some specific non-canonical DNA base sequence contexts, while the removal of the same lesions by the nucleotide excision repair mechanism is efficient in duplexes in which all base pairs are complementary. Here we show that the nucleotide excision repair activity in human cell extracts is moderate-to-high in the case of two stereoisomeric DNA lesions derived from the pro-carcinogen benzo[a]pyrene (cis- and trans-B[a]P-N-2-dG adducts) in a normal DNA duplex. By contrast, the nucleotide excision repair activity is completely abrogated when the canonical cytosine base opposite the B[a]P-dG adducts is replaced by an abasic site in duplex DNA. However, base excision repair of the abasic site persists. In order to understand the structural origins of these striking phenomena, we used NMR and molecular spectroscopy techniques to evaluate the conformational features of 11mer DNA duplexes containing these B[a]P-dG lesions opposite abasic sites. Our results show that in these duplexes containing the clustered lesions, both B[a]P-dG adducts adopt base-displaced intercalated conformations, with the B[a]P aromatic rings intercalated into the DNA helix. To explain the persistence of base excision repair in the face of the opposed bulky B[a]P ring system, molecular modeling results suggest how the APE1 base excision repair endonuclease, that excises abasic lesions, can bind productively even with the trans-B[a]P-dG positioned opposite the abasic site. We hypothesize that the nucleotide excision repair resistance is fostered by local B[a] P residue-DNA base stacking interactions at the abasic sites, that are facilitated by the absence of the cytosine partner base in the complementary strand. More broadly, this study sets the stage for elucidating the interplay between base excision and nucleotide excision repair in processing different types of clustered DNA lesions that are substrates of nucleotide excision repair or base excision repair mechanisms.	[Liu, Zhi; Kropachev, Konstantin; Geacintov, Nicholas E.] NYU, Dept Chem, New York, NY 10010 USA; [Ding, Shuang; Lei, Jia; Broyde, Suse] NYU, Dept Biol, New York, NY 10003 USA; [Amin, Shantu] Penn State Univ, Dept Pharmacol, Hershey, PA USA	New York University; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Geacintov, NE (corresponding author), NYU, Dept Chem, New York, NY 10010 USA.	ng1@nyu.edu			NIH - NIEHS [5R01ES024050]; NIH [CA-28038]; National Science Foundation [MCB060037]; National Center for Research Resources, NIH [C06 RR-16572]; NSF [MRI 0116222]; NYSTAR;  [CA-75449]; NATIONAL CANCER INSTITUTE [R01CA075449, R01CA028038] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024050] Funding Source: NIH RePORTER	NIH - NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); NYSTAR; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH - NIEHS grant 5R01ES024050 to NEG and NIH CA-28038 to SB. Computational infrastructure and systems management were partially supported by CA-75449 to SB. Funding for open access charge: NIH - NIEHS grant 5R01ES024050 to NEG. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. Computations were carried out on our own cluster of Dell workstations, the Multipurpose High Performance Computing Resources of New York University (NYU-ITS), and the Extreme Science and Engineering Discovery Environment (XSEDE) computational resources, which is supported by National Science Foundation Grant MCB060037. Components of this work were conducted in the Shared Instrumentation Facility at NYU that was constructed with support from Research Facilities Improvement Grant C06 RR-16572 from the National Center for Research Resources, NIH. The acquisition of the 500MHz spectrometer was supported by NSF Grant MRI 0116222. The data collected at the New York Structural Biology Center NYSBC was made possible by a grant from NYSTAR.	Alekseev S, 2015, CELL MOL LIFE SCI, V72, P2177, DOI 10.1007/s00018-015-1859-5; [Anonymous], PYMOL MOL GRAPHICS S; Arunan E, 2011, PURE APPL CHEM, V83, P1637, DOI 10.1351/PAC-REC-10-01-02; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buterin T, 2005, CHEM BIOL, V12, P913, DOI 10.1016/j.chembiol.2005.06.011; Cai YQ, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/174252; Case D, 2006, AMBER 9; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Chen J, 2008, NUCLEIC ACIDS RES, V36, P253, DOI 10.1093/nar/gkm622; Chen JY, 2007, BIOCHEMISTRY-US, V46, P3096, DOI 10.1021/bi6024269; Chen XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6849; CHENG SC, 1989, CHEM RES TOXICOL, V2, P334, DOI 10.1021/tx00011a011; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CONNEY AH, 1982, CANCER RES, V42, P4875; COSMAN M, 1994, BIOCHEMISTRY-US, V33, P11507, DOI 10.1021/bi00204a013; COSMAN M, 1993, BIOCHEMISTRY-US, V32, P4145, DOI 10.1021/bi00067a001; COSMAN M, 1992, P NATL ACAD SCI USA, V89, P1914, DOI 10.1073/pnas.89.5.1914; COSMAN M, 1994, BIOCHEMISTRY-US, V33, P11518, DOI 10.1021/bi00204a014; COSMAN M, 1990, CARCINOGENESIS, V11, P1667, DOI 10.1093/carcin/11.9.1667; DELOSSANTOS C, 1992, BIOCHEMISTRY-US, V31, P5245, DOI 10.1021/bi00138a002; Geacintov NE, 1997, CHEM RES TOXICOL, V10, P111, DOI 10.1021/tx9601418; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Goddard T. D., 2006, SPARKY 3; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Hazel RD, 2010, BIOCHEMISTRY-US, V49, P8978, DOI 10.1021/bi101021e; Hess MT, 1997, MOL CELL BIOL, V17, P7069, DOI 10.1128/MCB.17.12.7069; Hinz JM, 2014, MUTAT RES-FUND MOL M, V766, P19, DOI 10.1016/j.mrfmmm.2014.05.008; Huang WD, 2002, CHEM RES TOXICOL, V15, P118, DOI 10.1021/tx010135y; Huang XW, 2002, CHEM RES TOXICOL, V15, P438, DOI 10.1021/tx015588h; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Kropachev K, 2009, J MOL BIOL, V386, P1193, DOI 10.1016/j.jmb.2008.12.082; Krzeminski J, 2011, CHEM RES TOXICOL, V24, P65, DOI 10.1021/tx100284h; Lin Z, 1998, NUCLEIC ACIDS RES, V26, P2385, DOI 10.1093/nar/26.10.2385; Liu Y, 2011, DNA REPAIR, V10, P684, DOI 10.1016/j.dnarep.2011.04.020; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Mathieu N, 2013, CURR BIOL, V23, P204, DOI 10.1016/j.cub.2012.12.032; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Mocquet V, 2007, EMBO J, V26, P2923, DOI 10.1038/sj.emboj.7601730; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mu H, 2013, BIOCHEMISTRY-US, V52, P5517, DOI 10.1021/bi4009177; PATEL DJ, 1987, Q REV BIOPHYS, V20, P35, DOI 10.1017/S0033583500004224; Reeves DA, 2011, NUCLEIC ACIDS RES, V39, P8752, DOI 10.1093/nar/gkr537; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shivji MKK, 1999, METH MOL B, V113, P373; Skosareva LV, 2012, DNA REPAIR, V11, P367, DOI 10.1016/j.dnarep.2012.01.002; Smirnov S, 2002, NUCLEIC ACIDS RES, V30, P5561, DOI 10.1093/nar/gkf688; Starostenko LV, 2014, DNA REPAIR, V24, P1, DOI 10.1016/j.dnarep.2014.10.005; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wood RD, 1999, BIOCHIMIE, V81, P39, DOI 10.1016/S0300-9084(99)80036-4; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+	52	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137124	10.1371/journal.pone.0137124	http://dx.doi.org/10.1371/journal.pone.0137124			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340000	gold, Green Submitted, Green Published			2022-12-27	WOS:000360688200023
J	McIlroy, SJ; Awata, T; Nierychlo, M; Albertsen, M; Kindaichi, T; Nielsen, PH				McIlroy, Simon Jon; Awata, Takanori; Nierychlo, Marta; Albertsen, Mads; Kindaichi, Tomonori; Nielsen, Per Halkjaer			Characterization of the In Situ Ecophysiology of Novel Phylotypes in Nutrient Removal Activated Sludge Treatment Plants	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; RNA GENE DATABASE; 16S RIBOSOMAL-RNA; OLIGONUCLEOTIDE PROBES; POPULATION-DYNAMICS; HYBRIDIZATION; MICROAUTORADIOGRAPHY; IDENTIFICATION; DIVERSITY; SEQUENCES	An in depth understanding of the ecology of activated sludge nutrient removal wastewater treatment systems requires detailed knowledge of the community composition and metabolic activities of individual members. Recent 16S rRNA gene amplicon surveys of activated sludge wastewater treatment plants with nutrient removal indicate the presence of a core set of bacterial genera. These organisms are likely responsible for the bulk of nutrient transformations underpinning the functions of these plants. While the basic activities of some of these genera in situ are known, there is little to no information for the majority. This study applied microautoradiography coupled with fluorescence in situ hybridization (MAR-FISH) for the in situ characterization of selected genus-level-phylotypes for which limited physiological information is available. These included Sulfuritalea and A21b, both within the class Betaproteobacteria, as well as Kaga01, within sub-group 10 of the phylum Acidobacteria. While the Sulfuritalea spp. were observed to be metabolically versatile, the A21b and Kaga01 phylotypes appeared to be highly specialized.	[McIlroy, Simon Jon; Awata, Takanori; Nierychlo, Marta; Albertsen, Mads; Nielsen, Per Halkjaer] Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, Aalborg, Denmark; [Awata, Takanori] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Awata, Takanori; Kindaichi, Tomonori] Hiroshima Univ, Grad Sch Engn, Dept Civil & Environm Engn, Higashihiroshima 7398527, Japan	Aalborg University; Nagoya University; Hiroshima University	Nielsen, PH (corresponding author), Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, Aalborg, Denmark.	phn@bio.aau.dk	McIlroy, Simon/P-4785-2017; Kindaichi, Tomonori/I-8551-2015; Nielsen, Per Halkjær/T-6796-2018; Albertsen, Mads/T-7358-2018	McIlroy, Simon/0000-0003-3749-8730; Kindaichi, Tomonori/0000-0003-1500-3397; Nielsen, Per Halkjær/0000-0002-6402-1877; Nierychlo, Marta/0000-0003-1756-3726; Albertsen, Mads/0000-0002-6151-190X	Innovation Fund Denmark [09-067230]; Japan Society for the Promotion of Science [12J00080]	Innovation Fund Denmark; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was partially supported by Innovation Fund Denmark (Grant No.: 09-067230) (http://innovationsfonden.dk/en)(PHN) and a Grant-inAid for JSPS Fellows from the Japan Society for the Promotion of Science (Grant No.: 12J00080)(http://www.jsps.go.jp/english/)(TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; Daims H, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P259; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Kindaichi T, 2013, ENVIRON MICROBIOL, V15, P1821, DOI 10.1111/1462-2920.12074; Lee N, 1999, APPL ENVIRON MICROB, V65, P1289; Ludwig W, 1997, FEMS MICROBIOL LETT, V153, P181, DOI 10.1016/S0378-1097(97)00256-5; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; McIlroy SJ, 2014, ISME J, V8, P613, DOI 10.1038/ismej.2013.162; McIlroy SJ, 2011, ENVIRON MICROBIOL, V13, P33, DOI 10.1111/j.1462-2920.2010.02306.x; McIlroy SJ, 2016, ENVIRON MICROBIOL, V18, P50, DOI 10.1111/1462-2920.12614; McIlroy SJ, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav062; Meisinger DB, 2007, ENVIRON MICROBIOL, V9, P1523, DOI 10.1111/j.1462-2920.2007.01271.x; Mielczarek AT, 2013, WATER SCI TECHNOL, V67, P2519, DOI 10.2166/wst.2013.151; Mielczarek AT, 2013, WATER RES, V47, P1529, DOI 10.1016/j.watres.2012.12.003; Nielsen JL, 2005, METHOD ENZYMOL, V397, P237, DOI 10.1016/S0076-6879(05)97014-6; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rasmussen H, 1996, WATER RES, V30, P551, DOI 10.1016/0043-1354(95)00203-0; Seviour R, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P1; Stoecker K, 2010, APPL ENVIRON MICROB, V76, P922, DOI 10.1128/AEM.02456-09; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Weelink SAB, 2009, FEMS MICROBIOL ECOL, V70, P575, DOI 10.1111/j.1574-6941.2009.00778.x; Yilmaz LS, 2011, APPL ENVIRON MICROB, V77, P1118, DOI 10.1128/AEM.01733-10; Zhang T, 2012, ISME J, V6, P1137, DOI 10.1038/ismej.2011.188	31	5	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136424	10.1371/journal.pone.0136424	http://dx.doi.org/10.1371/journal.pone.0136424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340564	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200008
J	Zhou, Y; Yin, XC; Duan, RJ; Hao, GP; Guo, JC; Jiang, XY				Zhou, Yang; Yin, Xiaochang; Duan, Ruijun; Hao, Gangping; Guo, Jianchun; Jiang, Xingyu			SpAHA1 and SpSOS1 Coordinate in Transgenic Yeast to Improve Salt Tolerance	PLOS ONE			English	Article							PLASMA-MEMBRANE; ARABIDOPSIS-THALIANA; NA+/H+ ANTIPORTER; OVEREXPRESSION; SOS1; AVP1; HOMEOSTASIS; EXPRESSION; SALINITY; DROUGHT	In plant cells, the plasma membrane Na+/H+ antiporter SOS1 (salt overly sensitive 1) mediates Na+ extrusion using the proton gradient generated by plasma membrane H+-ATPases, and these two proteins are key plant halotolerance factors. In the present study, two genes from Sesuvium portulacastrum, encoding plasma membrane Na+/H+ antiporter (SpSOS1) and H+-ATPase (SpAHA1), were cloned. Localization of each protein was studied in tobacco cells, and their functions were analyzed in yeast cells. Both SpSOS1 and SpAHA1 are plasma membrane-bound proteins. Real-time polymerase chain reaction (PCR) analyses showed that SpSOS1 and SpAHA1 were induced by salinity, and their expression patterns in roots under salinity were similar. Compared with untransformed yeast cells, SpSOS1 increased the salt tolerance of transgenic yeast by decreasing the Na+ content. The Na+/H+ exchange activity at plasma membrane vesicles was higher in SpSOS1-transgenic yeast than in the untransformed strain. No change was observed in the salt tolerance of yeast cells expressing SpAHA1 alone; however, in yeast transformed with both SpSOS1 and SpAHA1, SpAHA1 generated an increased proton gradient that stimulated the Na+/H+ exchange activity of SpSOS1. In this scenario, more Na+ ions were transported out of cells, and the yeast cells co-expressing SpSOS1 and SpAHA1 grew better than the cells transformed with only SpSOS1 or SpAHA1. These findings demonstrate that the plasma membrane Na+/H+ antiporter SpSOS1 and H+-ATPase SpAHA1 can function in coordination. These results provide a reference for developing more salt-tolerant crops via co-transformation with the plasma membrane Na+/H+ antiporter and H+-ATPase.	[Zhou, Yang; Duan, Ruijun; Guo, Jianchun] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China; [Zhou, Yang; Guo, Jianchun] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Zhou, Yang; Yin, Xiaochang; Jiang, Xingyu] Hainan Univ, Coll Agr, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Peoples R China; [Hao, Gangping] Taishan Med Univ, Dept Biochem, Tai An, Shandong, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Huazhong Agricultural University; Hainan University; Shandong First Medical University & Shandong Academy of Medical Sciences	Guo, JC (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China.	jianchunguoh@163.com; jiangxingyu2002@yahoo.com	duan, rui/AAK-8037-2020		Natural Science Foundation of China [31260218, 31160185]; Scientific and Technological Foundation of Hainan Province [ZDZX2013023]; Central Level, Non-profit, Scientific Research Institutes for Basic R&D Operations Special Fund Program [ITBB130302]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Foundation of Hainan Province; Central Level, Non-profit, Scientific Research Institutes for Basic R&D Operations Special Fund Program	This work was supported by the Natural Science Foundation of China (No. 31260218, 31160185), the Scientific and Technological Foundation of Hainan Province (No. ZDZX2013023) and the Central Level, Non-profit, Scientific Research Institutes for Basic R&D Operations Special Fund Program (No. ITBB130302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Gouiaa S, 2012, PLANT MOL BIOL, V79, P137, DOI 10.1007/s11103-012-9901-6; Hong S, 2013, ARCH BIOCHEM BIOPHYS, V537, P125, DOI 10.1016/j.abb.2013.07.005; Kerkeb L, 2001, PHYSIOL PLANTARUM, V113, P217, DOI 10.1034/j.1399-3054.2001.1130209.x; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Liu SP, 2010, J PLANT BIOL, V53, P444, DOI 10.1007/s12374-010-9135-6; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; MENENDEZ A, 1995, ANAL BIOCHEM, V230, P308, DOI 10.1006/abio.1995.1479; Oh DH, 2009, PLANT PHYSIOL, V151, P210, DOI 10.1104/pp.109.137802; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; Tang RJ, 2010, PLANT MOL BIOL, V74, P367, DOI 10.1007/s11103-010-9680-x; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Xu HX, 2008, ARCH BIOCHEM BIOPHYS, V473, P8, DOI 10.1016/j.abb.2008.02.018; Xu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078098; [杨成龙 Yang Chenglong], 2010, [生态学报, Acta Ecologica Sinica], V30, P4617; Yang Q, 2009, MOL PLANT, V2, P22, DOI 10.1093/mp/ssn058; Yi XP, 2014, J PROTEOMICS, V99, P84, DOI 10.1016/j.jprot.2014.01.017; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhao FY, 2006, MOL BREEDING, V17, P341, DOI 10.1007/s11032-006-9005-6	28	25	32	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137447	10.1371/journal.pone.0137447	http://dx.doi.org/10.1371/journal.pone.0137447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340746	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200060
J	Yang, X; Chang, HR; Yin, YW				Yang, Xu; Chang, Hae Ryung; Yin, Y. Whitney			Yeast Mitochondrial Transcription Factor Mtf1 Determines the Precision of Promoter-Directed Initiation of RNA Polymerase Rpo41	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SPECIFICITY FACTOR; STRUCTURAL BASIS; GENE-EXPRESSION; TERMINAL DOMAIN; RIBOSOMAL-RNA; DNA; RECOGNITION; MECHANISM; COMPLEX	Despite their clear T7-bacteriophage origin, mitochondrial RNA polymerases have evolved to require transcription factors. All mitochondrial polymerases contain an extra N-terminal domain that has no counterpart in the self-proficient phage enzyme, which is therefore hypothesized to interact with transcription factors. We studied a series of N-terminal deletion mutants of yeast mitochondrial RNA polymerase, Rpo41, and have found that the N-terminal region does not abolish the effects of Mtf1; rather it contributes directly to enzyme catalysis. Mtf1 can rescue the defective Rpo41 enzymes resulted from N-terminal domain deletions. Although Rpo41 appears to have retained all promoter recognition elements found in T7 RNAP, the elements are not independently functional, and Mtf1 is necessary and sufficient for holoenzyme promoter-directed transcription activity.	[Yang, Xu; Chang, Hae Ryung] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Yin, Y. Whitney] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Medical Branch Galveston	Yin, YW (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol, Galveston, TX 77555 USA.	ywyin@utmb.edu			National Institutes of Health [GM083703]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083703, R01GM110591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health Grant GM083703.	BISWAS TK, 1985, P NATL ACAD SCI USA, V82, P1954, DOI 10.1073/pnas.82.7.1954; Bryan AC, 2002, GENETICS, V160, P75; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1998, COLD SPRING HARB SYM, V63, P263, DOI 10.1101/sqb.1998.63.263; Cliften PF, 1997, GENE DEV, V11, P2897, DOI 10.1101/gad.11.21.2897; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; Karlok MA, 2002, J BIOL CHEM, V277, P28143, DOI 10.1074/jbc.M204123200; Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; Paratkar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228023; Paratkar S, 2010, J BIOL CHEM, V285, P3949, DOI 10.1074/jbc.M109.050732; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; SCHINKEL AH, 1986, EMBO J, V5, P1041, DOI 10.1002/j.1460-2075.1986.tb04320.x; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Wang YH, 1999, P NATL ACAD SCI USA, V96, P8046, DOI 10.1073/pnas.96.14.8046; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; WILCOXEN SE, 1988, J BIOL CHEM, V263, P12346; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136879	10.1371/journal.pone.0136879	http://dx.doi.org/10.1371/journal.pone.0136879			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332125	gold, Green Submitted, Green Published			2022-12-27	WOS:000360613800077
J	Alam, M; Deng, XW; Philipson, C; Bassaganya-Riera, J; Bisset, K; Carbo, A; Eubank, S; Hontecillas, R; Hoops, S; Mei, YG; Abedi, V; Marathe, M				Alam, Maksudul; Deng, Xinwei; Philipson, Casandra; Bassaganya-Riera, Josep; Bisset, Keith; Carbo, Adria; Eubank, Stephen; Hontecillas, Raquel; Hoops, Stefan; Mei, Yongguo; Abedi, Vida; Marathe, Madhav			Sensitivity Analysis of an ENteric Immunity SImulator (ENISI)-Based Model of Immune Responses to Helicobacter pylori Infection	PLOS ONE			English	Article							AGENT-BASED MODEL; IN-SILICO; INFLAMMATION; SYSTEMS	Agent-based models (ABM) are widely used to study immune systems, providing a procedural and interactive view of the underlying system. The interaction of components and the behavior of individual objects is described procedurally as a function of the internal states and the local interactions, which are often stochastic in nature. Such models typically have complex structures and consist of a large number of modeling parameters. Determining the key modeling parameters which govern the outcomes of the system is very challenging. Sensitivity analysis plays a vital role in quantifying the impact of modeling parameters in massively interacting systems, including large complex ABM. The high computational cost of executing simulations impedes running experiments with exhaustive parameter settings. Existing techniques of analyzing such a complex system typically focus on local sensitivity analysis, i.e. one parameter at a time, or a close "neighborhood" of particular parameter settings. However, such methods are not adequate to measure the uncertainty and sensitivity of parameters accurately because they overlook the global impacts of parameters on the system. In this article, we develop novel experimental design and analysis techniques to perform both global and local sensitivity analysis of large-scale ABMs. The proposed method can efficiently identify the most significant parameters and quantify their contributions to outcomes of the system. We demonstrate the proposed methodology for ENteric Immune SImulator (ENISI), a large-scale ABM environment, using a computational model of immune responses to Helicobacter pylori colonization of the gastric mucosa.	[Alam, Maksudul; Bisset, Keith; Eubank, Stephen; Marathe, Madhav] Virginia Tech, Network Dynam & Simulat Sci Lab, Virginia Bioinformat Inst, Blacksburg, VA USA; [Philipson, Casandra; Bassaganya-Riera, Josep; Carbo, Adria; Hontecillas, Raquel; Hoops, Stefan; Mei, Yongguo; Abedi, Vida] Virginia Tech, Nutr Immunol & Mol Med Lab, Virginia Bioinformat Inst, Blacksburg, VA USA; [Alam, Maksudul; Deng, Xinwei; Philipson, Casandra; Bassaganya-Riera, Josep; Bisset, Keith; Carbo, Adria; Eubank, Stephen; Hontecillas, Raquel; Hoops, Stefan; Mei, Yongguo; Abedi, Vida; Marathe, Madhav] Virginia Tech, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Bassaganya-Riera, Josep] Virginia Tech, Dept Biomed Sci & Pathobiol, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA USA; [Alam, Maksudul; Marathe, Madhav] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Deng, Xinwei] Virginia Tech, Dept Stat, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Deng, XW (corresponding author), Virginia Tech, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	xdeng@vt.edu	Eubank, Stephen/AAD-5089-2021; Deng, Xinwei/AAH-8310-2021; Alam, Maksudul/Q-9238-2019; Philipson, Casandra/AAY-5746-2021; Eubank, Stephen/D-7497-2011	Deng, Xinwei/0000-0002-1560-2405; Alam, Maksudul/0000-0002-4941-463X; Eubank, Stephen/0000-0002-7177-309X; Abedi, Vida/0000-0001-7689-933X	Defense Threat Reduction Agency (DTRA)-RD (HPC) Award [HDTRA1-09-1-0017]; DTRA-Validation Award [HDTRA1-11-1-0016]; DTRA-Comprehensive National Incident Management System (CNIMS) Award [HDRTA1-11-D-0016-0001]; National Science Foundation (NSF) PetaApps Grant [OCI-0904844]; NSF Network Science and Engineering (NetSE) Grant [CNS-1011769]; NSF Software Development for Cyberinfrastructure (SDCI) Grant [OCI-1032677]; National Institutes of Health (NIH) MIDAS project [2U01GM070694-7]; National Institute of Allergy and Infectious Diseases (NIAID) NIH project [HHSN272201000056C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070694] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1032677] Funding Source: National Science Foundation	Defense Threat Reduction Agency (DTRA)-RD (HPC) Award; DTRA-Validation Award; DTRA-Comprehensive National Incident Management System (CNIMS) Award; National Science Foundation (NSF) PetaApps Grant(National Science Foundation (NSF)); NSF Network Science and Engineering (NetSE) Grant(National Science Foundation (NSF)); NSF Software Development for Cyberinfrastructure (SDCI) Grant(National Science Foundation (NSF)); National Institutes of Health (NIH) MIDAS project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID) NIH project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work has been partially supported by Defense Threat Reduction Agency (DTRA)-R&D (HPC) Award No. HDTRA1-09-1-0017, DTRA-Validation Award No. HDTRA1-11-1-0016, DTRA-Comprehensive National Incident Management System (CNIMS) Award No. HDRTA1-11-D-0016-0001, National Science Foundation (NSF) PetaApps Grant OCI-0904844, NSF Network Science and Engineering (NetSE) Grant CNS-1011769, NSF Software Development for Cyberinfrastructure (SDCI) Grant OCI-1032677, National Institutes of Health (NIH) MIDAS project 2U01GM070694-7, and National Institute of Allergy and Infectious Diseases (NIAID) & NIH project HHSN272201000056C.	An G, 2006, J CRIT CARE, V21, P105, DOI 10.1016/j.jcrc.2005.11.012; An G, 2008, J BURN CARE RES; An G, 2001, SHOCK; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; [Anonymous], 2003, USERS GUIDE BRAVE NE; Arwade SR, 2010, ENG STRUCT, V32, P1, DOI 10.1016/j.engstruct.2009.08.011; Baldazzi V, 2006, CELL IMMUNOL, V244, P77, DOI 10.1016/j.cellimm.2006.12.006; BARRETT C, 2008, SC 08; Barrett C, 2001, TRANSIMS TRANSPORTAT; Barrett CL, 2009, FUNDAMENTAL PROBLEMS; Barrett E, 2007, APPL ENVIRON MICROB, V73, P2333, DOI 10.1128/AEM.01855-06; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050069; Bauer AL, 2009, INFORM SCIENCES, V179, P1379, DOI 10.1016/j.ins.2008.11.012; Bauer KW, 1999, J MULTICRITERIA DECI, DOI [10.1002/(SICI)1099-1360(199905)8:3%3C162::AID-MCDA241%3E3.3.CO;2-O, DOI 10.1002/(SICI)1099-1360(199905)8:3%3C162::AID-MCDA241%3E3.3.CO;2-O]; Bisset K, 2012, PAR DISTR PROC S IPD; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Box G.E.P., 2005, STAT EXPT; Broeke GAT, 2014, SENSITIVITY ANAL AGE; Brooks RJ, 2001, EUROPEAN J AGRONOMY; Cacuci D.G, 2005, SENSITIVITY UNCERTAI; Carbo A, 2015, MOJ IMMUNOL; Carbo A, 2014, MBIO, V5, DOI 10.1128/mBio.01243-14; Carbo A, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00031; Carbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073365; Carbo A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003027; Do H, 2008, P 2008 INT S SOFTW T; Dong X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009249; Duca KA, 2007, PLOS PATHOG, V3, P1388, DOI 10.1371/journal.ppat.0030137; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fonoberova M, 2013, RELIAB ENG SYST SAFE, V118, P8, DOI 10.1016/j.ress.2013.04.004; Forrest S, 2007, IMMUNOL REV; Frey HC, 2002, IDENTIFICATION REV S; Hamby DM, 1995, HLTH PHYS; Happe K., 2005, P 11 INT C EUR ASS A; Helton JC, 2006, RELIAB ENG SYST SAFE, V91, P1175, DOI 10.1016/j.ress.2005.11.017; Helton JC, 2008, COMPUTATIONAL METHOD; Kaech SM, 2003, SCIENCE, V300, P263, DOI 10.1126/science.1084511; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kelton, 1999, SIMULATION MODELING; Kleijnen J. P., 1992, SIMULATION STAT PERS; Kronsteiner B, 2014, GUT MICROBES, V5, P357, DOI 10.4161/gmic.28899; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Leber A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134849; Ligmann-Zielinska A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109779; LIM JT, 1989, APPL MATH MODEL, V13, P479, DOI 10.1016/0307-904X(89)90096-6; Lowry SF, 2008, J LEUKOC BIOL; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Mei Y, 2012, BIOINF BIOM BIBM 201; Mei Y, 2014, BIOINF BIOM BIBM 201; Mei YG, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S12-S2; Mi Q, 2007, WOUND REPAIR REGEN, V15, P671, DOI 10.1111/j.1524-475X.2007.00271.x; Montgomery D.C., 2012, DESIGN ANAL EXPT; Morris MD, 2008, TECHNOMETRICS, V50, P205, DOI 10.1198/004017008000000208; Naresh R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008352; Neugebauer EA, 2001, SHOCK; Noordegraaf AV, 2003, EUROPEAN J OPERATION; Parry HR, 2013, ENVIRON MODELL SOFTW, V45, P104, DOI 10.1016/j.envsoft.2012.08.006; Ramarao N, 2001, INFECT IMMUN, V69, P2604, DOI 10.1128/IAI.69.4.2604-2611.2001; Rodriguez-Fernandez M, 2012, INT J ROBUST NONLIN, V22, P1082, DOI 10.1002/rnc.2797; Sacks J., 1989, STAT SCI, V4, P409, DOI [10.1214/ss/1177012413, DOI 10.1214/SS/1177012413]; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Saltelli Andrea, 2010, COMPUTER PHYS COMMUN; Santner T. J, 2003, DESIGN ANAL COMPUTER; Scheffe H, 1959, ANAL VARIANCE; Schouten M, 2014, ENVIRON MODELL SOFTW, V54, P196, DOI 10.1016/j.envsoft.2014.01.003; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Seber George A. F., 2012, LINEAR REGRESSION AN; Seely AJ, 2000, CRIT CARE MED; Shapiro M, 2008, J THEOR BIOL, V252, P633, DOI 10.1016/j.jtbi.2008.01.032; Sher AA, 2013, FUTURE GENER COMP SY, V29, P591, DOI 10.1016/j.future.2011.09.006; Sigal M, 2015, GASTROENTEROLOGY, V148, P1392, DOI 10.1053/j.gastro.2015.02.049; Sloane NJ., 1999, ORTHOGONAL ARRAYS TH, DOI [10.1007/978-1-4612-1478-6, DOI 10.1007/978-1-4612-1478-6]; Sumner T, 2012, J R SOC INTERFACE, V9, P2156, DOI 10.1098/rsif.2011.0891; Sumner T, 2012, J R SOC INTERFACE, V9, P701, DOI 10.1098/rsif.2011.0783; Sumner T, 2010, SENSITIVITY ANAL SYS; Vodovotz Y., 2006, SHOCK; Wendelsdorf K, 2011, ENTERIC IMMUNITY SIM; Wendelsdorf K., 2011, P IEEE INT C BIOINF; Wendelsdorf KV, 2012, IEEE T NANOBIOSCI, V11, P273, DOI 10.1109/TNB.2012.2211891; Wu C. J., 2011, EXPT PLANNING ANAL O	82	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136139	10.1371/journal.pone.0136139	http://dx.doi.org/10.1371/journal.pone.0136139			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327290	gold, Green Submitted, Green Published			2022-12-27	WOS:000360437700029
J	Deb, A; Kundu, S				Deb, Arindam; Kundu, Sudip			Deciphering Cis-Regulatory Element Mediated Combinatorial Regulation in Rice under Blast Infected Condition	PLOS ONE			English	Article							DOMAIN TRANSCRIPTION FACTOR; GENE-EXPRESSION; DEFENSE RESPONSES; PROMOTER; NETWORKS; ACID; RESISTANCE; MODULES; MOTIFS; DETERMINANTS	Combinations of cis-regulatory elements (CREs) present at the promoters facilitate the binding of several transcription factors (TFs), thereby altering the consequent gene expressions. Due to the eminent complexity of the regulatory mechanism, the combinatorics of CRE-mediated transcriptional regulation has been elusive. In this work, we have developed a new methodology that quantifies the co-occurrence tendencies of CREs present in a set of promoter sequences; these co-occurrence scores are filtered in three consecutive steps to test their statistical significance; and the significantly co-occurring CRE pairs are presented as networks. These networks of co-occurring CREs are further transformed to derive higher order of regulatory combinatorics. We have further applied this methodology on the differentially up-regulated gene-sets of rice tissues under fungal (Magnaporthe) infected conditions to demonstrate how it helps to understand the CRE-mediated combinatorial gene regulation. Our analysis includes a wide spectrum of biologically important results. The CRE pairs having a strong tendency to co-occur often exhibit very similar joint distribution patterns at the promoters of rice. We couple the network approach with experimental results of plant gene regulation and defense mechanisms and find evidences of auto and cross regulation among TF families, cross-talk among multiple hormone signaling pathways, similarities and dissimilarities in regulatory combinatorics between different tissues, etc. Our analyses have pointed a highly distributed nature of the combinatorial gene regulation facilitating an efficient alteration in response to fungal attack. All together, our proposed methodology could be an important approach in understanding the combinatorial gene regulation. It can be further applied to unravel the tissue and/or condition specific combinatorial gene regulation in other eukaryotic systems with the availability of annotated genomic sequences and suitable experimental data.	[Deb, Arindam; Kundu, Sudip] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India; [Kundu, Sudip] Univ Calcutta, Ctr Excellence Syst Biol & Biomed Engn TEQIP Phas, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta	Kundu, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India.	skbmbg@caluniv.ac.in			UGC (RFSMS), Government of India; Center of Excellence in Systems Biology and Biomedical Engineering (TEQIP Phase II), University of Calcutta	UGC (RFSMS), Government of India; Center of Excellence in Systems Biology and Biomedical Engineering (TEQIP Phase II), University of Calcutta	AD is supported by a research fellowship provided by the UGC (RFSMS), Government of India. This work is supported by Center of Excellence in Systems Biology and Biomedical Engineering (TEQIP Phase II), University of Calcutta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Aftabuddin M, 2007, BIOPHYS J, V93, P225, DOI 10.1529/biophysj.106.098004; Assmann Sarah M, 2005, Sci STKE, V2005, pcm13, DOI 10.1126/stke.3102005cm13; Balaji S, 2006, J MOL BIOL, V360, P204, DOI 10.1016/j.jmb.2006.04.026; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Banerjee N, 2003, NUCLEIC ACIDS RES, V31, P7024, DOI 10.1093/nar/gkg894; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Buchel AS, 1999, PLANT MOL BIOL, V40, P387, DOI 10.1023/A:1006144505121; Cao PJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-17; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Choi J, 2011, TRENDS PLANT SCI, V16, P388, DOI 10.1016/j.tplants.2011.03.003; Dozmorov MG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S14; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grennan AK, 2008, PLANT PHYSIOL, V146, P1457, DOI 10.1104/pp.104.900254; Hannenhalli S, 2002, NUCLEIC ACIDS RES, V30, P4278, DOI 10.1093/nar/gkf535; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kato M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r56; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lenka SK, 2009, PLANT MOL BIOL, V69, P261, DOI 10.1007/s11103-008-9423-4; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lin RM, 2007, PLANT SCI, V172, P120, DOI 10.1016/j.plantsci.2006.07.019; Lindlof A, 2009, BIOINFORMATICS, V25, P1345, DOI 10.1093/bioinformatics/btp172; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Luo H, 2005, PLANT BIOLOGY, V7, P459, DOI 10.1055/s-2005-865851; Mallik S, 2015, NUCLEIC ACIDS RES, V43, P5352, DOI 10.1093/nar/gkv448; Marcel S, 2010, PLANT CELL, V22, P3177, DOI 10.1105/tpc.110.078048; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Mohanty B, 2012, GENE, V511, P235, DOI 10.1016/j.gene.2012.09.048; Murakami K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-112; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nishizawa Y, 1999, THEOR APPL GENET, V99, P383, DOI 10.1007/s001220051248; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pati A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-218; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Puente P, 1996, EMBO J, V15, P3732, DOI 10.1002/j.1460-2075.1996.tb00743.x; Raffaele S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00098; Redner S, 2008, NATURE, V453, P47, DOI 10.1038/453047a; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; RIEPING M, 1992, MOL GEN GENET, V231, P226, DOI 10.1007/BF00279795; Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221; Ross EJH, 2004, J EXP BOT, V55, P1721, DOI 10.1093/jxb/erh211; Singh KB, 1998, PLANT PHYSIOL, V118, P1111, DOI 10.1104/pp.118.4.1111; Smit A, 1996, REPEATMASKER OPEN 30; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sudarsanam P, 2002, GENOME RES, V12, P1723, DOI 10.1101/gr.301202; Sun LJ, 2013, PLANT MOL BIOL, V81, P41, DOI 10.1007/s11103-012-9981-3; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Van Verk MC, 2009, ADV BOT RES, V51, P397, DOI 10.1016/S0065-2296(09)51010-5; Vandenbon A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S11; Vardhanabhuti S, 2007, NUCLEIC ACIDS RES, V35, P3203, DOI 10.1093/nar/gkm201; Wei T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059720; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Xie Z, 2006, PLANT J, V46, P231, DOI 10.1111/j.1365-313X.2006.02694.x; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P917, DOI 10.1093/nar/gkj487; Zhou DX, 1999, TRENDS PLANT SCI, V4, P210, DOI 10.1016/S1360-1385(99)01418-1	79	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137295	10.1371/journal.pone.0137295	http://dx.doi.org/10.1371/journal.pone.0137295			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327607	Green Submitted, gold, Green Published			2022-12-27	WOS:000360437700109
J	Fonovic, UP; Kos, J				Fonovic, Ursa Pecar; Kos, Janko			Cathepsin X Cleaves Profilin 1 C-Terminal Tyr139 and Influences Clathrin-Mediated Endocytosis	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; BINDING-SITE; ACTIN; PHOSPHORYLATION; POLY(L-PROLINE); PHAGOCYTOSIS; PROGRESSION; MIGRATION; INVASION; MUTANTS	Cathepsin X, a cysteine carboxypeptidase, is upregulated in several types of cancer. Its molecular target in tumor cells is profilin 1, a known tumor suppressor and regulator of actin cytoskeleton dynamics. Cathepsin X cleaves off the C-terminal Tyr139 of profilin 1, affecting binding of poly-L-proline ligands and, consequently, tumor cell migration and invasion. Profilin 1 with mutations at the C-terminus, transiently expressed in prostate cancer cells PC-3, showed that Tyr139 is important for proper function of profilin 1 as a tumor suppressor. Cleaving off Tyr139 prevents the binding of clathrin, a poly-L-proline ligand involved in endocytosis. More profilin 1-clathrin complexes were present in PC-3 cells when cathepsin X was inhibited by its specific inhibitor AMS36 or silenced by siRNA. As a consequence, the endocytosis of FITC-labeled dextran and transferrin conjugate was significantly increased. These results constitute the first report of the regulation of clathrin-mediated endocytosis in tumor cells through proteolytic processing of profilin 1.	[Fonovic, Ursa Pecar; Kos, Janko] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Kos, J (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia.	janko.kos@ffa.uni-lj.si			Slovenian Research Agency [P4-0127, J4-5529]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency grants P4-0127 (J.K.) and J4-5529 (J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BjorkegrenSjogren C, 1997, FEBS LETT, V418, P258, DOI 10.1016/S0014-5793(97)01376-8; CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Fan Y, 2014, NAT CELL BIOL, V16, P445, DOI 10.1038/ncb2954; Fan Y, 2012, NAT CELL BIOL, V14, P1046, DOI 10.1038/ncb2580; Fonovic UP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053918; Fonovic UP, 2009, ACTA CHIM SLOV, V56, P985; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; Gautier JJ, 2011, J CELL SCI, V124, P3414, DOI 10.1242/jcs.081083; Jevnikar Z, 2008, J CELL SCI, V121, P2652, DOI 10.1242/jcs.023721; Jevnikar Z, 2011, IUBMB LIFE, V63, P686, DOI 10.1002/iub.505; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Karlsson R, 2007, MOL BIOL INTELL UNIT, P29, DOI 10.1007/978-0-387-46407-7_3; Kasina S, 2005, J BIOCHEM, V138, P687, DOI 10.1093/jb/mvi163; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Kraus S, 2011, EUR J CELL BIOL, V90, P678, DOI 10.1016/j.ejcb.2011.03.008; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; Lechner AM, 2006, J BIOL CHEM, V281, P39588, DOI 10.1074/jbc.M513439200; Lu PJ, 1996, BIOCHEMISTRY-US, V35, P14027, DOI 10.1021/bi961878z; MALM B, 1983, J MUSCLE RES CELL M, V4, P569, DOI 10.1007/BF00712116; Mondin M, 2010, J BIOL CHEM, V285, P40060, DOI 10.1074/jbc.M110.140442; Mutch LJ, 2014, TRAFFIC, V15, P648, DOI 10.1111/tra.12165; Nagler DK, 2004, PROSTATE, V60, P109, DOI 10.1002/pros.20046; Nagler DK, 2010, INT IMMUNOPHARMACOL, V10, P134, DOI 10.1016/j.intimp.2009.09.018; Obermajer N, 2009, INT J BIOCHEM CELL B, V41, P1685, DOI 10.1016/j.biocel.2009.02.019; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Puzer L, 2005, BIOL CHEM, V386, P1191, DOI 10.1515/BC.2005.136; RAGHUNATHAN V, 1992, FEBS LETT, V297, P46, DOI 10.1016/0014-5793(92)80324-A; Sadaghiani AM, 2007, CHEM BIOL, V14, P499, DOI 10.1016/j.chembiol.2007.03.010; Seastone DJ, 2001, J CELL SCI, V114, P2673; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; SOHN RH, 1995, J BIOL CHEM, V270, P21114, DOI 10.1074/jbc.270.36.21114; Staudt ND, 2010, HAEMATOL-HEMATOL J, V95, P1452, DOI 10.3324/haematol.2009.018671; Temesvari L, 2000, MOL BIOL CELL, V11, P2019, DOI 10.1091/mbc.11.6.2019; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024967; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wolven AK, 2000, J CELL BIOL, V150, P895, DOI 10.1083/jcb.150.4.895	39	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137217	10.1371/journal.pone.0137217	http://dx.doi.org/10.1371/journal.pone.0137217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325675	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700104
J	Kriticos, DJ; Brunel, S; Ota, N; Fried, G; Lansink, AGJMO; Panetta, FD; Prasad, TVR; Shabbir, A; Yaacoby, T				Kriticos, Darren J.; Brunel, Sarah; Ota, Noboru; Fried, Guillaume; Lansink, Alfons G. J. M. Oude; Panetta, F. Dane; Prasad, T. V. Ramachandra; Shabbir, Asad; Yaacoby, Tuvia			Downscaling Pest Risk Analyses: Identifying Current and Future Potentially Suitable Habitats for Parthenium hysterophorus with Particular Reference to Europe and North Africa	PLOS ONE			English	Article							GEOGRAPHICAL-DISTRIBUTION; WEED; ASTERACEAE; DISTRIBUTIONS; EASTERN; FLY	Pest Risk Assessments (PRAs) routinely employ climatic niche models to identify endangered areas. Typically, these models consider only climatic factors, ignoring the 'Swiss Cheese' nature of species ranges due to the interplay of climatic and habitat factors. As part of a PRA conducted for the European and Mediterranean Plant Protection Organization, we developed a climatic niche model for Parthenium hysterophorus, explicitly including the effects of irrigation where it was known to be practiced. We then downscaled the climatic risk model using two different methods to identify the suitable habitat types: expert opinion (following the EPPO PRA guidelines) and inferred from the global spatial distribution. The PRA revealed a substantial risk to the EPPO region and Central and Western Africa, highlighting the desirability of avoiding an invasion by P. hysterophorus. We also consider the effects of climate change on the modelled risks. The climate change scenario indicated the risk of substantial further spread of P. hysterophorus in temperate northern hemisphere regions (North America, Europe and the northern Middle East), and also high elevation equatorial regions (Western Brazil, Central Africa, and South East Asia) if minimum temperatures increase substantially. Downscaling the climate model using habitat factors resulted in substantial (approximately 22-53%) reductions in the areas estimated to be endangered. Applying expert assessments as to suitable habitat classes resulted in the greatest reduction in the estimated endangered area, whereas inferring suitable habitats factors from distribution data identified more land use classes and a larger endangered area. Despite some scaling issues with using a globally conformal Land Use Systems dataset, the inferential downscaling method shows promise as a routine addition to the PRA toolkit, as either a direct model component, or simply as a means of better informing an expert assessment of the suitable habitat types.	[Kriticos, Darren J.] CSIRO, Canberra, ACT, Australia; [Brunel, Sarah] European & Mediterranean Plant Protect Org, Paris, France; [Ota, Noboru] CSIRO, Wembley, WA, Australia; [Fried, Guillaume] Anses, Lab Sante Vegetaux, Montferrier Lez cede, France; [Lansink, Alfons G. J. M. Oude] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Panetta, F. Dane] Univ Melbourne, Parkville, Vic 3052, Australia; [Prasad, T. V. Ramachandra] Univ Agr Sci, Directorate Weed Sci Res Ctr, Bengaluru, India; [Shabbir, Asad] Univ Punjab, Dept Bot, Lahore, Pakistan; [Yaacoby, Tuvia] Bet Dagan Agr Ctr, Minist Agr & Rural Dev, Plant Protect & Inspect Serv, Bet Dagan, Israel	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux; Wageningen University & Research; University of Melbourne; University of Agricultural Sciences Bangalore; University of Punjab	Kriticos, DJ (corresponding author), CSIRO, GPO Box 1700, Canberra, ACT, Australia.	darren.kriticos@csiro.au	Shabbir, Asad/AAD-8808-2019; Kriticos, Darren J/A-4170-2008; Fried, Guillaume/B-4777-2015; Ota, Noboru/ABE-4698-2020; Oude Lansink, Alfons GJM/H-8840-2012	Shabbir, Asad/0000-0003-4468-6019; Kriticos, Darren J/0000-0003-2599-8105; Fried, Guillaume/0000-0002-3653-195X; Oude Lansink, Alfons GJM/0000-0002-9273-6044; , Noboru/0000-0002-8759-9030				Adkins S, 2014, PEST MANAG SCI, V70, P1023, DOI 10.1002/ps.3708; Andrewartha H.G., 1984, ECOLOGICAL WEB MORE; Asad Shabbir, 2012, Pakistan Journal of Weed Science Research, V18, P581; Auld BA, 1982, WEEDS-U, V2, P56; Baker RHA, 2003, BCPC INTERNATIONAL CONGRESS CROP SCIENCE & TECHNOLOGY 2003, VOL 1 AND 2, CONGRESS PROCEEDINGS, P1201; BOOTH TH, 1987, AGR FOREST METEOROL, V39, P241, DOI 10.1016/0168-1923(87)90041-4; Bossard M, 2000, CORINE LAND COVER TE; Boulos L, 1984, WEED FLORA EGYPT; Brouwer C., 1985, IRRIGATION WATER MAN; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; CABI, 2014, PARTH HYST; Chippendale J. F., 1994, Plant Protection Quarterly, V9, P73; Clark K, 2011, INT PARTHENIUM NEWS, V3, P1; DAFNI A, 1982, PLANT SYST EVOL, V140, P1, DOI 10.1007/BF02409894; Department of Natural Resources the Arts and Sport, 2010, NT WEED RISK ASS SPE; Dhileepan K., 2009, V5, P227; Dhileepan K, 2012, WEED SCI, V60, P571, DOI 10.1614/WS-D-12-00005.1; EPPO, 2014, PEST RISK AN PARTH H; EPPO, 2013, PQR EPPO DAT QUAR PE; EPPO, 2011, PM 5 3 5 GUID PEST R, P1; FAO, 2006, INT STAND PHYT MEAS; Grime JP, 1979, PLANT STRATEGIES VEG, P7; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON MF, 1994, GEODERMA, V62, P45, DOI 10.1016/0016-7061(94)90027-2; Kandasamy O.S., 2005, P 2 INT C PARTHENIUM, P134; Khosla S. N., 1981, Pesticides, V15, P18; KILIAN N., 2002, WILLDENOWIA, V32, P239, DOI DOI 10.3372/WI.32.32207; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; McConnachie AJ, 2011, WEED RES, V51, P71, DOI 10.1111/j.1365-3180.2010.00820.x; McFadyen R E, 1995, Aust Fam Physician, V24, P1455; MCFADYEN RC, 1992, CROP PROT, V11, P400, DOI 10.1016/0261-2194(92)90021-V; Mirek Z., 2002, SERIA BIODIVERSITY P, V1; MURPHY ST, 2006, AID TRADE INT ASSIST; Navie S. C., 1996, Plant Protection Quarterly, V11, P76; Navie SC, 1998, WEED RES, V38, P335, DOI 10.1046/j.1365-3180.1998.00104.x; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Ramachandra Prasad T, 2010, INT C BIOD, P206; Ramachandra Prasad T.V., 2010, P 3 INT C PARTHENIUM, P13; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst RW, 2014, BIOL INVASIONS, V16, P239, DOI 10.1007/s10530-013-0523-y; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tamado T, 2002, INT J PEST MANAGE, V48, P183, DOI 10.1080/09670870110101739; Towers G. H. N., 1992, Proceedings of the 1st International Weed Control Congress., P134; Verloove F, 2006, CATALOGUE NEOPHYTES; Wabuyele Emily, 2014, Journal of East African Natural History, V103, P49; Watt MS, 2011, WEED SCI, V59, P538, DOI 10.1614/WS-D-11-00032.1; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; WILLIAMS JD, 1980, WEED RES, V20, P47, DOI 10.1111/j.1365-3180.1980.tb00040.x; WILLIAMS JD, 1985, AUST VET J, V62, P367, DOI 10.1111/j.1751-0813.1985.tb14210.x; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152	57	29	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0132807	10.1371/journal.pone.0132807	http://dx.doi.org/10.1371/journal.pone.0132807			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325680	Green Submitted, gold, Green Published			2022-12-27	WOS:000360437700005
J	Markov, OV; Mironova, NL; Sennikov, SV; Vlassov, VV; Zenkova, MA				Markov, Oleg V.; Mironova, Nadezhda L.; Sennikov, Sergey V.; Vlassov, Valentin V.; Zenkova, Marina A.			Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma	PLOS ONE			English	Article							CANCER-IMMUNOTHERAPY; GENETIC-MODIFICATION; MESSENGER-RNA; PHASE-II; VACCINATION; RESPONSES; IMMUNITY; IMMUNOGENICITY; IMMUNIZATION; INDUCTION	Recent data on the application of dendritic cells (DCs) as anti-tumor vaccines has shown their great potential in therapy and prophylaxis of cancer. Here we report on a comparison of two treatment schemes with DCs that display the models of prophylactic and therapeutic vaccination using three different experimental tumor models: namely, Krebs-2 adenocarcinoma (primary tumor), melanoma (B16, metastatic tumor without a primary node) and Lewis lung carcinoma (LLC, metastatic tumor with a primary node). Dendritic cells generated from bone marrow-derived DC precursors and loaded with lysate of tumor cells or transfected with the complexes of total tumor RNA with cationic liposomes were used for vaccination. Lipofectamine 2000 and liposomes consisting of helper lipid DOPE (1,2-dioleoyl- sn-glycero-3-phosphoethanolamine) and cationic lipid 2D3 (1,26-Bis(1,2-de-O-tetradecyl-rac-glycerol)-7,11,16,20-tetraazahexacosan tetrahydrocloride) were used for RNA transfection. It was shown that DCs loaded with tumor lysate were ineffective in contrast to tumor-derived RNA. Therapeutic vaccination with DCs loaded by lipoplexes RNA/Lipofectamine 2000 was the most efficient for treatment of non-metastatic Krebs-2, where a 1.9-fold tumor growth retardation was observed. Single prophylactic vaccination with DCs loaded by lipoplexes RNA/2D3 was the most efficient to treat highly aggressive metastatic tumors LLC and B16, where 4.7- and 10-fold suppression of the number of lung metastases was observed, respectively. Antimetastatic effect of single prophylactic DC vaccination in metastatic melanoma model was accompanied by the reductions in the levels of Th2-specific cytokines however the change of the levels of Th1/Th2/Th17 master regulators was not found. Failure of double prophylactic vaccination is explained by Th17-response polarization associated with autoimmune and pro-inflammatory reactions. In the case of therapeutic DC vaccine the polarization of Th1-response was found nevertheless the antimetastatic effect was less effective in comparison with prophylactic DC vaccine.	[Markov, Oleg V.; Mironova, Nadezhda L.; Vlassov, Valentin V.; Zenkova, Marina A.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia; [Sennikov, Sergey V.] Russian Acad Sci, Fed State Budgetary Inst Res Inst Clin Immunol, Siberian Branch, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Russian Academy of Sciences	Zenkova, MA (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia.	marzen@niboch.nsc.ru	SENNIKOV, SERGEY/GPS-7277-2022; Markov, Oleg V/G-2676-2013; Zenkova, Marina A/G-5088-2013; Zenkova, Marina A./H-4666-2014; Vlassov, Valentin/F-4720-2013	SENNIKOV, SERGEY/0000-0002-7366-7768; Mironova, Nadezhda/0000-0003-4375-0269; Zenkova, Marina/0000-0003-4044-1049; Markov, Oleg/0000-0002-8381-1890; Vlassov, Valentin/0000-0003-2845-2992	Russian Academy of Science under the programs "Molecular and Cellular Biology"; Special Purpose Program "Research and Development in a Priority Direction of Development of a Scientific and Technological Complex of Russia" [14.607.21.0043, RFMEFI60714X0043]; Interdisciplinary grant of SB RAS [86];  [SS-01350.2014.4];  [1619.2013.4]	Russian Academy of Science under the programs "Molecular and Cellular Biology"; Special Purpose Program "Research and Development in a Priority Direction of Development of a Scientific and Technological Complex of Russia"; Interdisciplinary grant of SB RAS; ; 	This research was supported by the Russian Academy of Science under the programs "Molecular and Cellular Biology"; Interdisciplinary grant of SB RAS no. 86, by the grant Scientific schools SS-01350.2014.4, and Special Purpose Program "Research and Development in a Priority Direction of Development of a Scientific and Technological Complex of Russia for 2014-2020" (Agreement No. 14.607.21.0043, project RFMEFI60714X0043). MOV was a recipient of Presidential fellowship 1619.2013.4.	Aarntzen EHJG, 2013, CANCER RES, V73, P19, DOI 10.1158/0008-5472.CAN-12-1127; Ahmed MS, 2014, CLIN EXP VACCINE RES, V3, P113, DOI 10.7774/cevr.2014.3.2.113; Akiyama Y, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-623; Aly HAA, 2012, J IMMUNOL METHODS, V382, P1, DOI 10.1016/j.jim.2012.05.014; Begum-Haque S, 2008, J NEUROIMMUNOL, V204, P58, DOI 10.1016/j.jneuroim.2008.07.018; Benencia F, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/425476; Benteyn D, 2015, EXPERT REV VACCINES, V14, P161, DOI 10.1586/14760584.2014.957684; Blalock LT, 2012, ONCOIMMUNOLOGY, V1, P287, DOI 10.4161/onci.18628; Breckpot K, 2004, J GENE MED, V6, P1175, DOI 10.1002/jgm.615; Drake CG, 2011, CANCER J, V17, P294, DOI 10.1097/PPO.0b013e3182325e78; Finn OJ, 2014, CANCER IMMUNOL RES, V2, P708, DOI 10.1158/2326-6066.CIR-14-0110; Florcken A, 2013, HUM VACC IMMUNOTHER, V9, P1217, DOI 10.4161/hv.24149; Frank SA, 2004, NAT REV GENET, V5, P764, DOI 10.1038/nrg1450; Hong XQ, 2013, INT J COLORECTAL DIS, V28, P25, DOI 10.1007/s00384-012-1530-7; Huck SP, 2008, CANCER IMMUNOL IMMUN, V57, P63, DOI 10.1007/s00262-007-0350-z; Iclozan C, 2013, CANCER IMMUNOL IMMUN, V62, P909, DOI 10.1007/s00262-013-1396-8; Kandalaft LE, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22664; Kim SK, 2013, CANCER LETT, V335, P278, DOI 10.1016/j.canlet.2013.02.038; Koido S, 2000, J IMMUNOL, V165, P5713, DOI 10.4049/jimmunol.165.10.5713; Kong WM, 2011, BRAIN BEHAV IMMUN, V25, P872, DOI 10.1016/j.bbi.2010.09.012; Lesterhuis WJ, 2010, ANTICANCER RES, V30, P5091; Liechtenstein T, 2013, VIRUS RES, V176, P1, DOI 10.1016/j.virusres.2013.05.007; Liu T, 2012, J PROTEOMICS, V75, P4747, DOI 10.1016/j.jprot.2012.01.035; Markov OO, 2012, J CONTROL RELEASE, V160, P200, DOI 10.1016/j.jconrel.2011.11.034; Matheoud D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019104; Matheoud D, 2010, BLOOD, V115, P4412, DOI 10.1182/blood-2009-11-255935; Meany Danni L, 2009, Expert Opin Med Diagn, V3, P597; Mendoza L, 2003, INT J ONCOL, V23, P243; Morse MA, 2013, ANN SURG, V258, P879, DOI 10.1097/SLA.0b013e318292919e; Mossoba ME, 2008, MOL THER, V16, P607, DOI 10.1038/sj.mt.6300390; Oda Y, 2012, J CONTROL RELEASE, V160, P362, DOI 10.1016/j.jconrel.2011.12.003; Palma M, 2012, CANCER IMMUNOL IMMUN, V61, P865, DOI 10.1007/s00262-011-1149-5; Palucka K, 2011, J INTERN MED, V269, P64, DOI 10.1111/j.1365-2796.2010.02317.x; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Pan K, 2010, INT J BIOL SCI, V6, P639; Pandey VK, 2012, INT IMMUNOPHARMACOL, V14, P641, DOI 10.1016/j.intimp.2012.09.020; Phuphanich S, 2013, CANCER IMMUNOL IMMUN, V62, P125, DOI 10.1007/s00262-012-1319-0; Prasad SJ, 2005, J IMMUNOL, V174, P90, DOI 10.4049/jimmunol.174.1.90; Ribas A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-89; Ricupito A, 2013, CANCER RES, V73, P3545, DOI 10.1158/0008-5472.CAN-12-2449; Rizzo MM, 2014, METHODS MOL BIOL, V1139, P41, DOI 10.1007/978-1-4939-0345-0_5; Salem ML, 2014, METHODS MOL BIOL, V1139, P479, DOI 10.1007/978-1-4939-0345-0_37; Samadi-Foroushani M, 2011, MED ONCOL, V28, pS660, DOI 10.1007/s12032-010-9720-z; Schaft N, 2006, HDB DENDRITIC CELLS, P1143, DOI [10.1002/9783527619696.ch55, DOI 10.1002/9783527619696.CH55]; Su Z, 2003, CANCER RES, V63, P2127; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tada F, 2012, INT J ONCOL, V41, P1601, DOI 10.3892/ijo.2012.1626; Topfer K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/918471; Tung N, 2011, JAMA-J AM MED ASSOC, V305, P2211, DOI 10.1001/jama.2011.678; Vik-Mo EO, 2013, CANCER IMMUNOL IMMUN, V62, P1499, DOI 10.1007/s00262-013-1453-3; Xie JP, 2010, LUNG CANCER, V68, P338, DOI 10.1016/j.lungcan.2009.07.007; Yang SX, 1999, INT J CANCER, V83, P532, DOI 10.1002/(SICI)1097-0215(19991112)83:4<532::AID-IJC16>3.0.CO;2-K	53	20	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136911	10.1371/journal.pone.0136911	http://dx.doi.org/10.1371/journal.pone.0136911			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325576	gold, Green Submitted, Green Published			2022-12-27	WOS:000360437700070
J	Terlaak, B; Bouwsema, H; van der Sluis, CK; Bongers, RM				Terlaak, Bernhard; Bouwsema, Hanneke; van der Sluis, Corry K.; Bongers, Raoul M.			Virtual Training of the Myosignal	PLOS ONE			English	Article							MYOELECTRIC CONTROL; EFFECT SIZE; PROSTHESIS; PERFORMANCE; STATISTICS; SIMULATOR; GAME	Objective To investigate which of three virtual training methods produces the largest learning effects on discrete and continuous myocontrol. The secondary objective was to examine the relation between myocontrol and manual motor control tests. Design A cohort analytic study. Setting University laboratory. Participants 3 groups of 12 able-bodied participants (N = 36). Interventions Participants trained the control over their myosignals on 3 consecutive days. Training was done with either myosignal feedback on a computer screen, a virtual myoelectric prosthetic hand or a computer game. Participants performed 2 myocontrol tests and 2 manual motor control tests before the first and after the last training session. They were asked to open and close a virtual prosthetic hand on 3 different velocities as a discrete myocontrol test and followed a line with their myosignals for 30 seconds as a continuous myocontrol test. The motor control tests were a pegboard and grip-force test. Main Outcome Measures Discrete myocontrol test: mean velocities. Continuous myocontrol test: error and error SD. Pegboard test: time to complete. Grip-force test: produced forces. Results No differences in learning effects on myocontrol were found for the different virtual training methods. Discrete myocontrol ability did not significantly improve as a result of training. Continuous myocontrol ability improved significantly as a result of training, both on average control and variability. All correlations between the motor control and myocontrol test outcome measures were below .50. Conclusions Three different virtual training methods showed comparable results when learning myocontrol. Continuous myocontrol was improved by training while discrete myocontrol was not. Myocontrol ability could not be predicted by the manual motor control tests.	[Terlaak, Bernhard; Bouwsema, Hanneke; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Bouwsema, Hanneke] Adelante Rehabil Ctr, Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Bouwsema, Hanneke] Maastricht Univ, Dept Rehabil Med, Res Sch CAPHRI, Maastricht, Netherlands; [van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands	University of Groningen; Maastricht University; University of Groningen	Bongers, RM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	r.m.bongers@umcg.nl	Bongers, Raoul/C-1094-2012	Bongers, Raoul/0000-0002-3518-7464	Otto Bock Healthcare GmbH, Vienna, Austria	Otto Bock Healthcare GmbH, Vienna, Austria	This research was performed while Hanneke Bouwsema was financially supported by Otto Bock Healthcare GmbH, Vienna, Austria. By legal contract, Otto Bock had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antuvan CW, 2014, IEEE T NEUR SYS REH, V22, P820, DOI 10.1109/TNSRE.2014.2302212; Armiger RS, 2008, 2008 IEEE BIOMEDICAL CIRCUITS AND SYSTEMS CONFERENCE - INTELLIGENT BIOMEDICAL SYSTEMS (BIOCAS), P121, DOI 10.1109/BIOCAS.2008.4696889; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Behrend C, 2011, J HAND SURG-AM, V36A, P1711, DOI 10.1016/j.jhsa.2011.07.024; Betker AL, 2006, ARCH PHYS MED REHAB, V87, P1141, DOI 10.1016/j.apmr.2006.04.010; Beylefeld AA, 2007, MED TEACH, V29, P933, DOI 10.1080/01421590701601550; Bouwsema H, 2010, ARCH PHYS MED REHAB, V91, P1442, DOI 10.1016/j.apmr.2010.06.025; BURGER H, 1994, PROSTHET ORTHOT INT, V18, P25; Campbell JID, 2012, BEHAV RES METHODS, V44, P1255, DOI 10.3758/s13428-012-0186-0; Cipriani C, 2011, IEEE ENG MED BIO, P1620, DOI 10.1109/IEMBS.2011.6090468; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dalley SA, 2009, IEEE-ASME T MECH, V14, P699, DOI 10.1109/TMECH.2009.2033113; Dawson MR, 2011, EXPERT REV MED DEVIC, V8, P581, DOI [10.1586/erd.11.23, 10.1586/ERD.11.23]; Di Pino G, 2009, PROG NEUROBIOL, V88, P114, DOI 10.1016/j.pneurobio.2009.03.001; Dudkiewicz I, 2004, DISABIL REHABIL, V26, P60, DOI 10.1080/09638280410001645094; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Fimbel EJ, 2006, HUM MOVEMENT SCI, V25, P165, DOI 10.1016/j.humov.2005.12.001; Fimbel EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001219; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Malone J M, 1984, J Rehabil Res Dev, V21, P33; Nazarpour K, 2012, J NEUROSCI, V32, P12349, DOI 10.1523/JNEUROSCI.5481-11.2012; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Oppenheim H, 2010, IEEE INT SYMP CIRC S, P957, DOI 10.1109/ISCAS.2010.5537390; Perez-Maldonado C, 2010, IEEE T NEUR SYS REH, V18, P203, DOI 10.1109/TNSRE.2009.2039394; Pistohl T, 2013, ANN BIOMED ENG, V41, P2687, DOI 10.1007/s10439-013-0876-5; Radhakrishnan SM, 2008, J NEUROPHYSIOL, V100, P2397, DOI 10.1152/jn.90614.2008; Resnik L, 2011, J REHABIL RES DEV, V48, P707, DOI 10.1682/JRRD.2010.07.0127; Romkema S, 2013, PHYS THER, V93, P22, DOI 10.2522/ptj.20120058; Schabowsky CN, 2008, EXP BRAIN RES, V188, P589, DOI 10.1007/s00221-008-1394-9; Soares A, 2003, J INTELL INF SYST, V21, P127, DOI 10.1023/A:1024758415877; Stansfield S, 2005, ST HEAL T, V111, P515; Takeuchi T, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P1351, DOI 10.1109/ICCME.2007.4381964; Weeks DL, 2003, ARCH PHYS MED REHAB, V84, P437, DOI 10.1053/apmr.2003.50014; Weir R, 2007, P ANN INT IEEE EMBS, P4359, DOI 10.1109/IEMBS.2007.4353302	34	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137161	10.1371/journal.pone.0137161	http://dx.doi.org/10.1371/journal.pone.0137161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ9KG	26351838	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800062
J	Hall, MK; Weidner, DA; Edwards, MAJ; Schwalbe, RA				Hall, M. Kristen; Weidner, Douglas A.; Edwards, Michael A. J.; Schwalbe, Ruth A.			Complex N-Glycans Influence the Spatial Arrangement of Voltage Gated Potassium Channels in Membranes of Neuronal-Derived Cells	PLOS ONE			English	Article							ION CHANNELS; GLYCOSYLATION AFFECTS; K+ CHANNELS; LOCALIZATION; SUBUNIT; DIVERSITY; BRAIN	The intrinsic electrical properties of a neuron depend on expression of voltage gated potassium (Kv) channel isoforms, as well as their distribution and density in the plasma membrane. Recently, we showed that N-glycosylation site occupancy of Kv3.1b modulated its placement in the cell body and neurites of a neuronal-derived cell line, B35 neuroblastoma cells. To extrapolate this mechanism to other N-glycosylated Kv channels, we evaluated the impact of N-glycosylation occupancy of Kv3.1a and Kv1.1 channels. Western blots revealed that wild type Kv3.1a and Kv1.1 alpha-subunits had complex and oligomannose N-glycans, respectively, and that abolishment of the N-glycosylation site(s) generated Kv proteins without N-glycans. Total internal reflection fluorescence microscopy images revealed that Nglycans of Kv3.1a contributed to its placement in the cell membrane while N-glycans had no effect on the distribution of Kv1.1. Based on particle analysis of EGFP-Kv proteins in the adhered membrane, glycosylated forms of Kv3.1a, Kv1.1, and Kv3.1b had differences in the number, size or density of Kv protein clusters in the cell membrane of neurites and cell body of B35 cells. Differences were also observed between the unglycosylated forms of the Kv proteins. Cell dissociation assays revealed that cell-cell adhesion was increased by the presence of complex N-glycans of Kv3.1a, like Kv3.1b, whereas cell adhesion was similar in the oligomannose and unglycosylated Kv1.1 subunit containing B35 cells. Our findings provide direct evidence that N-glycans of Kv3.1 splice variants contribute to the placement of these glycoproteins in the plasma membrane of neuronal-derived cells while those of Kv1.1 were absent. Further when the cell membrane distribution of the Kv channel was modified by N-glycans then the cell-cell adhesion properties were altered. Our study demonstrates that N-glycosylation of Kv3.1a, like Kv3.1b, provides a mechanism for the distribution of these proteins to the cell body and outgrowths and thereby can generate different voltage-dependent conductances in these membranes.	[Hall, M. Kristen; Edwards, Michael A. J.; Schwalbe, Ruth A.] E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA; [Weidner, Douglas A.] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Schwalbe, RA (corresponding author), E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA.	schwalber@ecu.edu		Weidner, Douglas/0000-0003-1397-1757	department of Biochemistry and Molecular Biology at ECU	department of Biochemistry and Molecular Biology at ECU	The department of Biochemistry and Molecular Biology at ECU provided the funds for this work.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Brooks NL, 2006, FEBS J, V273, P3287, DOI 10.1111/j.1742-4658.2006.05339.x; Cartwright TA, 2007, BBA-GEN SUBJECTS, V1770, P666, DOI 10.1016/j.bbagen.2006.11.013; Cartwright TA, 2009, BIOSCIENCE REP, V29, P301, DOI 10.1042/BSR20080149; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Ednie AR, 2012, COMPR PHYSIOL, V2, P1269, DOI 10.1002/cphy.c110044; Hakomori S, 2004, GLYCOCONJUGATE J, V21, P125, DOI 10.1023/B:GLYC.0000044844.95878.cf; Hall MK, 2014, BBA-GEN SUBJECTS, V1840, P595, DOI 10.1016/j.bbagen.2013.10.025; Hall MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019317; Hall MK, 2014, FEBS OPEN BIO, V4, P892, DOI 10.1016/j.fob.2014.10.006; Hall MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075013; Hall MK, 2011, FEBS LETT, V585, P3322, DOI 10.1016/j.febslet.2011.09.021; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; LUNEAU CJ, 1991, P NATL ACAD SCI USA, V88, P3932, DOI 10.1073/pnas.88.9.3932; Otey CA, 2003, METHOD CELL BIOL, V71, P287, DOI 10.1016/S0091-679X(03)01013-6; Ozaita A, 2002, J NEUROPHYSIOL, V88, P394, DOI 10.1152/jn.2002.88.1.394; SAMBROOK J, 1992, MOL CLONING LAB MANU; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137138	10.1371/journal.pone.0137138	http://dx.doi.org/10.1371/journal.pone.0137138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348848	Green Submitted, gold, Green Published			2022-12-27	WOS:000360897600023
J	Sugino, H; Tsumura, S; Kunimoto, M; Noda, M; Chikuie, D; Noda, C; Yamashita, M; Watanabe, H; Ishii, H; Tashiro, T; Iwata, K; Kono, T; Tsumura, K; Sumiya, T; Takeno, S; Hirakawa, K				Sugino, Hirotoshi; Tsumura, Shigeru; Kunimoto, Masaru; Noda, Masuhiro; Chikuie, Daisuke; Noda, Chieko; Yamashita, Mariko; Watanabe, Hiroshi; Ishii, Hidemasa; Tashiro, Toru; Iwata, Kazuhiro; Kono, Takashi; Tsumura, Kaoru; Sumiya, Takahiro; Takeno, Sachio; Hirakawa, Katsuhiro			Influence of Pneumococcal Conjugate Vaccine on Acute Otitis Media with Severe Middle Ear Inflammation: A Retrospective Multicenter Study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; CONTROLLED-TRIAL; CHILDREN; EFFICACY; JAPAN; MANAGEMENT; RESISTANCE; DIAGNOSIS; SEROTYPE; INFANTS	The Japanese guidelines for acute otitis media in children recommend classifying acute otitis media by age, manifestations and local findings, and also recommend myringotomy for moderate- grade cases with severe local findings, severe-grade cases, and treatment-resistant cases. The heptavalent pneumococcal conjugate vaccine was released in Japan in February 2010. In Hiroshima City, public funding allowing free inoculation with this vaccine was initiated from January 2011, and the number of vaccinated individuals has since increased dramatically. This study investigated changes in the number of myringotomies performed to treat acute otitis media during the 5-year period from January 2008 to December 2012 at two hospitals and five clinics in the Asa Area of Hiroshima City, Japan. A total of 3,165 myringotomies for acute otitis media were performed. The rate of procedures per child-year performed in < 5-year-old children decreased by 29.1% in 2011 and by 25.2% in 2012 compared to the mean rate performed in the 3 years prior to the introduction of public funding. A total of 895 myringotomies were performed for 1-year-old infants. The rate of myringotomies per child-year performed for acute otitis media in 1-year-old infants decreased significantly in the 2 years after the introduction of public funding for heptavalent pneumococcal conjugate vaccine compared to all years before introduction ( p<0.000001). Our results suggest a benefit of heptavalent pneumococcal conjugate vaccine for acute otitis media in reducing the financial burden of myringotomy. In addition, this vaccine may help prevent acute otitis media with severe middle ear inflammation in 1-year-old infants.	[Sugino, Hirotoshi; Tsumura, Shigeru; Kunimoto, Masaru; Noda, Masuhiro; Chikuie, Daisuke; Noda, Chieko; Yamashita, Mariko; Watanabe, Hiroshi; Ishii, Hidemasa; Tashiro, Toru; Iwata, Kazuhiro; Kono, Takashi; Tsumura, Kaoru] Asa Med Assoc, Hiroshima, Japan; [Sugino, Hirotoshi] Sugino Pediat Clin, Hiroshima, Japan; [Tsumura, Shigeru] Tsumura ENT Clin, Hiroshima, Japan; [Kunimoto, Masaru; Kono, Takashi; Takeno, Sachio; Hirakawa, Katsuhiro] Hiroshima Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Biomed & Hlth Sci, Appl Life Sci, Hiroshima, Japan; [Kunimoto, Masaru] Kunimoto ENT Clin, Hiroshima, Japan; [Noda, Masuhiro; Noda, Chieko] Noda ENT Clin, Hiroshima, Japan; [Chikuie, Daisuke] Hiroshima Kyouritsu Hosp, Hiroshima, Japan; [Yamashita, Mariko] Yamashita Clin, Hiroshima, Japan; [Watanabe, Hiroshi] Watanabe ENT Clin, Hiroshima, Japan; [Ishii, Hidemasa; Iwata, Kazuhiro; Kono, Takashi; Tsumura, Kaoru] Hiroshima City Asa Hosp, Hiroshima, Japan; [Tashiro, Toru] Tashiro ENT Clin, Hiroshima, Japan; [Sumiya, Takahiro] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University	Kunimoto, M (corresponding author), Asa Med Assoc, Hiroshima, Japan.	makunimoto@hotmail.com	Sumiya, Takahiro/ABF-1750-2020; Takeno, Sachio/AAX-9118-2021	Kunimoto, Masaru/0000-0002-1128-5449; Takeno, Sachio/0000-0002-9853-2501				Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Chiba N, 2010, EPIDEMIOL INFECT, V138, P61, DOI 10.1017/S0950268809990239; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Fireman B, 2003, PEDIATR INFECT DIS J, V22, P10, DOI 10.1097/00006454-200301000-00006; Fortanier AC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub4; Hotomi M, 2008, J CLIN MICROBIOL, V46, P3808, DOI 10.1128/JCM.01782-08; Kamiya Hitoshi, 2007, Kansenshogaku Zasshi, V81, P59; Kilpi T, 2003, CLIN INFECT DIS, V37, P1155, DOI 10.1086/378744; Kitamura K, 2015, AURIS NASUS LARYNX, V42, P99, DOI 10.1016/j.anl.2014.09.006; Marom T, 2014, JAMA PEDIATR, V168, P68, DOI 10.1001/jamapediatrics.2013.3924; O'Brien KL, 2008, PEDIATR INFECT DIS J, V27, P71, DOI 10.1097/INF.0b013e318159228f; Otsuka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068711; Palmu AAI, 2004, PEDIATR INFECT DIS J, V23, P732, DOI 10.1097/01.inf.0000133049.30299.5d; Shiragami M, 2015, INFECT DIS THER, V4, P93, DOI 10.1007/s40121-014-0053-7; Subcommittee of Clinical Practice Guideline for Diagnosis and Management of Acute Otitis Media in Children (Japan Otological Society Japan Society for Pediatric Otorhinolaryngology Japan Society for Infectious Diseases in Otolaryngology), 2012, Auris Nasus Larynx, V39, P1, DOI 10.1016/j.anl.2011.09.008; Suzuki K, 2008, J JPN SOC INFECT DIS, V26, P15; Suzuki K, 2015, J INFECT CHEMOTHER, V21, P483, DOI 10.1016/j.jiac.2015.03.005; Tamir SO, 2015, CLIN OTOLARYNGOL, V40, P370, DOI 10.1111/coa.12384; Taylor S, 2012, CLIN INFECT DIS, V54, P1765, DOI 10.1093/cid/cis292; Yamanaka N, 2015, PRACTICA OTO RHINO L, V108, P177	20	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137546	10.1371/journal.pone.0137546	http://dx.doi.org/10.1371/journal.pone.0137546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348230	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600054
J	Cho, YJ; Silverstein, R; Geisinger, MT; Martinkovich, S; Corkill, H; Cunnick, JM; Planey, SL; Arnott, JA				Cho, Youngjin; Silverstein, Rachel; Geisinger, Max T.; Martinkovich, Stephen; Corkill, Holly; Cunnick, Jess M.; Planey, Sonia L.; Arnott, John A.			AFAP1 Is a Novel Downstream Mediator of TGF-beta 1 for CCN2 Induction in Osteoblasts	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; CHONDROCYTE-SPECIFIC GENE; ACTIN-FILAMENT INTEGRITY; HUMAN LUNG FIBROBLASTS; SMOOTH-MUSCLE-CELLS; FETAL-RAT CALVARIAE; SRC FAMILY KINASES; TGF-BETA; C-SRC; TRANSFORMING GROWTH-FACTOR-BETA-1	Background CCN2 acts as an anabolic growth factor to regulate osteoblast differentiation and function. CCN2 is induced by TGF-beta 1 and acts as a mediator of TGF-beta 1 induced matrix production in osteoblasts and Src is required for CCN2 induction by TGF-beta 1; however, the molecular mechanisms that control CCN2 induction in osteoblasts are poorly understood. AFAP1 binds activated forms of Src and can direct the activation of Src in certain cell types, however a role for AFAP1 downstream of TGF-beta 1 or in osteoblats is undefined. In this study, we investigated the role of AFAP1 for CCN2 induction by TGF-beta 1 in primary osteoblasts. Results We demonstrated that AFAP1 expression in osteoblasts occurs in a biphasic pattern with maximal expression levels occurring during osteoblast proliferation (similar to day 3), reduced expression during matrix production/maturation (similar to day 14-21), an a further increase in expression during mineralization (similar to day 21). AFAP1 expression is induced by TGF-beta 1 treatment in osteoblasts during days 7, 14 and 21. In osteoblasts, AFAP1 binds to Src and is required for Src activation by TGF-beta 1 and CCN2 promoter activity and protein induction by TGF-beta 1 treatment was impaired using AFAP1 siRNA, indicating the requirement of AFAP1 for CCN2 induction by TGF-beta 1. We also demonstrated that TGF-beta 1 induction of extracellular matrix protein collagen XIIa occurs in an AFAP1 dependent fashion. Conclusions This study demonstrates that AFAP1 is an essential downstream signaling component of TGF-beta 1 for Src activation, CCN2 induction and collagen XIIa in osteoblasts.	[Cho, Youngjin; Silverstein, Rachel; Geisinger, Max T.; Martinkovich, Stephen; Corkill, Holly; Cunnick, Jess M.; Planey, Sonia L.; Arnott, John A.] Commonwealth Med Coll, Scranton, PA 18509 USA	Geisinger Commonwealth School of Medicine	Arnott, JA (corresponding author), Commonwealth Med Coll, Scranton, PA 18509 USA.	jarnott@tcmedc.org	Cunnick, Jess/F-1715-2018; Lobo, Sonia/H-6889-2018	Lobo, Sonia/0000-0002-7406-6956	Commonwealth Medical College	Commonwealth Medical College	Support for this project was provided by The Commonwealth Medical College.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Arnott JA, 2008, BONE, V42, P871, DOI 10.1016/j.bone.2008.01.006; Arnott JA, 2007, J CELL PHYSIOL, V210, P843, DOI 10.1002/jcp.20917; Arnott JA, 2008, BONE; Baisden JM, 2001, ONCOGENE, V20, P6435, DOI 10.1038/sj.onc.1204784; Blom IE, 2001, NEPHROL DIAL TRANSPL, V16, P1139, DOI 10.1093/ndt/16.6.1139; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Boguslawski G, 2000, J BIOL CHEM, V275, P999, DOI 10.1074/jbc.275.2.999; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; CENTRELLA M, 1987, J BONE MINER RES, V2, P29; CENTRELLA M, 1992, ENDOCRINOLOGY, V131, P2863, DOI 10.1210/en.131.6.2863; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Cunnick JM, 2015, ONCOGENE, V34, P2640, DOI 10.1038/onc.2014.205; Cunnick JM, 2014, ONCOGENE O, DOI [10.1038/onc.2014.205, DOI 10.1038/ONC.2014.205]; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dorfleutner A, 2008, J CELL SCI, V121, P2394, DOI 10.1242/jcs.026187; Dorfleutner A, 2007, J CELL PHYSIOL, V213, P740, DOI 10.1002/jcp.21143; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fan WH, 2000, BIOCHEM BIOPH RES CO, V275, P312, DOI 10.1006/bbrc.2000.3314; FLYNN DC, 1993, MOL CELL BIOL, V13, P7892, DOI 10.1128/MCB.13.12.7892; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Gatesman A, 2004, MOL CELL BIOL, V24, P7578, DOI 10.1128/MCB.24.17.7578-7597.2004; Gore-Hyer E, 2002, AM J PHYSIOL-RENAL, V283, pF707, DOI 10.1152/ajprenal.00007.2002; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Guappone AC, 1998, MOL CARCINOGEN, V22, P110, DOI 10.1002/(SICI)1098-2744(199806)22:2<110::AID-MC6>3.0.CO;2-Q; Guappone AC, 1997, MOL CELL BIOCHEM, V175, P243, DOI 10.1023/A:1006840104666; HOCK JM, 1990, ENDOCRINOLOGY, V126, P421, DOI 10.1210/endo-126-1-421; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kim HP, 2005, BBA-MOL CELL RES, V1743, P151, DOI 10.1016/j.bbamcr.2004.09.014; Kim HP, 2004, BIOCHEM J, V379, P141, DOI 10.1042/BJ20031408; Kim JT, 2002, J BIOL CHEM, V277, P31938, DOI 10.1074/jbc.M201178200; Kucich U, 2001, ARCH BIOCHEM BIOPHYS, V395, P103, DOI 10.1006/abbi.2001.2571; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Lee SJ, 2013, BIOCHEM J, V456, P109, DOI 10.1042/BJ20130744; Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x; Lener T, 2006, EUR J CELL BIOL, V85, P183, DOI 10.1016/j.ejcb.2005.08.001; Li Xiaotong, 2002, Zhonghua Kou Qiang Yi Xue Za Zhi, V37, P135; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Massague J, 2000, GENE DEV, V14, P627; Mishra R, 2007, AM J PHYSIOL-CELL PH, V292, pC1361, DOI 10.1152/ajpcell.00370.2006; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nakanishi T, 1997, BIOCHEM BIOPH RES CO, V234, P206, DOI 10.1006/bbrc.1997.6528; Nishida T, 2002, J CELL PHYSIOL, V192, P55, DOI 10.1002/jcp.10113; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; PARISI MS, 2005, BONE; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Qian Y, 2004, J CELL BIOCHEM, V91, P602, DOI 10.1002/jcb.10725; Qian Y, 2000, EXP CELL RES, V255, P102, DOI 10.1006/excr.1999.4795; Qian Y, 2002, MOL BIOL CELL, V13, P2311, DOI 10.1091/mbc.E01-12-0148; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; Sato M, 2005, ARTERIOSCL THROM VAS, V25, P341, DOI 10.1161/01.ATV.0000152608.29351.8f; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Skingley Ann, 2007, Br J Community Nurs, V12, P28; Snyder BN, 2011, EUR J CELL BIOL, V90, P376, DOI 10.1016/j.ejcb.2010.11.016; Suzuki K, 2006, UROLOGY, V67, P647, DOI 10.1016/j.urology.2005.10.013; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Tanaka Y, 2004, J BIOL CHEM, V279, P8567, DOI 10.1074/jbc.M309131200; Tang CH, 2007, J CELL PHYSIOL, V211, P45, DOI 10.1002/jcp.20896; Ungefroren H, 2011, CURR CANCER DRUG TAR, V11, P524, DOI 10.2174/156800911795538075; Utsugi M, 2003, AM J RESP CELL MOL, V28, P754, DOI 10.1165/rcmb.4892; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Walker VG, 2007, AM J PHYSIOL-CELL PH, V293, pC119, DOI 10.1152/ajpcell.00525.2006; Way KJ, 2002, DIABETES, V51, P2709, DOI 10.2337/diabetes.51.9.2709; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004; Xu J, 2000, J CELL BIOCHEM, V77, P103, DOI 10.1002/(SICI)1097-4644(20000401)77:1<103::AID-JCB11>3.0.CO;2-G; Zhang J, 2007, J CLIN INVEST, V117, P2962, DOI 10.1172/JCI30710; Zhang X, 2010, J CELL PHYSIOL, V224, P691, DOI 10.1002/jcp.22173	76	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0136712	10.1371/journal.pone.0136712	http://dx.doi.org/10.1371/journal.pone.0136712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340021	gold, Green Submitted, Green Published			2022-12-27	WOS:000360688200013
J	Inoue, H				Inoue, Hiroyasu			Evidence for a Creative Dilemma Posed by Repeated Collaborations	PLOS ONE			English	Article							TEAM; PERFORMANCE; KNOWLEDGE	We focused on how repeat collaborations in projects for inventions affect performance. Repeat collaborations have two contradictory aspects. A positive aspect is team development or experience, and a negative aspect is team degeneration or decline. Since both contradicting phenomena are observed, inventors have a dilemma as to whether they should keep collaborating in a team or not. The dilemma has not previously been quantitatively analyzed. We provide quantitative and extensive analyses of the dilemma in creative projects by using patent data from Japan and the United States. We confirm three predictions to quantitatively validate the existence of the dilemma. The first prediction is that the greater the patent a team achieves, the longer the team will work together. The second prediction is that the impact of consecutive patents decreases after a team makes a remarkable invention, which is measured by the impact of patents. The third prediction is that the expectation of impact with new teams is greater than that with the same teams successful in the past. We find these predictions are validated in patents published in Japan and the United States. On the basis of these three predictions, we can quantitatively validate the dilemma in creative projects. We also propose preventive strategies for degeneration. One is developing technological diversity, and another is developing inventor diversity in teams. We find the two strategies are both effective by validating with the data.	Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo 6500044, Japan	University of Hyogo	Inoue, H (corresponding author), Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo 6500044, Japan.	inoue@sim.u-hyogo.ac.jp			Japan Society for the Promotion of Science [KAKENHI 15K01217]; Grants-in-Aid for Scientific Research [24530506] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science, grant number KAKENHI 15K01217 (grant url: https://kaken.nii.ac.jp/d/p/15K01217.en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowler P.J., 2005, MAKING MODERN SCI HI; Christensen C. M., 2001, INNOVATORS DILEMMA N; Delmestri G, 2005, J MANAGE STUD, V42, P975, DOI 10.1111/j.1467-6486.2005.00529.x; Drucker P. F., 1992, AGE DISCONTINUITY GU; GERSICK CJG, 1990, ORGAN BEHAV HUM DEC, V47, P65, DOI 10.1016/0749-5978(90)90047-D; Gorman JC, 2011, J EXP PSYCHOL-APPL, V17, P303, DOI 10.1037/a0025149; Gorman JC, 2010, NONLIN DYNAM PSYCHOL, V14, P265; Goto A, 2007, RES POLICY, V36, P1431, DOI 10.1016/j.respol.2007.06.005; Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110; Griliches Z., 1998, R D PRODUCTIVITY EC; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Hall B, 2001, 8498 NBER, P8498; Inoue H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121973; Janis I. L, 1982, GROUPTHINK, V2nd; Jones B. F., 2005, NBER WORKING PAPER S; KATZ R, 1982, ADMIN SCI QUART, V27, P81, DOI 10.2307/2392547; Kozlowski S.W.J., 2003, HDB PSYCHOL IND ORG, P333, DOI [10.1002/9781118133880.hop212017, DOI 10.1002/0471264385.WEI1214]; Lai R., 2012, DISAMBIGUATION COAUT; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; McEvily SK, 2002, STRATEGIC MANAGE J, V23, P285, DOI 10.1002/smj.223; Merton Robert K., 1979, SOCIOLOGY SCI THEORE, P223; Perretti F, 2007, J ORGAN BEHAV, V28, P563, DOI 10.1002/job.464; Porac JF, 2004, RES POLICY, V33, P661, DOI 10.1016/j.respol.2004.01.007; Porter M.E., 1998, COMPETITION, V1st ed., P197; Reagans R, 2004, ADMIN SCI QUART, V49, P101; Schwab A, 2008, ACAD MANAGE J, V51, P1117, DOI 10.5465/AMJ.2008.35732606; Skilton PF, 2010, ACAD MANAGE REV, V35, P118, DOI 10.5465/AMR.2010.45577886; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	29	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137418	10.1371/journal.pone.0137418	http://dx.doi.org/10.1371/journal.pone.0137418			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ6BA	26340441	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200057
J	Cuadrado-Godia, E; Regueiro, A; Nunez, J; Diaz-Ricard, M; Novella, S; Oliveras, A; Valverde, MA; Marrugat, J; Ois, A; Giralt-Steinhauer, E; Sanchis, J; Escolar, G; Hermenegildo, C; Heras, M; Roquer, J				Cuadrado-Godia, Elisa; Regueiro, Ander; Nunez, Julio; Diaz-Ricard, Maribel; Novella, Susana; Oliveras, Anna; Valverde, Miguel A.; Marrugat, Jaume; Ois, Angel; Giralt-Steinhauer, Eva; Sanchis, Juan; Escolar, Ginses; Hermenegildo, Carlos; Heras, Magda; Roquer, Jaume			Endothelial Progenitor Cells Predict Cardiovascular Events after Atherothrombotic Stroke and Acute Myocardial Infarction. A PROCELL Substudy	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; VON-WILLEBRAND-FACTOR; RISK PREDICTION; REDUCED NUMBER; BONE-MARROW; TRANSPLANTATION; MOBILIZATION	Introduction The aim of this study was to determine prognostic factors for the risk of new vascular events during the first 6 months after acute myocardial infarction (AMI) or atherothrombotic stroke (AS). We were interested in the prognostic role of endothelial progenitor cells (EPC) and circulating endothelial cells (CEC) Methods Between February 2009 and July 2012, 100 AMI and 50 AS patients were consecutively studied in three Spanish centres. Patients with previously documented coronary artery disease or ischemic strokes were excluded. Samples were collected within 24h of onset of symptoms. EPC and CEC were studied using flow cytometry and categorized by quartiles. Patients were followed for up to 6 months. NVE was defined as new acute coronary syndrome, transient ischemic attack (TIA), stroke, or any hospitalization or death from cardiovascular causes. The variables included in the analysis included: vascular risk factors, carotid intima-media thickness (IMT), atherosclerotic burden and basal EPC and CEC count. Multivariate survival analysis was performed using Cox regression analysis. Results During follow-up, 19 patients (12.66%) had a new vascular event (5 strokes; 3 TIAs; 4 AMI; 6 hospitalizations; 1 death). Vascular events were associated with age (P = 0.039), carotid IMT >= 0.9 (P = 0.044), and EPC count (P = 0.041) in the univariate analysis. Multivariate Cox regression analysis showed an independent association with EPC in the lowest quartile (HR: 10.33, 95% CI (1.22-87.34), P = 0.032] and IMT >= 0.9 [HR: 4.12, 95% CI (1.21-13.95), P = 0.023]. Conclusions Basal EPC and IMT >= 0.9 can predict future vascular events in patients with AMI and AS, but CEC count does not affect cardiovascular risk.	[Cuadrado-Godia, Elisa; Ois, Angel; Giralt-Steinhauer, Eva; Roquer, Jaume] DCEXS Univ Pompeu Fabra, Dept Neurol, Neurovasc Res Grp, IMIM Hosp del Mar,Inst Hosp del Mar Invest Med,U, Barcelona, Spain; [Regueiro, Ander; Heras, Magda] Univ Barcelona, Dept Cardiol, Thorax Inst, Hosp Clin, Barcelona, Spain; [Nunez, Julio; Sanchis, Juan] Univ Valencia, Dept Cardiol, Hosp Clin Univ, Sch Med, Valencia, Spain; [Diaz-Ricard, Maribel; Escolar, Ginses] Univ Barcelona, Hemotherapy Hemostasis Dept, Biomed Diagnost Ctr, Hosp Clin, Barcelona, Spain; [Novella, Susana; Hermenegildo, Carlos] Hosp Clin, Valencia INCLIVA Biomed Res Inst, Valencia, Spain; [Novella, Susana; Hermenegildo, Carlos] Univ Valencia, Dept Physiol, Valencia, Spain; [Oliveras, Anna] Univ Autonoma Barcelona, Hosp del Mar, Dept Nephrol, E-08193 Barcelona, Spain; [Valverde, Miguel A.] Univ Pompeu Fabra, Lab Mol Physiol & Channelopathies, Dept Expt & Hlth Sci, Barcelona, Spain; [Marrugat, Jaume] IMIM, Epidemiol & Cardiovasc Genet Grp, Barcelona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; University of Barcelona; University of Valencia; University of Barcelona; Hospital Clinic de Barcelona; University of Valencia; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM)	Cuadrado-Godia, E (corresponding author), DCEXS Univ Pompeu Fabra, Dept Neurol, Neurovasc Res Grp, IMIM Hosp del Mar,Inst Hosp del Mar Invest Med,U, Barcelona, Spain.	ecuadrado@parcdesalutmar.cat	Albaladejo, Gines Escolar/AAC-9695-2020; Hermenegildo, Carlos/C-5995-2008; Ois, A/X-2922-2019; Escolar, Gines/ABF-9003-2021; Escolar, Gines/I-1530-2015; Ois, A/AAE-7583-2022; Oliveras, Anna/I-2269-2019; Roquer, Jaume/G-8919-2017; Novella, Susana/A-7406-2017	Albaladejo, Gines Escolar/0000-0002-6658-0381; Ois, A/0000-0002-1375-5950; Escolar, Gines/0000-0002-6658-0381; Ois, A/0000-0002-1375-5950; Oliveras, Anna/0000-0002-5503-545X; Roquer, Jaume/0000-0001-5992-2606; Novella, Susana/0000-0001-8303-7252; Hermenegildo, Carlos/0000-0002-4015-2645; Giralt Steinhauer, Eva/0000-0002-7463-0983; Valverde, Miguel A./0000-0002-6961-3361; Nunez, Julio/0000-0003-1672-7119; Marrugat, Jaume/0000-0003-3320-554X; Cuadrado-Godia, Elisa/0000-0002-9147-875X	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, FONDO DE INVESTIGACION SANITARIA, Instituto de Salud Carlos III) [PI080459]; Spain's Ministry of Health (RED DE INVESTIGACION CARDIOVASCULAR) [PI080459, RIC RD12/0042/0010, RIC RD12/0042/0052, RD12/0042/0020]	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, FONDO DE INVESTIGACION SANITARIA, Instituto de Salud Carlos III); Spain's Ministry of Health (RED DE INVESTIGACION CARDIOVASCULAR)	This study was supported in part by Spain's Ministry of Health (Ministerio de Sanidad y Consumo, FONDO DE INVESTIGACION SANITARIA, Instituto de Salud Carlos III. Grant number: PI080459, RED DE INVESTIGACION CARDIOVASCULAR (RIC RD12/0042/0010, RIC RD12/0042/0052, RD12/0042/0020). The sponsor had no role in study design, dat collection and analysis, decision to publish or preparation of the manuscript.	Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Boos CJ, 2006, J AM COLL CARDIOL, V48, P1538, DOI 10.1016/j.jacc.2006.02.078; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Ciccone MM, 2012, RESP MED, V106, P740, DOI 10.1016/j.rmed.2011.12.016; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Dzau VJ, 2005, HYPERTENSION, V46, P7, DOI 10.1161/01.HYP.0000168923.92885.f7; Fadini GP, 2007, ATHEROSCLEROSIS, V194, P46, DOI 10.1016/j.atherosclerosis.2007.03.046; Fadini GP, 2009, ATHEROSCLEROSIS, V207, P213, DOI 10.1016/j.atherosclerosis.2009.03.040; Grau M, 2007, EUR J CARDIOV PREV R, V14, P653; Hess DC, 2002, STROKE, V33, P1362, DOI 10.1161/01.STR.0000014925.09415.C3; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Lackland DT, 2012, STROKE, V43, P1998, DOI 10.1161/STR.0b013e31825bcdac; Lee KW, 2005, BLOOD, V105, P526, DOI 10.1182/blood-2004-03-1106; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Lorenzen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011477; Makin AJ, 2004, EUR HEART J, V25, P371, DOI 10.1016/j.ehj.2003.04.001; McClung JA, 2005, DIABETOLOGIA, V48, P345, DOI 10.1007/s00125-004-1647-5; Nadar SK, 2005, THROMB HAEMOSTASIS, V94, P707; Navarro-Sobrino M, 2010, MICROVASC RES, V80, P317, DOI 10.1016/j.mvr.2010.05.008; Ois A, 2013, NEUROLOGY, V81, P575, DOI 10.1212/WNL.0b013e31829e6f37; Rafii S, 2002, SEMIN CELL DEV BIOL, V13, P61, DOI 10.1006/scdb.2001.0285; Regueiro A, 2015, J MOL CELL CARDIOL, V80, P146, DOI 10.1016/j.yjmcc.2015.01.005; Roquer J, 2007, ARCH NEUROL-CHICAGO, V64, P699, DOI 10.1001/archneur.64.5.699; Roquer J, 2011, STROKE, V42, P3099, DOI 10.1161/STROKEAHA.110.612010; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shintani S, 2001, CIRCULATION; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Touboul PJ, 2004, CEREBROVASC DIS, V18, P346, DOI 10.1159/000081812; Umemura T, 2008, AM J HYPERTENS, V21, P1203, DOI 10.1038/ajh.2008.278; Vasa M, 2001, CIRCULATION; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Williamson K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00030; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401	36	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0132415	10.1371/journal.pone.0132415	http://dx.doi.org/10.1371/journal.pone.0132415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332322	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800001
J	Gol'din, P; Steeman, ME				Gol'din, Pavel; Steeman, Mette Elstrup			From Problem Taxa to Problem Solver: A New Miocene Family, Tranatocetidae, Brings Perspective on Baleen Whale Evolution	PLOS ONE			English	Article							CETACEA; MYSTICETI; CETOTHERIIDAE; PLIOCENE; PHYLOGENY; MAMMALIA; DENMARK	Miocene baleen whales were highly diverse and included tens of genera. However, their taxonomy and phylogeny, as well as relationships with living whales, are still a subject of controversy. Here, "Mesocetus" argillarius, a poorly known specimen from Denmark, is redescribed with a focus on the cranial anatomy. It was found to represent not only a new genus, Tranatocetus gen. nov., but also a new family; Tranatocetidae. The whales of this family have the rostral bones either overriding or dividing the frontals; the rostral bones are contacting the parietals and nasals dividing the maxillae on the vertex; the occipital shield is dorsoventrally bent. The tympanic bulla is particularly characteristic of this family featuring a short, narrow anterior portion with a rounded or squared anterior end and a wider and higher posterior portion that is swollen in the posteroventral area. A phylogenetic analysis including 51 taxa supports a monophyletic group comprising most Neogene and modern whales, with Tranatocetidae being possibly closer related to Balaenopteridae (rorquals) than to Cetotheriidae. Tranatocetidae exhibit a charahteristic bulla shape. In fact, all Neogene and modern mysticete families examined have a unique shape of the tympanic bulla that is diagnostic at family-level. Inclusion of problematic taxa like Tranatocetus argillarius in phylogenies brings new understanding of the distribution and diagnostic value of character traits. This underlines the need for re-examination of earlier described specimens in the light of the wealth of new information published in later years.	[Gol'din, Pavel; Steeman, Mette Elstrup] Museum Southern Jutland, Dept Nat Hist & Palaeontol, DK-6510 Gram, Denmark		Gol'din, P (corresponding author), Museum Southern Jutland, Dept Nat Hist & Palaeontol, Lergravsvej 2, DK-6510 Gram, Denmark.	pago@museum-sonderjylland.dk	Gol'din, Pavel/C-2061-2016	Gol'din, Pavel/0000-0001-6118-1384; Elstrup, Mette/0000-0003-2285-4368	Ministry of Culture of Denmark [FORM.2014-0033]	Ministry of Culture of Denmark	The work of PG was supported by the Grant of the Ministry of Culture of Denmark, FORM.2014-0033.	Beneden P. J. Van, 1880, Bulletin de l'Academie de Belgique, V(2), P11; Beyer C., 2005, PALAEONTOS, V7, P19; Bisconti M, 2006, J VERTEBR PALEONTOL, V26, P344, DOI 10.1671/0272-4634(2006)26[344:TANBWF]2.0.CO;2; Bisconti M, 2015, J SYST PALAEONTOL, V13, P377, DOI 10.1080/14772019.2014.890136; Bouetel V, 2006, GEODIVERSITAS, V28, P319; Brandt J.F., 1871, B ACAD IMPERIALE SCI, V16, P563; Brandt J.-F., 1873, MEMOIRES LACADEMIE I, V20, P1, DOI DOI 10.5962/BHL.TITLE.39524; COPE ED, 1896, P AM PHILOS SOC, V35, P139; CZYZEWSKA T, 1976, Acta Palaeontologica Polonica, V21, P259; El Adli JJ, 2014, ZOOL J LINN SOC-LOND, V170, P400, DOI 10.1111/zoj.12108; Fordyce Ewan, 2001, P169; Fordyce RE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2645; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; GoL'Din P, 2014, ACTA PALAEONTOL POL, V59, P795, DOI 10.4202/app.2012.0107; Gol'din P, 2014, J VERTEBR PALEONTOL, V34, P419, DOI 10.1080/02724634.2013.799482; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Kasuya T., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P1; Kellogg R, 1940, B LAB MINERALOGICO G, V3, P13; Kellogg R., 1934, CARNEGIE I WASHINGTO, V447, P83; Kellogg R, 1931, P CALIFORNIA ACAD SC, V19, P217; Kellogg R, 2012, KELLOGG ILLUSTRATION; Kimura T, 2010, J VERTEBR PALEONTOL, V30, P577, DOI 10.1080/02724631003621912; Marx FG, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140434; Marx FG, 2011, J MAMM EVOL, V18, P77, DOI 10.1007/s10914-010-9148-4; Mchedlidze G.A., 1984, FOSSIL WHALE MIOCENE; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Piasecki S., 2005, GRAM BOOK PALAEONTOS, V7, P29; Rasmussen L. B., 1966, Danmarks Geologiske Undersogelse Raekke II, V88, P1; ROTH F, 1978, ZOOL SCR, V7, P63, DOI 10.1111/j.1463-6409.1978.tb00589.x; Sanders Albert E., 2002, Smithsonian Contributions to Paleobiology, V93, P313; Schnetler K.I., 2005, Palaeontos, V7, P62; Schulte H.W, 1916, MEM AM MUS NATUR HIS, V1, P391; Steeman ME, 2009, PALAEONTOLOGY, V52, P1169, DOI 10.1111/j.1475-4983.2009.00893.x; Steeman ME, 2007, ZOOL J LINN SOC-LOND, V150, P875, DOI 10.1111/j.1096-3642.2007.00313.x; Steeman ME, 2010, J SYST PALAEONTOL, V8, P63, DOI 10.1080/14772011003594961; Tsai CH, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0875; Van Beneden P.-J., 1880, OSTEOGRAPHIE CETACES; Van Beneden P. J., 1886, ANN MUSEE ROYAL HIST, V13, P1; Van Beneden P-J., 1859, B ACAD ROYALE SCI LE, V8, P123; Vandelli AA, 1831, HIST MEMORIAS ACAD R, V2, P281	41	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135500	10.1371/journal.pone.0135500	http://dx.doi.org/10.1371/journal.pone.0135500			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331471	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800031
J	Gray, CA; Runyon, JB; Jenkins, MJ; Giunta, AD				Gray, Curtis A.; Runyon, Justin B.; Jenkins, Michael J.; Giunta, Andrew D.			Mountain Pine Beetles Use Volatile Cues to Locate Host Limber Pine and Avoid Non-Host Great Basin Bristlecone Pine	PLOS ONE			English	Article							DENDROCTONUS-PONDEROSAE COLEOPTERA; LODGEPOLE PINE; HOPKINS COLEOPTERA; SCOLYTIDAE; MONOTERPENES; ORIENTATION; INTEGRATION; PHEROMONES; RESPONSES; OUTBREAKS	The tree-killing mountain pine beetle (Dendroctonus ponderosae Hopkins) is an important disturbance agent of western North American forests and recent outbreaks have affected tens of millions of hectares of trees. Most western North American pines (Pinus spp.) are hosts and are successfully attacked by mountain pine beetles whereas a handful of pine species are not suitable hosts and are rarely attacked. How pioneering females locate host trees is not well understood, with prevailing theory involving random landings and/or visual cues. Here we show that female mountain pine beetles orient toward volatile organic compounds (VOCs) from host limber pine (Pinus flexilis James) and away from VOCs of non-host Great Basin bristlecone pine (Pinus longaeva Bailey) in a Y-tube olfactometer. When presented with VOCs of both trees, females overwhelmingly choose limber pine over Great Basin bristlecone pine. Analysis of VOCs collected from co-occurring limber and Great Basin bristlecone pine trees revealed only a few quantitative differences. Noticeable differences included the monoterpenes 3-carene and D-limonene which were produced in greater amounts by host limber pine. We found no evidence that 3-carene is important for beetles when selecting trees, it was not attractive alone and its addition to Great Basin bristlecone pine VOCs did not alter female selection. However, addition of D-limonene to Great Basin bristlecone pine VOCs disrupted the ability of beetles to distinguish between tree species. When presented alone, D-limonene did not affect behavior, suggesting that the response is mediated by multiple compounds. A better understanding of host selection by mountain pine beetles could improve strategies for managing this important forest insect. Moreover, elucidating how Great Basin bristlecone pine escapes attack by mountain pine beetles could provide insight into mechanisms underlying the incredible longevity of this tree species.	[Gray, Curtis A.; Jenkins, Michael J.; Giunta, Andrew D.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Runyon, Justin B.] US Forest Serv, USDA, Rocky Mt Res Stn, Forestry Sci Lab, Bozeman, MT USA	Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); United States Forest Service	Gray, CA (corresponding author), Utah State Univ, Dept Wildland Resources, 5230 Old Main Hill, Logan, UT 84322 USA.	curtis.gray@aggiemail.usu.edu			USFS EM Project [INT-EM-F-10-02]; Utah Agricultural Experiment Station (UAES) UTA Project [1070]; USDA National Needs Graduate Fellowship Competitive NIFA Grant; PECASE (President's Early Career Award in Science and Engineering)	USFS EM Project; Utah Agricultural Experiment Station (UAES) UTA Project; USDA National Needs Graduate Fellowship Competitive NIFA Grant; PECASE (President's Early Career Award in Science and Engineering)	This project was supported by funding from USFS EM Project INT-EM-F-10-02, Utah Agricultural Experiment Station (UAES) UTA Project 1070, USDA National Needs Graduate Fellowship Competitive NIFA Grant, and PECASE (President's Early Career Award in Science and Engineering) to Justin Runyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister D, 2006, ECOLOGY, V87, P1816, DOI 10.1890/0012-9658(2006)87[1816:FBPFDS]2.0.CO;2; BILLINGS RF, 1976, ENVIRON ENTOMOL, V5, P171, DOI 10.1093/ee/5.1.171; Borden J, 1986, MECH INSECT OLFACTIO; Borden JH, 2008, J ECON ENTOMOL, V101, P1266, DOI 10.1603/0022-0493(2008)101[1266:SBOMFA]2.0.CO;2; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; BURNELL DG, 1977, RES POPUL ECOL, V19, P99, DOI 10.1007/BF02510942; Campbell SA, 2006, ECOL ENTOMOL, V31, P437, DOI 10.1111/j.1365-2311.2006.00809.x; Campbell SA, 2009, OIKOS, V118, P553, DOI 10.1111/j.1600-0706.2009.16761.x; Daisy BH, 2002, MICROBIOL-SGM, V148, P3737, DOI 10.1099/00221287-148-11-3737; Gibson K., 2008, MOUNTAIN PINE BEETLE; Griffin JM, 2011, FOREST ECOL MANAG, V261, P1077, DOI 10.1016/j.foreco.2010.12.031; Hansen EM, 2014, FOREST SCI, V60, P476, DOI 10.5849/forsci.13-039; HUNT DWA, 1989, CAN J FOREST RES, V19, P1275, DOI 10.1139/x89-194; HYNUM BG, 1980, CAN ENTOMOL, V112, P185, DOI 10.4039/Ent112185-2; Jenkins MJ, 2014, FOREST SCI, V60, P489, DOI 10.5849/forsci.13-017; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LANGOR DW, 1989, CAN ENTOMOL, V121, P149, DOI 10.4039/Ent121149-2; Liu ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022005; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; LYON R. L., 1958, CANADIAN ENT, V90, P582; Man G, 2010, MAJOR FOREST INSECT; MOECK HA, 1991, CAN ENTOMOL, V123, P299, DOI 10.4039/Ent123299-2; Page WG, 2014, FOREST SCI, V60, P691, DOI 10.5849/forsci.13-050; Page WG, 2012, CAN J FOREST RES, V42, P1631, DOI [10.1139/X2012-094, 10.1139/x2012-094]; Piesik D, 2008, AGR FOREST ENTOMOL, V10, P245, DOI 10.1111/j.1461-9563.2008.00380.x; PITMAN GB, 1968, NATURE, V218, P168, DOI 10.1038/218168a0; Progar RA, 2014, FOREST SCI, V60, P414, DOI 10.5849/forsci.13-010; Pureswaran DS, 2004, CHEMOECOLOGY, V14, P59, DOI 10.1007/s00049-003-0261-1; Pureswaran DS, 2004, BIOCHEM SYST ECOL, V32, P1109, DOI 10.1016/j.bse.2004.04.006; R Development Core Team, 2012, R LANG ENV STAT COMP; Raffa Kenneth F., 1993, P103; RUDINSKY JA, 1966, SCIENCE, V152, P218, DOI 10.1126/science.152.3719.218; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Saab VA, 2014, FOREST SCI, V60, P539, DOI 10.5849/forsci.13-022; Safranyik L, 2004, FOREST ECOL MANAG, V200, P23, DOI 10.1016/j.foreco.2004.06.004; Safranyik L., 2007, BIOL EPIDEMIOLOGY MO, P3; Schoettle AW, 2004, RMRSP32 USDA FOR SER, P124; SHEPHERD RF, 1966, CAN ENTOMOL, V98, P507, DOI 10.4039/Ent98507-5; Sokal R. R., 1981, BIOMETRY; Stritch L, 2011, PINUS LONGAEVA IUCN; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; VISSER JH, 1978, ENTOMOL EXP APPL, V24, P738, DOI 10.1007/BF02385130; Vite JP, 1962, CONTRIB BOYCE THOMPS, V21, P3; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Youngblood AP, 1985, INT187 USDA FOR SERV	45	27	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135752	10.1371/journal.pone.0135752	http://dx.doi.org/10.1371/journal.pone.0135752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332317	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800039
J	Jeruschke, S; Jeruschke, K; DiStasio, A; Karaterzi, S; Buscher, AK; Nalbant, P; Klein-Hitpass, L; Hoyer, PF; Weiss, J; Stottmann, RW; Weber, S				Jeruschke, Stefanie; Jeruschke, Kay; DiStasio, Andrew; Karaterzi, Sinem; Buescher, Anja K.; Nalbant, Perihan; Klein-Hitpass, Ludger; Hoyer, Peter F.; Weiss, Juergen; Stottmann, Rolf W.; Weber, Stefanie			Everolimus Stabilizes Podocyte Microtubules via Enhancing TUBB2B and DCDC2 Expression	PLOS ONE			English	Article							MORPHOGENETIC ACTIVITY; ACTIN CYTOSKELETON; DCX SUPERFAMILY; RAT-KIDNEY; DOUBLECORTIN; PROTEIN; GENE; MUTATIONS; CELLS; MOUSE	Background Glomerular podocytes are highly differentiated cells that are key components of the kidney filtration units. The podocyte cytoskeleton builds the basis for the dynamic podocyte cytoarchitecture and plays a central role for proper podocyte function. Recent studies implicate that immunosuppressive agents including the mTOR-inhibitor everolimus have a protective role directly on the stability of the podocyte actin cytoskeleton. In contrast, a potential stabilization of microtubules by everolimus has not been studied so far. Methods To elucidate mechanisms underlying mTOR-inhibitor mediated cytoskeletal rearrangements, we carried out microarray gene expression studies to identify target genes and corresponding pathways in response to everolimus. We analyzed the effect of everolimus in a puromycin aminonucleoside experimental in vitro model of podocyte injury. Results Upon treatment with puromycin aminonucleoside, microarray analysis revealed gene clusters involved in cytoskeletal reorganization, cell adhesion, migration and extracellular matrix composition to be affected. Everolimus was capable of protecting podocytes from injury, both on transcriptional and protein level. Rescued genes included tubulin beta 2B class IIb (TUBB2B) and doublecortin domain containing 2 (DCDC2), both involved in microtubule structure formation in neuronal cells but not identified in podocytes so far. Validating gene expression data, Western-blot analysis in cultured podocytes demonstrated an increase of TUBB2B and DCDC2 protein after everolimus treatment, and immunohistochemistry in healthy control kidneys confirmed a podocyte-specific expression. Interestingly, Tubb2(bbrdp/brdp) mice revealed a delay in glomerular podocyte development as showed by podocyte-specific markers Wilm's tumour 1, Podocin, Nephrin and Synaptopodin. Conclusions Taken together, our study suggests that off-target, non-immune mediated effects of the mTOR-inhibitor everolimus on the podocyte cytoskeleton might involve regulation of microtubules, revealing a potential novel role of TUBB2B and DCDC2 in glomerular podocyte development.	[Jeruschke, Stefanie; Karaterzi, Sinem; Buescher, Anja K.; Hoyer, Peter F.; Weber, Stefanie] Univ Hosp Essen, Pediat Nephrol, Pediat 2, Essen, Germany; [Jeruschke, Kay; Weiss, Juergen] German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Dusseldorf, Germany; [DiStasio, Andrew; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [DiStasio, Andrew; Stottmann, Rolf W.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Nalbant, Perihan] Univ Duisburg Essen, Ctr Med Biotechnol, Mol Cell Biol, Essen, Germany; [Klein-Hitpass, Ludger] Univ Duisburg Essen, Inst Cell Biol, Essen, Germany	University of Duisburg Essen; Deutsches Diabetes-Zentrum (DDZ); Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Duisburg Essen; University of Duisburg Essen	Jeruschke, S (corresponding author), Univ Hosp Essen, Pediat Nephrol, Pediat 2, Essen, Germany.	Stefanie.Jeruschke@uk-essen.de	Stottmann, Rolf/GRO-3453-2022; Stottmann, Rolf/U-6589-2019	Stottmann, Rolf/0000-0003-4512-6806; 	Deutsche Forschungsgemeinschaft [BU 2602/3-1]; Forschungsunterstuttzungskreis Kindernephrologie e. V	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsunterstuttzungskreis Kindernephrologie e. V	AKB and SW received financial support from the Deutsche Forschungsgemeinschaft (BU 2602/3-1) and Stefanie Jeruschke from the Forschungsunterstuttzungskreis Kindernephrologie e. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PM, 1981, KIDNEY INT, V20, P549, DOI 10.1038/ki.1981.176; ANDREWS PM, 1977, AM J ANAT, V150, P53, DOI 10.1002/aja.1001500104; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; Breuss M, 2014, ADV EXP MED BIOL, V800, P75, DOI 10.1007/978-94-007-7687-6_5; Buscher AK, 2012, EUR J PEDIATR, V171, P1151, DOI 10.1007/s00431-011-1668-2; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Cong EH, 2014, J AM SOC NEPHROL, V25, P2435, DOI 10.1681/ASN.2013101126; Coquelle FM, 2006, CELL CYCLE, V5, P976, DOI 10.4161/cc.5.9.2715; Cortes P, 2000, KIDNEY INT, V58, P2452, DOI 10.1046/j.1523-1755.2000.00428.x; Dehmelt L, 2006, BRAIN CELL BIOL, V35, P39, DOI 10.1007/s11068-006-9001-0; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; FARQUHAR MG, 1957, J EXP MED, V106, P649, DOI 10.1084/jem.106.5.649; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2011, ACTA NEUROPATHOL, V121, P149, DOI 10.1007/s00401-010-0768-9; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jeruschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055980; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; KERJASCHKI D, 1978, LAB INVEST, V39, P430; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kobayashi N, 1998, J CELL BIOL, V143, P1961, DOI 10.1083/jcb.143.7.1961; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Kobayashi N, 2000, BIOCHEM BIOPH RES CO, V268, P306, DOI 10.1006/bbrc.2000.2126; Kobayashi N, 2001, MARC MALPIG SYMP SER, V7, P423; Kobayashi N, 2001, HISTOCHEM CELL BIOL, V115, P255; Liu JS, 2012, MOL CELL, V47, P707, DOI 10.1016/j.molcel.2012.06.025; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Reiner O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-188; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Scaife RM, 2003, MOL BIOL CELL, V14, P4605, DOI 10.1091/mbc.E02-11-0739; Schueler M, 2015, AM J HUM GENET, V96, P81, DOI 10.1016/j.ajhg.2014.12.002; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Stottmann RW, 2013, HUM MOL GENET, V22, P4053, DOI 10.1093/hmg/ddt255; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; TYSON GE, 1977, VIRCHOWS ARCH B, V25, P105; VASMANT D, 1984, ANAT REC, V210, P17, DOI 10.1002/ar.1092100104; VILLASANTE A, 1986, MOL CELL BIOL, V6, P2409, DOI 10.1128/MCB.6.7.2409; WANG D, 1986, J CELL BIOL, V103, P1903, DOI 10.1083/jcb.103.5.1903; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Weiner JA, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00004; WHITESIDE CI, 1993, AM J PATHOL, V142, P1641; Yuan HP, 2002, AM J PHYSIOL-RENAL, V282, pF585, DOI 10.1152/ajprenal.00290.2001	57	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137043	10.1371/journal.pone.0137043	http://dx.doi.org/10.1371/journal.pone.0137043			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331477	gold, Green Published, Green Submitted			2022-12-27	WOS:000360613800091
J	Sun, CJ; Lu, J; Yi, GQ; Yuan, JW; Duan, ZY; Qu, LJ; Xu, GY; Wang, KH; Yang, N				Sun, Congjiao; Lu, Jian; Yi, Guoqiang; Yuan, Jingwei; Duan, Zhongyi; Qu, Lujiang; Xu, Guiyun; Wang, Kehua; Yang, Ning			Promising Loci and Genes for Yolk and Ovary Weight in Chickens Revealed by a Genome-Wide Association Study	PLOS ONE			English	Article							EGG-YOLK; RECEPTOR; HENS; LIPOPROTEIN; ABSORPTION; PROTEINS; QUALITY; START; ZAR1	Because it serves as the cytoplasm of the oocyte and provides a large amount of reserves, the egg yolk has biological significance for developing embryos. The ovary and its hierarchy of follicles are the main reproductive organs responsible for yolk deposition in chickens. However, the genetic architecture underlying the yolk and ovarian follicle weights remains elusive. Here, we measured the yolk weight (YW) at 11 age points from onset of egg laying to 72 weeks of age and measured the follicle weight (FW) and ovary weight (OW) at 73 weeks as part of a comprehensive genome-wide association study (GWAS) in 1,534 F-2 hens derived from reciprocal crosses between White Leghorn (WL) and Dongxiang chickens (DX). For all ages, YWs exhibited moderate single nucleotide polymorphism (SNP)-based heritability estimates (0.25-0.38), while the estimates for FW (0.16) and OW (0.20) were relatively low. Independent univariate genome-wide screens for each trait identified 12, 3, and 31 novel significant associations with YW, FW, and OW, respectively. A list of candidate genes such as ZAR1, STARD13, ACER1b, ACSBG2, and DHRS12 were identified for having a plausible function in yolk and follicle development. These genes are important to the initiation of embryogenesis, lipid transport, lipoprotein synthesis, lipid droplet promotion, and steroid hormone metabolism, respectively. Our study provides for the first time a genome-wide association (GWA) analysis for follicle and ovary weight. Identification of the promising loci as well as potential candidate genes will greatly advance our understanding of the genetic basis underlying dynamic yolk weight and ovarian follicle development and has practical significance in breeding programs for the alteration of yolk weight at different age points.	[Sun, Congjiao; Yi, Guoqiang; Yuan, Jingwei; Duan, Zhongyi; Qu, Lujiang; Xu, Guiyun; Yang, Ning] China Agr Univ, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Sun, Congjiao; Yi, Guoqiang; Yuan, Jingwei; Duan, Zhongyi; Qu, Lujiang; Xu, Guiyun; Yang, Ning] China Agr Univ, MOA Key Lab Anim Genet & Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Lu, Jian; Wang, Kehua] Jiangsu Inst Poultry Sci, Yangzhou, Jiangsu, Peoples R China	China Agricultural University; China Agricultural University	Yang, N (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	nyang@cau.edu.cn		Yang, Ning/0000-0001-5772-3320	National Natural Science Foundation of China [31472084]; National High Technology Development Plan of China [2013AA102501]; Programs for Changjiang Scholars and Innovative Research in University [IRT1191]; China Agriculture Research Systems [CARS-41]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Development Plan of China(National High Technology Research and Development Program of China); Programs for Changjiang Scholars and Innovative Research in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China Agriculture Research Systems	The current research was funded in part by the National Natural Science Foundation of China (31472084), the National High Technology Development Plan of China (2013AA102501), Programs for Changjiang Scholars and Innovative Research in University (IRT1191), and China Agriculture Research Systems (CARS-41).	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Anton M, 2005, P 17 EUR S QUAL POUL, V62, P429; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bakowska JC, 2007, MOL BIOL CELL, V18, P1683, DOI 10.1091/mbc.E06-09-0833; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brooke RE, 2004, EUR J NEUROSCI, V20, P3313, DOI 10.1111/j.1460-9568.2004.03730.x; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burley R., 1989, AVIAN EGG CHEM BIOL; D'Andre HC, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-43; DEELEY RG, 1985, CAN J BIOCHEM CELL B, V63, P882, DOI 10.1139/o85-109; EVANS AJ, 1987, J BIOL CHEM, V262, P501; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; GEORGE R, 1987, J BIOL CHEM, V262, P16838; Hartmann C, 2001, WORLD POULTRY SCI J, V57, P13, DOI 10.1079/WPS20010003; Humphrey HHC, 2001, BIOL REPROD, V64, P390, DOI 10.1095/biolreprod64.1.390; Kinsella RJ, 2011, DATABASE-OXFORD, V2011, P56; Kovacs-Nolan J, 2005, J AGR FOOD CHEM, V53, P8421, DOI 10.1021/jf050964f; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Liu W, 2011, PLOS ONE, V6, P1427; MACLACHLAN I, 1994, J BIOL CHEM, V269, P24127; Mann K, 2008, PROTEOMICS, V8, P178, DOI 10.1002/pmic.200700790; Maritzen T, 2010, TRAFFIC, V11, P8, DOI 10.1111/j.1600-0854.2009.00971.x; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Michailidis G, 2010, VET RES COMMUN, V34, P173, DOI 10.1007/s11259-010-9343-z; Mine Y, 2006, WORLD POULTRY SCI J, V62, P87, DOI 10.1079/WPS200586; Nangsuay A, 2011, POULTRY SCI, V90, P2648, DOI 10.3382/ps.2011-01415; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; Nimpf J, 1998, ATHEROSCLEROSIS, V141, P191, DOI 10.1016/S0021-9150(98)00172-5; ODLIND V, 1995, ACTA ONCOL, V34, P53, DOI 10.3109/02841869509094059; Onagbesan O, 2009, ANIM REPROD SCI, V111, P121, DOI 10.1016/j.anireprosci.2008.09.017; Penning TM, 2003, HUM REPROD UPDATE, V9, P193, DOI 10.1093/humupd/dmg022; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sasaki O, 2004, ANIM GENET, V35, P188, DOI 10.1111/j.1365-2052.2004.01133.x; SHEN XY, 1993, CELL TISSUE RES, V272, P459, DOI 10.1007/BF00318552; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Suk YO, 2001, POULTRY SCI, V80, P855, DOI 10.1093/ps/80.7.855; Tuiskula-Haavisto M, 2002, POULTRY SCI, V81, P919, DOI 10.1093/ps/81.7.919; Van Immerseel F., 2011, IMPROVING SAFETY QUA, V2, DOI [10.1533/9780857093929, DOI 10.1533/9780857093929]; Wang YJ, 2007, ENDOCRINOLOGY, V148, P3426, DOI 10.1210/en.2006-1383; Wenger DA, 1997, HUM MUTAT, V10, P268, DOI 10.1002/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D; Wolc A, 2014, J ANIM BREED GENET, V131, P173, DOI 10.1111/jbg.12086; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Wu XM, 2003, BIOL REPROD, V69, P861, DOI 10.1095/biolreprod.103.016022; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhao J. H., 2014, GAP GENETIC ANAL PAC; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	48	26	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137145	10.1371/journal.pone.0137145	http://dx.doi.org/10.1371/journal.pone.0137145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332579	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800102
J	Nakayama, A; Morita, H; Nakao, T; Yamaguchi, T; Sumida, T; Ikeda, Y; Kumagai, H; Motozawa, Y; Takahashi, T; Imaizumi, A; Hashimoto, T; Nagai, R; Komuro, I				Nakayama, Atsuko; Morita, Hiroyuki; Nakao, Tomoko; Yamaguchi, Toshihiro; Sumida, Tomokazu; Ikeda, Yuichi; Kumagai, Hidetoshi; Motozawa, Yoshihiro; Takahashi, Tsukasa; Imaizumi, Atsushi; Hashimoto, Tadashi; Nagai, Ryozo; Komuro, Issei			A Food-Derived Flavonoid Luteolin Protects against Angiotensin II-Induced Cardiac Remodeling	PLOS ONE			English	Article							HUMAN HYPERTROPHIC CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; OXIDATIVE STRESS; HEART-FAILURE; GENE-EXPRESSION; NADPH OXIDASE; MOUSE MODEL; TGF-BETA; RATS; FIBROBLASTS	Oxidative stress has been implicated in cardiac remodeling (cardiac fibrosis and hypertrophy), which impairs cardiac function and metabolism; therefore, it is anticipated antioxidative compounds will have protective properties against cardiac remodeling. Luteolin (3',4',5,7-tetrahydroxyflavone), a widely distributed flavonoid found in many herbal extracts including celery, green pepper, perilla leaves and seeds, and chamomile, is a known to be a potent antioxidant and was previously demonstrated to exert an antifibrotic effect in the lungs and the liver. In this study, we clearly demonstrate that oral pretreatment with the higher-luteolin diet (0.035% (wt/wt)) protected against cardiac fibrosis and hypertrophy as well as a hyperoxidative state in Ang II-infused rats. In cardiac tissue, increased gene expression levels of TGF beta 1, CTGF, Nox2, Nox4, ANP, and BNP induced by Ang II were restored by oral pretreatment of this high-luteolin diet. In cultured rat cardiac fibroblasts, H2O2-induced TGF beta 1 expression and the phosphorylation of JNK were suppressed by luteolin pretreatment. In conclusion, food-derived luteolin has protective actions against Ang II-induced cardiac remodeling, which could be mediated through attenuation of oxidative stress.	[Nakayama, Atsuko; Nakao, Tomoko; Yamaguchi, Toshihiro; Sumida, Tomokazu; Ikeda, Yuichi; Kumagai, Hidetoshi; Motozawa, Yoshihiro; Nagai, Ryozo; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Morita, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Translat Res Healthcare & Clin Sci, Tokyo, Japan; [Takahashi, Tsukasa; Imaizumi, Atsushi; Hashimoto, Tadashi] Theravalues Corp, Tokyo, Japan	University of Tokyo; University of Tokyo	Morita, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Translat Res Healthcare & Clin Sci, Tokyo, Japan.	hmrt-tky@umin.net		Sumida, Tomokazu/0000-0002-9806-2642	Theravalues Corporation (Tokyo, Japan)	Theravalues Corporation (Tokyo, Japan)	This research is supported by the Theravalues Corporation (Tokyo, Japan). The funder provided support in the form of salaries for authors TT, AI, TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ago T, 2011, CIRC J, V75, P1791, DOI 10.1253/circj.CJ-11-0388; Ando C, 2009, FEBS LETT, V583, P3649, DOI 10.1016/j.febslet.2009.10.045; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388; Brilla CG, 2000, CARDIOVASC RES, V47, P1, DOI 10.1016/S0008-6363(00)00092-4; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chen CY, 2010, J AGR FOOD CHEM, V58, P11653, DOI 10.1021/jf1031668; Cheng TH, 2003, J AM COLL CARDIOL, V42, P1845, DOI 10.1016/j.jacc.2003.06.010; Diez J, 2002, CIRCULATION, V105, P2512, DOI 10.1161/01.CIR.0000017264.66561.3D; Diez J, 2001, CURR OPIN CARDIOL, V16, P328, DOI 10.1097/00001573-200111000-00003; Diez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Domitrovic R, 2009, TOXICOL APPL PHARM, V241, P311, DOI 10.1016/j.taap.2009.09.001; Juric D, 2007, AM J PHYSIOL-HEART C, V292, pH2138, DOI 10.1152/ajpheart.00852.2006; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; Li LP, 2013, PHARMAZIE, V68, P195, DOI 10.1691/ph.2013.2744; Liao PH, 2011, CIRC J, V75, P443, DOI 10.1253/circj.CJ-10-0381; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Lombardi R, 2009, CIRCULATION, V119, P1398, DOI 10.1161/CIRCULATIONAHA.108.790501; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Marian AJ, 2006, J AM COLL CARDIOL, V47, P827, DOI 10.1016/j.jacc.2005.10.041; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Okada H, 2005, CIRCULATION, V111, P2430, DOI 10.1161/01.CIR.0000165066.71481.8E; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Shimoi K, 1998, FEBS LETT, V438, P220, DOI 10.1016/S0014-5793(98)01304-0; Sia YT, 2002, CIRCULATION, V105, P2549, DOI 10.1161/01.CIR.0000016721.84535.00; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Sumitomo-Ueda Y, 2010, HYPERTENSION, V56, P430, DOI 10.1161/HYPERTENSIONAHA.110.152207; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Werner Christian M, 2008, Ther Adv Cardiovasc Dis, V2, P167, DOI 10.1177/1753944708091777; Yu CM, 2001, J AM COLL CARDIOL, V38, P1207, DOI 10.1016/S0735-1097(01)01518-2; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; Zhang P, 2011, AM J PHYSIOL-HEART C, V301, pH147, DOI 10.1152/ajpheart.00026.2011; Zhang W, 2012, CLIN EXP PHARMACOL P, V39, P429, DOI 10.1111/j.1440-1681.2012.05692.x; Zhao WY, 2008, MOL CELL BIOCHEM, V317, P43, DOI 10.1007/s11010-008-9803-8	44	13	15	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137106	10.1371/journal.pone.0137106	http://dx.doi.org/10.1371/journal.pone.0137106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327560	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700097
J	Li, Y; Zhang, W; Wang, RG; Wang, PL; Su, XO				Li, Yang; Zhang, Wei; Wang, Rui-Guo; Wang, Pei-Long; Su, Xiao-Ou			Development of a Efficient and Sensitive Dispersive Liquid-Liquid Microextraction Technique for Extraction and Preconcentration of 10 beta(2)-Agonists in Animal Urine	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; BETA-ADRENERGIC AGONISTS; PHASE MICROEXTRACTION; WATER SAMPLES; CAPILLARY-ELECTROPHORESIS; GAS-CHROMATOGRAPHY; PERFORMANCE; LIVER; CLENBUTEROL; BOVINE	Dispersive liquid-liquid microextraction (DLLME) coupled with ultra-performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS) was developed for the extraction and determination of 10 beta(2)-agonists in animal urine. Some experimental parameters, such as the type and volume of the extraction solvent, the concentration of the dispersant, the salt concentration, the pH value of the sample solution, the extraction time and the speed of centrifugation, were investigated and optimized. Under the optimized conditions, a good enrichment factors (4.8 to 32.3) were obtained for the extraction. The enrichment factor show that the concentration rate of DLLME is significantly higher than other pretreatment methods, and the detection sensitivity has been greatly improved. The calibration curves were linear, the correlation coefficient ranged from 0.9928 to 0.9999 for the concentration range of 0.05 to 50 ngmL(-1) and 0.1 to 50 ngmL(-1), and the relative standard deviations (RSDs, n = 15, intra and inter-day precision) at a concentration of 5 ngmL(-1) were in the range of 1.8 to 14.6%. The limits of detection (LODs) for the 10 beta(2)-agonists, based on a signal-to-noise ratio (S/N) of 3, were in the range of 0.01 to 0.03 ngmL(-1). The proposed method was used to identify beta(2)-agonists in three types of animal urine (swine, cattle, sheep), and the relative recoveries from each matrix were in the range of 89.2 to 106.8%, 90.0 to 109.8% and 89.2 to 107.2%, respectively.	[Li, Yang; Zhang, Wei; Wang, Rui-Guo; Wang, Pei-Long; Su, Xiao-Ou] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Su, XO (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Beijing 100193, Peoples R China.	suxiaoou@caas.cn	Wang, Peilong/R-4412-2016; Li, Xiaomin/ABI-2638-2020	Wang, Peilong/0000-0003-1585-2727; 	Special Fund for Agro-scientific Research in the Public Interest of China [201203088-01]	Special Fund for Agro-scientific Research in the Public Interest of China	The authors received financial support from the Special Fund for Agro-scientific Research in the Public Interest of China (No. 201203088-01).	Amendola L, 2002, J CHROMATOGR B, V773, P7, DOI 10.1016/S1570-0232(02)00141-1; Antignac JP, 2003, ANAL CHIM ACTA, V483, P325, DOI 10.1016/S0003-2670(02)01379-X; Assadi Y, 2010, CHROMATOGRAPHIA, V71, P1137, DOI 10.1365/s10337-010-1616-8; Bidari A, 2011, FOOD CHEM, V126, P1840, DOI 10.1016/j.foodchem.2010.11.142; Bocca B, 2003, J AOAC INT, V86, P8; Caban M, 2011, J CHROMATOGR A, V1218, P8110, DOI 10.1016/j.chroma.2011.08.093; Caldas SS, 2010, ANAL CHIM ACTA, V665, P55, DOI 10.1016/j.aca.2010.03.004; Campone L, 2011, J CHROMATOGR A, V1218, P7648, DOI 10.1016/j.chroma.2011.05.028; Chan TYK, 1999, J TOXICOL-CLIN TOXIC, V37, P517, DOI 10.1081/CLT-100102525; Chang LY, 2005, J FOOD DRUG ANAL, V13, P163; Chen H, 2010, J CHROMATOGR A, V1217, P1244, DOI 10.1016/j.chroma.2009.12.062; Chen HX, 2009, ANAL CHIM ACTA, V632, P80, DOI 10.1016/j.aca.2008.10.068; Crescenzi C, 2001, ANAL CHEM, V73, P2171, DOI 10.1021/ac0014360; Ebrahimzadeh H, 2008, J CHROMATOGR B, V863, P229, DOI 10.1016/j.jchromb.2008.01.005; Fu LY, 2009, ANAL CHIM ACTA, V632, P289, DOI 10.1016/j.aca.2008.11.020; Gonzalez-Penas E, 2004, J CHROMATOGR A, V1025, P163, DOI 10.1016/j.chroma.2003.10.113; Haasnoot W, 2002, ANALYST, V127, P87, DOI 10.1039/b108885h; He LJ, 2009, ANAL CHIM ACTA, V655, P52, DOI 10.1016/j.aca.2009.09.044; Herrera-Herrera AV, 2010, TRAC-TREND ANAL CHEM, V29, P728, DOI 10.1016/j.trac.2010.03.016; Kootstra PR, 2005, ANAL CHIM ACTA, V529, P75, DOI 10.1016/j.aca.2004.09.053; Lehner AF, 2004, CHROMATOGRAPHIA, V59, pS79, DOI 10.1365/s10337-004-0249-1; Li JQ, 2013, J CONTROL SCI ENG, V2013, DOI 10.1155/2013/657182; Liu Y, 2009, J CHROMATOGR A, V1216, P885, DOI 10.1016/j.chroma.2008.11.076; Lv LL, 2010, J CHROMATOGR A, V1217, P2365, DOI 10.1016/j.chroma.2010.01.081; Mazzanti G, 2003, TOXICOLOGY, V187, P91, DOI 10.1016/S0300-483X(03)00059-3; Mirzaei M, 2011, J HAZARD MATER, V186, P1739, DOI 10.1016/j.jhazmat.2010.12.080; Mitchell GA, 1998, J ANIM SCI, V76, P208; Moema D, 2012, ANAL CHIM ACTA, V730, P80, DOI 10.1016/j.aca.2011.11.036; Moragues F, 2009, ANAL CHIM ACTA, V637, P193, DOI 10.1016/j.aca.2008.10.065; Nicoli R, 2013, J CHROMATOGR A, V1292, P142, DOI 10.1016/j.chroma.2012.12.008; Nielen MWF, 2008, ANAL BIOANAL CHEM, V391, P199, DOI 10.1007/s00216-007-1760-7; Nuhu AA, 2011, J CHROMATOGR B, V879, P1180, DOI 10.1016/j.jchromb.2011.02.009; Ravelo-Perez LM, 2009, J CHROMATOGR A, V1216, P7336, DOI 10.1016/j.chroma.2009.08.012; Rezaee M, 2009, J CHROMATOGR A, V1216, P1511, DOI 10.1016/j.chroma.2008.12.091; Rezaee M, 2006, J CHROMATOGR A, V1116, P1, DOI 10.1016/j.chroma.2006.03.007; Shao B, 2009, FOOD CHEM, V114, P1115, DOI 10.1016/j.foodchem.2008.10.063; Shelver WL, 2002, J AGR FOOD CHEM, V50, P2742, DOI 10.1021/jf011372+; Sheu SY, 2009, ANAL CHIM ACTA, V654, P148, DOI 10.1016/j.aca.2009.09.026; Pena MT, 2009, J CHROMATOGR A, V1216, P6356, DOI 10.1016/j.chroma.2009.07.032; Traynor IM, 2003, ANAL CHIM ACTA, V483, P187, DOI 10.1016/S0003-2670(03)00256-3; Us MF, 2013, ELECTROPHORESIS, V34, P854, DOI 10.1002/elps.201200348; Waldeck B, 2002, EUR J PHARMACOL, V445, P1, DOI 10.1016/S0014-2999(02)01728-4; Wang L, 2010, CHROMATOGRAPHIA, V71, P737, DOI 10.1365/s10337-010-1495-z; Wang WY, 2010, MEAT SCI, V85, P302, DOI 10.1016/j.meatsci.2010.01.018; Wang Y, 2010, J CHROMATOGR A, V1217, P4241, DOI 10.1016/j.chroma.2010.03.031; Williams LD, 2004, J CHROMATOGR B, V813, P35, DOI 10.1016/j.jchromb.2004.09.005; Yamini Y, 2006, J CHROMATOGR A, V1124, P57, DOI 10.1016/j.chroma.2006.05.001; Zhang JH, 2011, J CHROMATOGR A, V1218, P6621, DOI 10.1016/j.chroma.2011.07.102; Zhang ZH, 2008, ANAL CHIM ACTA, V621, P185, DOI 10.1016/j.aca.2008.05.016	49	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137194	10.1371/journal.pone.0137194	http://dx.doi.org/10.1371/journal.pone.0137194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348922	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600024
J	Aribi, M; Meziane, W; Habi, S; Boulatika, Y; Marchandin, H; Aymeric, JL				Aribi, Mourad; Meziane, Warda; Habi, Salim; Boulatika, Yasser; Marchandin, Helene; Aymeric, Jean-Luc			Macrophage Bactericidal Activities against Staphylococcus aureus Are Enhanced In Vivo by Selenium Supplementation in a Dose-Dependent Manner	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; CHEMOTAXIS INHIBITORY PROTEIN; MOUSE PERITONEAL-MACROPHAGES; REACTIVE OXYGEN; DOWN-REGULATION; CUTTING EDGE; L-ARGININE; ACTIVATION; EXPRESSION	Background Dietary selenium is of fundamental importance to maintain optimal immune function and enhance immunity during infection. To this end, we examined the effect of selenium on macrophage bactericidal activities against Staphylococcus aureus. Methods Assays were performed in golden Syrian hamsters and peritoneal macrophages cultured with S. aureus and different concentrations of selenium. Results Infected and selenium-supplemented animals have significantly decreased levels of serum nitric oxide (NO) production when compared with infected but non-selenium-supplemented animals at day 7 post-infection (p < 0.05). A low dose of 5 ng/mL selenium induced a significant decrease in macrophage NO production, but significant increase in hydrogen peroxide (H2O2) levels (respectively, p = 0.009, p < 0.001). The NO production and H2O2 levels were significantly increased with increasing concentrations of selenium; the optimal macrophage activity levels were reached at 20 ng/mL. The concentration of 5 ng/mL of selenium induced a significant decrease in the bacterial arginase activity but a significant increase in the macrophage arginase activity. The dose of 20 ng/mL selenium induced a significant decrease of bacterial growth (p < 0.0001) and a significant increase in macrophage phagocytic activity, NO production/arginase balance and S. aureus killing (for all comparisons, p < 0.001). Conclusions Selenium acts in a dose-dependent manner on macrophage activation, phagocytosis and bacterial killing suggesting that inadequate doses may cause a loss of macrophage bactericidal activities and that selenium supplementation could enhance the in vivo control of immune response to S. aureus.	[Aribi, Mourad; Meziane, Warda; Habi, Salim; Boulatika, Yasser] Univ Tlemcen, Dept Biol, Lab Appl Mol Biol & Immunol, Tilimsen 13000, Algeria; [Marchandin, Helene] Univ Montpellier I, Equipe Pathogenes Hydr Sante Environm, UMR HydroSci Montpellier 5569, F-34093 Montpellier 5, France; [Marchandin, Helene] Ctr Hosp Reg Univ, Lab Bacteriol, F-34295 Montpellier 5, France; [Aymeric, Jean-Luc] Univ Montpellier, INRA, UM2, UMR1333,Lab Divers Genomes & Interact Microorgani, F-34095 Montpellier 05, France	Universite Abou Bekr Belkaid; Universite de Montpellier; INRAE; Universite de Montpellier	Aribi, M (corresponding author), Univ Tlemcen, Dept Biol, Lab Appl Mol Biol & Immunol, Tilimsen 13000, Algeria.	m_aribi@mail.univ-tlemcen.dz	Aribi, Mourad/M-9790-2018; Aribi, Mourad/Q-1290-2016; MARCHANDIN, Hélène/AAM-8288-2021; MEZIANE, Warda/P-7543-2016	Aribi, Mourad/0000-0002-6522-7252; Aribi, Mourad/0000-0002-6522-7252; MARCHANDIN, Hélène/0000-0003-2130-6335; MEZIANE, Warda/0000-0003-0985-8786				Akil M, 2011, BRATISL MED J, V112, P314; Amdahl H, 2013, J IMMUNOL, V191, P1775, DOI 10.4049/jimmunol.1300638; Aslam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068993; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chen KJ, 2014, FOOD CHEM TOXICOL, V74, P91, DOI 10.1016/j.fct.2014.09.003; Chudobova D, 2014, FEMS MICROBIOL LETT, V351, P195, DOI 10.1111/1574-6968.12353; Colleluori DM, 2001, BIOCHEMISTRY-US, V40, P9356, DOI 10.1021/bi010783g; CORRALIZA IM, 1995, BIOCHEM BIOPH RES CO, V206, P667, DOI 10.1006/bbrc.1995.1094; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Dai JH, 2001, IMMUNOLOGY, V103, P235, DOI 10.1046/j.1365-2567.2001.01224.x; de Andrade D, 2000, Rev Panam Salud Publica, V7, P179; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; DING AH, 1988, J IMMUNOL, V141, P2407; DUCROS V, 2004, EMC ENDOCRINOLOGIE, V1, P19, DOI DOI 10.1016/j.emcend.2003.10.001; Erickson KL, 2000, J INFECT DIS, V182, pS5, DOI 10.1086/315922; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fox S, 2010, ACTA BIOMATER, V6, P1515, DOI 10.1016/j.actbio.2009.10.038; Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043; Fritzsche C, 2010, IMMUNOBIOLOGY, V215, P826, DOI 10.1016/j.imbio.2010.05.022; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Giadinis N, 2000, COMP IMMUNOL MICROB, V23, P129, DOI 10.1016/S0147-9571(99)00066-1; Gladyshev VN, 2001, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, P99; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; HASSALL DG, 1995, CYTOMETRY, V21, P352, DOI 10.1002/cyto.990210407; Horta Maria Fatima, 2012, J Parasitol Res, V2012, P203818, DOI 10.1155/2012/203818; Trevino-Villarreal JH, 2012, INFECT IMMUN, V80, P3587, DOI 10.1128/IAI.00446-12; Johnston MJG, 2010, INFECT IMMUN, V78, P1364, DOI 10.1128/IAI.01349-08; Karimian Parastoo, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P219, DOI 10.1016/S2221-1691(14)60235-5; Kiremidjian-Schumacher L, 1998, Z ERNAHRUNGSWISS, V37, P50; Klasen S, 2001, BRIT J PHARMACOL, V132, P1349, DOI 10.1038/sj.bjp.0703951; Kraus D, 2008, FUTURE MICROBIOL, V3, P437, DOI 10.2217/17460913.3.4.437; Krstic B, 2012, BIOL TRACE ELEM RES, V146, P68, DOI 10.1007/s12011-011-9229-0; Krut O, 2003, INFECT IMMUN, V71, P2716, DOI 10.1128/IAI.71.5.2716-2723.2003; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Lahiri A, 2010, VIRULENCE, V1, P563, DOI 10.4161/viru.1.6.13623; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; Maehira F, 2003, CLIN CHIM ACTA, V334, P163, DOI 10.1016/S0009-8981(03)00223-7; Mathews SM, 2006, CORNEA, V25, P806, DOI 10.1097/01.ico.0000224636.57062.90; Mehrzad J, 2009, VET MICROBIOL, V134, P106, DOI 10.1016/j.vetmic.2008.09.001; Meraz IM, 2014, MOL PHARMACEUT, V11, P3484, DOI 10.1021/mp5002697; More P, 2012, IMMUNOPHARM IMMUNOT, V34, P368, DOI 10.3109/08923973.2011.606324; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Nair SP, 2000, RHEUMATOLOGY, V39, P821, DOI 10.1093/rheumatology/39.8.821; Nelson SM, 2011, J NUTR, V141, P1754, DOI 10.3945/jn.111.141176; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; POULSEN HD, 1989, ACTA VET SCAND, V30, P371; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; PREDARI SC, 1991, ANTIMICROB AGENTS CH, V35, P2568, DOI 10.1128/AAC.35.12.2568; Puertollano MA, 2011, CURR TOP MED CHEM, V11, P1752; Rasigade JP, 2011, FEMS IMMUNOL MED MIC, V62, P368, DOI 10.1111/j.1574-695X.2011.00808.x; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Rotllant J, 2004, DEV COMP IMMUNOL, V28, P815, DOI 10.1016/j.dci.2003.11.001; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Safir N, 2003, CLIN CHEM LAB MED, V41, P1005, DOI 10.1515/CCLM.2003.154; Sanchez-Miranda E, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/762020; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Shih YT, 2007, J ETHNOPHARMACOL, V112, P537, DOI 10.1016/j.jep.2007.04.015; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; SZABO C, 1994, BRIT J PHARMACOL, V112, P355, DOI 10.1111/j.1476-5381.1994.tb13078.x; Teixeira FM, 2008, CLIN EXP IMMUNOL, V154, P255, DOI 10.1111/j.1365-2249.2008.03728.x; Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; Tran PL, 2012, ANTIMICROB AGENTS CH, V56, P972, DOI 10.1128/AAC.05680-11; Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; URBAN T, 1986, IMMUNOPHARMACOLOGY, V12, P167, DOI 10.1016/0162-3109(86)90042-1; Valenta J, 2011, INTENS CARE MED, V37, P808, DOI 10.1007/s00134-011-2153-0; Vanhommerig E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104561; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Vunta H, 2008, MOL NUTR FOOD RES, V52, P1316, DOI 10.1002/mnfr.200700346; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Weidenmaier C, 2012, TRENDS MICROBIOL, V20, P243, DOI 10.1016/j.tim.2012.03.004; Woods JA, 2000, IMMUNOL CELL BIOL, V78, P545, DOI 10.1046/j.1440-1711.2000.00960.x; Wrann CD, 2007, CELL IMMUNOL, V245, P63, DOI 10.1016/j.cellimm.2007.04.001; Wright AJ, 2007, MOL IMMUNOL, V44, P2507, DOI 10.1016/j.molimm.2006.12.022; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; Youn HS, 2008, INT IMMUNOPHARMACOL, V8, P495, DOI 10.1016/j.intimp.2007.12.008; Yun CH, 2007, INT IMMUNOPHARMACOL, V7, P1192, DOI 10.1016/j.intimp.2007.05.002; Zeng HW, 2013, NUTRIENTS, V5, P97, DOI 10.3390/nu5010097; Zhang XL, 2013, INT J BIOCHEM CELL B, V45, P995, DOI 10.1016/j.biocel.2013.02.008	84	35	41	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0135515	10.1371/journal.pone.0135515	http://dx.doi.org/10.1371/journal.pone.0135515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340099	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200004
J	Dogandzic, T; Braun, DR; McPherron, SP				Dogandzic, Tamara; Braun, David R.; McPherron, Shannon P.			Edge Length and Surface Area of a Blank: Experimental Assessment of Measures, Size Predictions and Utility	PLOS ONE			English	Article							TECHNOLOGICAL ORGANIZATION; MEASURING REDUCTION; FORMAL APPROACH; MIDDLE; CURATION; MOBILITY; BLADES; MASS; VARIABILITY; STRATEGIES	Blank size and form represent one of the main sources of variation in lithic assemblages. They reflect economic properties of blanks and factors such as efficiency and use life. These properties require reliable measures of size, namely edge length and surface area. These measures, however, are not easily captured with calipers. Most attempts to quantify these features employ estimates; however, the efficacy of these estimations for measuring critical features such as blank surface area and edge length has never been properly evaluated. In addition, these parameters are even more difficult to acquire for retouched implements as their original size and hence indication of their previous utility have been lost. It has been suggested, in controlled experimental conditions, that two platform variables, platform thickness and exterior platform angle, are crucial in determining blank size and shape meaning that knappers can control the interaction between size and efficiency by selecting specific core angles and controlling where fracture is initiated. The robustness of these models has rarely been tested and confirmed in context other than controlled experiments. In this paper, we evaluate which currently employed caliper measurement methods result in the highest accuracy of size estimations of blanks, and we evaluate how platform variables can be used to indirectly infer aspects of size on retouched artifacts. Furthermore, we investigate measures of different platform management strategies that control the shape and size of artifacts. To investigate these questions, we created an experimental lithic assemblage, we digitized images to calculate 2D surface area and edge length, which are used as a point of comparison for the caliper measurements and additional analyses. The analysis of aspects of size determinations and the utility of blanks contributes to our understanding of the technological strategies of prehistoric knappers and what economic decisions they made during process of blank production.	[Dogandzic, Tamara; Braun, David R.; McPherron, Shannon P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Braun, David R.] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Washington, DC USA	Max Planck Society; George Washington University	Dogandzic, T (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	tamara_dogandzic@eva.mpg.de			Max Planck Society; Alexander von Humboldt Foundation; National Research Foundation of South Africa [74206]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Research Foundation of South Africa(National Research Foundation - South Africa)	This project was funded by the Max Planck Society. DRB received additional support from the Alexander von Humboldt Foundation and the National Research Foundation of South Africa (74206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREFSKY W, 1994, AM ANTIQUITY, V59, P21, DOI 10.2307/3085499; Andrefsky W., 2005, CAMB MAN ARCHAEOL, DOI DOI 10.1017/CBO9780511810244; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], J ARCHAEOLOGICAL MET, DOI DOI 10.1007/BF02229424; BAMFORTH DB, 1986, AM ANTIQUITY, V51, P38, DOI 10.2307/280392; BAMFORTH DB, 1991, AM ANTIQUITY, V56, P216, DOI 10.2307/281416; Bar-Yosef O, 1999, AM ANTHROPOL, V101, P322, DOI 10.1525/aa.1999.101.2.322; BINFORD LR, 1979, J ANTHROPOL RES, V35, P255, DOI 10.1086/jar.35.3.3629902; Blades B. S., 2001, LITHIC TECHNOLOGY ME; Blades BS, 2003, AM ANTIQUITY, V68, P141, DOI 10.2307/3557037; Boeda E., 1994, CONCEPT LEVALLOIS VA; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Bordes F., 1961, TYPOLOGIE PALEOLITHI; Brantingham PJ, 2006, CURR ANTHROPOL, V47, P435, DOI 10.1086/503062; Brantingham PJ, 2001, J ARCHAEOL SCI, V28, P747, DOI 10.1006/jasc.2000.0594; Braun D.R., 2003, OLDOWAN RATHER MORE, P117; Braun DR, 2005, LITHIC TECHNOL, V30, P107, DOI 10.1080/01977261.2005.11721029; Braun DR, 2008, J HUM EVOL, V55, P1053, DOI 10.1016/j.jhevol.2008.05.020; Bretzke K, 2012, J ARCHAEOL SCI, V39, P3741, DOI 10.1016/j.jas.2012.06.039; Cadieux N, 2013, LITHIC TECHNOL, V38, P46, DOI 10.1179/0197726113Z.0000000004; CHAZAN M, 1995, CURR ANTHROPOL, V36, P749, DOI 10.1086/204430; Clark J.D., 2001, KALAMBO FALLS PREHIS, pCambridg; Clark J. D., 1974, KALAMBO FALLS PREHIS, V2; Clarkson C, 2002, J ARCHAEOL SCI, V29, P65, DOI 10.1006/jasc.2001.0702; Clarkson C, 2011, J ARCHAEOL SCI, V38, P1062, DOI 10.1016/j.jas.2010.12.001; Davis ZJ, 1998, J ARCHAEOL SCI, V25, P603, DOI 10.1006/jasc.1997.0255; Debenath A., 1994, HANDBOOK; Delagnes A, 2011, J ARCHAEOL SCI, V38, P1771, DOI 10.1016/j.jas.2011.04.007; Dibble HL, 2006, CURR ANTHROPOL, V47, P777, DOI 10.1086/506282; Dibble HL, 2009, J ARCHAEOL SCI, V36, P1945, DOI 10.1016/j.jas.2009.05.004; Dibble Harold L., 1995, J ARCHAEOL METHOD TH, V2, P299, DOI [10.1007/BF02229003, DOI 10.1007/BF02229003]; Dibble HL, 1998, J ARCHAEOL SCI, V25, P611, DOI 10.1006/jasc.1997.0254; DIBBLE HL, 1981, J ARCHAEOL SCI, V8, P283, DOI 10.1016/0305-4403(81)90004-2; DIBBLE HL, 1995, J ARCHAEOL SCI, V22, P429, DOI 10.1006/jasc.1995.0042; DIBBLE HL, 1991, J ANTHROPOL RES, V47, P239, DOI 10.1086/jar.47.2.3630327; DIBBLE HL, 1987, AM ANTIQUITY, V52, P109, DOI 10.2307/281062; DIBBLE HL, 1981, AM ANTIQUITY, V46, P178, DOI 10.2307/279998; Dibble HL, 1995, MIDDLE PALEOLITHIC S, P27; Dibble HL, 1999, LITHIC TECHNOL, V24, P38, DOI DOI 10.1080/01977261.1999.11720944; Dibble HL, 1997, LITHIC TECHNOL, V22, P150, DOI [10.1080/01977261.1997.11754540, DOI 10.1080/01977261.1997.11754540]; Eren MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029273; Eren MI, 2008, LITHIC TECHNOLOGY: MEASURES OF PRODUCTION, USE, AND CURATION, P49, DOI 10.1017/CBO9780511499661.004; Eren MI, 2008, J HUM EVOL, V55, P952, DOI 10.1016/j.jhevol.2008.07.009; Eren MI, 2005, J ARCHAEOL SCI, V32, P1190, DOI 10.1016/j.jas.2005.03.003; FRISON GC, 1968, AM ANTIQUITY, V33, P149, DOI 10.2307/278516; Geneste J-M, 1985, ANAL LITHIQUE IND MO, P572; Gromping U, 2007, AM STAT, V61, P139, DOI 10.1198/000313007X188252; Hiscock P, 2007, AM ANTIQUITY, V72, P176, DOI 10.2307/40035303; Hiscock P, 2010, WORLD ARCHAEOL, V42, P545, DOI 10.1080/00438243.2010.517669; Hiscock P, 2008, LITHIC TECHNOLOGY: MEASURES OF PRODUCTION, USE, AND CURATION, P106, DOI 10.1017/CBO9780511499661.006; Holdaway S, 2012, J ARCHAEOL METHOD TH, V19, P101, DOI 10.1007/s10816-011-9103-6; Inizan M-L., 1995, TECHNOLOGIE PIERRE T; Jelinek A., 1976, CULTURAL CHANGE CONT, P19; Jelinek A.J., 1977, ERETZ ISRAEL, V13, P87; KELLY RL, 1992, ANNU REV ANTHROPOL, V21, P43, DOI 10.1146/annurev.an.21.100192.000355; Kuhn SL, 2004, WORLD ARCHAEOL, V36, P561, DOI 10.1080/0043824042000303737; KUHN SL, 1992, AM ANTIQUITY, V57, P115, DOI 10.2307/2694838; KUHN SL, 1990, J ARCHAEOL SCI, V17, P583, DOI 10.1016/0305-4403(90)90038-7; Kuhn SL, 1996, AM ANTIQUITY, V61, P591, DOI 10.2307/281843; KUHN SL, 1994, AM ANTIQUITY, V59, P426, DOI 10.2307/282456; Kuhn SL., 1993, ARCHAEOLOGICAL PAPER, V4, P25, DOI [10.1525/ap3a.1993.4.1.25, DOI 10.1525/AP3A.1993.4.1.25]; Kuhn SL., 1995, MOUSTERIAN LITHIC TE, DOI [10.1515/9781400864034, DOI 10.1515/9781400864034]; Leach BF, 1969, CONCEPT SIMILARITY P; Leroi-Gourhan A., 1964, GESTE PAROLE TECHNIQ; Lin SC, 2013, AM ANTIQUITY, V78, P724, DOI 10.7183/0002-7316.78.4.724; Lycett SJ, 2013, J ARCHAEOL SCI, V40, P2384, DOI 10.1016/j.jas.2013.01.016; Mackay A, 2008, J ARCHAEOL SCI, V35, P614, DOI 10.1016/j.jas.2007.05.013; Mackay A, 2008, J ARCHAEOL SCI, V35, P1521, DOI 10.1016/j.jas.2007.10.015; Magnani M, 2014, J ARCHAEOL SCI, V46, P37, DOI 10.1016/j.jas.2014.02.029; Marks AE, 2006, INTERD CONTRIB ARCH, P121, DOI 10.1007/0-387-24661-4_7; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McPherron S., 1995, LITHICS, V16, P47; McPherron S. P., 2003, PREHISTORIC BIFACES, P55; McPherron SP, 2014, J ARCHAEOL SCI, V49, P70, DOI 10.1016/j.jas.2014.04.003; Morrow TA, 1996, AM ANTIQUITY, V61, P581, DOI 10.2307/281842; Muller A, 2014, J ARCHAEOL SCI, V52, P31, DOI 10.1016/j.jas.2014.08.025; Nelson M.C., 1991, ARCHAEOLOGICAL METHO, P57, DOI DOI 10.2307/20170213; Rasic J, 2001, ALASKAN BLADE CORES, P233; Rensink E., 1991, U KANSAS PUBLICATION, V19, P141; REVILLION S, 1994, IND LAMINAIRES PALEO; Rezek Z, 2011, J ARCHAEOL SCI, V38, P1346, DOI 10.1016/j.jas.2011.01.014; ROLLAND N, 1990, AM ANTIQUITY, V55, P480, DOI 10.2307/281279; Roth BJ, 1998, AM ANTIQUITY, V63, P47, DOI 10.2307/2694775; SHEETS PD, 1972, SCIENCE, V175, P632, DOI 10.1126/science.175.4022.632; SHOTT M, 1986, J ANTHROPOL RES, V42, P15, DOI 10.1086/jar.42.1.3630378; Shott MJ, 2007, LITHIC TECHNOL, V32, P131, DOI 10.1080/01977261.2007.11721048; Shott MJ, 2007, J ARCHAEOL SCI, V34, P1016, DOI 10.1016/j.jas.2006.09.009; Shott MJ, 2000, J ARCHAEOL SCI, V27, P877, DOI 10.1006/jasc.1999.0499; Shott MJ, 1996, J ANTHROPOL RES, V52, P259, DOI 10.1086/jar.52.3.3630085; Shott MJ, 2005, J ARCHAEOL SCI, V32, P653, DOI 10.1016/j.jas.2004.11.012; Speth JD, 1972, AM ANTIQUITY, V40, P203; Tactikos J. C., 2003, LITHIC ANAL MILLENNI, P151; Tixier J, 1980, PREHISTOIRE PIERRE T; Torrence Robin., 1983, HUNTER GATHERER EC P, P11, DOI DOI 10.1073/PNAS.0913047107; Tostevin GB., 2012, SEEING LITHICS MIDDL; Turq A., 1989, B SOC PREHISTORIQUE, V86, P244, DOI [DOI 10.3406/BSPF.1989.9390, 10.3406/bspf.1989.9390]; Turq A., 1992, MIDDLE PALEOLITHIC A, V72, P75; Turq AL., 2000, PALEO, V2, P310; Van Peer P., 1992, LEVALLOIS REDUCTION, V13; Wendorf F., 1975, PROBLEMS PREHISTORY	100	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0133984	10.1371/journal.pone.0133984	http://dx.doi.org/10.1371/journal.pone.0133984			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332773	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800006
J	Kitchen, MO; Bryan, RT; Haworth, KE; Emes, RD; Luscombe, C; Gommersall, L; Cheng, KK; Zeegers, MP; James, ND; Devall, AJ; Fryer, AA; Farrell, WE				Kitchen, Mark O.; Bryan, Richard T.; Haworth, Kim E.; Emes, Richard D.; Luscombe, Christopher; Gommersall, Lyndon; Cheng, K. K.; Zeegers, Maurice P.; James, Nicholas D.; Devall, Adam J.; Fryer, Anthony A.; Farrell, William E.			Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer	PLOS ONE			English	Article							DNA METHYLATION; URINE SEDIMENTS; MARKERS; PATTERNS; IDENTIFICATION; EPIGENETICS; BIOMARKERS; CARCINOMA; GENES; STAGE	Introduction Inappropriate DNA methylation is frequently associated with human tumour development, and in specific cases, is associated with clinical outcomes. Previous reports of DNA methylation in low/intermediate grade non-muscle invasive bladder cancer (NMIBC) have suggested that specific patterns of DNA methylation may have a role as diagnostic or prognostic biomarkers. In view of the aggressive and clinically unpredictable nature of high-grade (HG) NMIBC, and the current shortage of the preferred treatment option (Bacillus: Calmette-Guerin), novel methylation analyses may similarly reveal biomarkers of disease outcome that could risk-stratify patients and guide clinical management at initial diagnosis. Methods Promoter-associated CpG island methylation was determined in primary tumour tissue of 36 initial presentation high-grade NMIBCs, 12 low/intermediate-grade NMIBCs and 3 normal bladder controls. The genes HOXA9, ISL1, NKX6-2, SPAG6, ZIC1 and ZNF154 were selected for investigation on the basis of previous reports and/or prognostic utility in low/intermediate-grade NMIBC. Methylation was determined by Pyrosequencing of sodium-bisulphite converted DNA, and then correlated with gene expression using RT-qPCR. Methylation was additionally correlated with tumour behaviour, including tumour recurrence and progression to muscle invasive bladder cancer or metastases. Results The ISL1 genes' promoter-associated island was more frequently methylated in recurrent and progressive high-grade tumours than their non-recurrent counterparts (60.0% vs. 18.2%, p = 0.008). ISL1 and HOXA9 showed significantly higher mean methylation in recurrent and progressive tumours compared to non-recurrent tumours (43.3% vs. 20.9%, p = 0.016 and 34.5% vs 17.6%, p = 0.017, respectively). Concurrent ISL1/HOXA9 methylation in HG-NMIBC reliably predicted tumour recurrence and progression within one year (Positive Predictive Value 91.7%), and was associated with disease-specific mortality (DSM). Conclusions In this study we report methylation differences and similarities between clinical sub-types of high-grade NMIBC. We report the potential ability of methylation biomarkers, at initial diagnosis, to predict tumour recurrence and progression within one year of diagnosis. We found that specific biomarkers reliably predict disease outcome and therefore may help guide patient treatment despite the unpredictable clinical course and heterogeneity of high-grade NMIBC. Further investigation is required, including validation in a larger patient cohort, to confirm the clinical utility of methylation biomarkers in high-grade NMIBC.	[Kitchen, Mark O.; Haworth, Kim E.; Fryer, Anthony A.; Farrell, William E.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England; [Kitchen, Mark O.; Luscombe, Christopher; Gommersall, Lyndon] Univ Hosp North Midlands NHS Trust, Dept Urol, Stoke On Trent, Staffs, England; [Bryan, Richard T.; Cheng, K. K.; Devall, Adam J.] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Emes, Richard D.] Univ Nottingham, Adv Data Anal Ctr, Nottingham NG7 2RD, England; [Zeegers, Maurice P.] Maastricht Univ, Med Ctr, Dept Complex Genet, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [James, Nicholas D.] Univ Warwick, Canc Res Unit, Coventry CV4 7AL, W Midlands, England	Keele University; University of Birmingham; University of Nottingham; Maastricht University; Maastricht University Medical Centre (MUMC); University of Warwick	Kitchen, MO (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.	m.o.kitchen@keele.ac.uk	Cheng, Kar/AAL-8899-2021; Bryan, Richard T/AAJ-9325-2021; Devall, Adam/AAC-9646-2022; Emes, Richard D/C-5341-2008; Kitchen, Mark O/J-4662-2012	Cheng, Kar/0000-0002-1516-1857; Bryan, Richard T/0000-0003-2853-4293; Emes, Richard D/0000-0001-6855-5481; Haworth, Kim/0000-0002-9460-4424; Fryer, Anthony/0000-0001-8678-0404; Kitchen, Mark/0000-0002-1124-2940; Zeegers, Maurice/0000-0002-2387-083X	North Staffordshire Medical Institute; University Hospital of North Midlands NHS Trust Cancer Charitable Foundation; Cancer Research UK; University of Birmingham; Birmingham & The Black Country and West Midlands North Comprehensive Local Research Network; Birmingham Experimental Cancer Medicine Centre; Birmingham & The Black Country and West Midlands South Comprehensive Local Research Network	North Staffordshire Medical Institute; University Hospital of North Midlands NHS Trust Cancer Charitable Foundation; Cancer Research UK(Cancer Research UK); University of Birmingham; Birmingham & The Black Country and West Midlands North Comprehensive Local Research Network; Birmingham Experimental Cancer Medicine Centre; Birmingham & The Black Country and West Midlands South Comprehensive Local Research Network	This work was supported by the North Staffordshire Medical Institute, Research Awards Committee, "Pump-Prime" Grant, and The University Hospital of North Midlands NHS Trust Cancer Charitable Foundation. BCPP is funded by Cancer Research UK, the University of Birmingham and the Birmingham & The Black Country and West Midlands North and South Comprehensive Local Research Networks, and sponsored by the University of Birmingham. The BCPP biospecimen collection is supported by funding from the Birmingham Experimental Cancer Medicine Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Azzawi H, 2011, ENDOCRINOLOGY, V152, P364, DOI 10.1210/en.2010-0886; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Boustead GB, 2014, BJU INT, V113, P924, DOI 10.1111/bju.12468; Catto JWF, 2005, J CLIN ONCOL, V23, P2903, DOI 10.1200/JCO.2005.03.163; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; De Berardinis E, 2011, INT UROL NEPHROL, V43, P1047, DOI 10.1007/s11255-011-9941-x; Dudley KJ, 2008, MOL CANCER RES, V6, P1567, DOI 10.1158/1541-7786.MCR-08-0234; Duong Cuong V, 2012, Endocr Relat Cancer, V19, P805, DOI 10.1530/ERC-12-0251; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Gontero P, 2014, EUR UROL; Gyparaki MT, 2013, J MOL MED, V91, P1249, DOI 10.1007/s00109-013-1088-z; Kalari S, 2010, ADV GENET, V70, P277, DOI [10.1016/B978-0-12-380866-0.60010-1, 10.1016/S0065-2660(10)70010-9]; Kim YJ, 2013, INT J CANCER, V133, P1135, DOI 10.1002/ijc.28121; Li YS, 2014, HUM MOL GENET, V23, P5378, DOI 10.1093/hmg/ddu256; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Netto GJ, 2012, NAT REV UROL, V9, P41, DOI 10.1038/nrurol.2011.193; Raj GV, 2007, J UROLOGY, V177, P1283, DOI 10.1016/j.juro.2006.11.090; Reinert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046297; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Tada Y, 2011, INT J ONCOL, V39, P727, DOI 10.3892/ijo.2011.1049; Tilki D, 2011, EUR UROL, V60, P484, DOI 10.1016/j.eururo.2011.05.053; Vedder MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096849; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861; Zeegers MP, 2010, BJU INT, V105, P784, DOI 10.1111/j.1464-410X.2009.08849.x	30	33	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137003	10.1371/journal.pone.0137003	http://dx.doi.org/10.1371/journal.pone.0137003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332997	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000360613800087
J	Lei, F; Yan, X; Zhao, FS; Zhang, SF; Zhang, QL; Zhou, H; Zheng, Y				Lei, Fang; Yan, Xiang; Zhao, Fusheng; Zhang, Senfeng; Zhang, Qilan; Zhou, Hua; Zheng, Yu			Impairment of Central Chemoreception in Neonatal Rats Induced by Maternal Cigarette Smoke Exposure during Pregnancy	PLOS ONE			English	Article							INFANT-DEATH-SYNDROME; PRENATAL NICOTINE EXPOSURE; SELF-REPORTED SMOKING; BRAIN-STEM; VENTILATORY RESPONSES; CARDIORESPIRATORY RESPONSE; BREATHING AUTOMATICITY; RETROTRAPEZOID NUCLEUS; PREBOTZINGER COMPLEX; RESPIRATORY CONTROL	It has been postulated that prenatal cigarette smoke exposure (CSE) increases the risk for sudden infant death syndrome. The victims of infant death syndrome suffer from respiratory abnormalities, such as central apnea, diminished chemoreflex and alteration in respiratory pattern during sleep. However, no experimental evidence on CSE model exists to confirm whether prenatal CSE gives rise to reduction of neonatal central chemoreception in in vitro preparations in absence of peripheral sensory feedback. The aim of the present study was to test the hypothesis that maternal CSE during pregnancy depresses central chemoreception of the neonatal rats. The pregnant rats were divided into two groups, control (n = 8) and CSE (n = 8). Experiments were performed on neonatal (0-3days) rat pups. Fictive respiratory activity was monitored by recording the rhythmic discharge from the hypoglossal rootlets of the medullary slices obtained from the neonatal rats. The burst frequency (BF) and integrated amplitude (IA) of the discharge were analyzed. Their responses to acidified artificial cerebrospinal fluid (aCSF) were tested to indicate the change of the central chemosensitivity. Under condition of perfusing with standard aCSF (pH 7.4), no significant difference was detected between the two groups in either BF or IA (P>0.05). Under condition of perfusing with acidified aCSF (pH 7.0), BF was increased and IA was decreased in both groups (P<0.01). However, their change rates in the CSE group were obviously smaller than that in the control group, 66.98 +/- 10.11% vs. 143.75 +/- 15.41% for BF and -22.38 +/- 2.51% vs. -44.90 +/- 3.92% for IA (P<0.01). In conclusion, these observations, in a prenatal CSE model, provide important evidence that maternal smoking during pregnancy exerts adverse effects on central chemoreception of neonates.	[Lei, Fang; Yan, Xiang; Zhao, Fusheng; Zhang, Senfeng; Zhang, Qilan; Zhou, Hua; Zheng, Yu] Sichuan Univ, Dept Physiol, West China Sch Preclin & Forens Med, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Zheng, Y (corresponding author), Sichuan Univ, Dept Physiol, West China Sch Preclin & Forens Med, Chengdu 610064, Sichuan, Peoples R China.	yzheng@scu.edu.com			National Natural Science Foundation of China [31271233, 31471096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work received funding from the National Natural Science Foundation of China (No.: 31271233, 31471096 URL: http://www.nsfc.gov.cn/). The author who received the funding: YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford OS, 1996, RESP PHYSIOL, V106, P1, DOI 10.1016/0034-5687(96)00051-5; Campbell AJ, 2001, ACTA PAEDIATR, V90, P793, DOI 10.1080/080352501750315726; Coddou C, 2009, PHILOS T R SOC B, V364, P2527, DOI 10.1098/rstb.2009.0078; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Fleming P, 2007, EARLY HUM DEV, V83, P721, DOI 10.1016/j.earlhumdev.2007.07.011; Goridis C, 2010, RESP PHYSIOL NEUROBI, V173, P312, DOI 10.1016/j.resp.2010.03.014; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Guyenet PG, 2008, J APPL PHYSIOL, V105, P404, DOI 10.1152/japplphysiol.90452.2008; Guyenet PG, 2009, RESP PHYSIOL NEUROBI, V168, P59, DOI 10.1016/j.resp.2009.02.001; Hafstrom O, 2002, AM J RESP CRIT CARE, V166, P1544, DOI 10.1164/rccm.200204-289OC; Kato I, 2001, AM J RESP CRIT CARE, V164, P1464, DOI 10.1164/ajrccm.164.8.2009001; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; Klebanoff MA, 1998, AM J EPIDEMIOL, V148, P259; Lavezzi AM, 2005, NEUROBIOL DIS, V20, P601, DOI 10.1016/j.nbd.2005.04.015; LEWIS KW, 1995, J PEDIATR-US, V127, P691, DOI 10.1016/S0022-3476(95)70155-9; LONGO LD, 1976, SCIENCE, V194, P523, DOI 10.1126/science.973133; MCLEAN HA, 1994, RESP PHYSIOL, V96, P49, DOI 10.1016/0034-5687(94)90105-8; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Neff RA, 2004, J NEUROSCI, V24, P9261, DOI 10.1523/JNEUROSCI.1918-04.2004; Nie LH, 2013, RESP PHYSIOL NEUROBI, V188, P29, DOI 10.1016/j.resp.2013.05.001; Paine SML, 2014, NEUROPATH APPL NEURO, V40, P364, DOI 10.1111/nan.12095; Pan JG, 2010, RESP PHYSIOL NEUROBI, V171, P181, DOI 10.1016/j.resp.2010.04.006; Pendlebury JD, 2008, AM J RESP CRIT CARE, V177, P1255, DOI 10.1164/rccm.200711-1739OC; Poole KA, 2000, AM J RESP CRIT CARE, V162, P801, DOI 10.1164/ajrccm.162.3.9909071; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Schuen JN, 1997, RESP PHYSIOL, V109, P231, DOI 10.1016/S0034-5687(97)00052-2; Shah T, 2006, AM J PUBLIC HEALTH, V96, P1757, DOI 10.2105/AJPH.2005.073213; Slotkin TA, 2005, NEUROPSYCHOPHARMACOL, V30, P129, DOI 10.1038/sj.npp.1300544; Slotkin TA, 2011, NEUROTOXICOL TERATOL, V33, P431, DOI 10.1016/j.ntt.2011.02.001; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Vasankari T, 2011, SCAND J PUBLIC HEALT, V39, P547, DOI 10.1177/1403494811401474; Zhang K, 2013, LEGAL MED-TOKYO, V15, P115, DOI 10.1016/j.legalmed.2012.10.007	32	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137362	10.1371/journal.pone.0137362	http://dx.doi.org/10.1371/journal.pone.0137362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26333001	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800127
J	Wang, YH; Chen, JJ; Ding, W; Yan, B; Gao, QQ; Zhou, JY				Wang, Yuehong; Chen, Junjun; Ding, Wei; Yan, Bing; Gao, Qiqi; Zhou, Jianying			Clinical Features and Gene Mutations of Lung Cancer Patients 30 Years of Age or Younger	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; THAN 50 YEARS; 1ST-LINE TREATMENT; OPEN-LABEL; ADENOCARCINOMA; CHEMOTHERAPY; ALK; MULTICENTER; PHASE-3; ROS1	Purpose Few studies examining the clinical features and gene mutations in lung cancer patients 30 years of age or younger have been published. A trend towards increasing morbidity has been noted in young patients; thus, an urgent need exists to explore this subgroup of patients. Methods Patients aged <= 30 years with pathologically diagnosed lung cancer were retrospectively evaluated. We reviewed the clinical features, gene mutations and prognosis of each patient. Results Forty-one patients were included in this study. The mean age was 26.4 +/- 3.5 years. Cough, tightness/dyspnea and chest pain were common symptoms, and 58.5% of patients presented with advanced stages of lung cancer. Adenocarcinoma was the predominant histologic type noted in these young patients. Masses and nodules were the dominant imaging features observed upon lung computed tomography (CT). Thoracic lymphadenopathy occurred very frequently in these patients. Five of 6 patients with echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) gene fusions presented solid masses with no ground-glass opacity (GGO) and thoracic multifocal lymphadenopathy. Six of 22 (27.2%) cases contained EML4-ALK gene fusions. In addition, 5 of 22 (22.7%) patients harbored epidermal growth factor receptor (EGFR) mutations, and 2 of 17 patients exhibited KRAS and ROS1 gene mutations. The median survival times were 44.2 months for patients with early stage disease and 8 months for patients with advanced NSCLC disease. The one-year and 5-year survival rates were 56.6% and 38.6%, respectively. Conclusions Increased gene mutation frequencies are noted in these very young lung cancer patients. This finding indicates that the detection of gene mutations in these patients is important and will help to determine the appropriate targeted therapy.	[Wang, Yuehong; Chen, Junjun; Yan, Bing; Zhou, Jianying] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Med, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Wei; Gao, Qiqi] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Med, Hangzhou 310003, Zhejiang, Peoples R China.	zjyhz@zju.edu.cn			Fund of Science Technology Department of Zhejiang Province [2012C33064]; Fund of Education Department of Zhejiang Province [Y201120841]	Fund of Science Technology Department of Zhejiang Province; Fund of Education Department of Zhejiang Province	This study was partly supported by the Fund of Science Technology Department of Zhejiang Province (No. 2012C33064) and the Fund of Education Department of Zhejiang Province (No. Y201120841).	Ak G, 2007, LUNG, V185, P279, DOI 10.1007/s00408-007-9021-2; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Cha YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103333; Doebele RC, 2012, CANCER-AM CANCER SOC, V118, P4502, DOI 10.1002/cncr.27409; Duan L, 2013, MINERVA CHIR, V68, P175; Fukui T, 2012, LUNG CANCER, V77, P319, DOI 10.1016/j.lungcan.2012.03.013; Hsu CL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-241; Hsu KH, 2011, J THORAC ONCOL, V6, P1066, DOI 10.1097/JTO.0b013e31821667b0; Jiang W, 2012, CHINESE MED J-PEKING, V125, P72, DOI 10.3760/cma.j.issn.0366-6999.2012.01.014; Kim L, 2012, J KOREAN MED SCI, V27, P1027, DOI 10.3346/jkms.2012.27.9.1027; Korpanty GJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00204; Kozielski J, 2012, WSPOLCZESNA ONKOL, V16, P413, DOI 10.5114/wo.2012.31770; Kuo CW, 2000, CHEST, V117, P354, DOI 10.1378/chest.117.2.354; Lara MS, 2014, LUNG CANCER, V85, P264, DOI 10.1016/j.lungcan.2014.04.007; Liam C K, 2000, Respirology, V5, P355; Marugame T, 2005, JPN J CLIN ONCOL, V35, P177, DOI 10.1093/jjco/hyi054; Mauri D, 2006, ANTICANCER RES, V26, P3175; MCDUFFIE HH, 1987, CANCER, V59, P1825, DOI 10.1002/1097-0142(19870515)59:10<1825::AID-CNCR2820591024>3.0.CO;2-2; Mizushima Y, 1999, CANCER, V85, P1730, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1730::AID-CNCR12>3.3.CO;2-7; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nagashima O, 2013, J THORAC DIS, V5, P27, DOI 10.3978/j.issn.2072-1439.2012.12.02; Nugent WC, 1997, ANN THORAC SURG, V63, P193; Pan YJ, 2014, LUNG CANCER, V84, P121, DOI 10.1016/j.lungcan.2014.02.007; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Park J, 2014, CANCER MED-US, V3, P118, DOI 10.1002/cam4.172; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; She J, 2013, CHEST, V143, P1117, DOI 10.1378/chest.11-2948; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Sholl LM, 2015, ARCH PATHOL LAB MED, V139, P469, DOI 10.5858/arpa.2014-0128-RA; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Strand TE, 2004, CANCER CAUSE CONTROL, V15, P27, DOI 10.1023/B:CACO.0000016575.31651.b0; Subramanian J, 2010, J THORAC ONCOL, V5, P23, DOI 10.1097/JTO.0b013e3181c41e8d; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tian DL, 2003, LUNG CANCER-J IASLC, V42, P215, DOI 10.1016/S0169-5002(03)00286-1; Togashi Y, 2011, CANCER-AM CANCER SOC, V117, P819, DOI 10.1002/cncr.25618; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; VandenBussche CJ, 2014, HUM PATHOL, V45, P2379, DOI 10.1016/j.humpath.2014.08.005; Whooley B P, 2000, Ann Thorac Cardiovasc Surg, V6, P86; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Ye T, 2014, J THORAC DIS, V6, P1396, DOI 10.3978/j.issn.2072-1439.2014.08.50; Zhang J, 2010, CANCER-AM CANCER SOC, V116, P3656, DOI 10.1002/cncr.25100; Zhao C, 2014, TRANSL ONCOL, V7, P363, DOI 10.1016/j.tranon.2014.04.013; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	46	10	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136659	10.1371/journal.pone.0136659	http://dx.doi.org/10.1371/journal.pone.0136659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332764	Green Submitted, gold, Green Published			2022-12-27	WOS:000360613800064
J	Feuer, R; Vlaic, S; Arlt, J; Sawodny, O; Dahmen, U; Zanger, UM; Thomas, M				Feuer, Ronny; Vlaic, Sebastian; Arlt, Janine; Sawodny, Oliver; Dahmen, Uta; Zanger, Ulrich M.; Thomas, Maria			LEMming: A Linear Error Model to Normalize Parallel Quantitative Real-Time PCR (qPCR) Data as an Alternative to Reference Gene Based Methods	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; RT-PCR; HOUSEKEEPING GENES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PARTIAL-HEPATECTOMY; RIBOSOMAL-RNA; BETA-ACTIN; QUANTIFICATION; EXPRESSION; FRAMEWORK	Background Gene expression analysis is an essential part of biological and medical investigations. Quantitative real-time PCR (qPCR) is characterized with excellent sensitivity, dynamic range, reproducibility and is still regarded to be the gold standard for quantifying transcripts abundance. Parallelization of qPCR such as by microfluidic Taqman Fluidigm Biomark Platform enables evaluation of multiple transcripts in samples treated under various conditions. Despite advanced technologies, correct evaluation of the measurements remains challenging. Most widely used methods for evaluating or calculating gene expression data include geNorm and Delta Delta C-t, respectively. They rely on one or several stable reference genes (RGs) for normalization, thus potentially causing biased results. We therefore applied multivariable regression with a tailored error model to overcome the necessity of stable RGs. Results We developed a RG independent data normalization approach based on a tailored linear error model for parallel qPCR data, called LEMming. It uses the assumption that the mean C-t values within samples of similarly treated groups are equal. Performance of LEMming was evaluated in three data sets with different stability patterns of RGs and compared to the results of geNorm normalization. Data set 1 showed that both methods gave similar results if stable RGs are available. Data set 2 included RGs which are stable according to geNorm criteria, but became differentially expressed in normalized data evaluated by a t-test. geNorm-normalized data showed an effect of a shifted mean per gene per condition whereas LEMming-normalized data did not. Comparing the decrease of standard deviation from raw data to geNorm and to LEMming, the latter was superior. In data set 3 according to geNorm calculated average expression stability and pairwise variation, stable RGs were available, but t-tests of raw data contradicted this. Normalization with RGs resulted in distorted data contradicting literature, while LEMming normalized data did not. Conclusions If RGs are coexpressed but are not independent of the experimental conditions the stability criteria based on inter- and intragroup variation fail. The linear error model developed, LEMming, overcomes the dependency of using RGs for parallel qPCR measurements, besides resolving biases of both technical and biological nature in qPCR. However, to distinguish systematic errors per treated group from a global treatment effect an additional measurement is needed. Quantification of total cDNA content per sample helps to identify systematic errors.	[Feuer, Ronny; Sawodny, Oliver] Univ Stuttgart, Inst Syst Dynam, D-70174 Stuttgart, Germany; [Vlaic, Sebastian; Arlt, Janine; Dahmen, Uta] Jena Univ Hosp, Dept Gen Visceral & Vasc Surg, Expt Transplantat Surg, Jena, Germany; [Vlaic, Sebastian] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Zanger, Ulrich M.; Thomas, Maria] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Zanger, Ulrich M.; Thomas, Maria] Univ Tubingen, Tubingen, Germany	University of Stuttgart; Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Feuer, R (corresponding author), Univ Stuttgart, Inst Syst Dynam, D-70174 Stuttgart, Germany.	ronny.feuer@isys.uni-stuttgart.de	Thomas, Maria/F-3315-2011; Zanger, Ulrich M./A-9364-2012	Thomas, Maria/0000-0001-6394-8710; Zanger, Ulrich M./0000-0002-5276-2002; Feuer, Ronny/0000-0002-5653-7670	Bundesministerium fuer Bildung und Forschung (BMBF)-Virtual Liver Network [FKZ 0315755, FKZ 0315736, FKZ 0315765, FKZ 0315751]; Robert Bosch Foundation, Stuttgart; DFG funding program Open Access Publishing, Deutsche Forschungsgemeinschaft (Optimierung der Leberlebendspende, Project B2) [Da251/5-2, Da251/5-3, KFO117, Klinische Forschergruppe 368 117]	Bundesministerium fuer Bildung und Forschung (BMBF)-Virtual Liver Network; Robert Bosch Foundation, Stuttgart; DFG funding program Open Access Publishing, Deutsche Forschungsgemeinschaft (Optimierung der Leberlebendspende, Project B2)	This work was funded by the Bundesministerium fuer Bildung und Forschung (BMBF)-Virtual Liver Network (grant FKZ 0315755, FKZ 0315736, FKZ 0315765, FKZ 0315751)-and Robert Bosch Foundation, Stuttgart and supported by the DFG funding program Open Access Publishing, Deutsche Forschungsgemeinschaft (Grant support: Klinische Forschergruppe 368 117-Optimierung der Leberlebendspende Grant number: Da251/5-2 und 3, Project B2, KFO117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Assy N, 1998, J LAB CLIN MED, V131, P251, DOI 10.1016/S0022-2143(98)90097-X; Ballester M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080385; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bennett J, 2015, PLANT CELL REP, V34, P1, DOI 10.1007/s00299-014-1692-6; BERETA J, 1995, BIOCHEM BIOPH RES CO, V217, P363, DOI 10.1006/bbrc.1995.2785; BHATIA P, 1994, ANAL BIOCHEM, V216, P223, DOI 10.1006/abio.1994.1028; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang TJ, 1998, ONCOL REP, V5, P469; de Jong KP, 1998, ANAL QUANT CYTOL, V20, P59; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huang H, 2014, ACC TRANSPLANTATION; Ling DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029788; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mar JC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-110; Matz MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071448; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pabinger Stephan, 2014, Biomol Detect Quantif, V1, P23; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Trevor Hastie, 1999, IMPUTING MISSING DAT; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	27	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0135852	10.1371/journal.pone.0135852	http://dx.doi.org/10.1371/journal.pone.0135852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325269	Green Submitted, gold, Green Published			2022-12-27	WOS:000360437700024
J	Hayat, T; Saeed, Y; Alsaedi, A; Asad, S				Hayat, T.; Saeed, Yusra; Alsaedi, A.; Asad, Sadia			Effects of Convective Heat and Mass Transfer in Flow of Powell-Eyring Fluid Past an Exponentially Stretching Sheet	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; POROUS-MEDIUM; MIXED CONVECTION; MAXWELL FLUID; SURFACE; PLATE; EQUATIONS; NANOFLUID; SLIP	The aim here is to investigate the effects of convective heat and mass transfer in the flow of Eyring-Powell fluid past an inclined exponential stretching surface. Mathematical formulation and analysis have been performed in the presence of Soret, Dufour and thermal radiation effects. The governing partial differential equations corresponding to the momentum, energy and concentration are reduced to a set of non-linear ordinary differential equations. Resulting nonlinear system is computed for the series solutions. Interval of convergence is determined. Physical interpretation is seen for the embedded parameters of interest. Skin friction coefficient, local Nusselt number and local Sherwood number are numerically computed and examined.	[Hayat, T.; Saeed, Yusra; Asad, Sadia] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Asad, S (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	asadsadia@ymail.com	Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasbandy S, 2013, QUAEST MATH, V36, P93, DOI 10.2989/16073606.2013.780336; Alsaedi A, 2012, COMMUN NONLINEAR SCI, V17, P4210, DOI 10.1016/j.cnsns.2012.03.008; Auranzaib Shafie S., 2013, J FRANKLIN I, V351, P1268; Awais M, 2014, COMPUT FLUIDS, V91, P21, DOI 10.1016/j.compfluid.2013.12.002; Aziz A, 2009, COMMUN NONLINEAR SCI, V14, P1064, DOI 10.1016/j.cnsns.2008.05.003; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Das K, 2011, INT J HEAT MASS TRAN, V54, P3505, DOI 10.1016/j.ijheatmasstransfer.2011.03.035; Das K, 2014, J EGYPTIAN MATH 0627; Hamad MAA, 2012, INT J HEAT MASS TRAN, V55, P1355, DOI 10.1016/j.ijheatmasstransfer.2011.08.043; Hayat T, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/8/084701; Hayat T, 2012, NUCL ENG DES, V252, P242, DOI 10.1016/j.nucengdes.2012.07.012; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P2375, DOI 10.1016/j.cnsns.2009.09.013; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P1183, DOI 10.1016/j.cnsns.2009.05.062; Hayat T, 2014, APPL MATH MECH, V35, P1; Joneidi AA, 2010, J TAIWAN INST CHEM E, V41, P35, DOI 10.1016/j.jtice.2009.05.008; Kandasamy R, 2011, NUCL ENG DES, V21, P55; KHANI F, 2012, J KING SAUD UNIV SCI, V24, P123, DOI DOI 10.1016/j.jksus.2010.09.002; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Pal D, 2013, APPL MATH COMPUT, V219, P7556, DOI 10.1016/j.amc.2012.10.119; Patil PM, 2014, INT J HEAT MASS TRAN, V70, P313, DOI 10.1016/j.ijheatmasstransfer.2013.11.021; Ramesh GK, 2014, AIN SHAMS ENG J, V5, P991, DOI 10.1016/j.asej.2014.04.003; Rashad AM, 2013, COMPUT FLUIDS, V86, P380, DOI 10.1016/j.compfluid.2013.07.030; Rashidi MM, 2014, AIN SHAMS ENG J, V5, P901, DOI 10.1016/j.asej.2014.02.007; Rostami B, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/496254; Shehzad SA, 2012, INT J HEAT MASS TRAN, V55, P3971, DOI 10.1016/j.ijheatmasstransfer.2012.03.027; Sheikholeslami M, 2014, J COMPUT THEOR NANOS, V11, P486, DOI 10.1166/jctn.2014.3384; Turkyilmazoglu M, 2013, APPL MATH MODEL, V37, P7539, DOI 10.1016/j.apm.2013.02.014; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P2264, DOI 10.1016/j.ijthermalsci.2011.05.014; Turkyilmazoglu M, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4027772	30	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0133831	10.1371/journal.pone.0133831	http://dx.doi.org/10.1371/journal.pone.0133831			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327398	gold, Green Submitted, Green Published			2022-12-27	WOS:000360437700008
J	Kim, BS; Rongisch, R; Hager, S; Grieb, G; Nourbakhsh, M; Rennekampff, HO; Bucala, R; Bernhagen, J; Pallua, N				Kim, Bong-Sung; Rongisch, Robert; Hager, Stephan; Grieb, Gerrit; Nourbakhsh, Mahtab; Rennekampff, Hans-Oliver; Bucala, Richard; Bernhagen, Juergen; Pallua, Norbert			Macrophage Migration Inhibitory Factor in Acute Adipose Tissue Inflammation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; IN-VITRO; CELL-MIGRATION; STROMAL CELLS; ADIPOCYTES; MIF; RELEASE; FIBROBLASTS; RECRUITMENT	Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine and has been implicated in inflammatory diseases. However, little is known about the regulation of MIF in adipose tissue and its impact on wound healing. The aim of this study was to investigate MIF expression in inflamed adipose and determine its role in inflammatory cell recruitment and wound healing. Adipose tissue was harvested from subcutaneous adipose tissue layers of 24 healthy subjects and from adipose tissue adjacent to acutely inflamed wounds of 21 patients undergoing wound debridement. MIF protein and mRNA expression were measured by ELISA and RT-PCR. Cell-specific MIF expression was visualized by immunohistochemistry. The functional role of MIF in cell recruitment was investigated by a chemotaxis assay and by flow cytometry of labeled macrophages that were injected into Mif(-/-) and wildtype mice. Wound healing was evaluated by an in vitro scratch assay on human fibroblast monolayers. MIF protein levels of native adipose tissue and supernatants from acutely inflamed wounds were significantly elevated when compared to healthy controls. MIF mRNA expression was increased in acutely inflamed adipose tissue indicating the activation of MIF gene transcription in response to adipose tissue inflammation. MIF is expressed in mature adipocytes and in infiltrated macrophages. Peripheral blood mononuclear cell migration was significantly increased towards supernatants derived from inflamed adipose tissue. This effect was partially abrogated by MIF-neutralizing antibodies. Moreover, when compared to wildtype mice, Mif(-/-) mice showed reduced infiltration of labeled macrophages into LPS-stimulated epididymal fat pads in vivo. Finally, MIF antibodies partially neutralized the detrimental effect of MIF on fibroblast wound healing. Our results indicate that increased MIF expression and rapid activation of the MIF gene in fat tissue adjacent to acute wound healing disorders may play a role in cell recruitment to the site of inflammation and wound healing.	[Kim, Bong-Sung; Rongisch, Robert; Hager, Stephan; Grieb, Gerrit; Nourbakhsh, Mahtab; Rennekampff, Hans-Oliver; Pallua, Norbert] Rhein Westfal TH Aachen, Dept Plast & Reconstruct Surg, Hand Surg Burn Ctr, Aachen, Germany; [Kim, Bong-Sung; Bucala, Richard] Yale Univ, Sch Med, Dept Med, New Haven, CT USA; [Kim, Bong-Sung; Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany	RWTH Aachen University; Yale University; RWTH Aachen University	Kim, BS (corresponding author), Rhein Westfal TH Aachen, Dept Plast & Reconstruct Surg, Hand Surg Burn Ctr, Aachen, Germany.	bkim@ukaachen.de	Nourbakhsh, Mahtab/U-8818-2019; Kim, Bong-Sung/AAR-3802-2021	Nourbakhsh, Mahtab/0000-0003-4102-0748; Nourbakhsh, Mahtab/0000-0003-0918-1736; Kim, Bong-Sung/0000-0002-0493-3196; Rongisch, Robert/0000-0002-6494-6466	"START"-a program for young scientists of the Medical Faculty at the RWTH Aachen University [691346, START 2013-2]; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [GZ: KI 1973/1-1]; DFG [PA 1271/5-1, SFB-TRR57/P03, BE 1977/7-1]; Interdisciplinary Center for Clinical Research (Interdisziplinare Zentrum fur Klinische Forschung, IZKF Aachen grant) [O2-2]; National Institute of Health [NIH R01 AI042310]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042310] Funding Source: NIH RePORTER	"START"-a program for young scientists of the Medical Faculty at the RWTH Aachen University; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (Interdisziplinare Zentrum fur Klinische Forschung, IZKF Aachen grant); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Bong-Sung Kim is supported by "START"-a program for young scientists of the Medical Faculty at the RWTH Aachen University (Project number: 691346, START 2013-2, https://www.rwth-aachen.de)-and the Research Fellowship Program of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG, GZ: KI 1973/1-1, www.dfg.de). Norbert Pallua is supported by DFG grant PA 1271/5-1. Jurgen Bernhagen is supported by DFG grants SFB-TRR57/P03 and BE 1977/7-1, and by the Interdisciplinary Center for Clinical Research (Interdisziplinare Zentrum fur Klinische Forschung, IZKF Aachen grant O2-2, www.izkf-aachen.de). Richard Bucala is supported by National Institute of Health (NIH R01 AI042310, www.nih.gov).	Aoki S, 2004, MOL BIOL CELL, V15, P4647, DOI 10.1091/mbc.E04-01-0038; Atalay S, 2014, BURNS, V40, P1375, DOI 10.1016/j.burns.2014.01.023; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Campbell CA, 2010, ANN PLAS SURG, V64, P327, DOI 10.1097/SAP.0b013e318199f82c; Chatterjee P, 2013, J BIOL CHEM, V288, P28324, DOI 10.1074/jbc.C113.495473; Cho KW, 2014, METHOD ENZYMOL, V537, P297, DOI 10.1016/B978-0-12-411619-1.00016-1; Collawn SS, 2012, ANN PLAS SURG, V68, P501, DOI 10.1097/SAP.0b013e31823b69fc; Dewor M, 2007, FEBS LETT, V581, P4734, DOI 10.1016/j.febslet.2007.08.071; Emmerson E, 2009, ENDOCRINOLOGY, V150, P2749, DOI 10.1210/en.2008-1569; Fain JN, 2006, METABOLISM, V55, P1113, DOI 10.1016/j.metabol.2006.04.008; Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Finucane OM, 2012, P NUTR SOC, V71, P622, DOI 10.1017/S0029665112000730; Gilliver SC, 2011, EXP DERMATOL, V20, P1, DOI 10.1111/j.1600-0625.2010.01194.x; Grieb G, 2012, WOUND REPAIR REGEN, V20, P707, DOI 10.1111/j.1524-475X.2012.00817.x; Hirokawa J, 1997, BIOCHEM BIOPH RES CO, V235, P94, DOI 10.1006/bbrc.1997.6745; Hirokawa J, 1998, J BIOCHEM, V123, P733; Ikeda D, 2008, ENDOCRINOLOGY, V149, P6037, DOI 10.1210/en.2008-0158; Kim BS, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.26; Kim HR, 2011, HORM METAB RES, V43, P642, DOI 10.1055/s-0031-1283150; Koska J, 2009, INT J OBESITY, V33, P842, DOI 10.1038/ijo.2009.106; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lopez YP, 2015, NEUROIMMUNOMODULAT, V22, P274, DOI 10.1159/000368554; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; NIINIKOSKI J, 1972, ANN SURG, V175, P588, DOI 10.1097/00000658-197204000-00020; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Pierpont YN, 2014, ISRN OBES, V2014, DOI [10.1155/2014/638936PMID:24701367, DOI 10.1155/2014/638936]; Schmidt BA, 2013, DEVELOPMENT, V140, P1517, DOI 10.1242/dev.087593; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Skurk T, 2005, ENDOCRINOLOGY, V146, P1006, DOI 10.1210/en.2004-0924; Sugihara H, 2001, BRIT J DERMATOL, V144, P244, DOI 10.1046/j.1365-2133.2001.04008.x; Trayhurn P, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2007.00316.x; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Vozarova B, 2002, DIABETOLOGIA, V45, P1739, DOI 10.1007/s00125-002-0896-4	35	20	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137366	10.1371/journal.pone.0137366	http://dx.doi.org/10.1371/journal.pone.0137366			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348853	Green Published, gold			2022-12-27	WOS:000360897600041
J	Kim, YG; Alvarez, M; Suzuki, H; Hirose, S; Izui, S; Tomino, Y; Huard, B; Suzuki, Y				Kim, Yang Gyun; Alvarez, Montserrat; Suzuki, Hitoshi; Hirose, Sachiko; Izui, Shozo; Tomino, Yasuhiko; Huard, Bertrand; Suzuki, Yusuke			Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy	PLOS ONE			English	Article							HUMAN MESANGIAL CELLS; EXTRACELLULAR-MATRIX; IMMUNE-COMPLEXES; BAFF; EXPRESSION; MONOCYTES; MICE; TACI; ACCUMULATION; FRACTALKINE	A proliferation-inducing ligand (APRIL) is a member of the tumor necrosis factor (TNF) superfamily. Despite advances in clinical and genetic studies, the details of the pathological roles of APRIL in IgA nephropathy (IgAN) remain to be fully defined. The present study aimed to further assess the pathological role of APRIL using a mouse model of IgAN. Mice with IgAN designated "grouped ddY" (gddY) were intraperitoneally administered an anti-APRIL monoclonal antibody (anti-APRIL Ab) or control IgG (Control Ab) twice each week for 2 weeks starting during the early stage of IgAN (6-7 weeks of age). Urinary albumin, serum IgA, and glomerular IgA deposition were evaluated. We further assessed the inflammatory responses during treatment by measuring the levels of the chemokine fractalkine (FKN) and its receptor CX3CR1 as well as the level of peripheral blood monocytosis. Anti-APRIL Ab treatment significantly decreased albuminuria and tissue damage combined with decreases in serum IgA levels and deposition of glomerular IgA. In contrast, the abundance of IgA(+)/B220+ or CD138(+)/B220(+) B cells in the spleen and bone marrow, respectively, was unchanged. Treating gddY mice with anti-April Ab reduced the overexpression of FKN/CX3CR1 in the kidney and the increase in the population of circulating Gr1(-)/CD115(+) monocytes. The size of the population of Gr1(-)/CD115(+) monocytes correlated with renal FKN and urinary albumin levels. Moreover, mice treated with anti-APRIL Ab exhibited reduced progression of IgAN, serum IgA levels, and glomerular IgA deposition as well as an attenuated inflammatory process mediated by FKN-associated activation of monocytes. To the best of our knowledge, this is the first study to implicate the APRIL signal transduction pathway in the pathogenesis of nephrogenic IgA production. Moreover, our findings identify APRIL as a potential target of therapy.	[Kim, Yang Gyun; Alvarez, Montserrat; Suzuki, Hitoshi; Tomino, Yasuhiko; Suzuki, Yusuke] Juntendo Univ, Sch Med, Dept Internal Med, Div Nephrol, Tokyo 113, Japan; [Kim, Yang Gyun] Kyung Hee Univ, Sch Med, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Alvarez, Montserrat; Izui, Shozo] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Hirose, Sachiko] Juntendo Univ, Sch Med, Dept Pathol, Tokyo 113, Japan; [Huard, Bertrand] INSERMU823, Inst Albert Bonniot, La Tronche, France; [Huard, Bertrand] Grenoble Alpes Univ, La Tronche, France	Juntendo University; Kyung Hee University; University of Geneva; Juntendo University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Suzuki, Y (corresponding author), Juntendo Univ, Sch Med, Dept Internal Med, Div Nephrol, Tokyo 113, Japan.	yusuke@juntendo.ac.jp	KIM, YANG GYUN/AAI-9821-2020; huard, bertrand/L-8011-2013	KIM, YANG GYUN/0000-0002-3497-5514; huard, bertrand/0000-0003-1358-6576	Ministry of Health, Labor and Welfare of Japan; Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program; Study Group on IgAN in Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program; Study Group on IgAN in Japan	This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Intractable Disease, from the Ministry of Health, Labor and Welfare of Japan, by a grant from Strategic Japanese (JST)-Swiss (ETHZ) Cooperative Scientific Program, and by a research grant from the Study Group on IgAN in Japan.	Aizawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095365; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Barratt J, 2004, SEMIN NEPHROL, V24, P197, DOI 10.1016/j.semnephrol.2004.01.002; Batten M, 2004, J IMMUNOL, V172, P812, DOI 10.4049/jimmunol.172.2.812; BOHLE A, 1992, PATHOL RES PRACT, V188, P908, DOI 10.1016/S0344-0338(11)80252-9; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; CHEN A, 1994, J PATHOL, V173, P119, DOI 10.1002/path.1711730208; Cox SN, 2012, KIDNEY INT, V82, P548, DOI 10.1038/ki.2012.147; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; FUJII K, 1990, AM J KIDNEY DIS, V16, P207, DOI 10.1016/S0272-6386(12)81019-5; Goto T, 2008, CLIN IMMUNOL, V126, P260, DOI 10.1016/j.clim.2007.11.003; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Huard B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031837; Ikezumi Y, 2006, NEPHROL DIAL TRANSPL, V21, P3466, DOI 10.1093/ndt/gfl455; IWASATO T, 1992, J EXP MED, V175, P1539, DOI 10.1084/jem.175.6.1539; Joo H, 2012, J EXP MED, V209, P1335, DOI 10.1084/jem.20111644; Kajiyama T, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/819646; LAN HY, 1991, KIDNEY INT, V40, P425, DOI 10.1038/ki.1991.229; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; LopezArmada MJ, 1996, J IMMUNOL, V157, P2136; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; McCarthy DD, 2006, CELL IMMUNOL, V241, P85, DOI 10.1016/j.cellimm.2006.08.002; McCarthy DD, 2011, J CLIN INVEST, V121, P3991, DOI 10.1172/JCI45563; Muso E, 1996, KIDNEY INT, V50, P1946, DOI 10.1038/ki.1996.517; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nakata J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089707; Okazaki K, 2012, J AM SOC NEPHROL, V23, P1364, DOI 10.1681/ASN.2011121160; Santiago-Raber ML, 2011, J AUTOIMMUN, V37, P171, DOI 10.1016/j.jaut.2011.05.015; Sato D, 2012, NEPHROL DIAL TRANSPL, V27, P1090, DOI 10.1093/ndt/gfr403; Song KH, 2013, DIABETOLOGIA, V56, P1661, DOI 10.1007/s00125-013-2907-z; Suzuki H, 2005, J AM SOC NEPHROL, V16, P1289, DOI 10.1681/ASN.2004030219; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; YOSHIKAWA N, 1987, KIDNEY INT, V32, P585, DOI 10.1038/ki.1987.248; Yoshimoto S, 2007, AM J KIDNEY DIS, V50, P47, DOI 10.1053/j.ajkd.2007.04.012; Yoshimura H, 2008, LIFE SCI, V82, P899, DOI 10.1016/j.lfs.2008.02.006; Zuo N, 2011, NEPHROL DIAL TRANSPL, V26, P2127, DOI 10.1093/ndt/gfq687	43	95	99	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137044	10.1371/journal.pone.0137044	http://dx.doi.org/10.1371/journal.pone.0137044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348210	gold, Green Published, Green Submitted			2022-12-27	WOS:000360897600018
J	Liang, KC; Patil, A; Nakai, K				Liang, Kuo-ching; Patil, Ashwini; Nakai, Kenta			Discovery of Intermediary Genes between Pathways Using Sparse Regression	PLOS ONE			English	Article							DENDRITIC CELL APOPTOSIS; ANTIGEN PRESENTATION; IFN-BETA; MYD88; TRIF; TLR; REGULARIZATION; TRANSCRIPTION; MATURATION; INDUCTION	The use of pathways and gene interaction networks for the analysis of differential expression experiments has allowed us to highlight the differences in gene expression profiles between samples in a systems biology perspective. The usefulness and accuracy of pathway analysis critically depend on our understanding of how genes interact with one another. That knowledge is continuously improving due to advances in next generation sequencing technologies and in computational methods. While most approaches treat each of them as independent entities, pathways actually coordinate to perform essential functions in a cell. In this work, we propose a methodology based on a sparse regression approach to find genes that act as intermediary to and interact with two pathways. We model each gene in a pathway using a set of predictor genes, and a connection is formed between the pathway gene and a predictor gene if the sparse regression coefficient corresponding to the predictor gene is non-zero. A predictor gene is a shared neighbor gene of two pathways if it is connected to at least one gene in each pathway. We compare the sparse regression approach to Weighted Correlation Network Analysis and a correlation distance based approach using time-course RNA-Seq data for dendritic cell from wild type, MyD88-knockout, and TRIF-knockout mice, and a set of RNA-Seq data from 60 Caucasian individuals. For the sparse regression approach, we found overrepresented functions for shared neighbor genes between TLR-signaling pathway and antigen processing and presentation, apoptosis, and Jak-Stat pathways that are supported by prior research, and compares favorably to Weighted Correlation Network Analysis in cases where the gene association signals are weak.	[Liang, Kuo-ching; Patil, Ashwini; Nakai, Kenta] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Nakai, K (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	knakai@ims.u-tokyo.ac.jp	Nakai, Kenta/B-7293-2009	Nakai, Kenta/0000-0002-8721-8883; Patil, Ashwini/0000-0002-3353-1970	Research on Regenerative Medicine for Clinical Application, Health and Labour Sciences Research Grants; Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovation R&D on Science and Technology (FIRST Program); Grants-in-Aid for Scientific Research [26830135] Funding Source: KAKEN	Research on Regenerative Medicine for Clinical Application, Health and Labour Sciences Research Grants; Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovation R&D on Science and Technology (FIRST Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research is funded in part by Research on Regenerative Medicine for Clinical Application, Health and Labour Sciences Research Grants (https://research-er.jp/projects/view/885791). This research is also funded by the Cabinet Office, Government of Japan and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovation R&D on Science and Technology (FIRST Program) for the Comprehensive understanding of immune dynamism: toward manipulation of immune responses (https://research-er. jp/projects/view/106146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew S., FASTQC QUALITY CONTR; Barrett DM, 2004, MOL CELL BIOL, V24, P6194, DOI 10.1128/MCB.24.14.6194-6204.2004; Brieger A, 2013, J IMMUNOL, V191, P1808, DOI 10.4049/jimmunol.1301261; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; De Trez C, 2005, J IMMUNOL, V175, P839, DOI 10.4049/jimmunol.175.2.839; Donato M, 2013, GENOME RES, V23, P1885, DOI 10.1101/gr.153551.112; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Famakin BM, 2011, BRAIN RES, V1388, P148, DOI 10.1016/j.brainres.2011.02.074; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frazee AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-449; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guilbault B, 2004, J BIOL CHEM, V279, P19523, DOI 10.1074/jbc.M314273200; Han JH, 2006, NAT IMMUNOL, V7, P370, DOI 10.1038/ni0406-370; Hartuv E, 1999, P 3 ANN INT C COMP M, P188, DOI [10.1145/299432.299483, DOI 10.1145/299432.299483]; Hayashi EA, 2005, J IMMUNOL, V174, P6639, DOI 10.4049/jimmunol.174.11.6639; Hu R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-20; Huber PJ, 2009, WILEY SERIES PROBABI, P200; Jonnalagadda S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-267; Jung S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku099; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kokkonen TS, 2010, J HISTOCHEM CYTOCHEM, V58, P131, DOI 10.1369/jhc.2009.954669; Kushwah R, 2010, J IMMUNOL, V185, P795, DOI 10.4049/jimmunol.1000325; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee M-LT, 2004, ANAL MICROARRAY GENE; Leonardson AS, 2010, HUM MOL GENET, V19, P159, DOI 10.1093/hmg/ddp476; Lu LN, 1996, J IMMUNOL, V157, P3577; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Marraco SAF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020189; Mentzen WI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-601; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Patil A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003323; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reim D, 2011, J LEUKOCYTE BIOL, V90, P613, DOI 10.1189/jlb.1110602; Roskrow MA, 1999, LEUKEMIA RES, V23, P549, DOI 10.1016/S0145-2126(99)00045-4; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spaggiari GM, 2002, BLOOD, V100, P4098, DOI 10.1182/blood-2002-04-1284; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang SQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5657; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Der Maaten L., 2009, J MACH LEARN RES, V10, P13, DOI [10.1080/ 135062804440 0 0102, DOI 10.1080/13506280444000102]; Ye Jieping, 2012, SIGKDD Explor, V14, P4; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao P, 2006, J MACH LEARN RES, V7, P2541; Zietara N, 2009, J IMMUNOL, V183, P1099, DOI 10.4049/jimmunol.0803214; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	58	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137222	10.1371/journal.pone.0137222	http://dx.doi.org/10.1371/journal.pone.0137222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348038	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600026
J	Tsoneva, D; Stritzker, J; Bedenk, K; Zhang, Q; Frentzen, A; Cappello, J; Fischer, U; Szalay, AA				Tsoneva, Desislava; Stritzker, Jochen; Bedenk, Kristina; Zhang, Qian; Frentzen, Alexa; Cappello, Joseph; Fischer, Utz; Szalay, Aladar A.			Drug-Encoded Biomarkers for Monitoring Biological Therapies	PLOS ONE			English	Article							ONCOLYTIC VACCINIA VIRUS; IN-VIVO; CANCER; GLUCURONIDASE; LUCIFERASE; INSERTION; BACTERIA; TUMORS; AGENT	Blood tests are necessary, easy-to-perform and low-cost alternatives for monitoring of oncolytic virotherapy and other biological therapies in translational research. Here we assessed three candidate proteins with the potential to be used as biomarkers in biological fluids: two glucuronidases from E. coli (GusA) and Staphylococcus sp. RLH1 (GusPlus), and the luciferase from Gaussia princeps (GLuc). The three genes encoding these proteins were inserted individually into vaccinia virus GLV-1h68 genome under the control of an identical promoter. The three resulting recombinant viruses were used to infect tumor cells in cultures and human tumor xenografts in nude mice. In contrast to the actively secreted GLuc, the cytoplasmic glucuronidases GusA and GusPlus were released into the supernatants only as a result of virus-mediated oncolysis. GusPlus resulted in the most sensitive detection of enzyme activity under controlled assay conditions in samples containing as little as 1 pg/ml of GusPlus, followed by GusA (25 pg/ml) and GLuc (>= 375 pg/ml). Unexpectedly, even though GusA had a lower specific activity compared to GusPlus, the substrate conversion in the serum of tumor-bearing mice injected with the GusA-encoding virus strains was substantially higher than that of GusPlus. This was attributed to a 3.2 fold and 16.2 fold longer half-life of GusA in the blood stream compared to GusPlus and GLuc respectively, thus a more sensitive monitor of virus replication than the other two enzymes. Due to the good correlation between enzymatic activity of expressed marker gene and virus titer, we conclude that the amount of the biomarker protein in the body fluid semiquantitatively represents the amount of virus in the infected tumors which was confirmed by low light imaging. We found GusA to be the most reliable biomarker for monitoring oncolytic virotherapy among the three tested markers.	[Tsoneva, Desislava; Bedenk, Kristina; Fischer, Utz; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany; [Stritzker, Jochen; Zhang, Qian; Frentzen, Alexa; Cappello, Joseph] Genelux Corp, San Diego Sci Ctr, San Diego, CA 92109 USA; [Stritzker, Jochen] Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany; [Fischer, Utz; Szalay, Aladar A.] Univ Calif San Diego, Dept Radiat Oncol, Moores Canc Ctr, San Diego, CA 92103 USA	University of Wurzburg; University of Wurzburg; University of California System; University of California San Diego	Stritzker, J (corresponding author), Genelux Corp, San Diego Sci Ctr, San Diego, CA 92109 USA.	js@genelux.com; szalay@biozentrum.uni-wuerzburg.de	Fischer, Utz/AAT-8422-2020; Fischer, Utz/A-4090-2016	Fischer, Utz/0000-0002-1465-6591; Fischer, Utz/0000-0002-1465-6591	Genelux Corporation; University of Wurzburg; German Research Foundation (DFG)	Genelux Corporation; University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG))	The work was supported by Genelux Corporation and a Service Grant awarded to the University of Wurzburg, graduate stipends from the University of Wurzburg. The publication costs were co-funded by the German Research Foundation (DFG) and the University of wurzburg in the funding program Open Access Publishing. The funder provided support in the form of salaries for authors (JS, QZ, AF, JC, UF, AAS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arul L, 2008, BIOINFORMATION, V2, P339, DOI 10.6026/97320630002339; Broothaerts W, 2005, NATURE, V433, P629, DOI 10.1038/nature03309; Browne AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019530; Chen NH, 2009, MOL MED, V15, P144, DOI 10.2119/molmed.2009.00014; Chen NG, 2010, FUTURE VIROL, V5, P763, DOI 10.2217/FVL.10.58; Coupar BEH, 2000, J GEN VIROL, V81, P431, DOI 10.1099/0022-1317-81-2-431; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; Haddad D, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-36; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Hess M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-172; Jefferson RA, 2002, MICROBIAL BETA GLUCU; Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545; Mansfield D, 2013, VALIDATION BIOMARKER; Phuong LK, 2003, CANCER RES, V63, P2462; Ruiz-Hernandez E, 2014, POLYM CHEM-UK, V5, P1674, DOI [10.1039/c3py01097j, 10.1039/C3PY01097J]; Stritzker J, 2013, P NATL ACAD SCI USA, V110, P3316, DOI 10.1073/pnas.1216916110; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937; Zenser TV, 1999, DRUG METAB DISPOS, V27, P1064; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146	21	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137573	10.1371/journal.pone.0137573	http://dx.doi.org/10.1371/journal.pone.0137573			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348361	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600055
J	Yoshimura, T; Suzuki, T; Mineki, S; Ohuchi, S				Yoshimura, Takeo; Suzuki, Takamasa; Mineki, Shigeru; Ohuchi, Shokichi			Controlled Microwave Heating Accelerates Rolling Circle Amplification	PLOS ONE			English	Article							ORGANIC-SYNTHESIS; PADLOCK PROBES; REPLICATION; OLIGONUCLEOTIDES; MOLECULES	Rolling circle amplification (RCA) generates single-stranded DNAs or RNA, and the diverse applications of this isothermal technique range from the sensitive detection of nucleic acids to analysis of single nucleotide polymorphisms. Microwave chemistry is widely applied to increase reaction rate as well as product yield and purity. The objectives of the present research were to apply microwave heating to RCA and indicate factors that contribute to the microwave selective heating effect. The microwave reaction temperature was strictly controlled using a microwave applicator optimized for enzymatic-scale reactions. Here, we showed that microwave-assisted RCA reactions catalyzed by either of the four thermostable DNA polymerases were accelerated over 4-folds compared with conventional RCA. Furthermore, the temperatures of the individual buffer components were specifically influenced by microwave heating. We concluded that microwave heating accelerated isothermal RCA of DNA because of the differential heating mechanisms of microwaves on the temperatures of reaction components, although the overall reaction temperatures were the same.	[Yoshimura, Takeo; Suzuki, Takamasa; Mineki, Shigeru] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 3058506, Japan; [Ohuchi, Shokichi] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Iizuka, Fukuoka 8208502, Japan	Tokyo University of Science; Kyushu Institute of Technology	Yoshimura, T (corresponding author), Tokyo Univ Sci, Dept Appl Biol Sci, 264 Yamazaki, Noda, Chiba 3058506, Japan.	yoshimura@rs.tus.ac.jp			Japan Society of the Promotion of Science [23655146]	Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society of the Promotion of Science, a Grant-in-Aid for Challenging Exploratory Research [23655146]; http://www.jsps.go.jp/english/index.html.	Abe N, 2013, ANGEW CHEM, V125, P7142; Baghbanzadeh M, 2011, ANGEW CHEM INT EDIT, V50, P11312, DOI 10.1002/anie.201101274; Bilecka I, 2010, NANOSCALE, V2, P1358, DOI 10.1039/b9nr00377k; BRANCH AD, 1984, SCIENCE, V223, P450, DOI 10.1126/science.6197756; Cheng YQ, 2008, ANAL BIOCHEM, V378, P123, DOI 10.1016/j.ab.2008.03.040; Collins JM, 2007, ORG BIOMOL CHEM, V5, P1141, DOI 10.1039/b617084f; DAROS JA, 1994, P NATL ACAD SCI USA, V91, P12813, DOI 10.1073/pnas.91.26.12813; Fermer C, 2003, EUR J PHARM SCI, V18, P129, DOI 10.1016/S0928-0987(02)00252-X; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; Goransson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031068; Gude V. G., 2013, SUSTAINABLE CHEM PRO, V1, P1, DOI DOI 10.1186/2043-7129-1-5; Hamblin GD, 2012, J AM CHEM SOC, V134, P2888, DOI 10.1021/ja2107492; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; Kappe C. O., 2012, MICROWAVES ORGANIC M, V2nd; Kappe CO, 2013, CHEM SOC REV, V42, P4977, DOI 10.1039/c3cs00010a; Kappe CO, 2009, MOL DIVERS, V13, P71, DOI 10.1007/s11030-009-9138-8; Kempitiya A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3078273; Korlach J, 2008, P NATL ACAD SCI USA, V105, P1176, DOI 10.1073/pnas.0710982105; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Lidstrom P, 2001, TETRAHEDRON, V57, P9225, DOI 10.1016/S0040-4020(01)00906-1; Liu DY, 1996, J AM CHEM SOC, V118, P1587, DOI 10.1021/ja952786k; Loupy A., 2006, MICROWAVES ORGANIC S; Martinez-Palou R, 2010, MOL DIVERS, V14, P3, DOI 10.1007/s11030-009-9159-3; Mochizuki D, 2011, MINI-REV ORG CHEM, V8, P294, DOI 10.2174/157019311796197409; Nagashima I, 2014, BIOSCI BIOTECH BIOCH, V78, P758, DOI 10.1080/09168451.2014.891931; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Orrling K, 2004, CHEM COMMUN, P790, DOI 10.1039/b317049g; Reddy PM, 2013, J PROTEOMICS, V80, P160, DOI 10.1016/j.jprot.2013.01.005; Sandoval WN, 2008, DRUG DISCOV TODAY, V13, P1075, DOI 10.1016/j.drudis.2008.08.007; Shaw KJ, 2010, LAB CHIP, V10, P1725, DOI 10.1039/c000357n; Suzuki M, 1996, J PHYS CHEM-US, V100, P7279, DOI 10.1021/jp953331k; Thomas DC, 1999, ARCH PATHOL LAB MED, V123, P1170; Wang B, 2005, J CLIN MICROBIOL, V43, P2339, DOI 10.1128/JCM.43.5.2339-2344.2005; Yadav GD, 2012, J MOL CATAL B-ENZYM, V81, P58, DOI 10.1016/j.molcatb.2012.05.007; Yoshimura Takeo, 2006, Nucleic Acids Symp Ser (Oxf), P305; Zhao H, 2009, J MOL CATAL B-ENZYM, V57, P149, DOI 10.1016/j.molcatb.2008.08.006	36	3	4	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0136532	10.1371/journal.pone.0136532	http://dx.doi.org/10.1371/journal.pone.0136532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348227	Green Submitted, Green Published, gold			2022-12-27	WOS:000360897600009
J	Anderson, GA; Udan, RS; Dickinson, ME; Henkelman, RM				Anderson, Gregory A.; Udan, Ryan S.; Dickinson, Mary E.; Henkelman, R. Mark			Cardiovascular Patterning as Determined by Hemodynamic Forces and Blood Vessel Genetics	PLOS ONE			English	Article							EMBRYONIC LETHALITY; VASCULAR DEFECTS; MICE LACKING; TGF-BETA; MOUSE; NOTCH; ENDOGLIN; VASCULOGENESIS; MORPHOGENESIS; ANGIOGENESIS	Background Vascular patterning depends on coordinated timing of arteriovenous specification of endothelial cells and the concomitant hemodynamic forces supplied by the onset of cardiac function. Using a combination of 3D imaging by OPT and embryo registration techniques, we sought to identify structural differences between three different mouse models of cardiovascular perturbation. Results Endoglin mutant mice shared a high degree of similarity to Mlc2a mutant mice, which have been shown to have a primary developmental heart defect causing secondary vessel remodeling failures. Dll4 mutant mice, which have well-characterized arterial blood vessel specification defects, showed distinct differences in vascular patterning when compared to the disruptions seen in Mlc2a(-/-) and Eng(-/-) models. While Mlc2a(-/-) and Eng(-/-) embryos exhibited significantly larger atria than wild-type, Dll(4-/-) embryos had significantly smaller hearts than wild-type, but this quantitative volume decrease was not limited to the developing atrium. Dll4(-/-) embryos also had atretic dorsal aortae and smaller trunks, suggesting that the cardiac abnormalities were secondary to primary arterial blood vessel specification defects. Conclusions The similarities in Eng(-/-) and Mlc2a(-/-) embryos suggest that Eng(-/-) mice may suffer from a primary heart developmental defect and secondary defects in vessel patterning, while defects in Dll4(-/-) embryos are consistent with primary defects in vessel patterning.	[Anderson, Gregory A.; Henkelman, R. Mark] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Anderson, Gregory A.; Henkelman, R. Mark] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Udan, Ryan S.; Dickinson, Mary E.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Baylor College of Medicine	Anderson, GA (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	gregory.anderson@mail.utoronto.ca	HENKELMAN, MARK/W-6847-2019		National Institute of Health [U54 HG006348-S1, R01 HL095586]; American Heart Association [10POST4280097]; National Institute of Health - National Institute of General Medical Sciences [K12 GM084897]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095586] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institute of Health - National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by: National Institute of Health, U54 HG006348-S1 (Mary E. Dickinson), National Institute of Health, R01 HL095586 (Mary E. Dickinson), American Heart Association, 10POST4280097 (Ryan S. Udan), and National Institute of Health - National Institute of General Medical Sciences, K12 GM084897, (Ryan S. Udan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GA, 2013, DEV DYNAM, V242, P527, DOI 10.1002/dvdy.23947; Argraves WS, 2005, ANAT REC PART A, V286A, P875, DOI 10.1002/ar.a.20232; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; Borges L, 2012, BLOOD, V119, P5417, DOI 10.1182/blood-2011-11-391896; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Carvalho RLC, 2004, DEVELOPMENT, V131, P6237, DOI 10.1242/dev.01529; Chaturvedi K, 2006, NEUROENDOCRINOLOGY, V83, P387, DOI 10.1159/000096049; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Culver JC, 2010, MICROCIRCULATION, V17, P164, DOI 10.1111/j.1549-8719.2010.00025.x; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gleave JA, 2012, PHYSIOL GENOMICS, V44, P778, DOI 10.1152/physiolgenomics.00055.2012; He C, 2008, DEVELOPMENT, V135, P2467, DOI 10.1242/dev.020131; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Huang CQ, 2003, DEVELOPMENT, V130, P6111, DOI 10.1242/dev.00831; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Kelsey L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003612; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; May SR, 2004, DEV BIOL, V270, P31, DOI 10.1016/j.ydbio.2004.02.006; Meadows SM, 2012, CIRC RES, V110, P34, DOI 10.1161/CIRCRESAHA.111.249847; Midgett M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0643; Nomura-Kitabayashi A, 2009, DEV BIOL, V335, P66, DOI 10.1016/j.ydbio.2009.08.016; Sacilotto N, 2013, P NATL ACAD SCI USA, V110, P11893, DOI 10.1073/pnas.1300805110; Schneider Juergen E., 2004, BMC Developmental Biology, V4, P1; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Slaney M., 1988, PRINCIPLES COMPUTERI; Solloway MJ, 2003, CARDIOVASC RES, V58, P264, DOI 10.1016/S0008-6363(03)00286-4; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Udan RS, 2013, DEVELOPMENT, V140, P4041, DOI 10.1242/dev.096255; Udan RS, 2013, WIRES DEV BIOL, V2, P327, DOI 10.1002/wdev.91; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Weninger WJ, 2006, ANAT EMBRYOL, V211, P213, DOI 10.1007/s00429-005-0073-x; Wong MD, 2014, DEVELOPMENT, V141, P2533, DOI 10.1242/dev.107722; Wong MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073491; Wong MD, 2012, DEVELOPMENT, V139, P3248, DOI 10.1242/dev.082016; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	46	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137175	10.1371/journal.pone.0137175	http://dx.doi.org/10.1371/journal.pone.0137175			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340748	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200030
J	Cao, LL; Ding, J; Dong, LG; Zhao, JY; Su, JM; Wang, LY; Sui, Y; Zhao, T; Wang, F; Jin, JJ; Cai, Y				Cao, Lingling; Ding, Jian; Dong, Liguo; Zhao, Jiayao; Su, Jiaming; Wang, Lingyao; Sui, Yi; Zhao, Tong; Wang, Fei; Jin, Jingji; Cai, Yong			Negative Regulation of p21(Waf1/Cip1) by Human INO80 Chromatin Remodeling Complex Is Implicated in Cell Cycle Phase G2/M Arrest and Abnormal Chromosome Stability	PLOS ONE			English	Article							P21; TRANSCRIPTION; REPLICATION; INHIBITOR; RECRUITMENT; SENESCENCE; PROTEINS; BIOLOGY; SITES	We previously identified an ATP-dependent human Ino80 (INO80) chromatin remodeling complex which shares a set of core subunits with yeast Ino80 complex. Although research evidence has suggested that INO80 complex functions in gene transcription and genome stability, the precise mechanism remains unclear. Herein, based on gene expression profiles from the INO80 complex-knockdown in HeLa cells, we first demonstrate that INO80 complex negatively regulates the p21(Waf1/Cip1) (p21) expression in a p53-mediated mechanism. In chromatin immunoprecipitation (ChIP) and a sequential ChIP (Re-ChIP) assays, we determined that the INO80 complex and p53 can bind to the same promoter region of p21 gene (-2.2kb and -1.0kb upstream of the p21 promoter region), and p53 is required for the recruitment of the INO80 complex to the p21 promoter. RNAi knockdown strategies of INO80 not only led to prolonged progression of cell cycle phase G2/M to G1, but it also resulted in abnormal chromosome stability. Interestingly, high expression of p21 was observed in most morphologically-changed cells, suggesting that negative regulation of p21 by INO80 complex might be implicated in maintaining the cell cycle process and chromosome stability. Together, our findings will provide a theoretical basis to further elucidate the cellular mechanisms of the INO80 complex.	[Cao, Lingling; Ding, Jian; Dong, Liguo; Zhao, Jiayao; Su, Jiaming; Wang, Lingyao; Sui, Yi; Zhao, Tong; Wang, Fei; Jin, Jingji; Cai, Yong] Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China; [Jin, Jingji; Cai, Yong] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China; [Jin, Jingji; Cai, Yong] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Jin, JJ (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China.	jjjin@jlu.edu.cn; caiyong62@jlu.edu.cn	Zhao, Jiayao/HDL-8501-2022	Dong, Liguo/0000-0002-8805-7487	National Natural Science Foundation of China [31071131, 31171245]; National Laboratory of Biomacromolecules, Institue of Biophysics, Chinese Academy of Sciences [O5SY02110A, 2012kf04]; Project of Jilin Province Science and Technology Development Program [20130413002GH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Laboratory of Biomacromolecules, Institue of Biophysics, Chinese Academy of Sciences; Project of Jilin Province Science and Technology Development Program	This work was supported by National Natural Science Foundation of China (No. 31071131&31171245, YC), National Laboratory of Biomacromolecules, Institue of Biophysics, Chinese Academy of Sciences (No. O5SY02110A, YC and 2012kf04, JJ) and the Project of Jilin Province Science and Technology Development Program (20130413002GH, YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2014, FEBS LETT, V588, P4065, DOI 10.1016/j.febslet.2014.09.033; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bennett G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3084; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cmielova J, 2011, J CELL BIOCHEM, V112, P3502, DOI 10.1002/jcb.23296; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Dutto I, 2015, ARCH TOXICOL, V89, P155, DOI 10.1007/s00204-014-1430-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gerhold CB, 2014, TRENDS CELL BIOL, V24, P619, DOI 10.1016/j.tcb.2014.06.004; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hur SK, 2010, CELL MOL LIFE SCI, V67, P2283, DOI 10.1007/s00018-010-0337-3; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kashiwaba S, 2010, BIOCHEM BIOPH RES CO, V402, P619, DOI 10.1016/j.bbrc.2010.10.066; Lee K, 2012, MECH AGEING DEV, V133, P686, DOI 10.1016/j.mad.2012.11.001; Li QL, 2014, ONCOTARGET, V5, P6387, DOI 10.18632/oncotarget.2201; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; Min JN, 2013, CELL RES, V23, P1396, DOI 10.1038/cr.2013.113; Nguyen VQ, 2013, CELL, V154, P1220, DOI 10.1016/j.cell.2013.08.018; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Seeber A, 2013, GENE DEV, V27, P1999, DOI 10.1101/gad.222992.113; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Truax AD, 2012, METHODS MOL BIOL, V809, P175, DOI 10.1007/978-1-61779-376-9_12; Tyson JJ, 2001, J THEOR BIOL, V210, P249, DOI 10.1006/jtbi.2001.2293; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vassileva I, 2014, NUCLEIC ACIDS RES, V42, P9074, DOI 10.1093/nar/gku605; Wang F, 2011, APOPTOSIS, V16, P301, DOI 10.1007/s10495-010-0559-8; Wang L, 2014, CELL STEM CELL, V14, P575, DOI 10.1016/j.stem.2014.02.013; Wang YM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-8; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Watanabe S, 2010, COLD SH Q B, V75, P35, DOI 10.1101/sqb.2010.75.063; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	45	16	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137411	10.1371/journal.pone.0137411	http://dx.doi.org/10.1371/journal.pone.0137411			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340092	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200054
J	Philippart, F; Bouroche, G; Timsit, JF; Garrouste-Orgeas, M; Azoulay, E; Darmon, M; Adrie, C; Allaouchiche, B; Ara-Somohano, C; Ruckly, S; Dumenil, AS; Souweine, B; Goldgran-Toledano, D; Bouadma, L; Misset, B				Philippart, Francois; Bouroche, Gaelle; Timsit, Jean-Francois; Garrouste-Orgeas, Maite; Azoulay, Elie; Darmon, Michael; Adrie, Christophe; Allaouchiche, Bernard; Ara-Somohano, Claire; Ruckly, Stephane; Dumenil, Anne-Sylvie; Souweine, Bertrand; Goldgran-Toledano, Dany; Bouadma, Lila; Misset, Benoit		Outcomerea Study Grp	Decreased Risk of Ventilator-Associated Pneumonia in Sepsis Due to Intra-Abdominal Infection	PLOS ONE			English	Article							ENDOTOXIN-TOLERANCE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; BACTERIAL CLEARANCE; HUMAN MONOCYTES; ANIMAL-MODELS; ORGAN FAILURE; LUNG INJURY; LIPOPOLYSACCHARIDE; MORTALITY	Rationale Experimental studies suggest that intra-abdominal infection (IAI) induces biological alterations that may affect the risk of lung infection. Objectives To investigate the potential effect of IAI at ICU admission on the subsequent occurrence of ventilator-associated pneumonia (VAP). Methods We used data entered into the French prospective multicenter Outcomerea database in 1997-2011. Consecutive patients who had severe sepsis and/or septic shock at ICU admission and required mechanical ventilation for more than 3 days were included. Patients with acute pancreatitis were not included. Measurements and Main Results Of 2623 database patients meeting the inclusion criteria, 290 (11.1%) had IAI and 2333 (88.9%) had other infections. The IAI group had fewer patients with VAP (56 [19.3%] vs. 806 [34.5%], P<0.01) and longer time to VAP (5.0 vs. 10.5 days; P<0.01). After adjustment on independent risk factors for VAP and previous antimicrobial use, IAI was associated with a decreased risk of VAP (hazard ratio, 0.62; 95% confidence interval, 0.46-0.83; P<0.0017). The pathogens responsible for VAP were not different between the groups with and without IAI (Pseudomonas aeruginosa, 345 [42.8%] and 24 [42.8%]; Enterobacteriaceae, 264 [32.8%] and 19 [34.0%]; and Staphylococcus aureus, 215 [26.7%] and 17 [30.4%], respectively). Crude ICU mortality was not different between the groups with and without IAI (81 [27.9%] and 747 [32.0%], P = 0.16). Conclusions In our observational study of mechanically ventilated ICU patients with severe sepsis and/or septic shock, VAP occurred less often and later in the group with IAIs compared to the group with infections at other sites.	[Philippart, Francois; Garrouste-Orgeas, Maite; Misset, Benoit] Grp Hosp Paris St Joseph, Med Surg ICU, Paris, France; [Bouroche, Gaelle] Inst Gustave Roussy, Dept Anesthesia & Intens Care, Villejuif, France; [Timsit, Jean-Francois; Garrouste-Orgeas, Maite; Ara-Somohano, Claire; Ruckly, Stephane] Univ Grenoble 1, U823, Albert Bonniot Inst, La Tronche, France; [Timsit, Jean-Francois] Grp Hosp Bichat Claude Bernard, Med ICU, Paris, France; [Azoulay, Elie] St Louis Teaching Hosp, Med ICU, Paris, France; [Azoulay, Elie; Bouadma, Lila] Univ Paris 07, Paris, France; [Darmon, Michael] St Etienne Hosp, Med ICU, St Etienne, France; [Adrie, Christophe] Cochin Hosp, Physiol Lab, Paris, France; [Allaouchiche, Bernard] Hop Edouard Herriot, Surg ICU, Lyon, France; [Allaouchiche, Bernard] Univ Lyon 1, F-69365 Lyon, France; [Ara-Somohano, Claire] Albert Michallon Teaching Hosp, Med ICU, Grenoble, France; [Dumenil, Anne-Sylvie] Hop Antoine Beclere, Surg ICU, Clamart, France; [Souweine, Bertrand] Gabriel Montpied Univ Hosp, Med ICU, Clermont Ferrand, France; [Goldgran-Toledano, Dany; Bouadma, Lila] Gonesse Hosp, Med Surg ICU, Gonesse, France; [Misset, Benoit] Univ Paris 05, Paris, France	Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Grenoble Alpes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; CHU Clermont Ferrand; UDICE-French Research Universities; Universite Paris Cite	Philippart, F (corresponding author), Grp Hosp Paris St Joseph, Med Surg ICU, Paris, France.	fphilippart@gmail.com	souweine, bertrand/HHR-8972-2022; Philippart, Francois/AAF-2791-2019; Misset, Benoit/P-7817-2018	Philippart, Francois/0000-0002-7323-0742; chevret, sylvie/0000-0001-6449-4730; Troche, Gilles/0000-0002-8150-6630; BOYER, Alexandre/0000-0003-4384-8872; MOURVILLIER, BRUNO/0000-0001-5227-1468; Darmon, Michael/0000-0003-4198-8038; Misset, Benoit/0000-0001-6466-0065				[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bekaert M, 2011, AM J RESP CRIT CARE, V184, P1133, DOI 10.1164/rccm.201105-0867OC; Bhatia M, 2012, AM J RESP CELL MOL, V46, P566, DOI 10.1165/rcmb.2011-0392TR; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cavaillon JM, 2006, J ENDOTOXIN RES, V12, P151, DOI 10.1179/096805106X102246; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; COX DR, 1972, J R STAT SOC B, V34, P187; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Fitting C, 2004, J INFECT DIS, V189, P1295, DOI 10.1086/382657; Franklin GA, 2003, AM J SURG, V186, P493, DOI 10.1016/j.amjsurg.2003.07.012; HARRIS SE, 1988, AM REV RESPIR DIS, V138, P1439, DOI 10.1164/ajrccm/138.6.1439; Heagy W, 2003, SHOCK, V19, P321, DOI 10.1097/00024382-200304000-00005; Hoogerwerf JJ, 2010, AM J RESP CELL MOL, V42, P349, DOI 10.1165/rcmb.2008-0362OC; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lu MF, 2008, CELL HOST MICROBE, V4, P293, DOI 10.1016/j.chom.2008.06.009; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; MCCARTNEY AC, 1983, INTENS CARE MED, V9, P117, DOI 10.1007/BF01772577; Morris AC, 2011, CRIT CARE MED, V39, P2218, DOI 10.1097/CCM.0b013e3182227d52; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Murphey ED, 2008, SHOCK, V29, P512, DOI 10.1097/SHK.0b013e318150776f; Neumann B, 1999, INT IMMUNOL, V11, P217, DOI 10.1093/intimm/11.2.217; Nguile-Makao M, 2010, INTENS CARE MED, V36, P781, DOI 10.1007/s00134-010-1824-6; Otero-Anton E, 2001, EUR SURG RES, V33, P77, DOI 10.1159/000049698; Parker LC, 2005, J LEUKOCYTE BIOL, V78, P1301, DOI 10.1189/jlb.0405236; Raven K, 2012, NAT MED, V18, P998, DOI 10.1038/nm0712-998a; Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shao BM, 2012, INNATE IMMUN-LONDON, V18, P825, DOI 10.1177/1753425912442431; Steinmuller M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-30; Thompson DA, 2006, ANN SURG, V243, P547, DOI 10.1097/01.sla.0000207097.38963.3b; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van Till JWO, 2007, SHOCK, V28, P504, DOI 10.1097/shk.0b013e318063e6ca; Varma TK, 2005, INFECT IMMUN, V73, P7340, DOI 10.1128/IAI.73.11.7340-7347.2005; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weijer S, 2002, J INFECT DIS, V186, P1748, DOI 10.1086/345675; Wheeler DS, 2008, SHOCK, V30, P267, DOI 10.1097/shk.0b013e318162c190; WHITE JC, 1986, J INFECT DIS, V153, P202, DOI 10.1093/infdis/153.2.202; ZHANG XK, 1993, J LEUKOCYTE BIOL, V54, P444, DOI 10.1002/jlb.54.5.444	45	2	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137262	10.1371/journal.pone.0137262	http://dx.doi.org/10.1371/journal.pone.0137262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339904	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200042
J	Jakubowicz, M; Berkowski, B; Lopez Correa, M; Jarochowska, E; Joachimski, M; Belka, Z				Jakubowicz, Michal; Berkowski, Blazej; Lopez Correa, Matthias; Jarochowska, Emilia; Joachimski, Michael; Belka, Zdzislaw			Stable Isotope Signatures of Middle Palaeozoic Ahermatypic Rugose Corals - Deciphering Secondary Alteration, Vital Fractionation Effects, and Palaeoecological Implications	PLOS ONE			English	Article							EASTERN ANTI-ATLAS; PENNSYLVANIAN KENDRICK FAUNA; HOLY CROSS MOUNTAINS; DEEP-SEA CORALS; ZIGZAG MICROSTRUCTURE; BIOLOGICAL CARBONATES; SCLERACTINIAN CORALS; SKELETAL CARBONATE; MUD MOUNDS; DIAGENESIS	This study investigates stable isotope signatures of five species of Silurian and Devonian deep-water, ahermatypic rugose corals, providing new insights into isotopic fractionation effects exhibited by Palaeozoic rugosans, and possible role of diagenetic processes in modifying their original isotopic signals. To minimize the influence of intraskeletal cements on the observed signatures, the analysed specimens included unusual species either devoid of large intraskeletal open spaces ('button corals': Microcyclus, Palaeocyclus), or typified by particularly thick corallite walls (Calceola). The corals were collected at four localities in the Holy Cross Mountains (Poland), Mader Basin (Morocco) and on Gotland (Sweden), representing distinct diagenetic histories and different styles of diagenetic alteration. To evaluate the resistance of the corallites to diagenesis, we applied various microscopic and trace element preservation tests. Distinct differences between isotopic compositions of the leastaltered and most-altered skeleton portions emphasise a critical role of material selection for geochemical studies of Palaeozoic corals. The least-altered parts of the specimens show marine or near-marine stable isotope signals and lack positive correlation between delta C-13 and delta O-18. In terms of isotopic fractionation mechanisms, Palaeozoic rugosans must have differed considerably from modern deep-water scleractinians, typified by significant depletion in both O-18 and C-13, and pronounced delta C-13-delta O-18 co-variance. The fractionation effects exhibited by rugosans seem similar rather to the minor isotopic effects typical of modern non-scleractinian corals (octocorals and hydrocorals). The results of the present study add to growing evidence for significant differences between Scleractinia and Rugosa, and agree with recent studies indicating that calcification mechanisms developed independently in these two groups of cnidarians. Consequently, particular caution is needed in using scleractinians as analogues in isotopic studies of extinct coral lineages. Answering some of the pertinent palaeoecological questions, such as that of the possibility of photosymbiosis in Palaeozoic corals, may not be possible based on stable isotope data.	[Jakubowicz, Michal] Adam Mickiewicz Univ, Inst Geoecol & Geoinformat, Poznan, Poland; [Berkowski, Blazej] Adam Mickiewicz Univ, Inst Geol, Poznan, Poland; [Lopez Correa, Matthias; Jarochowska, Emilia; Joachimski, Michael] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, D-91054 Erlangen, Germany; [Lopez Correa, Matthias] German Univ Technol Oman GUtech, Muscat, Oman; [Belka, Zdzislaw] Adam Mickiewicz Univ, Isotope Lab, Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University; University of Erlangen Nuremberg; Adam Mickiewicz University	Jakubowicz, M (corresponding author), Adam Mickiewicz Univ, Inst Geoecol & Geoinformat, Poznan, Poland.	mjakub@amu.edu.pl	Belka, Zdzislaw/A-5177-2008; Joachimski, Michael M./B-9477-2011; Correa, Matthias López/A-2477-2011; Jarochowska, Emilia/AAK-1439-2021; Berkowski, Blazej/A-1244-2008; Jakubowicz, Michal/Q-6329-2016	Belka, Zdzislaw/0000-0001-9634-610X; Correa, Matthias López/0000-0002-6996-1876; Jarochowska, Emilia/0000-0001-8937-9405; Jakubowicz, Michal/0000-0001-7995-0532; Berkowski, Blazej/0000-0001-7249-0182; Joachimski, Michael/0000-0001-6088-3261	Polish Ministry of Science and Higher Education [IP2014 016373]; German Academic Exchange Service (DAAD)	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The study was funded by a Polish Ministry of Science and Higher Education grant No. IP2014 016373. MJ was supported by German Academic Exchange Service (DAAD) during his stay at Friedrich-Alexander University. MJ is a scholarship holder of Adam Mickiewicz University Foundation for the academic year 2014-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JF, 2003, GEOCHIM COSMOCHIM AC, V67, P1129, DOI 10.1016/S0016-7037(02)01203-6; Ahmad SM, 2011, QUATERN INT, V238, P107, DOI 10.1016/j.quaint.2009.11.020; Allison N, 2007, GEOCHIM COSMOCHIM AC, V71, P4693, DOI 10.1016/j.gca.2007.07.026; [Anonymous], 2001, ATLAS EARTH HIST; BANNER JL, 1990, GEOCHIM COSMOCHIM AC, V54, P3123, DOI 10.1016/0016-7037(90)90128-8; Barbin Vincent, 1995, Geobios Memoire Special (Villeurbanne), V18, P39; Bathurst R.G., 1975, CARBONATE SEDIMENTS; Belka Z, 1998, J SEDIMENT RES, V68, P368, DOI 10.2110/jsr.68.368; Berkowski B, 2008, PALAEOGEOGR PALAEOCL, V265, P87, DOI 10.1016/j.palaeo.2008.04.018; Berkowski B, 2008, PALAEONTOGR ABT A, V284, P17; Black H, 2012, U ALABAMA MCNAIR J, V12, P19; BRAND U, 1981, CHEM GEOL, V32, P1, DOI 10.1016/0009-2541(81)90124-8; BRAND U, 1989, GLOBAL PLANET CHANGE, V75, P311, DOI 10.1016/0921-8181(89)90008-8; BRAND U, 1981, J SEDIMENT PETROL, V51, P987; Brand U, 2004, CHEM GEOL, V204, P23, DOI 10.1016/j.chemgeo.2003.10.013; Brand U, 2003, CHEM GEOL, V198, P305, DOI 10.1016/S0009-2541(03)00032-9; BRAND U, 1983, CHEM GEOL, V40, P167, DOI 10.1016/0009-2541(83)90097-9; BRAND U, 1981, CHEM GEOL, V32, P17, DOI 10.1016/0009-2541(81)90125-X; Brand U., 2011, ASS AUSTR PALEONTOL, V41, P9; Calner M., 2004, ERLANGER GEOLOGISCHE, V5, P113; Constantz B.R., 1986, P53; Coronado I, 2013, PALAEOGEOGR PALAEOCL, V386, P286, DOI 10.1016/j.palaeo.2013.05.030; DENISON RE, 1994, CHEM GEOL, V112, P131, DOI 10.1016/0009-2541(94)90110-4; Doring S, 2001, FACIES, V44, P137, DOI 10.1007/BF02668171; Dzik J., 1981, Przeglad Geologiczny, V29, P125; Enmar R, 2000, GEOCHIM COSMOCHIM AC, V64, P3123, DOI 10.1016/S0016-7037(00)00417-8; Ezaki Y, 1997, PALAEONTOLOGY, V40, P1; Fedorowski J, 1997, ACTA PALAEONTOL POL, V42, P446; Fedorowski J., 2003, GEOLOGOS, V6, P89; Franchi F, 2012, B GEOSCI, V87, P1, DOI 10.3140/bull.geosci.1294; Frankowiak K, 2013, PALAIOS, V28, P333, DOI 10.2110/palo.2012.p12-116r; Gagan MK, 2000, QUATERNARY SCI REV, V19, P45, DOI 10.1016/S0277-3791(99)00054-2; GIVEN RK, 1985, J SEDIMENT PETROL, V55, P430; Grottoli AG, 2007, EARTH-SCI REV, V81, P67, DOI 10.1016/j.earscirev.2006.10.001; Heikoop JM, 2000, GEOCHIM COSMOCHIM AC, V64, P975, DOI 10.1016/S0016-7037(99)00363-4; Hendy EJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001462; HENRICH R, 1995, FACIES, V32, P71, DOI 10.1007/BF02536865; Hill D., 1981, TREATISE INVERTEBRAT; Hill TM, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003443; Jaffres JBD, 2007, EARTH-SCI REV, V83, P83, DOI 10.1016/j.earscirev.2007.04.002; JAMES NP, 1983, GEOSCI CAN, V10, P162; Jeppsson L, 2006, GFF, V128, P109, DOI 10.1080/11035890601282109; Joachimski MM, 2005, GEOCHIM COSMOCHIM AC, V69, P4035, DOI 10.1016/j.gca.2004.11.017; Kaufmann B, 1997, J SEDIMENT RES, V67, P945; Kaufmann B., 1998, ACTA GEOL POL, V48, P43; Kaufmann Bernd, 1998, Geological Society Special Publication, V149, P417, DOI 10.1144/GSL.SP.1999.149.01.19; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; Lazar B, 2004, GEOCHIM COSMOCHIM AC, V68, P4583, DOI 10.1016/j.gca.2004.03.029; Lee MR, 2005, J SEDIMENT RES, V75, P313, DOI 10.2110/jsr.2005.023; LONGMAN MW, 1980, AAPG BULL, V64, P461; Lopez Correa M, 2010, DEEP-SEA RES PT II, V57, P471, DOI 10.1016/j.dsr2.2009.08.016; MACHEL HG, 1991, SEPM SHORT, V25, P9; Marali S, 2013, PALAEOGEOGR PALAEOCL, V373, P25, DOI 10.1016/j.palaeo.2012.06.017; MARSHALL JD, 1992, GEOL MAG, V129, P143, DOI 10.1017/S0016756800008244; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P151, DOI 10.1016/0016-7037(89)90282-2; McConnaughey TA, 2003, CORAL REEFS, V22, P316, DOI 10.1007/s00338-003-0325-2; McConnaughey TA, 1997, GEOCHIM COSMOCHIM AC, V61, P611, DOI 10.1016/S0016-7037(96)00361-4; Melim LA, 2002, MAR GEOL, V185, P27, DOI 10.1016/S0025-3227(01)00289-4; Mienis F, 2008, THESIS VRIJE U AMSTE; Moore C.H., 1989, CARBONATE DIAGENESIS; Muller A, 2001, GEOPHYS RES LETT, V28, P4471, DOI 10.1029/2001GL013577; Munnecke A, 1996, FACIES, V34, P159, DOI 10.1007/BF02546162; Munnecke A, 2003, PALAEOGEOGR PALAEOCL, V195, P99, DOI 10.1016/S0031-0182(03)00304-3; NEUMAN BEE, 1988, LETHAIA, V21, P97, DOI 10.1111/j.1502-3931.1988.tb00801.x; Nothdurft Luke D., 2007, Schriftenreihe der Erdwissenschaftlichen Kommissionen, V17, P85; Nothdurft LD, 2009, FACIES, V55, P161, DOI 10.1007/s10347-008-0167-z; Oliver William A. Jr, 1996, Paleontological Society Papers, V1, P107; Pajchlowa M, 1957, B I GEOLOGICZNEGO, V122, P145; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; PATTERSON WP, 1994, GEOLOGY, V22, P127, DOI 10.1130/0091-7613(1994)022<0127:SDOMPC>2.3.CO;2; Perrin C, 2007, J SEDIMENT RES, V77, P495, DOI 10.2110/jsr.2007.051; Plusquellec Y., 1971, Annls Soc geol Nord, V91, P129; POPP BN, 1986, J SEDIMENT PETROL, V56, P715; Poprawa P, 1999, TECTONOPHYSICS, V314, P219, DOI 10.1016/S0040-1951(99)00245-0; Rabier C, 2008, SEDIMENT GEOL, V211, P73, DOI 10.1016/j.sedgeo.2008.08.005; Richter DK, 2003, MINER PETROL, V79, P127, DOI 10.1007/s00710-003-0237-4; Rodriguez S., 1989, Memoir of the Association of Australasian Palaeontologists, V8, P157; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Rosales I, 2001, SEDIMENTOLOGY, V48, P1149, DOI 10.1046/j.1365-3091.2001.00412.x; Sadler J, 2014, EARTH-SCI REV, V139, P291, DOI 10.1016/j.earscirev.2014.10.002; SANDBERG PA, 1975, J PALEONTOL, V49, P587; Sayani HR, 2011, GEOCHIM COSMOCHIM AC, V75, P6361, DOI 10.1016/j.gca.2011.08.026; Scrutton Colin T., 1996, Proceedings of the Yorkshire Geological Society, V51, P1; Scrutton CT, 1998, P YORKS GEOL SOC, V52, P1, DOI 10.1144/pygs.52.1.1; Scrutton CT, 1997, P YORKS GEOL SOC, V51, P177, DOI 10.1144/pygs.51.3.177; Smith AM, 2003, EARTH-SCI REV, V63, P1, DOI 10.1016/S0012-8252(02)00164-2; Smith JE, 2000, PALAIOS, V15, P25, DOI 10.2307/3515589; Sorauf James E., 1993, Courier Forschungsinstitut Senckenberg, V164, P63; Sorauf JE, 1996, PALAIOS, V11, P64, DOI 10.2307/3515117; Sorauf JE, 2003, J PALEONTOL, V77, P16, DOI 10.1666/0022-3360(2003)077<0016:TOASOZ>2.0.CO;2; Soto F., 1978, Trabajos de Geologia, V10, P425; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; STANLEY GD, 1995, PALEOBIOLOGY, V21, P179, DOI 10.1017/S0094837300013191; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stolarski J, 2007, SCIENCE, V318, P92, DOI 10.1126/science.1149237; Stolarski J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-316; Stolarski Jaroslaw, 1993, Courier Forschungsinstitut Senckenberg, V164, P169; Turnau E, 1999, REV PALAEOBOT PALYNO, V106, P237, DOI 10.1016/S0034-6667(99)00011-1; van Geldern R, 2006, PALAEOGEOGR PALAEOCL, V240, P47, DOI 10.1016/j.palaeo.2006.03.045; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; Webb GE, 2002, GEOLOGY, V30, P415, DOI 10.1130/0091-7613(2002)030<0415:ZMIRCA>2.0.CO;2; WEBER JN, 1970, CHEM GEOL, V6, P93, DOI 10.1016/0009-2541(70)90009-4; WEBER JN, 1972, MAR BIOL, V15, P293, DOI 10.1007/BF00401388; WEFER G, 1991, MAR GEOL, V100, P207, DOI 10.1016/0025-3227(91)90234-U; Wenzel B, 1996, PALAEOGEOGR PALAEOCL, V122, P143, DOI 10.1016/0031-0182(95)00094-1; Wisshak M, 2009, MAR ECOL PROG SER, V397, P197, DOI 10.3354/meps08165; Wood R, 2003, T GEOBIOL, V20, P33; WRIGHT AJ, 2010, MEM ASSOC AUSTRALAS, P159; Zapalski MK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2663; Zaton M, 2011, J PALEONTOL, V85, P757, DOI 10.1666/11-005.1	110	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136289	10.1371/journal.pone.0136289	http://dx.doi.org/10.1371/journal.pone.0136289			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334730	gold, Green Published, Green Submitted			2022-12-27	WOS:000360615400013
J	Mao, XB; Liu, MH; Tang, J; Chen, H; Chen, DW; Yu, B; He, J; Yu, J; Zheng, P				Mao, Xiangbing; Liu, Minghui; Tang, Jun; Chen, Hao; Chen, Daiwen; Yu, Bing; He, Jun; Yu, Jie; Zheng, Ping			Dietary Leucine Supplementation Improves the Mucin Production in the Jejunal Mucosa of the Weaned Pigs Challenged by Porcine Rotavirus	PLOS ONE			English	Article							SIGNALING PATHWAY; IMMUNE-RESPONSES; BARRIER FUNCTION; INTESTINAL BARRIER; PROTEIN-METABOLISM; C2C12 MYOTUBES; WEANLING PIGS; FED PIGLETS; THREONINE; MUSCLE	The present study was mainly conducted to determine whether dietary leucine supplementation could attenuate the decrease of the mucin production in the jejunal mucosa of weaned pigs infected by porcine rotavirus (PRV). A total of 24 crossbred barrows weaned at 21 d of age were assigned randomly to 1 of 2 diets supplemented with 1.00% L-leucine or 0.68% L-alanine (isonitrogenous control) for 17 d. On day 11, all pigs were orally infused PRV or the sterile essential medium. During the first 10 d of trial, dietary leucine supplementation could improve the feed efficiency (P = 0.09). The ADG and feed efficiency were impaired by PRV infusion (P<0.05). PRV infusion also increased mean cumulative score of diarrhea, serum rotavirus antibody concentration and crypt depth of the jejunal mucosa (P<0.05), and decreased villus height: crypt depth (P = 0.07), goblet cell numbers (P<0.05), mucin 1 and 2 concentrations (P<0.05) and phosphorylated mTOR level (P<0.05) of the jejunal mucosa in weaned pigs. Dietary leucine supplementation could attenuate the effects of PRV infusion on feed efficiency (P = 0.09) and mean cumulative score of diarrhea (P = 0.09), and improve the effects of PRV infusion on villus height: crypt depth (P = 0.06), goblet cell numbers (P<0.05), mucin 1 (P = 0.08) and 2 (P = 0.07) concentrations and phosphorylated mTOR level (P = 0.08) of the jejunal mucosa in weaned pigs. These results suggest that dietary 1% leucine supplementation alleviated the decrease of mucin production and goblet cell numbers in the jejunal mucosa of weaned pigs challenged by PRV possibly via activation of the mTOR signaling.	[Mao, Xiangbing; Liu, Minghui; Tang, Jun; Chen, Hao; Chen, Daiwen; Yu, Bing; He, Jun; Yu, Jie; Zheng, Ping] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China; [Mao, Xiangbing; Liu, Minghui; Tang, Jun; Chen, Hao; Chen, Daiwen; Yu, Bing; He, Jun; Yu, Jie; Zheng, Ping] Minist Educ, Key Lab Anim Dis Resistance Nutr, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University	Mao, XB (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China.	acatmxb2003@163.com			National Natural Science Foundation of China [31201812]; earmarked fund for the China Agriculture Research System [CARS-36]; Science and Technology Support Program of Sichuan Province [13ZC2237]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the China Agriculture Research System; Science and Technology Support Program of Sichuan Province	This study was financially supported by the grant from National Natural Science Foundation of China (31201812), the earmarked fund for the China Agriculture Research System (CARS-36), and the grant from the Science and Technology Support Program of Sichuan Province (13ZC2237).	[Anonymous], 1998, NUTRIENT REQUIREMENT; Arnold MM, 2011, J VIROL, V85, P1970, DOI 10.1128/JVI.01801-10; Association of Official Analytical Chemists, 1995, 99003 AOAC; Balage M, 2011, J NUTR BIOCHEM, V22, P219, DOI 10.1016/j.jnutbio.2010.02.001; Bansil R, 2006, CURR OPIN COLLOID IN, V11, P164, DOI 10.1016/j.cocis.2005.11.001; BARNETT B, 1983, MED CLIN N AM, V67, P1031, DOI 10.1016/S0025-7125(16)31165-8; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Boshuizen JA, 2005, VIROLOGY, V337, P210, DOI 10.1016/j.virol.2005.03.039; Botic T, 2007, INT J FOOD MICROBIOL, V115, P227, DOI 10.1016/j.ijfoodmicro.2006.10.044; Chen H, 2015, J NUTR, V145, P51, DOI 10.3945/jn.114.201772; Chen H, 2013, BRIT J NUTR, V110, P1837, DOI 10.1017/S0007114513001293; Chu L., 2012, THESIS CHINA AGR U; Coeffier M, 2011, AM J CLIN NUTR, V93, P1255, DOI 10.3945/ajcn.111.013649; COMA J, 1995, J ANIM SCI, V73, P472; Dibner JJ, 2004, J APPL POULTRY RES, V13, P86, DOI 10.1093/japr/13.1.86; Dodd KM, 2012, AM J PHYSIOL-ENDOC M, V302, pE1329, DOI 10.1152/ajpendo.00525.2011; DONELLI GO, 1994, COMP IMMUNOL MICROB, V17, P305, DOI 10.1016/0147-9571(94)90050-7; EDMONDS MS, 1987, J ANIM SCI, V64, P1664, DOI 10.2527/jas1987.6461664x; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Forstner Janet F., 1994, P1255; GATNAU R, 1995, J ANIM SCI, V73, P159; Goodman CA, 2014, REV PHYSIOL BIOCH P, V166, P43, DOI 10.1007/112_2013_17; Langkamp-Henken B, 1992, Nutr Clin Pract, V7, P100, DOI 10.1177/0115426592007003100; Liu FN, 2010, VIRAL IMMUNOL, V23, P135, DOI 10.1089/vim.2009.0088; Lopez N, 2010, PEPTIDES, V31, P1361, DOI 10.1016/j.peptides.2010.03.028; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Magalhaes JG, 2007, SEMIN IMMUNOL, V19, P106, DOI 10.1016/j.smim.2006.12.006; MANTLE M, 1981, BIOCHEM J, V195, P267, DOI 10.1042/bj1950267; Mao X, 2011, CHINESE J ANIM SCI, V47, P26; Mao XB, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-49; Mao XB, 2013, BRIT J NUTR, V110, P256, DOI 10.1017/S0007114512004849; Mao XB, 2011, MOL BIOL REP, V38, P3201, DOI 10.1007/s11033-010-9992-6; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Rieu I, 2003, J NUTR, V133, P1198, DOI 10.1093/jn/133.4.1198; Roh C, 2003, AM J PHYSIOL-ENDOC M, V284, pE322, DOI 10.1152/ajpendo.00230.2002; Sasaki M, 2007, PROG HISTOCHEM CYTO, V42, P61, DOI 10.1016/j.proghi.2007.02.001; Schaart MW, 2005, J NUTR, V135, P765, DOI 10.1093/jn/135.4.765; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Stoll B, 1999, AM J PHYSIOL-ENDOC M, V277, pE168, DOI 10.1152/ajpendo.1999.277.1.E168; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Torrazza RM, 2010, J NUTR, V140, P2145, DOI 10.3945/jn.110.128421; Wang WW, 2010, J NUTR, V140, P981, DOI 10.3945/jn.109.118497; Wu SP, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-22; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Yuan LJ, 1998, J VIROL, V72, P330, DOI 10.1128/JVI.72.1.330-338.1998; Zhao Y, 2014, BRIT J NUTR, V112, P381, DOI 10.1017/S000711451400097X	48	21	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137380	10.1371/journal.pone.0137380	http://dx.doi.org/10.1371/journal.pone.0137380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26336074	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400056
J	Yong, CSM; Sharkey, J; Duscio, B; Venville, B; Wei, WZ; Jones, RF; Slaney, CY; Arnau, GM; Papenfuss, AT; Schroder, J; Darcy, PK; Kershaw, MH				Yong, Carmen S. M.; Sharkey, Janelle; Duscio, Belinda; Venville, Ben; Wei, Wei-Zen; Jones, Richard F.; Slaney, Clare Y.; Arnau, Gisela Mir; Papenfuss, Anthony T.; Schroeder, Jan; Darcy, Phillip K.; Kershaw, Michael H.			Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; MAMMARY-TUMOR VIRUS; MODIFIED T-CELLS; CHROMOSOMAL INTEGRATION; DNA VACCINATION; COPY NUMBER; FUSION GENE; EXPRESSION; CANCER; PROTEIN	The development of antigen-targeted therapeutics is dependent on the preferential expression of tumor-associated antigens (TAA) at targetable levels on the tumor. Tumor-associated antigens can be generated de novo or can arise from altered expression of normal basal proteins, such as the up-regulation of human epidermal growth factor receptor 2 (Her2/ErbB2). To properly assess the development of Her2 therapeutics in an immune tolerant model, we previously generated a transgenic mouse model in which expression of the human Her2 protein was present in both the brain and mammary tissue. This mouse model has facilitated the development of Her2 targeted therapies in a clinically relevant and suitable model. While heterozygous Her2(+/-) mice appear to develop in a similar manner to wild type mice (Her2(-/-)), it has proven difficult to generate homozygous Her2(+/+) mice, potentially due to embryonic lethality. In this study, we performed whole genome sequencing to determine if the integration site of the Her2 transgene was responsible for this lethality. Indeed, we report that the Her2 transgene had integrated into the Pds5b (precocious dissociation of sisters) gene on chromosome 5, as a 162 copy concatemer. Furthermore, our findings demonstrate that Her2(+/+) mice, similar to Pds5b(-/-) mice, are embryonic lethal and confirm the necessity for Pds5b in embryonic development. This study confirms the value of whole genome sequencing in determining the integration site of transgenes to gain insight into associated phenotypes.	[Yong, Carmen S. M.; Sharkey, Janelle; Duscio, Belinda; Venville, Ben; Slaney, Clare Y.; Darcy, Phillip K.; Kershaw, Michael H.] Univ Melbourne, Canc Immunol Res Program, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Wei, Wei-Zen; Jones, Richard F.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Wei, Wei-Zen; Jones, Richard F.] Karmanos Canc Inst, Detroit, MI USA; [Arnau, Gisela Mir; Papenfuss, Anthony T.] Peter MacCallum Canc Ctr, Mol Genom Core, East Melbourne, Vic 3002, Australia; [Papenfuss, Anthony T.; Schroeder, Jan] Peter MacCallum Canc Ctr, Bioinformat & Canc Genom, East Melbourne, Vic 3002, Australia; [Papenfuss, Anthony T.; Schroeder, Jan] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Papenfuss, Anthony T.; Schroeder, Jan] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Schroeder, Jan] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3010, Australia; [Darcy, Phillip K.] Monash Univ, Dept Immunol, Prahran, Vic 3181, Australia	Peter Maccallum Cancer Center; University of Melbourne; Wayne State University; Barbara Ann Karmanos Cancer Institute; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Monash University	Kershaw, MH (corresponding author), Univ Melbourne, Canc Immunol Res Program, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia.	michael.kershaw@petermac.org	Papenfuss, Anthony T/C-6297-2008; Slaney, Clare/AHC-2382-2022	Papenfuss, Anthony T/0000-0002-1102-8506; Slaney, Clare/0000-0002-6986-6115; Mir Arnau, Gisela/0000-0002-9005-3485; SCHROEDER, JAN/0000-0001-5270-0605; Darcy, Phillip/0000-0002-5303-9561; Kershaw, Michael/0000-0002-2697-487X	Cancer Council of Victoria, Australia [1066554]; National Health and Medical Research Council (NHMRC) of Australia [1003667]; Senior Research Fellowships from the NHMRC; National Health and Medical Research Council (NHMRC) Career Development Fellowship [1003856]; NHMRC Program [1054618]; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme; National Breast Cancer Foundation [PF-12-14] Funding Source: researchfish	Cancer Council of Victoria, Australia(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Senior Research Fellowships from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme(Australian GovernmentNational Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	This work was supported by grants from the Cancer Council of Victoria, Australia (1066554) and the National Health and Medical Research Council (NHMRC) of Australia (1003667). MHK and PKD were supported by Senior Research Fellowships from the NHMRC. ATP was supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship (1003856), an NHMRC Program Grant (1054618) and benefitted from support by the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP JO, 1989, MOL BIOL MED, V6, P283; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; BRINSTER RL, 1981, CELL, V27, P223, DOI 10.1016/0092-8674(81)90376-7; Burstein HJ, 2005, NEW ENGL J MED, V353, P1652, DOI 10.1056/NEJMp058197; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Chen ZY, 2001, MOL THER, V3, P403, DOI 10.1006/mthe.2001.0278; CHOI YW, 1987, J VIROL, V61, P3013, DOI 10.1128/JVI.61.10.3013-3019.1987; De Giovanni C, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3602; Finkle D, 2004, CLIN CANCER RES, V10, P2499, DOI 10.1158/1078-0432.CCR-03-0448; FOLGER KR, 1982, MOL CELL BIOL, V2, P1372, DOI 10.1128/MCB.2.11.1372; Geck P, 2000, P NATL ACAD SCI USA, V97, P10185, DOI 10.1073/pnas.97.18.10185; HAMADA T, 1993, GENE, V128, P197, DOI 10.1016/0378-1119(93)90563-I; Hanker AB, 2013, P NATL ACAD SCI USA, V110, P14372, DOI 10.1073/pnas.1303204110; HENRARD D, 1988, J VIROL, V62, P3046, DOI 10.1128/JVI.62.8.3046-3049.1988; Jacob JB, 2010, CANCER RES, V70, P119, DOI 10.1158/0008-5472.CAN-09-2554; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Kershaw MH, 2004, J IMMUNOL, V173, P2143, DOI 10.4049/jimmunol.173.3.2143; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Mar N, 2015, LUNG CANCER, V87, P220, DOI 10.1016/j.lungcan.2014.12.018; Matsuoka T, 2015, WORLD J CLIN CASES, V3, P42, DOI 10.12998/wjcc.v3.i1.42; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Piechocki MP, 2003, J IMMUNOL, V171, P5787, DOI 10.4049/jimmunol.171.11.5787; PITTIUS CW, 1988, P NATL ACAD SCI USA, V85, P5874, DOI 10.1073/pnas.85.16.5874; Pollock NI, 2015, CLIN CANCER RES, V21, P526, DOI 10.1158/1078-0432.CCR-14-1432; Pupa SM, 2001, GENE THER, V8, P75, DOI 10.1038/sj.gt.3301360; Radkevich-Brown O, 2009, CANCER RES, V69, P212, DOI 10.1158/0008-5472.CAN-08-3092; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Ross JS, 1998, STEM CELLS, V16, P413, DOI 10.1002/stem.160413; Schroder J, 2014, BIOINFORMATICS; SHILONI E, 1993, CANCER IMMUNOL IMMUN, V37, P286, DOI 10.1007/BF01518450; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Singer SM, 1996, P NATL ACAD SCI USA, V93, P2947, DOI 10.1073/pnas.93.7.2947; Singer T, 2003, METH MOL B, V236, P241; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; Wang LXJ, 2010, CANCER RES, V70, P9591, DOI 10.1158/0008-5472.CAN-10-2884; Wang SH, 2014, INT J BIOL SCI, V10, P25, DOI 10.7150/ijbs.6309; Wang SW, 2002, J CELL SCI, V115, P587; WEN JY, 1995, MOL REPROD DEV, V41, P399, DOI 10.1002/mrd.1080410402; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; Yan BW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-58; Zerafa N, 2005, J IMMUNOL, V175, P5586, DOI 10.4049/jimmunol.175.9.5586; Zhang B, 2007, DEVELOPMENT, V134, P3191, DOI 10.1242/dev.005884; Zhang B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005232; Zhang M, 2000, ONCOGENE, V19, P6053, DOI 10.1038/sj.onc.1204006	51	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136817	10.1371/journal.pone.0136817	http://dx.doi.org/10.1371/journal.pone.0136817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334628	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400028
J	Suh, JH; Chattopadhyay, A; Sieglaff, DH; Samaniego, CS; Cox, MB; Webb, P				Suh, Ji Ho; Chattopadhyay, Arundhati; Sieglaff, Douglas H.; Samaniego, Cheryl Storer; Cox, Marc B.; Webb, Paul			Similarities and Distinctions in Actions of Surface-Directed and Classic Androgen Receptor Antagonists	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; NUCLEAR RECEPTOR; DOMAIN; ANTIANDROGEN; EXPRESSION; TRANSCRIPTION; INHIBITION; MECHANISMS	The androgen receptor (AR) surface-directed antagonist MJC13 inhibits AR function and proliferation of prostate cancer (PC) cells. These effects are related to arrest of an AR/chaperone complex in the cytoplasm. Here, we compared MJC13 and classic AR antagonists such as flutamide and bicalutamide. Microarray analysis and confirmatory qRT-PCR reveals that MJC13 and flutamide inhibit dihydrotestosterone (DHT)-dependent genes in LNCaP PC cells. Both compounds are equally effective on a genome wide basis and as effective as second generation AR antagonists (MDV3100, ARN-509) at selected genes. MJC13 inhibits AR binding to the prostate specific antigen (PSA) promoter more strongly than flutamide, consistent with different mechanisms of action. Examination of efficacy of MJC13 in conditions that reflect aspects castrate resistant prostate cancer (CRPC) reveals that it inhibits flutamide activation of an AR mutant (ART877A) that emerges during flutamide withdrawal syndrome, but displays greatly restricted gene-specific activity in 22Rv1 cells that express a constitutively active truncated AR and is inactive against glucocorticoid receptor (GR), which can co-opt androgen-dependent signaling networks in CRPC. Importantly, MJC13 inhibits AR interactions with SRC2 and beta-catenin in the nucleus and, unlike flutamide, strongly inhibits amplification of AR activity obtained with transfected SRC2 and beta-catenin. MJC13 also inhibits DHT and beta-catenin-enhanced cell division in LNCaP cells. Thus, a surface-directed antagonist can block AR activity in some conditions in which a classic antagonist fails and may display utility in particular forms of CRPC.	[Suh, Ji Ho; Chattopadhyay, Arundhati; Sieglaff, Douglas H.; Webb, Paul] Houston Methodist Res Inst, Genom Med Program, Houston, TX 77030 USA; [Samaniego, Cheryl Storer; Cox, Marc B.] Univ Texas El Paso, Border Biomed Res Ctr, Dept Biol Sci, El Paso, TX 79902 USA	The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; University of Texas El Paso	Webb, P (corresponding author), Houston Methodist Res Inst, Genom Med Program, 66670 Bertner Ave,R8-114, Houston, TX 77030 USA.	PWebb@tmhs.org		Cox, Marc/0000-0001-7854-2676	Cancer Prevention and Research Institute of Texas (CPRIT) [RP110444-P3, RP110444-C2, RP110444-P2]	Cancer Prevention and Research Institute of Texas (CPRIT)	Cancer Prevention and Research Institute of Texas (CPRIT), http://www.cprit.state.tx.us/. RP110444-P3 (PW); RP110444-C2 (PW); RP110444-P2 (MBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Askew EB, 2012, MOL CELL ENDOCRINOL, V348, P403, DOI 10.1016/j.mce.2011.03.026; Bao BY, 2008, PROSTATE, V68, P839, DOI 10.1002/pros.20749; Beildeck ME, 2010, EXP CELL RES, V316, P1763, DOI 10.1016/j.yexcr.2010.02.001; Bergerat JP, 2009, HUM MUTAT, V30, P145, DOI 10.1002/humu.20848; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; De Leon JT, 2011, P NATL ACAD SCI USA, V108, P11878, DOI 10.1073/pnas.1105160108; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Fletterick RJ, 2005, BJU INT, V96, P2, DOI 10.1111/j.1464-410X.2005.05940.x; Grosdidier S, 2012, MOL ENDOCRINOL, V26, P1078, DOI 10.1210/me.2011-1281; Gupta E, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-55; Haile S, 2011, CELL MOL LIFE SCI, V68, P3971, DOI 10.1007/s00018-011-0766-7; Hu YC, 2004, J BIOL CHEM, V279, P33438, DOI 10.1074/jbc.M401781200; Ishioka J, 2009, INT J UROL, V16, P516, DOI 10.1111/j.1442-2042.2009.02284.x; Jehle K, 2014, J BIOL CHEM, V289, P8839, DOI 10.1074/jbc.M113.534859; Jung SJ, 2013, WORLD J MENS HEALTH, V31, P36, DOI 10.5534/wjmh.2013.31.1.36; Kai L, 2011, ANTICANCER RES, V31, P3323; Lee E, 2013, P NATL ACAD SCI USA, V110, P15710, DOI 10.1073/pnas.1218168110; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lu S, 2007, MOL CANCER THER, V6, P2057, DOI 10.1158/1535-7163.MCT-06-0735; Marhefka CA, 2001, J MED CHEM, V44, P1729, DOI 10.1021/jm0005353; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Munuganti RSN, 2014, CHEM BIOL, V21, P1476, DOI 10.1016/j.chembiol.2014.09.012; Pitkanen-Arsiola T, 2006, PROSTATE, V66, P1177, DOI 10.1002/pros.20450; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rathkopf D, 2013, CANCER J, V19, P43, DOI 10.1097/PPO.0b013e318282635a; Ryu BJ, 2013, BIOORG MED CHEM LETT, V23, P3887, DOI 10.1016/j.bmcl.2013.04.065; Sadana P, 2011, ACS CHEM BIOL, V6, P1096, DOI 10.1021/cb200092v; Samaniego CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134015; Shah S, 2010, EXPERT REV ANTICANC, V10, P89, DOI [10.1586/era.09.161, 10.1586/ERA.09.161]; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Smyth G. K., 2004, APPL GENET MOL BIOL, V3, DOI DOI 10.2202/1544-6115.1027; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Suh JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070097; Truica CI, 2000, CANCER RES, V60, P4709; Urushibara M, 2007, PROSTATE, V67, P799, DOI 10.1002/pros.20542; Wang G, 2006, J CELL BIOCHEM, V98, P36, DOI 10.1002/jcb.20802; Wen SM, 2014, CANCER TREAT REV, V40, P31, DOI 10.1016/j.ctrv.2013.07.008; Williams SB, 2011, EXPERT OPIN PHARMACO, V12, P2069, DOI 10.1517/14656566.2011.590133; Yokoyama NN, 2014, AM J CLIN EXP UROL, V2, P27; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Yumoto F, 2012, P NATL ACAD SCI USA, V109, P143, DOI 10.1073/pnas.1117036108; Zaman N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113190	48	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137103	10.1371/journal.pone.0137103	http://dx.doi.org/10.1371/journal.pone.0137103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332122	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800097
J	Vora, KS; Yasobant, S; Sengupta, R; De Costa, A; Upadhyay, A; Mavalankar, DV				Vora, Kranti Suresh; Yasobant, Sandul; Sengupta, Raja; De Costa, Ayesha; Upadhyay, Ashish; Mavalankar, Dileep V.			Options for Optimal Coverage of Free C-Section Services for Poor Mothers in Indian State of Gujarat: Location Allocation Analysis Using GIS	PLOS ONE			English	Article							MATERNAL HEALTH; MODELS; ACCESSIBILITY	Background Gujarat, a western state of India, has seen a steep rise in the proportion of institutional deliveries over the last decade. However, there has been a limited access to cesarean section (C-Section) deliveries for complicated obstetric cases especially for poor rural women. C-section is a lifesaving intervention that can prevent both maternal and perinatal mortality. Poor women bear a disproportionate burden of maternal mortality, and lack of access to C-section, especially for these women, is an important contributor for high maternal and perinatal mortality in resource limited settings. To improve access for this underserved population in the context of inadequate public provision of emergency obstetric services, the state government of Gujarat initiated a public private partnership program called "Chiranjeevi Yojana" (CY) in 2005 to increase the number of facilities providing free C-section services. This study aimed to analyze the current availability of these services in three districts of Gujarat and to identify the best locations for additional service centres to optimize access to free C-section services using Geographic Information System technology. Methodology Supply and demand for obstetric care were calculated using secondary data from sources such as Census and primary data from cross-sectional facility survey. The study is unique in using primary data from facilities, which was collected in 2012-13. Information on obstetric beds and functionality of facilities to calculate supply was collected using pretested questionnaire by trained researchers after obtaining written consent from the participating facilities. Census data of population and birth rates for the study districts was used for demand calculations. Location-allocation model of ArcGIS 10 was used for analyses. Results Currently, about 50 to 84% of populations in all three study districts have access to free C-section facilities within a 20km radius. The model suggests that about 80-96% of the population can be covered for free C-section services with addition of 4-6 centres in critical but underserved regions. It was also suggested that upgrading of public sector facilities with minimal investment can improve the services. Conclusion This study highlights utility of Geographic Information System technology for planning service centres to optimize access to vital lifesaving procedure such as C-section. Although the location allocation methodology has been available for decades, it has been used sparsely by public health professionals. This paper makes an important contribution to the literature for use of the method for planning in resource limited settings.	[Vora, Kranti Suresh; Yasobant, Sandul; Upadhyay, Ashish; Mavalankar, Dileep V.] Indian Inst Publ Hlth Gandhinagar, Ahmadabad, Gujarat, India; [Sengupta, Raja] McGill Univ, Dept Geog, Montreal, PQ, Canada; [De Costa, Ayesha] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	McGill University; Karolinska Institutet	Vora, KS (corresponding author), Indian Inst Publ Hlth Gandhinagar, Ahmadabad, Gujarat, India.	kvora@iiphg.org	Upadhyay, Ashishkumar/B-8600-2016; Mavalankar, Dileep/AAX-6931-2020; Yasobant, Dr. Sandul/I-4008-2013	Upadhyay, Ashishkumar/0000-0002-9197-7030; Mavalankar, Dileep/0000-0003-0498-3799; Yasobant, Dr. Sandul/0000-0003-1770-8745; Sengupta, Raja/0000-0003-4914-5844	European Community [261304]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme under grant agreement no. 261304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, RUR HLTH STAT IND ST; [Anonymous], 2012, SAMPL REG SYST B; Averting Maternal Death and Disability (AMDD), NEED ASS EM NEWB CAR; BENNETT VL, 1982, SOC SCI MED, V16, P63, DOI 10.1016/0277-9536(82)90424-5; Bhat R, 2009, J HEALTH POPUL NUTR, V27, P249, DOI 10.3329/jhpn.v27i2.3367; Census of India, 2014, SIZ GROWTH RAT DISTR; Church R., 1974, PAP REG SCI ASS, V32, P101, DOI DOI 10.1007/BF01942293; Church RL, 1994, 945 NCGIA U CAL SANT; CURRENT J, 1992, DECISION SCI, V23, P221, DOI 10.1111/j.1540-5915.1992.tb00385.x; Das A., 1999, DEV SOC, V28, P313; De Costa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095704; Directorate of Economics and Statistics, 2012, GOV GUJ SOC EC REV B, V34; EATON DJ, 1986, J OPER RES SOC, V37, P113, DOI 10.1057/jors.1986.21; ESRI, 2011, ARCGIS DESKT REL 10; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Graham WJ, CAN SKILLED ATTENDAN; HAKIMI SL, 1964, OPER RES, V12, P450, DOI 10.1287/opre.12.3.450; HODGSON MJ, 1988, SOC SCI MED, V26, P153, DOI 10.1016/0277-9536(88)90054-8; Indian Public Health Standards, 2012, GUID HOSP; Joseph R, 1997, E AFR GEOGR REV, V19, P13; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mavalankar DV, 2009, J HEALTH POPUL NUTR, V27, P235; McLafferty SL, 2003, ANNU REV PUBL HEALTH, V24, P25, DOI 10.1146/annurev.publhealth.24.012902.141012; Mohanan M, 2014, B WORLD HEALTH ORGAN, V92, P187, DOI 10.2471/BLT.13.124644; Murawski L., 2009, SOCIOECONOMIC PLANNI, V43, P101, DOI [10.1016/j.seps.2008.02.012, DOI 10.1016/J.SEPS.2008.02.012]; OPPONG JR, 1994, PROF GEOGR, V46, P199, DOI 10.1111/j.0033-0124.1994.00199.x; Rahman SU, 2000, EUR J OPER RES, V123, P437, DOI 10.1016/S0377-2217(99)00289-1; Ram F, 2008, PROGR PROSPECTS MILL; Ravindran TKS, 2011, ECON POLIT WEEKLY, V26, P46; Registrar General of Inida, 2011, TABL 1 MAT MORT RAT; RUSHTON G, 1984, INT REGIONAL SCI REV, V9, P217, DOI 10.1177/016001768400900303; Saxena D, 2013, LANCET, V381, P129; Sidney K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-699; Sjngh A, 2009, B WORLD HEALTH ORGAN, V87, P960, DOI 10.2471/BLT.08.060228; Smith HK, 2009, EUR J OPER RES, V193, P768, DOI 10.1016/j.ejor.2007.07.031; TEITZ MB, 1968, OPER RES, V16, P955, DOI 10.1287/opre.16.5.955; The Indian Road Congress (IRC), 1990, GEOM DES STAND RUR N; United Nations Population Fund, 2010, REP SKILL ATT BIRTH; Walsh SJ, 1997, HEALTH SERV RES, V32, P243; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization (WHO), 2008, TOOLK MON HLTH SYST; Yasobant S, 2014, GLOBAL J MED RES, V14, P21	43	3	4	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137122	10.1371/journal.pone.0137122	http://dx.doi.org/10.1371/journal.pone.0137122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	26332207	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800098
J	Domitrovic, T; Raymundo, DP; da Silva, TF; Palhano, FL				Domitrovic, Tatiana; Raymundo, Diana P.; da Silva, Tiago Fernandes; Palhano, Fernando L.			Experimental Evidence for a Revision in the Annotation of Putative Pyridoxamine 5 '-Phosphate Oxidases P(N/M)P from Fungi	PLOS ONE			English	Article							FMN-BINDING PROTEIN; X-RAY-STRUCTURE; PYRIDOXINE 5'-PHOSPHATE; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; PSI-BLAST; DATABASE; PATHWAY	Pyridoxinamine 5'-phosphate oxidases (P(N/M) P oxidases) that bind flavin mononucleotide (FMN) and oxidize pyridoxine 5'-phosphate or pyridoxamine 5'-phosphate to form pyridoxal 5'-phosphate (PLP) are an important class of enzymes that play a central role in cell metabolism. Failure to generate an adequate supply of PLP is very detrimental to most organisms and is often clinically manifested as a neurological disorder in mammals. In this study, we analyzed the function of YLR456Wand YPR172W, two homologous genes of unknown function from S. cerevisiae that have been annotated as putative P(N/M) P oxidases based on sequence homology. Different experimental approaches indicated that neither protein catalyzes PLP formation nor binds FMN. On the other hand, our analysis confirmed the enzymatic activity of Pdx3, the S. cerevisiae protein previously implicated in PLP biosynthesis by genetic and structural characterization. After a careful sequence analysis comparing the putative and confirmed P(N/M) P oxidases, we found that the protein domain (PF01243) that led to the YLR456W and YPR172W annotation is a poor indicator of P(N/M) P oxidase activity. We suggest that a combination of two Pfam domains (PF01243 and PF10590) present in Pdx3 and other confirmed P(N/M) P oxidases would be a stronger predictor of this molecular function. This work exemplifies the importance of experimental validation to rectify genome annotation and proposes a revision in the annotation of at least 400 sequences from a wide variety of fungal species that are homologous to YLR456Wand are currently misrepresented as putative P(N/M) P oxidases.	[Domitrovic, Tatiana] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil; [Raymundo, Diana P.; Palhano, Fernando L.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Programa Biol Estrutural, Rio De Janeiro, Brazil; [da Silva, Tiago Fernandes] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Avaliacao & Sintese Subst Bioat LASSBio, Rio De Janeiro, Brazil; [da Silva, Tiago Fernandes] Univ Fed Rio de Janeiro, Inst Quim, Programa Grad Quim PGQu, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Domitrovic, T (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil.	domitrovic@micro.ufrj.br; palhano@bioqmed.ufrj.br	Palhano, Fernando/AAB-3144-2021; Domitrovic, Tatiana/AAX-1142-2021	Palhano, Fernando/0000-0001-5336-632X; Domitrovic, Tatiana/0000-0001-9196-9412	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); INCT de Biologia Estrutural e Bioimagem	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT de Biologia Estrutural e Bioimagem	Support for FLP was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and INCT de Biologia Estrutural e Bioimagem. Support for TD was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biswal BK, 2006, ACTA CRYSTALLOGR F, V62, P735, DOI 10.1107/S1744309106025012; Biswal BK, 2005, ACTA CRYSTALLOGR D, V61, P1492, DOI 10.1107/S0907444905026673; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Canaan S, 2005, FEBS LETT, V579, P215, DOI 10.1016/j.febslet.2004.11.069; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chosrowjan H, 2010, J PHYS CHEM B, V114, P6175, DOI 10.1021/jp912137s; Costanzo MC, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar004; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dessimoz C, 2013, TRENDS GENET, V29, P609, DOI 10.1016/j.tig.2013.09.005; di Salvo ML, 2011, BBA-PROTEINS PROTEOM, V1814, P1597, DOI 10.1016/j.bbapap.2010.12.006; di Salvo ML, 2002, J MOL BIOL, V315, P385, DOI 10.1006/jmbi.2001.5254; Domitrovic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011163; Hess DC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000407; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Kitamura M, 2007, J BIOCHEM, V141, P459, DOI 10.1093/jb/mvm051; KWON O, 1991, J BIOL CHEM, V266, P22136; Kwon OS, 1999, BIOCHIMIE, V81, P1057, DOI 10.1016/S0300-9084(99)00329-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P975, DOI 10.1038/nsb1297-975; Liu XH, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-23; LOUBBARDI A, 1995, J BACTERIOL, V177, P1817, DOI 10.1128/jb.177.7.1817-1823.1995; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mashalidis EH, 2015, PROTEIN SCI, V24, P729, DOI 10.1002/pro.2645; Mashalidis EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027643; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Musayev FN, 2009, J BIOL CHEM, V284, P30949, DOI 10.1074/jbc.M109.038372; Musayev FN, 2003, PROTEIN SCI, V12, P1455, DOI 10.1110/ps.0356203; Parsons JF, 2004, ACTA CRYSTALLOGR D, V60, P2110, DOI 10.1107/S0907444904022474; Pedelacq JD, 2006, PROTEINS, V62, P563, DOI 10.1002/prot.20824; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Safo MK, 2005, ACTA CRYSTALLOGR D, V61, P599, DOI 10.1107/S0907444905005512; Safo MK, 2001, J MOL BIOL, V310, P817, DOI 10.1006/jmbi.2001.4734; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Suto K, 2000, ACTA CRYSTALLOGR D, V56, P368, DOI 10.1107/S0907444900000111; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xu NN, 2013, ACTA CRYSTALLOGR D, V69, P1403, DOI 10.1107/S0907444913008354	44	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136761	10.1371/journal.pone.0136761	http://dx.doi.org/10.1371/journal.pone.0136761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327315	gold, Green Submitted, Green Published			2022-12-27	WOS:000360437700062
J	Hacker, K; Maas, R; Kornhuber, J; Fromm, MF; Zolk, O				Hacker, Kristina; Maas, Renke; Kornhuber, Johannes; Fromm, Martin F.; Zolk, Oliver			Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates	PLOS ONE			English	Article							DRUG DISPOSITION; HEALTHY-SUBJECTS; HUMAN MULTIDRUG; CIMETIDINE; PHARMACOKINETICS; DETERMINANTS; SITAGLIPTIN; INVOLVEMENT; MECHANISMS; RELEASE	The importance of the organic cation transporter OCT2 in the renal excretion of cationic drugs raises the possibility of drug-drug interactions (DDIs) in which an inhibitor (perpetrator) drug decreases OCT2-dependent renal clearance of a victim (substrate) drug. In fact, there are clinically significant interactions for drugs that are known substrates of OCT2 such as metformin. To identify drugs as inhibitors for OCT2, individual drugs or entire drug libraries have been investigated in vitro by using experimental probe substrates such as 1-methyl-4-phenylpyridinium (MPP+) or 4-4-dimethylaminostyryl-N-methylpyridinium (ASP(+)). It has been questioned whether the inhibition data obtained with an experimental probe substrate such as MPP+ or ASP(+) might be used to predict the inhibition against other, clinical relevant substrates such as metformin. Here we compared the OCT2 inhibition profile data for the substrates metformin, MPP+ and ASP(+). We used human embryonic kidney (HEK 293) cells stably overexpressing human OCT2 as the test system to screen 125 frequently prescribed drugs as inhibitors of OCT2-mediated metformin and MPP+ uptake. Data on inhibition of OCT2-mediated ASP(+) uptake were obtained from previous literature. A moderate correlation between the inhibition of OCT2-mediated MPP+, ASP(+), and metformin uptake was observed (pairwise r(s) between 0.27 and 0.48, all P < 0.05). Of note, the correlation in the inhibition profile between structurally similar substrates such as MPP+ and ASP(+) (Tani-moto similarity T = 0.28) was even lower (r(s) = 0.27) than the correlation between structurally distinct substrates, such as ASP(+) and metformin (T = 0.01; r(s) = 0.48) or MPP+ and metformin (T = 0.01; r(s) = 0.40). We identified selective as well as universal OCT2 inhibitors, which inhibited transport by more than 50% of one substrate only or of all substrates, respectively. Our data suggest that the predictive value for drug-drug interactions using experimental substrates rather than the specific victim drug is limited.	[Hacker, Kristina; Maas, Renke; Fromm, Martin F.; Zolk, Oliver] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Zolk, Oliver] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89069 Ulm, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Ulm University	Fromm, MF (corresponding author), Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany.	Martin.Fromm@fau.de	Kornhuber, Johannes/B-9613-2014	Kornhuber, Johannes/0000-0002-8096-3987; Zolk, Oliver/0000-0002-8220-3834	German Federal Ministry of Education and Research (BMBF) [13EX1015B]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This project was funded by the German Federal Ministry of Education and Research (BMBF), project grant No. 13EX1015B to M.F.F., R.M., and J.K. in the framework of the Leading Edge Cluster Medical Valley EMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belzer M, 2013, J PHARMACOL EXP THER, V346, P300, DOI 10.1124/jpet.113.203257; Choi MK, 2010, XENOBIOTICA, V40, P817, DOI 10.3109/00498254.2010.520349; Ding Y, 2014, EUR J CLIN PHARMACOL, V70, P141, DOI 10.1007/s00228-013-1604-7; Ekins S, 2012, CLIN PHARMACOL THER, V92, P661, DOI 10.1038/clpt.2012.164; FDA, 2012, GUIDANCE FOR INDUSTR; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Girke T, 2005, PLANT PHYSIOL, V138, P573, DOI 10.1104/pp.105.062687; Grun B, 2013, BRIT J CLIN PHARMACO, V76, P787, DOI 10.1111/bcp.12079; Haenisch B, 2011, PSYCHOPHARMACOLOGY, V217, P289, DOI 10.1007/s00213-011-2281-9; Harper JN, 2013, AM J PHYSIOL-RENAL, V304, pF56, DOI 10.1152/ajprenal.00486.2012; Herman GA, 2006, CURR MED RES OPIN, V22, P1939, DOI 10.1185/030079906X132587; Ito S, 2012, J PHARMACOL EXP THER, V340, P393, DOI 10.1124/jpet.111.184986; Ito S, 2010, J PHARMACOL EXP THER, V333, P341, DOI 10.1124/jpet.109.163642; Kido Y, 2011, J MED CHEM, V54, P4548, DOI 10.1021/jm2001629; Kim A, 2014, DRUG METAB DISPOS, V42, P1174, DOI 10.1124/dmd.113.055616; Kim MK, 2006, ARCH PHARM RES, V29, P605, DOI 10.1007/BF02969273; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Kusuhara H, 2011, CLIN PHARMACOL THER, V89, P837, DOI 10.1038/clpt.2011.36; Lips KS, 2007, EUR UROL, V51, P1042, DOI 10.1016/j.eururo.2006.10.028; Nies AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022163; Oefelein MG, 2013, CLIN DRUG INVEST, V33, P123, DOI 10.1007/s40261-012-0049-6; Regenthal R, 1999, J CLIN MONITOR COMP, V15, P529, DOI 10.1023/A:1009935116877; SLEIJFER DT, 1987, CANCER, V60, P2823; SOMOGYI A, 1987, CLIN PHARMACOKINET, V12, P321, DOI 10.2165/00003088-198712050-00002; SOMOGYI A, 1987, BRIT J CLIN PHARMACO, V23, P545, DOI 10.1111/j.1365-2125.1987.tb03090.x; Suhre WM, 2005, MOL PHARMACOL, V67, P1067, DOI 10.1124/mol.104.004713; Tanihara Y, 2007, BIOCHEM PHARMACOL, V74, P359, DOI 10.1016/j.bcp.2007.04.010; Thevenod F, 2013, MOL PHARMACEUT, V10, P3045, DOI 10.1021/mp400113d; Tsuda M, 2009, J PHARMACOL EXP THER, V329, P185, DOI 10.1124/jpet.108.147918; Varma MVS, 2009, J MED CHEM, V52, P4844, DOI 10.1021/jm900403j; Volk C, 2003, MOL PHARMACOL, V64, P1037, DOI 10.1124/mol.64.5.1037; Wang K, 2014, PROG NEURO-PSYCHOPH, V53, P90, DOI 10.1016/j.pnpbp.2014.03.005; Xu Y, 2013, MOL PHARMACEUT, V10, P4611, DOI 10.1021/mp400423g; Zolk O, 2009, DRUG METAB DISPOS, V37, P1312, DOI 10.1124/dmd.108.023762; Zolk O, 2009, N-S ARCH PHARMACOL, V379, P337, DOI 10.1007/s00210-008-0369-5	36	66	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136451	10.1371/journal.pone.0136451	http://dx.doi.org/10.1371/journal.pone.0136451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327616	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700043
J	Carter, DW; Crosson, S; Liese, C				Carter, David W.; Crosson, Scott; Liese, Christopher			Nowcasting Intraseasonal Recreational Fishing Harvest with Internet Search Volume	PLOS ONE			English	Article							FISHERIES; BEHAVIOR; TRENDS; TIME	Estimates of recreational fishing harvest are often unavailable until after a fishing season has ended. This lag in information complicates efforts to stay within the quota. The simplest way to monitor quota within the season is to use harvest information from the previous year. This works well when fishery conditions are stable, but is inaccurate when fishery conditions are changing. We develop regression-based models to "nowcast" intraseasonal recreational fishing harvest in the presence of changing fishery conditions. Our basic model accounts for seasonality, changes in the fishing season, and important events in the fishery. Our extended model uses Google Trends data on the internet search volume relevant to the fishery of interest. We demonstrate the model with the Gulf of Mexico red snapper fishery where the recreational sector has exceeded the quota nearly every year since 2007. Our results confirm that data for the previous year works well to predict intraseasonal harvest for a year (2012) where fishery conditions are consistent with historic patterns. However, for a year (2013) of unprecedented harvest and management activity our regression model using search volume for the term "red snapper season" generates intraseasonal nowcasts that are 27% more accurate than the basic model without the internet search information and 29% more accurate than the prediction based on the previous year. Reliable nowcasts of intraseasonal harvest could make in-season (or in-year) management feasible and increase the likelihood of staying within quota. Our nowcasting approach using internet search volumemight have the potential to improve quota management in other fisheries where conditions change year-to-year.	[Carter, David W.; Crosson, Scott; Liese, Christopher] NOAA, Social Sci Res Grp, Southeast Fisheries Sci Ctr, Miami, FL 33149 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Carter, DW (corresponding author), NOAA, Social Sci Res Grp, Southeast Fisheries Sci Ctr, Miami, FL 33149 USA.	david.w.carter@noaa.gov	Carter, David W/G-7472-2016	Carter, David W/0000-0001-8960-7236; Crosson, Scott/0000-0002-8126-1282				[Anonymous], [No title captured]; [Anonymous], 2014, R LANG ENV STAT COMP; Antenucci D, 2014, 20010 NBER, DOI [10.3386/w20010, DOI 10.3386/W20010]; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; CANOVA F, 1995, J BUS ECON STAT, V13, P237, DOI 10.2307/1392184; Chen T, 2015, CONTEMP ECON POLICY, V33, P395, DOI 10.1111/coep.12074; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Crosson S, 2013, SCI PUBL POLICY, V40, DOI 10.1093/scipol/scs104; Farmer NA, 2015, N AM J FISH MANAGE, V35, P720, DOI 10.1080/02755947.2015.1044628; Fondeur Y, 2013, ECON MODEL, V30, P117, DOI 10.1016/j.econmod.2012.07.017; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; Hyndman RobJ., 2018, FORECASTING PRINCIPL; Kumar S, 2011, GOOGLE CORRELATE WHI; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Martin DR, 2014, FISH RES, V157, P24, DOI 10.1016/j.fishres.2014.03.013; Martin DR, 2012, FISHERIES, V37, P458, DOI 10.1080/03632415.2012.722875; Methot RD, 2014, ICES J MAR SCI, V71, P183, DOI 10.1093/icesjms/fst119; Southeast Regional Office (SERO), 2013, SEROLAPP201305 NOAA; Wilde GR, 2013, FISHERIES MANAG ECOL, V20, P211, DOI 10.1111/fme.12009; Wu L., 2014, FUTURE PREDICTION GO	22	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137752	10.1371/journal.pone.0137752	http://dx.doi.org/10.1371/journal.pone.0137752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ8YQ	26348645	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600057
J	Lou, LP; Yao, LD; Cheng, GH; Wang, LX; He, YF; Hu, BL				Lou, Liping; Yao, Lingdan; Cheng, Guanghuan; Wang, Lixiao; He, Yunfeng; Hu, Baolan			Application of Rice-Straw Biochar and Microorganisms in Nonylphenol Remediation: Adsorption-Biodegradation Coupling Relationship and Mechanism	PLOS ONE			English	Article							ACTIVATED CARBON; BLACK CARBON; SORPTION; BIOAVAILABILITY; DESORPTION; SOIL; PENTACHLOROPHENOL; PHENANTHRENE; DEGRADATION; AMENDMENT	Biochar adsorption presents a potential remediation method for the control of hydrophobic organic compounds (HOCs) pollution in the environment. It has been found that HOCs bound on biochar become less bioavailable, so speculations have been proposed that HOCs will persist for longer half-life periods in biochar-amended soil/sediment. To investigate how biochar application affects coupled adsorption-biodegradation, nonylphenol was selected as the target contaminant, and biochar derived from rice straw was applied as the adsorbent. The results showed that there was an optimal dosage of biochar in the presence of both adsorption and biodegradation for a given nonylphenol concentration, thus allowing the transformation of nonylphenol to be optimized. Approximately 47.6% of the nonylphenol was biodegraded in two days when 0.005 g biochar was added to 50 mg/L of nonylphenol, which was 125% higher than the relative quantity biodegraded without biochar, though the resistant desorption component of nonylphenol reached 87.1%. All adsorptive forms of nonylphenol (f(rap), f(slow), f(r)) decreased gradually during the biodegradation experiment, and the resistant desorption fraction of nonylphenol (f(r)) on biochar could also be biodegraded. It was concluded that an appropriate amount of biochar could stimulate biodegradation, not only illustrating that the dosage of biochar had an enormous influence on the half-life periods of HOCs but also alleviating concerns that enhanced HOCs binding by biochar may cause secondary pollution in biochar-modified environment.	[Lou, Liping; Yao, Lingdan; Cheng, Guanghuan; Wang, Lixiao; He, Yunfeng; Hu, Baolan] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Hu, BL (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	blhu@zju.edu.cn			National Natural Science Foundation of China [41371447]; National Science-technology Support Plan Projects [2013BAC16B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science-technology Support Plan Projects	This research is financially supported by the National Natural Science Foundation of China (41371447) and the National Science-technology Support Plan Projects (2013BAC16B04), which supported the experiments of microorganisms study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2000, ENVIRON SCI TECHNOL, V34, P4259, DOI 10.1021/es001069+; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Mariel AC, 2014, ENVIRON TOXICOL PHAR, V38, P634, DOI 10.1016/j.etap.2014.08.014; Chai YZ, 2012, ENVIRON SCI TECHNOL, V46, P1035, DOI 10.1021/es2029697; Chen BL, 2009, CHEMOSPHERE, V76, P127, DOI 10.1016/j.chemosphere.2009.02.004; Cheng GH, 2014, J SOIL SEDIMENT, V14, P344, DOI 10.1007/s11368-013-0700-8; De Weert J, 2010, APPL MICROBIOL BIOT, V86, P761, DOI 10.1007/s00253-009-2394-9; Farrell M, 2013, SCI TOTAL ENVIRON, V465, P288, DOI 10.1016/j.scitotenv.2013.03.090; Gai XP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113888, 10.1371/journal.pone.0097730]; Gurwick NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075932; Kong LL, 2014, REV ENVIRON CONTAM T, V228, P83, DOI 10.1007/978-3-319-01619-1_4; Kukkonen JVK, 2005, ENVIRON TOXICOL CHEM, V24, P877, DOI 10.1897/04-171R.1; Liu J, 2014, ENVIRON POLLUT, V186, P83, DOI 10.1016/j.envpol.2013.11.017; Lou LP, 2014, ENVIRON POLLUT, V190, P101, DOI 10.1016/j.envpol.2014.03.027; Luo L, 2011, J HAZARD MATER, V185, P639, DOI 10.1016/j.jhazmat.2010.09.066; Marchal G, 2013, ENVIRON POLLUT, V181, P200, DOI 10.1016/j.envpol.2013.06.026; Martin SM, 2012, J HAZARD MATER, V231, P70, DOI 10.1016/j.jhazmat.2012.06.040; Mercier A, 2014, WATER RES, V59, P304, DOI 10.1016/j.watres.2014.04.021; Mercier A, 2013, J SOIL SEDIMENT, V13, P793, DOI 10.1007/s11368-012-0647-1; Meynet P, 2012, ENVIRON SCI TECHNOL, V46, P5057, DOI 10.1021/es2043905; Muter O, 2014, ECOTOX ENVIRON SAFE, V109, P93, DOI 10.1016/j.ecoenv.2014.08.012; Park JH, 2011, PLANT SOIL, V348, P439, DOI 10.1007/s11104-011-0948-y; Ren XM, 2011, CHEM ENG J, V170, P395, DOI 10.1016/j.cej.2010.08.045; Rhodes AH, 2012, ENVIRON SCI TECHNOL, V46, P12445, DOI 10.1021/es3025098; Smith JL, 2010, SOIL BIOL BIOCHEM, V42, P2345, DOI 10.1016/j.soilbio.2010.09.013; Sopena F, 2013, CHEMOSPHERE, V91, P1525, DOI 10.1016/j.chemosphere.2012.12.031; Tanghe T, 1999, APPL ENVIRON MICROB, V65, P746; Tatarkova V, 2013, ECOTOX ENVIRON SAFE, V92, P215, DOI 10.1016/j.ecoenv.2013.02.005; Tong H, 2014, SOIL BIOL BIOCHEM, V70, P142, DOI 10.1016/j.soilbio.2013.12.012; Toyama T, 2011, ENVIRON SCI TECHNOL, V45, P6524, DOI 10.1021/es201061a; Wang Z, 2014, INT BIODETER BIODEGR, V92, P1, DOI 10.1016/j.ibiod.2014.04.004; Writer JH, 2011, ENVIRON SCI TECHNOL, V45, P4370, DOI 10.1021/es2000134; Xin J, 2014, ECOTOX ENVIRON SAFE, V106, P27, DOI 10.1016/j.ecoenv.2014.04.036; Xu RK, 2011, BIORESOURCE TECHNOL, V102, P10293, DOI 10.1016/j.biortech.2011.08.089; Yang YN, 2003, ENVIRON SCI TECHNOL, V37, P3635, DOI 10.1021/es034006a; Zhang QZ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102062, 10.1371/journal.pone.0105500]	36	14	15	11	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137467	10.1371/journal.pone.0137467	http://dx.doi.org/10.1371/journal.pone.0137467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348485	Green Published, Green Submitted, gold			2022-12-27	WOS:000360897600047
J	Yip, M; Saripan, MI; Wells, K; Bradley, DA				Yip, Mary; Saripan, M. Iqbal; Wells, Kevin; Bradley, David A.			Monte Carlo Simulations for the Detection of Buried Objects Using Single Sided Backscattered Radiation	PLOS ONE			English	Article								Background Detection of buried improvised explosive devices (IEDs) is a delicate task, leading to a need to develop sensitive stand-off detection technology. The shape, composition and size of the IEDs can be expected to be revised over time in an effort to overcome increasingly sophisticated detection methods. As an example, for the most part, landmines are found through metal detection which has led to increasing use of non-ferrous materials such as wood or plastic containers for chemical based explosives being developed. Methodology Monte Carlo simulations have been undertaken considering three different commercially available detector materials (hyperpure-Ge (HPGe), lanthanum(III) bromide (LaBr) and thallium activated sodium iodide (NaI(Tl)), applied at a stand-off distance of 50 cm from the surface and burial depths of 0, 5 and 10 cm, with sand as the obfuscating medium. Target materials representing medium density wood and mild steel have been considered. Each detector has been modelled as a 10 cm thick cylinder with a 20 cm diameter. Principal Findings It appears that HPGe represents the most promising detector for this application. Although it was not the highest density material studied, its excellent energy resolving capability leads to the highest quality spectra from which detection decisions can be inferred. Conclusions The simulation work undertaken here suggests that a vehicle-born threat detection system could be envisaged using a single betatron and a series of detectors operating in parallel observing the space directly in front of the vehicle path. Furthermore, results show that non-ferrous materials such as wood can be effectively discerned in such remote-operated detection system, with the potential to apply a signature analysis template matching technique for real-time analysis of such data.	[Yip, Mary; Wells, Kevin] Univ Surrey, Fac Engn & Phys Sci, Ctr Vis Speech & Signal Proc, Guildford GU2 7XH, Surrey, England; [Yip, Mary; Bradley, David A.] Univ Surrey, Fac Engn & Phys Sci, Dept Phys, Guildford GU2 7XH, Surrey, England; [Saripan, M. Iqbal] Univ Putra Malaysia, Dept Comp & Commun Syst Engn, Fac Engn, Serdang 43400, Malaysia	University of Surrey; University of Surrey; Universiti Putra Malaysia	Wells, K (corresponding author), Univ Surrey, Fac Engn & Phys Sci, Ctr Vis Speech & Signal Proc, Guildford GU2 7XH, Surrey, England.	k.wells@surrey.ac.uk	Saripan, M Iqbal/A-9582-2010	Saripan, M Iqbal/0000-0002-3005-5331	United Kingdom Government Defence agency	United Kingdom Government Defence agency	This work was funded by a grant from a United Kingdom Government Defence agency to perform a stand-alone feasibility study in detecting buried objects with X-ray radiation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bousselham A, 2009, IEEE NUCL SCI CONF R, P2370, DOI 10.1109/NSSMIC.2009.5402210; Bradley DA, 2011, NUCL INSTRUM METH A, V652, P466, DOI 10.1016/j.nima.2011.01.142; BRADLEY DA, 1991, APPL RADIAT ISOTOPES, V42, P771; Buffler A, 2004, RADIAT PHYS CHEM, V71, P853, DOI 10.1016/j.radphyschem.2004.04.110; Chalmers A, 2003, P SOC PHOTO-OPT INS, V5199, P19; Datema CP, 2002, NUCL INSTRUM METH A, V488, P441, DOI 10.1016/S0168-9002(02)00402-3; Dunn WL, 2007, NUCL INSTRUM METH A, V580, P778, DOI 10.1016/j.nima.2007.05.188; Faust AA, 2009, IEEE T NUCL SCI, V56, P299, DOI 10.1109/TNS.2008.2009537; Harding G, 1997, NUCL INSTRUM METH A, V398, P409, DOI 10.1016/S0168-9002(97)00901-7; JME Ltd, 2011, BET RANG; Khodyuk IV, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/48/485402; Knoll, 2000, RAD DETECTION MEASUR; Menge PR, 2007, NUCL INSTRUM METH A, V579, P6, DOI 10.1016/j.nima.2007.04.002; Nuclear and Radiation Studies Board (NRSB) and Earth and Life Studies (DELS), 2008, RAD SOURC US REPL AB, P67; OWENS A, 1985, NUCL INSTRUM METH A, V238, P473, DOI 10.1016/0168-9002(85)90487-5; Qinetiq, 2009, FAST POW VERS HIGH P; Suppliersonline, 1999, CARB STEELS 1010; van Loef EVD, 2001, APPL PHYS LETT, V79, P1573, DOI 10.1063/1.1385342	18	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0135769	10.1371/journal.pone.0135769	http://dx.doi.org/10.1371/journal.pone.0135769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348619	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600003
J	Kim, HJ; Park, JH; Lee, S; Son, HY; Hwang, J; Chae, J; Yun, JM; Kwon, H; Kim, JI; Cho, B				Kim, Hyun-Jin; Park, Jin-Ho; Lee, Seungbok; Son, Ho-Young; Hwang, Jinha; Chae, Jeesoo; Yun, Jae Moon; Kwon, Hyuktae; Kim, Jong-Il; Cho, Belong			A Common Variant of NGEF Is Associated with Abdominal Visceral Fat in Korean Men	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; BODY-MASS INDEX; METABOLIC SYNDROME; WAIST CIRCUMFERENCE; RISK-FACTORS; OBESITY; OVERWEIGHT	Central adiposity, rather than body mass index (BMI), is a key pathophysiological feature of the development of obesity-related diseases. Although genetic studies by anthropometric measures such as waist circumference have been widely conducted, genetic studies for abdominal fat deposition measured by computed tomography (CT) have been rarely performed. A total of 1,243 participants who were recruited from two health check-up centers were included in this study. We selected four and three single-nucleotide polymorphisms (SNPs) in NGEF and RGS6, respectively, and analyzed the associations between the seven SNPs and central adiposity measured by CT using an additive, dominant, or recessive model. The participants were generally healthy middle-aged men (50.7 +/- 5.3 years). In the additive model, the rs11678490 A allele of NGEF was significantly associated with total adipose tissue, visceral adipose tissue (VAT), and subcutaneous adipose tissue (all P < 0.05). The AA genotype of this SNP in the recessive model showed a more significant association with all adiposity traits, and its association with VAT remained significant even after adjustment for BMI (P = 0.005). In the overall or visceral obesity group analysis, the AA genotype of rs11678490 showed no association with overall obesity (P = 0.148), whereas it was significantly associated with visceral obesity both before (P = 0.010) and after (P = 0.029) adjustment for BMI. In particular, an AA genotype effect was conspicuous between lower and upper groups with 5% extreme VAT phenotypes (OR = 9.59, 95% CI = 1.50-61.31). However, we found no significant association between SNPs of RGS6 and central adiposity. We identified a visceral-fat-associated SNP, rs11678490 of NGEF, in Korean men. This study suggests that the genetic background of central adiposity and BMI is different, and that additional efforts should be made to find the unique genetic architecture of intra-abdominal fat accumulation.	[Kim, Hyun-Jin] Seoul Natl Univ, Sch Publ Hlth, Inst Hlth & Environm, Seoul, South Korea; [Park, Jin-Ho; Yun, Jae Moon; Cho, Belong] Seoul Natl Univ Hosp, Dept Family Med, Seoul 110744, South Korea; [Lee, Seungbok; Kim, Jong-Il] Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea; [Son, Ho-Young; Kim, Jong-Il] Seoul Natl Univ, Coll Med, Dept Biochem, Seoul, South Korea; [Hwang, Jinha; Chae, Jeesoo; Kim, Jong-Il] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kwon, Hyuktae] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Inst Healthcare Res, Dept Family Med, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, JI (corresponding author), Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea.	jongil@snu.ac.kr; belong@snu.ac.kr	KIM, JONG-IL/D-1019-2011; SON, HO YOUNG/AAJ-3905-2020; Kwon, Hyuktae/C-4286-2013; Cho, Belong/GLU-3443-2022	KIM, JONG-IL/0000-0002-7240-3744; Kwon, Hyuktae/0000-0002-0312-3650; Cho, Belong/0000-0001-9558-689X; Son, Hwa-Young/0000-0003-4388-0952; Ho-young, Son/0000-0001-6326-5071; Seungbok, Lee/0000-0002-3145-8714	iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [113032032HD020]; National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2012R1A5A2A44671346]	iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This research was supported by iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (Grant No. 113032032HD020) and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2012R1A5A2A44671346).	Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Chrostowska M, 2013, BEST PRACT RES CL EN, V27, P147, DOI 10.1016/j.beem.2013.01.004; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Kim HI, 2011, J KOREAN MED SCI, V26, P906, DOI 10.3346/jkms.2011.26.7.906; Lear SA, 2007, STROKE, V38, P2422, DOI 10.1161/STROKEAHA.107.484113; Norris JM, 2009, OBESITY, V17, P1932, DOI 10.1038/oby.2009.143; Park YW, 2001, OBES RES, V9, P381, DOI 10.1038/oby.2001.49; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	24	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137564	10.1371/journal.pone.0137564	http://dx.doi.org/10.1371/journal.pone.0137564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340433	Green Submitted, Green Published, gold			2022-12-27	WOS:000360688200067
J	Worku, N; Stich, A; Daugschies, A; Wenzel, I; Kurz, R; Thieme, R; Kurz, S; Birkenmeier, G				Worku, Netsanet; Stich, August; Daugschies, Arwid; Wenzel, Iris; Kurz, Randy; Thieme, Rene; Kurz, Susanne; Birkenmeier, Gerd			Ethyl Pyruvate Emerges as a Safe and Fast Acting Agent against Trypanosoma brucei by Targeting Pyruvate Kinase Activity	PLOS ONE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; SLEEPING SICKNESS; IN-VITRO; TRANSPORT; DRUGS; EXPRESSION; NIFURTIMOX; INHIBITORS; PROTEIN; DESIGN	Background Human African Trypanosomiasis (HAT) also called sleeping sickness is an infectious disease in humans caused by an extracellular protozoan parasite. The disease, if left untreated, results in 100% mortality. Currently available drugs are full of severe drawbacks and fail to escape the fast development of trypanosoma resistance. Due to similarities in cell metabolism between cancerous tumors and trypanosoma cells, some of the current registered drugs against HAT have also been tested in cancer chemotherapy. Here we demonstrate for the first time that the simple ester, ethyl pyruvate, comprises such properties. Results The current study covers the efficacy and corresponding target evaluation of ethyl pyruvate on T. brucei cell lines using a combination of biochemical techniques including cell proliferation assays, enzyme kinetics, phasecontrast microscopic video imaging and ex vivo toxicity tests. We have shown that ethyl pyruvate effectively kills trypanosomes most probably by net ATP depletion through inhibition of pyruvate kinase (Ki = 3.0 +/- 0.29 mM). The potential of ethyl pyruvate as a trypanocidal compound is also strengthened by its fast acting property, killing cells within three hours post exposure. This has been demonstrated using video imaging of live cells as well as concentration and time dependency experiments. Most importantly, ethyl pyruvate produces minimal side effects in human red cells and is known to easily cross the blood-brain-barrier. This makes it a promising candidate for effective treatment of the two clinical stages of sleeping sickness. Trypanosome drug-resistance tests indicate irreversible cell death and a low incidence of resistance development under experimental conditions. Conclusion Our results present ethyl pyruvate as a safe and fast acting trypanocidal compound and show that it inhibits the enzyme pyruvate kinase. Competitive inhibition of this enzyme was found to cause ATP depletion and cell death. Due to its ability to easily cross the blood-brain-barrier, ethyl pyruvate could be considered as new candidate agent to treat the hemo-lymphatic as well as neurological stages of sleeping sickness.	[Worku, Netsanet; Kurz, Randy; Kurz, Susanne; Birkenmeier, Gerd] Univ Leipzig, Inst Biochem, Fac Med, D-04103 Leipzig, Germany; [Stich, August] Med Mission Inst, Dept Trop Med, D-97067 Wurzburg, Germany; [Daugschies, Arwid] Univ Leipzig, Dept Vet Parasitol, Fac Vet Med, D-04103 Leipzig, Germany; [Wenzel, Iris] Univ Leipzig, Dept Phys, Fac Nat Sci, D-04103 Leipzig, Germany; [Thieme, Rene] Univ Med Ctr Leipzig, Dept Visceral Transplantat Thorac & Vasc Surg, D-04103 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Birkenmeier, G (corresponding author), Univ Leipzig, Inst Biochem, Fac Med, Johannisallee 30, D-04103 Leipzig, Germany.	Gerd.Birkenmeier@medizin.uni-leipzig.de			Deutscher Akademischer Austauschdienst (DAAD) [A/10/90327]	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	NW has highly acknowledged the Deutscher Akademischer Austauschdienst (DAAD) for the support (Ref. No.: A/10/90327).	Babokhov P, 2013, PATHOG GLOB HEALTH, V107, P242, DOI 10.1179/2047773213Y.0000000105; BARNARD JP, 1993, J BIOL CHEM, V268, P3654; Barrett SV, 2000, PARASITOL TODAY, V16, P7, DOI 10.1016/S0169-4758(99)01560-4; Baunacke M, 2014, PROSTATE, V74, P48, DOI 10.1002/pros.22728; Belluti F, 2014, CHEMMEDCHEM, V9, P371, DOI 10.1002/cmdc.201300399; Bennett-Guerrero E, 2009, J CARDIOTHOR VASC AN, V23, P324, DOI 10.1053/j.jvca.2008.08.005; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; Borges S, 2014, BREAST CANCER RES TR, V144, P79, DOI 10.1007/s10549-014-2857-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALLENS M, 1991, MOL BIOCHEM PARASIT, V47, P19, DOI 10.1016/0166-6851(91)90144-U; CALLENS M, 1992, MOL BIOCHEM PARASIT, V50, P235, DOI 10.1016/0166-6851(92)90220-E; Clayton CE, 1996, PARASITOL TODAY, V12, P465, DOI 10.1016/S0169-4758(96)10073-9; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Diaz MV, 2014, ACTA TROP, V134, P1, DOI 10.1016/j.actatropica.2014.02.012; DOCAMPO R, 1981, BIOCHEM PHARMACOL, V30, P1947, DOI 10.1016/0006-2952(81)90204-5; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghosh A, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1164, DOI 10.1134/S0006297911100105; Greig N, 2009, FEBS J, V276, P376, DOI 10.1111/j.1742-4658.2008.06788.x; Hall JPJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003502; Headrick DR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002772; Hollenbach M, 2008, BIOCHEM PHARMACOL, V76, P631, DOI 10.1016/j.bcp.2008.06.006; Keita M, 1997, EXP PARASITOL, V85, P183, DOI 10.1006/expr.1996.4136; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; KOPPERSCHLAGER G, 1993, EUR J BIOCHEM, V217, P527, DOI 10.1111/j.1432-1033.1993.tb18273.x; MANNERVIK B, 1972, EUR J BIOCHEM, V29, P276, DOI 10.1111/j.1432-1033.1972.tb01985.x; Meyskens FL, 1999, CLIN CANCER RES, V5, P945; Morgan HP, 2011, J BIOL CHEM, V286, P31232, DOI 10.1074/jbc.M110.212613; Nowicki MW, 2008, BIOORGAN MED CHEM, V16, P5050, DOI 10.1016/j.bmc.2008.03.045; Park SY, 2011, CANCER LETT, V303, P150, DOI 10.1016/j.canlet.2010.12.024; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; Sanchez MA, 2013, J BIOL CHEM, V288, P14428, DOI 10.1074/jbc.M113.473157; Santel T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003508; Schroeder EL, 2011, EQUINE VET J, V43, P341, DOI 10.1111/j.2042-3306.2010.00214.x; Steverding D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-15; Stich A, 2013, LANCET INFECT DIS, V13, P733, DOI 10.1016/S1473-3099(13)70191-9; Sykes S, 2015, EUKARYOT CELL, V14, P206, DOI 10.1128/EC.00214-14; Vanderheyden N, 2000, BIOCHEM J, V346, P53, DOI 10.1042/0264-6021:3460053; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; WARBURG O, 1956, SCIENCE, V124, P269; Watson CP, 2012, BRAIN RES, V1436, P111, DOI 10.1016/j.brainres.2011.11.053; Welburn SC, 2009, PARASITOLOGY, V136, P1943, DOI 10.1017/S0031182009006416; Wendler A, 2009, MOL BIOCHEM PARASIT, V163, P19, DOI 10.1016/j.molbiopara.2008.09.005; WIEMER EAC, 1992, BIOCHEM BIOPH RES CO, V184, P1028, DOI 10.1016/0006-291X(92)90694-G; Worku Netsanet, 2013, ISRN Biochem, V2013, P910308, DOI 10.1155/2013/910308	47	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137353	10.1371/journal.pone.0137353	http://dx.doi.org/10.1371/journal.pone.0137353			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340747	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200050
J	Wu, WY; He, Y; Lu, J; Lu, YM; Wu, JS; Liu, YX				Wu, Weiyuan; He, Yi; Lu, Jian; Lu, Yuemei; Wu, Jinsong; Liu, Yingxia			Transition of bla(OXA-58-like) to bla(OXA-23-like) in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; PREVALENT OXA CARBAPENEMASES; MULTIPLEX PCR; HIGH-LEVEL; RESISTANCE; GENE; EXPRESSION; SPP.; EPIDEMIOLOGY; ACQUISITION	Background The prevalence of carbapenem-resistant Acinetobacter baumannii in hospitals has been increasing worldwide. This study aims to investigate the carbapenemase genes and the clonal relatedness among A. baumannii clinical isolates in a Chinese hospital. Methods Carbapenemase genes and the upstream locations of insertion sequences were detected by polymerase chain reaction (PCR), and the clonal relatedness of isolates was determined by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing. Results A total of 231 nonduplicate carbapenemase gene-harboring A. baumannii clinical isolates recovered from Shenzhen People's Hospital, were investigated between 2002 and 2009. bla(OXA-23-like), bla(OXA-58-like), bla(OXA-40-like), and ISAba1-bla(OXA-51-like) were identified in 119, 107, 1, and 4 isolates, respectively. IS1008-Delta ISAba3, ISAba3, and ISAba1 were detected upstream of the bla(OXA-58-like) gene in 69, 35, and 3 isolates, respectively. All bla(OXA-23-like) genes but one had an upstream insertion of ISAba1. bla(OXA-58-like) was the most common carbapenemase gene in A. baumannii before 2008, thereafter bla(OXA-23-like) became rapidly prevalent and replaced blaOXA-58-like in 2009. The majority of bla(OXA-58-like)-carrying isolates showed lower level of resistance to imipenem and meropenem (minimum inhibitory concentrations (MICs), 1 mu g/ml to 16 mu g/ml), compared with the majority of bla(OXA-23-like)-carrying isolates (MICs, 16 mu g/ml to 64 mu g/ml for both imipenem and meropenem). All 231 bla(OXA) carbapenemase gene-harboring isolates belonged to 14 PFGE types (A-N), and three dominant clones A, J, and H accounted for 43.3%, 42.0%, and 8.2% of the tested isolates, respectively. Clone A (sequence type ST92/ST208) with bla(OXA-58-like) was the most prevalent before 2008. Clone H (ST229) with bla(OXA-23-like) became striking between 2007 and 2008. Clone J (ST381) with bla(OXA-23-like) rapidly spread and replaced clones A and H in 2009. Conclusion This study is the first to reveal that the distinct bla(OXA-23-like)-carrying A. baumannii ST381 displaced the previously prevalent bla(OXA-58-like)-carrying A. baumannii ST92/ST208, resulting in the rapidly increasing resistance to carbapenems in A. baumannii in Shenzhen People's Hospital in 2009.	[Wu, Weiyuan; Lu, Yuemei; Wu, Jinsong] Jinan Univ, Shenzhen Peoples Hosp, Key Lab Pathogen Microorganism & Bacterial Resist, Dept Lab Med,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China; [He, Yi; Lu, Jian; Liu, Yingxia] Third Peoples Hosp Shenzhen, Dept Infect Dis, Shenzhen, Guangdong, Peoples R China	Jinan University	Wu, WY (corresponding author), Jinan Univ, Shenzhen Peoples Hosp, Key Lab Pathogen Microorganism & Bacterial Resist, Dept Lab Med,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China.	weiywu@163.com			Natural Science Foundation of Guangdong Province, China [5009113]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province)	This work was supported by Natural Science Foundation of Guangdong Province, China. (5009113) (http://www.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bertini A, 2007, ANTIMICROB AGENTS CH, V51, P2324, DOI 10.1128/AAC.01502-06; Chen TL, 2008, ANTIMICROB AGENTS CH, V52, P2573, DOI 10.1128/AAC.00393-08; Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Coelho J, 2006, ANTIMICROB AGENTS CH, V50, P756, DOI 10.1128/AAC.50.2.756-758.2006; Corvec S, 2007, ANTIMICROB AGENTS CH, V51, P1530, DOI 10.1128/AAC.01132-06; D'Arezzo S, 2011, J ANTIMICROB CHEMOTH, V66, P54, DOI 10.1093/jac/dkq407; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Evans BA, 2010, J ANTIMICROB CHEMOTH, V65, P1586, DOI 10.1093/jac/dkq180; Fu YQ, 2010, J ANTIMICROB CHEMOTH, V65, P644, DOI 10.1093/jac/dkq027; Heritier C, 2005, ANTIMICROB AGENTS CH, V49, P3198, DOI 10.1128/AAC.49.8.3198-3202.2005; Higgins PG, 2013, ANTIMICROB AGENTS CH, V57, P2121, DOI 10.1128/AAC.02413-12; Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014; Higgins PG, 2004, J ANTIMICROB CHEMOTH, V54, P821, DOI 10.1093/jac/dkh427; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Minandri F, 2012, J CLIN MICROBIOL, V50, P590, DOI 10.1128/JCM.05555-11; Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852; Nemec A, 2008, J ANTIMICROB CHEMOTH, V62, P484, DOI 10.1093/jac/dkn205; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1442, DOI 10.1128/AAC.50.4.1442-1448.2006; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Ravasi P, 2011, ANTIMICROB AGENTS CH, V55, P917, DOI 10.1128/AAC.00491-10; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Wang H, 2007, ANTIMICROB AGENTS CH, V51, P4022, DOI 10.1128/AAC.01259-06; Wang J., 2014, PLOS ONE, V9, P9, DOI DOI 10.1371/journal.pone.0104882; Wang XH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-234; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Zhou H, 2007, J CLIN MICROBIOL, V45, P4054, DOI 10.1128/JCM.00343-07	34	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137174	10.1371/journal.pone.0137174	http://dx.doi.org/10.1371/journal.pone.0137174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340666	Green Published, gold, Green Submitted			2022-12-27	WOS:000360688200029
J	Zhang, QH; Du, YJ; Zhang, JL; Xu, XJ; Xue, FQ; Guo, C; Huang, Y; Lukas, RJ; Chang, YC				Zhang, Qinhui; Du, Yingjie; Zhang, Jianliang; Xu, Xiaojun; Xue, Fenqin; Guo, Cong; Huang, Yao; Lukas, Ronald J.; Chang, Yongchang			Functional Impact of 14 Single Nucleotide Polymorphisms Causing Missense Mutations of Human alpha 7 Nicotinic Receptor	PLOS ONE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; POSITIVE ALLOSTERIC MODULATION; GATED ION-CHANNEL; ACETYLCHOLINE-RECEPTORS; AGONIST-BINDING; INTERNATIONAL UNION; SILENT AGONIST; AMINO-ACIDS; ACTIVATION; PHARMACOLOGY	The alpha 7nicotinic receptor (nAChR) is a major subtype of the nAChRs in the central nervous system, and the receptor plays an important role in brain function. In the dbSNP database, there are 55 single nucleotide polymorphisms (SNPs) that cause missense mutations of the human alpha 7nAChR in the coding region. In this study, we tested the impact of 14 SNPs that cause missense mutations in the agonist binding site or the coupling region between binding site and channel gate on the receptor function. The wild type or mutant receptors were expressed or co-expressed in Xenopus oocytes, and the agonist-induced currents were tested using two-electrode voltage clamp. Our results demonstrated that 6 mutants were nonfunctional, 4 mutants had reduced current expression, and 1 mutants altered ACh and nicotine efficacy in the opposite direction, and one additional mutant had slightly reduced agonist sensitivity. Interestingly, the function of most of these nonfunctional mutants could be rescued by a7nAChR positive allosteric modulator PNU-120596 and agonist-PAM 4BP-TQS. Finally, when coexpressed with the wild type, the nonfunctional mutants could also influence the receptor function. These changes of the receptor properties by the mutations could potentially have an impact on the physiological function of the alpha 7nAChR-mediated cholinergic synaptic transmission and anti-inflammatory effects in the human SNP carriers. Rescuing the nonfunctional mutants could provide a novel way to treat the related disorders.	[Zhang, Qinhui; Guo, Cong] Sichuan Univ, Dept Zool, Coll Life Sci, Chengdu 610064, Sichuan Provinc, Peoples R China; [Zhang, Qinhui; Guo, Cong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Qinhui; Zhang, Jianliang; Xu, Xiaojun; Xue, Fenqin; Lukas, Ronald J.; Chang, Yongchang] St Josephs Hosp, Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA; [Du, Yingjie] Univ Calif Los Angeles, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90095 USA; [Zhang, Jianliang] Capital Med Univ, Beijing Key Lab Brain Major Disorders,Beijing Ins, Beijing Ctr Neural Regenerat & Repair,Dept Neurob, Key Lab Neurodegenerat Dis,Minist Educ, Beijing 100069, Peoples R China; [Zhang, Jianliang] Beijing Neurosci Disciplines, State Key Lab Incubat Base, Beijing 100069, Peoples R China; [Xue, Fenqin] Capital Med Univ, Core Facil Ctr, Core Facil Electrophysiol, Beijing 100069, Peoples R China; [Huang, Yao] St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ 85013 USA	Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of California System; University of California Los Angeles; Capital Medical University; Capital Medical University; St. Joseph's Hospital and Medical Center	Chang, YC (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA.	yongchang.chang@dignityhealth.org			National Institute of General Medical Sciences [R01GM085237]; Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085237] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (R01GM085237), and Barrow Neurological Foundation (to YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Andersen N, 2013, P NATL ACAD SCI USA, V110, P20819, DOI 10.1073/pnas.1315775110; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chang YC, 2009, ACTA PHARMACOL SIN, V30, P663, DOI 10.1038/aps.2009.51; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; Chen YH, 2006, J BIOL CHEM, V281, P18184, DOI 10.1074/jbc.M600349200; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Chojnacka K, 2013, BIOORG MED CHEM LETT, V23, P4145, DOI 10.1016/j.bmcl.2013.05.039; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Criado M, 2010, BBA-BIOMEMBRANES, V1798, P654, DOI 10.1016/j.bbamem.2009.12.013; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Davies PA, 2003, J BIOL CHEM, V278, P712, DOI 10.1074/jbc.M208814200; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Elmslie F, 1997, MED GENETIK, V9, P15; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Horenstein NA, 2007, J BIOL CHEM, V282, P5899, DOI 10.1074/jbc.M609202200; Johnston GAR, 2003, CNS NEUROL DISORD-DR, V2, P260, DOI 10.2174/1568007033482805; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Mowrey D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064326; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Newell JG, 2004, J NEUROSCI, V24, P11226, DOI 10.1523/JNEUROSCI.3746-04.2004; Nordman JC, 2012, J CELL SCI, V125, P5502, DOI 10.1242/jcs.110379; Northrop NA, 2011, J PHARMACOL EXP THER, V336, P900, DOI 10.1124/jpet.110.177287; Olsen JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091232; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Papke RL, 2015, NEUROPHARMACOLOGY, V91, P34, DOI 10.1016/j.neuropharm.2014.12.002; Papke RL, 2014, J BIOL CHEM, V289, P4515, DOI 10.1074/jbc.M113.524603; Purohit P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3984; Purohit P, 2012, P NATL ACAD SCI USA, V109, P9384, DOI 10.1073/pnas.1203633109; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Sedelnikova A, 2005, J BIOL CHEM, V280, P1535, DOI 10.1074/jbc.M409908200; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Sherry ST, 1999, GENOME RES, V9, P677; Spurny R, 2015, P NATL ACAD SCI USA, V112, pE2543, DOI 10.1073/pnas.1418289112; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Uteshev VV, 2014, EUR J PHARMACOL, V727, P181, DOI 10.1016/j.ejphar.2014.01.072; van Maanen MA, 2009, NAT REV RHEUMATOL, V5, P229, DOI 10.1038/nrrheum.2009.31; Vicente-Agullo F, 2001, BIOCHEMISTRY-US, V40, P8300, DOI 10.1021/bi010087g; Wang DW, 2010, J PHARMACOL EXP THER, V335, P553, DOI 10.1124/jpet.110.169961; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2009, J PHARMACOL EXP THER, V330, P40, DOI 10.1124/jpet.109.151225; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	53	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137588	10.1371/journal.pone.0137588	http://dx.doi.org/10.1371/journal.pone.0137588			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340537	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200068
J	Avila, LCM; Bruggemann, TR; Bobinski, F; da Silva, MD; Oliveira, RC; Martins, DF; Mazzardo-Martins, L; Duarte, MMMF; de Souza, LF; Dafre, A; Vieira, RD; Santos, ARS; Bonorino, KC; Kunzler, DDH				Avila, Leonardo C. M.; Bruggemann, Thayse R.; Bobinski, Franciane; da Silva, Morgana Duarte; Oliveira, Regiane Carvalho; Martins, Daniel Fernandes; Mazzardo-Martins, Leidiane; Medeiros Frescura Duarte, Marta Maria; de Souza, Luiz Felipe; Dafre, Alcir; Vieira, Rodolfo de Paula; Soares Santos, Adair Roberto; Bonorino, Kelly Cattelan; Kunzler, Deborah de C. Hizume			Effects of High-Intensity Swimming on Lung Inflammation and Oxidative Stress in a Murine Model of DEP-Induced Injury	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; AEROBIC EXERCISE; AIR-POLLUTION; CYTOCHROME-P450 1A1; PARTICULATE MATTER; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; GENE-EXPRESSION; TERM EXPOSURE; MOUSE MODEL	Studies have reported that exposure to diesel exhaust particles (DEPs) induces lung inflammation and increases oxidative stress, and both effects are susceptible to changes via regular aerobic exercise in rehabilitation programs. However, the effects of exercise on lungs exposed to DEP after the cessation of exercise are not clear. Therefore, the aim of this study was to evaluate the effects of high-intensity swimming on lung inflammation and oxidative stress in mice exposed to DEP concomitantly and after exercise cessation. Male Swiss mice were divided into 4 groups: Control (n = 12), Swimming (30 min/day) (n = 8), DEP (3 mg/mL-10 mu L/mouse) (n = 9) and DEP+Swimming (n = 8). The high-intensity swimming was characterized by an increase in blood lactate levels greater than 1 mmoL/L between 10th and 30th minutes of exercise. Twenty-four hours after the final exposure to DEP, the anesthetized mice were euthanized, and we counted the number of total and differential inflammatory cells in the bronchoalveolar fluid (BALF), measured the lung homogenate levels of IL-1 beta, TNF-alpha, IL-6, INF-(sic), IL-10, and IL-1ra using ELISA, and measured the levels of glutathione, non-protein thiols (GSH-t and NPSH) and the antioxidant enzymes catalase and glutathione peroxidase (GPx) in the lung. Swimming sessions decreased the number of total cells (p<0.001), neutrophils and lymphocytes (p<0.001; p<0.05) in the BALF, as well as lung levels of IL-1 beta (p = 0.002), TNF-alpha (p = 0.003), IL-6 (p = 0.0001) and IFN-(sic) (p = 0.0001). However, the levels of IL-10 (p = 0.01) and IL-1ra (p = 0.0002) increased in the swimming groups compared with the control groups, as did the CAT lung levels (p = 0.0001). Simultaneously, swimming resulted in an increase in the GSH-t and NPSH lung levels in the DEP group (p = 0.0001 and p<0.002). We concluded that in this experimental model, the high-intensity swimming sessions decreased the lung inflammation and oxidative stress status during DEP-induced lung inflammation in mice.	[Avila, Leonardo C. M.; Bruggemann, Thayse R.; Bonorino, Kelly Cattelan; Kunzler, Deborah de C. Hizume] Univ Estado Santa Catarina, Dept Phys Therapy, Florianopolis, SC, Brazil; [Bruggemann, Thayse R.; Oliveira, Regiane Carvalho; Kunzler, Deborah de C. Hizume] Univ Sao Paulo, Sch Med, Dept Med LIM 5 & LIM 20, BR-05508 Sao Paulo, Brazil; [Bobinski, Franciane; Mazzardo-Martins, Leidiane; Soares Santos, Adair Roberto] Univ Estado Santa Catarina, Dept Biol Sci, Florianopolis, SC, Brazil; [da Silva, Morgana Duarte] Pampa Fed Univ, Dept Phys Therapy, Uruguaiana, RS, Brazil; [Martins, Daniel Fernandes] Univ Southern Santa Catarina, Postgrad Program Hlth Sci, Lab Expt Neurosci, Palhoca, SC, Brazil; [Medeiros Frescura Duarte, Marta Maria] Brazil Lutheran Univ, Hlth Sci Ctr, Santa Maria, RS, Brazil; [de Souza, Luiz Felipe; Dafre, Alcir] Univ Fed Santa Catarina, Dept Biochem, Florianopolis, SC, Brazil; [Vieira, Rodolfo de Paula] Nove de Julho Univ, Sao Paulo UNINOVE, Postgrad Program Rehabil Sci, Bauru, SP, Brazil	Universidade do Estado de Santa Catarina; Universidade de Sao Paulo; Universidade do Estado de Santa Catarina; Universidade Federal do Pampa; Universidade do Sul de Santa Catarina; Universidade Federal de Santa Catarina (UFSC); Universidade Nove de Julho	Kunzler, DDH (corresponding author), Univ Estado Santa Catarina, Dept Phys Therapy, Florianopolis, SC, Brazil.	dehizume@gmail.com	Bobinski, Franciane/ABB-5476-2021; Hizume-Kunzler, Deborah/AAG-1482-2019; Santos, Adair/C-5565-2013; de Paula Vieira, Rodolfo/E-9315-2011; Martins, Daniel Fernandes/J-7125-2014; de Souza, Luiz/J-2999-2017; da Silva, Morgana D/D-4942-2015; Dafre, Alcir/AAE-7738-2019; Carvalho Oliveira, Regiani/B-8471-2012; Bobinski, Franciane/AAV-8234-2020; Martins, Daniel/D-3493-2018	Bobinski, Franciane/0000-0002-3537-1712; Hizume-Kunzler, Deborah/0000-0002-7954-3192; Santos, Adair/0000-0002-6435-4698; de Paula Vieira, Rodolfo/0000-0001-6379-1143; de Souza, Luiz/0000-0002-0497-8538; da Silva, Morgana D/0000-0002-2487-236X; Dafre, Alcir/0000-0001-8097-4611; Carvalho Oliveira, Regiani/0000-0003-2871-0162; Martins, Daniel Fernandes/0000-0003-0066-6745; Mazzardo Martins, Leidiane/0000-0003-0345-2339; Martins, Daniel/0000-0003-1484-3167	Brazilian Scientific Agency: National Council for Scientific and Technological Development	Brazilian Scientific Agency: National Council for Scientific and Technological Development	This study was supported by the following Brazilian Scientific Agency: National Council for Scientific and Technological Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom T P, 1981, Methods Enzymol, V77, P373; Avula CPR, 1999, AGING CLIN EXP RES, V11, P246, DOI 10.1007/BF03339665; Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380; Baulig A, 2003, AM J PHYSIOL-LUNG C, V285, pL671, DOI 10.1152/ajplung.00419.2002; Becker S, 1996, TOXICOL APPL PHARM, V141, P637, DOI 10.1006/taap.1996.0330; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Bonvallot V, 2001, AM J RESP CELL MOL, V25, P515, DOI 10.1165/ajrcmb.25.4.4515; Camiletti-Moiron D, 2013, SCAND J MED SCI SPOR, V23, pe202, DOI 10.1111/sms.12065; Cao D, 2007, AM J PHYSIOL-LUNG C, V292, pL422, DOI 10.1152/ajplung.00204.2006; Chaudhuri N, 2010, AM J PHYSIOL-LUNG C, V299, pL263, DOI 10.1152/ajplung.00297.2009; de Araujo CC, 2012, J APPL PHYSIOL, V112, P1206, DOI 10.1152/japplphysiol.01061.2011; den Hartigh LJ, 2010, TOXICOL IN VITRO, V24, P1993, DOI 10.1016/j.tiv.2010.08.017; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; Duffin R, 2007, YONSEI MED J, V48, P561, DOI 10.3349/ymj.2007.48.4.561; Dutra MF, 2012, NEUROL SCI, V33, P1137, DOI 10.1007/s10072-011-0925-5; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emmendoerffer A, 2000, TOXICOL LETT, V112, P185, DOI 10.1016/S0378-4274(99)00285-4; Ferreira JCB, 2007, CLIN EXP PHARMACOL P, V34, P760, DOI 10.1111/j.1440-1681.2007.04635.x; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Fridovich I, 1998, J EXP BIOL, V201, P1203; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Hall KE, 2013, METABOLISM, V62, P1485, DOI 10.1016/j.metabol.2013.05.012; Halonen JI, 2008, THORAX, V63, P635, DOI 10.1136/thx.2007.091371; Inoue K, 2006, ARCH TOXICOL, V80, P275, DOI 10.1007/s00204-005-0040-6; JENKINS RR, 1993, MED SCI SPORT EXER, V25, P210; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Kivela R, 2006, FASEB J, V20, P1570, DOI 10.1096/fj.05-4780fje; Kooter I, 2010, J TOXICOL-US, V2010, DOI 10.1155/2010/206057; Kuphal KE, 2007, J PAIN, V8, P989, DOI 10.1016/j.jpain.2007.08.001; Laks D, 2008, INHAL TOXICOL, V20, P1037, DOI [10.1080/08958370802112922, 10.1080/08958370802112922 ]; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Luks V, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-24; Maier KL, 2008, INHAL TOXICOL, V20, P319, DOI [10.1080/08958370701866313, 10.1080/08958370701866313 ]; Menegali BT, 2009, PULM PHARMACOL THER, V22, P567, DOI 10.1016/j.pupt.2009.08.003; Nel AE, 1998, J ALLERGY CLIN IMMUN, V102, P539, DOI 10.1016/S0091-6749(98)70269-6; Park EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025892; Pastva A, 2004, J IMMUNOL, V172, P4520, DOI 10.4049/jimmunol.172.7.4520; Patel H, 2011, TOXICOL LETT, V200, P124, DOI 10.1016/j.toxlet.2010.11.007; Patel MM, 2010, ENVIRON HEALTH PERSP, V118, P1338, DOI 10.1289/ehp.0901499; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Ramos DS, 2010, MED SCI SPORT EXER, V42, P113, DOI 10.1249/MSS.0b013e3181ad1c72; Rao KMK, 2005, ENVIRON HEALTH PERSP, V113, P612, DOI 10.1289/ehp.7696; Reischl E, 2007, COMP BIOCHEM PHYS C, V146, P22, DOI 10.1016/j.cbpc.2006.07.015; Rover L, 2001, QUIM NOVA, V24, P112; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Salvi SS, 2000, AM J RESP CRIT CARE, V161, P550, DOI 10.1164/ajrccm.161.2.9905052; Saxon A, 2005, NAT IMMUNOL, V6, P223, DOI 10.1038/ni0305-223; SCHWARTZ J, 1994, ENVIRON RES, V64, P26, DOI 10.1006/enrs.1994.1004; Schwarze PE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685142; Silva RA, 2010, EUR RESPIR J, V35, P994, DOI 10.1183/09031936.00049509; Souza LC, 2013, NEUROTOX RES, V24, P148, DOI 10.1007/s12640-012-9373-0; Stang J, 2014, CLIN PHYSL FUNCT IMA; Steerenberg PA, 1998, EXP LUNG RES, V24, P85, DOI 10.3109/01902149809046056; Takano H, 2002, AM J RESP CRIT CARE, V165, P1329, DOI 10.1164/rccm.2108122; Toledo AC, 2012, EUR RESPIR J, V39, P254, DOI 10.1183/09031936.00003411; Vieira RD, 2012, MED SCI SPORT EXER, V44, P1227, DOI 10.1249/MSS.0b013e31824b2877; Vieira RP, 2008, AM J PHYSIOL-LUNG C, V295, pL670, DOI 10.1152/ajplung.00465.2007; Vieira RP, 2007, AM J RESP CRIT CARE, V176, P871, DOI 10.1164/rccm.200610-1567OC; Vieira RP, 2011, RESP PHYSIOL NEUROBI, V175, P383, DOI 10.1016/j.resp.2011.01.002; Yang HM, 1997, EXP LUNG RES, V23, P269, DOI 10.3109/01902149709087372; Young DR, 2014, CIRC-HEART FAIL, V7, P21, DOI 10.1161/CIRCHEARTFAILURE.113.000529; YSSEL H, 1992, J IMMUNOL, V149, P2378; Zhao HW, 2006, ENVIRON HEALTH PERSP, V114, P1253, DOI 10.1289/ehp.9063; Zhao HW, 2009, J TOXICOL ENV HEAL A, V72, P560, DOI 10.1080/15287390802706330	68	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137273	10.1371/journal.pone.0137273	http://dx.doi.org/10.1371/journal.pone.0137273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332044	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800116
J	Bronstad, PM; Albu, A; Bowers, AR; Goldstein, R; Peli, E				Bronstad, P. Matthew; Albu, Amanda; Bowers, Alex R.; Goldstein, Robert; Peli, Eli			Driving with Central Visual Field Loss II: How Scotomas above or below the Preferred Retinal Locus (PRL) Affect Hazard Detection in a Driving Simulator	PLOS ONE			English	Article							DRIVERS; HABITS	We determined whether binocular central scotomas above or below the preferred retinal locus affect detection of hazards (pedestrians) approaching from the side. Seven participants with central field loss (CFL), and seven age-and sex-matched controls with normal vision (NV), each completed two sessions of 5 test drives (each approximately 10 minutes long) in a driving simulator. Participants pressed the horn when detecting pedestrians that appeared at one of four eccentricities (-14 degrees, -4 degrees, left, 4 degrees, or 14 degrees, right, relative to car heading). Pedestrians walked or ran towards the travel lane on a collision course with the participant's vehicle, thus remaining in the same area of the visual field, assuming participant's steady forward gaze down the travel lane. Detection rates were nearly 100% for all participants. CFL participant reaction times were longer (median 2.27s, 95% CI 2.13 to 2.47) than NVs (median 1.17s, 95% CI 1.10 to 2.13; difference p<0.01), and CFL participants would have been unable to stop for 21% of pedestrians, compared with 3% for NV, p<0.001. Although the scotomas were not expected to obscure pedestrian hazards, gaze tracking revealed that scotomas did sometimes interfere with detection; late reactions usually occurred when pedestrians were entirely or partially obscured by the scotoma (time obscured correlated with reaction times, r = 0.57, p<0.001). We previously showed that scotomas lateral to the preferred retinal locus delay reaction times to a greater extent; however, taken together, the results of our studies suggest that any binocular CFL might negatively impact timely hazard detection while driving and should be a consideration when evaluating vision for driving.	[Bronstad, P. Matthew; Albu, Amanda; Bowers, Alex R.; Goldstein, Robert; Peli, Eli] Harvard Univ, Sch Med, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Bronstad, PM (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, Massachusetts Eye & Ear, Boston, MA 02115 USA.	matthew_bronstad@meei.harvard.edu		Bowers, Alex/0000-0002-6038-0178; Peli, Eli/0000-0002-1340-9257	National Institutes of Health [EY12890, EY018680, 2P30EY003790]; NATIONAL EYE INSTITUTE [K99EY018680, R00EY018680, P30EY003790, R01EY012890, R24EY012890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY12890 (EP), EY018680 (ARB), and 2P30EY003790. The funding organization had no role in the design or conduct of this research.	Alberti CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089381; American Association of State Highway and Transportation Officials, 2004, POL GEOM DES HIGHW S; Ball K, 1998, ACCIDENT ANAL PREV, V30, P313, DOI 10.1016/S0001-4575(97)00102-4; Bowers AR, 2005, INVEST OPHTH VIS SCI, V46, P66, DOI 10.1167/iovs.04-0271; Bronstad PM, 2013, JAMA OPHTHALMOL, V131, P303, DOI 10.1001/jamaophthalmol.2013.1443; Bronstad PM, 2009, 5 INT DRIV S HUM FAC; Bronstad PM, 2011, DRIV ASS C DAC N AM; DeCarlo DK, 2003, OPTOMETRY VISION SCI, V80, P207, DOI 10.1097/00006324-200303000-00010; Evans L., 2004, TRAFFIC SAFETY; Fletcher Donald C, 2012, Optom Vis Sci, V89, P1395, DOI 10.1097/OPX.0b013e318264cc77; Legge G., 2013, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2013.1974:E1-E3, DOI 10.1001/JAMAOPHTHALMOL.2013.1974:E1-E3]; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202, DOI 10.1111/j.1532-5415.1997.tb04508.x; Matthew Bronstad P, 2011, J Clin Exp Ophthalmol, V2011, P1; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Peli E, 2005, TRANSPORT RES REC, P128; Peli E., 2002, DRIVING CONFIDENCE P; Peli E, 1979, 12 INT C MED BIOL EN; Petzold A, 2005, OPHTHALMOLOGICA, V219, P191, DOI 10.1159/000085727; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Rauscher FG, 2007, 79 DEP TRANSP; Reinhard J, 2007, VISION RES, V47, P2076, DOI 10.1016/j.visres.2007.04.012; Sengupta S, 2014, OPHTHALMOLOGY, V121, P727, DOI 10.1016/j.ophtha.2013.09.042; SZLYK JP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1033, DOI 10.1001/archopht.1995.01100080085033; U.S. Department of Transportation FHA, SUMM TRAV TRENDS 200; Verezen CA, 2011, OPTOMETRY VISION SCI, V88, P1164, DOI 10.1097/OPX.0b013e31822891e0; Woods RL, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3292015; Yazdan-Ashoori P, 2010, J NEURO-OPHTHALMOL, V30, P177, DOI 10.1097/WNO.0b013e3181dfa982; ZEEVI YY, 1979, J OPT SOC AM, V69, P1274, DOI 10.1364/JOSA.69.001274	28	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136517	10.1371/journal.pone.0136517	http://dx.doi.org/10.1371/journal.pone.0136517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332315	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800059
J	Hu, K; Harris, DL; Yamaguchi, T; von Andrian, UH; Hamrah, P				Hu, Kai; Harris, Deshea L.; Yamaguchi, Takefumi; von Andrian, Ulrich H.; Hamrah, Pedram			A Dual Role for Corneal Dendritic Cells in Herpes Simplex Keratitis: Local Suppression of Corneal Damage and Promotion of Systemic Viral Dissemination	PLOS ONE			English	Article							VIRUS TYPE-1 LATENCY; LANGERHANS CELLS; MACROPHAGE-DEPLETION; STROMAL KERATITIS; OCULAR INFECTION; MOUSE MACROPHAGE; HSV-1 INFECTION; IMMUNE EVASION; NERVOUS-SYSTEM; LYMPH-NODES	The cornea is the shield to the foreign world and thus, a primary site for peripheral infections. However, transparency and vision are incompatible with inflammation and scarring that may result from infections. Thus, the cornea is required to perform a delicate balance between fighting infections and preserving vision. To date, little is known about the specific role of antigen-presenting cells in viral keratitis. In this study, utilizing an established murine model of primary acute herpes simplex virus (HSV)-1 keratitis, we demonstrate that primary HSV keratitis results in increased conventional dendritic cells (cDCs) and macrophages within 24 hours after infection. Local depletion of cDCs in CD11c-DTR mice by subconjuntival diphtheria toxin injections, led to increased viral proliferation, and influx of inflammatory cells, resulting in increased scarring and clinical keratitis. In addition, while HSV infection resulted in significant corneal nerve destruction, local depletion of cDCs resulted in a much more severe loss of corneal nerves. Further, local cDC depletion resulted in decreased corneal nerve infection, and subsequently decreased and delayed systemic viral transmission in the trigeminal ganglion and draining lymph node, resulting in decreased mortality of mice. In contrast, sham depletion or depletion of macrophages through local injection of clodronate liposomes had neither a significant impact on the cornea, nor an effect on systemic viral transmission. In conclusion, we demonstrate that corneal cDCs may play a primary role in local corneal defense during viral keratitis and preserve vision, at the cost of inducing systemic viral dissemination, leading to increased mortality.	[Hu, Kai; Harris, Deshea L.; Yamaguchi, Takefumi; Hamrah, Pedram] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA 02114 USA; [Hu, Kai; Yamaguchi, Takefumi; Hamrah, Pedram] Harvard Univ, Sch Med, Dept Ophthalmol, Cornea Serv,Massachusetts Eye & Ear Infirm, Boston, MA USA; [Hu, Kai; Harris, Deshea L.; Yamaguchi, Takefumi; von Andrian, Ulrich H.; Hamrah, Pedram] Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst,Program Cellular & Mol Med, Boston, MA USA; [Harris, Deshea L.; Hamrah, Pedram] Tufts Univ, Sch Med, Dept Ophthalmol, Tufts Med Ctr, Boston, MA 02111 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Div Immunol, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Tufts Medical Center; Tufts University; Harvard University; Harvard Medical School	Hamrah, P (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA 02114 USA.	phamrah@tuftsmedicalcenter.org	Yamaguchi, Takefumi/AEV-4169-2022; YAMAGUCHI, Takefumi/AAY-6964-2020	Harris, Deshea/0000-0002-8194-1827; Yamaguchi, Takefumi/0000-0002-2546-2813	NIH [K08-EY020575, R01-EY022695]; Research to Prevent Blindness Career Development Award; Falk Medical Research Trust; MEEI Foundation; NATIONAL EYE INSTITUTE [R01EY022695, K08EY020575] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Falk Medical Research Trust; MEEI Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the NIH: K08-EY020575 (PH), R01-EY022695 (PH), Research to Prevent Blindness Career Development Award (PH), Falk Medical Research Trust (PH), and MEEI Foundation (PH).	Allen SJ, 2011, J VIROL, V85, P9945, DOI 10.1128/JVI.05208-11; ASBELL PA, 1987, CURR EYE RES, V6, P179, DOI 10.3109/02713688709020087; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bauer D, 2000, CURR EYE RES, V20, P45; Bauer D, 2012, INVEST OPHTH VIS SCI, V53, P799, DOI 10.1167/iovs.11-7617; Bedoui S, 2009, J IMMUNOL, V182, P4200, DOI 10.4049/jimmunol.0802286; Brissette-Storkus CS, 2002, INVEST OPHTH VIS SCI, V43, P2264; Buela KAG, 2015, J IMMUNOL, V194, P379, DOI 10.4049/jimmunol.1402326; Cheng H, 2000, INVEST OPHTH VIS SCI, V41, P1402; Chentoufi AA, 2012, VIRAL IMMUNOL, V25, P204, DOI 10.1089/vim.2011.0091; Coffin RS, 1998, GENE THER, V5, P718, DOI 10.1038/sj.gt.3300634; Cruzat A, 2011, INVEST OPHTH VIS SCI, V52, P5136, DOI 10.1167/iovs.10-7048; Duan R, 2007, INVEST OPHTH VIS SCI, V48, P277, DOI 10.1167/iovs.06-0053; Edelmann KH, 2001, J VIROL, V75, P612, DOI 10.1128/JVI.75.2.612-621.2001; Eidsmo L, 2009, J IMMUNOL, V182, P3165, DOI 10.4049/jimmunol.0802950; Frank GM, 2012, J IMMUNOL, V188, P1350, DOI 10.4049/jimmunol.1101968; GILLETTE TE, 1982, OPHTHALMOLOGY, V89, P700; Goldwich A, 2011, J LEUKOCYTE BIOL, V89, P973, DOI 10.1189/jlb.0310180; Hamrah P, 2003, J LEUKOCYTE BIOL, V74, P172, DOI 10.1189/jlb.1102544; Hamrah P, 2003, INVEST OPHTH VIS SCI, V44, P581, DOI 10.1167/iovs.02-0838; Hamrah P, 2002, INVEST OPHTH VIS SCI, V43, P639; Hamrah P, 2012, OPHTHALMOLOGY, V119, P1791, DOI 10.1016/j.ophtha.2012.03.005; Hamrah P, 2010, OPHTHALMOLOGY, V117, P1930, DOI 10.1016/j.ophtha.2010.07.010; HENDRICKS RL, 1992, J IMMUNOL, V148, P2522; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Inoue T, 2000, INVEST OPHTH VIS SCI, V41, P4209; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kassim SH, 2006, J VIROL, V80, P3985, DOI 10.1128/JVI.80.8.3985-3993.2006; KAYE SB, 1992, BRIT J OPHTHALMOL, V76, P412, DOI 10.1136/bjo.76.7.412; Kovacs SK, 2009, CURR EYE RES, V34, P896, DOI 10.3109/02713680903184250; Kradin R, 1997, AM J PATHOL, V150, P1735; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Kummer M, 2007, J VIROL, V81, P6326, DOI 10.1128/JVI.02327-06; Labetoulle M, 2000, INVEST OPHTH VIS SCI, V41, P2600; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; LEWKOWICZMOSS SJ, 1987, EXP EYE RES, V45, P127, DOI 10.1016/S0014-4835(87)80084-2; LIESEGANG TJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P1155, DOI 10.1001/archopht.1989.01070020221029; Liu GQ, 2011, MOL VIS, V17, P2129; Liu Y, 2002, J EXP MED, V195, P259, DOI 10.1084/jem.20010838; Maruyama K, 2012, INVEST OPHTH VIS SCI, V53, P3145, DOI 10.1167/iovs.11-8010; McGillis JP, 1990, ANN N Y ACAD SCI, V594, P85; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; MILLER JK, 1993, INVEST OPHTH VIS SCI, V34, P2282; Miranda-Saksena M, 2000, J VIROL, V74, P1827, DOI 10.1128/JVI.74.4.1827-1839.2000; Mott K, 2007, INVEST OPHTH VIS SCI, V48, P5605, DOI 10.1167/iovs.07-0894; Mott KR, 2008, J VIROL, V82, P9870, DOI 10.1128/JVI.00566-08; Mott KR, 2007, J VIROL, V81, P12962, DOI 10.1128/JVI.01442-07; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Mott KR, 2008, CLIN VACCINE IMMUNOL, V15, P1859, DOI 10.1128/CVI.00318-08; Neumann J, 2003, J IMMUNOL, V171, P3075, DOI 10.4049/jimmunol.171.6.3075; PEPOSE JS, 1989, CURR EYE RES, V8, P851, DOI 10.3109/02713688909000875; Pollara G, 2003, J INFECT DIS, V187, P165, DOI 10.1086/367675; RABIN BS, 1989, CRIT REV IMMUNOL, V9, P279; Raftery MJ, 2006, J IMMUNOL, V177, P6207, DOI 10.4049/jimmunol.177.9.6207; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Schon E, 2001, J REPROD IMMUNOL, V50, P87, DOI 10.1016/S0165-0378(00)00094-2; Shah A, 2010, MOL VIS, V16, P2476; Slegers TPAM, 2003, CURR EYE RES, V26, P73, DOI 10.1076/ceyr.26.2.73.14510; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; SPRECHER E, 1989, ARCH VIROL, V107, P191, DOI 10.1007/BF01317916; STREILEIN JW, 1979, NATURE, V282, P326, DOI 10.1038/282326a0; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; WATSON CPN, 1991, PAIN, V44, P105, DOI 10.1016/0304-3959(91)90124-G; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Xia LK, 2010, MOL VIS, V16, P2071; Xia LJ, 2002, J CLIN INVEST, V109, P939; YASUMOTO S, 1986, ARCH VIROL, V90, P261, DOI 10.1007/BF01317375; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961	70	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137123	10.1371/journal.pone.0137123	http://dx.doi.org/10.1371/journal.pone.0137123			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332302	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800099
J	Liu, J; Gao, L; Zang, DW				Liu, Juan; Gao, Lina; Zang, Dawei			Elevated Levels of IFN-gamma in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; MOUSE MODEL; ALS; ASTROCYTES; INTERLEUKIN-12; ACTIVATION; EXPRESSION; MICROGLIA; CYTOKINES; BIOMARKER	Objectives To explore whether the levels of IFN-gamma in cerebral spinal fluid (CSF) and serum are elevated in ALS patients and to analyze the correlations between the IFN-gamma levels and disease progression. Methods CSF and serum samples were obtained from 52 ALS patients and 31 non-ALS patients. The levels of IFN-gamma in CSF and serum were assessed, and disease progression parameters, including the disease interval (months from onset, MFO), the revised ALS Functional Rating Scale (ALSFRS-r) score and the disease progression rate (DPR) were analyzed by registered neurologists. All samples were measured using a commercial enzyme-linked immunosorbent assay. Statistical analyses were performed using Prism software. Results Compared to the non-ALS patients, the ALS patients displayed significantly increased levels of IFN-gamma in both CSF and serum, and these values consistently correlated with disease progression. Conclusions These results demonstrated that IFN-gamma in CSF may serve as a biomarker of ALS differentiation and progression. CSF IFN-gamma was a more reliable biomarker of disease diagnosis and progression than serum IFN-gamma.	[Liu, Juan] Tianjin Med Univ, Tianjin Ctr Hosp 1, Dept Lab Med, Microbiol Grp, Tianjin, Peoples R China; [Gao, Lina; Zang, Dawei] Tianjin Med Univ, Tianjin Ctr Hosp 1, Dept Neurol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Zang, DW (corresponding author), Tianjin Med Univ, Tianjin Ctr Hosp 1, Dept Neurol, Tianjin, Peoples R China.	zangdawei@gmail.com			Tianjin Health Bureau [11KG104]	Tianjin Health Bureau	This work was supported by the Tianjin Health Bureau (11KG104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer J, 2012, EUR J NEUROL, V19, P752, DOI 10.1111/j.1468-1331.2011.03623.x; Aebischer J, 2011, CELL DEATH DIFFER, V18, P754, DOI 10.1038/cdd.2010.143; Babu GN, 2008, NEUROCHEM RES, V33, P1145, DOI 10.1007/s11064-007-9564-x; Bao Y, 2014, J AUTOIMMUN; Belanger M, 2011, J NEUROCHEM, V116, P564, DOI 10.1111/j.1471-4159.2010.07135.x; Cardona-Rossinyol A, 2013, CELL MOL NEUROBIOL, V33, P421, DOI 10.1007/s10571-013-9908-9; Chelstowska B, 2014, BIOMARKERS, V19, P571, DOI 10.3109/1354750X.2014.949867; Czlonkowska A, 2005, CURR PHARM DESIGN, V11, P1017, DOI 10.2174/1381612053381693; Ford LS, 2004, AMYOTROPH LATERAL SC, V5, P118, DOI 10.1080/14660820410019125; Hashioka S, 2010, J NEUROIMMUNOL, V225, P91, DOI 10.1016/j.jneuroim.2010.04.023; Jang E, 2013, J IMMUNOL, V191, P5204, DOI 10.4049/jimmunol.1301637; Kwon MS, 2014, J NEUROCHEM; Lin HW, 2009, J NEUROCHEM, V111, P808, DOI 10.1111/j.1471-4159.2009.06366.x; Matsumoto T, 2012, NEUROSCI LETT, V520, P115, DOI 10.1016/j.neulet.2012.05.048; Medina TS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-264; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Mitchell RM, 2010, MUSCLE NERVE, V42, P95, DOI 10.1002/mus.21625; Otsmane B, 2014, NEUROREPORT, V25, P49, DOI 10.1097/WNR.0000000000000043; Rentzos M, 2010, EUR NEUROL, V63, P285, DOI 10.1159/000287582; Su XWW, 2013, JAMA NEUROL, V70, P1505, DOI 10.1001/jamaneurol.2013.4646; Tateishi T, 2010, J NEUROIMMUNOL, V222, P76, DOI 10.1016/j.jneuroim.2010.03.004; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Xu B, 2014, HISTOL HISTOPATHOL, V29, P1437, DOI 10.14670/HH-29.1437	24	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136937	10.1371/journal.pone.0136937	http://dx.doi.org/10.1371/journal.pone.0136937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332465	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800081
J	Carlotti, E; Wrench, D; Rosignoli, G; Marzec, J; Sangaralingam, A; Hazanov, L; Michaeli, M; Hallam, S; Chaplin, T; Iqbal, S; Calaminici, M; Young, B; Mehr, R; Campbell, P; Fitzgibbon, J; Gribben, JG				Carlotti, Emanuela; Wrench, David; Rosignoli, Guglielmo; Marzec, Jacek; Sangaralingam, Ajanthah; Hazanov, Lena; Michaeli, Miri; Hallam, Simon; Chaplin, Tracy; Iqbal, Sameena; Calaminici, Maria; Young, Bryan; Mehr, Ramit; Campbell, Peter; Fitzgibbon, Jude; Gribben, John G.			High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSFORMATION; PROGRESSION; PATTERNS; MUTATION; CANCER; CENTROBLASTS; CENTROCYTES; SELECTION; SUBCLONE	Understanding the dynamics of evolution of Follicular Lymphoma (FL) clones during disease progression is important for monitoring and targeting this tumor effectively. Genetic profiling of serial FL biopsies and examples of FL transmission following bone marrow transplant suggest that this disease may evolve by divergent evolution from a common ancestor cell. However where this ancestor cell resides and how it evolves is still unclear. The analysis of the pattern of somatic hypermutation of the immunoglobulin gene (Ig) is traditionally used for tracking the physiological clonal evolution of B cells within the germinal center and allows to discriminate those cells that have just entered the germinal center and display features of ancestor cells from those B cells that keep re-circulating across different lymphoid organs. Here we investigated the pattern of somatic hypermutation of the heavy chain of the immunoglobulin gene (IgH-VH) in 4 flow-sorted B cells subpopulations belonging to different stages of differentiation, from sequential lymph node biopsies of cases displaying diverse patterns of evolution, using the GS-FLX Titanium sequencing platform. We observed an unexpectedly high level of clonality, with hundreds of distinct tumor subclones in the different subpopulations from the same sample, the majority detected at a frequency <10(-2). By using a lineage trees analysis we observed in all our FL and t-FL cases that the oligoclonal FL population was trapped in a narrow intermediate stage of maturation that maintains the capacity to undergo SHM, but was unable to further differentiate. The presence of such a complex architecture highlights challenges currently encountered in finding a cure for this disease.	[Carlotti, Emanuela; Wrench, David; Hallam, Simon; Chaplin, Tracy; Iqbal, Sameena; Calaminici, Maria; Young, Bryan; Fitzgibbon, Jude; Gribben, John G.] Barts Canc Inst, Ctr Haematooncol, London, England; [Rosignoli, Guglielmo] Barts Canc Inst, Flow Cytometry Core Facil, London, England; [Marzec, Jacek; Sangaralingam, Ajanthah] Barts Canc Inst, Ctr Mol Oncol, London, England; [Hazanov, Lena; Michaeli, Miri; Mehr, Ramit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Campbell, Peter] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Bar Ilan University; Wellcome Trust Sanger Institute	Gribben, JG (corresponding author), Barts Canc Inst, Ctr Haematooncol, London, England.	j.gribben@qmul.ac.uk	Strefford, Jonathan/B-2826-2009	Strefford, Jonathan/0000-0002-0972-2881; Fitzgibbon, Jude/0000-0002-9069-1866; Marzec, Jacek/0000-0001-6577-8866; Mehr, Ramit/0000-0002-4303-6834	Cancer Research UK [C1574/A6806]; Cancer Research UK [15968] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (C1574/A6806) with a program award to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts WM, 2001, BLOOD, V98, P238, DOI 10.1182/blood.V98.1.238; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Barak M, 2008, J IMMUNOL METHODS, V338, P67, DOI 10.1016/j.jim.2008.06.006; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carlotti E, 2009, BLOOD, V113, P3553, DOI 10.1182/blood-2008-08-174839; Caron G, 2009, J IMMUNOL, V182, P7595, DOI 10.4049/jimmunol.0804272; Choi S, 2007, BLOOD, V110, P632, DOI 10.1182/blood-2007-01-067785; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Eide MB, 2010, BLOOD, V116, P1489, DOI 10.1182/blood-2010-03-272278; Fitzgibbon J, 2007, LEUKEMIA, V21, P1514, DOI 10.1038/sj.leu.2404696; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Green MR, 2013, BLOOD, V121, P1604, DOI 10.1182/blood-2012-09-457283; Gribben JG, 2007, BLOOD, V109, P4617, DOI 10.1182/blood-2006-10-041863; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Hogerkorp CM, 2006, J IMMUNOL, V177, P4341, DOI 10.4049/jimmunol.177.7.4341; Jiang YW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0432-0; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lossos IS, 2011, BEST PRACT RES CL HA, V24, P147, DOI 10.1016/j.beha.2011.02.006; Mamessier E, 2014, HAEMATOLOGICA, V99, P481, DOI 10.3324/haematol.2013.094474; Martinez-Climent JA, 2010, HAEMATOL-HEMATOL J, V95, P293, DOI 10.3324/haematol.2009.013318; Montoto S, 2007, J CLIN ONCOL, V25, P2426, DOI 10.1200/JCO.2006.09.3260; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Pasqualucci L, 2014, CELL REP, V6, P130, DOI 10.1016/j.celrep.2013.12.027; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Ruminy P, 2008, BLOOD, V112, P1951, DOI 10.1182/blood-2007-11-124560; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Strothmeyer AM, 2010, BLOOD, V116, P1734, DOI 10.1182/blood-2010-02-270199; Sungalee S, 2014, J CLIN INVEST, V124, P5337, DOI 10.1172/JCI72415; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Weigert O, 2012, CANCER DISCOV, V2, P47, DOI 10.1158/2159-8290.CD-11-0208; Yoshida N, 2011, J IMMUNOL, V186, P2800, DOI 10.4049/jimmunol.1003401	37	23	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0134833	10.1371/journal.pone.0134833	http://dx.doi.org/10.1371/journal.pone.0134833			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325507	gold, Green Published, Green Submitted			2022-12-27	WOS:000360437700015
J	Khan, JA; Mustafa, M; Hayat, T; Alsaedi, A				Khan, Junaid Ahmad; Mustafa, M.; Hayat, T.; Alsaedi, A.			Numerical Study of Cattaneo-Christov Heat Flux Model for Viscoelastic Flow Due to an Exponentially Stretching Surface	PLOS ONE			English	Article							STAGNATION-POINT FLOW; MAXWELL FLUID; VELOCITY SLIP; UCM FLUID; MHD FLOW; SHEET	This work deals with the flow and heat transfer in upper-convected Maxwell fluid above an exponentially stretching surface. Cattaneo-Christov heat flux model is employed for the formulation of the energy equation. This model can predict the effects of thermal relaxation time on the boundary layer. Similarity approach is utilized to normalize the governing boundary layer equations. Local similarity solutions are achieved by shooting approach together with fourth-fifth-order Runge-Kutta integration technique and Newton's method. Our computations reveal that fluid temperature has inverse relationship with the thermal relaxation time. Further the fluid velocity is a decreasing function of the fluid relaxation time. A comparison of Fourier's law and the Cattaneo-Christov's law is also presented. Present attempt even in the case of Newtonian fluid is not yet available in the literature.	[Khan, Junaid Ahmad] Natl Univ Sci & Technol NUST, Res Ctr Modeling & Simulat RCMS, Islamabad 44000, Pakistan; [Mustafa, M.] Natl Univ Sci & Technol NUST, Sch Nat Sci SNS, Islamabad 44000, Pakistan; [Hayat, T.] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah 21589, Saudi Arabia	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University	Mustafa, M (corresponding author), Natl Univ Sci & Technol NUST, Sch Nat Sci SNS, Islamabad 44000, Pakistan.	meraj_mm@hotmail.com	Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/Y-2524-2019; Alsaedi, Ahmed/A-2094-2013; Mustafa Hashmi, Meraj/P-1769-2014; Ahmad, Junaid/AAE-8872-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasbandy S, 2014, INT J NUMER METHOD H, V24, P390, DOI 10.1108/HFF-05-2012-0096; Abel MS, 2012, MECCANICA, V47, P385, DOI 10.1007/s11012-011-9448-7; Awais M, 2014, INT J NUMER METHOD H, V24, P483, DOI 10.1108/HFF-04-2012-0084; Cao BY, 2007, J APPL PHYS, V102, DOI 10.1063/1.2775215; Cattaneo C., 1948, ATTI SEMIN MAT FIS, V3, P83, DOI DOI 10.1007/978-3-642-11051-1_5; Christov CI, 2009, MECH RES COMMUN, V36, P481, DOI 10.1016/j.mechrescom.2008.11.003; Ciarletta M, 2010, MECH RES COMMUN, V37, P445, DOI 10.1016/j.mechrescom.2010.06.002; Dong Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3634113; Fourier J.-B.J., 1822, THEORIE ANAL CHALEUR; Han SH, 2014, APPL MATH LETT, V38, P87, DOI 10.1016/j.aml.2014.07.013; Hayat T, 2014, INT J NUMER METHOD H, V24, P1073, DOI 10.1108/HFF-01-2013-0011; Hayat T, 2012, INT J NUMER METH FL, V68, P233, DOI 10.1002/fld.2503; Hayat T, 2014, INT J NUMER METHOD H, V24, P760, DOI 10.1108/HFF-09-2012-0219; Hsiao KL, 2014, ARAB J SCI ENG, V39, P4325, DOI 10.1007/s13369-014-1065-z; Magyari E, 1999, J PHYS D APPL PHYS, V32, P577, DOI 10.1088/0022-3727/32/5/012; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4916364; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4907927; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4917306; Shateyi S, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-196; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068139; Straughan B, 2010, INT J HEAT MASS TRAN, V53, P95, DOI 10.1016/j.ijheatmasstransfer.2009.10.001; Zhang MK, 2013, INT J HEAT MASS TRAN, V67, P1072, DOI 10.1016/j.ijheatmasstransfer.2013.08.102; Zheng LC, 2011, COMPUT MATH APPL, V61, P2209, DOI 10.1016/j.camwa.2010.09.017; Zheng LC, 2013, J FRANKLIN I, V350, P990, DOI 10.1016/j.jfranklin.2013.01.022; Zheng LC, 2012, MATH COMPUT MODEL, V56, P133, DOI 10.1016/j.mcm.2011.11.080; Zheng LC, 2012, CHEM ENG COMMUN, V199, P1, DOI 10.1080/00986445.2010.524503; Zheng LC, 2011, COMMUN NONLINEAR SCI, V16, P731, DOI 10.1016/j.cnsns.2010.05.022	27	70	71	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137363	10.1371/journal.pone.0137363	http://dx.doi.org/10.1371/journal.pone.0137363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325426	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700113
J	Longo, C; Piana, S; Lallas, A; Moscarella, E; Lombardi, M; Raucci, M; Pellacani, G; Argenziano, G				Longo, Caterina; Piana, Simonetta; Lallas, Aimilios; Moscarella, Elvira; Lombardi, Mara; Raucci, Margherita; Pellacani, Giovanni; Argenziano, Giuseppe			Routine Clinical-Pathologic Correlation of Pigmented Skin Tumors Can Influence Patient Management	PLOS ONE			English	Article							TOTAL-BODY PHOTOGRAPHY; HISTOPATHOLOGIC DIAGNOSIS; LENTIGINOUS MELANOMA; DIGITAL DERMATOSCOPY; FOLLOW-UP; HIGH-RISK; LESIONS	Background Several studies have demonstrated the benefit of integrating clinical with pathologic information, to obtain a confident diagnosis for melanocytic tumors. However, all those studies were conducted retrospectively and no data are currently available about the role of a clinical-pathologic correlation approach on a daily basis in clinical practice. Aim of the Study In our study, we evaluated the impact of a routine clinical-pathologic correlation approach for difficult skin tumors seen over 3 years in a tertiary referral center. Results Interestingly, a re-appraisal was requested for 158 out of 2015 (7.7%) excised lesions because clinical-pathologic correlation was missing. Of note, in 0.6% of them (13 out of 2045) the first histologic diagnosis was revised in the light of clinical information that assisted the Pathologist to re-evaluate the histopathologic findings that might be bland or inconspicuous per se. Conclusion In conclusion, our study demonstrated that an integrated approach involving clinicians and pathologists allows improving management of selected patients by shifting from a simply disease-focused management (melanoma versus nevus) to a patient-centered approach.	[Longo, Caterina; Lallas, Aimilios; Moscarella, Elvira; Lombardi, Mara; Raucci, Margherita; Argenziano, Giuseppe] Arcispedale Santa Maria Nuova IRCCS, Dermatol & Skin Canc Unit, Reggio Emilia, Italy; [Piana, Simonetta] Arcispedale Santa Maria Nuova IRCCS, Pathol Unit, Reggio Emilia, Italy; [Pellacani, Giovanni] Univ Modena & Reggio Emilia, Dermatol Unit, Modena, Italy	IRCCS Arcispedale S. Maria Nuova; IRCCS Arcispedale S. Maria Nuova; Universita di Modena e Reggio Emilia	Longo, C (corresponding author), Arcispedale Santa Maria Nuova IRCCS, Dermatol & Skin Canc Unit, Reggio Emilia, Italy.	longo.caterina@gmail.com	Longo, Caterina/A-8046-2012; Lallas, Aimilios/O-4986-2019; PIANA, SIMONETTA/AAC-9158-2019; pellacani, giovanni/E-8573-2011; Argenziano, Giuseppe/E-5926-2010	Longo, Caterina/0000-0002-8218-3896; Lallas, Aimilios/0000-0002-7193-0964; PIANA, SIMONETTA/0000-0003-4875-6977; pellacani, giovanni/0000-0002-7222-2951; Argenziano, Giuseppe/0000-0003-1413-8214	Italian Ministry of Health [RF-2010-2316524]	Italian Ministry of Health(Ministry of Health, Italy)	This study was supported in part by the Italian Ministry of Health (RF-2010-2316524). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no other fundings for this study.	Argenziano G, 2012, J AM ACAD DERMATOL, V67, P54, DOI 10.1016/j.jaad.2011.07.019; Aslan C, 2012, J AM ACAD DERMATOL, V66, P393, DOI 10.1016/j.jaad.2010.12.031; Bauer J, 2006, BRIT J DERMATOL, V155, P546, DOI 10.1111/j.1365-2133.2006.07342.x; Cerroni L, 2010, J AM ACAD DERMATOL, V63, P647, DOI 10.1016/j.jaad.2009.09.009; Chang JH, 2001, CANCER-AM CANCER SOC, V91, P1231, DOI 10.1002/1097-0142(20010401)91:7<1231::AID-CNCR1123>3.0.CO;2-K; Ferrara G, 2008, HISTOPATHOLOGY, V52, P523, DOI 10.1111/j.1365-2559.2008.02943.x; Ferrara G, 2002, CANCER, V95, P1094, DOI 10.1002/cncr.10768; Ferrara G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005375; Gaudi S, 2013, J AM ACAD DERMATOL, V68, P119, DOI 10.1016/j.jaad.2012.06.034; King R, 2005, MODERN PATHOL, V18, P1397, DOI 10.1038/modpathol.3800454; Lodha S, 2008, J CUTAN PATHOL, V35, P349, DOI 10.1111/j.1600-0560.2007.00970.x; McGinnis KS, 2002, ARCH DERMATOL, V138, P617, DOI 10.1001/archderm.138.5.617; Newman EA, 2006, CANCER, V107, P2346, DOI 10.1002/cncr.22266; Salerni G, 2013, J EUR ACAD DERMATOL, V27, P805, DOI 10.1111/jdv.12032; Salerni G, 2012, J AM ACAD DERMATOL, V67, P836, DOI 10.1016/j.jaad.2012.01.028; Salerni G, 2012, J AM ACAD DERMATOL, V67, pE17, DOI 10.1016/j.jaad.2011.04.008; Soyer HP, 2005, ARCH DERMATOL, V141, P209, DOI 10.1001/archderm.141.2.209; Zalaudek I, 2006, EXPERT REV DERMATOL, V4, P579; Zalaudek I, 2013, DERMATOL CLIN, V31, P549, DOI 10.1016/j.det.2013.06.011	19	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136031	10.1371/journal.pone.0136031	http://dx.doi.org/10.1371/journal.pone.0136031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325678	Green Published, Green Submitted, gold			2022-12-27	WOS:000360437700027
J	Breese, EH; Buechele, C; Dawson, C; Cleary, ML; Porteus, MH				Breese, Erin H.; Buechele, Corina; Dawson, Catherine; Cleary, Michael L.; Porteus, Matthew H.			Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells	PLOS ONE			English	Article							THERAPY-RELATED LEUKEMIA; ACUTE MYELOID-LEUKEMIA; WIDE ANALYSIS; GENE; INFANT; REARRANGEMENTS; MLL-AF4; MUTATIONS; MODEL; BREAKPOINTS	One of the challenging questions in cancer biology is how a normal cell transforms into a cancer cell. There is strong evidence that specific chromosomal translocations are a key element in this transformation process. Our studies focus on understanding the developmental mechanism by which a normal stem or progenitor cell transforms into leukemia. Here we used engineered nucleases to induce simultaneous specific double strand breaks in the MLL gene and two different known translocation partners (AF4 and AF9), which resulted in specific chromosomal translocations in K562 cells as well as primary hematopoietic stem and progenitor cells (HSPCs). The initiation of a specific MLL translocation in a small number of HSPCs likely mimics the leukemia-initiating event that occurs in patients. In our studies, the creation of specific MLL translocations in CD34+ cells was not sufficient to transform cells in vitro. Rather, a variety of fates was observed for translocation positive cells including cell loss over time, a transient proliferative advantage followed by loss of the clone, or a persistent proliferative advantage. These studies highlight the application of genome engineering tools in primary human HSPCs to induce and prospectively study the consequences of initiating translocation events in leukemia pathogenesis.	[Breese, Erin H.; Dawson, Catherine] Stanford Univ, Div Pediat Hematol Oncol, Dept Pediat, Stanford, CA 94305 USA; [Buechele, Corina; Cleary, Michael L.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Porteus, Matthew H.] Stanford Univ, Div Pediat Stem Cell Transplantat & Regenerat Med, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Cleary, ML (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	mcleary@stanford.edu; mporteus@stanford.edu			St. Baldrick's Foundation; Deutsche Krebshilfe, Germany; Children's Health Initiative of the Packard Foundation; Hyundai Hope on Wheels; Public Health Service (PHS) grant [CA116606]	St. Baldrick's Foundation; Deutsche Krebshilfe, Germany(Deutsche Krebshilfe); Children's Health Initiative of the Packard Foundation; Hyundai Hope on Wheels; Public Health Service (PHS) grant	This work was supported by the St. Baldrick's Foundation (E.B.), the Deutsche Krebshilfe, Germany (C.B.), the Children's Health Initiative of the Packard Foundation (M.P.), Hyundai Hope on Wheels (M.P.), and a Public Health Service (PHS) grant (CA116606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Borst L, 2012, BRIT J HAEMATOL, V157, P476, DOI 10.1111/j.1365-2141.2012.09083.x; Brunet E, 2009, P NATL ACAD SCI USA, V106, P10620, DOI 10.1073/pnas.0902076106; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen WL, 2006, BLOOD, V108, P669, DOI 10.1182/blood-2005-08-3498; Chen W, 2011, BLOOD, V117, P3474, DOI 10.1182/blood-2010-11-317529; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Chowdhury T, 2008, BLOOD CELL MOL DIS, V40, P192, DOI 10.1016/j.bcmd.2007.07.005; Cowell IG, 2012, INT J ENV RES PUB HE, V9, P2075, DOI 10.3390/ijerph9062075; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; Dobbins SE, 2013, GENE CHROMOSOME CANC, V52, P954, DOI 10.1002/gcc.22090; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Greaves M, 1999, EUR J CANCER, V35, P1941, DOI 10.1016/S0959-8049(99)00296-8; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Howlader N, 2014, SEER CANC STAT REV; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Jansen MWJC, 2007, LEUKEMIA, V21, P633, DOI 10.1038/sj.leu.2404578; Langer T, 2003, GENE CHROMOSOME CANC, V36, P393, DOI 10.1002/gcc.10167; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Liang DC, 2006, CANCER, V106, P950, DOI 10.1002/cncr.21687; Libura J, 2005, BLOOD, V105, P2124, DOI 10.1182/blood-2004-07-2683; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Montes R, 2014, LEUKEMIA, V28, P666, DOI 10.1038/leu.2013.346; Montes R, 2011, BLOOD, V117, P4746, DOI 10.1182/blood-2010-12-322230; Moriya K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037892; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Piganeau M, 2013, GENOME RES, V23, P1182, DOI 10.1101/gr.147314.112; Piller GJ, 2001, BRIT J HAEMATOL, V112, P282, DOI 10.1046/j.1365-2141.2001.02411.x; Prelle C, 2013, LEUKEMIA, V27, P1425, DOI 10.1038/leu.2012.365; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Reichel M, 2001, ONCOGENE, V20, P2900, DOI 10.1038/sj.onc.1204401; Sam TN, 2012, PEDIATR BLOOD CANCER, V58, P836, DOI 10.1002/pbc.23274; Siraj AK, 2002, CLIN CANCER RES, V8, P3832; Stam RW, 2013, BLOOD, V121, P3780, DOI 10.1182/blood-2013-03-491738; SUPER HJG, 1993, BLOOD, V82, P3705; Taketani T, 2004, BLOOD, V103, P1085, DOI 10.1182/blood-2003-02-0418; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Weinstock David M, 2008, J Natl Cancer Inst Monogr, P20, DOI 10.1093/jncimonographs/lgn009	41	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0136644	10.1371/journal.pone.0136644	http://dx.doi.org/10.1371/journal.pone.0136644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26351841	Green Published, Green Submitted, gold			2022-12-27	WOS:000360932800044
J	Kakinuma, R; Moriyama, N; Muramatsu, Y; Gomi, S; Suzuki, M; Nagasawa, H; Kusumoto, M; Aso, T; Muramatsu, Y; Tsuchida, T; Tsuta, K; Maeshima, AM; Tochigi, N; Watanabe, S; Sugihara, N; Tsukagoshi, S; Saito, Y; Kazama, M; Ashizawa, K; Awai, K; Honda, O; Ishikawa, H; Koizumi, N; Komoto, D; Moriya, H; Oda, S; Oshiro, Y; Yanagawa, M; Tomiyama, N; Asamura, H				Kakinuma, Ryutaro; Moriyama, Noriyuki; Muramatsu, Yukio; Gomi, Shiho; Suzuki, Masahiro; Nagasawa, Hirobumi; Kusumoto, Masahiko; Aso, Tomohiko; Muramatsu, Yoshihisa; Tsuchida, Takaaki; Tsuta, Koji; Maeshima, Akiko Miyagi; Tochigi, Naobumi; Watanabe, Shun-ichi; Sugihara, Naoki; Tsukagoshi, Shinsuke; Saito, Yasuo; Kazama, Masahiro; Ashizawa, Kazuto; Awai, Kazuo; Honda, Osamu; Ishikawa, Hiroyuki; Koizumi, Naoya; Komoto, Daisuke; Moriya, Hiroshi; Oda, Seitaro; Oshiro, Yasuji; Yanagawa, Masahiro; Tomiyama, Noriyuki; Asamura, Hisao			Ultra-High-Resolution Computed Tomography of the Lung: Image Quality of a Prototype Scanner	PLOS ONE			English	Article							THIN-SECTION CT; SOLITARY PULMONARY-LESIONS; MULTIDETECTOR CT; NODULES; BENIGN; CANCER; CLASSIFICATION; FEATURES; CM; DIFFERENTIATION	Purpose The image noise and image quality of a prototype ultra-high-resolution computed tomography (U-HRCT) scanner was evaluated and compared with those of conventional high-resolution CT (C-HRCT) scanners. Materials and Methods This study was approved by the institutional review board. A U-HRCT scanner prototype with 0.25 mm x 4 rows and operating at 120 mAs was used. The C-HRCT images were obtained using a 0.5 mm x 16 or 0.5 mm x 64 detector-row CT scanner operating at 150 mAs. Images from both scanners were reconstructed at 0.1-mm intervals; the slice thickness was 0.25 mm for the U-HRCT scanner and 0.5 mm for the C-HRCT scanners. For both scanners, the display field of view was 80 mm. The image noise of each scanner was evaluated using a phantom. U-HRCT and C-HRCT images of 53 images selected from 37 lung nodules were then observed and graded using a 5-point score by 10 board-certified thoracic radiologists. The images were presented to the observers randomly and in a blinded manner. Results The image noise for U-HRCT (100.87 +/- 0.51 Hounsfield units [HU]) was greater than that for C-HRCT (40.41 +/- 0.52 HU; P < .0001). The image quality of U-HRCT was graded as superior to that of C-HRCT (P < .0001) for all of the following parameters that were examined: margins of subsolid and solid nodules, edges of solid components and pulmonary vessels in subsolid nodules, air bronchograms, pleural indentations, margins of pulmonary vessels, edges of bronchi, and interlobar fissures. Conclusion Despite a larger image noise, the prototype U-HRCT scanner had a significantly better image quality than the C-HRCT scanners.	[Kakinuma, Ryutaro; Moriyama, Noriyuki; Muramatsu, Yukio] Natl Canc Ctr, Div Canc Screening, Res Ctr Canc Prevent & Screening, Chuo Ku, Tokyo 104, Japan; [Kakinuma, Ryutaro; Gomi, Shiho; Suzuki, Masahiro; Nagasawa, Hirobumi; Kusumoto, Masahiko; Aso, Tomohiko] Natl Canc Ctr, Dept Radiol, Chuo Ku, Tokyo, Japan; [Kusumoto, Masahiko; Muramatsu, Yoshihisa] Natl Canc Ctr Hosp East, Dept Radiol, Kashiwa, Chiba, Japan; [Tsuchida, Takaaki] Natl Canc Ctr, Dept Endoscopy, Resp Endoscopy Div, Chuo Ku, Tokyo, Japan; [Tsuta, Koji; Maeshima, Akiko Miyagi; Tochigi, Naobumi] Natl Canc Ctr, Div Pathol, Chuo Ku, Tokyo, Japan; [Watanabe, Shun-ichi; Asamura, Hisao] Natl Canc Ctr, Dept Thorac Surg, Chuo Ku, Tokyo, Japan; [Sugihara, Naoki; Tsukagoshi, Shinsuke; Saito, Yasuo; Kazama, Masahiro] Toshiba Med Syst Corp, Dept CT Syst Div, Otawara, Tochigi, Japan; [Ashizawa, Kazuto] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oncol, Nagasaki 852, Japan; [Awai, Kazuo; Komoto, Daisuke] Hiroshima Univ, Inst & Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan; [Honda, Osamu; Yanagawa, Masahiro; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Dept Radiol, Suita, Osaka, Japan; [Ishikawa, Hiroyuki] Niigata Univ, Med & Dent Hosp, Dept Radiol, Niigata, Japan; [Koizumi, Naoya] Niigata Canc Ctr Hosp, Dept Radiol, Niigata, Japan; [Moriya, Hiroshi] Ohara Gen Hosp, Dept Radiol, Fukushima, Japan; [Oda, Seitaro] Kumamoto Univ, Fac Life Sci, Dept Diagnost Radiol, Kumamoto, Japan; [Oshiro, Yasuji] Natl Hosp Org Okinawa Natl Hosp, Dept Radiol, Ginowan, Okinawa, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Toshiba Corporation; Nagasaki University; Hiroshima University; Osaka University; Niigata University; Kumamoto University	Kakinuma, R (corresponding author), Natl Canc Ctr, Div Canc Screening, Res Ctr Canc Prevent & Screening, Chuo Ku, Tokyo 104, Japan.	rkaki@ncc.go.jp	Yanagawa, Masahiro/AAD-2306-2022	Yanagawa, Masahiro/0000-0002-0911-6769; Tsuchida, Takaaki/0000-0002-4878-1956	Third-term Comprehensive Cancer Control Strategy - Ministry of Health, Labour and Welfare, Tokyo, Japan [19-1, 22-019]; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation; National Cancer Center Research and Development Fund [48-A-12]; Toshiba Medical Systems Corporation	Third-term Comprehensive Cancer Control Strategy - Ministry of Health, Labour and Welfare, Tokyo, Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation; National Cancer Center Research and Development Fund(National Cancer Center - Japan); Toshiba Medical Systems Corporation	This research was supported in part by a Grant-in-Aid from the Third-term Comprehensive Cancer Control Strategy sponsored by the Ministry of Health, Labour and Welfare (http://www.mhlw.go.jp/english/), Tokyo, Japan (19-1, 22-019), by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, and by the National Cancer Center (http://www.ncc.go.jp/en/index.html) Research and Development Fund (48-A-12). Toshiba Medical Systems Corporation provided support in the form of salaries for authors NS, ST, YS & MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akata S, 2008, CLIN IMAG, V32, P259, DOI 10.1016/j.clinimag.2007.10.002; Armato SG, 2007, ACAD RADIOL, V14, P1409, DOI 10.1016/j.acra.2007.07.008; Austin JHM, 2013, RADIOLOGY, V266, P62, DOI 10.1148/radiol.12120240; Choi JA, 2000, EUR RADIOL, V10, P1304, DOI 10.1007/s003300000315; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Fan L, 2012, BRIT J RADIOL, V85, P897, DOI 10.1259/bjr/33150223; Gremse F, 2011, RADIOLOGY, V260, P709, DOI 10.1148/radiol.11110069; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hattori A, 2014, EUR J CARDIO-THORAC, V45, P699, DOI 10.1093/ejcts/ezt467; Henschke CI, 2002, AM J ROENTGENOL, V178, P1053, DOI 10.2214/ajr.178.5.1781053; International Electrotechnical Commission, 2019, EV ROUT TEST MED I 3; Ishikawa H, 2007, J COMPUT ASSIST TOMO, V31, P409, DOI 10.1097/01.rct.0000243451.25986.10; Jiang BH, 2014, ACTA RADIOL, V55, P302, DOI 10.1177/0284185113495834; Kishi K, 2004, LUNG CANCER, V44, P43, DOI 10.1016/j.lungcan.2003.09.024; KURIYAMA K, 1991, AM J ROENTGENOL, V156, P921, DOI 10.2214/ajr.156.5.2017952; KURIYAMA K, 1987, AM J ROENTGENOL, V149, P1139, DOI 10.2214/ajr.149.6.1139; Lee HJ, 2009, EUR RADIOL, V19, P552, DOI 10.1007/s00330-008-1188-2; Li F, 2004, RADIOLOGY, V233, P793, DOI 10.1148/radiol.2333031018; Li M, 2004, LUNG CANCER, V46, P349, DOI 10.1016/j.lungcan.2004.05.017; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; MORI K, 1990, RADIOLOGY, V177, P843, DOI 10.1148/radiology.177.3.2243999; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Nakata M, 2002, CHEST, V121, P1464, DOI 10.1378/chest.121.5.1464; Oda S, 2008, AM J ROENTGENOL, V190, P1363, DOI 10.2214/AJR.07.3101; Seemann MD, 1999, EUR RADIOL, V9, P409, DOI 10.1007/s003300050683; Takahashi M, 2014, J THORAC CARDIOV SUR, V147, P54, DOI 10.1016/j.jtcvs.2013.08.058; TAKANASHI N, 1995, LUNG CANCER-J IASLC, V13, P105, DOI 10.1016/0169-5002(95)00488-2; Takashima S, 2003, AM J ROENTGENOL, V180, P955, DOI 10.2214/ajr.180.4.1800955; Takashima S, 2003, AM J ROENTGENOL, V180, P1255, DOI 10.2214/ajr.180.5.1801255; Todo G, 1982, Rinsho Hoshasen, V27, P1319; TRAVIS WD, 2011, J THORAC ONCOL, V6, P244, DOI DOI 10.1097/JT0.0B013E318206A221; Tsukagoshi S, 2007, PHYS MED BIOL, V52, P791, DOI 10.1088/0031-9155/52/3/018; Yanagawa M, 2010, RADIOLOGY, V255, P944, DOI 10.1148/radiol.10091010; Yang ZG, 2001, AM J ROENTGENOL, V176, P1399, DOI 10.2214/ajr.176.6.1761399; Yoon HE, 2005, GEN THORAC CARDIOVAS, V53, P22; ZWIREWICH CV, 1991, RADIOLOGY, V179, P469, DOI 10.1148/radiology.179.2.2014294	36	70	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2015	10	9							e0137165	10.1371/journal.pone.0137165	http://dx.doi.org/10.1371/journal.pone.0137165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ9KG	26352144	gold, Green Published, Green Submitted			2022-12-27	WOS:000360932800063
J	Chaparro-Garcia, A; Schwizer, S; Sklenar, J; Yoshida, K; Petre, B; Bos, JIB; Schornack, S; Jones, AME; Bozkurt, TO; Kamoun, S				Chaparro-Garcia, Angela; Schwizer, Simon; Sklenar, Jan; Yoshida, Kentaro; Petre, Benjamin; Bos, Jorunn I. B.; Schornack, Sebastian; Jones, Alexandra M. E.; Bozkurt, Tolga O.; Kamoun, Sophien			Phytophthora infestans RXLR-WY Effector AVR3a Associates with Dynamin-Related Protein 2 Required for Endocytosis of the Plant Pattern Recognition Receptor FLS2	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; INNATE IMMUNITY; NICOTIANA-BENTHAMIANA; PLASMA-MEMBRANE; CELL-DEATH; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; TRIGGERED IMMUNITY; DEFENSE RESPONSES; HIGH-THROUGHPUT	Pathogens utilize effectors to suppress basal plant defense known as PTI (Pathogen-associated molecular pattern-triggered immunity). However, our knowledge of PTI suppression by filamentous plant pathogens, i.e. fungi and oomycetes, remains fragmentary. Previous work revealed that the co-receptor BAK1/SERK3 contributes to basal immunity against the potato pathogen Phytophthora infestans. Moreover BAK1/SERK3 is required for the cell death induced by P. infestans elicitin INF1, a protein with characteristics of PAMPs. The P. infestans host-translocated RXLR-WY effector AVR3a is known to supress INF1-mediated cell death by binding the plant E3 ligase CMPG1. In contrast, AVR3a(KI-Y147del), a deletion mutant of the C-terminal tyrosine of AVR3a, fails to bind CMPG1 and does not suppress INF1-mediated cell death. Here, we studied the extent to which AVR3a and its variants perturb additional BAK1/SERK3-dependent PTI responses in N. benthamiana using the elicitor/receptor pair flg22/FLS2 as a model. We found that all tested variants of AVR3a suppress defense responses triggered by flg22 and reduce internalization of activated FLS2. Moreover, we discovered that AVR3a associates with the Dynamin-Related Protein 2 (DRP2), a plant GTPase implicated in receptor-mediated endocytosis. Interestingly, silencing of DRP2 impaired ligand-induced FLS2 internalization but did not affect internalization of the growth receptor BRI1. Our results suggest that AVR3a associates with a key cellular trafficking and membrane-remodeling complex involved in immune receptor-mediated endocytosis. We conclude that AVR3a is a multifunctional effector that can suppress BAK1/SERK3-mediated immunity through at least two different pathways.	[Chaparro-Garcia, Angela; Schwizer, Simon; Sklenar, Jan; Yoshida, Kentaro; Petre, Benjamin; Bos, Jorunn I. B.; Schornack, Sebastian; Jones, Alexandra M. E.; Bozkurt, Tolga O.; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bozkurt, TO (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	o.bozkurt@imperial.ac.uk; sophien.kamoun@tsl.ac.uk	Bozkurt, Tolga Osman/AAA-8014-2019; Schornack, Sebastian/A-3650-2011; Schornack, Sebastian/AAE-4897-2020; Jones, Alexandra/B-5227-2009; Kamoun, Sophien/B-3529-2009; Bozkurt, Tolga O/C-9764-2014; Bos, Jorunn IB/E-4703-2011; Petre, Benjamin/AAF-1156-2019	Bozkurt, Tolga Osman/0000-0003-0507-6875; Schornack, Sebastian/0000-0002-7836-5881; Schornack, Sebastian/0000-0002-7836-5881; Jones, Alexandra/0000-0003-2571-8708; Kamoun, Sophien/0000-0002-0290-0315; Bozkurt, Tolga O/0000-0003-0507-6875; Bos, Jorunn IB/0000-0003-3222-8643; Petre, Benjamin/0000-0002-3204-4249; Yoshida, Kentaro/0000-0002-3614-1759	Gatsby Charitable Foundation; European Research Council (ERC); Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BB/I020470/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I020470/1] Funding Source: researchfish	Gatsby Charitable Foundation; European Research Council (ERC)(European Research Council (ERC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded through grants by the Gatsby Charitable Foundation, European Research Council (ERC) and Biotechnology and Biological Sciences Research Council (BBSRC) to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Backues SK, 2010, PLANT CELL, V22, P3218, DOI 10.1105/tpc.110.077727; Bar M, 2010, PLANT J, V63, P791, DOI 10.1111/j.1365-313X.2010.04282.x; Basquin C, 2013, J CELL SCI, V126, P1099, DOI 10.1242/jcs.110932; Beck M, 2012, PLANT CELL, V24, P4205, DOI 10.1105/tpc.112.100263; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bos JIB, 2009, MOL PLANT MICROBE IN, V22, P269, DOI 10.1094/MPMI-22-3-0269; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Bozkurt TO, 2014, REROUTING PLANT LATE; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Caillaud MC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004496; Cao YR, 2014, ELIFE, V3, DOI 10.7554/eLife.03766; Chaparro-Garcia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016608; Chen X, 2011, CURR OPIN PLANT BIOL, V14, P674, DOI 10.1016/j.pbi.2011.08.006; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Chockalingam A, 2009, IMMUNOL CELL BIOL, V87, P209, DOI 10.1038/icb.2008.101; Choi SW, 2013, PLANT CELL, V25, P1174, DOI 10.1105/tpc.112.108803; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Di Rubbo S, 2013, PLANT CELL, V25, P2986, DOI 10.1105/tpc.113.114058; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelhardt S, 2012, PLANT CELL, V24, P5142, DOI 10.1105/tpc.112.104992; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Fujimoto M, 2008, PLANT CELL REP, V27, P1581, DOI 10.1007/s00299-008-0583-0; Fujimoto M, 2010, P NATL ACAD SCI USA, V107, P6094, DOI 10.1073/pnas.0913562107; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gilroy EM, 2011, NEW PHYTOL, V190, P653, DOI 10.1111/j.1469-8137.2011.03643.x; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hann DR, 2007, PLANT J, V49, P607, DOI 10.1111/j.1365-313X.2006.02981.x; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Helliwell C, 2003, METHODS, V30, P289, DOI 10.1016/S1046-2023(03)00036-7; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Hong Z, 2003, PLANT MOL BIOL, V53, P261, DOI 10.1023/B:PLAN.0000007000.29697.81; Huang J, 2015, BIOCHEM BIOPH RES CO, V456, P238, DOI 10.1016/j.bbrc.2014.11.065; Irani NG, 2012, NAT CHEM BIOL, V8, P583, DOI [10.1038/nchembio.958, 10.1038/NCHEMBIO.958]; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kamoun S, 1998, PHYTOPATHOLOGY, V88, P1315, DOI 10.1094/PHYTO.1998.88.12.1315; Larroque M, 2013, J EXP BOT, V64, P3615, DOI 10.1093/jxb/ert195; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lu Dongping, 2010, Commun Integr Biol, V3, P80; Lu YJ, 2012, CELL MICROBIOL, V14, P682, DOI 10.1111/j.1462-5822.2012.01751.x; Macho AP, 2015, CURR OPIN MICROBIOL, V23, P14, DOI 10.1016/j.mib.2014.10.009; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Monaghan J, 2012, CURR OPIN PLANT BIOL, V15, P349, DOI 10.1016/j.pbi.2012.05.006; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Ntoukakis V, 2011, PLANT CELL, V23, P3871, DOI 10.1105/tpc.111.090779; Okmen B, 2014, CURR OPIN PLANT BIOL, V20, P19, DOI 10.1016/j.pbi.2014.03.011; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Petre B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001801; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rafiqi M, 2012, CURR OPIN PLANT BIOL, V15, P477, DOI 10.1016/j.pbi.2012.05.003; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; RCore Team, 2020, R LANG ENV STAT COMP; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Robatzek S, 2014, ENDOCYTOSIS AT THE C; Robinson DG, 2008, PLANT PHYSIOL, V147, P1482, DOI 10.1104/pp.108.120105; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Rovenich H, 2014, CURR OPIN PLANT BIOL, V20, P96, DOI 10.1016/j.pbi.2014.05.001; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Salomon S, 2006, PLANT SIGNAL BEHAV, V1, P293, DOI 10.4161/psb.1.6.3594; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Segonzac C, 2011, CURR OPIN MICROBIOL, V14, P54, DOI 10.1016/j.mib.2010.12.005; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Smith JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004578; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Taylor NG, 2011, PLANT MOL BIOL, V76, P117, DOI 10.1007/s11103-011-9773-1; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Vogel F, 2007, TRAFFIC, V8, P1205, DOI 10.1111/j.1600-0854.2007.00608.x; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Win J, 2011, METHODS MOL BIOL, V712, P181, DOI 10.1007/978-1-61737-998-7_15; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108; Zheng XZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004057; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	103	49	54	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137071	10.1371/journal.pone.0137071	http://dx.doi.org/10.1371/journal.pone.0137071			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348328	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000360897600019
J	Dragset, MS; Barczak, AK; Kannan, N; Maerk, M; Flo, TH; Valla, S; Rubin, EJ; Steigedal, M				Dragset, Marte S.; Barczak, Amy K.; Kannan, Nisha; Maerk, Mali; Flo, Trude H.; Valla, Svein; Rubin, Eric J.; Steigedal, Magnus			Benzoic Acid-Inducible Gene Expression in Mycobacteria	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; META-CLEAVAGE PATHWAY; ESCHERICHIA-COLI; PM PROMOTER; TOL PLASMID; TETRACYCLINE REPRESSORS; TUBERCULOSIS; SMEGMATIS; XYLS; PROTEIN	Conditional expression is a powerful tool to investigate the role of bacterial genes. Here, we adapt the Pseudomonas putida-derived positively regulated XylS/Pm expression system to control inducible gene expression in Mycobacterium smegmatis and Mycobacterium tuberculosis, the causative agent of human tuberculosis. By making simple changes to a Gram-negative broad-host-range XylS/Pm-regulated gene expression vector, we prove that it is possible to adapt this well-studied expression system to non-Gram-negative species. With the benzoic acid-derived inducer m-toluate, we achieve a robust, time- and dose-dependent reversible induction of Pm-mediated expression in mycobacteria, with low background expression levels. XylS/Pm is thus an important addition to existing mycobacterial expression tools, especially when low basal expression is of particular importance.	[Dragset, Marte S.; Rubin, Eric J.; Steigedal, Magnus] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Dragset, Marte S.; Kannan, Nisha; Maerk, Mali; Flo, Trude H.; Steigedal, Magnus] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Dragset, Marte S.; Valla, Svein] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Barczak, Amy K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Steigedal, Magnus] Cent Norway Reg Hlth Author, Stjordal, Norway	Harvard University; Harvard T.H. Chan School of Public Health; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Harvard University; Massachusetts General Hospital	Steigedal, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	magnus.steigedal@ntnu.no	Steigedal, Magnus/H-7053-2019; Flo, Trude Helen/E-1311-2013	Steigedal, Magnus/0000-0002-3695-3132; Flo, Trude Helen/0000-0002-2569-0381; Maerk, Mali/0000-0001-7447-0687	Research Council of Norway through its Centres of Excellence funding scheme [223255/F50]; Research Council of Norway [220836/F10, 246944/F10]; NTNU; Liaison Committee; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER	Research Council of Norway through its Centres of Excellence funding scheme; Research Council of Norway(Research Council of Norway); NTNU; Liaison Committee; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 223255/F50. In addition the Research Council of Norway supported the work through project numbers 220836/F10 and 246944/F10. In addition NTNU and the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) contributed with funding to the study.	Bakke I, 2009, APPL ENVIRON MICROB, V75, P2002, DOI 10.1128/AEM.02315-08; Berg L, 2012, J BIOTECHNOL, V158, P224, DOI 10.1016/j.jbiotec.2011.07.012; Bernheim F, 1942, J BIOL CHEM, V143, P383; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Brautaset T, 2009, MICROB BIOTECHNOL, V2, P15, DOI 10.1111/j.1751-7915.2008.00048.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; Carroll P, 2007, FEMS MICROBIOL LETT, V274, P73, DOI 10.1111/j.1574-6968.2007.00842.x; Connell ND, 1995, METHOD CELL BIOL, V45, P107, DOI DOI 10.1016/S0091-679X(08)61848-8; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; Dragset MS, 2015, ANTIMICROB AGENTS CH, V59, P2256, DOI 10.1128/AAC.05114-14; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Grant SS, 2013, ACS CHEM BIOL, V8, P2224, DOI 10.1021/cb4004817; Guo XV, 2007, J BACTERIOL, V189, P4614, DOI 10.1128/JB.00216-07; Hernandez-Abanto SM, 2006, ARCH MICROBIOL, V186, P459, DOI 10.1007/s00203-006-0160-2; Hickey MJ, 1996, ANTIMICROB AGENTS CH, V40, P400, DOI 10.1128/AAC.40.2.400; Higgins DR, 1998, METH MOL B, V103, P41; HOWARD NS, 1995, GENE, V166, P181, DOI 10.1016/0378-1119(95)00597-X; INOUYE S, 1987, J BACTERIOL, V169, P3587, DOI 10.1128/jb.169.8.3587-3592.1987; Kaneko T, 2011, FUTURE MED CHEM, V3, P1373, DOI [10.4155/fmc.11.115, 10.4155/FMC.11.115]; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Komeda H, 1996, P NATL ACAD SCI USA, V93, P10572, DOI 10.1073/pnas.93.20.10572; Lale R, 2011, APPL ENVIRON MICROB, V77, P2648, DOI 10.1128/AEM.02091-10; Lambert RJ, 1999, J APPL MICROBIOL, V86, P157, DOI 10.1046/j.1365-2672.1999.00646.x; Lim A, 2000, BIOL CHEM, V381, P517, DOI 10.1515/BC.2000.066; Medina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023055; MERMOD N, 1986, J BACTERIOL, V167, P447, DOI 10.1128/jb.167.2.447-454.1986; Miesel L, 2003, NAT REV GENET, V4, P442, DOI 10.1038/nrg1086; Milligan DL, 2007, J BACTERIOL, V189, P8381, DOI 10.1128/JB.01201-07; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; RAMOS JL, 1990, J MOL BIOL, V211, P373, DOI 10.1016/0022-2836(90)90358-S; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Ruiz R, 2003, J BACTERIOL, V185, P3036, DOI 10.1128/JB.185.10.3036-3041.2003; SCHEIN CH, 1988, BIO-TECHNOL, V6, P291, DOI 10.1038/nbt0388-291; Schleif R, 2000, TRENDS GENET, V16, P559, DOI 10.1016/S0168-9525(00)02153-3; Seeliger JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029266; Silva PEA, 2001, ANTIMICROB AGENTS CH, V45, P800, DOI 10.1128/AAC.45.3.800-804.2001; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tabor S, 1992, Biotechnology, V24, P280; Wegerer A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-2; WHO Food Standards, 2014, CODEX AL BENZ; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Winther-Larsen HC, 2000, METAB ENG, V2, P79, DOI 10.1006/mben.1999.0142; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578; Zwick F, 2013, BIOENGINEERED, V4, P431, DOI 10.4161/bioe.24703; Zwick F, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-262	54	5	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0134544	10.1371/journal.pone.0134544	http://dx.doi.org/10.1371/journal.pone.0134544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26348349	Green Published, gold, Green Submitted			2022-12-27	WOS:000360897600001
J	Kao, LT; Lee, HC; Lin, HC; Tsai, MC; Chung, SD				Kao, Li-Ting; Lee, Hsin-Chien; Lin, Herng-Ching; Tsai, Ming-Chieh; Chung, Shiu-Dong			Healthcare Service Utilization by Patients with Obstructive Sleep Apnea: A Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; INTERMITTENT HYPOXIA; ECONOMIC-IMPACT; ASSOCIATION; DIAGNOSIS; ACTIVATION; RESOURCES; MORBIDITY; PATHWAYS; OBESITY	Objective Although obstructive sleep apnea (OSA) is not a life-threatening disease, very few studies have compared differences in healthcare service utilization between patients with and those without OSA in an Asian population according to different age groups. This study attempted to investigate differences in healthcare service utilization between patients with and those without OSA in different age groups in Taiwan. Methods Sampled subjects and data on their health service utilization were retrieved from the Taiwan Longitudinal Health Insurance Database 2005. We included 568 patients with OSA and 2840 subjects without OSA. Each subject was followed for a 1-year period to evaluate their healthcare resource utilization. Wilcoxon-Mann-Whitney tests were performed to compare differences in healthcare utilization between patients with and those without OSA during the 1-year follow-up period. Results As to all healthcare service utilization, patients with OSA had significantly more outpatient visits (30.3 vs. 18.6), outpatient costs (US$1231.2 vs. US$764.8), inpatient days (1.8 vs. 1.2), inpatient costs (US$563.6 vs. US$276.7), and total costs (US$1794.8 vs. US$1041.5) than comparison subjects during the 1-year follow-up period. Moreover, patients with OSA aged 40 similar to 49 and 50 similar to 59 years respectively incurred 2.11- and 2.02-fold higher total costs compared to patients without OSA. However, patients with OSA aged over 70 years did not have higher total costs compared to those without OSA. Conclusions This study found that patients with OSA had greater healthcare service utilization than those without OSA. Additionally, patients with OSA in the 40 similar to 49- and 50 similar to 59-year age groups had about 2-fold higher total costs of healthcare services than those without OSA.	[Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kao, Li-Ting; Lee, Hsin-Chien; Lin, Herng-Ching; Chung, Shiu-Dong] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Tsai, Ming-Chieh] Cathay Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Chung, Shiu-Dong] Fu Jen Catholic Univ, Sch Med, Hsingchuang, Taiwan; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, New Taipei City, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Cathay General Hospital; Fu Jen Catholic University; Far Eastern Memorial Hospital	Chung, SD (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	chungshiudong@gmail.com	Kao, Li-Ting/W-9287-2018	Kao, Li-Ting/0000-0003-0692-7408				Addison-Brown KJ, 2014, J SLEEP RES, V23, P69, DOI 10.1111/jsr.12086; Albarrak M, 2005, SLEEP, V28, P1306, DOI 10.1093/sleep/28.10.1306; AlGhanim N, 2008, LUNG, V186, P7, DOI 10.1007/s00408-007-9055-5; Bahammam A, 1999, SLEEP, V22, P740, DOI 10.1093/sleep/22.6.740; Baldwin CM, 2001, SLEEP, V24, P96, DOI 10.1093/sleep/24.1.96; Banno K, 2006, SLEEP, V29, P1307, DOI 10.1093/sleep/29.10.1307; Banno K, 2009, SLEEP, V32, P247, DOI 10.1093/sleep/32.2.247; Berg G, 2001, CHEST, V120, P377, DOI 10.1378/chest.120.2.377; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Diaz K, 2014, ANN THORAC MED, V9, P92, DOI 10.4103/1817-1737.128854; Dong JY, 2013, ATHEROSCLEROSIS, V229, P489, DOI 10.1016/j.atherosclerosis.2013.04.026; Greenberg-Dotan S, 2007, SLEEP, V30, P1173, DOI 10.1093/sleep/30.9.1173; Jelic S, 2008, TRENDS CARDIOVAS MED, V18, P253, DOI 10.1016/j.tcm.2008.11.008; Jennum P, 2011, THORAX, V66, P560, DOI 10.1136/thx.2010.143958; Jennum P, 2014, EUR RESPIR J, V43, P134, DOI 10.1183/09031936.00169212; Jurado-Gamez B, 2014, ARCH BRONCONEUMOL; Kapur V, 1999, SLEEP, V22, P749, DOI 10.1093/sleep/22.6.749; Kryger MH, 1996, SLEEP, V19, pS111, DOI 10.1093/sleep/19.suppl_9.S111; Lam Jamie C M, 2009, Expert Rev Respir Med, V3, P177, DOI 10.1586/ers.09.10; Lee RWW, 2010, SLEEP, V33, P1075, DOI 10.1093/sleep/33.8.1075; Mannarino MR, 2012, EUR J INTERN MED, V23, P586, DOI 10.1016/j.ejim.2012.05.013; Otake K, 2002, THORAX, V57, P417, DOI 10.1136/thorax.57.5.417; Peppard PE, 2006, ARCH INTERN MED, V166, P1709, DOI 10.1001/archinte.166.16.1709; Reuveni H, 2008, EUR RESPIR J, V31, P273, DOI 10.1183/09031936.00097907; Ronald J, 1999, SLEEP, V22, P225, DOI 10.1093/sleep/22.2.225; Ronald J, 1998, Sleep Res Online, V1, P71; Ronksley PE, 2009, THORAX, V64, P834, DOI 10.1136/thx.2009.115105; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Ryan Silke, 2008, Archives of Physiology and Biochemistry, V114, P261, DOI [10.1080/13813450802307337, 10.1080/13813450802307337 ]; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Smith R, 2002, CHEST, V121, P164, DOI 10.1378/chest.121.1.164; Tarasiuk A, 2005, CHEST, V128, P1310, DOI 10.1378/chest.128.3.1310; Tarasiuk A, 2008, J AM GERIATR SOC, V56, P247, DOI 10.1111/j.1532-5415.2007.01544.x; Tarasiuk A, 2013, CURR OPIN PULM MED, V19, P639, DOI 10.1097/MCP.0b013e3283659e1e; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Ziegler Michael G, 2011, Drug Discov Today Dis Models, V8, P155	37	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137459	10.1371/journal.pone.0137459	http://dx.doi.org/10.1371/journal.pone.0137459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339792	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200061
J	Mookerjee, S; Batabyal, P; Sarkar, MH; Palit, A				Mookerjee, Subham; Batabyal, Prasenjit; Sarkar, Madhumanti Halder; Palit, Anup			Seasonal Prevalence of Enteropathogenic Vibrio and Their Phages in the Riverine Estuarine Ecosystem of South Bengal	PLOS ONE			English	Article							HOSPITALIZED DIARRHEAL PATIENTS; WEST-BENGAL; POTABLE WATER; CHOLERAE; KOLKATA; FLUVIALIS; NON-O1; IDENTIFICATION; CONTAMINATION; CYCLONE	Diarrheal disease remains an unsolved problem in developing countries. The emergence of new etiological agents (non-cholera vibrios) is a major cause of concern for health planners. We attempted to unveil the seasonal dynamics of entero-pathogenic Vibrios in Gangetic riverine- estuarine ecosystem. 120 surface water samples were collected for a period of one year from 3 sampling sites on the Hooghly river. Five enteropathogenic Vibrio species, V. cholerae (35%), V. parahaemolyticus (22.5%), V. mimicus (19.1%), V. alginolyticus (15.8%) and V. vulnificus (11.6%), were present in the water samples. The vibriophages, V. vulnificus phi (17.5%), V. alginolyticus phi (17.5%), V. parahaemolyticus phi (10%), V. cholerae non-O1/O139 phi (26.6%) and V. mimicus phi (9.1%), were also detected in these samples. The highest number of Vibrios were noted in the monsoon (20-34 degrees C), and to a lesser extent, in the summer (24-36 degrees C) seasons. Samples positive for phages for any of the identified Vibrio species were mostly devoid of that particular bacterial organism and vice versa. The detection of toxin genes and resistance to beta-lactam antibiotics in some environmental enteropathogenic Vibrio species in the aquatic niches is a significant outcome. This finding is instrumental in the south Bengal diarrhoeal incidence.	[Mookerjee, Subham; Batabyal, Prasenjit; Sarkar, Madhumanti Halder; Palit, Anup] Indian Council Med Res, Natl Inst Cholera & Enter Dis, Div Bacteriol, Scheme XM, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Palit, A (corresponding author), Indian Council Med Res, Natl Inst Cholera & Enter Dis, Div Bacteriol, Scheme XM, P-33,CIT Rd, Kolkata, India.	anup.palit@gmail.com						Barbieri E, 1999, APPL ENVIRON MICROB, V65, P2748; Batabyal P, 2014, INFECT GENET EVOL, V26, P359, DOI 10.1016/j.meegid.2014.06.001; Batabyal P, 2014, SCI TOTAL ENVIRON, V472, P154, DOI 10.1016/j.scitotenv.2013.10.093; Batabyal P, 2013, ACTA TROP, V127, P153, DOI 10.1016/j.actatropica.2013.04.015; Batabyal P, 2012, JPN J INFECT DIS, V65, P358, DOI 10.7883/yoken.65.358; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bhattacharjee S, 2010, J HEALTH POPUL NUTR, V28, P311; Bross MH, 2007, AM FAM PHYSICIAN, V76, P539; Chakraborty R, 2006, J MED MICROBIOL, V55, P805, DOI 10.1099/jmm.0.46395-0; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Chowdhury G, 2012, EMERG INFECT DIS, V18, P1868, DOI 10.3201/eid1811.120520; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Dutta D, 2013, EMERG INFECT DIS, V19, P464, DOI 10.3201/eid1903.121156; EPSTEIN PR, 1993, LANCET, V342, P1216, DOI 10.1016/0140-6736(93)92191-U; Kanungo S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-830; Mahmud ZH, 2006, MICROBIOL RES, V161, P25, DOI 10.1016/j.micres.2005.04.005; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mookerjee S, 2014, J VIROL METHODS, V208, P115, DOI 10.1016/j.jviromet.2014.07.036; Mookerjee S, 2014, ENVIRON MONIT ASSESS, V186, P6241, DOI 10.1007/s10661-014-3851-1; Nair GB, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-4; Nhung PH, 2007, DIAGN MICR INFEC DIS, V59, P271, DOI 10.1016/j.diagmicrobio.2007.05.016; Palit A, 2010, LETT APPL MICROBIOL, V51, P241, DOI 10.1111/j.1472-765X.2010.02873.x; Palit A., 2013, ENCY FOOD SAFETY, P570; Palit A, 2012, WATER SCI TECHNOL, V66, P299, DOI 10.2166/wst.2012.177; Paul D, 2012, J MICROB BIOTEC FOOD, V2, P713; Ramamurthy T, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00091; Rhodes M., 2013, J MARINE BIOL OCEANO, V2, P2, DOI DOI 10.4172/2324-8661.1000109; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; US EPA, 2001, 821R01029 USEPA; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P297; WHO, 2011, KOBE REP; [No title captured]	32	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137338	10.1371/journal.pone.0137338	http://dx.doi.org/10.1371/journal.pone.0137338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340543	gold, Green Published, Green Submitted			2022-12-27	WOS:000360688200048
J	Ramallal, R; Toledo, E; Martinez-Gonzalez, MA; Hernandez-Hernandez, A; Garcia-Arellano, A; Shivappa, N; Hebert, JR; Ruiz-Canela, M				Ramallal, Raul; Toledo, Estefania; Martinez-Gonzalez, Miguel A.; Hernandez-Hernandez, Aitor; Garcia-Arellano, Ana; Shivappa, Nitin; Hebert, James R.; Ruiz-Canela, Miguel			Dietary Inflammatory Index and Incidence of Cardiovascular Disease in the SUN Cohort	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MEDITERRANEAN DIET; INTERLEUKIN-1-BETA INHIBITION; PRIMARY PREVENTION; MARKERS; RISK; PATTERNS; CONSUMPTION; VALIDATION; ADHERENCE	Background Diet is known to play a key role in atherogenesis and in the development of cardiovascular events. Dietary factors may mediate these processes acting as potential modulators of inflammation. Potential Links between inflammatory properties of diet and the occurrence of cardiovascular events have not been tested previously. Objective We aimed to assess the association between the dietary inflammatory index (DII), a method to assess the inflammatory potential of the diet, and incident cardiovascular disease. Methods In the prospective, dynamic SUN cohort, 18,794 middle-aged, Spanish university graduates were followed up for 8.9 years (median). A validated 136-item food-frequency questionnaire was used to calculate the DII. The DII is based on scientific evidence about the relationship between diet and inflammatory biomarkers (C-reactive protein, IL-1 beta, IL-4, IL-6, IL-10 and TNF-alpha). Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association between the DII and incident cardiovascular disease (myocardial infarction, stroke or cardiovascular death). Results The risk for cardiovascular events progressively increased with each increasing quartile of DII (p(trend) = 0.017). The multivariable-adjusted HR for participants in the highest (most pro-inflammatory) vs. the lowest quartile of the DII was 2.03 (95% CI 1.06-3.88). Conclusions A pro-inflammatory diet was associated with a significantly higher risk for developing cardiovascular events.	[Ramallal, Raul] Complejo Hosp Navarra, Serv Navarro Salud, Dept Cardiol, Pamplona, Spain; [Ramallal, Raul; Toledo, Estefania; Martinez-Gonzalez, Miguel A.; Hernandez-Hernandez, Aitor; Garcia-Arellano, Ana; Ruiz-Canela, Miguel] Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain; [Ramallal, Raul; Toledo, Estefania; Martinez-Gonzalez, Miguel A.; Hernandez-Hernandez, Aitor; Garcia-Arellano, Ana; Ruiz-Canela, Miguel] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Toledo, Estefania; Martinez-Gonzalez, Miguel A.; Garcia-Arellano, Ana; Ruiz-Canela, Miguel] Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain; [Shivappa, Nitin] Univ S Carolina, Canc Prevent & Control Program, Columbia, SC 29208 USA; [Shivappa, Nitin; Hebert, James R.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Servicio Navarro de Salud - Osasunbidea; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ruiz-Canela, M (corresponding author), Navarra Inst Hlth Res, IdiSNA, Pamplona, Spain.	mcanela@unav.es	Hernandez Hernandez, Aitor/AAT-6858-2020; Ruiz-Canela, Miguel/I-7738-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Toledo, Estefania/H-6211-2014; Shivappa, Nitin/X-2215-2018	Hernandez Hernandez, Aitor/0000-0002-2124-6099; Ruiz-Canela, Miguel/0000-0002-7684-2787; Toledo, Estefania/0000-0002-6263-4434; Shivappa, Nitin/0000-0003-0441-8896; GARCIA ARELLANO, ANA/0000-0003-1491-9627; Hernandez- Hernandez, Aitor/0000-0001-5759-3773	Spanish Ministry of Health; European Regional Development Fund (FEDER) [PI10/02658, PI10/02293, PI13/00615, PI14/1668, PI14/01798, PI14/1754, RD06/0045, G03/140]; Navarra Regional Government [45/2011, 111/2014]; University of Navarra; United States National Institute of Diabetes and Digestive and Kidney Diseases [R44DK103377]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK103377] Funding Source: NIH RePORTER	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Regional Development Fund (FEDER)(European Commission); Navarra Regional Government; University of Navarra; United States National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Seguimiento Universidad de Navarra (SUN) study has received funding from the Spanish Ministry of Health and European Regional Development Fund (FEDER) (current Grants PI10/02658, PI10/02293, PI13/00615, PI14/1668, PI14/01798, PI14/1754) RD06/0045, G03/140, the Navarra Regional Government (45/2011, 111/2014) and the University of Navarra. Drs. Shivappa and Hebert were supported by grant number R44DK103377 from the United States National Institute of Diabetes and Digestive and Kidney Diseases. Funding sources had no role in the design, collection, analysis, and interpretation of the data; in the writing, or in the decision to submit the paper for publication.	Akbaraly TN, 2015, AM J MED, V128, P152, DOI 10.1016/j.amjmed.2014.10.002; Akesson A, 2014, J AM COLL CARDIOL, V64, P1299, DOI 10.1016/j.jacc.2014.06.1190; Martinez-Gonzalez MA, 2014, CURR OPIN LIPIDOL, V25, P20, DOI 10.1097/MOL.0000000000000044; Barbaresko J, 2013, NUTR REV, V71, P511, DOI 10.1111/nure.12035; Bes-Rastrollo M, 2005, REV ESP OBESIDAD, V3, P352; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, P126, DOI 10.1016/j.numecd.2009.08.005; Cheng JM, 2014, AM J CARDIOL, V114, P1497, DOI 10.1016/j.amjcard.2014.08.013; Cuadrado C., 2013, FOOD COMPOSITION TAB, V16th ed.; Dias JA, 2015, ATHEROSCLEROSIS, V238, P38, DOI 10.1016/j.atherosclerosis.2014.11.006; Esmaillzadeh A, 2006, AM J CLIN NUTR, V84, P1489, DOI 10.1093/ajcn/84.6.1489; Esmaillzadeh A, 2010, PUBLIC HEALTH NUTR, V13, P1395, DOI 10.1017/S1368980009992126; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Everett BM, 2013, AM HEART J, V166, P199, DOI 10.1016/j.ahj.2013.03.018; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Garcia-Arellano A, 2015, NUTRIENTS, V7, P4124, DOI 10.3390/nu7064124; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Hermsdorff HHM, 2011, EUR J NUTR, V50, P61, DOI 10.1007/s00394-010-0115-x; Hermsdorff HHM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-42; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kuczmarski MF, 2013, J ACAD NUTR DIET, V113, P1620, DOI 10.1016/j.jand.2013.07.004; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; Ma YS, 2006, AM J CLIN NUTR, V83, P760, DOI 10.1093/ajcn/83.4.760; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Martinez-Gonzalez MA, 2011, NUTR METAB CARDIOVAS, V21, P237, DOI 10.1016/j.numecd.2009.10.005; Martinez-Gonzalez MA, 2005, PUBLIC HEALTH NUTR, V8, P920, DOI 10.1079/PHN2005745; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Mataix J, 2009, FOOD COMPOSITION TAB; Nettleton JA, 2006, AM J CLIN NUTR, V83, P1369, DOI 10.1093/ajcn/83.6.1369; Plotnick GD, 1997, JAMA-J AM MED ASSOC, V278, P1682, DOI 10.1001/jama.278.20.1682; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Ridker PM, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0295-3; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Root MM, 2012, NUTRIENTS, V4, P29, DOI 10.3390/nu4010029; Ruiz-Canela M, 2015, BRIT J NUTR, V113, P984, DOI 10.1017/S0007114514004401; Segui-Gomez M, 2006, INT J EPIDEMIOL, V35, P1417, DOI 10.1093/ije/dyl223; Shivappa N, 2014, CANCER EPIDEM BIOMAR, V23, P2383, DOI 10.1158/1055-9965.EPI-14-0537; Shivappa N, 2015, BRIT J NUTR, V113, P292, DOI 10.1017/S0007114514003626; Shivappa N, 2015, BRIT J NUTR, V113, P278, DOI 10.1017/S0007114514003572; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1825, DOI 10.1017/S1368980013002565; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115; Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169; Tabung FK, 2015, CANCER CAUSE CONTROL, V26, P399, DOI 10.1007/s10552-014-0515-y; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Willeit P, 2014, EUR J PREV CARD 1121; Willett W, 2012, NUTR EPIDEMIOLOGY, P74; Wood L, 2014, RESPIROLOGY, V19, P37, DOI 10.1111/cea.12323; World Health Organization, 2008, The global burden of disease: 2004 update; Zamora-Ros R, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0447-x	53	102	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0135221	10.1371/journal.pone.0135221	http://dx.doi.org/10.1371/journal.pone.0135221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340022	Green Published, gold			2022-12-27	WOS:000360688200003
J	Thanapirom, K; Suksawatamnuay, S; Sukeepaisarnjaroen, W; Tangkijvanich, P; Treeprasertsuk, S; Thaimai, P; Wasitthankasem, R; Poovorawan, Y; Komolmit, P				Thanapirom, Kessarin; Suksawatamnuay, Sirinporn; Sukeepaisarnjaroen, Wattana; Tangkijvanich, Pisit; Treeprasertsuk, Sombat; Thaimai, Panarat; Wasitthankasem, Rujipat; Poovorawan, Yong; Komolmit, Piyawat			Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; DIPEPTIDYL-PEPTIDASE-IV; INTERFERON-GAMMA; RIBAVIRIN THERAPY; PLUS RIBAVIRIN; VIRAL RESPONSE; IP-10 LEVELS; HCV; EXPRESSION; PROTEIN-10	Pretreatment serumlevels of interferon-.-inducible protein-10 (IP-10, CXCL10) and dipeptidyl peptidase-4 (DPP IV) predict treatment response in chronic hepatitis C (CHC). The association between functional genetic polymorphisms of CXCL10 and DPP4 and treatment outcome has not previously been studied. This study aimed to determine the association between genetic variations of CXCL10 and DPP4 and the outcome of treatment with pegylated interferon-alpha (PEG-IFN-alpha) based therapy in Thai patients with CHC. 602 Thai patients with CHC treated using a PEG-IFN-alpha based regimen were genotyped for CXCL10 rs56061981 G>A and IL28B rs12979860 C>T. In addition, in patients infected with CHC genotype 1, DPP4 (rs13015258 A>C, rs17848916 T>C, rs41268649 G>A, and rs 17574 T>C) were genotyped. Correlations between single nucleotide polymorphisms, genotype, and treatment response were analyzed. The rate of sustained virologic response (SVR) was higher for the CC genotype of IL28B rs12979860 polymorphisms than for non-CC in both genotype 1 (60.6% vs. 29.4%, P < 0.001) and non-genotype 1 (69.4% vs. 49.1%, P < 0.05) CHC. SVR was not associated with the CXCL10 gene variant in all viral genotypes or DPP4 gene polymorphisms in viral genotype1. Multivariate analysis revealed IL28B rs12979860 CC genotype (OR = 3.12; 95% CI, 1.72-5.67; P < 0.001), hepatitis C virus RNA < 400,000 IU/ml (OR = 2.21; 95% CI, 1.22-3.99, P < 0.05), age < 45 years (OR = 2.03; 95% CI, 1.11-3.68; P < 0.05), and liver fibrosis stage 0-1 (OR = 1.64; 95% CI, 1.01-2.65, P < 0.05) were independent factors for SVR. Unfavorable IL28B rs12979860 CT or TT genotypes with the CXCL10 rs56061981 non-GG genotype were associated with a higher SVR than GG genotype (66.7% vs. 33.0%, P = 0.004) in viral genotype 1. In Thai CHC genotype 1 infected patients with an unfavorable IL28B rs12979860 CT/TT genotype, the complementary CXCL10 polymorphism strongly enhances prediction of treatment response.	[Thanapirom, Kessarin; Suksawatamnuay, Sirinporn; Treeprasertsuk, Sombat; Thaimai, Panarat; Komolmit, Piyawat] Chulalongkorn Univ, Fac Med, Dept Med, Div Gastroenterol, Bangkok 10330, Thailand; [Sukeepaisarnjaroen, Wattana] Khon Kaen Univ, Fac Med, Srinagarind Hosp, Gastroenterol Unit,Dept Med, Khon Kaen, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok 10330, Thailand; [Wasitthankasem, Rujipat; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok 10330, Thailand	Chulalongkorn University; Khon Kaen University; Chulalongkorn University; Chulalongkorn University	Komolmit, P (corresponding author), Chulalongkorn Univ, Fac Med, Dept Med, Div Gastroenterol, Bangkok 10330, Thailand.	pkomolmit@yahoo.co.uk	Komolmit, Piyawat/AAD-1629-2020; treeprasertsuk, sombat/T-6855-2019; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Thanapirom, Kessarin/O-6346-2015; Sukeepaisarnjaroen, Wattana/GQH-3065-2022	Komolmit, Piyawat/0000-0002-1357-9547; Treeprasertsuk, Sombat/0000-0001-6459-8329; Poovorawan, Yong/0000-0002-2337-6807	Ratchadaphiseksomphot Endowment Fund [CU's SRP_05_55_30_01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530155]	Ratchadaphiseksomphot Endowment Fund; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University)	This work was supported by the Ratchadaphiseksomphot Endowment Fund Part of the "Grants for Junior or Terminated Executive staff" (CU's SRP_05_55_30_01) and the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530155).	Amanzada A, 2012, DIGESTION, V86, P218, DOI 10.1159/000339879; Amanzada A, 2013, J MED VIROL, V85, P1534, DOI 10.1002/jmv.23632; Amanzada A, 2012, J MED VIROL, V84, P1208, DOI 10.1002/jmv.23323; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bouchard L, 2009, ACTA DIABETOL, V46, P13, DOI 10.1007/s00592-008-0049-4; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Charles ED, 2011, J CLIN INVEST, V121, P25, DOI 10.1172/JCI45610; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Deng GH, 2008, GASTROENTEROLOGY, V134, P716, DOI 10.1053/j.gastro.2007.12.044; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; Feld JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080003; Firneisz G, 2001, SCAND J GASTROENTERO, V36, P877, DOI 10.1080/003655201750313423; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Grebely J, 2013, HEPATOLOGY, V57, P2124, DOI 10.1002/hep.26263; Grungreiff K, 2009, MOL MED REP, V2, P63, DOI 10.3892/mmr_00000062; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; HEGEN M, 1990, J IMMUNOL, V144, P2908; Heydtmann M, 2009, HEPATOLOGY, V49, P676, DOI 10.1002/hep.22763; Ikura Y, 1996, AM J GASTROENTEROL, V91, P1367; Itou M, 2008, J GASTROEN HEPATOL, V23, P244, DOI 10.1111/j.1440-1746.2007.05183.x; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Lange CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040159; Mihm S, 2003, J MED VIROL, V70, P562, DOI 10.1002/jmv.10431; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Soderholm J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056991; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Turcot V, 2011, OBESITY, V19, P388, DOI 10.1038/oby.2010.198; Xu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072799; You CR, 2011, GUT LIVER, V5, P506, DOI 10.5009/gnl.2011.5.4.506	35	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137365	10.1371/journal.pone.0137365	http://dx.doi.org/10.1371/journal.pone.0137365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26339796	Green Published, Green Submitted, gold			2022-12-27	WOS:000360688200051
J	Wang, P; Liu, HF; Jiang, T; Yang, JL				Wang, Peng; Liu, Huifang; Jiang, Ting; Yang, Julun			Cigarette Smoking and the Risk of Adult Myeloid Disease: A Meta-Analysis	PLOS ONE			English	Article							ABERRANT DNA METHYLATION; HAIR DYE USE; MYELODYSPLASTIC SYNDROMES; CYTOGENETIC ABNORMALITIES; TELOMERE LENGTH; LEUKEMIA RISK; BONE-MARROW; EXPRESSION; PROGRESSION; ASSOCIATION	Background The adult myeloid diseases, myelodysplastic syndrome and acute myeloid leukemia, have been reported to be associated with cigarette smoking, but the results have been conflicting. Previous studies may have ignored the relationship between myelodysplastic syndrome and acute myeloid leukemia, where approximately one-third of myelodysplastic syndrome cases will progress to acute myeloid leukemia, which could induce a serious bias in independent analyses. For the purposes of researching pathogenesis, we suggest that myelodysplastic syndrome and acute myeloid leukemia should be regarded as a single class of adult myeloid disease, and herein assessed the relationship between cigarette smoking and the risk of adult myeloid disease. Methods The PubMed, Cochrane Library, EBSCO, and EMBASE databases were systematically searched for reports published from 1990 to 2015. Two authors independently assessed the methodological quality and the extracted data. The odds ratios and adjusted odds ratios (OR), a sensitivity analysis, and the publication bias were analyzed using the CMA v2 (Comprehensive Meta Analysis Version 2) software program. Results Twenty-five studies were included in this meta-analysis. The publication dates ranged from 1990 to 2014. The pooled OR in current smokers and ever-smokers showed an increased risk of adult myeloid disease, with ORs of 1.45 (95% CI, 1.30-1.62; p<0.001) and 1.23 (95% CI 1.15-1.32; p<0.001) versus non-smokers, respectively. In the subset analyses, the OR of adult myeloid disease was increased regardless of the form of disease, geographical region, NOS (Newcastle Ottawa Scale) score, and source of controls. The smoking status was divided into <20 and >= 20 cigarettes per day, and these groups had ORs of developing adult myeloid disease of 1.24 (95% CI, 1.09-1.40; p = 0.001) and 1.32 (95% CI, 1.14-1.53; p<0.001), respectively. In the groups divided based on the number of years the subjects had smoked (<20 and >= 20 years), the ORs were 1.05 (95% CI, 0.90-1.23; p = 0.25) and 1.30 (95% CI, 1.16-1.45; p<0.001), respectively. Similarly, <20 and >= 20 pack-years were associated with ORs of 1.15 (95% CI, 1.03-1.29; p = 0.017) and 1.34 (95% CI, 1.18-1.52; p<0.001), respectively. Conclusions This meta-analysis, for the first time, combined myelodysplastic syndrome with acute myeloid leukemia to assess the overall risk of adult myeloid disease, and it demonstrated that cigarette smoking is associated with a significantly increased risk of adult myeloid disease.	[Wang, Peng; Liu, Huifang; Yang, Julun] Kunming Univ Sci & Technol, Fac Med, Dept Pathol, Kunming, Peoples R China; [Jiang, Ting] Kunming Med Univ, Kunming Gen Hosp, Dept Pathol, Clin Coll, Kunming, Peoples R China; [Yang, Julun] Kunming Gen Hosp, Dept Pathol, Kunming, Peoples R China	Kunming University of Science & Technology; Kunming General Hospital; Kunming Medical University; Kunming General Hospital	Yang, JL (corresponding author), Kunming Univ Sci & Technol, Fac Med, Dept Pathol, Kunming, Peoples R China.	yangjulun@sina.com	WANG, Peng/GSN-5263-2022					Ades L, 2014, LANCET, V383, P2239, DOI 10.1016/S0140-6736(13)61901-7; [Anonymous], 2013, SURVEILLANCE EPIDEMI; Aul C, 1998, HAEMATOLOGICA, V83, P71; BELL DA, 1995, JNCI-J NATL CANCER I, V87, P223, DOI 10.1093/jnci/87.3.223; Benetatos L, 2010, LEUKEMIA RES, V34, P148, DOI 10.1016/j.leukres.2009.06.019; Bjork J, 2001, LEUKEMIA RES, V25, P865, DOI 10.1016/S0145-2126(01)00048-0; Bjork J, 2009, LEUKEMIA RES, V33, P788, DOI 10.1016/j.leukres.2008.10.009; Bowden J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-41; BROWN LM, 1992, AM J EPIDEMIOL, V135, P763; BROWNSON RC, 1991, AM J EPIDEMIOL, V134, P938, DOI 10.1093/oxfordjournals.aje.a116177; Chia VM, 2006, CANCER RES, V66, P6877, DOI 10.1158/0008-5472.CAN-06-1535; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Dalamaga M, 2002, CANCER CAUSE CONTROL, V13, P603, DOI 10.1023/A:1019573319803; Davis RE, 1998, LEUKEMIA RES, V22, P767, DOI 10.1016/S0145-2126(98)00051-4; Duarte-Davidson R, 2001, OCCUP ENVIRON MED, V58, P2, DOI 10.1136/oem.58.1.2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ettou S, 2012, LEUKEMIA, V26, P2297, DOI 10.1038/leu.2012.152; Fenaux P, 2014, ANN ONCOL, V25, P57, DOI 10.1093/annonc/mdu180; Fircanis S, 2014, AM J HEMATOL, V89, pE125, DOI 10.1002/ajh.23744; Guida F, 2015, HUM MOL GENET, V24, P2349, DOI 10.1093/hmg/ddu751; Heinrichs S, 2005, BRIT J HAEMATOL, V130, P83, DOI 10.1111/j.1365-2141.2005.05555.x; Hofmann WK, 2005, ANNU REV MED, V56, P1, DOI 10.1146/annurev.med.56.082103.104704; Huang JJ, 2013, REPROD TOXICOL, V35, P89, DOI 10.1016/j.reprotox.2012.07.003; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V83, P1; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Kao HW, 2011, NEOPLASIA, V13, P1035, DOI 10.1593/neo.111192; Kasim K, 2005, CANCER CAUSE CONTROL, V16, P489, DOI 10.1007/s10552-004-7115-1; Kim DH, 2001, CANCER RES, V61, P3419; Kim HN, 2012, LEUKEMIA LYMPHOMA, V53, P681, DOI 10.3109/10428194.2011.625576; Lichtman MA, 2007, LEUKEMIA, V21, P1137, DOI 10.1038/sj.leu.2404698; Liu YQ Z F, 2013, CHINA CANC, V22, P528; Lv L, 2011, AM J HEMATOL, V86, P163, DOI 10.1002/ajh.21941; Ma X, 2007, CANCER-AM CANCER SOC, V109, P1536, DOI 10.1002/cncr.22570; MCLAUGHLIN JK, 1989, JNCI-J NATL CANCER I, V81, P1262, DOI 10.1093/jnci/81.16.1262; MELE A, 1994, AM J EPIDEMIOL, V139, P609, DOI 10.1093/oxfordjournals.aje.a117050; Mohammad H, 2002, BRIT J HAEMATOL, V117, P359, DOI 10.1046/j.1365-2141.2002.03458.x; Mori N, 2000, CANCER RES, V60, P3039; Musselman JRB, 2013, CANCER EPIDEMIOL, V37, P410, DOI 10.1016/j.canep.2013.03.012; Nagata C, 1999, LEUKEMIA RES, V23, P57, DOI 10.1016/S0145-2126(98)00135-0; National Comprehensive Cancer Network, 2014, CLIN PRACT GUID ONC; Nisse C, 2001, BRIT J HAEMATOL, V112, P927, DOI 10.1046/j.1365-2141.2001.02645.x; Ohyashiki K, 2001, LEUKEMIA LYMPHOMA, V42, P291, DOI 10.3109/10428190109064585; Oka D, 2009, CANCER-AM CANCER SOC, V115, P3412, DOI 10.1002/cncr.24394; Ozcan MA, 2013, EXPERT REV HEMATOL, V6, P165, DOI [10.1586/ehm.13.7, 10.1586/EHM.13.7]; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P12; Pekmezovic T, 2006, ANN HEMATOL, V85, P514, DOI 10.1007/s00277-006-0128-y; Pogoda JM, 2002, AM J EPIDEMIOL, V155, P546, DOI 10.1093/aje/155.6.546; Poloni A, 2013, LEUKEMIA RES, V37, P1538, DOI 10.1016/j.leukres.2013.07.022; Poynter JN, 2009, CANCER EPIDEM BIOMAR, V18, P2745, DOI 10.1158/1055-9965.EPI-09-0517; Richardson DB, 2008, CANCER CAUSE CONTROL, V19, P43, DOI 10.1007/s10552-007-9068-7; Samowitz WS, 2006, J NATL CANCER I, V98, P1731, DOI 10.1093/jnci/djj468; SANDLER DP, 1993, J NATL CANCER I, V85, P1994, DOI 10.1093/jnci/85.24.1994; Sarir H, 2010, BIOCHEM PHARMACOL, V79, P698, DOI 10.1016/j.bcp.2009.10.001; SEVERSON RK, 1990, AM J EPIDEMIOL, V132, P418, DOI 10.1093/oxfordjournals.aje.a115676; Speer SA, 2002, J ENVIRON HEALTH, V64, P9; Stagnaro E, 2001, CANCER CAUSE CONTROL, V12, P325, DOI 10.1023/A:1011216102871; Stifter G, 2005, EUR J HAEMATOL, V75, P485, DOI 10.1111/j.1600-0609.2005.00551.x; Strom SS, 2012, CANCER-AM CANCER SOC, V118, P4589, DOI 10.1002/cncr.27442; Strom SS, 2005, LEUKEMIA, V19, P1912, DOI 10.1038/sj.leu.2403945; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tasaka T, 1996, LEUKEMIA RES, V20, P113, DOI 10.1016/0145-2126(95)00119-0; Tong HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067537; Verde Z, 2015, ENVIRON RES, V140, P488, DOI 10.1016/j.envres.2015.05.008; WAKABAYASHI I, 1994, INTERNAL MED, V33, P198, DOI 10.2169/internalmedicine.33.198; Wang HY, 2003, TOXICOL PATHOL, V31, P220, DOI 10.1080/01926230390183715; WEST RR, 1995, LEUKEMIA RES, V19, P127, DOI 10.1016/0145-2126(94)00141-V; Wilson AB, 2014, CANCER EPIDEMIOL, V38, P544, DOI 10.1016/j.canep.2014.08.003; Wong O, 2009, REGUL TOXICOL PHARM, V55, P340, DOI 10.1016/j.yrtph.2009.08.007; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhang LP, 2011, CARCINOGENESIS, V32, P605, DOI 10.1093/carcin/bgq286	71	11	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2015	10	9							e0137300	10.1371/journal.pone.0137300	http://dx.doi.org/10.1371/journal.pone.0137300			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ6BA	26340093	gold, Green Submitted, Green Published			2022-12-27	WOS:000360688200044
J	Jongman, SR; Meyer, AS; Roelofs, A				Jongman, Suzanne R.; Meyer, Antje S.; Roelofs, Ardi			The Role of Sustained Attention in the Production of Conjoined Noun Phrases: An Individual Differences Study	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; DUAL-TASK INTERFERENCE; FALSE DISCOVERY RATE; NAMING OBJECTS; SELECTION; DISTRIBUTIONS; ALERTNESS; VIGILANCE; SYSTEM; SPAN	It has previously been shown that language production, performed simultaneously with a nonlinguistic task, involves sustained attention. Sustained attention concerns the ability to maintain alertness over time. Here, we aimed to replicate the previous finding by showing that individuals call upon sustained attention when they plan single noun phrases (e.g., "the carrot") and perform a manual arrow categorization task. In addition, we investigated whether speakers also recruit sustained attention when they produce conjoined noun phrases (e.g., "the carrot and the bucket") describing two pictures, that is, when both the first and second task are linguistic. We found that sustained attention correlated with the proportion of abnormally slow phrase-production responses. Individuals with poor sustained attention displayed a greater number of very slow responses than individuals with better sustained attention. Importantly, this relationship was obtained both for the production of single phrases while performing a nonlinguistic manual task, and the production of noun phrase conjunctions in referring to two spatially separated objects. Inhibition and updating abilities were also measured. These scores did not correlate with our measure of sustained attention, suggesting that sustained attention and executive control are distinct. Overall, the results suggest that planning conjoined noun phrases involves sustained attention, and that language production happens less automatically than has often been assumed.	[Jongman, Suzanne R.; Meyer, Antje S.; Roelofs, Ardi] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Jongman, Suzanne R.] Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Meyer, Antje S.; Roelofs, Ardi] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Max Planck Society; Radboud University Nijmegen	Jongman, SR (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	srjongman@gmail.com	Roelofs, Ardi/A-5311-2010	Jongman, Suzanne/0000-0003-1987-2215	IMPRS PhD fellowship from the Max Planck Society	IMPRS PhD fellowship from the Max Planck Society	This work was supported by an IMPRS PhD fellowship from the Max Planck Society to SRJ.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Baayen RH, LANGUAGER DATA SETS; Balota DA, 2011, CURR DIR PSYCHOL SCI, V20, P160, DOI 10.1177/0963721411408885; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2013, LME4 LINEAR MIXED EF; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boersma P., 2010, PRAAT DOING PHONETIC, DOI DOI 10.1007/s10072-018-3598-5; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Cook AE, 2008, J EXP PSYCHOL LEARN, V34, P886, DOI 10.1037/0278-7393.34.4.886; De Jong R, 1999, ACTA PSYCHOL, V101, P379, DOI 10.1016/S0001-6918(99)00012-8; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Ferreira VS, 2002, J EXP PSYCHOL LEARN, V28, P1187, DOI 10.1037//0278-7393.28.6.1187; Garrod S, 2007, ADV BEHAV BRAIN SCI, P1; Griffin ZM, 2001, COGNITION, V82, pB1, DOI 10.1016/S0010-0277(01)00138-X; HEATHCOTE A, 1991, PSYCHOL BULL, V109, P340, DOI 10.1037/0033-2909.109.2.340; Heathcote A, 2004, BEHAV RES METH INS C, V36, P277, DOI 10.3758/BF03195574; Jongman SR, 2015, Q J EXP PSYCHOL, V68, P710, DOI 10.1080/17470218.2014.964736; Koch I, 2010, PSYCHON B REV, V17, P1, DOI 10.3758/PBR.17.1.1; Korvorst M, 2006, Q J EXP PSYCHOL, V59, P296, DOI 10.1080/17470210500151691; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Lewandowsky S, 2011, J EXP PSYCHOL LEARN, V37, P720, DOI 10.1037/a0022639; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; Matthews G, 2001, PERS INDIV DIFFER, V31, P575, DOI 10.1016/S0191-8869(00)00162-8; McAuley T, 2006, DEV NEUROPSYCHOL, V29, P447, DOI 10.1207/s15326942dn2903_4; Meiran N, 2005, EXP PSYCHOL, V52, P109, DOI 10.1027/1618-3169.52.2.109; Meyer AS, 2000, PSYCHON B REV, V7, P314, DOI 10.3758/BF03212987; Meyer AS, 1998, COGNITION, V66, pB25, DOI 10.1016/S0010-0277(98)00009-2; Meyer AS, 2003, J MEM LANG, V48, P131, DOI 10.1016/S0749-596X(02)00509-0; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; PARASURAMAN R, 1989, PSYCHOL AGING, V4, P339, DOI 10.1037/0882-7974.4.3.339; Pashler H, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P277; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Piai V, 2013, ACTA PSYCHOL, V142, P332, DOI 10.1016/j.actpsy.2013.01.006; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; R Core Team, R LANG ENV STAT COMP; Roelofs A, 2008, J EXP PSYCHOL HUMAN, V34, P1580, DOI 10.1037/a0012476; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Sepede G, 2012, BIPOLAR DISORD, V14, P764, DOI 10.1111/bdi.12007; Severens E, 2005, ACTA PSYCHOL, V119, P159, DOI 10.1016/j.actpsy.2005.01.002; Shao ZS, 2012, Q J EXP PSYCHOL, V65, P1927, DOI 10.1080/17470218.2012.670252; Szekely A., 2000, CRL NEWSLETTER, V12, P3; Tokowicz N., 2004, BILING-LANG COGN, V7, P255, DOI DOI 10.1017/S1366728904001634; Unsworth N, 2010, INTELLIGENCE, V38, P111, DOI 10.1016/j.intell.2009.08.002; Van Zandt T, 2000, PSYCHON B REV, V7, P424, DOI 10.3758/BF03214357; Williams VSL, 1999, J EDUC BEHAV STAT, V24, P42, DOI 10.2307/1165261	54	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137557	10.1371/journal.pone.0137557	http://dx.doi.org/10.1371/journal.pone.0137557			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ5AJ	26335441	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400067
J	Nanumyan, V; Garas, A; Schweitzer, F				Nanumyan, Vahan; Garas, Antonios; Schweitzer, Frank			The Network of Counterparty Risk: Analysing Correlations in OTC Derivatives	PLOS ONE			English	Article								Counterparty risk denotes the risk that a party defaults in a bilateral contract. This risk not only depends on the two parties involved, but also on the risk from various other contracts each of these parties holds. In rather informal markets, such as the OTC (over-the-counter) derivative market, institutions only report their aggregated quarterly risk exposure, but no details about their counterparties. Hence, little is known about the diversification of counterparty risk. In this paper, we reconstruct the weighted and time-dependent network of counterparty risk in the OTC derivatives market of the United States between 1998 and 2012. To proxy unknown bilateral exposures, we first study the co-occurrence patterns of institutions based on their quarterly activity and ranking in the official report. The network obtained this way is further analysed by a weighted k-core decomposition, to reveal a core-periphery structure. This allows us to compare the activity-based ranking with a topology-based ranking, to identify the most important institutions and their mutual dependencies. We also analyse correlations in these activities, to show strong similarities in the behavior of the core institutions. Our analysis clearly demonstrates the clustering of counterparty risk in a small set of about a dozen US banks. This not only increases the default risk of the central institutions, but also the default risk of peripheral institutions which have contracts with the central ones. Hence, all institutions indirectly have to bear (part of) the counterparty risk of all others, which needs to be better reflected in the price of OTC derivatives.	[Nanumyan, Vahan; Garas, Antonios; Schweitzer, Frank] ETH, Chair Syst Design, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Schweitzer, F (corresponding author), ETH, Chair Syst Design, Zurich, Switzerland.	fschweitzer@ethz.ch	Schweitzer, Frank/B-2127-2012; Nanumyan, Vahan/AAE-6632-2020	Schweitzer, Frank/0000-0003-1551-6491; Nanumyan, Vahan/0000-0001-9054-3217; Garas, Antonios/0000-0001-6914-0819	Swiss National Science Foundation [CR12I1_127000]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Project CR12I1_127000 OTC Derivatives and Systemic Risk in Financial Networks financed by the Swiss National Science Foundation.	Basel Committee on Banking Supervision, 2013, SUP FRAM MEAS CONTR; Burkholz R, 2015, ETH RISK CTR WP SERI; Cecchetti SG, 2009, BIS Q REV, V2009, P45; Feng X, 2013, INT J MODERN PHYS C; Garas A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/8/083030; Gini C., 1997, RIV POLIT ECON, V87, P769; Hendricks D, 1994, NETTING AGREEMENTS C; Kaushik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061815; Miguel A, 2008, COUNTERPARTY RISK CO; Office of the Comptroller of the Currency, 2012, Q REP BANK DER ACT; Singh MM., 2010, COLLATERAL NETTING S; Tasca P, 2014, J FINANC STABIL, V15, P43, DOI 10.1016/j.jfs.2014.08.006; Waldman AR, 1993, AM U L REV, V43, P1023	13	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136638	10.1371/journal.pone.0136638	http://dx.doi.org/10.1371/journal.pone.0136638			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335223	Green Published, gold, Green Submitted			2022-12-27	WOS:000360615400017
J	Tatsumi, H; Nakatani, E; Kanno, T; Nariai, Y; Kagimura, T; Sekine, J				Tatsumi, Hiroto; Nakatani, Eiji; Kanno, Takahiro; Nariai, Yoshiki; Kagimura, Tatsuo; Sekine, Joji			Clinical Features and Treatment Modes of Mandibular Fracture at the Department of Oral and Maxillofacial Surgery, Shimane University Hospital, Japan	PLOS ONE			English	Article							RIGID INTERNAL-FIXATION; RECONSTRUCTION; REDUCTION	Background The number of elderly patients with maxillofacial trauma is rapidly increasing due to active lifestyles and longevity. Shimane prefecture has the fastest growing proportion of elderly individuals in Japan. The aim of this study was to reveal the distinctive features and treatment modes of mandibular fracture treatment mode in patients requiring hospitalization at the Department of Oral and Maxillofacial Surgery, Shimane University Hospital, Japan. Patients and Methods Patient age, sex, period between injury and first consultation, years since injury, cause of injury, fracture site, treatment, and duration of hospitalization were evaluated. Univariate Poisson regression, relative risk with 95% confidence interval based on the Wald test, Fisher's exact test, and Kruskal-Wallis test were used to explore associations among clinical and demographic variables. Results In total, 305 patients were diagnosed with and hospitalized for mandibular fracture from 1980 to 2010. Younger age increased the risk for mandibular fracture. Incidence was higher in males than females, particularly in the young, but the male to female ratio decreased with age. The period until first hospital consultation decreased progressively over the study period. Fall was a much more frequent cause in patients aged >= 60 than in those aged <60 years. Mandibular fracture with condyle, symphysis, and angle involvement were most common and were associated with sex, age, and treatment mode. Length of hospitalization has decreased since 1980. Conclusion In our department, patients aged >= 60 years accounted for a greater proportion of mandibular fracture cases than in many previous studies, reflecting the greater proportion of elderly residents in Shimane prefecture.	[Tatsumi, Hiroto; Kanno, Takahiro; Nariai, Yoshiki; Sekine, Joji] Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan; [Nakatani, Eiji; Kagimura, Tatsuo] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan	Shimane University; Institute for Biomedical Research & Innovation (IBRI)	Sekine, J (corresponding author), Shimane Univ, Fac Med, Dept Oral & Maxillofacial Surg, Izumo, Shimane, Japan.	georges@med.shimane-u.ac.jp	Nakatani, Eiji/O-2782-2013	Nakatani, Eiji/0000-0002-4876-446X				Adeyemo WL, 2008, WORLD J SURG, V32, P2631, DOI 10.1007/s00268-008-9773-8; Atilgan S, 2010, J APPL ORAL SCI, V18, P17, DOI 10.1590/S1678-77572010000100005; Bakardjiev A, 2007, J CRANIO MAXILL SURG, V35, P147, DOI 10.1016/j.jcms.2007.01.005; Bither S, 2008, DENT TRAUMATOL, V24, P468, DOI 10.1111/j.1600-9657.2008.00606.x; Bormann KH, 2009, J ORAL MAXIL SURG, V67, P1251, DOI 10.1016/j.joms.2008.09.022; Chrcanovic BR, 2012, J CRANIO MAXILL SURG, V40, P116, DOI 10.1016/j.jcms.2011.03.012; Czerwinski M, 2008, CAN J PLAST SURG, V16, P36, DOI 10.1177/229255030801600107; de Matos FP, 2010, INT J ORAL MAX SURG, V39, P10, DOI 10.1016/j.ijom.2009.10.005; Domanski MC, 2011, J CRANIOFAC SURG, V22, P2260, DOI 10.1097/SCS.0b013e31823270e3; Eskitascioglu T, 2013, ULUS TRAVMA ACIL CER, V19, P348, DOI 10.5505/tjtes.2013.56313; Brasileiro BF, 2006, ORAL SURG ORAL MED O, V102, P28, DOI 10.1016/j.tripleo.2005.07.023; Fonceca RJ, 1991, ORAL MAXILLOFACIAL T, P238; GOLDSCHMIDT MJ, 1995, J ORAL MAXIL SURG, V53, P1145, DOI 10.1016/0278-2391(95)90620-7; Gutta R, 2014, J ORAL MAXIL SURG, V72, P550, DOI 10.1016/j.joms.2013.09.005; Iida S, 2003, J CRANIO MAXILL SURG, V31, P278, DOI 10.1016/S1010-5182(03)00069-6; Jung HW, 2014, J KOR ASSOC ORAL MAX, V40, P21, DOI 10.5125/jkaoms.2014.40.1.21; Kanno T, 2014, INT J ORAL MAX SURG, V43, P177, DOI 10.1016/j.ijom.2013.08.008; Kanno T, 2011, J ORAL MAXIL SURG, V69, pE372, DOI 10.1016/j.joms.2011.02.040; Kloss FR, 2011, INT J ORAL MAX SURG, V40, P33, DOI 10.1016/j.ijom.2010.08.006; Maliska Maximiana Cristina de Souza, 2009, Braz. oral res., V23, P268, DOI 10.1590/S1806-83242009000300008; Ministry of Internal Affairs and Communications, JAP STAT YB; Sasaki R, 2009, ORAL SCI INT, V6, P1; SEKINE J, 1995, J ORAL MAXIL SURG, V53, P1317, DOI 10.1016/0278-2391(95)90592-8; Tatsumi H, 2014, INT J ORAL MAX SURG, V43, P185, DOI 10.1016/j.ijom.2013.07.742; United Nations, WORLD POP PROSP 2008; Wang GS, 2012, OR SURG OR MED OR PA, V113, P356, DOI 10.1016/j.tripleo.2011.03.034; Wilde F, 2014, CRANIOMAX TRAUM REC, V7, P158, DOI 10.1055/s-0034-1371356; Yu H, 2013, J CRANIOMAXILLOFAC S	28	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0136278	10.1371/journal.pone.0136278	http://dx.doi.org/10.1371/journal.pone.0136278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26334627	Green Submitted, gold, Green Published			2022-12-27	WOS:000360615400012
J	Theysohn, JM; Ruhlmann, M; Muller, S; Dechene, A; Best, J; Haubold, J; Umutlu, L; Gerken, G; Bockisch, A; Lauenstein, TC				Theysohn, Jens M.; Ruhlmann, Marcus; Mueller, Stefan; Dechene, Alexander; Best, Jan; Haubold, Johannes; Umutlu, Lale; Gerken, Guido; Bockisch, Andreas; Lauenstein, Thomas C.			Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?	PLOS ONE			English	Article							INTERNAL RADIATION-THERAPY; HEPATIC-TUMORS; HEPATOCELLULAR-CARCINOMA; LIVER-TUMORS; CANCER; COMPLICATIONS; RADIOTHERAPY; TC-99M-MAA; ARTERY; SIRT	Purpose Selective Internal Radiation Therapy (SIRT) with (90)yttrium (Y-90) is an increasingly used therapeutic option for unresectable liver malignancies. Nontarget embolization of extrahepatic tissue secondary to vascular shunting can lead to SIRT associated complications. Our aim was to assess whether extrahepatic shunts can reliably be diagnosed based on hepatic digital subtraction angiography (DSA) or whether subsequent SPECT/CT data can provide additional information. Materials and Methods 825 patients with hepatocellular carcinoma (n = 636), hepatic metastases (n = 158) or cholangiocellular carcinoma (n = 31) were retrospectively analyzed. During hepatic DSA 128 arteries causing shunt flow to gastrointestinal tissue were coilembolized (right gastric artery n = 63, gastroduodenal artery n = 29; branches to duodenum/pancreas n = 36). Technectium-99m-labeled human serum albumin (HSA) was injected in all 825 patients. SPECT/CT data was used to identify additional or remaining shunts to extrahepatic tissue. Results An unexpected uptake of HSA in extrahepatic tissue was found by SPECT/CT in 54/825 (6.5%) patients (located in stomach n = 13, duodenum n = 26, distal bowel segments n = 12, kidney n = 1, diaphragm n = 2). These patients underwent repeated DSA and newly identified shunt vessels were coilembolized in 22/54 patients, while in 12/54 patients a more distal catheter position for repeat injection of HSA was chosen. In 20/54 patients the repeated SPECT/CT data still revealed an extrahepatic HSA uptake. These patients did not receive SIRT. Conclusion Most extrahepatic shunts can be identified on DSA prior to Y-90 therapy. However, SPECT-CT data helps to identify additional shunts that were initially not seen on DSA.	[Theysohn, Jens M.; Haubold, Johannes; Umutlu, Lale; Lauenstein, Thomas C.] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Ruhlmann, Marcus; Mueller, Stefan; Bockisch, Andreas] Univ Hosp Essen, Dept Nucl Med, Essen, Germany; [Dechene, Alexander; Best, Jan; Gerken, Guido] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Theysohn, JM (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	jens.theysohn@uni-due.de	Best, Jan/AAG-2350-2020	Best, Jan/0000-0003-2074-0930				Ahmadzadehfar H, 2014, EUR J NUCL MED MOL I, V41, pS115, DOI 10.1007/s00259-013-2675-5; Ahmadzadehfar H, 2010, J NUCL MED, V51, P1206, DOI 10.2967/jnumed.109.074559; Barentsz MW, 2011, CARDIOVASC INTER RAD, V34, P1074, DOI 10.1007/s00270-010-0088-4; Crowder CD, 2009, AM J SURG PATHOL, V33, P963, DOI 10.1097/PAS.0b013e31817ed787; Dudeck O, 2012, CARDIOVASC INTER RAD, V35, P1083, DOI 10.1007/s00270-011-0252-5; Floridi C, 2014, RADIOL MED, V119, P521, DOI 10.1007/s11547-014-0429-5; Gaba RC, 2014, RADIOLOGY, V271, P602, DOI 10.1148/radiol.14131969; Gates VL, 2014, J VASC INTERV RADIOL, V25, P266, DOI 10.1016/j.jvir.2013.11.005; Geisel D, 2014, ANTICANCER RES, V34, P4315; Gordon AC, 2014, J VASC INTERV RADIOL, V25, P1523, DOI 10.1016/j.jvir.2014.07.007; Hamami ME, 2009, J NUCL MED, V50, P688, DOI 10.2967/jnumed.108.058347; Heusner TA, 2010, ROFO-FORTSCHR RONTG, V182, P603, DOI 10.1055/s-0029-1245192; Hong K, 2009, J VASC INTERV RADIOL, V20, P360, DOI 10.1016/j.jvir.2008.11.019; Jakobs TF, 2007, EUR RADIOL, V17, P1320, DOI 10.1007/s00330-006-0508-7; Jiang ML, 2011, CANCER BIOTHER RADIO, V26, P511, DOI 10.1089/cbr.2010.0944; Kao YH, 2011, ANN NUCL MED, V25, P365, DOI 10.1007/s12149-010-0464-9; Konda A, 2009, GASTROINTEST ENDOSC, V70, P561, DOI 10.1016/j.gie.2009.03.015; Lam M, 2013, CARDIOVASC INTER RAD, V36, P1536, DOI 10.1007/s00270-013-0579-1; Lencioni R, 2012, RADIOLOGY, V262, P43, DOI 10.1148/radiol.11110144; Maleux G, 2013, J VASC INTERV RADIOL, V24, P797, DOI 10.1016/j.jvir.2013.01.503; Malfertheiner P, 2014, FUTURE ONCOL, V10, P17, DOI 10.2217/fon.14.218; Paprottka PM, 2012, CARDIOVASC INTER RAD, V35, P454, DOI 10.1007/s00270-011-0169-z; Pech M, 2009, CARDIOVASC INTER RAD, V32, P455, DOI 10.1007/s00270-008-9498-y; Peterson JL, 2013, BRACHYTHERAPY, V12, P573, DOI 10.1016/j.brachy.2013.05.008; Riaz A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00198; Rodriguez-Lago I, 2013, WORLD J GASTROENTERO, V19, P2935, DOI 10.3748/wjg.v19.i19.2935; Schelhorn J, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-595; Theysohn JM, 2013, CARDIOVASC INTER RAD, V36, P1015, DOI 10.1007/s00270-012-0474-1; Yu NC, 2013, INT J RADIAT ONCOL, V85, P834, DOI 10.1016/j.ijrobp.2012.06.051; Zarva A, 2014, J NUCL MED, V55, P360, DOI 10.2967/jnumed.113.127662	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2015	10	9							e0137587	10.1371/journal.pone.0137587	http://dx.doi.org/10.1371/journal.pone.0137587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ5AJ	26335790	Green Published, Green Submitted, gold			2022-12-27	WOS:000360615400070
J	Gu, AX; Jie, YM; Sun, L; Zhao, SP; Mingyan, E; You, QS				Gu, Anxin; Jie, Yamin; Sun, Liang; Zhao, Shuping; Mingyan, E.; You, Qingshan			RhNRG-1 beta Protects the Myocardium against Irradiation-Induced Damage via the ErbB2-ERK-SIRT1 Signaling Pathway	PLOS ONE			English	Article							HEART; MICE; NEUREGULIN-1; SURVIVAL; GENE; REGENERATION; DYSFUNCTION; INHIBITION; EXPRESSION; MYOCYTES	Radiation-induced heart disease (RIHD), which is a serious side effect of the radiotherapy applied for various tumors due to the inevitable irradiation of the heart, cannot be treated effectively using current clinical therapies. Here, we demonstrated that rhNRG-1 beta, an epidermal growth factor (EGF)-like protein, protects myocardium tissue against irradiation-induced damage and preserves cardiac function. rhNRG-1 beta effectively ameliorated irradiation- induced myocardial nuclear damage in both cultured adult rat-derived cardiomyocytes and rat myocardium tissue via NRG/ErbB2 signaling. By activating ErbB2, rhNRG-1 beta maintained mitochondrial integrity, ATP production, respiratory chain function and the Krebs cycle status in irradiated cardiomyocytes. Moreover, the protection of irradiated cardiomyocytes and myocardium tissue by rhNRG-1 beta was at least partly mediated by the activation of the ErbB2-ERK-SIRT1 signaling pathway. Long-term observations further showed that rhNRG-1 beta administered in the peri-irradiation period exerts continuous protective effects on cardiac pump function, the myocardial energy metabolism, cardiomyocyte volume and interstitial fibrosis in the rats receiving radiation via NRG/ErbB2 signaling. Our findings indicate that rhNRG-1 beta can protect the myocardium against irradiation-induced damage and preserve cardiac function via the ErbB2-ERK-SIRT1 signaling pathway.	[Gu, Anxin; Zhao, Shuping; Mingyan, E.; You, Qingshan] Harbin Med Univ, Affiliated Tumor Hosp, Dept Radiotherapy, Harbin, Heilongjiang, Peoples R China; [Jie, Yamin] Harbin Med Univ, Affiliated Hosp 4, Dept Radiotherapy, Harbin, Heilongjiang, Peoples R China; [Sun, Liang] Harbin Med Univ, Dept Human Anat, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Mingyan, E (corresponding author), Harbin Med Univ, Affiliated Tumor Hosp, Dept Radiotherapy, Harbin, Heilongjiang, Peoples R China.	emingyan889@163.com; youqingshanradio@163.com			Heilongjiang Province Science and Technology Project Fund [GC07C354]	Heilongjiang Province Science and Technology Project Fund	This work was supported by Heilongjiang Province Science and Technology Project Fund (GC07C354; to ME).	Akman-Anderson L, 2007, INFECT IMMUN, V75, P4012, DOI 10.1128/IAI.00645-07; An T, 2013, PHYSIOL RES, V62, P379, DOI 10.33549/physiolres.932435; Baban B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124059; Barjaktarovic Z, 2013, RADIOTHER ONCOL, V106, P404, DOI 10.1016/j.radonc.2013.01.017; Bassino E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119790; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Cervera AM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-89; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chua YL, 2009, ONCOGENE, V28, P4041, DOI 10.1038/onc.2009.259; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; CORN BW, 1990, J CLIN ONCOL, V8, P741, DOI 10.1200/JCO.1990.8.4.741; D'Uva G, 2015, NAT CELL BIOL, V17, P627, DOI 10.1038/ncb3149; Darby SC, 2010, INT J RADIAT ONCOL, V76, P656, DOI 10.1016/j.ijrobp.2009.09.064; Erven K, 2013, INT J RADIAT ONCOL, V85, P1172, DOI 10.1016/j.ijrobp.2012.09.022; Gao RL, 2010, J AM COLL CARDIOL, V55, P1907, DOI 10.1016/j.jacc.2009.12.044; Ghobadi G, 2012, INT J RADIAT ONCOL, V84, pE639, DOI 10.1016/j.ijrobp.2012.07.2362; Hill MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055741; Kim YC, 2009, P NATL ACAD SCI USA, V106, P13707, DOI 10.1073/pnas.0903938106; Lai D, 2010, CIRC RES, V107, P715, DOI 10.1161/CIRCRESAHA.110.218693; Lemmens K, 2006, J BIOL CHEM, V281, P19469, DOI 10.1074/jbc.M600399200; Lenarczyk M, 2013, RADIAT RES, V180, P247, DOI 10.1667/RR3292.1; Li JG, 2014, INT J MOL SCI, V15, P5928, DOI 10.3390/ijms15045928; Liu SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107865; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Okoshi K, 2004, CIRCULATION, V110, P713, DOI 10.1161/01.CIR.0000138109.32748.80; Ong SB, 2013, ANTIOXID REDOX SIGN, V19, P400, DOI 10.1089/ars.2012.4777; Planavila A, 2012, J MOL CELL CARDIOL, V53, P521, DOI 10.1016/j.yjmcc.2012.07.019; Polidoro L, 2013, J CARDIOVASC TRANSL, V6, P221, DOI 10.1007/s12265-012-9436-x; Polizzotti BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5171; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Rizk SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114560; Sardaro A, 2012, RADIOTHER ONCOL, V103, P133, DOI 10.1016/j.radonc.2012.02.008; Schwarz K, 2014, INT J CARDIOL, V171, P134, DOI 10.1016/j.ijcard.2013.12.014; Shukla PC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1601; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sridharan V, 2014, RADIAT RES, V181, P324, DOI 10.1667/RR13452.1; Sridharan V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068762; Srinivasan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077129; Sun L, 2014, STEM CELLS DEV, V23, P2104, DOI 10.1089/scd.2013.0563; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tian Y, 2012, CIRC RES, V110, P1023, DOI 10.1161/CIRCRESAHA.111.243899; Tony H, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/597032; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Wadugu B, 2012, AM J PHYSIOL-HEART C, V302, pH2139, DOI 10.1152/ajpheart.00063.2012; Wang JX, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.41; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yu H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056514, 10.1371/journal.pone.0080815]; Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066779; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	51	20	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137337	10.1371/journal.pone.0137337	http://dx.doi.org/10.1371/journal.pone.0137337			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332771	Green Submitted, Green Published, gold			2022-12-27	WOS:000360613800124
J	Lam, CT; Krieger, MS; Gallagher, JE; Asma, B; Muasher, LC; Schmitt, JW; Ramanujam, N				Lam, Christopher T.; Krieger, Marlee S.; Gallagher, Jennifer E.; Asma, Betsy; Muasher, Lisa C.; Schmitt, John W.; Ramanujam, Nimmi			Design of a Novel Low Cost Point of Care Tampon (POCkeT) Colposcope for Use in Resource Limited Settings	PLOS ONE			English	Article							INDIRECT OPHTHALMOSCOPY VIO; CERVICAL-CANCER PREVENTION; VISUAL INSPECTION; SWEDE SCORE; RANDOMIZED-TRIAL; RURAL MEXICO; TISSUE BASIS; HAND-HELD; SYSTEM; WOMEN	Introduction Current guidelines by WHO for cervical cancer screening in low- and middle-income countries involves visual inspection with acetic acid (VIA) of the cervix, followed by treatment during the same visit or a subsequent visit with cryotherapy if a suspicious lesion is found. Implementation of these guidelines is hampered by a lack of: trained health workers, reliable technology, and access to screening facilities. A low cost ultra-portable Point of Care Tampon based digital colposcope (POCkeT Colposcope) for use at the community level setting, which has the unique form factor of a tampon, can be inserted into the vagina to capture images of the cervix, which are on par with that of a state of the art colposcope, at a fraction of the cost. A repository of images to be compiled that can be used to empower front line workers to become more effective through virtual dynamic training. By task shifting to the community setting, this technology could potentially provide significantly greater cervical screening access to where the most vulnerable women live. The POCkeT Colposcope's concentric LED ring provides comparable white and green field illumination at a fraction of the electrical power required in commercial colposcopes. Evaluation with standard optical imaging targets to assess the POCkeT Colposcope against the state of the art digital colposcope and other VIAM technologies. Results Our POCkeT Colposcope has comparable resolving power, color reproduction accuracy, minimal lens distortion, and illumination when compared to commercially available colposcopes. In vitro and pilot in vivo imaging results are promising with our POCkeT Colposcope capturing comparable quality images to commercial systems. Conclusion The POCkeT Colposcope is capable of capturing images suitable for cervical lesion analysis. Our portable low cost system could potentially increase access to cervical cancer screening in limited resource settings through task shifting to community health workers.	[Lam, Christopher T.; Krieger, Marlee S.; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Gallagher, Jennifer E.] Duke Univ, Dept Surg, Durham, NC 27706 USA; [Krieger, Marlee S.; Ramanujam, Nimmi] Duke Univ, Ctr Global Womens Hlth Technol, Durham, NC 27706 USA; [Lam, Christopher T.; Krieger, Marlee S.; Asma, Betsy; Ramanujam, Nimmi] Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA; [Muasher, Lisa C.; Schmitt, John W.] Duke Univ, Dept Obstet & Gynecol, Durham, NC 27706 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Lam, CT (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	CTL11@duke.edu	Ramanujam, Nimmi/AAA-7575-2021	Ramanujam, Nimmi/0000-0001-7319-8415	National Institute of Health Quick Trials [5R21CA162747-02]; NATIONAL CANCER INSTITUTE [R01CA195500, R01CA193380, R21CA162747] Funding Source: NIH RePORTER	National Institute of Health Quick Trials; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health Quick Trials (Grant: 5R21CA162747-02 http://projectreporter.nih.gov/project_info_description.cfm? projectnumber=5R21CA162747-02) to NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal P, 2011, ARCH GYNECOL OBSTET, V284, P397, DOI 10.1007/s00404-010-1673-0; ANSI/IESNA, 2007, RP27307 ANSIIESNA, P24; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Ballagh SA, 2004, CONTRACEPTION, V70, P241, DOI 10.1016/j.contraception.2004.03.002; Bowring J, 2010, J LOW GENIT TRACT DI, V14, P301, DOI 10.1097/LGT.0b013e3181d77756; Brookner CK, 1997, PHOTOCHEM PHOTOBIOL, V65, P1020, DOI 10.1111/j.1751-1097.1997.tb07963.x; Cronje HS, 2011, BEST PRACT RES CL OB, V25, P575, DOI 10.1016/j.bpobgyn.2011.05.002; Crowley DL.G, 2012, COMPREHENSIVE GYNECO; Das A, 2011, IM SYST TECHN IST 20; El Meslouhi O, 2011, OPEN COMPUT SCI, V1, P341, DOI 10.2478/s13537-011-0020-2; Estrada R, 2012, BIOMED OPT EXPRESS, V3, P327, DOI 10.1364/BOE.3.000327; Estrada R, 2011, BIOMED OPT EXPRESS, V2, P2871, DOI 10.1364/BOE.2.002871; Ferlay J., 2002, GLOBOCAN 2002 CANC I; FERRIS DG, 1991, J FAM PRACTICE, V33, P633; FERRIS DG, 1991, J FAM PRACTICE, V33, P506; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gono K, 2004, J BIOMED OPT, V9, P568, DOI 10.1117/1.1695563; Hopman EH, 1998, EUR J OBSTET GYN R B, V77, P229, DOI 10.1016/S0301-2115(97)00267-4; Hoyo C, 2005, PREV MED, V41, P439, DOI 10.1016/j.ypmed.2004.11.021; Kahn JA, 2003, OBSTET GYNECOL, V101, P490, DOI 10.1016/S0029-7844(02)02592-9; Klug B, 2012, UNDERSTANDING CAMERA; Koren N, 2006, ELECT IMAGING; Krishnan S, 2013, ONCOLOGIST, V18, P1285, DOI 10.1634/theoncologist.2013-0292; Larsen M, 1997, FAM PRACT, V14, P148, DOI 10.1093/fampra/14.2.148; Li WJ, 2006, LECT NOTES COMPUT SC, V4292, P627; Li WJ, 2006, OPT EXPRESS, V14, P12887, DOI 10.1364/OE.14.012887; Li WJ, 2005, LECT NOTES COMPUT SC, V3765, P240; Lluis-Gomez A, 2014, CONS EL ICCE 2014 IE; Lyimo FS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-22; Nakappan S, 2007, GYNECOL ONCOL, V107, pS215, DOI 10.1016/j.ygyno.2007.07.016; Nessa A, 2014, INT J GYNECOL CANCER, V24, P339, DOI 10.1097/IGC.0000000000000042; Ngonzi J, 2013, J LOW GENIT TRACT DI, V17, P372, DOI 10.1097/LGT.0b013e31827ba7c5; O'Connor DM, 2008, OBSTET GYN CLIN N AM, V35, P565, DOI 10.1016/j.ogc.2008.09.009; Parashari A, 2000, B WORLD HEALTH ORGAN, V78, P964; Perez-Cruz E, 2005, SALUD PUBLICA MEXICO, V47, P39, DOI 10.1590/S0036-36342005000100007; REID R, 1984, AM J OBSTET GYNECOL, V149, P293, DOI 10.1016/0002-9378(84)90229-1; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Schmitt J, 2013, COST NEW DIGITAL COL; Sellors JW, 2004, JAIDS-J ACQ IMM DEF, V37, pS160, DOI 10.1097/00126334-200410013-00005; Sharma G, 2005, COLOR RES APPL, V30, P21, DOI 10.1002/col.20070; Sodhani P, 2006, CYTOPATHOLOGY, V17, P348, DOI 10.1111/j.1365-2303.2006.00351.x; Volpi D, 2014, SPIE BIOS; Walmer DK, 2004, JAIDS-J ACQ IMM DEF, V37, pS167, DOI 10.1097/00126334-200410013-00006; Wang Q, 2013, INT C OPT INSTR TECH; Watkins MM, 2002, INT J GYNECOL CANCER, V12, P475, DOI 10.1046/j.1525-1438.2002.01170.x; Wentzensen N, 2012, CLIN CANCER RES, V18, P4154, DOI 10.1158/1078-0432.CCR-12-0270; Williams CM, 2008, POP STUD-J DEMOG, V62, P335, DOI 10.1080/00324720802315459; Winkler JL, 2008, REV PANAM SALUD PUBL, V23, P1, DOI 10.1590/S1020-49892008000100001; Winkler JL, 2003, INT J GYNECOL OBSTET, V81, P35, DOI 10.1016/S0020-7292(02)00413-7; Xue Z, 2007, MED IMAGING; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633; Zimmerman-Moreno G, 2006, MED IMAGING	53	42	42	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135869	10.1371/journal.pone.0135869	http://dx.doi.org/10.1371/journal.pone.0135869			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332673	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800043
J	Larsen, PE; Collart, FR; Dai, Y				Larsen, Peter E.; Collart, Frank R.; Dai, Yang			Predicting Ecological Roles in the Rhizosphere Using Metabolome and Transportome Modeling	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; SIGNALING PATHWAY; BACTERIA; KEGG; IDENTIFICATION; PATHOGENS; SYSTEM; HONEY	The ability to obtain complete genome sequences from bacteria in environmental samples, such as soil samples from the rhizosphere, has highlighted the microbial diversity and complexity of environmental communities. However, new algorithms to analyze genome sequence information in the context of community structure are needed to enhance our understanding of the specific ecological roles of these organisms in soil environments. We present a machine learning approach using sequenced Pseudomonad genomes coupled with outputs of metabolic and transportomic computational models for identifying the most predictive molecular mechanisms indicative of a Pseudomonad's ecological role in the rhizosphere: a biofilm, biocontrol agent, promoter of plant growth, or plant pathogen. Computational predictions of ecological niche were highly accurate overall with models trained on transportomic model output being the most accurate (Leave One Out Validation F-scores between 0.82 and 0.89). The strongest predictive molecular mechanism features for rhizosphere ecological niche overlap with many previously reported analyses of Pseudomonad interactions in the rhizosphere, suggesting that this approach successfully informs a system-scale level understanding of how Pseudomonads sense and interact with their environments. The observation that an organism's transportome is highly predictive of its ecological niche is a novel discovery and may have implications in our understanding microbial ecology. The framework developed here can be generalized to the analysis of any bacteria across a wide range of environments and ecological niches making this approach a powerful tool for providing insights into functional predictions from bacterial genomic data.	[Larsen, Peter E.; Collart, Frank R.] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Larsen, Peter E.; Dai, Yang] Univ Illinois, Dept Bioengn, Chicago, IL USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Larsen, PE (corresponding author), Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	plarsen@anl.gov		Collart, Frank/0000-0001-6942-4483	UChicago Argonne, LLC; U.S. Department of Energy, Office of Biological and Environmental Research (BER), BER's Genomic Science Program; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	UChicago Argonne, LLC; U.S. Department of Energy, Office of Biological and Environmental Research (BER), BER's Genomic Science Program(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This contribution originates in part from the "Environment Sensing and Response" Scientific Focus Area (SFA) program at Argonne National Laboratory. This research was supported by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne"), and the U.S. Department of Energy, Office of Biological and Environmental Research (BER), as part of BER's Genomic Science Program. This research has been funded by the U.S. Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Lateif K, 2012, PLANT SIGNAL BEHAV, V7, P636, DOI 10.4161/psb.20039; Alhede M, 2014, ADV APPL MICROBIOL, V86, P1, DOI 10.1016/B978-0-12-800262-9.00001-9; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bannert A, 2011, APPL ENVIRON MICROB, V77, P6109, DOI 10.1128/AEM.01751-10; Baslan T, 2014, CURR OPIN GENET DEV, V26, P59, DOI 10.1016/j.gde.2014.06.004; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bowden G H, 1997, Adv Dent Res, V11, P81; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; CLARKE PH, 1982, A VAN LEEUW J MICROB, V48, P105, DOI 10.1007/BF00405197; Conde C, 2006, PLANT PHYSIOL, V141, P1563, DOI 10.1104/pp.106.080804; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Costaglioli P, 2012, MICROBIOLOGYOPEN, V1, P326, DOI 10.1002/mbo3.33; Devoid Scott, 2013, Methods Mol Biol, V985, P17, DOI 10.1007/978-1-62703-299-5_2; Dorel C, 2006, RES MICROBIOL, V157, P306, DOI 10.1016/j.resmic.2005.12.003; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Filiatrault MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055594; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Gamper H, 2005, NEW PHYTOL, V167, P531, DOI 10.1111/j.1469-8137.2005.01440.x; Garbeva P, 2009, MICROB ECOL, V58, P36, DOI 10.1007/s00248-009-9502-3; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haran S, 1996, MICROBIOL-UK, V142, P2321, DOI 10.1099/00221287-142-9-2321; Hu XZ, 2013, P NATL ACAD SCI USA, V110, P678, DOI 10.1073/pnas.1215033110; Hussain SS, 2011, BIOTECHNOL ADV, V29, P300, DOI 10.1016/j.biotechadv.2011.01.003; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Jones ML, GUT MICROBES, V5; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kapitein N, 2013, CURR OPIN MICROBIOL, V16, P52, DOI 10.1016/j.mib.2012.11.009; Kilty SJ, 2011, INT FORUM ALLERGY RH, V1, P348, DOI 10.1002/alr.20073; Knief C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00216; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Kraepiel AML, 2009, BIOMETALS, V22, P573, DOI 10.1007/s10534-009-9222-7; Kulma A, 2007, PLANT SCI, V172, P433, DOI 10.1016/j.plantsci.2006.10.013; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lalonde S, 1999, PLANT CELL, V11, P707, DOI 10.1105/tpc.11.4.707; Larsen PE, 2015, ISME J, V9, P166, DOI 10.1038/ismej.2014.107; Larsen PE, 2014, IEEE ENG MED BIO, P314, DOI 10.1109/EMBC.2014.6943592; Larsen Peter E, 2011, Microb Inform Exp, V1, P4, DOI 10.1186/2042-5783-1-4; Lennon JT, 2012, ECOLOGY, V93, P1867, DOI 10.1890/11-1745.1; Ma HY, 2013, J CONTROL RELEASE, V172, P1035, DOI 10.1016/j.jconrel.2013.10.005; Majtan J, 2014, PHYTOTHER RES, V28, P69, DOI 10.1002/ptr.4957; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; MILLER KJ, 1986, SCIENCE, V231, P48, DOI 10.1126/science.3941890; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Newton AC, 2010, TRENDS MICROBIOL, V18, P365, DOI 10.1016/j.tim.2010.06.002; Okazaki Y, PLANT J; Olczak T, 2012, ARCH MICROBIOL, V194, P719, DOI 10.1007/s00203-012-0804-3; Peer WA, 2013, CURR OPIN PLANT BIOL, V16, P561, DOI 10.1016/j.pbi.2013.08.003; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Phillips D. A., 1992, Mycorrhiza, V1, P55, DOI 10.1007/BF00206136; Quiles F, 2014, BIOFOULING, V30, P709, DOI 10.1080/08927014.2014.915956; Raffaele S, 2009, PLANT SIGNAL BEHAV, V4, P94, DOI 10.4161/psb.4.2.7580; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Rudrappa T, 2008, FEMS MICROBIOL ECOL, V64, P153, DOI 10.1111/j.1574-6941.2008.00465.x; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; SANDS DC, 1970, J BACTERIOL, V101, P9, DOI 10.1128/JB.101.1.9-23.1970; Scott NM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00108; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Sims A, 2012, WATER RES, V46, P4121, DOI 10.1016/j.watres.2012.05.007; Singh S, 2012, CURR OPIN PLANT BIOL, V15, P444, DOI 10.1016/j.pbi.2012.04.002; Steinkellner S, 2007, MOLECULES, V12, P1290, DOI 10.3390/12071290; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Suen G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000743; TALAGA P, 1994, J BACTERIOL, V176, P6538, DOI 10.1128/JB.176.21.6538-6544.1994; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Tielen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071845; Winter G, 2013, ENVIRON MICROBIOL, V15, P1901, DOI 10.1111/1462-2920.12064; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; You J, 2009, WATER RES, V43, P1801, DOI 10.1016/j.watres.2009.01.016	76	8	8	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0132837	10.1371/journal.pone.0132837	http://dx.doi.org/10.1371/journal.pone.0132837			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332409	Green Published, Green Submitted, gold			2022-12-27	WOS:000360613800002
J	Villanueva, VM; Oldfield, LM; Hatfull, GF				Villanueva, Valerie M.; Oldfield, Lauren M.; Hatfull, Graham F.			An Unusual Phage Repressor Encoded by Mycobacteriophage BPs	PLOS ONE			English	Article							GENE-EXPRESSION; SEQUENCE; INTEGRATION; EVOLUTION; IMMUNITY; PHI-C31	Temperate bacteriophages express transcription repressors that maintain lysogeny by down-regulating lytic promoters and confer superinfection immunity. Repressor regulation is critical to the outcome of infection-lysogenic or lytic growth-as well as prophage induction into lytic replication. Mycobacteriophage BPs and its relatives use an unusual integration-dependent immunity system in which the phage attachment site (attP) is located within the repressor gene (33) such that site-specific integration leads to synthesis of a prophage-encoded product (gp33(103)) that is 33 residues shorter at its C-terminus than the virallyencoded protein (gp33(136)). However, the shorter form of the repressor (gp33103) is stable and active in repression of the early lytic promoter PR, whereas the longer virally-encoded form (gp33136) is inactive due to targeted degradation via a C-terminal ssrA-like tag. We show here that both forms of the repressor bind similarly to the 33-34 intergenic regulatory region, and that BPs gp33(103) is a tetramer in solution. The BPs gp33(103) repressor binds to five regulatory regions spanning the BPs genome, and regulates four promoters including the early lytic promoter, P-R. BPs gp33(103) has a complex pattern of DNA recognition in which a full operator binding site contains two half sites separated by a variable spacer, and BPs gp33(103) induces a DNA bend at the full operator site but not a half site. The operator site structure is unusual in that one half site corresponds to a 12 bp palindrome identified previously, but the other half site is a highly variable variant of the palindrome.	[Villanueva, Valerie M.; Oldfield, Lauren M.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hatfull, GF (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu			NIH [GM093901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM093901] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH GM093901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; Bibb LA, 2002, MOL MICROBIOL, V45, P1515, DOI 10.1046/j.1365-2958.2002.03130.x; Broussard GW, 2013, MOL CELL, V49, P237, DOI 10.1016/j.molcel.2012.11.012; Broussard GW., 2013, BACTERIOPHAGE, V3, DOI DOI 10.4161/BACT.24186; Brown KL, 1997, EMBO J, V16, P5914, DOI 10.1093/emboj/16.19.5914; Dedrick RM, 2013, MOL MICROBIOL, V88, P577, DOI 10.1111/mmi.12210; DONNELLYWU MK, 1993, MOL MICROBIOL, V7, P407, DOI 10.1111/j.1365-2958.1993.tb01132.x; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; HATFULL GF, 1993, MOL MICROBIOL, V7, P395, DOI 10.1111/j.1365-2958.1993.tb01131.x; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2011, CURR OPIN VIROL, V1, P298, DOI 10.1016/j.coviro.2011.06.009; Lewis D, 2011, P NATL ACAD SCI USA, V108, P14807, DOI 10.1073/pnas.1111221108; Little JW, 2010, CURR BIOL, V20, pR724, DOI 10.1016/j.cub.2010.06.028; Oldfield LM, 2014, J BACTERIOL, V196, P3589, DOI 10.1128/JB.01801-14; Petrova ZO, 2015, MYCOBACTERIOPH UNPUB; Pope WH, 2015, ELIFE, V4, DOI 10.7554/eLife.06416; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; PTASHNE M, 1982, SCI AM, V247, P128, DOI 10.1038/scientificamerican1182-128; Ptashne M, 1987, A GENETIC SWITCH; RIMPHANITCHAYAKIT V, 1990, EMBO J, V9, P719, DOI 10.1002/j.1460-2075.1990.tb08165.x; SINCLAIR RB, 1988, MOL GEN GENET, V213, P269, DOI 10.1007/BF00339591; SMITH MCM, 1991, MOL MICROBIOL, V5, P2833, DOI 10.1111/j.1365-2958.1991.tb01992.x; Smith MCM, 1999, NUCLEIC ACIDS RES, V27, P2145, DOI 10.1093/nar/27.10.2145; Zwieb C, 2009, METHODS MOL BIOL, V543, P547, DOI 10.1007/978-1-60327-015-1_32	24	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0137187	10.1371/journal.pone.0137187	http://dx.doi.org/10.1371/journal.pone.0137187			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26332854	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000360613800106
J	Sammallahti, S; Lahti, M; Pyhala, R; Lahti, J; Pesonen, AK; Heinonen, K; Hovi, P; Eriksson, JG; Strang-Karlsson, S; Jarvenpaa, AL; Andersson, S; Kajantie, E; Ralkkonen, K				Sammallahti, Sara; Lahti, Marius; Pyhala, Riikka; Lahti, Jari; Pesonen, Anu-Katriina; Heinonen, Kati; Hovi, Petteri; Eriksson, Johan G.; Strang-Karlsson, Sonja; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero; Ralkkonen, Katri			Infant Growth after Preterm Birth and Mental Health in Young Adulthood	PLOS ONE			English	Article							NEUROCOGNITIVE ABILITIES; BEHAVIORAL SYMPTOMS; HEAD CIRCUMFERENCE; GESTATIONAL-AGE; LINEAR GROWTH; WEIGHT; BORN; DISORDER; ADOLESCENTS; HELSINKI	Objectives Faster growth after preterm birth benefits long-term cognitive functioning. Whether these benefits extend to mental health remains largely unknown. We examined if faster growth in infancy is associated with better self-reported mental health in young adults born preterm at very low birth weight (VLBW) (<1500g). Study Design As young adults, participants of the Helsinki Study of Very Low Birth Weight Adults self-reported symptoms of depression and attention deficit/hyperactivity disorder (ADHD) (n = 157) and other psychiatric problems (n = 104). As main predictors of mental health outcomes in linear regression models, we used infant weight, length, and head circumference at birth, term, and 12 months of corrected age, and growth between these time points. Growth data were collected from records and measures at term and at 12 months of corrected age were interpolated. Additionally, we examined the moderating effects of intrauterine growth restriction. Results Size at birth, term, or 12 months of corrected age, or growth between these time points were not associated with mental health outcomes (p-values >0.05). Intrauterine growth restriction did not systematically moderate any associations. Conclusions Despite the high variability in early growth of VLBW infants, the previously described association between slow growth in infancy and poorer cognitive functioning in later life is not reflected in symptoms of depression, ADHD, and other psychiatric problems. This suggests that the development of cognitive and psychiatric problems may have dissimilar critical periods in VLBW infants.	[Sammallahti, Sara; Lahti, Marius; Pyhala, Riikka; Lahti, Jari; Pesonen, Anu-Katriina; Heinonen, Kati; Ralkkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Sammallahti, Sara; Hovi, Petteri; Eriksson, Johan G.; Strang-Karlsson, Sonja; Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki, Finland; [Sammallahti, Sara; Hovi, Petteri; Strang-Karlsson, Sonja; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Sammallahti, Sara; Hovi, Petteri; Strang-Karlsson, Sonja; Jarvenpaa, Anna-Liisa; Andersson, Sture; Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Lahti, Jari; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, Dept Obstet & Gynaecol, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Vaasa Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu	Sammallahti, S (corresponding author), Univ Helsinki, Inst Behav Sci, Helsinki, Finland.	sara.sammallahti@helsinki.fi	Lahti, Jari/P-2283-2019; Lahti, Jari/P-7987-2018; Pyhälä, Riikka/AAG-1947-2021; Lahti-Pulkkinen, Marius/Q-2472-2017	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Sammallahti, Sara/0000-0001-8928-000X; Eriksson, Johan/0000-0002-2516-2060; Lahti-Pulkkinen, Marius/0000-0002-5244-5525; Raikkonen, Katri/0000-0003-3124-3470; Pesonen, Anu-Katriina/0000-0002-0662-6261; Heinonen, Kati/0000-0002-1262-5599	Academy of Finland, University of Helsinki; Finnish Medical Society Duodecim, Finska Lakaresallskapet; Foundation for Pediatric Research in Finland; Finnish Special Governmental Subsidy for Health Sciences; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Emil Aaltonen foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Yrjo Jahnsson Foundation; Orion-Pharma Foundation; Sigrid Juselius Foundation; Finnish National Graduate School of Clinical Investigation; Wilhelm and Else Stockmann Foundation; Research Foundation of the University of Helsinki; Pediatric Graduate School, University of Helsinki; Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish	Academy of Finland, University of Helsinki(Academy of Finland); Finnish Medical Society Duodecim, Finska Lakaresallskapet; Foundation for Pediatric Research in Finland; Finnish Special Governmental Subsidy for Health Sciences; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Emil Aaltonen foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Yrjo Jahnsson Foundation; Orion-Pharma Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish National Graduate School of Clinical Investigation; Wilhelm and Else Stockmann Foundation; Research Foundation of the University of Helsinki; Pediatric Graduate School, University of Helsinki; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was carried out as part of the larger research project, the Helsinki Study of Very Low Birth Weight Adults, which has been funded by the Academy of Finland, University of Helsinki, the Finnish Medical Society Duodecim, Finska Lakaresallskapet, the Foundation for Pediatric Research in Finland, the Finnish Special Governmental Subsidy for Health Sciences, the Jalmari and Rauha Ahokas Foundation, the Juho Vainio Foundation, the Emil Aaltonen foundation, the Novo Nordisk Foundation, the Paivikki and Sakari Sohlberg Foundation, the Signe and Ane Gyllenberg Foundation, the Yrjo Jahnsson Foundation, the Orion-Pharma Foundation, the Sigrid Juselius Foundation, the Finnish National Graduate School of Clinical Investigation, the Wilhelm and Else Stockmann Foundation, Research Foundation of the University of Helsinki, and the Pediatric Graduate School, University of Helsinki. Apart from the aforementioned general funding, the authors received no grants specifically for carrying out the current study, and the authors have no financial relationships relevant to this article to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Abel KM, 2010, ARCH GEN PSYCHIAT, V67, P923, DOI 10.1001/archgenpsychiatry.2010.100; Achenbach TM, 2003, MANUAL ASEBA ADULT F; Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belfort MB, 2013, J PEDIATR-US, V163, P1564, DOI 10.1016/j.jpeds.2013.06.032; Boyle MH, 2011, PSYCHOL MED, V41, P1763, DOI 10.1017/S0033291710002357; Brandt I, 2003, J PEDIATR-US, V142, P463, DOI 10.1067/mpd.2003.149; Class QA, 2014, BRIT J PSYCHIAT, V205, P355, DOI 10.1192/bjp.bp.113.143693; D'Onofrio BM, 2013, JAMA PSYCHIAT, V70, P1231, DOI 10.1001/jamapsychiatry.2013.2107; De Quiros GB, 2001, ANN NY ACAD SCI, V931, P140; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gustafsson WM, 2009, ACTA PSYCHIAT SCAND, V119, P54, DOI 10.1111/j.1600-0447.2008.01267.x; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Hallin AL, 2010, ACTA PAEDIATR, V99, P1401, DOI 10.1111/j.1651-2227.2010.01850.x; Heinonen K, 2013, PEDIATRICS, V131, pE243, DOI 10.1542/peds.2012-0839; Heinonen K, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-91; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2011, PEDIATRICS, V127, pE304, DOI 10.1542/peds.2010-2199; Hovi P, 2010, J PEDIATR-US, V156, P54, DOI 10.1016/j.jpeds.2009.07.022; Howson CP, 2012, BORN TOO SOON THE GL; Huang C, 2013, INT J EPIDEMIOL, V42, P160, DOI 10.1093/ije/dys207; Kajantie E, 2014, SEMIN FETAL NEONAT M, V19, P112, DOI 10.1016/j.siny.2013.11.006; Lafeber HN, 2013, AM J CLIN NUTR, V98, p556S, DOI 10.3945/ajcn.112.045039; Lohaugen GCC, 2010, DEV MED CHILD NEUROL, V52, P1133, DOI 10.1111/j.1469-8749.2010.03743.x; Lund LK, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-146; Lund LK, 2012, EARLY HUM DEV, V88, P623, DOI 10.1016/j.earlhumdev.2012.01.006; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Nosarti C, 2007, J INT NEUROPSYCH SOC, V13, P571, DOI 10.1017/S1355617707070725; Nosarti C, 2012, ARCH GEN PSYCHIAT, V69, P610, DOI 10.1001/archgenpsychiatry.2011.1374; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Pihkala J, 1989, Duodecim, V105, P1540; Pyhala R, 2011, NEUROLOGY, V77, P2052, DOI 10.1212/WNL.0b013e31823b473e; Pyhala R, 2014, PEDIATRICS, V134, P1075, DOI 10.1542/peds.2014-1097; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raikkonen K, 2008, ARCH GEN PSYCHIAT, V65, P290, DOI 10.1001/archgenpsychiatry.2007.40; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Sammallahti S, 2014, J PEDIATR-US, V165, P1109, DOI 10.1016/j.jpeds.2014.08.028; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; SORVA R, 1990, ACTA PAEDIATR SCAND, V79, P490, DOI 10.1111/j.1651-2227.1990.tb11502.x; SORVA R, 1984, ACTA PAEDIATR SCAND, V73, P527, DOI 10.1111/j.1651-2227.1984.tb09965.x; Stathis SL, 1999, DEV MED CHILD NEUROL, V41, P375, DOI 10.1017/S0012162299000833; Stockings E, 2015, J AFFECT DISORDERS, V174, P447, DOI 10.1016/j.jad.2014.11.061; Strang-Karlsson S, 2008, AM J PSYCHIAT, V165, P1345, DOI 10.1176/appi.ajp.2008.08010085; Weisglas-Kuperus N, 2009, ARCH DIS CHILD-FETAL, V94, pF196, DOI 10.1136/adc.2007.135095; Yeung MY, 2006, ACTA PAEDIATR, V95, P909, DOI 10.1080/08035250600724507	46	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0137092	10.1371/journal.pone.0137092	http://dx.doi.org/10.1371/journal.pone.0137092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327229	Green Published, gold, Green Submitted			2022-12-27	WOS:000360437700094
J	Sengupta, D; Kar, S				Sengupta, Dola; Kar, Sandip			Are Quasi-Steady-State Approximated Models Suitable for Quantifying Intrinsic Noise Accurately?	PLOS ONE			English	Article							POSITIVE FEEDBACK; GENE-EXPRESSION; STOCHASTICITY; QUANTIFICATION; BISTABILITY; BACILLUS	Large gene regulatory networks (GRN) are often modeled with quasi-steady-state approximation (QSSA) to reduce the huge computational time required for intrinsic noise quantification using Gillespie stochastic simulation algorithm (SSA). However, the question still remains whether the stochastic QSSA model measures the intrinsic noise as accurately as the SSA performed for a detailed mechanistic model or not? To address this issue, we have constructed mechanistic and QSSA models for few frequently observed GRNs exhibiting switching behavior and performed stochastic simulations with them. Our results strongly suggest that the performance of a stochastic QSSA model in comparison to SSA performed for a mechanistic model critically relies on the absolute values of the mRNA and protein half-lives involved in the corresponding GRN. The extent of accuracy level achieved by the stochastic QSSA model calculations will depend on the level of bursting frequency generated due to the absolute value of the half-life of either mRNA or protein or for both the species. For the GRNs considered, the stochastic QSSA quantifies the intrinsic noise at the protein level with greater accuracy and for larger combinations of half-life values of mRNA and protein, whereas in case of mRNA the satisfactory accuracy level can only be reached for limited combinations of absolute values of half-lives. Further, we have clearly demonstrated that the abundance levels of mRNA and protein hardly matter for such comparison between QSSA and mechanistic models. Based on our findings, we conclude that QSSA model can be a good choice for evaluating intrinsic noise for other GRNs as well, provided we make a rational choice based on experimental half-life values available in literature.	[Sengupta, Dola; Kar, Sandip] Indian Inst Technol, Dept Chem, Mumbai 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kar, S (corresponding author), Indian Inst Technol, Dept Chem, Mumbai 400076, Maharashtra, India.	sandipkar@chem.iitb.ac.in			Industrial research and consultancy centre, IIT Bombay [13IRCCSG008]; Department of science and technology, India [EMR/2014/000500]	Industrial research and consultancy centre, IIT Bombay; Department of science and technology, India(Department of Science & Technology (India))	This work was supported by 13IRCCSG008, http://www.ircc.iitb.ac.in, Industrial research and consultancy centre, IIT Bombay, SK; and EMR/2014/000500, http://www.dst.gov.in, Department of science and technology, India, SK.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cantini L, 2014, J THEOR BIOL, V349, P92, DOI 10.1016/j.jtbi.2014.01.035; Cao Y, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2052596; Cao Y, 2005, J CHEM PHYS, V122, DOI [10.1063/1.1824902, 10.1063/1.1924598]; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gerard C, 2009, P NATL ACAD SCI USA, V106, P21643, DOI 10.1073/pnas.0903827106; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kar S, 2009, P NATL ACAD SCI USA, V106, P6471, DOI 10.1073/pnas.0810034106; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; Meyer R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00451; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Overton KW, 2014, P NATL ACAD SCI USA, V111, pE4386, DOI 10.1073/pnas.1409797111; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Perumal TM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-41; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Sarkar AX, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000914; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thomas P, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-39; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	39	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136668	10.1371/journal.pone.0136668	http://dx.doi.org/10.1371/journal.pone.0136668			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26327626	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700054
J	Shi, PT; Huang, XH; Wang, J; Zhang, J; Deng, S; Wu, YH				Shi, Peiteng; Huang, Xiaohan; Wang, Jun; Zhang, Jiang; Deng, Su; Wu, Yahui			A Geometric Representation of Collective Attention Flows	PLOS ONE			English	Article							WORLD-WIDE-WEB; INTERNET; COMPLEX	With the fast development of Internet and WWW, "information overload" has become an overwhelming problem, and collective attention of users will play a more important role nowadays. As a result, knowing how collective attention distributes and flows among different websites is the first step to understand the underlying dynamics of attention on WWW. In this paper, we propose a method to embed a large number of web sites into a high dimensional Euclidean space according to the novel concept of flow distance, which both considers connection topology between sites and collective click behaviors of users. With this geometric representation, we visualize the attention flow in the data set of Indiana university clickstream over one day. It turns out that all the websites can be embedded into a 20 dimensional ball, in which, close sites are always visited by users sequentially. The distributions of websites, attention flows, and dissipations can be divided into three spherical crowns (core, interim, and periphery). 20% popular sites (Google. com, Myspace. com, Facebook. com, etc.) attracting 75% attention flows with only 55% dissipations (log off users) locate in the central layer with the radius 4.1. While 60% sites attracting only about 22% traffics with almost 38% dissipations locate in the middle area with radius between 4.1 and 6.3. Other 20% sites are far from the central area. All the cumulative distributions of variables can be well fitted by "S"-shaped curves. And the patterns are stable across different periods. Thus, the overall distribution and the dynamics of collective attention on websites can be well exhibited by this geometric representation.	[Shi, Peiteng; Huang, Xiaohan; Wang, Jun; Deng, Su; Wu, Yahui] Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China; [Shi, Peiteng; Zhang, Jiang] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	National University of Defense Technology - China; Beijing Normal University	Zhang, J (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	zhangjiang@bnu.edu.cn			Beijing Higher Education Young Elite Teacher Project [YETP0291]; Natural Science Foundation of China [61401482]	Beijing Higher Education Young Elite Teacher Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Higher Education Young Elite Teacher Project under Grant No. YETP0291, http://www.bjedu.gov.cn. Yahui Wu received funding from Natural Science Foundation of China under Grant No. 61401482, http://isisn.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Banerjee A., 2001, P WEB MIN WORKSH 1 S, V143, P144; Blochl F, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046127; Brainerd J., 2001, Proceedings IEEE Symposium on Information Visualization 2001. INFOVIS 2001, P153; Bucklin RE, 2002, MARKET LETT, V13, P245, DOI 10.1023/A:1020231107662; Cherkassky BV, 1996, MATH PROGRAM, V73, P129, DOI 10.1007/BF02592101; DOMO, 2013, DAT NEV SLEEPS; Dreger H, 2006, USENIX Association Proceedings of the 15th USENIX Security Symposium, P257; Eysenbach G, 2002, JAMA-J AM MED ASSOC, V287, P2691, DOI 10.1001/jama.287.20.2691; Gleeson JP, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.048701; Golder SA, 2006, J INF SCI, V32, P198, DOI 10.1177/0165551506062337; Guo L, 2015, ARXIV150106058; Hofgesang PI, 2005, ECML PKDD DISCOVERY; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Huberman B.A., 2009, SOCIAL ATTENTION AGE, P62; Huberman BA, 1998, SCIENCE, V280, P95, DOI 10.1126/science.280.5360.95; Huberman BA, 2008, COMPUTER, V41, P103, DOI 10.1109/MC.2008.450; Islam T, 2002, INT J FORECASTING, V18, P605, DOI 10.1016/S0169-2070(02)00073-0; Kammenhuber N., 2006, P 6 ACM SIGCOMM C IN, P245, DOI [DOI 10.1145/1177080.1177110, 10.1145/1177080.1177110]; Liu Y., 2008, P 31 ANN INT ACM SIG, P451, DOI DOI 10.1145/1390334.1390412]; Lovasz L, 1993, BOLYAI MATH STUD, V1, P9; Meiss M. R., 2008, P INT C WEB SEARCH W, P65, DOI DOI 10.1145/1341531.1341543; Meiss MR, 2010, LECT NOTES COMPUT SC, V6516, P50, DOI 10.1007/978-3-642-18009-5_6; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Page Lawrence, 1999, 199966 STANF INFOLAB; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Richards TJ, 2015, AGR APPL EC ASS 2015; Shavitt Y, 2004, IEEE ACM T NETWORK, V12, P993, DOI 10.1109/TNET.2004.838597; Shi LW, 2013, EUR PHYS J B, V86, DOI [10.1140/epjb/e2012-30584-1, 10.1140/epjb/e2013-40132-2]; Shi PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098247; Simon H. A., 1971, COMPUTERS COMMUNICAT, V37, P40; Tetali P., 1991, J THEOR PROBAB, V4, P101, DOI [DOI 10.1007/BF01046996, 10.1007/BF01046996]; The World Bank, 2014, INT US; Tutte W. T., 1963, P LOND MATH SOC, Vs3-s13, P743, DOI DOI 10.1112/PLMS/S3-13.1.743; Wallace J.M., 2006, INTRO OVERVIEW ATMOS, P1, DOI [10.1016/B978-0-12-732951-2.50006-5, DOI 10.1016/B978-0-12-732951-2.50006-5]; Weng L, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00335; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Wu LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102646; Zhao J, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P259, DOI 10.1145/2702123.2702419	39	5	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2015	10	9							e0136243	10.1371/journal.pone.0136243	http://dx.doi.org/10.1371/journal.pone.0136243			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ2NK	26325390	Green Submitted, Green Published, gold			2022-12-27	WOS:000360437700036
J	Lee, SY; Ryan, ME; Hamlet, AF; Palen, WJ; Lawler, JJ; Halabisky, M				Lee, Se-Yeun; Ryan, Maureen E.; Hamlet, Alan F.; Palen, Wendy J.; Lawler, Joshua J.; Halabisky, Meghan			Projecting the Hydrologic Impacts of Climate Change on Montane Wetlands	PLOS ONE			English	Article							NORTHERN PRAIRIE WETLANDS; WATER; MODEL; TRENDS; SIZE; RESTORATION; ECOSYSTEMS; AMPHIBIANS; STREAMFLOW; RESOURCES	Wetlands are globally important ecosystems that provide critical services for natural communities and human society. Montane wetland ecosystems are expected to be among the most sensitive to changing climate, as their persistence depends on factors directly influenced by climate (e.g. precipitation, snowpack, evaporation). Despite their importance and climate sensitivity, wetlands tend to be understudied due to a lack of tools and data relative to what is available for other ecosystem types. Here, we develop and demonstrate a new method for projecting climate-induced hydrologic changes in montane wetlands. Using observed wetland water levels and soil moisture simulated by the physically based Variable Infiltration Capacity (VIC) hydrologic model, we developed site-specific regression models relating soil moisture to observed wetland water levels to simulate the hydrologic behavior of four types of montane wetlands (ephemeral, intermediate, perennial, permanent wetlands) in the U.S. Pacific Northwest. The hybrid models captured observed wetland dynamics in many cases, though were less robust in others. We then used these models to a) hindcast historical wetland behavior in response to observed climate variability (1916-2010 or later) and classify wetland types, and b) project the impacts of climate change on montane wetlands using global climate model scenarios for the 2040s and 2080s (A1B emissions scenario). These future projections show that climate-induced changes to key driving variables (reduced snowpack, higher evapotranspiration, extended summer drought) will result in earlier and faster drawdown in Pacific Northwest montane wetlands, leading to systematic reductions in water levels, shortened wetland hydroperiods, and increased probability of drying. Intermediate hydroperiod wetlands are projected to experience the greatest changes. For the 2080s scenario, widespread conversion of intermediate wetlands to fastdrying ephemeral wetlands will likely reduce wetland habitat availability for many species.	[Lee, Se-Yeun; Hamlet, Alan F.] Univ Washington, Climate Impacts Grp, Seattle, WA 98195 USA; [Ryan, Maureen E.; Lawler, Joshua J.; Halabisky, Meghan] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Ryan, Maureen E.; Palen, Wendy J.] Simon Fraser Univ, Dept Biol, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Hamlet, Alan F.] Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Simon Fraser University; University of Notre Dame	Ryan, ME (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	mo@csp-inc.org			David H. Smith Conservation Research Fellowship Program; North Pacific Landscape Conservation Cooperative [F11AC00080]; Northwest Climate Science Center [GS276A-A]; Canada Research Chairs Program; Grants-in-Aid for Scientific Research [14F04070] Funding Source: KAKEN	David H. Smith Conservation Research Fellowship Program; North Pacific Landscape Conservation Cooperative; Northwest Climate Science Center; Canada Research Chairs Program(Canada Research Chairs); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The David H. Smith Conservation Research Fellowship Program funded MER's salary and field research (no grant number; smithfellows.org). The North Pacific Landscape Conservation Cooperative funded SL's salary, a workshop to share results, and equipment (USFWS grant #F11AC00080; http://www.northpacificlcc.org/). The Northwest Climate Science Center provided salary support for SL, MER, AFH, JJL, and MH and funding for field research (USGS grant #GS276A-A; http://www.doi.gov/csc/Northwest/index.cfm). The Canada Research Chairs Program provided salary for WJP (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; Burkett V, 2000, J AM WATER RESOUR AS, V36, P313, DOI 10.1111/j.1752-1688.2000.tb04270.x; CARPENTER SR, 1992, ANNU REV ECOL SYST, V23, P119, DOI 10.1146/annurev.es.23.110192.001003; Cherkauer KA, 2003, GLOBAL PLANET CHANGE, V38, P151, DOI 10.1016/S0921-8181(03)00025-0; Dahl T., 1990, WETLANDS LOSSES US 1; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; Davidson C, 2004, ECOL APPL, V14, P1892, DOI 10.1890/03-5224; Elsner MM, 2010, CLIMATIC CHANGE, V102, P225, DOI 10.1007/s10584-010-9855-0; Epanchin PN, 2010, ECOLOGY, V91, P2406, DOI 10.1890/09-1974.1; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Garwood J, COMMUNICATION; Garwood JM, 2007, ECOLOGY CASCADES FRO; GIRDNER SF, 1995, J PLANKTON RES, V17, P1731, DOI 10.1093/plankt/17.9.1731; Halabisky M, 2013, WETL SCI PRAC, V30, P12; Halabisky M, USING LIDAR OBJECT B; Hamlet AF, 2005, J CLIMATE, V18, P4545, DOI 10.1175/JCLI3538.1; Hamlet AF, 2003, ATMOS OCEAN, V51, P392; Hamlet AF, 2007, J CLIMATE, V20, P1468, DOI 10.1175/JCLI4051.1; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Hruby T, 2006, STATE DEP ECOLOGY PU; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Johnson AC, 2009, SCI TOTAL ENVIRON, V407, P4787, DOI 10.1016/j.scitotenv.2009.05.018; Johnson WC, 2010, BIOSCIENCE, V60, P128, DOI 10.1525/bio.2010.60.2.7; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; Knapp RA, 2007, BIOL CONSERV, V135, P11, DOI 10.1016/j.biocon.2006.09.013; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; Littell J. S., 2011, 09JV11015600039 USDA, P1; Metz B, 2007, P 8 SESS WORK GROUP; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING WE, P68; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Mote PW, 2003, CLIMATIC CHANGE, V61, P45, DOI 10.1023/A:1026302914358; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; O'Regan SM, 2014, ECOLOGY, V95, P845, DOI 10.1890/13-0916.1; Payne JT, 2004, CLIMATIC CHANGE, V62, P233, DOI 10.1023/B:CLIM.0000013694.18154.d6; Pearl C, COMMUNICATION; Piovia-Scott J, 2011, BIOL CONSERV, V144, P2913, DOI 10.1016/j.biocon.2011.08.008; Poiani KA, 1996, LIMNOL OCEANOGR, V41, P871, DOI 10.4319/lo.1996.41.5.0871; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; R Core Team, 2015, R LANG ENV STAT COMP; Ryan ME, 2014, FRONT ECOL ENVIRON, V12, P232, DOI 10.1890/130145; Safeeq M, 2014, J HYDROMETEOROL, V15, P2501, DOI 10.1175/JHM-D-13-0198.1; Salathe EP, 2013, UNCERTAINTY EXTREME; Salathe EP, 2010, CLIMATIC CHANGE, V102, P51, DOI 10.1007/s10584-010-9849-y; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Snodgrass JW, 2000, CONSERV BIOL, V14, P414, DOI 10.1046/j.1523-1739.2000.99161.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stewart IT, 2004, CLIMATIC CHANGE, V62, P217, DOI 10.1023/B:CLIM.0000013702.22656.e8; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Tarr M, 2008, IMPORTANCE HYDROPERI, VAvailable; Taylor BE, 2006, CONSERV BIOL, V20, P792, DOI 10.1111/j.1523-1739.2005.00321.x; Tohver IM, 2014, J AM WATER RESOUR AS, V50, P1461, DOI 10.1111/jawr.12199; Walls SC, 2013, WETLANDS, V33, P345, DOI 10.1007/s13157-013-0391-3; Washington Department of Natural Resources, 2011, STAT WASH NAT HER PL; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wenger SJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008839; Werner BA, 2013, ECOL EVOL, V3, P3471, DOI 10.1002/ece3.731; Zambrano-Bigiarini M, 2014, PACKAGE HYDROGOF GOO; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	62	133	140	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0136385	10.1371/journal.pone.0136385	http://dx.doi.org/10.1371/journal.pone.0136385			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ4ZT	26331850	Green Published, gold, Green Submitted			2022-12-27	WOS:000360613800054
J	Geng, YQ; Zhang, JJ; Yan, YD; Yu, BW; Geng, L; Sun, T				Geng, Yanquan; Zhang, Junjie; Yan, Yongda; Yu, Bowen; Geng, Lin; Sun, Tao			Experimental and Theoretical Investigation of Crystallographic Orientation Dependence of Nanoscratching of Single Crystalline Copper	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; INDUCED DEFORMATION; SIMULATION; NANOINDENTATION; NANOSTRUCTURE; SCRATCH; FABRICATION; MICROSCOPY; EVOLUTION; ALUMINUM	In the present work, we perform experiments and molecular dynamics simulations to elucidate the underlying deformation mechanisms of single crystalline copper under the load-controlled multi-passes nanoscratching using a triangular pyramidal probe. The correlation of microscopic deformation behavior of the material with macroscopically-observed machining results is revealed. Moreover, the influence of crystallographic orientation on the nanoscratching of single crystalline copper is examined. Our simulation results indicate that the plastic deformation of single crystalline Cu under the nanoscratching is exclusively governed by dislocation mechanisms. However, there is no glissile dislocation structure formed due to the probe oscillation under the load-controlled mode. Both experiments and MD simulations demonstrate that the machined surface morphologies in terms of groove depth and surface pile-up exhibit strong crystallographic orientation dependence, because of different geometries of activated slip planes cutting with free surfaces and strain hardening abilities associated with different crystallographic orientations.	[Geng, Yanquan; Yan, Yongda] Harbin Inst Technol, Inst Robot, State Key Lab Robot & Syst, Harbin 150008, Heilongjiang, Peoples R China; [Geng, Yanquan; Zhang, Junjie; Yan, Yongda; Yu, Bowen; Sun, Tao] Harbin Inst Technol, Ctr Precis Engn, Harbin 150001, Heilongjiang, Peoples R China; [Zhang, Junjie; Geng, Lin] Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Heilongjiang, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology; Harbin Institute of Technology	Zhang, JJ (corresponding author), Harbin Inst Technol, Ctr Precis Engn, Harbin 150001, Heilongjiang, Peoples R China.	zhjj505@gmail.com; yanyongda@hit.edu.cn	Yan, Yongda/M-7315-2017; Geng, Yanquan/AAD-9914-2020; Geng, Yanquan/Q-1119-2015; Feng, Li/GQQ-3764-2022; SUN, TAO/HGA-0197-2022; Lin, Geng/AAS-4901-2020; Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Yan, Yongda/0000-0002-9290-5362; Wang, Xin/0000-0002-4457-7376; Geng, Yanquan/0000-0003-3499-0551; Zhang, Junjie/0000-0002-9636-5551; Geng, Yanquan/0000-0003-0958-0999	National Natural Science Foundation of China [51222504, 51275114, 51405106]; Author of National Excellent Doctoral Dissertation of PR China [201031]; Program for New Century Excellent Talents in University [NCET-11-0812]; China Postdoctoral Science Foundation [2012M511463, 2013T60358]; Heilongjiang Postdoctoral Fund [LBH-Z11143]; National Program for Support of Top-notch Young Professors	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Fund; National Program for Support of Top-notch Young Professors	The authors gratefully acknowledge financial supports of the National Natural Science Foundation of China (51222504, 51275114 and 51405106), the Author of National Excellent Doctoral Dissertation of PR China (201031), the Program for New Century Excellent Talents in University (NCET-11-0812), the China Postdoctoral Science Foundation (2012M511463 and 2013T60358), the Heilongjiang Postdoctoral Fund (LBH-Z11143) and the the National Program for Support of Top-notch Young Professors.	Ciesielski PN, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-47; Dongmo LS, 2000, ULTRAMICROSCOPY, V85, P141, DOI 10.1016/S0304-3991(00)00051-6; Fanzio P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00791; FOILES SM, 1986, PHYS REV B, V33, P7983, DOI 10.1103/PhysRevB.33.7983; Geng YQ, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4825405; Gregory JG, 2010, J MATER RES, V25, P921; HONEYCUTT JD, 1987, J PHYS CHEM-US, V91, P4950, DOI 10.1021/j100303a014; Ju SP, 2007, MOL SIMULAT, V33, P905, DOI 10.1080/08927020701392954; Komanduri R, 2000, WEAR, V240, P113, DOI 10.1016/S0043-1648(00)00358-6; Lin YC, 2014, MOL PHYS, V112, P1115, DOI 10.1080/00268976.2013.833657; Liu H, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/17/175301; Lu C, 2009, WEAR, V267, P1961, DOI 10.1016/j.wear.2009.05.006; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Nazirizadeh Y, 2013, OPT EXPRESS, V21, P18661, DOI 10.1364/OE.21.018661; Pitchuka SB, 2014, J THERM SPRAY TECHN, V23, P502, DOI 10.1007/s11666-013-0021-x; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Podymova NB, 2014, LASER PHYS, V24, DOI 10.1088/1054-660X/24/8/086003; Salehinia I, 2014, INT J PLASTICITY, V52, P133, DOI 10.1016/j.ijplas.2013.04.010; Salehinia I, 2013, MAT SCI ENG A-STRUCT, V588, P340, DOI 10.1016/j.msea.2013.09.059; Singh A, 2011, ACTA MATER, V59, P7311, DOI 10.1016/j.actamat.2011.08.014; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Suchowski H, 2013, SCIENCE, V342, P1223, DOI 10.1126/science.1244303; Tak M, 2014, BIOSENS BIOELECTRON, V59, P200, DOI 10.1016/j.bios.2014.03.036; Tschopp MA, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2715137; Tseng AA, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3609921; Tseng AA, 2010, J VAC SCI TECHNOL B, V28, P202, DOI 10.1116/1.3292944; Tseng AA, 2009, J APPL PHYS, V106, DOI 10.1063/1.3197313; Wang Y, 2004, ACTA MATER, V52, P2229, DOI 10.1016/j.actamat.2004.01.016; Wu B, 2006, NANO LETT, V6, P468, DOI 10.1021/nl052427f; Wu SL, 2013, ACS APPL MATER INTER, V5, P4769, DOI 10.1021/am400092w; Yan YD, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-212; Zhang JJ, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/19/195301; Zhang JJ, 2013, MODEL SIMUL MATER SC, V21, DOI 10.1088/0965-0393/21/6/065001; Zhang JJ, 2012, COMP MATER SCI, V59, P14, DOI 10.1016/j.commatsci.2012.02.024; Zhang JJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054109; Zhang JJ, 2009, APPL PHYS A-MATER, V94, P593, DOI 10.1007/s00339-008-4903-6; Zhang P, 2013, APPL SURF SCI, V280, P751, DOI 10.1016/j.apsusc.2013.05.056; Zheng YG, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2839581	38	62	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131886	10.1371/journal.pone.0131886	http://dx.doi.org/10.1371/journal.pone.0131886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147506	Green Published, Green Submitted, gold			2022-12-27	WOS:000358157600156
J	Geng, YF; Guo, DH; Li, CQ; Wang, EY; Wei, S; Wang, ZH; Yao, S; Zhao, XW; Su, MJ; Wang, XY; Wang, JF; Wu, R; Feng, L; Sun, DB				Geng, Yufei; Guo, Donghua; Li, Chunqiu; Wang, Enyu; Wei, Shan; Wang, Zhihui; Yao, Shuang; Zhao, Xiwen; Su, Mingjun; Wang, Xinyu; Wang, Jianfa; Wu, Rui; Feng, Li; Sun, Dongbo			Co-Circulation of the Rare CPV-2c with Unique Gln370Arg Substitution, New CPV-2b with Unique Thr440Ala Substitution, and New CPV-2a with High Prevalence and Variation in Heilongjiang Province, Northeast China	PLOS ONE			English	Article							CANINE PARVOVIRUS STRAINS; GENETIC-ANALYSIS; VP2 GENE; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; DOGS; EMERGENCE; EVOLUTION; RECOMBINATION; REVEALS	To trace evolution of canine parvovirus-2 (CPV-2), a total of 201 stool samples were collected from dogs with diarrhea in Heilongjiang province of northeast China from May 2014 to April 2015. The presence of CPV-2 in the samples was determined by PCR amplification of the VP2 gene (568 bp) of CPV-2. The results revealed that 95 samples (47.26%) were positive for CPV-2, and they showed 98.8%-100% nucleotide identity and 97.6%-100% amino acid identity. Of 95 CPV-2-positive samples, types new2a (Ser297Ala), new2b (Ser297Ala), and 2c accounted for 64.21%, 21.05%, and 14.74%, respectively. The positive rate of CPV-2 and the distribution of the new2a, new2b and 2c types exhibited differences among regions, seasons, and ages. Immunized dogs accounted for 48.42% of 95 CPV-2-positive samples. Coinfections with canine coronavirus, canine kobuvirus, and canine bocavirus were identified. Phylogenetic analysis revealed that the identified new2a, new2b, and CPV-2c strains in our study exhibited a close relationship with most of the CPV-2 strains from China; type new2a strains exhibited high variability, forming three subgroups; type new2b and CPV-2c strains formed one group with reference strains from China. Of 95 CPV-2 strains, Tyr324Ile and Thr440Ala substitutions accounted for 100% and 64.21%, respectively; all type new2b strains exhibited the Thr440Ala substitution, while the unique Gln370Arg substitution was found in all type 2c strains. Recombination analysis using entire VP2 gene indicated possible recombination events between the identified CPV-2 strains and reference strains from China. Our data revealed the co-circulation of new CPV-2a, new CPV-2b, and rare CPV-2c, as well as potential recombination events among Chinese CPV-2 strains.	[Geng, Yufei; Guo, Donghua; Li, Chunqiu; Wang, Enyu; Wei, Shan; Wang, Zhihui; Yao, Shuang; Zhao, Xiwen; Su, Mingjun; Wang, Xinyu; Wang, Jianfa; Wu, Rui; Sun, Dongbo] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing 163319, Peoples R China; [Feng, Li] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin 150001, Peoples R China	Heilongjiang Bayi Agricultural University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Sun, DB (corresponding author), Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, 2 Xinyang Rd, Daqing 163319, Peoples R China.	dongbosun@126.com	Yan, Yongda/M-7315-2017; Geng, Yanquan/AAD-9914-2020; Geng, Yanquan/Q-1119-2015; Feng, Li/GQQ-3764-2022; SUN, TAO/HGA-0197-2022; Lin, Geng/AAS-4901-2020; Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022	Yan, Yongda/0000-0002-9290-5362; Wang, Xin/0000-0002-4457-7376; Geng, Yanquan/0000-0003-3499-0551; Zhang, Junjie/0000-0002-9636-5551; Geng, Yanquan/0000-0003-0958-0999	Program for New Century Excellent Talents in Heilongjiang Provincial University [1252-NCET-016]	Program for New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the Program for New Century Excellent Talents in Heilongjiang Provincial University (grant no. 1252-NCET-016).	Bodewes R, 2014, VET MICROBIOL, V174, P1, DOI 10.1016/j.vetmic.2014.08.025; Buonavoglia C, 2001, J GEN VIROL, V82, P3021, DOI 10.1099/0022-1317-82-12-3021; Cavalli A, 2014, J VET DIAGN INVEST, V26, P563, DOI 10.1177/1040638714538965; Costa EM, 2014, VET MICROBIOL, V168, P8, DOI 10.1016/j.vetmic.2013.10.002; Csagola A, 2014, ARCH VIROL, V159, P2441, DOI 10.1007/s00705-014-2068-5; Decaro N, 2009, VIROLOGY, V385, P5, DOI 10.1016/j.virol.2008.12.016; Decaro N, 2007, EMERG INFECT DIS, V13, P1222, DOI 10.3201/eid1308.070505; Decaro N, 2012, VET MICROBIOL, V155, P1, DOI 10.1016/j.vetmic.2011.09.007; Decaro N, 2011, VET J, V187, P195, DOI 10.1016/j.tvjl.2009.10.027; Di Martino B, 2013, VET MICROBIOL, V166, P246, DOI 10.1016/j.vetmic.2013.05.007; Dogonyaro BB, 2013, VET MICROBIOL, V165, P460, DOI 10.1016/j.vetmic.2013.04.022; Calderon MG, 2009, J VIROL METHODS, V159, P141, DOI 10.1016/j.jviromet.2009.03.013; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071; Grellet A, 2012, VET MICROBIOL, V157, P214, DOI 10.1016/j.vetmic.2011.11.012; Han SC, 2015, ARCH MICROBIOL, V197, P621, DOI 10.1007/s00203-015-1093-4; Hoelzer K, 2008, J GEN VIROL, V89, P2280, DOI 10.1099/vir.0.2008/002055-0; Hong C, 2007, J VET DIAGN INVEST, V19, P535, DOI 10.1177/104063870701900512; Hueffer K, 2003, J VIROL, V77, P1718, DOI 10.1128/JVI.77.3.1718-1726.2003; Ikeda Y, 2000, VIROLOGY, V278, P13, DOI 10.1006/viro.2000.0653; Jeoung SY, 2008, J VET MED SCI, V70, P719, DOI 10.1292/jvms.70.719; Kapil S, 2007, J CLIN MICROBIOL, V45, P4044, DOI 10.1128/JCM.01300-07; KELLY WR, 1978, AUST VET J, V54, P593, DOI 10.1111/j.1751-0813.1978.tb02426.x; Lau SKP, 2012, J GEN VIROL, V93, P1573, DOI 10.1099/vir.0.042531-0; Lin CN, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-39; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Maya L, 2013, ARCH VIROL, V158, P1133, DOI 10.1007/s00705-012-1591-5; Meers J, 2007, AUST VET J, V85, P392, DOI 10.1111/j.1751-0813.2007.00206.x; Mesquita JR, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-107; Mittal M, 2014, INFECT GENET EVOL, V23, P1, DOI 10.1016/j.meegid.2014.01.015; Mukhopadhyay HK, 2014, VIRUS GENES, V48, P89, DOI 10.1007/s11262-013-1000-5; Nandi S, 2010, RES VET SCI, V88, P169, DOI 10.1016/j.rvsc.2009.05.018; Nelson CDS, 2007, VIROLOGY, V361, P283, DOI 10.1016/j.virol.2006.11.032; Ohshima T, 2008, J VET MED SCI, V70, P769, DOI 10.1292/jvms.70.769; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; PARRISH CR, 1985, SCIENCE, V230, P1046, DOI 10.1126/science.4059921; Pedroza-Roldan C, 2015, J VET DIAGN INVEST, V27, P107, DOI 10.1177/1040638714559969; Pereira CAD, 2007, INFECT GENET EVOL, V7, P399, DOI 10.1016/j.meegid.2006.03.007; Perez R, 2007, VET MICROBIOL, V124, P147, DOI 10.1016/j.vetmic.2007.04.028; Perez R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111779; Phromnoi S, 2010, VIRUS GENES, V41, P23, DOI 10.1007/s11262-010-0475-6; Pinto LD, 2012, VIRUS RES, V165, P29, DOI 10.1016/j.virusres.2012.01.001; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Raj JM, 2010, INFECT GENET EVOL, V10, P1237, DOI 10.1016/j.meegid.2010.08.005; SMITH JM, 1992, J MOL EVOL, V34, P126; Soma T, 2013, RES VET SCI, V94, P368, DOI 10.1016/j.rvsc.2012.09.013; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timurkan MO, 2015, VET ITAL, V51, P39, DOI 10.12834/VetIt.263.908.3; Xu J, 2015, TRANSBOUND EMERG DIS, V62, P91, DOI 10.1111/tbed.12078; Yi L, 2016, TRANSBOUND EMERG DIS, V63, pE262, DOI 10.1111/tbed.12268; Zhang RZ, 2010, VIRUS GENES, V40, P397, DOI 10.1007/s11262-010-0466-7; Zhao YB, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-272; Zhong ZJ, 2014, INT J MOL SCI, V15, P12166, DOI 10.3390/ijms150712166	55	62	73	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2015	10	9							e0137288	10.1371/journal.pone.0137288	http://dx.doi.org/10.1371/journal.pone.0137288			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ8YQ	26147506	Green Submitted, Green Published, gold			2022-12-27	WOS:000360897600031
J	Lee, S				Lee, Sean			A Sketch of Language History in the Korean Peninsula	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; HOMOGENEITY; BARRIERS; MODEL	Among 7100 languages spoken on Earth, the Koreanic language is the 13th largest, with about 77 million speakers in and around the Korean Peninsula. In comparison to other languages of similar size, however, surprisingly little is known about the evolution of the Koreanic language. This is mainly due to two reasons. The first reason is that the genealogical relationship of the Koreanic to other neighboring languages remains uncertain, and thus inference from the linguistic comparative method provides only provisional evidence. The second reason is that, as the ancestral Koreanic speakers lacked their own writing system until around 500 years ago, there are scant historical materials to peer into the past, except for those preserved in Sinitic characters that we have no straightforward way of interpreting. Here I attempt to overcome these disadvantages and shed some light on the linguistic history of the Korean Peninsula, by analyzing the internal variation of the Koreanic language with methods adopted from evolutionary biology. The preliminary results presented here suggest that the evolutionary history of the Koreanic language is characterized by a weak hierarchical structure, and intensive gene/culture flows within the Korean Peninsula seem to have promoted linguistic homogeneity among the Koreanic variants. Despite the gene/culture flows, however, there are still three detectable linguistic barriers in the Korean Peninsula that appear to have been shaped by geographical features such as mountains, elevated areas, and ocean. I discuss these findings in an inclusive manner to lay the groundwork for future studies.	Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo, Japan	University of Tokyo	Lee, S (corresponding author), Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo, Japan.	seanlee@darwin.c.u-tokyo.ac.jp			 [2604070]; Grants-in-Aid for Scientific Research [14F04070] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows (2604070). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikhenvald AY, 2006, AREAL DIFFUSION AND; Alekseyenko AV, 2008, SYST BIOL, V57, P772, DOI 10.1080/10635150802434394; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2014, ETHNOLOGUE LANGUAGES; [Anonymous], 2006, LANGUAGE KOREAN CULT; [Anonymous], [No title captured], DOI DOI 10.1075/DIA.23.1.04HAM; Axelsen JB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3029; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Blust R., 2013, THE AUSTRONESIAN LAN; Bouckaert R., 2014, DENSITREE 2 SEEING T, DOI [10.1101/012401, DOI 10.1101/012401]; Bowern C, 2012, P ROY SOC B-BIOL SCI, V279, P4590, DOI 10.1098/rspb.2012.1842; Brassel K.E., 1979, GEOGR ANAL, V325, P31, DOI [10.1111/j.1538-4632.1979.tb00695.x, DOI 10.1111/J.1538-4632.1979.TB00695.X]; Crowley T, 2010, AN INTRODUCTION TO H; Dixon RMW, 1997, THE RISE AND FALL OF; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dunn Michael., 2015, ROUTLEDGE HDB HIST L, P190; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gray RD, 2013, STRUNGMANN FORUM REP, P285; Greenhill S. J., 2015, ROUTLEDGE HDB HIST L, P557; Greenhill SJ, 2009, P ROY SOC B-BIOL SCI, V276, P2299, DOI 10.1098/rspb.2008.1944; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; Holden Clare, 2006, PHYLOGENETIC METHODS, P19; Hong SB, 2014, GENES GENOM, V36, P583, DOI 10.1007/s13258-014-0194-9; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hymes D, 1974, PIDGINIZATION AND CR; Jin HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004210; Kim SH, 2010, INT J LEGAL MED, V124, P653, DOI 10.1007/s00414-010-0501-1; Kim YJ, 2013, GENES GENOM, V35, P355, DOI 10.1007/s13258-013-0082-8; Lee KM, 2011, HISTORY OF THE KOREAN LANGUAGE, P1, DOI 10.1017/CBO9780511974045; Lee S, 2014, J EVOLUTION BIOL, V27, P1905, DOI 10.1111/jeb.12442; Lee SH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041009; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062243; Lee S, 2011, P ROY SOC B-BIOL SCI, V278, P3662, DOI 10.1098/rspb.2011.0518; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MARTIN SE, 1966, LANGUAGE, V42, P185, DOI 10.2307/411687; Mayr E., 1998, THIS IS BIOLOGY; Monmonier MS, 1973, GEOGRAPHICAL ANALYSI; Nam K., 2014, KYOHAKKOE SACEN A MI; Nanmal ohwi chongbo chori yonguso, 2010, URIMAL PANGEN SACEN; Ogura S, 1944, CHOSENGO HOGEN NO KE; Ogura S, 1940, THE OUTLINE OF THE K; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2013, R A LANGUAGE AND ENV; Reesink G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000241; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; Simpson A., 2007, LANGUAGE AND NATIONA; Sohn H-M, 2001, THE KOREAN LANGUAGE; Starostin S, 2003, LANGUAGES OF THE WOR; Starostin SA, 2003, ETYMOLOGICAL DICTION; Trudgill Peter, 2004, LINGUIST TYPOL, V8, P305, DOI DOI 10.1515/LITY.2004.8.3.305; Voronoi G, 1908, J REINE ANGEW MATH, V134, P198, DOI 10.1515/crll.1908.134.198; Vovin A, 2010, KOREA JAPONICA; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	59	133	140	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2015	10	5							e0128448	10.1371/journal.pone.0128448	http://dx.doi.org/10.1371/journal.pone.0128448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CJ2MQ	26331850	Green Published, Green Submitted, gold			2022-12-27	WOS:000355319400091
